<SEC-DOCUMENT>0001131399-25-000007.txt : 20250303
<SEC-HEADER>0001131399-25-000007.hdr.sgml : 20250303
<ACCEPTANCE-DATETIME>20250303110339
ACCESSION NUMBER:		0001131399-25-000007
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		403
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250303
DATE AS OF CHANGE:		20250303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GSK plc
		CENTRAL INDEX KEY:			0001131399
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15170
		FILM NUMBER:		25695104

	BUSINESS ADDRESS:	
		STREET 1:		79 NEW OXFORD STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			WC1A 1DG
		BUSINESS PHONE:		011442080475000

	MAIL ADDRESS:	
		STREET 1:		79 NEW OXFORD STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			WC1A 1DG

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GSK PLC
		DATE OF NAME CHANGE:	20220516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLAXOSMITHKLINE PLC
		DATE OF NAME CHANGE:	20010105
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>gsk-20241231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3a546e24-b21d-4f2c-8496-4bed728e8d38,g:19b91481-759e-443e-bc09-8752e6669383,d:dc89fa1ee07645df9629d157a4b46752-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:gsk="http://www.gsk.com/20241231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/><title>gsk-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-54">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-55">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-56">0001131399</ix:nonNumeric><ix:nonFraction unitRef="pensionscheme" contextRef="c-1049" decimals="0" name="gsk:NumberOfPrincipalUKDefinedBenefitPensionSchemes" scale="0" id="f-3560">1</ix:nonFraction><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1188" decimals="4" name="ifrs-full:ParValuePerShare" scale="0" id="f-3902">0.3125</ix:nonFraction><ix:nonNumeric contextRef="c-1828" name="gsk:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:duryear" id="f-5889">2.5</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gsk-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:unit id="gbpPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="therapeuticarea"><xbrli:measure>gsk:therapeuticArea</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="pensionscheme"><xbrli:measure>gsk:pensionScheme</xbrli:measure></xbrli:unit><xbrli:unit id="country"><xbrli:measure>gsk:country</xbrli:measure></xbrli:unit><xbrli:unit id="segments"><xbrli:measure>gsk:Segments</xbrli:measure></xbrli:unit><xbrli:unit id="productgroup"><xbrli:measure>gsk:productGroup</xbrli:measure></xbrli:unit><xbrli:unit id="wholesalers"><xbrli:measure>gsk:wholesalers</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="numberofemployees"><xbrli:measure>gsk:numberOfEmployees</xbrli:measure></xbrli:unit><xbrli:unit id="company"><xbrli:measure>gsk:company</xbrli:measure></xbrli:unit><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="partnership"><xbrli:measure>gsk:partnership</xbrli:measure></xbrli:unit><xbrli:unit id="restructuringprogramme"><xbrli:measure>gsk:restructuringProgramme</xbrli:measure></xbrli:unit><xbrli:unit id="payment"><xbrli:measure>gsk:payment</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="sar"><xbrli:measure>iso4217:SAR</xbrli:measure></xbrli:unit><xbrli:unit id="performancemeasure"><xbrli:measure>gsk:performanceMeasure</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>gsk:member</xbrli:measure></xbrli:unit><xbrli:unit id="patent"><xbrli:measure>gsk:patent</xbrli:measure></xbrli:unit><xbrli:unit id="hearing"><xbrli:measure>gsk:hearing</xbrli:measure></xbrli:unit><xbrli:unit id="classaction"><xbrli:measure>gsk:classAction</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>gsk:plaintiff</xbrli:measure></xbrli:unit><xbrli:unit id="case"><xbrli:measure>gsk:case</xbrli:measure></xbrli:unit><xbrli:unit id="employee"><xbrli:measure>gsk:employee</xbrli:measure></xbrli:unit><xbrli:unit id="krw"><xbrli:measure>iso4217:KRW</xbrli:measure></xbrli:unit><xbrli:unit id="agreement"><xbrli:measure>gsk:agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfEachClassAxis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfEachClassAxis">gsk:ThreePointSixTwoFiveNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfEachClassAxis">gsk:ThreePointEightSevenFiveNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfEachClassAxis">gsk:ThreePointThreeSevenFiveNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfEachClassAxis">gsk:SixPointThreeSevenFiveNotesDue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfEachClassAxis">gsk:FourPointTwoZeroZeroNotesDue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:FreeholdBuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:FreeholdBuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:LeaseholdLandAndBuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:LeaseholdLandAndBuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PlantAndMachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PlantAndMachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:EquipmentAndVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:EquipmentAndVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">gsk:RemainingBookValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">gsk:RemainingBookValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:ERPSoftwareSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:ERPSoftwareSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:OtherComputerSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:OtherComputerSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">gsk:USPharmaceuticalsAndVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">gsk:USPharmaceuticalsAndVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">gsk:USPharmaceuticalsAndVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">gsk:USPharmaceuticalsAndVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ActuarialAssumptionPercentageRateAxis">gsk:ActuarialAssumptionPercentageRateChangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ActuarialAssumptionPercentageRateAxis">gsk:ActuarialAssumptionPercentageRateChangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ifrs-full:BusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ifrs-full:BusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:ShionogiViiVHealthcareJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:ShionogiViiVHealthcareJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">gsk:SensitivityAnalysisForActuarialAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ActuarialAssumptionPercentageRateAxis">gsk:ActuarialAssumptionPercentageRateChangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">gsk:SensitivityAnalysisForActuarialAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ActuarialAssumptionPercentageRateAxis">gsk:ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ShinglesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ShinglesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ShinglesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:MeningitisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:MeningitisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:MeningitisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:RSVArexvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:RSVArexvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:RSVArexvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:InfluenzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:InfluenzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:InfluenzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:EstablishedVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:EstablishedVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:EstablishedVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:PandemicVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:PandemicVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:PandemicVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:VaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:VaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:VaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:HIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:HIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:HIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ImmunoInflammationRespiratoryAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ImmunoInflammationRespiratoryAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ImmunoInflammationRespiratoryAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:HIVOncologyImmunoInflammationRespiratoryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:HIVOncologyImmunoInflammationRespiratoryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:HIVOncologyImmunoInflammationRespiratoryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:SpecialtyMedicineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:SpecialtyMedicineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:SpecialtyMedicineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:RespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:RespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:RespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:OtherGeneralMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:OtherGeneralMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:OtherGeneralMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:GeneralMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:GeneralMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:GeneralMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gsk:Wholesalers3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:SegmentConsolidationItemAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">gsk:PfizerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">gsk:PfizerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GileadSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:LiquidationOrDisposalOfOverseasSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:LiquidationOrDisposalOfOverseasSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:LiquidationOrDisposalOfOverseasSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">gsk:LiquidationOrDisposalOfInterestInAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">gsk:LiquidationOrDisposalOfInterestInAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:PurposeAxis">gsk:ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:PurposeAxis">gsk:ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:PurposeAxis">gsk:ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:CashSettledAndOtherPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:CashSettledAndOtherPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:CashSettledAndOtherPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:SellingGeneralAndAdministrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:SellingGeneralAndAdministrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:SellingGeneralAndAdministrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:SeparationRestructuringProgrammeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:SeparationRestructuringProgrammeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:SeparationRestructuringProgrammeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:SignificantAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:LegacyProgrammesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:SignificantAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ArrangementTypeAxis">gsk:LegacyProgrammesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:RestructuringCostsAxis">gsk:CostOfMajorRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:RestructuringCostsAxis">gsk:CostOfMajorRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:RestructuringCostsAxis">gsk:CostOfMajorRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">gsk:OtherAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">gsk:OtherAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">gsk:OtherAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:OverseasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:OverseasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TaxReformsPeriodOfApplicationAxis">gsk:OriginationAndReversalOfTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">gsk:AcceleratedCapitalAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">gsk:IntraGroupProfitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionAndAwardSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:WithinTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:WithinTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:AvailableIndefinitelyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:AvailableIndefinitelyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FirstInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FirstInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FirstInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:SecondInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:SecondInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:SecondInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ThirdInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ThirdInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ThirdInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:FourthInterimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:PropertyPlantAndEquipmentAndVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">gsk:NetBookValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:MajorRestructuringProgrammesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:MajorRestructuringProgrammesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:LowerCarbonPropellantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">gsk:LowerCarbonPropellantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:PlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:CommercialOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">gsk:LicencesAndFranchisesAmortisedBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">ifrs-full:InternallyGeneratedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:TesaroAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:TesaroAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:MeningitisPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:MeningitisPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:AffinivaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:AffinivaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:CamlipixantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:CamlipixantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:MomelotinibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:MomelotinibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:DolutegravirIncludingCabotegravirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:DolutegravirIncludingCabotegravirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:AiolosAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:AiolosAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:CureVacAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:CureVacAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:IteosAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:IteosAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:AlectorAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:AlectorAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:BenlystaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:BenlystaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:ShingrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:ShingrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:HansohPharmaAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:HansohPharmaAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:ChimagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:ChimagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:RSVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:RSVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:BMSAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:BMSAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:SperoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:SperoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:WaveLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:WaveLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:ArrowheadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:ArrowheadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:UCBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:UCBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:DTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:DTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:RelvarBreoAnoroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:RelvarBreoAnoroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:StiefelTradeNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:StiefelTradeNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:FluarixFluLavalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:FluarixFluLavalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:OkairosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:OkairosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:OthersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsMaterialToEntityAxis">gsk:OthersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">gsk:FlagshipPioneeringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:CurrentEquityInvestmentsMeasuredAsFVTPLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:CurrentEquityInvestmentsMeasuredAsFVTPLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:CurrentEquityInvestmentsMeasuredAsFVTPLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:CurrentEquityInvestmentsMeasuredAsFVTPLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:CurrentEquityInvestmentsMeasuredAsFVTPLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:OtherInvestmentsNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:WaveLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:WaveLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CrisprTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:CrisprTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gsk:SROneCapitalFundIBLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gsk:SROneCapitalFundIBLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:InvestmentsMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherNonCurrentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherNonCurrentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherNonCurrentReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherNonCurrentReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherNonCurrentReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:RemainingBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherNonCurrentReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:RemainingBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CreditImpairmentOfFinancialInstrumentsAxis">ifrs-full:FinancialInstrumentsCreditimpairedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CreditImpairmentOfFinancialInstrumentsAxis">ifrs-full:FinancialInstrumentsCreditimpairedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:OtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfEuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:Debt1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:Debt1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-733"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-734"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-737"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-740"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-743"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-752"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-753"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:NewYorkStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-755"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherLongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-758"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherLongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-761"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:NonInterestBearingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:NonInterestBearingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:UsCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-766"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:UsCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:UsCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:EuroCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-769"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">gsk:EuroCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-771"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-773"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-775"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ShortTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ShortTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-777"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-779"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-780"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-782"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-784"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">gsk:LondonStockExchangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:LetterOfCreditHeldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-788"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:LetterOfCreditHeldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-790"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UkDefinedBenefitAndDefinedContributionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UkDefinedBenefitAndDefinedContributionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UkDefinedBenefitAndDefinedContributionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UsDefinedBenefitAndDefinedContributionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UsDefinedBenefitAndDefinedContributionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UsDefinedBenefitAndDefinedContributionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:OtherOverseasPensionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:OtherOverseasPensionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:OtherOverseasPensionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UnfundedPostRetirementHealthcareSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UnfundedPostRetirementHealthcareSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UnfundedPostRetirementHealthcareSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">gsk:DefinedBenefitHybridPensionSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">gsk:DefinedBenefitHybridPensionSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">gsk:DefinedBenefitHybridPensionSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">ifrs-full:PostemploymentMedicalDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">ifrs-full:PostemploymentMedicalDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CharacteristicsOfDefinedBenefitPlansAxis">ifrs-full:PostemploymentMedicalDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">gsk:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:CurrentPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:CurrentPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ProjectedPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">gsk:ProjectedPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TransfereeAxis">gsk:SLPPartneshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-832"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TransfereeAxis">gsk:SLPPartneshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TransfereeAxis">gsk:SLPPartneshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TransfereeAxis">gsk:SLPPartneshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:GlaxoWellcomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-837"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-845"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-846"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-855"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">gsk:ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-859"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-861"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-865"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-871"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-880"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-886"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-887"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-888"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-890"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-891"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-892"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-895"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-897"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-898"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-899"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-900"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-907"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:ListedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UnlistedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">gsk:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:GroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-932"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-933"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-934"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-935"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-936"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-937"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-938"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-939"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-940"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-941"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-942"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-944"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-946"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-947"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-948"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-949"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-950"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-951"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-952"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-954"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-955"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-956"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-957"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-958"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-959"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-960"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-961"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-962"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-963"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-964"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-965"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:UKDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:USCashBalancePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-967"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:USCashBalancePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-970"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-971"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-972"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-974"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-976"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-977"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-978"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-979"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-980"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-981"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-982"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-983"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-985"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-986"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-987"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-988"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-989"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-990"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-991"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-993"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-994"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-995"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-996"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-997"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-999"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1006"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">gsk:TwoThousandThirtyOneAndThereafterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationActiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1017"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationActiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationActiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationRetiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationRetiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationRetiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationDeferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationDeferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationDeferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:PensionDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationActiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationActiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationActiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationRetiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1032"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationRetiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationRetiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1034"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationDeferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1035"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationDeferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1036"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:DefinedBenefitObligationDeferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1037"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1038"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1039"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1040"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1042"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:PostRetirementBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1043"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ChangeInAssumptionsAxis">gsk:ZeroPointTwoFivePercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1044"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ChangeInAssumptionsAxis">gsk:ZeroPointSevenFivePercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1045"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ChangeInAssumptionsAxis">gsk:ZeroPointTwoFivePercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1046"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ChangeInAssumptionsAxis">gsk:ZeroPointSevenFivePercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1047"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ChangeInAssumptionsAxis">gsk:OneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ChangeInAssumptionsAxis">gsk:OnePercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1049"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">gsk:SmithKlineBeechamLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1050"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:LegalAndOtherDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1051"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1052"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:EmployeeRelatedProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:OtherProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:LegalAndOtherDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1055"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1056"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:EmployeeRelatedProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:OtherProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1058"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:LegalAndOtherDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1059"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1060"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:EmployeeRelatedProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1061"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:OtherProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1062"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:LegalAndOtherDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1063"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:MajorRestructuringProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1064"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">gsk:MajorRestructuringProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1065"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfIndividual1Axis">gsk:DisabledEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1066"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:TitleOfIndividual1Axis">gsk:DisabledEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1067"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1068"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1069"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1070"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1071"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1072"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1074"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1075"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1076"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1077"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1078"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1079"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1081"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1082"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1083"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1084"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1085"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1086"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1087"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1088"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1089"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1090"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1091"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1092"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:OtherBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1095"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AiolosBioInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1096"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1097"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1098"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:CommercialisedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:CommercialisedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:PipelineAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:PipelineAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageIncreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskTenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskFifteenPercentageDecreaseInSalesForecastsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfUsDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentAppreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:ShionogiViivHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenCentDepreciationOfEuroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:NovartisVaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:CategoriesOfCommitmentsAxis">gsk:CarbonRemovalProjectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:CategoriesOfCommitmentsAxis">gsk:CarbonRemovalProjectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:CategoriesOfCommitmentsAxis">gsk:LowerCarbonPropellantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:CategoriesOfCommitmentsAxis">gsk:LowerCarbonPropellantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EmployeeShareOwnershipPlanHeldForFutureExerciseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:ExecutiveSupplementalSavingsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FreeIssueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:FairValueReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:EventAxis">gsk:DemergerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:ContinuingAndDiscontinuedOperationAxis">gsk:ConsumerHealthcareBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">gsk:EsopTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:MiscellaneousOtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:MiscellaneousComponentsOfEquityAxis">gsk:NonDistributableMergerAndPreMergerReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:MiscellaneousComponentsOfEquityAxis">gsk:NonDistributableMergerAndPreMergerReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:MiscellaneousComponentsOfEquityAxis">gsk:NonDistributableMergerAndPreMergerReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:MiscellaneousComponentsOfEquityAxis">ifrs-full:CapitalRedemptionReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:MiscellaneousComponentsOfEquityAxis">ifrs-full:CapitalRedemptionReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:MiscellaneousComponentsOfEquityAxis">ifrs-full:CapitalRedemptionReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:IndexVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:IndexVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:MedicxiVenturesILimitedPartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">gsk:MedicxiVenturesILimitedPartnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-01-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AiolosBioInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:ElsieBiotechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ifrs-full:BusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:TotalForAllBusinessDivesturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:BellusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:BellusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">gsk:DeferredTaxationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ifrs-full:BusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:TotalForAllBusinessDivesturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:SierraOncologyIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:SierraOncologyIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-15</xbrli:startDate><xbrli:endDate>2022-08-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:SierraOncologyIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:SierraOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:GlaxoSaudiArabiaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:GskAggregateHoldingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ContinuingAndDiscontinuedOperationAxis">gsk:ConsumerHealthcareBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:GskShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:GskAndGsksConsolidatedEsotTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:ScottishLimitedPartnershipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">gsk:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ContinuingAndDiscontinuedOperationAxis">gsk:ConsumerHealthcareBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:GskHoldingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:GskAggregateHoldingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">gsk:GskHoldingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:InvestmentAxis">gsk:HaleonPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:ContinuingAndDiscontinuedOperationAxis">gsk:ConsumerHealthcareBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ifrs-full:BusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:TotalForAllBusinessDivesturesDemergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:TotalForAllBusinessDivesturesOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:BankOverdrafts1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:BankOverdrafts1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:BankOverdrafts1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCurrentDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCurrentDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCurrentDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:NetDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:NetDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:NetDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:AccruedInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:AccruedInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:AccruedInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:BankOverdrafts1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:BankOverdrafts1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCurrentDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCurrentDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:EuropeanUsMediumTermNotesAndBankFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:NetDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:NetDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:AccruedInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">gsk:AccruedInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UsCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:UsCommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:EuroCommercialPaperProgrammeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">gsk:EuroCommercialPaperProgrammeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">ifrs-full:ExternalCreditGradesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:WholesalerInTheUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">ifrs-full:ExternalCreditGradesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:WholesalerInTheUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:LowerThanBBBBaa3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:LowerThanBBBBaa3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:HalkBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:HN</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:BancoDeAmericaCentralAndBancoDeHondurasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:EC</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:BancoDeLaProduccionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:BancoBradescoItauUniBancoBancoDoBrasilAndCaixaEconomicaFederalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BbbOrBaaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BbbOrBaaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBB-OrBaaThreeRatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBB-OrBaaThreeRatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">gsk:BancaPopolareDiSondrioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBB-OrBaaThreeRatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">gsk:OTPBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBB-OrBaaThreeRatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">gsk:StateBankOfIndiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBB-OrBaaThreeRatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">gsk:BancoDeCreditoDelPeruMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:AAAOrAaaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:AaOrAaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:AorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBPlusOrBaOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:AAAOrAaaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:AaOrAaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:AorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ExternalCreditGradesAxis">gsk:BBPlusOrBaOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:NonUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:InLineWithOtherPharmaceuticalCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">gsk:InLineWithOtherPharmaceuticalCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:DueFromThreeWholesalersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:DueFromThreeWholesalersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:DueFromThreeWholesalersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:DueFromThreeWholesalersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:WholesaleAndRetailCreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:InsuranceContractsAxis">gsk:GroupCreditEnhancementsAndCreditInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:InsuranceContractsAxis">gsk:GroupCreditEnhancementsAndCreditInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:LiquidInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CurrentEquityAndOtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CurrentEquityAndOtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:BondsInDesignatedHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:BondsInDesignatedHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:BankLoansAndOverdraftsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:BankLoansAndOverdraftsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperInADesignatedHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:CommercialPaperInADesignatedHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherCommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherBorrowingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:OtherBorrowingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CurrentEquityAndOtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CurrentEquityAndOtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CurrentEquityAndOtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CurrentEquityAndOtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:OtherFinancialInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:NoncurrentAssetsOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:CashAndCashEquivalentsFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:ContingentConsiderationLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:ShionogiViiVHealthcareJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:ShionogiViiVHealthcareJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:NovartisVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:NovartisVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">gsk:FinancialLiabilitiesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">gsk:FinancialLiabilitiesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:ShionogiViiVHealthcareJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:ShionogiViiVHealthcareJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:NovartisVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">gsk:NovartisVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:AffinivaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:FinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:NonFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:FinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:NonFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:AmortizedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">gsk:AmortizedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:NonFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:FinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">gsk:NonFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">gsk:TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:EmbeddedAndOtherDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:EmbeddedAndOtherDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:EmbeddedAndOtherDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:EmbeddedAndOtherDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">ifrs-full:OptionContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:BondsInDesignatedHedgingRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">gsk:BondsInDesignatedHedgingRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:ForeignExchangeRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:ForeignExchangeRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:ForeignExchangeRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:ForeignExchangeRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:ForeignExchangeRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BuyForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BuyForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BuyForeignCurrencyThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BuyForeignCurrencyThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BuyForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BuyForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:SellForeignCurrencyOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsLessThanThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingThreeToSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:BorrowingsOverSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">gsk:NetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:ReserveOfChangeInValueOfTimeValueOfOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">ifrs-full:InterestRateSwapContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">ifrs-full:InterestRateSwapContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:PreHedgingOfLongTermInterestRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">gsk:MaturedInThePastPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:PreHedgingOfLongTermInterestRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">gsk:MaturedInThePastPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:PreHedgingOfLongTermInterestRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">gsk:MaturedInThePastPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">gsk:PreHedgingOfLongTermInterestRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">gsk:MaturedInThePastPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialAssetsAxis">gsk:DerivativeFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialLiabilitiesAxis">gsk:TradesAndOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialLiabilitiesAxis">gsk:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialAssetsAxis">gsk:TradeAndOtherReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialAssetsAxis">gsk:DerivativeFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialLiabilitiesAxis">gsk:TradesAndOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfFinancialLiabilitiesAxis">gsk:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:FloatingAndFixedRateDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenYenAppreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenYenAppreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1733"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenYenAppreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1734"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenYenAppreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenYenDepreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskTenYenDepreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1737"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenYenDepreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:CurrencyRiskFifteenYenDepreciationOfYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:InterestRateSensitivityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1740"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:InterestRateSensitivityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:InterestRateSensitivityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">gsk:InterestRateSensitivityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentMovementInUSDInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1743"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1752"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1753"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">gsk:InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1755"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1758"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1761"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1766"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1769"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1771"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1773"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1775"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1777"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1779"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1780"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1782"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1784"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:NonDerivativesFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeForwardContractsAndSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1788"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeForwardContractsAndSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeForwardContractsAndSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1790"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeForwardContractsAndSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeForwardContractsAndSwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">gsk:ForeignExchangeForwardContractsAndSwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:SavingsRelatedShareOptionSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:FreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:TsrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:RAndDNewProductPerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PipelineProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:TsrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PipelineProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ProfitMeasureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:SaleMeasureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ESGEnvironmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:AwardType1Axis">gsk:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:PerformanceSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionsAndSavingsRelatedOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionsAndSavingsRelatedOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareOptionsAndSavingsRelatedOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:SavingsRelatedShareOptionSchemesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">gsk:ShareValuePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoOperationsUkLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoWellcomeUkLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1832"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineCapitalPLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineExportLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineFinancePLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GSKFinanceNo2LimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineHoldingsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1837"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIhcLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIntellectualPropertyNo.2LimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIntellectualPropertyNo.3LimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIntellectualPropertyNo.4LimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIntellectualPropertyLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineResearchAndDevelopmentLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineServicesUnlimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1845"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineUnitedKingdomLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1846"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineUsTradingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:SetFirstLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:SmithKlineBeechamLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViivHealthcareFinanceLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViivHealthcareUnitedKingdomNo.3LimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthCareUnitedKingdomLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:EnglandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineAgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoWellcomeProductionS.A.SMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineB.v.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1855"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineBiologicalsSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineGmbHAndCoKGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineManufacturingSpAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklinePharmaGmbhMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1859"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlinePharmaceuticalsSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1861"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineSPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineSingleMemberA.e.b.e.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineTradingServicesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GskCapitalB.v.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1865"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GSKServicesSPZOOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:PL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GSKVaccinesGmbHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GSKVaccinesSRLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:JscGlaxosmithklineTradingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:LaboratoireGlaxoSmithKlineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:LaboratoriosViiVHealthCareSLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1871"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViivHealthcareGmbhMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViivHealthcareSRLItalyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthcareSASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:AffinivaxIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:AiolosBioInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:CorixaCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineCapitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineHoldingsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1880"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:HumanGenomeSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:StiefelLaboratoriesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:TesaroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViiVHealthcareCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSaudiArabiaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GSKLifeSciencesFZEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1886"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineColombiaS.A.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CO</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1887"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoWellcomeManufacturingPteLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1888"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineThailandLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GSKBiopharmaArgentinaS.A.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1890"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineAustraliaPtyLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1891"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineBrasilLimitadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1892"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineFarEastB.v.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1895"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineKKMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineKoreaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1897"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlineLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:HK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1898"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklineMexicoS.a.DeC.v.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:MX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1899"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxoSmithKlinePakistanLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:PK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1900"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GlaxosmithklinePharmaceuticalsLimitedIndiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GskEnterpriseManagementCoLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:GskPharmaVietnamCompanyLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:VN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:IDBiomedicalCorporationOfQuebecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">gsk:ViivHealthcareK.kMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:CoregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:CoregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1907"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:CoregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:VaccineAxis">gsk:SpikevaxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:VaccineAxis">gsk:MRESVIAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gsk:VaccineAxis">gsk:ComirnatyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:MRNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">gsk:ConclusionOfMajorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:RSVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:RSVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:RSVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:RSVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:AvandiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">gsk:ConclusionOfMajorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">gsk:ConclusionOfMajorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacQuiTamMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">gsk:OntarioAndQuebecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZantacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZofranMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZofranMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZofranMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1932"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">gsk:GSKKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1933"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">gsk:GSKKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1934"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">gsk:GSKKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1935"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZejulaRoyaltyDisputeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-10-01</xbrli:startDate><xbrli:endDate>2012-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1936"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gsk:ZejulaRoyaltyDisputeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-05</xbrli:startDate><xbrli:endDate>2023-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1937"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorBusinessCombinationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:IDRxInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-13</xbrli:startDate><xbrli:endDate>2025-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1938"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorBusinessCombinationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">gsk:IDRxInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1939"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1940"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001131399</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="gsk:TrancheAxis">gsk:FirstTrancheMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-24</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-313 f-322 f-327 f-348 f-352 f-359 f-364 f-373 f-379 f-388 f-393 f-405 f-409 f-417 f-422 f-428 f-437 f-446 f-451 f-467 f-471 f-478 f-483 f-489 f-498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-589 f-590 f-591 f-598 f-599 f-600 f-601 f-602 f-603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"/></ix:resources></ix:header></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 552pt;"></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 552pt;"></div></div><div><div style="position: absolute; top: 42.52pt;" id="idc89fa1ee07645df9629d157a4b46752_1"></div><div style="position: var(--position); top: 42.52pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 552.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 552.75pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 62.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 143.08pt; position: var(--position); text-decoration: none; white-space: pre;">As filed with the Securities and Exchange Commission o<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 385.39pt; position: var(--position); text-decoration: none; white-space: pre;">n March 3,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 429.86pt; position: var(--position); text-decoration: none; white-space: pre;"> 2025<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 16.5pt; position: var(--position); top: 82.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16.5pt; font-style: normal; font-weight: bold; left: 232.21pt; position: var(--position); text-decoration: none; white-space: pre;">UNITED STATES<span style="display: inline-block; height: 12.01pt;"></span></span></div><div style="line-height: 16.5pt; position: var(--position); top: 98.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16.5pt; font-style: normal; font-weight: bold; left: 122.71pt; position: var(--position); text-decoration: none; white-space: pre;">SECURITIES AND EXCHANGE COMMISSION<span style="display: inline-block; height: 12.01pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 117.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 235.45pt; position: var(--position); text-decoration: none; white-space: pre;">Washington, D.C. 20549<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 130.71pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 552.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 16.5pt; line-height: 16.5pt; position: var(--position); top: 153.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16.5pt; font-style: normal; font-weight: bold; left: 254.2pt; position: var(--position); text-decoration: none; white-space: pre;">FORM <span style="display: inline-block; height: 12.01pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 16.5pt; font-style: normal; font-weight: bold; left: 307.33pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">20-F</ix:nonNumeric><span style="display: inline-block; height: 12.01pt;"></span></span></div><div style="position: var(--position); top: 169.81pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 552.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 184.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 24.11pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="f-2">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 33.48pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 40.14pt; position: var(--position); text-decoration: none; white-space: pre;">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 197.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 263.52pt; position: var(--position); text-decoration: none; white-space: pre;">ACT OF 1934<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 210.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 290.97pt; position: var(--position); text-decoration: none; white-space: pre;">OR<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 227.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 32.03pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-3">&#9746;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 41.4pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 48.06pt; position: var(--position); text-decoration: none; white-space: pre;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 240.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 285.5pt; position: var(--position); text-decoration: none; white-space: pre;">1934<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 264.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 203.02pt; position: var(--position); text-decoration: none; white-space: pre;">For the fiscal year ended<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 308.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-5"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 311.44pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 369.92pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 372.42pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-6">2024</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><div style="line-height: 9pt; position: var(--position); top: 283.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 290.97pt; position: var(--position); text-decoration: none; white-space: pre;">OR<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 300.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 21.66pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-7">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 31.03pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 37.69pt; position: var(--position); text-decoration: none; white-space: pre;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 313.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 285.5pt; position: var(--position); text-decoration: none; white-space: pre;">1934<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 290.97pt; position: var(--position); text-decoration: none; white-space: pre;">OR<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 343.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 29.58pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="f-8">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 38.949999999999996pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 45.61pt; position: var(--position); text-decoration: none; white-space: pre;">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 356.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 263.52pt; position: var(--position); text-decoration: none; white-space: pre;">ACT OF 1934<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 379.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 201.02pt; position: var(--position); white-space: pre;">Date of event requiring this shell company report<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 396.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><span style="left: 188.98pt; position: var(--position);">&#160; &#160; &#160;  For the transition period from<span style="display: inline-block; height: 6.55pt; width: 65.14pt;"></span></span><span style="left: 397.98pt; position: var(--position);">to<span style="display: inline-block; height: 6.55pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 410.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 227.51pt; position: var(--position); text-decoration: none; white-space: pre;">Commission file number <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 334.93pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-9">1-15170</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 420.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><div style="font-size: 0pt; left: 23.62pt; position: var(--position); top: 0pt; width: 537.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 21.5pt; position: var(--position); top: 439.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 21.5pt; font-style: normal; font-weight: bold; left: 255.92pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-10">GSK plc</ix:nonNumeric><span style="display: inline-block; height: 15.65pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 461.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 185.56pt; position: var(--position); text-decoration: none; white-space: pre;">(Exact name of Registrant as specified in its charter)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 471.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span><div style="font-size: 0pt; left: 23.62pt; position: var(--position); top: 0pt; width: 537.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 491.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 279.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-11">England</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 500.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 221.6pt; position: var(--position); text-decoration: none; white-space: pre;">(Jurisdiction of incorporation or organization)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 514.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 186.82pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-12">79 New Oxford Street</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 277.76pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 282.76pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">London</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 315.7pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 320.7pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">WC1A 1DG</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 368.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 373.15999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-15">England</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 524.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 232.44pt; position: var(--position); text-decoration: none; white-space: pre;">(Address of principal executive offices)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 538.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 266.49pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelName" id="f-16">Victoria Whyte</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 328.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 547.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 255.49pt; position: var(--position); text-decoration: none; white-space: pre;">Company Secretary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 558.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 280.23pt; position: var(--position); text-decoration: none; white-space: pre;">GSK plc<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 570.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 251pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-17">79 New Oxford Street</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 341.94pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 580.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 255.02pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-18">London</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 287.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 292.96000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-19">WC1A 1DG</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 340.42pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 591.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 279.99pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-20">England</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 603.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 261.34pt; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 266.59pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:CityAreaCode" id="f-21">44 20</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 289.09pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 291.59pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-2" name="dei:LocalPhoneNumber" id="f-22">8047 5000</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 613.42pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelEmailAddress" id="f-23"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 234.11pt; position: var(--position); text-decoration: none; white-space: pre;">company<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 273.58000000000004pt; position: var(--position); text-decoration: none; white-space: pre;">.secretary@gsk.com<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><div style="line-height: 7pt; position: var(--position); top: 623.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 141.55pt; position: var(--position); text-decoration: none; white-space: pre;">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 133.63pt; position: var(--position); text-decoration: none; white-space: pre;">Securities registered or to be registered pursuant to Section 12(b) of the Act:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 647.13pt; width: 595.44pt;"><div style="font-size: 0pt; left: 18.72pt; position: var(--position); top: 0pt; width: 558pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 186pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 186pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 186pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 186pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 61.92pt; position: var(--position); text-decoration: underline; white-space: pre;">Title of Each Class<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 0pt; width: 186pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 62.31pt; position: var(--position); text-decoration: underline; white-space: pre;">Trading Symbol(s)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 0pt; width: 186pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 16.07pt; position: var(--position); text-decoration: underline; white-space: pre;">Name of Each Exchange On Which Registered <span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 11.25pt; width: 186pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.04pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-24">American Depositary Shares</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 141.47pt; position: var(--position); white-space: pre;">, each <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.29pt; position: var(--position); white-space: pre;">representing 2 Ordinary Shares, Par value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 66.76pt; position: var(--position); white-space: pre;">31 1&#8260;4 pence<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 11.25pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 83.25pt; position: var(--position); white-space: pre;"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-25">GSK</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 11.25pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.53pt; position: var(--position); white-space: pre;"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-26">New York Stock Exchange</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 46.5pt; width: 186pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><ix:nonNumeric contextRef="c-4" name="dei:Security12bTitle" id="f-27"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 43.52pt; position: var(--position); text-decoration: none; white-space: pre;">3.625%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 74.02000000000001pt; position: var(--position); white-space: pre;"> Notes due 2025<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 46.5pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-4" name="dei:TradingSymbol" id="f-28">GSK/25</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 46.5pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-29">New York Stock Exchange</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 59.25pt; width: 186pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><ix:nonNumeric contextRef="c-5" name="dei:Security12bTitle" id="f-30"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 43.52pt; position: var(--position); text-decoration: none; white-space: pre;">3.875%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 74.02000000000001pt; position: var(--position); white-space: pre;"> Notes due 2028<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 59.25pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-5" name="dei:TradingSymbol" id="f-31">GSK/28</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 59.25pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-32">New York Stock Exchange</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 72pt; width: 186pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><ix:nonNumeric contextRef="c-6" name="dei:Security12bTitle" id="f-33"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 43.52pt; position: var(--position); text-decoration: none; white-space: pre;">3.375%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 74.02000000000001pt; position: var(--position); white-space: pre;"> Notes due 2029<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 72pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-6" name="dei:TradingSymbol" id="f-34">GSK/29</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 72pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-35">New York Stock Exchange</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 186pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><ix:nonNumeric contextRef="c-7" name="dei:Security12bTitle" id="f-36"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 43.52pt; position: var(--position); text-decoration: none; white-space: pre;">6.375%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 74.02000000000001pt; position: var(--position); white-space: pre;"> Notes due 2038<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 84.75pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-7" name="dei:TradingSymbol" id="f-37">GSK/38</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 84.75pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-7" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-38">New York Stock Exchange</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 97.5pt; width: 186pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><ix:nonNumeric contextRef="c-8" name="dei:Security12bTitle" id="f-39"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 43.52pt; position: var(--position); text-decoration: none; white-space: pre;">4.200%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 74.02000000000001pt; position: var(--position); white-space: pre;"> Notes due 2043<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 97.5pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-8" name="dei:TradingSymbol" id="f-40">GSK/43</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 372pt; position: var(--position); top: 97.5pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.53pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-8" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-41">New York Stock Exchange</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 769.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 132.38pt; position: var(--position); text-decoration: none; white-space: pre;"> Securities registered or to be registered pursuant to Section 12(g) of the Act:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 778.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 286.48pt; position: var(--position); text-decoration: none; white-space: pre;">None<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 789.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 274.21pt; position: var(--position); text-decoration: none; white-space: pre;">(Title of class)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 552pt;"></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 552pt;"></div></div><div><div style="line-height: 9pt; position: var(--position); top: 49.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 111.41pt; position: var(--position); text-decoration: none; white-space: pre;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 69.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 286.48pt; position: var(--position); white-space: pre;">None<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 79.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 274.21pt; position: var(--position); white-space: pre;">(Title of class)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 87.14pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 552.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 100.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 111.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">by the annual report.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 134.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 160.97pt; position: var(--position); white-space: pre;">Ordinary Shares of Par value 31 1&#8260;4<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 310.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> pence <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; white-space: pre;"><span style="left: 341.89pt; position: var(--position);">each<span style="display: inline-block; height: 6.55pt; width: 14.59pt;"></span></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 376.97pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-42">4,314,303,734</ix:nonFraction><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 156.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 179.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 266.43pt; position: var(--position); white-space: pre;">&#9746;&#160; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 278.3pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-43">Yes</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 292.98pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; &#9744; No<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 202.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 213.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">15(d) of the Securities Exchange Act of 1934.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 224.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 267.68pt; position: var(--position); white-space: pre;">&#9744; Yes&#160; &#160; &#160; &#9746; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.26pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-44">No</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Note &#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 258.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Exchange Act of 1934 from their obligations under those Sections.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 281.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 292.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">subject to such filing requirements for the past 90 days.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 315.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 263.93pt; position: var(--position); white-space: pre;">&#9746;&#160; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 275.8pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-45">Yes</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 290.48pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; &#160; &#9744; No<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 349.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 360.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">required to submit such files).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 371.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 263.93pt; position: var(--position); white-space: pre;">&#9746;&#160; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 275.8pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-46">Yes</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 290.48pt; position: var(--position); white-space: pre;">&#160; &#160; &#160; &#160; &#9744; No<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 394.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 405.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">growth company. See definition of &#8220;accelerated filer,&#8221; &#8220;large accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Exchange Act:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 439.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 64.77pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-47">Large accelerated filer</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.70999999999998pt; position: var(--position); white-space: pre;">&#160; &#9746;&#160; &#160; &#160; &#160; &#160; &#160;  Accelerated filer&#160; &#9744;&#160; &#160; &#160; &#160;  Non-accelerated filer&#160; &#9744;&#160; &#160; &#160; &#160;  Emerging growth company <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 523.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-48">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 462.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 473.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 484.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">provided pursuant to Section 13 (a) of the Exchange Act. &#9744;<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 496.06pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 552.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 509.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 520.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Accounting Standards Codification after April 5, 2012.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 543.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 554.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 565.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">accounting firm that prepared or issued its audit report. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 241.64pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-49">&#9746;</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 599.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">included in the filing reflect the correction of an error to previously issued financial statements. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 396.53999999999996pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-50">&#9744;</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 622.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 633.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 656.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 676.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 570pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 237.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 186pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 146.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 45.94pt; position: var(--position); text-decoration: none; white-space: pre;">U.S. GAAP &#9744;<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 237.75pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 237.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAccountingStandard" id="f-51">International Financial Reporting Standards</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 175.51999999999998pt; position: var(--position); white-space: pre;"> as issued by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 237.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">the International Accounting Standards Board &#9746;<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 0pt; width: 186pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 76.99pt; position: var(--position); white-space: pre;">Other <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 101.97999999999999pt; position: var(--position); white-space: pre;">&#9744;<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 705.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 716.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">elected to follow.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 727.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 251.95pt; position: var(--position); white-space: pre;">Item 17&#160; &#9744;&#160; &#160; Item 18 &#9744;<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 750.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 772.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 267.68pt; position: var(--position); white-space: pre;">&#9744; Yes&#160; &#160; &#160; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 306.73pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-52">&#9746;</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.76pt; position: var(--position); white-space: pre;"> No<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 784.24pt; width: 595.44pt;"><div style="font-size: 0pt; left: 21.26pt; position: var(--position); top: 0pt; width: 552.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 552.75pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 792.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 21.26pt; position: var(--position); white-space: pre;">Auditor Firm - Deloitte LLP - PCAOB&#160; ID No <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 196.95999999999998pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-53">1147</ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 216.29999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 218.79999999999998pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 18.46pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 516pt;"></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 516pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 39.69pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 2.81pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Form 20-F Cross Reference Guide<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_7"></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 39.69pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 124.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 39.69pt; position: var(--position); top: 0pt; width: 516pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 21.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 235.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 205.5pt;"/></tr><tr style="height: 36.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 257.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 257.25pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">20F Item<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Page and caption references<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.38pt; width: 205.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">in this document*<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Identity of Directors, Senior Management and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Advisers<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Offer Statistics and Expected Timetable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 79.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Key information<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. [Reserved]<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Capitalisation and Indebtedness<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Reasons for offer and use of proceeds<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 141.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Risk Factors<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 141.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_538">265</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i59a0d33488c04eee9773c8d9f9f1ba75_19114">268</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 65.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27f24adb8ed14564b0e7ab7e0cc1fb14_11164">285</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 157.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 157.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Information on the Company<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">A. History and development of the company<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i98187f0b279e42da8fe584992267d7a6_0-0-1-1-824386">92</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2730b6f80ae547b889d43bfcfac98b6f_1475">93</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 24.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2730b6f80ae547b889d43bfcfac98b6f_1543">97</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 39.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 44.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i85a7883afb7a42668794ca0331023acb_11211">237</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i85a7883afb7a42668794ca0331023acb_11209">241</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.78999999999999pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105515">292</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 102.78999999999999pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 110.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105516">293</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 125.78pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 130.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ibb3e9e0c590e476fb58151bf8c774ad2_5654">313</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 145.78pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 150.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0bea432c992c4a71bf59b49d4f20544d_396">314</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 186pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Business overview<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 186pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i640a77962aab40899d3fbd1aee5e036c_88">1</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 4.8pt; position: var(--position); white-space: pre;">- <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.290000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i41592996075d4ee09394e2c60639d1fa_30-0-1-1-824402">29</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 20.29pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 25.29pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9af18e01f3c64597bec53f654ec7d075_98">32</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.29pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.279999999999994pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i49d099ae3fff431e990215666cabee4c_5036">40</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.279999999999994pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 58.279999999999994pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i866f533545ce41cbadadd18d71a608b2_26">44</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.28pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 76.27pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i790f5ce0ebd74867a80debd26af98cda_8729">58</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 86.27pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.27pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaa5d1c6e3428427db1aa51670414d36a_25480">62</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 101.27pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 109.25999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ibd2eb8e296404096b4e58bb54852fca9_76">74</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 119.25999999999999pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 124.25999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaa69ed5b47b64a3499303dc2ad625cc1_0-0-1-1-821446">196</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 139.26000000000002pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 147.25pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib84191dc3eac484f96385acf57e586f3_3562">198</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 162.25pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 167.25pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i85a7883afb7a42668794ca0331023acb_11211">237</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 182.25pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i85a7883afb7a42668794ca0331023acb_11209">241</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1bc4fd6132a8429dba354d6173c8333f_0-0-1-1-824424">271</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i629949df649b4df6a43ce60f256ec9c6_555">276</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 213pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Organisational structure<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 213pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie185e4dd03f2448cadabbbc77961fd02_0-0-1-1-823249">264</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">,&#160; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.3pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_697">303</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.3pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 45.29pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0a0bc1ef88344c3fbe4978aa0129185c_1516">310</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Property, plant and equipment<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2730b6f80ae547b889d43bfcfac98b6f_1475">93</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1ec62ed4bc6141e2bd2b2de939752937_0-0-1-1-823259">198</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_427">208</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 49.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i35244e3a4cf64fb88c11f8ecc6503e45_2738">209</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 244.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.63pt; position: var(--position); text-decoration: none; white-space: pre;">4A<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 244.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Unresolved staff comments<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 244.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 260.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Operating and Financial Review and Prospects<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 273pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Operating results<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 273pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_49">8</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 4.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 12.790000000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i02c3dfbea84f4e1caa1e2347e5a39b62_7221">9</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9d435d5ae79f4880b20d86356910836b_36">75</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 32.79pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.779999999999994pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7686">102</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 55.779999999999994pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 60.779999999999994pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35514">246</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.78pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 80.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35515">253</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 95.78pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 103.77pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35516">256</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 118.77pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 123.77pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35517">259</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 138.77pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 146.76000000000002pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35518">260</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 288.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Liquidity and capital resources<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 288.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i98187f0b279e42da8fe584992267d7a6_0-0-1-1-824386">92</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2730b6f80ae547b889d43bfcfac98b6f_1543">97</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 32.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0c08e7537c07466cba8dc796e114c1cd_0-0-1-1-824444">99</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 47.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i600fea19361e4c1aa058eb25e204a38c_0-0-1-1-821446">216</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.78999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iea3fa1831d90487a8261b922b6b9e452_0-0-1-1-821446">218</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.78999999999999pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iefb21abf5bab402db7fb405a4b02d67b_3291">219</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 105.78pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 110.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if7f05fba416046898f9dd6e7a55a209c_0-0-1-1-821446">232</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 125.78pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 130.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0c523670d8e84ad8a96288f79dd9015d_0-0-1-1-821446">245</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 145.78pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.77pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3b9ac3fc24f54baf9a5671cfa2b8d000_0-0-1-1-821446">261</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 304.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Research and development, patents and licences, etc.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 304.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_52">10</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i41592996075d4ee09394e2c60639d1fa_30-0-1-1-824402">29</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 27.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 32.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 47.79pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 55.779999999999994pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_574">276</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 320.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Trend information<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 320.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9d435d5ae79f4880b20d86356910836b_36">75</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7686">102</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 336pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">E. Critical accounting estimates<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 336pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 351.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 351.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Directors, Senior Managers and Employees<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 364.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Directors and senior management<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 364.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i18f4470164a04ff7a6513acac2743218_0-0-1-1-821446">104</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i26a81cbda51c42fbbdcc287c651be078_120">109</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 380.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Compensation<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 380.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_28963">134</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28336">172</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_526">262</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 65.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i64d01e803b4c4157a1b84355aaad07bc_4572">263</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 396pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Board practices<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 396pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ic03d980f386144648d2ae3aa4e28de5e_1309">5</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 4.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i18f4470164a04ff7a6513acac2743218_0-0-1-1-821446">104</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 24.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 32.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i05f3d03bed7044b0896d2750d4d11063_536">107</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 47.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 52.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i045a8f02f1c1423cbc8769bc5d57e6df_2741">113</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.13pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 72.13pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44091">127</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.13pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 95.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44105">133</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 110.11999999999999pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 115.11999999999999pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_28963">134</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 130.12pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 135.12pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i42ae43ba5a88405f9f9aca9b6db79026_0-0-1-1-824464">163</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 150.12pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 158.11pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28336">172</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Employees<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i84ab3913040d458d93ab3a7ce3569dcd_0-0-1-1-824494">201</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_475">220</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i312420a3d6d442b5a9ced8bc507e3d14_30-0-1-1-824492">228</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_565">270</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 427.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">E. Share ownership<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 427.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6c0b125e757a4ea89adb5df88b7e0ee7_0-0-1-1-821446">144</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_8788">149</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_8789">150</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifdf922b90c1e421090bab303715daafc_0-0-1-1-824514">160</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 85.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i10596c5c84ac403fa9b751bce52bbabf_4469">161</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 100.78pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 105.78pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i64d01e803b4c4157a1b84355aaad07bc_4573">262</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 120.78pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 128.77pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i64d01e803b4c4157a1b84355aaad07bc_4545">263</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 143.77pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 443.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">F. Disclosure of a registrant&#8217;s action to recover <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">erroneously awarded compensation<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 443.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 470.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 470.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Major Shareholders and Related Party Transactions<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 483pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Major shareholders<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 483pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5272">173</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8b8f599eed654c6e85cf442c2fb50161_6087">286</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i60c8d07006604afb873c7b5c1a95bed9_901">288</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 498.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Related party transactions<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 498.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_511">236</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1ed0f69669d6410b8634beaa3e754e83_0-0-1-5-821446">294</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 514.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Interests of experts and counsel<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 514.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 530.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">8<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Information<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 543pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Consolidated Financial Statements and Other Financial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Information<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 543pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_337">175</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_541">268</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib84191dc3eac484f96385acf57e586f3_3563">198</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_661">288</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 570pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Significant Changes<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 570pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_538">265</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i59a0d33488c04eee9773c8d9f9f1ba75_19114">268</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 585.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 585.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The Offer and Listing<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 598.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Offer and listing details<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 598.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8b8f599eed654c6e85cf442c2fb50161_6088">287</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 614.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Plan of distribution<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 614.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 630pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Markets<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 630pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8b8f599eed654c6e85cf442c2fb50161_6087">286</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8b8f599eed654c6e85cf442c2fb50161_6088">287</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 645.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Selling shareholders<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 645.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 661.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">E. Dilution<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 661.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 516pt;"></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 516pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 39.69pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Form 20-F Cross Reference Guide continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 39.69pt; position: var(--position); top: 0pt; width: 516pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 21.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 235.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 205.5pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">F. Expenses of the issue<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 28.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">10<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Additional information<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Share Capital<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 57pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Memorandum and Articles of Association<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 57pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105515">292</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105516">293</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0bea432c992c4a71bf59b49d4f20544d_396">314</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Material contracts<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1ed0f69669d6410b8634beaa3e754e83_0-0-1-5-821446">294</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Exchange controls<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8b8f599eed654c6e85cf442c2fb50161_6087">286</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">E. Taxation<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_670">290</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i98a746406a444b7985babbff9a78bf40_11036">291</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 120pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">F. Dividends and paying agents<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 120pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 135.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">G. Statement by experts<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 135.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">H. Documents on display<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if8bc787354ec4663b4033dfe884628b8_2037">289</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 167.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">I. Subsidiary information<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 167.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 183pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">J. Annual Report to Security Holders<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 183pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Quantitative and Qualitative Disclosures about Market <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Risk<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0c08e7537c07466cba8dc796e114c1cd_0-0-1-1-824444">99</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_523">245</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3b9ac3fc24f54baf9a5671cfa2b8d000_0-0-1-1-821446">261</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 225.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Description of Securities Other Than Equity Securities<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Debt securities<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Warrants and Rights<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 270pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Other Securities<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 270pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 285.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. American Depository Shares<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 285.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105520">295</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 301.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 301.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Defaults, Dividend Arrearages and Delinquencies<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 301.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 317.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 317.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Material Modifications to the Rights of Security <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Holders and Use of Proceeds<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 317.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 344.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 344.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Controls and Procedures<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 344.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44421">130</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie7bb0cadabf34676b88e6d9dab7f886f_1973">299</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); white-space: pre;"> - <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie7bb0cadabf34676b88e6d9dab7f886f_1972">300</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 57.79pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.79pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#id049f66b4eaf4c87820773f0dfd5c2be_0-0-1-1-824580">301</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 360pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 360pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">[Reserved]<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 375.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 375.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">A. Audit Committee Financial Expert<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 375.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie03156c997354de09dbceb1686216b85_0-1-1-1-824589">105</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ice499ac0d689441e8c4c6946358b1659_8525">112</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.14pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 39.14pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie7bb0cadabf34676b88e6d9dab7f886f_1973">299</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 391.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 391.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">B. Code of Ethics<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 391.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44105">133</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-5-824337">297</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 407.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 407.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">C. Principal Accountant Fees and Services<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 407.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44105">133</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-5-824337">297</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 423pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 423pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">D. Exemptions from the Listing Standards for Audit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Committees<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 423pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 450pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 450pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">E. Purchase of Equity Securities by the Issuer and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Affiliated Purchasers<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 450pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 477pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 477pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">F. Change in Registrant&#8217;s Certifying Accountant<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 477pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 492.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 492.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">G. Corporate Governance<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 492.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifcc8df5449354dd2b9795314def7a291_4596">302</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 508.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 508.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">H. Mine Safety Disclosure<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 508.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 526.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 526.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">I. Disclosure regarding Foreign Jurisdictions that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Prevent Inspections<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 526.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 553.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 553.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">J. Insider Trading Policies<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 553.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105518">296</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 569.25pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 569.25pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">K. Cybersecurity Disclosures<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 569.25pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2607421ce2e541fba19f69f995c13712_1038">60</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i12be51524cf14b329e83851e353ced97_2-0-1-1-825315">107</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 29.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 34.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5c3dc689c3424363b4dea78a37255c4b_7-0-1-1-821446">108</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 49.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 54.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44692">128</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.8pt; position: var(--position); white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 74.8pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i97793aaf5fcd42f689800beb9dbf6c6d_0-0-1-1-824607">282</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 89.8pt; position: var(--position); white-space: pre;">,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.3pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaba1f3b1f85449a9baa50bb8040a23a3_0-0-1-5-824335">296</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 585pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">17<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 585pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Statements<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 585pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">See Item 8 above<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 600.75pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">18<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 600.75pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Statements<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 600.75pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 616.5pt; width: 21.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 21.75pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.12pt; position: var(--position); text-decoration: none; white-space: pre;">19<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 21.75pt; overflow: hidden; position: var(--position); top: 616.5pt; width: 235.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 235.5pt;"><span style="color: #ee7330; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Exhibits<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 310.5pt; overflow: hidden; position: var(--position); top: 616.5pt; width: 205.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Exhibit Index<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_13"></div><div style="background-color: transparent; height: 841.91pt; left: 0pt; opacity: 1; position: var(--position); top: 0pt; width: 595.28pt; z-index: 1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g1.jpg" alt="20F cover.jpg" style="height: 841.91pt; width: 595.28pt;"/></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"></div></div><div><div style="position: absolute; top: 48.19pt;" id="idc89fa1ee07645df9629d157a4b46752_22"></div><div style="line-height: 14pt; position: var(--position); top: 48.19pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: 0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contents<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="background-color: transparent; height: 841.89pt; left: 388.06pt; opacity: 1; position: var(--position); top: 0pt; width: 207.33pt; z-index: 5;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g2.jpg" alt="IFC NEW IMAGE.jpg" style="height: 841.89pt; width: 207.33pt;"/></div></div></div></div><div style="position: var(--position); top: 70.68pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 159.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 17.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 142.5pt;"/></tr><tr style="height: 21pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 159.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 5.91pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: 0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 21pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_28">1</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 21pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_28">Ahead Together</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_31">2</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 33.75pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_31">Business model</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_40">4</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 46.5pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s statement<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 59.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_46">6</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 59.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">CEO&#8217;s statement<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_49">8</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 71.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_49">Our external environment</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_52">10</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 84pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_52">Research and development</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_91">30</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 96.75pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_91">Commercial operations</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_115">44</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 109.5pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_115">Responsible business</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 123.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">56</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 123.75pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">Our culture and people</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 135.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_154">59</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 135.75pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_151">Risk management and </a><span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_151">disclosure&#160;statements</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 157.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 157.5pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_193">Group financial review</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 159.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: 0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 198pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">104</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 198pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">The Board and</a><span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.55pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">GSK&#160;Leadership&#160;Team</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_265">110</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 219.75pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_265">Chair&#8217;s governance statement</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 234pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">113</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 234pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">Corporate governance architecture</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_271">116</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 248.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Board activities<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 262.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_289">122</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 262.5pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_220">Board committee reports</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 276.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 276.75pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 291pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_331">164</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 291pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration policy<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_334">173</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 305.25pt; width: 142.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 142.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_262">Directors&#8217; report</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 130.5pt; left: 67.1pt; opacity: 1; position: var(--position); top: 453.54pt; width: 126pt; z-index: 1;"><div><div style="font-size: 0pt; width: 126pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 15.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 126pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 126pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: 0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">How to navigate this report<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 33pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 15.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 15.75pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 13.86pt; width: 11.34pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33pt; left: 15.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 110.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Page reference for more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information within&#160;this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 15.75pt;"><div><div style="position: var(--position); top: 7.02pt; width: 15.75pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g4.jpg" alt="Globe.jpg" style="height: 11.34pt; width: 11.34pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 15.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 110.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 9.59pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Visit gsk.com for more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 19.79pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 126pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 126pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: 0.02em; position: var(--position); text-decoration: none; white-space: pre;">Our supplements<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 15.75pt;"><div><div style="position: var(--position); top: 2.67pt; width: 15.75pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g5.jpg" alt="Down-arrow.jpg" style="height: 11.08pt; width: 9.35pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 15.75pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 110.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: 0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: 0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance Report is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: 0.008em; position: var(--position); text-decoration: none; white-space: pre;">available on gsk.com<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div><div style="background-color: transparent; height: 157.32pt; left: 51.42pt; opacity: 1; position: var(--position); top: 628.31pt; width: 292.42pt; z-index: 3;"><div><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 2.83pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.029em; position: var(--position); text-decoration: none; white-space: pre;">Cautionary statement<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.23pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 32.96pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ibb3e9e0c590e476fb58151bf8c774ad2_5653">313</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 44.99pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;"> of this document for the cautionary statement regarding&#160;forward-looking <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.63pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">statements. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 33.53pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.027em; position: var(--position); text-decoration: none; white-space: pre;">Non-IFRS measures<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 41.93pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">We use a number of adjusted, non-International Financial Reporting Standards (IFRS) <span style="display: inline-block; height: 5.09pt;"></span><span id="i7f8e2eb9229a41f6b4e11d259ef91838_535"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 50.33pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">measures to report the performance of our business. Total reported results represent the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 58.73pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s overall performance under IFRS. Core results and other non-IFRS measures may <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 67.13pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">be considered in addition to, but not as a substitute for or&#160;superior to, information <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 75.53pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">presented in accor<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dance with IFRS. Core results and&#160;other non-IFRS measures are defined <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 83.93pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on pages <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 30.45pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9510c9847c6040bfa7e14a02ad5607ad_1228">77</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 38.47pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 40.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 54.02pt; letter-spacing: 0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">78<span style="display: inline-block; height: 5.09pt;"></span><span id="i7f8e2eb9229a41f6b4e11d259ef91838_525"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 62.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and reconciliations to&#160;the nearest IFRS measures are on pages <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 259.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_217">88</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 267.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 277.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e4ae46c605c4ded86b536f771a8d159_0-0-1-1-821446">90</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 284.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 100.73pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: 0.027em; position: var(--position); text-decoration: none; white-space: pre;">Websites<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 109.13pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information on our website or any other website referenced in this Annual Report on Form 20-<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 117.53pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">F is not incorporated into this Annual Report on Form 20-F and should not be considered to be <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 125.93pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a part of this Annual Report on Form 20-F. We have included any references to the website as <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 134.33pt; width: 292.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an inactive textual reference only.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div></div></div><div style="background-color: transparent; height: 147.75pt; left: 56.58pt; opacity: 1; position: var(--position); top: 446.1pt; width: 148.25pt; z-index: -2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g6.jpg" alt="IFC_roundedbox-V2.jpg" style="height: 147.75pt; width: 148.25pt;"/></div></div></div></div><div style="position: var(--position); top: 70.68pt; width: 595.44pt;"><div style="font-size: 0pt; left: 222.81pt; position: var(--position); top: 0pt; width: 157.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 17.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 140.25pt;"/></tr><tr style="height: 21pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 157.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 5.91pt; width: 157.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: 0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 21pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_346">176</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 21pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_343">Directors&#8217; statement of responsibilities</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">178</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 35.25pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">Report of Independent Registered </a><span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">Public Accounting Firm</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">182</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 57pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">Financial statements</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_370">186</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 69pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_370">Notes to the financial statements</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 157.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 157.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: 0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_565">270</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 108pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of employees<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 122.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 122.25pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">Product development pipeline</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 135pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 135pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk factors<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_655">286</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 147.75pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_655">Share capital and control</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_661">288</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 162pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_661">Dividends</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_664">289</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 174.75pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_664">Financial calendar 2025</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 187.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_667">289</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 187.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_667">Annual General Meeting 2025</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 201.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_670">290</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 201.75pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_670">Tax information for shareholders</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 213.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_673">292</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 213.75pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Additional information<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if82f25ba1b444b79b54f72c88eb84a57_0-0-1-1-821446">298</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 225.75pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder services and contacts<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_685">299</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 238.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">US law and regulation<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 251.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_688">301</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 251.25pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Public Accounting Firm<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 274.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_691">302</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 17.25pt; overflow: hidden; position: var(--position); top: 274.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance comparison<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 286.5pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_697">303</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 17.25pt; overflow: hidden; position: var(--position); top: 286.5pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Group companies<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 299.25pt; width: 17.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.94pt; width: 17.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_703">311</a><span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 17.25pt; overflow: hidden; position: var(--position); top: 299.25pt; width: 140.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Glossary of terms<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 8pt; position: var(--position); top: 426.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 219.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="background-color: transparent; height: 164.96pt; left: 223.02pt; opacity: 1; position: var(--position); top: 451.65pt; width: 130.77pt; z-index: 2;"><div><div><div><div style="line-height: 9pt; position: var(--position); top: 2.83pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Front cover image: Lungs<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 16.43pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As well as supplying vaccines to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 26.63pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">help prevent respiratory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 36.83pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infections, we are developing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 47.03pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments that could transform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 57.23pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the standard of&#160;care for people <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 67.43pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affected by conditions including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 77.63pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asthma and chronic obstructive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 87.83pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pulmonary disease. Our pipeline <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 98.03pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also includes potential new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 108.23pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approaches for unmet lung cancer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 118.43pt; width: 130.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">needs<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_25"></div><div style="background-color: transparent; height: 181.53pt; left: 246.55pt; opacity: 1; position: var(--position); top: 58.59pt; width: 309pt; z-index: 1;"><div><div><div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 2.83pt; width: 309pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 2.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our purpose<span style="display: inline-block; height: 10.19pt;"></span><span id="i640a77962aab40899d3fbd1aee5e036c_88"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 26.63pt; width: 309pt;"><span style="font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 2.83pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">We unite science, <span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 63.63pt; width: 309pt;"><span style="font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 2.83pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">technology and<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 100.63pt; width: 309pt;"><span style="font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 2.19pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">talent to get ahead<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 137.63pt; width: 309pt;"><span style="font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 2.19pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">of disease together<span style="display: inline-block; height: 23.29pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 841.89pt; left: 0pt; opacity: 1; position: var(--position); top: 0pt; width: 238.8pt; z-index: 2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g7.jpg" alt="P1 NEW IMAGE.jpg" style="height: 841.89pt; width: 238.8pt;"/></div></div></div></div><div style="position: absolute; top: 130.33pt;" id="idc89fa1ee07645df9629d157a4b46752_28"></div><div style="line-height: 12pt; position: var(--position); top: 246.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; position: var(--position); text-decoration: none; white-space: pre;">for health impact<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 260.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; position: var(--position); text-decoration: none; white-space: pre;">+ shareholder returns <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 275.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; position: var(--position); text-decoration: none; white-space: pre;">+ thriving people<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 512.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: 0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 278.78000000000003pt; letter-spacing: 0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">strategy<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="background-color: transparent; height: 41.51pt; left: 250.86pt; opacity: 1; position: var(--position); top: 400.09pt; width: 291.97pt; z-index: 1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g8.jpg" alt="P1 Ahead together.jpg" style="height: 41.51pt; width: 291.97pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 530.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 271.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevent and treat disease <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 408.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 545.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.001em; position: var(--position); text-decoration: none; white-space: pre;">speci<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 278.81pt; letter-spacing: -0.001em; position: var(--position); text-decoration: none; white-space: pre;">alty medicines, vaccines<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 407.88pt; letter-spacing: -0.001em; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 411.20000000000005pt; letter-spacing: -0.001em; position: var(--position); text-decoration: none; white-space: pre;">and general medicines. <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 574.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">We focus on the science of the immune <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 588.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.78pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">system and advanced technologies, investing <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 602.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.78pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">in four core therapeutic areas &#8211; <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 417.44000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory, <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 617.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology and <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 341.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflammation;<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 411.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> oncology; HIV;<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 631.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and infectious diseases<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 374.09000000000003pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; to impact health at scale.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 660.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We operate responsibly for all our stakeholders <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 674.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by prioritising Innovation,&#160;Performance and <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 479.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trust.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="position: var(--position); top: 695.35pt; width: 595.44pt;"><div style="font-size: 0pt; left: 250.86pt; position: var(--position); top: 0pt; width: 267pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 257.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 16.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 257.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 257.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read about how our business model delivers our strategy on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 220.62pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_31">2</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 14pt; position: var(--position); top: 725.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 744.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">We are ambitious for patients, accountable <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 759.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 250.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">for impact and we do<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 359.77pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> the r<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 386.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">ight thing.<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="position: var(--position); top: 779.45pt; width: 595.44pt;"><div style="font-size: 0pt; left: 250.86pt; position: var(--position); top: 0pt; width: 267pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 257.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 16.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 257.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 257.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read about our culture and people on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 146.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">56</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 50.25pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 50.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 34pt; position: var(--position); top: 16.85pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 34pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Business model<span style="display: inline-block; height: 24.75pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_31"></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As<span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 70.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a focused <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 137.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma<span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 203.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> company, we discover, develop and deliver medicines <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 130.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and vaccines. We <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 166.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aim to positively impact the health of 2.5 billion people by the <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 146.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">end of the decade.<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="position: var(--position); top: 163.79pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 192.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Central to our success<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 207.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.769999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">are our people: experts<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 222.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.769999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">in science, technology, <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 237.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 252.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">commercialisation...<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 30pt; position: var(--position); top: 188.54pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">68,600<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 224.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">GSK people across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 235.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.06pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">75 countries worldwide<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 30pt; position: var(--position); top: 249.88pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 285.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing sites<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 30pt; position: var(--position); top: 188.54pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 385.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6.4bn<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 224.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D investment in <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 463.77pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 30pt; position: var(--position); top: 249.88pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18,000<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 285.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">suppliers working directly<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 297.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.35pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">with GSK<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 326.76pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g9.jpg" alt="BM_line-and-down-arrow.jpg" style="height: 12.01pt; width: 487.72pt;"/></div></div></div><div style="line-height: 12pt; position: var(--position); top: 343.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">...who are identifying, <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 358.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">researching, developing <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 373.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.769999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and delivering...<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 343.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our specialty medicines<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 315.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> prevent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 371.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;treat diseases, from HIV, cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and asthma to immune-inflammation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases like lupus. Many are first or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">best-in-class.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 420.31pt; width: 595.44pt;"><div style="font-size: 0pt; left: 221.15pt; position: var(--position); top: 0pt; width: 94.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_103">32</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 441.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 457.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our broad portfolio of&#160;general <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 468.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines, from inhalers for asthma <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 479.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 238.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 264.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to antibiotics, improve life <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 490.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for millions of people around the world.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 373.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 502.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Many are market leaders.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 517.6pt; width: 595.44pt;"><div style="font-size: 0pt; left: 221.15pt; position: var(--position); top: 0pt; width: 99pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 89.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_109">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 343.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 359.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have one of the broadest portfolios <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 371.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of vaccines in the industry, targeting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases at every stage of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">life,&#160;helping to protect people from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV, meningitis, shingles, hepatitis <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;many&#160;more.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 431.56pt; width: 595.44pt;"><div style="font-size: 0pt; left: 388.44pt; position: var(--position); top: 0pt; width: 105.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 16.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 96pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_106">35</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 77.89999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 544.35pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g9.jpg" alt="BM_line-and-down-arrow.jpg" style="height: 12.01pt; width: 487.72pt;"/></div></div></div><div style="line-height: 12pt; position: var(--position); top: 561.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">...products that prevent <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 576.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.74pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">and change the course <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 591.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.74pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">of disease in&#160;our&#160;four core <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 606.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">therapeutic areas...<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 561.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory, immunology <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 577.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and inflammation <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 593.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re harnessing our deep knowledge <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 604.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">of inflammatory mechanisms and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 615.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">science of the immune system to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">redefine the future of respiratory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 638.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">medicine and target lung, liver and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 649.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">kidney disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 664.89pt; width: 595.44pt;"><div style="font-size: 0pt; left: 221.15pt; position: var(--position); top: 0pt; width: 102pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_67">13</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 685.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 701.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re leaders in HIV, focused <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 712.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on&#160;ending&#160;the global epidemic. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 724.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#160;have&#160;an<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 268.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> industry-leading <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 735.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline,&#160;driven by patient insights.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 750.93pt; width: 595.44pt;"><div style="font-size: 0pt; left: 221.15pt; position: var(--position); top: 0pt; width: 102pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_76">20</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 561.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 577.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">Our ambition is to help increase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 588.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">overall&#160;quality of life, maximise survival <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 599.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">and change the course of disease, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 611pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">expanding from our current focus on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 622.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">blood and women&#8217;s cancers into lung <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 633.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">and gastrointestinal cancers, as well <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 644.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">as&#160;other solid tumours. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 660.25pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.94pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 15.75pt;"></span></span><div style="font-size: 0pt; left: 388.44pt; position: var(--position); top: 0pt; width: 97.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 87.75pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 87.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_73">16</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 680.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Infectious diseases<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 696.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 405.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases pipeline and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 707.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">portfolio,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 422.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 424.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including HIV, is&#160;the&#160;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 505.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">broadest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 719.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in&#160;the industry.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 734.51pt; width: 595.44pt;"><div style="font-size: 0pt; left: 388.44pt; position: var(--position); top: 0pt; width: 123pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="3" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_82">22</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business model continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="background-color: transparent; height: 26.3pt; left: 54.24pt; opacity: 1; position: var(--position); top: 787.11pt; width: 486.83pt; z-index: 1;"><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 0pt; width: 486.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">W<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e believe that we are on track to achieve our ambition of reaching 2.5 billion people by the end of the decade. Our estimated patient reach figure from <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 8.4pt; width: 486.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2021 to the end of 2024 is at least 2 billion people, excluding patient reach for albendazole donations in 2024 as this data is not yet available.<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 442.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> For more <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 16.8pt; width: 486.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">detail see Access on pag<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 87.99000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 93.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_130">46</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 101.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 107.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nd for more detail on our methodology see our Responsible Business Performance Report.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g9.jpg" alt="BM_line-and-down-arrow.jpg" style="height: 12.01pt; width: 487.72pt;"/></div></div></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 130.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8230;using<span style="display: inline-block; height: 8.73pt;"></span><span id="ia9d65aac50bd4fee988d68c0bdd5b30f_3763"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 93.99000000000001pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 97.22999999999999pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">advanced<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 145.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.769999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">technologies<span style="display: inline-block; height: 8.73pt;"></span><span id="ia9d65aac50bd4fee988d68c0bdd5b30f_3747"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 120.03pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8230;<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 132.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 188.51pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 148.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At every step of the R&amp;D <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 159.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process, w<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 231.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e are<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 251.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> using<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 275.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> data <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 170.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tech<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 205.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, including AI, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 182.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform technologies to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 193.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be&#160;faster, more effective <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 204.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;more predictive in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 215.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discovering and developing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 227.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovative medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 238.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 253.79pt; width: 595.44pt;"><div style="font-size: 0pt; left: 188.51pt; position: var(--position); top: 0pt; width: 108.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: 1.09pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 11.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.019em; position: var(--position); text-decoration: none; white-space: pre;">Read how technology <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.13pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.019em; position: var(--position); text-decoration: none; white-space: pre;">enables our R&amp;D on page <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 19.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.019em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_85">26</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 132.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 310.4pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 148.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We use technology to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 159.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reach people and patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 170.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">better and faster through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 182.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">smart manufacturing; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 193.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">helping patients and their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 204.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carers to manage their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 215.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions; and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 227.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">empowering our people to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 238.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">do their best&#160;work.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 132.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 430.88pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Partnership<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 148.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We collaborate in new ways <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 159.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across the technology and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 170.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biotech industries and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 182.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">academia, so that we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 193.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">can&#160;work with the latest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 204.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advances in expertise and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 215.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology to get ahead <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 227.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of&#160;disease together.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 242.69pt; width: 595.44pt;"><div style="font-size: 0pt; left: 430.88pt; position: var(--position); top: 0pt; width: 106.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 296.04pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g9.jpg" alt="BM_line-and-down-arrow.jpg" style="height: 12.01pt; width: 487.72pt;"/></div></div></div><div style="line-height: 12pt; position: var(--position); top: 316.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">...steered by our <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 331.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.769999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">long-term priorities<span style="display: inline-block; height: 8.73pt;"></span><span id="ia9d65aac50bd4fee988d68c0bdd5b30f_3751"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 151.24pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">...<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 319.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 188.5pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Innovation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We develop and launch <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new&#160;medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines&#160;where they <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are&#160;needed, with better, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 380.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">faster&#160;and smarter R&amp;D.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 395.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 188.5pt; position: var(--position); top: 0pt; width: 108.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="4" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: 1.09pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 3pt; width: 97.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.72pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more about our <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D&#160;on&#160;page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 48.870000000000005pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_52">10</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 9pt;"><td colspan="2" rowspan="1" style="display: none;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 319.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 310.39pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Driven by our innovation, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we have delivered <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 357.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistent sales<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 373.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and profit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 368.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 337.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and improved our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 380.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 310.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term strategy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 381.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 395.59pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 417.64pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 25.5pt;"></span></span><div style="font-size: 0pt; left: 310.39pt; position: var(--position); top: 0pt; width: 107.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="4" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 97.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.47pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read about our commercial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 10.97pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">operations on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 67.56pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_91">30</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="2" rowspan="1" style="display: none;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 319.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 430.87pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trust<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We focus on issues that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matter most to our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business, our stakeholders, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and society, and where we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 380.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">can have the greatest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 391.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 430.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 406.84pt; width: 595.44pt;"><div style="font-size: 0pt; left: 430.87pt; position: var(--position); top: 0pt; width: 110.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 100.5pt;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="4" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.34pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.08pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 3pt; width: 100.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.47pt; width: 100.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Read more in Responsible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 10.97pt; width: 100.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 63.800000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_115">44</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="2" rowspan="1" style="display: none;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 442.34pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g9.jpg" alt="BM_line-and-down-arrow.jpg" style="height: 12.01pt; width: 487.72pt;"/></div></div></div><div style="line-height: 12pt; position: var(--position); top: 459.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#8230;creating <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 474.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.74pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">value for...<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 459.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 188.51pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Patients<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 30pt; position: var(--position); top: 472.55pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;2bn<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 508.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">estimated patients reached <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 519.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.42pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">between 2021 and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 263.38pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 283.02pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 551.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 188.51pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Shareholders<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 30pt; position: var(--position); top: 564.39pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">61p<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">per share dividend<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 260.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 459.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 377.02pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Society and the economy<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 30pt; position: var(--position); top: 472.55pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.3bn<span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">corporate income tax paid; in addition <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 376.93pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">we pay duties, levies, transactional and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 531.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">employment taxes<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 551.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 377.02pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">People<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 30pt; position: var(--position); top: 564.5pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 30pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">85% <span style="display: inline-block; height: 21.84pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 600.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of GSK people surveyed agree that their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 611.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">job gives them the opportunity to do <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 623pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 377.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenging and interesting work <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 645.94pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g9.jpg" alt="BM_line-and-down-arrow.jpg" style="height: 12.01pt; width: 487.72pt;"/></div></div></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 668.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">..<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 60.28pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">.and enabling <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 683.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">rein<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 73.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">vestment to<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 698.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 53.74pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">get ahea<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 99.46000000000001pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">d of disease<span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 669.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 212.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">returns<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 249.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we make set us up to reinvest in discovering and <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 683.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing new medicines and vaccines to prevent and change the <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 698.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">course of disease. Helping people to live healthier lives eases <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 12pt; position: var(--position); top: 712.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 188.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pressure on health systems and <span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 359.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supports<span style="display: inline-block; height: 8.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 405.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> economic prosperity.&#160; &#160;  <span style="display: inline-block; height: 8.73pt;"></span></span></div><div style="position: var(--position); top: 742.3pt; width: 595.44pt;"><div style="font-size: 0pt; left: 188.55pt; position: var(--position); top: 0pt; width: 352.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 174.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 9.75pt;"><div><div style="position: var(--position); top: 2.63pt; width: 9.75pt;"><div style="left: 0.48pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 10.74pt; width: 8.79pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 9.75pt; position: var(--position); top: 0pt; width: 174.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 174.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Being a responsible business is an integral part of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.13pt; width: 174.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our strategy and culture. Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.76999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_115">44</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: 1.09pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g3.jpg" alt="Read-more.jpg" style="height: 11.1pt; width: 9.07pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195.75pt; position: var(--position); top: 0pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Our strategy is supported by a robust <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.13pt; width: 156.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">framework for monitoring and managing risk, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 19.63pt; width: 156.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">described on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 65.13pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_160">60</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="4" rowspan="1" style="display: none;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 781.8pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 34pt; position: var(--position); top: 3.35pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 34pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s statement<span style="display: inline-block; height: 24.75pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="background-color: transparent; height: 227.83pt; left: 53.86pt; opacity: 1; position: var(--position); top: 562.39pt; width: 319.75pt; z-index: 1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g10.jpg" alt="New chair pic.jpg" style="height: 227.83pt; width: 319.75pt;"/></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_40"></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Another year of strong performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and meaningful R&amp;D progress<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 141.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 provided further evidence that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 152.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma and her executive team have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seized the opportunity of the demerger <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to make fundamental improvements to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s operational performance, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitiveness and pipeline.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 214.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our long-term conviction remains that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 226.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changing population demographics <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 237.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and disease patterns mean that GSK&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 248.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purpose to get ahead of disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 259.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters more than ever. By delivering <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 271.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovative new medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 282.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines to prevent and change the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 293.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">course of disease, GSK is creating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustained value for patients, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare systems and society at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">large. Over time, we are determined <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 338.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that this will also translate into <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 349.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustained increased value for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strategic progress<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 391.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK continues to perform to a new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standard. 2024 marked the third <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consecutive year of strong sales and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">core operating profit and earnings per <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share growth. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 453.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have built a much stronger <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 464.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform for GSK to deliver consistent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 475.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and dependable performance, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underpinned by a new resilience and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 498.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales mix across the portfolio. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 515.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This was demonstrated in 2024, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 526.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong performance delivered despite <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 537.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">some challenges in Vaccines. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These were outweighed by strong <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth across our Specialty Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business, with our Respiratory/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Immunology, Oncology and HIV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">franchises all registering sales growth <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at AER and CER.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The first phase of GSK&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transformation, since the demerger, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has built a foundation of consistent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">execution and delivery. The priority <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now is to build on this foundation as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK moves into the second phase of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its transformation, focused on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">executing pipeline delivery, preparing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the next wave of innovation. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 293.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder returns<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 307.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Equally, the Board recognises that the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 318.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">value of GSK shares does not currently <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 329.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">reflect our confidence in our growth <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 340.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">strategy. The Board is extremely <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 352.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">mindful of this and the need to deliver <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 363.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">better shareholder value over the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 374.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">short-, medium- and long-term <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 385.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">timeframes.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 267.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board has thought deeply about <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this gap between the market&#8217;s view of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valuation and our own. While investing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the business will always be the first <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority for use of capital, the Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 458.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">believes that the balance sheet is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 470.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now strong enough to support a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 481.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share buyback. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This should be seen as a clear <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstration in the Board&#8217;s belief in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the medium- and long-term growth <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prospects for GSK.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D progress<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company&#8217;s core focus remains <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progressing and strengthening the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline and R&amp;D performance. This is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the number one priority for the Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a whole and the Science <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee specifically. We continue to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">constructively challenge the executive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">team on their scientific and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial assumptions and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 278.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial returns expected from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 290.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposed R&amp;D investments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 307.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board was encouraged to see <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 318.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">good progress made during the year, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 329.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">both organically and through business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 340.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development, with 13 positive phase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 352.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">III readouts. This pipeline progress <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 363.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supports the Board&#8217;s confidence in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 374.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery of expected growth by 2031. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 385.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a result, the Board is increasingly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 397.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turning its attention to pipeline <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 408.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities beyond 2031 based on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company&#8217;s deep understanding of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 430.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the immune system and leading <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 442.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capabilities in platform and data <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 453.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technologies. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 470.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disciplined deployment of capital <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 481.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">towards R&amp;D remains central to this. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 492.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have chosen to both progress and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 503.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decline business development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 515.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities over the course of this <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 526.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year, not least as we now see <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 537.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities to accelerate certain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 548.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets in Respiratory, Immunology &amp; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 560.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inflammation and Oncology.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 577.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 590.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to evolve our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 601.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy to support <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 613.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery against the company&#8217;s goals <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 624.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and seek to further increase alignment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 635.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of shareholder and management <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 646.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experiences. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 663.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the Remuneration Report we set out <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 675.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposed changes which seek to both <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 686.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anchor our remuneration against the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 697.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">peer group we compete with and to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 708.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure we are even more focused on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 720.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incentivising financial over-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 731.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance and pipeline over-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 742.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery in the near, mid and long <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 753.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">term.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s statement continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="background-color: transparent; height: 841.89pt; left: 388.06pt; opacity: 1; position: var(--position); top: 0pt; width: 207.33pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g2.jpg" alt="IFC NEW IMAGE.jpg" style="height: 841.89pt; width: 207.33pt;"/></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have consulted extensively with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders in developing the new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposals, which will be voted on in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the usual way at our 2025 AGM.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Resolving <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 98.62pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 127.17pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> litigation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beyond the company&#8217;s strategic and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D priorities, the Board has focused <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on reducing unnecessary exposures <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the company and shareholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The retirement of the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 138.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 166.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> risk, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through the settling of the vast majority <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of cases in the US, was clear <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstration of this. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We strongly believe this action is in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">best long-term interests of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders, helping draw a line <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 307.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the litigation and providing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 318.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">closure without any admission of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 346.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This was a good example of the Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 357.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and leadership team working closely <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 368.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">together, along with independent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 380.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experts, to act in shareholder <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 391.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 408.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Culture and responsibility <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 421.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As I have said before, I believe that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 433.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one of the strongest drivers of GSK&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 444.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term performance is the culture <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 455.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shift which Emma and her team are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 466.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driving. This is seen in a focus on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 478.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">behaviours such as accountability and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 489.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">smart decision-making; and continued <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 500.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">very high engagement scores among <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 511.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK people.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board continues to support the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 540.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-standing proactive approach <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 551.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taken by the company to build trust <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 562.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and operate responsibility. Through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 573.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the relevant Board committees, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 585.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">examined progress in priority areas <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 596.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as access to medicines, where <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 607.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company again ranked strongly in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 618.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external benchmarks in 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 630.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antimicrobial resistance (AMR), and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 641.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our climate and nature sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 652.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 669.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board evolution<span style="display: inline-block; height: 6.55pt;"></span><span id="ic03d980f386144648d2ae3aa4e28de5e_1309"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 683pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As I&#8217;ve noted previously, we continue <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 694.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to evolve the Board to ensure we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 705.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide robust oversight and scrutiny <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 716.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of management. We have now built <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 728pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deep industry skills and experience <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 739.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all parts of the biopharma value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 750.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain, including strategically important <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 761.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas to GSK such as genetics, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 773pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology and AI. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we were delighted to welcome <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee to the Board. Jeannie is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">Vice Chair of the Department of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">Genetics at Harvard Medical School. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">Her deep expertise in scientific and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">medical innovation, including in the field <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">of RNA biology and epigenetics, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">are key parts of GSK&#8217;s R&amp;D approach, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 203.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">together with her experience in public <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 214.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">health, bring a strong additional <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 225.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.018000000000000002em; position: var(--position); text-decoration: none; white-space: pre;">perspective to Board discussions.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We will also bid farewell to Dr Jesse <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodman, who will step down from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board at the 2025 AGM having <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">served nine years as a Non-Executive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 287.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director. The Board as a whole, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 299.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Science Committee in particular, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 310.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have benefitted hugely from Jesse&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 321.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wealth of expertise in infectious <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 332.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases, regulation and public health. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 344.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He has made a fantastic contribution <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 355.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to GSK and we wish him all the very <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 366.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">best for the future. As Jesse steps <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">down, we are delighted that Dr Gavin <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 389.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Screaton will join the Board as a Non-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 400.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director from 1 May 2025. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 411.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">His deep expertise in immunology and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 422.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases, together with his <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 434.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considerable experience in public <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 445.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health, will help to replace Jesse&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 456.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">skillset and experience; and bring a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 467.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valuable perspective to the Board.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 484.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Conclusion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 498.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We believe the company continues to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 509.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthen across all parts of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 520.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business. That we have not <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 532.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrated this more in shareholder <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 543.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value is a source of determination to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 554.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">do so. The Board is strongly focused <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 565.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on this and helping the executive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieve the growth strategy set, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will ultimately drive investor <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 599.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence and in parallel, shareholder <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 610.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 627.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are many things that are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 638.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">precious about GSK but one that sits <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 650.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">above all is our people &#8211; and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 661.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purpose that drives them to improve <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 672.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health and the lives of patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 683.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide. I would like to thank all our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 695.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people, as well as our partners, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 706.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customers and shareholders, for their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 717.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued commitment through the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 728.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">past year. Together, we look forward to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 740.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">another year of success in 2025.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 754.45pt; width: 595.44pt;"><div style="left: 221.15pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g11.jpg" alt="JS signature for Annual Report.jpg" style="height: 33.55pt; width: 99.21pt;"/></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 793pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 804.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 34pt; position: var(--position); top: 3.35pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 34pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO&#8217;s statement<span style="display: inline-block; height: 24.75pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="background-color: transparent; height: 226.77pt; left: 56.4pt; opacity: 1; position: var(--position); top: 565.38pt; width: 320.05pt; z-index: 1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g12.jpg" alt="New Emma portrait.jpg" style="height: 226.77pt; width: 320.05pt;"/></div></div></div></div><div style="background-color: transparent; height: 34.36pt; left: 391.66pt; opacity: 1; position: var(--position); top: 776.43pt; width: 161.18pt; z-index: 2;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 10.4pt; width: 161.18pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Penmenvy<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 44.150000000000006pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our 5-in-1 meningococcal vaccine, <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.8pt; width: 161.18pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was approved in the US in February 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div><div style="position: absolute; top: 120.47pt;" id="idc89fa1ee07645df9629d157a4b46752_46"></div><div style="line-height: 9pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 will mark three years since the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 131.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demerger and the creation of GSK <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 142.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a new dedicated biopharma <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 154.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company, for patients and for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 165.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 112.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 182.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The demerger enabled a fundamental <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 193.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructure of GSK and its balance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 204.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet, bringing new capacity to invest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 216.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in growth and to deliver returns to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 227.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 244.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Three years on, we have established a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 255.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong track record of performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have developed an attractive, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reshaped portfolio and pipeline of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines and Vaccines, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 317.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with Specialty now representing close <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to 40% of GSK&#8217;s sales. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 345.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have delivered sustained year-on-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 356.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year sharper operational performance, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 368.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profitability and cash improvements.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strong 2024 performance<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 133.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s excellent performance in 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 145.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrates the transformation of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 156.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 173.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group sales were <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 293.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;31.4 billion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 340.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, up <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 358.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 371.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 184.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 244.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 257.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER, and excluding <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 195.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 sales, growth was up <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 350.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 363.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 207.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 244.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 257.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 224.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This was driven by strong growth and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 235.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing contribution from Specialty <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 246.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicines, with growth in all areas, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 257.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than offsetting headwinds in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 269.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Respiratory/Immunology, sales <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 297.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were up <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 255.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 268.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 293.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 311.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER, driven by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 308.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 248.89000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our anti-IL5 biologic medicine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 319.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 238.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 272.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our treatment for auto-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 331.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immune disease lupus.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology sales almost doubled to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than &#163;1.4 billion. Specialty <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 370.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines for ovarian and endometrial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 381.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancers, together with <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 310.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 339.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 392.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new treatment for myelofibrosis <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 404.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients with anaemia, all grew rapidly, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 415.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven by increased uptake and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 426.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognition of their benefit by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oncologists. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV sales grew <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 283.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 301.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 326.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 344.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 466.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with 20% of total HIV sales now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 477.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">coming from new long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 488.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">injectables for treatment and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 499.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention (PrEP). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine sales were down <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 490.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 503.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; AER, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 131.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 401.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER, reflecting challenges we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 142.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have seen from external pressures, in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 154.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US and China, for Arexvy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 165.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix. While we expect these to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 176.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue in 2025, we are confident that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 187.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these vaccines, together with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 199.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline opportunities we have in this <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 210.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of our portfolio, will deliver <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meaningful contributions to medium- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 232.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and long-term growth. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 249.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines also delivered <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 261.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">another strong year of performance, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 272.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with sales up <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 442.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 455.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 480.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 493.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 283.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 418.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> strengthening its position even <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 294.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further as the top-selling medicine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 306.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide for COPD and asthma.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline momentum <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 336.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In R&amp;D, execution in the late-stage <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline was exceptional, with 13 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positive phase III clinical trial readouts <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 370.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2024 across Respiratory, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 381.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Immunology &amp; Inflammation (RI&amp;I), <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 392.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology, HIV and Infectious <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 404.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diseases &#8211; a record for the company. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 421.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are now focused on the clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 432.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development of 14 scale innovation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 443.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities &#8211; the majority in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty medicines. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 471.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These include five new product <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 482.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approvals expected in 2025<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 497.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 500.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, at the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 494.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forefront of which are potential step-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 505.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in treatment for multiple <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 516.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">myeloma, with <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 447.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 478.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> our novel ADC <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 527.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment; and depemokimab &#8211; our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 539.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new ultra-long-acting medicine for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 550.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment of severe asthma.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 567.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I was also pleased to see further <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 578.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthening of our mid- and early-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 589.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stage pipeline, with progress and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 601.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">addition of several new assets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 612.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including two high-potential oncology <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines &#8211; targeting B7-H3 and B7-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">H4 antigens; novel IL33 and TSLP <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 646.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory treatments; and successful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 657.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">steps forward in our development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 668.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes for ultra-long-acting HIV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 679.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.25pt; position: var(--position); text-decoration: none; white-space: pre;">2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 50.25pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 50.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 38.44pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO&#8217;s statement continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Targeted business development (BD) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 131.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also remains a key priority. In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 142.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we completed transactions to acquire <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 154.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets in oncology and RI&amp;I; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 165.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthened platform capabilities in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 176.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA and oligonucleotides; and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 187.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entered into several new research <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 199.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alliances, including a collaboration <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 210.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with Flagship Pioneering &#8211; providing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">us with access to a portfolio of more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than 40 bioplatform companies. Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 244.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recent agreement to acquire IDRx, Inc <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 255.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is a good example of what we expect <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to do going forward.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Capital allocation and shareholder <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">returns<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 311.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We remain extremely focused on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disciplined allocation of capital. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our first priority for capital remains to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invest in growth and in R&amp;D &#8211; both <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">organically and in targeted business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development &#8211; at scale and pace. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D expenditure was over &#163;6 billion in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 396.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, and we invested &#163;2.3 billion of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 407.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital in targeted BD. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">With the pipeline opportunities we now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 435.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have, we are deliberately prioritising <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment to accelerate development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 458.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of key assets in RI&amp;I and Oncology &#8211; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 469.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alongside long-acting HIV medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 480.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and existing core Vaccines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 491.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 508.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition to investing in growth, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 520.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remain focused on improving returns <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 531.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for shareholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our primary mechanism for this <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 131.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remains our progressive dividend. For <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 142.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 we declared a full year dividend <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 154.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 61p, and we expect to pay 64p in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 165.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 182.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also look to deliver further returns, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 193.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when circumstances and opportunities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 204.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allow, and have announced our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 216.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intention to buy back &#163;2 billion of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 227.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares over the next 18 months. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 238.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">believe this offers a very attractive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">return for shareholders at current <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 261.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share price levels.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 278.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Very importantly, our outperformance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 289.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and stronger balance sheet support all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 300.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our plans to invest competitively for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 311.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth &#8211; in pipeline and in BD &#8211; as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well as deliver enhanced returns to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 334.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operating as a Responsible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 375.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is committed to operating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 386.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibly. This is core to who we are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 398.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a company and to delivering our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambition for patients, our people and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 420.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term business success.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We maintained good progress in our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 448.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">six priority areas to build Trust in 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 460.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with an overall performance rating of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 471.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8220;on track&#8221; for the third consecutive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 482.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 499.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Importantly, we retained a leadership <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 510.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">position in the Access to Medicine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Index where we have been placed first <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 533.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or second since its inception in 2008.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 550.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are also making great progress <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 561.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against the ambition we set ourselves <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 572.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2021 to positively impact the health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 583.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 2.5 billion people over ten years, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 595.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with latest estimates indicating that we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 606.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have reached at least two billion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 617.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 634.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Being responsive to the environment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 645.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which we operate and the changing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 657.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectations of our key stakeholders, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 668.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is critical to building trust. With that in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 679.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mind, we continue to review and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 690.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolve the actions we are taking in all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 702.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our six areas. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 719.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 221.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Culture <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 732.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At GSK, our culture is centred around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 743.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being ambitious for patients, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 755.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accountable for our impact and doing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 766.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the right thing and we continue to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 777.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make meaningful progress.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture lays the foundation for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 131.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how, together, we deliver our strategy, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 142.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our business performance and positive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 154.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health impact at scale. It also drives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 165.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our strong commitment to creating an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 176.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment where talented people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 187.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">can thrive, feel valued, included, are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 199.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">able to focus on what matters and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 210.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pursue exciting career development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 238.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to see highly positive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement of our people &#8211; with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 261.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scores of more than 80% again last <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 272.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year in our internal survey. Increased <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence in the delivery of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy was also reflected in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">survey, and we were delighted to see <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 317.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positive feedback on the effectiveness <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our managers &#8211; with 79% rated as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly effective by their teams.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 356.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 388.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Clear momentum as we look ahead<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 370.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As we look ahead, I am very optimistic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 381.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the future at GSK and our ability to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 392.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliver our growth strategy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">develop the next wave of meaningful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 415.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D innovation.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 432.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our portfolio is demonstrating growth <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 443.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and resilience in key areas of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapeutic strength.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 471.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This comes on the back of a strong <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 482.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">track record of operational delivery <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 494.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and accelerating progress in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 505.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovation and pipeline development.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 522.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As ever, it is our wonderful teams and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 533.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partners who fuel this progress, and I <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 544.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">want to thank them for all they have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 556.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieved during 2024, for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 567.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">momentum they are bringing into <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 578.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025, and for the inspiration they bring <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 589.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to us all. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 606.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All of this underscores GSK&#8217;s clear <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 618.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunity to deliver scale health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 629.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact to patients, and attractive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 640.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">returns to shareholders, through the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 651.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decade and beyond. Combining <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 663.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">science, technology, and the talent of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 674.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our people, to get ahead of disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 685.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">together.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 708.54pt; width: 595.44pt;"><div style="left: 388.44pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g13.jpg" alt="Emma Walmslely_Signature.jpg" style="height: 21.31pt; width: 138.61pt;"/></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 734.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 746.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">8<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our external environment<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_49"></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">Our<span style="display: inline-block; height: 10.19pt;"></span><span id="i02c3dfbea84f4e1caa1e2347e5a39b62_7219"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 76.64pt; letter-spacing: -0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 79.57pt; letter-spacing: -0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">Ahead<span style="display: inline-block; height: 10.19pt;"></span><span id="i02c3dfbea84f4e1caa1e2347e5a39b62_7220"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 119.12pt; letter-spacing: -0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;"> Together strategy and long-term priorities of Innovation, Performance <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 130.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.013000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">and Trust respond to major trends influencing the healthcare landscape.<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="position: var(--position); top: 173.99pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Innovation<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 196.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Convergence of science and technology continues <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 16pt; line-height: 16pt; position: var(--position); top: 216.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">to<span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 66.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> shape research and development opportunities<span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 399.25pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="background-color: transparent; height: 347.81pt; left: 301.61pt; opacity: 1; position: var(--position); top: 246.18pt; width: 236.78pt; z-index: -3;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g14.jpg" alt="Ext env 1.jpg" style="height: 347.81pt; width: 236.78pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 246.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A deeper insight into human biology, combined with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 257.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential to access and compute vast amounts of data, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 269.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to shape discovery and development of new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 280.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapies. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 94.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advances in understanding of human genetics <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 291.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and functional genomics, in tandem with artificial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 302.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intelligence and machine learning (AI/ML), are enabling <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 314.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientists to decode the mechanisms of disease. A better <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 325.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understanding of biological processes, such as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 336.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflammation and ageing of the immune system, is paving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the way for earlier, more precise intervention to change the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">course of disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 376.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the biopharma industry continued to look to new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 387.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mechanisms, technologies and opportunities. Oncology, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 398.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory and infectious diseases are forecast to be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">among the top ten therapy areas by 2028, based on global <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 421.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">spend. Around a quarter of oncology trials now focus on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 432.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">novel mechanisms, especially antibody drug conjugates, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 443.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multi-specific antibodies, and cell and gene therapies<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 262.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 267.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obesity drug trials are increasing, there is also more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 466.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attention on obesity medications in the context of studies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 477.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">into other diseases; and the longer-term health needs that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 488.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could emerge due to obesity being effectively controlled.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 505.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The transformative potential of scientific and technological <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advances continues to prompt innovative partnerships and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">collaborations across sectors. The biopharma industry <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 539.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">completed around 60 AI/ML focused deals in 2024. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 550.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Countries also continue to look to innovation generated by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 561.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic industries, including biopharma, to support growth. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 573.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">China has taken steps to bolster its R&amp;D environment, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 584.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its share of global biopharma companies rising to<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 247.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 16% in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 595.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024. The US retains the greatest share, with 39%. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 257.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 316.14pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 338.40999999999997pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">response<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 273.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 331.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> convergence of science and technology is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changing discovery and development. At all stages of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our R&amp;D, we&#8217;re harnessing the opportunity to be more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">precise in our research targets, to identify the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, and to increase the chances of successfully <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing medicines and vaccines that make a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 338.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difference to them. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 355.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to invest for growth in new, best-in-class <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 365.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 410.71999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Our R&amp;D approach <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 376.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combines our scientific focus on the immune system, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 387.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including human genetics, functional genomics and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 398.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">single-cell profiling, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 394.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the use of advanced <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technologies. Our innovation is driven through both <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 419.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.09999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in-house R&amp;D as well as partnering with leading <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 430.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">institutions to access cutting-edge research and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 441.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 457.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We work with our peers and governments to make <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 468.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sure that the policy and regulatory environment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 479.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stimulates and protects innovative research and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 490.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development within a culture that builds trust with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 501.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transparency. This includes policies at a national level <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 511.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to invest in and recognise the value of innovation, as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 522.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well as global frameworks to enable <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 459.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 505.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 533.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 361.16999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> access to, and deployment of, data and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 544.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 334.96999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technologie<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 380.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 384.96999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 560.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 529.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  <span style="display: inline-block; height: 20.25pt;"></span></span><div style="font-size: 0pt; left: 316.14pt; position: var(--position); top: 0pt; width: 213pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.92pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more about our R&amp;D to prevent and change the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.42pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">course of disease on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 94.5pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_52">10</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 102.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 112.83pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_88">29</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 32pt; position: var(--position); top: 623.08pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;9.9bn<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 660.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total deal value of AI/ML transactions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 671.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">completed&#160;by the biopharma sector in 2024. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 623.08pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 301.97pt; position: var(--position); text-decoration: none; white-space: pre;">$440bn<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 660.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Projected<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> global spending on oncology medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 671.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2028, according to IQVIA, making it the leading <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 682.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapy area as novel cancer treatments continue <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 693.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to be launched.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.63pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our external environment continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 10.12pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 16pt; position: var(--position); top: 143.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Changing demographics and health system pressures <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 16pt; line-height: 16pt; position: var(--position); top: 162.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.74pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">pave&#160;the way for a <span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 186.52999999999997pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">shift to<span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 232.66000000000003pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> preventative healthcare <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Life expectancy is rising once <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 172.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">again, following a dip during <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 204.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the COVID-19 pandemic<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 150.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. By 2030, the share of the world&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 215.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">population aged 60 and over will have risen to 1.4 billion. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 226.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">But&#160;a&#160;longer life does not always equate to a healthier life. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 237.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the US and Europe, rates of chronic disease, obesity and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disability have increased over successive generations. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changing demographics, and more complex health needs, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 277.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">put economies and health systems under increasing strain. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 288.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Although medicines comprise a relatively small proportion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 300.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of overall health budgets, containing drug costs remains <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 311.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a&#160;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 61.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> including for countries across Europe and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 322.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US&#160;as&#160;they look to manage health spending. U<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 237.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nder the US <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 333.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inflation Reduction Act, Medicare reduced prices for ten <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 345.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 96.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> But as population dynamics change, there is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 356.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing recognition of the val<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 178.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ue of preventative, pre-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 367.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emptive healthcare to support future health system <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 378.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainability and economic growth. Adult immunisation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alone can return up to 19 times its initial investment through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 401.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health and wider socio-economic benefits.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 218.67pt; left: 302.91pt; opacity: 1; position: var(--position); top: 192.05pt; width: 236.78pt; z-index: -2;"><div><div><div><div style="position: var(--position);"><img src="gsk-20241231_g16.jpg" alt="Ext env 2.jpg" style="height: 218.67pt; width: 236.78pt;"/></div></div></div></div><div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 204.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 316.14pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our response<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 219.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preven<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 344.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ting and mitigating the effects of disease, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 230.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;helping people to live well, is an important lever <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 241.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;improve health and strengthen productivity and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 511.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 252.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economic growth. We are investing in innovation to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 263.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">help prevent illness in the first place and prevent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 273.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progression of disease. Realising the full potential of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this innovation needs the right systems in place to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value the full health, social and economic benefits of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preventative healthcare. It also needs the appropriate<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 526.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 317.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infrastructure to help people access<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 456.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> care at the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 350.29999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 359.66999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the right place. We are engaging with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 338.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders to identify constructive <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 459.55999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 482.29999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> solutions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 349.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that would shift health systems from spending on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 360.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sickness to investing in health<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 433.84999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 436.31pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="position: var(--position); top: 376.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 529.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 20.25pt;"></span></span><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 224.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 11.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 22.5pt; position: var(--position); top: 0pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.92pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more about our commercial operations and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.42pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">performance on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 78.24pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_91">30</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 86.44pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 96.57pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4f3cafc74160423787557cf6ea4ca335_10721">43</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7.5pt; position: var(--position); top: 407.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 327.48pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="position: var(--position); top: 449.96pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ib34bb0e24db540c2998d1e5aaaa34da1_0-0-1-1-821446"></span><div style="height: 24.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 10.12pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trust<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 16pt; position: var(--position); top: 479.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Building trust and transparency is key to implementing innovation<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 510.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">People&#8217;s understanding of, and familiarity with, the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 521.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma industry remains relatively low. This contributes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 532.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to a lack of trust in the sector and levels of trust vary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 543.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significantly across geographies. The industry faces <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 555.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued scrutiny across a range of issues. Questions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 566.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">span from how the industry delivers a consistent, safe and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable supply of products that address unmet needs, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through to sourcing and using health data. Despite <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant strides to widen access to medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines, inequities remain both within and between <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 622.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries. As a result, the industry&#8217;s business model <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 633.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to come into question. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The role of the sector in responding to sustainability and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 662.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health security challenges, including pandemics and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 673.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rising tide of antimicrobial resistance (AMR), was also in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 684.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">spotlight again during 2024. Governments around the world <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 695.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreed a new political declaration on AMR, calling for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 707.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concerted investment in new medicines and vaccines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 718.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improved access to antibiotics, vaccines and diagnostics. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 281.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 735.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 216.01pt; left: 303.61pt; opacity: 1; position: var(--position); top: 510.16pt; width: 236.78pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g17.jpg" alt="Ext env 3.jpg" style="height: 216.01pt; width: 236.78pt;"/></div></div></div></div><div style="line-height: 11pt; position: var(--position); top: 521.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 316.14pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our response<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 537.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Building trust and transparency remains central to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 548.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustaining innovation and bringing medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 558.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines to patients; it is also core to delivering on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 569.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our&#160;ambitions for shareholders and society at large. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 580.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We recognise that challenge and it&#8217;s why we have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 591.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">embedded six areas of responsible busines<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 487.42999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s &#8211; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 602.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access; global health and health security; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 612.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment; inclusion and diversity; ethical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards; and product governance. These are areas <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where we can have the greatest impact. This ranges <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 645.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from delivering medicines and vaccines to the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 656.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient, at the right time, to&#160;responding to risks posed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 666.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by new pandemics, increasing resistance to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 677.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antimicrobials and the consequences of climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 688.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change and n<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 370.15999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ature los<span style="display: inline-block; height: 6.55pt;"></span><span id="i02c3dfbea84f4e1caa1e2347e5a39b62_7221"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 404.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 704.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 506.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 21.75pt;"></span></span><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 201.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 179.25pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 11.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 22.5pt; position: var(--position); top: 0pt; width: 179.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 179.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">Read more in the Responsible Business section on <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.13pt; width: 179.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.599999999999998pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_115">44</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.76pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 42.81pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifb5a2e4fe28c4808a3d7229e5ede1da1_4170">55</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">10<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 62.36pt;" id="idc89fa1ee07645df9629d157a4b46752_52"></div><div style="font-size: 12pt; line-height: 40pt; position: var(--position); top: 62.36pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 40pt; font-style: normal; font-weight: normal; left: 65.17pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">Research<span style="display: inline-block; height: 29.12pt;"></span><span id="ic9c1c2893e264d88abb1243fd3bfaf9a_30"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 40pt; font-style: normal; font-weight: normal; left: 228.32999999999998pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;"> and development<span style="display: inline-block; height: 29.12pt;"></span></span></div><div style="height: 104.24pt; left: 389.86pt; position: var(--position); top: 689.54pt; width: 153.07pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g18.gif" alt="" style="height: 114.24pt; width: 163.07pt;"/></div><div><div><div><div style="transform: translate(1.25pt, 1.25pt);"><div style="line-height: 8pt; position: var(--position); top: 8.5pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A scientist based at our Upper <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 18.1pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Providence site in the US, working in <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.7pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our Research Technologies group. <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 37.3pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This&#160;group is the foundation of our <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.9pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicine discovery, bringing together <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 56.5pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform and data groups to advance <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 66.1pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development across our therapy <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 75.7pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas including oncology and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.3pt; width: 150.57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div></div></div><div style="background-color: transparent; height: 677.78pt; left: 0.1pt; opacity: 1; position: var(--position); top: 163.9pt; width: 595.28pt; z-index: -1;"><div><div><div><div style="position: var(--position);"><img src="gsk-20241231_g19.jpg" alt="New R&amp;D divider.jpg" style="height: 677.78pt; width: 595.28pt;"/></div></div></div></div><div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.82pt; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 54pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_55"></div><div style="position: absolute; top: 114.19pt;" id="idc89fa1ee07645df9629d157a4b46752_58"></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 114.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">We <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 78.15pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">focus on the science <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 207.25pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of the immune system and advanced technologies <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 130.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;<span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 69.07pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">drive innovation &#8211; preventing and treating the most challenging diseases, <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 147.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">better and faster. <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 175.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Highlights<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 189.33pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">71<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 226.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets in the pipeline<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 189.33pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">19<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 226.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> assets in phase III/registration<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 32pt; position: var(--position); top: 189.33pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 226.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positive phase III readouts<span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 237.43pt; left: 53.88pt; position: var(--position); top: 254.68pt; width: 487.56pt; z-index: -1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g20.gif" alt="" style="height: 247.43pt; width: 497.56pt;"/></div><div><div><div style="transform: translate(2.09pt, 2.09pt);"></div></div></div></div><div style="position: var(--position); top: 257.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 483.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 230.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 224.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 224.25pt; left: 7.5pt; overflow: hidden; position: var(--position); top: 5.25pt; width: 230.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive phase III data and regulatory filing <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.83pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: italic; font-weight: normal; left: 26.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 59.150000000000006pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in COPD<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 32.93pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive phase III data and regulatory <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 46.13pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">filings&#160;for depemokimab, ultra-long-acting <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 59.33pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anti-IL5 biologic including for severe <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 72.53pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eosinophilic asthma<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 89.63pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 13.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive phase III data for <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: italic; font-weight: normal; left: 138.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 174.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, including <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 102.83pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall survival, and filings in 2L+ relapsed/<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 116.03pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refractory multiple myeloma<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 133.13pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 87.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> approval for myelofibrosis <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 146.33pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients with anaemia in Japan following <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 159.53pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approvals in the US, EU and UK<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 176.63pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: italic; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: italic; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 50.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> approval expanded to all adult <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 189.83pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients with primary advanced or recurrent <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 203.03pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endometrial cancer in the US and EU<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 221.92pt; width: 230.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 5.25pt; width: 225.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Breakthrough Therapy (US) and Priority <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.83pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicine (EU) designations for B7-H3-<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.03pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targeted ADC, GSK&#8217;227, in relapsed/<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 42.23pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refractory osteosarcoma<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 59.33pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fast-Track designation for bepirovirsen <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 72.53pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in&#160;chronic hepatitis B in the US and Japan <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 89.63pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin filed in the US as potential <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 102.83pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first&#160;new antibiotic for uUTI in 20 years <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 119.93pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: italic; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: italic; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 42.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> approval in adults aged 50-59 in <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 133.13pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;US, EU and Japan) and data indicating <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 146.33pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protection over three full RSV seasons<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 165.22pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Targeted business development including <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 178.42pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deals with Elsie Biotechnologies and <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 191.62pt; width: 225.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisition of IDRx<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.15pt; font-style: normal; font-weight: normal; left: 101.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.8pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 5.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 506.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our R&amp;D approach<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 66.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combining<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 107.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 109.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our understanding<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 181.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the science of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immune system with cutting-edge technology, we can <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 544.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discover and develop new medicines and vaccines with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 555.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;potential to transform people&#8217;s lives.&#160; &#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 572.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 83.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, we inv<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 113.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ested <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 138pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6.4 billion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 180.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in R&amp;D across our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 583.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">portfolio, up <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 102.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 115.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 168.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 171.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">C<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 177.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">E<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 183.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R on 2023. We have 71 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 595.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets in development, most of which have the potential to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 606.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be the first or best of their kind.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We focus our research and development on four therapy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas: respiratory, immunology and inflammation; oncology; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 645.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV; and infectious diseases. These are areas where <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 657.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant patient need remains and where we have the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 668.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strongest expertise and ability to deliver differentiated and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 679.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">needed medicines and vaccines at scale. P<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 224.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">atients are <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 268.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 690.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the heart of everything we do &#8211; we engage with them and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 702.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their healthcare providers to deeply understand the impact <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 713.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of disease and deliver innovation where it matters most. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 730.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rapid advances in science and technology are unlocking <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 741.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new opportunities to prevent and treat disease. Being able <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 752.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to better predict and pre-empt the course of disease means <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 764.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we can prevent it occurring in the first place and intervene <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 775.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earlier to slow its progress and limit further complications. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 786.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This can result in better outcomes, not only for patients, but <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 797.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for health systems and societies too. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 506.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Focusing on execution, technology and <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 519.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">culture<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 535.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Three priorities guide our research and development:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 552.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Execution<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 355.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; accelerating delivery of our pipeline of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 563.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovative medicines and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 415.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 450.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for patients who need <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 574.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">them. Find out more about the latest developments <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 585.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across our four therapy areas:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 599.12pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 15pt;"></span></span><div style="font-size: 0pt; left: 307.16pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.18pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_61">12</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 624.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 363.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 370.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> acting as a catalyst for R&amp;D at all stages, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 636.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from how we choose research targets to making clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 647.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trials as effective as possible. Discover how we deploy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 658.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced data and platform technologies<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 476.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to develop<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 519.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 669.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines that make a meaningful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 681.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difference to people&#8217;s health:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 426.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 694.38pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 15pt;"></span></span><div style="font-size: 0pt; left: 307.16pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.18pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_85">26</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 720.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Culture<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 344.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; focusing on delivering what matters most &#8211; for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 731.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, stakeholders and our people &#8211; better and faster. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 742.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">See how we f<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 366.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oster an environment where our people can <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 753.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thrive, make the right decisions, take smart risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 765.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">work effectively with each other and our partners: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 778.39pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 15pt;"></span></span><div style="font-size: 0pt; left: 307.16pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.18pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i790f5ce0ebd74867a80debd26af98cda_8703">58</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 804.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 313.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 315.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Closed in February 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 54pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_61"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Execution<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Accelerating <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 109.41pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">delivery<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 142.84pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> of our pipeline of innovative <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines for patients who need them<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our pipeline continues to grow and strengthen and we now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 182.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have 54 medicines and 17 vaccines in development.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 199.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over the past year we began nine phase I development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes, moved six assets into phase II and two into <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III. We had 13 positive phase III data readouts and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 233.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23 approvals or regulatory filings. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our focus and investment in R&amp;D are driving increased <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 261.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">productivity with <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 119.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">end-to-end success rates<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 219.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> more than <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 273pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">doubling from 2018-2023. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 157.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our phase III <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 211.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development cycle <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">times are now in the top quartile for the industry<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 241.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 244.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 246.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 249.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 301.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our rate of progress gives us confidence in our medium- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 312.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and long-term growth strategy. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 176.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From 2025 onwards we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expect a series of major launches with peak year sales of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 334.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over &#163;2 billion, with five approvals in 2025<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 218.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> alone. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 250.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also looking ahead to the next wave of R&amp;D innovation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on an even deeper understanding of the science of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the immune system with investment in scientific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 379.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partnerships and advanced platform and data technologies, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 391.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to identify the right target, the right intervention and the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 402.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient. This will drive longer-term growth and value for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 413.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, shareholders and our people. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 430.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In respiratory, we reported positive pivotal results for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 261.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 289.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 441.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in COPD and depemokimab, the world&#8217;s first six-monthly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 453.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">injectable for severe asthma and chronic rhinosinusitis with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 464.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nasal polyps (CRSwNP). This reinforced our ambition to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 475.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redefine the future of respiratory medicine. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 492.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also continued to see significant momentum in our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 503.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expanding oncology portfolio. This included approvals for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 515.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in endometrial cancer and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 194.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 218.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in myelofibrosis. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 526.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We saw positive phase III data for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 189.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 222.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in multiple <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 537.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">myeloma,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.50999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> including significantly improved overall survival <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 548.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates versus standard of care.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 171.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> This data <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 213pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highlighted<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 256.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> its <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 560.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential to materially redefine clinical practice.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We made progress towards introducing innovative long-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acting injectable regimens for HIV treatment and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 599.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention, with positive real-world data for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 225.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 261.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 610.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">promising phase I data for our ultra-long-acting formulation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 622.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of cabotegravir. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continued to strengthen our leadership in infectious <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases. Our market-leading RSV vaccine, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 228.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 255.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, gained <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 661.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expanded approvals in adults aged 50-59 and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 672.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrated sustained efficacy over three RSV seasons. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 683.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We submitted gepotidacin for regulatory review. This is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 695.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potentially the first in a new class of oral antibiotics in 20 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 706.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for uncomplicated urinary tract infections, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 717.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recurrently affects around one third of women. Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oligonucleotide, bepirovirsen, was granted Fast-Track <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">status in the US and Japan. This takes us a step closer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">towards a functional cure for chronic hepatitis B<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 491.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 181.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affects around 300 million people worldwide. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 482.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 198.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strengthening innovation through collaboration <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 208.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;business development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To complement our in-house R&amp;D, we partner with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 233.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">world&#8217;s best minds and leading institutions to enable access <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to novel science and technology. This allows us to add to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 256.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our pipeline, bring in unique data insights and integrate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 267.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform technologies to find new ways of addressing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 278.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 295.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Targeted business development in 2024 resulted in 12 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions and discovery collaborations across biotech. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 530.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 318pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">June 2024 we acquired Elsie Biotechnologies whose <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform technology will expand our oligonucleotide <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline. We supplemented our pipeline with acquisitions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 352.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T-cell engager<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 409.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CMG1A46 from Chimagen for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development in lupus, and a TSLP inhibitor from Aiolos Bio <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for asthma and other respiratory conditions.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 391.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also partnered with Flagship Pioneering and its portfolio <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 40+ bioplatform companies, aiming to discover and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">develop new potential medicines and vaccines. Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">presence in gastrointestinal oncology was strengthened <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 338.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisition of IDRx Inc. which includes IDRx-42,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 527.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly selective KI<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 376pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 381.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> tyrosine kinase inhibitor<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 476.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 479.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In addition, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 458.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we have the option to acquire DB-1324, an antibody drug <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 469.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conjugate (ADC), from Duality Biologics.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Collaboration with academia is at the heart of scientific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 498.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress and a fundamental part of our R&amp;D approach to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 509.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">better understand disease processes. In October 2024, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 520.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">announced a five-year collaboration with Cambridge <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 531.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">University focusing on kidney and respiratory disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 543.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re&#160;also working with Boston University&#8217;s Center for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 554.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regenerative Medicine to develop a better understanding of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 565.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory diseases such as pulmonary <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 464.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fibrosis and with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 576.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oxford University to advance novel cancer research, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 588.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused on the potential of cancer prevention through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 599.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccination<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 349.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 616.32pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more about our technology collaborations on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 187.59pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ia09805a2489c4acfbb9bafafa8edf0a5_12468">28</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 640.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Focusing on our four core therapeutic areas<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 653.56pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory, immunology and inflammation, see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 177.60999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_67">13</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 12.75pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Oncology, see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.50999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_73">16</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 25.5pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">HIV, see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.550000000000004pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_76">20</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 38.25pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Infectious diseases, see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 101.36999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_82">22</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 41.87pt; left: 49.36pt; opacity: 1; position: var(--position); top: 766.05pt; width: 230.26pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Source: Centre for Medicines Research<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 10.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Penmenvy<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 44.150000000000006pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our 5-in-1 meningococcal vaccine, was approved in the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.8pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US in February 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 29.2pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acquisition completed in February 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_67"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory, immunology and inflammation <span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For over five decades, we have been at the forefront of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 161.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most complex respiratory health challenges. We have a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 172.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deep understanding of the underlying drivers of disease in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 184.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">different groups of patients with conditions like asthma and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 195.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chronic obstructive pulmonary disease (COPD). Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 206.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambition is to redefine the future of respiratory medicine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 217.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with a broad portfolio of next-generation long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 229.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments that work in distinct ways to help as many <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 240.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients as possible. We continue to pursue the most <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 251.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambitious treatment goals, aiming for early interventions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 262.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that prevent, treat and stop disease, limiting future <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 274.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complications for patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 291.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our deep understanding of the immune system is also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 302.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leading to advances in our growing immunology pipeline. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 313.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Here, we&#8217;re building on our decades of knowledge in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 324.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflammatory mechanisms to target fibrotic lung, liver and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 336.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">kidney disease with innovative treatments that aim to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">modify underlying disease dysfunction and prevent disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 358.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progression. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 105.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 375.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">In this section:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 388.95pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 16.31pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asset<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential indication/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">label expansion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 61.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 27.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1&#160; <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 33.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(mepolizumab)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-IL5 monoclonal antibody <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for five respiratory conditions<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depemokimab <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-IL5 monoclonal antibody <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for four respiratory conditions<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Camlipixant<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P2X3 inhibitor for refractory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chronic cough <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 33.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 37.199999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 39.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(belimumab)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-BLyS monoclonal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody&#160;for systemic lupus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">erythematosus and lupus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.03pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nephritis<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CMG1A46<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dual CD19 and CD20-targeted <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T-cell engager for lupus and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related auto-immune conditions<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 178.5pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;990 <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 178.5pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antisense oligonucleotide <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for&#160;metabolic dysfunction-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated steatohepatitis <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.03pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;alcoholic liver disease <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 223.5pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Linerixibat <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 223.5pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IBAT inhibitor for cholestatic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pruritus in primary biliary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cholangitis <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 658.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See a more detailed pipeline listing on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_88">29</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.82999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 175.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 17.29pt; left: 49.36pt; opacity: 1; position: var(--position); top: 772.82pt; width: 230.26pt; z-index: 2;"><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets with existing approval or in development for label expansion <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are italicised<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory<span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 100.83pt; left: 304.44pt; position: var(--position); top: 172.67pt; width: 240.75pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g21.gif" alt="" style="height: 110.83pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 8.15pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Half of the top six causes of death globally are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 19.4pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lung&#160;diseases, which claim around seven million <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 30.65pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lives&#160;each year.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 47.59pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alongside lung cancer, COPD and lower respiratory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 58.84pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tract infections are critical healthcare challenges with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 70.09pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD affecting more than 300 million <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 81.34pt; width: 237.84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people&#160;globally. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 282.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory diseases can create a significant physical, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">social and emotional burden for those affected, along with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 305.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial impact on people and healthcare systems. Older <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments that are typically used to manage them are not <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">always adequate. This is why we&#8217;re focusing our research <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on medicines that can potentially better control symptoms <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and slow disease progression by targeting underlying <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drivers of disease, like inflammation. For some patients, it <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 372.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may even be possible to achieve clinical remission, where <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 384.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they no longer experience symptoms and exacerbations, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 395.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">don&#8217;t need to use oral steroids, and have stabilised lung <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 406.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">function. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 423.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Next-generation treatments for patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 434.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">with IL5 mediated conditions<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For some patients with respiratory conditions like severe <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 459.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asthma, COPD and chronic rhinosinusitis with nasal polyps <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 470.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(CRSwNP), their disease is driven by &#8216;type 2&#8217; inflammation. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 481.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A&#160;cytokine (protein), known as interleukin-5 (IL5), plays a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 492.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key role in driving this inflammation, making it a proven <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 504.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment target for these patients. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Type 2 inflammation is the underlying driver of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 532.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unpredictable exacerbations and is seen in more than 80% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 543.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of people with severe asthma and up to 40% of people with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 554.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD. Rarer diseases including eosinophilic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 566.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">granulomatosis with polyangiitis (EGPA) and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 577.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hypereosinophilic syndrome (HES) are also driven by IL5. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 594.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We now have two anti-IL5 biologic treatments in our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 605.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline. Our aim is to achieve more than simply controlling <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 616.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the symptoms of these inflammatory diseases. Instead, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 627.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strive to identify and target the underlying disease process <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 639.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to slow, or even stop, disease progression. This may help <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 650.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduce the risk of organ damage and achieve clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 661.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remission, where possible.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 678.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We pioneered the research that established the role of IL5 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 689.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in respiratory diseases and continue to apply our knowledge <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 701.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as we explore other inflammatory pathways which may be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 712.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future targets. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">14<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Extending the impact of <span style="display: inline-block; height: 6.55pt;"></span><span id="ib80eecc1a6a7479c9d49ca3dd24e0496_169"></span><span id="ib80eecc1a6a7479c9d49ca3dd24e0496_170"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 148.65pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 176.20999999999998pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> to more patients<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 241.99pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Despite the availability of inhaled therapies, around half <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of&#160;respiratory patients continue to experience debilitating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attacks (exacerbations) of their disease each year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preventing these exacerbations, including the most severe <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">events that lead to emergency hospital visits or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hospitalisation, is a key treatment goal to reduce the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact&#160;on patients and on healthcare resources. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (mepolizumab), our anti-IL5 biologic (monoclonal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody), is the only treatment in the US and Europe with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indications in four IL5 mediated diseases.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 250.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we gained new approvals for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 204.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 232.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In Japan, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 262.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">it&#160;was approved for CRSwNP in cases where standard <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments aren&#8217;t controlling disease. An estimated two <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million people suffer from chronic rhinosinusitis in Japan, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with 200,000 needing surgery for nasal polyps. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 312.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was also approved for use in two additional <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indications in China. Alongside its indication in EGPA, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 335.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is now approved as a treatment for severe asthma <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 346.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with an eosinophilic phenotype and in CRSwNP, making it <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 357.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the first targeted IL5 treatment in both conditions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In China, asthma affects 46 million adults, 6% of whom <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience severe asthma, and CRSwNP affects <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately 35 million people.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 414.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In September 2024, we presented positive pivotal results <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from our phase III MATINEE trial of mepolizumab in patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with COPD. The study met its primary endpoint, with data <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">showing a statistically significant and clinically meaningful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 459.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction in the annualised rate of moderate or severe <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 470.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exacerbations compared to placebo. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Based on these data, in December 2024, the US FDA <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 498.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accepted a regulatory submission seeking a new indication <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 509.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the use of mepolizumab in patients with COPD. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 526.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Improving outcomes for patients with&#160;ultra-long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 537.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">treatments<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 551pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-acting therapies that target the underlying drivers of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 562.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease to provide sustained suppression of inflammation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 573.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could further advance treatment of severe asthma and other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 584.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory or immune mediated disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 601.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depemokimab has the potential to be the first approved <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 612.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ultra-long-acting anti-IL5 biologic with six-month dosing. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 624.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This could offer millions of patients with respiratory diseases <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 635.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustained efficacy benefits including a reduction in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 646.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exacerbations and hospitalisations, as well as limiting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 657.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cumulative lung damage and disease progression with just <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 669.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">two injections per year. Extended dosing intervals could <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 680.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also help tackle other barriers to patients achieving optimal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 691.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcomes, such as adherence challenges or the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 702.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inconvenience of frequent healthcare appointments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we announced positive results from the SWIFT-1 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and SWIFT-2 phase III trials of depemokimab in patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with severe asthma with type 2 inflammation. Both trials <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">met&#160;their primary endpoints with statistically significant <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reductions in the annualised rate of clinically significant <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exacerbations (asthma attacks) over 52 weeks versus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">placebo. Importantly, there was also a 72% reduction in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exacerbations leading to hospitalisation. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In October 2024, we also announced positive phase III <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data&#160;from our ANCHOR-1 and ANCHOR-2 trials for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depemokimab in patients with CRSwNP. Data from the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ANCHOR and SWIFT programmes have been used to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support filing acceptances in China, Japan and Europe, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;regulatory submission in the US, for the use of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depemokimab for two indications; in asthma with type 2 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 287.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflammation and CRSwNP. Additional submissions will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 299.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur through 2025. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to explore other potential long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory treatments in our early pipeline that could benefit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 338.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a broader range of patients. These include our&#160;<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 349.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-acting anti-thymic stromal lymphopoietin (TSLP) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monoclonal antibody, currently in phase II for patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 372.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whose asthma is not driven by type 2 inflammation; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 383.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;our anti-IL33 asset in phase I for COPD. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 400.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Addressing the unmet need in refractory chronic cough <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 411.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">with camlipixant<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Camlipixant, our potential treatment for patients with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refractory chronic cough (RCC), became part of our pipeline <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through the acquisition of Bellus Health in 2023. It is in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 458.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III development. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 475.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clinical data has shown that by selectively inhibiting P2X3 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receptors, camlipixant may reduce cough frequency for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 497.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RCC patients with a relatively low incidence of dysgeusia. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 514.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chronic cough affects around 28 million people, and around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 526.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 million suffer from RCC for over a year. RCC is a cough <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 537.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that lasts for more than eight weeks, doesn&#8217;t respond to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 548.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment for an underlying condition and is otherwise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 559.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unexplained. There&#8217;s currently no effective treatment, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 571.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients often cycling through other therapies and seeing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 582.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specialists with no resolution. They can also suffer from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 593.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depression, incontinence and sleep loss.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Immunology<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">Our deep understanding of the immune system is opening up <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">new opportunities to help patients with a range of immune-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">mediated conditions beyond respiratory. Data and platform <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 163.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">technology collaborations are enabling us to understand <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 174.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">underlying disease processes, reach previously inaccessible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 185.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">targets and better identify patients for treatment. Our work in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 196.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">human genetics and phenotyping is generating insights that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 208.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">are informing moves into other areas, including liver disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 224.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Broadening use of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 134.01pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 170.92000000000002pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> for immune-mediated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 235.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">conditions<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to develop <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 149.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 183.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our anti-B lymphocyte <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 260.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stimulator monoclonal antibody, for a range of immune-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 271.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mediated conditions, as well as systemic lupus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">erythematosus (SLE) and lupus nephritis (LN). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 299.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> has been approved to treat adults and children <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 311.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with SLE and LN in more than 60 countries, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 322.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;US,&#160;Japan, Europe and the UK. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta&#8217;s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 94.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> robust and expansive evidence includes nine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">randomised controlled trials (RCT), including six placebo-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlled phase III trials in adult SLE, including LN. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 378.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These data underpin <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 138.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta&#8217;s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 178.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> potential in the short- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;long-term treatment of SLE and LN, including reduction <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 401.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of flares, tapering of oral corticosteroids (OCS) and helping <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 412.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to prevent damage to vital organs via a disease modifying <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 423.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">action. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 440.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Reinforcing our portfolio for lupus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In October 2024, we acquired CMG1A46 from Chimagen <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 465.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biosciences to reinforce our portfolio for the treatment of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 476.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lupus and underlying drivers of autoimmune disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 488.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CMG1A46, a clinical-stage dual CD19 and CD20-targeted <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 499.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T&#160;cell-engager, has the potential to deplete uncontrolled B <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 510.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cells present in autoimmune diseases, such as lupus.&#160;<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I trials in lupus are likely to begin in 2025.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Building on our early pipeline to address liver disorders<span style="display: inline-block; height: 6.55pt;"></span><span id="ib80eecc1a6a7479c9d49ca3dd24e0496_172"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;990 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;990 is our investigational RNA interference therapeutic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">for steatotic liver disease (SLD), an area of substantial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 162.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">unmet need. Around 26 million patients globally have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 174.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">advanced alcoholic liver disease (ALD) and it accounts for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 185.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">half of liver-related deaths in developed countries. There are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 196.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">currently no pharmacological treatments available. Around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 207.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">265 million patients globally have metabolic dysfunction-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 219.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">associated steatohepatitis (MASH), which causes a build-up <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 230.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">of fat in the liver that can eventually lead to scarring and, in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 241.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">some cases, severe liver damage, liver failure and even <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 252.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">death. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 269.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Genetic analysis has shown a strong association between <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 281.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the HSD17B13 gene and advanced ALD and MASH. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 292.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;990 targets HSD17B13 resulting in highly specific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 303.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">binding to receptors that are only expressed on liver cells. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 314.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It&#160;is now in early development to address the liver fibrosis <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 326.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated with ALD and MASH and prevent disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 337.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progression with an improved dosing schedule versus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 348.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">current treatment options. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 365.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Linerixibat<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 378.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Linerixibat is our investigational product for the treatment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of&#160;cholestatic pruritus in patients with primary biliary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 401.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cholangitis (PBC). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 418.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cholestatic pruritus causes an internal itch that cannot be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 429.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relieved by scratching. Linerixibat has the potential to be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 440.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;first global therapy to treat this itch. It is a minimally <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 452.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">absorbed small molecule inhibitor of an ileal bile acid <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 463.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transporter (IBAT), administered as an oral tablet. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 480.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In November 2024, positive phase III results demonstrated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 491.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a&#160;statistically significant improvement in itch versus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 502.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">placebo, potentially supporting patients whose quality of life <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 514.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is significantly affected by persistent itching.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_73"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cancer is one of the world&#8217;s leading causes of death, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 161.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment options are still limited for many patients. Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 172.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambition is to help increase overall quality of life, maximise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 184.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">survival and change the course of disease, expanding from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 195.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our current focus on blood and gynaecologic cancers into <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 206.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lung and gastrointestinal cancers, as well as other solid <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 217.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tumours with our antibody drug conjugates. Our research <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 229.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uses precision medicine-based technology to match the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 240.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">right treatment to the right patient. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 257.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cancer is complex with multiple, connected biological <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 268.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes contributing to the development and progression <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 279.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of disease. Our oncology portfolio includes a range of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 291.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines that target different aspects of cancer biology, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 302.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including uncontrolled cell division (<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 193.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep; Ojjaara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 257.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 313.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immune system evasion (<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 154.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and DNA mutation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 324.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 56.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, B7-H3 ADC; B7-H4 ADC). As our understanding of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 336.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these disease processes deepens, we&#8217;re exploring the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential of our medicines, alone and in combination, across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 358.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiple cancer types with the aim of offering <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 369.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transformational solutions for as many patients as possible.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 386.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">In this section:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 400.2pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.86pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 192.75pt;"></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 228pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 132.75pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 16.34pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asset<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.07pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential indication/label <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.87pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expansion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 40.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: italic; font-weight: normal; left: 30.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 32.099999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(belantamab <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mafodotin)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BCMA-targeted antibody drug <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conjugate (ADC) for multiple <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">myeloma <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: italic; font-weight: normal; left: 62.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(momelotinib)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JAK1, JAK2 and ACVR1 inhibitor <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for myelofibrosis with anaemia<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli (dostarlimab)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-PD1 monoclonal antibody <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for endometrial, colorectal, head <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and neck, and lung cancers<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: italic; font-weight: normal; left: 24.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 25.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(niraparib)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PARP inhibitor for ovarian, brain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and lung cancer<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;227 <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B7-H3-targeted ADC for lung <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer and other solid tumours<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 95.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;584<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 132.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B7-H4-targeted ADC for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 132.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gynaecological cancers<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 603.71pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See a more detailed pipeline listing on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_88">29</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.82999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 175.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 17.29pt; left: 49.36pt; opacity: 1; position: var(--position); top: 792.05pt; width: 230.26pt; z-index: 7;"><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets with existing approval or in development for label expansion <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are italicised<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Targeting uncontrolled cell division<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 166.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 337.78000000000003pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; potential to redefine multiple myeloma <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 177.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">treatment<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 144.57pt; left: 303.69pt; position: var(--position); top: 197.36pt; width: 240.75pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g22.gif" alt="" style="height: 154.57pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(2.16pt, 2.16pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 9.58pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multiple myeloma is the third most common blood <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 20.83pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer globally, with around 180,000 cases <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 32.08pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diagnosed every year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 49.02pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The five-year survival rate is under 60%, and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 60.27pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease is considered treatable but not curable. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 77.21pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multiple myeloma often becomes resistant to existing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 88.46pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments, which may require inpatient care, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 99.71pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlining the need for new therapies with novel <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 110.96pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mechanisms of action that can be easily <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 122.21pt; width: 236.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">administered in the clinic.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 335.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (belantamab mafodotin) is our antibody-drug <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conjugate treatment for relapsed/refractory multiple <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">myeloma, which we&#8217;re evaluating in early lines of treatment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in combination with novel therapies and current standard of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 396.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">care treatments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we announced pivotal data from our DREAMM <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development programme showing the potential for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 435.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belantamab mafodotin to become a new standard of care at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first relapse or later for patients with multiple myeloma. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 463.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The DREAMM-7 phase III trial showed patients receiving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 475.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 335.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, combined with bortezomib and dexamethasone <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(BVd), lived a median of almost three times longer without <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 497.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their disease progressing than those receiving a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 508.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">daratumumab-based combination. A subsequent planned <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 520.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">analysis, presented at ASH in December 2024, showed that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 531.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients receiving the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 391.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 422.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> combination had a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 542.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statistically significant and clinically meaningful 42% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 553.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction in the risk of death versus standard of care which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 565.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may translate to giving patients a median additional three <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 576.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years of life, based on projections. The DREAMM-8 phase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 587.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">III study showed a nearly 50% lower risk of disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 598.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progression or death, as well as a positive overall survival <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 610.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trend, for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 342.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 373.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, in combination with pomalidomide plus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 621.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dexamethasone (BPd), compared to standard of care.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 638.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Both studies also reinforced the well-characterised side-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 649.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effect profile of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 365.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 396.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, with patient quality of life that is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 660.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparable to standards of care. Eye-related side effects <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 672.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were shown to be managed effectively through dose <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 683.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">modifications without compromising efficacy. Ease of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 694.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">administration in a community setting is likely to be an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 705.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additional advantage for patients and their healthcare <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 717.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">professionals.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 103.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combinations were accepted for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory review in the US, Europe, Japan, UK, Canada <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and China under priority review. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 181.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 212.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was also granted <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">orphan drug designation in Japan and, in combination with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BorDex, received Breakthrough Therapy Designation in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">China, reflecting the high unmet need and potential for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improvement in patient outcomes over available treatment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">options in relapsed/refractory multiple myeloma.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In December 2024, we started a phase III trial, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DREAMM-10, with belantamab mafodotin as a first-line <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiple myeloma treatment.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 248.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 119.31pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; improving outcomes for patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 259.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">with myelofibrosis with anaemia<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 108.71pt; left: 52.75pt; position: var(--position); top: 281.29pt; width: 240.75pt; z-index: 2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g23.gif" alt="" style="height: 118.71pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.57pt, 1.57pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 9.12pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Myelofibrosis (MF) is a rare blood cancer that affects <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 20.37pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">around 1 in 500,000 people around the world. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 37.31pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">About 40% of MF patients are anaemic at diagnosis, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 48.56pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and nearly all eventually develop anaemia and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 59.81pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">become dependent on regular blood transfusions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 76.75pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This leads to around 30% stopping treatment with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 88pt; width: 237.61pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established therapies. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 399.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, known as <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 127.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 158.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in several countries, is the only <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 410.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicine indicated for newly diagnosed and previously <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 421.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treated MF patients with anaemia. It is a new standard of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 433.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">care, as more established MF treatments can exacerbate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 444.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anaemia. Taken orally once a day it is the only therapy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 455.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrating durable clinical benefit on spleen response, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 466.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">symptoms and anaemia for patients with MF.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 483.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 88.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 117.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was approved under the brand name <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 495.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 85.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in the EU and UK, as well as in Japan, where 70% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 506.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of patients with primary MF and 50% with secondary MF <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 517.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have moderate to severe anaemia when they&#8217;re diagnosed. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These approvals followed US approval in 2023.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Targeting immune system evasion<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 341.23pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; treating more patients with endometrial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 96.38pt; left: 303.69pt; position: var(--position); top: 162.52pt; width: 240.75pt; z-index: 3;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g24.gif" alt="" style="height: 106.38pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.39pt, 1.39pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 8.76pt; width: 237.97pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Endometrial, or uterine, cancer is the most common <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 20.01pt; width: 237.97pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gynaecologic cancer in developed countries.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 36.95pt; width: 237.97pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Globally around 1.6 million people live with active <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 48.2pt; width: 237.97pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease, with 417,000 new cases reported each year.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 65.14pt; width: 237.97pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Around 15-20% of patients have advanced disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 76.39pt; width: 237.97pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when they&#8217;re diagnosed.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 268.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli (<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 343.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dostarlimab) is the foundation of our ongoing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 279.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immuno-oncology-based research and development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 290.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme. Our targeted research approach has identified <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 302.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities to address a specific biomarker, known as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 313.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dMMR/MSI-H, that is present in some gynaecologic and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 324.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other cancer types, such as colorectal cancer.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 341.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In combination with chemotherapy, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 444.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 477.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 352.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first&#160;new medicine to be approved for patients with dMMR/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MSI-H primary advanced or recurrent endometrial cancer in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 375.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decades. It is the only immuno-oncology-based treatment to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 386.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">show a statistically significant improvement in&#160;overall <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">survival for all patients with this type of endometrial cancer. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 414.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our phase III RUBY trial showed that patients treated with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 338.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and chemotherapy had a 31% lower risk of death <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than those treated only with chemotherapy.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the US FDA expanded approval for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 480.07000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 513.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> plus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 465.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chemotherapy to include all patients with primary advanced <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 476.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or recurrent endometrial cancer. In January 2025, the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European Commission also expanded approval to the same <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 499.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">group in the EU. This broadens the previous indication to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 510.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include mismatch repair proficient (MMRp)/microsatellite <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stable (MSS) tumours. These represent approximately 75% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 532.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of patients diagnosed with this type of endometrial cancer, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 544.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">who have limited treatment options.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">18<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Unprecedented results in locally advanced&#160;dMMR&#160;<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">rectal cancer<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 108.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 83.37pt; left: 52.75pt; position: var(--position); top: 143.85pt; width: 240.75pt; z-index: 4;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g25.gif" alt="" style="height: 93.37pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.20pt, 1.20pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 16.54pt; width: 238.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Colorectal cancer is the third most diagnosed cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 27.79pt; width: 238.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the world.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 44.73pt; width: 238.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It accounts for around a tenth of all cancer cases, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 55.98pt; width: 238.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is the second leading cause of cancer-related death.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 236.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The dMMR/MSI-H biomarker is also present in colorectal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 247.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancers, so we&#8217;re using this, along with our advanced AI <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 259.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and ML technologies, to inform our development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 270.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme for dostarlimab beyond endometrial cancer.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 287.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we announced updated results from a phase II <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 298.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">study of dostarlimab in locally advanced, dMMR rectal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 309.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer, with all 42 patients showing no evidence of disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 321.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">after treatment. This is a collaborative study with Memorial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 332.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sloan Kettering Cancer Center evaluating dostarlimab as a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 343.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first-line treatment and alternative to life-altering surgery. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 354.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our AZUR-1 trial is an ongoing global phase II registrational <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 366.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical trial that aims to confirm these promising findings. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Based on these data, the FDA granted Breakthrough <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 388.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Therapy Designation for dostarlimab reflecting its potential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 399.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in this patient population.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 416.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are also advancing studies evaluating dostarlimab in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 427.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients with advanced/metastatic stages of dMMR/MSI-H <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 439.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">colon cancer. AZUR-2 is our ongoing phase III trial for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 450.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dMMR/MSI-H advanced colon cancer to replace <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 461.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chemotherapy as the current standard of care after surgery.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Differentiated clinical trial design in unresected <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">head and neck cancer<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 141.73pt; left: 303.69pt; position: var(--position); top: 143.85pt; width: 240.75pt; z-index: 5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g26.gif" alt="" style="height: 151.72pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(2.04pt, 2.04pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 25.16pt; width: 236.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Head and neck cancer accounts for approximately <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 36.41pt; width: 236.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5% of all cancer cases and deaths, globally, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 47.66pt; width: 236.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;incidence increasing across many countries.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 64.6pt; width: 236.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nine in 10 patients with head and neck cancer have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 75.85pt; width: 236.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">squamous cell carcinoma, and the majority are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 87.1pt; width: 236.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diagnosed with locally advanced disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we started our JADE phase III study evaluating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dostarlimab in locally advanced head and neck cancer, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 317.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where long-term survival remains poor and significant <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unmet need exists. Building on learnings from previous <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">studies, JADE has key design characteristics that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">differentiate from other approaches and increase our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence that dostarlimab has the potential to benefit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients where other immunotherapies have failed.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Exploring the impact of dostarlimab combinations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 404.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re studying dostarlimab in combination with several <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 415.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential therapeutic options for non-small cell lung cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 426.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(NSCLC).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 443.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The GALAXIES-Lung 301 phase III trial is investigating our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anti-TIGIT antibody, belrestotug, in combination with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 466.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dostarlimab in first-line PDL1-high NSCLC. We started this <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 477.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trial in 2024 based on promising interim results from the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 488.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GALAXIES-Lung 201 phase II trial.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 505.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our phase III COSTAR-Lung trial in second-line advanced <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NSCLC continues to evaluate a triplet combination of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cobolimab, our anti-TIM-3 antibody, plus dostarlimab plus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 539.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chemotherapy, compared to a doublet combination of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 550.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dostarlimab plus chemotherapy, compared to standard of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 561.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">care chemotherapy alone. We expect the trial to read out in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 573pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">19<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Targeting mutation and repair of DNA<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Niraparib &#8211; our PARP inhibitor for ovarian cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;beyond <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 153.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to assess the potential of niraparib, currently <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 164.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved as <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 105.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 129.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for ovarian cancer, across multiple <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 176.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tumour types and in combination with other agents.In June <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 187.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, the GLIOFOCUS phase III trial began, evaluating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 198.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">niraparib in newly diagnosed MGMT unmethylated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">glioblastoma (brain cancer). This is sponsored by the Ivy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brain Tumor Center and supported by GSK. The decision to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress to phase III was prompted by positive results in an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 243.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earlier clinical trial, conducted by the Ivy Brain Tumor <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Center, where niraparib showed significant results in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reaching the tumour and changing how the cancer grew.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The broader development programme for niraparib includes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the ZEAL-1L phase III trial evaluating niraparib in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 305.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combination with standard of care for the maintenance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment of first-line advanced NSCLC, and the FIRST <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III trial assessing its potential in combination with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dostarlimab in first-line ovarian cancer which met its primary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endpoint. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;227 B7-H3 targeted ADC &#8211; promising preliminary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">data in extensive stage small-cell lung cancer<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 93.54pt; left: 304.88pt; position: var(--position); top: 141.85pt; width: 240.75pt; z-index: 6;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g27.gif" alt="" style="height: 103.54pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.35pt, 1.35pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 10.23pt; width: 238.05pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lung cancer is the leading cause of cancer-related <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 21.48pt; width: 238.05pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deaths worldwide, accounting for the highest mortality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 32.73pt; width: 238.05pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates among both men and women.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 49.67pt; width: 238.05pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Most lung cancers are non-small-cell lung cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 60.92pt; width: 238.05pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(NSCLC) which is often diagnosed at advanced <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 72.17pt; width: 238.05pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stages where treatment options are limited. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 244.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;227 is our investigational B7-H3-targeted antibody-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug conjugate (ADC). B7-H3 is over-expressed in a wide <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 267.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">range of solid tumour types, including lung.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the US FDA granted Breakthrough Therapy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Designation for GSK&#8217;227 for patients with extensive-stage <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">small-cell lung cancer (ES-SCLC) with disease progression <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 317.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on or after platinum-based chemotherapy (relapsed or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refractory). GSK&#8217;227 also received Priority Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(PRIME) Designation from the EMA. These designations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflect the significant unmet need in ES-SCLC and are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on promising early data from the ARTEMIS-001 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase I study which were presented at the 2024 World <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Conference on Lung Cancer. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect to conduct a broad development programme for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;227 and, in 2024, started a phase I platform study for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced solid tumours, which includes a cohort for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients with relapsed or refractory ES-SCLC. In December <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, the US FDA granted Breakthrough Therapy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 458.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Designation for GSK&#8217;227 in late-line relapsed or refractory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 469.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">osteosarcoma. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re also exploring two other ADCs. GSK&#8217;584, our B7-H4-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 498.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targeted ADC, is being evaluated for gynaecologic cancers, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 509.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as endometrial and ovarian cancer. And we have an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 520.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exclusive option to acquire ADC, DB-1324 from Duality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 531.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biologics for gastrointestinal tumours.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_76"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For nearly four decades, we&#8217;ve worked to improve the lives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 161.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of people living with HIV or those who could benefit from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 172.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 71.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 112.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Having launched the first long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 184.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">injectable options for HIV treatment and prevention, patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 195.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now only need to take medication a few times a year <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 206.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instead of every day. We are focused on even longer-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 217.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">options for treatment and prevention, including the option to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 229.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treat at home as well as ultimately finding a cure.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 104.88pt; left: 52.75pt; position: var(--position); top: 250.36pt; width: 240.75pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g28.gif" alt="" style="height: 114.88pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.51pt, 1.51pt);"><div style="line-height: 9pt; position: var(--position); top: 10.11pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40 million people live with HIV globally, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 21.36pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.3&#160;million new cases diagnosed in 2023. In the US, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 32.61pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">around one third of people living with HIV struggle <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 43.86pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;maintain viral suppression.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 60.8pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV incidence continues to grow despite progress in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 72.05pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">care, highlighting that an urgent need still exists for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 83.3pt; width: 237.72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new options to prevent and treat HIV.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 364.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our work in HIV is led by ViiV Healthcare, which we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 375.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">majority-own, with Pfizer and Shionogi as shareholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 387.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare is the only company exclusively dedicated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 398.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to treating and preventing HIV with an ambition to end the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 409.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV epidemic.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 426.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare&#8217;s integrase strand transfer inhibitors <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(INSTIs), the core of our current long-acting and daily <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 449.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapies, are trusted by healthcare professionals <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 460.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide for their potency, durability, long-term tolerability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 471.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and high barrier to resistance. The foundation was set with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 482.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our first INSTI-based medicine, dolutegravir, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 494.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established a gold-standard for daily oral therapy. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 250.35000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 505.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">follow up, long-acting cabotegravir injectables, increased <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 516.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dosing intervals to every two months. And now, our aim is to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 527.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase the treatment and prevention dosing interval to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 539.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">every four to six months. This could mean fewer visits to the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 550.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinic for people, as well as more choices for treatment and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 561.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention, and the assurance of long-term efficacy. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 578.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Working towards a clear mission to leave no person living <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 589.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with HIV behind, and grounded in our deep understanding <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of patient insights, we took more steps in 2024 towards <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 612.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing a new generation of longer-acting medicines to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 623.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treat or prevent <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 116.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 130.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 17.29pt; left: 49.36pt; opacity: 1; position: var(--position); top: 789.86pt; width: 230.26pt; z-index: 2;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets with existing approval or in development for label expansion <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are italicised<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">In this <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 330.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">section<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 358.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 163.82pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 17.81pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asset<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.82pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential indication/label <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 15.62pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expansion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 40.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 42.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(cabotegravir/ <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rilpivirine)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-acting 2DR for HIV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(dolutegravir/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lamivudine)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2DR for HIV treatment<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(cabotegravir)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 84pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-acting PrEP for HIV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 0pt; overflow: hidden; position: var(--position); top: 111pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;744 (cabotegravir/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CAB-ULA)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 111pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ultra-long-acting HIV treatment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and prevention<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 0pt; overflow: hidden; position: var(--position); top: 138pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH&#8217;184<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 138pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Third-generation INSTI for HIV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 165pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> VH&#8217;310<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 165pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ultra-long-acting HIV treatment<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 354.51pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See a more detailed pipeline listing on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_88">29</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.82999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 175.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 377.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 356.67pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; underlining the efficacy&#160;<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of our&#160;long-acting <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 399.61pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">treatment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 407.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 345.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (cabotegravir; rilpivirine) is the world&#8217;s first and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 418.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">only complete, long-acting injectable treatment for HIV,&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 429.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launched in 32 markets around the world. Administered in a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 440.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinic, only six times a year, it provides people living with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 452.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV with an alternative to daily pills. The result is that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 463.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people living with HIV may have a better quality of life by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 474.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improving their treatment adherence and reducing stigma or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 485.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fear of disclosure. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 502.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, interim data from the LATITUDE phase III trial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 513.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">showed <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 338.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 378.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was more effective than daily oral <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 525.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapy at maintaining viral load suppression in people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 536.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">living with HIV with a history of antiretroviral treatment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 547.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adherence challenges. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 396.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are many reasons why it is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 558.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difficult for people to stick to daily treatment including pill <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 570.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fatigue, the daily reminder of HIV or the fear of having their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 581.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV status disclosed<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 385.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. CROWN, a follow-up study to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 592.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LATITUDE, is a clinical trial evaluating the use of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 498.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 603.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in people living with HIV who are experienced with daily oral <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 615.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment, but have not successfully suppressed the virus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 626.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and have detectable levels of HIV.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 643.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 341.56pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; showing the effectiveness <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 656.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of our oral daily treatment option<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 672.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 333.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is our oral two-drug daily treatment regimen, based <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 683.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on dolutegravir, and approved in the US, Europe, Japan, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 695.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Australia and other countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 711.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the phase IV PASO DOBLE study comparing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 723.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 333.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to the three-drug regimen Biktarvy showed <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 505.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 533.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 734.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">had non-inferior <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 369.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efficacy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 398.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, while participants also showed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 745.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statistically significantly lower weight gain when taking <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 756.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 333.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> over the course of 48 weeks. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 773.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We know that people living with HIV are concerned about <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 785.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taking more medicines as they age, as well as being <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 796.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interested in their metabolic health.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">21<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 101.45pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; UK approval and real-world <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">studies reinforcing more than 99% <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 139.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness for <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 142.79000000000002pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 155.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prevention is a vital part of ending the HIV epidemic, but <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 166.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">globally only about<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 127.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 15%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 147.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of people who could benefit from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 178.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pre-exposure prophylaxis (PrEP) are taking it to reduce the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 189.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk of sexually transmitted HIV. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 180.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 216.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cabotegravir) is the world&#8217;s first long-acting injectable PrEP. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It is administered by a healthcare physician six times a year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 228.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since the pioneering US launch of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 190.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 227.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in 2022, it has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 240.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also been approved in the EU, Australia, South Africa and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 251.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">several other countrie<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 139.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 146.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 183.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 219.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> received <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 262.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">marketing authorisation in the UK from the Medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 273.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Health products Regulatory Agency (MHRA). Additional <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 285.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory submissions are underway.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 302.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In July<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 79.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 2024,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 104.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we announced positive data for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 232.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 268.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> use <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 313.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during pregnancy. Women of childbearing age in sub-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 324.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Saharan Africa experience disproportionately high rates of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 335.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV. These data showed that <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 170.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 206.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 227.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generally<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 263.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> well <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tolerated among women who became pregnant and that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 358.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pregnancy outcomes were similar to those with no <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 369.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cabotegravir exposure. These data add to the evidence for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 380.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 90.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> as a prevention option for women.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">We also saw high effectiveness, 99%, of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 212.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 249.16000000000003pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"> in studies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">that spanned gender diverse populations in the US<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 250.89pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 420.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">participants from Black and Hispanic communities.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 249.82999999999998pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 437.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Ultra-long-acting pipeline &#8211; positive data <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 450.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">supports continued progression to extended <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 463.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">dosing intervals<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 479.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are focused on enabling even longer treatment and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 490.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention intervals of up to four months and longer, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 501.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">building our leadership in long-acting therapies. This would <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 513.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">see people making just three clinic visits a year, doubling <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 524.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the current dosing interval available today for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 233.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 274.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 535.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 71.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 552.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">Data from the phase I trial of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 168.25pt; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;744,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.57999999999998pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 206.94pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">our investigational <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 563.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">ultra-long-acting formulation of cabotegravir (CAB-ULA), <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 575.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">showed a dosing interval of at least four months was <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 586.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">possible. This supports a move to the next stage of clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 597.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">development. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The trial demonstrated that intramuscular (IM) dosing of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CAB-ULA slows drug absorption compared to the current <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CAB-LA formulation, producing a more desirable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmacokinetic profile that supports less frequent dosing. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Also, the safety and tolerability of the new formulation was <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparable to our current profile for IM dosing with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved CAB-LA formulation.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additionally, we selected rilpivirine as the partner for CAB-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ULA for our every four-month treatment option. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regimen selection is based on progress in formulation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">studies for rilpivirine and builds on existing positive patient <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and physician experience with these medicines in our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">current portfolio.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 271.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A registrational study is also in progress to evaluate using <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 282.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CAB-ULA to prevent HIV in adults. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 299.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Extending dosing and delivery options<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 315.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our goal is to offer treatment and prevention options that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allow for every-six-monthly dosing as well as self-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">administered medicines by the end of the decade. As part of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 348.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our development work, we are exploring the next generation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 360.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of integrase inhibitors and partner agents to reach six <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 371.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">months and beyond.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we announced data for VH&#8217;184, our third-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 399.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generation investigational INSTI. Early phase I data showed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 410.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positive findings to support the development of VH&#8217;184, as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 422.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a potential for ultra-long-acting dosing and coverage of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 433.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">INSTI-resistant viruses. As well as a unique resistance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 444.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profile, further analysis also showed a good safety and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tolerability profile for VH184. Building on our legacy of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing new integrase inhibitors, these positive findings <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reinforce that integrase inhibitors will remain the gold <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standard in HIV, trusted for their efficacy, long-term <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tolerability and high barrier to resistance. As such, VH184 is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 512.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an excellent candidate for further development for ultra-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 523.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-acting and self-administered therapy.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 540.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Another compound, VH&#8217;310, is an inactive compound <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 551.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(known as a prodrug) that converts to active cabotegravir <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 562.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when administered into the body. Preclinical studies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">showed that VH310 delivered long-duration cabotegravir for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 585.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than 50 weeks. A first-time-in-human study that will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 596.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">look at the pharmacokinetic and safety profile is planned for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 607.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">22<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_82"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infectious diseases<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infectious diseases cause around one in six deaths <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 161.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide. They also put significant strain on healthcare <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 172.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">systems and societies. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 189.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We intend to have a positive impact on the lives of more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 201.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than 2.5 billion people by the end of the decade and a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 212.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant proportion of this will be through our work in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 223.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases. Our portfolio here is the broadest in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 234.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our&#160;industry.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 251.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our priorities include seasonal infections, like respiratory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 262.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">syncytial virus (RSV) and influenza; chronic infections, like <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 274.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hepatitis B, shingles and HIV; common childhood diseases, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 285.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including measles; and rarer but critical conditions like <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 296.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningitis. We also focus on bacterial infections, where <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 307.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antimicrobial resistance is creating an urgent need for new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 319.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 336.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">In this section:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 349.64pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 106.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 16.34pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asset<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.07pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential indication/label <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.87pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expansion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 40.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine for respiratory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">syncytial&#160;virus <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine for shingles<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MenABCWY vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidate<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 63pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine candidate for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningitis<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bepirovirsen<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 87pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antisense oligonucleotide for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chronic hepatitis B<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 111pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pneumococcal vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 106.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidates<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 111pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine for pneumococcal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases in adults and infants<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 135pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccine candidates<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 135pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccines for seasonal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenza, H5N1 pre-pandemic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenza, and SARS-CoV-2<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antibiotic for uncomplicated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">urinary tract infections and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncomplicated urogenital <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 35.03pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gonorrhoea<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 106.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 106.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tebipenem<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 106.5pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 129.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antibiotic for complicated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">urinary tract infections <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 599.58pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See a more detailed pipeline listing on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_88">29</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.82999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 175.15pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 17.29pt; left: 49.36pt; opacity: 1; position: var(--position); top: 781.82pt; width: 230.26pt; z-index: 8;"><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets with existing approval or in development for label expansion <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are italicised<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 343.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; expanding protection against RSV <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 163.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">with&#160;our market-leading vaccine <span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 155.91pt; left: 303.38pt; position: var(--position); top: 187.86pt; width: 240.75pt; z-index: 2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g29.gif" alt="" style="height: 165.91pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.60pt, 1.60pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 10.19pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV affects around 64 million people of all ages <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 21.44pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">every year, causing approximately 470,000 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 32.69pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hospitalisations and 33,000 deaths annually in people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 43.94pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">60 and over in industrialised countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 60.88pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 33 million people in the US and Europe aged <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 72.13pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50-59 have a medical condition that increases their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 83.38pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk of severe RSV outcomes. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 100.32pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">People with certain underlying medical conditions, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 111.57pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">like COPD, asthma, heart failure and diabetes, are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 122.82pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at&#160;increased risk from RSV, which can worsen these <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 134.07pt; width: 237.55pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions and lead to pneumonia or death.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 353.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 339.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 366.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our RSV vaccine, gained expanded <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 364.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approvals in the US, Europe and Japan for the prevention <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 375.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of lower respiratory tract infection disease (LRTD) in adults <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 386.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aged 50 to 59 at increased risk. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 431.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 458.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was originally <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 398.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved for adults 60 and over in a number of markets in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023. It is now available for that group in over 50 countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 426.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further adding to the body of evidence supporting <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 503.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 530.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we shared new data from the AReSVi-006 phase III trial. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 448.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This showed that one dose of the vaccine is efficacious <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 460.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against RSV-LRTD and severe LRTD in adults aged 60 and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 471.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">older over three full RSV seasons. These results included <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 482.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efficacy against different RSV subtypes, in adults with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 493.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced age (70-79 years of age) and those with certain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 505.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying medical conditions. Safety and reactogenicity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data were consistent with initial observations from the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 527.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III programme. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 544.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive data were also reported showing the vaccine&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 555.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efficacy and safety in adults aged 18 and above at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 567.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased risk from RSV, including immunocompromised <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 578.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients. We continue to provide data on longer-term follow-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 589.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">up to help recommending bodies determine future RSV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 600.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revaccination schedules. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 617.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To ease access to important adult vaccines, we generate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 628.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data to show our vaccines can be co-administered. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 640.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following data on co-administration with seasonal flu <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 651.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines in 2023, in 2024 we presented data confirming <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 662.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 322.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 349.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> can also be administered together with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 673.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shingles vaccine, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 375.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 407.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Further co-administration trials, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 685.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including with pneumococcal vaccines, are ongoing. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">23<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 100.14pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; showing our vaccine&#8217;s long-lasting <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">duration of protection against shingles<span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 144.57pt; left: 52.75pt; position: var(--position); top: 148.3pt; width: 240.75pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g30.gif" alt="" style="height: 154.57pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(2.08pt, 2.08pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 9.66pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Up to one in three people develop shingles in their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 20.91pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lifetime, sometimes with serious consequences, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 32.16pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including loss of vision and nerve pain, which affects <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 43.41pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">up to 30% of people.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 60.35pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By the age of 50, most adults already have the virus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 71.6pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that causes shingles inside their body, even though <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 82.85pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not everyone will develop it.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 99.79pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As people age, and their immune response to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 111.04pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infection wanes, the risk of developing shingles <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 122.29pt; width: 236.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increases.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 302.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 86.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our shingles vaccine, is available in 52 countries <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 313.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for people over 50. In most of these countries it is also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 324.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available for people over 18 who are at increased risk of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 335.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shingles. The vaccine combines one of our adjuvants with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an antigen chosen to enhance a protective immune <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 358.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">response. This formulation may help to address the natural <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 369.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">age-related decline in immune response that can make it <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 380.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more difficult to protect older people from disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the China National Medical Products <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Administration (NMPA) accepted our regulatory application <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 420.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 66.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 98.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to prevent shingles in people of 18 years and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 431.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over at increased risk. The vaccine is already approved in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 442.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">China for people of 50 and over. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 459.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we published data showing that <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 215.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 247.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> gives a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 471.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">high level of protection for more than a decade in people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 482.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aged 50 and over. The ZOSTER-049 long-term follow-up <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 493.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III trial showed 82% efficacy within the 11th year <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 504.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following vaccination. The study, covering 7,000 people in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18&#160;countries, also showed over 73% cumulative efficacy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 527.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from year 6 to 11 for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 135.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 167.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in people over 70. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 544.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A separate retrospective observational study sponsored by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 555.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK, ZOSTER-122, evaluated a potential association <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 566.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 90.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 122.17999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> vaccination and reduced dementia risk, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 578.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared to the risk in those who received one or more of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 589.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">two other elective adult vaccines recommended for similar <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 600.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">age groups. These earlier initial results were encouraging <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 611.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and were consistent with the growing body of evidence. The <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 623.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ZOSTER-122 results were presented at the Alzheimer's <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 634.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Association's 2024 International Conference. We continue <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 645.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to investigate this area.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Reducing the burden of meningitis with <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">our&#160;meningococcal vaccines <span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 102.05pt; left: 303.69pt; position: var(--position); top: 148.3pt; width: 240.75pt; z-index: 3;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g31.gif" alt="" style="height: 112.05pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.47pt, 1.47pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 17.14pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are approximately 1.2 million cases of invasive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 28.39pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningococcal disease (IMD) worldwide each year.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 45.33pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Up to one in 10 people diagnosed with IMD will die, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 56.58pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">despite treatment. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 259.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our meningitis ACWY vaccine <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 425.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 457.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and meningitis B <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 270.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 337.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 370.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> protect against most forms of IMD. Our 5-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 282.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in-1 MenABCWY vaccine candidate combines them, aiming <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 293.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to protect against the five most common types of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 304.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningococcus with one vaccine. In 2024, the US FDA <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 315.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accepted the file for this vaccine candidate for regulatory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 330.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 333.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 344.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The vaccine could simplify immunisation by reducing the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 355.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of injections required. In turn, this could increase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 366.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunisation rates. Although meningitis B is the most <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">common group of IMD-causing bacteria in US adolescents <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 389.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and young adults, just under 12% of them have had the two <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 400.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">doses of vaccine needed to provide protection. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 417.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our phase III trial to assess the safety and effectiveness of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 428.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the MenABCWY vaccine candidate found the breadth of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 439.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immune response to be consistent with <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 461.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 493.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 451.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 336.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 468.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fast-track designations for our <span style="display: inline-block; height: 8pt;"></span><span id="ib43e1c3d8b9c49d9ad2264d1a0a2d875_172"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 481.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">investigational medicine for chronic hepatitis <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 494.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">B (CHB)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 85.04pt; left: 303.69pt; position: var(--position); top: 518.52pt; width: 240.75pt; z-index: 4;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g32.gif" alt="" style="height: 95.04pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.23pt, 1.23pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 17.35pt; width: 238.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">257 million people worldwide are living with CHB, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 28.6pt; width: 238.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">though only around 10% are diagnosed.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 45.54pt; width: 238.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nearly one million people die each year from hepatitis <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 56.79pt; width: 238.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B and related complications, such as liver&#160;cancer.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 612.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The WHO has highlighted hepatitis B as a global public <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 624.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health threat, setting targets for its elimination by 2030 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 635.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through improved diagnosis and treatment, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 646.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preventative vaccination programmes.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 663.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bepirovirsen, our triple-action antisense oligonucleotide, is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 674.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a potential new treatment option for people with CHB when <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 686.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combined with oral antiviral therapies, called nucleoside/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 697.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nucleotide analogues (NAs). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 714.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data from the B-Clear and B-Sure phase IIb trials show <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 725.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bepirovirsen is the only single agent in phase III <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 736.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development to provide evidence of clinically meaningful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 748.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">functional cure response when combined with oral NAs. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 759.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current treatments (pegylated interferon) provide less than <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 770.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8% functional cure rate, with less than 1% for oral <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 781.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 798.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 313.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 315.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This vaccine was approved in the US in February 2025, as <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 496.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Penmenvy<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, bepirovirsen was granted Fast Track designation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the treatment of CHB by the US FDA, as well as SENKU <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designation by the Japanese Ministry of Health, Labour and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Welfare, reflecting its potential to address an unmet medical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">need for a serious and life-threatening condition. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The B-Well phase III clinical trial programme is now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underway with both pivotal trials achieving full recruitment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ahead of schedule.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 214.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other infectious diseases<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 230.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Influenza and respiratory combinations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 107.72pt; left: 51.69pt; position: var(--position); top: 251.32pt; width: 240.75pt; z-index: 5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g33.gif" alt="" style="height: 117.72pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.55pt, 1.55pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 5.87pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Influenza is an enduring public health challenge. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 17.12pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are around one billion seasonal influenza <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 28.37pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cases each year worldwide, with up to five million <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 39.62pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leading to severe illness and up to 650,000 proving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 50.87pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fatal.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 67.81pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Globally, over 772 million cases of COVID-19 have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 79.06pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been confirmed and nearly seven million deaths <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 90.31pt; width: 237.64pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have&#160;been reported.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 368.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re developing mRNA-based vaccines for influenza and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 379.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19, including combinations. In 2024, we achieved <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">several important milestones across our mRNA <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development programme. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 419.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We reported positive data from a phase II study for a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 430.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 vaccine candidate. This showed single booster <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 441.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">doses for both monovalent and bivalent modified vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 452.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidates produced meaningful immune responses with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 464.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acceptable reactogenicity profiles across all tested dose <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 475.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">levels. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 492.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For seasonal influenza, we announced positive results from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 503.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our phase II trial. This studied a range of mRNA <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 514.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">formulations in older and younger adults to evaluate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 526.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine candidates that could improve on standard immune <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 537.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responses against influenza A and B strains. Data <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 548.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confirmed that the mRNA vaccine candidates elicited strong <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 559.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall antibody titres with an acceptable safety profile. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 571.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These results supported progression of our seasonal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 582.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenza vaccine programme into late-stage development. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 593.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive data from both programmes enabled the start of a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 604.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combined phase I/II study for a seasonal influenza and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 616.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 combination vaccine candidate in 2024.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As part of our commitment to helping governments around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the world with pandemic preparedness, we started a phase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I/II study of an investigational influenza A (H5N1) pre-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pandemic vaccine candidate. The investigational vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has received Fast Track designation from the US FDA. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we restructured our collaboration with CureVac into <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a new licensing agreement. Under the new terms, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumed full control of developing and manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidate vaccines for influenza and COVID-19, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combinations, together with worldwide rights to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercialise them.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 248.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pneumococcal disease<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 102.05pt; left: 302.5pt; position: var(--position); top: 268.81pt; width: 240.75pt; z-index: 7;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g31.gif" alt="" style="height: 112.05pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.47pt, 1.47pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 11.51pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Worldwide, around one million children lose their lives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 22.76pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to pneumococcal disease each year.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 39.7pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the US, pneumococcal pneumonia causes around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 50.95pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">150,000 hospitalisations annually.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 67.89pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pneumococcal resistance to antimicrobials is a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 79.14pt; width: 237.8pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">serious and growing global problem.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 380.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are using the innovative MAPS vaccine platform <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 392.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology to progress development of new vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 403.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidates with best-in-class potential for pneumococcal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 414.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases. MAPS technology potentially enables higher <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody responses against more disease-causing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">serotypes for broader and stronger protection. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have programmes to develop multivalent vaccines for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 465.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">both infants and adults that provide the broadest possible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 476.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">coverage and high immunogenicity. We are prioritising 30 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plus-valent pneumococcal vaccine candidates for adults <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 499.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and infants currently in pre-clinical development with first <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 510.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subject, first visit expected in 2025. Our 24-valent vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidate for infants is currently in phase II development.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 538.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Herpes simplex virus<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 552.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following a combined phase I/II proof-of-concept study to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 563.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assess our early-stage therapeutic herpes simplex virus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 574.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(HSV) vaccine candidate, we decided not to progress it to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 585.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III. We will continue to generate follow-up data that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 597.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could offer valuable insights into recurrent genital herpes. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 608.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the unmet medical need, we&#8217;ll review all our relevant <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 619.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data and studies to progress further research.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Antibiotics and antimicrobial resistance<span style="display: inline-block; height: 8pt;"></span><span id="ib43e1c3d8b9c49d9ad2264d1a0a2d875_169"></span><span id="ib43e1c3d8b9c49d9ad2264d1a0a2d875_171"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin &#8211; progress towards a new treatment for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">uncomplicated urinary tract infections (uUTIs) and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">gonorrhoea <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 133.23pt; left: 52.75pt; position: var(--position); top: 172.04pt; width: 240.75pt; z-index: 6;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g34.gif" alt="" style="height: 143.22pt; width: 250.75pt;"/></div><div><div><div style="transform: translate(1.92pt, 1.92pt);"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 12.63pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over half of all women are affected by uUTIs in their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 23.88pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lifetime, with around 30% suffering from recurrent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 35.13pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease which can cause significant discomfort, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 46.38pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact daily activities, and lead to other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 57.63pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complications.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 74.57pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are around 82 million new cases of gonorrhoea <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 85.82pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">globally each year and neisseria gonorrhoeae, the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 97.07pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bacteria causing gonorrhoea, is recognised by the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 108.32pt; width: 236.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">World Health Organization as a priority pathogen.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 314.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin is our investigational, first-in-class oral <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 325.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibiotic, with a novel mechanism of action for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 337.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment of female adults and adolescents with uUTIs. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 348.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New treatments are needed, as the number of uUTIs <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">caused by drug-resistant bacteria is increasing. This can <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 370.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result in higher treatment failure rates. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 387.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following positive results from our phase III EAGLE-2 and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 399.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EAGLE-3 trials, gepotidacin was accepted for priority review <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 410.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the US FDA in 2024. In these studies, gepotidacin <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 421.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrated non-inferiority to the current standard of care <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 432.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for uUTIs. If approved, gepotidacin will offer a much-needed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additional oral treatment option for patients at risk of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment failure associated with resistance or recurrence of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uUTI.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 152.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin is also in development for uncomplicated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">urogenital gonorrhoea in adolescents and adults. In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we announced positive data from our phase III EAGLE-1 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trial. Gepotidacin performed as well as intramuscular <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ceftriaxone plus oral azithromycin, a leading combination <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment for gonorrhoea. The results show gepotidacin has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the potential to be a novel treatment option amid rising <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resistance to other treatments, and for patients who have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allergies and intolerances to other treatments.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 259.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We had also been investigating a potential vaccine for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 271.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gonorrhoea. Following results from the phase I/II study, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 282.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decided not to progress to phase III.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 299.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Tebipenem &#8211; treating complicated urinary tract <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 310.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">infections<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Through our partnership with Spero Therapeutics, Inc., we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 334.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have an exclusive licence agreement for tebipenem HBr, a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 346pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">late-stage oral carbapenem antibiotic with the potential to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 357.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treat complicated urinary tract infections (cUTIs). If <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 368.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved, tebipenem HBr will address an unmet medical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 379.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">need for a novel oral antibiotic as an alternative to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 391pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intravenous hospital therapy for drug-resistant cUTIs. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 407.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PIVOT-PO, the pivotal phase III trial for tebipenem, is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 419.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ongoing. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">26<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_85"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 491.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 491.25pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 491.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 491.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Technology<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology is helping us to understand the human immune <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 157.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">system and the underlying biology of disease like never <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 168.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">before. This gives us the opportunity to transform every part <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 179.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of R&amp;D, from how we choose research targets and identify <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 190.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, to how we design medicines and vaccines, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 202.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make clinical trials as effective as possible. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 219.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increasingly, technology is enabling a more dynamic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 230.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach to R&amp;D. For example, we&#8217;re using machine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 241.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">learning algorithms to identify potential drug targets and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 252.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced data analytics to predict patient responses. We&#8217;re <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 264.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also implementing digita<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 149.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l twins, which<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 201.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> will help us realise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 275.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our ambition of accelerating our clinical trials and getting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines to patients faster. In 2024, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 297.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued to advance our pipeline by harnessing both <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 267.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 309.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and platform technologies.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 325.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Data technology<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 138.12pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; deep understanding of <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 339.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">disease<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 355.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 72.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> tech, including <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 134.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data itself, digital capabilities, artificial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 366.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intelligence (AI) and machine learning <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 205.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(ML),<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 225.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> gives<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 249.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> us an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unprecedented depth of understanding of patients, human <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 388.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biology, and disease mechanisms. Our world-leading data <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 400.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sources allow us to push the boundaries of what&#8217;s possible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 411.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and enable our teams to work faster and with greater <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 422.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">precision. For example, applying AI and ML to our work in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 433.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">human genetics and functional genomics has significantly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 445.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enhanced our understanding of disease processes. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 456.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">means we can more accurately target the molecular <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 467.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pathways responsible for diseases such as cancer or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 478.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chronic disorders, helping to prevent disease progression <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 490.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and alter its course more effectively.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 195.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 506.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Platform technology &#8211; finding the right match <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Platform technologies enable us to design and develop new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 534.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines for diseases that are hard to treat <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 545.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with traditional small molecules or biologics. Across our four <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 556.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapy areas, these new platforms enable us to evaluate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 567.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the best possible clinical effect for patients and could lead to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">solutions for diseases previously thought untreatable.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our novel platform technologies include:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 162.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Advanced monoclonal antibodies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 176.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These modulate a patient&#8217;s immune system and are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 187.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">produced by a single clone of cells or cell lines, consisting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 198.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of identical molecules. We have the platforms to create <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 210.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">best-in-class monoclonal antibodies (eg IL5) with favourable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tolerability profiles, as well as bi-specific and tri-specific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 232.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibodies, These advancements aim to provide more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 243.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effective and durable treatment options, addressing both <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the treatment and prevention of disease, and helping <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 266.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improve long-term health outcomes for patients. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 283.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Antibody-drug conjugates <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 296.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antibody-drug conjugates (ADCs) consist of monoclonal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 307.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibodies linked to potent cytotoxic drugs. They are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 319.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designed to target malignant cells more precisely, sparing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 330.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthy tissue and addressing a key challenge in treating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 341.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer. Our portfolio includes <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 422.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 453.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> as a potential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 352.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment for relapsed/refractory multiple myeloma, and two <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 364.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigational ADCs targeting B7-H3 and B7-H4, proteins <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 375.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that are highly expressed across a range of different cancer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 386.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">types. We also have an exclusive option agreement to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 397.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">license ADC, DB-1324 from Duality Biologic for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 409.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gastrointestinal tumours. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 426.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Small molecule design <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 439.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This is the process of creating tiny chemical compounds <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 450.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that can precisely target and interact with specific proteins <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 462.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or enzymes in the body to treat diseases. W<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 477.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e&#8217;re building a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 473.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">digital chemistry platform to transform the discovery of small <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 484.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">molecule medicines by using AI/ML and automation. <span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 512.38pt; position: var(--position); text-decoration: none; white-space: pre;">This <span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 495.87pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;">will help create chemical compounds at an industry-<span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 507.12pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;">leading scale, quickly and efficiently, through a unique <span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 518.37pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;">generative design platform that we have developed. <span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 514.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This <span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 529.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform should enable us to deliver small molecules, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 540.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">covalent medicines, and innovative treatments like <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 552.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody-drug conjugates (ADCs) to patients with increased <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 563.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success and speed. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 580.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oligonucleotides<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 593.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These address hard-to-treat diseases with high unmet need <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 605.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by modulating gene expression and transcription. About half <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 616.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of therapeutic targets are difficult to solve with traditional <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 627.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">small molecules or biologics. Oligonucleotides could <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 638.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">address RNA-based <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 387.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 422.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> which were previously <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thought to be untreatable with traditional drugs.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">27<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our oligonucleotides include bepirovirsen for chronic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hepatitis B (see page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 139.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib43e1c3d8b9c49d9ad2264d1a0a2d875_172">23</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 149.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 172.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> </span><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 175.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;990 (see page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 255.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib80eecc1a6a7479c9d49ca3dd24e0496_172">15</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 265.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which we&#8217;re developing as a potential treatment for steatotic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liver disease. Our acquisition of Elsie Biotechnologies in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 brings together Elsie&#8217;s expertise and our internal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capabilities in AI/ML to accelerate a next-generation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oligonucleotide platform. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 152.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This will further enable us to create <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">predictive models for designing oligonucleotides aimed at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 203.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difficult-to-treat diseases that affect large numbers of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 214.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">MAPS technology <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">This technology targets complex <span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 184.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infections through <span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multivalent vaccines which generate multiple different <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immune responses to both disease-specific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 278.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">polysaccharides and protein antigens. We&#8217;re using MAPS <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 290.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology to develop a portfolio of vaccines against <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 301.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pneumococcal disease. MAPS technology has the potential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 312.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to expand the coverage of vaccines against current and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future pathogens. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">mRNA technology <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 354.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This technology helps the human immune system to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 365.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevent or fight disease with vaccines that enable the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 376.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">body&#8217;s own cells to produce specific proteins and antigens. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 388pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This technology has the potential for rapid deployment with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 399.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new vaccine targets. We have influenza and COVID-19 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 410.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccine programmes. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Advan<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 80.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ced adjuvants <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 440.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hese<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 78.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> enhance the body&#8217;s immune response to increase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 452.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the efficacy of vaccines and open up new vaccine targets. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 463.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We design combinations of adjuvant/antigens specific to the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 474.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">need of the patient groups we want to help protect. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 485.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjuvants are a key part of our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 177.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 204.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 224.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 256.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 497.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines and may help overcome the natural age-related <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decline in immunity that contributes to the challenge of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protecting older adults. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Accelerating innovation in our pipeline <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data and platform technologies help us in four main ways:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 146.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Choosing the right targets<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 159.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data tech helps us to choose and prioritise genetic targets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 170.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most likely to have a positive impact on patients&#8217; health and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 182.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change the course of disease. This accelerates <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 193.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development and increases probability of success, so we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 204.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">can bring new medicines to patients who need them, faster.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For depemokimab, predictive modelling, alongside our work <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 232.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to understand disease processes, has enabled us to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 244.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress straight to phase III from phase I for four <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 255.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory indications.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 272.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For our oligonucleotide GSK&#8217;990, computational analysis of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 283.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">genetic data, including gene expression profiles and genetic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 294.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">variations associated with <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 408.66pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">metabolic dysfunction-associated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 306.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">steatohepatitis (<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 366.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MASH) across several genetic datasets, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 317.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enabled us to identify and validate targets for MASH, giving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 328.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">us confidence to in-license the asset. The analysis also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 339.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">found a link to alcohol-related liver disease (ALD), opening <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 351.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">up another potential indication and increasing the asset&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 362.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential value. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 379.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Identifying the right patients<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 392.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our technologies help us understand which patients may <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respond best to our treatments at specific points in their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 415.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 432.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the case of our oligonucleotide bepirovirsen, AI and ML <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 443.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are helping us to achieve functional cure in more patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 454.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with chronic hepatitis B. Modelling retrospective data from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 465.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our phase II trial showed us how different patients might <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 477.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respond to treatment. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 494.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re using the dMMR/MSI-H biomarker, present in some <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 505.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endometrial and colorectal cancer tumours, to inform <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical development of our treatment <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 452.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 486.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 490.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">And we&#8217;re<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 530.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 527.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">using advanced technologies like organoids (3D tumour <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 539.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">models grown in the lab), deep-tissue profiling and digital <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 550.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pathology to match it to the right patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 567.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These predictive approaches improve our development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 578.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success rates, so we&#8217;re more likely to observe a substantial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 589.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical effect. They also help us see which patients are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 601.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most likely to respond. This enables doctors to make more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 612.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">informed and tailored decisions about which treatments are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">right for an individual patient&#8217;s cancer. This is particularly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">important for tumours with dMMR/MSI-H, which don&#8217;t <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 646.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respond as well to chemotherapy.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">28<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Designing and manufacturing the right treatment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 98.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> gives us more options to reach our genetically <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">validated targets by choosing the treatment method<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 256.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(modality)<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 92.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> most likely to succeed and make a meaningful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difference. It also allows us to sustain and control quality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and consistency throughout development and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In oncology, we&#8217;re evaluating targeted ADCs in certain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">types of small-cell lung cancer, ovarian cancer and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endometrial cancer. ADCs combine an antibody that targets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a specific characteristic of a tumour cell with a payload <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carrying an anti-cancer agent, such as chemotherapy. The <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targeted antibody acts like a &#8216;lock-and-key,&#8217; so that the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payload can deliver the cancer-killing medicine inside the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 278.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tumour. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In HIV, we&#8217;re<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 103.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> using platform technologies to develop ultra-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 307.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-acting treatment and prevention medicines, based on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 318.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cabotegravir. We&#8217;re improving drug delivery with an enzyme <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to safely open up more space under the skin to inject more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug subcutaneously. We can also extend the drug&#8217;s dosing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 352.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interval by slowing down its absorption and deliver a longer-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lasting option using other biopharmaceutical approaches to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">modify formulation.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 391.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Making clinical trials more effective<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 404.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 98.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is also a tool for accelerating our clinical studies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and improving their outcomes, from the early stages of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">design to recruiting patients, collecting samples and making <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory submissions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To reach more patients faster, we&#8217;re saving time and cost by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 466.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">automating clinical and regulatory submission documents <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with AI, for instance in certain phase III trials of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 239.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 273.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 489.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and depemokimab. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 132.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we continued our year-on-year <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 500.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction in submission times with median submission time <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 511.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being 24% less than in 2023. This has enabled us to file key <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 523.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets, such as depemokimab, faster. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 205.35000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 534.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implementing<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 106.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> digital twins<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 155.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> across 10 studies in 2025, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 545.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alongside other cutting-edge technology, to help realise our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 556.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambition of reducing the number of patients needed by an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 568.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">average of 15%, in clinical trials where these methods are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology also helps with clarifying complex decisions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 320.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">example,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 356.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> when planning the phase III study for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 507.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 534.4300000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our RSV vaccine, we used predictive modelling algorithms <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to identify where in the world the first RSV cases would <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur, clarifying decisions such as when to start, where to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recruit and how many people to enrol. This ultimately made <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development faster and more precise for what is now the<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 528.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market leading RSV vaccine for older adults<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 477.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 206.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Getting ahead together with our network <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 219.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 317.90000000000003pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">collaborations across tech<span style="display: inline-block; height: 8pt;"></span><span id="ia09805a2489c4acfbb9bafafa8edf0a5_12468"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 235.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We work with current and potential collaborators on the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 246.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most impactful data sources, platform technologies, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 257.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">translational tools to foster transformational innovation and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 268.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accelerate our pipeline.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 396.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 285.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Collaborations with UK Biobank, Alliance for Genomic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 297.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discovery (new in 2024) and FinnGen give us access to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 308.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">large genetic datasets to deepen our understanding of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 319.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease. We integrate them with other datasets, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 330.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our own, and use AI and ML to generate insights that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 342.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enable us to significantly improve and accelerate drug <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 353.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discovery and development.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 370.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We work with Tempus, a precision medicine biotech, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 381.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">King&#8217;s College London as part of our work to match the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 392.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient to the right treatment and the right point of disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For instance, we&#8217;re replicating clinical conditions using <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 415.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tumour models from patient-derived organoids alongside <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 426.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">digital pathology and AI to increase our speed and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 437.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">probability of success in development at our Digital <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 449.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biological Twin Lab in Stevenage.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 465.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we announced new collaborations that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 477.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complement our existing rich data sources and help us get <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 488.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a deeper understanding of disease mechanisms and human <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 499.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biology. They include:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oc<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 324.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hr<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 332.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e Bio, to explore drivers of liver disease by using <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 527.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patholog<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 347.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">y-derived human in vitro models<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 473.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 544.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relation, to identify and validate new therapeutic targets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 556.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for fibrotic disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">University of Cambridge and Cambridge Hospitals to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 584.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">establish the Cambridge-GSK Translational Immunology <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 595.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Collaboration (CG-TIC) focused on kidney and respiratory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 606.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Center for Regenerative Medicine of Boston University <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 635pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Boston Medical Center to focus on pulmonary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 646.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fibrosis.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 663.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oxford University to advance novel cancer research, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 674.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused on the potential of cancer prevention through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 685.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccination.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">29<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_88"></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline overview<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have 71 assets in development, of which 19 are late-stage. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 146.22pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III/Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.019em; position: var(--position); text-decoration: none; white-space: pre;">camlipixant (P2X3 receptor antagonist) Refractory chronic cough<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depemokimab (Long-acting anti-IL5 antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 149.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 152pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Asthma<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 178.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2,3<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">latozinemab (Anti-sortilin antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 113.64999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 116.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Frontotemporal dementia<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 201.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">linerixibat (IBAT inhibitor) Cholestatic pruritus in primary biliary <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cholangitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low carbon version of MDI<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 88.17999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90.86999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 94.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 121.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Beta 2 adrenergic receptor <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agonist) Asthma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Anti-IL5 antibody) COPD<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 109.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">belrestotug (Anti-TIGIT antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 105.14999999999999pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 107.78999999999999pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;"> Non-small cell lung cancer<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 194.77pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 117pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Anti-BCMA ADC)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 86.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Multiple myeloma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 129.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cobolimab (Anti-TIM-3 antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 105.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 108.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Non-small cell lung cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Anti-PD-1 antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 97.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 99.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> dMMR/MSI-H colon cancer<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 191.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (PARP inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 74.61999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 77.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Ovarian cancer<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 129.76000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.35pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Arexvy<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.71pt; position: var(--position); white-space: pre;"> (Recombinant protein, adjuvanted)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 139.76000000000002pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 142.47pt; position: var(--position); white-space: pre;"> RSV adults (18-49 YoA <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">AIR)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 14.780000000000001pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 188.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bepirovirsen (Antisense oligonucleotide)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 131.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 134.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Chronic HBV infection<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 208.89000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 201pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Recombinant protein, OMV) Meningitis B (infants US)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 213.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gepotidacin (BTI inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 84.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 87.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Uncomplicated UTI<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 152.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2,3<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 226.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ibrexafungerp (Antifungal glucan synthase inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 169.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 171.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Invasive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidiasis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 246.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MenABCWY vaccine (Recombinant protein, OMV, conjugated vaccine) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MenABCWY, 1st Gen<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 70.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3, 10<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 267pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tebipenem pivoxil (Antibacterial carbapenem)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 148.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 151.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Complicated UTI<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 279pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4178116 (Live, attenuated) Varicella new strain<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 291.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.310000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Anti-BLys antibody) Systemic sclerosis associated ILD<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 211.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2,6<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 316.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK1070806 (Anti-IL18 antibody) Atopic dermatitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 329.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3915393 (TG2 inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 93.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 96.67999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Pulmonary fibrosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 342pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4527226 (Anti-sortilin antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 118.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 120.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Alzheimer&#8217;s disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 354.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4532990 (HSD17B13 RNA interference)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 147.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.07000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> NASH/MASH<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 196.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5784283 (TSLP monoclonal antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 140.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 142.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Asthma<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 169.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">7<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 380.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4381562 (Anti-PVRIG antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 120.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 122.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 393pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nelistotug (Anti-CD96 antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 102.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 105.67999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 405.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cabotegravir (Integrase inhibitor) HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 418.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH3810109 (Broadly neutralizing antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 141.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 144.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 431.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH3739937 (Maturation inhibitor) HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 444pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH4011499 (Capsid protein inhibitor) HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 456.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH4524184 (Integrase inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 105.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 107.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 469.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alpibectir (Ethionamide booster)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 104.61999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 107.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Tuberculosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 482.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ganfeborole (Leucyl t-RNA synthetase inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 155.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Tuberculosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 495pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3437949 (Recombinant protein, adjuvanted)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 160.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 163.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Malaria fractional <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dose<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 515.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3536852 (GMMA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 74.67999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 77.36999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Shigella<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 528pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3993129 (Recombinant subunit, adjuvanted) Cytomegalovirus<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 219.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">8<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 540.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4023393 (Recombinant protein, OMV, conjugated vaccine) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MenABCWY, 2nd Gen<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">8<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 561pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4077164 (Bivalent GMMA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 103.14999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 105.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Invasive non-typhoidal salmonella<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 219.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 573.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4382276 (mRNA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.11999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Seasonal flu<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 586.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4396687 (mRNA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.11999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> COVID-19<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 599.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4406371 (Live, attenuated) MMRV new strain<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 612pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5101955 (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 49.029999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAPS<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 70.14999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Pneumococcal 24-valent paed)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 174.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 177.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Paediatric <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pneumococcal disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 146.22pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5536522 (mRNA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.11999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Flu H5N1 pre-pandemic<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 157.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">8<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5637608 (Hepatitis B virus-targeted siRNA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 157.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 160.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Chronic HBV <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sanfetrinem cilexetil (Serine beta lactamase inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 173.88000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 176.57000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Tuberculosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3862995 (Anti-IL33 antibody) COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3888130 (Anti-IL7 antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 107.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 109.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Autoimmune disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4172239 (DNMT1 inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 105.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 107.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Sickle cell disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4347859 (Interferon pathway modulator) Systemic lupus <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">erythematosus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 113.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4527363 (B-cell modulator) Systemic lupus erythematosus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4528287 (Anti-IL23-IL18 bispecific antibody) Inflammatory bowel <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 145.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4771261 (Monoclonal antibody against novel kidney target) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Autosomal dominant PKD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5462688 (RNA-editing oligonucleotide)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 143.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 145.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Alpha-1 antitrypsin <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deficiency<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 186pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5926371 (Anti-CD19-CD20-CD3 trispecific antibody)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 187.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 190.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Autoimmune disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belantamab (Anti-BCMA antibody) Multiple myeloma<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 172.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4418959 (Werner helicase inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 133.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 135.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> dMMR/MSI-H solid tumours<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 229.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">8<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 231.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4524101 (DNA polymerase theta inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 153.88000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 156.57000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Cancer<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 182.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">8<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 244.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5733584 (ADC targeting B7-H4)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 121.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 123.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Gynaecologic malignancies<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 257.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5764227 (ADC targeting B7-H3)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 121.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 123.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Solid tumours<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 270pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">XMT-2056<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 34.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">9<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (STING agonist ADC)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 109.92999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 112.61999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH4527079 (HIV entry inhibitor) HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 295.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3536867 (Bivalent conjugate)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 112.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 114.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Salmonella (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 158.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">typhoid + paratyphoid<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 229.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 308.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3772701 (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 49.029999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P. falciparum<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 92.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> whole cell inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 157.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 160.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Malaria<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 321pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3882347 (FimH antagonist)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 105.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 108.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Uncomplicated UTI<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 333.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3923868 (PI4K beta inhibitor) Rhinovirus disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3965193 (PAPD5/PAPD7 inhibitor) Chronic HBV infection<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 204.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">8<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4024484 (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 49.029999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P. falciparum<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 92.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> whole cell inhibitor)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 157.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 160.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Malaria<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 372pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5251738 (TLR8 agonist)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 95.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 98.39999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Chronic HBV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 384.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5102188 (Recombinant subunit, adjuvanted) UTI<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 397.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5475152 (mRNA)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.11999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Seasonal flu/COVID-19<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 230.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><span id="i41592996075d4ee09394e2c60639d1fa_30-0-1-1-824402"></span><div style="height: 230.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 415.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets are ordered by therapy area within each phase: respiratory, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology and inflammation; oncology; HIV; and infectious diseases. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Only the most advanced indications are shown for each asset. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 32.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In-licence or other alliance relationship with third party<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 43.03pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional indications or candidates also under investigation<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 53.43pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In registration<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 63.83pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III trial in patients with progranulin gene mutation<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 74.23pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Metered dose inhaler<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 84.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In phase II/III study<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 95.03pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(7)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II study start expected in 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 105.43pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(8)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In phase I/II study <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 115.83pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(9)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has an exclusive global license option to co-develop and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 124.23pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 13.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercialise the candidate<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 134.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(10) Approved in February 2025 in the US as Penmenvy&#160; &#160; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 149.03pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADC: antibody drug conjugate; AIR: at increased risk; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 157.43pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD: chronic obstructive pulmonary disease; GMMA: generalised <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 165.83pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">modules for membrane antigens; HBV: hepatitis B virus; ILD: interstitial lung <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 174.23pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease; MMRV: measles, mumps, rubella &amp; varicella; NASH/MASH: non-<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 182.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 191.03pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">OMV: outer membrane vesicle; PKD: polycystic kidney disease; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 199.43pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV: respiratory syncytial virus; siRNA: small interfering RNA; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 207.83pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UTI: urinary tract infection; YoA: years of age.&#160;  <span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">30<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 62.36pt;" id="idc89fa1ee07645df9629d157a4b46752_91"></div><div style="font-size: 12pt; line-height: 40pt; position: var(--position); top: 62.36pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 40pt; font-style: normal; font-weight: normal; left: 96.33pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Commercial<span style="display: inline-block; height: 29.12pt;"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 40pt; font-style: normal; font-weight: normal; left: 305.65pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> operations<span style="display: inline-block; height: 29.12pt;"></span></span></div><div style="height: 66pt; left: 53.86pt; position: var(--position); top: 717.5pt; width: 153.07pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g35.gif" alt="" style="height: 76pt; width: 163.07pt;"/></div><div><div><div style="transform: translate(0.79pt, 0.79pt);"><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.2pt; width: 151.48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technicians<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">working at our Jurong <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 16.8pt; width: 151.48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">facility in Singapore &#8211; one of our sites <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 26.4pt; width: 151.48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where we bring together R&amp;D and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 36pt; width: 151.48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing to streamline the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 45.6pt; width: 151.48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">journey from development to delivery. <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 678.13pt; left: 0.1pt; opacity: 1; position: var(--position); top: 163.55pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g36.jpg" alt="New Comm Ops divider.jpg" style="height: 678.13pt; width: 595.28pt;"/></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">31<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 2.81pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial operations<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_97"></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">We delivered another year of excellent commercial performance in 2024. <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 130.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.75pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sales grew to over &#163;31 billion &#8211; with strong growth and accelerating <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 146.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.75pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">momentum in Specialty Medicines offsetting lower vaccine sales. <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="position: var(--position); top: 185.68pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 12.19pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total sales<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 214.68pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 164.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 157.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 165.75pt;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 164.25pt;"><div><div style="line-height: 36pt; position: var(--position); top: 1.31pt; width: 164.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;31.4bn<span style="display: inline-block; height: 26.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 157.5pt;"><div><div style="line-height: 32pt; position: var(--position); top: 3.18pt; width: 157.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">+3%<span style="display: inline-block; height: 23.29pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 321.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 165.75pt;"><div><div style="line-height: 32pt; position: var(--position); top: 3.18pt; width: 165.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">+7%<span style="display: inline-block; height: 23.29pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 164.25pt; position: var(--position); top: 35.25pt; width: 157.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.92pt; width: 157.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321.75pt; position: var(--position); top: 35.25pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.92pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 313.85pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 12.19pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover by product groups<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 348.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 32pt; position: var(--position); top: 360.1pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;11.8bn<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 399.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 68.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 89.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">19%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 104.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="position: var(--position); top: 417.12pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;7.1bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 3.71pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/ <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.51pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 12.75pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.3bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 48pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.4bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 497.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 133.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 122.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 122.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_103">32</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 348.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 32pt; position: var(--position); top: 360.1pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 218.32pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;9.1bn<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 397.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-7%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 234.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 255.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-4%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 268.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="position: var(--position); top: 415.12pt; width: 595.44pt;"><div style="font-size: 0pt; left: 221.15pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingles<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.4bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Established<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 12.75pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.3bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 25.5pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.4bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 38.25pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.6bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Influenza<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 51pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.4bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 489.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 221.15pt; position: var(--position); top: 0pt; width: 133.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 122.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 122.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_106">35</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 348.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 32pt; position: var(--position); top: 360.1pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 32pt; font-style: normal; font-weight: normal; left: 385.61pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;10.4bn<span style="display: inline-block; height: 23.29pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 397.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 399.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 420.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 431.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="position: var(--position); top: 415.12pt; width: 595.44pt;"><div style="font-size: 0pt; left: 388.44pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;7.2bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 77.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 3.26pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other general <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 12.75pt; width: 48pt;"><div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.2bn<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 496.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 388.44pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 15pt;"></span></span><div style="font-size: 0pt; left: 390.7pt; position: var(--position); top: 0pt; width: 133.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 122.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 122.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 69.69999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_109">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 520.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 531.27pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 541.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial operations is presented with Specialty Medicines first to reflect that this is our largest business by value.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 558.77pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 219pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 207.75pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 207.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 207.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See Group financial review on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 120.99pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 129.19pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for more detail.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">32<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 99pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 487.5pt;"><div><div style="line-height: 36pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty <span style="display: inline-block; height: 26.2pt;"></span></span></div><div style="line-height: 36pt; position: var(--position); top: 45.83pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicines<span style="display: inline-block; height: 26.2pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_103"></div><div style="background-color: transparent; height: 841.89pt; left: 305.2pt; opacity: 1; position: var(--position); top: 0pt; width: 290.18pt; z-index: -2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g37.jpg" alt="Specialty divider.jpg" style="height: 841.89pt; width: 290.18pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 163.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our specialty medicines prevent <span style="display: inline-block; height: 10.19pt;"></span><span id="i9af18e01f3c64597bec53f654ec7d075_98"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 180.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;treat diseases, from HIV and <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 197.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">respiratory diseases, to immune-<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 214.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">inflammation diseases like lupus, <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 230.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">to cancer. Many are first or best-<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 247.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">in-class.<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="position: var(--position); top: 307.19pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 222pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 16.18pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accelerating momentum and strong <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.38pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance across all therapy areas<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 16.18pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines contributed more than <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.38pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80% of Group revenue growth <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 109.5pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 16.18pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Double-digit growth in HIV, respiratory/<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.38pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology and oncology<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 59.34pt; left: 53.86pt; opacity: 1; position: var(--position); top: 744.3pt; width: 223.5pt; z-index: 2;"><div><div><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Image: Endometrial cancer <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 15.24pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our treatment for endometrial cancer, is a PD-1-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 24.84pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">blocking antibody available in 33 countries that we are <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 34.44pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing to investigate for future monotherapy and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 44.04pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combination regimens in multiple tumour types.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">33<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance: Specialty Medicines continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 177.75pt;"/></tr><tr style="height: 12.75pt;"><td colspan="6" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Key marketed products<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 84.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 95.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disease<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total revenue<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key information<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 24pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV treatment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2.2bn <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">23%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 24pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">27%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 24pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir-based two-drug regimen. Now launched <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 54 markets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tivicay<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV treatment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.4bn <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir tablet for use in combination with other <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antiretroviral agents. Marketed in 69 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Triumeq<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV treatment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.3bn <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-14%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-11%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir-based fixed-dose combination tablets. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Marketed in 64 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Vocabria + Rekambys <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in Europe and Japan)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV treatment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.0bn <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">43%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">47%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">First complete long-acting injectable regimen <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(cabotegravir, rilpivirine). Launched in 32 markets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Juluca<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 120pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV treatment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 120pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;685m <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 120pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 120pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 120pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir-based two-drug regimen. Marketed in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV prevention<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;279m <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">87%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">93%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">First long-acting injectable (cabotegravir) for HIV <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention. Approved in 25 markets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rukobia<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV treatment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;161m <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">41%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Extended-release tablets for people living with multi-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug resistant HIV-1 for use in combination with other <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antiretrovirals. Launched in 17 markets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory eosinophil-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven diseases<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.8bn <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The first treatment to be indicated in the US and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Europe for use across four IL-5 mediated diseases <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.919999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib80eecc1a6a7479c9d49ca3dd24e0496_169">14</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 43.199999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in R&amp;D)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 219pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lupus and lupus <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nephritis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 219pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.5bn <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 219pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 219pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 219pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Only biologic approved to treat both SLE and LN, in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adults and paediatrics, in the US, Europe and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">elsewhere<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ovarian cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;593m <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">17%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PARP inhibitor commercially available in over 40 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Endometrial cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;467m <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PD-1-blocking antibody available in 33 countries that <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we are continuing to investigate for future <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monotherapy and combination regimens in multiple <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tumour types<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Myelofibrosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;353m <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved in 13 markets as the only treatment <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specifically indicated for myelofibrosis patients with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anaemia<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 477.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty medicines, along with vaccines, now dominate our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 488.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reshaped portfolio and pipeline. Specialty Medicines sales <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 499.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;11.8 billion<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 122.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, up <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 139.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 157.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 182.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 185.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">19%<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 203.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER, reflecting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 510.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued growth across disease areas, with strong <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 522.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performances in respiratory/immunology, oncology and HIV. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 291.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 549.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We drive growth by accelerating our pipeline as well as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 560.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prioritising business development, targeting acquisitions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 572.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and partnerships to strengthen and complement our core <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 583.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapy areas.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 600.35pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 477.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/immunology <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 490.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In respiratory/immunology, sales growth for our market-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 501.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leading medicines <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 378.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 406.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 426.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 460.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> continued, driven <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 513.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by patient demand across US, European and International <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 524.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 541.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 332.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our IL5 antagonist monoclonal antibody with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 552.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indications across four IL5 mediated diseases (eosinophil <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 563.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease), continues to drive growth. Strong performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 574.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all regions reflects the higher patient demand for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 586.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatments addressing eosinophilic-led disease.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 603.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 338.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our monoclonal antibody treatment for lupus, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 614.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to grow as the only biologic approved for both <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 625.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">systemic lupus erythematosus and lupus nephritis. We&#8217;re <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 636.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused on helping to identify and treat patients earlier, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 648.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">before lupus progresses and organ damage occurs. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">34<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance: Specialty Medicines continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 94.75999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 97.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology sales growth was driven by strong performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across the portfolio for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 144.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 177.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 182.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 245.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 78.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. With pivotal trial data and regulatory filings in place, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we are also preparing for a new launch of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 219.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a PD-1-blocking antibody, is the backbone of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ongoing immuno-oncology-based research and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development programme. Strong sales at the end of 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">followed FDA approval expanding the indication to include <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all adults with primary advanced or recurrent endometrial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer. A robust clinical trial programme includes studies of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> alone and in combination with other therapies in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gynaecologic, colorectal and lung cancers, as well as where <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there are opportunities for transformational outcomes.&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 85.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a JAK-1, JAK-2 and ACVR1 inhibitor, has grown <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strongly largely driven by continued uptake in the US since <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 307.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its launch in 2023. This was followed by successful 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 318.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launches in the UK, Germany and Japan. The robust <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market response reflects the significant unmet need that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 85.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> can help address. It&#8217;s a myelofibrosis therapy that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 352.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treats enlarged spleen and constitutional symptoms, like <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bone pain and night sweats, but is also specifically <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indicated for patients with anaemia, which can be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exacerbated by more established treatments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In ovarian cancer, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 126.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 150.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> delivered continued double-digit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth driven by increased patient demand and volume <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all regions, as well as geographical expansion. In <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 more than 16,000 patients every month were treated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide with <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 114.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 138.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> as a maintenance therapy for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 458.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced ovarian cancer. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 319.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 322.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV sales were driven by strong demand for long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">injectable medicines (<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 390.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva, Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 472.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 494.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 523.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our long-acting medicines continue to see increased <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">momentum and are critical to our long-term growth. By the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">end of 2024 they represented 20% of total HIV sales <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared to 16% for 2023 and contributed over 50% of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total HIV growth. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 345.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the world&#8217;s first and only complete long-acting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regimen for HIV treatment, is available in the US, Europe, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Japan, China and Australia and continues to be supported <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by strong label evolution and data. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 262.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 340.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the world&#8217;s first long-acting medicine for HIV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention, is approved in 25 countries including the US, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 284.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK, EU, Australia and South Africa, and is critical to ending <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the global epidemic.&#160; &#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 312.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales of oral two-drug regimen (D<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 437.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ovato, Juluca<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 490.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">represent 42% of the total HIV portfolio. and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 480.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 508.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 335.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to be the largest product. It is a dolutegravir-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 346.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based oral two-drug regimen, approved in the US, Europe, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 357.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Japan, Australia, and other countries worldwide. Sales of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 368.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tivicay<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 332.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 352.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Triumeq<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 384.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> fell during the year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our strategy for growth is centred on our innovative portfolio <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of medicines that are transforming HIV treatment and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 408.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention while delivering on individual needs.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 438.82pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 219pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 207.75pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 207.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 207.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See Group financial review on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 120.99pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 129.19pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for more detail.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">35<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 80.25pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 487.5pt;"><div><div style="line-height: 36pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 26.2pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_106"></div><div style="background-color: transparent; height: 841.89pt; left: 304.3pt; opacity: 1; position: var(--position); top: 0pt; width: 291.08pt; z-index: -2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g38.jpg" alt="NEW.Vaccines.divider.image.jpg" style="height: 841.89pt; width: 291.08pt;"/></div></div></div></div><div style="line-height: 14pt; position: var(--position); top: 163.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our vaccines portfolio targets <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 180.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases at every stage <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 197.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of<span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 65.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> life, helping to protect people from <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 214.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">RSV, meningitis, shingles, hepatitis <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 230.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and many more.<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="position: var(--position); top: 290.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 222pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 54.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 16.18pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales impacted by short-term headwinds, <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.38pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong growth outside the US<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 54.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 16.18pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Established vaccines continued to grow <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.38pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across International and the US<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 54.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 9.58pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis vaccines had their strongest year <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 22.78pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of sales to date with double-digit growth <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 35.98pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all regions<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 50.57pt; left: 53.86pt; opacity: 1; position: var(--position); top: 753.26pt; width: 239.58pt; z-index: 2;"><div><div><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 0pt; width: 239.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Image: Meningococcal serogroups (ABCWY) meningitis bacteria<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 15.24pt; width: 239.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 15.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 43.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 45.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vacc<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 62.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ine<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> helps protect against invasive <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.84pt; width: 239.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningococcal disease caused by Neisseria meningitis <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 34.44pt; width: 239.58pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">serogroups A, C, Y and W and is available in over 60 countries. <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">36<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 14.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance: Vaccines continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 177.75pt;"/></tr><tr style="height: 12.75pt;"><td colspan="6" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Key products<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 84.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 95.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disease<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total revenue<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key information<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 24pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Herpes zoster (shingles)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.4bn<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-2%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 24pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 24pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market-leading recombinant, adjuvanted vaccine <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indicated for the prevention of shingles in adults. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Launched in 52 markets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">group B<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.0bn<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">19%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved in 55 countries for the prevention of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invasive meningococcal disease (IMD) caused by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Neisseria meningitis serogroup B<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">group A, C, W and Y<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;387m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> helps protect against IMD caused by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Neisseria meningitidis serogroups A, C, Y and W and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is available in more than 60 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;590m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-52%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-51%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market-leading RSV vaccine in the US for older <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adults, approved in more than 50 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fluarix, FluLaval<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 132pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Seasonal influenza<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 132pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;408m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 132pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-19%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 132pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-16%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 132pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trivalent vaccine available in the US, with other <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets transitioning from quadrivalent to trivalent by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engerix, Twinrix, Havrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hepatitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;692m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">13%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">17%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growing hepatitis portfolio leadership through <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased coverage and strengthened <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations. <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 63.019999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engerix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> adult is available in 91 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 34.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Twinrix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 57.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> adult in 51 countries, and <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 144.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Havrix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 165.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adult in 86 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Boostrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diphtheria, tetanus, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acellular pertussis <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">booster<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;681m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">11%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">14%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Available in 77 countries and market leader in the US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rotarix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rotavirus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;587m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-4%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-1%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Paediatric vaccine available in over 100 countries <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and on 96 national immunisation programmes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 264pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infanrix,<span style="display: inline-block; height: 5.46pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 26.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> Pediarix</span><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 264pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diphtheria, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tetanus, pertussis, polio, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hepatitis B, haemophilus <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenza type B<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 264pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;512m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 264pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-8%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 264pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-5%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 264pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infanrix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is available in 170 countries. <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 121.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pediarix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 148.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available in the US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Synflorix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Invasive disease, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pneumonia, acute otitis <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">media<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;226m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-18%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-15%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Synflorix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, available in 91 countries, including WHO <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pre-qualification<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Priorix, Priorix <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tetra, Varilrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Measles, mumps, rubella <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and chickenpox<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;323m<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">22%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">26%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Priorix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.810000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> continues to gain share in the US. <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 136.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Priorix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 157.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available in 70 countries, Varilrix in 54 countries, and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Priorix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.810000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Tetra in 5 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cervarix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human papilloma virus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;72m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-40%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-38%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An important option against HPV. <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 111.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cervarix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 138.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> two-dose <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">schedule for girls aged 9-14 launched in China in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 527.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our portfolio of more than 20 marketed vaccines is one of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 538.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the broadest in the industry. Vaccines sales were &#163;9.1 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 549.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion, down 7% AER and 4% CER. This <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 216.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected the <span style="display: inline-block; height: 6.55pt;"></span><span id="i9f00269d8cf54294bd8a33da4a7b1886_5693"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 561.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenges we&#8217;ve seen from external pressures in the US <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 572.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and China for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 109.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 137.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 156.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.97000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. We expect these to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 583.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue in 2025, but remain confident that <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 224.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 251.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 256.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 288.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 594.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and our vaccines pipeline will contribute meaningfully in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 606.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medium and long term.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our focus is on strong execution in key markets with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing portfolio, and on delivering the value of our pipeline <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 645.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with new launches so we can bring our vaccines to as many <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 656.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 80.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> as possible. Preventing seasonal viral and high-risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 668.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bacterial diseases remains a key focus for us. This is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 679.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">becoming even more important as populations age. From <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 690.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the age of around 50, our immune system starts to decline, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 701.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leading to increased risk from infectious diseases. Our adult <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 713.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccination portfolio is critical to helping older adults remain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 724.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">active, healthy participants in society.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 527.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our discovery, development and supply of vaccines at scale <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 538.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are built on a long-term commitment to building trust <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 549.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through transparency; and ensuring the quality and safety <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 561.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our products.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 578.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines are complex and highly technical to develop and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 589.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacture. Our established platform technologies, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjuvanted vaccines and the new platforms we're building, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including mRNA technologies and MAPS technology, are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 623.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">core to our continued growth in vaccines.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 466.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 468.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">They enable us to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tackle the most challenging diseases at every stage of life <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 645.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including influenza and pneumococcal disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">37<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240.75pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 14.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance: Vaccines continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Drivers of <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 107.33pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 143.47pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> across the portfolio <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 142.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 88.49000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 115.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> declined in 2024. US sales decreased due <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 154.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to lower demand partly related to a more limited <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 165.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendation from the Advisory Committee on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 176.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Immunization Practices (ACIP) for individuals aged 60 to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 187.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">74. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 204.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Despite lower sales in the US, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 175.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 202.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> maintained a market-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 215.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leading position. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 120.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">More than ten million of the 83 million US <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 227.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adults aged 60 and older at risk have been vaccinated with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 238.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Data on safety, immunogenicity and duration of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protection reinforce the strong and durable defence this <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 260.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uniquely adjuvanted vaccine offers against RSV. Through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 272.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expanded indications in the US, EU, and other countries <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and geographic expansion, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 163.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 190.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> continues to support our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market leadership ambition with multi-billion-pound sales <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 305.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 104.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we believe we&#8217;re well positioned for growth<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 275.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 317.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over the medium and longer term. This is a result of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy&#8217;s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> differentiated profile, our partnering retailers, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established expertise in the older adult population and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ability to co-administer <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 144.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 172.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with other important adult <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines such as <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 124.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 156.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and seasonal flu. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 379.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is approved in over 50 markets globally, 17 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries have national RSV vaccination recommendations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 401.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for older adults and six, including the US, have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 412.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reimbursement programmes. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 170.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">With further approvals <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected in 2025-26, as well as appropriate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 435.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations from public health authorities, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 245.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 273.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the potential to<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 112.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> relieve pressure on healthcare systems and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 457.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">help prevent the severe consequences of RSV globally.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 474.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 488.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 86.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> grew significantly in International in the year, driven <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 499.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by a national immunisation programme in Australia and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 510.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply to our co-promotion partner in China, but declined in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the final quarter reflecting lower sales in China. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 539.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nearly 87<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 94.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million people are already protected with at least <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 550.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one dose of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 102.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 135.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and our ambition is to vaccinate more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 561.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than 100 million people by 2026. In the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 209.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 224.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 40% of the 120 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 572.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million adults recommended to receive <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 208.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 240.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> have been <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 584.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccinated. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 101.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 133.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is now available in 52 countries.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A number of factors drove growth outside the US, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 612.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the launch of<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 104.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the national<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> immunisation programme in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Australia and expanded European public funding. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 634.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply China through our exclusive agreement with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 645.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chongqing Zhifei Biological Products, Ltd. to distribute and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 657.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">promote <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 89.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 121.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> through its network of over 30,000 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 668.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccination points.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 127.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> In 2024, we revised and extended our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 679.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic collaboration with Zhifei, to bring innovative <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 690.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines to more than 500 million people in China. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 255.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 702.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to see large opportunities for growth across the top <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 713.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 markets <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 100.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outside<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 129.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the US where the average immunisation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 724.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate is around 7%.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 339.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 360.42pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis vaccines achieved double-digit growth with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 337.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (meningitis B) achieving sales of over &#163;1 billion for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the first time. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 358.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 393.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 443.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">grow strongly due to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">factors including a <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 378.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendation in Germany and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased demand from Australian immunisation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 359.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 391.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (meningitis ACWY) grew due to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">favourable delivery timing in International markets and US <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CDC purchasing patterns. We&#8217;re now planning for our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 216.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pentavalent MenABCWY vaccine candidate that combines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 228.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these established vaccines. To improve our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 239.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitiveness, we&#8217;ll look to drive future growth with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiple lifecycle innovations in the coming years, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launching <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 345.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 377.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in a convenient liquid formulation in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 273.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additional countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Established vaccines<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our established vaccines portfolio remains key. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">portfolio includes vaccines that protect against hepatitis, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rotavirus and measles &#8211; it represents a third of our total <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines business. Established vaccines continued to grow <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 348.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as we sought to maximise uptake among those who need <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 359.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">them. This is achieved through prioritising specific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 371.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">segments for growth, such as strengthened <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 382.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations for hepatitis in adults, and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 479.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> increasing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 393.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awareness of the importance of vaccination. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 427.44pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 219pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 207.75pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 207.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 207.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See Group financial review on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 120.99pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 129.19pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for more detail<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">38<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 120pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 487.5pt;"><div><div style="line-height: 36pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General <span style="display: inline-block; height: 26.2pt;"></span></span></div><div style="line-height: 36pt; position: var(--position); top: 45.83pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicines<span style="display: inline-block; height: 26.2pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_109"></div><div style="background-color: transparent; height: 841.89pt; left: 304.3pt; opacity: 1; position: var(--position); top: 0pt; width: 291.08pt; z-index: -2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g39.jpg" alt="Gen Meds divider.jpg" style="height: 841.89pt; width: 291.08pt;"/></div></div></div></div><div style="line-height: 14pt; position: var(--position); top: 163.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our broad portfolio of general <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 180.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">medicines, from inhalers for asthma <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 197.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and COPD to antibiotics, improve <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 214.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">life for millions of people around the <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 230.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">world. Many are market leaders. <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="position: var(--position); top: 290.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 222pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 54.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 16.18pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General medicines contributed one third of <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 29.38pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group turnover <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 69.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 23.68pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strong performance driven by both <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 36.88pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory and other general medicines <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 69.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 124.5pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 23.68pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 36.089999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> remains number one brand in COPD <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 36.88pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and asthma globally<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 49.17pt; left: 53.86pt; opacity: 1; position: var(--position); top: 750.92pt; width: 223.5pt; z-index: 2;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 0pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Image: Streptococcus pneumonia bacteria <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 15.24pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since launching more than 40 years ago, <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 145.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 183.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is a <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.84pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global leader in oral antibiotics by sales value, helping to treat <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 34.44pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">common infections including pneumonia.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">39<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance: General Medicines continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 177.75pt;"/></tr><tr style="height: 12.75pt;"><td colspan="6" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Key marketed products<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 84.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 95.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disease<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 180pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total revenue<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 270pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key information<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy Ellipta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2.7bn<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.310000000000002pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">23%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">27%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Top-selling brand in asthma and COPD globally and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most prescribed single inhaler triple therapy (SITT) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide. Available in 60 countries for COPD, with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dual indications for asthma and COPD in 22 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relvar/Breo Ellipta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 72pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 72pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.1bn<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.310000000000002pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 72pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 72pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 72pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">One of the leading ICS/LABA<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 96.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 98.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> treatments worldwide <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by sales value, available in 69 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Seretide/Advair<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.1bn<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.310000000000002pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-7%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">One of the leading ICS/LABA<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 96.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 98.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> treatments worldwide <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by sales value, available in over 100 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;702m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-6%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global market-leading SABA<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 94.39999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 97.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> reliever by sales value, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available in over 100 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro Ellipta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;572m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global market leader in the LAMA/LABA<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 132.39000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 135.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> class by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value and volume (unit sales), approved in over 70 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 162pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common bacterial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infections<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 162pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;635m<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 162pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 162pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">7%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 162pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global leader in oral antibiotics by sales value, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available in over 100 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avodart &amp; Duodart<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benign prostatic <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hyperplasia (BPH)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;336m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market leaders by sales value and volume in the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global dutasteride and dutasteride+tamsulosin FDC<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 168.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 171.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market respectively, and approved in over 85 and 80 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries respectively<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avamys<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Allergic rhinitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;252m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.37pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-16%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">-11%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global leader in the intranasal corticosteroids <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prescription class by sales value and volume, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available in over 80 countries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dermovate, Betnovate, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cutivate, Eumovate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inflammatory skin <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 1.8099999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#163;207m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.38pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">11%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 309.75pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 177.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dermovate is the global leader in the topical <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corticosteroids market by value and volume sales <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and available across around 75 markets globally, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">excluding the US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 412.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ICS/LABA: inhaled corticosteroid/long-acting beta agonists<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 422.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SABA: short-acting beta agonist<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 432.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LABA/LAMA: long-acting beta agonists/long-acting muscarinic antagonists<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 443.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FDC: fixed-dose combination<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 453.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key information source IQVIA<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 479.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Every day, our broad portfolio of General Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 491.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products, many of them market leaders, make life better for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 502.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">millions of people all over the world. Over the next decade, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 513.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our ambition is for these products to have a positive impact <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 524.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the lives of hundreds of millions of patients. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 541.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines sales were &#163;10.4 billion, up 2% AER, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 553.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6% CER. Sales growth was primarily driven by <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 239.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 269.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. For <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 564.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other general medicines, growth in antibiotics and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 575.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dermatology in International markets was offset by global <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 586.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">declines from continued generic competition across the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 598.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">portfolio.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 615.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The portfolio includes medicines typically prescribed in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 626.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primary care. We supply them in more than 100 countries, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 637.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and they represent over 92% of our total medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 648.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines supply <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 119.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volume<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 147.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In 2024, General Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 660.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contributed one third of our sales, helping to fund growth <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 671.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and investment in R&amp;D and returns to shareholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 479.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory and infectious diseases therapeutics make up <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 491.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">77% of our General Medicines revenue, and we expect our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 502.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asthma and COPD medicines <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 424.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 454.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 474.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 497.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to grow <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 513.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further, alongside continued growth for select established <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 524.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products in emerging markets. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 541.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To maximise returns, we prioritise investment in brands that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 553.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are growing strongly, while managing the expected decline <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 564.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of other products in mature markets as they lose their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 575.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patent exclusivity. We use our deep expertise in respiratory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 586.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and infectious diseases to support the launch of new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 598.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines. Those currently in development include our low-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 609.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carbon <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 334.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 366.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> inhaler (see below) and novel infectious <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 620.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease medicines (gepotidacin and tebipenem). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 637.6pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more in R&amp;D on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 95.02pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib43e1c3d8b9c49d9ad2264d1a0a2d875_171">25</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">40<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance: General Medicines continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Drivers of <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 107.33pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our main growth drivers in General Medicines in 2024 were <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 83.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 88.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 112.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 132.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 174.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 157.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 170.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 88.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 118.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our single inhaler triple therapy (SITT) for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 182.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asthma and COPD, continued to grow globally. It&#8217;s licensed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 193.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 60 countries for COPD, with dual indications for asthma <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 204.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and COPD in 22 countries, including the US and Japan. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 215.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">received new approvals in 2024, extending <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 225.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 254.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 227.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">availability to asthma patients in Saudi Arabia and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 238.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indonesia.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 255.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 83.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is the number one SITT globally, selling over 37 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 266.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million packs &#8211; more than twice the volume of the nearest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 277.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitor<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 95.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.2925pt; vertical-align: sub; white-space: pre;">.<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 97.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> In 2024, Trelegy reinforced its position as the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">top-selling brand in asthma and COPD globally, supported <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 300.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by its leading position in the two largest markets, the US <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 311.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Japan, and by the SITT class&#8217;s positive positioning in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 322.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD scientific evidence and global guidelines. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The 2023 <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 93.99000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global Initiative for Chronic Obstructive Lung <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 351.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disease (GOLD) guidelines recommended triple therapy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 362.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over ICS/LABA for exacerbating patients. This has helped <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 373.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to continue the strengthening of the SITT market which, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 384.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seven years after<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 122.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> first launch<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 167.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, is still growing at over 30% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 396.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year on year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 413.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increasing scientific evidence and new biological <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 424.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapeutic options in COPD are now reinforcing the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 435.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunity for more ambitious goals for COPD <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 446.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management for HCPs and patients. We expect a market <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 458.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shift towards optimising treatments, favouring growth for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 469.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SITT class, as the combination of ICS, LABA and LAMA is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 480.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the backbone for add-on biologic treatments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 497.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 98.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 127.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to be a key driver of growth in General <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicines in the coming years.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Anoro<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 328.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is approved in approximately 70 countries to treat <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">symptomatic COPD. It remains the global market leader in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the LAMA/LABA class by volume (unit sales), w<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 491.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ith global <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales (excluding US, and International at AER) continuing to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">grow.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 326.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 328.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro&#8217;s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 358.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> strong clinical data profile includes head-to-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">head data in the LAMA/LABA class and versus other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">common initial maintenance therapy options, such as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LAMA.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 236.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 336.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> remains an important medicine for approximately <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">35 million patients in more than 100 countries, some 55 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 258.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years after it launched. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 397.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 414.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 446.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> metered dose inhalers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 269.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(MDIs) represent a significant proportion of our carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 281.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions. In 2024, we began phase III clinical trials of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 292.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D programme to redevelop <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 425.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 457.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> MDIs by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 303.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transitioning to a lower-carbon propellant; this could reduce <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 314.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">greenhouse gas emissions from our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 448.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 481.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> inhalers by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 326.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately 90%. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 343pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 356.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since launching more than 40 years ago, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 469.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augment<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 504.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 511.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 367.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global leader in oral antibiotics<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 424.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 425.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; h<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 438.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as reached over 2.73 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 378.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion people and demand continues to be strong across all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 390.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regions.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 336.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 338.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 386.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which is available in over 100 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 401.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries, is categorised by the World Health Organization <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 412.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as an AWaRE Access antibiotic. Access antibiotics are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 423.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommended as first or second choice treatments for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 435.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">common infections because of factors like their lower <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential for antimicrobial <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 406.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resistance<span style="display: inline-block; height: 6.55pt;"></span><span id="i49d099ae3fff431e990215666cabee4c_5036"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 446.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 480.37pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 219pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 207.75pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 207.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 207.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See Group financial review on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 120.99pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 129.19pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for more detail<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.89pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.28pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.54pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.47pt; position: var(--position); text-decoration: none; white-space: pre;">41<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.28pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 541.36pt; position: var(--position);"><span style="display: inline-block; height: 175.5pt; width: 16.5pt;"></span></span><span style="left: 557.86pt; position: var(--position);"><span style="display: inline-block; height: 175.5pt; width: 36pt;"></span></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 120pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 487.5pt;"><div><div style="line-height: 36pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing <span style="display: inline-block; height: 26.2pt;"></span></span></div><div style="line-height: 36pt; position: var(--position); top: 45.83pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">and supply<span style="display: inline-block; height: 26.2pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_112"></div><div style="background-color: transparent; height: 841.89pt; left: 304.3pt; opacity: 1; position: var(--position); top: 0.61pt; width: 291.08pt; z-index: -3;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g40.jpg" alt="Manufacturing divider.jpg" style="height: 841.89pt; width: 291.08pt;"/></div></div></div></div><div style="line-height: 14pt; position: var(--position); top: 163.79pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our global supply chain is critical <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 180.59pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.75pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">to manufacturing and supplying <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 197.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.75pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">reliable, <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 105.52pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">high-quality<span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 175.75pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> medicines <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 214.19pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and vaccines to meet patients&#8217; <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 230.99pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">needs and drive our performance. <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 307.19pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024 we saw the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 133.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first full year of our integrated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 318.44pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">netw<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 72.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ork of medicines and vaccines manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.69pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sites.&#160;This is part of our strategy to build an ever-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.94pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more&#160;competitive and resilient global supply chain. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 352.19pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By&#160;bringing together our teams and expertise in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363.44pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines, we&#8217;ve increased efficiency <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.69pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;helped make sure we have the capacity and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.94pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capabilities, especially in areas like digital and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.19pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology, to deliver&#160;our new products.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 414.13pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This network of 37 medicines and vaccines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.38pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing sites delivered 1.7 billion packs of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.63pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and 409 million vaccine doses in 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.88pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;help&#160;make a positive impact on the health of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 459.13pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">millions&#160;of&#160;people. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 476.07pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our focus on productivity and efficiency contributed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.32pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;an&#160;improvement in gross profit margin in 2024.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 504.26pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Accelerating innovation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 520.15pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our global supply chain is not just core to our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 531.4pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations; it&#8217;s vital for innovation too. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 548.34pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our global supply chain teams are part of how we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 559.59pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevent and change the course of disease, bringing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 570.84pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our&#160;innovations to patients as quickly, efficiently and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 582.09pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectively as possible. They&#8217;re involved early in product <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 593.34pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and process development, working with R&amp;D to make <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 604.59pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sure that what works in clinical trials can be scaled up <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 615.84pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;commercial production. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 632.78pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These teams support the lifecycle management of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 644.03pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recently launched assets to secure supply and enable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 655.28pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth. In 2024, this included, for example, increasing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 666.53pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capacity to meet demand and future growth for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 240.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 677.78pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Omjjara<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 85.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, our medicine for myelofibrosis in patients with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 689.03pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anaemia, following <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 130.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expanded<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 169.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> approval in&#160;the EU, the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 700.28pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK and Japan.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 47.27pt; left: 51.92pt; opacity: 1; position: var(--position); top: 747.13pt; width: 223.5pt; z-index: 2;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 0pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Image: HIV virus<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.24pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Smart manufacturing, including use of digital twins, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 24.2pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is&#160;helping&#160;us to scale up manufacturing and launch&#160;<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 33.16pt; width: 223.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plans&#160;&#8211; including for our HIV pipeline.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.89pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.28pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.54pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.47pt; position: var(--position); text-decoration: none; white-space: pre;">42<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.28pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 254.25pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operations: Manufacturing and supply continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">They also support the development of second-generation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products. For <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 108.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">example,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 144.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we&#8217;re bringing on additional <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capacity to deliver <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 127.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 159.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> liquid to more patients around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the world following regulatory approvals in Argentina and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the European Union. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 138.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 169.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> liquid is a new single-vial, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fully liquid presentation of our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 171.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 203.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> meningococcal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8217;ve also started to prepare for the production of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 254.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 286.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fully liquid, a new presentation of our shingles vaccine that, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">if approved, would offer a convenient option for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmacists, physicians and other healthcare professionals <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">who administer vaccinations.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 259.77pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Also, the supply chain teams are preparing for the new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 271.02pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets that we&#8217;re expecting to register and launch in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 282.27pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">coming years, for example <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 160.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 191.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (multiple myeloma), <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 293.52pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gepotidacin (uncomplicated urinary tract infections), <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">camlipixant (refractory chronic cough) and bepirovirsen <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(chronic hepatitis B).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 332.96pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To advance the discovery and development of best-in-class <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 344.21pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines, we&#8217;re investing and partnering in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 355.46pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a&#160;range of platform technologies, including antibody drug <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 366.71pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conjugates (ADCs), <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 133.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oligonucleotides, mRNA and MAPS <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.96pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 96.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. As&#160;manufacturing platform technologies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 389.21pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">become more complex, the need for collaboration between <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 400.46pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D and manufacturing increases. Bringing R&amp;D and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 411.71pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing together at the same locations helps us <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 422.96pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make a seamless transition from process development to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 434.21pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical trials production to commercial production. This co-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 445.46pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">location is already happening at our sites in Upper Merion in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 456.71pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US, Ware in the UK, Wavre in Belgium and Jurong in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.96pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Singapore. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 484.9pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Investing for the future<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 500.79pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> continue to invest in reshaping, simplifying and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 512.04pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthening our network.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.98pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As part of an investment of up to <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 184.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$800 <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 206.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 231.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 540.23pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Marietta site in Pennsylvania, our largest US manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 551.48pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment to date, we&#8217;re bringing R&amp;D and manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 562.73pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">together in one location. The new R&amp;D and commercial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.98pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">facilities will double the size and capacity of the site.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 590.92pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The new multi-purpose facility will be capable of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 602.17pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing sterile liquid medicines and vaccines for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 613.42pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which there is ever-increasing demand. This facility will also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 624.67pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">house a state-of-the-art R&amp;D pilot plant to manufacture <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 635.92pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines for clinical trials. Also, we&#8217;ll establish a new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 647.17pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines drug substance facility at the site, dedicated to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 658.42pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing products based on our novel MAPS <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 669.67pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology, subsequent to future regulatory submissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 680.92pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and approvals.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 697.86pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The new multi-purpose facility at the Marietta site will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 709.11pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incorporate the latest technologies for solar panels, electric <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 720.36pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">heat generation, and water and energy reclamation. Both <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 731.61pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">facilities will feature smart utility and electrical system <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 742.86pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monitoring and controls, digital twins for continuous process <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 754.11pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">optimisation, robotics for material handling, and predictive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 765.36pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintenance and digital scheduling enabled by artificial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 776.61pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intelligence. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These investments in innovative technologies and platforms <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrate our commitment to advancing science, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology and sustainability.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 152.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To support the delivery of our innovative portfolio and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline, we&#8217;re also investing up to &#163;128 million to expand <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sterile manufacturing capacity at our Barnard Castle facility <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the UK. This investment will expand manufacturing of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">newest, next-generation specialty medicines at the site, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underpinning our commitment to cutting-edge <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical manufacturing in the UK. As part of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">modernisation of our Barnard Castle site, we are also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposing to transfer production of some older products <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the dermatology portfolio to external manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partners. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 282.27pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the UK, we also confirmed that in 2025 we will close our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 293.52pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cephalosporin antibiotics manufacturing operations &#8211; our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">site at Ulverston and a facility in Barnard Castle. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">follows our 2021 announcement, when we said that, in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.27pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">absence of alternatives, we would close these operations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 338.52pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following the completion of our contract manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 349.77pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreement with Sandoz.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 400.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 366.71pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Harnessing technology<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.6pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology is transforming how we manufacture medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.85pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and vaccines, enabling us to increase the speed, quality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 405.1pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and scale of product supply.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 422.04pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology helps us optimise efficiency and effectiveness <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 433.29pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across our operations. We&#8217;re reducing cycle time and cost <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 444.54pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the Chemistry, Manufacturing and Controls (CMC) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.79pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development process, the manufacturing and quality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.04pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes as well as the end-to-end supply chain and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.29pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution processes. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 495.23pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re using data to help us monitor production in real time, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 506.48pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">spot ways to increase yields and predict when equipment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 517.73pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">needs maintenance.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 534.67pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re using smart manufacturing technologies for greater <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 545.92pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efficiency, productivity, sustainability and cost savings. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 557.17pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Smart manufacturing is not about replacing people with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 568.42pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology, it&#8217;s about enabling us to work smarter and more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.67pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efficiently. We can augment our human creativity, expertise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 590.92pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and problem solving with data and AI, increasing our impact <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 602.17pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and delivering better and faster for patients. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 619.11pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For example, we have introduced an AI tool to quickly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 630.36pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determine the best transportation route to deliver our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 641.61pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines to patients. The tool does this by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 652.86pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">analysing vast amounts of data, including stock availability, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 664.11pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost, carbon emissions and batch details such as readiness <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 675.36pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to ship at a given time. As a result, we can save costs, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 686.61pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduce carbon emissions and make sure stock reaches its <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 697.86pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">destination on time for patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.89pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.28pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.54pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.47pt; position: var(--position); text-decoration: none; white-space: pre;">43<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.28pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 254.25pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operations: Manufacturing and supply continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Across our supply chain we&#8217;re using 54 digital twin models <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on 12 products to digitally simulate the process, anticipate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">failures and accelerate manufacturing. For <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 223.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 255.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, using a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">digital twin helped us optimise the lyophilisation<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 240.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (freeze-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drying)<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 81.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> step and unlock capacity to produce an extra 1 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million doses to protect more people from shingles. Digital <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">twins are also helping us deliver right first-time <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 238.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 281.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfer to scale up manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 190.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and launch plans for our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 203.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV pipeline, including cabotegravir<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 192.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 197.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Automation and robotics also help to improve ergonomics, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase efficiency and deliver more medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines around the world, on time every time. At Upper <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Merion in the US, a digitised scheduling system alone has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">created 10% extra capacity by removing bottlenecks in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations, while other technology has improved safety, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 287.83pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduced deviations and human error, and improved yields. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve also gained external recognition. Our Wavre vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">formulation unit in Belgium received the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 212.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 214.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Factory of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.27pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Future<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 79.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8217; label from a group of Belgian and European <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 338.52pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agencies dedicated to digital and pharmaceutical industries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 349.77pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This label recognised our continuous investment in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 361.02pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">digitisation, talent development, smart processes, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 372.27pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainable products and world-class production. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 389.21pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Building sustainability<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 405.1pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024 we activated a 56-acre solar farm and two wind <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.35pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turbines at our antibiotics manufacturing site at Irvine in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.6pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK. The new infrastructure will generate over half of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.85pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">facility&#8217;s electricity, effectively tripling its on-site renewable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 450.1pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electricity generation.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.04pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also opened a &#8364;50 million vaccines logistics hub at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.29pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gembloux in Belgium, which will run on 100% renewable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.54pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">power and be self-sufficient by 2025, thanks to solar panels <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.79pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">covering its roof. The 40,000 square-metre facility, our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 512.04pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">largest warehouse worldwide, exports 1 million doses of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 523.29pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines a day and stores millions more destined for more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 534.54pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than 160 countries.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 551.48pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our low-carbon <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 117.21000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 149.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> inhaler for asthma and COPD, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 562.73pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currently in phase III trials, has the potential to cut the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.98pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product&#8217;s carbon emissions by approximately 90%, through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 585.23pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new propellant technology. We confirmed plans to invest in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 596.48pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our site at Evreux in France to manufacture the inhaler, so <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 607.73pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that we&#8217;re ready to start supply, should clinical trials and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 618.98pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory processes be successful. The first of three filling <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 630.23pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lines is already installed and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 167.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operational<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 211.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 647.17pt; width: 595.28pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 10.49pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For more on our approach to sustainability and progress made <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">at&#160;our sites, see&#160;our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 17.29pt; left: 49.36pt; opacity: 1; position: var(--position); top: 797.57pt; width: 248.14pt; z-index: 3;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 248.14pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Analysis for GSK conducted by McKinsey &amp; Company&#8217;s POBOS <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 248.14pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benchmark<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Promoting responsible manufacturing<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re also committed to responsible manufacturing. Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Worthing antibiotics site became the first in the UK to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 151.78pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieve BSI AMR Kitemark certification. This gives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 163.03pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independent assurance that the antibiotics manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 174.28pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process at Worthing meets rigorous international standards <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 185.53pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and is<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 328.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 330.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of our broader efforts to address antimicrobial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 196.78pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resistance (AMR) and support global health. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 213.72pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our goal is for all our global antibiotics manufacturing sites <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 224.97pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to be certified in the coming years, demonstrating our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 236.22pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitment to responsible manufacturing and getting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.47pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ahead of AMR. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 264.41pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Delivering quality, safety and reliability<span style="display: inline-block; height: 8pt;"></span><span id="i4f3cafc74160423787557cf6ea4ca335_10721"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 280.3pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To meet patients&#8217; needs and keep ourselves competitive, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 291.55pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quality, safety and reliable supply are essential. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 308.49pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our reliability remains strong, with an on-time, in-full (OTIF) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 319.74pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measure of 99%, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 374.56000000000006pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">putting <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 403.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">us in the top quartile against the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 330.99pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry bench<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 362.64000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mark<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 382.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 385.69000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.93pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we had 104 regulatory inspections at our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.18pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing sites and local operating companies, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 370.43pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared with 114 in 2023. We received zero warning <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 381.68pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">letters from the US FDA, one critical finding from the MHRA <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 392.93pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and no critical findings from the European Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 404.18pt; width: 595.28pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agency (EMA) in 2024.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 421.12pt; width: 595.28pt;"><div style="font-size: 0pt; left: 304.72pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more about product governance on page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 157.13pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_145">55</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">44<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 62.36pt;" id="idc89fa1ee07645df9629d157a4b46752_115"></div><div style="font-size: 12pt; line-height: 40pt; position: var(--position); top: 62.36pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 40pt; font-style: normal; font-weight: normal; left: 113.2pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">Responsible<span style="display: inline-block; height: 29.12pt;"></span><span id="i866f533545ce41cbadadd18d71a608b2_26"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 40pt; font-style: normal; font-weight: normal; left: 322.28000000000003pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;"> business<span style="display: inline-block; height: 29.12pt;"></span></span></div><div style="height: 55.08pt; left: 53.86pt; position: var(--position); top: 723.24pt; width: 147.08pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g42.gif" alt="" style="height: 65.08pt; width: 157.08pt;"/></div><div><div><div style="transform: translate(0.66pt, 0.66pt);"><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 8.73pt; width: 145.76pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A s<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cientist<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 42.730000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> working in the tuberculosis <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 18.33pt; width: 145.76pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biology lab at our global health <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.93pt; width: 145.76pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">research and development site in <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 37.53pt; width: 145.76pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tres Cantos, Spain.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 677.49pt; left: 0.1pt; opacity: 1; position: var(--position); top: 164.19pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g43.jpg" alt="Resp.bus.divider.image.jpg" style="height: 677.49pt; width: 595.28pt;"/></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">45<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_118"></div><div style="position: absolute; top: 114.19pt;" id="idc89fa1ee07645df9629d157a4b46752_124"></div><div style="position: var(--position); top: 114.19pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our approach<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 146.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Being a responsible business is an integral part of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy and culture. Our Trust priority supports our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business performance and long-term growth. It helps us <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">build trust with our stakeholders, reduce risk, supports our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 191.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people to thrive and to deliver health impact at scale. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 208.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Six focus areas help us to address what is most material to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our business and most important to our stakeholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 237.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">They are: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Access to healthcare<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 270.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global health and health security<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 286.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Environment<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 303.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inclusion and diversity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 319.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ethical standards<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 336.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product governance<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 142.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 352.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These focus areas are core to our strategy, help support <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 364.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term business success and are where we can have the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 375.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">greatest positive impact on some of society&#8217;s most urgent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 386.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenges. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 403.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">Being responsive to the environment in which we operate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 414.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">and the changing expectations of our key stakeholders is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 426.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">critical to building trust. With that in mind, we continue to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 437.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">review and evolve the actions we are taking in all of our six <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 448.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">areas.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 78.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 465.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specifically for inclusion and diversity, we are presently <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 476.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">working to understand and evaluate the impact of the legal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 488.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment. We are progressing this work and reviewing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 499.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities, with the following principles in mind:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 516.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Firstly, as ever, we will always comply with the law and be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 527.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respectful of the environment in which we operate. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 544.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Secondly, we remain fully committed to equal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 555.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employment opportunity, non-discrimination, and merit-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 566.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based decision-making in the way we recruit, manage <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 578.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and develop our people.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 595.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">And thirdly, we continue to believe that an inclusive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 606.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture, with different perspectives and experiences, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 617.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">helps drive superior business performance and deliver <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 628.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">better health outcomes for patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 645.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">We periodically undertake materiality assessments to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 657.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">assess key issues. In 2024, we undertook a double <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 668.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">materiality assessment in preparation for the new reporting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 679.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">requirements under the EU's Corporate Sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 690.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Reporting Directive, which will inform our reporting for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 702.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">financial year 2025, published in 2026.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 203.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 97.91pt; left: 46.97pt; opacity: 1; position: var(--position); top: 772.02pt; width: 235.42pt; z-index: 1;"><div><div><div><div><div style="line-height: 7pt; position: var(--position); top: 10.4pt; width: 235.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have met our previously set overarching ethnicity and gender <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.8pt; width: 235.42pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspirations but not all individual components<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 146.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 160.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Rating<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 176.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating measures <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 187.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the progress we are making on delivering against our Trust <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 198.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority. The rating is one of our corporate KPIs and tracks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress against key metrics aligned to each of our six <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus areas. We continue to evolve our Performance Rating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to ensure it measures what matters most and meets the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 243.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectations of our stakeholders. We review our metrics <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each year, so that they are stretching and achievable and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guide progress towards our long-term goals. The executive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 277.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leadership team and the Board, via the Corporate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 288.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility Committee (CRC), review the metrics that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 299.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make up this rating each year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this report, we set out progress made against inclusion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 327.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and diversity (I&amp;D) commitments previously set for 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and which are reflected in our overall Responsible Business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Rating for the year. In 2024, we measured <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress towards our previously stated 2025 aspirations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 372.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(set out on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 371.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_139">52</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 381.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). In 2024, we largely met<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 481.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 484.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 384.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leadership aspirations. Going forward, we will make <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 395.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in several areas related to inclusion and diversity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 406.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to ensure continued compliance with the law and being <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 417.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respectful of our operating environment, including no longer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 429.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">setting aspirational targets for our leadership and supplier <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 440.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 457.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">How we assess performance <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 475pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The GSK Leadership Team (GLT) is accountable for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivering progress against the metrics and regularly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 497.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews performance along with the CRC.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 514.44pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page 108<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 534.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each individual metric is assessed as either: on track (the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 545.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">metric has been met or exceeded); on track with work to do <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 556.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(at least 80% of the metric has been achieved); or off track <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 568.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(metric has been missed by more than 20%). To calculate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 579.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the overall Performance Rating, we aggregate performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 590.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all metrics into a single score. This score shows <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 601.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether we are on track, on track with work to do, or off <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 613.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">track. This rating is defined below:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 630.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On track:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 340.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 70% or more of all metrics are on track <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 647.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On track with work to do:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 402.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> more than 50% of all metrics <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 658.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are either on track, or on track with work to do <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 131.74pt; left: 304.22pt; position: var(--position); top: 680pt; width: 234.38pt; z-index: 2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g44.gif" alt="" style="height: 141.74pt; width: 244.38pt;"/></div><div><div><div style="transform: translate(1.64pt, 1.64pt);"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 8.86pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 8.5pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 Responsible Business <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 22.06pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 8.5pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance&#160;Rating<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 37.95pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our 2024 Responsible Business Performance Rating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 49.2pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is on track, based on 91% of all performance metrics <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 60.45pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being met or exceeded.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 77.39pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since we introduced the metric in 2022, we&#8217;ve <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 88.64pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintained on-track performance against our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 99.89pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance rating each year. Where we have work to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 111.14pt; width: 231.09pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">do, we have plans in place and monitor our progress. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">46<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 7pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="height: 149.25pt; left: 53.94pt; position: var(--position); top: 109.43pt; width: 484.66pt; z-index: -1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g45.gif" alt="" style="height: 159.25pt; width: 494.66pt;"/></div><div><div><div style="transform: translate(1.67pt, 1.67pt);"></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 123.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 59.53pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">External benchmarking (as at February 2025) <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 139.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investors frequently ask us about our performance in key <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ratings including:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 166.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Access to Medicines:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 2nd in the Access to Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 177.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Index, among 20 of the world&#8217;s largest pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 188.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 205.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S&amp;P Corporate Sustainability Assessment:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 237.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 78 and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 215.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included in the DJSI World and&#160; Europe indices <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FTSE4Good:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 121.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Member of FTSE4Good Index since 200<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 283.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 139.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CDP:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 334.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> A in Climate change, A in Water security, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 150.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B in Forests <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 166.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainalytics: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 372.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low risk rating<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 183.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MSCI:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 338.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AA rating<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 199.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Moody's Analytics: <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 388.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ESG Overall Score of 62 <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 212.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(out of 100, sector average 38)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 230.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ISS Corporate Rating: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 402.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B+ rating<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: absolute; top: 287.18pt;" id="idc89fa1ee07645df9629d157a4b46752_130"></div><div style="position: var(--position); top: 287.18pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Access<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 319.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our aim is to positively impact the health of 2.5 billion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 331.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people by the end of 2030 by making our medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 342.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines available as widely as possible. We will do this <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 353.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through responsible pricing, strategic access programmes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 364.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and partnerships. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 381.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 397.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Make our products available at value-based prices that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 409.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are sustainable for our business and implement access <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 420.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategies that increase the use of our medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 431.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines to treat and protect underserved people.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 448.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating metric<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 461.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Progress towards our 2030 goal of reaching 1.3 billion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 473.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people in lower income countries with our products<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 490.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 506.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By making our medicines and vaccines available at prices <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 517.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that are both accessible to our patients and sustainable for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our business, we are able to grow our business and secure <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 539.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a return to invest in future R&amp;D. As well as through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 551.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible pricing, we expand our reach through strategic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 562.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access and partnerships to make our medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 573.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines more widely available in lower income countries.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 590.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Measuring our progress on access and impact on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 601.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">health at scale<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 614.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2021, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 99.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> set the ambition to positively impact the health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 33.62pt; left: 52.01pt; opacity: 1; position: var(--position); top: 775.97pt; width: 230.26pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding patient reach for albendazole donations in 2024 as the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data is not yet available.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 2.5 billion people over ten years. This includes 1.2 billion <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 637.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people in high and upper-middle countries and 1.3 billion in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 648.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">low and lower-middle income countries. We believe that we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 659.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are on track to achieve our ambition. Our estimated patient <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 671pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reach figure from 2021 to the end of 2024<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 217.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 220.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is at least two <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 682.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion people, of which 1.5 billion are in low and lower-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 693.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">middle income countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 318.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Although we have exceeded our original estimate in low <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 329.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and lower-middle income countries, we don&#8217;t expect <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress towards our ambition to be linear. Reaching <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 351.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals becomes increasingly challenging the nearer we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are to our goal as we don&#8217;t recount those we&#8217;ve already <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reached, and those not yet reached may be harder to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 385.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access. We are also working with our partners to help <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 396.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eradicate diseases like Lymphatic filariasis so expect the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 408.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of patients reached by this programme to naturally <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 419.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decline. Estimating patient reach and measuring health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 430.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact is a complex and emerging area and we recognise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 441.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the importance of transparency and industry collaboration to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 453.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advance in this <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 366.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">area<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 384.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 470pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Evidence-based pricing that recognises benefits <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 483.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We set responsible prices in line with the benefits we bring <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 494.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to patients and health systems, measured by clinical, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 505.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economic and social outcomes. We compare our offer to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 517.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">what is already available for patients and we generate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evidence from clinical trials to establish the added value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 539.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided by our medicines and vaccines. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 556.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We aim to create stability and predictability for payers and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 567.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our business while focusing on access to our medicines to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 579.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improve patient outcomes, engaging proactively on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 590.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upcoming product launches for budget planning, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 601.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusting prices to account for inflation. In the US in 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 612.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our combined average net price (after discounts, rebates or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 624.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other allowances) for our pharmaceutical and vaccines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 635.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">portfolio increased by 5.2%, due to product mix and gross <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 646.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to net pricing favourability, while the average list price <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 657.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased by 1.5%, compared with 2.3% (list) for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 669.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry. Over the past five years, the average net price for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 680.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our products increased 2.3% annually, while the average list <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 691.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">price rose by 3.1%, compared with 4.2% (list) for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 702.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">47<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Access strategies focused on lower income countries <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We reserve our lowest vaccine prices for Gavi, the Vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alliance, and similar organisations. These commitments <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 162.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enable us to deliver manufacturing efficiencies, which help <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 174.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">us to maintain lower prices for lower-income countries. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 185.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have partnered with Gavi, which is a public-private <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 196.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partnership, since its foundation in 2000 and have supplied <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 207.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than one billion vaccine doses to date.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 224.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Through our partnership with Gavi, in 2024 we delivered <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 236.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">around 6 million doses of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 155.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cervarix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 188.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, supplied around 45 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 247.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million doses of our pneumococcal vaccine,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 225.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Synflorix, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 267.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 258.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">43 million doses of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rotarix<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 158.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 275.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are a long-standing supplier of oral polio vaccines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 286.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through UNICEF. In 2024, we supplied around 131 million <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 298pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">doses to help eradicate the disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Malaria<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following the end of the WHO-coordinated Malaria Vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Implementation Programme, we continue to support the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">onward roll-out of RTS,S/AS01 in endemic countries. From <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2019 to 2023, over two million children in Ghana, Kenya <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Malawi received at least one dose of the vaccine, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 384.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was developed by GSK and our partners. WHO evaluations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 395.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the pilot showed high public health impact due to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 407.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction in mortality and hospitalisation rates. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re also rolling out doses of RTS,S/AS01 to nine African <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 435.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries, as part of our commitment to supply 18 million <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">doses to Gavi-eligible countries between 2023 and 2025. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 457.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We plan to produce 15 million doses of RTS,S/AS01 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 469.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annually from 2026-2028. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, Brazil and Thailand became the first malaria-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 497.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">endemic countries to introduce new single-dose radical cure <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 508.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">medicines to prevent the relapse of Plasmodium vivax (P. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 519.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">vivax) malaria. Tafenoquine targets the liver-stage of P. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 531.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">vivax malaria and, when used in combination with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 542.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">chloroquine for the blood-stage infection, is effective in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 553.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">preventing malaria relapses. Approvals for tafenoquine have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 564.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">been granted in 11 countries, including the US, and the drug <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 576.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">is undergoing marketing authorisation evaluation in a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 587.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">number of other countries where P. vivax is endemic. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 604.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In December, the 150mg tablet formulation of tafenoquine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 615.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">received WHO Pre-qualification. We anticipate that up to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ten additional countries could introduce tafenoquine in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 638pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-28. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 654.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Lymphatic filariasis (LF)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 668.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we donated 442 million albendazole tablets to help <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 679.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">end these NTDs. This brings the total we have donated to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 690.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over 12 billion tablets. The number of tablets we are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 702.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">donating is declining each year, given the gradual <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 713.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eradication of the NTDs that the medicine is targeting. The <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 724.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme has benefited over 935 million people since it <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 735.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">began, according to WHO data. We remain committed to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 747.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supplying albendazole to endemic countries until LF is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 758.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eliminated everywhere.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By the end of 2024, CAB LA for PrEP had been supplied at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a non-profit price in a total of 11 low and middle income <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries. We have also committed to tripling our annual <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply of CAB LA for PrEP for programmatic use, making at <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">least two million doses available in 2025-26 to meet <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growing demand where HIV burden and unmet need are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">greatest. In addition, ViiV has prioritised countries for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 205.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">registration of CAB LA for PrEP based on high HIV burden <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 216.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and PrEP readiness. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following the signing of voluntary licences for CAB LA for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PrEP with three generic manufacturers, via the Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent Pool (MPP), ViiV is engaging with these companies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to expedite generic development and access. ViiV also has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 278.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voluntary licensing agreements with 15 generic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 290.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturers to produce and sell low-cost single or fixed-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 301.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dose combination products containing our HIV medicine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 312.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dolutegravir for adults, with one direct licence and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 323.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">others via the Medicines Patent Pool (MPP). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 340.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are similar agreements with 14 generic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 352.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturers for paediatric dolutegravir, as well as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 363.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">separate agreements to drive access to dolutegravir in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 374.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain upper-middle income countries.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 391.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over the 10 years of partnership between ViiV, the MPP, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 402.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and generic manufacturers, more than one billion packs of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 413.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generic dolutegravir-based medicines have been supplied. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 425.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By the end of 2024, more than 23 million people across 129 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries had access to a generic dolutegravir-containing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 447.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 464.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Generic paediatric formulations of dolutegravir are now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 475.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available in more than 100 countries, increasing access to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">age-appropriate treatment options for children living with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 498.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV where the burden of need is highest. This was <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 509.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accelerated by a public-private partnership between ViiV, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 520.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Clinton Health Access Initiative, Unitaid and generic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 532.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturers with sublicences from the MPP.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 549.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 9.66pt; width: 9.92pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For full details of our progress in our six focus areas, please see <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">48<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_133"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><span id="iff769b67a8d6448583d7fbc1fc3d3422_6065"></span><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global health and health security<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 146.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are helping to address the biggest health challenges <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 157.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">faced by people around the world.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 174.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 190.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To develop novel products and technologies to treat <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 201.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and prevent priority diseases, including pandemic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 212.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">threats.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 229.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 240.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">metrics <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 87.99000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Progress six Global Health pipeline assets to address <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 264.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority WHO diseases <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 281.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Progress eight active R&amp;D projects that address <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 292.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pathogens prioritised by WHO and CDC as posing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 302.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the highest level of concern due to drug resistance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 313.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(critical and/or urgent threats)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 330.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">We have a unique and important role to play in improving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">health for patients around the world and helping the world <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">prepare for future health security challenges. We do this by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 379.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">developing products and technologies to treat and prevent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 391.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">priority diseases. We have the largest priority pipeline <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 402.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">among 20 of the world&#8217;s largest pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 413.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">companies<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 96.89pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 100.11pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">, addressing high-burden diseases identified as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 424.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">priorities by external global health stakeholders, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 436.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">the WHO. This supports our long-term growth by driving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 447.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">product innovation and helps us attract and retain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 458.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">outstanding people. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 475.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D for high-burden diseases in lower income <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 17.29pt; left: 54.74pt; opacity: 1; position: var(--position); top: 808.53pt; width: 230.26pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Access to Medicine Index<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 486.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">countries <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 499.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re&#8239;committed to changing the trajectory of high burden <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 511.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases in lower income countries&#8239;with a focus on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention and treatment of infectious diseases, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those with AMR potential.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 550.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2022,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 86.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we announced an investment of &#163;1 billion over 10 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 561.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years to accelerate global health R&amp;D (together with ViiV <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare). By the end of 2024, we had invested 33% of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 584.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this and progressed six Global Health pipeline assets to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 595.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">address priority WHO diseases. The current Global Health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 606.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D pipeline consists of more than 25 medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 618.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines in development, of which more than one third are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 629.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in clinical development. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 646.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to tackling TB, one of the world&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 657.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deadliest infectious diseases. We have developed a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 668.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">promising candidate vaccine, M72/AS01E, up to proof of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 679.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concept (phase IIb). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 696.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have partnered with the Bill and Melinda Gates Medical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 708.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research Institute (Gates MRI). Gates MRI has begun a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 719.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase III trial in seven countries (funded by the Gates <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 730.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foundation and the Wellcome Trust), with the first doses <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 741.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">given in South Africa in March 2024. If proven effective, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 753.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">M72 could potentially become the first new TB vaccine that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 764.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meets the WHO target product profile for over 100 years.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 146.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To date, together with our partners, we&#8217;ve brought two <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 157.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products for the prevention and treatment of malaria to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 168.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market &#8211; the world&#8217;s first vaccine against malaria (see <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 179.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Access, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 338.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 360.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_130">46</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 370.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), and a single-dose, radical cure for P. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 191.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vivax malaria, which are both WHO pre-qualified. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 208.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strengthening health security<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Getting ahead of antimicrobial resistance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 232.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">with our innovation<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 245.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">AMR is an urgent threat to public health. We&#8217;re developing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 257.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">new antimicrobials and vaccines to prevent and treat <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 268.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases. Our investment in innovation to respond <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 279.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">to AMR has resulted in one of the largest AMR relevant R&amp;D <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">pipelines in the industry. We have more than 30 R&amp;D <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 302.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">projects across medicines and vaccines that are relevant to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 313.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">AMR, of which 12 target pathogens deemed &#8216;critical&#8217; by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 324.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">WHO and/or&#160; &#8216;urgent&#8217; by the Centers for Disease Control and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">Prevention, excluding TB which was added by WHO earlier <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 347.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">in 2024. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 364.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, gepotidacin, our investigational, first-in-class oral <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 375.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibiotic, with a novel mechanism of action for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 386.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment of female adults and adolescents with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 397.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncomplicated urinary tract infections (uUTI), was accepted <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 409.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for priority review by the US FDA. Gepotidacin is also in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 420.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development for uncomplicated urogenital gonorrhoea in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 431.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adolescents and adults. We announced positive data from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 442.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our phase III EAGLE-1 trial.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 459.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to progress candidate vaccines against <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 471.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">several enteric diseases which contribute to the burden of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 482.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AMR in lower income countries, including invasive non-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 493.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">typhoidal salmonella, klebsiella, shigella, typhoid and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 504.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">paratyphoid fever.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 521.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Ensuring sustainable, appropriate use and manufacture <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 532.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of antibiotics<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 546.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to run several initiatives to support appropriate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 557.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use of antibiotics. We provide education for healthcare <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 568.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">professionals around the world about using and prescribing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibiotics appropriately, and the importance of surveillance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 591.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">studies. We&#8217;ve maintained our long-running multinational <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 602.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Survey of Antibiotic Resistance programme and are running <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 613.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibiotic surveillance studies to support antimicrobial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 624.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets in late-stage development.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 641.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Investing in innovation and partnership to find <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 652.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and scale solutions to AMR<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 666.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we announced a &#163;45 million pledge to support the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 677.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fleming Initiative, a new global network combining <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 688.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific, technology, clinical, policy and public engagement <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 699.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expertise to develop new AMR interventions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 716.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The initiative will bring together our infectious disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 727.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expertise with Imperial College London and Imperial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 739.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">College Healthcare NHS Trust&#8217;s clinical and research <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 750.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capabilities and a global network of experts to find, test, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 761.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scale solutions to AMR. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">49<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have also committed &#8364;4.5 million to the Global Antibiotic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research &amp; Development Partnership (GARDP) to support <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainable access to antibiotics in lower income countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GARDP focuses on developing and providing access to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">much-needed antibiotics that are effective against WHO-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority pathogens, particularly in low and middle income <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Partnering for pandemic preparedness<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">With outbreaks of Mpox, bird flu and the Marburg virus, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health security remained high on the global agenda during <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024. To help prevent and respond to future health security <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emergency, we are working with governments and other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders to strengthen global preparedness.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In April 2024, we initiated a combined phase I/II study of an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigational influenza A (H5N1) pre-pandemic vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidate, evaluating safety, reactogenicity and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunogenicity in healthy younger and older adults. The <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine candidate has been granted Fast Track designation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the US FDA. This programme reflects GSK&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitment to helping authorities with pandemic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preparedness. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 209.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 9.66pt; width: 9.92pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For full details of our progress in our six focus areas, please see <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: absolute; top: 293.52pt;" id="idc89fa1ee07645df9629d157a4b46752_136"></div><div style="position: var(--position); top: 293.52pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ia6ee21255b7a440488ff8bcb5240d059_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Environment<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 331.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate change and nature loss threaten human health and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 343.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pose risks to business resilience. To get ahead of disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 354.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and to help ensure long-term business success, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 365.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we need to take action on climate and nature.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 391.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 407.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commit to a net zero, nature positive, healthier planet <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with ambitious goals set for 2030 and 2045.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 436.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating <span style="display: inline-block; height: 6.55pt;"></span><span id="i0708c2b1321c4a4183f149fb80e260e3_12488"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">metrics 2024<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 107.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 460.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Climate<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 473.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operational emissions reduction (Scope 1 &amp; 2 market- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 484.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based emissions)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 501.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Industrialisation of low-carbon<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 180.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 214.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> initiated, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 511.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical and non-clinical data available to support <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory submissions; in 2024, to complete clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">studies to enable filing of low carbon <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 208.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 550pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of carbon credit volume in project pipeline<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 274.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 566.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average of the percentage of GSK sites and suppliers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 590.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliant with wastewater active pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 601.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ingredient (API) limits and the percentage of sites and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 612.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers that are compliant with the AMR Industry <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 623.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alliance Common Antibiotic Manufacturing Framework <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 633.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and discharge limits<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Land<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 663.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of paper packaging and palm oil certified<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 680.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Waste<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 693.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operational waste reduction at our sites<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 62.24pt; left: 54.3pt; opacity: 1; position: var(--position); top: 745.79pt; width: 249.54pt; z-index: 1;"><div><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 0pt; width: 249.54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These metrics are related to the Responsible Business Performance <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 8.4pt; width: 249.54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rating 2024. See Responsible Business Performance Report 2024 for <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 16.8pt; width: 249.54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more information. <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also measure and report performance against our <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 25.2pt; width: 249.54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wider set of long-term environmental sustainability targets, which we <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 33.6pt; width: 249.54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">publish on gsk.com<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div></div></div><div style="line-height: 11pt; position: var(--position); top: 331.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 347.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate change and nature loss are changing the spread <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 359.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and burden of disease and are an urgent threat to human <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 370.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health. That&#8217;s why we have set ambitious environmental <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 381.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">goals for 2030 and 2045. These goals address our impacts <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 392.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across our entire value chain, from drug discovery to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposal of our products. Meeting them will help support our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 415.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term performance by protecting our supply chains, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 426.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">help us adapt ahead of anticipated regulation change and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 437.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">providing potential growth opportunities as demand <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 449.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increases for medicines and vaccines with a lower <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 460.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environmental impact.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 477.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Climate<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 493.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have a clear pathway to a net zero impact on climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 504.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with ambitious targets for 2030 and 2045. These targets are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 515.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved by the Science Based Targets initiative (SBTi) Net <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 526.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zero Standard.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 543.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our value chain carbon footprint<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 431.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 434.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is made up of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 493.07000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 &amp; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 555.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2 emissions from our own operations (7%) and Scope 3 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 566.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions from our supply chain (37%), logistics (3%), from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people using our products (mostly metered-dose inhalers) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(53%) and from the disposal of our products (&lt;1%). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 605.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Long-term targets<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 619.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 318.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0% absolute reduction in greenhouse gas emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 630.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from a 2020 baseline, across all scopes, and investment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 641.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in nature-based solutions for the remaining 20% of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 653.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">footprint by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 669.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net zero greenhouse gas emissions across our full value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 680.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain by 2045: 90% absolute reduction in emissions from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 691.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a 2020 baseline, across all scopes, and all residual <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 702.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions neutralised<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 718.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% imported renewable electricity by 2025 and 100% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 729.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewable electricity (imported and generated) by 2030 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 740.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Scope 2)<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress to date on carbon reduction pathway<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we reduced our Scope 1 &amp; 2 carbon emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 137.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 12% compared with 2023, and by <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 208.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">36<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 218.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% compared with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 148.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our 2020 baseline. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our overall Scope 3 emissions are 10% lower than our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">baseline year of 2020, falling by 0.14% in 2023 (our latest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available data) compared with 2022<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 202.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 206.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The reduction in our Scope 1 &amp; 2 carbon emissions in 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was primarily driven by energy efficiency measures in our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing processes, our ongoing transition to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 253.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewable energy and reducing propellant emissions during <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the manufacturing of inhalers.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 281.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we reached 90% imported renewable electricity, 7 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 293.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">percentage points higher than the 83% we used in 2023. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also have a longer-term target to have 100% of all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 315.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electricity imported and from self-generated from renewable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sources by 2030, and in 2024 we achieved 90%. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 343.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The goods and services we buy to make our medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 355.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines account for approximately 31% of our total carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 366.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions footprint. In 2023 (our latest available data), the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 377.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions from our supply chain increased by 6%, primarily <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven by an increase in purchased goods and services. As <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 400.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our supply chain initiatives mature, and we move to activity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 411.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based rather than spend based emissions, we expect to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 422.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">see the effects in reduced upstream Scope 3 emissions. As <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 433.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of our Sustainable Procurement Programme, we have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 445.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engaged <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the top 30 carbon emitting suppliers involved <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 456.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the production of our medicines and vaccines. At the end <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 2024, 22 of these suppliers had shared their action plans <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with us to achieve carbon reductions by 2030 in line with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 490.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our Scope 3 targets. We actively support our highest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 501.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emitting suppliers, engage with service providers and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 512.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to embed sustainability into procurement <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 523.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes. We&#8217;re also collaborating with our peers to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 535.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">address the shared challenge posed by supply chain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 546.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 563.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The use of our medicines and vaccines makes up 53% of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 574.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our total footprint. Most of this is from the propellant used in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 585.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">metered-dose inhalers for asthma and chronic obstructive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 597.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pulmonary disease (COPD).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 614.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Millions of people with respiratory conditions worldwide use <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 625.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our rescue metered dose inhaler (MDI) medication, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 257.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 289.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 636.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(salbutamol). We completed the 2024 planned clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 647.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">studies and began phase III trials in 2024 of a low carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 659.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">version containing a next generation propellant which has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 670.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the potential to reduce emissions of the inhaler by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 681.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately 90%. If successful, regulatory submissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 692.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will begin in 2025. This is in addition to dry powder inhaler <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 704.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alternatives which already exist, are propellant-free, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 715.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have a lower carbon footprint.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 41.76pt; left: 54.55pt; opacity: 1; position: var(--position); top: 782.48pt; width: 230.26pt; z-index: 2;"><div><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Scope 3 data is currently based on the latest available 2023 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data, however, from 2025 we are aiming to report in-year data <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 16.8pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all scopes<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div></div></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Investing in carbon credits<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We plan to secure carbon credits for the 20% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 137.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions we estimate to have as residual in 2030, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 148.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for a maximum of 10% residual emissions by 2045 (from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 159.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a 2020 baseline). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 172.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the end of 2024, we had secured 33% of carbon credit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 184.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volume we need by 2030 in the project pipeline. We invest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 195.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in nature across our value chain and are also prioritising <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 206.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term nature projects for carbon credits. We are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 217.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currently contributing to the protection and restoration of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 229.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over 2 million hectares of land. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 245.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Nature<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 261.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human health relies on the fundamentals of nature like <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 273.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clean air and fresh water, and nature loss has a range of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 284.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">negative impacts on health. Protecting nature helps make <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 295.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our business more resilient and helps to ensure the ongoing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 306.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply of raw materials needed to manufacture our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 318.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are part of the first group of companies to be working <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the Science Based Target Network (SBTN) in a pilot to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set validated science-based targets for nature, starting with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">freshwater.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 385.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are closely following the evolving policy landscape on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 396.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access and benefit sharing related to Digital Sequence <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 408.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information from genetic resources. We publish our latest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">position on Access and Benefit Sharing of Genetic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 430.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Resources and Related Information on gsk.com. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 447.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 461.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We use water across our operations and supply chain for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 472.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the production of our medicines and vaccines.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieve good water stewardship at 100% of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sites by 2025<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 513.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, 100% of our sites continued to achieve good water <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 524.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stewardship status, in line with the Alliance for Water <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 536.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stewardship&#8217;s definition.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 553.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reduce overall water use in our operations by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 563.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20% by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We met our overall water reduction target across our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">network in 2022. In 2024, we reduced overall water use in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 599.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our operations by an additional 5% compared with 2023 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This is a decrease of 28% for overall water use from our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 622.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020 baseline. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 639.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Be <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 356.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">water neutral<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 407.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in our own operations and at key <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers in water-stressed regions by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 663.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">We used water risk data from the World Resources Institute <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 674.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">(WRI) and the World Wildlife Fund (WWF) to understand <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 686.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">which of our sites are located in water-stressed basins and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 697.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">therefore face increasing water availability, quality and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 708.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">access risks. We define water neutrality at these sites using <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 719.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">three criteria: achieving the Alliance for Water Stewardship <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 731.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Standard certification, reducing water use by 20% and by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 742.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">replenishing water quantity in the basin equivalent to the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 753.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">site&#8217;s 2030 footprint. We&#8217;ve identified five sites in three <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 764.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">water-stressed basins where we have operations across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 776.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Algeria, India and Pakistan. We have projects underway to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 787.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">achieve water neutrality in one of these, the Godavari basin <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 798.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">in India. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">51<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieve zero active API levels<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 210.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 213.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for all sites and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key suppliers by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 137.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, &gt;99% of all sites and key suppliers had API <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 148.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discharges below predicted no-effect concentration levels <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as defined by the AMR Industry Alliance and API <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wastewater discharge limits compared with 87% in 2023. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 182.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This improvement has been driven by successful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 193.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement with suppliers. 100% of our own sites <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remained within AMR Alliance and API Wastewater <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 216.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discharge limits.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 233.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Land<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 246.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Land degradation and conversion can have a range of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 258.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">negative health impacts. We&#8217;ve identified six priority sites in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 269.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Belgium, France, Spain, the US and UK based on proximity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 280.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to Protected Areas and Key Biodiversity Areas. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 297.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive impact on biodiversity<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 210.97000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 214.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at all GSK owned <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 308.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sites by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 321.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">66% of GSK sites are under biodiversity management <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 333.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plans, an increase of 45% from 2023. In 2024, we delivered <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 344.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projects to remove non-native species and restore native <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 355.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fauna at our Ware, Wavre, Zebulon and Evreux <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 366.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing sites, with the aim of achieving a biodiversity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 378.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uplift. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 395.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of key<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 140.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 144.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> naturally-derived materials <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 405.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainably sourced and deforestation free by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">58% of our total spend on the 12 highest priority materials<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 281.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 284.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 430.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is covered by an action plan to achieve sustainable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 441.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sourcing by 2030. We are committed to 100% paper <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 453.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">packaging and palm oil certified by 2025. In 2024, 93% of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 464.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our paper packaging was derived from certified sources or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 475.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from recycled raw materials, up from 86% in 2023. 93% of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 486.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our core palm oil materials were credible third-party <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 498.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certified<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 84.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a decrease from 98% from 2023. We're also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 509.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">looking at opportunities to reduce or avoid the use of some <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 520.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">natural materials. For example, an extract from the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 531.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">soapbark tree is an essential ingredient in vaccine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 543.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjuvants. We are working on a process improvement to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 554.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliver a significant yield increase, reducing our nature <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 565.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact and improving supply resilience.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 582.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oceans<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 596pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Degradation of the world&#8217;s oceans, caused by factors such <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 607.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as climate change, marine pollution and over-fishing, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 618.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacts human health and business resilience.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 635.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 648.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of key marine-derived materials to be sustainably <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 659.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sourced by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 152pt; left: 54.92pt; opacity: 1; position: var(--position); top: 680.98pt; width: 234.83pt; z-index: 3;"><div><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Below the predicted no-effect concentration level, as defined by the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AMR Alliance and API Wastewater discharge limits<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.8pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Using the Natural England Biodiversity Net Gain methodology <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 29.2pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Definition clarified in 2024 to reflect priority materials<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 39.6pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aluminium, Cellulose (HPMC &amp; MCC), Eggs, Horseshoe Crab Blood, <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 48pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lactose, Palm Oil, Paper packaging, Rapeseed Oil, Soap Bark Extract <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 56.4pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(QS-21), Soy, Squalene, Sugar (Glucose, Mannitol, Sorbitol, Sucrose)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 66.8pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We consider the principles and criteria determined by the Forest <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 75.2pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stewardship Council (FSC) and the Programme for the Endorsement <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 83.6pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of Forest Certification (PEFC) as an appropriate standard for <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 92pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainable forest management<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 102.4pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Including a 20% reduction in routine hazardous and non-hazardous <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 110.8pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">waste. Target updated in 2024 to remove specific reference to the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 119.2pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">elimination of operational single-use plastics. This work has been <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 127.6pt; width: 234.83pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">integrated into the overall operational waste target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">The long-term focus for these specific materials is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">avoidance of use, through moving to horseshoe crab blood <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">free alternatives. A horseshoe crab blood-derived material, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">Limulus amebocyte lysate (LAL) is required by some <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">regulators to be used in pharmaceutical quality control <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">processes to ensure the quality and safety of medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">vaccines. We continue to make progress on LAL volume <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">reductions and transitioning to LAL-free alternatives for new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 203.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">products, where applicable, and water testing, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 214.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">accounts for the majority of our use.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">We are engaging with regulators to seek further guidance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">on requirements to switch to LAL-free alternative, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">particularly for legacy products. In 2024, we became co-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">lead of an industry group through the Pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">Supply Chain Initiative to accelerate the transition to LAL-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 287.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.006em; position: var(--position); text-decoration: none; white-space: pre;">free testing. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Squalene is used as an ingredient in one of our pandemic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine adjuvants. In 2024, we identified and are currently <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 327.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluating potential non-animal alternatives. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 344.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Waste<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The overuse of natural resources and the generation of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">waste and pollution are key drivers of climate change and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 380.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature loss. Using fewer natural resources can reduce the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 391.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business risk of material scarcity, while also reducing costs. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 408.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25% environmental impact reduction for our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products and packaging by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 432.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From 2024, all newly developed or acquired medicines will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 443.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now have Sustainable Design Plans applied. These use <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry-leading product sustainability methodologies to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 466.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include environmental considerations at every step of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 477.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product decision-making process, from product design to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 488.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposal. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 505.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 340.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zero operational waste<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 433.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">6 <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 438.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we reduced operational waste by 5% compared <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 530.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with 2023, a total of 25% since 2020. The amount of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 541.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materials recovered by circular routes increased by 1% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 553.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from 2023 to 54%. This was driven by a revision to our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 564.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">definition of circularity to exclude waste streams subject to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 575.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory requirements which prevent them from entering <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 586.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circular routes. We have maintained zero operational waste <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 598.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to landfill.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 615.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target: <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 342.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% waste reduction from our supply chain by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 625.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 639.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For our supply chain, we&#8217;re working on a waste footprint <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessment to help with supplier engagement on waste <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 661.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 678.78pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 9.68pt; width: 9.92pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For full details of our progress in our six focus areas, please see <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">52<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_139"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i0054a983ee4f47dc891a2434bec778d0_0-0-1-1-821446"></span><div style="height: 27pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inclusion and diversity<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 147.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To be a successful business and deliver positive health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact at scale, we must meet patients&#8217; needs with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">research that includes those impacted by the disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 181.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under study, attract and retain the best talent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 192.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regardless of background, and support all GSK people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to thrive. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this report, we set out progress made against I&amp;D <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitments previously set for 2024, and which are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 243.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected in our overall Responsible Business Performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rating for the year. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 271.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 282.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">metrics 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 295.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Representative clinical studies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 309.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50% of phase III trials completing enrolment in 2024 that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 320.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 84.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">met<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 99.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> our required threshold<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 188.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 191.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 194.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 195.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of trial participants, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 331.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistent with disease epidemiology<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 348.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we measured progress towards our previously <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 359.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stated 2025 aspirations (set out below). In 2024, we<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 257.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 260.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">largely <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 370.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">met<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 68.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 71.96000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 73.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the leadership aspirations. Going forward, we will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make changes in several areas related to inclusion and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diversity to ensure continued compliance with the law and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being respectful of our operating environment, including no <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 415.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">longer setting aspirational targets for our leadership and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supplier programmes.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 444.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Previous leadership aspirations through fair and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 454.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">equitable<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 92.69pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> opportunities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 468.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspire to have women hold at least 45% of VP-and-above <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 479.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">roles globally <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 496.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspire to have at least 30% ethnically diverse leaders in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 507.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our roles at VP-and-above in the US, and increase the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">percentage of Black or African American, and Hispanic or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 530.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Latino(a) VP-and-above leaders year on year <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 547.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspire to have at least 18% ethnically diverse leaders in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 558.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our roles at VP-and-above in the UK, and increase the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 569.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">percentage of Black VP-and-above leaders year on year<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 586.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Previous supplier programme aspirational targets<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Improve year-on-year spend with US-based certified <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diverse-owned suppliers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 628.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 644.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Representative c<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 124.69pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">linical studies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 657.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diseases and medicines can affect people differently <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 669.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depending on their ethnicity, sex, race and age so we need <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 680.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to make sure that our clinical trials include those affected by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 691.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the disease under study. This supports our business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 702.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance by providing healthcare providers and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 714.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals who are prescribed our medicines and vaccines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 725.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence in the safety and effectiveness of our products.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 56.4pt; left: 56.38pt; opacity: 1; position: var(--position); top: 776.23pt; width: 230.26pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined by meeting &#8805;70% of each demographic objective described <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the plan based on disease epidemiology. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 18.8pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have met our previously set overarching ethnicity and gender <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.2pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspirations but not all individual components.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 147.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since 2022, all our phase III clinical trials have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representation plans in place before commencing enrolment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to reflect the people most impacted by a particular disease. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 181.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For example, our respiratory syncytial virus (RSV) clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 192.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development programme has been recognised by external <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experts for the robustness of the data reflecting the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 214.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">population at risk, hence informing prescribers and people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 226.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the vaccine's potential impact. Our phase III RSV clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 237.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trials were designed to ensure the broadest geographic <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 248.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">footprint and the broadest population representing people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 259.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with underlying health conditions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 276.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Now our focus is on actual enrolment of participants <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 288.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacted by the disease under study. 88% of phase III trials <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 299.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">completing enrolment in 2024 met our enrolment thresholds <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 310.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">needed so that trial participants represent the disease <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 321.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">epidemiology under study. This exceeds our 2024 target of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 333.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50%.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 350.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Building a high-performing, inclusive organisation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 363.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over recent years, we&#8217;ve delivered a step-change in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 374.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance and we believe in the power of an inclusive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 386.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture and differing perspectives and experiences to unlock <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 397.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the full potential of the company. This helps attract and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 408.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retain outstanding talent, develop innovative solutions, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drive better decision-making, supporting long-term <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 431.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance and better health outcomes for patients.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 447.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We want GSK to be a workplace where our employees can <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 459.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feel a sense of belonging, be themselves, and have their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 470.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">different perspectives and characteristics valued, because <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 481.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this helps everyone perform at their best. We measure <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 492.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employee sentiment on inclusion as part of our employee <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 504.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">survey, which includes questions on employees feeling <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 515.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">welcome and included, feeling able to be themselves, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 526.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valuing different perspectives, and agreeing on ways of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 537.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">working that enable them to perform at their best. In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 549.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our employee engagement was strong at 81% favourable.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 566.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our ERGs, employee-led communities that are open to all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees, are key partners to help us build an inclusive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture. For example, in 2024, we worked in partnership <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 599.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with our Disability Confidence Network to launch our new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global Accessibility Inclusion Standard that sets out <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 622.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">minimum expectations to help address accessibility for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 633.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people living with disabilities and long-term health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 644.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 661.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to equal employment opportunity, non-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 673.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discrimination and merit-based decision-making in the way <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 684.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we recruit, manage and develop our people. We previously <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 695.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set leadership aspirations for race and ethnicity in senior <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 706.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positions in the US and UK and gender aspirations for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 718.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior positions globally. At the end of 2024, we had largely <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 729.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">met<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 319.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 322.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> these aspirations.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 746.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the end of 2024, women held 48% of VP-and-above <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 757.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">roles globally, and made up 48% of all employees in 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 768.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 51% of all management roles.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">53<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the UK at the end of 2024, 21.8% of our leaders at VP-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and-above were ethnically diverse and we had 3.1% Black <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leaders at VP-and-above. In the US, 38.3% of our leaders <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at VP-and-above were ethnically diverse.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 215.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 218.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We had 8.4% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Black or African American leaders at VP-and-above and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5.9% <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 76.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hispanic or Latino(a) leaders at VP-and-a<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 240.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bove.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We remain committed to abiding by the laws in all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions in which we operate, including anti-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discrimination laws. We make changes as necessary as law <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and policy evolves. Going forward, we will make changes in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">several areas related to inclusion and diversity to en<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 258.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sure <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued compliance with the law and being respectful of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our operating environment, including no longer setting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspirational targets for our leadership and supplier <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 293.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair and equal pay practices are crucial to create an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment where people feel welcome, valued, included <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and supported to thrive. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.016em; position: var(--position); text-decoration: none; white-space: pre;">We conduct country-based reviews and ensure all markets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.016em; position: var(--position); text-decoration: none; white-space: pre;">have clear guidance, tools and support to ensure pay <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.016em; position: var(--position); text-decoration: none; white-space: pre;">fairness.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 337.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 152.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If unexplained differences are detected, we address them <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through our compensation processes. Our UK pay gap <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting is available on gsk.com. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Supplier programme <span style="display: inline-block; height: 6.55pt;"></span><span id="i3fa2ce72ece5422188c7b72ed53afa8f_6704"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over the last year, we have increased our spending with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 217.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers owned by people in under-represented groups in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 228.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US and we expanded this programme to the UK.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 245.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2025, we will no longer set aspirational targets and will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 256.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review this programme to ensure continued compliance with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 267.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the law and being respectful of our operating environment, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the aim of continued outreach to a broad <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 485.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">range<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 508.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers and delivery of business value.&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 304.45pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 9.66pt; width: 9.92pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For full details of our progress in our six focus areas, please see <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: absolute; top: 353.59pt;" id="idc89fa1ee07645df9629d157a4b46752_142"></div><div style="position: var(--position); top: 353.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><span id="if26aa048fa5d47a2af468ff4bae75b64_6578"></span><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ethical standards<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 392.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect all of our people to behave ethically, do the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 403.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thing and Speak Up about any concerns they have. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 414.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expect the same behaviour from our suppliers.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 431.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 447.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Promote ethical behaviour across our business by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 458.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supporting our employees to do the right thing and working <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 469.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with suppliers that share our standards and operate in a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 481.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible way.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 498.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">metrics 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of employees and complementary workers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complete GSK&#8217;s 2024 mandatory training <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 549.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of employees who believe they &#8216;can and do <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 560.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Speak Up if things don&#8217;t feel right&#8217; is above the general <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 571.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry benchmark<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 140.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 587.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80% of direct high-risk suppliers achieve GSK&#8217;s minimum <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 598.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EcoVadis score or have an improvement plan in place <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 615.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 630.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">How we do things is as important as what we do. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 30.51pt; left: 42.73pt; opacity: 1; position: var(--position); top: 782.89pt; width: 230.26pt; z-index: 1;"><div><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The general industry benchmark is 67% according to research by <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">KornFerry<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div></div></div><div style="line-height: 9pt; position: var(--position); top: 642.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">means that it is important that all our people, and everyone <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 653.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">who works on our behalf, conducts themselves in the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 664.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">way. This builds trust in what we do, protects our business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 675.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and helps create a workplace where we all thrive. Getting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 687.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">this wrong is costly to our business in terms of legal and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 698.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">financial risk as well as undermining trust with key <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 709.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders. Our Code of Conduct (The Code) guides our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 720.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">people to do the right thing and act on any concerns they <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 732.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">have<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 73.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 392.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Code is supported by specific global policies and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 403.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards and an accompanying global learning curriculum, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 414.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which all our people are required to complete. In 2024, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 425.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of our employees and 99% of complementary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 437.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">workers completed this training. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 453.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have additional ABAC training for our people in certain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 465.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">high-risk roles or geographic regions. This helps them <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 476.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identify and mitigate any potential ABAC risk &#8211; especially in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 487.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">third-party relationships &#8211; and recognise, report and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 498.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manage conflicts of&#8239;interest. In 2024, 100% of this subset of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 510.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees and 98% of complementary workers completed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 521.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this training.&#8239; Our approach to managing ABAC risk, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 532.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other risks relating to ethical standards, forms part of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 543.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well-embedded risk management framework, which is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 555.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">described on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 380.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_160">60</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 390.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#8239; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 572.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Reporting and investigating concerns<span style="display: inline-block; height: 6.55pt;"></span><span id="if26aa048fa5d47a2af468ff4bae75b64_6580"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 463.61pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8239; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 585.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anyone inside or outside GSK can raise concerns or speak <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 596.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to our integrity lines, confidentially and anonymously, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 608.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">without fear of retaliation. We take every concern seriously <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 619.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and review every report to see whether we need to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 630.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigate formally. If our investigations show an employee <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 641.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has breached our policies, we take action in line with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 653.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policies, procedures and local requirements. In 2024, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 664.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued our focus on enhancing our controls, monitoring <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 675.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities and timely case closure. The number of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 686.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees disciplined for policy violations increased from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 698.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the prior year primarily due to localised incidents in a few <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 709.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries with large workforces. These incidents mainly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 720.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">involved individual breaches of internal policy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 731.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procedures.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">54<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment to <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 138.03pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">human rights <span style="display: inline-block; height: 6.55pt;"></span><span id="if26aa048fa5d47a2af468ff4bae75b64_6581"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to respecting internationally recognised <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">human rights wherever we do business. We are signatories <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the UN Global Compact and our Human Rights Position <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Statement lays out our commitment to the UN Guiding <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Principles on Business and Human Rights. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we updated our salient issues &#8211; those areas where <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s potential to impact on human rights is greatest &#8211; to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">reflect how and where we influence human rights. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 228.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">Our refreshed salient issues are healthcare access and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 239.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">affordability, safety of patients and trial participants, working <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">conditions, environmental health impacts, and artificial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 262.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">intelligence and data protection. We continue to make <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">progress in integrating the management of these issues <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 284.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">within our operations and how we conduct our business<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 270.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 301.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Working with third parties <span style="display: inline-block; height: 6.55pt;"></span><span id="if26aa048fa5d47a2af468ff4bae75b64_6582"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect our third parties to comply with applicable laws <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and regulations and to adopt, at minimum, our ABAC and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">labour rights principles and, where relevant, to comply with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 348.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our standards on quality, patient safety, health and safety, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 359.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data and cyber security, and the environment. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 376.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we assessed our high-risk third parties, totalling <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over 12,500 assessments across 17 risk areas. We also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 399.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use tools to assess how suppliers manage risks, including <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 410.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EcoVadis desktop assessments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also conducted 41 supplier audits in 2024 following <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry standard Pharmaceutical Supply Chain Initiative <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 450.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guidelines. We trained almost 1,400 supplier employees on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 461.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EHS this year, strengthened EHS contractual obligations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 472.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and worked with suppliers to help them improve their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 483.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EcoVadis scores. If a third party has a significant EHS <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 495.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incident, we have a process in place to pause supply, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 506.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the decision on whether to restart or discontinue work with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 517.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the third party depending on completion of an improvement <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 528.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plan and trajectory.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 545.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we deployed a contractor safety programme <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 557.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all GSK operations. This is a management system <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 568.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">using best-known methods to reduce risks associated with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">services performed by contractors. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Using data and AI responsibly <span style="display: inline-block; height: 6.55pt;"></span><span id="if26aa048fa5d47a2af468ff4bae75b64_6583"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We take our responsibility for data ethics and privacy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seriously and we exercise high standards of integrity in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dealing with the personal information of our employees, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, clinical research participants, healthcare providers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other stakeholders. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Digital and Privacy Governance Board oversees our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall data ethics and privacy operating model, supported <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by digital and privacy legal experts and compliance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">professionals. The board monitors fast-evolving legislation, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations, guidance and requirements being published by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global regulators.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 262.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">Cyber security threats have become more sophisticated and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">are increasing with our expanding digital footprint. We deploy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 284.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">cyber security controls, monitor and mitigate new and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">emerging cyber threats to protect GSK from cyber security <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 307.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">risks<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 322.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 323.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we continued to embed our cross-functional AI <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Governance Council (AIGC) to oversee our AI strategy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">to ensure responsible adoption of AI/ML. We also introduced <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">a new responsible AI Standard Operating Procedure, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 368.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">defines the requirements for all development and/or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 380.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">procurement of AI systems across GSK, and established a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 391.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">framework for business functions to integrate AI risk review <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 402.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">and management within existing risk management <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 413.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">compliance boards. Our public policy position on responsible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 425.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">AI sets out our views, commitments and asks of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 436.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">policymakers.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 453.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Political engagement <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 466.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to the highest ethical standards and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legislative requirements in all of our political engagements. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We do not make corporate political contributions, nor do we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sponsor party political meetings anywhere around the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 511.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">world. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 526.13pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 9.66pt; width: 9.92pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For full details of our progress in our six focus areas, please see <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">55<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_145"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i6d30ebd61b5d421cb7bb1ae5947a3ca9_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product governance<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We commit to maintaining robust quality and safety <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 178.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes, and using data and new technologies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 190.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibly. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 207.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Rating <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 217.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.79pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">metrics 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average number of critical and major findings per <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 242.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inspection by FDA/MHRA/EMA regulator<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 222.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 226.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 258.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of inspections from all regulators with no <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 269.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">critical findings or official action indicated <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of FDA warning letters <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 302.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total number of Class I/II external product recalls across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 313.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all markets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 329.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Register and disclose all interventional clinical trials of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 340.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK products. Specifically, register protocol summaries <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 351.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for studies initiated in 2024; and disclose results <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 362.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">summaries for studies with results due in 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 378.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 394.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To be ambitious for patients, we&#8217;re focused on delivering a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 405.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">high-quality, safe and reliable supply of our products around <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 417.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the world. This supports our long-term growth. To ensure we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 428.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meet the high standards we set ourselves, and that are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 439.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected of us externally, we have rigorous quality systems <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 450.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in place across the company. These systems make sure the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 462.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines we deliver are safe and r<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 248.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eliable. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 479.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 77.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> issues arise, our quality systems, in line with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 490.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">values-driven culture, help us respond swiftly and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 501.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transparently. In these instances, we prioritise patient safety <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 512.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and work collaboratively to investigate the cause of issues, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 524.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused on science. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 135.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By way of example<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 209.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, we initiated a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 535.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voluntary recall of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 126.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> products and suspended the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 546.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">release, distribution and supply of all dose forms of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 256.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 283.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 557.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2019. GSK and the scientific community have undertaken <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 574.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extensive tests and investigations into the safety of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 585.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product. The scientific consensus remains that there is no <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 597.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistent or reliable evidence that ranitidine increases the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 608.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk of any cancer. For information on the recent <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 244.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 272.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 619.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settlements, see Legal proceedings on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 231.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i59a0d33488c04eee9773c8d9f9f1ba75_19113">266</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 245.97000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 636.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">A focus on quality<span style="display: inline-block; height: 6.55pt;"></span><span id="ifb5a2e4fe28c4808a3d7229e5ede1da1_4169"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 130.51pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 650.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our detailed and specific quality framework describes how <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 661.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we comply with regulatory requirements and other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 672.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards across our markets. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 689.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Quality Management System provides the standards <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 12.51pt; left: 45.12pt; opacity: 1; position: var(--position); top: 793.35pt; width: 252.54pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 252.54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We consider any observations from the US FDA as major<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 700.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that must be followed by GSK people to support good <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 712.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution and manufacturing practice. It helps us maintain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 723.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a standardised and compliant approach to all our quality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 734.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities, aligned to the regulatory expectations of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 745.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets that we supply to.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Regulatory inspections and recalls <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 165.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we had 104 regulatory inspections at our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 176.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing sites and local operating companies, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 187.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared with 114 in 2023. We received zero warning <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 199.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">letters from the US FDA, one critical finding from the MHRA <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 210.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and no critical findings from the European Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agency (EMA) in 2024. We respond to and learn from all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 232.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inspection findings, taking the necessary actions to address <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 244.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">them.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 261.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2024, we had two Class I and two Class II product <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 272.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recalls. We engaged with regulators and responded quickly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 283.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to prioritise patient safety. We will not hesitate to recall <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 294.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products voluntarily if necessary to protect patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 311.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Clinical data transparency<span style="display: inline-block; height: 6.55pt;"></span><span id="ifb5a2e4fe28c4808a3d7229e5ede1da1_4170"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 325.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to transparency of data from clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 336.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">studies that evaluate our medicines and vaccines, because <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 347.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we want to enable access to information about our research <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 358.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to study participants, patients, healthcare providers and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 370.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wider public. It also allows us to acknowledge the invaluable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 381.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution of the people who take part in our clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 392.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">research.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 409.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clinical trial transparency is an area that is becoming <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 420.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasingly regulated globally. Our policy regarding the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 432.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosure of human subject research enables us to comply <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 443.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with international regulations and balances our commitment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 454.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to transparency with the increasing need to ensure that our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 465.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data assets are appropriately protected.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 482.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the past two years, we have broadened our policy to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 494.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">encompass the dissemination of plain language summaries <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 505.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our trial results to both trial participants and the general <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 516.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">public. This applies to trials starting after 1 January 2023. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since the GSK trial register was set up in 2004, we have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 544.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made 8,036 protocol summaries and 7,029 summaries of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 556.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results available. We have also listed 2,721 clinical trials for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 567.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data sharing via www.vivli.org.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 584.2pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 9.66pt; width: 9.92pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.22pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">For full details of our progress in our six focus areas, please see <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">our Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">56<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 120pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 55.5pt; width: 487.5pt;"><div><div style="line-height: 36pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture <span style="display: inline-block; height: 26.2pt;"></span></span></div><div style="line-height: 36pt; position: var(--position); top: 45.83pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 36pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and people<span style="display: inline-block; height: 26.2pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_148"></div><div style="background-color: transparent; height: 841.89pt; left: 303.87pt; opacity: 1; position: var(--position); top: 0pt; width: 291.38pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g46.jpg" alt="Culture image.jpg" style="height: 841.89pt; width: 291.38pt;"/></div></div></div></div><div style="line-height: 14pt; position: var(--position); top: 163.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our purpose &#8211; to unite science, <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 180.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">technology and talent to get ahead <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 197.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of disease together &#8211; puts our <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 214.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">people at the heart of our <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 211.04000000000002pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">success <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 230.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 80.64pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">we have defined a single <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 14pt; line-height: 14pt; position: var(--position); top: 247.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">culture for GSK <span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 151.59pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">globally<span style="display: inline-block; height: 10.19pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 197.13pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 14pt; position: var(--position); top: 163.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 318.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 298.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our culture<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 320.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 222pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 11.31pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ambitious for patients<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 115.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to deliver what <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 24.51pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters better and faster<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 11.31pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accountable for impact<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 120.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with clear <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 24.51pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ownership and support to succeed<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 222pt;"><div><div style="line-height: 11pt; position: var(--position); top: 11.31pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Do the right thing<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 90.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with integrity and care <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 24.51pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">because people count on us<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 469.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">People and patients around the world count on the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 480.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines we make &#8211; so we&#8217;re committed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 491.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to creating an environment where our people can thrive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 502.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> focus on what matters most.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 519.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture of being ambitious for patients, accountable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 531.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for impact and doing the right thing is the foundation for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 542.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how, together, we deliver for patients, shareholders and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 553.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our people.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 570.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This means we s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 120.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upport our people to<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 200.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> focus<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 224.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, doing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 581.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">things&#160;better and faster. It means settin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 207.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">g clear <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 592.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">objectives, creating accountability for results and giving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 604.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">everyone the support and space they need to succeed. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 615.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It&#160;also means doing everything responsibly with integrity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and care.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 643.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture is embedded in everything we do, from our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 654.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recruitment and onboarding, training and development, to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 666.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our assessments of performance and promotion. The Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 677.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regularly monitors and assesses how we've embedded our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 688.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 58.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ulture. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 705.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">E<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 59.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ach year, everyone signs up to the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 197.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 219.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; which sets out <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 716.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our culture as well as the commitments GSK and our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 728.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people make so we can deliver on our ambition in the right <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 739.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">way. A<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 79.46000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nd each year, we measure our progress in making <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 750.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this culture the way we work together every day.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 767.53pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g41.jpg" alt="Globe.icon.jpg" style="height: 10.49pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See The Code on gsk.com<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 71.25pt; left: 451.44pt; position: var(--position); top: 730.88pt; width: 106.05pt; z-index: 2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g47.gif" alt="" style="height: 81.25pt; width: 116.05pt;"/></div><div><div><div style="transform: translate(0.85pt, 0.85pt);"><div style="line-height: 8pt; position: var(--position); top: 7.2pt; width: 104.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An intern who joined us <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 104.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2024 in the UK. We <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.4pt; width: 104.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are committed to giving <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36pt; width: 104.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outstanding people the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 45.6pt; width: 104.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chance to build their skills <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.2pt; width: 104.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and capabilities.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">57<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture and people continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Developing outstanding people<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To develop and deliver transformative medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines, we recruit and develop outstanding people and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 151.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">give them opportunities to build their skills and capabilities.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 168.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From the moment people join <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 172.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK, we deliver an engaging <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 179.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">onboarding approach to accelerate the growth of our new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 191.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joiners with support from their manager and team.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 208.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect all our people to have an agreed development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 219.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plan and we invest in learning and development initiatives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 230.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which everyone can access.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology remains key to our purpose and to delivering <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 258.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our ambitions. Building digital fluency and behaviours <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 270.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across the organisation is a priority, with a focus on AI, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 281.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data&#160;&amp; analytics, experimentation and fostering curiosity. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 292.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have built our people's skills with training, as well as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global events such as DataCon, where our people can learn <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 315.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how to apply digital, data and technology tools to become <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more digitally fluent. This year, more than 13,000 of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people took part.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 354.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our managers play a crucial role in helping their teams <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 365.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;perform and thrive. We expect them to motivate, focus, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 377.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">care for and develop their teams and we deliver training <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anchored in these four areas. In 2024, approximately 700 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 399.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior directors attended our three-day in-person event <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 410.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">called Leading Leaders across 24 global sessions. We also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 422.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to invest in growing the next generation of senior <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 433.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leaders. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024 over 1,300 people attended our refreshed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 444.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">First Line Leader programme to support our foundational <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 455.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectations of leadership at GSK.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 472.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To measure the effectiveness of our managers, their teams <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 483.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide feedback through an annual One80 survey, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 495.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managers receive anonymised aggregate feedback. In <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 506.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, 79% of our managers were rated as highly effective <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 517.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by their teams.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Recognising and rewarding people<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sharing our success and recognising and rewarding our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people fairly, not just on the progress we have made but <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 151.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how we have made it, continues to be an important part of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 163.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our culture. Our bonus scheme rewards performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 174.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across the company, and we also award 10% of our people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 185.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each year with &#8216;Ahead Together&#8217; awards for delivering <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 196.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceptional performance and being ambitious for patients, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 208.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accountable for their impact, and doing the right thing. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 519.4200000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 219.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also identify 5% of people as having missed performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 230.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for not delivering on their objectives or living the culture<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 521.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 247.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Helping people thrive<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 263.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">People thrive in different ways, but there are common <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 274.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">themes that matter to everyone. We strive to be a place <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 285.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where people feel welcome and valued, in an environment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 297.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(including our policies, workplaces and ways of working) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 308.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that enables and supports them to deliver at their best. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 319.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">includes our approach to hybrid working for those in office-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 330.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based roles, which allows the right balance of on-site and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 342.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remote working.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 359.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Health, wellbeing and volunteering<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 374.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preventing disease and keeping people well are at the heart <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 386.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of what we do. We provide a range of health and wellbeing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 397.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits to support people to manage their physical, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 408.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emotional, mental and financial wellbeing through different <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 419.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">life stages in ways that work for them. These include:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 436.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Thrive Global, a science-led digital platform which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 447.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supports mental resilience and overall wellbeing with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 458.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">personalised, AI-driven micro steps towards individual <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 469.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">goals. We have so far launched this in eight countries, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 480.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reaching 56% of our people with positive uptake and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 490.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 507.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our global Partnership for Prevention <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 462.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 510.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 518.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provides our people and their families with access to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preventive healthcare services in line with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 539.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations of the World Health Organization <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 550.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(WHO).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 567.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Global Employee Assistance <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 446.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Programme,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 495.07000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 577.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offers free, confidential help and support for our people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 588.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and their families 24/7. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 605.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial wellbeing support for our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 451.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 482.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which includes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 615.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access to <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 353.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Nudge&#8217;, a<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 393.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> financial education platform in over <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">60 countries, helping people manage their finances and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 637.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieve their financial goals. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">58<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our culture and people continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To enable <span style="display: inline-block; height: 6.55pt;"></span><span id="i790f5ce0ebd74867a80debd26af98cda_8707"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 94.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our managers to better care for their teams by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 566.84pt; left: 305.16pt; opacity: 1; position: var(--position); top: 112.75pt; width: 238.11pt; z-index: -3;"><div><div><div><div style="position: var(--position);"><img src="gsk-20241231_g48.jpg" alt="Culture panel.jpg" style="height: 566.84pt; width: 238.11pt;"/></div></div></div></div><div></div></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identifying and responding to their people's challenges, 88% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of managers have undertaken mental health training since <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the end of 2019.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We encourage our people to volunteer so we can make an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">even bigger impact on our communities. We match <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volunteering opportunities to our ambition, strategy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charitable investment themes: Health for people, Health for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the planet, Innovators for the future. This year our people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have donated over 47,000 hours of volunteering time.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 237.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">How people experience GSK<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 253.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to listening to our people. We regularly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 264.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measure their experience of GSK as a place to work, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 275.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including through an annual survey for all our people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">featuring questions on engagement, confidence, inclusivity, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 298.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our culture focus areas and trust priorities. In 2024 we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 309.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued to see a high engagement score of 81% and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 320.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased confidence in the delivery of our strategy. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 331.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also continued to see high scores in our culture focus areas <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 343.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; ambitious for patients, accountability for impact and doing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 354.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the right thing &#8211; as well as measures of inclusion, with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 365.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improvements in many areas. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 316.68pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our culture in action &#8211; driving R&amp;D<span style="display: inline-block; height: 8pt;"></span><span id="i790f5ce0ebd74867a80debd26af98cda_8703"></span><span id="i790f5ce0ebd74867a80debd26af98cda_8723"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our cultu<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 352.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">re pil<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 371.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lars &#8211; ambitious for patients, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accountable for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 379.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 405.71999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and doing <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 452.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 464.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> right thing &#8211; <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 515.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 162.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fundamental to our success in researching and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 172.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing innovative medicines and vaccines. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 183.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alongside exec<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 376.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ution and technology, culture is one of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 194.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our three R&amp;D priorities &#8211; as culture is what unites us <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to deliver better and faster for patients.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, we&#8217;ve continued to encourage behaviours <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across our R&amp;D organisation that <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 449.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">embed<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 477.03999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> our culture. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 243.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our employee engagement survey in R&amp;D showed an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased score in all three culture pillars.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 270.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We aim to give everyone &#8211; scientists, researchers, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 281.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data experts, trial specialists, technologists and more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 292.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; the chance to thrive and make smart choices so we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">can get ahead of disease together. To enable people <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 313.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to succeed today and tomorrow, people have focused <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 324.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual objectives, with a stretch goal to support their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future development.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 352pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Being ambitious for patients means an absolute focus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 362.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on our key assets and four therapy areas, where we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 373.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have the strongest expertise and the greatest chance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 384.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of making an impact for patients, and driving growth, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 395.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on a large scale. We put the patient at the centre of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 406pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">everything we do. Through interviews, focus groups <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and regular collaboration with patient councils, we&#8217;ve <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">integrated insights from patients, including those living <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with cancer and respiratory diseases, across the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 449.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product lifecycle, helping us to deliver improved <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 460pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcomes for those living with and at risk of disease.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 476.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our R&amp;D teams and leaders are dedicated to making <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 487.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">informed decisions at pace. Accountability for smart <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 498.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decision-making is enhanced by streamlined <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance structures and an environment of robust <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific debate. This approach is supporting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 530.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enhanced productivity in R&amp;D, including an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 541.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improvement in end-to-end success rates and an <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 552.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accelerated development strategy for key assets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 562.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including depemokimab.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 579.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patients are counting on us, so it&#8217;s critical that we act <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 590.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with integrity and care. Our ambition for patients <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drives us to do the right thing, making sure that we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus our efforts on accelerating significant assets that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 622.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meet<span style="display: inline-block; height: 6.55pt;"></span><span id="i790f5ce0ebd74867a80debd26af98cda_8729"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 335.96999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> their needs and have the highest probability of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 633.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 348.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 649.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 222.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 11.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 22.5pt; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 200.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Read more about our innovation in R&amp;D on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 167.23pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_52">10</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 175.43pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 185.56pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_88">29</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">59<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 712.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 102.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 382.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 180pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_154"></div><div style="line-height: 60pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.035em; position: var(--position); text-decoration: none; white-space: pre;">Risk management<span style="display: inline-block; height: 43.68pt;"></span></span><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 505.82pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="background-color: transparent; height: 841.91pt; left: 0pt; opacity: 1; position: var(--position); top: 0pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g49.jpg" alt="AR__main_divider_pages background.jpg" style="height: 841.91pt; width: 595.28pt;"/></div></div></div></div><div style="line-height: 60pt; position: var(--position); top: 179.39pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">and disclosure<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="line-height: 60pt; position: var(--position); top: 245.39pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 52.36pt; letter-spacing: -0.025em; position: var(--position); text-decoration: none; white-space: pre;">statements<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="position: var(--position); top: 485.38pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 249.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this section<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk management<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 12.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_160">60</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 27.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_166">62</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nature-related financial disclosures<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 42.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_175">71</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employees by gender<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 57.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_184">74</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">60<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 2.81pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk management<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_160"></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our strategy for growth is underpinned by a well-embedded risk management <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 130.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and internal control framework, overseen and evaluated by our Board. <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 169.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Managing risk effectively through controls <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 182.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and guidance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 198.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our risk management and internal control framework <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enables our Board to evaluate and oversee how we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manage principal and emerging risks in line with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy and long-term priorities.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our policy sets out the requirements, roles and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 260.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibilities for the management and governance of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 271.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks&#160;and controls and provides guidance on the essential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">elements of our internal control framework. We routinely <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluate our risk management and internal control <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 305.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework for improvements. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 322.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board oversight and clear accountability<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 338.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board oversees our system of risk management and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 349.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal control and establishes our risk appetite, supported <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 360.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Audit &amp; Risk Committee (ARC). The Corporate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 372.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility Committee (CRC) and Science Committee&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 383.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assess the effectiveness of risk management strategies <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 394.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that&#160;fall within their remits. Cyber security risks are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 405.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overseen by both the ARC and the Board. We describe the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 417.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibilities and remits of the Board and its committees <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 428.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">113</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 102.75999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 445.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Risk Oversight and Compliance Council (ROCC), co-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 456.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chaired by our Group General Counsel and our Chief <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 467.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compliance Officer, helps the ARC, CRC and Science <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 479.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee to oversee risks, and the strategies used to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 490.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">address them. At the same time, risk management and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 501.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance boards (RMCBs) across the Group promote the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 512.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;tone from the top,&#8217; establish our risk culture, oversee the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 524.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of risk management activities, and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 535.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">communicate information about internal controls. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 546.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management is accountable for delivering on its objectives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 557.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in line with the established risk appetite that applies to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 569.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principal risks. The Disclosure Committee is responsible for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 580.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considering the materiality of information and determining <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 591.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the disclosure of this information in a timely way. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 608.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An enterprise risk owner is responsible for each principal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 619.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk, overseen by a GSK Leadership Team (GLT) member, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 630.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and reports risk and mitigation to ROCC and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 642.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate Board committee each quarter. Significant risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 653.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or issues can also be escalated to the GLT, RMCB, or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 664.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate risk governance forum (eg Global Safety Board) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 675.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">throughout the year as needed. Legal &amp; Compliance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 687.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support these efforts by advising on our business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 698.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategies, activities, risks and controls. Audit &amp; Assurance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 709.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assesses the adequacy and effectiveness of our framework.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 169.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Assessing current, evolving and emerging <span style="display: inline-block; height: 8pt;"></span><span id="i2607421ce2e541fba19f69f995c13712_1038"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 182.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">risks<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 198.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We use our enterprise risk assessment methodology to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assess all risk, including our principal risks. Our enterprise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk assessment methodology considers the likelihood and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact of risks, and the timescale over which a risk could <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 243.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur based on the most probable scenario and in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">context of our existing internal controls. Our impact <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessments include considerations across patient safety, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 277.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quality and supply; environment, health and safety; legal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 288.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters; people; regulatory; reputation; strategic objectives; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 299.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and finance, incorporating materiality thresholds. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As well as considering current and evolving risks, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluate emerging risks that could affect our ability to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieve our long-term priorities over a <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 456.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three-year<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 497.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> horizo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 523.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 528.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also define risks as &#8216;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 400.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emerging<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 437.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8217; if we need to know more <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">about how likely they are to materialise, or what impact they <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">would have if they did. We keep emerging risks and their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 384.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact on the company under evaluation to assess whether <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 395.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they should be&#160;elevated to principal risks. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 412.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our risk management and compliance boards at all levels <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 423.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scan for emerging risks year-round, and ROCC discusses <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 434.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolving and emerging risks at each meeting. We also scan <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the risk horizon throughout the year to identify external <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 457.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trends that may be opportunities and/or emerging risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 468.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monitor our business activities and internal environment. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 485.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ROCC conducts an annual risk review to assess principal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 496.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and emerging risks for the company, supported by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extensive analysis of external trends and insights, senior-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level interviews and recommendations from risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 530.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management and compliance boards and risk owners. This <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 541.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual review is shared with the ARC and Board for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 553.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessment and agreement and forms the basis for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 564.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following year&#8217;s risk management focus. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 581.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-57" continuedAt="f-57-1">Our business strategy, results of operations and financial </ix:nonNumeric><span style="display: inline-block; height: 6.55pt;"></span></span></div><ix:continuation id="f-57-1"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 592.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">condition have not, as far as we are aware, been materially <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 603.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affected by risks from cyber security threats, including as a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 615.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result of previous cyber security incidents, but we cannot <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide assurance that they will not be materially affected in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 637.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the future by such risks and any future material incidents.<span style="display: inline-block; height: 6.55pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">61<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk management continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our risk management and internal control <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">framework <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our risk management and internal control framework is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 153.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in&#160;line with industry standards and legal and regulatory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 164.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements, and we regularly monitor for proposed or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 176.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new&#160;requirements. The framework defines the essential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 187.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">elements we expect and helps us to identify, assess, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 198.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manage, report and oversee risk relevant to our business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 209.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities. This framework helps make sure we manage <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 221.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our&#160;risks proportionately, in line with our risk appetite, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 232.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">throughout the year in a timely and transparent way to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 243.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support our strategic objectives. We&#8217;re assessing the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 254.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revised&#160;UK Corporate Governance Code and implementing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the new requirements. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 283.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For our principal risks, which include information and cyber <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 294.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">security, we define enterprise risk plans that include a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 305.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">description of the risk, its context, our assessment, risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 316.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appetite, how we will treat the risk and the actions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 328.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">businesses will take to mitigate the risk in line with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 339.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal control framework. These plans enable our Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 350.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committees to assess the effectiveness of our risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 361.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management strategies. We report on our principal risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and emerging risks to ROCC and the respective Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 384.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committees every quarter, to drive more dynamic, data- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 395.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven discussions, agile risk management strategies and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 406.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight. We report on existing control measures, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 418.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implementation, emerging risks, external insights and key <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 429.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk indicators with risk reporting thresholds aligned to risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 440.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appetite. We include risks and mitigations associated with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 451.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant events around us, such as geopolitical tensions.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 468.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Code sets out the overarching expectations for our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 480.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees and complementary workers. We aim to do the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 491.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">right thing with integrity and care as part of our culture. Our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 502.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk management framework complements our culture and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 513.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Speak Up processes in making sure that we identify and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 525.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mitigate risks effectively. We monitor our most important <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 536.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks and take action to address issues. Our annual <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 547.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confirmation exercise with General Managers, Site <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 558.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors, senior leaders and GLT, checks that key risks are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 570.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well managed, and that actions are in place to address <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 581.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gaps. Our principal risks include controls for responding to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 592.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">problems within their risk plans. We also have business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 603.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuity planning embedded in our framework and our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 615.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">critical processes, so we can continue business operations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 626.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the event of a crisis. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">How we report our risks<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For full risk <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 350.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">definitions, potential impact, context and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mitigating activities, see Risk <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 420.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Factors<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 450.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 465.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 485.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 487.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 502.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks related to ESG that are not assessed as principal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 163.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks, including environmental sustainability and climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 174.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change, are managed through our six focus areas, as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 185.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">described in our Responsible Business Performance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 196.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 213.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.18pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_166">62</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 44.38pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for more about climate-related risk management<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 239.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Changes to our risks for 2025 <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 255.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In our December 2024 annual risk review, the ARC agreed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 266.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to ROCC&#8217;s recommendation of our principal and emerging <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 277.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks for 2025. Our principal risks will remain largely the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 289.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">same, with consistent ROCC member ownership and minor <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 300.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk definition updates. We will also include a pipeline <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 311.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery principal risk (the risk that we fail or have delays in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 322.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the delivery of our pipeline). This risk will continue to be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 334.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overseen by our well established R&amp;D governance and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 345.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Scientific Officer. This addition reflects the evolving <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 356.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external reporting regulations and paramount importance of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 367.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discovering and developing new medicines and vaccines to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 379.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 395.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additionally for 2025, the following emerging risk themes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 407.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will be assessed throughout the year:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 424.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Skills and capability planning (the risk that we fail to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 435.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure adequate skills and capability planning to enable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery of our strategic priorities);<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 463.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regulatory environment (the risk that GSK fails to adapt <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 474.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to changes in the regulatory environment, new or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 486.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amended legislation in relation to the pharmaceutical and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 497.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare industry); and<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 514.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Geopolitical developments (the risk that geopolitical and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 525.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">social tensions give rise to restrictive measures that may <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 536.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">negatively impact GSK&#8217;s operations).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 553.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our prior data management emerging risk is now <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 565pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">embedded in our business operations and principal risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 576.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and will be removed as an emerging risk for 2025. We will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 587.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to monitor the external landscape and ensure that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 598.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any new emerging risks are adequately addressed within <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 610pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our existing risk management governance.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 626.94pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Environment &#8211; see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 84.35pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_136">49</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 15pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures &#8211; see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 160.39pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_166">62</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 30pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">ARC report &#8211; see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.82pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44091">127</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 45pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Internal control framework &#8211; see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 127.83999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44092">130</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 60pt; width: 225pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 225pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Legal proceedings &#8211; see page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 103.11999999999999pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_538">265</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">62<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_166"></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our<span style="display: inline-block; height: 6.55pt;"></span><span id="iaa5d1c6e3428427db1aa51670414d36a_25480"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 68.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> climate-related financial disclosures are consistent with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the recommendations and recommended disclosures of the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Task Force on Climate-related Financial Disclosures <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(TCFD), including the TCFD all-sector guidance, and in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance with the requirements of UKLR 6.6.6(8)R<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 262.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (UK <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 169.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Listing Rules)<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 107.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; The disclosures are in compliance with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 180.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies (Strategic Report) (Climate-related Financial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 192.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disclosure) Regulations 2022 of the Companies Act 2006. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We update our climate risk and impact assessments <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 214.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annually. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Governance <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 247.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board&#8217;s oversight of climate-related risks <span style="display: inline-block; height: 6.55pt;"></span><span id="iaa5d1c6e3428427db1aa51670414d36a_25455"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 258.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and opportunities<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 275.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board considers climate-related matters throughout the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 300.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year. This includes assessing risk management processes, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 311.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenging and endorsing the business plan and budgets, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 322.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including overseeing major capital expenditures, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 334.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions and divestments.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 351.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Corporate Responsibility Committee (CRC) exercises <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 362.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight, provides guidance and reviews ou<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 229.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">r responsible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 373.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 91.49000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance, including climate-related risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 384.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities, and environmental performance against our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 396.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate and nature targets. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 413.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The CRC receives quarterly updates on environmental <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 424.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainability, including climate. Regular attendees <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 435.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include the CEO and the President Global Supply Chain.&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 452.47pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.18pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">113</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.93pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for further details of the Board architecture<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 478.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 100.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CRC <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 125.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">met five times and discussed climate-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 489.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related issues on three <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 146.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">separate<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 181.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 183.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occasions<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 223.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 500.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managemen<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 103.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">t. Th<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 121.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e CRC:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 517.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessed mid-point performance towards our 2030 and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 528.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2045 nature positive and net zero ambitions<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 545.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussed the health impacts of climate change<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 562.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed mid-year performance of the metrics used in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business Performance Rating for 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 590.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved our climate disclosure statement and final <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 600.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business Performance Rating for 2023 and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 611.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other public environmental reporting and disclosures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 628.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management&#8217;s role in assessing and managing climate- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 639.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related risks and opportunities<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 656.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK Leadership Team (GLT)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 669.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The GLT meets regularly, giving members an opportunity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 681.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;discuss strategic, financial and reputational matters. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 697.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The President, Global Supply Chain, a GLT member, has <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 709.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management responsibility for environmental sustainability, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 720.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which includes our climate targets. The President is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 731.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible for governance and oversight of risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 742.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities and makes sure there is an effective <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 754.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework to manage the risks and opportunities across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 765.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each of our business units. The framework also enables us <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 776.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;deliver on our commitments to a net zero, nature positive, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 787.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthier planet, with ambitious goals set for 2030 and 2045 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 799.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across our entire value chain.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The GLT reviewed and di<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 404pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scussed the mid-ye<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 480.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ar and year-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">end performance for key climate and nature metrics (see <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 327.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_136">49</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 337.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) as part of reviewing our Responsible Business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Rating. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK Sustainability Council <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Sustainability Council, held quarterly, is attended by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior leaders from across the business. Members include <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leaders from Procurement, Finance, HR, Compliance, R&amp;D, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing and Corporate Affairs. The Council is co-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chaired by the President Global Supply Chain and the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 519.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vice <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President Sustainability (VP Sustainability)<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 472.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and supported <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 245.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the global Sustainability team and external third parties, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 256.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">who provide specialist expertise and advice to the business. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the Council:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved the annual targets for the climate and nature <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 301pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key performance indicators (KPIs) of the sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 311.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 328.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed monthly performance and escalations of any <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 339.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential concerns or issues <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 355.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved the annual climate risk review and approach <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 366.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for risk disclosure<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed how we are preparing for the new EU reporting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 410.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed the sustainability data strategy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 420.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implementation plan to create a robust data foundation for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 431.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ESG reporting and compliance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 448.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed R&amp;D&#8217;s approach to use Sustainable Design <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 459.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plans for new products in development<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 475.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other business support<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Sustainability Council is supported in assessing and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managing climate-related risks and opportunities by:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 517.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the sustainability programme steering team, chaired by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 528.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the VP Sustainability, which meets monthly and co-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 538.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ordinates the sustainability programme. This team <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 549.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monitors programme performance and the progress of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 560.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the enablers required to deliver the sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 571.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 587.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Sustainability Risk and Opportunity Co<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 480.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mmittee<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 511.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 598.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was established in 2024 and is a cross-functional team <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 609.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the Sustainability, EHS, Finance, Supply Chain and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 620.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Procurement. The Committee meets quarterly and reports <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 630.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the Sustainability Council.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 647.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the results of climate scenario modelling are shared with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 658.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Sustainability Council and business unit Risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 669pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management Control Boards (RMCB).<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 685.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business sustainability councils which meet quarterly to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 696.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review their business unit performance and delivery <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 707.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against our sustainability ambition. These are chaired by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 717.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior leaders who also attend the Sustainability Council.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">63<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Metered Dose Inhaler steering team, which is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attended by senior leaders from across the commercial, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 134.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply chain, regulatory and R&amp;D teams aligned to our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 145.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory business. This team is chaired by the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 156.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President Global Supply Chain, who also chairs the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 167.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability Council, and is the decision-making body <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 178.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the programme to reduce the climate impact of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 188.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">metered dose inhalers which make up t<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 217.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">o approximately <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 199.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50% o<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">f our total GHG emissions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 216.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Capital Allocations Board (CAB), which is chaired <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 227.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the CFO and includes the Group Financial Controller, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 237.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews climate-related capital expenditure as part of its <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 248.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual planning and capital allocation process. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 265.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a reporting hub, which was established in 2023, provides <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 275.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight and assurance of data, including on carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 286.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the carbon credit programme steering committee, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">includes the Group Financial Controller and the VP <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 324.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability, who also attends Sustainability Council, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews the due diligence outcomes of potential carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credit projects and the performance of established <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments, and makes new investment decisions. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 373.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strategy <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 389.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The climate-related risks and opportunities we have <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 400.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identified over the short, medium and long term<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 417.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We consider climate-related risks and opportunities in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 429.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three different time horizons: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 446.02pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">short term (up to three years) aligning with financial <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 456.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">planning timeframes.<span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 473.31pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medium term (four to ten years) aligning with long-term <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 484.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business forecasting timeframes. <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.6pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long term (more than ten years) to enable us to explore <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 511.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the uncertainties in changes to weather, disease patterns <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and societal responses to climate change across the <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">globe.<span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 549.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have identified and prioritised these climate-related <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 560.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks and opportunities: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 577.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risks:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 591.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 98.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to regulations governing the supply of high <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 602.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global warming potential (GWP) substances by the EU, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 613.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK and US governments could restrict our ability to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 624.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacture metered dose inhalers. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 641.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future regulatory policy responses to address climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 652.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change could lead to the imposition of carbon taxes by <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 663.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries where we manufacture and source goods from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 674.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">third parties. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 690.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing levels of water stress could lead to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 701.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interruptions to supply of water to our and third-party <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 712.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply sites. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 728.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing frequency and impact of extreme weather <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 739.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">events could disrupt GSK and third-party supplier sites.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature-based projects might not deliver enough carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credits to offset 2 million tonnes CO<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 453.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.2925pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 456.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e per year from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 134.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030, meaning that we have to buy more credits at higher <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 145.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 162.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunities:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At COP28 in 2023, more than 70 countries committed to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide low-carbon healthcare systems. This could lead <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to increasing demand for low-carbon medicines and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 208.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 350.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 224.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We set out the processes for identifying and assessing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 235.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related risks and opportunities in the Risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management section. The Sustainability Risk and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 258.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity Committee monitors for emerging risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 269.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new data to include in future assessments. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The impact of climate-related risks and opportunities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 297.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on our business, strategy and financial planning<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our commitment to work towards a net zero, nature <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positive, healthier planet with ambitious goals set for 2030 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2045 is embedded in our strategic long-term priorities, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 348.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">always considering the social, environmental and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 359.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance impacts of everything we do from laboratory to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 371.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient. Our&#160;overall target to reach net zero greenhouse gas <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions across the value chain by 2045 from a 2020 base <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year was approved by the Science Based Targets initiative <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 404.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SBTi) in 2023. Underpinning this headline target are our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 416.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SBTi<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 323.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-approved near-term and long-term carbon reduction <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets aligned to the 1.5&#176;C pathway.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 444.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 328.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> near-t<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 353.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">erm carbon reduction target is an 80% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction in Scope 1 &amp; 2 and Scope 3 carbon emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 465.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2030. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 482.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our long-term carbon reduction target is a 90% reduction <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 493.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in Scope 1 &amp; 2 and Scope 3 carbon emissions by 2045. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 503.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Both targets are measured against a 2020 baseline.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 520.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Transition plan<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 533.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re taking action to reduce emissions across our full <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 545.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value chain, prioritising the highest-impact areas. We'll <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 556.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invest around &#163;1 billion from 2020-30 to deliver emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 567.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reductions and removals to achieve our targets through the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 578.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities outlined below.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 595.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beyond 2030 we expect we will be left with the harder-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 607.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to-tackle emissions from across our supply chain, our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 618.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">own operations, logistics, and disposal. In many cases, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 629.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">addressing these residual emissions is likely to depend <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 640.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on technologies, infrastructure and regulatory frameworks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 652.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that require broad public/private collaboration. So our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 663.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decarbonisation plan is interdependent with the broader <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 674.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economic transition and follows a similar timeframe.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 691.53pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 233.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="position: var(--position); top: 2.63pt; width: 11.25pt;"><div style="left: -0.2pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 10.18pt; width: 10.77pt;"/></div></div></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.18pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_136">49</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 44.38pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> for further details of our progress in reducing carbon <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.13pt; width: 222pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">emissions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">64<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Direct operations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To continue reducing Scope 1 &amp; 2 emissions across our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations by 2030, we&#8217;re focusing on: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 155.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maximising energy efficiency in our sites through our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 165.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-standing energy efficiency programme<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 182.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transitioning to 100% imported renewable electricity <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 193.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2025 and to 100% imported and generated renewable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electricity by 2030 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exploring opportunities to use biogas to replace natural <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gas for energy and heat production<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing the use of electric vehicles by our sales fleet<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 264.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risks and uncertainties<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 277.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In some markets where we operate, accessing renewable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 288.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electricity will be challenging because of the limited <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 300.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generation capacity and the market boundary rules <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 311.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governing imported electricity. In 2024, we&#8217;ve taken action <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 322.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to mitigate this risk by signing a 10-year deal from 2025 to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 333.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply our manufacturing sites in Singapore with 100% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 345.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewable electricity purchased through renewable energy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 356.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certificates from solar projects.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 174.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 373.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are uncertainties in the transition to renewable heat. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 384.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">High-temperature heat produced by electricity is not <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 395.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generally commercially available today. Biogas can replace <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 407.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">natural gas without introducing major changes to facilities, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 418.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">but is not widely available in the locations where we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 429.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operate. The use of biomass as fuel could introduce issues <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 440.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of land use change and impacts on local air quality.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 457.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The transition to 100% electric vehicles by 2030 could be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 469.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restricted by vehicle availability, lack of charging <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 480.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infrastructure and sourcing of key materials for battery <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 491.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">production. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 508.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Supply chain<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 522.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Sustainable Procurement Programme requires our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 533.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers to disclose emissions and set carbon reduction <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 544.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets aligned with a 1.5&#176;C reduction pathway. We also <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 555.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">work with suppliers, particularly those with the largest <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 567.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">footprint, to encourage them to adopt new sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 578.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures. We&#8217;re exploring the sourcing of low-carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 589.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materials for use in our products and packaging.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 606.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supply chain emissions are a shared challenge across our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 617.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sector, and we&#8217;re working with our peers on collaborative <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 628.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initiatives such as: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 645.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Activate<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 108.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 110.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme to help active pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 656.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ingredients (API) suppliers accelerate decarbonisation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 667.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initiatives <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 684pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Energize programme to encourage the use of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 694.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewable energy throughout the pharmaceutical sector&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 705.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply chain <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 722.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Manufacture 2030 initiative to encourage suppliers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 732.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to measure, manage and reduce their emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risks and uncertainties<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical manufacturing processes are highly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulated by different agencies across the world, which may <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">slow down the implementation of some decarbonisation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initiatives.&#160; &#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our supply chains are complex and can involve several <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intermediate stages of production that are highly product-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specific. Our volume demand on specific materials is quite <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">low, which can reduce our ability to influence where we only <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purchase a small share of a supplier&#8217;s production. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 239.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Many suppliers are based in regions where renewable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electricity and heat are less available than elsewhere. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 267.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Measuring Scope 3 emissions is complex and challenging <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and there's a lack of primary data from suppliers. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Methodologies involve using spend-based estimates mixed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 301.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in with activity-based data, industry average data and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 312.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extrapolations based on subjective choices and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 323.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgements.&#160; As data systems, processes and controls <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mature and more primary data becomes available, there <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may be the need to restate reported emissions data in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 374.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Product impact<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The use of our products makes up 53% of our carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 399.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">footprint. Patient use of our rescue metered dose inhaler <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 410.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(MDI) medication, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 377.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 409.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (salbutamol), accounts for 45% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 421.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our carbon footprint. In 2024, we began phase III clinical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 433.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trials for our low-carbon <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 400.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 432.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> programme to redevelop <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 444.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this inhaler by transitioning to a next-generation propellant, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which has the potential to reduce emissions from the inhaler <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 466.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by approximately 90%. If trials are successful, regulatory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">submissions will begin in 2025 and work is underway to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">establish manufacturing capability for this inhaler at our site <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in Evreux, France, and at strategic contract manufacturing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 511.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partners. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 528.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are playing a leading role in developing a new standard <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 540.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to measure and report the environmental footprints of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 551.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical products. This work is co-sponsored with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 562.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the UK NHS and the Office of Life Sciences and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharma LCA consortium of 11 global pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 585.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies, with support from the Pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 596.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Environment Group and the Sustainable Markets Initiative. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 613.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risks and uncertainties<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 626.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Metered dose inhalers are complex devices, and any new <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medical propellant must meet a specific range of technical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 649.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance characteristics to be safe and efficacious for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 660.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients.&#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 677.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re engaging with medical regulators such as the US <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 688.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Food and Drug Administration (FDA), European Medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 699.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agency (EMA) and the UK Medicines and Healthcare <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 711.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Products Regulatory Agency (MHRA) on how advances <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 722.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in pharmaceutical product design can reduce the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 733.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environmental impact of medicines.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">65<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Carbon credits<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While we&#8217;re focused on emissions reductions to meet our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carbon targets, we&#8217;re also investing in high-quality nature <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protection and restoration projects. These support our net <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">zero and nature positive goals and deliver co-benefits to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">human health to generate carbon credits to offset annually <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the 20% of our baseline value chain carbon footprint from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030. The volume of credits required will taper down to 10% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as we continue to reduce our emissions, aiming to achieve <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 216.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">net zero emissions across our full value chain by 2045. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 228.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our criteria for high-quality projects include avoidance of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 239.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">harm, transparency, additionality, permanence, mitigation of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leakage, project monitoring, reporting and verification <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of claims and avoidance of double counting. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 278.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For our 2030 target, we&#8217;re prioritising carbon removal <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credits, but we&#8217;ll also secure a proportion of carbon <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 301.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">avoidance and reductions credits in recognition of their <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 312.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">critical role in conserving existing carbon stocks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 323.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protecting nature. For our 2045 net zero target, we&#8217;ll <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aim to secure only carbon removal credits.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 352.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risks and uncertainties<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 365.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We recognise that this is a fast-moving field, and that <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 376.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">methodologies and guidelines will likely evolve as we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implement our plans. We commit to remaining flexible <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 399.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and transparent about our progress and learning.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There&#8217;s a risk that the nature-based projects don&#8217;t deliver <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enough carbon credits to meet our needs in a given year <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and that we may need to buy more credits at higher cost.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Climate scenarios <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 469.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We use climate scenarios to inform management about <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 480.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate risks, reporting the results to Risk Management <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 491.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Control Boards (RMCB) in the business, as well as to the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 502.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability Council.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 519.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve developed modelling tools with the support of third <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 531.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties that enable us to model the impacts of physical and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 542.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transition risks where our sites and supply chains are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 553.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">located. For example, we have modelled the probability of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 564.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an interruption from an extreme weather event at our k<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 268.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 273.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">y <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 576.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sites and supplier sites and the subsequent financial impact <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 587.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of that interruption, assuming the inventory levels carried <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 598.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under existing business continuity plans. We&#8217;ve modelled <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 609.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the impact of future carbon taxes, such as direct taxes on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 621.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">energy-related emissions, emissions trading schemes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 632.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and taxes from carbon border adjustment mechanisms <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 643.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assuming we deliver our carbon reduction glidepath to 2030 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 654.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and beyond. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 671.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We intend to review the climate scenarios we use again in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 683pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 to make sure they&#8217;ll stay up to date.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 216.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 80.71pt; left: 53.86pt; opacity: 1; position: var(--position); top: 722.16pt; width: 237.03pt; z-index: 1;"><div><div><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 0pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IEA Net Zero <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 52.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 83.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> scenario, https://www.iea.org/reports/global-<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">energy-and-climate-model/net-zero-emissions-by-2050-scenario-nze <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 16.8pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">last accessed 17 November 2022 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.2pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IEA World Energy Outlook 2021, Chapter 2, p94, download report from <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 35.6pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">https://www.iea.org/reports/world-energy-outlook-2021/overview, last <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 44pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accessed 17 November 2022<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 54.4pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IEA Announced Pledges, https://www.iea.org/reports/global-energy-<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 62.8pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and-climate-model/announced-pledges-scenario-aps last accessed&#160; 17 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 71.2pt; width: 237.03pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">November 2022<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Net zero scenario (SSP 1 &#8211; RCP 1.9) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This scenario sets out a narrow but achievable pathway for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the global energy sector to achieve net zero CO<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 493.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.2925pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 496.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2050<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 336.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 339.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. It doesn&#8217;t rely on emissions reduction from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outside the energy sector to achieve its goal. The scenario <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 171.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is consistent with limiting the global temperature rise to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 183.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5&#176;C without a temperature overshoot. Net zero means <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 194.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">huge declines in the use of coal, oil and gas and a shift to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 205.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewable energy sources.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Low-carbon scenario (SSP 1 &#8211; RCP 2.6) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 236.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this scenario, all current net zero pledges are achieved in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 247.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">full and there are extensive efforts to realise near-term <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 258.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions reductions; advanced economies reach net zero <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 269.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions by 2050, China around 2060, and all other <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 281.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries by 2070 at the latest<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 423.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 426.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The scenario is consistent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 292.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with limiting the global temperature rise to below 2&#176;C. With <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">some level of net negative emissions after 2070, the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">temperature rise could be reduced to 1.5&#176;C in 2100.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 331.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Current trajectory scenario (SSP 2 &#8211; RCP 4.5) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 345.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This scenario sets out to show to what extent announced <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 356.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambitions and targets are on the path to deliver the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 367.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions reductions required to achieve net zero <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 378.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions by 2050<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 378.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 381.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The temperature rise will exceed 2&#176;C <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 390.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2100, with a more noticeable shift to happen in the latter <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 401.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">half of the century. A net zero pledge for emissions within <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 412.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the scenario does not necessarily mean that CO<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 494.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.2925pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 498.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> emissions <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 423.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the energy sector need to reach net zero, but there&#8217;s <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 435.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an allocation for carbon offsetting within the pledges. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 452.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">Breach of planetary boundaries scenarios (SSP 5 &#8211; RCP <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 462.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">8.5) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 476.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This scenario is not aligned to any of the pledges laid out in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 487.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Paris Agreement and is one where countries are unable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 498.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to meet the United Nations Sustainable Development <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 510.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goals. This scenario will have the most severe physical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 521.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consequences for the planet. The temperature rise will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 532.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceed 4&#176;C by 2100, leading to high loss of biodiversity and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 543.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">species extinction. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 560.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 576.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our processes for identifying and assessing climate-related <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 604.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The nature of the risks and opportunities from climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 616.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change depends not only on the physical aspects of climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 627.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change, but also regulatory and commercial changes in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets in which we operate, including pressures to reduce <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 649.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the climate impact of our metered dose inhaler medicines.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 666.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our risk management policies are designed to address all <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 678.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">types of risks, including the Group principal risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 689.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncertainties. Climate risk management follows the same <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 700.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy and framework. Risks from climate change at Group <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 711.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level fall under the governance of the CRC with the support <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 723.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Sustainability Council. In<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 426.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividual ri<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 463.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sks from climate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 734.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change are raised with appropriate business unit or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 745.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">functional Risk Management Control Boards to integrate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 756.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these risks into business risk management processes.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">66<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Sustainability Risk and Opportunity Committee meets <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quarterly to review and assess business intelligence, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory monitoring reports, and escalations from across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK. The outcomes of impact assessments are reported to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Sustainability Council.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our processes for managing climate-related risk<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 192.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the purposes of this disclosure, we differentiate <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between &#8216;physical&#8217; and &#8216;transition&#8217; climate-related risks.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Physical risks are typically identified at the asset or project <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level and are managed depending on the level of risk <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessed. We use climate scenario analysis to model the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential impacts of our prioritised physical risks, which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">helps us understand the resilience of our supply chains <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 276.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against climate change. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 293.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transition risks are typically risks associated with changes <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to regulations or societal expectations during the transition <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 316.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to a lower-carbon economy. They&#8217;re identified at enterprise <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 327.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level and at market level. We manage transition risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 338.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through our investment decisions, our sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 349.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transformation programme and our procedures. For <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 361.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">example, we manage risks which may arise from product <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 372.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims based on environmental performance by using <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 383.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external accreditation processes and organisations to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 394.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review the evidence used to support these claims. We use <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 406.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a shadow carbon price of $100 per tonne CO<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 231.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.2925pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 234.85000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e to inform <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 417.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decision-making on investments in major capital <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 428.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expenditure to understand the implications on potential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 439.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carbon offset costs for the carbon emissions from our value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 451.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain in 2030. This value is based on the recommendation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 462.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Carbon Pricing Leadership Coalition that concluded <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 473.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2017 that the explicit carbon price level required to drive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 484.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change to restrict temperature increases to below 1.5&#176;C is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 496.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at least US$50&#8211;100/tCO<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 150.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.2925pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 153.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> by 20<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 177.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30. <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 192.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We monitor the value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 507.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">used for internal carbon pricing against estimates for the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 518.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future costs of carbon credits.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 535.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Communications and Government Affairs team <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 546.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manages corporate reputation by identifying and monitoring <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 558.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related issues and undertaking <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 569.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">both proactive and reactive engagement with relevant <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 580.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholder groups.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 597.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of how we manage our prioritised risks are in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 608.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Risk Table below.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How we integrate our processes for identifying, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing and managing climate-related risks into <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall risk management<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 152.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Once a year, a cross-functional team from Sustainability, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance, Supply Chain and Procurement functions reviews <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate risks. It considers climate-related risks from a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic and operational perspective to make sure we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 197.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintain a comprehensive view of the different types of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate risks we face and the different time horizons in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 220.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which they may affect us. The team reviews previously <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identified climate risks, plus new or emerging risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 242.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities, and makes recommendations in a paper to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Sustainability Council. Risk assessment papers are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prepared for the prioritised risks, considering the likelihood <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 276.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and financial impact on us of each risk under different <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 287.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate scenarios. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 304.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We analyse each risk and opportunity to understand how <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 316.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we&#8217;re managing them, the metrics and targets being used <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 327.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the potential impact on our total profit using a low <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 338.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(&lt;&#163;100 million), medium (&#163;100 million&#8211;&#163;250 million) or high <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 349.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(&gt;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 312.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;250 million<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 360.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) threshold.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 366.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The impact assessments are approved by the VP <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 377.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability and a Finance VP from our Global Supply <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 389.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chain business unit. The results are shared with the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 400.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability Council, Business Unit Risk Management and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 411.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compliance Boards (RMCB) and the Finance RMCB to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 422.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make sure risks are both contextualised with other business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 434.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks and managed appropriately. This allows management <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 445.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to take a holistic view and optimise risk mitigation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 456.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responses, to make sure that responses to climate-related <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks are properly integrated into the relevant business unit <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 479.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and function activities.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 496.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The resilience of our strategy, considering different <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 507.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related scenarios, including a 2&#176;C or lower <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 518.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 535.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We used the climate scenarios described above to stress <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 546.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">test the resilience of the business by considering the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 558.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacts of potential physical and transition risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 569.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities on the locations where we operate as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 580.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">described in the table below. The modelling didn&#8217;t identify <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 591.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any material impact to our business resilience.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 608.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The transition to supplying renewable energy to our own <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 620.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations and our supply chain through power purchase <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 631.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreements and continuing our long-standing energy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 642.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">water efficiency programmes increases the resilience of our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 653.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">67<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Physical risks<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 104.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 0pt; width: 113.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk description<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential impact<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our response<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 104.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assumptions<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 57pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57pt; left: 6pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk from increasing levels <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of water stress leading to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interruptions to supply of water <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to our sites and third-party <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply sites. <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current trajectory <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 31.43pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 8.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 137.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 167.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve identified three water basins in water-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stressed areas in Algeria, India and Pakistan <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where we have manufacturing sites, and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where we aim to be water neutral.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At our manufacturing facility in Nashik, India <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we&#8217;ve built plants for rainwater harvesting.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 70.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The climate scenario analysis has identified <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 79.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a&#160;number of sites and supplier sites located in <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 89.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">water basins that could become water-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 99.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stressed by 2050, and which have been added <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 108.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to a watch list. We&#8217;ll monitor changes to the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 118.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk levels and update our site water risk <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 127.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessments appropriately.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 137.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 104.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial impact is <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on a three-month <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply chain interruption as <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a worst case.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 80.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We and our third-party <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers use freshwater as <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;main source of water to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacture medicines and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines. If water availability <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was restricted at a factory, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations would be <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interrupted.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Breach of planetary <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">boundaries <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 31.43pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 41.03pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 8.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-left: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increasing frequency of <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extreme weather events <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">causing disruption to our and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">third-party supplier sites.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current trajectory <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 31.43pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 8.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 178.5pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 167.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The climate scenario modelling indicated that, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the seven physical perils, flood from rainfall <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">presents the highest likelihood of an acute <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interruption. However, the risk of flooding from <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rainfall and from the other extreme weather <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">events is expected to remain very low.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve performed risk assessments for our <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing and other operations and have <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business continuity plans which we review <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 94.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annually to respond to the impacts of extreme <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 103.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">weather events, including adopting appropriate <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 113.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mitigation plans. <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 127.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have a well-established loss prevention <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 137.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and risk engineering programme to identify a <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 147.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">range of risks that could affect our sites and, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 156.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where flood risks exist, we&#8217;ve taken action to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 166.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mitigate them. <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 178.5pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 104.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial impact is <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on a three-month <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply chain interruption as <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a worst case.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 131.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 217.5pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Extreme weather events from <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any one of precipitation <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(rainfall), flood from <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">precipitation, riverine flood, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extreme wind, wildfire, and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extreme heat can result in <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">short-term interruptions to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing at <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 79.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.24000000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our or supplier sites.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 217.5pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Breach of <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">planetary <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">boundaries <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 41.03pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 50.63pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 8.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 80.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nature-based projects fail to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliver the anticipated volumes <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of carbon credits from lower-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than-expected growth or the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result of a natural catastrophe.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lower-than-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anticipated <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth&#160;scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 31.43pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 160.5pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 167.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We established a governance framework <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;manage each project with our external <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partners.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Any issues are escalated to the Carbon Credit <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Programme Steering Committee.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 160.5pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 104.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We assume a future cost of <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$100 per tonne CO<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 67.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 2.037pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e by <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030. <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the lower-than-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anticipated growth scenario <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we assume a 25% under-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery in a single year as <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the issues will have been <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 79.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identified early enough to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 89.03pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">take other preventative <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 98.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 113.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For a natural catastrophe <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 122.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario, we assume 25% of <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 132.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the projects will be affected <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 142.03pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the impact will last <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 151.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">five&#160;years. <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 80.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 439.5pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This could lead to buying more <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carbon credits at higher cost to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make up the shortfall.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 439.5pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Natural <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">catastrophe <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 31.43pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 662.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 673.12pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 436.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 144pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#197;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 0pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low financial impact &lt;&#163;100m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 15pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 15pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#167;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 15pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium financial impact &#163;100m&#8211;&#163;250m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 30pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 30pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#162;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 30pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">High financial impact &gt;&#163;250m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">68<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Transition risks<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 104.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 0pt; width: 113.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk description<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential impact<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our response<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 104.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assumptions<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 122.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 122.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">Regulations governing the use <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">of high GWP substances have <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">been updated in the EU and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.02em; position: var(--position); text-decoration: none; white-space: pre;">US.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This could lead to increasing <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs and restrict the ability <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;manufacture our metered <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dose inhaler (MDI) products <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that use a high GWP <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 94.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">propellant (HFA134a).<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 127.5pt; position: var(--position); top: 22.5pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current trajectory <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#162;<span style="display: inline-block; height: 6.93pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 122.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 167.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are investing in a R&amp;D programme to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redevelop our <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 50.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (salbutamol) inhaler by <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transitioning to a lower-carbon propellant that <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could potentially reduce its carbon emissions <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by approximately 90%, if clinical trials are <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">successful. Work is underway to establish <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing capability for this inhaler at our <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">site in Evreux, France, and at strategic <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 79.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contract manufacturing partners.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 94.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We already have a portfolio of dry powder <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 103.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inhaler products that don&#8217;t use propellants and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 113.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that are not affected by this risk.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 122.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 104.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial impact <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumes the reformulated <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product is approved by <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulators and launched <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">according to plan.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 131.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Future regulatory policy <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responses to address climate <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change could lead to the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">imposition of carbon taxes <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by&#160;countries where we <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacture and source <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">goods from third parties. <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net zero scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 21.83pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low-carbon <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 60.23pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 69.83pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 8.64pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 89.03pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current trajectory <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 98.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenario<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 108.23pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 6.93pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.93pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 10.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.93pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 117.83pt; width: 71.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 8.64pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8.64pt;"></span></span><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 8.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 167.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are managing this risk by reducing our <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value chain carbon emissions in line with our <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transition plan described above. We&#8217;ll review <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our carbon tax modelling in 2025 to account for <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes to announced commitments to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">introduce carbon taxes since 2022.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 104.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial impact <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumes we deliver an <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80%&#160;reduction in carbon <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions by 2030 and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumes carbon tax values <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 50.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are as per IEA scenarios, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.23pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supplemented by data from <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 69.83pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy pledges for a small <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 79.43pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of countries.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 426.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 436.51pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 436.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 144pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#197;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 0pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low financial impact &lt;&#163;100m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 15pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 15pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#167;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 15pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium financial impact &#163;100m&#8211;&#163;250m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 30pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 30pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#162;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 30pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">High financial impact &gt;&#163;250m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">69<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity<span style="display: inline-block; height: 8pt;"></span><span id="iaa5d1c6e3428427db1aa51670414d36a_25476"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 104.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 0pt; width: 113.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk description<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Potential impact<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our response<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 104.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 5.91pt; width: 104.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assumptions<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 287.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 287.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 113.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At COP28 in November 2023, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than 70 countries <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committed to provide low-<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carbon healthcare systems.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.03pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This could lead to increasing <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.63pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demand for low-carbon <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.23pt; width: 113.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 287.25pt; left: 127.5pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">No financial impact <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 287.25pt; left: 207.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 167.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re reducing our own Scope 1 &amp; 2 carbon <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions, which in turn reduces the Scope 3 <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">footprint of our customers and suppliers. <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re investing in a R&amp;D programme to <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 46.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redevelop our <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 50.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 78.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (salbutamol) inhaler by <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 55.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transitioning to a lower-carbon propellant that <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could potentially reduce its carbon emissions <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 74.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by approximately 90%, if clinical trials are <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">successful. <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 99.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From 2024, all newly developed or acquired <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 108.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines will have Sustainable Design Plans <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 118.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applied.&#160; <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 132.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are a founding member of the Circularity <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 142.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in&#160;Primary Pharmaceutical Packaging <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 152.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accelerator (CiPPPA), which brings together <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 161.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partners from across the sector to address the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 171.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainable packaging of medicines and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 180.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 195.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are playing a leading role in developing <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 205.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a&#160;new standard to measure and report the <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 214.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environmental footprints of pharmaceutical <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 224.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products as part of the Pharma LCA <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 233.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consortium.<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 248.43pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re developing methodologies to calculate <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 258.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the environmental impact of products and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 267.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines from a patient care pathway <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 277.23pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">perspective.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 287.25pt; left: 383.25pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 104.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 449.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 459.76pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 436.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 144pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 152.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#197;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 0pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low financial impact &lt;&#163;100m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#245;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 15pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 15pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#167;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 15pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium financial impact &#163;100m&lt;&#163;250m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #f36633; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#242;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 14.25pt; position: var(--position); top: 30pt; width: 97.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long term<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 111.75pt; overflow: hidden; position: var(--position); top: 30pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings 2', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">&#162;<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 126pt; position: var(--position); top: 30pt; width: 144pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">High financial impact &gt;&#163;250m<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">70<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Metrics<span style="display: inline-block; height: 8pt;"></span><span id="iaa5d1c6e3428427db1aa51670414d36a_25453"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 91.78pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> and targets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The metrics we use to assess climate-related risks and opportunities in line with our strategy and risk management process<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 538.6999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 146.22pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 126.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 360pt;"/></tr><tr style="height: 152.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 152.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 126.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a. Disclose the metrics used by&#160;<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.24000000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the organisation to assess climate <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks and opportunities in line <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with&#160;its strategy and risk <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management process<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 152.25pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 360pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have considered the key metrics following the TCFD guidance of Tables A1.1 and A1.2 as well as <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the metrics consistent with cross-industry, climate-related metrics. Based on that, our strategic metrics <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are:&#160;  <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 34.43pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 &amp; 2 emissions (market-based and location-based approach), described in the table below<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.03pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 3 emissions, described in the table below <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 59.63pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% renewably sourced electricity, described in the table below<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 72.23pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total supplied water, described in the table below<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 84.83pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total waste and materials, described in the table below<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 97.43pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business Performance Rating, as part of our senior leaders&#8217; remuneration policy - see <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 107.03pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on page <span style="display: inline-block; height: 5.82pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 41.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 119.63pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sites that have achieved water stewardship, described in the table below<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 132.23pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible Business Performance Report includes more metrics used to support the strategic <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 141.83pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">metrics listed&#160;above.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 101.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 126.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">b. Disclose Scope 1, 2 and if <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable Scope 3 GHG <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emissions and related&#160;risks<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 360pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In energy and carbon emissions, see table below:<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.23pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 emissions from energy<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 27.83pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 emissions from other sources<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 40.43pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 2 emissions (market-based)<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 53.03pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 2 emissions (location-based)<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 65.63pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 3 emissions metrics <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 78.23pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 &amp; 2 emissions intensity metrics<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 90.83pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prioritised physical and transition risks are included in the Risk Table above.<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 134.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 134.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 253.5pt; width: 126.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c. Describe the targets used by <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the organisation to manage <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related risks and <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.43pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities and performance <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 41.03pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against targets<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 134.25pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 253.5pt; width: 360pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.34pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our targets (measured against a 2020 baseline where applicable) are:<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.94pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 80% absolute reduction in greenhouse gas emissions from a 2020 baseline, across all scopes, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.54pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;investment in nature-based solutions for the remaining 20% of our footprint by 2030<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 38.14pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net zero greenhouse gas emissions across our full value chain by 2045: 90% absolute reduction <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 47.74pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in&#160;emissions from a 2020 baseline, across all scopes, and all residual emissions neutralised <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 60.34pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% renewable electricity by 2025 (Scope 2)<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 72.94pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieve good water stewardship at 100% of our sites by 2025<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 85.54pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reduce overall water use in our operations by 20% in 2030<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 98.14pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zero operational waste<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 91.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 94.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 96.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by 2030<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 124.94999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 127.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 111.94pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Be water neutral in our own operations and at key suppliers in water-stressed regions by 2030<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 124.54pt; width: 360pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The performance against our targets is on page <span style="display: inline-block; height: 5.82pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 168.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_136">49</a><span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 177.20000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 179.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 544.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Including a 20% reduction in routine hazardous and non-hazardous waste. Target updated in 2024 to remove specific reference to the elimination of <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 553.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operational single-use plastics. This work has been integrated into the overall operational waste target<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 563.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">See Basis of Reporting 2024 in the ESG resources section of gsk.com (https://www.gsk.com/en-gb/responsibility/esg-resources/) for detailed <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 572.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">methodologies for measuring and reporting all GSK environmental KPIs<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 599.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We commit to a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045 across our entire <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 610.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value chain. We report progress in reducing Scope 1 &amp; 2 carbon emissions, Scope 3 carbon emissions, energy use, % <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 622.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewable energy, wat<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 142.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">er and wa<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 181.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ste annually towards these targets in the Environment section on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 461.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_136">49</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 471.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and in our public <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 633.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responses to the CDP Climate, Water and Forest questionnaires.<span style="display: inline-block; height: 8.25pt;"></span></span><span style="font-family: 'Calibri', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 309.75pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 8.25pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">71<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 15.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_172"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Metrics data<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carbon emissions<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 125.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="position: var(--position); top: 168.77pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 275.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carbon emissions &#8216;000 tonnes CO<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 97.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 1.6555pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 100.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 emissions (from energy)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 12pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">289<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 12pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">301<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 12pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">320<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 emissions (other<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 83.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 86.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 24.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">232<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 24.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">279<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 24.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">306<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 2 emissions (market-based)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 37.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 57.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 65.92999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 37.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">64<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 37.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">88<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 2 emissions (location-based)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 50.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">234<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 65.92999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 50.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">240<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 50.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">265<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 3 emissions<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 62.199999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 63pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 63pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8,983<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 63pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8,995<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 75.75pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK Scope 1 &amp; 2 emissions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 75.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">92<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 75.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">102<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 75.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 57.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">111<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 262.35pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 275.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 275.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other metrics<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 &amp; 2 emissions from energy/sales revenue (tonnes CO<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 205.51000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 1.9109999999999998pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 208.20000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e/&#163;m)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 12pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10.6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 12pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 12pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scope 1 &amp; 2 emissions from energy/FTE (tonnes CO<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 173.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: 1.9109999999999998pt; vertical-align: sub; white-space: pre;">2<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 175.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e/FTE)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 24.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4.9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 24.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5.2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 24.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5.9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total energy used (GWh)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 37.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,577<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 65.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 37.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,636<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 37.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,759<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK energy used (GWh)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 50.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">658<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 50.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">711<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 50.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">735<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% renewably sourced electricity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 63pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">90%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 63pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">83%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 63pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">73%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 75.75pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total supplied water million m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 96.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 75.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 55.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7.0<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 65.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 75.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7.4<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 75.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7.5<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total supplied water in areas of high water stress million m<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 191.64000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 194.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 88.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 55.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.3<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 65.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 88.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 88.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total waste &#8216;000 metric tonnes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 101.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">47.3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 101.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">49.7<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 101.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50.2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 275.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 275.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% sites that have achieved water stewardship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 275.25pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 49.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 346.5pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 49.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 114pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 49.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 397.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carbon emissions are calculated according to the Greenhouse Gas Protocol: A Corporate Accounting and Reporting Standard (revised edition). We use <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 405.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market-based Scope 2 emissions for reporting purposes and report Scope 3 emissions across all 15 categories in our Responsible Business Performance <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 413.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 424.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Other&#8217; refers to emissions from sales force vehicles, propellant emissions released during manufacture of inhalers (the majority of propellant emissions, <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 432.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">released during patient use, are included in Scope 3 carbon emissions), on-site waste, or wastewater treatment and refrigerant gas losses<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 443.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We collect and publish Scope 3 data across 15 categories. The most recent Scope 3 data available is for 2023 as the process of compiling the 2024 data is <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 451.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not yet complete, except for 2024 Scope 3 emissions from patient use of inhalers, which are disclosed in the Responsible Business Performance Report. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 459.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We will publish this data once it becomes available and it will be included in the 2025 Responsible Business Performance Report<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 470.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Methodologies for reporting and measurements are provided in the Basis of Reporting 2024 in the ESG resources section of gsk.com (https://<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 478.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">www.gsk.com/en-gb/responsibility/esg-resources/)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: absolute; top: 516.44pt;" id="idc89fa1ee07645df9629d157a4b46752_175"></div><div style="position: var(--position); top: 516.44pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nature-related financial disclosures <span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 548.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re committed to contributing to a nature positive world <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 560.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by avoiding and reducing nature impacts, as well as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 571.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protecting and restoring nature. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 588.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human health relies on the fundamentals of nature: clean <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 599.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">air and fresh water. Nature loss has a range of negative <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 610.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacts on health, for example, reduced air quality <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 622.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increases the incidence and severity of respiratory diseases <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 633.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and habitat degradation and deforestation are increasing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 644.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the risk of new human pathogens and pandemics. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 655.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To protect human health and get ahead of disease, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 667.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we need to protect nature.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 684.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re members of several working groups of the Taskforce <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 695.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on Nature-related Financial Disclosures (TNFD) and were <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 706.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 60.769999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vo<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 70.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lved in developing the TNFD Additional sector guidance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 717.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; Biotechnology and pharmaceuticals publication. We&#8217;ve <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 729.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committed to make a full disclosure against the TNFD <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 740.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework in early 2026 and we&#8217;re now piloting the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 751.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework for a second year.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 548.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Governance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 564.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board&#8217;s oversight of nature-related dependencies, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 576.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacts, risks and opportunities<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 429.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 592.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As described on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 393.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaa5d1c6e3428427db1aa51670414d36a_25455">62</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 403.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 609.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management&#8217;s role in assessing and managing nature-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 621.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related dependencies, impacts, risks and opportunities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As well as the disclosure on page <span style="display: inline-block; height: 6.55pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 439.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaa5d1c6e3428427db1aa51670414d36a_25455">62</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 449.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 649.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Council revi<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 351.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ewed the results of the pilot process to set <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 660.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Based Targets for Nature <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 440.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SBTN). <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 677.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A new Nature Working Grou<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 415.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p chaired by the Nature Lead <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 688.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was established to support the Sustainability Council and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 700.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Steering Committee. It&#8217;s attended by representatives of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 711.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Procurement, Manufacturing, Communications and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 722.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Government Affairs,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 383.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and subject matter experts. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">72<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nature-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our human rights policies, engagement activities and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight with respect to indigenous peoples, local <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">communities, and other affected stakeholders<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 152.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We publish our position on human rights on gsk.com. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 164.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have a responsibility to respect human rights through our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagements with patients, our employees, our suppliers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 186.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the communities in which we live and operate.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 203.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ll continue to develop policies and procedures related to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 214.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders&#8217; engagement and human rights specifically in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 226.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relation to our assessment of impacts and our action on <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 237.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 254.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: line-through; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">As nature investments are always context-dependant, it is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 265.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">key for us to work with expert partners and NGOs to make <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 275.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">sure project implementation includes local experts and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">local communities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before we make decisions on protection and restoration <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 313.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projects, we run a human rights assessment as part of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 324.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our broader due diligence. This allows us to understand <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 335.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the local context and history, the process that partners <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 346.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use or plan to use to engage and involve local <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 357.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">communities (including Free, Prior and Informed Consent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 367.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(FPIC) and grievance mechanisms) and how benefits will <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 378.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be shared <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 395.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve developed a toolkit to support project developers, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 406.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investors and buyers to understand and enable health <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 417.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcomes from protecting and restoring nature<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 434.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strategy<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 450.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The nature-related dependencies, impacts, risks and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 461.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities we&#8217;ve identified over the short, medium <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 473.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and long term<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 101.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 503.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater is essential for the production of our medicines <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 514.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and vaccines.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 531.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our primary operational impact on water availability is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 542.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through our own manufacturing sites and key suppliers <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 554.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">located in areas of water stress.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 571.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Releases of Active Pharmaceutical Ingredients are a priority <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 582.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus for us regarding water quality.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 194.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 197.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Pharmaceutical <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 593.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">residues may sometimes pass into the environment as <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 604.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of the normal biological process following patient use. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 616.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To a lesser extent, pharmaceuticals can also enter the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 627.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment from unused medical products or factory <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discharges. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 655.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are concerns that long-term exposure to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 666.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmaceuticals in the environment can pose a risk to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 678.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environmental species, including aquatic life. The presence <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 689.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of antibiotics in the environment, and its potential impact <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 700.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on driving antibiotic resistance as well as reducing microbial <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 711.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biodiversity, is a growing concern for many stakeholders<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 274.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 277.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 47.29pt; left: 53.86pt; opacity: 1; position: var(--position); top: 754.02pt; width: 236.29pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 0pt; width: 236.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For more information see our public policy: https://www.gsk.com/<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 8.4pt; width: 236.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">media/8867/gsk-position-on-pharmaceuticals-in-the-environment-<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 16.8pt; width: 236.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">march-2022.pdf<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 27.2pt; width: 236.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 16.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ead more about our position on antimicrobial resistance in our public <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 35.6pt; width: 236.29pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Land<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 325.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our primary dependency and impact on land is due to the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">natural materials we source, some of which derive from <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">land-based commodities, a key driver of deforestation and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">land use change, globally. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oceans<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 191.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our impacts and dependencies on oceans come primarily <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 202.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from two marine-derived materials that are part of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 213.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing medicines and vaccines, specifically <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 224.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">horseshoe crab blood and squalene.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 241.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Atmosphere<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 255.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our primary impact on air quality is from combustion of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 266.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fossil fuels in our operations and supply chain.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 283.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The effect nature-related dependencies, impacts, risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 294.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and opportunities have on our business model, value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 305.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain, strategy and financial planning, as well as any <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 317.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transition plans or analysis in place<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 334.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re committed to contributing to a nature-positive world in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 345.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">line with the Global Biodiversity Framework to halt and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 356.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reverse biodiversity loss by 2030. Our approach is through <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 367.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">four focus areas, which are aligned to the &#8216;realms&#8217; of nature <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 379.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as defined by TNFD and SBTN &#8211; freshwater, land, oceans <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 390.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and atmosphere &#8211; including the biodiversity of living species <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 401.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in them. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 418.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re taking action across the four realms of nature in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 429.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these ways: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 446.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avoiding and reducing our impacts on nature across our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 457.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">full value chain<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 474.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investing in the protection and restoration of nature<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 490.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Helping to drive collective action for nature<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 507.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We set targets in 2020 with a focus on the realms of nature, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 518.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as well as supportive targets on waste and materials. We <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 529.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report progress against our nature plan and targets on page <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 540.77pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_136">49</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 557.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The resilience of our strategy to nature-related risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 568.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and opportunities, taking into consideration different <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 580.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scenarios<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 346.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 597.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We manage organisational resilience to nature related risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 608.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through the implementation of our sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 619.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme. We&#8217;re working to develop nature scenarios in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 630.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">line with emerging guidance.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 647.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The locations of our direct operations that meet the criteria <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 659.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for priority locations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 676.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 689.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve identified five of our sites located in three water-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 700.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stressed basins in Algeria, India and Pakistan, which we&#8217;ve <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 712.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prioritised for investment in water neutrality.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 728.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Land<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 742.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve identified six priority sites in Belgium, France, Spain, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 753.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US and UK based on proximity to Protected Areas and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 764.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key Biodiversity Areas.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">73<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nature-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk and impact management<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our processes for identifying, assessing and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 138.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prioritising nature-related dependencies, impacts, risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 149.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and opportunities in our direct operations and value <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 160.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 177.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re following the TNFD LEAP (Locate, Evaluate, Assess <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Prepare) methodology to better understand our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature-related risks and opportunities. We&#8217;re part of the first <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">group of companies to be working with the Science Based <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 222.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target Network (SBTN) in a pilot to set validated science-<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 233.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based targets for nature, starting with freshwater.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our processes for managing nature-related dependencies, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 262.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacts, risks and opportunities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We manage nature-related dependencies, impacts, risks <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 290.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and opportunities by implementing our sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 301.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme. We set targets in 2020 with a focus on the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 312.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">realms of nature, as well as supportive targets on waste <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 323.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and materials. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 340.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Water<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 354.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All our sites complete a GSK water stewardship <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 365.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessment and implement action plans to comply with our <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 376.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standard. For our sites located in water-stressed areas, we <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 388.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aim to secure certification under the Alliance for Water <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 399.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stewardship standard.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our sites located in water-stressed areas are prioritised for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">catchment-level projects of water replenishment, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restoration, and regeneration activities that aim to deliver <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 450.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measurable environmental and social outcomes.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re committed to making sure discharges from the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 478.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing of active pharmaceutical ingredients<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 254.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (API)<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 277.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including antibiotics, don&#8217;t adversely affect people or the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 500.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 517.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Land <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 531.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re implementing land management action plans across <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 542.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our estate which aim to deliver a biodiversity improvement <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 553.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with a focus on our highest-priority sites.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 570.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have an Eco-design programme to reduce the impacts <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 581.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of all our products and packaging and all newly developed <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 593.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or acquired medicines now have Sustainable Design Plans <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 604.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applied. These use industry-leading product sustainability <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 615.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">methodologies to make sure we consider environmental <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 626.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact at every step of the product decision-making <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 638.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process, from product design to disposal.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 655.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;ve set ambitious standards for suppliers who provide us <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 666.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with materials that are highly dependent on nature. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 683.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have roadmaps with an aim to achieve 100% certified <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 694.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">paper and palm oil by 2025. We&#8217;ve engaged with <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 705.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated suppliers to map the full supply chains involved, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 717.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understand existing sustainability standards, identify gaps <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 728.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and establish action plans. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re a founding member of the Circularity in Primary <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical Packaging Accelerator (CiPPPA), a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">collaborative initiative across the pharmaceutical supply <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 147.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain to develop and deploy solutions for the recycling of <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 158.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primary pharmaceutical<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 397.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> packaging.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 175.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oceans<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 188.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re working to reduce the volume of marine-derived <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 200.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materials, for example through process efficiencies, and are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">looking to transition to alternative materials. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 228.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the meantime, we&#8217;re working to implement our Marine <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 239.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainable Sourcing Standard, which outlines the specific <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements that we ask our suppliers of marine-derived <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 262.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materials to follow.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Atmosphere<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 292.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 314.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024,<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 336.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we completed an in-depth air quality assessment <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 303.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the Stockholm Environment Institute (SEI) and the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 314.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">University of York, using the methodology outlined in the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 326.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Practical Guide for Business written by the Climate &amp; Clean <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 337.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Air Coalition and SEI.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 354.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re managing our impacts on air pollution by transitioning <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 365.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to renewable electricity and an electric fleet, and increasing <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 376.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the volumes of waste sent to circular routes of disposal.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 393.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We&#8217;re members of the Alliance for Clean Air through the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 405.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clean Air Fund (CAF) and the World Economic Forum, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 416.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which aims to drive corporate action on clean air to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 427.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accelerate climate action and create healthy communities <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 438.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">around the world. <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 455.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How our processes for identifying, assessing, <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 467.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prioritising and monitoring nature-related risks are <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 478.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">integrated into and inform our overall risk management <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 489.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 348.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 506.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We manage any identified impacts, dependencies and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 517.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature-related risks through our sustainability governance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 528.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">structures. We&#8217;re working to develop nature scenarios in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 540.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">line with emerging guidance.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 557.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Metrics and targets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 573.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We report performance against three nature metrics which <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 584.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are part of our Responsible Business performance metric.&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 595.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our targets for managing our nature commitments are in <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 606.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the table below<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 364.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">74<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nature-related financial disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 393pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="i988ee89b3f2445c6b1e4e363a249a548_0-0-1-1-821446"></span><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Realm<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key performance indicator<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 12pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average of the percentage of GSK sites and suppliers compliant with wastewater active pharmaceutical <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.23pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ingredient (API) limits and the percentage of sites and suppliers that are compliant with the AMR Industry <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.83pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alliance Common Antibiotic Manufacturing Framework and discharge limits<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Land<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of paper packaging and palm oil certified<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Waste and materials<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operational waste reduction at our sites<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 192.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We set <span style="display: inline-block; height: 6.55pt;"></span><span id="ia14d46c5f3324d4790861e4d7b030f4a_11032"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 83.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 105.71000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> targets for managing our <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 207.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature commitments:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 209.27pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 393pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Focus area<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 95.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Freshwater<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 12pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of our sites to achieve good water stewardship by 2025 and reduce overall water use by 20% by 2030 <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.23pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Be water neutral in own operations and at key suppliers in water-stressed regions by 2030 <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.83pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieve zero impact API levels<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 119.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 122.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for all sites and key suppliers by 2030<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 255.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 258.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Land<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 48pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive impact on biodiversity<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 116.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">3 <span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 121.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at all GSK owned sites by 2030 <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.23pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of key<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 54.660000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">4<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 57.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> naturally-derived materials sustainably sourced and deforestation free by 2030<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 333.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">2,<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 337.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oceans<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 74.25pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of marine-derived materials sustainably sourced by 2030 <span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Atmosphere<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 86.25pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% renewable electricity by 2025 (Scope 2)<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 171.85999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 174.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.23pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80% reduction in carbon emissions across our full value chain by 2030<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 257.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 260.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.83pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net zero carbon emissions across our full value chain by 2045<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 228.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">2 <span style="display: inline-block; height: 3.7830000000000004pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 95.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Waste and materials<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 121.5pt; width: 393pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zero operational waste<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 91.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">5<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 94.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> by 2030<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 124.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">2,6<span style="display: inline-block; height: 3.7830000000000004pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 131.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 14.23pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% waste reduction from supply chain by 2030 <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.83pt; width: 393pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25% environmental impact reduction for our products and packaging by 2030<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 376.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Below the Predicted No-Effect Concentration level, as defined by the AMR Alliance and API Wastewater discharge limits<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 387.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Linked with the remuneration of our senior leaders<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 397.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Using the Natural England Biodiversity Net Gain methodology<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 407.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Definition clarified in 2024 to reflect priority materials<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 418.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Including a 20% reduction in routine hazardous and non-hazardous waste<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 428.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target updated in 2024 to remove specific reference to the elimination of operational single-use plastics. This work has been integrated into the overall <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 437.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operational waste target<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: absolute; top: 461.97pt;" id="idc89fa1ee07645df9629d157a4b46752_184"></div><div style="position: var(--position); top: 461.97pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employees by gender<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Reported<span style="display: inline-block; height: 6.18pt;"></span><span id="ibd2eb8e296404096b4e58bb54852fca9_76"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 88.78pt; position: var(--position); white-space: pre;"> in compliance with the Companies Act s.212C(8):<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 511.11pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 232.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 85.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 85.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 85.5pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Male<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 61.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Female<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 69.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 232.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 232.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 19.650000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 14.25pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 78.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318pt; position: var(--position); top: 14.25pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 78.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 14.25pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 232.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 232.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 43.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1,2<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 28.5pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8,735<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318pt; position: var(--position); top: 28.5pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9,046<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 28.5pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">17,781<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 232.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 232.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All employees<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 46.059999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">3<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 232.5pt; position: var(--position); top: 42.75pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">35,413<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 318pt; position: var(--position); top: 42.75pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33,216<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 42.75pt; width: 85.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 85.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">68,629<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 575.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Headcounts as of 31 December 2024<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 586.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior managers as defined in the Companies Act 2006 (Strategic Report and Directors&#8217; Report) Regulations 2013<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 596.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Total&#8217; calculated as full-time equivalent employees (FTEs) as of 31 December 2024. &#8216;Male&#8217; and &#8216;female&#8217; calculated by applying &#8216;all employees&#8217; gender <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 605.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diversity percentages to &#8216;total&#8217; FTE number<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">75<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 96.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 158.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 329.25pt; position: var(--position); top: 0pt; width: 158.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 6.66pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 32.8pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_190"></div><div style="font-size: 60pt; line-height: 60pt; position: var(--position); top: 113.39pt; width: 595.56pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 43.68pt;"></span><span id="i9d435d5ae79f4880b20d86356910836b_36"></span><span id="i9d435d5ae79f4880b20d86356910836b_37"></span></span><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 217.57999999999998pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"> financial <span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="background-color: transparent; height: 841.91pt; left: 0.16pt; opacity: 1; position: var(--position); top: 0pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g49.jpg" alt="AR__main_divider_pages background.jpg" style="height: 841.91pt; width: 595.28pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 182.38pt; width: 595.56pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">review<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="position: var(--position); top: 485.91pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 249.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this section<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance summary<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 12.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_199">76</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reporting framework<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 27.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_205">77</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 42.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_211">81</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjusting items<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 57.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_217">88</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash generation and conversion<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 72.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_223">92</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial position and resources<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 87.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_229">93</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approach to tax<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 102.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_232">98</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury policies<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 117.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 15.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_238">99</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capital allocation<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 132.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_241">100</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical accounting policies<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 147.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_244">101</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">76<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_199"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance summary<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Total results of the Group are set out below. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 167.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 231pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 85.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 62.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">31,376<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">30,328<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(9,048)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(28.8)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(8,565)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(28.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">22,328<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.07pt; position: var(--position);">71.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">21,763<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.07pt; position: var(--position);">71.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.87pt;"></span></span><span style="left: 11.5pt; position: var(--position);">(11,015)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(35.1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(9,385)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(30.9)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">17<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">20<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(6,401)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(20.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(6,223)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(20.5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Royalty income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">639<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29.21pt; position: var(--position);">2.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">953<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29.21pt; position: var(--position);">3.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating income/(expense)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(1,530)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.75pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.75pt; position: var(--position);">(4.9)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(363)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.75pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.75pt; position: var(--position);">(1.3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;(100)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;(100)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">4,021<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 273.75pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.07pt; position: var(--position);">12.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">6,745<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.07pt; position: var(--position);">22.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(40)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net finance costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 132pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(547)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 132pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(677)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after tax profits/(losses) of associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 144.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.48pt;"></span></span><span style="left: 30.11pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 144.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.48pt;"></span></span><span style="left: 30.11pt; position: var(--position);">(5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 157.5pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit/(loss) on disposal of interest in associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 157.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 157.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">3,477<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">6,064<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(43)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(34)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 183pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 183pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(526)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 183pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(756)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">2,951<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">5,308<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(44)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 195.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(36)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 208.5pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit attributable to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 208.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">376<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 208.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">380<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 221.25pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 221.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">2,575<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 221.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">4,928<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 234pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">2,951<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 234pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">5,308<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 234pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.97pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(44)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 234pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.97pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(36)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 246.75pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 246.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">63.2p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 246.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">121.6p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 246.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.97pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(48)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 246.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.97pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(40)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 231pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 231pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total earnings per ADS (US$)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 231pt; position: var(--position); top: 272.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.07pt;"></span></span><span style="left: 24.7pt; position: var(--position);">1.62<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 316.5pt; position: var(--position); top: 272.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.07pt;"></span></span><span style="left: 24.7pt; position: var(--position);">3.02<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 463.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Core results for the Group are set out below. Reconciliations between Total results and Core results for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 454.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 491.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 510.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are set <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_217">88</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 114.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3f37d536c8fc47f5b85267e58409d4dc_0-0-1-1-821446">89</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 489.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 234pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 85.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 62.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 12pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">31,376<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">30,328<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 30pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(7,870)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(25.1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(7,716)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(25.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 42.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(8,974)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(28.6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(9,029)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(29.8)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 32.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 32.94pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 55.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(6,023)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(19.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(5,750)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 22.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 22.61pt; position: var(--position);">(19.0)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 68.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Royalty income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">639<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29.21pt; position: var(--position);">2.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">953<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29.21pt; position: var(--position);">3.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">9,148<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 276.75pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.07pt; position: var(--position);">29.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">8,786<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.07pt; position: var(--position);">29.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 93.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core profit before taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">8,613<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">8,112<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 106.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(1,462)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.01pt;"></span></span><span style="left: 15.64pt; position: var(--position);">(1,257)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">16<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 119.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">24<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core profit after taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 132pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">7,151<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 132pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">6,855<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 132pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 132pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core profit attributable to non-controlling interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 144.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">654<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 144.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 157.5pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 157.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">6,497<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 157.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">6,283<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core profit after taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">7,151<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.93pt;"></span></span><span style="left: 20.56pt; position: var(--position);">6,855<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 183pt; width: 234pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 234pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core earnings per share (p)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 183pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">159.3p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 183pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.79pt;"></span></span><span style="left: 16.419999999999998pt; position: var(--position);">155.1p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 183pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 183pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.26pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 72pt; left: 106.5pt; opacity: 1; position: var(--position); top: 542.78pt; width: 72pt; z-index: 1;"><div><div><div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">77<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_205"></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reporting framework<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 144.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total and Core results<span style="display: inline-block; height: 8pt;"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_1225"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_1226"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_1227"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group financial review discusses the operating and <span style="display: inline-block; height: 6.18pt;"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_1228"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial performance of the Group, its cash flows and financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">position and our resources. The results for each year are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared primarily with the results of the preceding year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 207.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total results<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 220.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total reported results represent the Group&#8217;s overall <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 230.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK made one update to its reporting framework in Q1 2024 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 256.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which was to change the description of Adjusted results to Core <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to align with European peers in the pharmaceutical industry but <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with no change to the basis or figures. In Q2 2024 an update <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was made to the definition of Core results to exclude amounts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 297.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">greater than &#163;25 million from the foreign currency translation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 307.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve which are reclassified to the income statement upon <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 318.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the liquidation of a subsidiary. There is no change to Total <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 328.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Results. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK also uses a number of adjusted, non-IFRS, measures to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report the performance of its business. Core results and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 364.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-IFRS measures may be considered in addition to, but&#160;not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a substitute for or superior to, information presented in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with IFRS. Core results are defined below and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other non-IFRS measures are defined on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i952b654fa1c6418e8b277f5791973299_0-0-1-1-821446">78</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK believes that Core results, when considered together with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total results, provide investors, analysts and other stakeholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with helpful complementary information to understand better <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the financial performance and position of the&#160;Group from period <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to period, and allow the Group&#8217;s performance to be more easily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared against the majority of its peer companies. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 472.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures are also used by management for planning and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 482.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting purposes and when determining compensation. They <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may not be directly comparable with similarly described <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures used by other companies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK encourages investors and analysts not to rely on any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">single&#160;financial measure but to review GSK&#8217;s Annual Reports, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including the financial statements and notes, in their entirety.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is committed to continuously improving its financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting, in line with evolving regulatory requirements and best <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">practice. In line with this practice, GSK expects to continue to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review and refine its reporting framework.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 601.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Core results<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core results exclude the following items in relation to our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations from Total results, together with the tax effects of all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 635.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of these items:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 651.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation of intangible assets (excluding computer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">software and capitalised development costs) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment of intangible assets (excluding computer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">software) and goodwill<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 694.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major restructuring costs, which include impairments of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tangible assets and computer software, (under specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 714.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board approved programmes that are structural, of a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 724.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant scale and where the costs of individual or related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 734.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projects exceed &#163;25 million) including integration costs <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 745.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following material acquisitions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 756.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction-related accounting or other adjustments related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 766.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to significant acquisitions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 144.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceeds and costs of disposals of associates, products <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and businesses; significant settlement income; significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal charges (net of insurance recoveries) and expenses on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the settlement of litigation and government investigations; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other operating income other than royalty income, and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 195.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">items including amounts reclassified from the foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 205.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency translation reserve to the income statement upon <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the liquidation of a subsidiary where the amount exceeds &#163;25 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Costs for all other ordinary course smaller scale restructuring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 252.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and legal charges and expenses are retained within both Total <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 262.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Core results.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As Core results include the benefits of Major restructuring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes but exclude significant costs (such as&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation of intangible assets except for computer software <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and capitalised development costs, significant legal, major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring and transaction items), they should not be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regarded as a complete picture of the Group&#8217;s financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance, which is presented in its Total results. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exclusion of other Adjusting items may result in Core earnings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being materially higher or lower than Total earnings. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particular, when significant impairments, restructuring charges <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and legal costs are excluded, Core earnings will be higher than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 390.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total earnings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 406.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has undertaken a number of Major restructuring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes in response to significant changes in the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trading environment or overall strategy or following material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions. Within the Pharmaceuticals sector, the highly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulated manufacturing operations and supply chains and long <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lifecycle of the business mean that restructuring programmes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particularly those that involve the rationalisation or closure of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing or R&amp;D sites, are likely to take several years to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complete. Costs, both cash and non-cash, of these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes are provided for as individual elements are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved and meet the accounting recognition criteria. As a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result, charges may be incurred over a number of years <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following the initiation of a Major restructuring programme.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant legal charges and expenses are those arising from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the settlement of litigation or government investigations that are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not in the normal course and are materially larger than more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regularly occurring individual matters. They also include certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">major legacy matters.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reconciliations between Total and Core results, providing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further information on the key Adjusting items for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 510.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 529.4200000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, are set out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_217">88</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e4ae46c605c4ded86b536f771a8d159_0-0-1-1-821446">90</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">78<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reporting framework continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Historical record of Adjusting items<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The reconciliations between Total and Core operating profit from continuing operations over the last three years can be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 133.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">summarised as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 149.84pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 359.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 40.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total operating profit from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">4,021<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">6,745<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">6,433<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible amortisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 29.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,002<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 29.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">719<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 29.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">739<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible impairment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 40.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">314<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 40.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">398<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 40.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">296<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major restructuring<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 51.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">353<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 51.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">382<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 51.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">321<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-related items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 63pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,881<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 63pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 63pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,750<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant legal, divestments and other items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 74.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,577<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 74.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.17pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(30)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 74.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.84pt;"></span></span><span style="left: 18.47pt; position: var(--position);">(1,388)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core results<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 88.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">9,148<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 88.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">8,786<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 88.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">8,151<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of the impact of transaction-related items on operating profit for each of the last three years is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 276.17pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 359.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 40.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration on former Shionogi-ViiV Healthcare JV (including Shionogi preferential dividends)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,533<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">934<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,431<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare put options and Pfizer preferential dividends<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 29.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">67<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 29.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.03pt;"></span></span><span style="left: 24.66pt; position: var(--position);">(245)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 29.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">85<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration on former Novartis Vaccines business<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 40.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">206<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 40.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.03pt;"></span></span><span style="left: 24.66pt; position: var(--position);">(187)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 40.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">193<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration on acquisition of Affinivax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 51.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.17pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(22)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 51.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">44<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 51.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">17<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 63pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">97<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 63pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">26<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 63pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.63pt;"></span></span><span style="left: 31.259999999999998pt; position: var(--position);">24<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 77.25pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-related items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 77.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,881<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402pt; position: var(--position); top: 77.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 77.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,750<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Full reconciliations between Total and Core results for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 255.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 299.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 302.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> including continuing and discontinued operations are set out on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.56pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_217">88</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 90.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 100.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e4ae46c605c4ded86b536f771a8d159_0-0-1-1-821446">90</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Further explanations on the Adjusting items for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 291.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 310.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, including the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 364.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement, are reported on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if5c8e35aea684d54b4c8e0a727deb8a3_392">91</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 526.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 417.34pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 227.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 227.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i952b654fa1c6418e8b277f5791973299_0-0-1-1-821446"></span><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 227.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 227.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other non-IFRS measures<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 443.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">CER and AER growth<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In order to illustrate underlying performance, it is the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 472.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">practice to discuss its results in terms of constant exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 482.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate&#160;(CER) growth. This represents growth calculated as if the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange rates used to determine the results of overseas <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies in Sterling had remained unchanged from those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">used in the comparative period. CER% represents growth at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 523.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">constant exchange rates. &#163;% or AER% represents growth at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actual exchange rates. For those countries which qualify as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hyperinflationary as defined by the criteria set out in IAS 29 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Financial Reporting in Hyperinflationary Economies&#8217; (Argentina <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Turkey) CER growth is adjusted using a more appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange rate reflecting depreciation of their respective <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies in order to provide comparability and not to distort <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER growth rates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 610.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Free cash flow<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Free cash flow is defined as the net cash inflow/outflow from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 636.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing operating activities less capital expenditure on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 646.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">property, plant and equipment and intangible assets, contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 656.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration payments, net finance costs, and dividends paid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to non-controlling interests, contributions from non-controlling <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests plus proceeds from the sale of property, plant and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 687.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equipment and intangible assets, and dividends received from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joint ventures and associates. It is used by management for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">planning and reporting purposes and in discussions with and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">presentations to investment analysts and rating agencies. Free <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 728.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flow growth is calculated on a reported basis. A <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 738.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reconciliation of net cash inflow to free cash flow is set out on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 748.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 74.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idd44d70d9ed24392bca06d18eb02fa07_904">92</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 417.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total net debt<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 430.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt is defined as total borrowings less cash, cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 440.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equivalents, liquid investments, and short-term loans to third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties that are subject to an insignificant risk of change in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value. Please see Note 30 &#8216;Net Debt&#8217; for the calculation of net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debt.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 487.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Working capital<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 503.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Working capital represents inventory and trade receivables <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 513.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">less&#160;trade payables.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">79<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reporting framework continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interests in ViiV Healthcare<span style="display: inline-block; height: 8pt;"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_1224"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_384"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 122.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trading profit allocations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 135.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As ViiV Healthcare is a subsidiary of the Group, 100% <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of&#160;its&#160;operating results (turnover, operating profit, profit after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax) are included within the Group income statement and then a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">portion of the earnings is allocated to the non-controlling <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests owned by the other shareholders, in line with their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respective equity shareholdings (Pfizer, Inc. (Pfizer) 11.7% and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi &amp; Co. Ltd (Shionogi) 10%). Each of the shareholders, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including GSK, is also entitled to preferential dividends <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determined by the performance of certain products that each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder contributed. As the relative performance of these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 237.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products changes over time, the proportion of the overall <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings allocated to each shareholder also changes. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particular, the increasing proportion of sales of dolutegravir- <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;cabotegravir-containing products has a favourable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact&#160;on the proportion of the preferential dividends that is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allocated to GSK. Adjusting items are allocated to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#160;based on their equity interests. GSK was entitled <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to&#160;approximately 85% of the Total earnings and 83% of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core earnings of ViiV Healthcare for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 190.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 192.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurements of the liabilities for the preferential dividends <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allocated to Pfizer and Shionogi are included within other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 355.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating income/(expenses).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 371.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Acquisition-related arrangements<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As consideration for the acquisition of Shionogi&#8217;s interest in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">former Shionogi-ViiV Healthcare joint venture in 2012, Shionogi <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 405.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">received the 10% equity stake in ViiV Healthcare and ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 415.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare also agreed to pay additional future cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 425.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration to Shionogi, contingent on the future sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance of the products being developed by that joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 446.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">venture, dolutegravir and cabotegravir. Under IFRS 3 &#8217;Business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combinations&#8217;, GSK was required to provide for the estimated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value of this contingent consideration at the time of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisition and is required to update the liability to the latest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimate of fair value at each subsequent period end. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability for the contingent consideration recognised in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 507.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet at the date of acquisition was &#163;659 million. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subsequent re-measurements are reflected within other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating income/(expenses) and within Adjusting items in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement in each period.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments to settle the contingent consideration are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made to Shionogi by ViiV Healthcare each quarter, based on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the actual sales performance and other income of the relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products in the previous quarter. These payments reduce the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet liability and hence are not recorded in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement, but are included in the cash flow. The cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments made to Shionogi by ViiV Healthcare in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.85000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 286.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,190&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As the liability is required to be recorded at the fair value of <span style="display: inline-block; height: 6.18pt;"></span><span id="i9510c9847c6040bfa7e14a02ad5607ad_385"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 651.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimated future payments, there is a significant timing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difference between the charges that are recorded in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total&#160;income statement to reflect movements in the fair value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 681.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the liability and the actual cash payments made to settle <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 692.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the&#160;liability.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The cash payments are reflected in the cash flow statement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 116.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partly in operating cash flows and partly within investing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 126.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities.&#160; All cash payments are now reflected in operating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 136.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities. The tax relief on these payments is reflected in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 147.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s Adjusting items as part of the tax charge. The part of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 157.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each payment relating to the original estimate of the fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the contingent consideration on the acquisition of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 177.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi-ViiV Healthcare joint venture in 2012 of &#163;659 million is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reported within investing activities in the cash flow statement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the part of each payment relating to the increase in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability since the acquisition is reported within operating cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movements in contingent consideration payable to Shionogi <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 260.48pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration at beginning <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; of the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">5,718<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">5,890<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement through income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and other movements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 38.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">1,533<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 38.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">934<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: operating cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 58.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.84pt;"></span></span><span style="left: 18.47pt; position: var(--position);">(1,190)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 58.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.84pt;"></span></span><span style="left: 18.47pt; position: var(--position);">(1,106)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 69.75pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 69.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.77pt;"></span></span><span style="left: 35.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 69.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.77pt;"></span></span><span style="left: 35.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration at end of the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">6,061<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 81pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">5,718<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 363.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Of the contingent consideration payable (on a post-tax basis) to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 373.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 420.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,127&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 477.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 482.32000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,017 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is expected to be paid within one year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 399.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Exit rights<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer may request an IPO of ViiV Healthcare at any time and if <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.4pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">either GSK does not consent to such IPO or an offering is not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 433.6pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">completed within nine months, Pfizer could require GSK to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 443.8pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquire its shareholding. Under the original agreements, GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">had the unconditional right, so long as it made no subsequent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution to its shareholders, to withhold its consent to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.4pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercise of the Pfizer put option and, as a result, in accordance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 484.6pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with IFRS, GSK did not recognise a liability for the put option on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 494.8pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its balance sheet. However, during Q1 2016, GSK notified <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer that it had irrevocably given up this right and accordingly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised the liability for the put option on the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.4pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet during Q1 2016 at an initial value of &#163;1,070 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.6pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million. Consistent with this revised treatment, at the end of Q1 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545.8pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2016 GSK also recognised liabilities for the future preferential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 556pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends anticipated to become payable to Pfizer and Shionogi <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 566.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the Group&#8217;s balance sheet.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer has the right to require GSK to acquire its shareholding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in ViiV Healthcare in certain circumstances at any time. A put <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">option liability is therefore recorded on the Group&#8217;s balance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 612.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet as a current liability. It is measured on the gross <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 622.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redemption basis derived from an internal valuation of the ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 633.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare business.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 648.98pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The closing balances of the liabilities related to Pfizer&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 659.18pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholding are as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 675.07pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 42.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer put option<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150.75pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">915<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 193.5pt; position: var(--position); top: 18pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.49pt;"></span></span><span style="left: 27.119999999999997pt; position: var(--position);">848<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reporting framework continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under the original agreements, Shionogi could also have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 116.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requested GSK to acquire its shareholding in ViiV Healthcare in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 126.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">six-month windows commencing in 2017, 2020 and 2022. GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 136.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">had the unconditional right, so long as it made no subsequent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 147.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution to its shareholders, to withhold its consent to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 157.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercise of the Shionogi put option and, as a result, GSK did <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not recognise a liability for the put option on its balance sheet. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">However, during Q1 2016, GSK notified Shionogi that it had <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">irrevocably given up this right and accordingly recognised the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability for the put option on the Group&#8217;s balance sheet during <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q1 2016 at an initial value of &#163;926 million. In Q4 2016, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi irrevocably agreed to waive its put option and, as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result, GSK de-recognised the liability for this put option on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s balance sheet directly to equity. The value of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability was &#163;1,244 million when it was de-recognised.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK also has a call option over Shionogi&#8217;s shareholding in ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare, which under the original agreements was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 291.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercisable in six-month windows commencing in 2027, 2030 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2032. GSK has now irrevocably agreed to waive the first <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">two exercise windows, but the last six-month window in 2032 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 321.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remains. As this call option is at fair value, it has no value for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting purposes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 352.08pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Reporting definitions<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 377.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Brand names and partner acknowledgements<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brand names appearing in italics throughout this document are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trademarks of GSK or associated companies or used under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 414.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">licence by the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 429.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Core Operating Margin<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating margin is Core operating profit divided by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 471.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 solutions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 487.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 solutions include the sales of pandemic adjuvant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160;other COVID-19 solutions principally during the year 2020 - <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 and including vaccine manufacturing&#160;and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 229.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Xevudy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated costs but does not include reinvestment in R&amp;D. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This categorisation is used by management and we believe is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">helpful to investors through providing clarity on the results of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group by showing the contribution to growth from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 solutions during this period.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 575.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Discontinued operations<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consumer Healthcare was presented as a discontinued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations from Q2 2022.&#160; The demerger of Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.4pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare was completed on 18 July 2022.&#160; The Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.6pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income Statement and Group Cash Flow Statement distinguish <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.8pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discontinuing operations from continuing operations for 2022.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General medicines are usually prescribed in the primary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 134.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">care or community settings by general healthcare practitioners. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 144.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For GSK, this includes medicines in inhaled respiratory, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dermatology, antibiotics and other diseases.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 170.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interest<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interest is the equity in a subsidiary not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.47pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attributable, directly or indirectly, to a parent.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 212.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Percentage points<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage points of growth which is abbreviated to ppts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 244.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">RAR (Returns and Rebates)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK sells to customers, both commercial and government <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mandated contracts, with reimbursement arrangements that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include rebates, chargebacks and a right of return for certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical products principally in the US. Revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognition reflects gross-to-net sales adjustments as a result. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These adjustments are known as the RAR accruals and are a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 321.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">source of significant estimation, uncertainty and fluctuation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which can have a material impact on reported revenue from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one accounting period to the next. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 357.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 373.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines are typically prescription medicines used to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treat complex or rare chronic conditions. For GSK, this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprises medicines in infectious diseases, HIV, Oncology, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 404.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/Immunology and Other.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 419.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover excluding COVID-19 solutions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover excluding COVID-19 solutions excludes the impact of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales of pandemic adjuvant within Vaccines and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 484.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Xevudy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines related to the COVID-19 pandemic. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management believes that the exclusion of the impact of these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 solutions sales aids comparability in the reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">periods and understanding of GSK&#8217;s growth including by region <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">versus prior periods. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 512.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total Operating Margin<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Operating margin is Total operating profit divided by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 554.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total Earnings per share<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unless otherwise stated, Total earnings per share refers to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total basic earnings per share. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">81<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_211"></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 490.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 490.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 490.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 144.74pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.91pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Group turnover<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 170.43pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 231pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 90pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 90pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 90pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Group turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #dbdbdb; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 90pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">31,376<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">30,328<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 90pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Group pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 90pt; position: var(--position); top: 32.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 32.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">194<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 32.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195.75pt; position: var(--position); top: 32.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 90pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Group turnover ex <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 solutions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 90pt; position: var(--position); top: 46.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">31,364<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 46.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">30,134<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 46.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195.75pt; position: var(--position); top: 46.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 253.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Group turnover by business<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 267.36pt; width: 595.56pt;"><div style="font-size: 0pt; left: 158.74pt; position: var(--position); top: 0pt; width: 129.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 129.75pt;"><div><div style="line-height: 12pt; position: var(--position); top: 0.98pt; width: 129.75pt;"><span style="color: #575756; font-family: 'Wingdings', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 9.25pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 14.25pt; width: 129.75pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.55pt; width: 129.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;9.1bn<span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 51.52pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 21.75pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER decline <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 48.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 59.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER decline <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 108.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 129.75pt;"><div><div style="line-height: 12pt; position: var(--position); top: 2.48pt; width: 129.75pt;"><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Speciality Medicines<span style="display: inline-block; height: 9.25pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60.75pt; width: 129.75pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.55pt; width: 129.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;11.8bn<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 21.75pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 62.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 109.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">19%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 129.75pt;"><div><div style="line-height: 12pt; position: var(--position); top: 2.48pt; width: 129.75pt;"><span style="color: #c6c6c6; font-family: 'Wingdings', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines<span style="display: inline-block; height: 9.25pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 107.25pt; width: 129.75pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.55pt; width: 129.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;10.4bn<span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 60.410000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 21.75pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 104.88pt; left: 53.86pt; opacity: 1; position: var(--position); top: 275.14pt; width: 104.88pt; z-index: 1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g50.gif" alt="1" style="height: 104.88pt; width: 104.88pt;"/></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 419.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Group turnover by geographic region<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 432.85pt; width: 595.56pt;"><div style="font-size: 0pt; left: 158.74pt; position: var(--position); top: 0pt; width: 129.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 129.75pt;"><div><div style="line-height: 12pt; position: var(--position); top: 1.81pt; width: 129.75pt;"><span style="color: #575756; font-family: 'Wingdings', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 9.25pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 14.25pt; width: 129.75pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.55pt; width: 129.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;16.4bn<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 21.75pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 129.75pt;"><div><div style="line-height: 12pt; position: var(--position); top: 2.56pt; width: 129.75pt;"><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Europe<span style="display: inline-block; height: 9.25pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 60.75pt; width: 129.75pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.55pt; width: 129.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;6.7bn<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 21.75pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 91.5pt; width: 129.75pt;"><div><div style="line-height: 12pt; position: var(--position); top: 2.56pt; width: 129.75pt;"><span style="color: #c6c6c6; font-family: 'Wingdings', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 9.25pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">International<span style="display: inline-block; height: 9.25pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 107.25pt; width: 129.75pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.55pt; width: 129.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;8.3bn<span style="display: inline-block; height: 11.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 51.52pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 21.75pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 46.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 58.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER growth <span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 105.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 104.88pt; left: 53.86pt; opacity: 1; position: var(--position); top: 435.51pt; width: 104.88pt; z-index: 2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g51.gif" alt="17" style="height: 104.88pt; width: 104.88pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 581.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK reports results under two segments namely Commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operations and Total R&amp;D. See Note 6, &#8216;Turnover and segment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information&#8217; to the consolidated financial statements for more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 612.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Commercial Operations segment has three product groups <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 635.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of Vaccines, Specialty Med<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">icines, and General Medicines.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 648.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines products, which includes sales of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 223.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 253.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 658.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines products which includes GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 681.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">marketed products for HIV, oncology, respiratory/immunology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other specialty medicines (including <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 213.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines products, which includes medicines in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 715.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inhaled respiratory, dermatology, antibiotics and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 725.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diseases that are typically accessed by patients through <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 735.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primary care settings<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 758.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1) Advisory Committee on Immunization Practices <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 769.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2) Centres for Disease Control and Prevention<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 779.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3) Based on data from IQVIA up until the end of Q3 2024 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 789.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4) Centers for Medicare &amp; Medicaid Services<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 144.74pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.91pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 170.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover (&#163;bn) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 183.92pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="font-size: 12pt; line-height: 22pt; position: var(--position); top: 12.37pt; width: 99.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 22pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;9.1bn<span style="display: inline-block; height: 16.01pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 99.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">AER decline<span style="display: inline-block; height: 7.68pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 168pt; overflow: hidden; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">CER decline<span style="display: inline-block; height: 7.68pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 14.25pt; width: 68.25pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">-7%<span style="display: inline-block; height: 11.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 14.25pt; width: 68.25pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">-4%<span style="display: inline-block; height: 11.64pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 34.5pt; width: 99.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 3.29pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">29% of Group turnover<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 0pt; position: var(--position); top: 236.17pt; width: 595.56pt;"><div style="left: 304.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g52.gif" alt="312" style="height: 56.69pt; width: 229.88pt;"/></div></div></div><div style="position: var(--position); top: 297.86pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #dbdbdb; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #dbdbdb; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">9,138<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #dbdbdb; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">9,864<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #dbdbdb; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(7)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #dbdbdb; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">150<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.16pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(100)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.16pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(100)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines ex COVID-19 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">solutions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">9,138<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">9,714<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines sales decreased primarily due to lower demand for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> related to a more limited ACIP<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 444.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> recommendation in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US and channel inventory consumption compared to launch <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year stocking in 2023. Meningitis vaccines had their strongest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 405.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year of sales to date with double-digit growth across all regions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Established vaccines continued to grow across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 426.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">International and the US. Overall, Vaccines performance was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also adversely impacted due to COVID-19 solution sales and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 446.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US CDC<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 337.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 343.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> stockpile replenishments in 2023, each impacting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">full year growth by 1 percentage point.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 475.8pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Shingles<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 350pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 493.25pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 17.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingles<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 17.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,364<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 17.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,446<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 17.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 17.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 337.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a vaccine against shingles, declined <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and grew <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 341.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER, with ex-US sales growth more than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offsetting lower sales in the US.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The US cumulative immunisation rate reached 40%, up five <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">percentage points compared to 12 months earlier.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 489.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 496.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decreased by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">21%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 415.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER reflecting the slowing pace <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 600.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of penetration of harder-to-reach unvaccinated consumers, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partially offset by favourable pricing. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 440.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales were also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">negatively impacted by changes in retail vaccine prioritisation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partly due to a transition to a new CMS<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 449.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> rule that changed how <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 641.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmacies process reimbursements from payers.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> grew significantly in International, driven by a national <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunisation programme in Australia and supply to our co-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">promotion partner in China. In Europe, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 450.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 480.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was driven by expanded public funding and higher uptake <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across multiple countries, partly offset by lower demand in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 708.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Germany. Markets outside the US represented 56% of 2024 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global sales (2023: 45%), with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 419.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> launched in 52 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 728.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries. The overwhelming majority of ex-US <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 481.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.57000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunity is concentrated in 10 markets where the average <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunisation rate is around 7% with significantly higher uptake <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in funded cohorts.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">82<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 121.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,437<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,260<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">14<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">18<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis vaccines achieved double-digit growth. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 240.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 271.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine against meningitis B, achieved sales of over &#163;1 billion <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the first time. Growth was primarily due to favourable pricing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mix and increased full year purchases from the CDC in the US, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendation in Germany and launch in Vietnam. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 218.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">RSV<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 234.77pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 19.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 42.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">590<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,238<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(52)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(51)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a RSV<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 108.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> vaccine for older adults had declining sales in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the year. US sales decreased due to lower demand partly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related to a more limited recommendation from ACIP for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals aged 60 to 74. Sales were also adversely impacted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by channel inventory consumption compared to the launch year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stocking in 2023. Arexvy maintained the market leading position <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in retail where the overwhelming majority of doses are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">administered. More than ten million US adults<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 223.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> aged 60 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">older at risk have been protected by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 189.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> since the launch in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q3 2023. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In countries outside the US, sales growth reflected uptake <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following a positive recommendation in Germany, initial tender <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliveries in Saudi Arabia and new launch inventory builds in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Australia and Brazil, partly offset in the quarter by lower <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demand in Canada. While <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 152.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is approved in 59 markets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">globally, 17 countries had national RSV vaccination <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations for older adults and 6, including the US, had <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reimbursement programmes in place at the year end.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 470.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Influenza<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 486.33pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Influenza<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">408<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">504<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(19)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(16)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fluarix/FluLaval<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales decreased driven by competitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pressure and lower market demand primarily in the US.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 553.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Established Vaccines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 570.56pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Established Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,339<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,266<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Established Vaccines growth reflected increased sales of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hepatitis vaccines across all regions, higher US market share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and European demand for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 153.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Boostrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and increased International <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply and US uptake of MMR/V<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 175.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> vaccines. This was partly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offset by adverse CDC stockpile movements for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 233.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rotarix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 260.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infanrix/Pediarix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 114.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Established Vaccine sales in 2024 included <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">around &#163;130 million of non-repeating contracted sales including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">divested brands which have now ceased.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 745.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1) Respiratory syncytial virus (2) Based on data from IQVIA <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 756.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3) Measles, mumps, rubella and varicella <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 766.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4) Based on sales data from 2024 and 2023: DoT Volume Market Share - <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 775.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IQVIA , GERS(France), Czech State Institute for Drug Control (SUKL), <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 783.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DLI Market Intelligence (Denmark), farmINFORM (Netherlands), <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 791.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cegedim Healthcare (Romania)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 4.78pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 135.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover (&#163;bn)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 149.23pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="font-size: 12pt; line-height: 22pt; position: var(--position); top: 16.12pt; width: 99.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 22pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;11.8bn<span style="display: inline-block; height: 16.01pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 99.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">AER growth<span style="display: inline-block; height: 7.68pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 168pt; overflow: hidden; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">CER growth<span style="display: inline-block; height: 7.68pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 14.25pt; width: 68.25pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 5.06pt; width: 68.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">15%<span style="display: inline-block; height: 11.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 14.25pt; width: 68.25pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 5.06pt; width: 68.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">19%<span style="display: inline-block; height: 11.64pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 99.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 99.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">38%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.8pt; position: var(--position); white-space: pre;"> of Group Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 0pt; position: var(--position); top: 207.48pt; width: 595.56pt;"><div style="left: 304.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g53.gif" alt="903" style="height: 56.69pt; width: 229.88pt;"/></div></div></div><div style="position: var(--position); top: 269.17pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Specialty Medicines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">11,810<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">10,244<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">15<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">19<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">44<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(73)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(73)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Speciality Medicines ex <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19 solutions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">11,798<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">10,200<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">16<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">19<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines sales grew by double-digit percentages <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.56pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflecting continued growth across disease areas, with strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.76pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performances in HIV, Respiratory/Immunology and Oncology.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 377.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 393.54pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">7,089<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">6,444<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV sales continue to grow double-digits driven by strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient demand for long-acting injectable medicines <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 307.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva, Apretude<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 406.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. This demand primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected a 2 percentage point<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 415.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> increase in market share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 475.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared to the prior period which contributed 10 percentage <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">points of growth in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 394.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The remainder of the growth was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven by favourable in-year pricing, including the positive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact from channel mix.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 521.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oral 2DR <span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 537.41pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oral 2DR <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">2,924<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">2,480<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">18<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">21<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 578.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales of Oral 2DR (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 377.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato, Juluca<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) now represent 42% of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total HIV portfolio. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 373.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the first and only once-daily oral <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2DR for the treatment of HIV infection in both treatment naive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 608.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and virally suppressed adults and adolescents continues to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 618.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the largest product in the HIV portfolio with sales of &#163;2,239 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million in 2024 and growing 23% AER, 27% CER versus <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 534.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 644.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Long-Acting Medicines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 660.88pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-Acting Medicines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,292<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">857<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">51<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">55<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 701.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-Acting Injectable Medicine sales contributed over 50% of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 711.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the total HIV growth in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 413.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the only complete <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 721.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-acting injectable regimen for HIV treatment, reached sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 732.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of &#163;1,013 million in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, growing 43% AER, 47% CER, due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 742.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong patient demand across US and Europe. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 480.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 514.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 752.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first long-acting injectable option for HIV prevention delivered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 762.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales of &#163;279 million in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, growing <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 447.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">87%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 464.07000000000005pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AER, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 488.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">93%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 772.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">83<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/Immunology and other<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/Immunology <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,299<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,025<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 178.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales primarily comprised contributions from <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 221.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 112.21000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in immunology. Sales growth in the full <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year was delivered for both <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 157.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 201.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, driven by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient demand globally across US, European and International <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 235.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 251.02pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,784<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,655<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 291.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is an IL-5 antagonist monoclonal antibody treatment for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">severe asthma, with additional indications including chronic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rhinosinusitis with nasal polyps, eosinophilic granulomatosis <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with polyangiitis (EGPA), and hypereosinophilic syndrome <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(HES). Sales growth was driven particularly by strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance in Europe and International regions, reflecting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">higher patient demand for treatments addressing eosinophilic-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">led disease. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 379pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 394.89pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,490<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,349<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">14<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.58pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a monoclonal antibody treatment for Lupus, continues <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to grow by double-digit percentages representing strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.98pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demand and volume growth in US, European and International <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.18pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regions, with bio-penetration rates having increased across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">many markets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 492.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 508.16pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,410<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">731<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">93<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">98<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strong Oncology sales growth continued driven by increasing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient demand for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 126.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a PARP<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 183.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> inhibitor, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 225.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PD-1<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 73.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.71000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> blocking antibody, and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 167.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a daily JAK1/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 579.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JAK2 and ACVR1<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 120.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 4.2575pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 126.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> inhibitor.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 160.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 595.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 611.23pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">593<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">523<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">17<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 651.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 76.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a PARP inhibitor treatment for ovarian cancer, grew by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">double-digit percentages, with strong growth delivered across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all regions with sustained increases in patient demand and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">higher volumes, further enhanced by positive price impacts in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 692.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 740.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1) PARP: a Poly ADP ribose polymerase <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 750.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2) PD-1: a programmed death receptor-1 blocking antibody <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 761.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3) JAK1/JAK2 and ACVR1: once a-day, oral JAK1/JAK2 and activin A <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 769.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receptor type 1 (ACVR1) inhibitor <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 779.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4) Chronic obstructive pulmonary disease&#160; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 790.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5) Average manufacturer price <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 122.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">467<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a medicine for first-line treatment in combination with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chemotherapy for patients with primary advanced or recurrent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endometrial cancer, continued to grow strongly. Strong sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were driven largely by increased patient uptake in the US, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following Q3 2024 FDA approval expanding the indication to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include all adult patients with primary advanced or recurrent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endometrial cancer.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 239.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 255.86pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">353<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a treatment for myelofibrosis patients with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anaemia, grew strongly largely driven by the US with continued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uptake in patients since its product launch in Q3 2023. Sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included increasing contributions from Europe and International <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regions following launches in the UK and Germany in Q1 2024, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and in Japan in Q3 2024<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 396.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 374.14pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 401.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover (&#163;bn)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 414.88pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="font-size: 12pt; line-height: 22pt; position: var(--position); top: 12.37pt; width: 99.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 22pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;10.4bn<span style="display: inline-block; height: 16.01pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 99.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">AER growth<span style="display: inline-block; height: 7.68pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 168pt; overflow: hidden; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">CER growth<span style="display: inline-block; height: 7.68pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 99.75pt; position: var(--position); top: 14.25pt; width: 68.25pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">2%<span style="display: inline-block; height: 11.64pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 14.25pt; width: 68.25pt;"><div><div style="font-size: 12pt; line-height: 16pt; position: var(--position); top: 3.19pt; width: 68.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">6%<span style="display: inline-block; height: 11.64pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 34.5pt; width: 99.75pt;"><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 3pt; width: 99.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33%<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 15.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of Group turnover<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 472.07pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 534.74pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 56.69pt;"></span></span><div style="left: 304.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g54.gif" alt="1444" style="height: 56.69pt; width: 229.88pt;"/></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales include contributions from both the Respiratory and Other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicine portfolios. Sales growth was primarily driven <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 316.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> a COPD<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 380.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and asthma medicine, with strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demand across all regions. Performance was adversely <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacted by the removal of the AMP<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 439.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 446.57000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> cap on Medicaid drug <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 586.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prices in the US. This removal impacted <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 455.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advair, Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 596.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lamictal<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> due to significant pricing reductions, reduced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 606.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial contracting, and the decision to discontinue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 616.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">branded <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 338.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. However, this has been fully offset by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased use of authorised generic versions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 483.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advair<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 332.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> while, significantly, continuing to provide access to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">84<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 122.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">7,213<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">6,825<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales growth reflected <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 139.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 167.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">'s strong performance in all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regions. In the US adverse impacts from the removal of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AMP cap were fully offset by the increased use of authorised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generic versions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 126.67999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advair<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 169.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 196.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, providing access to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines for patients.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 219.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 235.46pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">2,702<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">2,202<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">23<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">27<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 276.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is the most prescribed SITT<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 186.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> treatment worldwide for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD and asthma. Sales grew <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 173.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> AER, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">27%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> CER in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 296.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year, driven largely by volume growth, whilst also benefiting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from favourable pricing. Strong volume growth continued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across all regions reflecting patient demand, SITT class growth, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 327.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and increased market share. Overall favourable pricing in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 337.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year was driven by US channel mix price adjustments in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first six months of&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, which moderated in the second half. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 363.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Seretide/Advair<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 379.33pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.06pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Seretide/Advair<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,057<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,139<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(7)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Seretide/Advair<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is a combination treatment used to treat <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 430.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asthma and COPD. Sales decreased in Europe and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 440.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">International reflecting continued generic erosion by competitor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products. This was partially offset by growth in the US driven <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">largely by favourable impacts from channel mix adjustments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 476.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other general medicines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 492.6pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other general medicines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,215<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">3,395<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other general medicines&#8217; g<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rowth decreased 5% at AER and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was flat at CER<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.75999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, with growth in antibiotics and dermatology in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 553.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">International markets offset by global declines from continued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 563.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generic competition across the portfolio.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 798.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1) Single inhaler triple therapy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 148.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 109.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover by regions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 125.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 138.88pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">16,384<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">15,820<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding COVID<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">16,374<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">15,810<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines double-digit growth in the year was driven <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by strong Oncology and HIV performance, and continued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 341.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 386.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine sales decreased <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primarily in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 347.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> due to lower demand related to a more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">limited ACIP recommendation and related channel inventory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consumption compared to the 2023 launch year stocking. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> also decreased reflecting lower demand driven by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued challenge of activating harder-to-reach consumers. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicine&#8217;s growth in the year was primarily driven by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased demand for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 388.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 416.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, with strong volume growth from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 305.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">higher patient demand and growth of the SITT market as well <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 315.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as favourable price benefits. Performance continues to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 325.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacted following the removal of the AMP cap on Medicaid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug prices, which particularly impacted <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 454.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advair<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 478.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 480.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 510.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lamictal<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. This was fully offset by the increased use of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorised generic versions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 419.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advair<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 443.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 461.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, providing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access to medicines for patients.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 382.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Europe<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 396.15pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">6,666<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">6,564<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">133<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(99)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(99)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding COVID<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">6,665<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">6,431<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines sales grew by double-digits in the year due <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to continued strong performance in Oncology, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 476.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology, and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 370.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in respiratory including the benefit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from new indication launches. HIV growth continued at a mid-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to-high single-digit percentage.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine sales grew in the year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">excluding the adverse impact of COVID-19 sales in 2023. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth was driven by expanded public funding across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">several markets, partly offset by lower demand in Germany. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 354.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales increased following&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations in Germany. General Medicines sales were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 562.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">broadly stable. Strong double-digit growth for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 474.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 502.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 573.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was offset by decreases across other general medicine <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 596.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">International<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 609.62pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">8,326<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">7,944<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">51<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(97)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 10.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;(100)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding COVID<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">8,325<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">7,893<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 674.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicine&#8217;s double-digit growth in the&#160; year was driven <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 684.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by HIV, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 333.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in Respiratory, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 418.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in Immunology, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 694.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology. Vaccine sales grew strongly in the year driven by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 704.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> related to the national immunisation program in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 715.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Australia and supply to our co-promotion partner in China <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 725.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">together with strong momentum in Meningitis vaccines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 735.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">single-digit growth in Established Vaccines sales. General <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 745.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicines sales decreased 3% at AER and grew 3% at CER, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 755.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with strong growth in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 384.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 416.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 457.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and dermatology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 766.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products, partially offset by a decrease in other general <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 776.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicine products.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">85<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 110.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(9,048)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(8,565)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">28.8%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">28.2%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">0.6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">0.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(7,870)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(7,716)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">25.1%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">25.4%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(0.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(0.7)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total and Core cost of sales as a percentage of sales benefited <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from price and channel mix benefits, as well as ongoing mix <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits in higher margin Specialty Medicines products, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply chain efficiencies. These benefits were offset in the year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by charges of &#163;150 million in Q4 2024 to drive future supply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 237.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain efficiencies. Total cost of sales also increased due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additional amortisation for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 152.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 193.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 263.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 279.86pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total selling, general and<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.37pt;"></span></span><span style="left: 4pt; position: var(--position);">(11,015)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(9,385)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">17<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">20<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 38.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">35.1%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 38.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">30.9%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 38.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">4.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 38.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">3.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core selling, general<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 50.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(8,974)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 50.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(9,029)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 50.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 50.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 70.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 70.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">28.6%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 70.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">29.8%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 70.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(1.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 70.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(1.3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 373.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total SG&amp;A growth was primarily driven by the increase in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant legal costs reflecting the charge of &#163;1.8 billion ($2.3 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion) in Q3 2024 in relation to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 171.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for the State Courts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlement, the Qui Tam Settlement, and the remaining 7% of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pending state court product liability cases, partially offset by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduced future legal costs. Since that time, the vast majority of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the remaining state court cases have been resolved or been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dismissed such that less than 1% of the state court cases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remain (see details on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_538">265</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 173.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 470.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core SG&amp;A growth was broadly flat at AER, with growth at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 480.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER driven by continued disciplined investment to support <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 490.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global market expansion and disease awareness for key assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 89.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 119.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala, Shingrix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 199.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment behind long-acting HIV medicines. Growth was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partly offset by a 1 percentage point favourable impact of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 531.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reversal of the legal provision taken in Q1 2023 for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 257.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 280.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">royalty dispute, following a successful appeal.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 557.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 573.72pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total research and<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(6,401)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(6,223)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 39pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">20.4%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 39pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">20.5%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 39pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(0.1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 39pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(0.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core research and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 51pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(6,023)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 51pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(5,750)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 51pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 51pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 71.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">19.2%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 71.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">19.0%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 71.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">0.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 71.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total R&amp;D growth was driven by an increase in Core R&amp;D <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment, partly offset by lower impairment charges <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared with the full year 2023. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 703.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core R&amp;D investment increased driven by progression across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 714.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the portfolio.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Specialty Medicines, investment increased in Respiratory, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 116.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Immunology and Inflammation to support late-stage clinical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 126.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development programmes for camlipixant (refractory chronic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 136.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cough), the long-acting TSLP asset acquired from the Aiolos <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 147.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisition, bepirovirsen (chronic hepatitis B) and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 490.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 522.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 157.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(autoimmune diseases), with ongoing strong investment in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depemokimab (asthma and eosinophilic inflammation). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Oncology, increased investment reflected acceleration on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody-drug-conjugates (ADCs) including those acquired from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hansoh Pharma at the end of 2023, and studies into <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 501.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(multiple myeloma) and<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 392.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Jemperli<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (endometrial cancer). In HIV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment increased on next-generation long-acting treatment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and preventative medicines.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Vaccines, clinical trial programmes associated with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pneumococcal Multi Antigen Presenting System (MAPS) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology and mRNA continued to drive investment.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These increases were partly offset by reductions following the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launches of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 350.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 394.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and progression to completion <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of gepotidacin and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 375.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> studies.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 322.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Royalty income<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 338.75pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total royalty income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">639<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">953<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core royalty income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">639<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">953<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The decrease in Total and Core royalty income primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected the cessation of the majority of Gardasil royalties at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the end of 2023, with 2024 Gardasil royalties of &#163;42 million <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2023: &#163;472 million). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This was partly offset by increases in Kesimpta and Biktarvy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">royalties.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 464.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other operating income/(expense)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 479.91pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating income/<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(expenses)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.34pt;"></span></span><span style="left: 10.969999999999999pt; position: var(--position);">(1,530)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(363)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 12.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;(100)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 12.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&gt;(100)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating expense reflected a charge of &#163;1,839 million <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2023: &#163;546 million) principally arising from the remeasurement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of contingent consideration liabilities (CCL). This primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected improved longer term HIV prospects as well as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">smaller foreign currency movements compared to 2023 and an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in liability for the Vaccines CCL. This was partly offset <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by higher other net income of &#163;287 million (2023: &#163;200 million) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as well as a fair value gain of &#163;22 million (2023: &#163;17 million <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 610.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss) on the retained stake in Haleon plc. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">86<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operating profit<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 122.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.43pt;"></span></span><span style="left: 13.059999999999999pt; position: var(--position);">4,021<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.43pt;"></span></span><span style="left: 13.059999999999999pt; position: var(--position);">6,745<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(40)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(33)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.94pt; position: var(--position);">12.8%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">22.2%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(9.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 19.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 19.25pt; position: var(--position);">(8.3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.43pt;"></span></span><span style="left: 13.059999999999999pt; position: var(--position);">9,148<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.43pt;"></span></span><span style="left: 13.059999999999999pt; position: var(--position);">8,786<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.94pt; position: var(--position);">29.2%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.94pt; position: var(--position);">29.0%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">0.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">0.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total operating profit and margin were lower primarily due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 209.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the charge of &#163;1.8 billion ($2.3 billion) for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 221.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 219.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settlement, higher CCL charges driven by improved longer term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 229.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV prospects and other remeasurements as well as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unfavourable foreign currency movements, additional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 249.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 114.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 155.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and minimal movements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on Haleon plc shares (2023 fair value loss). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating profit growth benefited from strong Specialty <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicines sales performance, with favourable product and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regional mix. This was partly offset by increased investment in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D and growth assets, and lower royalty income. 2024 also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">includes a favourable impact from the reversal of the legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provision taken in Q1 2023 for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 182.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> royalty dispute, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following a successful appeal. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The adverse impact of lower sales of COVID-19 solutions had a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">two percentage points impact in the full year on Total and Core <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating profit growth and a 0.4 percentage point impact on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total and Core operating profit margin. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 399.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Core operating profit by business<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 415.44pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">15,335<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">14,656<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">48.9%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.57pt; position: var(--position);">48.3%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">0.5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.71pt; position: var(--position);">1.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(5,845)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.51pt;"></span></span><span style="left: 8.14pt; position: var(--position);">(5,607)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations Core operating profit benefited from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong Specialty Medicines sales performance and favourable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product and regional mix, as well as price and channel mix <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits and supply chain efficiencies, and a reversal of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 520.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 76.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> royalty dispute legal provision in Q1 2024. This was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partly offset by charges to drive future supply chain efficiencies, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued disciplined investment in growth assets and lower <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">royalty income. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The R&amp;D segment operating expenses growth was driven by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 577.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued spend across the portfolio, and increased investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 587.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in Specialty Medicines including camlipixant, bepirovirsen and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, as well as the long-acting TSLP asset acquired as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 608.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of the Aiolos acquisition. In Oncology, increased <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 618.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 105.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and ADC assets was offset by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 628.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment decreases following the launches of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 232.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 638.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progression to completion of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 161.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> studies. In HIV, investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on long-acting medicines continued, and in Vaccines, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 659.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pneumococcal (MAPS) and mRNA continued to drive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 669.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Net finance costs<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 113.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net finance cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(547)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(677)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(19)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(18)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core net finance cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(532)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(669)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(20)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(19)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The decrease in net finance costs was mainly driven by lower <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest on short-term financing as a result of cash received <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the disposal of all Haleon plc shares, savings from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maturing bonds, and higher interest income on cash, partly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offset by fair value movements on net investment hedges. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparator to 2023 also benefited from the net cost of bond <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">buybacks completed in Q1 2023. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 242.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share of after tax profits of associates and <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 256.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">joint ventures<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The share of after tax loss of associates and joint ventures was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 541.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> share of loss).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 301.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Profit on disposal of interest in associates<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.18pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group also reported a profit on disposal of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests in associates and joint ventures of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 467.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 503.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 531.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> profit).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 353.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Profit before tax<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taking account of net finance costs, the share of profits or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">losses of associates and profit or loss on disposal of interest in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 389.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associates,Total profit before taxation was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3,477 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 514.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 399.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compared with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,064 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 443.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 415.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 431.6pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 165.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK current year charge<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">186<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">207<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of world current year charge<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,458<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,371<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge/(credit) in respect of prior periods<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.67pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(92)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 42pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);">43<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total current taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,552<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 54pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">1,621<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total deferred taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 66pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.34pt;"></span></span><span style="left: 10.969999999999999pt; position: var(--position);">(1,026)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 66pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(865)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 165.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation on total profits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 78pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">526<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 78pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">756<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The charge of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;526 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> represented an effective tax rate on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total results of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.1%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.5%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and reflected the different <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax effects of the various Adjusting items. Tax on Core profit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,462 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and represented an effective Core <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax rate of 17.0% (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.5%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 420.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Issues related to taxation are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">described in Note 14, &#8216;Taxation&#8217; to the financial statements. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 593.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group continues to believe it has made adequate provision for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 603.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the liabilities likely to arise from periods which are open and not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 613.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">yet agreed by tax authorities. The ultimate liability for such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 624.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters may vary from the amounts provided and is dependent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 634.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upon the outcome of agreements with relevant tax authorities.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">87<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial performance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interests (NCI)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 123.89pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total continuing<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">376<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">380<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 25.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 25.44pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">654<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">14<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">20<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 176.58pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The decrease in total NCIs at AER was driven by lower ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 186.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare Total profits, reflecting adverse currency impacts, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.98pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with an allocation of &#163;356 million (2023: &#163;374 million). The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 207.18pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in Total NCIs at CER was driven by higher ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare Total profits (partly offset by a higher <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.58pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remeasurement loss on the CCL) as well as higher net profits in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 237.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">some of the Group's other entities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.67pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The increase in Core NCIs primarily reflected higher core profit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allocations from ViiV Healthcare, with &#163;634 million in 2024 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.07pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2023: &#163;566 million), as well as higher net profits in some of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s other entities with NCIs.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 316.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Earnings per share from operations<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 331.94pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;p<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.8pt;"></span></span><span style="left: 13.43pt; position: var(--position);">63.2p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">121.6p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(48)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(40)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">159.3p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.66pt;"></span></span><span style="left: 9.29pt; position: var(--position);">155.1p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 30.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 386.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The decrease in Total EPS was primarily due to a charge of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 396.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.8 billion ($2.3 billion) for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 170.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 196.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement (see details <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 406.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i59a0d33488c04eee9773c8d9f9f1ba75_19135">266</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 100.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and higher CCL charges. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The increase in the Core EPS primarily reflected the growth in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating profit as well as lower finance costs, partly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offset by a higher effective taxation rate and higher non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling interests. Lower sales of COVID-19 solutions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 463.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduced Core EPS by two percentage points in the full year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Currency impact on results<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 122.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.700000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m/&#163;p<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.620000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.700000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m/&#163;p<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER% <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">31,376<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">30,328<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 33pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 33pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.43pt;"></span></span><span style="left: 13.059999999999999pt; position: var(--position);">63.2p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 33pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">121.6p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 33pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(48)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 33pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 21.3pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(40)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 45.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">159.3p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 45.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.29pt;"></span></span><span style="left: 8.92pt; position: var(--position);">155.1p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165.75pt; position: var(--position); top: 45.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.9pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.9pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 45.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.76pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The adverse currency impact primarily reflected the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.58pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthening of Sterling against the US Dollar, Euro, Yen and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emerging market currencies. Exchange gains or losses on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.98pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settlement of intercompany transactions had a negligible impact <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.18pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on Total and Core EPS.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 249.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dividends<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 265.16pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board has declared four interim dividends resulting in a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total dividend for the year of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">61p<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> per share.&#160;The GSK Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.56pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend in 2023 was 58p per share. Please refer to Note 16, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.76pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">'Dividends' to the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 311.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dividend policy<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends remain an essential component of total shareholder <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">return and GSK recognises the importance of dividends to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders. On 23 June 2021, at the GSK Investor Update, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 358.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK set out that from 2022 a progressive dividend policy will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 368.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be implemented guided by a 40 to 60 percent pay-out ratio <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 378.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through the investment cycle. Consistent with this, GSK&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 388.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">declared an increased dividend of 16p for Q4 2024 and 61p per <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share for full year 2024. The expected dividend for 2025 is 64p <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 409.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">per share. In setting its dividend policy, GSK considers the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital allocation priorities of the Group and its investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy for growth alongside the sustainability of the dividend.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">88<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_217"></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjusting items<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 139.05pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 201pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/></tr><tr style="height: 50.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="i8eb45e5502ea4186974fedc498d5be2b_0-0-1-1-821446"></span><div style="height: 50.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 201pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Core results reconciliation <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 18.52pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 19.26pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 0pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 19.26pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.46pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.26pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Divestments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160; other <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">items<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 0pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 27.06pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.86pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.66pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross profit <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 50.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.04pt;"></span></span><span style="left: 12.669999999999998pt; position: var(--position);">22,328<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 50.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">947<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 50.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 50.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">163<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 50.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">40<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 50.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">28<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 50.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.04pt;"></span></span><span style="left: 12.669999999999998pt; position: var(--position);">23,506<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating profit <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 61.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">4,021<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 61.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.43pt;"></span></span><span style="left: 22.06pt; position: var(--position);">1,002<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 61.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">314<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 61.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">353<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 61.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,881<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 61.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,577<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 61.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">9,148<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before taxation <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 72.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">3,477<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.43pt;"></span></span><span style="left: 22.06pt; position: var(--position);">1,002<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 72.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">314<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 72.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">354<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 72.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,881<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 72.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,585<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 72.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">8,613<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 84pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">2,951<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 84pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">794<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 84pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">251<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 84pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">274<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 84pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,570<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 84pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,311<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 84pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">7,151<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 95.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 95.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">2,575<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 95.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">794<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 95.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">251<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 95.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">274<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 95.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,292<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 95.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,311<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 95.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">6,497<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 109.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);">63.2p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 109.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);">19.5p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 109.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.69pt;"></span></span><span style="left: 21.32pt; position: var(--position);">6.1p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 109.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.44pt;"></span></span><span style="left: 25.07pt; position: var(--position);">6.7p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 109.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.8pt;"></span></span><span style="left: 19.43pt; position: var(--position);">31.7p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 109.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.8pt;"></span></span><span style="left: 19.43pt; position: var(--position);">32.1p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 109.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.41pt;"></span></span><span style="left: 13.04pt; position: var(--position);">159.3p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of shares (millions)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 126.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">4,077<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 126.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 126.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 126.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 126.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 126.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 126.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">4,077<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core gross profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 163.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 163.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(9,048)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 163.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">947<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 163.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 163.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">163<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 163.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">40<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 163.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">28<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 163.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(7,870)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 187.5pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 198.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.12pt;"></span></span><span style="left: 7.75pt; position: var(--position);">(11,015)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 198.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 198.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">160<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 198.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.9pt;"></span></span><span style="left: 33.53pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 198.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,879<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 198.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(8,974)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 210pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(6,401)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 210pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.76pt;"></span></span><span style="left: 32.39pt; position: var(--position);">55<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 210pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">314<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 210pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">9<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 210pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 210pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 210pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(6,023)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 221.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating (expense)/income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 221.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.45pt;"></span></span><span style="left: 18.08pt; position: var(--position);">(891)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 221.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 221.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 221.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.26pt;"></span></span><span style="left: 30.89pt; position: var(--position);">21<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 221.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,839<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 221.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(330)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 221.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.6pt;"></span></span><span style="left: 19.23pt; position: var(--position);">639<span style="display: inline-block; height: 5.46pt; width: 6.6pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit before tax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net finance costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 256.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.45pt;"></span></span><span style="left: 18.08pt; position: var(--position);">(547)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 256.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 256.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 256.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 256.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 256.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">14<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 256.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.45pt;"></span></span><span style="left: 18.08pt; position: var(--position);">(532)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 267.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after tax losses of associates<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 267.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.73pt;"></span></span><span style="left: 26.36pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 267.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 267.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 267.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 267.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 267.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 267.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.73pt;"></span></span><span style="left: 26.36pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 288pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit/(loss) on disposal of interest in associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 288pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.65pt;"></span></span><span style="left: 31.279999999999998pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 288pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 288pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 288pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 288pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 288pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.98pt;"></span></span><span style="left: 28.61pt; position: var(--position);">(6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 288pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.65pt;"></span></span><span style="left: 31.279999999999998pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 315pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit after tax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 326.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 326.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.45pt;"></span></span><span style="left: 18.08pt; position: var(--position);">(526)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 326.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.7pt;"></span></span><span style="left: 23.33pt; position: var(--position);">(208)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 326.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.59pt;"></span></span><span style="left: 22.22pt; position: var(--position);">(63)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 326.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(80)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 326.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(311)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 326.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(274)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 326.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(1,462)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 350.25pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 361.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 361.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">376<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 361.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 284.25pt; position: var(--position); top: 361.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 361.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366pt; position: var(--position); top: 361.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">278<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 361.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 361.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">654<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">89<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjusting items continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 201pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="i3f37d536c8fc47f5b85267e58409d4dc_0-0-1-1-821446"></span><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 201pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Core results reconciliation <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 18.52pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 0pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 406.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Divestments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">items<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 0pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 57.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.29pt;"></span></span><span style="left: 14.919999999999998pt; position: var(--position);">21,763<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 57.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">647<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 57.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 57.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">164<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 57.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 57.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">25<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 57.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.04pt;"></span></span><span style="left: 12.669999999999998pt; position: var(--position);">22,612<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 69pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">6,745<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 69pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">719<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 69pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">398<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 69pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">382<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 69pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 69pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(30)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 69pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">8,786<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before taxation <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 80.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">6,064<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 80.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">719<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 80.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">398<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 80.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">383<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 80.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 80.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(24)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 80.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">8,112<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 91.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">5,308<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 91.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">565<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 91.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">304<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 91.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">300<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 91.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);">472<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 91.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 91.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">6,855<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 102.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">4,928<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 102.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">565<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 102.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">304<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 102.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">300<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 102.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);">280<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 102.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 102.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">6,283<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 117pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 117pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.66pt;"></span></span><span style="left: 15.29pt; position: var(--position);">121.6p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 117pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.3pt;"></span></span><span style="left: 20.93pt; position: var(--position);">13.9p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 117pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.69pt;"></span></span><span style="left: 21.32pt; position: var(--position);">7.5p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 117pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.44pt;"></span></span><span style="left: 25.07pt; position: var(--position);">7.4p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 117pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.44pt;"></span></span><span style="left: 22.07pt; position: var(--position);">6.9p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 117pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.48pt;"></span></span><span style="left: 21.11pt; position: var(--position);">(2.2p)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 117pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.41pt;"></span></span><span style="left: 13.04pt; position: var(--position);">155.1p<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of shares (millions)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 134.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">4,052<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 134.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 134.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 134.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 134.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.54pt;"></span></span><span style="left: 36.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 134.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 134.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);">4,052<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 486.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core gross profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 172.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(8,565)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 172.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">647<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 172.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 172.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">164<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 172.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 172.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">25<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 172.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(7,716)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 486.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 207.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(9,385)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 207.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 207.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 207.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">216<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 207.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 207.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">127<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 207.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(9,029)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 219pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(6,223)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 219pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.26pt;"></span></span><span style="left: 30.89pt; position: var(--position);">72<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 219pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">398<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 219pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 219pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.54pt;"></span></span><span style="left: 36.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 219pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.9pt;"></span></span><span style="left: 33.53pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 219pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(5,750)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 230.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating (expense)/income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 230.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">590<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 230.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 230.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 230.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 230.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);">546<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 230.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(183)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 230.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">953<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 486.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit before tax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 265.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net finance costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 265.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(677)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 265.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 265.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 265.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 265.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.54pt;"></span></span><span style="left: 36.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 265.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.9pt;"></span></span><span style="left: 33.53pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 265.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.45pt;"></span></span><span style="left: 18.08pt; position: var(--position);">(669)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 276.75pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after tax losses of associates<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 276.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.98pt;"></span></span><span style="left: 28.61pt; position: var(--position);">(5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 276.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 276.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 276.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 276.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.54pt;"></span></span><span style="left: 36.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 276.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 276.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.73pt;"></span></span><span style="left: 26.36pt; position: var(--position);">(5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 297pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit/(loss) on disposal of interest in associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 297pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.9pt;"></span></span><span style="left: 33.53pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 297pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 297pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 297pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 297pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.54pt;"></span></span><span style="left: 36.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 297pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.98pt;"></span></span><span style="left: 28.61pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 297pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.65pt;"></span></span><span style="left: 31.279999999999998pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 321pt; width: 486.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit after tax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 332.25pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 332.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(756)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 332.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(154)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 332.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.59pt;"></span></span><span style="left: 22.22pt; position: var(--position);">(94)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 332.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(83)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 332.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(100)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 332.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(70)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 332.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.26pt;"></span></span><span style="left: 11.89pt; position: var(--position);">(1,257)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 356.25pt; width: 486.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 201pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to non-controlling<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 367.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">380<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 367.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 367.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.79pt;"></span></span><span style="left: 35.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 367.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 367.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);">192<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 367.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 367.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">90<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjusting items continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="i8e4ae46c605c4ded86b536f771a8d159_0-0-1-1-821446"></span><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 159.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Core results reconciliation <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 18.52pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit from <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discontinued<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 0pt; width: 42.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 403.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Divestments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">items<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross profit from continuing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 57.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">19,770<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 57.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 57.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">648<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 57.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 57.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">102<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 57.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">45<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 57.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">18<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 57.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.29pt;"></span></span><span style="left: 14.919999999999998pt; position: var(--position);">20,583<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating profit from continuing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 78pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.18pt;"></span></span><span style="left: 7.81pt; position: var(--position);">6,433<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 78pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 78pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">739<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 78pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">296<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 78pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">321<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 78pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,750<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 78pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,388)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 78pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">8,151<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before taxation from<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 98.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.18pt;"></span></span><span style="left: 7.81pt; position: var(--position);">5,628<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 98.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 98.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">739<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 98.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">296<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 98.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">323<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 98.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,750<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 98.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,378)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 98.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">7,358<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 118.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation from<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 118.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.18pt;"></span></span><span style="left: 7.81pt; position: var(--position);">4,921<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 118.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 118.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">589<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 118.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">232<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 118.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">236<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 118.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,508<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 118.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,266)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 118.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">6,220<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation from<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 138.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">10,700<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 138.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.37pt;"></span></span><span style="left: 13pt; position: var(--position);">(10,700)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 138.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 138.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 138.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 138.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 138.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 138.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 159pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit after taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 159pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">15,621<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 159pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.37pt;"></span></span><span style="left: 13pt; position: var(--position);">(10,700)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 159pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">589<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 159pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">232<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 159pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">236<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 159pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,508<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 159pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,266)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 159pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">6,220<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 170.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.18pt;"></span></span><span style="left: 7.81pt; position: var(--position);">4,461<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 170.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 170.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">589<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 170.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">232<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 170.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">236<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 170.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,373<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 170.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,266)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 170.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">5,625<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 193.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 193.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">10,495<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 193.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.37pt;"></span></span><span style="left: 13pt; position: var(--position);">(10,495)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 193.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 193.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 193.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 193.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 193.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 193.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 216.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 216.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">14,956<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.37pt;"></span></span><span style="left: 13pt; position: var(--position);">(10,495)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">589<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">232<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 216.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">236<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,373<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,266)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 216.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">5,625<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 228pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 228pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">110.8p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 228pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.43pt;"></span></span><span style="left: 22.06pt; position: var(--position);">14.6p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 228pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.57pt;"></span></span><span style="left: 23.2pt; position: var(--position);">5.8p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 228pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.07pt;"></span></span><span style="left: 24.7pt; position: var(--position);">5.9p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 228pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">34.1p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 228pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(31.5)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 33.53pt; position: var(--position);">p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 228pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.29pt;"></span></span><span style="left: 14.919999999999998pt; position: var(--position);">139.7p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 248.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">260.6p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 248.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.37pt;"></span></span><span style="left: 13pt; position: var(--position);">(260.6)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 36.53pt; position: var(--position);">p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 248.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 248.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 248.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 248.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 248.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 248.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Basic earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 268.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 1.04pt;"></span></span><span style="left: 3.67pt; position: var(--position);">371.4p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 268.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.37pt;"></span></span><span style="left: 13pt; position: var(--position);">(260.6)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 36.53pt; position: var(--position);">p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 268.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.43pt;"></span></span><span style="left: 22.06pt; position: var(--position);">14.6p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 268.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.57pt;"></span></span><span style="left: 23.2pt; position: var(--position);">5.8p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 268.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.07pt;"></span></span><span style="left: 24.7pt; position: var(--position);">5.9p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 268.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">34.1p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 268.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(31.5)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 33.53pt; position: var(--position);">p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 268.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.29pt;"></span></span><span style="left: 14.919999999999998pt; position: var(--position);">139.7p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of shares (millions)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 279.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.18pt;"></span></span><span style="left: 7.81pt; position: var(--position);">4,026<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 279.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 279.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 279.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 279.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 279.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 279.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 279.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">4,026<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 486pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core gross profit from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 315pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 315pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.26pt;"></span></span><span style="left: 2.8899999999999997pt; position: var(--position);">(9,554)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 315pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 315pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.62pt;"></span></span><span style="left: 28.25pt; position: var(--position);">648<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 315pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 315pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">102<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 315pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">45<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 315pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">18<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 315pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(8,741)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 339pt; width: 486pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core operating profit from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 350.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 350.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.26pt;"></span></span><span style="left: 2.8899999999999997pt; position: var(--position);">(8,372)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 350.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 350.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 350.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 350.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.12pt;"></span></span><span style="left: 26.75pt; position: var(--position);">180<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 350.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">13<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 350.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">51<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 350.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(8,128)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 361.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 361.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.26pt;"></span></span><span style="left: 2.8899999999999997pt; position: var(--position);">(5,488)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 361.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 361.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.76pt;"></span></span><span style="left: 32.39pt; position: var(--position);">91<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 361.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">296<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 361.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.26pt;"></span></span><span style="left: 30.89pt; position: var(--position);">39<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 361.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 361.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 361.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(5,062)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 372.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating (expense)/income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 372.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.37pt;"></span></span><span style="left: 14pt; position: var(--position);">523<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 372.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 372.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 372.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 372.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 372.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.43pt;"></span></span><span style="left: 19.06pt; position: var(--position);">1,692<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 372.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.51pt;"></span></span><span style="left: 14.14pt; position: var(--position);">(1,457)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 372.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">758<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 396.75pt; width: 486pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit before tax from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 408pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net finance costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 408pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 6.45pt;"></span></span><span style="left: 9.08pt; position: var(--position);">(803)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 408pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 408pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 408pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 408pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.4pt;"></span></span><span style="left: 35.03pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 408pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 408pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.76pt;"></span></span><span style="left: 29.39pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 408pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.7pt;"></span></span><span style="left: 20.33pt; position: var(--position);">(791)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 419.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after tax losses of associates<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 419.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.73pt;"></span></span><span style="left: 17.36pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 419.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 419.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 419.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 419.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 419.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 419.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 419.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.98pt;"></span></span><span style="left: 28.61pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 444.75pt; width: 486pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit after tax from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 456pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 456pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.28pt;"></span></span><span style="left: 11.91pt; position: var(--position);">(707)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 456pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.41pt;"></span></span><span style="left: 41.04pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 456pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(150)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 456pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.67pt;"></span></span><span style="left: 27.3pt; position: var(--position);">(64)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 456pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.17pt;"></span></span><span style="left: 28.8pt; position: var(--position);">(87)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 456pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.53pt;"></span></span><span style="left: 23.16pt; position: var(--position);">(242)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 456pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.99pt;"></span></span><span style="left: 25.619999999999997pt; position: var(--position);">112<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 456pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.34pt;"></span></span><span style="left: 16.97pt; position: var(--position);">(1,138)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="9" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 480pt; width: 486pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 486pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following adjustments are made in arriving at Core profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 491.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to non-controlling<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; interests from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 491.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.37pt;"></span></span><span style="left: 14pt; position: var(--position);">460<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 491.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 491.25pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 491.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 491.25pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 491.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">135<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 491.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 491.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">595<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 511.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to non-controlling<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; interests from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 511.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.37pt;"></span></span><span style="left: 14pt; position: var(--position);">205<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 511.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.7pt;"></span></span><span style="left: 23.33pt; position: var(--position);">(205)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 511.5pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 511.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 511.5pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 511.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 511.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 511.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 531.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit attributable to non-controlling<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 531.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.37pt;"></span></span><span style="left: 14pt; position: var(--position);">665<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 531.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.7pt;"></span></span><span style="left: 23.33pt; position: var(--position);">(205)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 531.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.04pt;"></span></span><span style="left: 40.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 531.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 319.5pt; position: var(--position); top: 531.75pt; width: 42.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 42.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.54pt;"></span></span><span style="left: 39.17pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 362.25pt; position: var(--position); top: 531.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">135<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 531.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.04pt;"></span></span><span style="left: 37.67pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 531.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.62pt;"></span></span><span style="left: 25.25pt; position: var(--position);">595<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">91<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjusting items continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Intangible asset amortisation<span style="display: inline-block; height: 8pt;"></span><span id="if5c8e35aea684d54b4c8e0a727deb8a3_392"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 122.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 6.18pt;"></span><span id="if5c8e35aea684d54b4c8e0a727deb8a3_393"></span><span id="if5c8e35aea684d54b4c8e0a727deb8a3_394"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 92.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_439">211</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for description and information on Intangible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 132.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset amortisation.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 148.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Intangible asset impairment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 164.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">See page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 92.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_439">211</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for description and information on Intangible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 174.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset impairment. No individual intangible asset accounted for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 184.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a material impairment. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 200.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Major restructuring and integration<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Within the Pharmaceuticals sector, the highly regulated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing operations and supply chains and long lifecycle <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the business mean that restructuring programmes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particularly those that involve the rationalisation or closure of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing or R&amp;D sites are likely to take several years to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complete.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major restructuring costs are those related to specific Board-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved Major restructuring programmes and are excluded <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from Core results. Major restructuring programmes, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">integration costs following material acquisitions, are those that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are structural and are of a significant scale where the costs of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individual or related projects exceed &#163;25 million. Other ordinary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">course smaller-scale restructuring costs are retained within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total and Core results.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Major restructuring charges incurred in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 220.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 241.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;353 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;382 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), analysed as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 396.62pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 0pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 0pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 11.25pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 11.25pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 11.25pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 11.25pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 182.25pt; position: var(--position); top: 11.25pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 11.25pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Separation<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; restructuring<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; programme<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 37.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">200<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 37.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">36<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 37.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">236<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 37.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">199<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 182.25pt; position: var(--position); top: 37.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">117<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 37.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">316<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; acquisitions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 66.75pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">59<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 66.75pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.27pt;"></span></span><span style="left: 18.9pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 66.75pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">60<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 66.75pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">65<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 182.25pt; position: var(--position); top: 66.75pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.27pt;"></span></span><span style="left: 18.9pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 66.75pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">66<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legacy programmes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 87pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">48<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 87pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.27pt;"></span></span><span style="left: 18.9pt; position: var(--position);">9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 87pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">57<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 87pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.81pt;"></span></span><span style="left: 16.44pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 182.25pt; position: var(--position); top: 87pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.27pt;"></span></span><span style="left: 18.9pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 87pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.27pt;"></span></span><span style="left: 18.9pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 98.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">307<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 98.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.13pt;"></span></span><span style="left: 14.760000000000002pt; position: var(--position);">46<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 98.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">353<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156pt; position: var(--position); top: 98.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">263<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 182.25pt; position: var(--position); top: 98.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">119<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 98.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.99pt;"></span></span><span style="left: 10.620000000000001pt; position: var(--position);">382<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Separation restructuring programme incurred cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charges of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 95.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;200 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 140.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> primarily from the restructuring of some <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 537.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial and administrative functions as well as Global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supply Chain. The non-cash charges of&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 206pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;36 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 246.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 557.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected the write-down of assets in administrative and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing locations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The programme focussed on the separation of GSK into two <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 593.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">separate companies and is now largely complete. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme has delivered its target of &#163;1.1 billion of annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">savings, with total costs expected at &#163;2.4 billion, with cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 624.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charges of &#163;1.7 billion and non-cash charges of &#163;0.7 billion.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Costs of significant acquisitions relate to integration costs of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sierra Oncology Inc. (Sierra) and Affinivax Inc. (Affinivax) which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were acquired in Q3 2022, BELLUS Health Inc. (Bellus) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquired in Q2 2023 and Aiolos acquired in Q1 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 686.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash charges of &#163;48 million under Legacy programmes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primarily arose from the divestment of the cephalosporins <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-related adjustments<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 122.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction-related adjustments resulted in a net charge of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 132.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,881 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 356.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;572 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), the majority of which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 142.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related to charges/(credits) for the remeasurement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent consideration liabilities, the liabilities for the Pfizer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">put option, and Pfizer and Shionogi preferential dividends in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 193.59pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 156.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 111.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge/(credit)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration on former <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Shionogi-ViiV Healthcare Joint Venture<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (including Shionogi preferential dividends)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,533<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">934<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare put options and Pfizer <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; preferential dividends<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 47.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">67<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 47.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(245)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 70.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration on former Novartis<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Vaccines business<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 70.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">206<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 70.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(187)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration on acquisition of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Affinivax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(22)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">44<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 117pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 117pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">97<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 117pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">26<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total transaction-related charges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 128.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,881<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 128.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">572<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,533 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> charge relating to the contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.98pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration for the former Shionogi-ViiV Healthcare joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 364.18pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">venture represented an increase in the valuation of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent consideration due to Shionogi, driven by &#163;1,107 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.58pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million from updated future sales forecasts and exchange rates, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 394.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the unwind of the discount for &#163;426 million. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 482.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.67pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 324.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;67 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 364.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> charge relating to the ViiV Healthcare put <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">option and Pfizer preferential dividends represented an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.07pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in the valuation of the put option primarily as a result <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of updated sales forecasts partly offset by higher preference <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.47pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends. The ViiV Healthcare contingent consideration liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.67pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is fair valued under IFRS. An explanation of the accounting for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the non-controlling interests in ViiV Healthcare is set out on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 482.07pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9510c9847c6040bfa7e14a02ad5607ad_384">79</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.96pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;206 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> charge relating to the contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.16pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration on the former Novartis Vaccines business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primarily related to changes to future sales forecasts. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 504.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 534.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;22 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 364.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> charge relating to the contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.45pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the former Novartis Vaccines business primarily related to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 554.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes to future sales forecasts. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 570.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Significant legal charges, Divestments and <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 583.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.78000000000003pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">other items<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant legal charges in the full year primarily reflected the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q3 2024 charge of &#163;1.8 billion ($2.3 billion) in relation to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 515.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 540.9200000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the State Courts Settlement, the Qui Tam Settlement, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the remaining 7% of pending state court product liability cases, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 640.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partially offset by reduced future legal costs.<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 468.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 656.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legal charges provide for all significant legal matters and are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 666.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not broken out separately by litigation or investigation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Divestments and other items primarily included other net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 692.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income from milestones and dividends related to investments, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 702.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as well as amounts reclassified from the foreign currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 713.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">translation reserve to the income statement upon the liquidation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 723.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of subsidiaries. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">92<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_223"></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i98187f0b279e42da8fe584992267d7a6_0-0-1-1-824386"></span><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash generation and conversion<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 146.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A summary of the consolidated cash flow statement is set out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 172.33pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net cash inflow from operating activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,554<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,768<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net cash (outflow) from investing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 29.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,229)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 29.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,595)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net cash inflow/(outflow) from financing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 49.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(4,726)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 49.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(5,641)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 69.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase /(decrease) in cash and bank <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 69.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">599<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 69.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(468)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 94.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and bank overdrafts at beginning of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 94.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,858<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 94.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,425<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 105.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(54)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 105.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(99)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 117pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase /(decrease) in cash and bank <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 117pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">599<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 117pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(468)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and bank overdrafts at end of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,403<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,858<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 153pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and bank overdrafts at end of year<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; comprise:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 173.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,870<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 173.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,936<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 184.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 184.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(467)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 184.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(78)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 195.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,403<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 195.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,858<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 390.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Reconciliation of net cash inflow from <span style="display: inline-block; height: 8pt;"></span><span id="idd44d70d9ed24392bca06d18eb02fa07_904"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 403.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">operating activities to free cash inflow<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A reconciliation of net cash inflow from operating activities, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which is the closest equivalent IFRS measure to free cash flow, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is shown below.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 455.4pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash inflow/(outflow) from operating<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,554<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,768<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchase of property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 39pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,399)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 39pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,314)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proceeds from sale of property, plant and<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 50.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">65<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 50.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">28<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 70.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchase of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 70.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,583)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 70.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,030)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proceeds from sale of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 81.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">131<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 81.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net finance costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 93pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(494)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 93pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(651)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends from joint ventures and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 104.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">15<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 104.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 115.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration paid (reported in<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; investing activities)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 115.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(19)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 115.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(11)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(416)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(412)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contribution from non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Free cash inflow<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,863<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,409<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 638.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash generated from operating activities was &#163;6,554 million <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 648.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2023: &#163;6,768 million), including &#163;672 million payments for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 658.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement. The increase excluding <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 213.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> reflected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 669.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">higher Core operating profit, the benefit of Q4 2023 <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 246.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 271.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receivables' collections in Q1 2024, lower pension contributions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 689.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and lower corporation tax payments, partly offset by the timing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 699.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact from lower returns and rebates, including the impact of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 709.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the removal of the AMP cap, and lower receivables at the end <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 720.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 162.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Capital expenditure and financial investment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments for tangible fixed assets amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,399 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,314 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and intangible fixed assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,583 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 434.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,030 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposals realised <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;196<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;40 million). The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in intangible assets primarily related to acquisitions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 229.02pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the year and an upfront payment to CureVac N.V. for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.22pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;342 million. Cash payments to acquire equity investments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 249.42pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;103 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;123 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ) and sales of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 259.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity investments realised &#163;2,356 million (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 488.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,832 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.82pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 285.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Free cash flow<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.6pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Free cash flow is the amount of cash generated by the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.8pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">after meeting our obligations for contingent consideration, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 322pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest, tax and dividends paid to non-controlling interests, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 332.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and after capital expenditure on property, plant and equipment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 342.4pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and intangible assets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 358.29pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Free cash inflow<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,863<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,409<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total cash payments to Shionogi in relation to the ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 408.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare contingent consideration liability in the year were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 418.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 309.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,190<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;1,106 million), all of which was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 428.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in cash flows from operating activities. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments are deductible for tax purposes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 454.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Future cash flow<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over the long term, we expect that future cash generated from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations will be sufficient to fund our operating and debt <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">servicing costs, normal levels of capital expenditure, obligations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under existing licensing agreements, expenditure arising from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring programmes and other routine outflows including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax, pension contributions and dividends, subject to the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 508.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8216;Risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Factors&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussed on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 439.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27f24adb8ed14564b0e7ab7e0cc1fb14_11163">285</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. We may from time to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time have additional demands for finance, such as for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions and share repurchases. We have access to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiple sources of liquidity from short and long-term capital <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets and financial institutions for such needs, in addition to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the cash flow from operations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 598.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group, has in its opinion, sufficient working capital to meet <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its present requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 624.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Please refer to "Group financial review&#8221; in the GSK Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report on Form 20-F for the year ended 31 December 2023 for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 645.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a discussion of 2023 financial results compared to 2022.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">93<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 8.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_229"></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial position and resources<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 144.74pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 40.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">9,227<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 40.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">9,020<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 51.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">846<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 51.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">937<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 63pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,982<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 63pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,811<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 74.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">15,515<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 74.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">14,768<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments in associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 85.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">96<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 85.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">55<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,137<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 108pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 108pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 119.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,757<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 119.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,049<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 130.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,942<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 130.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,584<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 141.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 141.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">42,466<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 141.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">40,361<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 159pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inventories<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 170.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">5,669<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 170.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">5,498<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current tax recoverable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 181.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">489<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 181.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">373<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">6,836<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">7,385<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 204pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 204pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">109<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 204pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">130<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 215.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 215.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,204<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 226.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 226.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">21<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 226.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">42<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 237.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,870<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 237.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,936<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 249pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets held for sale<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 249pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 249pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">76<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 260.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">16,997<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 260.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">18,644<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 271.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 271.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">59,463<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 271.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">59,005<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 288.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 300pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 311.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 311.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,349)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 311.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,813)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 322.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 322.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,172)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 322.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,053)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 333.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 333.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,335)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 333.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,844)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 345pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 345pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(192)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 345pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(114)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 356.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current tax payable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 356.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(703)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 356.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(500)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 367.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,946)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 367.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(744)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 378.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(21,697)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 378.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(21,068)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 396pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 407.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 407.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(14,637)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 407.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,205)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 418.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation tax payable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 418.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 418.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(75)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 429.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 429.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(382)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 429.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(311)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 441pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions and other post-employment benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 441pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,864)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 441pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,340)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 452.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 452.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(589)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 452.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(495)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 463.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(6,108)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(5,609)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 474.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,100)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,107)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 486pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(24,680)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(25,142)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 497.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(46,377)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(46,210)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 508.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">13,086<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">12,795<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 525.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total equity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 525.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">13,086<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 525.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">12,795<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 144.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 8pt;"></span><span id="i2730b6f80ae547b889d43bfcfac98b6f_1475"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our business is science-based, technology-intensive and highly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulated by governmental authorities. We allocate significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial resources to the renewal and maintenance of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">property, plant, equipment and vehicles to minimise risks of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interruption to production and to ensure compliance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory standards. A number of our processes use <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hazardous materials.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 237.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The total cost of our property, plant and equipment at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 504.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;19,710 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 452.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, with a net book value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 316.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;9,227 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Of this, land and buildings represented <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,766 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 356.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, plant, equipment and vehicles <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 477.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 479.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;4,147 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 531.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 533.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and assets in construction <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 406.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,314 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invested <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,393 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in new property, plant and equipment. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This was mainly related to a large number of projects for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewal, improvement and expansion of facilities at various <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide sites to support new product development and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launches as well as to improve the efficiency of existing supply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chains. Property is mainly held freehold. New investment is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financed from our liquid resources. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.82000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">had contractual commitments for future capital expenditure of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;754 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. We believe that our property and plant facilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are adequate for our current requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 396.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;846 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> compared with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;937 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease in the year primarily reflected depreciation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;211&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and disposals and impairments amounting to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;102&#160;million, partially offset by additions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 464.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;230 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 509.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 468.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 484.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill increased to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 387.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,982 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.57000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 324.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,811 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> primarily as a result of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;210 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 509.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions-related transactions, partially offset by exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate losses and other small movements of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 462.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 465.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;39 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 531.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets include the cost of intangibles acquired <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 557.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from third parties and computer software. The net book value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other intangible assets as at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;15,515 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 577.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;14,768 million). The increase primarily reflected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additions, net of disposals and write-offs, of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,585<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">partly offset by impairment losses, net of reversals and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 608.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation, of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,771<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million and exchange rate losses of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">91<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 540.1800000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 618.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 634.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 302.03pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Investments in associates and joint ventures<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 653.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We held investments in associates and joint ventures with a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 663.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carrying value at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;96 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 496.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 673.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;55 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). See Note 21, 'Investments in associates and joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 684.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ventures' to the financial statements, for more details.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">94<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial position and resources continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 207.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;nil<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 220.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 232.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 134.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,204 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Current equity investments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 144.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprise equity investments which the Group holds with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intention to sell and which it may sell in the short term. Where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 164.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquired with this intention, they are measured at fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 174.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through the profit and loss (FVTPL). They are initially recorded <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at fair value plus transaction costs and then remeasured at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 195.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsequent reporting dates to fair value. Unrealised gains and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 205.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">losses are recognised in the income statement. During 2024, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 215.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the disposal of the remaining Haleon plc shares resulted in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 225.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gross proceeds of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,226 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 177.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;1,863 million). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 241.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.67pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> we held other investments with a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carrying value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,100 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 174.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,137 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 256.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.07pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most significant investments held at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 188.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 191.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in WAVE Life Sciences Ltd, SR One Capital Fund I-B, LP and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.47pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Crispr Therapeutics AG. These investments had a fair value at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 287.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.67pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of &#163;165 million (2023: &#163;55 million), &#163;135 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 318.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million (2023: &#163;102 million) and &#163;101 million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 245.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;158 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.07pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million) respectively. The other investments included equity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.27pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakes in companies with which we have research <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.47pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">collaborations, and which provide access to biotechnology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 359.67pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developments of potential interest and interests in companies <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.87pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that arise from business divestments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 385.76pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments: assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.65pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We held current derivative financial assets at fair value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 268.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 270.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;109 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.85pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 85.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;130&#160;million). The majority of these financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.05pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments related to foreign exchange contracts both <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designated and not designated as accounting hedges.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 255.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 448.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Inventories<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inventories amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 148.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5,669 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5,498 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 283.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 65.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 490.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,836 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;7,385 million) at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.98000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The decrease is mainly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven by lower <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 112.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales in the US.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 542.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,757 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 232.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 256.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 260.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,049 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) at 31 December 2024. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 168.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 584.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments: liabilities<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We held current derivative financial liabilities at fair value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 610.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;192 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 126.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;114 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 170.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). This is primarily related to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">foreign exchange contracts both designated and not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designated as accounting hedges.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 122.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, trade and other payables were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 509.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;15,335 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 132.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> compared with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 387.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;15,844 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 446.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 532.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 142.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The decrease was primarily driven by lower returns and rebates <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accruals. See Note 29, 'Trade and other payables' to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 178.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Provisions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We carried deferred tax provisions and other short-term and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-current provisions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,917 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 534.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 215.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,550 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Other provisions at the year-end <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 225.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,446 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;267 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) related to legal and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 235.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other disputes, including the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 411.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.44000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement, and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 501.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;273 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 245.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;282 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) related to Major restructuring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes. Provision has been made for legal and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disputes, indemnified disposal liabilities, employee-related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities and the costs of the restructuring programme to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extent that at the balance sheet date a legal or constructive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obligation existed and could be reliably estimated.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 312.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pensions and other post-employment <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 325.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We account for pension and other post-employment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements in accordance with IAS 19. The net deficits were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 540.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;103 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;763 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) on pension arrangements and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;863 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;943 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) on unfunded post-employment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 382.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities. See Note 31, 'Pensions and other post-employment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 392.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits' to the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 408.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current liabilities<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current liabilities amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,100 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 510.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 522.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,107 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 459.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 450.62pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;7,280 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 503.32000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 381.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,662 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 497.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,061 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5,718 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) represented the estimated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">present value of amounts payable to Shionogi relating to ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 507.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;502 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 397.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;516&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) represented the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.51pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimated present value of contingent consideration payable to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.71pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the former shareholders of Affinivax and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 457.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;575 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 502.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 531.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.91pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;424 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) represented the estimated present value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.11pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent consideration payable to Novartis related to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.31pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines acquisition.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.2pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The liability due to Shionogi was &#163;289 million in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.4pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preferential dividends. An explanation of the accounting for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.6pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-controlling interests in ViiV Healthcare is set out on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 533.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.8pt; width: 595.56pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9510c9847c6040bfa7e14a02ad5607ad_384">79</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Of the total contingent consideration payable (on a post-tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basis) at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 341.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 417.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,127 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;1,107 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.09pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million) is expected to be paid within one year to Shionogi. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 651.29pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration payable is expected to be paid over a number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.49pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years. As a result, the total estimated liabilities are discounted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671.69pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to their present values, on a post-tax basis using post-tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 681.89pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discount rates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.78pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Shionogi-ViiV Healthcare contingent consideration liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.98pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is discounted at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Affinivax contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.18pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability is discounted at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9.0%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and the Novartis Vaccines <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 728.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent consideration liability is discounted partly at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 509.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8.0%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.6700000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 532.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 738.58pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and partly at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 355.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9.0%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">95<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial position and resources continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Maturity profile of bond debt <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 122.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m equivalent<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 0pt; position: var(--position); top: 131.79pt; width: 595.56pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g55.gif" alt="633" style="height: 212.59pt; width: 490.39pt;"/></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 89.59pt; opacity: 1; position: var(--position); top: 270.14pt; width: 14.17pt; z-index: 1;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); white-space: pre;">$<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 154.55pt; opacity: 1; position: var(--position); top: 226.89pt; width: 14.17pt; z-index: 2;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); white-space: pre;">$<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 176.75pt; opacity: 1; position: var(--position); top: 270.31pt; width: 14.17pt; z-index: 3;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); white-space: pre;">$<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 285.27pt; opacity: 1; position: var(--position); top: 300.39pt; width: 14.17pt; z-index: 4;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); white-space: pre;">$<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 373.01pt; opacity: 1; position: var(--position); top: 168.34pt; width: 14.17pt; z-index: 5;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); white-space: pre;">$<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 481.69pt; opacity: 1; position: var(--position); top: 300.89pt; width: 14.17pt; z-index: 6;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.15pt; position: var(--position); white-space: pre;">$<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 89.59pt; opacity: 1; position: var(--position); top: 224.14pt; width: 14.17pt; z-index: 7;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 111.09pt; opacity: 1; position: var(--position); top: 286.72pt; width: 14.17pt; z-index: 8;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 133.03pt; opacity: 1; position: var(--position); top: 299.14pt; width: 14.17pt; z-index: 9;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 176.75pt; opacity: 1; position: var(--position); top: 239.99pt; width: 14.17pt; z-index: 10;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 198.49pt; opacity: 1; position: var(--position); top: 283.72pt; width: 14.17pt; z-index: 11;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 219.69pt; opacity: 1; position: var(--position); top: 287.72pt; width: 14.17pt; z-index: 12;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 241.73pt; opacity: 1; position: var(--position); top: 286.97pt; width: 14.17pt; z-index: 13;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 154.55pt; opacity: 1; position: var(--position); top: 171.04pt; width: 14.17pt; z-index: 14;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 264.03pt; opacity: 1; position: var(--position); top: 287.8pt; width: 14.17pt; z-index: 15;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 307.24pt; opacity: 1; position: var(--position); top: 274.72pt; width: 14.17pt; z-index: 16;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 394.43pt; opacity: 1; position: var(--position); top: 283.97pt; width: 14.17pt; z-index: 17;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 459.91pt; opacity: 1; position: var(--position); top: 294.89pt; width: 14.17pt; z-index: 18;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 525.69pt; opacity: 1; position: var(--position); top: 303.39pt; width: 14.17pt; z-index: 19;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 154.55pt; opacity: 1; position: var(--position); top: 153.69pt; width: 14.17pt; z-index: 20;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.74pt; position: var(--position); white-space: pre;">&#165;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 133.03pt; opacity: 1; position: var(--position); top: 275.52pt; width: 14.17pt; z-index: 21;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 5.03pt; position: var(--position); white-space: pre;">&#163;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 329.64pt; opacity: 1; position: var(--position); top: 293.31pt; width: 14.17pt; z-index: 22;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 14.17pt; left: 111.24pt; opacity: 1; position: var(--position); top: 225.84pt; width: 14.17pt; z-index: 23;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 2.9pt; width: 14.17pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 4.44pt; position: var(--position); white-space: pre;">&#8364;<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 358.38pt; width: 595.56pt;"><div style="font-size: 0pt; left: 167.28pt; position: var(--position); top: 0pt; width: 261pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 65.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$ US bonds<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 65.25pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8364; EUR bonds<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163; GBP bonds<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195.75pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.25pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#165; JPY bonds<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 374.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; letter-spacing: -0.008em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Net debt <span style="display: inline-block; height: 8pt; width: 25.72pt;"></span></span><span style="left: 125.86pt; position: var(--position);"><span style="display: inline-block; height: 8pt; width: 36pt;"></span></span><span style="left: 161.86pt; position: var(--position);"><span style="display: inline-block; height: 8pt; width: 36pt;"></span></span><span style="left: 197.86pt; position: var(--position);"><span style="display: inline-block; height: 8pt; width: 36pt;"></span></span><span style="left: 233.86pt; position: var(--position);"><span style="display: inline-block; height: 8pt; width: 36pt;"></span></span><span style="left: 269.86pt; position: var(--position);"><span style="display: inline-block; height: 8pt; width: 36pt;"></span></span></span></div><div style="position: var(--position); top: 387.83pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">21<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">42<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,870<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,936<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,349)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,813)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(14,637)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,205)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt the end of the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 66pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(13,095)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 66pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,040)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 66.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, net debt was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 192.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;13.1 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, compared <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 71.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 73.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;15.0 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> as at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 212.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, comprising gross <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debt of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;17.0 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 128.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and cash and liquid investments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.9 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 507.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Net&#160;debt decreased by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.9 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> primarily due to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 271.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2.9 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> net cash inflow, after &#163;0.7 billion of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 208.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments, and &#163;2.4 billion proceeds from the disposal of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments, primarily due to sale of the remaining retained <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stake in Haleon plc. This was partly offset by the net acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs of Aiolos and Elsie Biotechnologies of &#163;0.8 billion and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends paid to shareholders of &#163;2.4 billion.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK had short-term borrowings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(including overdrafts and lease liabilities) repayable within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12&#160;months of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2.3 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and &#163;1.4 billion repayable in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsequent year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK&#8217;s cash and liquid investments were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.9pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held as follows:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 651.1pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 237.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 158.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bank balances and deposits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,590<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,942<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US Treasury and Treasury repo only money <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; market funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">300<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">155<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquidity funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 50.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">980<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 50.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">839<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 62.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,870<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 62.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,936<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments &#8211; government securities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 74.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">21<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 74.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">42<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 86.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,891<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198pt; position: var(--position); top: 86.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,978<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and liquid investments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3.1 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.82000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2.2 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were held centrally at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of cash and gross debt after the effects of hedging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 440.01pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">21<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">42<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">3,870<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,936<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross debt&#160; &#8211; fixed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(16,060)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(16,898)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#8211; floating<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(924)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,120)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#8211; non-interest bearing<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 66pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 66pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 77.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 77.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(13,095)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 77.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,040)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">96<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial position and resources continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Movements in net debt<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 113.19pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net debt at beginning of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,040)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(17,197)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in cash and bank<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">599<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(468)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 50.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(21)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 50.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(72)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of long-term loans(1)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 62.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,615<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 62.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,260<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issue of long-term notes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 74.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(1,075)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 74.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(223)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net (increase)/decrease in short-term loans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 85.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">811<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 85.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">333<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in other short-term loans(2)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(266)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of other short-term loans(2)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 108pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">81<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 108pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 119.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">226<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 119.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">197<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investments/(debt) of subsidiary <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> undertakings acquired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 131.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 131.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">50<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 154.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">117<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 154.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">554<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-cash movements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 166.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(142)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 166.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(474)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 178.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 178.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">1,945<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 178.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,157<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 190.5pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net debt at end of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 190.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(13,095)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 190.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(15,040)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 326.38pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 224.25pt;"/></tr><tr style="height: 45pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 12pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 12pt; overflow: hidden; position: var(--position); top: 0pt; width: 224.25pt;"><div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 3.34pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 218.96pt;">Repayment of long-term loans for 2024 of &#163;1,615 million (2023: &#163;2,260<span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 221.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 1.91pt;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 11.74pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 218.91pt;">million; 2022: &#163;6,668 million) includes the current portion of long-term<span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 221.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 1.91pt;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 20.14pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 219.01pt;">borrowings of &#163;1,615 million (2023: &#163;2,116 million; 2022: &#163;5,074 million)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 221.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 1.91pt;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 28.54pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 218.97pt;">which was classified as short term borrowing on the balance sheet and<span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 221.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 1.91pt;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 36.94pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 169.42pt;">previously presented as repayment of short-term loans.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 45pt; width: 12pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 12pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 12pt; overflow: hidden; position: var(--position); top: 45pt; width: 224.25pt;"><div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 2.89pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 218.99pt;">Other short-term loans include bank loans presented within short-term<span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 221.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 1.91pt;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 11.29pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 218.99pt;">borrowings on the balance sheet, with an initial maturity of greater than<span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 221.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 1.91pt;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 19.69pt; width: 224.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 42.37pt;">three months.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 408.38pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total equity<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.16pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 66.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, total equity had increased from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.36pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;12,795 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 121.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 207.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;13,086 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 457.25pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A summary of the movements in equity is set out below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 473.14pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total equity at beginning of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">12,795<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">10,096<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">2,778<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 30pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);">4,991<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deconsolidation of former subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,444)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(2,247)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares issued<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 66pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">20<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 66pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">10<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes in non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging gain/loss transferred to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; non-financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);">36<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 110.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">344<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 110.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);">307<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 122.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 122.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 122.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contributions from non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 134.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 134.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 146.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 146.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(416)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 146.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(412)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 158.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total equity at end of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 156.75pt; position: var(--position); top: 158.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">13,086<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 196.5pt; position: var(--position); top: 158.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);">12,795<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share purchases<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK held 169.2 million shares as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 133.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury shares (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 370.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: 197.1 million shares) at a cost of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,958 million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;3,447 million), which has been deducted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 153.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from retained earnings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 169.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 5 February, GSK announced an intention to commence a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2 billion share buyback programme, to be implemented over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the next 18 months. The programme commenced on 24 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 332.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, 27.8 million Treasury shares were transferred to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee Share Ownership Plan (ESOP) Trusts. Shares are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held by the Trusts to satisfy future exercises of options and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards under the Group share option and award schemes.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 524.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 262.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A proportion of the shares held by the Trusts are in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards where the rules of the scheme require GSK to satisfy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercises through market purchases rather than the issue of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new shares. The shares held by the Trusts are matched to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">options and awards granted.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the ESOP Trusts held <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">64.3 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">58.8 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) GSK shares against the future exercise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of&#160;share options and share awards and for the Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplemental Savings plan. The carrying value of<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;397 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;288 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) has been deducted from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other reserves. The market value of these shares was &#163;866 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;853 million).<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">97<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial position and resources continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Contractual<span style="display: inline-block; height: 8pt;"></span><span id="i2730b6f80ae547b889d43bfcfac98b6f_1543"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 114.03pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> obligations and commitments<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial commitments are summarised in Note 36, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">'Commitments' and Note 44, &#8216;Financial instruments and related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosures&#8217; to the financial statements. The amounts below <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.68pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">represent the anticipated undiscounted contractual cash flows <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 169.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the Group&#8217;s key financial commitments. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group anticipates gross contractual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 195.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;16 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for borrowings (excluding interest) of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.75999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is payable within one year and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;14&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable after one year. Total undiscounted interest payable on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these loans amounts to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5.2 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 218.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.5 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable within one year and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;4.7&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is payable after more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than one year. Commitments in respect of loans and future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest payable on loans are disclosed before taking into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">account the effect of derivatives. Refer to Note 44. &#8216;Financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments and related disclosures&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_523">245</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 236.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had intangible assets capital&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;19&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Of these, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 227.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 229.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> would fall due <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within one year and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;18 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> would fall due after more than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one year. These commitments include milestone payments, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which are dependent on successful clinical development or on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meeting specified sales targets, and which represent the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 364.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maximum that would be paid if all milestones, however unlikely, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were to be achieved. The amounts are not risk-adjusted or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discounted. Refer to Note 36. &#8216;Commitments&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 255.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_496">232</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 269.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more details. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group anticipates gross contractual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.1 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for lease liabilities (excluding interest) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.2 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is payable within one year and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 244.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.9&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 284.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is payable after one year. Total undiscounted interest payable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on lease liabilities amounts to &#163;0.2 billion, most of which is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable after more than one year.&#160; Refer to Note 44. &#8216;Financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 472.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments and related disclosures&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35505">261</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 236.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 482.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had property, plant and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equipment capital commitments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.8 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.5 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; is payable within one year and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.3&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is payable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">after one year.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 107.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refer to Note 36. &#8216;Commitments&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 268.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_496">232</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for more details.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 66.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.2 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment commitments of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.1 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is payable within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one year and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.1&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is payable after one year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Contingent liabilities <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.08pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other contingent liabilities are set out in Note 35, 'Contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.28pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities' to the financial statements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table sets out contingent liabilities, comprising <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guarantees and other items arising in the normal course of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business, and when they are expected to expire.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 191.46pt; width: 595.56pt;"><div style="font-size: 0pt; left: 304.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 86.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 86.25pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 116.25pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 yr<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1-3 yrs<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3-5 yrs<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5 yrs+<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 86.25pt; position: var(--position); top: 18pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 116.25pt; position: var(--position); top: 18pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 18pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 18pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 18pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 29.25pt; width: 86.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Guarantees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 86.25pt; position: var(--position); top: 29.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 116.25pt; position: var(--position); top: 29.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 29.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">1.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 29.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 29.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">1.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 40.5pt; width: 86.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Other contingent<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 86.25pt; position: var(--position); top: 40.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.88pt;"></span></span><span style="left: 18.51pt; position: var(--position);">20<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 116.25pt; position: var(--position); top: 40.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 40.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">3.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 40.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">9.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 40.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">8.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63.75pt; width: 86.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 86.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 86.25pt; position: var(--position); top: 63.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.88pt;"></span></span><span style="left: 18.51pt; position: var(--position);">26<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 116.25pt; position: var(--position); top: 63.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 63.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 63.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">9.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 63.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.83pt;"></span></span><span style="left: 16.46pt; position: var(--position);">9.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the normal course of business, we have provided various <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.66pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indemnification guarantees in respect of business disposals <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 297.86pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which legal and other disputes have subsequently arisen. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A provision is made where an outflow of resources is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered probable and a reliable estimate can be made of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the likely outcome of the dispute and this is included in Note 32, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">'Other provisions' to the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We provide for the outcome of tax, legal and other disputes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when an outflow of resources is considered probable and a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable estimate of the outflow may be made. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 390.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, other than for those disputes where provision has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made, it was not possible to make a reliable estimate of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential outflow of funds that might be required to settle <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disputes where the possibility of there being an outflow was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than remote.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The ultimate liability for such matters may vary significantly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.73pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the amounts provided and is dependent upon negotiations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.93pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the relevant tax authorities and the outcome of litigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.13pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings, where relevant. This is discussed further in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.33pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">factors&#8217;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 370.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 387.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27f24adb8ed14564b0e7ab7e0cc1fb14_11163">285</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 415.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and Note 47, 'Legal proceedings' <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.53pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.55pt; position: var(--position); text-decoration: none; white-space: pre;">98<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_232"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approach to tax<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business makes a major contribution to the public purse <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through its tax contribution. This includes direct taxes (such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporate income tax) and indirect taxes (such as VAT, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environmental taxes and customs duties) as well as other taxes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(such as employment taxes and property taxes). It is therefore <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">important that companies explain their approach to tax. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">helps inform dialogue about tax and tax policy.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are supportive of efforts to ensure companies are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriately transparent about how their tax affairs are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managed. To this end, our Tax Strategy is set out in detail <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within the Public policies section of our website and we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regularly engage in discussions with stakeholders who are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">keen to understand our tax profile and our approach to tax.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We support the exchange of country-by-country reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(CBCR) data between tax authorities as, validated against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing information held on taxpayers, it will support their ability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to ensure multinational groups pay the right amount of tax in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the right places. Our published Tax Strategy includes a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">summary of our country-by-country reporting (CBCR) data.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a global biopharmaceutical company, we have a substantial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 372.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business and employment presence in many countries around <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the world and pay a significant amount of tax. This includes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporate income tax and other business taxes, and tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated with our employees. We also collect a significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount of tax on behalf of governments, such as income tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from payments to our employees and VAT along our supply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chain. Further information in relation to GSK&#8217;s total tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution, giving a better reflection of our overall fiscal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution in a particular country, can be found in our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">published Tax Strategy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 480.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are subject to taxation throughout our supply chain. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 490.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">worldwide nature of our operations means that our cross-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 500.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">border supply routes, necessary to ensure supplies of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines into numerous countries, can result in conflicting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims from tax authorities as to the profits to be taxed in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 531.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individual countries. This can lead to double taxation (with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profits taxed in more than one country).&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 557.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To mitigate the risk of double taxation, profits are recognised in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">territories by reference to the activities performed there and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value they generate. To ensure the profits recognised in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 588.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions are aligned to the activity undertaken there, and in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 598.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">line with current OECD guidelines, we base our transfer pricing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 608.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy on the arm&#8217;s length principle and support our transfer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 618.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prices with economic analysis and reports. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 634.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We do not engage in artificial tax arrangements &#8211; those without <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 644.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business or commercial substance. We do not seek to avoid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax by the use of &#8216;tax havens&#8217; or transactions we would not fully <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 665.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclose to a tax authority. We have a zero-tolerance approach <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 675.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to tax evasion and the facilitation of tax evasion. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax risk in all countries in which we operate is managed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through robust internal policies, processes, training and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance programmes. Our Board of Directors, supported by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Audit &amp; Risk Committee (ARC), are responsible for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approving our tax policies and risk management arrangements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as part of our wider risk management and internal control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework. Our Risk Oversight and Compliance Council <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(ROCC) and the Audit and Assurance function help the ARC <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversee tax risks and the strategies used to address them. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We seek to maintain open and constructive relationships with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax authorities worldwide, meeting regularly to discuss our tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affairs and real time business updates wherever possible to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support their work and help manage tax risk in accordance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our framework.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We monitor government debate on tax policy in our key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions so that we can understand and share an informed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">point of view regarding any potential future changes in tax law, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in support of a transparent and sustainable tax system. Where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant, we provide pragmatic and constructive business input <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to tax policy makers either directly or through industry trade <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 367.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bodies, to help inform reforms that support economic growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 377.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and job creation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 332.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group corporate tax charge was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;526 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;756 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) on profits before tax of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;3,477 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,064 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) representing an effective tax rate of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.1% (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: 12.5%). We made cash tax payments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 508.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,307 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in the year (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 393.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,328 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). In addition to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taxes we pay on our profits, we pay duties, levies, transactional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and employment taxes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s Total tax rate for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 415.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 434.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of 15.1% (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: 12.5%) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 480.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was lower than the Core tax rate reflecting the different tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effects of various Adjusting items, including the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 478.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> impact of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortisation and impairments of intangible assets at higher tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 511.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 319.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s and the impact of the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 406.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.82000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Core tax rate for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was 17% (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: 15.5%). The rate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 537.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to benefit from innovation incentives available in key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 547.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">territories in which we operate, such as the UK and Belgium <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 557.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent Box regimes, albeit at a reduced level following <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">introduction of global minimum corporate tax rate provisions, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">line with the OECD&#8217;s Pillar 2 model rules, with effect from 1 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 588.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">January 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further details about our corporate tax charges for the year are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set out in Note 14 'Taxation' to the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.61pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.56pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.26pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.61pt; position: var(--position); text-decoration: none; white-space: pre;">99<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_238"></div><div style="position: var(--position); top: 106.3pt; width: 595.56pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i0c08e7537c07466cba8dc796e114c1cd_0-0-1-1-824444"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury policies&#160; <span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 144.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We report in Sterling and pay dividends out of Sterling cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows. The role of Treasury is to monitor and manage the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s external and internal funding requirements and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial risks in support of our strategic objectives. GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operates on a global basis, primarily through subsidiary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 195.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies, and we manage our capital to ensure that our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 205.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries are able to operate as going concerns and to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">optimise returns to shareholders through an appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance of debt and equity. Treasury activities are governed by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policies approved annually by the Board of Directors, and most <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recently on 10 October 2024. A Treasury Management Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 256.94pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(TMG) meeting, chaired by our Chief Financial Officer, takes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.14pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">place on a regular basis to review Treasury activities. Its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.34pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">members receive management information relating to these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.54pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 303.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Treasury operations<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The objective of GSK&#8217;s Treasury activities is to minimise the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">post-tax net cost of financial operations and reduce its volatility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in order to benefit earnings and cash flows. GSK uses a variety <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of financial instruments to finance its operations and derivative <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial instruments to manage market risks from these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations. Derivatives principally comprise foreign exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.52pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forward contracts and swaps which are used to swap <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 390.72pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">borrowings and liquid assets into currencies required for Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 400.92pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purposes, as well as interest rate swaps which are used to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.12pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manage exposure to financial risks from changes in interest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives are used exclusively for hedging purposes in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relation to underlying business activities and not as trading or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">speculative instruments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 473.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Capital management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s financial strategy, implemented through the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial architecture, supports GSK&#8217;s strategic priorities and is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regularly reviewed by the Board. We manage the capital <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">structure of the Group through an appropriate mix of debt and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 530.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity. We continue to manage our financial policies to a credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 540.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profile that particularly targets ratings of at least A2/A (Moody's/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 550.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S&amp;P), through the cycle. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 566.48pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s policy is to borrow centrally in order to meet anticipated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">funding requirements. Our cash flow forecasts and funding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements are monitored by the TMG on a regular basis. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 612.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our strategy is to diversify liquidity sources using a range of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 623.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">facilities and to maintain broad access to financial markets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.06pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each day, we sweep cash to or from a number of global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.26pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries to central treasury accounts for liquidity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 659.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management purposes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 144.74pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate risk management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.63pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s objective is to minimise the effective net interest cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.83pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and to balance the mix of debt at fixed and floating interest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.03pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates over time. The policy on interest rate risk management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.23pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">limits the net amount of floating rate debt to a specific cap, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.43pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed and agreed no less than annually by the Board.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 217.32pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange risk management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our objective is to minimise the exposure of overseas operating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries to transaction risk by matching local currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income with local currency costs where possible. Foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency transaction exposures arising on external and internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trade flows are selectively hedged. GSK&#8217;s internal trading <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions are matched centrally and we manage inter-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.41pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company payment terms to reduce foreign currency risk. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.61pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where possible, we manage the cash surpluses or borrowing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.81pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements of subsidiary companies centrally using forward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 325.01pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts to hedge future repayments back into the originating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.21pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.1pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In order to reduce foreign currency translation exposure, we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.3pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seek to denominate borrowings in the currencies of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.5pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principal assets and cash flows. These are primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.7pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">denominated in US Dollars, Euros and Sterling. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings can be swapped into other currencies as required. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings denominated in, or swapped into, foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies that match investments in overseas Group assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 428.19pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may be treated as a hedge against the relevant assets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.39pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Forward contracts in major currencies are also used to reduce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.59pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exposure to the Group&#8217;s investment in overseas Group assets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.79pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The TMG reviews the ratio of borrowings to assets for major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.99pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies regularly.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 484.88pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Commodity risk management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.77pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our objective is to minimise income statement volatility arising <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.97pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from fluctuations in commodity prices, where practical and cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.17pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effective to do so. The TMG is authorised to approve the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.37pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">execution of certain financial derivatives to hedge commodity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.57pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">price exposures.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 557.46pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Counterparty risk management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.35pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We set global counterparty limits for each of our banking and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.55pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment counterparties based on long-term credit ratings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 593.75pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from Moody&#8217;s and Standard &amp; Poor&#8217;s. Usage of these limits is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 603.95pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actively monitored and any breach of these limits would be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.15pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reported to the Chief Financial Officer immediately. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.04pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition, relationship banks and their credit ratings are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.24pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed regularly so that, when changes in ratings occur, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.44pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes can be made to investment levels or to authority limits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.64pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as appropriate. All banking counterparty limits are reviewed at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.84pt; width: 595.56pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">least annually.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_241"></div><div style="position: var(--position); top: 106.3pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 472.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capital allocation<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 139.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Capital allocation framework to support <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 152.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">investment and returns<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Priority is to invest for growth, coupled with attractive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder returns<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 197.31pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g56.jpg" alt="GFR.infographic - 2024-V4.jpg" style="height: 233.2pt; width: 229.75pt;"/></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 438.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2bn share buyback programme to be completed over 18 months<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 132.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Our capital allocation framework to support <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 146.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">investment and returns<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our capital allocation framework means our first priority <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remains to invest in the business, with capital allocated towards <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development of the pipeline, both organic and targeted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business development. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also remain committed to delivering attractive returns to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders and pursuing a progressive dividend policy, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guided by a 40 to 60 percent pay-out ratio through the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment cycle. In setting its dividend policy, GSK considers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 249.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the priorities of the Group and its investment strategy for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 259.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth, alongside the sustainability of the dividend.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consistent with this, and reflecting strong business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 285.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance during the year, GSK declared an increased <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 347.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">61p<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> per share for the full year 2024. The expected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend for 2025 is 64p.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the event of surplus cash, the excess would be considered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for further returns to shareholders. We remain committed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintaining a balance sheet with a strong investment grade <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credit rating.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 368.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the significant transformation since the demerger, we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 378.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now have a strong balance sheet, which gives us a high level of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flexibility for the acceleration of organic investments and further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business development, whilst also enabling a step up in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 409.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder returns. We expect to augment our dividend with a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2 billion share buyback programme to be completed over the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">next 18 months.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">101<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_244"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i360c081a04ba42c58c417ef19fbff61a_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical accounting policies<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 150.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group consolidated financial statements have been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 160.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prepared in accordance with UK-adopted international <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting standards in conformity with the requirements of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies Act 2006 and the International Financial Reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standards (IFRS) as issued by the International Accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standard Boards (IASB).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are required to make estimates and assumptions that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect the amounts of assets, liabilities, revenue and expenses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 237.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reported in the financial statements. Actual amounts and results <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could differ from those estimates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 263.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The critical accounting policies relate to the following areas:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 279.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation (Note 14)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legal and other disputes (Note 47)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent liabilities (Note 35)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions and other post-employment benefits (Note 31<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of intangible assets (Note 20)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 351.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information on the judgements and estimates made in these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas is given in Note 3, 'Critical accounting judgements and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key sources of estimation uncertainty' to the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 397.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In respect of the turnover accounting policy, our largest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 424.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business is US Commercial Operations, and the US market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has the most complex arrangements for rebates, discounts and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowances. The following briefly describes the nature of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements in existence in our US Commercial Operations:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 470.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have arrangements with certain indirect customers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 480.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whereby the customer is able to buy products from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 490.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wholesalers at reduced prices. A chargeback represents the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difference between the invoice price to the wholesaler and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the indirect customer&#8217;s contractual discounted price. Accruals <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for estimating chargebacks are calculated based on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 531.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">terms of each agreement, historical experience and product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth rates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 553.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Customer rebates are offered to key managed care and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 563.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group Purchasing Organisations and other direct and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 573.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indirect customers. These arrangements require the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customer to achieve certain formulary status, performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 593.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets relating to the value of product purchased or pre-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determined market shares relative to competitors. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accrual for customer rebates is estimated based on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 624.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specific terms in each agreement, historical experience and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 634.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product growth rates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 150.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The US Medicaid programme is a state-administered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 160.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme providing assistance to certain poor and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vulnerable patients. In 1990, the Medicaid Drug Rebate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Program was established to reduce state and federal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expenditure on prescription drugs. In 2010, the Patient <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Protection and Affordable Care Act became law. We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 211.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">participate by providing rebates to states. Accruals for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicaid rebates are calculated based on the specific terms <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the relevant regulations or the Patient Protection and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affordable Care Act.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 253.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash discounts are offered to customers to encourage <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 263.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prompt payment. These are accrued for at the time of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invoicing and adjusted subsequently to reflect actual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We record an accrual for estimated sales returns by applying <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">historical experience of customer returns to the amounts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 315.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invoiced, together with market-related information such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 325.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stock levels at wholesalers, anticipated price increases and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitor activity.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 351.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A reconciliation of gross turnover to net turnover for US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 377.97pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 0pt; width: 57pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 57pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 40.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 0pt; width: 55.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 55.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 0pt; width: 55.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 55.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 11.25pt; width: 29.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 29.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 11.25pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Margin<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 11.25pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 11.25pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Margin<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 11.25pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 11.25pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Margin<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 29.25pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.66pt;"></span></span><span style="left: 3.29pt; position: var(--position);">30,484<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 29.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">32,359<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 29.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 180.75pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">29,814<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 29.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.12pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.12pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market-driven<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; segments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 47.25pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 2.34pt;"></span></span><span style="left: 4.97pt; position: var(--position);">(7,704)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 47.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(25)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 47.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.84pt;"></span></span><span style="left: 3.4699999999999998pt; position: var(--position);">(8,874)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 47.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(27)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 47.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.84pt;"></span></span><span style="left: 3.4699999999999998pt; position: var(--position);">(8,275)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 47.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(28)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Government<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; mandated and<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; state programmes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 67.5pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 2.34pt;"></span></span><span style="left: 4.97pt; position: var(--position);">(5,394)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 67.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(18)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 67.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.84pt;"></span></span><span style="left: 3.4699999999999998pt; position: var(--position);">(6,385)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 67.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(20)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 67.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.84pt;"></span></span><span style="left: 3.4699999999999998pt; position: var(--position);">(6,218)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 67.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(21)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash discounts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 96.75pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.53pt;"></span></span><span style="left: 11.16pt; position: var(--position);">(502)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 96.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 96.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.03pt;"></span></span><span style="left: 9.66pt; position: var(--position);">(566)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 96.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 96.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.03pt;"></span></span><span style="left: 9.66pt; position: var(--position);">(536)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 96.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Customer returns<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 108.75pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.53pt;"></span></span><span style="left: 11.16pt; position: var(--position);">(272)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 108.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 108.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.03pt;"></span></span><span style="left: 9.66pt; position: var(--position);">(344)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 108.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 108.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.03pt;"></span></span><span style="left: 9.66pt; position: var(--position);">(255)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 108.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prior year<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 120.75pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.99pt;"></span></span><span style="left: 13.620000000000001pt; position: var(--position);">631<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 120.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.4pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 120.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.49pt;"></span></span><span style="left: 12.120000000000001pt; position: var(--position);">591<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 120.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.4pt; position: var(--position);">2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 120.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.49pt;"></span></span><span style="left: 12.120000000000001pt; position: var(--position);">780<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 120.75pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.4pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.4pt; position: var(--position);">3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 144pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.53pt;"></span></span><span style="left: 11.16pt; position: var(--position);">(859)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 144pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 144pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.03pt;"></span></span><span style="left: 9.66pt; position: var(--position);">(961)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 144pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 180.75pt; position: var(--position); top: 144pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.03pt;"></span></span><span style="left: 9.66pt; position: var(--position);">(768)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 144pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.94pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.94pt; position: var(--position);">(2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total deductions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 68.25pt; overflow: hidden; position: var(--position); top: 156pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">(14,100)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 156pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(47)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 156pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">(16,539)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 156pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(51)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 180.75pt; overflow: hidden; position: var(--position); top: 156pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">(15,272)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 156pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.8pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.8pt; position: var(--position);">(51)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 168pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 0.29pt;"></span></span><span style="left: 2.92pt; position: var(--position);">16,384<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 97.5pt; position: var(--position); top: 168pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.26pt; position: var(--position);">53<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 168pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">15,820<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153pt; position: var(--position); top: 168pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.26pt; position: var(--position);">49<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 180.75pt; overflow: hidden; position: var(--position); top: 168pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">14,542<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 168pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.26pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.26pt; position: var(--position);">49<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 568.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market-driven segments consist primarily of managed care and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicare plans with which we negotiate contract pricing that is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">honoured via rebates and chargebacks. Mandated segments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 599.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consist primarily of Medicaid and federal government <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes which receive government-mandated pricing via <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 619.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rebates and chargebacks.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">102<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical accounting policies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overall<span style="display: inline-block; height: 6.18pt;"></span><span id="i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7689"></span><span id="i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7690"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales deduction as a percentage of sale<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decreased year over year in line with our commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracting strategy, movement in product mix and steps taken <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to address removal of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the Average Manufacturer Price (AMP) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cap<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 69.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Deductions within the year were split approximately as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">follows: General Medicines 61%, Specialty Medicines 28% and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines 11%.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the total accrual for&#160; discounts, rebates, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowances and returns for US Commercial Operations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 107.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5,235<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 128.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 187.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5,951<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A monthly process is operated to monitor inventory levels at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wholesalers for any abnormal movements. This process uses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gross sales volumes, prescription volumes based on third-party <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data sources and information received from key wholesalers. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The aim of this is to maintain inventories at a consistent level <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from year to year based on the pattern of consumption.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On this basis, US Commercial Operations inventory levels at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wholesalers and in other distribution channels at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were estimated to amount to approximately four weeks of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">turnover. This calculation uses third-party information, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accuracy of which cannot be totally verified, but is believed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be sufficiently reliable for this purpose.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 354.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Legal and other disputes<span style="display: inline-block; height: 8pt;"></span><span id="i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7687"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In respect of the accounting policy for legal and other disputes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the following briefly describes the process by which we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determine the level of provision that is necessary.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In accordance with the requirements of IAS 37, &#8216;Provisions, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent liabilities and contingent assets&#8217;, we provide for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anticipated settlement costs where an outflow of resources is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered probable and a reliable estimate may be made of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the likely outcome of the dispute and legal and other expenses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arising from claims against the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We may become involved in significant legal proceedings, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of which it is not possible to meaningfully assess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether the outcome will result in a probable outflow, or to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quantify or reliably estimate the liability, if any, that could result <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from ultimate resolution of the proceedings. In these cases, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate disclosure about such cases would be included in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Annual Report, but no provision would be made.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This position could change over time and, therefore, there can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be no assurance that any losses that result from the outcome <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of any legal proceedings will not exceed by a material amount <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the amount of the provisions reported in the Group&#8217;s financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Like many pharmaceutical companies, we are faced with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">various complex product liability, anti-trust and patent litigation, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as well as investigations of our operations conducted by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">various governmental regulatory agencies. Throughout the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year, the General Counsel of the Group, as head of the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal function, supported by the Senior Vice President and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Head of Global Litigation for the Group, who is responsible for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all litigation and government investigations, routinely brief the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer, the Chief Financial Officer and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors on the significant litigation pending against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group and governmental investigations of the Group. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These meetings, as appropriate, detail the status of significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation and government investigations and review matters <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as the number of claims notified to us, information on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential claims not yet notified, assessment of the validity of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims, progress made in settling claims, recent settlement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">levels and potential reimbursement by insurers.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The meetings<span style="display: inline-block; height: 6.18pt;"></span><span id="i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7688"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 355.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> also include an assessment of whether or not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 442.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there is sufficient information available for us to be able to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make a reliable estimate of the potential outcomes of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disputes. Often, external counsel assisting us with various <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation matters and investigations will also assist in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">briefing of the Board and senior management. Following these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussions, for those matters where it is possible to make a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable estimate of the amount of a provision, if any, that may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be required, the level of provision for legal and other disputes is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed and adjusted as appropriate. These matters are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 533.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussed further in Note 47, 'Legal proceedings' to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">f<span style="display: inline-block; height: 6.18pt;"></span><span id="i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7683"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inancial statements<span style="display: inline-block; height: 6.18pt;"></span><span id="i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7686"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 379.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">103<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 517.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 96.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 158.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 317.25pt; position: var(--position); top: 23.25pt; width: 200.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 74.8pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="background-color: transparent; height: 841.91pt; left: 0pt; opacity: 1; position: var(--position); top: 0pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g49.jpg" alt="AR__main_divider_pages background.jpg" style="height: 841.91pt; width: 595.28pt;"/></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_253"></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Corporate<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 182.38pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">governance<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="position: var(--position); top: 482.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 249.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this section<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_259">The Board and GSK Leadership Team</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 12.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_259">104</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_265">Chair&#8217;s governance statement</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 27.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 10pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_265">110</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">Corporate governance architecture</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 42.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 10pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">113</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_271">Board activities</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 57.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 10pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_271">116</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_289">Board committee report</a><span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 113.50999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 72.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_289">122</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 87.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_331">Remuneration policy </a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 102.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_331">164</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 219.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_334">Directors&#8217; report</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219.75pt; position: var(--position); top: 117.75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_334">173</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">104<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">The Board <span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_256"></div><div style="position: absolute; top: 114.19pt;" id="idc89fa1ee07645df9629d157a4b46752_259"></div><div style="position: var(--position); top: 114.19pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 321pt;"/></tr><tr style="height: 153.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="i18f4470164a04ff7a6513acac2743218_0-0-1-1-821446"></span><div style="height: 153.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds, CBE<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Chair<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 65<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> British<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 September 2019<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 153.75pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jon has extensive international financial, life sciences and governance experience.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 23.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jon served as an Independent Non-Executive Director of HSBC Holdings plc from April 2014 and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as Chairman of the Group Audit Committee from 1 September 2014 and Deputy Group <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chairman from August 2018, until his retirement from the Board in February 2020. He was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">previously Chairman of HSBC Bank plc, Chief Financial Officer of Novartis AG, Partner and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Managing Director of Goldman Sachs, Chief Financial Officer of AstraZeneca plc, and a Partner <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at KPMG. Jon was previously a Senior Advisor to Chatham House.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jon is a Fellow of the Institute of Chartered Accountants in England and Wales, an Honorary <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fellow of the Oxford School of Pharmacology, and an Honorary Member of the Academy of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medical Sciences. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 110.75pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 119.75pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Director, Genomics England Limited having previously served as its Chairman; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 128.75pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Chair, Energy Aspects; Member, European Round Table for Industry; Member, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 137.75pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investor &amp; Issuer Forum (I&amp;IF) Steering Committee.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 95.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 95.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 153.75pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dame Emma Walmsley<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 55<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> British<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 January 2017<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 55.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer from <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 64.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 April 2017<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 95.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 153.75pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before being appointed as GSK&#8217;s CEO, Emma was the CEO of GSK Consumer Healthcare, a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joint venture between GSK and Novartis, from its creation in March 2015. Emma joined GSK in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2010 from L&#8217;Oreal, having worked there for 17 years in a variety of roles in Paris, London, New <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">York and Shanghai. Emma&#8217;s position as an Independent Director of Microsoft, Inc., further <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supplements the technology and cyber security experience she brings to the Board. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma holds an MA in Classics and Modern Languages from Oxford University. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Director, Microsoft, Inc. <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 140.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 140.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 249pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Financial Officer<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 62<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 36.5pt; position: var(--position);"> British<span style="display: inline-block; height: 5.46pt; width: 12.65pt;"></span></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 May 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 140.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 249pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie has an extensive financial and life sciences background, having been the Group CFO of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Smith &amp; Nephew from 2013 to 2017 and serving as a Non-Executive Director and Audit Chair of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Roche Holding AG from 2016 to 2022. Before this, Julie was Interim Group CFO of AstraZeneca <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plc, having worked in a wide range of commercial, strategic and financial positions across three <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continents over a 25 year period. Julie was also Chief Operating Officer and CFO and Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director of Burberry Group plc from 2017 to 2023, where her responsibilities included Finance, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transformation, Information Technology and oversight of cyber security, Investor Relations and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie is a Fellow of the Institute of Chartered Accountants and the Institute of Tax. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Co-Chair, CFO Leadership Network, Accounting for Sustainability (part of the King Charles III <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charitable Fund Group of Companies); Patron, Oxford University Women in Business; Non-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director and Chair of the Audit Committee, Diageo plc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 149.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 149.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 389.25pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth (Liz) McKee Anderson<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 67<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 September 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 149.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 389.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liz brings significant experience in commercial biopharmaceuticals and is a seasoned biotech <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">board member. Her significant experience in commercial biopharmaceuticals, both operationally <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and at Board level, as well as her deep understanding of the biotechnology sector and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">application of technology, are invaluable to GSK as a pure biopharma company.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before her current roles, Liz served as Worldwide Vice President and commercial leader in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases and vaccines and also for immunology and oncology at Janssen <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceuticals, and as Vice President and General Manager at Wyeth Vaccines. Liz was also <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">previously a Board member of Huntsworth Plc and a Board Member and Chair of the Science, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology and Investment Committee of Bavarian Nordic A/S. Liz has a degree in Engineering <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Technical Management and an MBA in Finance.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board Member, BioMarin Pharmaceutical, Inc; Board Member, Revolution Medicines, Inc; Board <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Member, Insmed, Inc; Trustee, The Wistar Institute; Director, Aro Biotherapeutics Company, a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">private company.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 55.01pt; position: var(--position); top: 567.83pt; width: 9.92pt; z-index: 38;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g57.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="background-color: #ffffff; font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">A</span><span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 69.1pt; position: var(--position); top: 567.83pt; width: 9.92pt; z-index: 39;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 56.41pt; position: var(--position); top: 176.32pt; width: 9.92pt; z-index: 42;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: 0.23pt; width: 7.01pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.98pt; position: var(--position); text-decoration: none; white-space: pre;">N<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 772.61pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 18pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 18pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 18pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 30.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 102.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 83.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 29.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 240.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 129pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 382.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 437.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 237.63pt; position: var(--position); top: 775.04pt; width: 9.92pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 279.18pt; position: var(--position); top: 775.04pt; width: 9.92pt; z-index: 2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 421.08pt; position: var(--position); top: 775.04pt; width: 9.92pt; z-index: 3;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); white-space: pre;">A<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 68.88pt; position: var(--position); top: 775.04pt; width: 9.92pt; z-index: 4;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div></div><div style="height: 9.92pt; left: 140.11pt; position: var(--position); top: 775.04pt; width: 9.92pt; z-index: 5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 476.14pt; position: var(--position); top: 774.37pt; width: 9.92pt; z-index: 9;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">105<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 321pt;"/></tr><tr style="height: 179.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="ie03156c997354de09dbceb1686216b85_0-0-1-1-821446"></span><div style="height: 179.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Independent Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 161.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 65<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 May 2020<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 55.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Independent Non-Executive Director <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 64.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from 18 July 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="ie03156c997354de09dbceb1686216b85_0-1-1-1-824589"></span><div style="height: 179.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charlie has a wealth of financial and management experience in global biopharma.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 23.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charlie retired from a successful career at Bristol Myers Squibb (BMS) in March 2020 where he <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held a number of leadership roles in commercial, strategy and finance. Beginning his career at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BMS in 1984, he held positions of increasing responsibility within the finance organisation and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">had commercial operational responsibility for Latin America, Middle East, Africa, Canada, Japan <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and several Pacific Rim countries. He was appointed Chief Financial Officer in 2010, Chief <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial Officer and Executive Vice President, Global Business Operations in 2016 and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Vice President and Head of Integration and Strategy &amp; Business Development in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2019. As Chief Financial Officer, Charlie had line management responsibility for Information <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology, including cyber security. Charlie successfully steered BMS through a period of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 104.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic transformation, including its $74 billion acquisition of Celgene. Charlie also served as a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 113.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">member of the Board of Colgate-Palmolive Company from 2017 until March 2020.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board Member, Kodiak Sciences Inc; Board Member, BioVector Inc; Advisory Board Member, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 143.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Drexel University&#8217;s LeBow College of Business; Advisor, Patent Protection Research.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 155.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board determined that Charlie has recent and relevant financial experience and agreed that <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 164.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he has the appropriate qualifications and background to be an audit committee financial expert.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 183.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 183.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 179.25pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 62<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 January 2018<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 55.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Scientific Officer and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 64.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President, R&amp;D from 1 April 2018 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 73.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transitioned to the role of Non-Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 82.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director on 1 August 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 183.75pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 179.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hal has had a distinguished career in biosciences, with a strong track record of research and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development (R&amp;D). He joined the Board of GSK in 2018 as Chief Scientific Officer and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President, R&amp;D, where he brought a new approach to R&amp;D which focused on science related to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the immune system, the use of human genetics and advanced technologies to help identify the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">next generation of transformational medicines. In August 2022, he transitioned to a Non-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director, with additional responsibilities to support R&amp;D. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before joining GSK, Hal was President, R&amp;D at Calico LLC (California Life Company), an <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alphabet-funded company that uses advanced technologies to increase understanding of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lifespan biology. Hal was previously Executive Vice President, Head of Global Product <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Development, and Chief Medical Officer of Roche, responsible for all the products in the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 104.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combined portfolio of Roche and Genentech. At Genentech, he was Senior Vice President of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 113.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Development and Chief Medical Officer. Hal was a Non-Executive Director and Chair of the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 122.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science &amp; Technology Committee at Juno Therapeutics, Inc until March 2018, when it was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 131.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquired by Celgene Corporation. He previously served as a Non-Executive Board Director of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 140.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GRAIL, Inc and an Advisory Board Member of Verily Life Sciences LLC.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 152.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 161.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO and Board Co-Chair, Altos Labs Inc; Associate Adjunct Professor, Epidemiology &amp; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 170.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biostatistics, University of California, San Francisco.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 140.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 140.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 363pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 135.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.150000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">62<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 6 May 2021<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 140.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 363pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anne brings extensive healthcare experience to the Board as a physician and entrepreneur <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combined with a passion for patient advocacy. She is a recognised health policy expert in the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development of global and national programmes for improving healthcare access for all patient <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">groups and in ensuring the voice of patients is reflected in research programmes.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prior to her current roles, Anne spent six years at Harvard Medical School and Massachusetts <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Hospital, where she was an instructor in paediatrics. She has also held leadership roles <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at the Commonwealth Fund and the Aetna Foundation. Anne was previously Deputy Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director and Chief Engagement Officer for The Patient-Centered Outcomes Research Institute in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US and Chief Patient Officer and Global Head of Patient Solutions at Sanofi. In addition, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anne was previously a member of the Board of Academy Health.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Founder and CEO, AbsoluteJOI Skincare; Board Member, Prolacta Bioscience; Board Member, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Omada Health, Inc; Member of Board of Trustees, Brown University. <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 52.01pt; position: var(--position); top: 194.22pt; width: 9.92pt; z-index: 11;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="color: #ffffff; font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); text-decoration: none; white-space: pre;">A<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 66.54pt; position: var(--position); top: 194.22pt; width: 9.92pt; z-index: 12;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 80.6pt; position: var(--position); top: 194.22pt; width: 9.92pt; z-index: 13;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 51.87pt; position: var(--position); top: 392.65pt; width: 9.92pt; z-index: 14;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 79.09pt; position: var(--position); top: 540.23pt; width: 9.92pt; z-index: 15;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 50.46pt; position: var(--position); top: 540.51pt; width: 9.92pt; z-index: 16;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="color: #ffffff; font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); text-decoration: none; white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 64.91pt; position: var(--position); top: 540.51pt; width: 9.92pt; z-index: 17;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 758.57pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 18pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 18pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 18pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 30.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 102.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 83.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 29.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 240.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 129pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 382.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 437.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 236.51pt; position: var(--position); top: 760.09pt; width: 9.92pt; z-index: 18;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 279.18pt; position: var(--position); top: 760.46pt; width: 9.92pt; z-index: 19;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 419.95pt; position: var(--position); top: 760.46pt; width: 9.92pt; z-index: 20;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); white-space: pre;">A<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 69.17pt; position: var(--position); top: 760.18pt; width: 9.92pt; z-index: 21;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div></div><div style="height: 9.92pt; left: 141.17pt; position: var(--position); top: 760.19pt; width: 9.92pt; z-index: 22;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 475.76pt; position: var(--position); top: 760.54pt; width: 9.92pt; z-index: 23;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">106<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 321pt;"/></tr><tr style="height: 219pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 219pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 59<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 October 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 219pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy is a highly experienced Non-Executive Director and has held significant leadership <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positions in a wide range of global businesses in public, private and non-profit sectors. She <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">possesses a wealth of strategic and consumer marketing expertise in particular across the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology and life sciences sectors. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy has strong executive management experience, having been Chief Executive Officer at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jack Wills Limited, Group Chief Marketing Officer at Vodafone Group plc and Partner at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">McKinsey &amp; Company. Wendy&#8217;s interest in science, healthcare and medical research dates to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">her time at McKinsey, where she worked with a range of healthcare clients in the US and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Europe. This was furthered during the years that she served on the Board of Cancer Research <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK. More recently, Wendy spent time as a Non-Executive Director of NHS England and as Chair <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 104.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the British Heart Foundation. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy has held several Non-Executive Director roles, amongst others, as Chair of the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committees of Great Portland Estates plc and Ocado Group plc, a member of the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration and Audit Committees of Whitbread plc and Senior Independent Director and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 143.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair of the Remuneration Committee of Oxford Nanopore Technologies plc. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 155.75pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Through her current and prior roles in technology companies, Wendy adds to the Board&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 164.75pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience in cyber security. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 176.79pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 185.79pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair of Logitech International S.A.; Vice Chair of the Board and Chair of the Compensation <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 194.79pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee, Sony Group Corporation; Member of the governing bodies of the University of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 203.79pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oxford; Trustee, University of Oxford. <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 266.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 266.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Harry (Hal) C Dietz<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Scientific &amp; Medical Expert <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 117.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 66<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 266.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 219pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hal brings extensive experience in the field of human genetics which is central to GSK&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach to R&amp;D. He is a former President of the American Society of Human Genetics and is <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised as the world&#8217;s leading authority on the genetic disorder known as Marfan Syndrome. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He also brings experience in developing novel therapies, particularly in relation to disease-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">modifying treatments for fibrotic and neurodegenerative diseases. In total, Hal has authored 282 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">original publications in peer-reviewed journals during his career.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a physician scientist, he has dedicated his entire career to the care and study of individuals <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with heritable connective tissue disorders with primary perturbations of extracellular matrix <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">homeostasis and function. His lab has identified the genes for many of these conditions, for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which he uses model systems to explain disease mechanisms.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hal has received many prestigious awards including the Curt Stern Award from the American <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Society of Human Genetics, the Colonel Harland Sanders Lifetime Achievement Award in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medical Genetics, the Taubman Prize for excellence in translational medical science, the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Harrington Prize from the American Society for Clinical Investigation and the Harrington <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 143.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discovery Institute, the Pasarow Award in Cardiovascular Research, the InBev-Baillet Latour <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 152.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Health Prize from Belgium, and the Research Achievement Award from the American Heart <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 161.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Association.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 173.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He is an inductee of the American Society for Clinical Investigation, the American Association for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 182.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Advancement of Science, the Association of American Physicians, the National Academy of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 191.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicine, and the National Academy of Sciences. Hal was previously an Investigator at the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 200.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Howard Hughes Medical Institute.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 212.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 221.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Victor A. McKusick Professor of Paediatrics, Medicine, and Molecular Biology &amp; Genetics in the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 230.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Department of Genetic Medicine, The Johns Hopkins University School of Medicine; Non-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 239.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Board Director, Altius Institute for Biomedical Sciences; Independent Chair, GSK&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 248.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human Genetics Scientific Advisory Board.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 10.27pt; left: 55.64pt; position: var(--position); top: 409.2pt; width: 10.3pt; z-index: 6;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g60.gif" alt="" style="height: 20.27pt; width: 20.3pt;"/></div><div><div><div style="transform: translate(1.51pt, 1.50pt);"><div style="line-height: 7pt; position: var(--position); top: -0.55pt; width: 7.28pt;"><span style="color: #ffffff; font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.71pt; position: var(--position); text-decoration: none; white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 67.18pt; position: var(--position); top: 176.67pt; width: 9.92pt; z-index: 36;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); white-space: pre;">A<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 54.26pt; position: var(--position); top: 176.67pt; width: 9.92pt; z-index: 37;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="color: #ffffff; font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); text-decoration: none; white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 80.79pt; position: var(--position); top: 176.67pt; width: 9.92pt; z-index: 40;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 94.39pt; position: var(--position); top: 176.67pt; width: 9.92pt; z-index: 41;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 748.89pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 18pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 18pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 18pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 30.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 102.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 83.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 29.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 240.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 129pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 382.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 437.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 236.88pt; position: var(--position); top: 750.61pt; width: 9.92pt; z-index: 24;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 278.81pt; position: var(--position); top: 750.61pt; width: 9.92pt; z-index: 25;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 421.45pt; position: var(--position); top: 750.61pt; width: 9.92pt; z-index: 26;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); white-space: pre;">A<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 68.51pt; position: var(--position); top: 750.99pt; width: 9.92pt; z-index: 27;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div></div><div style="height: 9.92pt; left: 140.11pt; position: var(--position); top: 750.61pt; width: 9.92pt; z-index: 28;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 475.76pt; position: var(--position); top: 751.44pt; width: 9.92pt; z-index: 29;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">107<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 321pt;"/></tr><tr style="height: 245.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 245.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 135.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Scientific &amp; Medical Expert <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 73<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.339999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 1 January 2016<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 245.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jesse brings scientific and public health expertise to the Board&#8217;s deliberations. He has a wealth <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of experience spanning science, medicine, vaccines, regulation and public health, and has a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proven record in addressing pressing public health needs in both the academic and federal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sectors.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jesse previously served in senior leadership positions at the US Food and Drug Administration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(FDA), including most recently as the FDA&#8217;s Chief Scientist and previously as Deputy <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commissioner for Science and Public Health and as Director of the Center for Biologics <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluation and Research (CBER).<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jesse played a leadership role in developing the FDA&#8217;s Regulatory Science and Medical <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Countermeasures Initiatives and has worked collaboratively with industry, academia, government <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and global public health and regulatory partners to prepare for and respond to major public <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">health threats, including emerging infectious diseases, disasters and terrorism. He led the FDA&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">response to West Nile Virus and to the 2009 H1N1 influenza pandemic and served on the Senior <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leadership Team for the 2010 White House Medical Countermeasure Review. Jesse was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 143.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">previously a member of both the Scientific Advisory Committee and the Regulatory and Legal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 152.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Working Group of the Coalition for Epidemic Preparedness Innovations (CEPI). In addition, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 161.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jesse was a Board Member of the Scientific Counselors for Infectious Diseases, Centers for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 170.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disease Control and Prevention (CDC).<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 182.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 191.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Professor of Medicine and Attending Physician, Infectious Diseases, Georgetown University and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 200.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">directs the Georgetown University Center on Medical Product Access, Safety and Stewardship <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 209.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(COMPASS); Board Member (formerly President), United States Pharmacopeia (USP); Board <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 218.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Member, Intellia Therapeutics Inc; Member, US National Academy of Medicine; Board Member, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 227.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BiomX Inc; Member of Committee on the Evidence Base for Lyme Infection-Associated Chronic <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 236.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Illnesses Treatment, National Academies Sciences Engineering Medicine.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 165pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 165pt; left: 0pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director&#160; &#160; &#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Scientific &amp; Medical Expert <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 60<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.449999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.92pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: 4 March 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 165pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jeannie is a pioneer in the field of RNA Biology and its application to drug development and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapeutics. In addition to senior leadership positions held at both Harvard Medical School and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Massachusetts General Hospital, Jeannie co-founded Translate Bio and Fulcrum <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Therapeutics, two biotech companies specialising in RNA and epigenetic therapies. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jeannie is a Member of the National Academy of Sciences and the National Academy of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicine. She is a Harrington Rare Disease Scholar of the Harrington Discovery Institute, a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recipient of the Lurie Prize from the Foundation for the National Institutes of Health, an awardee <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Centennial Prize from the Genetics Society of America, the 2010 Molecular Biology Prize <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the 2020 Cozzarelli Prize from the National Academy of Sciences, U.S.A, and a Fellow of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the American Association for the Advancement of Science. She has also served on the Board of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 104.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Genetics Society of America. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Endowed Chair of Molecular Biology, Vice Chair of Genetics and Professor of Genetics (&amp; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pathology), Harvard Medical School; Chair of Molecular Biology, Massachusetts General <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 143.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hospital; Co-Founder and Consultant, Fulcrum Therapeutics; Scientific Advisory Board member, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 152.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skyhawk Therapeutics Inc.; Manager and Registered Agent, Pink Onion LLC.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 161.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="i12be51524cf14b329e83851e353ced97_2-0-1-1-825315"></span><span id="i12be51524cf14b329e83851e353ced97_2-0-1-2-821446"></span><div style="height: 161.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 410.25pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Vishal Sikka<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 135.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Age:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.100000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 57<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nationality:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> American<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18 July 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 161.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 410.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.65pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.65pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vishal has a distinguished background in technology, particularly in Artificial Intelligence (AI) and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.65pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Machine Learning (ML), which are central to GSK&#8217;s approach to R&amp;D. He also brings a deep <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.65pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understanding of cyber security to the Board. He is the founder and CEO of Vianai Systems, Inc, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.65pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a Silicon Valley-based company that provides advanced technological software and services in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.65pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AI and ML to large enterprises around the world.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before founding Vianai Systems in 2019, Vishal served as CEO of Infosys Limited, where he led <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an innovative strategy to help clients renew existing IT landscapes, using AI/automation, design <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thinking and next-generation technologies to transform customer experiences. He also served as <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a member of the Executive Board of SAP SE, prior to which he was its Chief Technology Officer, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 95.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and also as a Board Member of Oracle Corporation. Vishal has a PhD in AI from Stanford <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 104.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">University and has co-authored several research abstracts related to AI, technology and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 113.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">database management.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 125.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External appointments<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 134.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Founder and CEO, Vianai Systems, Inc; Member, Supervisory Board, BMW AG; Member of the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 143.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advisory Board of Stanford University's AI Center (Institute for Human-Centered Artificial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 152.69pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intelligence).<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 54.14pt; position: var(--position); top: 184.69pt; width: 9.92pt; z-index: 7;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 66.9pt; position: var(--position); top: 184.69pt; width: 9.92pt; z-index: 8;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 54.14pt; position: var(--position); top: 581.63pt; width: 9.86pt; z-index: 10;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g61.gif" alt="" style="height: 19.92pt; width: 19.86pt;"/></div><div><div><div style="transform: translate(1.44pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 6.97pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.04pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 54.89pt; position: var(--position); top: 423.94pt; width: 9.92pt; z-index: 43;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 67.64pt; position: var(--position); top: 423.94pt; width: 9.92pt; z-index: 44;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 689.97pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 18pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 18pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 18pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 30.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 102.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 83.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 29.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 240.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 129pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 382.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 437.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 53.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 9.92pt; left: 239.51pt; position: var(--position); top: 691.38pt; width: 9.92pt; z-index: 30;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.58pt; position: var(--position); white-space: pre;">S<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 280.68pt; position: var(--position); top: 691.38pt; width: 9.92pt; z-index: 31;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0.88pt; position: var(--position); white-space: pre;">N<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 423.7pt; position: var(--position); top: 691.76pt; width: 9.92pt; z-index: 32;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.16pt; position: var(--position); white-space: pre;">A<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 71.51pt; position: var(--position); top: 691.76pt; width: 9.92pt; z-index: 33;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g59.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div></div><div style="height: 9.92pt; left: 143.12pt; position: var(--position); top: 691.01pt; width: 9.92pt; z-index: 34;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.06pt; position: var(--position); white-space: pre;">C<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="height: 9.92pt; left: 478.38pt; position: var(--position); top: 692.59pt; width: 9.92pt; z-index: 35;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g58.gif" alt="" style="height: 19.92pt; width: 19.92pt;"/></div><div><div><div style="transform: translate(1.45pt, 1.45pt);"><div style="line-height: 7pt; position: var(--position); top: -0.67pt; width: 7.01pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 1.27pt; position: var(--position); white-space: pre;">R<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 717.91pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 308.25pt;"/></tr><tr style="height: 20.25pt;"><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Directors departing during <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 113.78999999999999pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urs Rohner<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 65.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 114pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 114pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 January 2015 to 8 May 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 179.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 308.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 308.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired from the company on 8 May 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 754.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Independence<span style="display: inline-block; height: 6.55pt;"></span><span id="i05f3d03bed7044b0896d2750d4d11063_535"></span><span id="i05f3d03bed7044b0896d2750d4d11063_536"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 113.46000000000001pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> statement<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 157.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board considers all its Non-Executive Directors who are identified above &#8211; except Dr Hal Barron &#8211; to be independent after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 775.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being assessed against Provision 10 of the Financial Reporting Council's UK Corporate Governance Code. Dr Jesse Goodman <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 786.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reached nine years of service and will step down from the Board at the 2025 AGM as planned. He continues to demonstrate all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 796.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the characteristics of independence expected by the Board in carrying out his role as a Director.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">108<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Leadership Team (GLT)<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_262"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 539.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 509.25pt;"></span></span><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 321pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 167.25pt; position: var(--position); top: 0pt; width: 321pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 257.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma joined GSK in 2010 and the GLT in 2011. See Board biographies on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 270.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">104</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 282.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 293.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i05f3d03bed7044b0896d2750d4d11063_536">107</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 305.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 31.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 31.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Financial Officer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 31.5pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie joined GSK and the GLT in 2023. See Board biographies on pages <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 238.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">104</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 250.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 261pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i05f3d03bed7044b0896d2750d4d11063_536">107</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 273.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 74.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 74.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diana Conrad<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief People Officer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 74.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 75pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diana was appointed Chief People Officer and member of the GLT in April 2019. She was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">previously Senior Vice President, HR, Pharmaceuticals R&amp;D from 2016 where she played a key <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic role as leader of the R&amp;D people and culture agenda to support its transformation.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diana joined GSK Canada&#8217;s HR team in 2000 where she held several roles of increasing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibility before becoming Senior Vice President, HR for Consumer Healthcare in 2009.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prior to joining GSK, she held HR roles in companies including GE Capital, Gennum Corporation <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Zenon Environmental Laboratories. Diana has an Honours Bachelor of Arts from McMaster <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">University in Canada.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 101.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 149.25pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">James Ford<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SVP &amp; Group General Counsel, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legal and Compliance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 149.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">James joined the GLT in 2018, when he was appointed Senior Vice President and Group <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Counsel, later taking responsibility for Compliance, Corporate Security and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investigations in 2021. He joined GSK in 1995 and has served as General Counsel Consumer <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare, General Counsel Global Pharmaceuticals, Vice President of Corporate Legal and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was Acting Head of Global Ethics and Compliance. Prior to GSK, James was a solicitor at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clifford Chance and DLA. He holds a law degree from the University of East Anglia and a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diploma in Competition Law from King's College. He is qualified as a solicitor in England and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wales and is an attorney at the New York State Bar. James is based in London and has <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">practised law and lived in the US, Singapore and Hong Kong. James was co-chair of the US-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 83.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based Civil Justice Reform Group 2019-2022, and is a director of the European General Counsel <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 92.63pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Association and the Association of Corporate Counsel.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 56.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 56.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 250.5pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sally Jackson<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SVP, Global Communications <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and CEO Office<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 56.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 250.5pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sally joined the GLT in March 2019 as Senior Vice President, Global Communications and CEO <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Office. She leads our Communications and Government Affairs function globally and is also the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO&#8217;s Chief of Staff. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prior to this, Sally was Senior Vice President, Office of the CEO and CFO and she previously <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">served as Head of Investor Relations. She joined GSK in 2001. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sally holds a degree in Natural Sciences from the University of Cambridge.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 101.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Luke Miels<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Commercial Officer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Luke joined GSK and the GLT in 2017. As Chief Commercial Officer he is responsible for our <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial portfolio of medicines and vaccines. Luke also co-chairs the Portfolio Investment <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board with Tony Wood and is a member of the ViiV Healthcare Board. Outside of GSK, Luke is a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">member of the Singapore Economic Development Board. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He previously worked for AstraZeneca as Executive Vice President of their European business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and, prior to that, was Executive Vice President of Global Product and Portfolio Strategy, Global <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medical Affairs and Corporate Affairs. Before that, he was head of Asia for Roche, based in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shanghai and then Singapore. Prior to that he held roles of increasing seniority at Roche, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sanofi-Aventis and AstraZeneca in the US, Europe and Asia. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 83.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Luke holds a Bachelor of Science degree in Biology from Flinders University in Adelaide and a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 92.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MBA from the Macquarie University, Sydney.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 101.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="i5c3dc689c3424363b4dea78a37255c4b_7-0-1-1-821446"></span><div style="height: 101.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 408pt; width: 167.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shobie Ramakrishnan<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Digital and Technology Officer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 101.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 408pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shobie joined the GLT in 2021. As Chief Digital and Technology Officer, she is responsible for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technology and Cyber Security at GSK. She joined GSK in 2018 as CDTO for GSK&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial business and has deep and broad experience in both biotech and hi-tech <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prior to GSK, Shobie held senior technology leadership roles in organisations including <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AstraZeneca, Salesforce, Genentech and Roche. She is Board Member Emeritus at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SustainableIT.org and was formerly a member of the board of directors at Remediant.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Outside of GSK, Shobie is a Non-Executive Director at Deliveroo. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shobie holds a Bachelor&#8217;s degree in Electronics Engineering from Vellore Institute of Technology, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 83.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">University of Madras, India.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">109<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Leadership Team (GLT) continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 167.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 321pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 167.25pt; position: var(--position); top: 0pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 321pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Skills and experience<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 68.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">David Redfern<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President, Corporate Development<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">David joined the GLT as Chief Strategy Officer in 2008 and is responsible for corporate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development and strategic planning. Previously, he was Senior Vice President, Northern Europe <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with responsibility for GSK&#8217;s pharmaceutical businesses in that region and, before that, he was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Vice President for Central and Eastern Europe. He joined GSK in 1994. David was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointed Chairman of the Board of ViiV Healthcare Limited in 2011 and a Non-Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director of the Aspen Pharmacare Holdings Limited Board in 2015.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He has a Bachelor of Science degree from Bristol University and is a Chartered Accountant.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 80.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regis Simard<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President, Global Supply Chain<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 80.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regis joined the GLT in 2018, when he became President, Pharmaceuticals Supply Chain.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 14.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He is responsible for the manufacturing and supply of GSK&#8217;s medicines and vaccines. In <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 23.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">addition, he leads Quality and Environment, Health, Safety and Sustainability at a corporate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level. Regis joined GSK in 2005 as a Site Director in France, rising to become Senior Vice <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President of Global Pharmaceuticals Manufacturing before his current role. Previously, he held <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior positions at Sony, Konica Minolta and Tyco Healthcare. He is a member of the Board of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">He is a mechanical engineer and holds an MBA.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 50.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 50.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phil Thomson<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President, Global Affairs<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 50.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phil joined the GLT in 2011. He was appointed President, Global Affairs in 2017, and has <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibility for the Group&#8217;s strategic approach to stakeholder engagement, reputation and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy development. Previously, Phil was Senior Vice President, Communications and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Government Affairs. He joined Glaxo Wellcome as a commercial trainee in 1996. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phil holds a degree in English, History and Russian Studies from Durham University. <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 98.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 98.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deborah Waterhouse<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO, ViiV Healthcare and President, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.24000000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Global Health <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 98.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 210pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deborah was appointed to the GLT in January 2020. She became Chief Executive Officer of ViiV <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare in April 2017. In addition to ViiV, Deborah also leads GSK&#8217;s Global Health <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">organisation.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deborah joined GSK in 1996 and, prior to ViiV, was the Senior Vice President of Primary Care <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within GSK&#8217;s US business. She has a strong track record of performance in both specialty and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primary care. Deborah led the HIV business in the UK before heading the HIV Centre of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excellence for Pharma Europe and held roles as General Manager of Australia and New Zealand <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Senior Vice President for Central and Eastern Europe.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deborah is a Non-Executive Director of Schroders plc and holds a degree in Economic History <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and English Literature from Liverpool University.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 125.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 125.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 308.25pt; width: 167.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tony Wood<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 167.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Scientific Officer <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 125.25pt; left: 167.25pt; overflow: hidden; position: var(--position); top: 308.25pt; width: 321pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tony was appointed Chief Scientific Officer (CSO), Head of R&amp;D and a member of GLT on 1 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">August 2022, following his appointment as CSO designate on 19 January 2022. He joined GSK <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from Pfizer in 2017 as Senior Vice President, Medicinal Science and Technology, responsible for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all science and technology platforms driving the delivery of new innovation.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tony has led large-scale global organisations in drug discovery and development in multiple <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapeutic areas, including immunology, oncology and infectious diseases. During his time at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer, Tony was responsible for the invention of a new antiretroviral medication used to treat HIV <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infection. He is a Fellow of the Academy of Medical Sciences, an Honorary Fellow of the Royal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Society of Chemistry (RSC), the highest honour given by the RSC, and a Fellow of the Royal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.67pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Society of Biology.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tony has a BSc in chemistry and PhD in organic synthesis from the University of Newcastle, and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was a postdoctoral fellow at Imperial College, London. He is also currently a visiting professor at <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 116.71pt; width: 321pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IMCM Oxford.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 557.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GLT members departing during <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 188.70999999999998pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 571.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 58.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">here were no changes<span style="display: inline-block; height: 5.09pt;"></span><span id="i26a81cbda51c42fbbdcc287c651be078_120"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 126.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to the composition of the GLT during 2024.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #ffffff; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">110<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s governance statement<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_265"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g62.jpg" alt="NEW GOV LETTER PANEL.V2.jpg" style="height: 183.08pt; width: 487.72pt;"/></div></div></div><div style="background-color: transparent; height: 177pt; left: 57pt; opacity: 1; position: var(--position); top: 116.54pt; width: 228.69pt; z-index: 1;"><div><div><div><div style="line-height: 12pt; position: var(--position); top: 11.34pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The primary focus of the Board&#8217;s work <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 25.54pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2024 was on building confidence in <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 39.74pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the growth strategy to 2031. In 2025, <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 53.94pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board will spend significantly more <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 68.14pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time on the period beyond 2031 and the <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 82.34pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced technologies that will shape <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 12pt; position: var(--position); top: 96.54pt; width: 228.69pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 12pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the industry <span style="display: inline-block; height: 11.52pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.32pt; width: 228.69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds, Chair <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 314.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board evolution<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 328.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board is now three years int<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 174.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">o GSK&#8217;s transition as a pure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 338.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma company. Each of my Board colleagues now brings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 348.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unique expertise and experience, contributing to the collective <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 359.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strength of the Board&#8217;s scientific and technological capabilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to oversee, support and challenge delivery of our strategy and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its underlying value proposition.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We now have the right balance of skills, background and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">knowledge to equip us to challenge and support GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leadership team on performance. Board discussions are richer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 425.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and have increased intensity with every Board member <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contributing based on their specialist areas of knowledge. Our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussions focus on delivering our strategy and value creation, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whilst driving sustained value for patients, healthcare systems <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and society at large. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 482.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board changes<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the appointments made in recent years, I am pleased to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 506.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report that looking forward we have reached a period of stability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the Board&#8217;s membership. I reported last year that Urs Rohner <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">would step down at the AGM and be succeeded by Wendy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Becker. I set out in last year&#8217;s report the process we followed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 547.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for Wendy&#8217;s selection and appointment.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 587.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board industry experience<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 0pt; position: var(--position); top: 607.45pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g63.gif" alt="1172" style="height: 102.04pt; width: 229.88pt;"/></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 328.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Nominations &amp; Corporate Governance Committee has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">since undertaken two further search processes in collaboration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 348.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the Science Committee to refresh the Board&#8217;s scientific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expertise. These follow the departure of Dr Laurie Glimcher <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the Board in October 2022 and in anticipation of Dr Jesse <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodman retiring from the Board after nine years&#8217; service in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 389.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">May 2025.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We were pleased to announce the appointment of Dr Jeannie <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lee in March last year. In addition, Dr Gavin Screaton will join <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 425.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board in May, as Jesse retires. They both bring expertise in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key parts of our R&amp;D approach. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jeannie is Vice Chair of the Department of Genetics at Harvard <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medical School. She has brought her deep expertise in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific and medical innovation, including in the field of RNA <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biology and epigenetics.&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gavin is a prominent figure in the field of immunology and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infectious diseases. He is Head of the Medical Sciences <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Division at the University of Oxford, one of the world&#8217;s leading <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 529.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">academic research centres. Gavin&#8217;s work extends to other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">critical infectious diseases, including HIV, SARS, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19, where his research has influenced treatment and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 559.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention strategies worldwide.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 586.92pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Director tenure<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 607.36pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g64.gif" alt="2363" style="height: 104.88pt; width: 104.88pt;"/></div></div><div style="font-size: 0pt; left: 409.68pt; position: var(--position); top: 59.88pt; width: 101.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 11.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 11.25pt;"><span style="color: #575756; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 3.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.21pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Up to 3 years: 40%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 11.25pt; width: 11.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 11.25pt;"><span style="color: #7c7c7b; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 3.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 11.25pt; width: 90pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.21pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3-6 years: 40%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 22.5pt; width: 11.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 11.25pt;"><span style="color: #a8a8a7; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 3.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 22.5pt; width: 90pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.21pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6-9 years: 10%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33.75pt; width: 11.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 11.25pt;"><span style="color: #c6c6c6; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 3.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 33.75pt; width: 90pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.21pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 9 years: 10%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #ffffff; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 292.01pt; position: var(--position); text-decoration: none; white-space: pre;">111<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s governance statement continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board focus in 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board, both individually and collectively, has been deeply committed to driving forward GSK's purpose, strategy and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 140.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture to support the creation of long-term shareholder value. During the year, the Board&#8217;s priorities and time was broadly <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused as<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 96.96000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> follows:<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 129.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 179.07pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g65.jpg" alt="Board focus V2.jpg" style="height: 275.05pt; width: 487.72pt;"/></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 475.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is continuing to deliver meaningful and consistent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance improvements. This needs to be sustained <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through effective capital allocation and thoughtful strategic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">choices.&#160; The Board and management&#8217;s agendas are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">completely aligned with a clear focus on the three time periods <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that management communicates on &#8211; financial performance to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026, pipeline progress and business development to support <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the growth ambitions to 2031, and the science and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technologies that support the long-term growth of the business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">beyond 2031.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 582.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The primary focus of the Board&#8217;s work in 2024 was on building <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 592.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence in growth to 2031. In 2025, the Board will spend <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 603.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significantly more time on the period beyond 2031 and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced technologies that will shape the industry.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 629.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board remains extremely focused on disciplined allocation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 639.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of capital. The Board reviewed all of the strategies and priorities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 649.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prior to updates provided to the market. Our first priority for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 659.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital remains to invest in growth in R&amp;D. The growth strategy, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 669.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the launch of a share buyback programme and the increased <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 680.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend expectations provided with the 2024 annual results <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 690.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were reviewed extensively in the second half of the year, along <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 700.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with GSK&#8217;s longer-term strategic plan. This followed the Board, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Audit &amp; Risk Committee and management&#8217;s significant work <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 720.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in reducing the unnecessary exposures for the company and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 731.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders in respect of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 166.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation. The retirement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 741.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 74.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Zanta<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c risk, through the settlement of the vast majority of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 751.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the cases in the US, was an important step.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Targeted business development remains a key priority. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board and Science Committee worked alongside Emma and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the management team to understand the scientific rationale, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitiveness of the assets under consideration, and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential returns and value creation. This was a significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activity in 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board visits are an important element of our Board programme. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In March, the Board had a three-day<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 439.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> immersion in<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> our HIV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 562.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">franchise with a visit to ViiV&#8217;s hub in North Carolina, US. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 572.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided an opportunity to ensure that the Board has a deeper <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 582.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understanding of the future prospects of the HIV business. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 592.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meetings involved a panel discussion with key external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 603.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders from the HIV community, together with meetings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the ViiV management team and its key talent. It then <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concluded with a poster session with the R&amp;D team in their lab <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 633.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to review the HIV pipeline and ongoing projects. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In March this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 643.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the Board will hold its meeting in Philadelphia, US, for an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 654.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immersion in Oncology. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #ffffff; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">112<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s governance statement continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D progress and technology<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The longer-term future of the company will come from deep <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 137.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainable productivity of internally and externally sourced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 147.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D and from our investment in technology. We continue to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 157.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus on the significant opportunities that can come from AI/ML, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which continues to be a theme running through every Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meeting. Indeed, the path we set out on is rooted in our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitment to transform our productivity through the use of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology.Last year&#8217;s Board&#8217;s R&amp;D updates centred on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology &#8211; including ADCs, mRNA and RNA vaccines, immune <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 218.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ageing and B cell depletion. We also reviewed therapy area <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tech and target discovery. These discussions as always are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supported and validated by prior deep dives undertaken by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee. The Board was also very pleased to track <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D&#8217;s execution in the late stage pipeline during the year with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an exceptional 13 positive phase III clinical trial readouts across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory, Immunology &amp; Inflammation, Oncology, HIV and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infectious Diseases &#8211; a record for the company.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board continues to embrace the potential of AI/ML in every <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of the business. It is crucial to our medium- and long- term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success. We draw from the Tech expertise of our Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">members, most especially Dr Hal Barron, with his experience at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Verily and Google, and Dr Vishal Sikka&#8217;s tech vantage points <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 356.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and experience. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our CEO also continues to bring insights from her role at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Microsoft, along with my own experience of the use of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology in biotechs and the UK&#8217;s national genomics <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes. We hold educational briefings on new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developments in AI/ML and review cyber and tech incidents in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the external environment to seek to ensure GSK&#8217;s environment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to safely evolve at pace. Our biggest investment has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been in R&amp;D, but every part of GSK now has technology built <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 194.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">into its optimisation. Given the importance of Tech it was a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 205.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specific focus of the CEO&#8217;s 2024 objectives. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="height: 155.25pt; left: 53.88pt; position: var(--position); top: 407.82pt; width: 487.56pt; z-index: -1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g66.gif" alt="" style="height: 165.25pt; width: 497.56pt;"/></div><div><div><div style="transform: translate(1.37pt, 1.37pt);"></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 415.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 59.53pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial<span style="display: inline-block; height: 8pt;"></span><span id="ice499ac0d689441e8c4c6946358b1659_8381"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 106.42pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Reporting Council&#8217;s UK Corporate Governance Code (FRC Code)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 431.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 59.53pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial experience<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In accordance with the FRC Code, the Board determined that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft has recent and relevant financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience. It also agreed that he has the appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">qualifications and background to be an audit committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial expert as defined by the Sarbanes-Oxley Act of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2002, and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has<span style="display: inline-block; height: 6.18pt;"></span><span id="ice499ac0d689441e8c4c6946358b1659_8525"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> determined that he is independent within the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meaning of the Securities Exchange Act of 1934, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as&#160;amended<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Members of the Audit &amp; Risk Committee also have financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and industry experience, details of which can be found in their&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biographies on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">104</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 156.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 167.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i05f3d03bed7044b0896d2750d4d11063_536">107</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 431.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">C<span style="display: inline-block; height: 6.55pt;"></span><span id="ice499ac0d689441e8c4c6946358b1659_8524"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 311.22pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ompliance statemen<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 396.4pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">t<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board is pleased to report in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 428.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 447.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> it was in full alignment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the provisions of the FRC Code. The Board&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">explanation of how the Board considers its workforce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement arrangements to be effective is set out on page <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.52pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5bc0b908ecb14a93aaa235d37da9fd20_9305">117</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board is also pleased to report that it has consistently <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applied the principles of the Code, as set out on the pages of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this Corporate Governance report. A copy of the FRC Code <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is available on the FRC&#8217;s website at www.frc.org.uk.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">113<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance architecture<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_268"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g67.jpg" alt="Corp Gov arch NEW 3.jpg" style="height: 118.57pt; width: 487.72pt;"/></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c<span style="display: inline-block; height: 6.18pt;"></span><span id="i045a8f02f1c1423cbc8769bc5d57e6df_2741"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 74.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">orporate governance architecture<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is a framework designed to improve the Board's effectiveness and to support its oversight of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the GSK Leadership Team (GLT) as it delivers the company's strategy. This framework continues to evolve to support our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infrastructure and priorities as a pure biopharma business. GSK&#8217;s internal control and risk management arrangements are integral <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to our overall corporate governance framework and are described on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_160">60</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_175">71</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44117">130</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To make sure the framework is as effective as it can be, it:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 297.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has a clear division of responsibilities for individual and collective Board roles, as described on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 435.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5b3c67d472cc4d06afe2970e36443ded_0-0-1-1-821446">114</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distributes workload to Board committees that have the requisite skills and focus<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has highly committed Board Directors who are motivated to carry out their roles and responsibilities for the success of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 344.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Nominations &amp; Corporate Governance Committee periodically reviews this architecture and recommends any changes to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 354.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board. In 2024, the Committee undertook such a review of the structure to ensure the Board was operating effectively. Further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details and the results of this review are set out on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0b9f97bc8b0248f788931dd091ad58d5_0-0-1-1-821446">122</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="background-color: transparent; height: 412.5pt; left: 61.86pt; opacity: 1; position: var(--position); top: 380.93pt; width: 474pt; z-index: 1;"><div><div style="font-size: 0pt; width: 474pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 305.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 355.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 3.29pt; width: 355.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee roles<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.31pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.11pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on page<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 8.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 12.75pt; width: 305.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 8.16pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Role and focus<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 12.75pt; width: 83.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 8.16pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 45.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Membership<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 59.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 59.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&amp; Corporate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 59.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 305.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reviews the structure, size and composition of the Board, including appointment of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">members to Board committees. Makes recommendations to the Board as appropriate. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plans and assesses orderly succession for Executive and Non-Executive Directors and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews management's succession plan to ensure its adequacy<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Is responsible for overseeing, monitoring and making recommendations to the Board on <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporate governance arrangements. Reviews Board and GLT conflicts of interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 59.25pt; left: 355.5pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Chair) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 28.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 4.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0b9f97bc8b0248f788931dd091ad58d5_0-0-1-1-821446">122</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44106">123</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 305.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supports the Board in its understanding of business development transactions and the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key strategic themes on which the company's R&amp;D strategy is based, by reviewing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying scientific assumptions in detail and giving the Board technical assurance. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supports oversight of R&amp;D-related risks<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 355.5pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz (Chair)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron&#160; &#160; &#160; &#160; &#160; &#160; &#160;  <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 87.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 4.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie2e8e10dc6b44dc79a030e5952fed63b_0-0-1-1-821446">124</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44115">125</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 126pt; width: 305.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considers GSK's Trust priority and has oversight of our Responsible Business approach <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and strategy, performance and reporting. This reflects the most important issues for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible and sustainable business growth. Has oversight of the views and interests of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our internal and external stakeholders, and reviews issues that could have a serious <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact on GSK&#8217;s business and reputation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 355.5pt; overflow: hidden; position: var(--position); top: 126pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal (Chair)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Vishal Sikka<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 126pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 3.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i12c9ca02685c42be9149e56e9b842bb7_0-0-1-1-821446">125</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44103">126</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 68.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 305.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reviews the financial reporting process, the integrity of the company&#8217;s financial statements, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the external and internal audit process, the system of internal control, and the identification <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and management of risks such as Information and cyber security, and the company&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process for monitoring compliance with laws, regulations and ethical codes of practice<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">Oversees Responsible Business data reporting and assurance. Initiates audit tenders, the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">selection and appointment of the external auditor, setting the auditor's remuneration and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.014em; position: var(--position); text-decoration: none; white-space: pre;">overseeing its work<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 355.5pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft (Chair)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth McKee <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anderson<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 173.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 3.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44091">127</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44105">133</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 71.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 71.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 71.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 305.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sets the company&#8217;s Remuneration policy having regard to GSK&#8217;s workforce remuneration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">so that GSK is able to recruit, retain and motivate its executives<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 23.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regularly reviews the Remuneration policy to make sure that it is consistent with the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s scale and scope of operations, supports the business strategy and growth <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plans, is aligned to the wider workforce and helps drive the creation of shareholder value<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(The Chair and the CEO are responsible for evaluating and making recommendations to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 62.67pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board about remuneration arrangements and policy for the Non-Executive Directors)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 71.25pt; left: 355.5pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker (Chair) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth McKee <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anderson&#160; &#160; &#160; &#160; &#160; &#160; &#160;  <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft&#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 241.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 3.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5266">174</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chairs&#8217;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 305.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acts on behalf of the Board between its scheduled meetings to take decisions on urgent <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters in accordance with matters and authority delegated to it by the Board from time to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 305.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 355.5pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(company Chair)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.67pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Independent <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.67pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.67pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee Chairs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438.75pt; position: var(--position); top: 312.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 12.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="4" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 360pt; width: 474pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 474pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each Board committee has written terms of reference that are approved by the Board and reviewed at least annually to make sure they comply <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 474pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the latest legal and regulatory requirements and reflect best practice developments. The Terms of reference of each Board committee is <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.67pt; width: 474pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available at gsk.com. <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="height: 417.25pt; left: 53.83pt; position: var(--position); top: 380.93pt; width: 486.53pt; z-index: -2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g68.gif" alt="" style="height: 427.25pt; width: 496.53pt;"/></div><div><div><div style="transform: translate(1.42pt, 1.42pt);"></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">114<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance architecture continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 17.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><span id="i5b3c67d472cc4d06afe2970e36443ded_0-0-1-1-821446"></span></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 417.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 17.25pt; position: var(--position); top: 14.25pt; width: 213.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Leadership<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 18.52pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 27.53pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 41.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leads and manages the business of the Board<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 52.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provides direction and focus<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 63.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">makes sure there is a clear structure for the Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 73.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and its committees to enable them to operate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 83.82pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectively<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 95.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintains a dialogue with shareholders about the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 105.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance of the company<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 116.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sets the Board agenda and ensures sufficient time is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 126.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allocated to promote effective debate and sound <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 136.82pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decision-making<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 148.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">makes sure the Board receives accurate, timely and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 158.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clear information<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 169.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meets regularly with each Non-Executive Director to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 179.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discuss individual contributions, performance and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 189.82pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">training and development needs<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares peer feedback as part of the Board evaluation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 211.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meets regularly with all the Non-Executive Directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independently of the Executive Directors<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 248.51pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.7pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; The Chair&#8217;s role description is available at gsk.com <span style="display: inline-block; height: 8.57pt;"></span></span><div style="left: 2.63pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 8.57pt; width: 9.07pt;"/></div></div></div><div style="line-height: 7.5pt; position: var(--position); top: 277.06pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Executive Officer<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.07pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.56pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manages the Group and its business<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.76pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">develops the Group&#8217;s strategic direction for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.96pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board's consideration and approval <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.16pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implements the agreed strategy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.36pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is supported by the GLT<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 354.56pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintains a continuous dialogue with shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.76pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">about the company&#8217;s performance<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 380.65pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.7pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; The Chief Executive Officer&#8217;s role description is available <span style="display: inline-block; height: 8.57pt;"></span></span><div style="left: 2.63pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 8.57pt; width: 9.07pt;"/></div></div></div><div style="line-height: 7.5pt; position: var(--position); top: 392.26pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160;  at gsk.com <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 629.96pt; left: 53.86pt; opacity: 1; position: var(--position); top: 113.39pt; width: 487.56pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g69.jpg" alt="NEW GOV ARCH BG.jpg" style="height: 629.96pt; width: 487.56pt;"/></div></div></div></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 306.22pt; position: var(--position); top: 0pt; width: 220.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 213.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 420pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 420pt; left: 3pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 213.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">Independent oversight and rigorous <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.83pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.015em; position: var(--position); text-decoration: none; white-space: pre;">challenge<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.72pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Independent Non-Executive Director<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 40.73pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 54.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acts as a sounding board for the Chair and a trusted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 64.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intermediary for other Directors<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 75.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">together with the Non-Executive Directors, leads the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 85.82pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual review of the Chair&#8217;s performance, taking into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 96.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">account the views of the Executive Directors<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 107.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discusses the results of the Chair&#8217;s effectiveness <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 117.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review with the Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 128.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leads the search and appointment process and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 138.82pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">makes the recommendation to the Board for a new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 160.22pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acts as an additional point of contact for shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.42pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and maintains an understanding of their issues and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.62pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concerns through meetings with shareholders and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.82pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">briefings from the Company Secretary and Investor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.02pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relations<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 216.91pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.7pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; The Senior Independent Non-Executive Director&#8217;s role<span style="display: inline-block; height: 8.57pt;"></span></span><div style="left: 2.63pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 8.57pt; width: 9.07pt;"/></div></div></div><div style="line-height: 7.5pt; position: var(--position); top: 228.52pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160;  description is available at gsk.com<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 250.51pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide a strong independent element to the Board<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.2pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">constructively support and challenge management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 285.4pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and scrutinise its performance in achieving agreed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.6pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliverables<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.8pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shape proposals about strategy and offer specialist <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advice to management<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.2pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each has a letter of appointment setting out the terms <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.4pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and conditions of their directorship<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.6pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">devote such time as is necessary to properly carry <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.8pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out their duties<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are expected to attend all meetings as required<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 394.69pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.7pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; The Non-Executive Directors' role description is available <span style="display: inline-block; height: 8.57pt;"></span></span><div style="left: 2.63pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g15.jpg" alt="Read.more.jpg" style="height: 8.57pt; width: 9.07pt;"/></div></div></div><div style="line-height: 7.5pt; position: var(--position); top: 406.3pt; width: 213.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160;  at gsk.com<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 586.6pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 465pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 102.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 362.25pt;"/></tr><tr style="height: 123.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 102.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 102.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; Company Secretary<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 11.64pt; width: 102.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; &#160;  Victoria Whyte<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102.75pt; position: var(--position); top: 0pt; width: 362.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">secretary to the Board and all Board committees<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 13.83pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supports the Board and Committee Chairs to plan agendas and annual programmes<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 25.03pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensures information is made available to Board members in a timely fashion<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 36.23pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supports the Chair to design and deliver Board inductions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 47.43pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">coordinates continuing business awareness and training for the Non-Executive Directors<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 58.63pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertakes internal Board and committee evaluations at the Chair's request<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 69.83pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advises the Directors on Board practice and procedures and corporate governance matters<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 81.03pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chairs the Group's Disclosure Committee<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 92.23pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operates a Board-approved appointments policy that reflects the Board and external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 102.43pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointment requirements of the UK Corporate Governance Code<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.63pt; width: 362.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is a point of contact for shareholders on all corporate governance matters<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">115<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance architecture continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span><span id="i045a8f02f1c1423cbc8769bc5d57e6df_2734"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 77.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Board and committee attendance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="background-color: transparent; height: 308.25pt; left: 55.3pt; opacity: 1; position: var(--position); top: 130.92pt; width: 480.75pt; z-index: 2;"><div><div style="font-size: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/></tr><tr style="height: 28.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chairs&#8217;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.97pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.77pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.57pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governance<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.11pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 123.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total number of routine meetings<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current members<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Attended<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 13.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 13.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth McKee Anderson<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4 (5)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 13.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 117pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 117pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 117pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5 (6)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (4)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4 (5)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (3)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (3)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 13.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (3)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 168pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 168pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 168pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee (joined 4 March 2024)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4 (5)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (4)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 13.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 193.5pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Vishal Sikka<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 193.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 193.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 207pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired members<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 13.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urs Rohner (until 8 May 2024)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (3)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 177.75pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 (1)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 228.75pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2 (2)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 (3)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 13.5pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.27pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 (1)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of additional meetings<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 126.75pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 279.75pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 330.75pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="15" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 246pt; width: 480.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 7.36pt; width: 480.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In agreement with the Chair, Charles Bancroft and Dr Anne Beal missed meetings in December and March 2024 respectively due to extenuating <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 15.76pt; width: 480.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances. Dr Jeannie Lee joined the Board in March 2024. In her first year as a director she was able to attend all meetings, other than the Board&#8217;s <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 24.16pt; width: 480.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meetings in May 2024 which unfortunately clashed with pre existing external commitments. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.56pt; width: 480.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For those Directors who served for part of the year, the numbers in brackets show the number of meetings they were eligible to attend. Details of committee <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 44.96pt; width: 480.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">members&#8217; skills and experience are included in their biographies on pages <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 228.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_256">104</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 240.20000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 249.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i05f3d03bed7044b0896d2750d4d11063_536">107</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 261.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="height: 191.4pt; left: 53.88pt; position: var(--position); top: 457.83pt; width: 487.56pt; z-index: -3;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g70.gif" alt="" style="height: 201.4pt; width: 497.56pt;"/></div><div><div><div style="transform: translate(1.25pt, 1.25pt);"></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 462.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  Board appointments policy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All our Non-Executive Directors are expected to devote such time as is necessary for the performance of their duties. Each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 489.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director is required to attend a minimum of 75% of scheduled Board and committee meetings. However, we recognise that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 499.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there may be rare occasions when this is not possible. Special allowance is also given during the first year of Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mem<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 78.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bership while ca<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lendars are aligned. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Board Directors&#8217; external appointments are governed by a Board-approved policy. External appointments can help Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and GLT members widen their expertise and knowledge, and perform their roles more effectively. When proposing a new Non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director appointment to the Board for approval, the Board considers the other demands on the individual&#8217;s time. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before being appointed to the Board, an individual is required to disclose the significant commitments they may have with an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indication of the time involved. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 582.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board considers and approves all additional external appointments for serving Directors, noting the nature of the role and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 592.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">type of organisation, time commitment and any potential conflicts that could arise.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 608.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Company Secretary maintains a register of commitments and potential conflicts. The Board is satisfied that given <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 618.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; other interests, each has sufficient time to carry out their GSK role. Our Executive and Non-Executive Directors may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 628.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertake a maximum of one and up to four other listed-company directorships respectively.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">116<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board activities<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_271"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g71.jpg" alt="Board activites.jpg" style="height: 58.7pt; width: 487.72pt;"/></div></div></div><div style="position: absolute; top: 187.71pt;" id="idc89fa1ee07645df9629d157a4b46752_274"></div><div style="position: var(--position); top: 187.71pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engagement<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 220.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Prioritising continuous en<span style="display: inline-block; height: 8pt;"></span><span id="i5bc0b908ecb14a93aaa235d37da9fd20_9307"></span><span id="i5bc0b908ecb14a93aaa235d37da9fd20_9308"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 187.88pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">gagement<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our stakeholders rightly have high expectations of us, and our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 246.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dynamic operating environment presents many challenges and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 256.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities. As a Board, we aim to balance our commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success with our stakeholders&#8217; expectations, upholding our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reputation, maintaining our licence to operate and building trust. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We engage with, or are briefed about, our stakeholders' views <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 297.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to make sure we identify and respond to their expectations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectively and appropriately. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 323.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How we engage with our main stakeholder groups &#8211; including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 333.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, shareholders, customers and our people &#8211; is covered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the pages of the Strategic report. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patients and our people are the heart of our culture. Our people <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are accountable for outcomes and committed to doing the right <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thing. Our culture is described on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">56</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i790f5ce0ebd74867a80debd26af98cda_8707">58</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 390.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic report.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 406.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The influence and importance of different stakeholder groups <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">can vary, depending on the matter being considered. Certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders&#8217; interests can be in conflict, meaning that we, as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board, need to make balanced judgements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Continuous stakeholder engagement and feedback helps us <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identify emerging issues. It also enables us to make decisions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the context of what is relevant and important to each of them.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our principal Board committees, and the GLT, undertake <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 499.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement on the Board&#8217;s behalf according to their remit. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 509.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">means that they can build a detailed understanding of how our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 519.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions or plans are affecting or might affect stakeholders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 529.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These insights are then shared with the Board.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In particular, the Board receives briefings on stakeholders&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">perspectives from the work of the Corporate Responsibility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee, which is discussed on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i12c9ca02685c42be9149e56e9b842bb7_0-0-1-1-821446">125</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44111">126</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 581.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board members regularly receive:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 597.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the CEO&#8217;s Board report<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 608.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a specific external stakeholder insights report. This provides <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 619.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic insights based on an analysis of key developments, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 629.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achievements and risks affecting our reputation and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 639.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">perceptions of all our external stakeholders<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a regular investor relations report which summarises investor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">perceptions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regular corporate governance, litigation and regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">updates<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board also learns of stakeholders&#8217; views through:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 724.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engagement and feedback events: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 186.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as quarterly investor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 735.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results calls, the Annual General Meeting, employee survey <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 745.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports, the Board&#8217;s workforce engagement activities, and from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 755.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experts presenting at Board or committee meetings. The Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also holds regular investor check-in meetings, which the Senior <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 775.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Non-Executive Director, Charles Bancroft, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 786.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sometimes joins, and is available for individual meetings with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 796.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investors.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 220.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other opportunities:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Board members also receive wider <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 230.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholder views during the annual strategy meeting with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 240.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GLT, as part of the yearly review of strategy, budget and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 250.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">planning processes. This also includes a review of specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 260.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">aspects of the company&#8217;s policies or strategy. In addition, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board members are encouraged to meet individually with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees, shareholders and other key stakeholders during <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their induction, and then on an ongoing basis. They are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected to report to the Board on such experiences where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 311.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant and material.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 327.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Engaging with our shareholders<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a Board, we aim to directly engage with and be directly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accountable to institutional investors and private retail <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders. We do this in several ways, including regular <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 374.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">communications, the Annual Governance Meeting, our Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 384.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Meeting, and through the work of our Investor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relations team, the Chair, Jonathan Symonds, and our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Company Secretary, Victoria Whyte. Our Senior Independent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Director, Charles Bancroft, is another point of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 425.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contact for our shareholders.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each quarter, our CEO, Emma Walmsley, and CFO, Julie <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 451.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brown, give results presentations to institutional investors, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">analysts and the media by webcast. They are also regularly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joined by the Chief Scientific Officer, the Chief Commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Officer, and CEO, ViiV Healthcare and President, Global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 492.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Health, GSK. They are able to provide investors with more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 502.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">detailed insights into their specific areas of responsibility.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Through regular meetings, Emma and Julie each have an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ongoing and active dialogue with institutional shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">about the company's performance, plans and objectives. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO: 69 engagements, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representing 36% of the company's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issued share capital<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 586.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CFO: 134 engagements, comprising 41% of the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issued share capital<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 618.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Chair maintains a consistent dialogue with shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 628.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">too &#8211; including fund and portfolio managers &#8211; and regularly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 638.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engages with governance and sustainability professionals. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 648.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and up to the date of publication of this Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 659.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report, Jon held over 30 individual meetings with a range of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 669.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">institutional shareholders, and met or corresponded with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders which make up approximately 60% of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 689.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s share capital. This enables him to gain a current <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 699.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understanding of shareholders' views, insights and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">perspectives of the company. He also discusses the continual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 720.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolution of the many aspects of Board governance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 730.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance oversight and succession.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">117<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board activities continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Annual Governance Meeting<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We held this year&#8217;s hybrid meeting in central London at our new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 137.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HQ. We invited institutional shareholders (representing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 147.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately 60% of our share capital), key investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 157.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry bodies and proxy advisory firms. Approximately 25 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representatives of various institutional shareholders and proxy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advisers attended the event, comprising around 30% of GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share capital.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The meeting is designed to be as interactive as possible. It <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 214.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">began with our Chair sharing the Board's priorities and focus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for 2024 and beyond, with our Remuneration Committee Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">then giving an update on the initial 2025 Remuneration Policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposals. Our Chair, Remuneration Committee Chair and our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors then held an informal and open <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussion of those issues on shareholders' minds, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">helped foster a richer dialogue.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The key themes covered included the:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board&#8217;s focus on value creation, governance and oversight of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board focus areas of 2024<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Initial proposals for the 2025 Remuneration Policy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The meeting was well received and shareholder feedback was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shared with the Board.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 381.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Annual General Meeting<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We were pleased to hold the company's AGM at the Royal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lancaster Hotel in May 2024 for shareholders to attend in-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 415.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">person or virtually (a hybrid meeting). <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We welcomed 125 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 425.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders in person and 38 shareholders virtually via the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lumi platform<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to watch and hear updates from our Chair and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the CEO, ask questions and to vote. Our shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved all resolutions, with majorities ranging from 92% to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99%.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our hybrid AGM this year will be held at a new venue, The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 492.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Landmark London hotel in Central London, which is located <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 502.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">near our new global headquarters. For more details see page <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.11pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_667">289</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 539.2pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g72.jpg" alt="New AGM pic.jpg" style="height: 146.65pt; width: 236.78pt;"/></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Engaging with our people<span style="display: inline-block; height: 8pt;"></span><span id="i5bc0b908ecb14a93aaa235d37da9fd20_9305"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 130.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have well-established and strong engagement mechanisms <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 141.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with our employees, which the Board monitors regularly. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement mechanisms are described on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">56</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 503.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 514.6800000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i790f5ce0ebd74867a80debd26af98cda_8707">58</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 524.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Four key governance channels help the Board understand what <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our people are thinking:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regular Board updates from our Chief People Officer and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO on culture and talent (please see pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.32000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">56</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 504.32000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i790f5ce0ebd74867a80debd26af98cda_8707">58</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.6800000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further details on our culture and people)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback from an annual employee engagement survey, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including questions on engagement, confidence and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inclusivity<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 250.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a range of pulse surveys of different-sized employee groups <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to help check sentiment on a quicker and more frequent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basis, and to provide valuable insights on the impact of major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initiatives, events or communications and direct engagement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Board<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 302.87pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g73.jpg" alt="Engagement pic.jpg" style="height: 141.89pt; width: 236.78pt;"/></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 455.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Workforce engagement: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before the company's demerger, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board reviewed its formal workforce engagement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements. We decided to move from a specific Workforce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engagement Director model and to apply an &#8216;alternative <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangement&#8217; to the three methods set out in the FRC Code.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 512.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given that the GSK Board was refreshed in terms of tenure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with a renewed purpose and focus as a global biopharma <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company, we considered at that time the importance of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adopting a collective Board engagement model. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to agree this to be the most effective approach to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure it hears employees&#8217; views directly.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The model operated effectively in 2024 through:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 594.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in-person receptions with local employees during Board site <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">visits, including in Durham (North Carolina, US), Boston <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Massachusetts, US) and our new global headquarters in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">central London<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 636.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Chair's site visits, including to Upper Providence <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 646.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Pennsylvania, US) and Wavre (Belgium) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 658.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Chair's attendance at management meetings, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 668.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Saudi Arabia and China<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Chair and Corporate Responsibility Committee Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 689.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">organising and attending ongoing meetings with leaders of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 699.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our employee resource groups to talk about how they <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience GSK and to hear their suggestions to further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 720.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enhance support and ensure that we meet the needs of all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 730.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our employees to enable them to do their best work for GSK<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 741.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a variety of bespoke engagements that have enabled a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 751.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">broad and open dialogue and facilitated first-hand <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 762.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement discussions between the Non-Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 772.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors and our people individually and as part of small <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 782.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">groups, encompassing perspectives on our strategy, purpose <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 792.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Ahead Together culture<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">118<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board activities continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_277"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meeting programme<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 143.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To work in the most effective way, the Board's annual meeting programme focuses on delivering our short-, medium- and long-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 153.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy. The Board meeting programme is completely aligned with the Board committees&#8217; and management&#8217;s agendas with a clear <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 163.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus on these three strategic time periods that we communicate on &#8211; financial performance to 2026, pipeline progress and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business development to support our growth ambitions to 2031, and the science and technologies that support growth beyond <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the year, the overriding focus of the Board&#8217;s work was on building confidence in our growth strategy to 2031. In 2025 the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board will spend increased time on our strategy beyond 2031.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 225.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In support of this work, the Board received papers and presentations and discussed progress with management and our people on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the key areas of focus set out below. These materials and discussions help the Board make effective decisions, and contribute to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 246.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its oversight of business performance and ensure good governance.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 262.21pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 60.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 213pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 213pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 60.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 60.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Areas of focus in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 60.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="7" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 91.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 60.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Execution of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 60.75pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 426pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overseeing GSK as a pure biopharma business and delivery of our 2031 growth strategy and beyond included:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 33pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">setting and approving the Board's 2024-2025 priorities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 47.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scrutinising updates on R&amp;D strategy and progress, and progression of our pipeline<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 61.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing approach to data technology to accelerate our ambitions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 72.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing the critical role and ambitions for our global supply chain <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 84pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussing our overall commercial strategy <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 98.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussing progress on our AI adoption strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="10" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 129pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 60.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strengthening <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">model<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 60.75pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 426pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overseeing the fundamentals of commercial execution, cost-base management, capital allocation, pipeline and culture included:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 121.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receiving regular reports from the CEO, CFO and CSO including the assessment of delivery of performance targets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 132.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing the product area strategy reports on Specialty Medicines, General Medicines and Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 147pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased growth strategy to 2031 and set short-term guidance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 158.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing GSK's capital allocation priorities to ensure investment for growth to deliver improved returns for shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 170.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instigating a &#163;2 billion share buyback programme<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 181.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluating business development transactions, acquisitions and strategic partnerships with third parties including iDRX, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chimagen Biosciences, Flagship Pioneering, CureVac and Aiolos Bio<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 201.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scrutinising the Group's financial performance, shareholder value creation and development of Investor Relations Roadmap<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 213.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing and endorsing approach to concluding <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 172.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 195.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> litigation <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 225pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approving the monetisation of the retained shares in Haleon<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="4" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 0pt; overflow: hidden; position: var(--position); top: 239.25pt; width: 60.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Enhancing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 60.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 60.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leadership<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 60.75pt; overflow: hidden; position: var(--position); top: 239.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overseeing culture and embedding Responsible Business included:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 253.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endorsing approach to Double Materiality Assessment reviewed by the Audit &amp; Risk and Corporate Responsibility <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committees&#8217; joint session<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 273.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approving the Responsible Business Performance Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 288pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing stakeholder perception research<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="12" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 183.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 299.25pt; width: 60.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regular <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 60.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 60.75pt; overflow: hidden; position: var(--position); top: 299.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board&#8217;s programme of governance included:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 313.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing the quarterly financial results, dividend proposals, earnings guidance, investor materials, results announcements <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.05pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2023 Annual Report and Form 20F, and receiving related reports from the external auditor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 334.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">setting the annual budget and the forward-looking three-year plan and long-range forecast<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 348.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conducting an annual review of the enterprise risk responsibility framework and enterprise-wide risks<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 363pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertaking an annual Board evaluation and implementing its agreed outcomes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 377.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receiving reports on Board committee work and reviewing and continuing to evolve the Board&#8217;s governance architecture<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 391.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluating the CEO&#8217;s 2024 performance, and setting her 2025 objectives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 405.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing culture, talent and succession plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 420pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 7.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engaging with our stakeholders and people to gather and understand their views about our activities, operations and culture<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 440.25pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewing the employee pulse survey results<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 454.5pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receiving reports on wider corporate governance and regulatory developments, and the Company Secretary&#8217;s report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 60.75pt; position: var(--position); top: 468.75pt; width: 426pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 426pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approving the company's modern slavery statement and gender pay gap positioning<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">119<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board activities continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_283"></div><div style="font-size: 12pt; line-height: 14pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: 51.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key decisions <span style="display: inline-block; height: 10.19pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 140.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In its decision-making, the Board focuses on GSK's priorities as a pure biopharma company with strong momentum and big <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambitions, whilst balancing the interests of our stakeholders. Examples of some of the key decisions taken by either the Board or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its Committees to drive our purpose, momentum and strategy include:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 177.18pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 101.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 107.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Decision<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">How the Board/Committee regarded stakeholder interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Stakeholder groups <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 128.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 128.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Upgraded ambition for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 26.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board considered <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 35.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upgrades to the long-term <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ambitions for GSK, through <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investing for&#160; the future and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 62.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrating belief in the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">short-, medium, and long-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">term and delivering attractive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">returns to shareholders. <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 128.25pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">In June 2021, GSK articulated to shareholders the growth strategy for the periods <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">to 2026 and 2031. This was updated at the beginning of 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Given GSK&#8217;s continued improved performance and strong momentum as a focused <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">biopharma company in addition to the settlement of the <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 184.34pt; position: var(--position); white-space: pre;">Zantac<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 207.26000000000002pt; position: var(--position); white-space: pre;"> litigation, the Board <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.48pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">and Audit &amp; Risk Committee agreed that a further update to investor expectations <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.85pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">was appropriate. The second update was announced with the company&#8217;s 2024 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 69.22pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">annual results in February 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 79.09pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 88.96pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The Board has reviewed with management the product and business forecasts and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.33pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">the gap between the market&#8217;s view of valuation and our own. The Board discussed <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.7pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">with management appropriate presentation of this to the market at a number of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 117.07pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">meetings throughout the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 128.25pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Governments and regulators, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">employees, healthcare <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">providers, patients and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">investors <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 167.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 167.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 139.5pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share buyback <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">programme<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 26.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board reviewed and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 35.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved plans for a &#163;2 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion share buyback <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 167.25pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 139.5pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"> The Board reviewed and approved plans for a &#163;2 billion share buyback<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">programme, to be implemented over the next 18 months. The programme <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.87pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">commenced on 24 February 2025 with an initial tranche of up to &#163;0.7 billion<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.61pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The priority for capital remains to invest in growth and in R&amp;D. Equally, the Board<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 51.48pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">recognises that the value of GSK shares does not currently reflect its confidence in<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 61.35pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">our growth strategy. The Board was very mindful of this and the need to deliver <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 70.72pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">better shareholder value over the short-, medium- and long-term timeframes. We <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.09pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">thought deeply about the gap between the market&#8217;s view of valuation and our own. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.46pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Whilst investing in the business will always be the first priority for the use of capital, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.83pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">the Board believes that the balance sheet is now strong enough to support a share<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 108.7pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">buyback. This was intended to be a clear demonstration of the Board&#8217;s belief in the<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 118.57pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">medium- and long-term growth prospects of GSK<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 138.31pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Importantly, the company will maintain planned increased levels of investment in<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 148.18pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D, new launches and targeted business development, alongside the share<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 158.05pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">buybacks<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 167.25pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 139.5pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Patients, employees and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">investors <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 119.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 119.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.35pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> litigation <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">resolution<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 26.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board approved the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 35.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settlement of the vast majority <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 5.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Zantac <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation cases<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 119.25pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The Audit &amp; Risk Committee exercised primary oversight for the<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 210.52pt; position: var(--position); white-space: pre;"> Zantac<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 235.52pt; position: var(--position); white-space: pre;"> litigation,<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">including the related accounting, disclosure and communication assessments. The<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 22.37pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Board approved the terms of the settlement of 93% (approximately 80,000 cases)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.24pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">of US state court <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 57.69pt; position: var(--position); white-space: pre;">Zantac<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 80.61pt; position: var(--position); white-space: pre;"> product liability cases for up to $2.2 billion. It also<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 42.11pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">approved a separate settlement to pay a total of $70 million to resolve the separate<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 51.98pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Zantac<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.720000000000002pt; position: var(--position); white-space: pre;"> qui tam complaint. The settlements were agreed with no admission of<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 61.85pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">liability<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 81.59pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The costs of these settlements were funded through existing resources, with no<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 91.46pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">changes to GSK&#8217;s growth agenda or investment plans for R&amp;D as a result. The <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 100.83pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">latest status of the <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 62.699999999999996pt; position: var(--position); white-space: pre;">Zantac <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 87.7pt; position: var(--position); white-space: pre;">litigation is set out in Note 47 to the Financial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 110.2pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">statements, Legal proceedings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 119.25pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Governments and regulators, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">employees, patients and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">investors <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 201pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 201pt; left: 0pt; overflow: hidden; position: var(--position); top: 426pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">reporting <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 26.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board endorsed the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 35.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations of the Audit <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&amp; Risk and Corporate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility committees to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 62.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adopt management's <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposals regarding the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Double Materiality <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assessment (DMA) and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolution of Responsible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 107.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business reporting<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 201pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 426pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;"> In a joint session, the Audit &amp; Risk and Corporate Responsibility committees<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">reviewed management's roadmap to compliance with the European Union<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 22.37pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Corporate Sustainability Reporting Directive (CSRD), for inclusion in GSK&#8217;s 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.24pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Annual and Responsible Business Performance &amp; Disclosure reports<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 51.98pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The DMA, which comprised both financial (risks and opportunities) and impact<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 61.85pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">(positive and negative) materiality assessments resulted in the identification of<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.72pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">eight subtopics broadly aligned with our six focus areas and our Responsible<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 81.59pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Business Performance Rating system<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 101.33pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The committees agreed, and the Board endorsed:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 111.2pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">management's assessment of the subtopics identified as being material<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 121.07pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">the materiality threshold used, based on the assessment of financial and impact <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 130.44pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">materiality<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 140.31pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">the proposed updates to our Responsible Business reporting strategy, including<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 150.18pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">the production of a Responsible Business Performance &amp; Disclosure Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 201pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 426pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Governments and regulators, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">employees, patients and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">investors <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">120<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board activities continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key decisions continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 101.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 279pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 107.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Decision<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 279pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">How the Board/Committee regarded stakeholder interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Stakeholder groups <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 171pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 171pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Data technology and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">accelerating GSK's <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 24.23pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ambition<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.72pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board reviewed and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.72pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endorsed plans, including <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 55.72pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress made on our AI <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 64.72pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adoption strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 171pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;"> The Board reviewed and provided feedback on the technology priority objectives<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">and management's approach to integrating technology into the core of GSK. In<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 22.37pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">particular, AI represented a transformative opportunity for patient and shareholder<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 32.24pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">impact, with a focus on achieving significant breakthroughs in scientific innovation,<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 42.11pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">target identification and accelerating the progress of our pipeline<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 61.85pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">While the opportunities presented by AI are clear and would be progressed at<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.72pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">pace, this would need to be balanced against:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 81.59pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">People and change: enlisting everyone at GSK in this effort and increasing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 90.96pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">digital fluency across the company<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 100.83pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">Data &amp; Trust: meeting and maintaining the highest standards with regard to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 110.2pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">trust and integrity in how we use and manage data<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 120.07pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">External healthcare ecosystem: assessing the ecosystem of healthcare <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 129.44pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">providers, payers and regulators for digital opportunities and risks to manage<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 149.18pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The Audit &amp; Risk Committee also undertook a review of the evolution and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 158.55pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">operational effectiveness of our AI Governance arrangements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 171pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Patients, employees, investors, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">governments and regulators, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">healthcare providers, payers<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 191.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 191.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business development<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 16.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Science Committee <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 25.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered the scientific <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 34.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">merits of business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 43.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development opportunities <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 52.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and, where relevant, for late <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 61.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stage assets commercial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 70.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews, prior to the Board's <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 79.12pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review and approval<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 191.25pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The Board, with support from the Science Committee and commercial reviews for<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">late stage assets, reviewed many business development opportunities during the<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 22.37pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">year. Those leading to concluded transactions included:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 42.11pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">restructuring of the CureVac collaboration under which GSK has assumed full <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 51.48pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">control of developing and manufacturing candidates for seasonal influenza and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 60.85pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">COVID-19 in phase II and avian influenza in phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 70.72pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">acquisition of an investigational T cell-engager from Chimagen Biosciences to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.09pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">expand the immunology pipeline<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.96pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">acquisition of iDRX, including the lead molecule being developed as a first- and-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 99.33pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">second-line therapy for the treatment of Gastrointestinal Stromal Tumour (GIST)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 109.2pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">partnership with Flagship Pioneering to discover novel medicines and vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 119.07pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">acquisition of Aiolos Bio, including the phase II-ready long-acting antibody for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 128.44pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">the treatment of adult patients with asthma and with potential for additional <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 137.81pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">indications<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 157.55pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">These deals were considered in the context of their potential to help us deliver <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 166.92pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">transformational medicines to patients and drive growth by accelerating our <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 176.29pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">pipeline<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 191.25pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Patients, employees and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">investors <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 117.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 117.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 373.5pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration policy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">review<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 26.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Remuneration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 35.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee approved a new <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and performance measures, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 62.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which is subject to a binding <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 71.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder vote at our 2025 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.92pt; width: 101.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual General Meeting<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 117.75pt; left: 101.25pt; overflow: hidden; position: var(--position); top: 373.5pt; width: 279pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Prior to developing the 2025 Remuneration policy, the Remuneration Committee <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">and Board chairs, on behalf of the Committee:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">undertook an extensive consultation process with our major investors, as well <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">as proxy advisers, on the proposed changes<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.98pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">met with the Chief People Officer and HR leads for each area of the business to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 60.35pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">hear their views on our remuneration arrangements at GSK and wider <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 69.72pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">workforce pay alignment opportunities<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 89.46pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The Committee then carefully considered the feedback be<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 194.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fore finalising the Policy. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 99.66pt; width: 279pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further details are on page<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 91.8pt; position: var(--position); white-space: pre;">s <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 97.63pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_28963">134</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 110.14pt; position: var(--position); white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 120.55pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28337">164</a><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 133.06pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 117.75pt; left: 380.25pt; overflow: hidden; position: var(--position); top: 373.5pt; width: 107.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Our people, investors, patients, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">governments, regulators and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 107.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">proxy advisers<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">121<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board activities continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_286"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluation<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 138.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 88.18pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">performance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board evaluates its performance, and that of its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committees, every year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The evaluation is normally carried out externally every third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year. The most recent external evaluation was facilitated in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022 by Jan Hall of No 4, a business advisory company that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 211.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">does not have any other connection with GSK. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The 2024 Board and committee evaluation was conducted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 237.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internally by the Senior Independent Non-Executive Director <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SID), supported by the Company Secretary.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 263.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Action points <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">After due consideration and discussion, the Board noted that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board had performed well during the year and was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing to deliver to a new standard. The first phase of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s transformation since the demerger had built a foundation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of consistent execution and delivery. The Board&#8217;s priorities, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme and meetings were well targeted and Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materials continued to improve and focus on key areas of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussion. Board discussions were robust and intense.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In terms of evaluating its performance for 2024, the Board&#8217;s key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 376.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration was that the value of GSK shares does not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currently reflect its confidence in GSK&#8217;s growth strategy.&#160; The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 397.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors were very determined that GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliver better shareholder value over the short-, medium- and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long- term timeframes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board thought deeply about the gap between the market&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">view of GSK&#8217;s valuation and its own, during the course of 2024.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Whilst the Board was clear<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> that investing<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in the business will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">always be the first priority for the use of capital, the balance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 474.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet is now strong enough to support a share buyback. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 484.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board wanted this to be seen as a clear demonstration of its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belief in the medium- and long-term growth prospects for GSK.&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 510.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board will continue to review performance in this regard <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 520.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and consider other actions to address the gap if necessary. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In terms of the action points from the 2024 Board evaluation, it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was noted that: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 562.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board held a deep dive with the Chief People Officer on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 572.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK culture and considered the key elements of GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture training provided to each employee. The Board would <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 593.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to be briefed on the evolution of GSK&#8217;s culture<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board engagement opportunities with employees were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased and had evolved to provide more focused <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 624.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagements. In addition, from 2025 the Board will begin <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engaging more frequently with the participants in GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 645.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Enterprise Leadership Programme<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 656.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Nominations &amp; Corporate Governance Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 666.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertook a review of each Board committee&#8217;s remit and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 676.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scope to ensure that they remained appropriate. They were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 687.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">then updated to reflect the changes<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 138.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board committee evaluations<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The review of the Board committees focused on potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities to further support GSK's momentum in its third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year as a pure biopharma company, to help remove duplication <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and support the delivery of the Board's priorities identified for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 195.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025. In addition, each committee reviewed its members' <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 205.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tenure,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> knowledge, expertise and composition<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each committee was considered to have operated effectively <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the following enhancements were agreed: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility Committee:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 453.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was considered to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 257.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performing well despite a challenging external environment.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 267.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The focus for 2025 would be to ensure that increased <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monitoring was in place so that GSK was able to respond to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 288.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolving global environment.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> would be spending even more time on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considering and identifying new science and technology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platforms that can continue to drive performance beyond 2030. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 334.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">More time would also be allocated to strategy review <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussions and blue sky thinking. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance Committee&#8217;s:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primary focus had resulted in the identification of excellent new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board members. Consideration would be given to creating time <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to identify expertise needed for the future to accelerate what <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comes next. Consideration would also be given to further map <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 411.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the potential routes for securing new Board members with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific experience in the future. The Committee would <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 432.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to ensure that its succession planning work was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 442.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regularly refreshed.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk Committee&#8217;s:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> continued progress had been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made in streamlining Committee materials. It was agreed that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this should continue to be an objective. Opportunities would be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sought to create more time for the consideration and discussion <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 499.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of risk. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committee:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was considered to be performing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well despite a challenging environment.&#160; The focus for 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">would be to finalise the Remuneration Policy for approval at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s AGM. The Committee would continue to balance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understand and navigate shareholder views and positions on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration across the globe to ensure that GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 576.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration policy could be as competitive as possible to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 586.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retain and recruit the talent needed for successful strategy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery. The Committee wanted to continue to track the wider <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">group&#8217;s philosophy on remuneration with a view that GSK could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 617.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be competitive in protecting and rewarding talent.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 627.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Opportunities to further streamline routine papers for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 637.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee would also be explored. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 653.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Chair's evaluation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 669.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The SID carried out the Chair's evaluation. He sought feedback <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 679.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the Chair's performance from the Directors individually and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 689.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">collectively. From this review, the Non-Executive Directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 699.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concluded that the Chair was leading the Board appropriately <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 710.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and effectively. The Chair and SID then discussed the results of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 720.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the review. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">122<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_289"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i0b9f97bc8b0248f788931dd091ad58d5_0-0-1-1-821446"></span><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance Committee report <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 138.64pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g74.jpg" alt="Jonathan.S.panel.jpg" style="height: 132.66pt; width: 487.72pt;"/></div></div></div><div style="background-color: transparent; height: 113.86pt; left: 57pt; opacity: 1; position: var(--position); top: 147.07pt; width: 283.5pt; z-index: 3;"><div><div><div><div style="line-height: 10.5pt; position: var(--position); top: 11.34pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: bold; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the year, we further strengthened the <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 23.41pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: bold; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific and medical expertise of the Board. Each of <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 35.48pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: bold; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">my Board colleagues brings a unique skill set to <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 47.55pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: bold; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribute to our collective purpose<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 188.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 77.91pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jonathan Symonds, Nominations &amp; Corporate Governance <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 89.16pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 292.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I am pleased to present my sixth report as Chair of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance Committee (the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 328.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board succession<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 344.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In my Chair&#8217;s Governance statement, I discussed the important <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 354.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board appointment processes that have been undertaken <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during 2024. A particular focus of the Committee this year has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 374.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been succession for the scientific and medical expertise of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board. Dr Jeannie Lee was appointed to the Board and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee in March 2024. The appointment of Dr <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gavin Screaton will also be effective from 1 May 2025. Further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details on the appointment of Dr Screaton are set out in my <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 425.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair&#8217;s Governance statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee seeks to follow best practice in all the searches <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">it makes, and appointments it recommends, to the Board, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreeing the criteria for each role, the interview panel and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considering a comprehensive longlist of candidates. Shortlisted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">candidates are interviewed and assessed against the chosen <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 492.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">criteria. Due diligence is then undertaken before the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">makes its final recommendation. Executive search firms are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointed according to the company&#8217;s procurement policy and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on their expertise relative to each role. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee only engages search firms that are signatories <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the Voluntary Code of Conduct of Executive Search Firms. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 559.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee worked with Russell Reynolds during 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 569.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">They also provided executive search services to the company. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee reviewed the potential for conflicts of interest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and judged that there were appropriate safeguards against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 606.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such conflicts. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">With the exception of the planned retirement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 616.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman, there are no imminent Non-Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director retirements for the Committee to consider.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 292.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance architecture<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">As part of its regular reviews of the company&#8217;s Corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">Governance architecture on behalf of the Board, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">Committee monitors the composition of all Board committees <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">in consultation with each Committee Chair. This is with a view <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">to ensuring their composition is appropriate and makes the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">best use of the Board members&#8217; knowledge, skills and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">experience. After the 2024 AGM, the Committee undertook an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">in-depth review of the each Board committee&#8217;s membership to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">ensure their composition was effectively calibrated to support <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); white-space: pre;">the Board&#8217;s priorities This resulted in:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">updates to the Nominations &amp; Corporate Governance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee&#8217;s membership to include the Science Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 439.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">although no changes to the Remuneration Committee&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">membership were needed, it was agreed that the Science <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair would be invited to attend meetings where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">his expertise would be of assistance in the Remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee&#8217;s deliberations. This would be particularly helpful <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 506.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with reviews of R&amp;D performance measures and targets<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the appointment of Wendy Becker to the Corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility Committee (CRC) to create a membership <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overlap between the CRC and Audit &amp; Risk Committee, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 553.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which was deemed to be helpful to both<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 568.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In parallel, we have overseen a complementary exercise to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further enhance the company&#8217;s Corporate Governance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">architecture. This involved an in-depth review of each Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 599.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committee&#8217;s Terms of Reference (Terms). This review sought <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">simplify and improve consistency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 641.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure continued alignment internally with current practice at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 651.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK and externally with laws, regulations and best practice <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 661.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 677.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accurately reflect the Board committees&#8217; continuing remit and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 688.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the delegation of respective duties and authorities continue to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complement one <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">another<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 714.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The agreed updated Terms included the creation of a &#8216;Common <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 724.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Terms of Reference&#8217; document to eliminate duplication of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 734.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">administrative and logistical matters common to all our Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 744.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committees. All our Terms are available at gsk.com.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">123<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44106"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee regularly reviews, on behalf of the Board, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s corporate governance positioning, the external rating of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s corporate governance practices and emerging corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board and GLT composition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to ensuring the most appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">composition of our Board and its committees. The Board and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management seek to support and encourage an inclusive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture throughout the company and being respectful of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating environment. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 248.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An effective Board includes a range and balance of skills, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience and knowledge, as well as professional and social-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economic background and independence, with individuals who <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are prepared to challenge each other collaboratively. This mix <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is complemented by a range of personal Board attributes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including character, intellect, judgement, honesty and courage.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 315.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee in collaboration with all our Non Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 325.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors continued to review our talent and succession <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipelines and the development plans for key management roles <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and their successors. During the year, we undertook our regular <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 356.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deep dive of the emerging senior talent that the GLT had <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identified. These are employees who were exceeding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 376.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectations or who are exceptionally talented and who have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the potential to take on a GLT role in the future. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 396.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussions include reviewing our strategic approach to talent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development planning. The Board seeks to meet with these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals at employee receptions and through other Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagement opportunities. Non Executive Directors now also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meet more informally with participants in our Enterprise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leadership Programme to get to know them better on a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">personal level and support their continued development as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential successors to our GLT leaders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the work of the Committee also included monitoring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our performance against the policy objectives we set to ensure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that our Board and committee composition and succession <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">planning promotes diversity, inclusion and equal opportunity, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pursuant to the principles of the FRC Code. These objectives <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included gender and ethnicity representation targets for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board in accordance with the Financial Conduct Authority <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(FCA)&#8217;s diversity targets, which we report on below (as required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 194.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the UK Listing Rules). We met or exceeded these objectives <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 205.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the reporting period.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee recognises that, going forward, the company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will make changes in several areas related to inclusion and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diversity to ensure continued compliance with the law and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being respectful of our operating environment, including no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">longer applying a Board diversity policy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board and GLT diversity data collection<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, diversity data has been gathered directly on a self-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identified basis as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board members: using a questionnaire<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GLT members: individual election held on GSK's HR <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">database<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As required by the UK Listing Rules, all data published in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 372.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following section of the report are as at 31 December 2024 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the date of publication. We also continue to oversee the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing pipeline of direct reports to the GLT. The Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is reviewing its future position with regards to the collection of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diversity data.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 445.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 459.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &amp; Corporate Governance Committee Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 469.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 510.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">FCA UK Listing Rule 6.6.6R(9) reporting<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 548.34pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 148.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/></tr><tr style="height: 39.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 148.5pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 24.36pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of Board <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 32.16pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 40.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">members<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 0pt; width: 69pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 24.36pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of the <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 32.16pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 49.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 287.25pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 8.76pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of senior <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 16.56pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positions on the Board <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 24.36pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(CEO, CFO, SID and <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 32.16pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 49.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 0pt; width: 71.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 24.36pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number in&#160; Executive <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 32.16pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 428.25pt; position: var(--position); top: 0pt; width: 59.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 16.56pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 24.36pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">executive <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 32.16pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 39.75pt; width: 148.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Gender identity or sex<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Men<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 148.5pt; position: var(--position); top: 54pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 54pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.37pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 287.25pt; position: var(--position); top: 54pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 54pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.45pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 428.25pt; position: var(--position); top: 54pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.62pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Women<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 148.5pt; position: var(--position); top: 68.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 68.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 287.25pt; position: var(--position); top: 68.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 68.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.45pt; position: var(--position); text-decoration: none; white-space: pre;">6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 428.25pt; position: var(--position); top: 68.25pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.62pt; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not specified/preferred not to say<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 148.5pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 218.25pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 60.95pt;"></span></span><span style="left: 63.580000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 287.25pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 357pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.2pt;"></span></span><span style="left: 65.83pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 428.25pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.2pt;"></span></span><span style="left: 53.830000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 148.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 5.81pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Ethnic background<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.1pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">White British or other White (including <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.47pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">minority white groups)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 148.5pt; position: var(--position); top: 116.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 12.47pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 116.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 12.47pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.37pt; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 287.25pt; position: var(--position); top: 116.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 12.47pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 116.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 12.47pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.28pt; position: var(--position); text-decoration: none; white-space: pre;">10<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 428.25pt; position: var(--position); top: 116.25pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 12.47pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.37pt; position: var(--position); text-decoration: none; white-space: pre;">83.3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Mixed/Multiple Ethnic Groups<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 148.5pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 218.25pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 60.95pt;"></span></span><span style="left: 63.580000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 287.25pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 357pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.2pt;"></span></span><span style="left: 65.83pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 428.25pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.2pt;"></span></span><span style="left: 53.830000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Asian/Asian British<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 148.5pt; position: var(--position); top: 151.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 151.5pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.37pt; position: var(--position); text-decoration: none; white-space: pre;">17%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 287.25pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 151.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.45pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 428.25pt; position: var(--position); top: 151.5pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.54pt; position: var(--position); text-decoration: none; white-space: pre;">8.3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Black/African/Caribbean/Black British<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 148.5pt; position: var(--position); top: 165.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.95pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 218.25pt; position: var(--position); top: 165.75pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 55.54pt; position: var(--position); text-decoration: none; white-space: pre;">8%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 287.25pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 357pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.2pt;"></span></span><span style="left: 65.83pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 428.25pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.2pt;"></span></span><span style="left: 53.830000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Other ethnic group<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 148.5pt; overflow: hidden; position: var(--position); top: 180pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 218.25pt; overflow: hidden; position: var(--position); top: 180pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 60.95pt;"></span></span><span style="left: 63.580000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 287.25pt; overflow: hidden; position: var(--position); top: 180pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 357pt; overflow: hidden; position: var(--position); top: 180pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.2pt;"></span></span><span style="left: 65.83pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 428.25pt; overflow: hidden; position: var(--position); top: 180pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.2pt;"></span></span><span style="left: 53.830000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 194.25pt; width: 148.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.92pt; width: 148.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Not specified/preferred not to say<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 148.5pt; overflow: hidden; position: var(--position); top: 194.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 218.25pt; overflow: hidden; position: var(--position); top: 194.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 60.95pt;"></span></span><span style="left: 63.580000000000005pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 287.25pt; overflow: hidden; position: var(--position); top: 194.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.7pt;"></span></span><span style="left: 64.33pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 194.25pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 7.22pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.45pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 428.25pt; position: var(--position); top: 194.25pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.92pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.54pt; position: var(--position); text-decoration: none; white-space: pre;">8.3%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">124<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ie2e8e10dc6b44dc79a030e5952fed63b_0-0-1-1-821446"></span><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee report <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 144.33pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g75.jpg" alt="Hal.D.panel.jpg" style="height: 133.31pt; width: 487.72pt;"/></div></div></div><div style="background-color: transparent; height: 113.86pt; left: 57pt; opacity: 1; position: var(--position); top: 150.07pt; width: 283.5pt; z-index: 4;"><div><div><div><div style="line-height: 10.5pt; position: var(--position); top: 11.34pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee has been impressed with the depth of <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 23.94pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific talent within GSK, as well as the use of <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 36.54pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology to accelerate scientific research. This has <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 49.14pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">driven exceptional progress in R&amp;D across each of our <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 61.74pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapeutic areas<span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 96.97pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz, Science Committee <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 285.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I am pleased to present my second report as Chair of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee (the Committee) on our activities during <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee&#8217;s key activities in 2024 were split into three <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 331.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">important areas:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline reviews: monitoring of GSK&#8217;s pipeline&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 358.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business development: undertaking technical reviews and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessment of the scientific foundation for potential business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development transactions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 389.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific deep-dives: discussing and analysing the key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 399.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientific and technology themes which drive the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 409.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D strategy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 432.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline progress<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 448.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2024, the Committee continued to monitor the strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress of R&amp;D. Our CSO, Dr Tony Wood, provided regular <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">updates on pipeline progress across the company&#8217;s four <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therapeutic areas:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 121.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> respiratory, immunology and inflammation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 489pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(RI&amp;I), oncology, HIV, vaccines and infectious diseases, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 499.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has included 13 positive pivotal data readouts. Particular <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 509.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highlights noted by the Committee during the year included: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive results for ultra long-acting biologic depemokimab, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supporting dual indication filings for severe asthma and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chronic rhinosinusitis with nasal polyps (CRSwNP)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expanded approval for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 149.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to all adult patients with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primary advanced or recurrent endometrial cancer in the US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 577.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and EU, including&#160; MMRp/MSS tumours which represent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 587.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately 75% of cases<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 598.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive phase III data for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 159.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 188.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, including progression free <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 608.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">survival and overall survival, and multiple regulatory filings in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 619.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2L+ relapsed/refractory multiple myeloma<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expanded approvals for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 153.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in adults aged 50-59 at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased risk in the US, EU and Japan, in addition to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positive new data demonstrating protection over three full <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV seasons<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin filed in the US as a potential first new antibiotic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for uncomplicated UTIs in 20 years<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 693.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regulatory designations, including Breakthrough Therapy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 703.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Designations and Priority Reviews, in the US, EU, China and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 713.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Japan for several assets including: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 193.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for 2L multiple <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 724.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">myeloma, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 101.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 132.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in dMMR/MSI-H locally advanced rectal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 734.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer, GSK&#8217;227 (B7-H3 ADC) in extensive-stage small-cell <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 744.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lung cancer and osteosarcoma, gepotidacin in uUTI and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 754.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bepirovirsen in hepatitis B, recognising their potential in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 764.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas of significant unmet need<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 285.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business development transactions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee continued to be actively engaged in evaluating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 311.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the scientific principles of business development transactions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the year, aligned to therapeutic area focus and strategy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 331.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key transactions reviewed by the Committee during the year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 357.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory, immunology and inflammation <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 491pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(RI&amp;I)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 374.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aiolos Bio: acquisition of a potentially best-in-class TSLP <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody (AIO-001) from Aiolos Bio, expanding GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory biologics and portfolio of mechanisms in COPD.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 406.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chimagen Biosciences: acquisition of an investigational T <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cell-engager from Chimagen Biosciences to expand GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunology pipeline in autoimmune diseases such as lupus<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 438.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flagship Pioneering: collaboration with the bioplatform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 448.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovation company Flagship Pioneering, with the goal of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discovering and developing a portfolio of future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transformational medicines and vaccines, starting in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respiratory and immunology<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 490.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relation Therapeutics: agreement with Relation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 500.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Therapeutics, using their Lab in the Loop platform to discover <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 510.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">novel targets for osteoarthritis, systemic sclerosis and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 520.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fibrotic mechanisms, supporting our data-tech driven <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 530.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach in respiratory, immunology and inflammation<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 552.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 569.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Duality Biologics and IDRx: licence agreement with Duality <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biologics for a CDH17 antibody-drug conjugate with potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">best-in-class treatment options in gastrointestinal cancers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 599.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and acquisition of IDRx, including lead molecule IDRX-41, a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly selective KIT tyrosine kinase inhibitor being developed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a first- and second-line therapy for the treatment of GIST. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These transactions add to GSK&#8217;s growing portfolio in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gastrointestinal cancers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 663.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data and platform technologies<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ochre Bio: licence agreement with Ochre Bio on a human <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 690.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liver cell platform and multi-modal data for AI/ML modelling <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 700.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and discovery to strengthen our data and platform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology capabilities<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 721.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elsie Biotechnologies: acquisition of Elsie Biotechnologies, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 731.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an oligonucleotide discovery and chemistry platform, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 742.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthening our platform technology capabilities<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">125<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Deep-dives into innovative science<span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44115"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the year, the Committee has continued to undertake <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deep-dives into some of the scientific principles and highly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovative technologies that support the execution of our R&amp;D <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priorities. These included, but were not limited to, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying scientific rationale for key transactions and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">application of data and platform technologies across target <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">choice, patient identification, molecule design and clinical trial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness. The Committee is confident in the strategic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach to generate pip<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 147.29000000000002pt; letter-spacing: -0.005em; position: var(--position); white-space: pre;">eline value with competitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); white-space: pre;">advantage.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Collaborating with other Board committees<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also supported the Remuneration Committee during its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 263.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review and implementation of the updated 2025 Remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy. In particular, we provided specialist guidance to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committee during the key considerations for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">selection, design, measurement and adoption of:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a new stretching Pipeline measure for the Annual bonus plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to reward delivery of shorter-term milestones for GSK's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority pipeline assets<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the evolution of the Pipeline Sustainability measure for our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Share Plan which now <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.35000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focuses on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">replenishment of the pipeline and longer-term performance<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee already reviews the Performance Share Plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline Progress targets annually prior to their approval by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committee.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Going forward, we will also assist in assessing and disclosing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance against both these measures. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Committee changes<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We welcomed Dr Jeannie Lee to the Committee following her <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointment to the Board on 4 March 2024. Dr Lee&#8217;s expertise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the field of RNA biology and its application to drug <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development and therapeutics has already offered useful <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insights into the Committee&#8217;s work and I look forward to her <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued contributions. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also look forward to welcoming Dr Gavin Screaton to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee, who will succeed Dr Jesse Goodman from 1 May <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025. His knowledge of immunology and infectious diseases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will provide invaluable perspective to the Committee&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 315.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 338.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 392.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><span id="ib3a1b760284845998626a8c56f77bf8a_44090"></span><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i12c9ca02685c42be9149e56e9b842bb7_0-0-1-1-821446"></span><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility Committee report <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 418.16pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g76.jpg" alt="Anne.B.panel.jpg" style="height: 131.77pt; width: 487.72pt;"/></div></div></div><div style="background-color: transparent; height: 113.86pt; left: 57pt; opacity: 1; position: var(--position); top: 423.9pt; width: 283.5pt; z-index: 1;"><div><div><div><div style="line-height: 10.5pt; position: var(--position); top: 11.34pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a Committee, we oversee our performance, progress <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 23.94pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and future plans across GSK&#8217;s six Responsible Business <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 36.54pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas. We view these areas as fundamental to <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 49.14pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainable growth, positive societal impact and <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 61.74pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consequential value for patients<span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 96.97pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal, Corporate Responsibility Committee <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 573.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I am pleased to present this report, which is my third as Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Corporate Responsibility Committee (the Committee). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To be successful over the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long term<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 186.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK needs to consider its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible business impacts and risks. The Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversees the six areas that address what is most material to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the business. These comprise the issues that matter the most <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to our internal and external stakeholders, including investors, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our people, healthcare professionals, governments and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulators and particularly our patients who are the recipients of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our portfolio of products and the ultimate dr<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ivers<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 697.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As we worked through our programme of activities this year, my <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 707.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee asked management how:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well the company is performing against, and making an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact on the six Responsible Business focus areas <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 743.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">embedded in our strategy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 759.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this supports our sustainable performance and long-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 769.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 785.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further improvements can be identified and implemented<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 573.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we can best report to our key stakeholders on what we have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">done and the level of impact we have made as we continue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 593.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to adapt to the reporting requirements of the UK, US and EU<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To support this, we built a number of in-depth sessions into our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme, including a combined session with the Audit &amp; Risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee on interrelated Annual Report and Responsible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business performance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 656.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">External context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the start of the year, we receive and discuss a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprehensive update on management&#8217;s assessment of and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">view on the external trends and outlook relevant to responsible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 702.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business issues. This sets the scene on the evolving investor, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 712.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economic, political, regulatory and cultural backdrop to our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trust priority, and provides valuable context for the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in advance of the business we undertake during the course of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 743.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the year. The Committee receives further updates if there are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 753.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any material changes to these external factors to help inform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 763.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our approach going forward. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">126<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Responding to health impacts of climate <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">change <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee heard from the Chief Scientific Officer and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 152.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President, Global Affairs on the health impacts of climate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change. This helped us gain a greater understanding of how <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK might need to evolve its therapy areas due to climate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change and nature loss. It also helped us identify the potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business risks and opportunities of our products, so they can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be factored into planning our R&amp;D. An independent review was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commissioned by management which assessed GSK&#8217;s product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and pipeline portfolio. These results were shared with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee. This analysis suggested that GSK is well <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positioned with innovative vaccines and medicines to address <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">some of the biggest health impacts arising from climate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change, especially in Infectious Diseases, HIV and Respiratory. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 280.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee encouraged management to continue this work&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to support the company&#8217;s long-term value proposition through <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effective development of our R&amp;D portfolio, strategic clinical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 311.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">choices and future investments in the supply chain. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 327.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress on climate and nature ambition<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee received a performance update on our pathway <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">towards our net zero and nature goals. We discussed how the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company was responding to external trends that could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accelerate or disrupt our progress to achieving these goals and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we were satisfied that these are being properly addressed. We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also considered and endorsed the implementation of a number <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of key adjustments to maintain momentum against these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stretching goals.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 430.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Health impact<span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44103"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44111"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 124.87pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s President, Global Health and President, Global Affairs, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outlined initial work that management had been undertaking to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">explore how we might develop an appropriate approach to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measuring health impact. This includes working with two third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties to shape and pilot new methodologies for both a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial and global health portfolio. The Committee asked <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 507.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management to keep in mind the importance of scale, access, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 517.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reach and health impact as key concepts to help reinforce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 527.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s value proposition to society and shareholders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Culture<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee heard from the Chief People Officer on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing work to build a high-performing organisation with an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inclusive culture. We were pleased with the progress that had <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been made across many aspects of talent and inclusion.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business Performance Rating<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Responsible Business Performance Rating is one of our&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">KPIs and helps us measure delivery of progress on the six <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas most material to our business. This is the third year that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Rating has been used and together with the Audit &amp; Risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee, we jointly continue to oversee its evolution to make <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sure it meets the expectations of key stakeholders and remains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant in respect of upcoming regulations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We monitored and evaluated GSK&#8217;s progress in 2024 against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the 22 metrics across the six focus areas comprising the Rating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at the half and full year, with a recommendation to the Board to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">publish a final 'on track' Responsible Business Performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rating. For more details, see page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 436pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_124">45</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the Strategic report <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and in the Responsible Business Performance Report &#8211; both of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which are available at gsk.com.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 345.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Collaborating with other Board Committees<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We supported the Remuneration Committee during its review <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and implementation of the updated 2025 Remuneration Policy.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 536.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Together with the Audit &amp; Risk Committee we jointly considered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 392.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the EU Corporate Sustainability Reporting Directive compliance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 402.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements for inclusion in GSK&#8217;s 2025 Annual and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 412.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business Performance reports for publication in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q1 2026. For more details on this review, please see page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 524.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44091">127</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 538.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our Audit &amp; Risk Committee Chair&#8217;s report.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 464.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility Committee Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">127<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 124.09pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><span id="ib3a1b760284845998626a8c56f77bf8a_44091"></span><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk Committee report <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 155.03pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g77.jpg" alt="Charles.B.panel.jpg" style="height: 131.03pt; width: 487.72pt;"/></div></div></div><div style="background-color: transparent; height: 113.86pt; left: 57pt; opacity: 1; position: var(--position); top: 157.77pt; width: 283.5pt; z-index: 2;"><div><div><div><div style="line-height: 10.5pt; position: var(--position); top: 11.34pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee&#8217;s activities during the year have focused <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 23.41pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on Financial, Legal and Risk and assurance aspects of <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); top: 35.48pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the business. Our work has <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 139.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underscored<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 197.70000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK's <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 47.55pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commitment to maintaining robust governance <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 59.62pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">frameworks and adapting to evolving regulatory <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 71.69pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements<span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 102.05pt; width: 283.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft, Audit &amp; Risk Committee<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 306.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I am pleased to present this report, which is my fourth as Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 76.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk Committee<span style="display: inline-block; height: 6.18pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44108"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (the Committee), and in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 327.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following pages I aim to share insights into the activities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 337.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertaken or overseen by the Committee during the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the beginning of the year, the Committee considered and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreed the Annual Programme for 2024 (the Programme) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which is designed to complement and underpin the Board&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 384.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priorities. These comprise the approach to financial, legal and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance, risk and assurance, internal control framework and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external auditing areas of oversight for the Committee. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 420.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management prepares and submits concise papers on the key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 430.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issues for the Committee to review, contribute to and make <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decisions on. Crucially, as Committee Chair, I have unfettered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access to the senior leadership, key members of their teams <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the external auditor. These include private Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sessions or regular one-on-one meetings outside the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 481.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee cycle.&#160; Based on the work the Committee has done <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 491.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or inspected during the year, GSK continues to exhibit a strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance culture, with a consistent tone and engagement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 512.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the top which runs throughout the organisation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We hold a selection of in-depth sessions in the Programme, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including regular reviews of cyber security and AI/ML control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment, and a combined meeting with the Corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 558.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsibility Committee (the Committees) on our Responsible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 568.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business performance, assurance and reporting, is discussed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 594.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial reporting:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 132.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The integrity of our financial statements, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 624pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including the Annual Report and quarterly results, remain at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 634.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">core of what the Committee does. This includes the review of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 644.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investor materials, our progressive dividend policy, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 654.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments and results announcements. Significant areas of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 664.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgement related to our financial statements are presented to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 675pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Committee by management and are commented on by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 685.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Auditor, including overlaps and any variances with the Auditor&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 695.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">key audit matters. Further details are included on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44100">131</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 273.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 705.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">my report and the Auditor&#8217;s report on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">178</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i42e75ef76e644b8c8d5c6954b9e40514_21474">181</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. We are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 715.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committed to representing GSK&#8217;s financial reporting disclosures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 726pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in a clear and transparent way and can confirm that the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 736.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial reporting and controls framework remains robust. No <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 746.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fundamental changes were required during the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK Corporate Governance Code updates:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> In January 2024, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial Reporting Council published an updated Code, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 327.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">includes a provision, effective 1 January 2026, requiring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 337.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies to report on the effectiveness of material financial, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operational, reporting, and compliance controls. As a dual-listed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company, GSK is well-positioned to meet these new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 368.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements. We reviewed and endorsed management&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 378.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach to focusing on GSK&#8217;s most material controls, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">involved aligning our Internal Control framework with US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley processes. I look forward to providing further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details of the implementation of this approach in our next <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report, before formally reporting against these new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls in GSK&#8217;s 2026 Annual Report. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 445.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible business reporting: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committees jointly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered the EU Corporate Sustainability Reporting Directive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(CSRD) compliance requirements for inclusion in GSK&#8217;s 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual and Responsible Business Performance reports for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">publication in Q1 2026. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CSRD establishes externally assured, mandatory reporting of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 512.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustainability issues, in relation to financial risks/opportunities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and positive or negative impacts on society and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment, against a standardised framework and taxonomy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committees considered the roadmap to CSRD <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance, then assessed and recommended to the Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 563.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">double materiality topics, based around GSK&#8217;s six <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business focus areas, identified by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 599.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management as being the correct ones for disclosure and to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be embedded into strategic decision-making<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adoption of an appropriate Responsible Business reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy for GSK in future years, as outlined by management<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 651.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assurance Hub:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 2024 saw the Hub complete its first full year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 661.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of operation after its successful launch in September 2023. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committees scrutinised measures taken by management in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing to strengthen the Hub&#8217;s governance, processes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assurance and controls, how the Hub was discharging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 702.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business as usual activities and progress being made in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 712.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projects the Hub is undertaking ahead of, and in readiness for, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s compliance with EU CSRD and SEC Climate reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and data requirements from 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 749.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committees&#8217; joint consideration of, and update on, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 759.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business Performance Rating for 2024 are set out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 769.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the Corporate Responsibility Committee (CRC) Chair&#8217;s report <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 779.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i12c9ca02685c42be9149e56e9b842bb7_0-0-1-1-821446">125</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">128<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 114.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Legal<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 130.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At each scheduled meeting, the Committee reviews legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 140.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">privileged reports given by the General Counsel on material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 150.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation and investigations. The Chief Compliance Officer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 161.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(CCO) also gives us updates. We monitor through to resolution <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 171.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">material and/or privileged investigations across the enterprise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 181.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that are either substantiated or unsubstantiated. Where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate any corrective/mitigatory actions and lessons <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">learned will be discussed. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee continued to exercise primary oversight for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> litigation, including related accounting, disclosure and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 238.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">communication assessments. This included assessing and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 248.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreeing the details of GSK&#8217;s proposed resolution of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 264.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settlement:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 274.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 93% (approximately 80,000 cases) of US state court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 284.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 90.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product liability cases for up to $2.2 billion and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a separate settlement of the associated qui tam complaint for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$70 million, prior to the public disclosure of the settlement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee is pleased to see the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 193.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk retired for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">best long-term interests of shareholders, with no admission of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability. The latest status of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 170.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> litigation is set out in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 47 to the Financial statements, Legal proceedings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 373.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk and assurance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 389.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk management:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 128.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK has a well-established and mature <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 399.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk management and internal control framework which is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 409.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">described on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44117">130</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The Committee continues to scrutinise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the operation of this framework and reviews refinements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposed by management to ensure it remains fit for purpose <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and is sustainable. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We monitor a dashboard of all GSK&#8217;s enterprise risks and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process by which they are identified and prioritised. Key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enterprise risk topics for consideration by the Committee are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determined dynamically during the year following reviews <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertaken at Risk and Oversight Council (ROCC) meetings. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 512.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following the review of the governance of enterprise risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management oversight, the CCO and I proposed an enhanced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 533pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach, with the Committee conducting more detailed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 543.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews of GSK&#8217;s Research practices, Patient safety and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 553.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scientific and patient engagement. These reviews were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 563.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">previously overseen by the Science Committee. The Science <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 573.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair now joins the Committee when we review <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these enterprise risks together. The CRC leads on the review of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 594.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those enterprise risks relating to its key areas of focus.&#160; The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee continues to review any significant enterprise risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">escalations or associated investigations.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following the 2024 review, we agreed to add Pipeline delivery <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a principal risk from 2025. This was agreed given the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolving external reporting regulations and the paramount <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">importance of discovering and developing new medicines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines. All enterprise risk plans were updated in 2024 to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include assessment of data management and technology, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">addition to the existing areas of impact of geopolitics and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exposure presented by third parties.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> In recognition of external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes to the wider workforce ecosystem, going forward we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 205.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will oversee the mitigation of the potential risk of GSK failing to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 215.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliver our strategic priorities as a result of inadequate skills or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 225.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">planning.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information<span style="display: inline-block; height: 6.18pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44692"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44693"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 351.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and cyber security<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 427.70000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> This is a principal risk for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK and a key oversight area for the Committee. The Chief <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Digital and Technology Officer (CDTO), Chief Information and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security Officer (CISO) and CCO present updates regularly on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information and cyber security, as well as assessments of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">status of their associated key risk indicators. We are joined by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">my Board colleague, Dr Vishal Sikka, for these discussions. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Sikka and the CDTO&#8217;s skills and experience, especially <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those related to cyber security, are set out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i05f3d03bed7044b0896d2750d4d11063_536">107</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.97pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i5c3dc689c3424363b4dea78a37255c4b_7-0-1-1-821446">108</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> respectively. The CISO and CCO&#8217;s experience and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibilities relating to cyber security are set out on page <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 359.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">133 of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> last year&#8217;s Annual Report<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the year, the Committee discussed a scheduled external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NIST review of ongoing delivery against GSK&#8217;s Cyber Security <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plan by a specialist firm of independent cyber experts. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry best practice framework is known as the National <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Institute of Standards and Technology Cyber Security <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Framework (NIST-CSF). We are pleased that GSK&#8217;s cyber <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maturity rating is currently positioned in the upper quartile of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our peers. This reflects an accelerated rate of execution and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maturity growth since the plan was approved by the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in mid-2022 when the maturity rating baseline was established. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Since then, there has been a significant improvement in control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness. This continued strengthening of controls will help <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to protect against the principal cyber security threats to GSK. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 507.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the ever-changing environment, we are currently <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considering recalibrating GSK's cyber maturity goals to further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenge GSK management to further enhance the protection <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our systems. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee is pleased with the rate of execution of the plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and progress made so far. We will continue to be briefed on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how the NIST assessment framework and methodologies <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to adapt. We are also keen to observe management&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deployment of other capabilities so that the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">defences remain relevant and robust in this rapidly evolving <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dynamic threat environment. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further details of the other measures taken during the year to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mitigate this risk are described on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 457.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_160">60</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_640">282</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">129<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AI Governance: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Responsible AI framework helps us <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintain clear guardrails as we scale adoption of AI across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK to drive innovation, growth and productivity and, in doing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">so, to accelerate our purpose.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In my report last year, I described the establishment by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board of the AI Governance Council (Council), its purpose and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities that helped to define, establish and oversee these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guardrails. The Council is aligned to the ROCC and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee&#8217;s reporting arrangements, as well as our other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance forums, as appropriate. A year after the Council&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">creation, the Committee was keen to examine the:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">structure and evolving operational effectiveness of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Council<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 263.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">functioning of the responsible AI governance architecture, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including the complementary roles, duties, ownership and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">composition of each of these AI forums<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall increase in maturity of our AI risk management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 325.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee was pleased with the significant initiatives that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Council had pursued and rolled out across the Group to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further enhance GSK&#8217;s AI environment. These included:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approving an AI Policy that embeds new AI principles and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">establishes guidelines for use of AI within the company. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy applies to all AI developed, procured, or used by our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 392.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people at GSK. Responsible AI training modules continue to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 402.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be rolled out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 418.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing, adopting and publishing an AI Standard <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 428.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating Procedure (AI SOP), defining steps required for all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 438.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development and/or procurement of AI systems across GSK<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monitoring an inventory of all AI models developed across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK. This is being actively monitored through the Council, as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the number of AI applications in use expands at pace across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the enterprise<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee received a briefing from the Head of Audit &amp; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assurance (A&amp;A) on the results of an initial audit, that primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused on evaluating how the AI Governance framework is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 531.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">embedding across GSK. This has also helped strengthen <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight capabilities by increasing the experience of the A&amp;A <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">team in conducting audits and oversight of new technologies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2025, the Committee is looking forward to monitoring how <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Council progresses its key focus areas. These include:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supporting business units in further improving and refocusing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their AI systems to align to the AI SOP<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing to embed and grow the Responsible AI SOP <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adoption throughout the organisation<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing to oversee and monitor AI systems, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing technical and operational best practices<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refining and maturing the Council&#8217;s governance approach for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scaled adoption of AI across GSK<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 243.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the formative stage of AI development and adoption, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee is keen to ensure an appropriate balance is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maintained between identifying, mitigating and monitoring key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 274.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AI risk areas across the enterprise and with our third parties, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 284.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">while harnessing the opportunities and capabilities of this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assurance:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 350.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Head of A&amp;A provides regular updates on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress against the agreed Assurance Plan. During the year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 331.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we reviewed detailed briefings on:&#160; &#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Third parties:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The level of assurance work undertaken by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A&amp;A and other assurance groups within the business, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 367.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">covering exposure to third party services and suppliers used <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 377.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by GSK was covered. Given GSK&#8217;s increasing reliance on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 387.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">third parties, particularly in high-risk areas such as R&amp;D, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there is a need to continue to strengthen the application of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal control management in this area. We reviewed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 418.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initiatives to drive sustainable improvements and further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 428.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enhance oversight in this regard.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business development (BD):<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> The execution of targeted BD <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deals is a key Board priority to help drive the future growth of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company. We reviewed a series of audits that examined <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">various aspects of BD, including diligence, governance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decision-making, contracting processes, and subsequent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">integration into the business. During future audits, A&amp;A will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus on the effectiveness of the implemented corrective <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions identified and embedded in such deals post approval. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">130<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Internal<span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44092"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44113"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44116"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44117"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44421"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44422"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 92.9pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> control framework<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board recognises its obligation to present a fair, balanced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and understandable assessment of GSK&#8217;s current position and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prospects. It is accountable for evaluating and approving the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of GSK&#8217;s internal controls, including financial, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operational and compliance controls, and risk management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We ensure the reliability of our financial reporting, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance with laws and regulations, through our internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control framework. This is a comprehensive enterprise-wide <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk management model, which supports the Board to identify, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluate and manage the Group&#8217;s principal and emerging risks, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as required by the FRC Code. The framework is designed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manage the risk of GSK not achieving its business objectives. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A fit-for-purpose framework &#8211; complemented by our corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture and Speak Up processes &#8211; ensures that the risks <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated with our business activities are actively and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 303.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectively controlled in line with our agreed risk appetite. We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">believe GSK&#8217;s framework provides reasonable, but not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">absolute, assurance against material misstatement or loss. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board mandates the Group&#8217;s Risk Oversight and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compliance Council (ROCC) of senior leaders to support the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee in overseeing risk management and internal control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities. It also provides the business with a framework for risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management and escalation of significant risks. Risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management and compliance boards (RMCBs) across the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group promote the &#8216;tone from the top&#8217; and establish our risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 411.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture, and ensure effective oversight of internal controls and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 421.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk management processes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each principal risk has an assigned risk owner, drawn from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior management, who is accountable for managing the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principal risk with oversight from a GLT member, which includes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">setting and implementing risk mitigation plans. Risk owners <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report quarterly on their respective risk management approach <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and progress at the ROCC and the appropriate Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committee. Our Compliance function assists the ROCC and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 509.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RMCBs. Compliance is responsible for advancing enterprise-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 519.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wide risk management and for developing risk-based and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 529.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ethically sound working practices. It also actively promotes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ethical behaviours by enabling all employees to operate in line <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with our culture and comply with applicable laws and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Audit &amp; Assurance (A&amp;A) function provides independent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assurance to senior management and the Board on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of risk management Group-wide, in line with an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreed assurance plan. This helps senior management and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board to meet their oversight and advisory responsibilities to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fulfil GSK&#8217;s strategic objectives and build trust with patients and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other stakeholders. A&amp;A has a dual reporting line to the CFO <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the Committee. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a Committee we receive regular reports from principal risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">owners, Compliance and A&amp;A on areas of significant risk to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group and on related internal controls. These reports assess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the internal control environment within each principal risk area, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including enhancements to strengthen controls. Once we have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered these reports, the Committee reports annually to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board on the effectiveness of GSK&#8217;s internal controls. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, through the authority delegated to the Committee, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board conducted a robust assessment of the Group&#8217;s principal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and emerging risks. This assessment in line with the FRC Code <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included consideration of the nature and extent of risk the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board is willing to take to achieve GSK&#8217;s strategic objectives.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 334.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board, via the Committee, also oversaw the effectiveness <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 344.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our internal control environment and risk management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 354.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes across the Group for the whole year, up to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approval date of this Annual Report. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">More detail about the review of the Group&#8217;s risk management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach is further discussed in the Risk management section <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the strategic report on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_154">59</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_184">74</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The management of each principal risk is explained in &#8216;Risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Factors&#8217; on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 387.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27f24adb8ed14564b0e7ab7e0cc1fb14_11164">285</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">131<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Significant issues relating to the financial statements<span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44100"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In considering GSK&#8217;s quarterly financial results announcements and the financial results in the 2024 Annual Report, the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed the significant issues and management judgements in determining those results. It reviewed management papers setting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out the key areas of risk, actions taken to quantify the effects of the relevant issues, and judgements made by management on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate accounting required to address those issues in the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The significant issues considered in relation to the financial statements for the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are set out in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following table, with a summary of the financial outcomes where appropriate. The Committee and the external auditor have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discussed the significant issues addressed by the Committee during the year and the areas of particular audit focus, as described <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the Independent Auditor&#8217;s Report on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">178</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i42e75ef76e644b8c8d5c6954b9e40514_21474">181</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 222.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 171.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 316.5pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 171.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 171.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant issues considered by the Committee <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 171.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in relation to the financial statements<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 316.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How the issue was addressed by the Committee<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 87.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 87.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Going concern basis for the preparation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the financial statements<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 87.75pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee considered the outcome of management&#8217;s half-yearly and year-end <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviews of current and forecast net debt positions and the various financing facilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and options available to the Group. The Committee also considered management&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review of the impacts of both the current economic environment and climate change. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following consideration of these assessments, which included stress testing and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 53.63pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">viability scenarios, sources of liquidity and funding, forecasts and estimates, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 63.83pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee confirmed that the application of the going concern basis for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 74.03pt; width: 316.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preparation of the financial statements continued to be appropriate.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 84pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 84pt; left: 0pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue recognition, including returns <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and rebates (RAR) accruals<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 84pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee reviewed management&#8217;s approach to the timing of recognition of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenue and accruals for customer returns and rebates. The RAR accrual for US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 107.75999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5.2&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 147.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed the basis on which the accrual had been made and concurred with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management&#8217;s judgements on the amounts involved. A fuller description of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 53.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process operated in US Commercial Operations in determining the level of accrual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 63.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">necessary is set out in Note 3 &#8216;Critical accounting judgements and key sources of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 74.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimation uncertainty&#8217; on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_244">101</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.32000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7683">102</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 110.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 110.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 190.5pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provisions for legal matters, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigations into various aspects of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s operations<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 110.25pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 190.5pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee received detailed reports on actual and potential litigation from both <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal and external legal counsel including the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 178.98000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.70000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> litigation, together with a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of detailed updates on investigations into various aspects of the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations. See Note 47 to the financial statements &#8216;Legal Proceedings&#8217; for more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details including the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: italic; font-weight: normal; left: 73.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 75.67999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.39999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> litigation.&#160; Management outlined the levels of provision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 53.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and corresponding disclosure considered necessary in respect of potential adverse <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 63.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation outcomes and also those areas where it was not yet possible to determine <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 74.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">if a provision was necessary, or its amount. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the provision for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 84.23pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal matters was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.4&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 107.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; see Note 32 to the financial statements, &#8216;Other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 94.43pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions&#8217; for more details.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 42.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 300.75pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provisions for uncertain tax positions<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42.75pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 300.75pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee considered current tax disputes and areas of potential risk and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concurred with management&#8217;s judgement on the levels of tax contingencies <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required. At 31&#160;December 2024, a tax payable liability of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.7&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions for uncertain tax positions was recognised on the Group&#8217;s balance sheet. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairments of intangible assets<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee reviewed management&#8217;s process for reviewing and testing goodwill <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other intangible assets for potential impairment. The Committee accepted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management&#8217;s judgements on the intangible assets that required writing down and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the resulting impairment losses of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.3&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 167.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in 2024. See Note 20 to the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements, &#8216;Other intangible assets&#8217; for more details.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 78pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 78pt; left: 0pt; overflow: hidden; position: var(--position); top: 401.25pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Valuation of contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in relation to ViiV Healthcare<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 78pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 401.25pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee considered management&#8217;s judgement that it was necessary to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase the liability to pay contingent consideration primarily as a result of&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increases in sales forecasts, updated exchange rate assumptions and the unwind of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the discount. After cash payments of nearly <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.2&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.85000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in the year, at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 18.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group's balance sheet included a contingent consideration liability of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 53.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6.1&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 39.879999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in relation to ViiV Healthcare. See Note 33 to the financial statements, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 63.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Contingent consideration liabilities&#8217; for more details.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 36.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 479.25pt; width: 171.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare put option<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 171.75pt; overflow: hidden; position: var(--position); top: 479.25pt; width: 316.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee reviewed and agreed the accounting for the Pfizer put option <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.24000000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and concurred with management&#8217;s judgement on the valuation of the put option <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 316.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.24000000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 9.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.9&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 49.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 60.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 132.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">132<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Effectiveness and quality of external audit <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">process<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee is committed to making sure that GSK receives <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 152.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a&#160;high-quality and effective external audit. In evaluating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deloitte&#8217;s performance during 2024, prior to making a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendation on its reappointment in early 2025, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee reviewed the effectiveness of its performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against the criteria which it agreed with management at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">beginning of 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The detailed criteria used to judge Deloitte's effectiveness as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external auditor are available at gsk.com. These are based on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the audit approach and strategy, ensuring a high-quality <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independent audit,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> effective relationship<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and value for money. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee monitors engagements with external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders relevant to our areas of oversight, including the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 286.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FRC and Securities and Exchange Commission.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We sought to ensure that Deloitte would deliver a smooth, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thorough and efficiently executed audit for 2024 and so <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the overall quality of the audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the independence of Deloitte <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether Deloitte showed an appropriate level of challenge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and scepticism in its work. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 387.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deloitte&#8217;s length of tenure was not taken into account when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 397.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing its independence and objectivity, given it only <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commenced its role as auditor in 2018. However, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee did consider how effectively it had assumed its role <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as auditor. The Committee also considered the outcomes of an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 438.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audit effectiveness review undertaken by a team independent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 448.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the auditor at Deloitte. As part of this process, interviews <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were undertaken with key GSK stakeholders including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive and Non-Executive Directors and key corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">functions. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> The interviews focused on assessment in a number of areas <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 520.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alignment to expectations of external auditor<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback on Deloitte team members, including on their skills <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and experience<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 553.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of communication and ways of working<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audit approach and quality<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas of focus for improvement<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 598.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As Committee Chair, I regularly meet independently with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 608.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audit partner. We also meet with the auditor privately at the end <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 618.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of each Committee meeting to discuss progress, as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 628.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 644.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Having reviewed the above feedback, and noted any areas of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">im<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provement to be implemented by the audit team for 2025, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 665.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee was satisfied with the: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of the auditor and the external audit process <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditor&#8217;s independence, qualifications, objectivity, expertise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 702.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and resources<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 718.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We agreed to recommend to the Board Deloitte's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 728.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reappointment at the next AGM, and did so free from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 738.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influence of any third party.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Audito<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 339.1pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">r&#8217;s reappoin<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 401.02pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">tment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">External auditor<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 142.77pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 111pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 125.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External auditor appointment<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Last tender<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 111pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 111pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">May&#8211;December 2016<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transition year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 111pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 111pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2017<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 39.75pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">First shareholder approval of current <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 39.75pt; width: 111pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 111pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">May 2018<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">First audited Annual Report and 20-F<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 60pt; width: 111pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 111pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Year ending 31 December 2018<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New lead audit engagement partner<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 111pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 111pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Next audit tender required by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 125.25pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 111pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 111pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026 (to take effect from 2028)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 259.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There were no contractual or similar obligations restricting the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s choice of external auditor. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 285.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Audit tender<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee considers that, during 2024, the company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 311.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complied with the mandatory audit processes and audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committee responsibility provisions of the Competition and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 331.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Markets Authority Statutory Audit Services Order 2014. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As Deloitte continues to maintain its independence and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">objectivity, and the Committee remains satisfied with its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 368.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance, GSK does not currently intend to tender the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 378.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external auditor contract before the end of the current required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period of 10 years identified above and considers that this is in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the best interests of shareholders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee was mindful that there were appointments of a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 424.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new CFO for GSK and lead audit partner for Deloitte during the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 financial year. These changes help further mitigate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 445.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks of any over-familiarity between the company and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditor. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">133<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board committee reports continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-audit services<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 132.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management operates on the presumption that other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accountancy firms will ordinarily provide non-audit services to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 152.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK. However, where the external auditor&#8217;s skills and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience make it the only suitable supplier of non-audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support &#8211; such as for audit-related matters, tax and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">services &#8211; it may be used, in the best interests of the company. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In line with GSK&#8217;s non-audit services policy, the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensures that auditor objectivity and independence are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">safeguarded by reviewing and pre-approving the external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditor&#8217;s provision of such services. The company policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complies with the FRC&#8217;s 2024 Revised Ethical Standard and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 250.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Sarbanes-Oxley Act of 2002. It observes the following core <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 260.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy features on engaging the external auditor for non-audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 270.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">services:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 286.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK non-audit services policy, key features: <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 303.4pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Process:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 45.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 190.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All non-audit services over &#163;50,000 are put to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitive tender with other financial services <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">providers, in line with the Group&#8217;s procurement process, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unless the skills and experience of the external auditor <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make it the only suitable supplier.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Safeguards:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 45.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 190.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adequate safeguards are established so that the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">objectivity and independence of the Group audit are not <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">threatened or compromised.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fee cap:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 45.75pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 190.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The total fee payable for non-audit services should not <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceed 50% of the annual audit fee, except in special <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances where there would be a clear advantage <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the auditor undertaking the additional work.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prohibitions:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 45.75pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 190.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s policy includes a &#8216;whitelist&#8217; of permitted non-audit <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">services in line with the relevant regulations. Any service <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not on this list is prohibited.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 65.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 65.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pre-approval:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 65.25pt; left: 45.75pt; overflow: hidden; position: var(--position); top: 144pt; width: 190.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All non-audit services require pre-approval as set out in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the table below to ensure services approved are <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistent with GSK&#8217;s non-audit policy for permissible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">services. This process ensures all services fall within the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scope of services permitted and pre-approved by the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee and does not represent a delegation of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authority for pre-approval.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 74.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 74.25pt; left: 45.75pt; overflow: hidden; position: var(--position); top: 209.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Value <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">More than &#163;50,000<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between &#163;25,000 and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;50,000<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under &#163;25,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 74.25pt; left: 141pt; overflow: hidden; position: var(--position); top: 209.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pre-approver<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair and CFO<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group Financial Controller<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Designate of the Group <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 95.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial Controller<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Audit and other services comparison (&#163;m)<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 0pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g78.gif" alt="42482" style="height: 120pt; width: 232.44pt;"/></div></div></div><div style="position: var(--position); top: 254.44pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 222pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #a8a8a7; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 14.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 14.25pt;"><span style="color: #575756; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 14.25pt; overflow: hidden; position: var(--position); top: 12pt; width: 222pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 222pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other Assurance services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further fees payable to Deloitte for non-audit services relating to the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consumer Healthcare demerger was &#163;4.4 million in 2022 as set out on <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page 129 of the 2022 Annual Report. A fee of &#163;0.2 million was paid to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the auditor in respect of GSK pension schemes in each of 2022, 2023 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2024.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 334.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fees paid to the company's auditor and its associates are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set out above. Further details are given in Note 8 to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements, &#8216;Operating profit&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 479.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_397">200</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee considered the level of non-audit services <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incurred as part of its annual review of Deloitte&#8217;s independence <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set out on the previous page and was satisfied that the auditor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued to be independent and exercised objectivity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 412.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">throughout 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 427.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fair, balanced and understandable <span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44119"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 441.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">assessment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 457.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The need for an annual report to be fair, balanced and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understandable is one of the key compliance requirements for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a company&#8217;s financial statements. To ensure that GSK&#8217;s Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report meets this requirement, we have a well-established and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">documented process governing the coordination and review of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group-wide contributions to the publication. This runs in parallel <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the process followed by the external auditor. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee received a summary of management&#8217;s approach to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s 2024 Annual Report to ensure it met the requirements of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the FRC Code. This enabled the Committee, and the Board, to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 559.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confirm that GSK&#8217;s 2024 Annual Report as a whole is fair, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 569.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balanced and understandable and provides the necessary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information for shareholders to assess the company&#8217;s position <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and performance, business model and strategy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 605.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Code of Conduct <span style="display: inline-block; height: 8pt;"></span><span id="ib3a1b760284845998626a8c56f77bf8a_44105"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 395.06pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and reporting lines <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have a number of well-established policies (including a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code of Conduct), which are available on gsk.com, together <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 641.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with details of our confidential Speak Up lines for reporting and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 651.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigating unlawful conduct.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 694.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit &amp; Risk Committee Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">134<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 13.94pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_292"></div><div style="position: absolute; top: 114.19pt;" id="idc89fa1ee07645df9629d157a4b46752_295"></div><div style="position: var(--position); top: 114.19pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g79.jpg" alt="Wendy.B.panel.jpg" style="height: 132.42pt; width: 487.56pt;"/></div></div></div><div style="background-color: transparent; height: 125.36pt; left: 57pt; opacity: 1; position: var(--position); top: 117.82pt; width: 304.94pt; z-index: 1;"><div><div><div><div style="line-height: 10.5pt; position: var(--position); top: 11.34pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is successfully entering its next stage as a global <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 23.94pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma company, delivering strong operational <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 36.54pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance. After active engagement with a range of <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 49.14pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders, we are proposing an updated Policy to enable <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); top: 61.74pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery of our Ahead Together strategy, <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 196.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outperformance<span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 269.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 74.34pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against our ambitions and the company&#8217;s ability to attract and <span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 86.94pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retain global high-calibre executives<span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); top: 105.23pt; width: 304.94pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker, Remuneration <span style="display: inline-block; height: 7.64pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 134.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee<span style="display: inline-block; height: 7.64pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 257.69pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 317.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 170.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 317.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 317.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Report contents include: <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 317.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 170.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 170.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Page reference<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 317.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 317.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committee Chair&#8217;s statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 317.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 170.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 170.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_295">134</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 317.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 317.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy consultation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 317.25pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 170.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 170.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_24120">135</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 317.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 317.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2024 Total remuneration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 317.25pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 170.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 170.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_304">144</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 317.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 317.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2025 Pay for performance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 317.25pt; overflow: hidden; position: var(--position); top: 45pt; width: 170.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 170.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_7794">151</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 317.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 317.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 317.25pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 170.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 170.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_331">164</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dear Shareholder<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 351.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On behalf of the Remuneration Committee, I am pleased to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">present our <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Report <span style="display: inline-block; height: 6.18pt;"></span><span id="i9661dafaf5fc49f8aa6d69d81c1d2708_28963"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 377.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This is my first report since I succeeded Urs Rohner as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair following our AGM in May 2024. I joined GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in October 2023 after many years of UK and multinational <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">board experience and have enjoyed learning about GSK and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 418.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how the Committee can continue to support GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 428.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transformation as a focused global biopharma business. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I will first report on the performance of GSK, the CEO and CFO <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">last year and the remuneration they have earned as a result.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 280.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">I <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will then turn to the Committee&#8217;s work in reviewing our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy for the next three years, ahead of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy renewal in May 2025.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 501.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Progress and Performance in 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 514.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">GSK delivered another year of strong operational performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">in 2024, with strong sales and core operating profit growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">driven by accelerating momentum of our Specialty Medicines <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">portfolio. This was achieved together with outstanding phase III <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">pipeline progress. We were also pleased to have resolved <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.91pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 279.41pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">vast majority of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 125.38pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.74pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;"> litigation overhang. We announced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 576.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">the closure of 93% of state court cases in October 2024 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 586.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.012em; position: var(--position); text-decoration: none; white-space: pre;">now have less than 1% of these state cases outstanding.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 602.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beyond financial achievements and positive progress behind a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 612.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reshaped pipeline, GSK has continued its momentum in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 622.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating as a Responsible Business (RB), as well as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthening its culture, with already high people survey <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 643.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results increasing further, while attracting and building <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 653.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outstanding capability in areas such as R&amp;D and AI.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 349.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 Annual bonus <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It is against this performance that the Committee reviewed the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual bonus measures for the CEO and CFO. Annual bonus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets are set to incentivise yearly progress towards the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery of our long-term strategy with a focus on delivering <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outperformance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The bonus is primarily focused on rewarding over-delivery of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial performance against the targets set at the start of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year, with those targets generally being ahead of external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consensus forecasts at the time they were set. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In terms of the two financial measures, the company delivered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong growth in sales and c<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 409.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ore<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> operating profit, both above <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">target. This demonstrated the resilience of the business given <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the challenging environment for our Vaccines business in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 506.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">second half of the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee also carefully reviewed performance against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the non-financial individual strategic and operational measures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the CEO and CFO for 2024. We have provided greater <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">detail on performance against each of their objectives and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achievements on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_7790">147</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 428.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_7772">148</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 582.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before finalising the bonus outcomes, the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 592.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered the broader performance of the company and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 602.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals. The Committee was satisfied that the payouts were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate given the strong financial and operational results <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for 2024, supporting delivery of our long-term strategy, though <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 633.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also recognising a less robust share price performance. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">135<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When all bonus measures are combined, the final payout <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against the maximum of 300% was 210% of base salary for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO (of which 110% of base salary was delivered in shares <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deferred for 3 years), and 198% of base salary for the CFO (of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which 99% of base salary was delivered in deferred shares), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">i.e. 70% and 66% of maximum respectively. Both of them over-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieved on their personal objectives. This compares to 2023 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bonuses of 288% for the CEO and 264% for the CFO, with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 194.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 step back driven by vaccine challenges in the second half <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 205.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Long-term incentive (LTI) awards<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Moving on to the performance of our 2022 Performance Share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plan (PSP) LTI award. This marks the end of the first grant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made under our 2022 Policy. The Committee was pleased at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the progress being made. Overall 80.75% of the total award <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the 2022 grant vested based on performance over the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 285.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three-year period from January 2022 to December 2024.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The grant had five measures, all of which vested to some <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 311.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extent. Three of the five measures were fully vested, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Sales growth, Core operating profit growth and our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible Business: Environment measure. The Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was encouraged that, for the first time in several years, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following repeated strong operational business performance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company&#8217;s relative TSR positioning has improved. GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 372.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ranked in fifth position against our current ten global pharma <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">peers (including GSK) for relative TSR performance, resulting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in above median positioning for GSK and an element of vesting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(12% of a possible 30%) for this component. In terms of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline Progress measure (which currently tracks major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory approvals and phase III pivotal trial starts), 18.75% <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of this element vested out of a total 20%. We are hopeful that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the progress we are making to develop our portfolio, together <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the continued improvement of our longer-term growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy, will be increasingly reflected in GSK&#8217;s valuation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 474.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further detail of the performance against these measures is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">given on pages<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_7798">149</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_7781">150</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 500.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before confirming the final total vesting level, the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 511.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered the overall performance measure outcomes of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">award, as well as shareholder experience. We agreed that, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 531.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">given the progress made, the outcome for the three-year period <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was appropriate.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 557.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total Variable Performance Pay for 2024 <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 571.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overall, 2024 resulted in total variable performance pay at 77% <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 581.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of maximum opportunity for the CEO. This was considered a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair reflection of the performance achieved. The CFO was not in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">role at the time of the 2022 PSP grant and, therefore, did not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receive this award.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Her performance resulted in a 66% bonus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 622.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outturn. The formulaic outturns for the CEO and CFO were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved without the exercise of any discretion. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 648.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy<span style="display: inline-block; height: 8pt;"></span><span id="i9661dafaf5fc49f8aa6d69d81c1d2708_24120"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 664.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given that our 2022 Policy is due for renewal at our AGM in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 674.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">May 2025, my first action on becoming Chair of the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 684.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was to lead our Policy review. This coincides with the second <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 694.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phase of GSK&#8217;s transformation as a global biopharma <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 704.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business. The 2022 Policy has been a critical &#8216;carrot and stick&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 715.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tool in our transformation journey. We continue to believe in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 725.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fundamental principle of incentivising out-performance and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">penalising under-performance to support our performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture and long-term strategy. This remains central to our 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy proposal. We are looking to retain the majority of its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">elements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">By way of reminder, phase one of GSK&#8217;s transformation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commenced in July 2022 with the separation of our consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare business, now called Haleon plc. GSK then <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changed from a global pharma and consumer healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company to a focused global biopharma business. This reset <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">followed shareholders&#8217; approval of our 2022 Policy in May <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">That Policy sought to reinforce the establishment of a strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance culture, setting a foundation for consistent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">execution and delivery. The business has since demonstrated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistent operational delivery and financial dependability with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a clear and growing number of pipeline assets developed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deliver our growth strategy to 2031. Since 2021, GSK has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">secured 17 approvals from the FDA and has 19 assets in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III trials. The number of key pipeline scale opportunities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with potential peak year sales<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 414.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">1 <span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launching between 2025 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031 has grown to 14. We believe that the 2022 Policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved by shareholders, was instrumental in driving this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improvement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is a very different business to four years ago. Our global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales have increased from approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 459.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;25 billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 497.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in 2021 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(including COVID-19 solutions) to over &#163;31 billion in 2024 with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistent quarter on quarter delivery.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Our product mix has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">improved with 67% derived from Specialty Medicines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines. The progressive dividend policy we set has seen the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual dividend payout increase too. The total dividend for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 is 61p with an expectation of 64p for 2025. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A &#163;2 billion <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 446.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share buy-back programme was also announced in February <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before reviewing GSK&#8217;s remuneration arrangements, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee reflected on GSK&#8217;s position globally today. The US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is our largest commercial market and represents more than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 503.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">52% of sales. Only 2% of our sales originate from the UK. T<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 526.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 513.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance of 46% of sales originate from the rest of the world. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 523.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The US is not only our largest market, it is also our largest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employer across the globe. We employ 12,108 people in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US (16% of our workforce) and the balance across the rest of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 554.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the world.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 341.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Our <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GLT<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is also multinational in its composition, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including American, Australian, British, Canadian and French <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nationals. We are truly an international business.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 590.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Changes for the 2025 Remuneration policy <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The purpose of our 2025 Policy is, therefore, to:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incentivise the delivery of the company&#8217;s Ahead Together <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy and 2031 growth strategy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 646.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reinforce the company&#8217;s pay for performance, particularly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 656.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out-performance, philosophy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enable the retention and attraction of talent as a global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma company<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 698.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">create the headroom to deliver market competitive reward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through the organisation<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="background-color: transparent; height: 49.59pt; left: 55.06pt; opacity: 1; position: var(--position); top: 745.81pt; width: 230.26pt; z-index: 4;"><div><div><div><div style="line-height: 7pt; position: var(--position); top: 10.4pt; width: 230.26pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding COVID-19 solutions<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">136<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g80.jpg" alt="GSK's global presence graphic - V4.jpg" style="height: 325.25pt; width: 487.72pt;"/></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 446.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 58.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 60.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was with t<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 97.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">his<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 119.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mind that we went on to develop our 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy proposal. We were driven by the need to be fully aligned <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to support successful delivery of our strategy and to ensure that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incumbents are paid appropriately to be retained and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incentivised and that the policy has sufficient flexibility to permit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">us to manage succession when required. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We sought to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 507.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evidence-based in our approach &#8211; but without being slavish to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> We interrogated numbers but we also looked more deeply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 527.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to our talent base today and into the future. We analysed our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">current competitors for talent as a global biopharma business. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This work leveraged several internal and external data points to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 558.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure it was comprehensive. The Committee drew on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 568.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expertise of the Science and the Corporate Responsibility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committees for specialist input too. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 594.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The conclusions supported the importance of:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 607.71pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Size-adj<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 92.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">usted Global Biopharma Peer Group:<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Evolving and <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 617.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focusing on one main performance and remuneration <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 628.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparator peer group, rather than three. Since the <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 638.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demerger of Haleon, an assessment of our talent flows <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 648.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflect that we are a biopharma company versus a generalist <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 658.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company and this new peer group is more relevant to those <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 668.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wins and losses. Within the peer group we are proposing, 11 <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the 13 companies benchmark their performance against <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 689.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK today. Aligning our diverse comparator peer groups <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 699.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enables us to ensure that pay is better aligned with the <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 709.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder experience and is appropriate throughout GSK&#8217;s <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 719.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global leadership team, using a robust basis for <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 730.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benchmarking and consistency in the assessment of our <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 740.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achievements. In addition to ensuring incumbents are paid <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 750.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriately, it also gives increased confidence that our <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 760.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policies will enable succession at the appropriate time to <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 770.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure that GSK remains able to attract and retain the best <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 781.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available global talent. <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The new peer group is intended to prove enduring and should <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remain relevant for some time as GSK&#8217;s growth. continues. Our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">methodology for setting the peer group is described on page<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 528.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.93pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_24127">137</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 492.82pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 205.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 6.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/></tr><tr style="height: 6.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6.75pt; overflow: hidden; position: var(--position); top: 6.75pt; width: 198.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Size-adjusted global biopharma peer group<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6.75pt; overflow: hidden; position: var(--position); top: 18pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Amgen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72pt; overflow: hidden; position: var(--position); top: 18pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Gilead<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 137.25pt; overflow: hidden; position: var(--position); top: 18pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Roche Holding<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6.75pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">AstraZeneca<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Merck KGaA<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 137.25pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Sanofi<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Bayer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Moderna<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 137.25pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Takeda<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6.75pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">BMS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6.75pt; overflow: hidden; position: var(--position); top: 63pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">CSL<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72pt; overflow: hidden; position: var(--position); top: 63pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Pfizer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="height: 76.8pt; left: 303.69pt; position: var(--position); top: 496.93pt; width: 235.5pt; z-index: -5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g81.gif" alt="" style="height: 86.8pt; width: 245.5pt;"/></div><div><div><div style="transform: translate(1.09pt, 1.09pt);"></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 599.65pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Competitive Compensation:<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 416.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Having reset our peer group, we <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered the remuneration arrangements for our CEO and <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CFO. Our CEO, whom we regard as a high performer, is <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currently positioned below the lower quartile of the new size-<span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted global biopharma peer group across all <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensation metrics, except base salary where she is <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positioned below median. This remains true even when <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">excluding US companies from our new group (see page <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.25pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_24127">137</a><span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 327.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">In ad<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.93pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">dition, analysis reflects that GSK is facing meaningful <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 707.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">external pay compression, with our CEO&#8217;s pay being more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 717.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">consistent with &#8216;number 2&#8217; roles in our peer group, making <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 727.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">attracting external talent challenging. GSK has significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 737.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">internal pay compression within our peer group, with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 748.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;headroom gap&#8217; (i.e. the gap from CEO to number 2 role <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 758.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">compensation) being over 40% less than the group average, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 768.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">which brings with it retention risk (see page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.67pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_24097">138</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.68pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">). We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 778.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">therefore intend to begin the move towards the median of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 788.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">new peer group in 2025, and during the term of the 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 799.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">Policy.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">137<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Alignment to Size-adjusted <span style="display: inline-block; height: 8pt;"></span><span id="i9661dafaf5fc49f8aa6d69d81c1d2708_24127"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 195.76pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Global Biopharma <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 292.08pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Peer Group<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 135.28pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g82.jpg" alt="Rem Infographic.V2.jpg" style="height: 279.25pt; width: 487.72pt;"/></div></div></div><div style="line-height: 11pt; position: var(--position); top: 419.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8pt;"></span></span></div><div style="background-color: transparent; height: 208.09pt; left: 53.8pt; opacity: 1; position: var(--position); top: 424.12pt; width: 487.72pt; z-index: -2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g83.jpg" alt="2024_TotalRemBenchmarking - Expanded - V4.jpg" style="height: 208.09pt; width: 487.72pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 435.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 62.769999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Expa<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 88.71000000000001pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">nded set o<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 142.84pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">f CEO Benchmarks<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; Median TDC (&#163;m)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 641.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK CEO remuneration versus new peer group (2024 data)<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="background-color: transparent; height: 140.12pt; left: 56.11pt; opacity: 1; position: var(--position); top: 661.88pt; width: 235.66pt; z-index: 6;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g84.jpg" alt="P151 Chart-2.jpg" style="height: 140.12pt; width: 235.66pt;"/></div></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 641.99pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic Alignment:<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> We assessed the other aspects of our <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 652.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration to ensure alignment to strategy. Given the <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 662.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priority now is to further demonstrate our ability to deliver the <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031 ambitions and beyond, we wish to ensure that our <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration approach is even more focused on <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incentivising execution against pipeline delivery. We will <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 703.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therefore increase the pipeline focus in our Annual <span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 502.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bonus <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 713.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">o<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 317.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bjectives while retaining and refining the pipeline focus in <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our LTI plan. <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In refreshing our approach, we have noted shareholders&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback regarding the importance of rigour in target setting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and assessment, as well as focusing on value creation. We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 770.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have worked closely with the Science Committee in this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 780.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regard.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">138<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 249.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 237.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 5.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; External compression: GSK CEO vs. #2 at pharma peers<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; TDC<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 368.89pt; left: 53.86pt; opacity: 1; position: var(--position); top: 109.42pt; width: 487.56pt; z-index: -4;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g85.jpg" alt="Rem compression boxes.jpg" style="height: 368.89pt; width: 487.56pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 155.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(&#163;m)<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.18pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 141.73pt;"></span></span><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g86.gif" alt="14409" style="height: 141.73pt; width: 459.75pt;"/></div></div></div><div style="position: var(--position); top: 311.35pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 21pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 383.25pt;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 83.25pt; position: var(--position); top: 0pt; width: 21pt;"><div><div style="line-height: 7pt; position: var(--position); top: 1.69pt; width: 21pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 3.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 338.99pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 249.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 237.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 5.72pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; Internal compression: headroom between #2 pay and CEO pay<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 249.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 249.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; Base salary<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 249.75pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 237.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.63pt; width: 237.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total direct compensation<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 378.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  <span style="display: inline-block; height: 96.37pt;"></span></span><div style="left: 60.82pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g87.gif" alt="14420" style="height: 96.37pt; width: 212.59pt;"/></div></div></div><div style="line-height: 0pt; position: var(--position); top: 378.49pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g88.gif" alt="14422" style="height: 96.37pt; width: 212.59pt;"/></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 495.75pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alignment to Shareholder Experience:<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Finally, in recognition <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the importance of further aligning shareholder and <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management experiences and shareholder input, we <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">propose to increase the weighting of our relative TSR PSP <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measure from 30% to 40%. This will be achieved by reducing <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the other PSP elements equally by 2.5%. We recognise that <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not all shareholders are supportive of the use of TSR <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures in LTI plans. To further align with shareholders and <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 577.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">simplify our arrangements our Share Ownership <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 587.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Requirement (SOR) will be updated to track the PSP LTI <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 597.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">grant multiple given to executive directors and to require that <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 607.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level be maintained for 2 years after cessation of <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 618.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employment. <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 634.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Engagement<span style="display: inline-block; height: 6.55pt;"></span><span id="i9661dafaf5fc49f8aa6d69d81c1d2708_24097"></span><span id="i9661dafaf5fc49f8aa6d69d81c1d2708_24123"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Th<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e Chair and I met to share our initial proposals with certain of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 657.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our major shareholders before refining our thinking and holding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 667.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">broader discussions in October and November 2024. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 678.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culminated in the presentation of our proposals at our Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 688.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governance Meeting in December 2024 and writing to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 698.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders representing approximately 60% of our share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital. We subsequently met again with shareholders to further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 718.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refine our proposals. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 734.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The full process we followed is set out on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2fdae0fcc1cf47049ec85bb2c40664fd_454">141</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 244.35000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. I would like <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 745.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to thank the many shareholders who engaged with us and for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 755.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their time and the thoughtfulness in their responses. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback was greatly valued and carefully considered before <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 775.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Committee decided how to proceed. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While it is never possible to reflect all feedback (as some views <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were irreconcilable), we carefully considered all feedback and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made a number of changes to reflect suggestions. There was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acknowledgement <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of GSK as a global biopharma company, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress that has been made operationally and the stronger <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positioning of the company, We also discussed: (1) the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate level of alignment with shareholder experience, (2) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparability with our geographically local peers, (3) our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 577.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence in the long-term pipeline and short-, medium- and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 587.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term growth strategy, and (4) the importance of providing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 597.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flexibility in the potential remuneration policy application over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 607.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following these collaborative conversations and engagement, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 634.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we refined our Bonus, LTIP and SOR proposals twice &#8211; once <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 644.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">after initial discussions with shareholders and then after more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 654.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">broader engagement. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 670.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Though there is recognition of the performance and progress <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 680.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made by our highly respected CEO, the importance of aligning <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 690.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our proposals to the shareholder experience meant it was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 700.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate to make changes to better align to shareholder <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 711.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience with phased share implementation, stronger <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 721.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholding requirements and greater reporting transparency. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 731.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our revised proposals will initially result in our CEO being <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 741.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remunerated between lo<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wer and median<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> quartile of our new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 751.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">size-adjusted global biopharma peer group. We will have the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 762.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flexibility to move towards median remuneration by the end of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 772.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the 2025 Policy period in line with shareholder experience. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">139<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Journey towards peer group median for Total Direct <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 124.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Compensation (TDC) <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 137.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All our analysis has confirmed that material changes are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 147.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currently required to the CFO&#8217;s package at this point. It also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 158.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confirmed the Committee&#8217;s starting point that the CEO&#8217;s current <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 168.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">package, which is currently in the lower quartile of the new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 178.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">size-adjusted global biopharma peer group, is insufficient either <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to reward her performance, or to provide the appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capacity for succession. As a result, we will look to target <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">median of the proposed new peer group&#8217;s total direct <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensation levels over time, with a continued strong bias <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">towards performance-related pay. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 245.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This will be achieved for the CEO by:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 261.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual bonus<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 116.11pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the current 3.00 times base salary maximum <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will be held. However, we will increase on-target bonus from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.00 times to 1.50 times base salary to help reach the new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">peer-group median level. The current approach of setting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets on a challenging basis consistent with our growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy will be maintained.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LTI:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 76.2pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 78.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the CEO&#8217;s LTI Policy award maximum multiple will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased from our current CEO Policy maximum of 6.00 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 348.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(with current grants at 5.75 times) to a maximum of 8.00 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 358.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">times base salary. The Committee will then increase the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 368.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO&#8217;s PSP LTI grant to 7.25 for 2025. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 384.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Thereafter we will only increase the CEO&#8217;s PSP LTI award <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiple from 7.25 times salary after GSK shares are re-rated, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or if required for succession purposes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 421.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition, for the CEO this increase will be aligned to a more <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 431.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demanding performance scale with the percentage of base <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">salary payable at threshold (TSR median) maintained at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 451.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately the current level of 143.75% of base salary. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this way any benefit from the increase in quantum will clearly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be linked to out-performance.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further, the top end of the TSR scale will be linked to upper <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quintile (20th percentile) performance, rather than the current <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upper quartile (25th percentile). This would then be one of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most demanding relative TSR measures in our new peer group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and will apply to the executive leadership team. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These combined changes will result in the CEO&#8217;s total &#8216;on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">target&#8217; remuneration opportunity being &#163;8.76 million, positioned <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">above the lower quartile of this peer group. Albeit, this remains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">closer to the lower quartile than the median. We will have the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capacity to move from here in line with shareholder experience. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 601.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee recognises that if GSK operated solely within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the UK, the 2025 Policy proposal could be viewed differently. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">That said, we are of the view that these changes are essential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to move towards competitive performance-related pay <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 642.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunity in the context of GSK&#8217;s global operations. Hence a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 652.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pure FTSE 100 peer group would not be appropriate.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 668.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Full details of the proposed 2025 Policy are set out on pages <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 678.49pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_331">164</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28009">172</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration policy implementation for 2025<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the 2025 Policy consultation process we also shared the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes we were proposing to the way we implement our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy, in particular in terms of our long- and short-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance measures. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025 Annual bonus and LTI performance measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 189.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the strategic importance of continued delivery of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline as explained earlier, we have chosen to add a Pipeline <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 209.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measure to the Annual bonus. The 2025<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 454.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Annual bonus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 219.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures for 2025 will ther<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efore be changed as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 235.75pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 234pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 110.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New for 2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales: 30%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales: 25%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core Operating Profit: 30%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core Operating Profit: 25%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RB: Inclusion: 10%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline: 20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic and operational: 30%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 45pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic, operational and RB: <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 311.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">The new short-term Pipeline measure is described in full on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.64pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i0af1792924ea4c95b3faa9a966c9365c_7794">151</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339.56pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">. It rewards delivery of shorter-term, large publicly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">reported R&amp;D milestones for GSK's priority pipeline assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">which together are expected to deliver the company's 2031 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">growth strategy. The Science Committee supports the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Committee in confirming the appropriateness and stretch in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 372.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline measure. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 388.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our 2025 PSP LTI measures have been updated<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> too and will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 414.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 234pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 123.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 123.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 110.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New for 2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relative TSR: 30%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relative TSR: 40%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales: 20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales: 17.5%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core Operating Profit: 20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core Operating Profit: 17.5%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline: 20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 45pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline: 17.5%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 123.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 123.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RB: Environment: 10%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 123.75pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RB: Composite Score: 7.5%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 493.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These measures seek to reinforce over-delivery of our longer-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">term growth strategy. The Pipeline measure has been updated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and focuses on the value and volume achievement of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall pipeline supporting our 2031 growth strategy and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 533.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">beyond. This measure<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 387.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> will only vest, either in full or in part, if at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the time of vesting <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the most recently governed and published <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031 sales outlook remains at a specified level. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our RB <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measure has been simplified to be directly aligned and reward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery against the company&#8217;s full RB programme. You can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">read in detail about our progress in year and our ambitions in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the context of our six RB focus areas set out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 508.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_118">45</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 529.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i790f5ce0ebd74867a80debd26af98cda_8707">58</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 539.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We will continue to have transparency of measures and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">140<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Path to ensuring competitive compensation<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee noted that the UK wider workforce annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 137.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase was 3.3%. It was agreed that the CFO&#8217;s performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 147.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">merited a base salary increase of 3.3%, and the CEO an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 157.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase of 5%.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The CEO&#8217;s increase was set marginally higher than that of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">general workforce increase given her very strong performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2024 and previous years, and her experience in the role, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whilst noting the benchmark data. This increase also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 214.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognises that the CEO&#8217;s base salary was 4-5% behind our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new size-adjusted performance group median based on 12-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">month old (i.e. 2024) data. It supports the long-term aim of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee to position CEO TDC at the median of our new size-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted global biopharma peer group over the course of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Policy. The Committee also noted the compression <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact on other colleagues of the CEO&#8217;s remuneration both <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 285.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internally and against peers. The increase is insufficient to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bridge the differential on TDC but, combined with the proposed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in performance pay, will begin to move CEO&#8217;s TDC, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">towards the median TDC of our new size-adjusted peer group.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.41pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.95pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span></span></div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Thank you<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Once again, I would like to take this opportunity to thank <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 137.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders for their input and engagement during this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 147.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy review, to help shape the new Policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 157.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">presented in this report. During this consultation we were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pleased to be able to engage with the majority of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s shareholder register. I would like to congratulate all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our people for all they have achieved in 2024 and the delivery <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of another excellent year of performance, and thank my fellow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee colleagues for their wise counsel and support in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 218.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing the new Policy. Last but not least, I would also like <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to thank colleagues on the Board from the Science and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Responsibility committees for their collaboration and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support in ensuring that these changes are robust and well <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">validated. I welcome all shareholders&#8217; feedback on this report <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ahead of our AGM. We look forward to receiving your support <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for our new Remuneration policy and Annual report on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration at our Annual General Meeting on 7 May 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committee Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25 February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">141<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy consultation<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_298"></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 8pt;"></span><span id="i2fdae0fcc1cf47049ec85bb2c40664fd_457"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 77.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Remuneration policy renewal<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 231.43pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">: Key changes for GSK as a pure biopharma company<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 139.09pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 483pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 6.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 72.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 72.75pt; left: 8.25pt; overflow: hidden; position: var(--position); top: 6.75pt; width: 113.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 19.12pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refocus on meaningful <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 29.92pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitive peer <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 40.72pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benchmark &#8211; aligned to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 51.52pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK purpose and talent <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 62.32pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 72.75pt; left: 129.75pt; overflow: hidden; position: var(--position); top: 6.75pt; width: 113.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 19.12pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Globally competitive <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 29.92pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensation for GSK and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 40.72pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance pay potential <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 51.52pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for CEO <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-right: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 72.75pt; left: 251.25pt; overflow: hidden; position: var(--position); top: 6.75pt; width: 113.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 19.12pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic alignment - <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 29.92pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deeper and sharper <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 40.72pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline focus across short- <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 51.52pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and long-term incentives<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-left: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 72.75pt; left: 372.75pt; overflow: hidden; position: var(--position); top: 6.75pt; width: 110.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 19.12pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alignment to shareholder <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 29.92pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 82.33pt; left: 53.86pt; position: var(--position); top: 140.96pt; width: 489.68pt; z-index: -2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g89.gif" alt="" style="height: 92.33pt; width: 499.68pt;"/></div><div><div><div style="transform: translate(0.40pt, 0.40pt);"></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 229.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK consultation process and impact<span style="display: inline-block; height: 8pt;"></span><span id="i2fdae0fcc1cf47049ec85bb2c40664fd_454"></span></span></div><div style="position: var(--position); top: 245.48pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 112.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 128.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">What we did<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 128.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engagement event<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 177pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dates<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 305.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 112.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investor participation<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(approx.)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 417.75pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 69.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">represented (approx.)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Review and understanding of existing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy and strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 39pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">May - July 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 59.25pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 128.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consultation with Board and senior <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 128.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human Resources Leaders on <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 128.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employee perspectives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 59.25pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">July - October 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Initial individual investor consultation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">October - December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 305.25pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">25 investors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 417.75pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">40%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 23.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Annual Governance Meeting<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 23.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 305.25pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.48pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Invited: 60 investors and proxy <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.85pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">advisors<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 23.72pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Attended: 25 investors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 417.75pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 22.37pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consultation letter - seeking feedback <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on proposal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 132pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 305.25pt; overflow: hidden; position: var(--position); top: 132pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">60 investors and proxy advisors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417.75pt; overflow: hidden; position: var(--position); top: 132pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Letter - explaining how feedback was <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered and incorporated<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">February 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 305.25pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">60 investors and proxy advisors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417.75pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">60%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meetings held with shareholders up to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">publication of Annual Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 177pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">December 2024 - February 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 305.25pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">12 investors and proxy advisors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417.75pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21pt;"><td colspan="4" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 204.75pt; width: 417.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 417.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">What we heard<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 128.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reinforced:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 177pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 177pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emphasised:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 237pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Logic of global biopharma group<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 237pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Better alignment with shareholder experience<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Uncompetitive CEO pay<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Differentiate GSK&#8217;s policy from other geographically local peers of a larger scale<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Performance stretch<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Request for greater transparency of Pipeline measures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 270.75pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Pipeline focus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 128.25pt; overflow: hidden; position: var(--position); top: 270.75pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Need for global compensation competitiveness, especially for succession<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="3" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 282pt; width: 305.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 305.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Impact on proposals<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 297pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Peer group &amp; salary<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 128.25pt; position: var(--position); top: 297pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Keep peer group and median aim but phase over the life of the plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 308.25pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Annual bonus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 128.25pt; position: var(--position); top: 308.25pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Reach market practice of 50% of bonus max for target, keeping max at market practice of 3.00 times <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">base salary<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.87pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Retain current Annual bonus deferral requirement, even after shareholding requirement is met, to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.24pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">enhance disclosure on pipeline and strategic operational measures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 89.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 89.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 349.5pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">LTIP<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 128.25pt; position: var(--position); top: 349.5pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Adjust LTIP maximum award to 8.00 times CEO base salary<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Cap the CEO&#8217;s award at 7.25 times base salary until a meaningful and sustained re-rating of GSK&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.87pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">shares or succession requires it <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Maintain Emma Walmsley&#8217;s payout at threshold at approximately the current percentage of base salary <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">(143.75% of base salary)<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.98pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Increase maximum vesting for TSR to be top quintile related performance<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 60.85pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Increase weighting of relative TSR measure from 30 to 40% of the PSP award<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 70.72pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Increase transparency of the pipeline measure and add a vesting underpin to demand 2031 sales <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 80.09pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">outlook at the time of vesting remains at a specified level<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 438.75pt; width: 128.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">SOR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 128.25pt; position: var(--position); top: 438.75pt; width: 359.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">Increase to match executives&#8217; PSP level. Increase post-cessation requirement to apply in full for 2 years <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 359.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); text-decoration: none; white-space: pre;">post-cessation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">142<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy consultation continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 128.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 112.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 128.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 128.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Net impact<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51pt;"><td colspan="5" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15pt; width: 487.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our revised proposals will initially result in our CEO being remunerated between lower quartile and median of our new size-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted global biopharma peer group. We will have the flexibility to move towards median remuneration by the end of the 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy period in line with shareholder experience. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 38.92pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net impact post consultation on CEO remuneration<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 144.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 119pt; left: 68.86pt; opacity: 1; position: var(--position); top: 197.39pt; width: 337.32pt; z-index: 2;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g90.jpg" alt="P154 chart V3.jpg" style="height: 119pt; width: 337.32pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 331.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025 Executive Director remuneration<span style="display: inline-block; height: 8pt;"></span><span id="i2fdae0fcc1cf47049ec85bb2c40664fd_456"></span></span></div><div style="position: var(--position); top: 347.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 162pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 0pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.03pt; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 0pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 61.63pt; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed remuneration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 22.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.24pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,430,792<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 22.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 62.24pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;1,022,697<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 33.75pt; width: 324pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 324pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 112.76pt; position: var(--position); text-decoration: none; white-space: pre;">Aligned to wider UK workforce<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Pay<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual bonus<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(% of salary)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 56.25pt; width: 324pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 324pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 114.52pt; position: var(--position); text-decoration: none; white-space: pre;">Maximum opportunity: 300%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 76.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.51pt; position: var(--position); text-decoration: none; white-space: pre;">On-target: 150%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 76.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.51pt; position: var(--position); text-decoration: none; white-space: pre;">On-target: 100% <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LTI<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 9.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(% of salary)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 87.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.1pt; position: var(--position); text-decoration: none; white-space: pre;">Maximum: 725%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 87.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 53.1pt; position: var(--position); text-decoration: none; white-space: pre;">Maximum: 400%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 108pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.67pt; position: var(--position); text-decoration: none; white-space: pre;">Threshold: 145% <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 108pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.67pt; position: var(--position); text-decoration: none; white-space: pre;">Threshold: 100%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share ownership requirement<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(% of salary)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 123pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 71.41pt; position: var(--position); text-decoration: none; white-space: pre;">725%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 324pt; position: var(--position); top: 123pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.35pt; position: var(--position); text-decoration: none; white-space: pre;">400%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 501.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; CEO LTI of 725% of base salary to be delivered via initial grant of 575% of base salary and a top-up award granted in May 2025 of 150% of base salary <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 510.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(subject to shareholder approval of the Remuneration Policy at the company's 2025 AGM). The top-up award would vest in May 2028<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 472.69pt; position: var(--position); white-space: pre;">.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">143<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 45pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 6.91pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 remuneration at a glance <span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_301"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Total remuneration<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 142.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley, CEO <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 142.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown, CFO<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 166.58pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g91.jpg" alt="Total Rem graphs V2.jpg" style="height: 53.76pt; width: 487.72pt;"/></div></div></div><div style="position: var(--position); top: 231.34pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 405.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 5.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 171pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 5.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 200.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.05pt; width: 12pt;"><span style="color: #f36633; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 17.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 171pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 171pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed pay &#8211; salary, benefits, pensions and other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 188.25pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.05pt; width: 12pt;"><span style="color: #929292; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 205.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 200.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 200.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance pay &#8211; annual bonus and vested LTIs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 258.29pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 14pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 14pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Pay for performance<span style="display: inline-block; height: 10.19pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 281.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 Annual bonus<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 135.09pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> o<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 142.94pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">utcome: Overall payout 70% and 66% of maximum for CEO and <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 411.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">CFO <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 432.40000000000003pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">respectively<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 294.78pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g92.jpg" alt="Rem bonus outcome graphic V2.jpg" style="height: 140.67pt; width: 487.72pt;"/></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 443.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 Annual bonus delivery<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 170.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 456.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 160.15pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 113.38pt;"></span></span><div style="left: 46.77pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g93.gif" alt="175" style="height: 113.38pt; width: 113.38pt;"/></div></div></div><div style="background-color: transparent; height: 58.91pt; left: 169.73pt; opacity: 1; position: var(--position); top: 494.35pt; width: 100.66pt; z-index: 1;"><div><div><div><div style="line-height: 9pt; position: var(--position); top: 0pt; width: 100.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 0pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley, CEO<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 13.49pt; width: 100.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overall bonus<span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="line-height: 10.5pt; position: var(--position); top: 26.09pt; width: 100.66pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: -0.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">210% of salary<span style="display: inline-block; height: 7.64pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 577.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.8pt; width: 12pt;"><span style="color: #f36633; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 15pt; overflow: hidden; position: var(--position); top: 0pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares deferred for 3 years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 12pt;"><span style="color: #929292; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 15pt; overflow: hidden; position: var(--position); top: 12pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 0pt; position: var(--position); top: 456.63pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g94.gif" alt="182" style="height: 113.38pt; width: 113.38pt;"/></div></div></div><div style="background-color: transparent; height: 58.91pt; left: 429.69pt; opacity: 1; position: var(--position); top: 493.24pt; width: 94.21pt; z-index: 2;"><div><div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 0pt; width: 94.21pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 0pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brow<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.77pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">n, CFO<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); top: 13.49pt; width: 94.21pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overall bonus<span style="display: inline-block; height: 7.64pt;"></span></span></div><div style="font-size: 12pt; line-height: 10.5pt; position: var(--position); top: 26.09pt; width: 94.21pt;"><span style="font-family: 'Arial', sans-serif; font-size: 10.5pt; font-style: normal; font-weight: normal; left: -0.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">198% of salary<span style="display: inline-block; height: 7.64pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 575.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 125.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.8pt; width: 12pt;"><span style="color: #f36633; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 15pt; overflow: hidden; position: var(--position); top: 0pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares deferred for 3 years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 12pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.63pt; width: 12pt;"><span style="color: #929292; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 15pt; overflow: hidden; position: var(--position); top: 12pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 619.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2022 PSP outcome: Overall vesting 80.75% of maximum<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 633.24pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g95.jpg" alt="Vesting graphic V5.jpg" style="height: 140.41pt; width: 487.72pt;"/></div></div></div><div style="position: var(--position); top: 778.65pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 178.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 108.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.05pt; width: 12pt;"><span style="color: #7c7c7b; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 15.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vested<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 55.5pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 10pt; position: var(--position); top: 2.05pt; width: 14.25pt;"><span style="color: #c6c6c6; font-family: 'Wingdings', sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 7.7pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 69.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 108.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 108.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lapsed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 794.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding COVID-19 solutions. Total sales is referred to as Group <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 267.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 295.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> elsewhere within the report <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 805.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This measure ceased to operate at the end of 2024<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">144<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_304"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i6c0b125e757a4ea89adb5df88b7e0ee7_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="font-size: 12pt; line-height: 18pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 13.1pt;"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: 39.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Total remuneration (audited)<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="height: 123.99pt; left: 52.38pt; position: var(--position); top: 151.79pt; width: 493.5pt; z-index: -14;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g96.gif" alt="" style="height: 133.99pt; width: 503.5pt;"/></div><div><div><div style="transform: translate(0.41pt, 0.41pt);"></div></div></div></div><div style="background-color: transparent; height: 106.5pt; left: 66.88pt; opacity: 1; position: var(--position); top: 161.76pt; width: 474.75pt; z-index: -4;"><div><div style="font-size: 0pt; width: 474.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 129pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 137.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 99pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 82.5pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 129pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fixed pay<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 65.45pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.79pt; width: 129pt;"><span style="color: #000000; font-family: 'GSK Precision Bold', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 392.25pt; position: var(--position); top: 15pt; width: 82.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 12.57pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.06pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">remuneration<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.96pt; width: 129pt;"><span style="color: #000000; font-family: 'GSK Precision Bold', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Pension<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 129pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 137.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.96pt; width: 137.25pt;"><span style="color: #000000; font-family: 'GSK Precision Bold', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Annual Bonus<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 266.25pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.35pt; width: 99pt;"><span style="font-family: 'GSK Precision Bold', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">LTI awards <span style="display: inline-block; height: 7.2pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 99pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">(2022 PSP award vesting)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.79pt; width: 129pt;"><span style="color: #000000; font-family: 'GSK Precision Bold', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 19.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 19.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.97pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Read more on<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 84.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">page 145<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 84.75pt; width: 137.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 137.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">pages 146 to 148<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 266.25pt; position: var(--position); top: 84.75pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 99pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">pages 149 and 150<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 392.25pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 82.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">below<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div><div style="height: 66.74pt; left: 182.88pt; position: var(--position); top: 163.98pt; width: 258.92pt; z-index: -12;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g97.gif" alt="" style="height: 76.73pt; width: 268.92pt;"/></div></div><div style="height: 66.74pt; left: 60.46pt; position: var(--position); top: 163.98pt; width: 115.81pt; z-index: -11;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g98.gif" alt="" style="height: 76.73pt; width: 125.81pt;"/></div></div><div style="height: 67.2pt; left: 447.73pt; position: var(--position); top: 163.73pt; width: 90.58pt; z-index: -9;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g99.gif" alt="" style="height: 77.2pt; width: 100.58pt;"/></div><div><div><div style="transform: translate(0.22pt, 0.22pt);"></div></div></div></div><div style="height: 22pt; left: 434.41pt; position: var(--position); top: 190.86pt; width: 22pt; z-index: 7;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g100.gif" alt="" style="height: 32pt; width: 32pt;"/></div><div><div><div style="transform: translate(3.22pt, 3.22pt);"></div></div></div></div><div style="height: 22pt; left: 299.16pt; position: var(--position); top: 191.86pt; width: 22pt; z-index: 8;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g100.gif" alt="" style="height: 32pt; width: 32pt;"/></div><div><div><div style="transform: translate(3.22pt, 3.22pt);"></div></div></div></div><div style="height: 22pt; left: 168.66pt; position: var(--position); top: 191.36pt; width: 22pt; z-index: 9;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g100.gif" alt="" style="height: 32pt; width: 32pt;"/></div><div><div><div style="transform: translate(3.22pt, 3.22pt);"></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 435.31pt; opacity: 1; position: var(--position); top: 189.82pt; width: 20.35pt; z-index: 12;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 20.35pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">=<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 300.66pt; opacity: 1; position: var(--position); top: 190.13pt; width: 19pt; z-index: 13;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 19pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 169.66pt; opacity: 1; position: var(--position); top: 190.13pt; width: 19pt; z-index: 14;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 19pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 30.37pt; left: 447.77pt; position: var(--position); top: 236.18pt; width: 90.28pt; z-index: -13;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g101.gif" alt="" style="height: 40.37pt; width: 100.28pt;"/></div></div><div style="height: 30.68pt; left: 182.86pt; position: var(--position); top: 236.18pt; width: 258.8pt; z-index: -10;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g102.gif" alt="" style="height: 40.68pt; width: 268.8pt;"/></div></div><div style="height: 31.27pt; left: 60.52pt; position: var(--position); top: 236.18pt; width: 116.22pt; z-index: -5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g103.gif" alt="" style="height: 41.27pt; width: 126.22pt;"/></div></div><div style="line-height: 8.5pt; position: var(--position); top: 285.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following sections from this page to page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iabcd5cf9399549a4a000f23e7510cc29_2541">163</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> provide details of each element of 2024 &#8216;Total remuneration&#8217; and how the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee implemented the company&#8217;s shareholder-approved 2022 Remuneration policy during the year in terms of fixed and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance pay.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 337.61pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ia4f1d20c03ed4b3a9b199cda4db379ef_0-0-1-1-825078"></span><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 Total remuneration (audited)<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 364.61pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 175.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 0pt; width: 151.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 151.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 83.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley, CEO<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 0pt; width: 151.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 151.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 98.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown, CFO <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 11.25pt; width: 75.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.769999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 11.25pt; width: 75.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.769999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 11.25pt; width: 75.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.769999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 11.25pt; width: 75.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.769999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 175.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fixed pay<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 20.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 42.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,363<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 42.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,310<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 42.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 57.49pt;"></span></span><span style="left: 60.120000000000005pt; position: var(--position);">990<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 42.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 60.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">635<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 54.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 57.49pt;"></span></span><span style="left: 60.120000000000005pt; position: var(--position);">180<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 54.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 57.49pt;"></span></span><span style="left: 60.120000000000005pt; position: var(--position);">212<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 54.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.63pt;"></span></span><span style="left: 64.26pt; position: var(--position);">64<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 54.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 66.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.63pt;"></span></span><span style="left: 64.26pt; position: var(--position);">98<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 66.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.63pt;"></span></span><span style="left: 64.26pt; position: var(--position);">94<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 66.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.63pt;"></span></span><span style="left: 64.26pt; position: var(--position);">69<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 66.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 64.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 18.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 78.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 62.44pt;"></span></span><span style="left: 65.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 78.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 62.44pt;"></span></span><span style="left: 65.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 78.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,088<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 78.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 55.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,411<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total fixed pay<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 90pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,641<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 90pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,616<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 90pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">2,211<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 90pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3,140<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 175.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual bonus<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 45.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 120pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">2,855<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 120pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">3,774<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 120pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,955<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 120pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,687<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vesting of PSP LTI awards<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 87.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 132pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">6,063<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 132pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">7,328<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.75pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 132pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 62.44pt;"></span></span><span style="left: 65.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 132pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 65.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total pay for performance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 144pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">8,918<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 144pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.16pt;"></span></span><span style="left: 49.79pt; position: var(--position);">11,102<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 144pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">1,955<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 144pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,687<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 175.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.72pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Total remuneration<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 181.5pt; position: var(--position); top: 161.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.16pt;"></span></span><span style="left: 49.79pt; position: var(--position);">10,559<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 257.25pt; position: var(--position); top: 161.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.16pt;"></span></span><span style="left: 49.79pt; position: var(--position);">12,718<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336pt; position: var(--position); top: 161.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.3pt;"></span></span><span style="left: 53.93pt; position: var(--position);">4,166<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 161.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4,827<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 552.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary:<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 88.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 90.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown joined the company on 3 April 2023. Her 2023 base salary of &#163;915,335 was pro-rated to reflect the time she worked as CFO Designate <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 561.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">until 1 May 2023 and as CFO until 31 December 2023<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 571.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other:<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Represents the sum paid in cash to Julie Brown, the CFO, as part of her buyout arrangements in relation to leaving Burberry, as set out in full on <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 579.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page 149 of the 2022 Annual Report. In setting the Buyout arrangements, which are staged over a two year period, the Committee sought to ensure she <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 588.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was compensated on a like-for-like basis as far as possible. In fulfilment of these arrangements, the CFO purchased 22,500 shares in June 2023<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 598.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred Annual Bonus Plan (DABP)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 185.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 187.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> The mandatory DABP bonus deferrals for 2023 and 2024 are set out on page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 428.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_322">160</a><span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 609.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022 PSP vesting in 2025<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 148.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 150.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> For the CEO, the figure has been valued based on the closing price on 18 February 2025 of &#163;14.43. The share price on 15 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 617.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February 2022, the date of grant, was &#163;15.71. Of the vested amounts for the CEO, nothing <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 344.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was attributable to share price appreciation over the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 625.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance period.<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 127.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> The Committee did not exercise any discretion in relation to the vesting of the awards or share price changes<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 636.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160;  <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 67.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All-employee share plans:<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 153.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> The CEO and CFO each contribute the maximum of &#163;250 and &#163;125 a month into the Share Save plan and to buy shares <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 644.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the Share Reward plan respectively. Further details of these HM Revenue &amp; Customs (HMRC) approved all-employee plans are set out on page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 527.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#icdfbc283136b489a9c31ebff2b59650e_6295">154</a><span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 655.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 67.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Malus and clawback<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 133.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 136.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> The Committee may in specific circumstances, and in line with stated principles, apply malus and clawback, as it determines <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 663.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate. Following due consideration by the Committee, there has been no recovery of sums paid (clawback) or reduction of outstanding awards or <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 671.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesting levels (malus) applied during <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 179.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 194.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in respect of<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 234.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> either the CEO or CFO<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">145<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration&#160; continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_307"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed pay 2024 and 2025 (audited)<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee is very aware of the sensitivity amongst stakeholders to levels of pay. Before setting or reviewing salary, it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered the average increases awarded to employees below Executive Directors and the multiplier effect of increases in base <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">salaries on total remuneration opportunity. The Committee considered the wider economic context, individual performance and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market positioning of the increases awarded. The table below sets out the base salaries and increases agreed for 2024 and 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the Executive Directors compared to increases for the UK workforce. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 224.41pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 81pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 56.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 81pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 25.11pt; width: 81pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and 2025 <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 32.91pt; width: 81pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effective dates<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 49.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% change<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.74pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.54pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 20.25pt; width: 81pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 64.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 20.25pt; width: 81pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 64.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330pt; position: var(--position); top: 20.25pt; width: 51pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 20.25pt; width: 56.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 56.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK employees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 81pt; position: var(--position); top: 40.5pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 57.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 April<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 40.5pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 67.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 67.46pt; position: var(--position);">3.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 40.5pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 67.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 67.46pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 81pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 45.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 67.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 67.46pt; position: var(--position);">5.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 54.75pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 67.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 67.46pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330pt; position: var(--position); top: 54.75pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.21pt; width: 51pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 7.2pt; width: 30.12pt;"></span></span><span style="left: 32.75pt; position: var(--position);">1,431<span style="display: inline-block; height: 7.2pt; width: 2.67pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 54.75pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.79pt; width: 56.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 7.2pt; width: 33.89pt;"></span></span><span style="left: 36.52pt; position: var(--position);">1,363<span style="display: inline-block; height: 7.2pt; width: 2.67pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 54.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);">1,310<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 81pt; position: var(--position); top: 69pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 45.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 69pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 67.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 67.46pt; position: var(--position);">3.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243pt; position: var(--position); top: 69pt; width: 81pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 81pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 67.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 67.46pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330pt; position: var(--position); top: 69pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.21pt; width: 51pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 7.2pt; width: 28.2pt;"></span></span><span style="left: 30.83pt; position: var(--position);">1,023<span style="display: inline-block; height: 7.2pt; width: 2.67pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 69pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.79pt; width: 56.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 7.2pt; width: 37.33pt;"></span></span><span style="left: 39.96pt; position: var(--position);">990<span style="display: inline-block; height: 7.2pt; width: 2.67pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 69pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);">952<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 318.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The CEO&#8217;s base salary increase was set marginally higher than that of the general workforce increase given her very strong <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance in 2024 and previous years, and her experience in role. This increase also recognises that the CEO&#8217;s base salary was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 338.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4-5% behind the median of our new size-adjusted global biopharma performance group (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on previously disclosed peer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 348.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company CEO remuneration).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Further, the increase supports the long-term aim of the Committee to position CEO total direct <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensation at the median of our size-adjusted global biopharma peer group over the course of the 2025 Policy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 390.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 406.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This table provides an analysis of total benefits (grossed up <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for tax) received by the Executive Directors in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 432.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The UK remuneration reporting regulations require the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company to add into each Executive Director&#8217;s total benefits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 453.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all items which are deemed by tax authorities to be a taxable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 463.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefit for them. These include employee benefits as well as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business-related services provided to employees to assist or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enable them to carry out their role, which a tax authority has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 494.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deemed to be a taxable &#8220;benefit&#8221; to the individual. As<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> these are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 504.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business expenses,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the company meets the tax which arises <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 514.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on them and therefore the items are shown grossed up for tax. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 390.93pt; width: 595.44pt;"><div style="font-size: 0pt; left: 306.22pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 131.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 0pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 18.75pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 18.75pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits available to employees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 44.25pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.49pt;"></span></span><span style="left: 33.12pt; position: var(--position);">103<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 44.25pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">118<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business-related services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 56.25pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.63pt;"></span></span><span style="left: 37.260000000000005pt; position: var(--position);">77<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 56.25pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">94<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 68.25pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.49pt;"></span></span><span style="left: 33.12pt; position: var(--position);">180<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 68.25pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">212<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 482.62pt; width: 595.44pt;"><div style="font-size: 0pt; left: 306.22pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 131.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits available to employees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 12pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.63pt;"></span></span><span style="left: 37.260000000000005pt; position: var(--position);">39<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 12pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business-related services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 24pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.63pt;"></span></span><span style="left: 37.260000000000005pt; position: var(--position);">25<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 24pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 131.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 131.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 131.25pt; position: var(--position); top: 36pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.63pt;"></span></span><span style="left: 37.260000000000005pt; position: var(--position);">64<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 36pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 557.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 573.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From 1 January 2023, pension arrangements for Executive Directors were aligned to the wider workforce. They received GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pension contributions or cash supplements of 7% of base salary and matching contributions of up to 3% on the first &#163;66,666 of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 594.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">salary for 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 610.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 88.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> below shows the breakdown of the pension values included in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Total remuneration<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 448.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_304">144</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 462.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 620.33pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 176.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 83.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 72.75pt;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 15.75pt; width: 176.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 21.47pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension remuneration values<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 15.75pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.67pt; width: 161.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 77.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley&#160; (&#163;000)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 15.75pt; width: 144pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.67pt; width: 144pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 79.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown (&#163;000)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 33pt; width: 83.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 5.16pt; width: 83.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 66.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 259.5pt; position: var(--position); top: 33pt; width: 78pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 5.16pt; width: 78pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 61.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 33pt; width: 71.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 5.16pt; width: 71.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 33pt; width: 72.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 5.16pt; width: 72.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 55.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 176.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK defined contribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 45.75pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 73.27pt;"></span></span><span style="left: 75.89999999999999pt; position: var(--position);">7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 259.5pt; position: var(--position); top: 45.75pt; width: 78pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 78pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 68.02pt;"></span></span><span style="left: 70.64999999999999pt; position: var(--position);">6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 45.75pt; width: 71.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.82pt; width: 57.29pt;"></span></span><span style="left: 59.92pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.82pt; width: 2.62pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 45.75pt; width: 72.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3.19pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.82pt; width: 58.79pt;"></span></span><span style="left: 61.42pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.82pt; width: 2.62pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 176.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employer cash contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 58.5pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 69.13pt;"></span></span><span style="left: 71.75999999999999pt; position: var(--position);">91<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 259.5pt; position: var(--position); top: 58.5pt; width: 78pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 78pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.88pt;"></span></span><span style="left: 66.51pt; position: var(--position);">88<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 58.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.97pt;"></span></span><span style="left: 59.6pt; position: var(--position);">69<span style="display: inline-block; height: 5.46pt; width: 2.62pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 58.5pt; width: 72.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 58.47pt;"></span></span><span style="left: 61.1pt; position: var(--position);">44<span style="display: inline-block; height: 5.46pt; width: 2.62pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 70.5pt; width: 176.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 176.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 176.25pt; position: var(--position); top: 70.5pt; width: 83.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 83.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 69.13pt;"></span></span><span style="left: 71.75999999999999pt; position: var(--position);">98<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 259.5pt; position: var(--position); top: 70.5pt; width: 78pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 78pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.88pt;"></span></span><span style="left: 66.51pt; position: var(--position);">94<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 343.5pt; position: var(--position); top: 70.5pt; width: 71.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 71.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.97pt;"></span></span><span style="left: 59.6pt; position: var(--position);">69<span style="display: inline-block; height: 5.46pt; width: 2.62pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 414.75pt; position: var(--position); top: 70.5pt; width: 72.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 58.47pt;"></span></span><span style="left: 61.1pt; position: var(--position);">44<span style="display: inline-block; height: 5.46pt; width: 2.62pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">146<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_310"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Pay for performance (audited)<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Annual Bonus<span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 62.25pt; left: 53.86pt; position: var(--position); top: 173.08pt; width: 109.7pt; z-index: 1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g104.gif" alt="" style="height: 72.25pt; width: 119.7pt;"/></div></div><div style="height: 62.25pt; left: 70.44pt; position: var(--position); top: 173.08pt; width: 93.12pt; z-index: 2;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g105.gif" alt="" style="height: 72.25pt; width: 103.12pt;"/></div></div><div style="height: 62.25pt; left: 166.39pt; position: var(--position); top: 173.08pt; width: 109.7pt; z-index: 4;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g106.gif" alt="" style="height: 72.25pt; width: 119.7pt;"/></div></div><div style="height: 62.25pt; left: 278.93pt; position: var(--position); top: 173.08pt; width: 106.01pt; z-index: 5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g107.gif" alt="" style="height: 72.25pt; width: 116.01pt;"/></div></div><div style="height: 62.03pt; left: 388.84pt; position: var(--position); top: 173.2pt; width: 49.46pt; z-index: 6;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g108.gif" alt="" style="height: 72.03pt; width: 59.46pt;"/></div></div><div style="height: 62.25pt; left: 442.99pt; position: var(--position); top: 173.2pt; width: 96.07pt; z-index: 7;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g109.gif" alt="" style="height: 72.25pt; width: 106.07pt;"/></div></div><div style="height: 62.25pt; left: 442.21pt; position: var(--position); top: 173.2pt; width: 75.77pt; z-index: 8;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g110.gif" alt="" style="height: 72.25pt; width: 85.77pt;"/></div></div><div style="background-color: #c6c6c6; height: 56.81pt; left: 183.9pt; opacity: 1; position: var(--position); top: 177.7pt; width: 75.15pt; z-index: 9;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 75.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 28.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core&#160; &#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 17.4pt; width: 75.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 9.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating profit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 27.6pt; width: 75.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 24.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 37.8pt; width: 75.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 29.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: #e3e3e3; height: 52.38pt; left: 297.73pt; opacity: 1; position: var(--position); top: 178.14pt; width: 65.4pt; z-index: 10;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 65.4pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 17.4pt; width: 65.4pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operational <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 27.6pt; width: 65.4pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 14.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 37.8pt; width: 65.4pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 24.220000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: #c6c6c6; height: 46.4pt; left: 69.94pt; opacity: 1; position: var(--position); top: 185.05pt; width: 75.51pt; z-index: 3;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 75.51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 17.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 17.4pt; width: 75.51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 25.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 27.6pt; width: 75.51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 29.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 42.5pt; left: 389.2pt; opacity: 1; position: var(--position); top: 183.08pt; width: 47.11pt; z-index: 11;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 47.11pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 16.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RB: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 17.4pt; width: 47.11pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 6.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inclusion<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 27.6pt; width: 47.11pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 15.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: #f36633; height: 25.19pt; left: 442.99pt; opacity: 1; position: var(--position); top: 191.73pt; width: 84.13pt; z-index: 12;"><div><div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 7.2pt; width: 84.13pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Bonus<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 377.09pt; opacity: 1; position: var(--position); top: 191.73pt; width: 19pt; z-index: 19;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 19pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 156.55pt; position: var(--position); top: 198.33pt; width: 14.37pt; z-index: 13;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 269.85pt; position: var(--position); top: 197.58pt; width: 14.37pt; z-index: 14;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 379.4pt; position: var(--position); top: 197.14pt; width: 14.37pt; z-index: 15;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 432.12pt; position: var(--position); top: 198.33pt; width: 14.37pt; z-index: 16;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 153.74pt; opacity: 1; position: var(--position); top: 192.92pt; width: 19pt; z-index: 17;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 19pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 267.16pt; opacity: 1; position: var(--position); top: 192.17pt; width: 19pt; z-index: 18;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 19pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 429.99pt; opacity: 1; position: var(--position); top: 193.67pt; width: 19pt; z-index: 20;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 19pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">=<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 241.31pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 375.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 213pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138.75pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 12pt;"><span style="color: #a8a8a7; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 12pt; position: var(--position); top: 0pt; width: 213pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.89pt; width: 213pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Measures: 60%<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 225pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 12pt;"><span style="color: #dbdbdb; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 0pt; width: 138.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.89pt; width: 138.75pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Operational: 40%<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 264.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 77.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Annual bonu<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 147.19pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">s performanc<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 215.85000000000002pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">e<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 221.88pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table shows the Annual bonuses earned compared to the bonus opportunity for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 420.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 308.53pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 478.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 43.5pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105.75pt; position: var(--position); top: 0pt; width: 144pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Bonus opportunity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 0pt; width: 144pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 144pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Bonus earned <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 0pt; width: 84.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Bonus Paid as<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(&#163;000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 16.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105.75pt; position: var(--position); top: 18.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(% of salary)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 18.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(% of salary)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 18.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 salary <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 18.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of Maximum <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 297.75pt; position: var(--position); top: 18.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of Salary <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earned<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 345.75pt; position: var(--position); top: 18.75pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total 2024 <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bonus (&#163;000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 18.75pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 18.75pt; width: 43.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 43.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 43.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(DABP <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 43.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Award)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 6pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 99.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 6pt; overflow: hidden; position: var(--position); top: 45pt; width: 99.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105.75pt; position: var(--position); top: 45pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 8.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 45pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 8.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">300<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 45pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">1,363<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 45pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 36.51pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 36.51pt; position: var(--position);">70<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 297.75pt; position: var(--position); top: 45pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 32.37pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 32.37pt; position: var(--position);">210<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 345.75pt; position: var(--position); top: 45pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,855<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 45pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.61pt;"></span></span><span style="left: 13.239999999999998pt; position: var(--position);">1,362.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 45pt; width: 43.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.86pt;"></span></span><span style="left: 15.489999999999998pt; position: var(--position);">1,492.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 6pt; overflow: hidden; position: var(--position); top: 57pt; width: 99.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.74pt;"></span></span><span style="left: 32.37pt; position: var(--position);">990<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 36.51pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 36.51pt; position: var(--position);">66<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 297.75pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 32.37pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 32.37pt; position: var(--position);">198<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-right: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 345.75pt; position: var(--position); top: 57pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,955<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-left: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 393.75pt; position: var(--position); top: 57pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">977.7<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 435pt; position: var(--position); top: 57pt; width: 43.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 43.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.05pt;"></span></span><span style="left: 21.68pt; position: var(--position);">977.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 120.26pt; left: 53.86pt; opacity: 1; position: var(--position); top: 296.02pt; width: 487.72pt; z-index: -46;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g112.jpg" alt="P158 Rem boxes.jpg" style="height: 120.26pt; width: 487.72pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 386.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of the mandatory deferral by Executive Directors into the Deferred Annual Bonus Plan for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 452.66999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> bonus are set out on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 396.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_322">160</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 94.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 422.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 59.53pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 69.39pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">24 Financial mea<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 140.24pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 145.17000000000002pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ur<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 154.01999999999998pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">es outcomes<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 60.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total sales <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 127.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 130.22pt; position: var(--position); text-decoration: none; white-space: pre;">e<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 134.39pt; position: var(--position); text-decoration: none; white-space: pre;">xclud<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 151.89pt; position: var(--position); text-decoration: none; white-space: pre;">ing COVID-19 solutions<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Core<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ope<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rating profit growth <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 441.01pt; position: var(--position); text-decoration: none; white-space: pre;">exc<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 452.68pt; position: var(--position); text-decoration: none; white-space: pre;">ludin<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 468.51pt; position: var(--position); text-decoration: none; white-space: pre;">g COVID-19 solutions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 461.01pt; width: 595.44pt;"><div style="left: 59.53pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g113.jpg" alt="GSK AR24 Rem financial measures - 20F.jpg" style="height: 96.92pt; width: 482.05pt;"/></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 574.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target settin<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 106.89pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">g<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These targets were set following consideration of analyst consensus as well as internal budgets. Threshold and maximum <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance was at 1% below and 5% above target growth respectively. The total sales growth and core operating profit growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 608.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets and outcomes for the purposes of the Annual bonus calculation are based on CER and excluding the commercial benefit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 618.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from COVID-19 solutions.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">147<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_7790"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 73.58pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Strategic and operational measures outcomes<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 137.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Target setting and review process<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the beginning of the year, after agreeing GSK&#8217;s three-year plan for 2024 &#8211; 2026 and following review of the company&#8217;s long term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth strategy, and the Board and Management&#8217;s priorities for the year ahead, the Committee agreed the financial bonus targets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the CEO and CFO. The Committee agreed their key deliverables for the year ahead as their individual strategic and operational <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures for 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the end of the year, after the Board&#8217;s review of GSK&#8217;s performance for 2024, the Committee received and considered specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance assessment reports against the deliverables set for each Executive Director. These showed the extent of achievement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against each deliverable. As with the financial bonus measures, the Committee was satisfied with the scale of the Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; achievements. In completing their assessment, the Committee considered shareholder experience and acknowledged in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particular that the market&#8217;s view of the valuation of GSK is substantially lower than the company&#8217;s own view and that the Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remains mindful of the need to deliver improving shareholder value over the short-, medium- and long-term timeframes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 264.45pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 57.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 354pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 57.75pt; position: var(--position); top: 0pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achievement during 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 0pt; width: 75.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.64pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance assessment<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 83.25pt;"><td colspan="3" rowspan="1" style="background-color: #ededed; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 14.25pt; width: 487.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 17.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">Emma led the executive team and the wider organisation to deliver continued, improved operating performance in 2024, with GSK&#8217;s <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 26.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">reshaped product portfolio demonstrating both strength and resilience, notably with an increased contribution from Specialty Medicines. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 35.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline development was also strong, with a record number of positive Ph III readouts in 2024, and the company now focused on <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">development of 14 scale growth opportunities expected to launch before 2031. This has resulted in further improvement to GSK&#8217;s growth <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">strategy. Alongside this, there was meaningful progress in culture, talent development and exemplary leadership as a responsible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 62.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 75.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">The following table sets out her performance against the Innovation, Performance, Trust and Culture objectives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 131.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Innovation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 57.75pt; position: var(--position); top: 97.5pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Delivered pipeline progression above target with 13 positive Ph III read outs<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Delivered innovation sales above plan, accounting for 37% of total sales. Material over-delivery in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty and General Medicines compensated for shortfall in Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D now focused on clinical development of 14 potential scale opportunities expected to launch before <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031. These include five product approvals planned in 2025, at the forefront of which are <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 304.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 329.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depemokimab<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Completed transactions to acquire assets in Oncology and Respiratory, Immunology &amp; Inflammation; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strengthened platform capabilities in mRNA and oligonucleotides; several new material research <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alliances established<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 83.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Good progress across the R&amp;D data/AI technology goals &#8211; target choice, patient identification, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 92.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">molecule design/chemical manufacturing and controls (CMC) and clinical trial effectiveness <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 101.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AI enabled acceleration of digital submissions, reducing number of weeks for last patient visit (LPV) first <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 110.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory submission by over 35%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 97.5pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exceeded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 89.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 89.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 57.75pt; position: var(--position); top: 228.75pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Delivered the financial plan exceeding guidance set for 2024, driven by strong growth and increasing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution from Specialty Medicines, with growth in all therapy areas, more than offsetting impact of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US and China environment on Vaccines <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Continued embedding of scale AI capability in global functions, manufacturing and commercial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations with measurable impact in sales and marketing ROI cost savings, quality and forecast <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accuracy<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant increase in deployment and upskilling of AI usage with &gt;29K attendees at the group-wide <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data Academy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 228.75pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 113.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 113.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 318pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trust<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 113.25pt; left: 57.75pt; overflow: hidden; position: var(--position); top: 318pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Personal leadership to deliver successful resolution of vast majority of US <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 254.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 277.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> litigation &#8211; managed <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in best interests of shareholders and without any admission of liability<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 Responsible Business Performance Rating &#8216;on track&#8217; for third consecutive year, demonstrating <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustained momentum in all six priority areas, alongside strong track record of performance delivery <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ranked second in the latest global Access to Medicine Index, where we have been placed first or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">second since its inception in 2008<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Progressed development of six Global Health pipeline assets to address priority World Health <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Organisation (WHO) diseases<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Environmental Sustainability &#8211; 16 of the 17 GSK KPIs at or above target. Low carbon Ventolin Ph III <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 83.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ongoing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 92.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">88% of Ph III trials completing enrolment met our thresholds for participants to represent the disease <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 101.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">epidemiology under study &#8211; well ahead of our 50% target for 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 318pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exceeded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 72pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 72pt; left: 0pt; overflow: hidden; position: var(--position); top: 431.25pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Culture<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 72pt; left: 57.75pt; overflow: hidden; position: var(--position); top: 431.25pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual employee survey improvement in confidence &#8211; up 3% to 83% overall<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Highly positive engagement scores of more than 80% again in internal survey<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strong champion of leadership and learning, sponsoring a range of leadership programs for first and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">second line leaders and successful delivery of our Enterprise Leadership Program with excellent <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback and engagement<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strong progress in executive leadership succession planning and quality<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New headquarters (HQ) move successfully completed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 431.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exceeded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 36.75pt;"><td colspan="3" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 503.25pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The Committee determined that the CEO clearly exceeded her individual objectives and that 78% out of the 90% maximum should be attributed <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.83pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">to her overall bonus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">148<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 57.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 354pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 57.75pt; position: var(--position); top: 0pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.55pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achievement during 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 0pt; width: 75.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.02pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance assessment<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 78pt;"><td colspan="3" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15pt; width: 487.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 18.52pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">Julie led the Finance Leadership Team and worked alongside the GSK Leadership Team (GLT) to deliver continued, improved operating <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 27.52pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">performance in 2024. Julie led a deep review of pipeline forecasting to support the upgrading of long-term growth strategy, and a strategic <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 36.52pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">review of R&amp;D investments to support smart resource allocation and ROI. Improved profits were delivered by securing a more competitive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 45.52pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">P&amp;L and increased use of SG&amp;A analytics. Julie continues to oversee the cyber security plan for GSK, with improvements in maturity and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 54.52pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">control effectiveness. Alongside this, she successfully led progress in culture, talent development and engagement of the Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 63.52pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: 0.025em; position: var(--position); text-decoration: none; white-space: pre;">organisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 108pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 108pt; left: 0pt; overflow: hidden; position: var(--position); top: 93pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Demonstrate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leadership<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 57.75pt; position: var(--position); top: 93pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deep review of pipeline forecasting to support upgrading of long-term growth strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic review of R&amp;D investments to increase spend and smart resource allocation to improve ROI. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total R&amp;D investment of &#163;6.4bn in 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strong focus on further improving momentum with business development, organic performance and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">productivity drivers to deliver a competitive P&amp;L<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Delivery of investor engagement programme including Investor Roadmap, 2024 Investor Update and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meet the Management events for Oncology and Early-Stage Pipeline<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Led detailed shareholder value gap analysis informing the investor communication programme<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Guidance, reporting, financial controls and external audit delivered effectively with no issues, with a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 83.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">step up in the clarity of the published quarterly reporting to the market<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 93pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exceeded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 92.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 92.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 201pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost discipline <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and cash flow <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 92.25pt; left: 57.75pt; overflow: hidden; position: var(--position); top: 201pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Organisational delivery of a more competitive P&amp;L, coupled with SG&amp;A analytics, delivering enhanced <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">core operating profit and core operating margin<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash generated from operations of &#163;7.9bn<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Effective, disciplined capital deployment to support business growth and shareholder returns including <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2.3bn allocated to targeted business development<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant progress in tech and AI-enabled changes in Finance, including Source to Pay, financial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process improvement, cash and treasury<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Successfully led the SG&amp;A ROI project with the purpose of driving competitive, precision analytics to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drive increased ROI whilst retaining a growth mindset<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 201pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exceeded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 54.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 54.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 293.25pt; width: 57.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Demonstrate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strong <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">culture and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 57.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leadership<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 54.75pt; left: 57.75pt; overflow: hidden; position: var(--position); top: 293.25pt; width: 354pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Positive progress on engagement and culture scores in the GSK survey driven by a focus on growth, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development and continued wellbeing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Successful implementation of succession and talent development planning including appointment of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three new Finance Leadership Team members<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 354pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cyber Maturity Plan: All 40 projects planned for 2024 delivery completed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 411.75pt; position: var(--position); top: 293.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="3" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 348pt; width: 487.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.02pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">The Committee determined that the CFO clearly met her individual objectives and that 66% out of the 90% maximum should be attributed to her <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">overall bonus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 501.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 73.58pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Responsible Business (RB): previously set inclusion aspirations<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 347.35pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.2575pt;"></span></span></div><div style="position: var(--position); top: 515.02pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 76.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 150.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 76.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 195pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 271.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 150.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 150.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 422.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.89pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Payout level<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 76.5pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 195pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 195pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Enterprise targets not met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 271.5pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directorate targets not met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 422.25pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nil (0%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 76.5pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 195pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 195pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Enterprise targets met, but not all directorate targets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 271.5pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Personal directorate targets met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 422.25pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target (10%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 76.5pt; position: var(--position); top: 39.75pt; width: 345.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 345.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 106.67pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Enterprise and all directorate targets met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 422.25pt; overflow: hidden; position: var(--position); top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum (20%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 76.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 76.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Outcome achieved<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 76.5pt; position: var(--position); top: 51pt; width: 195pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Maximum payout &#8211; 20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 271.5pt; position: var(--position); top: 51pt; width: 150.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 150.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); white-space: pre;">Maximum payout &#8211; 20%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 587.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overview of performance against previously set leadership inclusion aspirations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We previously set aspirational targets for diversity of senior leadership to be achieved by 2025. The Committee agreed interim, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual aspirational targets for 2024 as part of this effort, including global gender representation and US and UK race and ethnicity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representation at an enterprise level for the CEO and at a directorate level for the CFO. An internal governance team audited <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance against these aspirations for the Committee.&#160; Going forward, we expect to make changes in several areas related to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 645.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inclusion, including no longer setting leadership aspirations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Delivery<span style="display: inline-block; height: 6.18pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_7772"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 86.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The interim aspirations were met in 2024, and resulted in the leadership aspirational targets set for 2025 being largely <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">met. At the year end, the GSK Enterprise performance was 48%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 292.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 295.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> gender representation and 38.3% US ethnicity and 21.8% UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ethnicity in our VP and above employee population. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 697.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 4.55pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.7814999999999999pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.3085pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 56.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This measure ceased to operate at the end of 2024<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 708.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 4.55pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.7814999999999999pt; vertical-align: super; white-space: pre;">2<span style="display: inline-block; height: 3.3085pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 56.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rounded percentile<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">149<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Vesting <span style="display: inline-block; height: 8pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_7798"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_8788"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 95.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">of 2022 PSP LTI awards<span style="display: inline-block; height: 8pt;"></span></span></div><div style="height: 48.19pt; left: 53.86pt; position: var(--position); top: 133.8pt; width: 60.08pt; z-index: 21;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g114.gif" alt="" style="height: 58.19pt; width: 70.08pt;"/></div></div><div style="background-color: transparent; height: 48.19pt; left: 60.7pt; opacity: 1; position: var(--position); top: 133.72pt; width: 64.87pt; z-index: 22;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 5.95pt; width: 64.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.53pt; position: var(--position); text-decoration: none; white-space: pre;">Relative Total&#160; <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 15.55pt; width: 64.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 10.68pt; position: var(--position); text-decoration: none; white-space: pre;">Shareholder <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 25.15pt; width: 64.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 20.45pt; position: var(--position); text-decoration: none; white-space: pre;">Return <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 34.75pt; width: 64.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.44pt; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.19pt; left: 218.43pt; position: var(--position); top: 134.08pt; width: 79.23pt; z-index: 23;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g115.gif" alt="" style="height: 58.19pt; width: 89.23pt;"/></div></div><div style="height: 48.19pt; left: 300.68pt; position: var(--position); top: 134.08pt; width: 79.37pt; z-index: 24;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g116.gif" alt="" style="height: 58.19pt; width: 89.37pt;"/></div></div><div style="height: 48.19pt; left: 383.24pt; position: var(--position); top: 134.08pt; width: 79.37pt; z-index: 25;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g116.gif" alt="" style="height: 58.19pt; width: 89.37pt;"/></div><div><div><div></div></div></div></div><div style="height: 48.19pt; left: 465.69pt; position: var(--position); top: 133.96pt; width: 79.37pt; z-index: 26;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g117.gif" alt="" style="height: 58.19pt; width: 89.37pt;"/></div></div><div style="height: 48.19pt; left: 465.77pt; position: var(--position); top: 134.08pt; width: 61.77pt; z-index: 27;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g118.gif" alt="" style="height: 58.19pt; width: 71.77pt;"/></div><div><div><div></div></div></div></div><div style="background-color: #c6c6c6; height: 41.78pt; left: 224.57pt; opacity: 1; position: var(--position); top: 135.99pt; width: 63.34pt; z-index: 28;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 2.74pt; width: 63.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23.01pt; position: var(--position); text-decoration: none; white-space: pre;">Core <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.34pt; width: 63.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.13pt; position: var(--position); text-decoration: none; white-space: pre;">Operating <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.94pt; width: 63.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.36pt; position: var(--position); text-decoration: none; white-space: pre;">Profit Growth<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.54pt; width: 63.34pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 23.67pt; position: var(--position); text-decoration: none; white-space: pre;">20%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 44.07pt; left: 312.03pt; opacity: 1; position: var(--position); top: 136.25pt; width: 61.77pt; z-index: 29;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.2pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 16.68pt; position: var(--position); text-decoration: none; white-space: pre;">Pipeline <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.9pt; position: var(--position); text-decoration: none; white-space: pre;">Progress<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.4pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.89pt; position: var(--position); text-decoration: none; white-space: pre;">20%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 42.5pt; left: 389.43pt; opacity: 1; position: var(--position); top: 136.65pt; width: 67.15pt; z-index: 30;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.2pt; width: 67.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.91pt; position: var(--position); text-decoration: none; white-space: pre;">RB: <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 67.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.15pt; position: var(--position); text-decoration: none; white-space: pre;">Environment<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.4pt; width: 67.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.58pt; position: var(--position); text-decoration: none; white-space: pre;">10%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.04pt; left: 136.06pt; position: var(--position); top: 134.08pt; width: 79.37pt; z-index: -50;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g119.gif" alt="" style="height: 58.04pt; width: 89.37pt;"/></div></div><div style="background-color: #c6c6c6; height: 41.78pt; left: 144.69pt; opacity: 1; position: var(--position); top: 137.37pt; width: 61.77pt; z-index: -49;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.54pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.35pt; position: var(--position); text-decoration: none; white-space: pre;">Total Sales <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.14pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.01pt; position: var(--position); text-decoration: none; white-space: pre;">Growth<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.74pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.89pt; position: var(--position); text-decoration: none; white-space: pre;">20%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.04pt; left: 71.54pt; position: var(--position); top: 133.96pt; width: 61.77pt; z-index: -45;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g120.gif" alt="" style="height: 58.04pt; width: 71.77pt;"/></div></div><div style="background-color: transparent; height: 23.17pt; left: 466.77pt; opacity: 1; position: var(--position); top: 147.45pt; width: 77.5pt; z-index: 31;"><div><div><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.2pt; width: 77.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 10.4pt; position: var(--position); text-decoration: none; white-space: pre;">To<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.84pt; position: var(--position); text-decoration: none; white-space: pre;">tal Vested LTI<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 127.68pt; position: var(--position); top: 150.72pt; width: 14.37pt; z-index: 32;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 130.51pt; opacity: 1; position: var(--position); top: 145.58pt; width: 7.44pt; z-index: 33;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 7.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 209.81pt; position: var(--position); top: 150.72pt; width: 14.37pt; z-index: 34;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div><div><div><div style="transform: translate(2.10pt, 2.10pt);"></div></div></div></div><div style="height: 14.37pt; left: 374.43pt; position: var(--position); top: 153.23pt; width: 14.37pt; z-index: 35;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 456.93pt; position: var(--position); top: 153.23pt; width: 14.37pt; z-index: 36;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 213.32pt; opacity: 1; position: var(--position); top: 145.58pt; width: 8.01pt; z-index: 37;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.01pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 377.57pt; opacity: 1; position: var(--position); top: 147.9pt; width: 8.12pt; z-index: 38;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.12pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 460.27pt; opacity: 1; position: var(--position); top: 148.2pt; width: 6.92pt; z-index: 39;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 6.92pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">=<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 291.23pt; position: var(--position); top: 153.23pt; width: 14.37pt; z-index: 42;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 295.04pt; opacity: 1; position: var(--position); top: 147.82pt; width: 8.23pt; z-index: 43;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.23pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="line-height: 9pt; position: var(--position); top: 197.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Overview of PSP LTI performance<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In line with the Committee&#8217;s agreed principles, actual performance against each measure is carefully reviewed and adjustments are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 220.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made, as appropriate. This ensures that the vesting outcome reflects genuine underlying business performance and has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivered in line with our culture and values. The Committee did not deem it necessary to exercise any discretion in relation to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesting of the awards or due to share price changes. Overall, 80.75% of the 2022 PSP awards vested against the targets set out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 267.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2022 PSP Outcomes<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 280.82pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 435pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 84pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 38.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 359.25pt; position: var(--position); top: 0pt; width: 75.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 0.66pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vesting level<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 3pt; position: var(--position); top: 8.25pt; width: 75.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance measures<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and relative weighting<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="5" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 8.25pt; width: 274.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 213.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance targets<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 8.25pt; width: 38.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maximum<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 8.25pt; width: 29.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">award<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="7" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 104.25pt; left: 3pt; overflow: hidden; position: var(--position); top: 27pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relative TSR <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(30%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162.75pt; position: var(--position); top: 27pt; width: 91.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 91.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">TSR ranking within comparator <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 91.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">group (10 companies)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 27pt; width: 99pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% vesting<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 27pt; width: 38.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 27pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 45.75pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 47.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 45.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1st, 2nd, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3rd<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 45.75pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 83.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 66pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4th<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 66pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">70<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 77.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5th<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 77.25pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 88.5pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 84pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 39.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Threshold<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: bold; left: 75.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 88.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Median<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 88.5pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 99.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6th to 10th<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 99.75pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 92.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 111pt; width: 274.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.79pt; width: 274.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 4.55pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.7814999999999999pt; vertical-align: super; white-space: pre;">(1) <span style="display: inline-block; height: 3.3085pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 6.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The median vesting threshold falls between two companies. The Relative TSR <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.19pt; width: 274.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparator group is set out on page 156.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 3pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total sales growth<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 59.239999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(20%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="5" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 274.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recognises the importance of the company's commercial ambitions with regard to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.67pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating profit growth. The measure vests in accordance with the same table as <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.67pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set out below for core operating profit growth, against a target of &#163;76.47bn.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 131.25pt; width: 38.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 131.25pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="2" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 31.5pt; left: 3pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating profit <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 22.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(20%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 274.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recognises the importance of the company's commercial ambitions with regard to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating profit growth against a target of &#163;22.49bn.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 160.5pt; width: 38.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 160.5pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162.75pt; position: var(--position); top: 180.75pt; width: 91.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 91.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance vs Target<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 180.75pt; width: 99pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% vesting<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 192pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 47.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 192pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.49pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.49pt; position: var(--position);">105<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 38.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 192pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 83.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 203.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.49pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.49pt; position: var(--position);">103<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 38.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 203.25pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 214.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 23.49pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 23.49pt; position: var(--position);">100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 38.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 214.5pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 225.75pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 45.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Threshold<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 225.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.63pt; position: var(--position);">99<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 38.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 225.75pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 88.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 237pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&lt;99%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 237pt; width: 99pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 99pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 92.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 3pt; overflow: hidden; position: var(--position); top: 252pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline progress<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(20%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 252pt; width: 274.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.11pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Targets strengthening our pipeline through progression of high quality assets into <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.48pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">pivotal trials and the achievement of regulatory approvals in major markets. The <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.85pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">points are allocated on achievement of these two equally weighted elements of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.22pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">10%.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 291.75pt; width: 84pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 56.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Measure<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162.75pt; position: var(--position); top: 291.75pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Threshold<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 291.75pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 291.75pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 291.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 310.5pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 17.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pivotal Trial starts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162.75pt; position: var(--position); top: 310.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 310.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 310.5pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 310.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 310.5pt; width: 38.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 310.5pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 22.97pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18.75<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 321.75pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 23.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major regulatory <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approval milestones<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162.75pt; position: var(--position); top: 321.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 321.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 254.25pt; position: var(--position); top: 321.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 321.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">22<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 321.75pt; width: 38.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">87.5<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 3pt; overflow: hidden; position: var(--position); top: 345pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RB: Environment <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(10%)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 345pt; width: 274.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.11pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Recognises the importance of our Responsible Business priority and ambitions of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.48pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">having a Nature Net positive and Climate Net Zero impact by 2030. The measure <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.85pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">includes six key performance measures (3x Climate ambitions and 3x Nature <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.22pt; width: 274.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">ambitions).<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 78.75pt; position: var(--position); top: 384.75pt; width: 84pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 34.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% vesting<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 162.75pt; overflow: hidden; position: var(--position); top: 384.75pt; width: 190.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.11pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Every measure must have been achieved, and at least <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.48pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">two of the six measures, at least one in Climate and one <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.85pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">in Nature, must have exceeded their targets at the end of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.22pt; width: 190.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">2024.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 367.5pt; position: var(--position); top: 384.75pt; width: 38.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 31.22pt; width: 38.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 384.75pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 31.22pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 3pt; overflow: hidden; position: var(--position); top: 427.5pt; width: 205.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 205.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total vesting in respect of 2022 PSP awards<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #575756; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 427.5pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 29.25pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80.75<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="6" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 3pt; overflow: hidden; position: var(--position); top: 442.5pt; width: 350.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 350.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2) excluding COVID-19 solutions<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">150<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline progress <span style="display: inline-block; height: 6.55pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_7781"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 130.55pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">- overview of assets contributing to outcome of this measure<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 137.58pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 390pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 390pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Assets contributing to outcome achieved<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 97.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Pivotal trial starts<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">(17 points)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 390pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 390pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">depemokimab - CRSwNP, bepirovirsen - HBV, cobolimab + dostarlimab + docetaxel NSCLC, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 308.41pt; position: var(--position); white-space: pre;">Blenrep<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 334.24pt; position: var(--position); white-space: pre;"> - 1L MM, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 390pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">dostarlimab - colon, camlipixant - RCC, tebipenem pivoxil - cUTI, dostarlimab unresect HNSCC, CD226 GALAXIES <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 390pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Lung-301, niraparib GBM study, Low Carbon <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 150.04000000000002pt; position: var(--position); white-space: pre;">Ventolin<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 177.12pt; position: var(--position); white-space: pre;"> and <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 193.79000000000002pt; position: var(--position); white-space: pre;">Benlysta<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 222.54000000000002pt; position: var(--position); white-space: pre;"> - CTD - ILD.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 97.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Regulatory approval <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">milestones<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.87pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">(21 points)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30.75pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 390pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 390pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">RSV OA PreF3 US, RSV OA PreF3 EU, cabotegravir HIV PrEP EU, dostarlimab (RUBY) US, dostarlimab (RUBY) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 390pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">EU, momelotinib - myelofibrosis US, momelotinib - myelofibrosis EU, <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: 229.19pt; position: var(--position); white-space: pre;">Shingrix<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 256.26pt; position: var(--position); white-space: pre;"> - China, and dostarlimib (RUBY - all <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 390pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">comers)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 222.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 55.519999999999996pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 75.24pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> PSP vesting<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 233.41pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 240pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 82.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 82.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 82.5pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 0pt; width: 82.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 56.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Granted<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 0pt; width: 82.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 82.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 55.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vested<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 74.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 0pt; width: 82.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 82.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Value of vested shares<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 74.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 82.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 61.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(&#163;000)<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 79.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;"> <span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 240pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 240pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 20.25pt; width: 82.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.77pt;"></span></span><span style="left: 52.400000000000006pt; position: var(--position);">461,059<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 322.5pt; position: var(--position); top: 20.25pt; width: 82.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.77pt;"></span></span><span style="left: 52.400000000000006pt; position: var(--position);">420,177<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405pt; position: var(--position); top: 20.25pt; width: 82.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 82.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.91pt;"></span></span><span style="left: 56.54pt; position: var(--position);">&#163;6,063<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 274.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The number of shares which vested and the value they represented at vesting includes dividend reinvestments during the performance period. These <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 283.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are based on the vesting price of &#163;14.43 on 18 February 2025 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 293.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The CFO joined GSK on 3 April 2023 and therefore did not receive the 2022 PSP award. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 320pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 6pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 336.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 77.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> LTI grants<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 363.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DABP award<span style="display: inline-block; height: 6.18pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_8789"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s, in respect of the deferral of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 269.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> bonus, and the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> PSP awards are set out below. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 379.17pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 59.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 136.5pt; position: var(--position); top: 0pt; width: 138pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 79.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 93.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> DABP awards<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 418.5pt; position: var(--position); top: 0pt; width: 69pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> PSP awards<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 12pt; width: 59.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 59.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of total 2023 <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 59.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bonus deferred<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 136.5pt; position: var(--position); top: 12pt; width: 69pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 12pt; width: 69pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Face value <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of award<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 61.260000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 52.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 12pt; width: 69pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Award level as % <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of base salary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 12pt; width: 69pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Face value <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.529999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of award<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 56.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(2)(3)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 52.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 418.5pt; position: var(--position); top: 12pt; width: 69pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 69pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 77.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 38.25pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 47.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 47.76pt; position: var(--position);">65<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 136.5pt; position: var(--position); top: 38.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">147,271<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 38.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,463<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 38.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.37pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 53.37pt; position: var(--position);">575<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 38.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7,835<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 418.5pt; position: var(--position); top: 38.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">468,449<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 77.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 50.25pt; width: 59.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 59.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 47.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 47.76pt; position: var(--position);">50<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 136.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.41pt;"></span></span><span style="left: 43.04pt; position: var(--position);">56,190<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 50.74pt;"></span></span><span style="left: 53.370000000000005pt; position: var(--position);">940<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 280.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.37pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 53.37pt; position: var(--position);">400<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3,960<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 418.5pt; position: var(--position); top: 50.25pt; width: 69pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 39.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">236,763<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 447.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The face values of the DABP and PSP awards has been calculated based on a share price of &#163;16.726, being the closing price on 7 February 2024 (the day <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 456.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">before the grants). DABP awards are nil-cost options for the Executive Directors. No performance conditions are attached to the DABP awards, as they <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 464.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflect the mandatory three-year deferrals in respect of the Annual Bonus for <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 300.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 474.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PSP awards are conditional shares, based on the performance measures set out on page 149 of the 2023 Annual Report<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 485.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The performance period for the <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 162.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 178.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> PSP awards is from 1 January 2024 to 31 December 2026. Awards vest at 25% of maximum for threshold <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 493.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance. Please see the 2023 Remuneration Report for details of the measures and targets for th<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 377.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e 2024 awards<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 522.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Malus and clawback policy<span style="display: inline-block; height: 8pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_7775"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the purposes of the 2025 Remuneration policy, there are no changes to the malus and clawback policy (as set out on page<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 523.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.96pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27993">166</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27983">167</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee reviews and discloses whether it, or the Recoupment Committee, has exercised malus or clawback. Disclosure is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">only made when the matter has been the subject of public reports of misconduct, where it has been fully resolved, where it is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legally permissible to disclose and where it can be made without unduly prejudicing the company and therefore shareholders. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">line with these disclosure guidelines, there were no matters to report during 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">151<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i818e5b9f1180495aa8fb72a0179dab50_0-0-1-1-821446"></span><div style="left: 0pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance in 2025<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 147.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre; width: 58.45pt;">Target setting<span style="display: inline-block; height: 6.55pt;"></span><span id="i0af1792924ea4c95b3faa9a966c9365c_7794"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 160.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following careful review of performance towards GSK&#8217;s 2031 growth strategy at the end of 2024 and pipeline progression, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 171.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three-year plan for 2025 &#8211; 2027 was set. The Board then agreed the guidance for the year ahead and the key priorities for the CEO <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 181.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the CFO. The Committee then considered these carefully together with current consensus expectations before setting the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors targets for the year ahead.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 207.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inevitably targets linked directly to our financial and strategic plan are commercially sensitive. The Committee does not therefore <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consider it appropriate to disclose these targets until the end of the year. To disclose them earlier may result in competitive harm. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details will be disclosed in the 2025 Annual Report. The targets and outcomes are calculated based on CER.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 243.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025 Annual bonus measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 48.19pt; left: 53.86pt; position: var(--position); top: 263.55pt; width: 73.58pt; z-index: -44;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g121.gif" alt="" style="height: 58.19pt; width: 83.58pt;"/></div></div><div style="background-color: transparent; height: 48.19pt; left: 73.94pt; opacity: 1; position: var(--position); top: 263.71pt; width: 53.93pt; z-index: 47;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 10.74pt; width: 53.93pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.09pt; position: var(--position); text-decoration: none; white-space: pre;">Total sales <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.34pt; width: 53.93pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.98pt; position: var(--position); text-decoration: none; white-space: pre;">growth <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 29.94pt; width: 53.93pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.97pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.19pt; left: 251.25pt; position: var(--position); top: 263.83pt; width: 76.54pt; z-index: 48;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g122.gif" alt="" style="height: 58.19pt; width: 86.54pt;"/></div></div><div style="height: 48.19pt; left: 331.14pt; position: var(--position); top: 263.83pt; width: 114pt; z-index: 49;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g123.gif" alt="" style="height: 58.19pt; width: 124pt;"/></div></div><div style="height: 48.19pt; left: 465.69pt; position: var(--position); top: 263.71pt; width: 79.37pt; z-index: 50;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g117.gif" alt="" style="height: 58.19pt; width: 89.37pt;"/></div></div><div style="height: 48.19pt; left: 449.19pt; position: var(--position); top: 263.83pt; width: 78.35pt; z-index: 51;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g124.gif" alt="" style="height: 58.19pt; width: 88.35pt;"/></div><div><div><div></div></div></div></div><div style="background-color: transparent; height: 41.78pt; left: 251.84pt; opacity: 1; position: var(--position); top: 265.74pt; width: 72.87pt; z-index: 52;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.54pt; width: 72.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;">Pipeline <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.14pt; width: 72.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.01pt; position: var(--position); text-decoration: none; white-space: pre;">performance<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.74pt; width: 72.87pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 28.44pt; position: var(--position); text-decoration: none; white-space: pre;">20%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.04pt; left: 153.06pt; position: var(--position); top: 263.83pt; width: 95.53pt; z-index: -29;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g125.gif" alt="" style="height: 58.04pt; width: 105.53pt;"/></div></div><div style="background-color: transparent; height: 41.78pt; left: 163.94pt; opacity: 1; position: var(--position); top: 267.12pt; width: 75pt; z-index: -28;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.54pt; width: 75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 11.09pt; position: var(--position); text-decoration: none; white-space: pre;">Core operating <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.14pt; width: 75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 15.53pt; position: var(--position); text-decoration: none; white-space: pre;">profit growth<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.74pt; width: 75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 29.5pt; position: var(--position); text-decoration: none; white-space: pre;">25%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.04pt; left: 102.9pt; position: var(--position); top: 263.91pt; width: 47.04pt; z-index: -25;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g126.gif" alt="" style="height: 58.04pt; width: 57.04pt;"/></div></div><div style="background-color: transparent; height: 44.07pt; left: 341.69pt; opacity: 1; position: var(--position); top: 267.5pt; width: 86pt; z-index: 53;"><div><div><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.2pt; width: 86pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.13pt; position: var(--position); text-decoration: none; white-space: pre;">Stra<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.78pt; position: var(--position); text-decoration: none; white-space: pre;">tegic, <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 16.8pt; width: 86pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.93pt; position: var(--position); text-decoration: none; white-space: pre;">Operational an<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 60.31pt; position: var(--position); text-decoration: none; white-space: pre;">d RB<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.4pt; width: 86pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 35pt; position: var(--position); text-decoration: none; white-space: pre;">30%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 27.8pt; left: 461.77pt; opacity: 1; position: var(--position); top: 274.2pt; width: 70.67pt; z-index: 54;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.2pt; width: 70.67pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 10.91pt; position: var(--position); text-decoration: none; white-space: pre;">Annual bonus <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 70.67pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 24.46pt; position: var(--position); text-decoration: none; white-space: pre;">award<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 146.26pt; opacity: 1; position: var(--position); top: 275.33pt; width: 7.44pt; z-index: 56;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 7.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 246.32pt; opacity: 1; position: var(--position); top: 275.33pt; width: 8.01pt; z-index: 59;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.01pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 325.74pt; opacity: 1; position: var(--position); top: 277.57pt; width: 8.23pt; z-index: 64;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.23pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 143.43pt; position: var(--position); top: 280.47pt; width: 14.37pt; z-index: 55;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 242.81pt; position: var(--position); top: 280.47pt; width: 14.37pt; z-index: 57;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div><div><div><div style="transform: translate(2.10pt, 2.10pt);"></div></div></div></div><div style="height: 14.37pt; left: 438.93pt; position: var(--position); top: 282.98pt; width: 14.37pt; z-index: 58;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 442.27pt; opacity: 1; position: var(--position); top: 277.95pt; width: 6.92pt; z-index: 60;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 6.92pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">=<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 321.93pt; position: var(--position); top: 282.98pt; width: 14.37pt; z-index: 63;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="position: var(--position); top: 315.78pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 347.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 182.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138.75pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 12pt;"><span style="color: #dbdbdb; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 12pt; position: var(--position); top: 0pt; width: 182.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.69pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Measures: 50%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 194.25pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 14.25pt;"><span style="color: #c6c6c6; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 208.5pt; position: var(--position); top: 0pt; width: 138.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.69pt; width: 138.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Operational: 50%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 339.22pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 195pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 229.5pt;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total sales and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit growth<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 0pt; width: 424.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">These targets are set following the Board&#8217;s annual planning process and consideration of analysts&#8217; consensus to ensure that <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">the targets are sufficiently stretching and support the Committee&#8217;s aim to incentivise and reward over performance.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 126.75pt;"><td colspan="1" rowspan="6" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 260.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 126.75pt; left: 63pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 424.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">This is a new element of the Annual Bonus for 2025. It is focused on ensuring that executives have a direct link to the delivery <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">of our pipeline milestones. It is designed to incentivise and reward &#8220;on-time in full&#8221; delivery of near term outcome based <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">milestones across our priority assets and business development objectives. It also creates alignment across the full Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">team.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 44.11pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Priority assets represent major launches and next wave programmes expected to deliver commercial success both in the near- <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.48pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">and mid-term, and beyond. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 66.85pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">For each of the major launches and next wave assets, key inflection points which are expected in 2025 have been set as the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 76.22pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">respective thresholds, targets and stretch deliverables, with those priorities weighted and assigned points based on their value <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 85.59pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">potential (i.e. contribution to Peak Year sales). Points will then be awarded in each case based on the milestones actually <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 94.96pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">achieved for the relevant assets. 82% of points are available for priority assets and 18% for business development. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 108.33pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The schedule of assets contributing to this measure for 2025, and their prioritisation were reviewed and approved by the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 117.7pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Science Committee before being agreed by the Committee. The 2025 assets are: <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 69.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 63pt; position: var(--position); top: 156pt; width: 195pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma portfolio: depemokimab &amp; TSLP<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD portfolio: mepolizumab, depemokimab, TSLP &amp; <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IL33<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.83pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Camlipixant<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.23pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 44.63pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B7-H3 &amp; B7-H4 ADCs<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 53.03pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 61.43pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV: Cab ULA, N6LS, &#8216;499, &#8216;301<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 156pt; width: 229.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA respiratory<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pneumococcal franchise<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MenABCWY<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 27.83pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bepirovirsen<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.23pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gepotidacin<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 44.63pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tebipenem<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 424.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The milestones achieved during the year (including business development) will be disclosed by therapeutic area:&#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 63pt; position: var(--position); top: 237pt; width: 195pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">Respiratory, Immunology and Inflammation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 237pt; width: 229.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">Oncology <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 63pt; position: var(--position); top: 248.25pt; width: 195pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 195pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">HIV <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258pt; position: var(--position); top: 248.25pt; width: 229.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 229.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">Infectious Diseases <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 63pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 424.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">in the 2025 Annual Report together with the resulting bonus multiplier and the total points achieved (including for business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 424.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">development). The progress achieved will be reviewed by the Science Committee before the Committee agrees the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 424.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">remuneration outcomes.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 289.5pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operational and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Responsible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 289.5pt; width: 424.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">The CEO and CFO&#8217;s key deliverables are agreed in principle by the Board before being set by the Committee in January each <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">year.&#160; They focus on supporting delivery of our guidance for the year, and towards the ultimate delivery of our medium and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">longer term strategic goals to 2031 and beyond.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">152<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025 Performance Share Plan measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="height: 48.19pt; left: 53.86pt; position: var(--position); top: 133.8pt; width: 54.08pt; z-index: 66;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g127.gif" alt="" style="height: 58.19pt; width: 64.08pt;"/></div></div><div style="background-color: transparent; height: 48.19pt; left: 60.7pt; opacity: 1; position: var(--position); top: 133.72pt; width: 53.24pt; z-index: 67;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 10.74pt; width: 53.24pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.75pt; position: var(--position); text-decoration: none; white-space: pre;">Total sales <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 20.34pt; width: 53.24pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: var(--position); text-decoration: none; white-space: pre;">growth<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 29.94pt; width: 53.24pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 15.29pt; position: var(--position); text-decoration: none; white-space: pre;">17.5%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.19pt; left: 200.93pt; position: var(--position); top: 134.08pt; width: 69.45pt; z-index: 68;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g128.gif" alt="" style="height: 58.19pt; width: 79.45pt;"/></div></div><div style="height: 48.19pt; left: 274.18pt; position: var(--position); top: 134.08pt; width: 51.76pt; z-index: 69;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g129.gif" alt="" style="height: 58.19pt; width: 61.76pt;"/></div></div><div style="height: 48.19pt; left: 329.94pt; position: var(--position); top: 134.08pt; width: 132.67pt; z-index: 70;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g130.gif" alt="" style="height: 58.19pt; width: 142.66pt;"/></div><div><div><div></div></div></div></div><div style="height: 48.19pt; left: 465.69pt; position: var(--position); top: 133.96pt; width: 79.37pt; z-index: 71;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g117.gif" alt="" style="height: 58.19pt; width: 89.37pt;"/></div></div><div style="height: 48.19pt; left: 465.77pt; position: var(--position); top: 134.08pt; width: 61.77pt; z-index: 72;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g118.gif" alt="" style="height: 58.19pt; width: 71.77pt;"/></div><div><div><div></div></div></div></div><div style="background-color: transparent; height: 41.78pt; left: 204.07pt; opacity: 1; position: var(--position); top: 135.99pt; width: 61.77pt; z-index: 73;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.54pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 16.68pt; position: var(--position); text-decoration: none; white-space: pre;">Pipeline <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 17.14pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 7.36pt; position: var(--position); text-decoration: none; white-space: pre;">Sustainability<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.74pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.56pt; position: var(--position); text-decoration: none; white-space: pre;">17.5%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 56.24pt; left: 278.03pt; opacity: 1; position: var(--position); top: 131.75pt; width: 42.91pt; z-index: 74;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.2pt; width: 42.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.79pt; position: var(--position); text-decoration: none; white-space: pre;">RB:<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 42.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.36pt; position: var(--position); text-decoration: none; white-space: pre;">Composite <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.4pt; width: 42.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 3.91pt; position: var(--position); text-decoration: none; white-space: pre;">scorecard<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 36pt; width: 42.91pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 12.35pt; position: var(--position); text-decoration: none; white-space: pre;">7.5%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 40.16pt; left: 466.77pt; opacity: 1; position: var(--position); top: 136.74pt; width: 77.5pt; z-index: 76;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 7.2pt; width: 77.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 15.88pt; position: var(--position); text-decoration: none; white-space: pre;">Performance <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 77.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 18.99pt; position: var(--position); text-decoration: none; white-space: pre;">Share Plan <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 26.4pt; width: 77.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.87pt; position: var(--position); text-decoration: none; white-space: pre;">award<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 48.04pt; left: 127.44pt; position: var(--position); top: 134.08pt; width: 69.45pt; z-index: -5;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g131.gif" alt="" style="height: 58.04pt; width: 79.45pt;"/></div></div><div style="height: 48.04pt; left: 61.94pt; position: var(--position); top: 133.96pt; width: 61.77pt; z-index: -1;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g132.gif" alt="" style="height: 58.04pt; width: 71.77pt;"/></div></div><div style="background-color: transparent; height: 34.66pt; left: 362.7pt; opacity: 1; position: var(--position); top: 144.49pt; width: 67.15pt; z-index: 75;"><div><div><div><div style="font-size: 12pt; line-height: 8pt; position: var(--position); top: 7.2pt; width: 67.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 10.12pt; position: var(--position); text-decoration: none; white-space: pre;">Rel<span style="display: inline-block; height: 5.82pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.1pt; position: var(--position); text-decoration: none; white-space: pre;">ative TSR<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 16.8pt; width: 67.15pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 25.58pt; position: var(--position); text-decoration: none; white-space: pre;">40%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 120.76pt; opacity: 1; position: var(--position); top: 145.58pt; width: 7.44pt; z-index: 78;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 7.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 194.57pt; opacity: 1; position: var(--position); top: 145.58pt; width: 8.01pt; z-index: 82;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.01pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 41.78pt; left: 131.19pt; opacity: 1; position: var(--position); top: 137.37pt; width: 61.77pt; z-index: -4;"><div><div><div><div style="line-height: 8pt; position: var(--position); top: 2.74pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 22.23pt; position: var(--position); text-decoration: none; white-space: pre;">Core <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 12.34pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.24pt; position: var(--position); text-decoration: none; white-space: pre;">operating <span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 21.94pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.91pt; position: var(--position); text-decoration: none; white-space: pre;">profit growth<span style="display: inline-block; height: 5.82pt;"></span></span></div><div style="line-height: 8pt; position: var(--position); top: 31.54pt; width: 61.77pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.56pt; position: var(--position); text-decoration: none; white-space: pre;">17.5%<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 117.93pt; position: var(--position); top: 150.72pt; width: 14.37pt; z-index: 77;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 191.06pt; position: var(--position); top: 150.72pt; width: 14.37pt; z-index: 79;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div><div><div><div style="transform: translate(2.10pt, 2.10pt);"></div></div></div></div><div style="height: 14.37pt; left: 320.43pt; position: var(--position); top: 153.23pt; width: 14.37pt; z-index: 80;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="height: 14.37pt; left: 456.93pt; position: var(--position); top: 153.23pt; width: 14.37pt; z-index: 81;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 323.57pt; opacity: 1; position: var(--position); top: 147.9pt; width: 8.12pt; z-index: 83;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.12pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="background-color: transparent; height: 25.19pt; left: 460.27pt; opacity: 1; position: var(--position); top: 148.2pt; width: 6.92pt; z-index: 84;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 6.92pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">=<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="height: 14.37pt; left: 264.23pt; position: var(--position); top: 153.23pt; width: 14.37pt; z-index: 87;"><div style="left: -5pt; position: var(--position); top: -5pt;"><img src="gsk-20241231_g111.gif" alt="" style="height: 24.36pt; width: 24.36pt;"/></div></div><div style="background-color: transparent; height: 25.19pt; left: 268.04pt; opacity: 1; position: var(--position); top: 147.82pt; width: 8.23pt; z-index: 88;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 7.2pt; width: 8.23pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 1.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 191.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 429pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 135.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 136.5pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 12pt;"><span style="color: #dbdbdb; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 12pt; position: var(--position); top: 0pt; width: 135.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.89pt; width: 135.75pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Financial Measures: 35%<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147.75pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 14.25pt;"><span style="color: #a8a8a7; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 0pt; width: 116.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.89pt; width: 116.25pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Operational: 25%<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 278.25pt; position: var(--position); top: 0pt; width: 14.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.77pt; width: 14.25pt;"><span style="color: #959592; font-family: 'Wingdings', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">l<span style="display: inline-block; height: 8.48pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 292.5pt; position: var(--position); top: 0pt; width: 136.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.89pt; width: 136.5pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Shareholder alignment: 40%<span style="display: inline-block; height: 6.72pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 208.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 117pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 105.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="7" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 87.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total sales and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Core operating <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit growth<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 0pt; width: 424.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These targets are set following the Board&#8217;s annual planning process and consideration of analysts&#8217; consensus to ensure that the targets <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are sufficiently stretching and support the Committee&#8217;s aim to incentivise and reward over performance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 117pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 117pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance vs Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 105.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 105.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proportion vesting<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Below threshold<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 117pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 117pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&lt;99% of Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 105.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 105.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nil<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Threshold<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 117pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 117pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99% of Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 105.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 105.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20%: CEO | 25%: CFO<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 54pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 54pt; width: 117pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 117pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 54pt; width: 105.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 105.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 117pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 117pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">103% of Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 105.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 105.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 117pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 117pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">105% of Target<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 381.75pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 105.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 105.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 144pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 144pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 144pt; left: 63pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 424.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Annual Bonus Pipeline Performance Measure focuses on OTIF delivery of near-term milestones for priority assets which are <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected to contribute to the growth in sales by 2031.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 23.43pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The PSP measure focuses on GSK&#8217;s replenishment of the pipeline and longer term pipeline performance. For inclusion, a Programme <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 31.83pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">must be either a New Moleculer Entity (NME), or a new indication which adds &#163;0.5 billion to Peak Year Sales. Programmes approved and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 40.23pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launched during the three-year window will contribute to the total number of assets and to the sales contribution. It is based on a matrixed <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 48.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessment of: <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 61.03pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline sales contribution to GSK&#8217;s long range forecast (LRF) outlook. The target and vesting will each be based on 10 year net risk <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 69.43pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted sales forecast i.e. the 2025 -2027 target based on the 2034 LRF and vesting based on the 2037 LRF and<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 77.83pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Number of Programmes in Phase 2 and 3 and Registration and Approval<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 90.23pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This element of the PSP will only vest, either in full or in part, if at the time of vesting the most recently governed and published 2031 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 98.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales outlook remains at a specified level. At the end of the period a list of the Programmes added or removed during the period will be <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 107.03pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosed. However, the pipeline sales contributions in the 2034 and 2037 LRFs and the assessment matrix will not be disclosed, as they <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 115.43pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are commercially sensitive. For the achievement of Threshold performance for both the Pipeline Sales contribution and the number of <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 123.83pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Programmes, the vesting proportions shall be 20% for the CEO, and 25% for the CFO<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 48.75pt;"><td colspan="1" rowspan="8" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 147pt; left: 0pt; overflow: hidden; position: var(--position); top: 231.75pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RB: Composite <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scorecard<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 48.75pt; left: 63pt; overflow: hidden; position: var(--position); top: 231.75pt; width: 424.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Composite scorecard focuses on all the Responsible Business metrics within the Responsible Business Performance Rating. The <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rating is reported on in detail in each year&#8217;s Annual Report with the scorecard providing a balanced assessment of performance against <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all our Responsible Business priorities. Further details on the Rating and performance in 2024 are given on page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 346.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_124">45</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 353.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 31.83pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance will be calculated by aggregating the annual performance across all the individual annual metrics within the rating for the 3 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 40.23pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years of the PSP performance period<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 280.5pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 280.5pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vesting Schedule<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 291.75pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">70% or more of all metrics are on track<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 291.75pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 303pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">60% of all metrics are on track<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 303pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 314.25pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50% of all metrics are on track<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 314.25pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 63pt; overflow: hidden; position: var(--position); top: 325.5pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.89pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 50% of all metrics are on track, but progress is being <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.29pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made because at least 50% are either on track, or on track with <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.69pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">work to do (the &#8216;threshold&#8217; vesting level)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 325.5pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20%: CEO<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25%: CFO<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 353.25pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.79pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 50% of all metrics are either on track or on track with <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">work to do, the rest (i.e. more than 50%) are off track<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 353.25pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nil<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51pt;"><td colspan="1" rowspan="7" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 127.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relative TSR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51pt; left: 63pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 424.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance against our new size-adjusted global biopharma peer group of 13 companies (set out on page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 330.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#icdfbc283136b489a9c31ebff2b59650e_6305">156</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 341.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) will be assessed using a <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">percentile vesting approach. This compares GSK&#8217;s actual TSR performance with that of our peers, rather than our previous approach <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which was to rank where GSK was placed within our previous global pharma peer group.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 31.83pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Threshold remains at median performance. Maximum performance has been stretched to require upper quintile performance for 100% <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 40.23pt; width: 424.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesting. Vesting levels between median and upper quintile are determined on the basis of a straight line interpolation<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 429.75pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">TSR Performance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 429.75pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vesting Schedule<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 441pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Above upper quintile<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 441pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 452.25pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Upper quintile<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 452.25pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100%<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 463.5pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between median and upper quintile<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 463.5pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Straight-line interpolation<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 474.75pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 12.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Median (threshold vesting)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 474.75pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20%: CEO<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25%: CFO<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 63pt; overflow: hidden; position: var(--position); top: 495pt; width: 201.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Below median of peer group<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 264.75pt; overflow: hidden; position: var(--position); top: 495pt; width: 222.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nil<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">153<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for performance (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ia8ca28f21ff34fa7a07895c16c98a406_0-0-1-1-821446"></span><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Performance pay<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 141.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025 Annual Bonus<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 154.82pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 483pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 288pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 99.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 0pt; width: 99.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 65.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of salary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 11.25pt; width: 95.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Target<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 11.25pt; width: 99.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 99.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 64.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maximum<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 288pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 22.5pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 81.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">150<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 22.5pt; width: 99.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.3pt; width: 99.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 84.61pt; position: var(--position); text-decoration: none; white-space: pre;">300<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 288pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 36.75pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 95.25pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 81.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 216.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50% of the equivalent of the first 200% of base salary earned is <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 261.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deferred<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 286.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and any portion in excess of 200% is deferred in full.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 240.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 63.72pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">25 LTI Awards<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 253.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below provides details of: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; the mandatory deferral of the 2024 Annual Bonus earned into the DABP and the associated awards granted. The shares<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; awarded have no performance conditions, but must be held for three years, regardless of continued employment; and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; 2025 awards granted under the PSP<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 311.76pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 120.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120.75pt; position: var(--position); top: 0pt; width: 183pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 183pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 124.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 DABP awards<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 419.25pt; position: var(--position); top: 0pt; width: 68.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 PSP awards<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120.75pt; position: var(--position); top: 12pt; width: 88.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 88.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 bonus deferred into <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 88.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares (% of salary)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 12pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 12pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Face value of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">award (&#163;000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306.75pt; position: var(--position); top: 12pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% base salary<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 42.300000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 12pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 419.25pt; position: var(--position); top: 12pt; width: 68.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Face value of award <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(&#163;000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 120.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 120.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120.75pt; position: var(--position); top: 30.75pt; width: 88.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 72.87pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 72.87pt; position: var(--position);">110<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 30.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">103,980<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 30.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);">1,492<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306.75pt; position: var(--position); top: 30.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.62pt; position: var(--position);">575<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 30.75pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">573,313<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 419.25pt; position: var(--position); top: 30.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8,227<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 120.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 120.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 120.75pt; position: var(--position); top: 42.75pt; width: 88.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 77.01pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 77.01pt; position: var(--position);">99<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 42.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">68,129<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 253.5pt; position: var(--position); top: 42.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);">978<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 306.75pt; position: var(--position); top: 42.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.62pt; position: var(--position);">400<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">285,072<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 419.25pt; position: var(--position); top: 42.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4,091<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 377.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 4.55pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.7814999999999999pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.3085pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 56.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Subject to shareholder approval of the 2025 Remuneration policy at the company&#8217;s AGM in May 2025, it is intended that the CEO&#8217;s PSP grant for 2025 be <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 385.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased to 7.25 times base salary with an additional PSP grant of 1.5 times base salary.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">154<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_313"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; pay in a wider setting<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 146.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Internal context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 170.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Workforce fairness<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 186.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In setting executive pay it is important that the Committee does so with a good understanding of the Group&#8217;s wider workforce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach to pay, with an emphasis on fairness and equal opportunities. To that end, the Committee Chair on an annual basis, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meets with senior <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 121.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human Resources Leaders<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> from across the company to understand their perspectives on pay and GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration arrangements for the wider workforce globally. This year was the sixth such annual meeting held and my first since <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">becoming Chair of the Committee.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 243.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Comparison of remuneration for employees and Executive Directors during <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 444.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 469.07pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 259.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 541.36pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 318pt;"></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 54pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 207.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 225.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 54pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 54pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Element<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 54pt; position: var(--position); top: 0pt; width: 207.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 207.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wider workforce and Executive Director pay <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 87pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 54pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 54pt; overflow: hidden; position: var(--position); top: 12pt; width: 433.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The market competitiveness of base salaries across the company is assessed at a local market level. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitiveness of roles is kept under regular review<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 28.72pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increases may also be made to reflect a change in scope of an individual&#8217;s role, responsibilities or experience<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 48.75pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 48.75pt; left: 54pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 433.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For our Executive Directors following a performance review, increases in base salaries are considered in line with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market practice, the average increase for the wider employee population and other comparator tools<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 28.72pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In agreeing increases for Executive Directors, the Committee is mindful of the multiplier effect on the individual&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 38.92pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total remuneration<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 33pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 54pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pensions<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33pt; left: 54pt; overflow: hidden; position: var(--position); top: 99pt; width: 433.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company seeks to provide an appropriate benefits and pensions package that is aligned to competitive&#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market practices in those countries in which the company operates and where our employees and Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors are based<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 111pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 111pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 54pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 111pt; left: 54pt; overflow: hidden; position: var(--position); top: 132pt; width: 433.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">With the exception of our sales force, who participate in separate arrangements, our wider workforce participates in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a plan based on performance against four business and financial measures. These are structured to reflect the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priorities of each specific business area <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 38.92pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This plan is designed to reward our employees&#8217; collective contribution to business achievement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 54.81pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Separate mechanisms are in place to recognise outstanding individual performance and to address under-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 65.01pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 80.9pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Executive Directors participate in the plan as follows. Any bonus up to 200% of salary is paid 50% in cash and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 91.1pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50% in shares deferred for three years. Bonus earned in excess of this (up to a maximum of 300% of salary) would <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 101.3pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be delivered fully in shares deferred for three years. Clawback and/or malus provisions apply<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 51pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51pt; left: 0pt; overflow: hidden; position: var(--position); top: 243pt; width: 54pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LTI plans<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51pt; left: 54pt; overflow: hidden; position: var(--position); top: 243pt; width: 433.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Vice President (SVP) and Vice President (VP) employees participate in the same Performance Share Plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as our Executive Directors. Clawback and/or malus provisions apply<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 28.72pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our SVP and VP employees, together with directors and managers below the GLT, receive annual Share Value Plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 38.92pt; width: 433.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards of restricted shares <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 294pt; width: 54pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.43pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ownership<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 54pt; overflow: hidden; position: var(--position); top: 294pt; width: 433.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 433.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All UK-based employees can participate in HMRC approved Share Save and Share Reward employee share plans<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 582.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 596.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dilution limits<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 125.29pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All awards are made under plans which incorporate dilution limits consistent with the guidelines published by the Investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 622.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Association. This limit is 10% in any rolling ten-year period for discretionary and all-employee<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> plans. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Estimated dilution from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing awards made over the last ten years up to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is 0.82%. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 648.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">All-employee share plans<span style="display: inline-block; height: 8pt;"></span><span id="icdfbc283136b489a9c31ebff2b59650e_6295"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 664.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Executive Directors may participate in HMRC approved all-employee share plans, namely the company&#8217;s Share Save and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 674.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share Reward plans, along with the wider UK workforce. Participants of the Share Save plan may save up to &#163;250 a month for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 684.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three years and from which they have the option to buy GSK shares at a discount of up to 20% to the share price at the start of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 694.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">savings contract. Participants of the Share Reward plan contribute up to &#163;125 a month to purchase GSK shares which the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company then matches on a one-for-one basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">155<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; pay in a wider setting continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">CEO and wider employee pay ratio<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 145.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 134.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 117.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 117.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 117.75pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 134.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 134.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial year<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 117.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lower quartile<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P25<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 252pt; overflow: hidden; position: var(--position); top: 0pt; width: 117.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Median<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P50<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 117.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Upper quartile<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 117.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P75<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 134.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">168:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 252pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">123:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 134.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 36pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">207:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 252pt; overflow: hidden; position: var(--position); top: 36pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">152:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 36pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">94:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 134.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">144:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 252pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">106:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">67:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 134.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2021<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">154:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 252pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">108:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">67:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 134.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">130:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 252pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">96:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">62:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 134.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 134.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2019<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 134.25pt; overflow: hidden; position: var(--position); top: 75pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">160:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 252pt; overflow: hidden; position: var(--position); top: 75pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">119:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 75pt; width: 117.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.16pt; width: 117.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">73:1<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 240.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK continues to use the Option A methodology because it is the most robust and statistically accurate way to calculate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three ratios from the options available under the Remuneration regulations. The pay ratio is lower than in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. This is influenced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 260.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the delivery of a slightly lower bonus for all, which impacts variable pay outcomes more significantly for our CEO who has a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">larger proportion of her pay based on performance than individuals at P25, P50 and P75. The CEO&#8217;s LTI vest was also lower than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2023 with nothing attributable to share price appreciation over the performance period. The 2022 award was granted at &#163;15.71 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and vested at &#163;14.43.&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The pay ratios above are calculated using actual earnings for the CEO and UK employees. The CEO&#8217;s total single figure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration of &#163;10.559 million for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 185.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and &#163;12.718 million for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 294.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are detailed on pag<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 387.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 394.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_304">144</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total remuneration for all UK full-time equivalent employees on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> has been calculated in line with the single figure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">methodology. This reflects their actual earnings received in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 274.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 293.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (which excludes business expenses), which were used to produce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the percentile calculation under Option A of the Remuneration regulations. Business expenses have been excluded as they are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reimbursed to employees and are not sufficiently substantial in value to significantly impact the ratios.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he table below shows <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the salary, total pay and benefits for each of the percentiles.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 395.88pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 0pt; width: 138pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 112.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P25 (&#163;)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 0pt; width: 138pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 112.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P50 (&#163;)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 0pt; width: 138pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 112.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P75 (&#163;)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 11.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 12.94pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 46.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 11.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.54pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 25.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total pay and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.94pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 42.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 11.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 12.94pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 46.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 11.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.54pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 25.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total pay and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.94pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 42.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 11.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 12.94pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 46.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 11.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 4.54pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 25.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total pay and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.94pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 42.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">41,845<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">62,876<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">57,635<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">85,924<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">82,629<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 32.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">136,010<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">39,903<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">61,490<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">55,057<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">83,783<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78,496<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 43.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">135,819<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37,776<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">58,883<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">52,107<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79,428<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">74,905<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 54.75pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">126,594<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2021<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37,251<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">53,151<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">51,492<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">76,234<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">72,997<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 66pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">122,852<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">36,924<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">54,133<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50,000<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">73,340<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">70,203<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 77.25pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">113,830<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2019<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 69pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">34,510<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50,467<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">47,029<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 279pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">68,200<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 45.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">66,561<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 88.5pt; width: 69pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 69pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">110,638<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 506.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee believes that the median pay ratio is consistent with the company&#8217;s pay, reward and progression policies. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The base salaries of all employees, including the Executive Directors, are set with reference to a range of factors including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market practice, experience and performance in role.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 542.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Relative importance of spend on pay<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he table shows total employee pay and dividends paid to shareholders.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 575.95pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 171.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 0pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Change <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 40.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 0pt; width: 171.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 171.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 171.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 160.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 156.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 161.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 93.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total employee pay<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 18.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.21pt; position: var(--position);">3.4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 18.75pt; width: 171.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">8,759<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 18.75pt; width: 173.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 148.8pt;"></span></span><span style="left: 151.43pt; position: var(--position);">8,473<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 93.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid in the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 30.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 35.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 35.21pt; position: var(--position);">8.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 142.5pt; position: var(--position); top: 30.75pt; width: 171.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 171.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 147.3pt;"></span></span><span style="left: 149.93pt; position: var(--position);">2,444<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 314.25pt; position: var(--position); top: 30.75pt; width: 173.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 148.8pt;"></span></span><span style="left: 151.43pt; position: var(--position);">2,247<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 629.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The figures in this table, reflecting payments made during each year and the impact of movements in exchange rates, are as set <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_403">201</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_424">207</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. However, cash dividends declared in respect of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,489&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2,355&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase o<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 92.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">f 5.7%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 116.46000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Please see Note 16 to the financial statements for further details.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 665.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total employee pay is based on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 173.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">69,305<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> employees, the average number of people employed during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">70,244<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). See <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 675.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 9 to the financial statements for further details.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he last share repurchase made by the company was in 2014. On 5 February 2025, GSK announced its intention to implement a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 701.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;2 billion share buyback programme to be completed over an 18-month period. The programme commenced on 24 February 2025 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 712.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with an initial tranche of up to &#163;0.7 billion.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 728.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Provision 40 of the FRC Code<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 743.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company&#8217;s 2022 Remuneration policy was approved on 4 May 2022 at GSK&#8217;s Annual General Meeting (and amended at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 754.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 Annual General Meeting) and has operated as intended in terms of company performance and quantum since its approval. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 764.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of how the 2022 Policy reflects Provision 40 of the FRC Code are set out on page 159 of the 2023 Annual Report. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">156<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; pay in a wider setting continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">External context<span style="display: inline-block; height: 8pt;"></span><span id="icdfbc283136b489a9c31ebff2b59650e_6305"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 77.98pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> target CEO total remuneration <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">positioning <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 158.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When reviewing the CEO&#8217;s remuneration, the Committee&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prim<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.21000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ary comparator group is the European cross-industry <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparator group. It also ref<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">erences pay for the Global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 58.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">harmace<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">utical comparator group<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 210.86pt; width: 595.44pt;"><div style="left: 53.86pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g133.jpg" alt="2024_TotalRemBenchmarking V2.jpg" style="height: 143.27pt; width: 236.78pt;"/></div></div></div><div style="line-height: 7pt; position: var(--position); top: 364.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration includes salary and the expected value of incentives based on <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 373.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Committee&#8217;s agreed benchmarking methodology <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 394.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Historic CEO remuneration<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 409.91pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 22.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 21.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 21.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 21.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 23.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 23.25pt;"/></tr><tr style="height: 12pt;"><td colspan="7" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 189.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 0pt; width: 23.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 12pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 74.25pt; position: var(--position); top: 12pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 12pt; width: 22.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 22.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 12pt; width: 21.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2021<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 12pt; width: 21.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 12pt; width: 21.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2019<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 12pt; width: 23.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2018<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 12pt; width: 23.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2017<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.42pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.42pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e3e3e3; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 48pt; overflow: hidden; position: var(--position); top: 24pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">10,559<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 74.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">12,718<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 102pt; overflow: hidden; position: var(--position); top: 24pt; width: 22.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 22.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">8,449<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 124.5pt; overflow: hidden; position: var(--position); top: 24pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">8,203<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 146.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">7,031<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 168pt; overflow: hidden; position: var(--position); top: 24pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">8,084<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 189.75pt; overflow: hidden; position: var(--position); top: 24pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.021em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">5,887<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 213pt; overflow: hidden; position: var(--position); top: 24pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.021em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">4,883<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maximum<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus award<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 69pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.13pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.13pt; position: var(--position);">70%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 74.25pt; position: var(--position); top: 69pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.63pt; position: var(--position);">96%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 69pt; width: 22.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 22.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.38pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.38pt; position: var(--position);">83%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 69pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.63pt; position: var(--position);">93%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 69pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.63pt; position: var(--position);">49%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 69pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.63pt; position: var(--position);">79%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 69pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.13pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.13pt; position: var(--position);">93%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 69pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.13pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.13pt; position: var(--position);">77%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vesting of LTI <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 48pt; position: var(--position); top: 89.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.13pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.13pt; position: var(--position);">81%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 74.25pt; position: var(--position); top: 89.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.63pt; position: var(--position);">69%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 89.25pt; width: 22.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 22.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.38pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.38pt; position: var(--position);">52%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 89.25pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.63pt; position: var(--position);">58%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 89.25pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.63pt; position: var(--position);">67%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 168pt; position: var(--position); top: 89.25pt; width: 21.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 21.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.63pt; position: var(--position);">67%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 89.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.13pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.13pt; position: var(--position);">59%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 213pt; position: var(--position); top: 89.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.13pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.13pt; position: var(--position);">69%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 530.1pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 71.25pt;"></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 186.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 112.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 23.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 25.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 25.5pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 112.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 62.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Andrew Witty<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 0pt; width: 25.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 112.5pt; position: var(--position); top: 12pt; width: 23.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2017<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 12pt; width: 25.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2016<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 12pt; width: 25.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2015<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total remuneration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 112.5pt; position: var(--position); top: 23.25pt; width: 23.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">715<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 135.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 25.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">6,830<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 161.25pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 25.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">6,661<span style="display: inline-block; height: 5.46pt; width: 9.09pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of maximum<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 112.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Bonus award<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 112.5pt; position: var(--position); top: 47.25pt; width: 23.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 47.25pt; width: 25.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 7.38pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 7.38pt; position: var(--position);">97%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 47.25pt; width: 25.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 3.24pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 3.24pt; position: var(--position);">100%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 59.25pt; width: 112.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 112.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vesting of LTI awards<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 112.5pt; position: var(--position); top: 59.25pt; width: 23.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 135.75pt; position: var(--position); top: 59.25pt; width: 25.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 7.38pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 7.38pt; position: var(--position);">33%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 59.25pt; width: 25.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 25.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 7.38pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 7.38pt; position: var(--position);">38%<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 607.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley&#8217;s total remuneration for 2017 includes her pay for the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 615.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period 1 January to 31 March 2017, before she became CEO<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 626.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Andrew Witty received a pro-rata payment for 2017 in lieu of a <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 634.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">variable bonus opportunity, in accordance with the 2014 Remuneration <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 642.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 653.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PSP and DABP awards for Sir Andrew Witty granted in 2015 did not vest <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 661.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">until April 2018, in accordance with the terms of the Recoupment Policy<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Comparator groups <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For 2024, the European cross-industry comparator group was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Committee's primary comparator group for the CEO and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CFO. The Global pharmaceutical comparator group was the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">secondary group for the CEO, and was also used to measure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relative TSR performance. Details of the new Size-adjusted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global Biopharma peer group to apply from 2025 onwards are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also set out below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 222.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 78.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78.75pt;"/></tr><tr style="height: 12pt;"><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 93.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024: European cross-industry comparator group<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 83.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 83.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 78.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Roche Holding AG <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LVMH<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anheuser-Busch InBev <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unilever<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SAP<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">L&#8217;Oreal<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novo Nordisk A/S <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Airbus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 83.25pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 12pt; width: 78.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Linde<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sanofi<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AstraZeneca<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diageo<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Siemens<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Christian Dior<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inditex<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BAT<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Volkswagen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 83.25pt; left: 157.5pt; overflow: hidden; position: var(--position); top: 12pt; width: 78.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deutsche Telekom<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Kering<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Heineken<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BASF<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vinci<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 47.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adidas<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 56.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bayer<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 65.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Safran<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 74.63pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reckitt Benckiser<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 322.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 238.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 238.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 238.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 101.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024: Global pharmaceutical comparator group<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 79.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">France<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 10.43pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sanofi<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.43pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Switzerland<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 27.23pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 36.23pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Roche Holdings<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 45.23pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 53.03pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AstraZeneca<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 75pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 159pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 10.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AbbVie<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 19.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amgen<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 23.400000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 28.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bristol-Myers Squibb<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 37.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Eli Lilly<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 46.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Johnson &amp; Johnson<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 55.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Merck &amp; Co<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 64.43pt; width: 159pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 413.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AbbVie and Amgen were included for remuneration benchmarking, but <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 422.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were not included in the relative TSR performance comparator group<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 432.64pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 78.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 78.75pt;"/></tr><tr style="height: 12pt;"><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 90.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025: Size-adjusted Global Biopharma peer group<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 78.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amgen<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AstraZeneca<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bayer<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bristol-Myers Squibb<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CSL<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57pt; left: 78.75pt; overflow: hidden; position: var(--position); top: 12pt; width: 78.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gilead<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Merck KGaA<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Moderna<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57pt; left: 157.5pt; overflow: hidden; position: var(--position); top: 12pt; width: 78.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Roche Holding<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sanofi<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 78.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Takeda<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">TSR Performance graph <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">The following graph sets out the performance of the company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">relative to the FTSE 100 Index and to the size-adjusted global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">biopharma peer group comparator group for the ten-year period <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.09000000000003pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.5pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">. These indices were selected for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">comparison purposes as they reflect both the primary index of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">which GSK is a constitu<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.83000000000004pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">ent and the industry in which GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.007em; position: var(--position); text-decoration: none; white-space: pre;">operates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 606.13pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g134.jpg" alt="TSR_Performance.2024.jpg" style="height: 187.23pt; width: 236.78pt;"/></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">157<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_316"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration governance<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Committee role and membership<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These details are available on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 188.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_268">113</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and are incorporated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by reference into this Report. The Chair, CEO, Chief People <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Officer, Head of Reward, Group Financial Controller and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Company Secretary assisted the Committee during the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 214.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Adviser to the Committee<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 230.1pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 234pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 87.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 87.75pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 58.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Willis Towers Watson plc <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(WTW)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 146.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FIT Remuneration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consultants (FIT)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 60pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adviser <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 58.5pt; overflow: hidden; position: var(--position); top: 24pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Both advisors are members of the Remuneration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consultants Group and operate under its code of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conduct for executive remuneration consulting in the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK which can be accessed at: <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 175.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">www.remunerationconsultantsgroup.com<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 48.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 48.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advice provided<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 48.75pt; left: 58.5pt; overflow: hidden; position: var(--position); top: 84pt; width: 175.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The Committee noted that neither WTW nor FIT <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">engagement partners or teams that provide <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">remuneration advice to the Committee have <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">connections with the company or its Directors that <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.11pt; width: 175.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">may impair their independence<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 51pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appointed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51pt; left: 58.5pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Appointed as the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Committee&#8217;s principal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">remuneration advisor in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">December 2022&#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51pt; left: 146.25pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Appointed in October <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2024 to provide specific <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">advice on the 2025 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.11pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">development process<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fees&#160; &#160; &#160;  <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(charged on a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materials basis)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 58.5pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2024: &#163;162,220<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.5pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">(2023: &#163;67,419)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 146.25pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">2024: &#163;21,243<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 131.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 222pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Conflicts of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 58.5pt; overflow: hidden; position: var(--position); top: 222pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">WTW provides market <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">data and other HR <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">consulting services to the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">company.&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.11pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The Committee regularly <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 49.48pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">reviews the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 58.85pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">arrangements for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.22pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">potential conflicts and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.59pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">where appropriate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.96pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">ensures safeguards are <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 96.33pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">in place<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 131.25pt; left: 146.25pt; overflow: hidden; position: var(--position); top: 222pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The Remuneration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">declared a prior business <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">relationship with FIT from <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.11pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">other companies where <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 49.48pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">she has worked with the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 58.85pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">consultant in her capacity <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.22pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">as a Remuneration <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 77.59pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair and/or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 86.96pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">member. Appropriate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 96.33pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">safeguards are in place <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 105.7pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">to ensure independence<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Statement of consideration of shareholder <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 165.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">views <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee engages in regular dialogue with shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and holds meetings with GSK&#8217;s largest investors to discuss and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">take feedback on its Remuneration policy practices and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 214.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance matters. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 230.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of the additional engagement undertaken in 2024 in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 240.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support of the Remuneration policy review are given on pages <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.81pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_24123">138</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2fdae0fcc1cf47049ec85bb2c40664fd_457">141</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The principal proxy advisory firms are also consulted regularly. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">They were also invited to our Annual Governance Meeting and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are sent engagement letters from the Committee and company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 297.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chairs.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 313.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">AGM voting<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of voting levels in respect of Remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements are set out below. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 358.17pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 242.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 42pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 41.25pt;"/></tr><tr style="height: 28.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 77.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.11pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total votes <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cast (billion)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 119.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 42pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.11pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total votes <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for (%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 28.5pt; left: 161.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.11pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total votes <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against (%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 41.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.31pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Votes <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.11pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">withheld <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.91pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(million)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 AGM<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 44.25pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.95pt; position: var(--position); text-decoration: none; white-space: pre;">2.8<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 119.25pt; position: var(--position); top: 44.25pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.78pt; position: var(--position); text-decoration: none; white-space: pre;">92.7<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.7pt; position: var(--position); text-decoration: none; white-space: pre;">7.3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 44.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.03pt; position: var(--position); text-decoration: none; white-space: pre;">38.7<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 AGM<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 66.75pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2.8<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 119.25pt; position: var(--position); top: 66.75pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">88.8<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11.2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 66.75pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">70.1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amendments to 2022 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 81pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2.9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 119.25pt; position: var(--position); top: 81pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 81pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 81pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10.7<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022 AGM<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 116.25pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 119.25pt; position: var(--position); top: 116.25pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">91.1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8.9<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 116.25pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Policy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 127.5pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 119.25pt; position: var(--position); top: 127.5pt; width: 42pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 42pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">61.8<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38.2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 127.5pt; width: 41.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 41.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">158<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration governance continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Committee focus during <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 181.44pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 96pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 391.5pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 0pt; width: 391.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 12.75pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items discussed<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 21.75pt; width: 96pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration policy<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 96pt; overflow: hidden; position: var(--position); top: 21.75pt; width: 391.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reviewed the current remuneration arrangements and developed and proposed 2025 Remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy in consultation with the other Non-Executive Directors and employee insights<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consultation with shareholders and consideration of feedback<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 53.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 53.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 96pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed Pay<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 57pt; width: 391.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered Executive Director and GLT performance, benchmarking competitiveness against GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparator groups<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reviewed GLT and Company Secretary salary recommendations for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director salary review recommendations for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reviewed company Chair&#8217;s fees for 2024 and 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 96pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pay for Performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Bonus<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 110.25pt; width: 391.5pt;"><div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director and GLT <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.64000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> bonus recommendations and set <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 280.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Executive Directors&#8217; bonus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">objectives<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 33pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33pt; left: 0pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 96pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LTI plans<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 142.5pt; width: 391.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered the LTI performance outcomes and award vesting for the CEO, Executive Directors, GLT <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and below <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Confirmed LTI grants for Executive Directors, GLT and below<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 93.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 93.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 96pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governance and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas of focus<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 96pt; position: var(--position); top: 175.5pt; width: 391.5pt;"><div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 2.63pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration considerations and Committee programme for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 12.83pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee evaluation and Annual Review of its Terms of Reference<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 23.03pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved 2023 Remuneration report <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 33.23pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Confirmed <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 52.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Group Budget for remuneration purposes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 43.43pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered AGM and Remuneration report feedback, the external remuneration environment and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 53.63pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance target disclosure for incentive plans<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 63.83pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreed Committee's key messages for Annual Governance Meeting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 74.03pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee Chair consulted with employee representatives on wider workforce pay practices and pay <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 84.23pt; width: 391.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 11.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generally<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 419.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 429.7pt; width: 595.44pt;"><div style="font-size: 0pt; left: 59.53pt; position: var(--position); top: 0pt; width: 481.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 96.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 246.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 96.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Payments (audited):<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 117pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 117pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to past Directors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 117pt; left: 96.75pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 384.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Iain Mackay stepped down from the Board in May 2023 and left the company on 31 December 2023:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 22.37pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">The vesting of Mr Mackay&#8217;s LTI awards, in accordance with the Recoupment policy, resulted in 232,302 shares <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">vesting (including dividends) in respect of his 2021 PSP award in January 2025. Based on the closing share <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">price on 21 January 2025 of &#163;13.585 per share, the value of his vested shares was &#163;3,155,823<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.98pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">In accordance with the Remuneration policy, 141,577 shares vested (including dividends) in respect of the 2022 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 60.35pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">PSP award. Based on the closing share price on 18 February 2025 of &#163;14.43 per share, the value of his vested <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 69.72pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">shares was &#163;2,042,956<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 79.59pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">These awards remain subject to the following holding periods. The 2021 PSP award holding period expires in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 88.96pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">February 2026, and the 2022 PSP award holding period expires in February 2027<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 98.83pt; width: 384.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.630000000000001pt; position: var(--position); white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.13pt; position: var(--position); white-space: pre;">In line with his service contract, Mr Mackay received gross benefits of &#163;160,761<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 129.75pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for loss of office<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 96.75pt; overflow: hidden; position: var(--position); top: 129.75pt; width: 246.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 246.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">No loss of office payments were made during 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">159<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_319"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors&#8217; fees<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 147.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company aims to provide the Chair and other Non-Executive Directors with fees that are competitive with those paid by other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 157.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies of equivalent size and complexity, subject to the limits contained in its Articles of Association.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 189.31pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 and 2025 Non-Executive Directors&#8217; fees<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Non-Executive Directors&#8217; fees that applied during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 273.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and will apply for 2025, are set out in the table below together with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees for 2025:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 242.4pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 348pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/></tr><tr style="height: 10.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 0pt; width: 139.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.91pt; width: 139.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 105.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Per annum<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 10.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 10.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 50.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="ib287d45091a34674911711cb9eb55e06_2-0-1-1-821446"></span><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 21.75pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair fee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 21.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;800,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 21.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;764,400<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standard NED annual fee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 33pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;122,258<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 33pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;118,352<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 348pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplemental fees<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair of the Audit &amp; Risk Committee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 58.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;80,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 58.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;80,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Senior Independent Director<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 72.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;50,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 72.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;50,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scientific &amp; Medical Experts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 84.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;30,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 84.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;30,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chairs of the Remuneration, Corporate Responsibility and Science committees and, when appointed, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Workforce Engagement Director<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 96.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;40,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 96.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;40,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 348pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 348pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Science Committee members undertaking significant additional responsibilities on behalf of GSK<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 117.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Up to &#163;200,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 117.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Up to &#163;200,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 383.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Fee Review<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 399.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following the annual review by the Committee at the end of 2024, it was determined that the Chair&#8217;s fee should be increased to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 409.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;800,000, an increase of 4.7%, marginally above the increase for the wider workforce of 3.3%. This increase reflects the additional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution made by the Chair and was supported by external benchmarking. The Chair and CEO reviewed the Non-Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 430.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; standard fee at the end of 2024, and agreed that it should be increased by 3.3%, in line with the wider workforce, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing it to &#163;122,258.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 456.17pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ib1f74dd452d544b7af7eb3f6b9f156c5_0-0-1-1-825086"></span><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024 Total Non-Executive Director fees (audited)<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 483.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The audited table below sets out the value of fees and benefits received by the Non-Executive Directors. Fees paid in a currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other than Sterling are converted using an average exchange rate that is reviewed from time to time. The average exchange rates <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 503.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were updated in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In 2024, fees were converted to US Dollars using an exchange rate of $1.242. Benefits comprise the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">grossed up cash value of travel and subsistence costs incurred in the normal course of business, in relation to attendance at Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Committee meetings and in fulfilling their role.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 534.17pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 158.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 46.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 46.5pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="3" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 158.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors&#8217; <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">emoluments (000) (audited)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 46.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 347.25pt; overflow: hidden; position: var(--position); top: 12pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed fees<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 158.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed fees<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 24pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 24pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total pay<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 24pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 24pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares/ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 24pt; width: 46.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 24pt; width: 46.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total pay<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 36pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;764<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 36pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;17<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 36pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;781<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 36pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;551<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 36pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;184<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 36pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">&#163;30<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 36pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">&#163;765<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth Anderson<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 48pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$147<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 48pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$59<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 48pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$206<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 48pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$100<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 48pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$33<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 48pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$30<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 48pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$163<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 60pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$308<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 60pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$25<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 60pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$333<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 60pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.94pt;"></span></span><span style="left: 36.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 60pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$295<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 60pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$28<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 60pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$323<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 72pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$396<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 72pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$66<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 72pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$462<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 72pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$344<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 72pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$33<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 72pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$78<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 72pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$455<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 84pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$197<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 84pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$58<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 84pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$255<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 84pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$156<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 84pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$33<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 84pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$34<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 84pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$223<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 96pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 96pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;145<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 96pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;12<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 96pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;157<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 96pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;21<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 96pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.13pt;"></span></span><span style="left: 35.760000000000005pt; position: var(--position);">&#163;7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 96pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.38pt;"></span></span><span style="left: 35.010000000000005pt; position: var(--position);">&#163;4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 96pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">&#163;32<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 107.25pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 107.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$234<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 107.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$41<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 107.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$275<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 107.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$191<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 107.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$33<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 107.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$40<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 107.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$264<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 119.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$185<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 119.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$43<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 119.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$228<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 119.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$144<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 119.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$33<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 119.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$44<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 119.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$221<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 131.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$152<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 131.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$14<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 131.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$166<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 131.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">$&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 131.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.8pt;"></span></span><span style="left: 32.43pt; position: var(--position);">$&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 131.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.05pt;"></span></span><span style="left: 31.68pt; position: var(--position);">$&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 131.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.05pt;"></span></span><span style="left: 31.68pt; position: var(--position);">$&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Vishal Sikka<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 142.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$147<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 142.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">$25<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 142.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$172<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 142.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.94pt;"></span></span><span style="left: 36.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 142.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">$134<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 142.5pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">$13<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 142.5pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">$147<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired Directors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 158.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 158.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urs Rohner<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 158.25pt; position: var(--position); top: 165.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;57<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 205.5pt; position: var(--position); top: 165.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;17<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 165.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;74<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 300pt; position: var(--position); top: 165.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);">&#163;133<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 347.25pt; position: var(--position); top: 165.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.99pt;"></span></span><span style="left: 31.619999999999997pt; position: var(--position);">&#163;28<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 394.5pt; position: var(--position); top: 165.75pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.24pt;"></span></span><span style="left: 30.869999999999997pt; position: var(--position);">&#163;40<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 165.75pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 46.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.1pt;"></span></span><span style="left: 26.73pt; position: var(--position);">&#163;201<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 722.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Director section of 2022 Remuneration policy<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 735.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At the 2023 AGM, shareholders approved an administrative amendment to the Non-Executive Director section of the Remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 746.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policy to allow the notional shares or ADS previously allocated under the Non-Executive Director plan to be delivered to the Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 756.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Non-Executive Directors at such time as the Committee and Board considered appropriate after any applicable tax withholding. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 766.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Chair and Mr Rohner's notional shares were released to them after the AGM in 2023. It is expected that the other Non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 776.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors holdings will be released to them before the company's AGM in May 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">160<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_322"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; interests in shares (audited)<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ifdf922b90c1e421090bab303715daafc_0-0-1-1-824514"></span><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors&#8217; interests in shares<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The interests of the Executive Directors of the company in office during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 319.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and their persons closely associated (PCA) are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 189.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shown in the table below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 204.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 541.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 86.25pt;"></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 95.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 72pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 5.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 4.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 4.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="6" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 0pt; width: 260.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 260.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 186.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As at <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 202.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 11.25pt; width: 130.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 130.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 42.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unvested share plan interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 22.5pt; width: 126.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 51.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total directors&#8217; interests<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 119.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 22.5pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beneficial interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 22.5pt; width: 125.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 125.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 45.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Not subject to performance<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 22.5pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subject to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 41.25pt; width: 54.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.41pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 41.25pt; width: 72pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.41pt; width: 72pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31 December 2024 <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 41.25pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.41pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 55.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 41.25pt; width: 62.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.41pt; width: 62.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 54.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 41.25pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.41pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Options<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 51.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(4,6)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 41.25pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.41pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 55.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 62.25pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.83pt;"></span></span><span style="left: 18.46pt; position: var(--position);">2,391,096<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 62.25pt; width: 72pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 72pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.08pt;"></span></span><span style="left: 35.71pt; position: var(--position);">2,011,795<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 62.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">925,267<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 62.25pt; width: 62.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.52pt;"></span></span><span style="left: 32.15pt; position: var(--position);">719,827<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 62.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">366,701<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 62.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.08pt;"></span></span><span style="left: 26.709999999999997pt; position: var(--position);">1,533,961<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 95.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 95.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 95.25pt; position: var(--position); top: 74.25pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.02pt;"></span></span><span style="left: 24.65pt; position: var(--position);">169,340<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 74.25pt; width: 72pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 72pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.27pt;"></span></span><span style="left: 41.900000000000006pt; position: var(--position);">100,532<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 227.25pt; position: var(--position); top: 74.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.41pt;"></span></span><span style="left: 37.04pt; position: var(--position);">42,655<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294.75pt; position: var(--position); top: 74.25pt; width: 62.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 48.94pt;"></span></span><span style="left: 51.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 357pt; position: var(--position); top: 74.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.41pt;"></span></span><span style="left: 37.04pt; position: var(--position);">57,877<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 74.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">523,727<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 300.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">None of the Directors hold vested but unexercised options.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 311.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total directors&#8217; interests includes beneficial interests and unvested share plan interests not subject to performance. For Emma Walmsley, the balance as at <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 319.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February 2025 includes shares awarded in <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 207.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 223.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, under the PSP and the DABP which vested in February 2025, less those sold to satisfy tax liabilities on <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 328.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the vested amounts where relevant. Executive Directors&#8217; shareholdings against their SOR are outlined below<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 338.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beneficial interests includes shares held by the Executive Directors and their PCAs. For Emma Walmsley and Julie Brown, this includes 2,751 shares and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 346.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">276 shares respectively purchased through the Share Reward plan<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 357.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unvested shares not subject to performance represent PSP shares which have vested but are subject to an additional two-year holding period <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 367.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unvested options not subject to performance represent bonus deferrals under the DABP which are awarded as nil-cost options (as described in note 6 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 376.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below). This figure excludes 790 options and 828 options held by Emma Walmsley and Julie Brown respectively under the Share Save plan<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 386.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unvested shares subject to performance represent unvested PSP awards<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 396.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DABP: The table below shows bonus deferrals and subsequent reinvestment of dividends under the DABP. The amounts represent the gross share <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 405.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balances prior to the sale of any shares to satisfy tax liabilities on vesting <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 415.68pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 11.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 287.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 11.25pt; position: var(--position); top: 0pt; width: 287.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 287.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 216.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DABP (Bonus deferrals)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 298.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February 2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31 December 2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 January 2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 11.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 287.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 287.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 298.5pt; position: var(--position); top: 11.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">393,053<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 11.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">366,701<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 11.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">258,843<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 11.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 287.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 287.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 298.5pt; position: var(--position); top: 24pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.27pt;"></span></span><span style="left: 32.9pt; position: var(--position);">126,649<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 24pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.41pt;"></span></span><span style="left: 37.04pt; position: var(--position);">57,877<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 24pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.69pt;"></span></span><span style="left: 52.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 463.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table sets out details of nil-cost options exercised during 2024 by Executive Directors: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 488.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 109.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 109.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Date of grant<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 172.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of shares<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.619999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under option<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 235.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Date of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercise<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 298.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Grant price<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market price <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.279999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at exercise<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain on exercise <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 45.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 17.25pt; width: 109.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 109.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 109.5pt; position: var(--position); top: 17.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10.02.2021<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 172.5pt; position: var(--position); top: 17.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">52,435<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 235.5pt; position: var(--position); top: 17.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.02.24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 298.5pt; position: var(--position); top: 17.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 361.5pt; position: var(--position); top: 17.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;16.52<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #6d6d6d; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 424.5pt; position: var(--position); top: 17.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 43.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;866<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 528.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The nil-cost options awarded in 2021 under the DABP represent the bonus deferred by the Executive Director and recorded as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration (under Annual Bonus) in the 2020 Total remuneration table. The number of shares under option includes the initial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">award together with reinvested dividends accrued to the date of exercise.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 578.48pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors&#8217; Share ownership requirements (SOR) (audited)<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 605.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To align the interests of Executive Directors with those of shareholders, they are required to build and maintain significant holdings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of shares in GSK over time. Executive Directors are required to continue to satisfy this SOR by holding 100% of their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SOR for the first 12 months after leaving GSK and not less than 50% of their SOR for months 13-24 thereafter. Shares subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 636.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance conditions are excluded from the SOR calculation until the end of the performance period. These vested shares are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 646.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">then included to the extent that the performance conditions are met. The value of the holdings has been calculated on a post-tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 656.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basis. Iain Mackay exceeded his SOR at the date of his retirement from the Board and continues to maintain his SOR. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 672.37pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 328.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 0pt; width: 104.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 104.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Value of holdings as % of salary <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 11.25pt; width: 54.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SOR<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.549999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> % of salary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 11.25pt; width: 51pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.46pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 11.25pt; width: 53.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 53.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 53.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 31.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6.5<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 31.5pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">17.25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 31.5pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16.01<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 43.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 43.5pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.48<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 434.25pt; position: var(--position); top: 43.5pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.08<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">161<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors interests in shares (audited) continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors&#8217; interests in shares<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 140.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The interests of the Non-Executive Directors in office during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 296.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and their persons closely associated (PCA) are shown in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 150.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">table below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 166.48pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 0pt; width: 195.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 195.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 103.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prior NED share allocation plan <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 11.25pt; width: 96pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 96pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total directors&#8217; interests as at<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 88.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 11.25pt; width: 99.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 99.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of shares/ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 22.5pt; width: 53.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 53.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NED SOR <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 53.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 53.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 45.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 22.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 24.21pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 22.5pt; width: 48pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; or date of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retirement<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 22.5pt; width: 51.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beneficial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.709999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.450000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.240000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> or date of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retirement<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 44.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 22.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reinvested <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">after <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year end<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 22.5pt; width: 48pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 22.5pt; width: 51.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elected &amp; <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allocated <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 51.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.799999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the year<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 44.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 22.5pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 January 2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 75.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 75.75pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 75.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">81,757<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 75.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">81,757<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 75.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.16pt;"></span></span><span style="left: 25.79pt; position: var(--position);">81,757<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 75.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 75.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 75.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 75.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 87pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In progress<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 87pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">2,367<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 87pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">2,367<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 87pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.3pt;"></span></span><span style="left: 29.93pt; position: var(--position);">2,367<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 87pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 87pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 87pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 87pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth Anderson<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 109.5pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In progress<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 109.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">2,180<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 109.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">2,159<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 109.5pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.3pt;"></span></span><span style="left: 29.93pt; position: var(--position);">2,159<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 109.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 109.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 109.5pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 109.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 120.75pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 120.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">32,164<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 120.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">31,270<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 120.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.16pt;"></span></span><span style="left: 25.79pt; position: var(--position);">14,757<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 120.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.74pt;"></span></span><span style="left: 32.37pt; position: var(--position);">754<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 120.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">16,513<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 120.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.49pt;"></span></span><span style="left: 36.120000000000005pt; position: var(--position);">709<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 120.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">15,804<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 132pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #7c7c7b; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 132pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 12.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">640,414<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 39.480000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 132pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.27pt;"></span></span><span style="left: 17.9pt; position: var(--position);">661,080<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 132pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.02pt;"></span></span><span style="left: 21.65pt; position: var(--position);">661,080<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 132pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 132pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 132pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 132pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 143.25pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In progress<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 1pt solid #7c7c7b; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">3,899<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">3,795<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 143.25pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.3pt;"></span></span><span style="left: 29.93pt; position: var(--position);">1,914<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.88pt;"></span></span><span style="left: 36.510000000000005pt; position: var(--position);">85<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">1,881<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 143.25pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.63pt;"></span></span><span style="left: 40.260000000000005pt; position: var(--position);">80<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 143.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">1,800<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 154.5pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In progress<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">3,673<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">3,579<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 154.5pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.3pt;"></span></span><span style="left: 29.93pt; position: var(--position);">1,914<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.88pt;"></span></span><span style="left: 36.510000000000005pt; position: var(--position);">76<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">1,665<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 154.5pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.63pt;"></span></span><span style="left: 40.260000000000005pt; position: var(--position);">71<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 154.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">1,593<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 165.75pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 165.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">15,714<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 165.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">15,094<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 165.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.3pt;"></span></span><span style="left: 29.93pt; position: var(--position);">1,914<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 165.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.74pt;"></span></span><span style="left: 32.37pt; position: var(--position);">602<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 165.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">13,180<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 165.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.49pt;"></span></span><span style="left: 36.120000000000005pt; position: var(--position);">566<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 165.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">12,614<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 177pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 177pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In progress<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 177pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.74pt;"></span></span><span style="left: 32.37pt; position: var(--position);">796<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 177pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.74pt;"></span></span><span style="left: 32.37pt; position: var(--position);">790<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 177pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.49pt;"></span></span><span style="left: 36.120000000000005pt; position: var(--position);">790<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 177pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 177pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 177pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 177pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 188.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vishal Sikka<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 188.25pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Met<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 188.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">8,337<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 188.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.55pt;"></span></span><span style="left: 26.18pt; position: var(--position);">8,257<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 188.25pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.3pt;"></span></span><span style="left: 29.93pt; position: var(--position);">8,257<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 188.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 188.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 188.25pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 188.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 199.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired Directors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 210.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urs Rohner<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 37.809999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(6)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 84.75pt; position: var(--position); top: 210.75pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.94pt;"></span></span><span style="left: 42.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 138pt; position: var(--position); top: 210.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 210.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.41pt;"></span></span><span style="left: 22.04pt; position: var(--position);">17,769<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 234pt; position: var(--position); top: 210.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.16pt;"></span></span><span style="left: 25.79pt; position: var(--position);">17,769<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 210.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 210.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387.75pt; position: var(--position); top: 210.75pt; width: 51.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 51.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.44pt;"></span></span><span style="left: 41.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 439.5pt; position: var(--position); top: 210.75pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.69pt;"></span></span><span style="left: 37.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 399.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NED Share Ownership Requirements: Since July 2022, the company has operated a minimum Non-Executive Director share ownership requirement (NED <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 407.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SOR) of at least one times the standard NED annual fee (or the Chair&#8217;s fee) to be maintained until after retirement. from the Board. The Chair and Non-<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 415.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors have transitioned from the previous NED share allocation plan (NED Plan) to purchasing shares and ADSs in the market from their net <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 424.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees. The company provides an arrangement so that they can use their net fees to purchase GSK shares or ADSs in the market.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 434.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total directors&#8217; interests include beneficial interests and any notional shares/ADS received as all or part of their fees under the previously operated NED <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 443.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plan. Dividends received on notional shares/ADS under the prior NED Plan during the year and in January 2025 were converted into notional shares/ADS <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 451.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as at 9 February 2025. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 461.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Total interests for Dr Barron have reduced since 31 December 2024 following the vesting of DABP awards granted to him in his former executive <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 470.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capacity as CSO. The DABP vest relates to the deferral of shares from the 2022 annual bonus. On vesting, shares are sold to meet an executive's tax <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 478.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities. Details of his transition from CSO to a Non-Executive Director are given on page 135 of the 2022 Annual Report <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 489.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beneficial interests includes shares/ADS held by the Non-Executive Directors and their PCAs<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 499.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">No<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 74.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tional shar<span style="display: inline-block; height: 5.09pt;"></span><span id="i10596c5c84ac403fa9b751bce52bbabf_4469"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 106.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">es/ADS allocated during the year under the NED plan relates to dividends reinvested during the year<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 509.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urs Rohner retired from the Board on 8 May 2024 <span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">162<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_325"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage change in remuneration of Directors<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 146.14pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 77.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 24.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 23.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 24.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 23.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 27.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 0pt; width: 79.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 percentage change<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 0pt; width: 78.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 78.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023 percentage change<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 0pt; width: 77.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 77.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022 percentage change<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 0pt; width: 75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2021 percentage change<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 0pt; width: 81pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 81pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020 percentage change<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 12pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.84pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.849999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 12pt; width: 27pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.599999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 12pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.849999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 12pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.84pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.849999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 12pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 12pt; width: 24.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 24.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 24.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 12pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.84pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 12pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.849999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 12pt; width: 23.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.850000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 12pt; width: 24.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.84pt; width: 24.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 24.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 24.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 12pt; width: 27pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.599999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 12pt; width: 23.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 23.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.850000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 12pt; width: 27pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.84pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 27pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.599999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 12pt; width: 26.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 26.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.849999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 12pt; width: 27.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.64pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonus<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.44pt; width: 27.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.349999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 77.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK employees<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 48.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 38.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 38.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 11pt; position: var(--position);">(0.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 38.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(16.0)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 38.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">7.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">0.92<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 38.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 7.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 7.07pt; position: var(--position);">34.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.21pt; position: var(--position);">3.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 38.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">2.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 296.25pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">44.81<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 38.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 11.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 11.21pt; position: var(--position);">2.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 38.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 38.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.57pt; position: var(--position);">4.85<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 38.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.46pt; position: var(--position);">2.5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 38.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 38.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">11.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 103.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 103.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 63.779999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2,3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 61.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 61.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.86pt; position: var(--position);">(15.1)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 61.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(24.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 61.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">61.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 61.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 7.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 7.07pt; position: var(--position);">20.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.21pt; position: var(--position);">3.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 61.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.25pt; position: var(--position);">(2.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 61.5pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.57pt; position: var(--position);">38.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 61.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 11.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 11.21pt; position: var(--position);">2.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 61.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 11pt; position: var(--position);">(5.0)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 61.5pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.57pt; position: var(--position);">94.6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 61.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.46pt; position: var(--position);">8.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 61.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(26.6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 61.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 7.61pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 7.61pt; position: var(--position);">(33.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 73.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 77.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 38.199999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 73.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.57pt; position: var(--position);">55.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 73.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.32pt; position: var(--position);">28.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 73.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.57pt; position: var(--position);">15.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 73.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 73.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 73.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 73.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 73.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 73.5pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 73.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 73.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 73.5pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 73.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 73.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 73.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="6" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 186.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 186.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 79.89999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2,3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jonathan Symonds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">3.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 99pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.86pt; position: var(--position);">(43.3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">5.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 99pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.93pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.93pt; position: var(--position);">200.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 99pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 99pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.21pt; position: var(--position);">0.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">233.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 99pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 99pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 99pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.32pt; position: var(--position);">50.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 99pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 99pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.18pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.18pt; position: var(--position);">201.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 13.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 99pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.17pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 113.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elizabeth Anderson<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 113.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.57pt; position: var(--position);">10.5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 113.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.32pt; position: var(--position);">96.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 113.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 113.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">209.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 113.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 113.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 113.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 113.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 113.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 113.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 113.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 113.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 113.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 113.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 113.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charles Bancroft<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 125.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.4<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 125.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.86pt; position: var(--position);">(10.7)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 125.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 125.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">2.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 125.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.93pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.93pt; position: var(--position);">180.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 125.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 125.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">36.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 125.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">100.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 125.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 125.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.93pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.93pt; position: var(--position);">156.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 125.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 125.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 125.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 125.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 125.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 77.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 45.199999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 137.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">5.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 137.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.86pt; position: var(--position);">(15.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 137.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 137.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">127.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 137.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.93pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.93pt; position: var(--position);">609.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 137.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 137.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 137.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 137.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 137.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 137.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 137.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 137.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 137.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 137.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 149.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Anne Beal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 149.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.2<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 149.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.32pt; position: var(--position);">70.6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 149.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 149.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">2.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 149.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.93pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.93pt; position: var(--position);">126.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 149.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 149.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.93pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.93pt; position: var(--position);">121.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 149.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 149.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 149.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 149.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 149.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 149.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 149.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 149.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 161.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">417.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 161.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.18pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.18pt; position: var(--position);">200.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 161.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 161.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 161.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 161.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 161.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 161.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 161.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 161.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 161.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 161.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 161.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 161.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 161.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Dietz<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 173.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 173.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 13.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 13.46pt; position: var(--position);">2.5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 173.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 173.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.25pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.25pt; position: var(--position);">(3.4)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 186.75pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">1900.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 173.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 173.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 173.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 173.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 173.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 173.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 173.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 173.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 173.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 173.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jesse Goodman<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 185.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">4.5<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 185.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 11pt; position: var(--position);">(2.3)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 185.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 185.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(27.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 185.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">41.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 185.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 185.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">11.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 185.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.57pt; position: var(--position);">34.8<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 185.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 185.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.75pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.75pt; position: var(--position);">(5.6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 185.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.0<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 185.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 185.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.86pt; position: var(--position);">(12.5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 185.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(65.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 185.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 197.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Jeannie Lee<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 197.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 197.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 197.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 197.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 197.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 197.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 197.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 197.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 197.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 197.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 197.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 197.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 197.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 197.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 197.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 209.25pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Vishal Sikka<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 209.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.71pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.71pt; position: var(--position);">9.7<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 209.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.32pt; position: var(--position);">92.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 209.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 209.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">131.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 209.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 209.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 209.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 209.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 209.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 209.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 209.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 209.25pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 209.25pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 16.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 16.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 209.25pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 209.25pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="4" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 221.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 156.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired Non-Executive Directors<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 232.5pt; width: 77.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 77.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urs Rohner<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 77.25pt; position: var(--position); top: 232.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(64.6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 103.5pt; position: var(--position); top: 232.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.86pt; position: var(--position);">(57.5)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 232.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 160.5pt; position: var(--position); top: 232.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.57pt; position: var(--position);">12.6<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 232.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 10.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 10.07pt; position: var(--position);">73.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 214.5pt; position: var(--position); top: 232.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 242.25pt; position: var(--position); top: 232.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 14.21pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 14.21pt; position: var(--position);">5.9<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 232.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.43pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.43pt; position: var(--position);">109.1<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 296.25pt; position: var(--position); top: 232.5pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 232.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.75pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.75pt; position: var(--position);">(5.6)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 232.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 5.18pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 5.18pt; position: var(--position);">175.0<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 232.5pt; width: 23.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 23.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 12.57pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 12.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 406.5pt; position: var(--position); top: 232.5pt; width: 27pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 9.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 9.32pt; position: var(--position);">16.3<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 232.5pt; width: 26.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 6.11pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 6.11pt; position: var(--position);">(69.2)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 459.75pt; position: var(--position); top: 232.5pt; width: 27.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 27.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 17.07pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 17.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 401.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This table is provided in accordance with Schedule 8 of The Companies (Directors&#8217; Remuneration Policy and Directors&#8217; Remuneration Report) <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 409.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regulations 2020. The UK employee population was considered to be the most relevant comparison as it most closely reflects the economic environment <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 418.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">encountered by the Executive Directors <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 428.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage changes have been calculated based on the <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 245.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 261.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Total remuneration table on page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 366.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i6c0b125e757a4ea89adb5df88b7e0ee7_0-0-1-1-821446">144</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 377.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for Executive Directors and the <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 476.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 491.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Total fees table <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 436.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on page<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 95.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 97.85000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib1f74dd452d544b7af7eb3f6b9f156c5_0-0-1-1-825086">159</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 109.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for Non-Executive Directors<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 447.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further information on Executive Directors&#8217; salary and benefits can be found on page <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 332.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_307">145</a><span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 457.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown joined the company on 3 April 2023. Her 2023 base salary of &#163;915,335 was prorated to reflect the time she worked as CFO Designate until 1 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 466.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">May 2023 and as CFO until 31 December 2023<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 476.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 70.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dr Hal Barron transitioned to a Non-Executive Director role on 1 August 2022 <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: absolute; top: 507.73pt;" id="idc89fa1ee07645df9629d157a4b46752_328"></div><div style="position: var(--position); top: 507.73pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors and Senior Management<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 540.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further information is provided on compensation and interests of Directors and Senior Management as a group (the group). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 550.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For this purpose, the group is defined as the Executive and Non-Executive Directors, other members of the GLT and the Company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Secretary. For the financial year <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 174.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the following table sets out aggregate remuneration for the group for the periods during <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 571.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which they served in that capacity. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 586.97pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 399.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 88.5pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 399.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 399.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 331.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration for <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 382.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 0pt; width: 88.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 88.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 82.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 399.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 399.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total compensation paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 12pt; width: 88.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 48.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31,954,832<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 399.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 399.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aggregate increase in accrued pension benefits (net of inflation)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 24pt; width: 88.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 63.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12,530<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 399.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 399.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aggregate payments to defined contribution schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 399.75pt; position: var(--position); top: 36pt; width: 88.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 88.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,366,412<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 645.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, members of the group were awarded shares and ADS under the company&#8217;s various LTI plans, as set out in the table <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below. To align the interests of Senior Management with those of shareholders, Executive Directors and GLT members are required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 666.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to build and maintain significant holdings of shares in GSK over time. GLT members are required to hold shares to an equivalent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 676.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiple of two times their base salary, and must continue to satisfy these share ownership requirements for a minimum of 12 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 686.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">months after leaving GSK. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 702.35pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 56.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 4.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 87.75pt;"/></tr><tr style="height: 9pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.02pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 66.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 0pt; width: 178.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.02pt; width: 178.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 89.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend reinvestment awards<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 10.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 9pt; width: 159.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.77pt; width: 159.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 96.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awarded during <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 142.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 9pt; width: 56.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.77pt; width: 56.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 9pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.77pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 9pt; width: 90.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.77pt; width: 90.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 67.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 9pt; width: 87.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.77pt; width: 87.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 71.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 19.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Share Plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 19.5pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.33pt;"></span></span><span style="left: 19.959999999999997pt; position: var(--position);">2,106,865<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 19.5pt; width: 90pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.41pt;"></span></span><span style="left: 64.03999999999999pt; position: var(--position);">57,636<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 19.5pt; width: 90.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 58.02pt;"></span></span><span style="left: 60.650000000000006pt; position: var(--position);">269,308<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 19.5pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.3pt;"></span></span><span style="left: 65.92999999999999pt; position: var(--position);">6,409<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 159.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred Investment Awards<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 93.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1,2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 32.25pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 42.94pt;"></span></span><span style="left: 45.57pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 32.25pt; width: 90pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 76.69pt;"></span></span><span style="left: 79.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 32.25pt; width: 90.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.3pt;"></span></span><span style="left: 68.92999999999999pt; position: var(--position);">7,490<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 32.25pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 69.49pt;"></span></span><span style="left: 72.11999999999999pt; position: var(--position);">169<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 159.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share Value Plan<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 57.099999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 159.75pt; position: var(--position); top: 45pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.66pt;"></span></span><span style="left: 30.29pt; position: var(--position);">10,050<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 45pt; width: 90pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 76.69pt;"></span></span><span style="left: 79.32pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 45pt; width: 90.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 90.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 77.44pt;"></span></span><span style="left: 80.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 401.25pt; position: var(--position); top: 45pt; width: 87.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 74.44pt;"></span></span><span style="left: 77.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 770.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notional shares and ADS <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 781.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors are not eligible to receive Deferred Investment Awards or participate in the Share Value Plan <span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">163<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors and Senior Management continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At&#160; 20 February 2025, <span style="display: inline-block; height: 6.18pt;"></span><span id="iabcd5cf9399549a4a000f23e7510cc29_2541"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the group and their PCAs had the following interests in shares and ADS of the company. Interests awarded <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the various LTI plans are described in Note 45 to the financial statements, &#8216;Employee share schemes&#8217; on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_526">262</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i64d01e803b4c4157a1b84355aaad07bc_4545">263</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 532.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 139.48pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 363.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 63pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 363.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.94pt; width: 363.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 276.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interests at <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 309.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 317.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> February 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 0pt; width: 63pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 63pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 363.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 363.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Owned<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 12pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4,351,616<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 12pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">700,013<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 363.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 363.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unexercised options<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 24pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4,810<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 24pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 363.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 363.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred Annual Bonus Plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 35.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,414,721<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 35.25pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">42,027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 363.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 363.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Share Plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 46.5pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8,095,450<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 46.5pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">302,840<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 363.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 363.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred Investment Awards<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 93.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1,2)<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 103.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 57.75pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">76,815<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 57.75pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 41.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,439<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 363.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 363.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share Value Plan<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 57.099999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363.75pt; position: var(--position); top: 69pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20,100<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 426.75pt; position: var(--position); top: 69pt; width: 63pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 63pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8212;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 231.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notional shares<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 242.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors are not eligible to receive Deferred Investmen<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 266.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">t Awards or p<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 306.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">articipate in the Share Value Plan<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 270.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors&#8217; external appointments<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 297.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company recognises that Executive Directors may be invited to become non-executive directors of other companies. Such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointments can broaden their knowledge and experience to the benefit of the company. Executive Directors are entitled to retain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any fees received from such appointments. Emma Walmsley is an independent non-executive director of Microsoft Corporation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown is an independent non-executive Director of Diageo plc. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 354.21pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i42ae43ba5a88405f9f9aca9b6db79026_0-0-1-1-824464"></span><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Service contracts and letters of appointment<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 381.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below sets out the dates of the Executive Directors&#8217; service contracts, which are available at the company&#8217;s registered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">office and on gsk.com.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 407.3pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 56.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 56.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 56.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 66pt; position: var(--position); top: 0pt; width: 56.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 56.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Date of contract<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 122.25pt; position: var(--position); top: 0pt; width: 56.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 56.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Effective date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 178.5pt; position: var(--position); top: 0pt; width: 56.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 56.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expiry date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emma Walmsley<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 66pt; overflow: hidden; position: var(--position); top: 12pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">29.03.17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 122.25pt; overflow: hidden; position: var(--position); top: 12pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">01.04.17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 178.5pt; overflow: hidden; position: var(--position); top: 12pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30.06.34<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 66pt; overflow: hidden; position: var(--position); top: 24pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25.09.22<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 122.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">01.05.23<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 178.5pt; overflow: hidden; position: var(--position); top: 24pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 453.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors have letters of appointment, which are also available to view at the company&#8217;s registered office. Each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Director is expected to serve on the Board until the end of the AGM following the third anniversary of their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 474.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointment, provided that they are elected and subsequently re-elected annually. Subject to mutual agreement, they may serve a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 484.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further one or two, three year terms, depending on the needs of the Board.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">164<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_331"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 488.25pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ib53d0916fdcf4cfe8e886ba14c69b0b1_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 488.25pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 488.25pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy <span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration poli<span style="display: inline-block; height: 8pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_28337"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 148.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">cy renewal<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our current Remuneration policy (policy) was approved by our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders at our Annual General&#160; Meeting on 4 May 2022 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when it received a 61.76% vote in favour. Shareholders are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being asked to approve a new policy at our Annual General <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meeting on 7 May 2025 which is intended to apply for the next <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three years.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2024, the Committee considered the policy to define the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma business&#8217; new approach to remuneration. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decision-making engagement process that the Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">followed for its determination, review and implementation of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposed new policy are set out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9661dafaf5fc49f8aa6d69d81c1d2708_24120">135</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2fdae0fcc1cf47049ec85bb2c40664fd_456">142</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 251.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee&#8217;s review of the policy sought to:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incentivise the delivery of the company&#8217;s Ahead Together <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy and 2031 growth strategy<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reinforce the company&#8217;s pay for performance, particularly in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over delivery <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enable retention and attraction of talent as a global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma company and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">create headroom to deliver market competitive reward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">throughout the organisation<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition, changes to the policy have been made to ensure its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implementation will support the delivery of our business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy whilst delivering a clear, understandable and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriately globally competitive package to attract, retain and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">motivate executive talent.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee developed the new policy for Executive and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors in the context of its oversight of wider <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">workforce pay, not directly with employees. It sought employee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insights from the Chief People Officer and senior Human <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Resources Leaders. It consulted with our largest shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in respect of the proposed changes and took shareholders&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 285.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback into account when finalising the new policy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The full policy that shareholders are asked to approve is set out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below on this page to page<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28009">172</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 327.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subject to shareholder approval on 7 May 2025 at GSK's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 337.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual General Meeting, the Remuneration policy for each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration element will be as outlined in the table below.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 408.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Future policy table<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 424.57pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 336pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Salary<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 18.52pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">&#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 336pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">To provide a core reward for the role. Set at a level appropriate to secure and retain high calibre <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">individuals needed to deliver the Group&#8217;s strategic priorities.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 54pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.11pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 463.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operation<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Individual&#8217;s role, experience, performance and independently <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sourced data for relevant comparator groups considered when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determining salary levels.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 512.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary increases typically take effect in the first quarter of each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salaries are normally paid in the currency of the Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director&#8217;s home country.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 564.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 578.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ther<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 71.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e is no form<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">al maximum limit and, ordinarily, salary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 588.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increases will be broadly in line with the average increases for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 598.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the wider GSK workforce.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">However, increases may be higher to reflect a change in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scope of the individual&#8217;s role, responsibilities or experience. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary adjustments may also reflect wider market conditions in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 507.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the geography in which the individual operates and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 517.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outperformance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 533.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of current salary levels are set out in the Annual report <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 543.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on remuneration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 559.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 572.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The overall performance of the individual is a key consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 582.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when determining salary increases.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 630.64pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 336pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Benefits<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 18.52pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 336pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Levels are set to recruit and retain high calibre individuals to execute the business strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 54pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.11pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 669.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operation<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors are eligible to receive benefits in line with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the policy for other employees which may vary by location.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These include, but are not limited to, car allowances, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 718.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare, life assurance/death&#160; in service (where not provided <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 729.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as part of the individual&#8217;s pension arrangements), personal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 739.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial advice and contractual post-retirement benefits. In line <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 749.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the policy for other employees, Executive Directors may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 759.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eligible to receive overseas relocation allowances and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 769.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">international transfer-related benefits when required. Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 780.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors in the UK are also eligible to participate in all-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 790.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employee share schemes (e.g. Share Save and Share Reward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 669.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plan), under which they are subject to the same terms as all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other employees.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 695.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To recognise the high business travel requirements of the role, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 705.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors are also entitled to car travel and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 715.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceptionally may be accompanied by their spouse/partner on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 725.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business trips. Other benefits include expenses incurred in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 735.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ordinary course of business, which are deemed to be taxable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 746.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits on the individual.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 762.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">W<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">here an Executive Director is based outside the UK, but is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 772.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required to travel to the UK to fulfil the responsibilities of their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 782.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">role and to attend Board Meetings, they may be subject to tax&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 792.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on their business travel expenses to and from the UK and on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 802.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the provision of any accommodation in the UK. Although in <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">165<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reality it represents a business expense, the tax treatment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requires that their travel and accommodation expenses are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">then included as benefits. Because of the business context, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax liabilities will be covered by the company on a grossed-up <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefit provision is tailored to reflect market practice in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">geography in which the Executive Director is based and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">different policies may apply if current or future Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors are based in a different country.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 126.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There is no formal maximum limit as benef<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its costs can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 137.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fluctuate depending on changes in provider cost and individual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 147.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 163.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of current benefits and costs are set out in the Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report on remuneration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 189.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance measure<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">None<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 218.64pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 336pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pension<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 336pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Pension arrangements provide a competitive level of retirement income.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 54pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.11pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 247.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operation<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 261.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension arrangements are structured in accordance with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 271.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plans operated in the country<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in which the individual is likely to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retire. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 297.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where the Executive Director chooses not to become a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">member of the pension plan the approach differs depending on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the country in which the individual is located. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 333.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where an individual is a member of a GSK legacy defined <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefit plan, a defined contribution plan or an alternative <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 354.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pension plan arrangement and is subsequently appointed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board, he or she may remain a member of that plan.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 380.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From the date of appointment, all new UK Executive Directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receive: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7% of base salary contribution to defined contribution plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and a further 3% in matched contributions subject to any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant cap and in line with implementation principles for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 460.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other members of the plan; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7% of base salary as a cash payment in lieu of pension <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 481.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution for the portion above the relevant cap;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: underline; white-space: pre;">or<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 504.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 7% of base salary as a cash payment in lieu of pension <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 514.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From the date of appointment, all new US Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors will participate in the GSK 401(k) plan<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 489.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(1) <span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 497.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Supplemental Savings Plan (ESSP)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 485.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(1) <span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with core <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contributions of 7% of base salary and bonus<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 480.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and matched <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contributions of 4% of base salary and bonus<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 480.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 325.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If the Executive Director chooses not to make a contribution <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the 401(k) and/or ESSP, there is no cash payment in lieu <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of pension contribution. GSK will continue to provide the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 356.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant core contributions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 378.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Eligible for appropriate equivalent arrangement not in excess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the US/UK arrangements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 426.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">None.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 456.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160; In the event of any change to the plans operated in the US, a similar <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 464.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment would be provided under any successor arrangements <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 473pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">introduced within the market<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 483.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2) Less bonus deferred under the DABP<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: var(--position); top: 525.78pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 336pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54pt;"/></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Annual bonus<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30.75pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 336pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">To incentivise and recognise execution of the business strategy on an annual basis. Rewards the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">achievement of stretching annual financial, pipeline, strategic, operational and trust measures.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 54pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.11pt; position: var(--position); text-decoration: none; white-space: pre;">Change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 563.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operation<span style="display: inline-block; height: 6.55pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_27988"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 577.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial, operational and business targets are set at the start <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 587.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the year by the Committee and bonus levels are determined <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 597.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Committee based on performance against those targets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strategic, operational and Responsible Business measures are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set at the start of the year by the Committee and performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 633.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against those measures is assessed by the Committee and, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 643.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where appropriate, with the Corporate Responsibility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 654.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 670pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors are required to defer part of any bonus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 680.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earned into shares, or ADS as appropriate, for three years. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 690.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50% of the equivalent of the first 200% of salary is deferred, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 700.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and any portion in excess of 200% is deferred in full. Deferred <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bonus shares are eligible for dividend equivalents up to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 721pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date of vesting.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 736.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee may adjust the formulaic vesting outcome <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 747.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(either up or down) to ensure that the overall outcome reflects <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 757.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying business performance over the vesting period. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 767.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cla<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 66.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wback and/or malus provisions apply as described on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 777.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pages<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 76.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27993">166</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27983">167</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 563.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 577.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The maximum bonus opportunity for Executive Directors is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 587.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">300% of salary. Below 99% of target performance, the bonus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 597.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payout on the financial measures will be nil. For target <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 607.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance, the bonus payout will be 150% of salary for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 617.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO and 100% of salary for the CFO.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 633.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Based on a combi<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nation of financial, operational and business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 657.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets with at least 50% of the bonus assessed against the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 667.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial measures. The weighting between different measures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 677.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will be determined each year according to business priorities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 688pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further details, including the measures to be used in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 698.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial year, are provided in the Annual report on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 724.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selection of annual bonus measures<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 734.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The annual bonus is designed to drive the achievement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 744.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s annual financial, strategic and operational measures. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 754.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The annual bonus opportunity is based on a formal review of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance against the prevailing targets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 780.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The annual bonus financial targets are set by reference to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 791.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal budget and external consensus targets.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">166<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 336pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54pt;"/></tr><tr style="height: 39.75pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 97.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Performance<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.83pt; width: 97.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 5.74pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 35.879999999999995pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Plan (PSP)<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 97.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 336pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.87pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">To incentivise and recognise delivery of the longer term business priorities, financial growth and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.24pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">increases in shareholder value compared to other global biopharma companies. In addition, to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.61pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">provide alignment with shareholder interests, a retention element, to encourage long-term <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.98pt; width: 336pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">shareholding and discourage excessive risk taking.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 433.5pt; position: var(--position); top: 0pt; width: 54pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.11pt; position: var(--position); text-decoration: none; white-space: pre;">Change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 163.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Op<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 66.21pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">eration<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 177.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Conditional awards are made annually with vesting dependent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the achievement of performance conditions over three years <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and are subject to an additional two-year holding period. PSP <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets are set by reference to internal budget and external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consensus targets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards are eligible for dividend equivalents up to the date of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesting and release.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee may adjust the formulaic vesting outcome <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(either up or down) to ensure that the overall outcome reflects <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying business performance over the vesting period.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clawback and/or malus provisions apply as described on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27993">166</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.78999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27983">167</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 322.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opportunity<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The normal maximum award limits that may be granted under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the PSP to an individual in any one year are set out in the table <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 372.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 237pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 150pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 87pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 0pt; width: 87pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 87pt;"><span style="font-family: 'Tahoma', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 51.62pt; position: var(--position); white-space: pre;">% of salary<span style="display: inline-block; height: 4.97pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 150pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">CEO<span style="display: inline-block; height: 5.62pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 11.25pt; width: 87pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87pt;"><span style="color: #000000; font-family: 'Calibri', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.97pt; position: var(--position); text-decoration: none; white-space: pre;">800<span style="display: inline-block; height: 5.62pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 150pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.25pt; position: var(--position); white-space: pre;">CFO<span style="display: inline-block; height: 5.62pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 23.25pt; width: 87pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.97pt; position: var(--position); white-space: pre;">400<span style="display: inline-block; height: 5.62pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 150pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 150pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.25pt; position: var(--position); white-space: pre;">Other Executive Director<span style="display: inline-block; height: 5.62pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 35.25pt; width: 87pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 87pt;"><span style="font-family: 'Calibri', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.97pt; position: var(--position); white-space: pre;">500<span style="display: inline-block; height: 5.62pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 163.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 177.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Based on a combination of financial, share price related and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic and Responsible Business performance conditions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which are aligned to the company&#8217;s strategic plan. For all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures, 25% of awards will vest at threshold performance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">except for the CEO where awards will vest at 20% for threshold <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance. Further details, including the performance targets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attached to the PSP in respect of each year, and the weightings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the targets for the 2025 PSP awards are provided in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 274.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Selection of long-term incentive measures<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee selects performance measures which focus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors&#8217; long-term remuneration on the delivery of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s key strategic priorities <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over the longer term and which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">align to shareholder experience. In addition to setting robust <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">targets, the Committee has implemented a number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">safeguards to ensure the targets are met in a sustainable way <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and performance reflects genuine achievement against targets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and therefore represents the delivery of value for shareholders.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For each performance measure, the impact of any acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or divestment may be quantified and adjusted for after the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">event. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 411.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Any major adjustment in the calculation of performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures will be disclosed to shareholders on vesting.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Audit &amp; Risk Committee chair and other members, who are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 448.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also members of the Committee, provide input on the Audit &amp; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Committee&#8217;s review of the Group&#8217;s performance and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">oversight of any risk factors relevant to remuneration decisions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 484.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of the rationale behind the performance measures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">selected and how they are calculated are set out in the Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 504.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report on remuneration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 520.75pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Share Ownership Requirements<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 168.36pt; position: var(--position); text-decoration: none; white-space: pre;">Change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To align the interests of Executive Directors with those of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders, they are required to build and maintain significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holdings of shares in GSK over time. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a minimum, Executive Directors are required to maintain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100% of their share ownership requirements for two years after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retirement from the company. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors&#8217; Share Ownership Requirements have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been reset to match their current annual PSP award level.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 646.6pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Clawback and malus<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.36pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The various incentive plans<span style="display: inline-block; height: 6.18pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_27993"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> include broad discretion when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing the outturn to consider wider factors and reduce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 693.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">levels accordingly. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the event of a &#8216;triggering event&#8217; (i.e. significant misconduct by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 719.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">way of violation of regulation, law, a significant GSK policy, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 729.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as the Code of Conduct, or a material misstatement or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 739.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restatement of results, or serious reputational damage), the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 749.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company will have the ability to claw back up to three years&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 759.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual and deferred bonuses as well as vested and unvested <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 770.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LTIs. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 786.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK may specify additional &#8216;triggering events&#8217; and/or different <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 796.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clawback periods where required to do so by regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements, including the rules of any government or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory authority or relevant securities exchange. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition, in respect of PSP awards<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> made from 2020<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, if a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">participant is subject to an investigation, then the vesting of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 719.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their awards may be delayed until the outcome of that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 729.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 745.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A separate Recoupment Committee has been established to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 755.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigate relevant &#8216;triggering events&#8217;. The Recoupment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee exercises this authority for the wider employee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 775.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">base. It comprises of senior executives with relevant oversight <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 786.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and appropriate experience, including the Senior Vice <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">167<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President,&#160; Chief Compliance Officer, and the Senior Vice <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">President and Group General Counsel, Legal and Compliance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In respect of each financial year, the Committee will disclose <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether it (or the Recoupment Committee) has exercised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clawback or malus. Disclosure will be made as required by law, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulation or the rules of any relevant securities exchange, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">otherwise only when the matter has been subject to public <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports of misconduct, where it has been fully resolved, where it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is legally permissible to disclose and where it can be made <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">without unduly prejudicing the company and therefore <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additionally, where there has been continuity of responsibility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between initiation of an adverse event and its emergence as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">problem, the adverse event should be taken into account in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing annual bonus awards and LTI vesting levels&#160; in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year the problem is identified and for future periods. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee (or Recoupment Committee) may make appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustments to individual annual bonuses as well as grant and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesting levels of LTI awards to reflect this.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 236.97pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Approach to recruitment remuneration<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.36pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 268.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee determines the remuneration package of new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors on a case-by-case&#160; basis&#160; depending&#160; on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the role, the market from which they will operate and their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience. Total remuneration levels will be set by reference to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a relevant pay comparator group and, where appropriate, will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allow for future development in the role.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It is expected that new Executive Directors will participate in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">short and long-term incentive plans on the same basis as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing directors. However, in exceptional circumstances, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee reserves the flexibility to set the incentive limit for a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 376.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new Executive Director at up to an additional 50% of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing limits.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 402.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee retains this flexibility in recognition of the high <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 412.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">levels of variable pay in GSK&#8217;s global pharmaceutical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitors. However, the Committee will only use this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flexibility when it is considered to be in the best interests of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company and its investors.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 459.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension arrangements for any external recruit as an Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 469.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director will be as set out in the Remuneration policy table on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 74.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27988">165</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 88.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other benefits will be provided in line with the policy for existing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where required and deemed appropriate by the Committee, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 531.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs of financial planning, legal and tax advice may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reimbursed.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where required to meet business needs, relocation support will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be provided in line with company policy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For any internal appointments, entitlements under existing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration elements will continue, including pension <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 315.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entitlements and any outstanding awards. However, where not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 325.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">already the case, internal appointments will be required to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">move to Executive Director contractual terms, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">termination provisions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee is mindful of the sensitivity relating to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recruitment packages and, in particular, the &#8216;buying out&#8217; of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights relating to previous employment. It will therefore seek to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 392.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">minimise such arrangements. However, in certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 402.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances, to enable the recruitment of exceptional talent, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 412.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Committee may determine that such arrangements are in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the best interests of the company and its shareholders. Such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements will, where possible, be on a like-for-like basis <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the forfeited remuneration terms. Arrangements will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 453.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therefore vary depending on the plans and arrangements put in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 463.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">place by the previous employer and may be in the form of cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or shares and may or may not be subject to performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 484.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions. Explanations will be provided where payments are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made as compensation for previous remuneration forfeited.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 510.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The remuneration arrangements for any newly appointed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 520.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director will be disclosed as soon as practicable after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 530.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the appointment.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 594.09pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Loss of office payment policy<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.36pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company does <span style="display: inline-block; height: 6.18pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_27983"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not have a policy of fixed term contracts. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Generally, contracts for new appointments will expire in line <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 646.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the applicable policy on retirement age, which since 2009 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 656.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has been 65.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contracts for existing Executive Directors will expire as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable on the dates shown on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i42ae43ba5a88405f9f9aca9b6db79026_0-0-1-1-824464">163</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.98000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notice period on termination by the employing company or the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Director is 12 calendar months. Where required and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 646.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deemed appropriate by the Committee when recruiting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 656.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">externally, an initial notice period of 2 years may be applied, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 666.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reducing to 12 calendar months over one year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The ability to impose a 12-month non-compete period (and a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-solicitation restriction)&#160; on an Executive Director is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 702.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered important by the company to have the ability to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 713.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protect the Group&#8217;s intellectual property and staff. In light of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this, the Committee believes that it would not be appropriate to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide for mitigation in the contracts.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">168<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Termination of employment<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the event that an Executive Director&#8217;s employment with the company terminates, the following policies and payments will apply.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 145.17pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 113.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 374.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Element of Remuneration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 374.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Loss of office payment policy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 77.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 77.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Termination payment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 77.25pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 374.25pt;"><span style="font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); white-space: pre;">Termination by notice:<span style="display: inline-block; height: 7.2pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 74.49pt; position: var(--position); white-space: pre;"> 12 months&#8217; annual salary payable on termination by the company (pro-rated where part <span style="display: inline-block; height: 7.2pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">of the notice period is worked). No termination payment is made in respect of any part of a notice period that <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">extends beyond the contract expiry date.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.24pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">A bonus element is not normally included in the termination payment. However, the terms of the contracts seek <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.61pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">to balance commercial imperatives and best practice.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.48pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Redundancy: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 45.699999999999996pt; position: var(--position); white-space: pre;">As above, for termination by notice. In the UK, only statutory redundancy pay will apply. In the US, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 59.48pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">the general severance policy does not apply.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 68.48pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retirement, death and ill-health, injury or disability:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 165.96pt; position: var(--position); white-space: pre;"> No termination payment.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 77.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 77.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LTI awards<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 77.25pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">PSP awards are governed by the plan rules as approved by shareholders. The following provisions will normally <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">apply:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Termination by notice:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.03pt; position: var(--position); white-space: pre;"> Unvested awards will lapse.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Redundancy, retirement, death, ill-health, injury, disability or any other reason:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 255.29000000000002pt; position: var(--position); white-space: pre;"> Generally, awards will continue to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 39.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">vest over the original timescales subject to performance and normally pro-rated for time.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 48.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">In the event of a change of control, PSP awards will vest, taking into account performance to date and normally <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 58.24pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">taking into account the proportion of the performance period that has elapsed. Alternatively, the awards may be <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 67.61pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">exchanged for new awards.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual bonus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Termination by notice by individual: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 116.98pt; position: var(--position); white-space: pre;">If an individual serves notice and the termination date falls before 31 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">December, the bonus is forfeited.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Termination by notice by the company, redundancy, retirement, death, ill-health, injury or disability:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 321.33pt; position: var(--position); white-space: pre;"> If the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">termination date falls during the financial year, eligible for pro-rated on-target bonus (if employed on 31 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">December, bonus payable based on actual results).<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 59.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 59.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 213pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mandatorily deferred bonus <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the DABP<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 59.25pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 213pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">DABP deferred bonus awards in respect of mandatorily deferred bonus amounts are governed by the plan rules <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">as approved by shareholders. The following provisions will normally apply:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Termination for gross misconduct: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 112.89pt; position: var(--position); white-space: pre;">Generally, unvested awards will lapse<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Any other reason:<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 58.449999999999996pt; position: var(--position); white-space: pre;"> Generally, awards will vest in full on the original vesting date.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 39.87pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">In the event of a change of control, awards will vest or may be exchanged for new awards.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 374.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Pension scheme contributions by the individual and the company, and any pension scheme benefit accruals, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 374.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">generally cease at the termination date in accordance with pension scheme rules. Access to pension scheme <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 374.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">benefits is governed by the pension scheme rules and country legislation.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 68.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 302.25pt; width: 113.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 113.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 68.25pt; left: 113.25pt; overflow: hidden; position: var(--position); top: 302.25pt; width: 374.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Generally, benefits will continue to apply until the termination date. The Committee may make payments in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">connection with an existing legal obligation or in respect of any claim related to the cessation of employment. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">This may include fees for outplacement assistance, legal and/or professional advice.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.24pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Termination by notice by the company and retirement (US executives): <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 233.06pt; position: var(--position); white-space: pre;">In line with the policy applicable to US <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.24pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">senior executives, they may become eligible, at a future date, to receive continuing medical and dental <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 49.24pt; width: 374.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">insurance after termination/retirement.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 9pt; position: var(--position); top: 526.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Termination by mutual agreement<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In certain circumstances, it can be in the best interests of the company for the Board to manage proactively succession planning <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 550.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the development of the senior talent pipeline. In such circumstances, the Board may therefore agree that an Executive&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">departure will be by mutual agreement. For this to apply, the Committee will need to be satisfied that the Executive has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demonstrated performance in line with expectations and where required they should have contributed to an orderly succession. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the case of an Executive Director, they would then be treated as a &#8216;good leaver&#8217; for the purposes of GSK&#8217;s long-term incentive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 590.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plans. If the termination date falls during the financial year, they would be eligible for a pro-rated on-target bonus and if they are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 601.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employed on 31 December, the bonus payable would be based on actual results.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee does not anticipate the exercise of discretion provided by the PSP and DABP plan rules in respect of termination <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 627.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments in a manner which would benefit an Executive Director. However, there may be unforeseen circumstances where this is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 637.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the best interests of the company and its shareholders. Where it is necessary to exercise discretion, explanations will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 663.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where an Executive Director leaves the company, the Committee will carry out an assessment of the individual&#8217;s performance and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 673.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conduct over the time in role. If it is determined that the individual&#8217;s performance or conduct was contrary to the legitimate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 683.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectations of the company, the Committee reserves the right to apply appropriate mechanisms such as clawback or reduction or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 694.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lapsing of outstanding incentive awards (malus), to ensure that any termination payments are in the best interests of the company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and its shareholders (see pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27993">166</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_27983">167</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">169<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="2" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Differences between Remuneration policy for Executive Directors and other employees<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 145.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When setting remuneration for the Executive Directors, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 155.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee considers the company&#8217;s strategic priorities, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevailing market conditions for global talent, the competitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment (through comparison with the remuneration of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">executives at companies of similar size, complexity and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">international reach) and the positioning and relativities of pay <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and employment conditions across the broader GSK workforce.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In particular, the Committee considers the range of base salary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rises for the workforces of those parts of GSK where the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors are employed. This is considered to be the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">most relevant comparison as these populations reflect most <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 262.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">closely the economic environments encountered by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The same principles apply to the Remuneration policy for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Executive Directors and other employees although the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration offered to Executive Directors under this policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has a stronger emphasis on performance-related pay than that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offered to other employees of the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salary and benefits (including pension) are tailored to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">local market.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The annual bonus plan applies to the wider employee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">population and is based on business performance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 397.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A combination of performance-related and restricted share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plans apply to the wider employee population.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 424.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All-employee share plans are available to employees in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK, including the HM Revenue &amp; Customs approved UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share Save and Share Reward Plans.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees are not directly consulted in respect of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration policy, Wendy Becker, the Committee Chair, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meets with the Chief People Officer and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 454.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">senior HR <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representatives from across the business <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to review employee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">feedback. Board members engage with employees around <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during Board meetings where they are encouraged to share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their views on t<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he company, management and remuneration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the wider organisation, we have aligned our performance&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and reward systems with our strategic priorities and a culture <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anchored in purpose and performance. Our performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">system evaluates employees on both &#8216;what&#8217; they need to do <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 262.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and &#8216;how&#8217; they do it. Also, for our most senior people we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disincentivise unethical working practices using a clawback <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mechanism that allows us to recover performance-related pay.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">170<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; 2025 Non-Executive Director remuneration policy<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.36pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 140.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 56.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 108pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 323.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Element<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 56.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 108pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Purpose and link to strategy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 323.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Operation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 69.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair's fees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69.75pt; left: 56.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 108pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">To provide an inclusive flat rate <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">fee that is competitive with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">those paid by other companies <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">of equivalent size and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 40.11pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">complexity subject to the limits <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 49.48pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">contained in GSK&#8217;s Articles of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 58.85pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Association.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 69.75pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 323.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">There is no formal maximum. However, fees are reviewed annually and set by reference to a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">review of the Chair&#8217;s performance and independently sourced market data.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The Committee is responsible for evaluating and making recommendations to the Board<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.61pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">on the fees payable to the Chair. The Chair does not participate in discussions in respect of their <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.98pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">fees.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 60pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic fees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 56.25pt; overflow: hidden; position: var(--position); top: 81pt; width: 108pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">As above<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 81pt; width: 323.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">There is no formal maximum. As with the Chair, fees are reviewed annually and set by reference <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">to independently sourced data.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The Chair and CEO are responsible for evaluating and making recommendations to the Board <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">on the fees payable to the company&#8217;s Non-Executive Directors.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 141pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fee payment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 56.25pt; overflow: hidden; position: var(--position); top: 141pt; width: 108pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Alignment with shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 141pt; width: 323.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Fees are paid in cash. Non-Executive Directors (including the Chair) are required to build an <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">ownership requirement to hold shares or ADS with an aggregate value at or above one times <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">their standard annual fee until their retirement from the Board.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 108pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 108pt; left: 0pt; overflow: hidden; position: var(--position); top: 171pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplemental <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 108pt; left: 56.25pt; overflow: hidden; position: var(--position); top: 171pt; width: 108pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">To compensate Non-Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Directors (other than the Chair) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">for taking on additional Board <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 30.74pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">responsibilities <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 108pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 171pt; width: 323.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Additional fees for the Senior Independent Director, Committee Chairs, Science &amp; Medical&#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Experts and the Workforce Engagement Director role as applicable.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 31.74pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The company has the authority to pay an additional fee, up to the equivalent of the Committee <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Chair supplement to a Non-Executive Director, should the company require significant additional <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.48pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">time commitment in exceptional or unforeseen circumstances.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 70.22pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The company has the authority to pay an additional fee of up to &#163;200,000 to Non-Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 79.59pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Directors (excluding the Chair) who are members of the Science Committee for undertaking <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 88.96pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">additional responsibilities on behalf of GSK and to support R&amp;D.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 98.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 98.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 279pt; width: 56.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 56.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 98.25pt; left: 56.25pt; overflow: hidden; position: var(--position); top: 279pt; width: 108pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">To facilitate execution of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">responsibilities and duties <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 108pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">required by the role.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 98.25pt; left: 164.25pt; overflow: hidden; position: var(--position); top: 279pt; width: 323.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Travel and subsistence costs for Non-Executive Directors are incurred in the normal course of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">business in relation to meetings on Board and Committee matters and other GSK-hosted events. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 21.37pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">For overseas- based Non-Executive Directors, this includes travel to meetings in the UK.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 41.11pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">In the event it is necessary for business purposes, whilst not normal practice, Non-Executive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 50.48pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Directors may be accompanied by their spouse or partner to these meetings or events. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 70.22pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">The costs associated with the above are all met by the company and, in some instances, they <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 79.59pt; width: 323.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">are deemed to be taxable and therefore treated as benefits for the Non-Executive Director.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 534.84pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Approach to recruitment fees<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.36pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 561.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following policy and principles apply to the roles of Chair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 572.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Non-Executive Director. It seeks to ensure alignment with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 582.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders through the requirement to invest in company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 592.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares and ADS.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 608.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fees will be set at a level that is competitive with those paid by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other companies of equivalent size and complexity.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 561.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fee levels for new Non-Executive Directors will be set on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">same basis as for existing Non-Executive Directors of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company, subject to local laws and regulations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the event of a Non-Executive Director with a different role <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and responsibilities being appointed, fee levels will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benchmarked and set by reference to comparable roles in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 642.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies of equivalent size and complexity.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 658.11pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Loss of office<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 290.25pt; position: var(--position); top: 0pt; width: 197.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 197.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 158.36pt; position: var(--position); text-decoration: none; white-space: pre;">No change<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 689.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Chair and other Non-Executive Directors are not entitled to receive any payments in respect of fees for loss of office when they <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 700pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retire or step down from the Board.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">171<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Scenarios for future total remuneration<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 145.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The charts opposite provide illustrations of the future total <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 155.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration for each of the Executive Directors in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the remuneration opportunity to be granted to each of them in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 under the proposed 2025 Remuneration policy. A range of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential outcomes is provided for each Executive Director and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the underlying assumptions are set out below.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 211.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">All scenarios use:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 225.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 base salary and pension contributions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 benefits figures.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The amounts shown under value of 2025 PSP award <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">multiples are based upon the relevant multiples for 2025. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 280.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fixed:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Includes base salary, pension and benefits. Excludes Pay for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance, ie. no Annual bonus would be paid and PSP <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards would not vest.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 336.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Expected:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Includes Fixed pay.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the Annual bonus, it is assumed that target performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is achieved.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For PSP awards, amounts reflect 50% vesting levels.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 405.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Maximum:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 418.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It is assumed that the Annual bonus would be payable at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 428.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maximum level (i.e. 300% of salary) and that the awards <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 439.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the PSP would vest in full.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 461.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Maximum with 50% share price increase:<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All elements are the same as Maximum but assuming a 50%&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in share price.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 145.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Emma <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 333.95pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Wal<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 349.73pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">msley <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 160.88pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g135.jpg" alt="New Emma Rem graph V3-1.jpg" style="height: 115.58pt; width: 236.78pt;"/></div></div></div><div style="line-height: 9pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="position: var(--position); top: 307.15pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g136.jpg" alt="New Julie Rem graph V2.jpg" style="height: 115.6pt; width: 236.78pt;"/></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">172<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 Remuneration policy report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Operation and scope of Remuneration policy<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 142.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Remuneration policy<span style="display: inline-block; height: 6.18pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_28009"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 147.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (Policy) is set out on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 252.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_331">164</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.28pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28009">172</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of this 2024 Annual Report on Form 20-F and it is intended <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that the Policy for GSK&#8217;s Executive and Non-Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors will operate for a period of three years from the date <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of approval at the company&#8217;s Annual General Meeting on 7 May <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee wrote the Policy principally in relation to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration arrangements for the Executive Directors, whilst <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taking into account the possible recruitment of a replacement or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an additional Executive Director during the operation of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy. The Committee intends the Policy to operate for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period set out above in its entirety. However, it may after due <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 270.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration seek to change the Policy during this period, but <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 280.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">only if it believes it is appropriate to do so for the long-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success of the company, after consultation with shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and having sought shareholder approval at a general meeting.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee reserves the right to make any remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments and/or payments for loss of office (including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 337.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercising any discretions available to it in connection with such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 347.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments) notwithstanding that they are not in line with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy where the terms of the payment were agreed:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(i)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">before the AGM on 7 May 2014 (the date the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first shareholder-approved Directors&#8217; remuneration policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">came into effect);<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 409.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(ii)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">before the Policy came into effect, provided that the terms <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 419.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the payment were consistent with the shareholder-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 430.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved Remuneration policy in force at the time they <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were agreed; or<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 142.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(iii)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at a time when the relevant individual was not a Director of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 152.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company and, in the opinion of the Committee, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payment was not in consideration for the individual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">becoming a Director of the company. For these purposes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;payments&#8217; includes the Committee satisfying awards of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">variable remuneration and, in relation to an award over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares or ADS, the terms of the payment are &#8216;agreed&#8217; at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time the award is granted.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance Share Plan (PSP) awards are subject to the terms <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the PSP plan rules under which the award has been granted. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee may adjust or amend awards only in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the provisions of the plan rules. This includes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 270.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">making adjustments to reflect one-off corporate events, such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 280.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a change in the company&#8217;s capital structure.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 296.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee may also make minor amendments to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Policy (for regulatory, exchange control, tax or administrative <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purposes or to take account of a change in legislation) without <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obtaining shareholder approval for such amendments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 342.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Statement of consideration of shareholder views<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 356.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Committee engages in regular dialogue with shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and holds annual meetings with GSK&#8217;s largest investors to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 376.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discuss and take feedback on its Remuneration policy practices <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and governance matters.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 472.02pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 290.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 197.25pt;"/></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i7d0e439bebbd46f5a2bff3ddf4a345b8_0-0-1-1-823731"></span><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 290.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Basis of preparation<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 503.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.18pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_28334"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_28335"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Annual report on remuneration<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> has been prepared in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the Companies Act 2006 and The Large and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium-sized Companies and Groups (Accounts and Reports)&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Amendment) Regulations 2013 (the Regulations). In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the Regulations, the following parts of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual report on remuneration are subject to audit: total <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remuneration figures for Executive Directors including further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details for each element of remuneration (salary, benefits, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pension, annual bonus and long-term incentive awards);<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-Executive Directors&#8217; fees and emoluments received in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year; Directors&#8217; interests in shares, including interests in GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share plans; payments to past Directors; payments for loss of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">office; and share ownership requirements and holdings, for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which the opinion thereon is expressed in pages 178-181. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remaining sections of the Annual report on remuneration are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not subject to audit nor are the pages referred to from within the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audited sections.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 591pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Annual report on remuneration has been approved by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 601.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board of Directors and signed on its behalf by:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wendy Becker<span style="display: inline-block; height: 6.18pt;"></span><span id="i4838aa2af2e84b87bae8d2fc4f9143cf_28336"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 646.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration Committee Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 656.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25 February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">173<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; report<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_334"></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Directors' powers<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Directors&#8217; powers<span style="display: inline-block; height: 6.18pt;"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5268"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are determined by UK legislation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our Articles of Association, which contain rules about their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointment and replacement. They provide that Directors may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be appointed by an ordinary resolution of the members or by a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resolution of the Board. If appointed by the Board, the Director <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">must retire at the next Annual General Meeting to be elected by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Articles also provide that all Directors are required to seek <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">re-election annually at our Annual General Meeting in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the FRC Code.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A Director will then cease to be a Director if he or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">she:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">becomes bankrupt<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ceases to be a Director by virtue of the Companies Act or the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 291.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suffers mental or physical ill health and the Board resolves <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 301.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that he or she shall cease to be a Director<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has missed Directors&#8217; meetings for a continuous period of six <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">months without permission and the Board resolves that he or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">she shall cease to be a Director<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 344.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is otherwise prohibited from being a Director by law<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resigns, or offers to resign and the Board accepts that offer<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is required to resign by the Board<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 382.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; conflicts of interest<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All Directors have a duty under the Companies Act 2006 to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">avoid a situation in which they have, or could have, a direct or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 418.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indirect conflict of interest or possible conflict with the company. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 428.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Articles provide a general power for the Board to authorise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 439.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such conflicts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board reviews any new potential or actual conflict, which is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recorded by the Company Secretary. Directors are not counted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 475.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the quorum for the authorisation of their own actual or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential conflicts. The Nominations &amp; Corporate Governance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee reviews the Register of Potential Conflicts on an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 506.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual basis which the Board subsequently approves.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 521.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On a continuing basis, the Directors are responsible for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">informing the Company Secretary of any such new actual or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 542.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential conflicts that may arise or if there are any changes in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances that may affect an authorisation previously <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 562.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">given. Even when provided with authorisation, a Director is not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 572.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">absolved from his or her statutory duty to promote the success <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the company. If an actual conflict arises post-authorisation, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 593.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board may choose to exclude the Director from receipt of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 603.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the relevant information and participation in the debate, or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suspend the Director from the Board, or, as a last resort, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">require the Director to resign.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 639.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Nominations &amp; Corporate Governance Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed the Register of Potential Conflict authorisations (the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Register of Potential Conflicts) in January 2024. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 670.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee reported to the Board that the conflicts had been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 680.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriately authorised and that the process for authorisation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 690.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued to operate effectively. The Committee then <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 701pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommended the approval of the Register of Potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 711.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Conflicts to the Board which it subsequently approved. Except <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 721.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as described in Note 40 to the financial statements, &#8216;Related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 731.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">party transactions&#8217;, during or at the end of the financial year no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 741.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Director or Person Closely Associated had any material interest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 752pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in any contract of significance with a Group company.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 767.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Articles prohibit a Director from voting on any resolution <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 778.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concerning his or her appointment or the terms or termination <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 788.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of his or her appointment.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Independent advice<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company has an agreed procedure for Directors to take <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independent legal and/or financial advice at the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense where they deem it necessary.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Indemnification of Directors<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 181.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Qualifying third party indemnity provisions (as defined in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies Act 2006) are in force for the benefit of Directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and former Directors who held office during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 467.57000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and up to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approval and signature of the Annual Report.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 227.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Change of control and essential contracts<span style="display: inline-block; height: 8pt;"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5272"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 243.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We do not have contracts or other arrangements which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individually are fundamental to the ability of the business to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operate effectively. Neither is the company party to any material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 274.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreements that would take effect, be altered, or terminate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 284.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upon a change of control following a takeover bid. We do not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have agreements with any Director that would provide <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 305.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensation for loss of office or employment resulting from a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 315.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">takeover, except that provisions of the company&#8217;s share plans <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 325.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may cause options and awards granted under such plans to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vest on a takeover.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 351.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of the termination provisions in the Executive Directors&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">service contracts are given in the full version of the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022 Remuneration policy which is available on gsk.com in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investors section.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 398.02pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Content of the Directors&#8217; report<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 421.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the purposes of the UK Companies Act 2006, the Directors&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report of GSK plc for the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.07000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprises:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 454.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; report<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 470.2pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 234pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 186.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 186.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 186.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 162.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Section<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 47.25pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pages<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 186.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 12pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">113 to 186<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 186.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee engagement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 186.75pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; 125<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 186.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; statements of responsibilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 40.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">188 and 189<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 186.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186.75pt; position: var(--position); top: 54.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">287 to 338 <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 544.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Strategic report sets out those matters required to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosed in the Directors&#8217; report which are considered to be of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategic importance:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 580.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 596.46pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 189.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 46.5pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 189.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 189.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 165.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Section<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 0pt; width: 46.5pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 46.5pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pages<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td></tr><tr style="height: 22.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 22.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk management objectives and policies<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 12pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">62 to 81 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.83pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 307 to <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 34.5pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Likely future developments of the company<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 34.5pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 to 111<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 45.75pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13 to 31<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business relationships<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 57pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">47 to 60<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diversity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 68.25pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">54 and 55<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provision of information to and consultations with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 79.5pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">54, 55 and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 12.83pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">58 to 60<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 189.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 189.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carbon emissions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 189.75pt; position: var(--position); top: 102.75pt; width: 46.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 46.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">51 to 53<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">174<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; report continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following information is also incorporated into the Directors&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 139.48pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 238.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 141.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 96.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 141.75pt; position: var(--position); top: 0pt; width: 96.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Location in Annual Report<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest capitalised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 12pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial statements, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes 17 and 20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Particulars of important post-balance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet events of the company or its <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial statements, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 48<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Publication of unaudited financial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of any long-term incentive <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Waiver of emoluments by a Director<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="6" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 109.5pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 102pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Waiver of future emoluments by a Director<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non pre-emptive issues of equity for cash<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 141.75pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non pre-emptive issues of equity for cash <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by any unlisted major subsidiary <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertaking<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 171pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Parent company participation in a placing <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by a listed subsidiary<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 191.25pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provision of services by a controlling <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder waiver of dividends<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial statements, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes 16 and 45<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 231.75pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder waiver of future dividends<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 231.75pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial statements, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 96.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes 16 and 45<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 252pt; width: 141.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 141.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreements with controlling shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 141.75pt; overflow: hidden; position: var(--position); top: 252pt; width: 96.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 96.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Not applicable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 416.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.55pt;"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5266"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5267"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5269"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 69.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Directors&#8217; report <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 429.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has been drawn up and presented in accordance with and in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliance upon English company law and the liabilities of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors in connection with that Report shall be subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 460.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the limitations and restrictions provided by such law.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was approved by the Board of Directors on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.97000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 290.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 481.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and signed on its behalf by:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 506.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5270"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.18pt;"></span><span id="if777c2edb3ef4a46804339e189a6b74e_5271"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">175<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 536.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 102.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 23.25pt; width: 290.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 290.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 164.8pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 44.25pt;"><td colspan="7" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_337"></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Financial <span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="background-color: transparent; height: 841.91pt; left: 0.1pt; opacity: 1; position: var(--position); top: 0pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g49.jpg" alt="AR__main_divider_pages background.jpg" style="height: 841.91pt; width: 595.28pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 182.38pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.26pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">statements<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="position: var(--position); top: 482.34pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 350.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 320.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 320.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 320.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this section<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 320.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.19pt; width: 320.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_343">Directors&#8217; statement of responsibilities</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 14.25pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_346">176</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 320.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.74pt; width: 320.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report of the Independent Registered Public Accounting Firm - <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.94pt; width: 320.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Deloitte LLP<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 32.25pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">178</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 320.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 320.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 60pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">182</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 320.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 320.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 75pt; width: 30pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 9.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_370">186</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">176<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; statement of responsibilities<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_346"></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Directors are responsible for preparing the Annual Report, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Remuneration report and the Group and parent company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements in accordance with applicable law and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK company law requires the Directors to prepare financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements for each financial year. The Directors are required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to prepare the Group consolidated financial statements in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with UK-adopted international accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards in conformity with the requirements of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies Act 2006 and the International Financial Reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standards (IFRS) as issued by the International Accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standards Board (IASB). Under company law the Directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">must not approve the financial statements unless they are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">satisfied that they give a true and fair view of the state of affairs <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Group and its profit or loss for that period. In preparing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the financial statements, the Directors are required to:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">select suitable accounting policies and then apply them <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consistently;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make judgements and accounting estimates that are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonable and prudent;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">state that the Group financial statements comply with IFRS, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as issued by the IASB and in conformity with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 351.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements of the Companies Act 2006; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prepare the financial statements on a going concern basis <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unless it is inappropriate to presume that the Group and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 382.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parent company will continue in business<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In preparing the Group financial statements, International <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 408.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounting Standard 1 requires that directors properly select <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and apply accounting policies; present information, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting policies, in a manner that provides relevant, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable, comparable and understandable information; provide <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 449.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additional disclosures when compliance with the specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 459.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements in IFRS Standards are insufficient to enable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">users to understand the impact of particular transactions, other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">events and conditions on the entity&#8217;s financial position and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial performance; and make an assessment of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s ability to continue as a going concern.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Directors are responsible for keeping adequate accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">records that are sufficient to show and explain the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions and disclose with reasonable accuracy at any time <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the financial position of the Group and to enable them to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure that the Group financial statements and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 164.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report comply with the Companies Act 2006. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 174.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">They are also responsible for safeguarding the assets of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 184.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group and hence for taking reasonable steps for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention and detection of fraud and other irregularities.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group financial statements for the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 495.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, comprising principal statements and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supporting notes, are set out in the &#8216;Financial statements&#8217; on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pages<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">182</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.51000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_541">268</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.19000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of this report<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 420.14000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The responsibilities of the auditor in relation to the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements are set out in the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Independent Auditor&#8217;s report on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pages<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_352">178</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.51000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i42e75ef76e644b8c8d5c6954b9e40514_21453">181</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.19000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial statements for the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.43000000000006pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 324.94000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 327.26000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are included in the Annual Report, which is published in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">printed form and made available on our website. The Directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are responsible for the maintenance and integrity of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporate and financial information included on the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">website. Legislation in the United Kingdom governing the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preparation and dissemination of financial statements may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">differ from legislation in other jurisdictions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each of the current Directors, whose names and functions are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">listed in the Corporate Governance section of the Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.82000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.14000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> confirms that, to the best of his or her <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">knowledge:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group financial statements, which have been prepared in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the applicable set of accounting standards <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and in conformity with the requirements of Companies Act <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2006, give a true and fair view of the assets, liabilities, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial position and profit of the Group; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the strategic report and risk sections of the Annual Report, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which represent the management report, include a fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review of the development and performance of the business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the position of the company and the Group taken as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 520.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whole, together with a description of the principal risks and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 530.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncertainties that it faces; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Annual Report and financial statement, taken as a whole, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are fair, balanced and understandable and provide the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information necessary for shareholders to assess the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s position and performance, business model and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">177<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 13.78pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors&#8217; statement of responsibilities continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Disclosure of information to auditor<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Directors in office at the date of this Annual Report have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each confirmed that:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">so far as he or she is aware, there is no relevant audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information of which the company&#8217;s auditor is unaware; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he or she has taken all the steps that he or she ought to have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taken as a Director to make himself or herself aware of any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant audit information and to establish that the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditor is aware of that information<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 191.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This confirmation is given and should be interpreted in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the provisions of section 418 of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies Act 2006.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 259.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Going concern basis<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pages<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_199">76</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7687">102</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 161.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_166">62</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 170.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaa5d1c6e3428427db1aa51670414d36a_25453">70</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 191.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> contain information on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the performance of the Group, its financial position, cash flows, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">net debt position, borrowing facilities and climate-related risks. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further information, including Treasury risk management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policies, exposures to market and credit risk and hedging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities, is given in Note 44, 'Financial instruments, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related disclosures' to the financial statements. Having <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessed the principal risks and other matters considered in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connection with the viability statement, the Directors considered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">it appropriate to adopt the going concern basis of accounting in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">preparing the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 393.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Internal control<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 409.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board, through the Audit &amp; Risk Committee, has reviewed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the assessment of risks and the internal control framework that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operates in GSK and has considered the effectiveness of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">system of internal control in operation in the Group for the year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">covered by this Annual Report and up to the date of its approval <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Board of Directors. Further detail on the review of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal controls is set out in the Governance report on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 279.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 480.62pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ib3a1b760284845998626a8c56f77bf8a_44113">130</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">The 2018 UK Corporate Governance Code<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board considers that GSK plc applies the principles and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complies with the provisions of the UK Corporate Governance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code maintained by the Financial Reporting Council, as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">described in the Corporate Governance section including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remuneration on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">103</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5267">174</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 443.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considers that the Annual Report, taken as a whole, is fair, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balanced and understandable, and provides the information <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">necessary for shareholders to assess the Group&#8217;s position and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance, business model and strategy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As required by the Financial Conduct Authority&#8217;s Listing Rules, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the auditor has considered the Directors&#8217; statement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance in relation to those points of the UK Corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governance Code which are specified for their review.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Annual Report for the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 447.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 521.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprising the Report of the Directors, the Remuneration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report, the Financial statements and Additional information for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investors, has been approved by the Board of Directors and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">signed on its behalf by<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 377.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">178<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.03em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting<span style="display: inline-block; height: 15.28pt;"></span></span></div><div style="line-height: 21pt; position: var(--position); top: 30.53pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.03em; position: var(--position); text-decoration: none; white-space: pre;">Firm<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 120.47pt;" id="idc89fa1ee07645df9629d157a4b46752_352"></div><div style="position: var(--position); top: 120.47pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ida94f57fa3214bf3b03349eb1fd5fbec_0-0-1-1-824708"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report on the audit of the financial statements<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 158.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To the shareholders and the Board of Directors of GSK plc<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 174.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opinion on the Financial Statements<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have audited the accompanying consolidated balance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheets of GSK plc and subsidiaries (the &#8220;Group&#8221;) as<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 246.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at 31 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">December 2024 and 2023, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the related consolidated income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements, statements of comprehensive income, statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of changes in equity, and cash flow statements, for each of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three years in the period ended 31 December 2024, and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related notes, included on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 177.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">182</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 191.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_541">268</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (collectively <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 262.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">referred to as the &#8220;financial statements&#8221;). In our opinion, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements present fairly, in all material respects, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial position of the Group as at 31 December 2024 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023, and the results of its operations and its cash flows for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each of the three years in the period ended 31 December 2024, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 313.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in conformity with IFRS Accounting Standards as issued by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 323.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">International Accounting Standards Board (IASB). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have also audited, in accordance with the standards of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Public Company Accounting Oversight Board (United States) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(PCAOB), the Group&#8217;s internal control over financial reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as at 31 December 2024, based on criteria established in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Internal Control &#8212; Integrated Framework (2013)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> issued by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 390.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee of Sponsoring Organizations of the Treadway <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 400.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commission and our report dated 3 March 2025, expressed an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 410.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unqualified opinion on the Group&#8217;s internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 420.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 436.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Basis for Opinion<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These financial statements are the responsibility of the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management. Our responsibility is to express an opinion on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s financial statements based on our audits. We are a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">public accounting firm registered with the PCAOB and are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required to be independent with respect to the Group in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the U.S. federal securities laws and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable rules and regulations of the Securities and Exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commission and the PCAOB. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We conducted our audits in accordance with the standards of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 550.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the PCAOB. Those standards require that we plan and perform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the audit to obtain reasonable assurance about whether the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements are free of material misstatement, whether <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">due to error or fraud. Our audits included performing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 590.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procedures to assess the risks of material misstatement of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 601.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements, whether due to error or fraud, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performing procedures that respond to those risks. Such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procedures included examining, on a test basis, evidence <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regarding the amounts and disclosures in the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 641.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements. Our audits also included evaluating the accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 652.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principles used and significant estimates made by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 662.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management, as well as evaluating the overall presentation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the financial statements. We believe that our audits provide a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonable basis for our opinion. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 698.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Critical Audit Matters<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 714.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The critical audit matters communicated below are matters <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 724.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arising from the current-period audit of the financial statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 734.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that were communicated or required to be communicated to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 745.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audit committee and that (1) relate to accounts or disclosures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 755.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that are material to the financial statements and (2) involved <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our especially challenging, subjective, or complex judgments. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 775.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The communication of critical audit matters does not alter in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 785.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any way our opinion on the financial statements, taken as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 796.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whole, and we are not, by communicating the critical audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 158.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters below, providing separate opinions on the critical audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 169.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters or on the accounts or disclosures to which they relate.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 185pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Valuation of the ViiV Healthcare Shionogi <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 198.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">contingent consideration liability <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 214.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounts impacted:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Contingent consideration liabilities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating expense <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 240.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refer to Notes 3 and 33 to the financial statements<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 256.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical Audit Matter Description<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has completed a number of significant transactions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which resulted in the recognition of material contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration liabilities, which are a key source of estimation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncertainty. The most significant of these liabilities was the ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare Shionogi Contingent Consideration Liability (ViiV <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CCL). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group completed the acquisition of the remaining 50% <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest in the Shionogi-ViiV Healthcare joint venture in 2012. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Upon completion, the Group recognised a contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration liability for the fair value of the expected future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments to be made to Shionogi. As at 31 December 2024 the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 389.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability was valued at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;6,061 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We identified the ViiV CCL as a critical audit matter because of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the significant estimates and assumptions relating to the sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forecasts used in valuing the ViiV CCL and the sensitivity of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valuation to these inputs. The most significant of these relate to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales forecasts in the United States (US) on certain products in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the treatment and prevention portfolio. Such forecasts are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on an assessment of the expected launch dates for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline assets, the ability to shift market practice and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prescriber behaviour towards long-acting injectable treatments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2-drug regimens, the size of the long-acting prevention <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 507.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market and subsequent sales volumes. There is incremental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 517.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenge in forecasting sales associated with recently <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">launched products due to the lack of historical actual data. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales forecasts also required significant audit effort to perform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate audit procedures to challenge and evaluate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 558.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonableness of those forecasts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How the Critical Audit Matter Was Addressed in the Audit<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 590.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We performed the following audit procedures, amongst others, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 600.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related primarily to the sales forecasts:&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tested the controls over the key inputs and assumptions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 626.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">used in the valuation of the contingent consideration liability, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 637.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including review controls over the sales forecasts of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment product portfolio used to value the ViiV CCL;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 663.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Obtained the Group&#8217;s assessment of the key inputs and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 673.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumptions used in the sales forecasts and evaluated the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 683.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonableness of these, including through enquiries of key <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 693.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individuals from the senior leadership team, commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 703.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy team and key personnel involved in the budgeting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 714.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and forecasting process, and inspection of supporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 724.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evidence; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 740.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated the US volume assumptions made by the Group to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 750.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimate sales forecasts. This involved benchmarking <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 760.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forecast market share data against external data, such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 770.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total prescription volumes and new patient prescription <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 780.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volumes, in order to assess for any sources of contradictory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 791.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evidence; <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">179<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 60pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 18.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report on the audit of the financial statements continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated the reasonableness of US pricing assumptions by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 130.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group, by comparing the forecasted Returns and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 140.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rebates rate by product against the current rate, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 151.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing the forecasted Returns and Rebates against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 161.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparable products and expected changes in payer policy; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered the results of clinical studies undertaken in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 187.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year by the Group and key competitors in order to assess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 197.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether these are corroborative or contradictory to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 207.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumptions used in the product portfolio sales forecasts in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 233.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benchmarked the Group&#8217;s sales forecasts against those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included in reports from 18 analysts and considered sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forecasts on both a total ViiV basis and an individual product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basis, assessing against identified contradictory data; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 280.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Together with our valuations specialists, assessed the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonableness of the overall valuation methodology, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including testing the valuation model for mechanical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accuracy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 326.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Valuation of US Returns and Rebates (RAR) <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 340.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">accruals <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounts impacted<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 133.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Turnover and Trade and other payables<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refer to Notes 3 and 29 to the financial statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 387.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical Audit Matter Description<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the US, the Group sells to customers under various <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial and government mandated contracts and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reimbursement arrangements that include rebates, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chargebacks and a right of return for certain pharmaceutical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 444.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products. Returns and rebates provided to customers under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 454.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these arrangements are accounted for as variable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considerations, and recognised as a reduction to revenue in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 474.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">form of gross-to-net sales adjustments. These adjustments are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">known as the Returns and Rebates (RAR) accruals and are a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 495.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">source of significant estimation uncertainty which could have a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">material impact on reported revenue. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the US Commercial Operations in 2024, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;14,100 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 270.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RAR deductions were made to gross revenue of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;30,484 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, resulting in net revenue of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;16,384 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The balance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet accrual at 31 December 2024 for US Commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;5,235 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 196.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The four most significant buying group to which the RAR <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 588.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accrual relates are Managed Care, Medicaid, Ryan White and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 598.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicare Part D. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The two main causes of significant estimation uncertainty are:&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The utilisation rate, which is the portion of total sales that will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be made into each buying group, estimated in recording the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accruals. The utilisation assumption is the most challenging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the key assumptions used to derive the accrual given that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">it is influenced by historical trends, projected market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions and other factors outside the control of the Group; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 691.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 707.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The time lag between the point of sale and the point at which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 717.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exact rebate amounts are known to the Group upon receipt <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 727.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of a claim. Those buying group with the longest time lag <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 738.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result in a greater accrued period, and therefore, a greater <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 748.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">level of estimation uncertainty in estimating the period-end <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 758.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accrual. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The level of estimation uncertainty is also impacted by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 130.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant shifts in channel mix driven by changes in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 140.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitive landscape, including competitor and generic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 151.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product launches, changes in government legislation and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 161.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">macroeconomic factors. As such, we focus on the utilisation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 171.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumptions for those products where we deem the level of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 181.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimation uncertainty to be the most significant.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 197.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We also focus on the period-end adjustments made to the RAR <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 207.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accruals. These adjustments reflected updates made to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initial assumptions included within the forecasted RAR rates <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and, in our view, present the greatest opportunity for fraud in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 238.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenue recognition (notwithstanding the existence of internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 248.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How the Critical Audit Matter Was Addressed in the Audit<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 280.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We performed the following audit procedures, amongst others, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related to estimates in the RAR accruals:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tested the key controls over the estimation of RAR accruals <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including the controls associated with the forecasting of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">utilisation rates process and the month-end accrual review <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 337.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated assumptions for a selection of utilisation rates, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focusing on certain products where we concluded the accrual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is most sensitive to these assumptions. Our procedures <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included comparison to historical utilisation rates, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration of historical accuracy and assessment of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projected market conditions such as the impact of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competition, new product launches, changes in government <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 424.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legislation and macroeconomic factors are appropriately <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected in the RAR accruals;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplemented this with substantive analytical procedures by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 457.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing an independent expectation of the accrual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance for each of the key segments, based on historical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims received adjusted to reflect market changes in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period third party information, on inventory held by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customers, and an assessment of the time lag between the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initial point of sale and the claim receipt. We then compared <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this independent expectation to those recorded to evaluate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 529.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the appropriateness of the year ending accrual position; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered the historical accuracy of estimates and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 552.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluated whether forecast assumptions had been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 562.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriately updated in a selection of cases where the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 572.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actual rebate claims differed to the amount accrued; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated the accuracy and completeness of period-end <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustments to the liability made as part of the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ongoing review of the estimated accrual; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 618.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performed audit procedures over the actual rebate payments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 628.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made in the year by agreeing to the relevant contract to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 639.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assess whether the rebate payments were in line with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 649.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contractual terms. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 665.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Valuation of other intangible assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounts impacted:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Other intangible assets, Cost of sales, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 691.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development, and Selling, general and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 701.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">administration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 717.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refer to Notes 3, 20 and 41 to the financial statements<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical Audit Matter Description<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As at 31 December 2024, the Group held <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;14,936 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 759.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other intangible assets (including licenses, patents, trademarks, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 769.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and trade names, but excluding goodwill and computer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 779.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">software). This includes <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;886 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 439.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of intangible assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 789.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquired as part of the acquisition of Aiolos Bio, Inc (Aiolos) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 800.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">180<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 60pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 18.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report on the audit of the financial statements continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets which are in-development and not available <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 130.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for use should be tested at least annually for impairment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 140.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">irrespective of whether an indication of impairment exists.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 158.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When the carrying amount of an individual intangible asset, or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 168.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash-generating unit to which an intangible asset belongs, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 178.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceeds its recoverable amount, an impairment is recognised. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recoverability of an intangible asset is derived from certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumptions and estimates of future trading performance which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">create significant estimation uncertainty.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 225.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The underlying assumptions include forecast sales pricing, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 235.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volume, growth rates and probability of technical and regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 245.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success of ongoing clinical trials. This includes assumptions on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">timing of cash flows determined by anticipated launch year, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">peak year sales, subsequent sales erosion due to generic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product competition and profit margin levels.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2024, impairment charges of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;314 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recorded. These were primarily full impairments due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cessation of research and development dictated by negative <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical trial readouts or lack of commercial attractiveness.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We identified the valuation of other intangible assets as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 348.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">critical audit matter due to the inherent judgements involved in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimating future cash flows. Auditing such assumptions and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimates required extensive audit effort to evaluate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonableness of forecasts and management judgements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How the Critical Audit Matter Was Addressed in the Audit<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 411.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We performed the following audit procedures, amongst others, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 421.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over the forecast sales pricing, volume, growth rates, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 431.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">probability of technical and regulatory success, and profit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">margin levels used in the assessment of the valuation of other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intangible assets:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tested review controls over the key inputs and assumptions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">used in the valuation of other intangible assets. The controls <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">encompass review of the valuation models, which contain a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of assumptions such as the probability of technical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and regulatory success, launch dates plus other revenue and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost assumptions;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inquired with key individuals from the corporate development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">team, commercial forecasting leads, and key personnel <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">involved in the assets research and development process. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We used the outcome of these inquiries to evaluate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s evidence to support key assumptions such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overall sales forecasts, peak year sales (including anticipated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market share, volume and uptake alongside price points <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where required), foreseeable competitive landscape, growth <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates, probability of regulatory and technical success and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 626.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">margins; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 642.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated the key inputs and assumptions applied in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 652.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimating sales and profit margin forecasts, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 662.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benchmarking of forecasts against external market data. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 673.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included independent market research of therapeutic area <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 683.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">price points, price growth rates, and anticipated competitor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 693.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market landscape, currently and at the time of forecast <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 703.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval, plus assessment of any sources of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 713.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contradictory evidence;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 729.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compared the forecast sales and profit margin levels to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 739.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plan data (asset by asset internal forecasts) approved by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 750.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Leadership Team and the Board of Directors, where the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 760.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in-development intangible asset is forecast to launch within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 770.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the next 3-year period;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assessed the historical accuracy of sales forecasts by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 130.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performing retrospective reviews across marketed assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 140.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within the business;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 156.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Engaged our fair valuation specialists to assess the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 166.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonableness of the valuation methodology applied as well <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as performing mechanical accuracy checks; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered whether events or transactions that occurred <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">after the balance sheet date, but before the reporting date, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect the conclusions reached on the carrying values of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 223.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets and associated disclosures.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 239.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Valuation of uncertain tax positions, <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 252.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">including transfer pricing<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounts impacted<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Corporation tax payable, Deferred tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities and Taxation charge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refer to Notes 3 and 14 to the financial statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical Audit Matter Description<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group operates in numerous jurisdictions and there are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">open tax and transfer pricing matters and exposures with UK, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US and overseas tax authorities that give rise to uncertain tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 357.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">positions. There is a wide range of possible outcomes for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 367.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions and contingencies. Certain judgements in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 377.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimates of tax exposures and contingencies are required in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 387.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">order to assess the adequacy of tax provisions, which are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 397.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sometimes complex as a result of the considerations required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over multiple tax laws and regulations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December 2024, the Group has recorded provisions of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;636 million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in respect of uncertain tax positions. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How the Critical Audit Matter Was Addressed in the Audit<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">With the support of our tax specialists, we assessed the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriateness of the uncertain tax provisions, focused on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those jurisdictions where the Group has the greatest potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exposure and where the highest level of judgement is required, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 506.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by performing the following audit procedures amongst others: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 522.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tested key controls over preparation, review and reporting of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 532.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgmental tax balances and transactions, which include <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 543.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions for uncertain tax provisions;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 558.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assessed the assumptions and judgements that are required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 569.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to determine the range of possible outcomes for recognition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and measurement of provisions for uncertain tax positions in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance with the requirements of IFRIC 23 <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 486.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Uncertainty <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 599.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over Income Tax Treatments; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Involved our transfer pricing specialists to evaluate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfer pricing methodology of the Group and associated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 636.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approach to provision recognition and measurement; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 651.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Considered evidence such as the actual results from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 662.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recent tax authority audits and enquiries, third-party tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advice obtained by the Group and our tax specialists&#8217; own <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">knowledge of market practice in relevant jurisdictions. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">181<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 60pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 60pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 18.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report on the audit of the financial statements continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 124.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Valuation of provisions and contingent <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 137.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">liabilities for significant legal proceedings <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 153.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounts impacted<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 133.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Contingent liabilities and Other operating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 163.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 179.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refer to Notes 35 and 47 to the financial statements<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 195.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Critical<span style="display: inline-block; height: 6.18pt;"></span><span id="i42e75ef76e644b8c8d5c6954b9e40514_21453"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: bold; left: 82.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Audit Matter Description<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 211.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group operates in an environment where it is subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant legal and administrative proceedings, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product liability, intellectual property, tax, anti-trust, consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fraud and governmental regulations.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 257.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is exposed to a number of regulatory and litigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters. The Group&#8217;s provision for these matters is &#163;1,446 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million at 31 December 2024 and the income statement charge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 288.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the year is &#163;2,039 million. Other matters are disclosed as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent liabilities where the criteria for recognising a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provision under IAS 37 <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 141.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provisions, Contingent Liabilities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent Assets<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are not met.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 334.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The most significant charges and provisions recorded in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of regulatory and litigation matters in the year relate to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 67.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> product litigation matter, which is classified as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant legal matter by the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant judgement is required by the Group in assessing the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following, as required by IAS 37 <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 174.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provisions, Contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liabilities and Contingent Assets<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, as to: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Whether a present obligation exists and whether the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcome will result in a probable outflow, particularly where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 438.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the outcome of litigation is uncertain and subject to additional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 448.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">court proceedings;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The determination of a reliable estimate of the amounts of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 474.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the obligation; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 490.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The nature and extent of any contingent liabilities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 500.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying significant estimation uncertainties disclosed.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 120.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">How the Critical Audit Matter Was Addressed in the Audit<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 136.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We performed the following audit procedures, amongst others, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 146.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to address the valuation of provisions and contingent liabilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 156.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for significant legal proceedings: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tested the Group&#8217;s controls over the valuation of provisions, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the robustness of the provision against the requirements of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IAS 37, the appropriateness of judgements used to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determine a &#8216;best estimate&#8217; and completeness and accuracy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of data used in the process;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated the assessment of the provisions, associated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">probabilities, and potential outcomes in accordance with IAS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated whether the methodology, data and significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgements and assumptions used in the valuation of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 286.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions are appropriate in the context of the applicable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 296.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial reporting framework;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inquired with and inspected correspondence from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s internal and external counsel to assess the litigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matters and evaluate the Group&#8217;s significant judgements and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumptions;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 358.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Read board minutes and settlement agreements to evaluate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 368.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management&#8217;s approach in respect of the litigation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreed the terms and conditions of such arrangements to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 389.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments made to evaluate the provisions already recorded <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 399.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and whether there is a requirement for additional provisions;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated external information, including analyst reports, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 425.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subject matter expert analysis and analogous litigation cases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 435.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to understand the views and expectations of the external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 445.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluated whether the disclosures made in the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements appropriately reflect the facts and critical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 482.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting judgements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">/s/ <span style="display: inline-block; height: 6.18pt;"></span><span id="i42e75ef76e644b8c8d5c6954b9e40514_21474"></span><span id="i42e75ef76e644b8c8d5c6954b9e40514_21475"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-58">Deloitte LLP</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-59">London, United Kingdom</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 397.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.09pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">3 March 2025</span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The first accounting period we audited was 31 December 2018.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">182<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 13.94pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated income statement<span style="display: inline-block; height: 15.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 39.94pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the year ended <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 91.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_355"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 312.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="i8e5e0787c5474b8785aa43dad1a6619f_1-1-1-1-821446"></span><div style="left: 312.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_391">6</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-60">31,376</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-61">30,328</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-62">29,324</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 27.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-63">9,048</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 27.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-64">8,565</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 27.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-65">9,554</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-66">22,328</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-67">21,763</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-68">19,770</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-69">11,015</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-70">9,385</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-71">8,372</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-72">6,401</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-73">6,223</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-74">5,488</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Royalty income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RevenueFromRoyalties" scale="6" id="f-75">639</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RevenueFromRoyalties" scale="6" id="f-76">953</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:RevenueFromRoyalties" scale="6" id="f-77">758</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other operating income/(expense)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 76.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_394">7</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="f-78">1,530</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="f-79">363</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="f-80">235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 86.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_397">8</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-81">4,021</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-82">6,745</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-83">6,433</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 96pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 96pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_409">11</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-84">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-85">115</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.51pt;"></span></span><span style="left: 33.14pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-86">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 105.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_412">12</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-87">669</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-88">792</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-89">879</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 115.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after tax profit/(loss) of associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 115.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_415">13</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 115.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-90">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 115.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-91">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 115.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-92">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit/(loss) on disposal of interests in associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 125.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets" scale="6" id="f-93">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 125.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets" scale="6" id="f-94">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 125.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets" format="ixt:fixed-zero" scale="6" id="f-95">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 135pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-96">3,477</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-97">6,064</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-98">5,628</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_418">14</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-99">526</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-100">756</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-101">707</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 154.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-102">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 154.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-103">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 154.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-104">4,921</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation from discontinued operations and other gains/(losses) from the demerger<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 164.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" format="ixt:fixed-zero" scale="6" id="f-105">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 164.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" format="ixt:fixed-zero" scale="6" id="f-106">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 164.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" format="ixt:num-dot-decimal" scale="6" id="f-107">3,049</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Re-measurement of discontinued operations distributed to shareholders on demerger<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 175.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.67pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" format="ixt:fixed-zero" scale="6" id="f-108">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 175.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" format="ixt:fixed-zero" scale="6" id="f-109">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 175.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" format="ixt:num-dot-decimal" scale="6" id="f-110">7,651</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 186.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-111">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 186.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-112">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 186.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-113">10,700</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit after taxation for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 196.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-114">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 196.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-115">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 196.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-116">15,621</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to non-controlling interests from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" scale="6" id="f-117">376</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" scale="6" id="f-118">380</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" scale="6" id="f-119">460</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 216pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeFromContinuingOperationsAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-120">2,575</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeFromContinuingOperationsAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-121">4,928</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeFromContinuingOperationsAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-122">4,461</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to non-controlling interests from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 225.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="f-123">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 225.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="f-124">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 225.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests" scale="6" id="f-125">205</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 235.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 235.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" format="ixt:fixed-zero" scale="6" id="f-126">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 235.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" format="ixt:fixed-zero" scale="6" id="f-127">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 235.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-128">10,495</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 245.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-129">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 245.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-130">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 245.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-131">15,621</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 255pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit attributable to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="f-132">376</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="f-133">380</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="f-134">665</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 264.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-135">2,575</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-136">4,928</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-137">14,956</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 274.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-138">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 274.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-139">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 274.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-140">15,621</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 284.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share (pence) from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 284.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_421">15</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 284.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.32pt;"></span></span><span style="left: 26.95pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-141">63.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 284.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-142">121.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 284.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-143">110.8</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 294pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share (pence) from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 294pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-144">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 294pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-145">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 294pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="-2" id="f-146">260.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total basic earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 303.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.32pt;"></span></span><span style="left: 26.95pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:BasicEarningsLossPerShare" scale="-2" id="f-147">63.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 303.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:BasicEarningsLossPerShare" scale="-2" id="f-148">121.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 303.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShare" scale="-2" id="f-149">371.4</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 313.5pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted earnings per share (pence) from continued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 313.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_421">15</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 313.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.32pt;"></span></span><span style="left: 26.95pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-150">62.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 313.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-151">119.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 313.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-152">109.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 323.25pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted earnings per share (pence) from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 323.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-153">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 323.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-154">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 323.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" scale="-2" id="f-155">257.0</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 333pt; width: 312.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 312.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total diluted earnings per share (pence)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 333pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.32pt;"></span></span><span style="left: 26.95pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:DilutedEarningsLossPerShare" scale="-2" id="f-156">62.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 333pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:DilutedEarningsLossPerShare" scale="-2" id="f-157">119.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 333pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.93pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:DilutedEarningsLossPerShare" scale="-2" id="f-158">366.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: absolute; top: 466.83pt;" id="idc89fa1ee07645df9629d157a4b46752_358"></div><div style="line-height: 18.5pt; position: var(--position); top: 466.83pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: 51.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated statement of comprehensive income<span style="display: inline-block; height: 13.46pt;"></span></span></div><div style="font-size: 13pt; line-height: 13pt; position: var(--position); top: 488.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 13pt; font-style: normal; font-weight: normal; left: 51.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the year ended <span style="display: inline-block; height: 9.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 13pt; font-style: normal; font-weight: normal; left: 158.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 9.46pt;"></span></span></div><div style="position: var(--position); top: 508.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 541.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 270pt;"></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-159">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-160">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-161">15,621</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that may be reclassified subsequently to continuing operations income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations" scale="6" id="f-162">392</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations" scale="6" id="f-163">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations" scale="6" id="f-164">113</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 0.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of overseas subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" scale="6" id="f-165">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" scale="6" id="f-166">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" scale="6" id="f-167">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-168">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="f-169">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="f-170">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax on fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-171">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-172">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-173">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 94.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of hedging<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 94.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.73pt;"></span></span><span style="left: 32.36pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" scale="6" id="f-174">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 94.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" format="ixt:fixed-zero" scale="6" id="f-175">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 94.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" format="ixt:fixed-zero" scale="6" id="f-176">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of cash flow hedges to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" scale="6" id="f-177">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" scale="6" id="f-178">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.51pt;"></span></span><span style="left: 33.14pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" scale="6" id="f-179">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="f-180">478</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="f-181">52</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="f-182">120</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 123.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that will not be reclassified to continuing operations income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 133.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets of non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" scale="6" id="f-183">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" scale="6" id="f-184">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" scale="6" id="f-185">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 143.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-186">100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 143.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-187">244</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 143.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-188">754</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 153pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.51pt;"></span></span><span style="left: 33.14pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToInvestmentsInEquityInstrumentsOfOtherComprehensiveIncome" scale="6" id="f-189">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.51pt;"></span></span><span style="left: 33.14pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToInvestmentsInEquityInstrumentsOfOtherComprehensiveIncome" scale="6" id="f-190">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 153pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.51pt;"></span></span><span style="left: 33.14pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToInvestmentsInEquityInstrumentsOfOtherComprehensiveIncome" scale="6" id="f-191">56</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:FairValueMovementsOnCashFlowHedgesNotReclassified" scale="6" id="f-192">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:FairValueMovementsOnCashFlowHedgesNotReclassified" scale="6" id="f-193">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:FairValueMovementsOnCashFlowHedgesNotReclassified" scale="6" id="f-194">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement gains/(losses) on defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 172.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-195">506</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 172.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-196">71</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 172.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-197">786</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on remeasurement losses/(gains) on defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-198">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-199">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-200">211</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="f-201">305</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="f-202">265</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-203">1,307</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 201.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income /(expense) for the year from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 201.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 201.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" scale="6" id="f-204">173</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 201.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" scale="6" id="f-205">317</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 201.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-206">1,187</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income for the year from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 211.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-207">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 211.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.65pt;"></span></span><span style="left: 37.28pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-208">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 211.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations" scale="6" id="f-209">356</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 221.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-210">2,778</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-211">4,991</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-212">14,790</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 231pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income for the year attributable to:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 240.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-213">2,406</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 240.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-214">4,636</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 240.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-215">14,153</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 250.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 250.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="6" id="f-216">372</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 250.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="6" id="f-217">355</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 250.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="6" id="f-218">637</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 260.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-219">2,778</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 260.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-220">4,991</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 260.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-221">14,790</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">183<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 13.94pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated balance sheet<span style="display: inline-block; height: 15.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 39.94pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the year ended <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 91.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_361"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_427">17</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-222">9,227</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-223">9,020</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_430">18</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-224">846</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-225">937</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_433">19</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-226">6,982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-227">6,811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_436">20</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-228">15,515</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-229">14,768</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments in associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_442">21</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" scale="6" id="f-230">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" scale="6" id="f-231">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_448">23</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-232">1,100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-233">1,137</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_418">14</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="f-234">6,757</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="f-235">6,049</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_523">44</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" scale="6" id="f-236">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-237">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_451">24</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-238">1,942</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-239">1,584</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 142.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-240">42,466</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 142.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-241">40,361</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 165pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inventories<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 176.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_454">25</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 176.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="f-242">5,669</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 176.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="f-243">5,498</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 187.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current tax recoverable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 187.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_418">14</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 187.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentTaxAssets" scale="6" id="f-244">489</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 187.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentTaxAssets" scale="6" id="f-245">373</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 198.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_457">26</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 198.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TradeAndOtherCurrentReceivables" format="ixt:num-dot-decimal" scale="6" id="f-246">6,836</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 198.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TradeAndOtherCurrentReceivables" format="ixt:num-dot-decimal" scale="6" id="f-247">7,385</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 210pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_523">44</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 210pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="f-248">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 210pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="f-249">130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 221.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_445">22</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:fixed-zero" scale="6" id="f-250">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:num-dot-decimal" scale="6" id="f-251">2,204</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 232.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 232.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_472">30</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 232.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:LiquidInvestments" scale="6" id="f-252">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 232.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:LiquidInvestments" scale="6" id="f-253">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 243.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 243.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_460">27</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 243.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-254">3,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 243.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-255">2,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 255pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets held for sale<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_463">28</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="f-256">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="f-257">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 266.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 266.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-258">16,997</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 266.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-259">18,644</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 277.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 277.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="f-260">59,463</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 277.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="f-261">59,005</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 300pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 312pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 323.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 323.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_472">30</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 323.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-262">2,349</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 323.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-263">2,813</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 334.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 334.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_484">33</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 334.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:ContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-264">1,172</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 334.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:ContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-265">1,053</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 345.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 345.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_466">29</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 345.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="6" id="f-266">15,335</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 345.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="6" id="f-267">15,844</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 357pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 357pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_523">44</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 357pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="f-268">192</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 357pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="f-269">114</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 368.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current tax payable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 368.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_418">14</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 368.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentTaxLiabilities" scale="6" id="f-270">703</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 368.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentTaxLiabilities" scale="6" id="f-271">500</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 379.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 379.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_481">32</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 379.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherShorttermProvisions" format="ixt:num-dot-decimal" scale="6" id="f-272">1,946</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 379.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherShorttermProvisions" scale="6" id="f-273">744</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 390.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 390.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-274">21,697</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 390.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-275">21,068</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 413.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 424.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 424.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_472">30</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 424.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-276">14,637</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 424.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-277">15,205</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 435.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation tax payable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 435.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_418">14</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 435.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="f-278">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 435.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" scale="6" id="f-279">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 447pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 447pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_418">14</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 447pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" scale="6" id="f-280">382</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 447pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" scale="6" id="f-281">311</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 458.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions and other post-employment benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 458.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_475">31</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 458.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-282">1,864</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 458.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-283">2,340</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 469.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 469.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_481">32</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 469.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-284">589</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 469.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-285">495</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 480.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 480.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_484">33</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 480.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-286">6,108</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 480.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-287">5,609</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 492pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 492pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_490">34</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 492pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-288">1,100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 492pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-289">1,107</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 503.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 503.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-290">24,680</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 503.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-291">25,142</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 514.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 514.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-292">46,377</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 514.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-293">46,210</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 525.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 525.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NetAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-294">13,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 525.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NetAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-295">12,795</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 548.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 559.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 559.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_499">37</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 559.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="6" id="f-296">1,348</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 559.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="6" id="f-297">1,348</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 570.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share premium account<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 570.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_499">37</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 570.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="6" id="f-298">3,473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 570.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="6" id="f-299">3,451</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 582pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained earnings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 582pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 582pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:RetainedEarnings" format="ixt:num-dot-decimal" scale="6" id="f-300">7,796</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 582pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:RetainedEarnings" format="ixt:num-dot-decimal" scale="6" id="f-301">7,239</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 593.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reserves<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 593.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">38</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 593.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-302">1,054</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 593.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-303">1,309</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 604.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholders&#8217; equity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 604.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-304">13,671</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 604.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-305">13,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 615.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 615.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="f-306">585</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 615.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="f-307">552</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 627pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total equity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 627pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-308">13,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 627pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-309">12,795</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 762.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial statements on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">182</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.85000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_541">268</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 246.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved by the Board<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;February 2025<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and signed on its behalf by<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 778.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sir Jonathan Symonds<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 791.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">184<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 13.94pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated statement of changes in equity<span style="display: inline-block; height: 15.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 39.94pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the year ended <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 91.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_364"></div><div style="position: var(--position); top: 106.3pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 201.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 0pt; width: 198.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 137.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholders&#8217; equity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">premium<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.430000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.940000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves*<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 11.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 201.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2021<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 37.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-13" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-310">1,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 37.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-14" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-311">3,301</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 37.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-15" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-312">7,944</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 37.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-16" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-313">2,463</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 37.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-17" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-314">15,055</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 37.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-18" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-315">6,287</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 37.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-19" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-316">21,342</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-317">14,956</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-318">14,956</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 48.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="ifrs-full:ProfitLoss" scale="6" id="f-319">665</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-320">15,621</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 60pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 60pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 60pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-321">89</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 60pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-322">714</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 60pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-323">803</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 60pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-324">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 60pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-325">831</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 71.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 71.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 71.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-326">14,867</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 71.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-327">714</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 71.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-328">14,153</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 71.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-329">637</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 71.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-330">14,790</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 82.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-331">1,409</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 82.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-332">1,409</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-cash distribution to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="gsk:NonCashDistributionToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="f-333">2,960</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 93.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:NonCashDistributionToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="f-334">2,960</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contributions from non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 105pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 105pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 105pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 105pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 105pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 105pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="gsk:IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" scale="6" id="f-335">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 105pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" scale="6" id="f-336">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 116.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" scale="6" id="f-337">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 116.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" scale="6" id="f-338">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deconsolidation of former subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 127.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary" format="ixt:num-dot-decimal" scale="6" id="f-339">3,045</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 127.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary" format="ixt:num-dot-decimal" scale="6" id="f-340">3,045</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-341">3,467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-342">3,467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 138.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 138.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-343">3,467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-cash dividend to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" format="ixt:num-dot-decimal" scale="6" id="f-344">15,526</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" format="ixt:num-dot-decimal" scale="6" id="f-345">15,526</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 150pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" format="ixt:num-dot-decimal" scale="6" id="f-346">15,526</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 0.47pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Realised after tax profit/(losses) on disposal or liquidation of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" scale="6" id="f-347">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" scale="6" id="f-348">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-349">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 161.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 161.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-350">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 179.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of associates and joint ventures realised<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; profits/(losses) on disposal of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 179.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 179.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 179.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" scale="6" id="f-351">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 179.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" scale="6" id="f-352">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 179.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-353">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 179.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 179.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-354">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 199.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares issued<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 199.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 199.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-24" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-355">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 199.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 199.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 199.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-356">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 199.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 199.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-357">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 209.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Write-down of shares held by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 209.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 209.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 209.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-358">911</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 209.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-359">911</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 209.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-360">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 209.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 209.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-361">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 220.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-24" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-362">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:num-dot-decimal" scale="6" id="f-363">1,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:num-dot-decimal" scale="6" id="f-364">1,200</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:fixed-zero" scale="6" id="f-365">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 220.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 220.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:fixed-zero" scale="6" id="f-366">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 231.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 231.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 231.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 231.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-367">357</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 231.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 231.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-368">357</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 231.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 231.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-369">357</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 243pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 243pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 243pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 243pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-370">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 243pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 243pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-371">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 243pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 243pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-372">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 0.47pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging gain after taxation transferred to<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; non-financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-373">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-21" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-374">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 252.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-375">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 270.75pt; width: 201.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 270.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-25" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-376">1,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 270.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-26" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-377">3,440</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 270.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-27" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-378">4,363</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 270.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-28" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-379">1,448</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 270.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-29" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-380">10,598</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 270.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-30" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="f-381">502</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 270.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-382">10,096</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 282pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 282pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 282pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 282pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-383">4,928</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 282pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 282pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-384">4,928</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 282pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" name="ifrs-full:ProfitLoss" scale="6" id="f-385">380</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 282pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-386">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 293.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 293.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 293.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 293.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-387">45</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 293.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-388">247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 293.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-389">292</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 293.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-390">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 293.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-391">317</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 304.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 304.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 304.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 304.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-392">4,883</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 304.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-393">247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 304.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-394">4,636</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 304.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-395">355</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 304.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-396">4,991</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 315.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 315.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 315.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 315.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 315.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 315.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 315.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="f-397">412</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 315.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="f-398">412</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 327pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contributions from non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 327pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 327pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 327pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 327pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 327pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 327pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" name="gsk:IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" scale="6" id="f-399">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 327pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" scale="6" id="f-400">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 338.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 338.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 338.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 338.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-401">2,247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 338.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 338.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-402">2,247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 338.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 338.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-403">2,247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 349.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Realised after tax profit/(losses) on disposal or liquidation of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 349.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 349.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 349.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" scale="6" id="f-404">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 349.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" scale="6" id="f-405">26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 349.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-406">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 349.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 349.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-407">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 369.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of associates and joint ventures realised<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; profits/(losses) on disposal of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 369.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 369.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 369.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" scale="6" id="f-408">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 369.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" scale="6" id="f-409">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 369.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-410">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 369.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 369.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-411">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 390pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares issued<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 390pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-36" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-412">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 390pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-37" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-413">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 390pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 390pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 390pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-414">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 390pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 390pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-415">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 399.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Write-down of shares held by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 399.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 399.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 399.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-416">324</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 399.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-417">324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 399.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-418">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 399.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 399.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-419">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 411pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 411pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 411pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-37" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-420">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 411pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-421">283</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 411pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-422">285</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 411pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:fixed-zero" scale="6" id="f-423">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 411pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 411pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:fixed-zero" scale="6" id="f-424">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 422.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 422.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 422.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 422.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-425">307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 422.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 422.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-426">307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 422.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 422.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-427">307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 433.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging gain after taxation transferred to<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; non-financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 433.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 433.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 433.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 433.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-428">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 433.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-429">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 433.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 433.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-430">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 453.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 453.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 453.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 453.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-431">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 453.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 453.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-33" decimals="-6" sign="-" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-432">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 453.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 453.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-433">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 463.5pt; width: 201.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-38" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-434">1,348</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-39" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-435">3,451</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-40" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-436">7,239</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-41" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-437">1,309</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-42" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-438">13,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 463.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-43" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="f-439">552</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 463.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-440">12,795</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 474.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-441">2,575</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-442">2,575</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 474.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" name="ifrs-full:ProfitLoss" scale="6" id="f-443">376</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 474.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-444">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 486pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-445">83</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-446">86</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-447">169</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 486pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-448">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 486pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-449">173</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 497.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income/(expense) for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-450">2,492</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-451">86</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-452">2,406</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 497.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-453">372</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 497.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="f-454">2,778</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 508.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 508.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="f-455">416</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 508.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="f-456">416</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 519.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contributions from non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 519.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 519.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 519.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 519.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 519.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 519.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" name="gsk:IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" scale="6" id="f-457">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 519.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" scale="6" id="f-458">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 531pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 531pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 531pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 531pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 531pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 531pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 531pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" name="gsk:IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" scale="6" id="f-459">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 531pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" scale="6" id="f-460">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 542.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 542.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 542.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 542.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-461">2,444</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 542.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 542.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-462">2,444</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 542.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 542.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DividendsPaid" format="ixt:num-dot-decimal" scale="6" id="f-463">2,444</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 553.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deconsolidation of former subsidiary<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 553.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 553.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 553.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 553.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 553.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 553.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary" scale="6" id="f-464">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 553.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary" scale="6" id="f-465">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 564.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Realised after tax profit/(losses) on disposal or liquidation of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 564.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 564.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 564.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" scale="6" id="f-466">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 564.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" scale="6" id="f-467">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 564.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-468">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 564.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 564.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseThroughDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-469">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 585pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of associates and joint ventures realised<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; profits/(losses) on disposal of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 585pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 585pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 585pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" scale="6" id="f-470">52</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 585pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" scale="6" id="f-471">52</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 585pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-472">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 585pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 585pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-473">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 605.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares issued<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 605.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 605.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-48" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-474">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 605.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 605.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 605.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-475">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 605.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 605.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-476">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 615pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Write-down of shares held by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 615pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 615pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 615pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" sign="-" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-477">362</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 615pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-478">362</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 615pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-479">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 615pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 615pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-480">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 626.25pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 626.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 626.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-48" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-481">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 626.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-482">457</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 626.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:SharesAcquiredByEsopTrusts" scale="6" id="f-483">459</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 626.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:fixed-zero" scale="6" id="f-484">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 626.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 626.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:SharesAcquiredByEsopTrusts" format="ixt:fixed-zero" scale="6" id="f-485">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 637.5pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 637.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 637.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 637.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-486">344</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 637.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 637.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-487">344</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 637.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 637.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="6" id="f-488">344</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 648.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 0.85pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging gain/(loss) after taxation transferred to<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; non-financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 648.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 648.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 648.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 648.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-489">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 648.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" sign="-" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-490">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 648.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 648.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-491">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 666.75pt; width: 201.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 201.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 666.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 666.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 666.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" sign="-" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-492">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 666.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 666.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-45" decimals="-6" sign="-" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-493">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 666.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 666.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" scale="6" id="f-494">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 676.5pt; width: 201.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 201.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201.75pt; position: var(--position); top: 676.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-49" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-495">1,348</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 241.5pt; position: var(--position); top: 676.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-50" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-496">3,473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 676.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-51" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-497">7,796</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 321pt; position: var(--position); top: 676.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-52" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-498">1,054</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 360.75pt; position: var(--position); top: 676.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-53" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-499">13,671</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 676.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-54" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="f-500">585</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 450.75pt; position: var(--position); top: 676.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.16pt;"></span></span><span style="left: 13.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-501">13,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 804.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A<span style="display: inline-block; height: 5.09pt;"></span></span><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 69.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n analysis of Other reserves is presented as part of Note 38, &#8216;Movements in equity&#8217;.<span style="display: inline-block; height: 5.09pt;"></span></span></ix:footnote></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">185<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 13.94pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated cash flow statement<span style="display: inline-block; height: 15.28pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 39.94pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the year ended <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 91.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_367"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow from operating activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation from continuing operations for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 29.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-502">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 29.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-503">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 29.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-504">4,921</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjustments reconciling profit after tax to operating cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_517">42</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForReconcileProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-505">4,910</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForReconcileProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-506">2,788</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForReconcileProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-507">3,023</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash generated from operations attributable to continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 51.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperations" format="ixt:num-dot-decimal" scale="6" id="f-508">7,861</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 51.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperations" format="ixt:num-dot-decimal" scale="6" id="f-509">8,096</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 51.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperations" format="ixt:num-dot-decimal" scale="6" id="f-510">7,944</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-511">1,307</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-512">1,328</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-513">1,310</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash inflow/(outflow) from continuing operating activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-514">6,554</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-515">6,768</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-516">6,634</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash generated from operations attributable to discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-517">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-518">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" scale="6" id="f-519">932</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation paid from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-520">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-521">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" scale="6" id="f-522">163</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net operating cash flows attributable to discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-523">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-524">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="f-525">769</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net cash inflow/(outflow) from operating activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 119.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-526">6,554</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 119.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-527">6,768</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 119.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-528">7,403</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 133.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow from investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchase of property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-529">1,399</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-530">1,314</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-531">1,143</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proceeds from sale of property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="f-532">65</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="f-533">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="f-534">146</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 167.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchase of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 167.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-535">1,583</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 167.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-536">1,030</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 167.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-537">1,115</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 178.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proceeds from sale of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 178.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="f-538">131</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 178.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="f-539">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 178.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="f-540">196</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchase of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 189.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" scale="6" id="f-541">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 189.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" scale="6" id="f-542">123</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 189.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" scale="6" id="f-543">143</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 201pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Increase)/decrease in liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInLiquidInvestments" scale="6" id="f-544">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInLiquidInvestments" scale="6" id="f-545">72</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInLiquidInvestments" scale="6" id="f-546">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 212.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchase of businesses, net of cash acquired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_514">41</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="f-547">805</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-548">1,457</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-549">3,108</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 223.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proceeds from sale of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 223.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-550">2,356</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 223.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-551">1,832</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 223.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" scale="6" id="f-552">238</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share transactions with non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 234.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" scale="6" id="f-553">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 234.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" format="ixt:fixed-zero" scale="6" id="f-554">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 234.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" format="ixt:fixed-zero" scale="6" id="f-555">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 246pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 246pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:OutflowOfCashThroughCCLClassifiedAsInvestingActivities" scale="6" id="f-556">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 246pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:OutflowOfCashThroughCCLClassifiedAsInvestingActivities" scale="6" id="f-557">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 246pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:OutflowOfCashThroughCCLClassifiedAsInvestingActivities" scale="6" id="f-558">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 257.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposal of businesses <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 257.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_514">41</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 257.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="f-559">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 257.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="f-560">49</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 257.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="f-561">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments in joint ventures and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 268.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-562">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 268.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-563">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 268.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-564">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Proceeds from disposal of associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 279.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-565">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 279.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-566">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 279.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-567">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 291pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest received<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="6" id="f-568">138</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="6" id="f-569">115</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="6" id="f-570">64</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 302.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend and distributions from investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 302.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" scale="6" id="f-571">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 302.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" scale="6" id="f-572">220</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 302.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" format="ixt:fixed-zero" scale="6" id="f-573">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 313.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends from joint ventures and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 313.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" scale="6" id="f-574">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 313.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" scale="6" id="f-575">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 313.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" scale="6" id="f-576">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash inflow/(outflow) from continuing investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 324.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-577">1,229</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 324.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-578">1,595</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 324.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-579">4,981</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 336pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investing cash flows attributable to discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 336pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-580">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 336pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-581">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 336pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-582">3,791</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 347.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net cash inflow/(outflow) from investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 347.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-583">1,229</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 347.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-584">1,595</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 347.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-585">8,772</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 364.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow from financing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 375.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issue of share capital<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 375.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_499">37</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 375.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-586">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 375.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-587">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 375.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-588">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 387pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of long-term loans <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 101.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 387pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-589">1,615</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 387pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-590">2,260</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 387pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-591">6,668</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 398.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issue of long-term notes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 398.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-592">1,075</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 398.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" scale="6" id="f-593">223</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 398.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-594">1,025</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 409.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net increase/(decrease) in short-term loans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 409.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ProceedsRepaymentsFromOfShortTermLoans" scale="6" id="f-595">811</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 409.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ProceedsRepaymentsFromOfShortTermLoans" scale="6" id="f-596">333</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 409.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ProceedsRepaymentsFromOfShortTermLoans" format="ixt:num-dot-decimal" scale="6" id="f-597">1,021</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 420.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in other short-term loans <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 112.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseInOtherShortTermLoans" scale="6" id="f-598">266</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncreaseDecreaseInOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-599">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncreaseDecreaseInOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-600">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 432pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of other short-term loans <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 122.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 432pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RepaymentOfOtherShortTermLoans" scale="6" id="f-601">81</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 432pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RepaymentOfOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-602">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 432pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RepaymentOfOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-603">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 443.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 443.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="f-604">226</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 443.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="f-605">197</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 443.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="f-606">202</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 454.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 454.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="6" id="f-607">632</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 454.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="6" id="f-608">766</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 454.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="6" id="f-609">848</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 465.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 465.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-610">2,444</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 465.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-611">2,247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 465.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-612">3,467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 477pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions to non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 477pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" scale="6" id="f-613">416</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 477pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" scale="6" id="f-614">412</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 477pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" scale="6" id="f-615">521</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 488.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contributions from non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 488.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" scale="6" id="f-616">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 488.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" scale="6" id="f-617">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 488.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" scale="6" id="f-618">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other financing items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 499.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="f-619">129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 499.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="f-620">334</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 499.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="f-621">376</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 510.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash inflow/(outflow) from continuing financing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 510.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-622">4,726</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 510.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-623">5,641</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 510.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-624">9,251</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 522pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net financing cash flows attributable to discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-625">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-626">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-627">10,074</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 533.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net cash inflow/(outflow) from financing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 533.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-628">4,726</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 533.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-629">5,641</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 533.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="6" id="f-630">823</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 544.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in cash and bank overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 544.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_520">43</a><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 544.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="6" id="f-631">599</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 544.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="6" id="f-632">468</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 544.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="6" id="f-633">546</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 561.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and bank overdrafts at the beginning of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 561.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-634">2,858</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 561.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-635">3,425</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 561.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-19" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-636">3,819</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 573pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 573pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="6" id="f-637">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 573pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="6" id="f-638">99</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 573pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="6" id="f-639">152</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 584.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in cash and bank overdrafts in the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 584.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="6" id="f-640">599</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 584.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="6" id="f-641">468</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 584.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="6" id="f-642">546</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 595.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and bank overdrafts at the end of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 595.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-643">3,403</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 595.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-644">2,858</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 595.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-645">3,425</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 609.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and bank overdrafts at end of year comprise:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 621pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 621pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-646">3,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 621pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-647">2,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 621pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-648">3,723</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 632.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 632.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="f-649">467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 632.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="f-650">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 632.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="f-651">298</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 643.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-652">3,403</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 643.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-653">2,858</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 643.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-654">3,425</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 778.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 474.75pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 12pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><ix:footnote id="fn-2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><div style="height: 26.25pt; left: 12pt; overflow: hidden; position: var(--position); top: 0pt; width: 474.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 474.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, there was a change in the presentation of cash flows from long-term and other short-term loans. For further information see Note <span style="display: inline-block; height: 5.09pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 422.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_520">43</a><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 429.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 474.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">'Reconciliation of net cash flow to movement in net debt'.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></ix:footnote></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">186<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 45.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 45.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 13.59pt; width: 484.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_370"></div><div style="position: absolute; top: 114.19pt;" id="idc89fa1ee07645df9629d157a4b46752_376"></div><div style="position: var(--position); top: 114.19pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="f-655" continuedAt="f-655-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1. Presentation of the financial statements <span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-655-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 152.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Description of business<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is a global biopharma group which prevents and treats <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease with specialty medicines, vaccines and general <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines. GSK focuses on the science of the immune system <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 199.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and advanced technologies, investing in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="therapeuticarea" contextRef="c-9" decimals="INF" name="gsk:NumberOfTherapeuticAreas" format="ixt-sec:numwordsen" scale="0" id="f-656">four</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> core therapeutic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 209.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">areas: respiratory, immunology and inflammation; oncology; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 219.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV; and infectious diseases.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 235.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Compliance with applicable law and IFRS<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 251.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements have been prepared in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 261.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with UK-adopted international accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 271.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards in conformity with the requirements of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 281.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies Act 2006 and the International Financial Reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standards as issued by the IASB ("IFRS Accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Standards").<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 318.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Composition of the consolidated financial <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 331.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">statements<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements are for the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consisting of GSK plc and its subsidiaries. The consolidated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements are drawn up in Sterling, the functional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency of GSK plc, and in accordance with the presentation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 388.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements of IFRS Accounting Standards. The consolidated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements comprise:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 414.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated income statement<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 425.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated statement of comprehensive income<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated balance sheet<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated statement of changes in equity<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated cash flow statement<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 486.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Composition of the Group<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A list of the subsidiaries and associates which, in the opinion of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Directors, principally affected the amount of profit or net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets of the Group is given in Note 46, &#8216;Principal Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 548.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial period<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:PeriodCoveredByFinancialStatements" id="f-657" continuedAt="f-657-1">These consolidated financial statements cover the financial </ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span></div><ix:continuation id="f-657-1" continuedAt="f-657-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year from 1 January to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 140.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, with comparative <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">figures for the financial years from 1 January to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and, where appropriate, from 1 January to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 605.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-657-2" continuedAt="f-657-3">2022</ix:continuation><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-657-3">.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 621.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Accounting principles and policies<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 636.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Directors have, at the time of approving the consolidated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements, a reasonable expectation that the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has adequate resources to continue in operational existence for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the foreseeable future. Thus, the financial statements have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been prepared on a going concern basis and using the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 687.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">historical cost convention modified by the revaluation of certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">items, as stated in the accounting policies. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 714pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements have been prepared in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 724.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the Group&#8217;s accounting policies approved by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 734.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board as described in Note 2, &#8216;Accounting principles and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 744.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policies&#8217;. Information on the application of these accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 754.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policies, including areas of estimation and judgement is given in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 765pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 3, &#8216;Critical accounting judgements and key sources of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 775.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimation uncertainty&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The preparation of the consolidated financial statements in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conformity with generally accepted accounting principles <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requires management to make estimates and assumptions that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect the reported amounts of assets and liabilities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosure of contingent assets and liabilities at the date of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated financial statements and the reported amounts of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenues and expenses during the reporting period. Actual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results could differ from those estimates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In preparing the consolidated financial statements, the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has evaluated the potential effects of both physical and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transitional climate change risks, along with planned mitigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efforts, on the valuation of assets and liabilities; with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration of the risks outlined in the Task Force on Climate-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related Financial Disclosures (TCFD).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As of 31 December 2024, the Group has determined that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related risks do not have a material impact on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant judgements and estimates and, as a result, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valuation of the assets or liabilities have not been impacted. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has reviewed the recoverable values of key assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impacted such as property, plant, and equipment, inventories, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 368.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">goodwill, and intangible assets given their potential exposure to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 378.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related risks, as well as the Group&#8217;s planned transition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 388.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">efforts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 404.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Among the risks identified is the impact on metered dose <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 414.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inhalers (MDI). The Group is mitigating this risk by transitioning <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to a lower-carbon propellant. This transition is not anticipated to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materially affect the recoverable amounts, or estimated useful <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lives, of related property, plant, and equipment. Additional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information can be found in Note 17 'Property, plant, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equipment'.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While the Group does not foresee any significant medium-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact at present, it remains aware of the evolving nature of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate-related risks. The Group continues to evaluate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implications on judgements and estimates, as well as on any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential effects on the preparation of the consolidated financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">187<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_379"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory" id="f-658" continuedAt="f-658-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 5.01pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2. Accounting principles and policies<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-658-1" continuedAt="f-658-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" id="f-659" continuedAt="f-659-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Consolidation<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-659-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The consolidated financial statements include:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the assets and liabilities, and the results and cash flows, of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Company and its subsidiaries, including ESOP Trusts;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s share of the results and net assets of associates <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and joint ventures; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s share of assets, liabilities, revenue and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 235.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expenses of joint operations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 251pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The financial statements of entities consolidated are made up <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 261.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to 31 December each year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Entities over which the Group has control are accounted for as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries and consolidated in the Group financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 297.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements. Control is achieved when an entity in the Group: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has power over the investee;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is exposed, or has rights, to variable returns from its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">involvement with the investee; and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has the ability to use its power to affect its returns.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This is generally through control over the financial and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating policies of the subsidiary.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where the Group has the ability to exercise joint control over, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and rights to, the net assets of entities, the entities are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounted for as joint ventures. Where the Group has the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ability to exercise joint control over an arrangement, but has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights to specified assets and obligations for specified liabilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the arrangement, the arrangement is accounted for as a joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operation. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where the Group has the ability to exercise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant influence over entities, they are accounted for as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associates<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The results, assets and liabilities of associates and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 475.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joint ventures are incorporated into the consolidated financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements using the equity method of accounting. The assets, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities, revenue and expenses of joint operations are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included in the consolidated financial statements in accordance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the Group&#8217;s rights and obligations. Interests acquired in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entities are consolidated from the date the Group acquires <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 536.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control and interests sold are de-consolidated from the date <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 546.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control ceases.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transactions and balances between subsidiaries are eliminated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and no profit before tax is taken on sales between subsidiaries <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">until the products are sold to customers outside the Group. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant proportion of profits on transactions with joint ventures, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 603.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joint operations and associates is also deferred until the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 613.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products are sold to third parties. Transactions with non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 623.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling interests are recorded directly in equity. Deferred tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 633.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relief on unrealised intra-Group profit is accounted for only to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 643.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the extent that it is considered recoverable.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 659.85pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" id="f-660" continuedAt="f-660-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business combinations<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-660-1" continuedAt="f-660-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 675.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business combinations are accounted for using the acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 685.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting method. Identifiable assets, liabilities and contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 696.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities acquired are measured at fair value at acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 706.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date. The consideration transferred is measured at fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 716.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and includes the fair value of any contingent consideration. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 732.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair value of contingent consideration liabilities is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 742.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reassessed at each balance sheet date with changes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 752.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in the income statement. Payments of contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 763.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration reduce the balance sheet liability and as a result <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 773.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are not recorded in the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The part of each payment relating to the original estimate of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value of the contingent consideration on acquisition is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reported within investing activities in the cash flow statement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the part of each payment relating to the increase in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability since the acquisition date is reported within operating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where fair value of the consideration transferred, together with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the non-controlling interest, exceeds the fair value of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 237.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets, liabilities and contingent liabilities acquired, the excess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is recorded as goodwill. The costs of effecting an acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are charged to the income statement in the period in which they <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are incurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill is capitalised as a separate item in the case of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries and as part of the cost of investment in the case of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">joint ventures and associates. Goodwill is denominated in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency of the operation acquired<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where fair value of the consideration transferred is below the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s interest in the net assets acquired, the difference is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised directly in the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where not all of the equity of a subsidiary is acquired the non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling interest is recognised either at fair value or at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-controlling interest&#8217;s share of the net assets of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiary, on a case-by-case basis. Changes in the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ownership percentage of subsidiaries are accounted for within <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.89pt; width: 595.44pt;"><ix:continuation id="f-660-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 433.78pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="f-661" continuedAt="f-661-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Foreign currency translation<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-661-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 449.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign currency transactions are booked in the functional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 459.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency of the Group company at the exchange rate ruling on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the date of transaction. Foreign currency monetary assets and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities are retranslated into the functional currency at rates of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange ruling at the balance sheet date. Exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">differences are included in the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On consolidation, assets and liabilities, including related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">goodwill, of overseas subsidiaries, associates and joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 536.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ventures, are translated into Sterling at rates of exchange ruling <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at the balance sheet date. The results and cash flows of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 557.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overseas subsidiaries, associates and joint ventures are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">translated into Sterling using average rates of exchange. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments arising when the opening net assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 593.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the profits for the year retained by overseas subsidiaries, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 603.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associates and joint ventures are translated into Sterling, less <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange differences arising on related foreign currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 624.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">borrowings which hedge the Group&#8217;s net investment in these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 634.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations, are taken to a separate component of equity within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 644.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retained earnings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When translating into Sterling the assets, liabilities, results and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows of overseas subsidiaries, associates and joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 680.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ventures which are reported in currencies of hyper-inflationary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economies, adjustments are made where material to reflect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 701.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">current price levels. Any gain or loss on net monetary position <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 711.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is charged to the consolidated income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">188<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-658-2" continuedAt="f-658-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2. Accounting principles and policies continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="f-662" continuedAt="f-662-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Revenue<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-662-1"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 158.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group receives revenue for supply of goods to external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customers against orders received. The majority of contracts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 179.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that GSK enters into relate to sales orders containing single <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 189.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance obligations for the delivery of pharmaceutical and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 199.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine products. The average duration of a sales order is less <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 209.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than 12 months so there is no significant element of financing.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 225.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue from the product sales is recognised when control of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 235.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the goods is passed to the customer. The point at which control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 245.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">passes is determined by each customer arrangement, but <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 256.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generally occurs on delivery to the customer. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue from the product sales represents net invoice value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including fixed and variable consideration. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 212.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration arises on the sale of goods as a result of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discounts and allowances given and accruals for estimated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 312.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future returns and rebates<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Revenue is not recognised in full <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">until it is highly probable that a significant reversal in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount of cumulative revenue recognised will not occur. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">methodology and assumptions used to estimate rebates and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">returns are monitored and adjusted regularly in the light of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 363.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contractual and legal obligations, historical trends, past <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experience and projected market conditions. Estimates <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated with returns and rebates are revisited at each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 394.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting date or when they are resolved and revenue is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 404.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted accordingly. Please refer to Note 3, 'Critical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 414.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting judgements and key sources of estimation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 425.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncertainty' for the details on rebates, discounts and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowances.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has entered into collaboration agreements, typically <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with other pharmaceutical or biotechnology companies to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">develop, produce and market medicines and vaccines that do <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not qualify as joint arrangements. When GSK has control over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the commercialisation activities, the Group recognises turnover <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and cost of sales on a gross basis. Profit sharing amounts and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">royalties due to the counterparty are recorded within cost of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales. Cost of sales includes cost of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-663">7</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 229.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recoveries of cost of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-664">45</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 176.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: cost of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 226.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-665">1,635</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from profit sharing arrangements and royalties due to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">counterparty. When the counterparty controls the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercialisation activities and records the sale, the Group is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not the principal in the customer contract and instead records <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its share of gross profit as co-promotion income, on a net basis, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 593.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within turnover. The nature of co-promotion activities is such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that the Group records no costs of sales. Commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operations turnover includes co-promotion revenue of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 624.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RevenueFromCoPromotionalActivities" format="ixt:num-dot-decimal" scale="6" id="f-666">1</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 94.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RevenueFromCoPromotionalActivities" format="ixt:num-dot-decimal" scale="6" id="f-667">1</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 176.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RevenueFromCoPromotionalActivities" format="ixt:num-dot-decimal" scale="6" id="f-668">3</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 216.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Reimbursements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 634.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to and from the counterparty under collaboration agreements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 644.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for &#8216;selling, general and administration&#8217; and &#8216;research and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 655.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development&#8217; costs are recorded net in the respective lines in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 665.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 142.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other operating income and royalty income<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK enters into development and marketing collaborations and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out-licences of the Group&#8217;s compounds or products to other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties. These contracts give rise to fixed and variable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration from upfront payments, development milestones, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales-based milestones and royalties. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income dependent on the achievement of a development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">milestone is recognised when it is highly probable that a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant reversal in the amount of cumulative revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised will not occur, which is usually when the related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">event occurs. Sales-based milestone income is recognised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when it is highly probable that the sales threshold will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reached.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales-based royalties on a licence of intellectual property are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not recognised until the relevant product sale occurs. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For all revenue, if the time between the recognition of revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and payment from the customer is expected to be more than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one year and the impact is material, the amount of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration is discounted using appropriate discount rates. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Value added tax and other sales taxes are excluded from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenue.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 388.71pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory" id="f-669" continuedAt="f-669-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Expenditure<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-669-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 404.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenditure is recognised in respect of goods and services <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 414.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">received when supplied in accordance with contractual terms. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 425pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provision is made when an obligation exists for a future liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in respect of a past event and where the amount of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obligation can be reliably estimated<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 435.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing start-up costs between validation and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achievement of normal production are expensed as incurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 487.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advertising and promotion expenditure is charged to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement as incurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 513.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shipment costs on inter-company transfers are charged to cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 523.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of sales; distribution costs on sales to customers are included <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in selling, general and administration expenditure. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Restructuring costs are recognised and provided for, where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate, in respect of the direct expenditure of a business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reorganisation where the plans are sufficiently detailed and well <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advanced, and where appropriate communication to those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affected has been undertaken.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 606.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Software as a service (SaaS) configuration costs are expensed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 616.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as they are incurred where the software being configured is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlled by the SaaS provider.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 642.74pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" id="f-670" continuedAt="f-670-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-670-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 658.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development expenditure is charged to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 668.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement in the period in which it is incurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 679.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Development expenditure is capitalised when the criteria for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 689.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognising an asset are met, usually when a regulatory filing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 699.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has been made in a major market and approval is considered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 709.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly probable. Property, plant and equipment used for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 719.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">research and development is capitalised and depreciated in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 730.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the Group&#8217;s policy.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">189<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-658-3" continuedAt="f-658-4"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2. Accounting principles and policies continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" id="f-671" continuedAt="f-671-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Legal and other disputes<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-671-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provision<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 88.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is made for the anticipated settlement costs of legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or other disputes against the Group where an outflow of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resources is considered probable and a reliable estimate can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be made of the likely outcome. In respect of product liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims related to certain products, provision is made when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there is sufficient history of claims made and settlements to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enable management to make a reliable estimate of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provision required to cover asserted and unasserted claims. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 60.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> certain cases, an incurred but not reported (IBNR) actuarial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technique is used to determine this estimate. In addition, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provision is made for legal or other expenses arising from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims received or other disputes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Group may become involved in legal proceedings, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of which it is not possible to meaningfully assess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether the outcome will result in a probable outflow, or to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quantify or reliably estimate the liability. In these cases, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate disclosure about such cases is included but no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provision is made. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Costs associated with claims made by the Group against third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties are charged to the income statement as they are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incurred.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 382.13pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="f-672" continuedAt="f-672-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pensions and other post-employment <span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-672-1"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 395.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The costs of providing pensions under defined benefit schemes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are calculated using the projected unit credit method and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">spread over the period during which benefit is expected to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">derived from the employees&#8217; services, consistent with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advice of qualified actuaries. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension obligations are measured as the present value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimated future cash flows discounted at rates reflecting the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">yields of high-quality corporate bonds. Pension scheme assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are measured at fair value at the balance sheet date.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 514.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The costs of other post-employment liabilities are calculated in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 524.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a similar way to defined benefit pension schemes and spread <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 534.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over the period during which benefit is expected to be derived <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the employees&#8217; services, in accordance with the advice of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">qualified actuaries. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 571.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The service cost of providing retirement benefits to employees <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 581.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the year, together with the cost of any curtailment, is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charged to operating profit in the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 607.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Actuarial gains and losses and the effect of changes in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 617.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actuarial assumptions are recognised in the statement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 627.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprehensive income in the year in which they arise. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 643.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s contributions to defined contribution plans are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 653.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charged to the income statement as incurred.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="f-673" continuedAt="f-673-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Employee share plans<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-673-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Incentives in the form of shares are provided to employees <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under share option and share award schemes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair values of these options and awards are calculated at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their grant dates using a Black-Scholes option pricing model <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and charged to the income statement over the relevant vesting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">periods.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group provides finance to ESOP Trusts to purchase <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company shares to meet the obligation to provide shares when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees exercise their options or awards. Costs of running <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the ESOP Trusts are charged to the income statement. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares held by the ESOP Trusts are deducted from other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 265.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves. A transfer is made between other reserves and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retained earnings over the vesting periods of the related share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">options or awards to reflect the ultimate proceeds receivable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from employees on exercise.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 308.93pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="f-674" continuedAt="f-674-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-674-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment (PP&amp;E) is stated at the cost of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purchase or construction, less accumulated depreciation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accumulated impairment. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financing costs are capitalised within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 355.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the cost of qualifying assets in construction.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation is calculated to write off the cost less residual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of PP&amp;E, excluding freehold land and assets under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">construction, using the straight-line basis over the expected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">useful life. Residual values and expected useful lives are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reviewed, and where appropriate adjusted annually.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 496.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" id="f-675" continuedAt="f-675-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 498.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The normal <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-675-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected useful lives of the major categories of PP&amp;E are:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 438.2pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 114pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 122.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 114pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 114pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Freehold buildings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 0pt; width: 122.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-55" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-676">20</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 80.82000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 91.11000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-56" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-677">50</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 99.39000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 114pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 114pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leasehold land and buildings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 14.25pt; width: 122.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease term or <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-57" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-678">20</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 80.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 91.10999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-58" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-679">50</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 99.38999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 28.5pt; width: 114pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 114pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plant and machinery<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 28.5pt; width: 122.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-59" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-680">10</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 80.82000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 91.11000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-60" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-681">20</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 99.39000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 114pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 114pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equipment and vehicles<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 42.75pt; width: 122.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 122.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-61" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-682">3</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 80.82000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 91.11000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-62" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="f-683">10</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 99.39000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On disposal of PP&amp;E, the cost and related accumulated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depreciation and impairments are removed from the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements and the net amount, less any proceeds, is taken to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 536.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 552.38pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="f-684" continuedAt="f-684-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Leases<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-684-1" continuedAt="f-684-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group recognises right of use assets under lease <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 578.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements in which it is the lessee, except for short-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leases (defined as leases with a lease term of 12 months or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">less) and leases of low value assets. Rights to use assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">owned by third parties under lease agreements are capitalised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at the inception of the lease and recognised on the balance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet. Right of use assets are initially measured at the amount <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the corresponding lease liability plus lease payments made <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at or before the commencement day, initial incremental direct <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs, asset retirement obligations and less any lease <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incentives received. They are subsequently measured at cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 680.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">less accumulated depreciation and impairment losses. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 696.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The corresponding liability to the lessor is recognised as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 706.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lease obligation within short and long-term borrowings. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 716.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lease liability is initially measured at the discounted present <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 726.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of the lease payments that are not paid at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 737.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commencement date. The carrying amount of the lease liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 747.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is subsequently increased to reflect interest on the liability and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 757.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduced by lease payments made.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">190<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-658-4" continuedAt="f-658-5"><div><ix:continuation id="f-684-2" continuedAt="f-684-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 120.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2. Accounting principles and policies continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 136.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For calculating the discounted lease liability on leases with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 146.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual payments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-63" decimals="-6" name="gsk:ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" format="ixt:num-dot-decimal" scale="6" id="f-685">2</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> or more, or a non-cancellable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">term of more than 10 years, the implicit rate in the lease is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">used. If this is not available, the incremental borrowing rate with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a lease specific adjustment is used. If neither of these is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available, and for leases with annual payments of less than <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 275.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-64" decimals="-6" name="gsk:ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" scale="6" id="f-686">2</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or a non-cancellable term of 10 years or less<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incremental borrowing rate is used. The incremental borrowing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate is the r<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 95.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ate of interest at which GSK would have been able <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to borrow for a similar term and with a similar <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">security the funds <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">necessary to obtain a similar asset in a similar market.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance costs are charged to the income statement so as to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">produce a constant periodic rate of charge on the remaining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance of the obligations for each accounting period.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variable rents which are not linked to an index or a rate are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of the lease liability and the right of use asset. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments are charged to the income statement as incurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease rental costs for short-term and low-value leases which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are not capitalised are also charged to the income statement as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-lease components are accounted for separately from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lease components in plant and equipment leases. For land and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">buildings or vehicle leases the lease and non-lease <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">components are accounted for together in the lease when the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-lease components can be reliably determined in advance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 408.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and are charged directly by the lessor.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If modifications or reassessments of lease obligations occur, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the lease liability and right of use asset are remeasured.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets where title is expected to pass to GSK at a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">point in the future are depreciated on a basis consistent with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">similar owned assets. In other cases, right of use assets are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depreciated over the shorter of the useful life of the asset or the <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.02pt; width: 595.44pt;"><ix:continuation id="f-684-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lease term.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 95.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 506.91pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory" id="f-687" continuedAt="f-687-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-687-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill is stated at cost less accumulated impairments. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill is deemed to have an indefinite useful life and is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tested for impairment at least annually.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where the fair value of the interest acquired in an entity&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets, liabilities and contingent liabilities exceeds the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration paid, this excess is recognised immediately as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gain in the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 605.58pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" id="f-688" continuedAt="f-688-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other intangible assets<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-688-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets have a finite life and are stated at cost less <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accumulated amortisation and accumulated impairments. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Licences, patents, know-how and marketing rights separately <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquired or acquired as part of a business combination are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortised over their estimated useful lives, generally not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceeding<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 92.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 94.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-65" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-689">30</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 126.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> using the straight-line basis, from the time <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they are available for use. The estimated useful lives for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determining the amortisation charge take into account patent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 708.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lives (exclusivity period), where applicable, as well as the value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obtained from periods of non-exclusivity. For Pharmaceutical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 729.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intangible assets, depending on the characteristics, competitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment and estimated long-term profits of the asset, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 87.99000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="gsk:AmortisableProportionOverExclusivityPeriod" scale="-2" id="f-690">80</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 116.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-67" decimals="2" name="gsk:AmortisableProportionOverExclusivityPeriod" scale="-2" id="f-691">90</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 133.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the book value is amortised over the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exclusivity period on a straight-line basis and the remaining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 769.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">book value is amortised over a non-exclusivity period of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 260.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-68" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-692">5</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 269.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-69" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-693">15</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 279.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 780.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 74.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on a straight-line basis. For Vaccines intangible assets, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 790.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost is usually amortised over the patent period plus <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-70" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-694">10</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">,<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 136.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-71" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-695">30</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> if no patent is granted, on a straight-line basis. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 146.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asset lives are reviewed, and where appropriate adjusted, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annually. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent milestone payments are recognised at the point that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the contingent event becomes probable. Any development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs incurred by the Group subsequent to the acquisition of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">licences, patents, know-how or marketing rights are written off <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the income statement when incurred, unless the criteria for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognition of an internally generated intangible asset are met, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">usually when a regulatory filing has been made in a major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market and approval is considered highly probable.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 259.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acquired in process R&amp;D and marketed products are valued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independently as part of the fair value of businesses acquired <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from third parties where they have a value which is substantial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and long <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">term<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 356.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and where the assets either are contractual or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal in nature or can be sold separately from the rest of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">businesses acquired.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The costs of acquiring and developing computer software for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal use are capitalised as other intangible assets where the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">software supports a significant business system and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expenditure leads to the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 394.45000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> creation of a durable asset controlled <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Group. ERP systems software is amortised over <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-72" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-696">7</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 515.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-73" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-697">10</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years and other computer software over <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-74" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-698">2</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-75" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="f-699">5</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 467.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> using the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">straight-line basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group capitalises certain implementation costs related to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cloud computing arrangements when it has control over the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">underlying software.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 440.02pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" id="f-700" continuedAt="f-700-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of non-current assets<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-700-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The carrying amounts of all non-current assets are reviewed for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment, either on a stand-alone basis or as part of a larger <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash generating unit, when there is an indication that the assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">might be impaired. Additionally, goodwill and intangible assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which are not yet available for use are tested for impairment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annually. Any provision for impairment is charged to the income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statement in the year concerned.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairments of goodwill are not reversed. Impairment losses on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other non-current assets are only reversed if there has been a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change in estimates used to determine recoverable amounts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and only to the extent that the revised recoverable amounts do <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not exceed the carrying amounts that would have existed, net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of depreciation or amortisation, had no impairments been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 610.09pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory" id="f-701" continuedAt="f-701-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Investments in associates, joint ventures and <span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-701-1" continuedAt="f-701-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 623.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">joint operations<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments in associates and joint ventures are carried in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated balance sheet at the Group&#8217;s share of their net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 659.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets at date of acquisition and of their post-acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 669.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retained profits or losses and other comprehensive income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 679.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">together with any goodwill arising on the acquisition. The Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 690.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognises the assets, liabilities, revenue and expenses of joint <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 700.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-701-2">operations in accordance with its rights and obligations.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">191<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-658-5" continuedAt="f-658-6"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2. Accounting principles and policies continued<span style="display: inline-block; height: 8pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 299.73pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" id="f-702" continuedAt="f-702-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Inventories<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-702-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inventories are included in the consolidated financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements at the lower of cost (including raw materials, direct <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">labour, other direct costs and related production overheads) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and net realisable value. Cost is generally determined on a first <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in, first out basis. Pre-launch inventory is held as an asset when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there is a high probability of regulatory approval for the product. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Before that point a provision is made against the carrying <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount to reduce it to its net realisable value; the provision is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">then reversed at the point when a high probability of regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approval is determined.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial instruments<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" id="f-703" continuedAt="f-703-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financia<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 89.77pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">l assets<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-703-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets are measured at amortised cost, fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through other comprehensive income (FVTOCI) or fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through profit or loss (FVTPL). The measurement basis is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 312.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determined by reference to both the business model for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managing the financial asset and the contractual cash flow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">characteristics of the financial asset. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 191pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For financial assets other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than trade receivables a 12-month expected credit loss (ECL) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowance is recorded on initial recognition. If there is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 363.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsequent evidence of a significant increase in the credit risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of an asset, the allowance is increased to reflect the full lifetime <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ECL. If there is no realistic prospect of recovery, the asset is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 394.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">written off. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expected credit losses are recognised in the income statement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on financial assets measured at amortised cost and at fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 430.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value through other comprehensive income apart from equity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 440.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 456.82pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DescriptionOfAccountingPolicyForCurrentEquityInvestmentsExplanatoryPolicyTextBlock" id="f-704" continuedAt="f-704-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-704-1" continuedAt="f-704-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments comprise equity investments which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group holds with the intention to sell and which it may sell <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the short term. Where acquired with this intention, they are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at FVTPL. They are initially recorded at fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and then remeasured at subsequent reporting dates to fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value. Unrealised gains and losses are recognised in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend income is recognised in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement when the Group&#8217;s right to receive payment is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Purchases and sales of current equity investments <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.11pt; width: 595.44pt;"><ix:continuation id="f-704-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are accounted for on the trade date.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 187.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 578pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DescriptionOfAccountingPolicyForOtherInvestmentPolicyTextBlock" id="f-705" continuedAt="f-705-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other investments<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-705-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments comprise equity investments and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments in limited life funds. The Group has elected to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designate the majority of its equity investments as measured at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 622.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTOCI. They are initially recorded at fair value plus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction costs and then remeasured at subsequent reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 642.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dates to fair value. Unrealised gains and losses are recognised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in other <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprehensive income. On disposal of the equity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment, gains and losses that have been deferred in other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 673.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comprehensive income are transferred directly to retained <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 683.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 88.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 699.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments in limited life funds are measured at FVTPL. They <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 709.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are initially recorded at fair value and then remeasured at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 719.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsequent reporting dates to fair value. Unrealised gains and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 729.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">losses are recognised in the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends on equity investments and distributions from funds <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are recognised in the income statement when the Group&#8217;s right <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to receive payment is established. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purchases and sales of Other investments are accounted for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the trade date.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 207.55pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" id="f-706" continuedAt="f-706-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-706-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables are measured in accordance with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business model under which each portfolio of trade receivables <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 241.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is held. The Group has portfolios in each of the three business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 251.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">models under IFRS 9: to collect the contractual cash flows <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 261.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where there is no <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">factoring<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> agreement in place (measured at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortised cost); <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to sell the contractual cash flows where the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trade receivables will be sold under a factoring agreement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(measured at FVTPL)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; and both to collect and to sell the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contractual cash flows where the trade receivables may be sold <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 312.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under a factoring arrangement (measured at FVTOCI). Trade <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receivables measured at amortised cost are carried at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">original invoice amount less allowances for expected credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">losses.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expected credit losses are calculated in accordance with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">simplified approach permitted by IFRS 9, using a provision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 376.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matrix applying lifetime historical credit loss experience to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 386.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trade receivables. The expected credit loss rate varies <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depending on whether, and the extent to which, settlement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the trade receivables is overdue and it is also adjusted as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate to reflect current economic conditions and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimates of future conditions. For the purpose of determining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credit loss rates, customers are classified into groupings that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have similar loss patterns. The key drivers of the loss rate are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the nature of the business unit and the location and type of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customer.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">When a trade receivable is determined to have no reasonable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectation of recovery it is written off, firstly against any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected credit loss allowance available and then to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 524.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subsequent recoveries of amounts previously provided for or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">written off are credited to the income statement. Long-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receivables are discounted where the effect is material.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 558.2pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" id="f-707" continuedAt="f-707-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-707-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 571.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash comprises cash in hand and on-demand deposits at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 581.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bank. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents include cash in transit, deposits made with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">banks or financial institutions with a maturity of three months or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">less from the date of acquisition and are measured at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortised cost.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Investments in money market funds are held at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 635.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value through profit or loss because the funds fail the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">solely <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 645.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments of principal and interest on principal outstanding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 655.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SPPI) test<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 668.87pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory" id="f-708" continuedAt="f-708-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-708-1" continuedAt="f-708-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All borrowings are initially recorded at the amount of proceeds <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 692.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">received, net of transaction costs. Borrowings are subsequently <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 702.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carried at amortised cost, with the difference between the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 712.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceeds, net of transaction costs, and the amount due on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 723.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redemption being recognised as a charge to the income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 733.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statement over the period of the relevant borrowing.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">192<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-658-6" continuedAt="f-658-7"><ix:continuation id="f-708-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2. Accounting principles and policies continued<span style="display: inline-block; height: 8pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" id="f-709" continuedAt="f-709-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-709-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 153.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments are used to manage exposure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 163.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to market risks. The principal derivative instruments used by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK are foreign currency swaps, interest rate swaps, foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 184.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange forward contracts and options. The Group does not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hold or issue derivative financial instruments for trading or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">speculative purposes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial assets and liabilities, including derivatives <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">embedded in host contracts which have been separated from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 237.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the host contract, are measured at fair value. Changes in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value of any derivative instruments that do not qualify for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge accounting are recognised immediately in the income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 281.25pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForHedgingExplanatory" id="f-710" continuedAt="f-710-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Hedge accounting<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-710-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated as the hedging instruments are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">classified at inception of the hedge relationship as cash flow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 315.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedges, net investment hedges or fair value hedges. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes in the fair value of derivatives designated as cash flow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedges are recognised in other comprehensive income to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extent that the hedges are effective and accumulated in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flow hedge reserve. Ineffective portions are recognised in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss immediately. Amounts deferred in the cash flow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 382.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge reserve are reclassified to the income statement when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 392.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the hedged item affects profit or loss, or if the hedged forecast <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 402.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction is to purchase a non-financial asset, the amount <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deferred in the cash flow hedge reserve is transferred directly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from equity and included in the carrying amount of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 433.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised non-financial asset.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges are accounted for in a similar way to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 459.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flow hedges which are reclassified to the income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 469.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statement when the hedged item affects profit or loss.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes in the fair value of derivatives designated as fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedges are recorded in the income statement, together with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in the fair value of the hedged asset or liability.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 521.5pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="f-711" continuedAt="f-711-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-711-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current tax is provided at the amounts expected to be paid, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applying tax rates that have been enacted or substantively <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 557.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enacted by the balance sheet date. The tax charge for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period is recognised in the consolidated income statement, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 578.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated statement of comprehensive income or directly in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity, according to the accounting treatment of the related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax is provided in full, using the liability method, on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 624.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">temporary differences arising between the tax bases of assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 634.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and liabilities and their carrying amounts in the consolidated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 645.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements. Deferred tax assets are recognised to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 655.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extent that it is probable that future taxable profits will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 665.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available against which the temporary differences can be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 675.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">utilised. Deferred tax is provided on temporary differences <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 685.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arising on investments in subsidiaries, associates and joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 696.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ventures, except where the timing of the reversal of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 706.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">temporary difference can be controlled and it is probable that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 716.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the temporary difference will not reverse in the foreseeable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 726.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future. Deferred tax is provided using rates of tax that have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 736.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been enacted or substantively enacted by the balance sheet <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 747.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date. Deferred tax assets and liabilities are offset when there is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 757.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a legally enforceable right to offset current tax assets against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 767.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">current tax liabilities and when they relate to income taxes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 777.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">levied by the same tax authority and the Company and its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 787.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries intend to settle their current tax assets and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 798.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities on a net basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets and liabilities are not recognised if the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">temporary differences arise from the initial recognition of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">goodwill or from the initial recognition of other assets and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities in a transaction (other than a business combination) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that affects neither the accounting nor the taxable profit or loss. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The exception to this is situations where there are equal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taxable and deductible temporary differences arising from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">same transaction. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unrecognised deferred tax assets are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reassessed at each reporting date and are recognised to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">extent that it has become probable that future taxable profits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 241.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will allow the deferred tax asset to be recovered.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where an uncertain tax position is identified, management will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make a judgement as to what the probable outcome will be, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assuming the relevant tax authority has full knowledge of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">situation. Where it is assessed that an economic outflow is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">probable to arise, a provision is made for the best estimate of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the liability. In estimating any such liability GSK applies a risk-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based approach which takes into account, as appropriate, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">probability that the Group would be able to obtain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensatory adjustments under international tax treaties. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These estimates take into account the specific circumstances <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 359.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of each dispute and relevant external advice.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 375.76pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="f-712" continuedAt="f-712-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Restructuring<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-712-1" continuedAt="f-712-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Costs of restructuring arise from restructuring programmes that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are planned and controlled by the Group. A provision for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring is recognised when there is a detailed formal plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in place, and management has created a valid expectation by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">separately announcing the main features of the plan to those <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.65pt; width: 595.44pt;"><ix:continuation id="f-712-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affected by it, or has started implementation.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 458.54pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" id="f-713" continuedAt="f-713-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Discounting<span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-713-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where the time value of money is material, balances are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 484.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discounted to current values using appropriate discount rates. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 494.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The unwinding of the discounts is recorded in finance income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and finance expense.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 520.92pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" id="f-714" continuedAt="f-714-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Assets and liabilities held for sale or <span style="display: inline-block; height: 8pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-714-1" continuedAt="f-714-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 534.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">distribution and discontinued operations<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 550.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets or disposal groups are classified as held for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sale or distribution if their carrying amount will be recovered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principally through sale or a distribution to shareholders rather <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than through continuing use, they are available for sale or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution in their present condition and the sale or distribution <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is considered highly probable. Assets held in Assets held for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sale or distribution are measured at the lower of their carrying <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount and fair value less costs to sell or distribute. Assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included in Assets held for sale or distribution are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depreciated or amortised. Assets and liabilities classified as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held for sale or distribution are presented in current assets and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">current liabilities separately from the other assets and liabilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the balance sheet. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A discontinued operation is a component of the Group that has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been disposed of, distributed or is classified as held for sale or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 708.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution and that represents a separate major line of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business. The results of discontinued operations are presented <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 729.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">separately in the consolidated income statement, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated statement of comprehensive income and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated statement of cash flows and comparatives are <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.7pt; width: 595.44pt;"><ix:continuation id="f-714-2"><ix:continuation id="f-658-7"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restated on a consistent basis.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">193<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 106.3pt;" id="idc89fa1ee07645df9629d157a4b46752_382"></div><div style="position: var(--position); top: 106.3pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" id="f-715" continuedAt="f-715-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i99698226e98140b8b0a3babdf80b5c36_0-0-1-1-821446"></span><div style="height: 44.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3. Critical accounting judgements and key sources of <span style="display: inline-block; height: 13.46pt;"></span></span></div><div style="line-height: 18.5pt; position: var(--position); top: 23.9pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimation uncertainty <span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-715-1" continuedAt="f-715-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In preparing the financial statements, management is required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to make judgements about when or how items should be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in the financial statements and estimates and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assumptions that affect the amounts of assets, liabilities, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenue and expenses reported in the financial statements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Actual amounts and results could differ from those estimates. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following are considered to be the critical accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgements and key sources of estimation uncertainty.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 248.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reported Group turnover for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 161.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-716">31,376</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 256.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 280.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-717">30,328</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 290.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Estimates<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross turnover is reduced by rebates, discounts, allowances <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and product returns given or expected to be given, which vary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by product arrangements and buying groups. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements with purchasing organisations are dependent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upon the submission of claims some time after the initial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 355pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognition of the sale. Accruals are made at the time of sale <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the estimated rebates, discounts or allowances payable or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">returns to be made, based on available market information and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">historical experience.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales of pharmaceutical and vaccine products in the US have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complex arrangements for rebates, discounts and allowances. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover of Commercial Operations products in the US for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-76" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-718">16,384</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 140.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-77" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-719">15,820</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) was after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recording deductions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-76" decimals="-6" name="gsk:CustomerReturnsDiscountsAndRebates" format="ixt:num-dot-decimal" scale="6" id="f-720">14,100</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-77" decimals="-6" name="gsk:CustomerReturnsDiscountsAndRebates" format="ixt:num-dot-decimal" scale="6" id="f-721">16,539</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 284.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for rebates, allowances, returns and other discounts. At <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the total accrual amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-78" decimals="-6" name="gsk:CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" format="ixt:num-dot-decimal" scale="6" id="f-722">5,235</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 472.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-79" decimals="-6" name="gsk:CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" format="ixt:num-dot-decimal" scale="6" id="f-723">5,951</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Due to the nature of these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 483.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accruals it is not practicable to give meaningful sensitivity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 493.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimates due to the large volume of variables that contribute to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 503.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the overall rebates, chargebacks, returns and other revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 513.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accruals.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As there can be significant variability in final outcomes, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group applies a constraint when measuring the variable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">element within revenue, so that revenue is recognised at a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suitably cautious amount. The objective of the constraint is to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensure that it is highly probable that a significant reversal of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenue will not occur when the uncertainties are resolved. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">constraint is applied by making suitably cautious estimates of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the inputs and assumptions used in estimating the variable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration. Because the amounts are estimated they may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not fully reflect the final outcome, and the amounts are subject <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to change dependent upon, amongst other things, the types of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">buying group and product sales mix. The constraints applied in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 651.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognising revenue mean that the risk of a material downward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment to revenue in the next financial year is low.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The level of accrual for rebates and returns is reviewed and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted regularly in the light of contractual and legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obligations, historical trends, past experience and projected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 708.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market conditions. Market conditions are evaluated using <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wholesaler and other third-party analyses, market research <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 729.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data and internally generated information. It is reasonably <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">possible that there could be a significant adjustment within the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">next 12 months to recognise additional revenue, if actual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcomes are better than the cautious constrained estimates. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue is not recognised in full until it is highly probable that a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant reversal in the amount of cumulative revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised will not occur. The amount of turnover recognised in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the year from performance obligations satisfied in previous <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">periods is set out in Note 6, &#8216;Turnover and segment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information&#8217;, and is an indication of the level of sensitivity in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimate.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Future events could cause the assumptions on which the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accruals are based to change, which could materially affect the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future results of the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 274.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The tax charge for the year was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-80" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-724">526</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 498.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-81" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-725">756</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). At 31 December <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 417.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, current tax payable was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentTaxLiabilities" scale="6" id="f-726">703</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentTaxLiabilities" scale="6" id="f-727">500</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), non-current corporation tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 321.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="f-728">nil</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 416.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" scale="6" id="f-729">75</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and current tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recoverable was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentTaxAssets" scale="6" id="f-730">489</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 436.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentTaxAssets" scale="6" id="f-731">373</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 347.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Judgement and estimates <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has open tax issues with a number of revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities. Management makes a judgement of whether there <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is sufficient information to be able to make a reliable estimate of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the outcome of the dispute. If insufficient information is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available, no provision is made.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If sufficient information is available, in estimating a potential tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability GSK applies a risk-based approach which takes into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">account, as appropriate, the probability that the Group would be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">able to obtain compensatory adjustments under international <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax treaties. These estimates take into account the specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances of each dispute and relevant external advice, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are inherently judgemental and could change substantially over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time as each dispute progresses and new facts emerge. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 504.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 317.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had recognised provisions of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 514.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:UncertainTaxPositionsRecognised" scale="6" id="f-732">636</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in respect of uncertain tax positions (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 488.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:UncertainTaxPositionsRecognised" scale="6" id="f-733">584</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Due to the number of uncertain tax positions held and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the number of jurisdictions to which these relate, it is not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">practicable to give meaningful sensitivity estimates. No <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncertain tax position is individually material to the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 571.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Factors affecting the tax charge in future years are set out in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 581.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 14, &#8216;Taxation&#8217;. GSK continues to believe that it has made <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adequate provision for the liabilities likely to arise from open <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessments. Where open issues exist, the ultimate liability for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 612.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such matters may vary from the amounts provided and is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 622.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dependent upon the outcome of negotiations with the relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax authorities or, if necessary, litigation proceedings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 648.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Legal and other disputes<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 664.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legal costs for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:LegalCosts" format="ixt:num-dot-decimal" scale="6" id="f-734">1,964</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 495.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:LegalCosts" scale="6" id="f-735">271</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 674.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 684.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> provisions for legal and other disputes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 695.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:LegalProceedingsProvision" format="ixt:num-dot-decimal" scale="6" id="f-736">1,446</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 434.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:LegalProceedingsProvision" scale="6" id="f-737">267</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 478.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 708.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Judgement<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 721.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management makes a judgement of whether there is sufficient <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 731.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information to be able to make a reliable estimate of the likely <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 741.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcome of the dispute and the legal and other expenses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 752.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arising from claims against the Group. If insufficient information <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 762.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is available, no provision is made and disclosure of the claim is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 772.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">given.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">194<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-715-2" continuedAt="f-715-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 106.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">3. Critical accounting judgements <span style="display: inline-block; height: 8pt;"></span><span id="i0dc4df1721734fd6be3a54511197ca70_11543"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 230pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">and key sources of estimation uncertainty continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The estimated provisions take into account the specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 134.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances of each dispute and relevant external advice, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 144.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are inherently judgemental and could change substantially over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time as each dispute progresses and new facts emerge. Details <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 164.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the status and various uncertainties involved in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 174.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant unresolved disputes are set out in Note 47, &#8216;Legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company&#8217;s Directors, having taken legal advice, have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established provisions after taking into account the relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">facts and circumstances of each matter and in accordance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting requirements. In respect of product liability claims <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 241.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related to certain products, there is sufficient history of claims <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 251.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made and settlements to enable management to make a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 262.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable estimate of the provision required to cover unasserted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group may become involved in legal proceedings, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of which it is not possible to meaningfully assess <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">whether the outcome will result in a probable outflow, or to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 318.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quantify or reliably estimate the liability. In these cases, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate disclosure about such cases would be provided, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">but no provision would be made and no contingent liability can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be quantified. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The ultimate liability for legal claims may vary from the amounts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided and is dependent upon the outcome of litigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings, investigations and possible settlement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">negotiations. The position could change over time and, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 406.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therefore, there can be no assurance that any losses that result <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the outcome of any legal proceedings will not exceed the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 426.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount of the provisions reported in the Group&#8217;s financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements by a material amount.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 452.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> income statement charge for contingent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:GainLossOnContingentConsiderationAndPutOptionLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-738">1,762</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:GainLossOnContingentConsiderationAndPutOptionLiabilities" scale="6" id="f-739">768</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 494.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the liability for contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 504.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-82" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-740">7,280</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-83" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-741">6,662</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Of this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-84" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-742">6,061</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-85" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-743">5,718</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 218.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) related to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisition of the former Shionogi-ViiV Healthcare joint venture <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2012.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 551.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Estimates<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Any contingent consideration included in the consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable for a business combination is recorded at fair value at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the date of acquisition. These fair values are generally based <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on risk-adjusted future cash flows discounted using appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 605.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">post-tax discount rates. The fair values are reviewed on a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regular basis, and any changes are reflected in the income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statement. See Note 33, &#8216;Contingent consideration liabilities&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 645.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pensions and other post-employment <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 658.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 674.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Judgement<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where a surplus on a defined benefit scheme arises, or there is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential for a surplus to arise from committed future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 708.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contributions, the rights of the Trustees to prevent the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obtaining a refund of that surplus in the future are considered in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 729.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determining whether it is necessary to restrict the amount of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">surplus that is recognised. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-1" decimals="0" name="gsk:NumberOfPensionSchemesInSurplus" format="ixt-sec:numwordsen" scale="0" id="f-744">Three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> UK schemes are in surplus <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-10" decimals="0" name="gsk:NumberOfPensionSchemesInSurplus" format="ixt-sec:numwordsen" scale="0" id="f-745">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> UK schemes), with a combined surplus of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:DefinedBenefitPlanSurplusNet" scale="6" id="f-746">725</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:DefinedBenefitPlanSurplusNet" scale="6" id="f-747">457</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 772.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are further recognised pension surpluses totalling<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:PensionSurplus" scale="6" id="f-748">173</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 782.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> spread across <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="country" contextRef="c-1" decimals="0" name="gsk:NumberOfCountriesWithPensionSurpluses" format="ixt-sec:numwordsen" scale="0" id="f-749">five</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 148.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> countries (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:PensionSurplus" scale="6" id="f-750">177</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 793.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="country" contextRef="c-10" decimals="0" name="gsk:NumberOfCountriesWithPensionSurpluses" format="ixt-sec:numwordsen" scale="0" id="f-751">five</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 66.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> countries). GSK has made the judgement that these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 803.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounts meet the requirements of recoverability.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 126.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Estimates<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 140.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The costs of providing pensions and other post-employment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits are assessed on the basis of assumptions selected by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management. These assumptions include future earnings and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pension increases, discount rates, expected long-term rates of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">return on assets and mortality rates, and are disclosed in Note <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31, &#8216;Pensions and other post-employment benefits&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discount rates are derived from AA rated corporate bond yields <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 214.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">except in countries where there is no deep market in corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bonds where government bond yields are used. A sensitivity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">analysis is provided in Note 31, &#8216;Pensions and other post-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employment benefits&#8217;, a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="4" name="gsk:PercentageOfDecreaseInDiscountRate" scale="-2" id="f-752">0.25</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> reduction in the discount rate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">would lead to an increase in the net pension deficit of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 265.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-86" decimals="-6" name="gsk:IncreaseInPlanDeficit" scale="6" id="f-753">320</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and an increase in the annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pension cost of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-86" decimals="-6" name="gsk:IncreaseInAnnualPensionCost" scale="6" id="f-754">17</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Similarly, a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="4" name="gsk:PercentageOfIncreaseInDiscountRate" scale="-2" id="f-755">0.25</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 529.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in the discount rate would lead to a decrease in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">net pension deficit of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-86" decimals="-6" name="gsk:DecreaseInPlanDeficit" scale="6" id="f-756">309</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease in the annual pension cost of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-86" decimals="-6" name="gsk:DecreaseInAnnualPensionCost" scale="6" id="f-757">19</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 332.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-87" decimals="4" name="gsk:PercentageOfDecreaseInDiscountRate" scale="-2" id="f-758">0.75</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> reduction in the discount rate would lead to an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 342.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase in the net pension deficit of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 495.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-87" decimals="-6" name="gsk:IncreaseInPlanDeficit" format="ixt:num-dot-decimal" scale="6" id="f-759">1,012</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 352.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and an increase in the annual pension cost of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-87" decimals="-6" name="gsk:IncreaseInAnnualPensionCost" scale="6" id="f-760">51</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Similarly, a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 446.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-87" decimals="4" name="gsk:PercentageOfIncreaseInDiscountRate" scale="-2" id="f-761">0.75</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> increase in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discount rate would lead to a decrease in the net pension deficit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-87" decimals="-6" name="gsk:DecreaseInPlanDeficit" scale="6" id="f-762">883</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and a decrease in the annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pension cost of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-87" decimals="-6" name="gsk:DecreaseInAnnualPensionCost" scale="6" id="f-763">55</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The selection of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">different assumptions could affect the future results of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 429.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of intangible assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group's intangible assets primarily comprise acquired <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">licences, patents, amortised brands, and product development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, these assets have a carrying <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-88" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-764">14,936</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-89" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-765">14,166</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Intangible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets are tested for impairment when indicators of impairment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arise, or annually where the asset is not yet in use. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 509.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Estimates<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the inherent uncertainty in pharmaceutical development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and commercialisation, there is significant estimation involved <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in determining the recoverable amount of intangible assets. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recoverable amount of intangible assets is determined as the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">higher of their fair value less costs of disposal and their value in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use. The value in use is estimated using discounted cash flow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">models, which require estimates such as future sales forecasts, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discount rates, probability of technical and regulatory success <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 604.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(PTRS) and the results from research and development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 614.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities. The key source of estimation uncertainty is in relation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 624.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the portfolio of intangible assets as a whole. Based on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 635.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of assets held and the different assumptions for each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 645.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset, it is not practicable to give a meaningful sensitivity <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 655.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-715-3">analysis.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">195<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_385"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" id="f-766" continuedAt="f-766-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4. New accounting requirements<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-766-1"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS accounting standards applicable <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 162.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">from 1 January 2024<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has adopted the following amendments to IFRS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting standards, with no material impact to the Group in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Classification of Liabilities as Current or Non-current and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current Liabilities with Covenants - Amendments to IAS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplier Finance Arrangements - Amendments to IAS 7 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IFRS 7. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease Liability in a Sale and Leaseback - Amendments to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IFRS 16.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 296.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">New IFRS accounting standards and amendments <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">issued but not yet effective<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Certain amendments to IFRS accounting standards and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interpretations have been published that are not mandatory <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> reporting period<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and have not been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">early adopted by the Group. The amendments and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interpretations that <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are not expected to have a material impact <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the results or financial position of the Group in future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting periods<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 116.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lack of Exchangeability - Amendments to IAS 21 (effective <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from 1 January 2025, endorsed by the UKEB).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 418.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Classification and Measurement of Financial Instruments - <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 and IFRS 7 (effective from 1 January <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026, not yet endorsed by the UKEB).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IFRS 19 Subsidiaries without Public Accountability: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disclosures (effective from 1 January 2027, not yet endorsed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 475.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the UKEB).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contracts Referencing Nature-dependent Electricity - <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amendments to IFRS 9 and IFRS 7 (effective from 1 January <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026, not yet endorsed by the UKEB).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IFRS 18 Presentation<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and Disclosure in Financial Statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was issued by the IASB on 9 April 2024 and introduces new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">presentation and disclosure requirements, particularly for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Furthermore <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the new accounting standard provides enhanced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principles<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on aggregation and disaggregation of information <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and introduces new <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosures<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for Management Performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Measures.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The requirements are effective for periods beginning on or after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 January 2027 and are not yet endorsed by the UKEB.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is assessing the impact of adopting the new requirements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 281.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">introduced by IFRS 18, and will adopt the standard for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 291.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting period ending 31 December 2027, subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endorsement in the UK.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 543.73pt;" id="idc89fa1ee07645df9629d157a4b46752_388"></div><div style="position: var(--position); top: 543.73pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" id="f-767" continuedAt="f-767-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5. Exchange rates<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-767-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group uses the average of ex<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change rates prevailing during the period to translate the results and cash flows of overseas <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries, joint ventures and associates into Sterling and period end rates to translate the net assets of those entities.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1" name="gsk:SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" id="f-768" continuedAt="f-768-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 501.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-768-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies which most influence these translations and the relevant exchange rates were:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 618.46pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 101.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average rates:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US$/&#163;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-769">1.28</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-91" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-770">1.24</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-92" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-771">1.24</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Euro/&#163;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-772">1.18</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-773">1.15</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-95" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-774">1.17</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 48pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Yen/&#163;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-96" decimals="0" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-775">193</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-97" decimals="0" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-776">175</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-98" decimals="0" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-777">161</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 618.46pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 101.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Period end rates:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 24pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US$/&#163;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-99" decimals="2" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-778">1.25</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-100" decimals="2" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-779">1.27</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-101" decimals="2" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-780">1.20</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 36pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Euro/&#163;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-102" decimals="2" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-781">1.20</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-103" decimals="2" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-782">1.15</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-104" decimals="2" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-783">1.13</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 48pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Yen/&#163;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-105" decimals="0" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-784">197</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-106" decimals="0" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-785">180</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-107" decimals="0" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="f-786">159</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">196<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_391"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" id="f-787" continuedAt="f-787-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="iaa69ed5b47b64a3499303dc2ad625cc1_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6. Turnover and segment information<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-787-1" continuedAt="f-787-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating segments are reported based on the financial information provided to the Chief Executive Officer and the responsibilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the GSK Leadership Team (GLT).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 187.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK reports under<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 260.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="segments" contextRef="c-1" decimals="0" name="gsk:NumberOfReportableOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-788">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 275.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> s<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">egments; Commercial Operations and Total R&amp;D. Members of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GLT are responsible for each segment.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Originally, GSK reported 2021 results under <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 218.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="segments" contextRef="c-108" decimals="0" name="gsk:NumberOfReportableOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-789">four</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 232.98000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> segments: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceuticals, Pharmaceuticals R&amp;D, Vaccines and Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare. However, the reporting of operating segments was changed in 2022 and with the demerger of Consumer Healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">only <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 71.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="segments" contextRef="c-10" decimals="0" name="gsk:NumberOfReportableOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-790"><ix:nonFraction unitRef="segments" contextRef="c-109" decimals="0" name="gsk:NumberOfReportableOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-791"><ix:nonFraction unitRef="segments" contextRef="c-1" decimals="0" name="gsk:NumberOfReportableOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-792">two</ix:nonFraction></ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating segments are reportable. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There is no change to the reportable segments in the current or prior <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 476.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">periods<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 504.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D investment is essential for the sustainability of the business. However for segment reporting the Commercial Operating profits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exclude allocations of globally funded R&amp;D.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Total R&amp;D segment is the responsibility of the Chief Scientific Officer and is reported as a separate segment. The operating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs of this segment includes R&amp;D activities across Specialty Medicines, including HIV and Vaccines. It includes R&amp;D and some <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, General and Administrative (SG&amp;A) costs relating to regulatory and other functions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s management reporting process allocates intra-Group profit on a product sale to the segment in which that sale is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recorded, and the profit analyses below have been presented on that basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 312.88pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfTurnoverBySegmentExplanatoryTableTextBlock" id="f-793" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover by segment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-110" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-794">31,376</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-111" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-795">30,328</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-112" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-796">29,324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-797">31,376</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-798">30,328</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-799">29,324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product sales are reported within <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="productgroup" contextRef="c-1" decimals="0" name="gsk:NumberOfProductGroups" format="ixt-sec:numwordsen" scale="0" id="f-800">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> product groups: Vaccines, Specialty Medicines and General Medicines.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 382.21pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfProductsAndServicesExplanatory" id="f-801" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingles<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-113" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-802">3,364</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-114" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-803">3,446</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-115" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-804">2,958</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-116" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-805">1,437</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-117" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-806">1,260</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-118" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-807">1,116</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-119" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-808">590</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-120" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-809">1,238</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-121" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="f-810">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Influenza<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-122" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-811">408</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-123" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-812">504</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-124" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-813">714</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Established Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-125" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-814">3,339</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-126" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-815">3,266</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-127" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-816">3,085</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-128" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-817">9,138</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-129" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-818">9,714</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-130" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-819">7,873</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-131" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="f-820">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-132" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-821">150</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-133" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-822">64</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-134" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-823">9,138</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-135" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-824">9,864</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-136" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-825">7,937</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-137" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-826">7,089</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-138" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-827">6,444</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-139" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-828">5,749</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/Immunology and Other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-140" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-829">3,299</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-141" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-830">3,025</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-142" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-831">2,609</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-143" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-832">1,410</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-144" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-833">731</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-145" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-834">602</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-146" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-835">11,798</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-147" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-836">10,200</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-148" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-837">8,960</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-149" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-838">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-150" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-839">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-151" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-840">2,309</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-152" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-841">11,810</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-153" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-842">10,244</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-154" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-843">11,269</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 204.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 204.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-155" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-844">7,213</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 204.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-156" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-845">6,825</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 204.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-157" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-846">6,548</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 216.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other General Medicines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 216.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-158" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-847">3,215</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 216.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-159" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-848">3,395</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 216.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-160" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-849">3,570</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 228.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-161" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-850">10,428</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 228.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-162" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-851">10,220</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 228.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-163" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-852">10,118</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 246.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 246.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-110" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-853">31,376</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 246.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-111" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-854">30,328</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 246.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-112" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-855">29,324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">197<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-787-2" continuedAt="f-787-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">6. Turnover and segment information continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, sales were made to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="wholesalers" contextRef="c-1" decimals="0" name="gsk:NumberOfUSWholesalers" format="ixt-sec:numwordsen" scale="0" id="f-856">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US wholesalers of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 271.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-164" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-857">4,538</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 322.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 327.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-165" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-858">4,494</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-166" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-859">4,045</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 482.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-167" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-860">4,792</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-168" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-861">4,498</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 185.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 190.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-169" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-862">4,161</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 287.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-170" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-863">3,366</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-171" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-864">3,531</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 447.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-172" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-865">3,227</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respectively, after allocating final-customer discounts to the wholesalers.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue recognised in the year from performance obligations satisfied in previous periods impacting turnover arises from changes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to prior year estimates of RAR (returns and rebates) accruals of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 292.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RevenueFromChangesToEstimatesOfRARAccruals" scale="6" id="f-866">740</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 342.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RevenueFromChangesToEstimatesOfRARAccruals" scale="6" id="f-867">728</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 202.36pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" id="f-868" continuedAt="f-868-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Segment profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-173" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-869">15,335</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-174" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-870">14,656</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-175" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-871">13,590</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-176" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-872">5,845</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-177" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-873">5,607</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-178" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-874">5,060</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Segment profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-179" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-875">9,490</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-180" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-876">9,049</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-181" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-877">8,530</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate and other unallocated costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-182" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" scale="6" id="f-878">342</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-183" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" scale="6" id="f-879">263</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-184" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" scale="6" id="f-880">379</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reconciling items between segment profit and operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-185" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-881">5,127</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-186" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-882">2,041</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-187" decimals="-6" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-883">1,718</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-884">4,021</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-885">6,745</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-886">6,433</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-887">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-888">115</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-889">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-890">669</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-891">792</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-892">879</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain on disposal of interest in associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 117.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:GainLossOnDisposalOfInterestInAssociates" scale="6" id="f-893">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 117.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:GainLossOnDisposalOfInterestInAssociates" scale="6" id="f-894">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 117.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:GainLossOnDisposalOfInterestInAssociates" format="ixt:fixed-zero" scale="6" id="f-895">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 129.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after-tax losses of associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 129.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-896">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 129.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-897">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 129.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-898">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 141.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before taxation from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 141.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-899">3,477</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 141.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-900">6,064</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 141.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-901">5,628</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 153.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 153.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-902">526</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 153.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-903">756</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 153.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-904">707</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation for the year from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 165.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-905">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 165.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-906">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 165.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-907">4,921</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 390.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reconciling items between segment profit and operating profit comprise items not specifically allocated to segment profit. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These include impairment and amortisation of intangible assets; major restructuring costs, which include impairments of tangible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets and computer software; transaction-related adjustments related to significant acquisitions; proceeds and costs of disposals <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of products and businesses; significant legal charges and expenses on the settlement of litigation and government investigations; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other operating income other than royalty income, and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other items including amounts reclassified from the foreign currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">translation reserve to the income statement upon the liquidation of a subsidiary where the amount exceeds &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" format="ixt:num-dot-decimal" scale="6" id="f-908">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Please <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refer to the detail of Other reconciling items between segment profit and operating profit in the analysis of adjusting items in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group financial review.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 478.09pt; width: 595.44pt;"><ix:continuation id="f-868-1" continuedAt="f-868-2"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation and amortisation by segment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-173" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-909">906</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-174" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-910">893</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-175" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-911">829</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-176" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-912">569</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-177" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-913">572</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-178" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-914">467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Segment depreciation and amortisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-179" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-915">1,475</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-180" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-916">1,465</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-181" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-917">1,296</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate and other unallocated depreciation and amortisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-182" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-918">74</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-183" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-919">110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-184" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-920">112</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reconciling items between segment depreciation and amortisation and total depreciation and<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; amortisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-185" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-921">1,002</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-186" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-922">719</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-187" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" scale="6" id="f-923">739</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total depreciation and amortisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 87pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-924">2,551</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 87pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-925">2,294</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 87pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DepreciationAndAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-926">2,147</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">198<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-787-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">6. Turnover and segment information continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:continuation id="f-868-2" continuedAt="f-868-3"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="i1ec62ed4bc6141e2bd2b2de939752937_0-0-1-1-823259"></span><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PP&amp;E, intangible asset and goodwill impairment by segment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-173" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-927">102</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-174" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-928">27</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-175" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-929">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-176" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-930">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-177" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-931">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-178" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-932">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Segment impairment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-179" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-933">124</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-180" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-934">40</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-181" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-935">61</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate and other unallocated impairment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-182" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-936">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-183" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-937">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-184" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-938">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reconciling items between segment impairment and total impairment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-185" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-939">302</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-186" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-940">432</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-187" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-941">420</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total impairment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-942">437</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-943">507</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-944">501</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><ix:continuation id="f-868-3"><div style="position: var(--position); top: 230.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PP&amp;E and intangible asset impairment reversals by segment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-173" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-945">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-174" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-946">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-175" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-947">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 24.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 24.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-176" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-948">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 24.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-177" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-949">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 24.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-178" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-950">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Segment impairment reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 36.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-179" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-951">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 36.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-180" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-952">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 36.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-181" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-953">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate and other unallocated impairment reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-182" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-954">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-183" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-955">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-184" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-956">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reconciling items between segment impairment reversals and total impairment reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-185" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-957">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-186" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-958">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-187" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-959">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total impairment reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-960">33</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-961">39</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-962">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 323.16pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 443.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 353.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 25.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 25.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 16.97pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net operating assets by segment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 25.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-188" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-963">12,501</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 25.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-189" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-964">12,302</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-190" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-965">7,459</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-191" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-966">7,021</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Segment net operating assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 49.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-192" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-967">19,960</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 49.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-193" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-968">19,323</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate and other unallocated net operating assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-194" decimals="-6" name="gsk:NetOperatingAssets" scale="6" id="f-969">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-195" decimals="-6" name="gsk:NetOperatingAssets" scale="6" id="f-970">625</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 73.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net operating assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-971">20,003</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:NetOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="f-972">19,948</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 91.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NetDebt" format="ixt:num-dot-decimal" scale="6" id="f-973">13,095</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 91.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NetDebt" format="ixt:num-dot-decimal" scale="6" id="f-974">15,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 103.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments in associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 103.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:InvestmentsInJointVenturesAndAssociates" scale="6" id="f-975">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 103.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:InvestmentsInJointVenturesAndAssociates" scale="6" id="f-976">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 115.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 115.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:fixed-zero" scale="6" id="f-977">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 115.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:num-dot-decimal" scale="6" id="f-978">2,204</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" scale="6" id="f-979">82</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="ifrs-full:DerivativeFinancialLiabilities" scale="6" id="f-980">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 139.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current and deferred taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 139.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:CurrentAndDeferredTaxation" format="ixt:num-dot-decimal" scale="6" id="f-981">6,161</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 139.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:CurrentAndDeferredTaxation" format="ixt:num-dot-decimal" scale="6" id="f-982">5,536</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets held for sale (excluding cash and cash equivalents)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 151.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="f-983">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 151.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="f-984">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 163.5pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 163.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NetAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-985">13,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 163.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NetAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-986">12,795</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Commercial Operations segment includes the Shionogi-ViiV Healthcare contingent consideration liability of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-196" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-987">6,061</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 520.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-197" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-988">5,718</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and the Pfizer put option of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-198" decimals="-6" name="gsk:PutOption" format="ixt:num-dot-decimal" scale="6" id="f-989">915</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 284.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 308.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-199" decimals="-6" name="gsk:PutOption" format="ixt:num-dot-decimal" scale="6" id="f-990">848</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 532.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">G<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 62.33pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">eographical informatio<span style="display: inline-block; height: 8pt;"></span><span id="ib84191dc3eac484f96385acf57e586f3_3563"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 179pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">n<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The UK is regarded as being the Group&#8217;s country of domicile<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 564.22pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" id="f-991" continuedAt="f-991-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover by location of customer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-200" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-992">708</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-201" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-993">693</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-202" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="f-994">695</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-203" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-995">16,384</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-204" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-996">15,820</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-205" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-997">14,542</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-206" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-998">14,284</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-207" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-999">13,815</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-208" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-1000">14,087</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">External turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-209" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-1001">31,376</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-210" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-1002">30,328</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-211" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="f-1003">29,324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-991-1"><div style="position: var(--position); top: 638.66pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 443.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 353.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets by location of subsidiary<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-212" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1004">7,803</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-213" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1005">6,464</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1006">13,977</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1007">13,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Belgium<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-216" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1008">5,378</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-217" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1009">5,337</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1010">5,588</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1011">6,606</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 353.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 353.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 353.25pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1012">32,746</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="f-1013">31,687</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 725.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets by location excludes amounts relating to other investments, deferred tax assets, derivative financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 735.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments, pension assets, amounts receivable under insurance contracts and certain other non-current receivables. There are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 745.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no other countries with individually material external revenue or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 290.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-current a<span style="display: inline-block; height: 6.18pt;"></span><span id="ib84191dc3eac484f96385acf57e586f3_3562"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ssets.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">199<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_394"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory" id="f-1014" continuedAt="f-1014-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">7. Other operating income/(expense)<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1014-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" id="f-1015" continuedAt="f-1015-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Upfront settlement income<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 86.50999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:UpfrontSettlementIncome" format="ixt:fixed-zero" scale="6" id="f-1016">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:UpfrontSettlementIncome" format="ixt:fixed-zero" scale="6" id="f-1017">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:UpfrontSettlementIncome" scale="6" id="f-1018">922</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value remeasurements of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" scale="6" id="f-1019">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" scale="6" id="f-1020">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" scale="6" id="f-1021">256</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposal of businesses and assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DisposalOfBusinessesAndAssets" scale="6" id="f-1022">246</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DisposalOfBusinessesAndAssets" scale="6" id="f-1023">61</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DisposalOfBusinessesAndAssets" scale="6" id="f-1024">215</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value remeasurements on contingent consideration recognised in business combinations<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 306.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-1025">1,751</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-1026">791</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-1027">1,607</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement of ViiV Healthcare put option liabilities and preferential dividends<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" scale="6" id="f-1028">67</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" scale="6" id="f-1029">245</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" scale="6" id="f-1030">85</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value adjustments on derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" format="ixt:fixed-zero" scale="6" id="f-1031">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" scale="6" id="f-1032">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" scale="6" id="f-1033">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other (expense)/income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:MiscellaneousOtherIncomeExpense" scale="6" id="f-1034">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:MiscellaneousOtherIncomeExpense" scale="6" id="f-1035">237</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:MiscellaneousOtherIncomeExpense" scale="6" id="f-1036">61</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1037">1,530</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="f-1038">363</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="f-1039">235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1015-1"><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 277.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 1 February 2022, ViiV Healthcare reached agreement with Gilead Sciences, Inc (Gilead) to settle the global patent infringement litigation relating to the <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 285.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercialisation of Gilead&#8217;s Biktarvy concerning ViiV Healthcare&#8217;s patents relating to dolutegravir, an anti-retroviral medication used, together with other <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 294.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines, to treat human immunodeficiency virus (HIV). Under the terms of the global settlement and licensing agreement, Gilead made an upfront <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 302.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payment of <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 101.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-7" name="gsk:UpfrontPayment" format="ixt:num-dot-decimal" scale="9" id="f-1040">1.25</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 138.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 142.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-220" decimals="-6" name="gsk:UpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="f-1041">922</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 179.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) to ViiV Healthcare on 15 February 2022. In addition, Gilead will also pay a <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 411.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="2" name="gsk:PercentageOfRoyaltyPayableOnFutureSales" scale="-2" id="f-1042">3</ix:nonFraction>%<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 421.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> royalty on all future US sales of <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 310.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biktarvy and in respect of the bictegravir component of any other future bictegravir-containing products sold in the US. These royalties will be payable by <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 319.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gilead to ViiV Healthcare from 1 February 2022 until the expiry of ViiV Healthcare&#8217;s US Patent No. 8,129,385 on 5 October 2027 and will be recorded as <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 327.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">royalty income in the income statement.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 338.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value remeasurements on contingent consideration disclosed above includes the fair value movements on related hedging contracts.<span style="display: inline-block; height: 5.09pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 358.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value remeasurements of equity investments in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> included a gain of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 342.46000000000004pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-221" decimals="-6" name="gsk:GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" scale="6" id="f-1043">22</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.90000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-222" decimals="-6" sign="-" name="gsk:GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-1044">17</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 446.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> loss) from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remeasurement<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the Group&#8217;s retained investment in Haleon plc. See details in Note 22, 'Current equity investments'.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposal of businesses and assets in 2024 and 2023 primarily includes <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 319.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">milestone income<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 400.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposal of businesses and assets in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 212.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> includes milestone income and the reversal of provisions no longer required. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">F<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 59.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">air val<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ue remeasurements on contingent consideration recognised as business combinations included a net charge of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 497.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-223" decimals="-6" name="ifrs-full:IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-1045">1,533</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 426.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> related to the acquisition of the former Shionogi-ViiV Healthcare joint venture, and a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-224" decimals="-6" name="ifrs-full:IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-1046">206</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> net charge payable to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis related to the Vaccines acquisition, together with fair value movements on related hedging contracts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other income in 2023 primarily included net income from dividends related to investments, including &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-222" decimals="-6" name="ifrs-full:DividendsReceived" format="ixt:num-dot-decimal" scale="6" id="f-1047">49</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 467pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> dividends received <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 463.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the retained investment in Haleon plc.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">200<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_397"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory" id="f-1048" continuedAt="f-1048-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8. Operating profit<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1048-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" id="f-1049" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following items have been included in operating profit:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee costs (Note 9)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="f-1050">8,759</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="f-1051">8,473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="f-1052">7,693</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Advertising<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdvertisingExpense" scale="6" id="f-1053">851</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdvertisingExpense" scale="6" id="f-1054">835</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdvertisingExpense" scale="6" id="f-1055">735</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distribution costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DistributionCosts" scale="6" id="f-1056">198</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DistributionCosts" scale="6" id="f-1057">199</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DistributionCosts" scale="6" id="f-1058">192</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation of property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1059">886</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1060">892</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1061">885</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of property, plant and equipment, net of reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1062">88</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1063">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1064">70</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation of right of use assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1065">211</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1066">190</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1067">176</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of right of use assets, net of reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ImpairmentOfRightOfUseAssetsNetOfReversals" scale="6" id="f-1068">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ImpairmentOfRightOfUseAssetsNetOfReversals" scale="6" id="f-1069">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ImpairmentOfRightOfUseAssetsNetOfReversals" scale="6" id="f-1070">40</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-1071">1,454</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-1072">1,212</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-1073">1,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of intangible assets, net of reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ImpairmentOfIntangibleAssetsNetOfReversal" scale="6" id="f-1074">317</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ImpairmentOfIntangibleAssetsNetOfReversal" scale="6" id="f-1075">418</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ImpairmentOfIntangibleAssetsNetOfReversal" scale="6" id="f-1076">365</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment of tangible and intangible assets held for sale, net of reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" format="ixt:fixed-zero" scale="6" id="f-1077">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" scale="6" id="f-1078">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" format="ixt:fixed-zero" scale="6" id="f-1079">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net foreign exchange (gains)/losses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="f-1080">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="f-1081">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="f-1082">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inventories:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Cost of inventories included in cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1083">6,495</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1084">6,576</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1085">6,137</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Write-down of inventories<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InventoryWritedown2011" format="ixt:num-dot-decimal" scale="6" id="f-1086">1,046</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InventoryWritedown2011" scale="6" id="f-1087">979</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InventoryWritedown2011" scale="6" id="f-1088">687</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Reversal of prior year write-down of inventories<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 186.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ReversalOfInventoryWritedown" scale="6" id="f-1089">630</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 186.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ReversalOfInventoryWritedown" scale="6" id="f-1090">598</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 186.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ReversalOfInventoryWritedown" scale="6" id="f-1091">483</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term lease charge<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 198.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="6" id="f-1092">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 198.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="6" id="f-1093">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 198.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="6" id="f-1094">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low-value lease charge<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 210.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="6" id="f-1095">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 210.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="6" id="f-1096">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 210.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="6" id="f-1097">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 222.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variable lease payments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 222.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" scale="6" id="f-1098">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 222.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" scale="6" id="f-1099">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 222.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" scale="6" id="f-1100">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fees payable to the company&#8217;s auditor and its associates in relation to the Group (see below)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 234.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="f-1101">23.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 234.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="f-1102">22.0</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 234.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="f-1103">26.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 409.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The reversals of prior year write-downs of inventories principally arise from the reassessment of usage or demand expectations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prior to inventory expiration.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 435.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net foreign exchange (gains)/losses include a net gain of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-225" decimals="-6" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="f-1104">87</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-226" decimals="-6" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="f-1105">34</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> gain; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 417.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-227" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="f-1106">2</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> loss) arising from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recycling of exchange on liquidation or disposal of overseas subsidiaries. The recycling of exchange on disposal of overseas <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associates is<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-228" decimals="-6" name="gsk:GainLossOnDisposalOfInterestInAssociates" format="ixt:fixed-zero" scale="0" id="f-1107">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-229" decimals="-6" name="gsk:GainLossOnDisposalOfInterestInAssociates" format="ixt:fixed-zero" scale="6" id="f-1108">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 158.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The recycling of exchange on disposal of overseas subsidiaries does not include recycling of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange on disposal of Consumer Healthcare subsidiaries as this is reported as Profit after taxation on demerger of discontinued <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included within operating profit are Major restructuring charges of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 298.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="f-1109">353</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 343.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" scale="6" id="f-1110">382</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 416.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 439.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" scale="6" id="f-1111">321</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), see Note <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10, &#8216;Major restructuring costs&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 518.14pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfAuditorsRemunerationExplanatory" id="f-1112" continuedAt="f-1112-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fees payable to the company&#8217;s auditor and its associates:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit of parent company and consolidated financial statements including attestation under <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; s.404 of Sarbanes-Oxley Act 2002<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-230" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1113">10.8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-231" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1114">10.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-232" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1115">10.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit of the company&#8217;s subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-233" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1116">10.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-234" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1117">10.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 40.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.83pt;"></span></span><span style="left: 31.459999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-235" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1118">9.7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total audit services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1119">21.1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1120">20.4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1121">20.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit-related and other assurance services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 64.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.83pt;"></span></span><span style="left: 31.459999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-5" name="gsk:AuditorsRemunerationForOtherAssuranceServices" scale="6" id="f-1122">2.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 64.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.83pt;"></span></span><span style="left: 31.459999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-5" name="gsk:AuditorsRemunerationForOtherAssuranceServices" scale="6" id="f-1123">1.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 64.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.83pt;"></span></span><span style="left: 31.459999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-5" name="gsk:AuditorsRemunerationForOtherAssuranceServices" scale="6" id="f-1124">6.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total audit services, audit-related and other assurance services<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-5" name="gsk:AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" scale="6" id="f-1125">23.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-5" name="gsk:AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" scale="6" id="f-1126">22.0</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-5" name="gsk:AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" scale="6" id="f-1127">26.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 617.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The other assurance services provided by the auditor related to agreed-upon procedures and other assurance services outside of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 627.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statutory audit requirements. Audit-related and other assurance services include <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-236" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" format="ixt:fixed-zero" scale="6" id="f-1128">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-237" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" format="ixt:fixed-zero" scale="6" id="f-1129">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 435.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-238" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" format="ixt:num-dot-decimal" scale="6" id="f-1130">4.4</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 478.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting accountant work performed in preparation for the Consumer Healthcare demerger. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 653.62pt; width: 595.44pt;"><ix:continuation id="f-1112-1" continuedAt="f-1112-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition to the above, fees paid to the auditor in respect of the GSK pension schemes were: <span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation></div><ix:continuation id="f-1112-2"><div style="position: var(--position); top: 669.51pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 349.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 18.75pt; width: 349.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 349.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Audit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.58pt;"></span></span><span style="left: 32.21pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-239" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1131">0.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.58pt;"></span></span><span style="left: 32.21pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-240" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1132">0.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.58pt;"></span></span><span style="left: 32.21pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-241" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="f-1133">0.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">201<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_403"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfEmployeeCostsExplanatory" id="f-1134" continuedAt="f-1134-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i84ab3913040d458d93ab3a7ce3569dcd_0-0-1-1-824494"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9. Employee costs<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1134-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" id="f-1135" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wages and salaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:WagesAndSalaries" format="ixt:num-dot-decimal" scale="6" id="f-1136">6,750</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:WagesAndSalaries" format="ixt:num-dot-decimal" scale="6" id="f-1137">6,706</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:WagesAndSalaries" format="ixt:num-dot-decimal" scale="6" id="f-1138">6,110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Social security costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:SocialSecurityContributions" scale="6" id="f-1139">862</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:SocialSecurityContributions" scale="6" id="f-1140">818</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:SocialSecurityContributions" scale="6" id="f-1141">763</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension and other post-employment costs, including augmentations (Note 31)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:PostEmploymentBenefitExpense" scale="6" id="f-1142">368</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:PostEmploymentBenefitExpense" scale="6" id="f-1143">356</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:PostEmploymentBenefitExpense" scale="6" id="f-1144">369</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1145">347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1146">321</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1147">314</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severance and other costs from integration and restructuring activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:TerminationBenefitsExpense" scale="6" id="f-1148">432</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:TerminationBenefitsExpense" scale="6" id="f-1149">272</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:TerminationBenefitsExpense" scale="6" id="f-1150">137</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="f-1151">8,759</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="f-1152">8,473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="f-1153">7,693</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group provides benefits to employees, commensurate with local practice in individual countries, including in some markets, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare insurance, subsidised car schemes and personal life assurance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.86pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" id="f-1154" continuedAt="f-1154-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The cost of share-based incentive plans is analysed as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1154-1"><div style="position: var(--position); top: 296.75pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share value plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-242" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1155">260</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-243" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1156">244</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-244" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1157">243</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Performance share plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-245" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1158">67</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-246" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1159">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-247" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1160">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share option plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-248" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1161">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-249" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1162">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-250" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1163">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash settled and other plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-251" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1164">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-252" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1165">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-253" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1166">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1167">347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1168">321</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-1169">314</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 386.19pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfNumberOfEmployeesTableTextBlock" id="f-1170" continuedAt="f-1170-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The average number of persons employed by the Group (including Directors) during the year:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1170-1"><div style="position: var(--position); top: 402.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-254" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1171">23,206</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-255" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1172">23,209</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="numberofemployees" contextRef="c-256" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1173">22,946</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-257" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1174">33,503</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-258" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1175">34,446</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="numberofemployees" contextRef="c-259" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1176">34,642</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-260" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1177">12,596</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-261" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1178">12,589</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="numberofemployees" contextRef="c-262" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1179">11,542</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total Continuing Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-1" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1180">69,305</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-10" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1181">70,244</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="numberofemployees" contextRef="c-11" decimals="0" name="gsk:AverageNumberOfEmployeesFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1182">69,130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discontinued Operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-1" decimals="0" name="gsk:AverageNumberOfEmployeesFromDiscontinuingOperations" format="ixt:fixed-zero" scale="0" id="f-1183">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-10" decimals="0" name="gsk:AverageNumberOfEmployeesFromDiscontinuingOperations" format="ixt:fixed-zero" scale="0" id="f-1184">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="numberofemployees" contextRef="c-11" decimals="0" name="gsk:AverageNumberOfEmployeesFromDiscontinuingOperations" format="ixt:num-dot-decimal" scale="0" id="f-1185">21,292</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-1" decimals="0" name="ifrs-full:AverageNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1186">69,305</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-10" decimals="0" name="ifrs-full:AverageNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1187">70,244</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="numberofemployees" contextRef="c-11" decimals="0" name="ifrs-full:AverageNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="f-1188">90,422</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note: Consumer Healthcare was divested on 18 July 2022 and is shown as Discontinued Operations in the above table<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The average monthly number of Group employees excludes temporary and contract staff.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.3pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" id="f-1189" continuedAt="f-1189-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The compensation of the Directors and senior management (members of the GLT) in aggregate, was as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1189-1"><div style="position: var(--position); top: 563.19pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wages and salaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="6" id="f-1190">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="6" id="f-1191">37</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="6" id="f-1192">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Social security costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:KeyManagementPersonnelCompensationSocialSecurityCosts" scale="6" id="f-1193">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:KeyManagementPersonnelCompensationSocialSecurityCosts" scale="6" id="f-1194">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:KeyManagementPersonnelCompensationSocialSecurityCosts" scale="6" id="f-1195">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension and other post-employment costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="6" id="f-1196">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="6" id="f-1197">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="6" id="f-1198">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="6" id="f-1199">38</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="6" id="f-1200">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="6" id="f-1201">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensation" scale="6" id="f-1202">77</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensation" scale="6" id="f-1203">74</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensation" scale="6" id="f-1204">66</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">202<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_406"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfMajorRestructuringCostsExplanatory" id="f-1205" continuedAt="f-1205-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10. Major restructuring costs<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1205-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Within the Pharmaceuticals sector, the highly regulated manufacturing operations and supply chains and long lifecycle of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business mean that restructuring programmes, particularly those that involve the rationalisation or closure of manufacturing or R&amp;D <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sites, are likely to take several years to complete. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major restructuring costs are those related to specific Board-approved Major restructuring programmes, including integration costs <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following material acquisitions, which are structural and are of a significant scale where the costs of individual or related projects <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceed <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 83.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-263" decimals="-6" name="gsk:MajorRestructuringCostThreshold" format="ixt:num-dot-decimal" scale="6" id="f-1206">25</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In January 2020, the Board approved a Separation restructuring programme to prepare for the separation of GSK into <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="company" contextRef="c-1" decimals="0" name="gsk:NumberOfCompaniesSplitInto" format="ixt-sec:numwordsen" scale="0" id="f-1207">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This programme is largely complete<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 232.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 236.35000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">After the acquisition of Sierra Oncology (July 2022) and Affinivax (August 2022), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Board approved a Major restructuring programme for the integration of significant acquisitions designed to integrate and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">achieve synergies. GSK acquired Bellus Health Inc<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. in June 2023 and Aiolos Bio, Inc. in February 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The total restructuring costs of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TotalRestructuringCosts" scale="6" id="f-1208">353</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 272.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TotalRestructuringCosts" scale="6" id="f-1209">382</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 317.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TotalRestructuringCosts" scale="6" id="f-1210">321</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) were incurred in the following areas: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Restructuring costs for separation of GSK into <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="company" contextRef="c-9" decimals="0" name="gsk:RestructuringNumberOfCompaniesSeparatedInto" format="ixt-sec:numwordsen" scale="0" id="f-1211">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> companies aiming to provide a robust and sustainable state for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical organisation<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Continued transformation of central functions, including GSK technology platforms and interfaces, to deliver greater digital <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 318.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">synergies, simplification of applications and staff reductions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 329.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The integration of acquisitions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.68pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfMajorRestructuringCostsChargedToOperatingProfitExplanatoryTableTextBlock" id="f-1212" continuedAt="f-1212-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of the costs charged to operating profit under these programmes was as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1212-1"><div style="position: var(--position); top: 367.57pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in provision for Major restructuring programmes (see Note 32)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" scale="6" id="f-1213">195</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" scale="6" id="f-1214">172</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" scale="6" id="f-1215">138</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount of provision reversed unused (see Note 32)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-264" decimals="-6" name="ifrs-full:ReversalOfProvisionsForCostOfRestructuring" scale="6" id="f-1216">51</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-265" decimals="-6" name="ifrs-full:ReversalOfProvisionsForCostOfRestructuring" scale="6" id="f-1217">55</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-266" decimals="-6" name="ifrs-full:ReversalOfProvisionsForCostOfRestructuring" scale="6" id="f-1218">111</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment (reversals)/losses recognised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-1219">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-1220">33</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-1221">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-cash charges/(credit)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherMaterialNoncashItems" scale="6" id="f-1222">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherMaterialNoncashItems" scale="6" id="f-1223">86</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherMaterialNoncashItems" scale="6" id="f-1224">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other cash costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:OtherCostsCashSettlement" scale="6" id="f-1225">163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:OtherCostsCashSettlement" scale="6" id="f-1226">146</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:OtherCostsCashSettlement" scale="6" id="f-1227">179</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TotalRestructuringCosts" scale="6" id="f-1228">353</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TotalRestructuringCosts" scale="6" id="f-1229">382</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TotalRestructuringCosts" scale="6" id="f-1230">321</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 469.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Provision reversals of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-264" decimals="-6" name="gsk:ProvisionReversalRestructuring" scale="6" id="f-1231">51</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 176.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> mainly relate to the Separation restructuring programme. Asset impairment credit of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.77000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:AssetImpairmentsCredit" scale="6" id="f-1232">12</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other non-cash charges of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 170.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:OtherNonCashCreditCharges" scale="6" id="f-1233">58</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> principally comprised fixed asset write-downs of manufacturing and accelerated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depreciation where asset lives have been shortened in the supply chain manufacturing network as a result of the Major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring programmes. All other charges have been or will be settled in cash and include site closure costs, consultancy and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">project management costs.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.7pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfRestructuringCostsExplanatoryTableTextBlock" id="f-1234" continuedAt="f-1234-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of Major restructuring charges by programme was as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1234-1"><div style="position: var(--position); top: 541.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 135pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 135pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 118.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Separation restructuring programme<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-264" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1235">200</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-264" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1236">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-264" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1237">236</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant acquisitions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-267" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1238">59</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-267" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1239">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-267" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1240">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legacy programmes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-268" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1241">48</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-268" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1242">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-268" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1243">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1244">307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1245">46</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1246">353</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 631.03pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 135pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 135pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 118.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-cash<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Separation restructuring programme<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-265" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1247">199</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-265" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1248">117</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-265" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1249">316</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant acquisitions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-269" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1250">65</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-269" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1251">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-269" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1252">66</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legacy programmes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-270" decimals="-6" sign="-" name="gsk:CashRestructuringCharges" scale="6" id="f-1253">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-270" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1254">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-270" decimals="-6" name="gsk:RestructuringCosts1" format="ixt:fixed-zero" scale="6" id="f-1255">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashRestructuringCharges" scale="6" id="f-1256">263</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:NonCashRestructuringCharges" scale="6" id="f-1257">119</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RestructuringCosts1" scale="6" id="f-1258">382</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 720.47pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" id="f-1259" continuedAt="f-1259-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of Major restructuring charges by income statement line was as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1259-1"><div style="position: var(--position); top: 730.67pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-271" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="f-1260">163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-272" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="f-1261">164</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-273" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="f-1262">102</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-271" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1263">160</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-272" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1264">216</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-273" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1265">180</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-271" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="f-1266">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-272" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="f-1267">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-273" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="f-1268">39</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #FFFFFF; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Other operating expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-271" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="f-1269">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-272" decimals="-6" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-1270">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-273" decimals="-6" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-1271">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-271" decimals="-6" name="gsk:CostChargedToOperatingProfit" scale="6" id="f-1272">353</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-272" decimals="-6" name="gsk:CostChargedToOperatingProfit" scale="6" id="f-1273">382</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-273" decimals="-6" name="gsk:CostChargedToOperatingProfit" scale="6" id="f-1274">321</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">203<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_409"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinanceIncomeExplanatory" id="f-1275" continuedAt="f-1275-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11. Finance income<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1275-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInterestIncomeExplanatory" id="f-1276" continuedAt="f-1276-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance income arising from:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets measured at amortised cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" scale="6" id="f-1277">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" scale="6" id="f-1278">48</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" scale="6" id="f-1279">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets measured at fair value through profit or loss<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" scale="6" id="f-1280">72</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" scale="6" id="f-1281">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" scale="6" id="f-1282">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Net losses)/net gains arising from net investment hedge relationships<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 229.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" scale="6" id="f-1283">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" format="ixt:fixed-zero" scale="6" id="f-1284">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" scale="6" id="f-1285">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other finance income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 67.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherFinanceIncome" scale="6" id="f-1286">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 67.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherFinanceIncome" scale="6" id="f-1287">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 67.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherFinanceIncome" scale="6" id="f-1288">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 79.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-1289">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 79.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-1290">115</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 79.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="f-1291">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1276-1"><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 254.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)&#160;  (Net losses)/net gains arising from net investment hedge relationships contains a <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 317.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-1292">15</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 350.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> loss relating to ineffectiveness on net investment hedges <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 262.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 67.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 82.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 86.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-1293">nil</ix:nonFraction><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 97.52000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 99.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 114.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 118.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-1294">nil</ix:nonFraction><span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 129.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 5.09pt;"></span></span></div></ix:continuation></ix:continuation><div style="position: absolute; top: 283.52pt;" id="idc89fa1ee07645df9629d157a4b46752_412"></div><div style="position: var(--position); top: 283.52pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="f-1295" continuedAt="f-1295-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12. Finance expense<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1295-1"><div style="position: var(--position); top: 321.96pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinanceCostExplanatory" id="f-1296" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance expense arising on:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Financial liabilities at amortised cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" scale="6" id="f-1297">569</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" scale="6" id="f-1298">672</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" scale="6" id="f-1299">789</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net losses arising from:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial instruments mandatorily measured at fair value through profit or loss<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" scale="6" id="f-1300">262</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" scale="6" id="f-1301">23</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" scale="6" id="f-1302">743</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retranslation of loans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:RetranslationOfLoan" scale="6" id="f-1303">266</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:RetranslationOfLoan" scale="6" id="f-1304">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RetranslationOfLoan" scale="6" id="f-1305">761</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of hedges from other comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ReclassificationAdjustmentsOnHedgesNetOfTax" scale="6" id="f-1306">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ReclassificationAdjustmentsOnHedgesNetOfTax" scale="6" id="f-1307">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ReclassificationAdjustmentsOnHedgesNetOfTax" scale="6" id="f-1308">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unwinding of discounts on provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" scale="6" id="f-1309">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" scale="6" id="f-1310">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" scale="6" id="f-1311">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance expense arising on lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="6" id="f-1312">46</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="6" id="f-1313">38</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="6" id="f-1314">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other finance expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherFinanceIncomeCost" scale="6" id="f-1315">29</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherFinanceIncomeCost" scale="6" id="f-1316">65</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherFinanceIncomeCost" scale="6" id="f-1317">33</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-1318">669</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-1319">792</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #FFFFFF; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="f-1320">879</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation><div style="position: absolute; top: 471.4pt;" id="idc89fa1ee07645df9629d157a4b46752_415"></div><div style="position: var(--position); top: 471.4pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAssociatesAndJointVenturesExplanatoryTextBlock" id="f-1321" continuedAt="f-1321-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13. Associates and joint ventures<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1321-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.84pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" id="f-1322" continuedAt="f-1322-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s share of after-tax profits and losses of associates and joint ventures is set out below:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1322-1"><div style="position: var(--position); top: 525.73pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after-tax (losses)/profits of associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-274" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1323">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-275" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1324">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-276" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1325">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after-tax losses of joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-1326">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1327">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-279" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1328">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1329">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1330">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-1331">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" id="f-1332" continuedAt="f-1332-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aggregated financial information in respect of GSK&#8217;s share of other associated undertakings and joint ventures is set out below:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1332-1"><div style="position: var(--position); top: 607.06pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 349.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 349.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 349.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after-tax losses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-280" decimals="-6" sign="-" name="ifrs-full:ProfitLoss" scale="6" id="f-1333">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-281" decimals="-6" sign="-" name="ifrs-full:ProfitLoss" scale="6" id="f-1334">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-282" decimals="-6" sign="-" name="ifrs-full:ProfitLoss" scale="6" id="f-1335">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 349.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 349.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of other comprehensive income/(expense)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-280" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-1336">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-281" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-1337">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-282" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-1338">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 349.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 349.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of total comprehensive income/(expense)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-280" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-1339">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-281" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-1340">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-282" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncome" scale="6" id="f-1341">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s sales to associates and joint ventures were &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 269.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:SalesToAssociatesAndJointVentures" format="ixt:fixed-zero" scale="0" id="f-1342">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 288.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:SalesToAssociatesAndJointVentures" format="ixt:fixed-zero" scale="0" id="f-1343">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 381.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:SalesToAssociatesAndJointVentures" format="ixt:fixed-zero" scale="0" id="f-1344">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Please refer to the balance sheet information on Note 21, 'Investments in associates and joint ventures'.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">204<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_418"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="f-1345" continuedAt="f-1345-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14. Taxation<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1345-1" continuedAt="f-1345-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfIncomeTaxExpenseBenefitsTableTextBlock" id="f-1346" continuedAt="f-1346-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s tax charge is the sum of the total current and deferred tax expense.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1346-1"><div style="position: var(--position); top: 167.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation charge based on profits for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK current year charge<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-283" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" scale="6" id="f-1347">186</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-284" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" scale="6" id="f-1348">207</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-285" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" scale="6" id="f-1349">200</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World current year charge<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-286" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="f-1350">1,458</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-287" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="f-1351">1,371</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-288" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="f-1352">1,351</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge/(credit) in respect of prior periods<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="6" id="f-1353">92</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="6" id="f-1354">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="6" id="f-1355">60</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="f-1356">1,552</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="f-1357">1,621</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="f-1358">1,491</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="f-1359">1,026</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="6" id="f-1360">865</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="6" id="f-1361">784</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-1362">526</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-1363">756</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-1364">707</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK made corporate income tax payments globally of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-8" name="ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="9" id="f-1365">1.3</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-8" name="ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities" scale="9" id="f-1366">1.3</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-283" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefund" scale="6" id="f-1367">106</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 512.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-284" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefund" scale="6" id="f-1368">205</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 279.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) was UK corporation tax paid to HMRC. These amounts are for corporate income tax only, and do not include the various <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other business taxes borne by GSK each year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 305.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The deferred tax credits in each period reflect current year losses where offset against taxable profits in future periods is probable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 315.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the release of deferred tax liabilities. The latter relates primarily to the unwind of deferred tax liabilities on intangible assets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.54pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" id="f-1369" continuedAt="f-1369-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table reconciles the tax charge calculated at the UK statutory rate on the Group profit before tax with the actual tax <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1369-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charge for the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 357.63pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reconciliation of taxation on Group profits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before tax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-1370">3,477</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-1371">6,064</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-1372">5,628</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK statutory rate of taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-283" decimals="-6" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="6" id="f-1373">869</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.95pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.95pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-283" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-1374">25.0</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-284" decimals="-6" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1375">1,425</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-284" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-1376">23.5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-285" decimals="-6" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1377">1,069</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-285" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-1378">19.0</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Differences in overseas taxation rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="6" id="f-1379">185</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.09pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.09pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" id="f-1380">5.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="6" id="f-1381">159</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" id="f-1382">2.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="6" id="f-1383">318</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" id="f-1384">5.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefit of intellectual property incentives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxEffectOfBenefitOfIntellectualPropertyIncentives" scale="6" id="f-1385">602</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.86pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="gsk:TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" scale="-2" id="f-1386">17.3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TaxEffectOfBenefitOfIntellectualPropertyIncentives" scale="6" id="f-1387">696</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.86pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="gsk:TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" scale="-2" id="f-1388">11.5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TaxEffectOfBenefitOfIntellectualPropertyIncentives" scale="6" id="f-1389">600</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.86pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.86pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" sign="-" name="gsk:TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" scale="-2" id="f-1390">10.7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D credits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxEffectOfResearchAndDevelopmentCredits" scale="6" id="f-1391">89</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="gsk:TaxRateEffectOfResearchAndDevelopmentCredits" scale="-2" id="f-1392">2.6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TaxEffectOfResearchAndDevelopmentCredits" scale="6" id="f-1393">121</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="gsk:TaxRateEffectOfResearchAndDevelopmentCredits" scale="-2" id="f-1394">2.0</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TaxEffectOfResearchAndDevelopmentCredits" scale="6" id="f-1395">119</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" sign="-" name="gsk:TaxRateEffectOfResearchAndDevelopmentCredits" scale="-2" id="f-1396">2.1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Permanent differences on disposals, acquisitions and transfers<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" scale="6" id="f-1397">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.09pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.09pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="gsk:TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" scale="-2" id="f-1398">0.1</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" scale="6" id="f-1399">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="gsk:TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" scale="-2" id="f-1400">0.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" scale="6" id="f-1401">275</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" name="gsk:TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" scale="-2" id="f-1402">4.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other permanent differences<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="6" id="f-1403">302</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.09pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.09pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="-2" id="f-1404">8.7</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="6" id="f-1405">102</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="-2" id="f-1406">1.7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="6" id="f-1407">82</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="-2" id="f-1408">1.5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Re-assessments of prior year current tax estimates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxEffectOfReassessmentsOfPriorYearEstimates" scale="6" id="f-1409">92</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="gsk:TaxRateEffectOfReassessmentsOfPriorYearEstimates" scale="-2" id="f-1410">2.6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:TaxEffectOfReassessmentsOfPriorYearEstimates" scale="6" id="f-1411">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 31.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 31.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="gsk:TaxRateEffectOfReassessmentsOfPriorYearEstimates" scale="-2" id="f-1412">0.7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TaxEffectOfReassessmentsOfPriorYearEstimates" scale="6" id="f-1413">60</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" sign="-" name="gsk:TaxRateEffectOfReassessmentsOfPriorYearEstimates" scale="-2" id="f-1414">1.1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Re-assessments of prior year deferred tax estimates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" scale="6" id="f-1415">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="gsk:TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" scale="-2" id="f-1416">1.2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" scale="6" id="f-1417">147</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="gsk:TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" scale="-2" id="f-1418">2.4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" scale="6" id="f-1419">233</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" sign="-" name="gsk:TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" scale="-2" id="f-1420">4.1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes in tax rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxEffectOfChangeInTaxRate" scale="6" id="f-1421">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="gsk:TaxRateEffectOfChangeInTaxRate" scale="-2" id="f-1422">0.3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TaxEffectOfChangeInTaxRate" scale="6" id="f-1423">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" sign="-" name="gsk:TaxRateEffectOfChangeInTaxRate" scale="-2" id="f-1424">0.3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:TaxEffectOfChangeInTaxRate" scale="6" id="f-1425">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 29pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 29pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" sign="-" name="gsk:TaxRateEffectOfChangeInTaxRate" scale="-2" id="f-1426">0.4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax charge/tax rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-1427">526</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.95pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.95pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="ifrs-full:AverageEffectiveTaxRate" scale="-2" id="f-1428">15.1</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-1429">756</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="ifrs-full:AverageEffectiveTaxRate" scale="-2" id="f-1430">12.5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-1431">707</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 27.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" name="ifrs-full:AverageEffectiveTaxRate" scale="-2" id="f-1432">12.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As a global biopharmaceutical company, we have a substantial business and employment presence in many countries around the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">world. The impact of differences in overseas taxation rates arose from profits being earned in countries with tax rates higher than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the UK statutory rate, the most significant of which in 2024 were France, Germany and Italy. This adverse impact was offset by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefit of intellectual property incentives such as the UK Patent Box and Belgian Innovation Income Deduction (IID) regimes, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide a reduced rate of corporation tax on profits earned from qualifying patents. We claim these incentives in the manner <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intended by the relevant statutory or regulatory framework. The introduction of new global minimum corporate income tax rules <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">introduced in the UK and Belgium with effect from 1 January 2024 (in line with the OECD&#8217;s Pillar 2 framework) resulted in a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduction in these incentives and an additional tax charge of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 283.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="f-1433">6</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 606.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other permanent differences includes the impact of the partial deductibility of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 341.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement costs.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 622.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s tax rate is also influenced by updates to estimates of prior period tax liabilities following closure of open issues with tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities in various jurisdictions and changes in tax rates. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 648.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Future tax charges, and therefore our effective tax rate, may be affected by factors such as acquisitions, disposals, restructuring, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 658.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the location of research and development activity, tax regime reforms and resolution of open matters as we continue to bring our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 668.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax affairs up to date around the world.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">205<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-1345-2" continuedAt="f-1345-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">14. Taxation continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" id="f-1434" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on items charged to equity and statement of comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1435">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1436">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1437">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1438">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1439">143</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1440">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1441">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1442">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1443">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1444">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1445">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1446">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" format="ixt:fixed-zero" scale="6" id="f-1447">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1448">150</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1449">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based payments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1450">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1451">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1452">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1453">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1454">184</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1455">211</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1456">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1457">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1458">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1459">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1460">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" scale="6" id="f-1461">68</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1462">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1463">169</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1464">277</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total charge/(credit) to equity and statement of comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1465">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1466">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" scale="6" id="f-1467">268</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All of the above items have been charged to the statement of comprehensive income except for tax on share-based payments. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 330.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Issues relating to taxation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are subject to taxation throughout our supply chain. The worldwide nature of our operations means that our <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 467.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cross-border <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">routes, necessary to ensure supplies of medicines into numerous countries, can result in conflicting claims from tax authorities as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the profits to be taxed in individual countries. This can lead to double taxation (with the same profits taxed in more than one <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">country). To mitigate the risk of double taxation, profits are recognised in territories by reference to the activities performed there <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the value they generate. To ensure the profits recognised in jurisdictions are aligned to the activity undertaken there, and in line <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with current OECD guidelines, we base our transfer pricing policy on the arm&#8217;s length principle and support our transfer prices with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">economic analysis and reports. The Group also has open items in several jurisdictions concerning such matters as the deductibility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of particular expenses and the tax treatment of certain business transactions. GSK applies a risk-based approach to determine the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 428.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions most likely to be subject to challenge and the probability that the Group would be able to obtain compensatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustments under international tax treaties.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The calculation of the Group&#8217;s total tax charge therefore necessarily involves a degree of estimation and judgement in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain items whose tax treatment cannot be finally determined until resolution has been reached with the relevant tax authority or, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as appropriate, through a formal legal process. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 311.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the Group had recognised provisions of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 462.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ProvisionsForUncertainTaxPosition" scale="6" id="f-1468">636</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 484.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of such uncertain tax positions (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 220.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ProvisionsForUncertainTaxPosition" scale="6" id="f-1469">584</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 269.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The net increase in recognised provisions during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 479.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was driven by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 494.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the reassessment of estimates and the agreement of a number of open issues with tax authorities in various jurisdictions. Whilst <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the ultimate liability for such matters may vary from the amounts provided and is dependent upon the outcome of agreements with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the relevant tax authorities, or litigation where appropriate, the Group continues to consider that it has made appropriate provision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for periods which are open and not yet agreed by the tax authorities.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A provision for deferred tax liabilities of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-289" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" scale="6" id="f-1470">159</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 244.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> as at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-290" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" scale="6" id="f-1471">165</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) has been made in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taxation that would be payable on the remittance of profits by certain overseas subsidiaries. Whilst the aggregate amount of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 561.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unremitted profits at the balance sheet date was approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-9" name="gsk:UnremittedEarnings" scale="9" id="f-1472">18</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 327.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 332.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 355.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-9" name="gsk:UnremittedEarnings" scale="9" id="f-1473">18</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 393.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), the majority of these unremitted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profits would not be subject to tax (including withholding tax) on repatriation, as UK legislation relating to company distributions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provides for exemption from tax for most overseas profits, subject to certain exceptions. Deferred tax is not provided on temporary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">differences of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:UnremittedProfitsForWhichDeferredTaxNotProvided" scale="6" id="f-1474">696</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 156.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:UnremittedProfitsForWhichDeferredTaxNotProvided" scale="6" id="f-1475">869</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) arising on unremitted profits as management has the ability to control any future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reversal and does not consider such a reversal to be probable.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">206<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-1345-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">14. Taxation continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" id="f-1476" continuedAt="f-1476-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movement in deferred tax assets and liabilities<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1476-1"><div style="position: var(--position); top: 155.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 161.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 44.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.26pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accelerated<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowances<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 13.26pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intra-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.46pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions &amp; <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.26pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other post <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employment <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">losses<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.46pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.26pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">option<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and award<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">schemes<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.46pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.26pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">net<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.06pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">temporary<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.86pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">differences<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 36.66pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 161.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-291" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1477">57</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 44.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-292" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1478">819</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-293" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1479">992</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 44.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-294" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1480">1,099</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-295" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1481">794</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 44.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-296" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1482">1,661</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-297" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1483">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-298" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1484">1,642</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 44.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1485">5,369</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 56.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-299" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1486">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 56.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.13pt;"></span></span><span style="left: 23.759999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-300" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1487">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-301" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1488">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 56.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.42pt;"></span></span><span style="left: 16.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-302" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1489">70</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 56.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-303" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1490">24</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 56.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.56pt;"></span></span><span style="left: 20.189999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-304" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1491">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 56.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-305" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1492">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 56.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-306" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1493">100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 56.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.28pt;"></span></span><span style="left: 11.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1494">127</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Credit/(charge) to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-307" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1495">72</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 68.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-308" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1496">229</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-309" decimals="-6" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1497">71</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 68.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.74pt;"></span></span><span style="left: 14.370000000000001pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-310" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1498">223</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-311" decimals="-6" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1499">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 68.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.74pt;"></span></span><span style="left: 14.370000000000001pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-312" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1500">335</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-313" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1501">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-314" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1502">80</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 68.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.74pt;"></span></span><span style="left: 14.370000000000001pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-315" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1503">865</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Credit/(charge) to statement of comprehensive<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 80.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-299" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1504">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 80.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-300" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1505">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-301" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1506">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 80.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-302" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1507">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 80.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-303" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1508">184</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 80.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-304" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1509">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 80.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-305" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1510">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 80.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-306" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1511">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 80.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.28pt;"></span></span><span style="left: 11.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1512">169</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions/disposals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 100.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-299" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1513">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 100.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-300" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="6" id="f-1514">144</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-301" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1515">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 100.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-302" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1516">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 100.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-303" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1517">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 100.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-304" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1518">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 100.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-305" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1519">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 100.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-306" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1520">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 100.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.28pt;"></span></span><span style="left: 11.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="6" id="f-1521">144</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D credits utilisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 112.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-299" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1522">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 112.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-300" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1523">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-301" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1524">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 112.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-302" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1525">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 112.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-303" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1526">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 112.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-304" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1527">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 112.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-305" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1528">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 112.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-306" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" scale="6" id="f-1529">56</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 112.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.42pt;"></span></span><span style="left: 16.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" scale="6" id="f-1530">56</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 124.5pt; width: 161.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 124.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-316" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1531">26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 124.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-317" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1532">676</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-318" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1533">921</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 124.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-319" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1534">1,252</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 124.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-320" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1535">571</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 124.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-321" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1536">1,994</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 124.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-322" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1537">74</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 124.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-323" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1538">1,576</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 124.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1539">5,738</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 136.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-324" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1540">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 136.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.67pt;"></span></span><span style="left: 21.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-325" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1541">37</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-326" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1542">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 136.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.42pt;"></span></span><span style="left: 16.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-327" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1543">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 136.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-328" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1544">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 136.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-329" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1545">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 136.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-330" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1546">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 136.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-331" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1547">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 136.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.42pt;"></span></span><span style="left: 16.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="6" id="f-1548">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Credit/(charge) to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 148.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-332" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1549">97</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 148.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.99pt;"></span></span><span style="left: 19.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-333" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1550">197</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 148.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-334" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1551">50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 148.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.88pt;"></span></span><span style="left: 18.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-335" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1552">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 148.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-336" decimals="-6" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1553">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 148.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 11.74pt;"></span></span><span style="left: 14.370000000000001pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-337" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1554">455</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 148.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.31pt;"></span></span><span style="left: 29.939999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-338" decimals="-6" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1555">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 148.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-339" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="6" id="f-1556">306</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 148.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-340" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-1557">1,026</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 160.5pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Credit/(charge) to statement of comprehensive<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 160.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-324" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1558">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 160.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-325" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1559">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 160.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-326" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1560">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 160.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-327" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1561">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 160.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-328" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1562">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 160.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-329" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1563">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 160.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-330" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="f-1564">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 160.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-331" decimals="-6" sign="-" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1565">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 160.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.28pt;"></span></span><span style="left: 11.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" scale="6" id="f-1566">100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acquisitions/disposals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-324" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1567">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 180.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-325" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="6" id="f-1568">190</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-326" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1569">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 180.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-327" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1570">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-328" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1571">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 180.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-329" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1572">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-330" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1573">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-331" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-1574">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 180.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 9.28pt;"></span></span><span style="left: 11.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="6" id="f-1575">190</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 161.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D credits utilisation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-324" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1576">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 192.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.27pt;"></span></span><span style="left: 27.9pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-325" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1577">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 192.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-326" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1578">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 192.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-327" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1579">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-328" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1580">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 192.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.02pt;"></span></span><span style="left: 22.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-329" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1581">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-330" decimals="-6" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" format="ixt:fixed-zero" scale="6" id="f-1582">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-331" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" scale="6" id="f-1583">69</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 192.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.42pt;"></span></span><span style="left: 16.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" scale="6" id="f-1584">69</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 204.75pt; width: 161.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 161.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 161.25pt; position: var(--position); top: 204.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-341" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1585">132</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 201pt; position: var(--position); top: 204.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.53pt;"></span></span><span style="left: 17.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-342" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1586">706</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 204.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-343" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1587">973</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 281.25pt; position: var(--position); top: 204.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-344" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1588">1,274</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 204.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-345" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1589">341</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351pt; position: var(--position); top: 204.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-346" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1590">2,449</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 381pt; position: var(--position); top: 204.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-347" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="f-1591">66</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420.75pt; position: var(--position); top: 204.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-348" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1592">1,846</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 460.5pt; position: var(--position); top: 204.75pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.55pt;"></span></span><span style="left: 8.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1593">6,375</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities in relation to intangible assets predominantly relate to temporary differences arising as a result of historic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business combinations. Acquisitions within the year predominantly relate to Aiolos Bio, Inc. (see Note 41, 'Acquisitions and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposals'). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group continues to recognise deferred tax assets on future obligations in respect of contingent consideration amounts payable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to minority shareholders. These payments are tax deductible at the point in time at which payment is made.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A deferred tax asset is recognised on intra-Group profits arising on inter-company inventory which are eliminated within the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated accounts. As intra-Group profits are not eliminated from the individual entities&#8217; tax returns a temporary difference <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arises that will reverse at the point in time inventory is sold externally.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The deferred tax asset of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DeferredTaxAssetsRecognizedOnTradingLosses" format="ixt:num-dot-decimal" scale="6" id="f-1594">2,449</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 206.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 229.85000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DeferredTaxAssetsRecognizedOnTradingLosses" format="ixt:num-dot-decimal" scale="6" id="f-1595">1,994</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) recognised on tax losses relates to trading losses. Such deferred tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets are only recognised to the extent Group long-range forecasts indicate sufficient future taxable profits will be available to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">utilise such assets (forecast by around 2030). Other net temporary differences included accrued expenses for which a tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deduction is only available on a paid basis.The Group has adopted the mandatory temporary exception to the recognition and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosure of deferred taxes arising from the jurisdictional implementation of the Pillar Two model rules, as required under IAS 12.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.67pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" id="f-1596" continuedAt="f-1596-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax asset and liabilities are recognised on the balance sheet as follows<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1596-1"><div style="position: var(--position); top: 554.56pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="f-1597">6,757</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="f-1598">6,049</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" scale="6" id="f-1599">382</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" scale="6" id="f-1600">311</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1601">6,375</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-1602">5,738</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="position: var(--position); top: 620pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="f-1603" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unrecognised tax losses and attributes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax losses<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unrecognised <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deferred tax <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax losses<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unrecognised <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deferred tax <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trading losses and attributes expiring:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Within 10 years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-349" decimals="-6" name="gsk:TaxLosses" format="ixt:num-dot-decimal" scale="6" id="f-1604">1,034</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-349" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1605">145</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-350" decimals="-6" name="gsk:TaxLosses" scale="6" id="f-1606">939</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-350" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1607">149</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 69.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">More than 10 years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-351" decimals="-6" name="gsk:TaxLosses" format="ixt:num-dot-decimal" scale="6" id="f-1608">1,598</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-351" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1609">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-352" decimals="-6" name="gsk:TaxLosses" format="ixt:num-dot-decimal" scale="6" id="f-1610">1,238</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-352" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1611">66</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Available indefinitely<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-353" decimals="-6" name="gsk:TaxLosses" scale="6" id="f-1612">693</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-353" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1613">161</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-354" decimals="-6" name="gsk:TaxLosses" scale="6" id="f-1614">228</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-354" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1615">47</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TaxLosses" format="ixt:num-dot-decimal" scale="6" id="f-1616">3,325</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1617">390</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:TaxLosses" format="ixt:num-dot-decimal" scale="6" id="f-1618">2,405</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnTradingLosses" scale="6" id="f-1619">262</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 111pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capital losses expiring:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Available indefinitely<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-353" decimals="-6" name="gsk:CapitalLosses" format="ixt:num-dot-decimal" scale="6" id="f-1620">2,253</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-353" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnCapitalLosses" scale="6" id="f-1621">565</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-354" decimals="-6" name="gsk:CapitalLosses" format="ixt:num-dot-decimal" scale="6" id="f-1622">2,261</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-354" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnCapitalLosses" scale="6" id="f-1623">567</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 135pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CapitalLosses" format="ixt:num-dot-decimal" scale="6" id="f-1624">2,253</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnCapitalLosses" scale="6" id="f-1625">565</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CapitalLosses" format="ixt:num-dot-decimal" scale="6" id="f-1626">2,261</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 135pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:UnrecognisedDeferredTaxAssetOnCapitalLosses" scale="6" id="f-1627">567</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 777.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax assets are only recognised where it is probable that future taxable profit will be available to utilise losses.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">207<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_421"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="f-1628" continuedAt="f-1628-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 490.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 490.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 490.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15. Earnings per share<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1628-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:EarningsPerShareExplanatory" id="f-1629" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.799999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pence<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.799999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pence<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pence<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-1630">63.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-1631">121.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-1632">110.8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-1633">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-1634">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="-2" id="f-1635">260.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total basic earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:BasicEarningsLossPerShare" scale="-2" id="f-1636">63.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:BasicEarningsLossPerShare" scale="-2" id="f-1637">121.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShare" scale="-2" id="f-1638">371.4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted earnings per share from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-1639">62.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-1640">119.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" scale="-2" id="f-1641">109.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted earnings per share from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-1642">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" format="ixt:fixed-zero" scale="-2" id="f-1643">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" scale="-2" id="f-1644">257.0</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total diluted earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.69pt;"></span></span><span style="left: 27.32pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="3" name="ifrs-full:DilutedEarningsLossPerShare" scale="-2" id="f-1645">62.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="3" name="ifrs-full:DilutedEarningsLossPerShare" scale="-2" id="f-1646">119.9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:DilutedEarningsLossPerShare" scale="-2" id="f-1647">366.2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 76.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings per share<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> has been calculated by dividing the profit attributable to shareholders by the weighted average number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares in issue during the period after deducting shares held by the ESOP Trusts for the future exercise of share options and share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards and Treasury shares. The trustees have waived their rights to cash dividends on the GSK shares held by the ESOP Trusts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted earnings per share has been calculated after adjusting the weighted average number of shares used in the basic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calculation to assume the conversion of all potentially dilutive shares. A potentially dilutive share forms part of the employee share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">schemes where its exercise price is below the average market price of GSK shares during the period and any performance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions attaching to the scheme have been met at the balance sheet date. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.55pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" id="f-1648" continuedAt="f-1648-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The numbers of shares used in calculating basic and diluted earnings per share are reconciled&#8239;below.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1648-1"><div style="position: var(--position); top: 365.44pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted average number of shares in issue<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.939999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">millions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.939999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">millions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.939999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">millions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="f-1649">4,077</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="f-1650">4,052</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-6" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="f-1651">4,026</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dilution for share options and awards<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" scale="6" id="f-1652">65</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" scale="6" id="f-1653">59</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-6" name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" scale="6" id="f-1654">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="f-1655">4,142</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="f-1656">4,111</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="f-1657">4,084</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="position: absolute; top: 446.77pt;" id="idc89fa1ee07645df9629d157a4b46752_424"></div><div style="position: var(--position); top: 446.77pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDividendsExplanatory" id="f-1658" continuedAt="f-1658-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16. Dividends<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1658-1"><div style="position: var(--position); top: 485.21pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfInterimDividendExplanatoryTableTextBlock" id="f-1659" continuedAt="f-1659-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 68.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 0pt; width: 39pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 12pt; width: 62.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Paid/payable<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">per share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(pence)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 12pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 44.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Paid<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">per share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(pence)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 12pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 44.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Paid<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">per share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(pence)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 39.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">First interim<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 39.75pt; width: 62.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11 July 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 39.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-355" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1660">15.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 39.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-355" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1661">612</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 39.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13 July 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 39.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-356" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1662">14.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 39.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-356" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1663">567</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 39.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 July 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 39.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-357" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1664">17.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 39.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-357" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1665">704</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Second interim<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 51.75pt; width: 62.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 4.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 October 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 51.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-358" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1666">15.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 51.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-358" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1667">612</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: -5.53pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12 October <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 51.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-359" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1668">14.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 51.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-359" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1669">568</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 51.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 6.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6 October 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 51.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-360" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1670">16.25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 51.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-360" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1671">654</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Third interim<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 63.75pt; width: 62.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9 January 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-361" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1672">15.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-361" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1673">612</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: -5.53pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11 January <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 63.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-362" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1674">14.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 63.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.37pt;"></span></span><span style="left: 23pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-362" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1675">568</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 348pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: -5.53pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12 January <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-363" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1676">13.75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-363" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1677">555</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fourth interim<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 68.25pt; position: var(--position); top: 75.75pt; width: 62.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 62.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 April 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 75.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-364" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1678">16.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 75.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-364" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1679">653</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210pt; position: var(--position); top: 75.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">11 April 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 75.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-365" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1680">16.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 75.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.49pt;"></span></span><span style="left: 20.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-365" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1681">652</ix:nonFraction>*<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 348pt; position: var(--position); top: 75.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13 April 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 75.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-366" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1682">13.75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 75.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.36pt;"></span></span><span style="left: 17.99pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-366" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" scale="6" id="f-1683">557</ix:nonFraction>**<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 68.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 68.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 130.5pt; position: var(--position); top: 87.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1684">61.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 170.25pt; position: var(--position); top: 87.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" format="ixt:num-dot-decimal" scale="6" id="f-1685">2,489</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 87.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.55pt;"></span></span><span style="left: 17.18pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-10" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1686">58.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 309pt; position: var(--position); top: 87.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.18pt;"></span></span><span style="left: 16.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" format="ixt:num-dot-decimal" scale="6" id="f-1687">2,355</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 87.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="4" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="-2" id="f-1688">61.25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 87.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.93pt;"></span></span><span style="left: 17.56pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:DividendsPaidOrdinaryShares" format="ixt:num-dot-decimal" scale="6" id="f-1689">2,470</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1659-1"><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 595.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">*<span style="display: inline-block; height: 5.09pt; width: 8.65pt;"></span></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The estimate for the fourth interim dividend for 2023 <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 214.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosed<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 241.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in the 2023 annual report was <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 329.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-367" decimals="-6" name="ifrs-full:CurrentDividendPayables" format="ixt:num-dot-decimal" scale="6" id="f-1690">649</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 367.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-368" decimals="-6" name="gsk:AdditionalProvisionForDividendPayable" format="ixt:num-dot-decimal" scale="6" id="f-1691">3</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 394.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> less than the dividend that was ultimately paid.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 606.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">**<span style="display: inline-block; height: 5.09pt; width: 5.96pt;"></span></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The estimate for the fourth interim dividend for <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 198.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022 <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 214.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosed in the 2022 annual report was <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 329.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-369" decimals="-6" name="ifrs-full:CurrentDividendPayables" format="ixt:num-dot-decimal" scale="6" id="f-1692">555</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 367.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-370" decimals="-6" name="gsk:AdditionalProvisionForDividendPayable" format="ixt:num-dot-decimal" scale="6" id="f-1693">2</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 394.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> less than the dividend that was ultimately paid.<span style="display: inline-block; height: 5.09pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">IFRS accounting standards<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, interim dividends are only recognised in the financial statements when paid and not when <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">declared. GSK normally pays a dividend two quarters after the quarter to which it relates and one quarter after it is declared. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> financial statements recognise those dividends paid in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 296.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, namely the third and fourth interim dividends for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 481pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first and second interim dividends for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 192.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 673.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The demerger of Consumer Healthcare in 2022 was effected by GSK declaring an interim dividend in specie of Haleon plc shares. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 683.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the distribution was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 190.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1694">15,526</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 699.43pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDividendsPaidTableTextBlock" id="f-1695" continuedAt="f-1695-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The amounts recognised in each year were as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1695-1"><div style="position: var(--position); top: 715.32pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 349.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 349.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 349.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash dividends to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CashDividendsPaidToShareholdersRecognizedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1696">2,444</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashDividendsPaidToShareholdersRecognizedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1697">2,247</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CashDividendsPaidToShareholdersRecognizedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1698">3,467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 349.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 349.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends in specie to shareholders in Haleon plc shares (Note 41)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" format="ixt:fixed-zero" scale="6" id="f-1699">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" format="ixt:fixed-zero" scale="6" id="f-1700">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1701">15,526</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DividendsRecognisedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1702">2,444</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DividendsRecognisedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1703">2,247</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DividendsRecognisedInYear" format="ixt:num-dot-decimal" scale="6" id="f-1704">18,993</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">208<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_427"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="f-1705" continuedAt="f-1705-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">17. Property, plant and equipment<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1705-1" continuedAt="f-1705-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="f-1706" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Land and<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">buildings<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.01pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plant,<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equipment<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and vehicles<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets in<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">construction<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-371" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1707">6,648</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-372" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1708">10,953</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-373" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1709">1,850</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-374" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1710">19,451</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-375" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1711">189</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-376" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1712">265</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-377" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1713">44</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1714">498</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-375" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="f-1715">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-376" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="f-1716">99</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-377" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1717">1,185</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1718">1,295</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capitalised borrowing costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-375" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1719">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-376" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1720">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-377" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" scale="6" id="f-1721">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" scale="6" id="f-1722">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-375" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1723">136</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-376" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1724">732</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-377" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1725">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1726">884</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-375" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1727">134</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-376" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1728">701</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-377" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1729">869</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1730">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-375" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1731">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-376" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1732">52</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-377" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1733">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1734">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-379" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1735">6,455</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-380" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1736">10,704</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-381" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1737">2,120</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-382" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1738">19,279</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-383" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1739">141</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-384" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1740">233</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-385" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1741">51</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1742">425</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-383" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="f-1743">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-384" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="f-1744">166</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-385" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1745">1,185</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1746">1,393</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capitalised borrowing costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-383" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1747">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-384" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1748">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-385" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" scale="6" id="f-1749">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" scale="6" id="f-1750">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-383" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1751">144</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-384" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1752">381</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-385" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1753">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1754">530</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-383" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1755">179</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-384" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1756">762</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-385" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1757">949</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1758">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-383" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1759">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-384" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1760">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-385" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1761">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1762">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 204pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-387" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1763">6,375</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-388" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1764">11,015</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-389" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1765">2,320</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-390" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1766">19,710</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 219pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-391" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1767">3,275</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 219pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-392" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1768">6,469</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 219pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-393" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1769">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 219pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-394" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1770">9,744</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 231pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 231pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-395" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1771">90</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 231pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-396" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1772">153</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 231pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-397" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1773">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 231pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1774">243</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 243pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 243pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-395" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1775">210</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 243pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-396" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1776">682</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 243pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-397" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1777">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 243pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1778">892</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 255pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-395" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1779">66</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-396" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1780">662</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-397" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1781">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 255pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1782">728</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 267pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 267pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-395" decimals="-6" sign="-" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1783">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 267pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-396" decimals="-6" sign="-" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1784">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 267pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-397" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1785">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 267pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" sign="-" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1786">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 279pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 279pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-395" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1787">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 279pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-396" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1788">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 279pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-397" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1789">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 279pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1790">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 291pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-399" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1791">3,323</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-400" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1792">6,311</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-401" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1793">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 291pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-402" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1794">9,634</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 303pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 303pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-403" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1795">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 303pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-404" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1796">139</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 303pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-405" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1797">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 303pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1798">215</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 315pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 315pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-403" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1799">211</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 315pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-404" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1800">675</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 315pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-405" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1801">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 315pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="f-1802">886</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 327pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 327pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-403" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1803">121</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 327pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-404" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1804">325</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 327pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-405" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1805">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 327pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1806">446</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 339pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 339pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-403" decimals="-6" sign="-" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1807">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 339pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-404" decimals="-6" sign="-" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1808">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 339pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-405" decimals="-6" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1809">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 339pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" sign="-" name="ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" scale="6" id="f-1810">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 351pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 351pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-403" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1811">27</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 351pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-404" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1812">26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 351pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-405" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1813">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 351pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1814">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 363pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 51.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 363pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-407" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1815">3,350</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 363pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-408" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1816">6,494</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 363pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-409" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1817">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 363pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-410" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1818">9,844</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 378pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 378pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-411" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1819">260</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 378pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-412" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1820">472</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 378pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-413" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1821">42</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 378pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-414" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1822">774</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 390pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 390pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-415" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1823">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 390pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-416" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1824">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 390pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-417" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1825">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 390pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1826">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 402pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 402pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-415" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1827">27</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 402pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-416" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1828">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 402pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-417" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1829">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 402pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1830">154</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 414pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment losses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 414pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-415" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1831">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 414pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-416" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1832">32</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 414pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-417" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1833">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 414pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1834">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 426pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reversal of impairments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 426pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-415" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1835">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 426pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-416" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1836">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 426pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-417" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1837">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 426pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1838">26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 438pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 438pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-419" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1839">237</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 438pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-420" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1840">360</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 438pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-421" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1841">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 438pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-422" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1842">625</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 450pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 450pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-423" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1843">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 450pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-424" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1844">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 450pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-425" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1845">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 450pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="f-1846">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 462pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 462pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-423" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1847">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 462pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-424" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1848">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 462pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-425" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1849">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 462pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="f-1850">80</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 474pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment losses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 474pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-423" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1851">27</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 474pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-424" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1852">84</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 474pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-425" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1853">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 474pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1854">116</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 486pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reversal of impairments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 486pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-423" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1855">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 486pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-424" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1856">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 486pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-425" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1857">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 486pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1858">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 498pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 498pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-423" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1859">24</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 498pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-424" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1860">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 498pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-425" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1861">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 498pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1862">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 510pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 510pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-427" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1863">259</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 510pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-428" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1864">374</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 510pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-429" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1865">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 510pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-430" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1866">639</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 522pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total accumulated depreciation and impairment at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 165.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-431" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1867">3,560</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-432" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1868">6,671</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-433" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1869">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 522pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-434" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1870">10,259</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 534pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total accumulated depreciation and impairment at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 165.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 534pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-435" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1871">3,609</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 534pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-436" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1872">6,868</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 534pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-437" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1873">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 534pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-438" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1874">10,483</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 546pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 59.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 546pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-439" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1875">3,113</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 546pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-440" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1876">4,012</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 546pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-441" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1877">1,808</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 546pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1878">8,933</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 558pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 59.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 558pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-442" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1879">2,895</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 558pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-443" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1880">4,033</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 558pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-444" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1881">2,092</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 558pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1882">9,020</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 570pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 59.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 570pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-445" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1883">2,766</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 570pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-446" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1884">4,147</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 570pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-447" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1885">2,314</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 570pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1886">9,227</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">209<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-1705-2" continuedAt="f-1705-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">17. Property, plant and equipment continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The weighted average interest rate for capitalised borrowing costs in the year was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="ifrs-full:CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" scale="-2" id="f-1887">4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="ifrs-full:CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" scale="-2" id="f-1888">4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Disposals and write-offs in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year included a number of assets with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-448" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1889">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> net book value that are no longer in use in the business.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The impairment losses principally arose from decisions to rationalise facilities and were calculated based on fair value less costs of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposal. The fair value less costs of disposal valuation methodology uses significant inputs which are not based on observable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market data, and therefore this valuation technique is classified as level 3 of the fair value hierarchy. These calculations determine <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the net present value of the projected risk-adjusted, post-tax cash flows of the relevant asset or cash generating unit, applying a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discount rate of the Group post-tax weighted average cost of capital (WACC) of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="gsk:WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" scale="-2" id="f-1890">7.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="2" name="gsk:WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" scale="-2" id="f-1891">7</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, adjusted where appropriate for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specific segment, country and currency risk. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets that continue to be used by the Group are generally assessed as part of their associated cash generating unit on a value in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use basis. For value in use calculations, the post-tax cash flows do not include the impact of future uncommitted restructuring plans <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or improvements. Where an impairment is indicated and a pre-tax cash flow calculation is expected to give a materially different <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result, the test would be reperformed using pre-tax cash flows and a pre-tax discount rate. The Group WACC is equivalent to a pre-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax discount rate of approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="2" name="gsk:WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" scale="-2" id="f-1892">9</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="2" name="gsk:WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" scale="-2" id="f-1893">9</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net impairment losses have been charged to cost of sales: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 274.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-449" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1894">62</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: net impairment reversals <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-450" decimals="-6" sign="-" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1895">1</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), R&amp;D: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 502.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-451" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1896">15</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: net impairment reversals <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-452" decimals="-6" sign="-" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1897">5</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.85000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and SG&amp;A: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-453" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1898">11</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 324.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-454" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1899">23</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 393.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), after crediting net impairment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reversals of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-455" decimals="-6" sign="-" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1900">10</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 163.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: net impairment losses <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 252.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-456" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="f-1901">27</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 292.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) arising from the Major restructuring programmes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 325.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reversals of impairment arose from subsequent reviews of the impaired assets where the conditions which gave rise to the original <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairments were deemed no longer to apply. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 226.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-457" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1902">15</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 299.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-458" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1903">17</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of the impairment reversal has been credited to cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of sales, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 87.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-459" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="f-1904">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 100.47999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 133.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-460" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1905">5</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of the impairment reversal has been credited to R&amp;D expenses and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-461" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="f-1906">13</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 462.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 495.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-462" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1907">4</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 526.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the impairment reversal has been credited to SG&amp;A. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-463" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1908">65</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 168.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 172.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-464" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="6" id="f-1909">34</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of computer software was reclassified from assets in construction to intangible assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 382.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on becoming ready for use.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has evaluated both the qualitative and quantitative effects of climate-related risks on the recoverable amounts of assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 408.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and has determined that there are no material impairments. As of 31 December 2024, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-465" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-1910">97</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 447.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-466" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1911">53</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) has been <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 418.92pt; width: 595.44pt;"><ix:continuation id="f-1705-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capitalised in property, plant, and equipment regarding the transition to a lower-carbon p<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ropellant<span style="display: inline-block; height: 6.18pt;"></span><span id="i35244e3a4cf64fb88c11f8ecc6503e45_2738"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 450.7pt;" id="idc89fa1ee07645df9629d157a4b46752_430"></div><div style="position: var(--position); top: 450.7pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="f-1912" continuedAt="f-1912-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18. Right of use assets<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1912-1" continuedAt="f-1912-2"><div style="position: var(--position); top: 489.14pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" id="f-1913" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Land and <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">buildings <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plant and <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equipment<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vehicles<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 59.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-467" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1914">561</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-468" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1915">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-469" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1916">120</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1917">687</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" scale="6" id="f-1918">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1919">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" scale="6" id="f-1920">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" scale="6" id="f-1921">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions through business combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1922">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1923">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1924">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1925">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1926">355</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1927">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1928">144</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1929">499</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 73.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1930">121</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1931">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1932">67</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1933">190</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" scale="6" id="f-1934">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1935">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" scale="6" id="f-1936">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" scale="6" id="f-1937">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" scale="6" id="f-1938">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1939">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1940">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" scale="6" id="f-1941">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-470" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersRightofuseAssets" scale="6" id="f-1942">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-471" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1943">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-472" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1944">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersRightofuseAssets" scale="6" id="f-1945">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 59.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-473" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1946">751</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-474" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1947">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-475" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1948">182</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1949">937</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-476" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" scale="6" id="f-1950">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-477" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1951">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-478" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" scale="6" id="f-1952">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" scale="6" id="f-1953">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-476" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1954">107</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-477" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1955">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-478" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1956">117</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="6" id="f-1957">230</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-476" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1958">126</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-477" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1959">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-478" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1960">83</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1961">211</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-476" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" scale="6" id="f-1962">92</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-477" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1963">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-478" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" scale="6" id="f-1964">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:DisposalsRightofuseAssets" scale="6" id="f-1965">102</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net Impairment Reversals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-476" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" scale="6" id="f-1966">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-477" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1967">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-478" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" format="ixt:fixed-zero" scale="6" id="f-1968">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" scale="6" id="f-1969">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 59.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-479" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1970">636</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-480" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1971">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-481" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1972">202</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:RightofuseAssets" scale="6" id="f-1973">846</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 703.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commitments for future payments related to leases not yet commenced but which we have committed to, leases of low-value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 714.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets and leases which are less than twelve months are not material.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 729.92pt; width: 595.44pt;"><ix:continuation id="f-1912-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An analysis of lease liabilities is set out in Note 30, &#8216;Net debt&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">210<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_433"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfGoodwillExplanatory" id="f-1974" continuedAt="f-1974-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">19. Goodwill<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-1974-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory" id="f-1975" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-382" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1976">6,811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-374" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1977">7,046</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" scale="6" id="f-1978">39</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" scale="6" id="f-1979">313</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions through business combinations (Note 41)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:AdditionalRecognitionGoodwill" scale="6" id="f-1980">210</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:AdditionalRecognitionGoodwill" scale="6" id="f-1981">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other movements (Note 41)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="gsk:IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" format="ixt:fixed-zero" scale="6" id="f-1982">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" sign="-" name="gsk:IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" scale="6" id="f-1983">31</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-390" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1984">6,982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-382" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1985">6,811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1986">6,811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1987">7,046</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1988">6,982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1989">6,811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 262.27pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAllocationOfGoodwillToSegmentsExplanatoryTableTextBlock" id="f-1990" continuedAt="f-1990-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All goodwill is allocated to the Group&#8217;s segments as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1990-1"><div style="position: var(--position); top: 278.16pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 488.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 398.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 398.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 398.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-482" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1991">6,076</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-483" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1992">5,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 398.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 398.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-484" decimals="-6" name="ifrs-full:Goodwill" scale="6" id="f-1993">906</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-485" decimals="-6" name="ifrs-full:Goodwill" scale="6" id="f-1994">860</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 398.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 398.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 398.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1995">6,982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1996">6,811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The recoverable amounts of the cash generating units are assessed using a fair value less costs of disposal model. Fair value less <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costs of disposal is calculated using a discounted cash flow approach, with a post-tax discount rate applied to the projected risk-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjusted post-tax cash flows and terminal value. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 376.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The discount rate used is based on the Group WACC of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-1997">7.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 288.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 311.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="2" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-1998">7</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), as most cash generating units have integrated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations across large parts of the Group. The discount rate is adjusted where appropriate for specific segment, country and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency risks. The valuation methodology uses significant inputs which are not based on observable market data, therefore this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valuation technique is classified as level 3 in the fair value hierarchy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Research &amp; development segment is evaluated on an arm's length pricing model, see assumptions below. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.27pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory" id="f-1999" continuedAt="f-1999-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details relating to the discounted cash flow models used in the impairment tests are as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-1999-1"><div style="position: var(--position); top: 455.16pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 156.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 110.25pt;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Valuation basis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value less costs of disposal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key assumptions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sales growth rates <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit margins<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Terminal growth rate<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.72pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.72pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Determination of assumptions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 57pt; width: 330.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 330.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth rates are internal forecasts based on both internal and external market information.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 330.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Margins reflect past experience, adjusted for expected changes.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 330.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Terminal growth rates based on management&#8217;s estimate of future long-term average growth rates.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.72pt; width: 330.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discount rates based on Group WACC, adjusted where appropriate.<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.72pt; width: 330.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation rates based on appropriate rates for each jurisdiction.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Period of specific projected cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows" id="f-2000">Five years</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 156.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 156.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Terminal growth rate and discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267pt; position: var(--position); top: 116.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Terminal growth rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 116.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 63.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267pt; position: var(--position); top: 140.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 82.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-486" decimals="2" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" scale="-2" id="f-2001">1</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 140.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-486" decimals="3" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-2002">7.5</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267pt; position: var(--position); top: 152.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 82.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-487" decimals="2" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" scale="-2" id="f-2003">1</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 152.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 76.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-487" decimals="3" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-2004">7.5</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267pt; position: var(--position); top: 176.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 82.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-488" decimals="2" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" scale="-2" id="f-2005">0</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 176.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 82.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-488" decimals="2" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-2006">7</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 156.75pt; overflow: hidden; position: var(--position); top: 188.25pt; width: 110.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267pt; position: var(--position); top: 188.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 82.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-489" decimals="2" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" scale="-2" id="f-2007">0</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 377.25pt; position: var(--position); top: 188.25pt; width: 110.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 110.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 82.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-489" decimals="2" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" id="f-2008">7</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 93.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> p.a.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 663.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The terminal growth rate does not exceed the long-term projected growth rates for relevant markets, reflects the impact of future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 673.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generic competition and takes account of new product launches. Goodwill is monitored for impairment at the segmental level and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 683.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the valuations indicated sufficient headroom such that a reasonably possible change to key assumptions is unlikely to result in an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 693.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment of the related goodwill.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 709.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has assessed the qualitative and quantitative impact of climate-related risks on asset recoverable amounts and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 719.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concluded that there are no material impairments.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">211<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_439"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="f-2009" continuedAt="f-2009-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20. Other intangible assets<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2009-1" continuedAt="f-2009-2"><div style="position: var(--position); top: 148.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="f-2010" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 288pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 0pt; width: 66pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.06pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Computer<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 16.86pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">software<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 24.66pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 0pt; width: 66pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.06pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Licences, patents, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 16.86pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortised brands <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 24.66pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 0pt; width: 66pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 16.86pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 49.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 24.66pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 54.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at 1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 32.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-490" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2011">1,959</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 32.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-491" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2012">25,717</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 32.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-374" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2013">27,676</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 43.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2014">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 43.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2015">664</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 43.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2016">694</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capitalised development costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 54.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" name="gsk:CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2017">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 54.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" name="gsk:CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2018">363</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 54.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="gsk:CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2019">363</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions through business combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 66pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2020">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 66pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2021">1,438</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 66pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2022">1,438</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 77.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 77.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2023">144</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 77.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2024">525</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 77.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2025">669</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and asset write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 88.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2026">125</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 88.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2027">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 88.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2028">138</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 99.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" name="gsk:IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2029">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 99.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" name="gsk:IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2030">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 99.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="gsk:IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2031">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 111pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 111pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-492" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2032">34</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 111pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-493" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2033">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 111pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-378" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2034">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 122.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at 31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 122.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-494" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2035">1,984</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 122.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-495" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2036">27,363</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 122.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-382" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2037">29,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 133.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 133.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-496" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2038">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 133.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-497" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2039">176</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 133.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2040">184</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capitalised development costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 144.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-496" decimals="-6" name="gsk:CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2041">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 144.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-497" decimals="-6" name="gsk:CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2042">246</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 144.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="gsk:CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2043">246</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions through business combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 156pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-496" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2044">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 156pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-497" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2045">913</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 156pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2046">913</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 167.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 167.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-496" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2047">166</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 167.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-497" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2048">1,270</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 167.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2049">1,436</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 178.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and asset write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 178.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-496" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2050">39</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 178.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-497" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2051">140</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 178.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2052">179</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 189.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-496" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2053">65</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 189.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-497" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2054">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 189.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-386" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2055">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 201pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost at 31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 201pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 41.55pt;"></span></span><span style="left: 44.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-498" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2056">2,168</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 201pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-499" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2057">29,471</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 201pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-390" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2058">31,639</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation at 1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 215.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-500" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2059">1,223</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 215.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-501" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2060">9,181</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 215.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-394" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2061">10,404</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 226.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 226.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-502" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2062">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 226.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-503" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2063">174</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 226.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2064">192</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 237.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-502" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2065">203</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 237.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-503" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2066">1,009</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 237.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2067">1,212</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 249pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and asset write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 249pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-502" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2068">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 249pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-503" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2069">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 249pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2070">108</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 260.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-502" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2071">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 260.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-503" decimals="-6" name="gsk:IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2072">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 260.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2073">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 271.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 271.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-502" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2074">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 271.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-503" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2075">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 271.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-398" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2076">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation at 31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 282.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-504" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2077">1,307</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 282.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-505" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2078">10,007</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 282.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-402" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2079">11,314</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 294pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 294pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-506" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2080">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 294pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-507" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2081">83</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 294pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2082">90</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 305.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 305.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-506" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2083">211</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 305.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-507" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2084">1,243</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 305.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2085">1,454</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 316.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and asset write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 316.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-506" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2086">33</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 316.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-507" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2087">47</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 316.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2088">80</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 327.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-506" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2089">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 327.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-507" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2090">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 327.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-406" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2091">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 339pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation at 31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 339pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-508" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2092">1,479</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 339pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-509" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2093">11,133</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 339pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-410" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2094">12,612</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 353.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment at 1&#160;January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 353.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-510" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2095">81</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 353.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-511" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2096">2,873</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 353.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-414" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2097">2,954</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 364.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 364.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-512" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2098">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 364.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-513" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2099">70</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 364.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2100">71</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 375.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment losses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 375.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-512" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2101">23</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 375.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-513" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2102">398</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 375.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2103">421</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 387pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reversal of impairments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 387pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-512" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2104">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 387pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-513" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2105">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 387pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2106">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 398.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and asset write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 398.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-512" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2107">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 398.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-513" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2108">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 398.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-418" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2109">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 409.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment at 31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 409.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.42pt;"></span></span><span style="left: 52.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-514" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2110">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 409.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-515" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2111">3,190</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 409.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-422" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2112">3,265</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 420.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 420.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-516" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2113">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 420.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-517" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2114">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 420.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2115">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 432pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment losses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 432pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.56pt;"></span></span><span style="left: 56.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-516" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2116">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 432pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-517" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2117">314</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 432pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2118">320</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 443.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reversal of impairments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 443.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-516" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2119">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 443.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-517" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2120">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 443.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2121">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 454.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and asset write-offs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 454.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 56.02pt;"></span></span><span style="left: 58.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-516" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2122">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 454.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-517" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2123">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 454.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.88pt;"></span></span><span style="left: 54.510000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-426" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2124">89</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 465.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment at 31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 465.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 45.28pt;"></span></span><span style="left: 47.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-518" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2125">110</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 465.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-519" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2126">3,402</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 465.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-430" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2127">3,512</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 5.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 482.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total accumulated amortisation and impairment at 31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 482.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-520" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2128">1,382</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 482.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-521" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2129">13,197</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 482.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-434" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2130">14,579</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 493.5pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total accumulated amortisation and impairment at 31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 493.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.09pt;"></span></span><span style="left: 41.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-522" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2131">1,589</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 493.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-523" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2132">14,535</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 493.5pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.95pt;"></span></span><span style="left: 37.580000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-438" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2133">16,124</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 504.75pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at 1 January 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 504.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-524" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2134">655</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 504.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-525" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2135">13,663</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 504.75pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2136">14,318</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 516pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at 31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 516pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-526" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2137">602</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 516pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-89" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2138">14,166</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 516pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2139">14,768</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 527.25pt; width: 288pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 288pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net book value at 31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 527.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 47.74pt;"></span></span><span style="left: 50.370000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-527" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2140">579</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 354pt; position: var(--position); top: 527.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-88" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2141">14,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 420pt; position: var(--position); top: 527.25pt; width: 66pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 66pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.41pt;"></span></span><span style="left: 40.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2142">15,515</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 694.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The weighted average interest rate for capitalised borrowing costs in the year was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="ifrs-full:CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" scale="-2" id="f-2143">4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="ifrs-full:CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" scale="-2" id="f-2144">4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The net book value of computer software included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-528" decimals="-6" name="ifrs-full:ComputerSoftware" scale="6" id="f-2145">231</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 286.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 292pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 310.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-529" decimals="-6" name="ifrs-full:ComputerSoftware" scale="6" id="f-2146">270</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of internally generated costs.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 724pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The carrying amount at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 216.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of intangible assets, for which impairments have been charged in the year following <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 734.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those impairments, was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:IntangibleAssetsForWhichImpairmentsHaveBeenCharged" scale="6" id="f-2147">427</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:IntangibleAssetsForWhichImpairmentsHaveBeenCharged" scale="6" id="f-2148">533</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), resulting from the appraisal of GSK&#8217;s assumptions related to in-licences <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 744.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and collaboration agreements. The carrying amount at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of intangible assets, after which impairment reversals <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 754.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have been charged in the year was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 187.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:IntangibleAssetsForWhichImpairmentsHaveBeenReversed" format="ixt:fixed-zero" scale="6" id="f-2149">nil</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 252.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 256.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:IntangibleAssetsForWhichImpairmentsHaveBeenReversed" format="ixt:fixed-zero" scale="6" id="f-2150">nil</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 296.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). No individual intangible asset accounted for a material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 764.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impairment.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">212<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-2009-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">20. Other <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 103.74000000000001pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">intangible<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 154.81pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> assets continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 133.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Please refer to Note 2, 'Accounting principles and policies' for the Group&#8217;s accounting policy and estimate of the useful life for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intangible assets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.26pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory" id="f-2151" continuedAt="f-2151-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation and impairment losses, net of reversals, have been charged in the income statement as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2151-1"><div style="position: var(--position); top: 175.15pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 51.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net impairment losses<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-449" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2152">982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-450" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2153">668</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-449" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2154">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-450" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2155">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-453" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2156">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-454" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2157">103</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-453" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2158">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-454" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2159">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-451" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2160">388</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-452" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2161">441</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-451" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2162">311</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-452" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2163">399</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2164">1,454</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2165">1,212</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2166">317</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="f-2167">418</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.09pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" id="f-2168" continuedAt="f-2168-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Licences, patents and amortised brands include a large number of acquired licences, patents, know-how agreements and <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2168-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">marketing rights, which are either marketed or in use, or still in development. Note 41, &#8216;Acquisitions and disposals&#8217; gives details of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additions through business combinations in the year. The carrying amounts of the largest individual items are as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 302.38pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tesaro Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-530" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2169">2,350</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-531" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2170">2,656</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis Portfolio<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-532" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2171">1,473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-533" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2172">1,717</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-534" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2173">1,452</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-535" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2174">1,429</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Camlipixant<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-536" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2175">1,438</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-537" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2176">1,438</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Momelotinib<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-538" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2177">1,408</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-539" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2178">1,470</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir (including Cabotegravir)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-540" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2179">967</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-541" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2180">1,059</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aiolos Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-542" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2181">887</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-543" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2182">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CureVac Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-544" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2183">535</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-545" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2184">191</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Iteos Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-546" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2185">471</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-547" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2186">443</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alector Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-548" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2187">371</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-549" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2188">425</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.49pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-550" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2189">298</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-551" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2190">424</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.49pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-552" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2191">277</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-553" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2192">289</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hansoh Pharma Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-554" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2193">247</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-555" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2194">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chimagen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 174pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-556" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2195">227</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 174pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-557" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2196">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 186pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RSV<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-558" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2197">201</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-559" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2198">139</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 198pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BMS Assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 198pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-560" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2199">173</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 198pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-561" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2200">191</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Spero<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 210pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-562" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2201">163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 210pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-563" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2202">163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 222pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wave Life Sciences<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 222pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-564" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2203">115</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 222pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-565" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2204">116</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 234pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arrowhead<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 234pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-566" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2205">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 234pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-567" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2206">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 246pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UCB<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 246pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-568" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2207">93</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 246pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-569" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2208">115</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 258pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DT<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 258pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-570" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2209">91</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 258pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-571" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2210">104</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 270pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.49pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relvar/Breo/Anoro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 270pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-572" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2211">86</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 270pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-573" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2212">125</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 282pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel Trade Name<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 282pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-574" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2213">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 282pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-575" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2214">116</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 294pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.49pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fluarix/FluLaval<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 294pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-576" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2215">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 294pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-577" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2216">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 306pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Okairos<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 306pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-578" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="f-2217">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 306pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-579" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="f-2218">198</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 318pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Others<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 318pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-580" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2219">1,360</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 318pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-581" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2220">1,144</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 330pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 330pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-582" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2221">14,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 330pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-583" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-2222">14,166</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 655.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 14 February 2024, GSK completed its acquisition of Aiolos Bio, Inc. The main asset acquired is AIO-001.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 3 July 2024, GSK and CureVac N.V. announced a restructuring of their existing collaboration into a new licensing agreement, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">order to work together to develop mRNA vaccines for infectious diseases.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, GSK announced collaborations with Hansoh Pharma to develop HS-20093 and HS-20089.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 703.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 29 October 2024, GSK entered into an agreement to acquire CMG1A46 from Chimagen Biosciences to expand its immunology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 714.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 727.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has evaluated both the qualitative and quantitative effects of climate-related risks on the recoverable amounts of assets <span style="display: inline-block; height: 6.18pt;"></span><span id="ic6350600483b4fcb8853f9457fd6579c_254"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 737.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and has determined that there are no material impairments.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">213<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_442"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" id="f-2223" continuedAt="f-2223-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">21. Investments in associates and joint ventures<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2223-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" id="f-2224" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Joint<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ventures<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Associates<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.779999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Joint<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ventures<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Associates<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.779999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-584" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="f-2225">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-585" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2226">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2227">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-586" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2228">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-587" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2229">64</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2230">74</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-2231">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-588" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2232">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2233">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-2234">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-589" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2235">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2236">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2237">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-588" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2238">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2239">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2240">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-589" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2241">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2242">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="gsk:DisposalsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2243">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-588" decimals="-6" name="gsk:DisposalsInAssociatesAndJointVentures" scale="6" id="f-2244">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DisposalsInAssociatesAndJointVentures" scale="6" id="f-2245">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" name="gsk:DisposalsInAssociatesAndJointVentures" scale="6" id="f-2246">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-589" decimals="-6" name="gsk:DisposalsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2247">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DisposalsInAssociatesAndJointVentures" scale="6" id="f-2248">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distributions received<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="gsk:DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2249">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-588" decimals="-6" name="gsk:DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2250">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2251">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" name="gsk:DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2252">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-589" decimals="-6" name="gsk:DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2253">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2254">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movements through other comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="gsk:FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2255">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-588" decimals="-6" name="gsk:FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2256">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2257">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" name="gsk:FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="f-2258">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-589" decimals="-6" name="gsk:FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2259">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" scale="6" id="f-2260">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit/(loss) after tax recognised in the consolidated income <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-277" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-2261">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-588" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-2262">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-2263">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-278" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-2264">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-589" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-2265">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="f-2266">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 118.5pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 118.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-590" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="f-2267">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 118.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-591" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2268">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 118.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2269">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 118.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-584" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="f-2270">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 118.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-585" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2271">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 118.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-2272">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the year GSK entered into a new research alliance with<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Flagship Pioneering, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inc. with an initial investment of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-592" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-2273">50</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 525.6999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-592" decimals="-6" name="gsk:AdditionsInInvestmentsInAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-2274">39</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Please refer to the income statement information in Note 13, 'Associates and joint ventures'.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 345.2pt;" id="idc89fa1ee07645df9629d157a4b46752_445"></div><div style="position: var(--position); top: 345.2pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfCurrentEquityInvestmentsTextBlock" id="f-2275" continuedAt="f-2275-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">22. Current equity investments<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2275-1"><div style="position: var(--position); top: 383.64pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" id="f-2276" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 212.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 212.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 212.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 42pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-593" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:num-dot-decimal" scale="6" id="f-2277">2,204</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 42pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-594" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:num-dot-decimal" scale="6" id="f-2278">4,087</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 212.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movements through profit or loss<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 54pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-595" decimals="-6" name="gsk:NetFairValueMovementsThroughProfitOrLossCurrentInvestments" scale="6" id="f-2279">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 54pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-596" decimals="-6" sign="-" name="gsk:NetFairValueMovementsThroughProfitOrLossCurrentInvestments" scale="6" id="f-2280">17</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 212.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and settlements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 66pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-595" decimals="-6" name="gsk:DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-2281">2,226</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 66pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-596" decimals="-6" name="gsk:DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-2282">1,863</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 212.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 78pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-595" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-2283">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 78pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-596" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2284">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 212.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 212.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 90pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-597" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:fixed-zero" scale="6" id="f-2285">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 90pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-593" decimals="-6" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" format="ixt:num-dot-decimal" scale="6" id="f-2286">2,204</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments represented Haleon plc shares held after the demerger of Consumer Healthcare<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Shares were held for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trading and measured at fair value through profit or loss (FVTPL) based on the Haleon plc share price with changes in fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">presented as Other operating income/(expense) in continuing operations. The Group&#8217;s investment in Haleon plc was fully disposed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of in May 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">214<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_448"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" id="f-2287" continuedAt="f-2287-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23. Other investments<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2287-1" continuedAt="f-2287-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfScheduleOfOtherInvestmentTableTextBlock" id="f-2288" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designated as <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTOCI<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">designated as <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTOCI<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-598" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2289">931</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-599" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2290">206</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-600" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-2291">1,137</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-601" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-2292">1,153</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-602" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2293">314</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-603" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-2294">1,467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-604" decimals="-6" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" scale="6" id="f-2295">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-605" decimals="-6" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" scale="6" id="f-2296">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-606" decimals="-6" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" scale="6" id="f-2297">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-607" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" scale="6" id="f-2298">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-608" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" scale="6" id="f-2299">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-609" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" scale="6" id="f-2300">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-604" decimals="-6" name="gsk:AdditionsToOtherInvestments" scale="6" id="f-2301">70</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-605" decimals="-6" name="gsk:AdditionsToOtherInvestments" scale="6" id="f-2302">38</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-606" decimals="-6" name="gsk:AdditionsToOtherInvestments" scale="6" id="f-2303">108</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-607" decimals="-6" name="gsk:AdditionsToOtherInvestments" scale="6" id="f-2304">93</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-608" decimals="-6" name="gsk:AdditionsToOtherInvestments" scale="6" id="f-2305">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-609" decimals="-6" name="gsk:AdditionsToOtherInvestments" scale="6" id="f-2306">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movements through other comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-604" decimals="-6" sign="-" name="gsk:NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" scale="6" id="f-2307">107</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-606" decimals="-6" sign="-" name="gsk:NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" scale="6" id="f-2308">107</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-607" decimals="-6" sign="-" name="gsk:NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" scale="6" id="f-2309">253</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-609" decimals="-6" sign="-" name="gsk:NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" scale="6" id="f-2310">253</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movements through profit or loss<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-605" decimals="-6" name="gsk:NetFairValueMovementsThroughProfitOrLossOtherInvestments" scale="6" id="f-2311">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-606" decimals="-6" name="gsk:NetFairValueMovementsThroughProfitOrLossOtherInvestments" scale="6" id="f-2312">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-608" decimals="-6" sign="-" name="gsk:NetFairValueMovementsThroughProfitOrLossOtherInvestments" scale="6" id="f-2313">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-609" decimals="-6" sign="-" name="gsk:NetFairValueMovementsThroughProfitOrLossOtherInvestments" scale="6" id="f-2314">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for sale<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-604" decimals="-6" name="gsk:DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-2315">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-605" decimals="-6" name="gsk:DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-2316">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-606" decimals="-6" name="gsk:DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-2317">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-607" decimals="-6" name="gsk:DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2318">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-608" decimals="-6" name="gsk:DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="f-2319">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-609" decimals="-6" name="gsk:DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2320">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-604" decimals="-6" name="gsk:DisposalsAndSettlementsOtherInvestments" scale="6" id="f-2321">55</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-605" decimals="-6" name="gsk:DisposalsAndSettlementsOtherInvestments" scale="6" id="f-2322">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-606" decimals="-6" name="gsk:DisposalsAndSettlementsOtherInvestments" scale="6" id="f-2323">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-607" decimals="-6" name="gsk:DisposalsAndSettlementsOtherInvestments" scale="6" id="f-2324">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-608" decimals="-6" name="gsk:DisposalsAndSettlementsOtherInvestments" format="ixt:fixed-zero" scale="6" id="f-2325">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-609" decimals="-6" name="gsk:DisposalsAndSettlementsOtherInvestments" scale="6" id="f-2326">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-610" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2327">843</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-611" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2328">257</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-612" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-2329">1,100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-598" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2330">931</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-599" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2331">206</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-600" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="f-2332">1,137</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current other investments comprise non-current equity investments which are recorded at fair value at each balance sheet <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date. For investments traded in an active market, the fair value is determined by reference to the relevant stock exchange quoted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bid price. For other investments, the fair value is estimated by management with reference to relevant available information, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including the current market value of similar instruments, recent financing rounds and discounted cash flows of the underlying net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets. Net fair value movements include the impact of exchange gains of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-613" decimals="-6" name="gsk:AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" scale="6" id="f-2333">2</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.77000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> through other comprehensive income and &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-614" decimals="-6" name="gsk:AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" format="ixt:fixed-zero" scale="0" id="f-2334">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 538.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">through profit or loss (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: exchange losse<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.13pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-615" decimals="-6" sign="-" name="gsk:AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" scale="6" id="f-2335">37</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 273.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> through other comprehensive income and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-616" decimals="-6" name="gsk:AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" format="ixt:fixed-zero" scale="0" id="f-2336">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 446.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> through profit or loss). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments include listed investments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ListedInvestments" scale="6" id="f-2337">646</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 300.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 305.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ListedInvestments" scale="6" id="f-2338">741</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has elected to designate the majority of its equity investments as measured at fair value through other comprehensive income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(FVTOCI). The most significant of these investments held at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were in Wave life Sciences Ltd, which had a fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 85.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 168.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-617" decimals="-6" name="gsk:InvestmentFairValue" scale="6" id="f-2339">165</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-618" decimals="-6" name="gsk:InvestmentFairValue" scale="6" id="f-2340">55</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and Crispr Therapeutics AG which had a fair value at 31 December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 408.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.53999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-619" decimals="-6" name="gsk:InvestmentFairValue" scale="6" id="f-2341">101</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-620" decimals="-6" name="gsk:InvestmentFairValue" scale="6" id="f-2342">158</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The other investments include equity stakes in companies with which GSK has research <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 418.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">collaborations and in companies which provide access to biotechnology developments of potential interest. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On disposal of equity investments measured at FVTOCI, the accumulated fair value movements are reclassified from the fair value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve to retained earnings. Investments measured at FVTOCI with a fair value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-621" decimals="-6" name="ifrs-full:FairValueOfInvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAtDateOfDerecognition" scale="6" id="f-2343">55</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-622" decimals="-6" name="ifrs-full:FairValueOfInvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAtDateOfDerecognition" scale="6" id="f-2344">20</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) were disposed of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the year. The cumulative profit on these investments after tax was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-613" decimals="-6" name="ifrs-full:CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" scale="6" id="f-2345">14</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: loss of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-615" decimals="-6" sign="-" name="ifrs-full:CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" scale="6" id="f-2346">26</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Certain other investments, such as investments in funds with limited lives and investments acquired with an intention to sell, are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at fair value through profit or loss (FVTPL). The most significant of these investments held at 31 December 2024 was SR <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.99pt; width: 595.44pt;"><ix:continuation id="f-2287-2" continuedAt="f-2287-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">One Capital Fund I-B, LP which had a fair value at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.98pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-623" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2347">135</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.73pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-624" decimals="-6" name="ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" scale="6" id="f-2348">102</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-2287-3">).</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 522.77pt;" id="idc89fa1ee07645df9629d157a4b46752_451"></div><div style="position: var(--position); top: 522.77pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory" id="f-2349" continuedAt="f-2349-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">24. Other non-current assets<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2349-1" continuedAt="f-2349-2"><div style="position: var(--position); top: 561.21pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" id="f-2350" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amounts receivable under insurance contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:ReceivablesRelatedToInsuranceContracts" scale="6" id="f-2351">957</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:ReceivablesRelatedToInsuranceContracts" scale="6" id="f-2352">854</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension schemes in surplus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan" scale="6" id="f-2353">898</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan" scale="6" id="f-2354">634</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentReceivables" scale="6" id="f-2355">87</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentReceivables" scale="6" id="f-2356">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-2357">1,942</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-2358">1,584</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 638.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amounts receivable under insurance contracts are held at cash surrender value with movements through profit or loss<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 491.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 654.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Within the other receivables of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentReceivables" scale="6" id="f-2359">87</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentReceivables" scale="6" id="f-2360">96</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-625" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2361">36</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-626" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2362">27</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 393.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is classified as financial assets of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 664.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-627" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2363">31</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-628" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2364">18</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 186.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is classified as fair value through profit or loss. On the remaining balance of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-629" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2365">5</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 508.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 674.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-630" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2366">9</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the expected credit loss allowance was immaterial at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 320.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 690.83pt; width: 595.44pt;"><ix:continuation id="f-2349-2" continuedAt="f-2349-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other receivables include<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 148.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:OtherNoncurrentNatureBasedCarbonReceivables" scale="6" id="f-2367">7</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 186.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> r<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 191.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">elating to nature-based carbon credits projects (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:OtherNoncurrentNatureBasedCarbonReceivables" scale="6" id="f-2368">7</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 428.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-2349-3">).</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">215<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_454"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInventoriesExplanatory" id="f-2369" continuedAt="f-2369-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25. Inventories<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2369-1" continuedAt="f-2369-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationOfInventoriesTableTextBlock" id="f-2370" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Raw materials and consumables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies" format="ixt:num-dot-decimal" scale="6" id="f-2371">1,361</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies" format="ixt:num-dot-decimal" scale="6" id="f-2372">1,594</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Work in progress<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="f-2373">2,683</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="f-2374">2,449</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finished goods<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="f-2375">1,625</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="f-2376">1,455</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="f-2377">5,669</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="f-2378">5,498</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 229.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As part of the TCFD one of the climate-related risks identified affects the metered dose inhalers (MDI). There is no impact on the <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-2369-2">recoverable value of the associated inventories held at year end.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 271.25pt;" id="idc89fa1ee07645df9629d157a4b46752_457"></div><div style="position: var(--position); top: 271.25pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" id="f-2379" continuedAt="f-2379-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">26. Trade and other receivables<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2379-1"><div style="position: var(--position); top: 309.69pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:CategoriesOfTradeAndOtherReceivablesTableTextBlock" id="f-2380" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables, net of loss allowance<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:num-dot-decimal" scale="6" id="f-2381">5,563</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:num-dot-decimal" scale="6" id="f-2382">5,905</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accrued income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:AccruedIncomeOtherThanContractAssets" scale="6" id="f-2383">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:AccruedIncomeOtherThanContractAssets" scale="6" id="f-2384">69</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prepayments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Prepayments" scale="6" id="f-2385">390</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Prepayments" scale="6" id="f-2386">355</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest receivable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:InterestReceivable" scale="6" id="f-2387">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:InterestReceivable" scale="6" id="f-2388">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee loans and advances<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:EmployeeLoansAndAdvances" scale="6" id="f-2389">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:EmployeeLoansAndAdvances" scale="6" id="f-2390">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherReceivables" scale="6" id="f-2391">857</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-2392">1,045</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-2393">6,836</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-2394">7,385</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-631" decimals="-6" name="ifrs-full:OtherReceivables" format="ixt:fixed-zero" scale="6" id="f-2395"><ix:nonFraction unitRef="gbp" contextRef="c-631" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:fixed-zero" scale="6" id="f-2396">no</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> trade or other receivable balances (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-632" decimals="-6" name="ifrs-full:OtherReceivables" format="ixt:fixed-zero" scale="6" id="f-2397"><ix:nonFraction unitRef="gbp" contextRef="c-632" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:fixed-zero" scale="6" id="f-2398">nil</ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) due from associates and joint ventures. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The most significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 433.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">component of other receivables comprises receivables for indirect and other taxes of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax" scale="6" id="f-2399">447</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 443.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax" format="ixt:num-dot-decimal" scale="6" id="f-2400">565</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 488.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 443.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant balance within other receivables is royalties receivable of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:RoyaltiesReceivable" format="ixt:num-dot-decimal" scale="6" id="f-2401">164</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:RoyaltiesReceivable" format="ixt:num-dot-decimal" scale="6" id="f-2402">226</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 459.42pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory" id="f-2403" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Loss allowance-trade receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-633" decimals="-6" sign="-" name="ifrs-full:FinancialAssets" scale="6" id="f-2404">85</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-634" decimals="-6" sign="-" name="ifrs-full:FinancialAssets" scale="6" id="f-2405">91</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-635" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2406">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-636" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="6" id="f-2407">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-635" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-2408">34</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-636" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="6" id="f-2409">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-635" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFinancialAssets" scale="6" id="f-2410">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-636" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-2411">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subsequent recoveries of amounts provided for<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-635" decimals="-6" name="gsk:IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" scale="6" id="f-2412">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-636" decimals="-6" name="gsk:IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" scale="6" id="f-2413">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Utilised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-635" decimals="-6" name="gsk:IncreaseDecreaseThroughUtilisationFinancialAssets" scale="6" id="f-2414">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-636" decimals="-6" name="gsk:IncreaseDecreaseThroughUtilisationFinancialAssets" scale="6" id="f-2415">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-637" decimals="-6" sign="-" name="ifrs-full:FinancialAssets" scale="6" id="f-2416">99</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-633" decimals="-6" sign="-" name="ifrs-full:FinancialAssets" scale="6" id="f-2417">85</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Of the total trade receivables balance,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-638" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-2418">13</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-639" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-2419">10</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is considered credit impaired, against which a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-637" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-2420">5</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-633" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-2421">8</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) expected credit loss allowance has been applied. No amount was purchased or originated credit impaired.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 598.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Within the other receivables of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherReceivables" scale="6" id="f-2422">857</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-2423">1,045</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 294.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-640" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2424">360</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 370.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-641" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2425">408</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is classified as financial assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-642" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2426">2</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-643" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="f-2427">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 163.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is classified as held at fair value through profit or loss. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, an expected credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss allowance of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-644" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2428">9</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-645" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-2429">3</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) was recognised in respect of financial assets, with a release in expected credit loss <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowance of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-646" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-2430">6</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-647" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-2431">3</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) reported in profit or loss during the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 645.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For more discussion on credit risk practices, please refer to Note 44, 'Financial instruments and related disclosures'.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">216<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_460"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" id="f-2432" continuedAt="f-2432-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i600fea19361e4c1aa058eb25e204a38c_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">27. Cash and cash equivalents<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2432-1" continuedAt="f-2432-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" id="f-2433" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash at bank and in hand<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Cash" scale="6" id="f-2434">943</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Cash" scale="6" id="f-2435">748</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2436">2,927</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2437">2,188</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2438">3,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2439">2,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 190.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" scale="6" id="f-2440">177</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" scale="6" id="f-2441">190</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 308.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) not available for general use due to restrictions applying in <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-2432-2">the subsidiaries where it is held. Restrictions include exchange controls and taxes on repatriation.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 253.56pt;" id="idc89fa1ee07645df9629d157a4b46752_463"></div><div style="position: var(--position); top: 253.56pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" id="f-2442" continuedAt="f-2442-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">28. Assets held for sale<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2442-1" continuedAt="f-2442-2"><div style="position: var(--position); top: 292pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" id="f-2443" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-648" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-2444">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-649" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="f-2445">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-648" decimals="-6" name="gsk:OtherAssetsNet" format="ixt:fixed-zero" scale="6" id="f-2446">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-649" decimals="-6" name="gsk:OtherAssetsNet" scale="6" id="f-2447">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-648" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="f-2448">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-649" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="f-2449">76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 358.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets and disposal groups are transferred to assets held for sale when it is expected that their carrying amounts will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be recovered principally through disposal and a sale is considered highly probable. They are held at the lower of carrying amount <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-2442-2">and fair value less costs to sell.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">217<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_469"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" id="f-2450" continuedAt="f-2450-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">29. Trade and other payables<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2450-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:SummaryOfTradePayablesExplanatoryTableTextBlock" id="f-2451" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="6" id="f-2452">3,462</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="6" id="f-2453">3,717</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wages and salaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:WagesAndSalariesPayable" format="ixt:num-dot-decimal" scale="6" id="f-2454">1,465</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:WagesAndSalariesPayable" format="ixt:num-dot-decimal" scale="6" id="f-2455">1,683</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Social security<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="6" id="f-2456">125</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="6" id="f-2457">126</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare put option<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:PutOptionPayable" scale="6" id="f-2458">915</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:PutOptionPayable" scale="6" id="f-2459">848</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherCurrentPayables" scale="6" id="f-2460">420</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 66.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherCurrentPayables" scale="6" id="f-2461">346</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ContractLiabilities" scale="6" id="f-2462">171</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ContractLiabilities" scale="6" id="f-2463">222</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Customer return and rebate accruals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:CustomerReturnAndRebateAccruals" format="ixt:num-dot-decimal" scale="6" id="f-2464">6,486</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:CustomerReturnAndRebateAccruals" format="ixt:num-dot-decimal" scale="6" id="f-2465">6,799</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other accruals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:OtherAccruals" format="ixt:num-dot-decimal" scale="6" id="f-2466">2,291</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:OtherAccruals" format="ixt:num-dot-decimal" scale="6" id="f-2467">2,103</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="6" id="f-2468">15,335</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:num-dot-decimal" scale="6" id="f-2469">15,844</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payable included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-631" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:fixed-zero" scale="6" id="f-2470">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-632" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayables" format="ixt:fixed-zero" scale="0" id="f-2471">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) due to associates and joint ventures. The Group provides limited supplier <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financing arrangements to certain suppliers. The amounts involved at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were not material.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 315.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue recognised in the year that was included in deferred income at 1 January 2024 was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RevenueAndOperatingIncome" scale="6" id="f-2472">176</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RevenueAndOperatingIncome" scale="6" id="f-2473">192</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Customer return and rebate accruals are provided for by the Group at the point of sale in respect of estimated rebates, discounts or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowances payable to customers<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 177.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, customer return and rebate accruals included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-78" decimals="-6" name="gsk:CustomerReturnAndRebateAccruals" format="ixt:num-dot-decimal" scale="6" id="f-2474">5,235</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 498.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-79" decimals="-6" name="gsk:CustomerReturnAndRebateAccruals" format="ixt:num-dot-decimal" scale="6" id="f-2475">5,781</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) in respect of US Commercial Operations. Accruals are made at the time of sale but the actual amounts paid are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on claims made some time after the initial recognition of the sale. As the amounts are estimated, they may not fully reflect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the final outcome and are subject to change dependent upon, amongst other things, the types of buying group and product sales <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 382.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mix. The level of accrual is reviewed and adjusted quarterly in light of historical experience of actual amounts paid and any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 392.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in arrangements. Future events could cause the assumptions on which the accruals are based to change, which could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 402.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect the future results of the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 418.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer&#8217;s put option over its shareholding in ViiV Healthcare is currently exercisable. Pfizer may request an IPO of ViiV Healthcare at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 428.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any time and if either GSK does not consent to such IPO or an offering is not completed within nine months, Pfizer could require <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK to acquire its shareholding. The amount of the liability for this put option, which is held on the gross redemption basis, is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 449.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">derived from an internal valuation of the ViiV Healthcare business, utilising both discounted forecast future cash flow and multiples-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 459.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based methodologies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 475.23pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" id="f-2476" continuedAt="f-2476-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below shows on an indicative basis the income statement and balance sheet sensitivity of the Pfizer put option to <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2476-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonably possible changes in key assumptions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 501.32pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in financial liability and loss/(gain) in income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% increase in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-650" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2477">92</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-651" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2478">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15% increase in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 31.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-652" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2479">139</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 31.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-653" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2480">126</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% decrease in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-654" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2481">92</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-655" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2482">84</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15% decrease in sales forecast*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-656" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2483">138</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-657" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2484">126</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% (100 basis points) increase in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 65.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-658" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="6" id="f-2485">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 65.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-659" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="6" id="f-2486">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.50% (150 basis points) increase in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-660" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="6" id="f-2487">32</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-661" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" scale="6" id="f-2488">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% (100 basis points) decrease in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-658" decimals="-6" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="6" id="f-2489">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-659" decimals="-6" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="6" id="f-2490">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.50% (150 basis points) decrease in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 99pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-662" decimals="-6" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="6" id="f-2491">34</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 99pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-663" decimals="-6" name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" scale="6" id="f-2492">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-664" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2493">62</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-665" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2494">54</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-666" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2495">97</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-667" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2496">85</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-668" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2497">53</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-669" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2498">46</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-670" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2499">76</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-671" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2500">67</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 155.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-672" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2501">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 155.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-673" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2502">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 166.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-674" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2503">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 166.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-675" decimals="-6" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2504">34</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 177.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 177.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-676" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2505">17</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 177.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-677" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2506">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 189pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-678" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2507">24</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-679" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInFinancialLiability" scale="6" id="f-2508">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 709.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">*<span style="display: inline-block; height: 5.09pt; width: 8.65pt;"></span></span><span style="left: 65.2pt; position: var(--position);">The sales forecast is for ViiV Healthcare sales only in respect of the ViiV Healthcare put option.<span style="display: inline-block; height: 5.09pt;"></span></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 730.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other accruals includes interest accrued on financial liabilities at amortised cost of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-2509">162</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 435.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-2510">162</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 480.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">218<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_472"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfBorrowingsExplanatory" id="f-2511" continuedAt="f-2511-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="iea3fa1831d90487a8261b922b6b9e452_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30. Net debt<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2511-1" continuedAt="f-2511-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory" id="f-2512" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 489pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 198.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 116.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 82.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 198.75pt; position: var(--position); top: 0pt; width: 116.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 116.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 65.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Listing exchange<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current assets:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-680" decimals="-6" name="gsk:LiquidInvestmentsCurrent" scale="6" id="f-2513">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-681" decimals="-6" name="gsk:LiquidInvestmentsCurrent" scale="6" id="f-2514">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-680" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2515">3,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-681" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2516">2,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-680" decimals="-6" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-2517">3,891</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-681" decimals="-6" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-2518">2,978</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term borrowings:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial paper<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CommercialPapersIssued" format="ixt:fixed-zero" scale="6" id="f-2519">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-2520">815</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bank loans, overdrafts and other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:BankLoansOverdraftsAndOther" scale="6" id="f-2521">762</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:BankLoansOverdraftsAndOther" scale="6" id="f-2522">191</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-682" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2523">3.000</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-683" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2524">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-684" decimals="-6" name="ifrs-full:ShorttermBorrowings" scale="6" id="f-2525">784</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-685" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2526">1.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-686" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2527">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-687" decimals="-6" name="ifrs-full:ShorttermBorrowings" scale="6" id="f-2528">867</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-688" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2529">4.000</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-689" decimals="-6" name="ifrs-full:ShorttermBorrowings" scale="6" id="f-2530">622</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 126.75pt; width: 45.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.82pt; width: 35.08pt;"></span></span><span style="left: 37.71pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-690" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2531">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.82pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-691" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2532">3.625</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-692" decimals="-6" name="ifrs-full:ShorttermBorrowings" scale="6" id="f-2533">797</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 138.75pt; width: 45.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 2.81pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.82pt; width: 35.08pt;"></span></span><span style="left: 37.71pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-693" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2534">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.82pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 150.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="f-2535">168</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 150.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="f-2536">156</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2537">2,349</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ShorttermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2538">2,813</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-term borrowings:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-688" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2539">4.000</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-689" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2540">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-690" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2541">650</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-691" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2542">3.625</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 198.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 198.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-692" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2543">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 198.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-693" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2544">783</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-694" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2545">1.000</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 210.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 210.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-695" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2546">581</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 210.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-696" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2547">608</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 222.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-697" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2548">1.250</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 222.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-698" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2549">829</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-699" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2550">867</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-700" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2551">3.000</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 234.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-701" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2552">414</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 234.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-702" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2553">434</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 246.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-703" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2554">3.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 246.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 246.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-704" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2555">307</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 246.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-705" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2556">306</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 258.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-706" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2557">3.875</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2028<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 258.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 258.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-707" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2558">1,393</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 258.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-708" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2559">1,370</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 270.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-709" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2560">0.883</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#165; Euro Medium Term Note 2028<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 270.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 270.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-710" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2561">216</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 270.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-711" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2562">235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-712" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2563">1.250</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2028<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 282.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-713" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2564">746</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 282.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-714" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2565">745</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-715" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2566">3.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 294.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-716" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2567">792</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 294.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-717" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2568">778</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-718" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2569">1.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 306.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 306.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-719" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2570">414</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 306.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-720" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2571">433</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 318.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-721" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2572">1.750</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2030<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 318.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 318.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-722" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2573">621</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 318.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-723" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2574">650</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 330.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-724" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2575">2.875</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 330.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 330.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-725" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2576">576</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 330.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-726" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2577">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 342.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-727" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2578">3.125</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2032<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 342.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 342.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-728" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2579">577</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 342.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-729" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2580">604</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 354.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-730" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2581">5.250</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2033<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 354.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 354.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-731" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2582">567</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 354.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-732" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2583">566</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 366.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-733" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2584">5.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2034<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 366.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 366.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-734" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2585">396</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 366.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-735" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2586">390</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-736" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2587">1.625</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2035<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 378.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-737" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2588">745</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 378.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-738" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2589">745</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 390.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-739" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2590">3.250</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8364; Euro Medium Term Note 2036<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 390.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 390.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-740" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2591">494</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 390.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-741" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:fixed-zero" scale="6" id="f-2592">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 402.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-742" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2593">6.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Note 2038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 402.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 402.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-743" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2594">2,176</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 402.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-744" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2595">2,139</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 414.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-745" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2596">6.375</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2039<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 414.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 414.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-746" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2597">627</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 414.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-747" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2598">627</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 426.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-748" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2599">5.250</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2042<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 426.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 426.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-749" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2600">472</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 426.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-750" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2601">472</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 438.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-751" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2602">4.200</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US$ US Medium Term Note 2043<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 438.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New York Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 438.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-752" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2603">392</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 438.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-753" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2604">385</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 450.75pt; width: 198.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-754" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2605">4.250</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2045<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 198.75pt; overflow: hidden; position: var(--position); top: 450.75pt; width: 116.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 116.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 450.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-755" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2606">366</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 450.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-756" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2607">366</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 462.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other long-term borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 462.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-757" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2608">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 462.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-758" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="f-2609">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 474.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 474.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2610">934</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 474.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-2611">1,051</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 486.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2612">14,637</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 486.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-2613">15,205</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 498.75pt; width: 198.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 198.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 498.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-2614">13,095</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 443.25pt; position: var(--position); top: 498.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-2615">15,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">219<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-2511-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">30. Net debt continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Current assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments are classified as financial assets at amortised cost. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 397.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, they included US Treasury Notes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other government bonds. The effective interest rate on liquid investments at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 498.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="gsk:EffectiveInterestRateOnAvailableForSaleFinancialInvestments" scale="-2" id="f-2616">4.3</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="gsk:EffectiveInterestRateOnAvailableForSaleFinancialInvestments" scale="-2" id="f-2617">0.9</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Liquid investment balances at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 274.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> earning interest at floating rates amount to<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-759" decimals="-6" name="gsk:LiquidInvestments" scale="6" id="f-2618">11</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-760" decimals="-6" name="gsk:LiquidInvestments" format="ixt:num-dot-decimal" scale="6" id="f-2619">31</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Liquid investment balances at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> earning interest at fixed rates amount to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-761" decimals="-6" name="gsk:LiquidInvestments" scale="6" id="f-2620">10</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 530.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-762" decimals="-6" name="gsk:LiquidInvestments" format="ixt:num-dot-decimal" scale="6" id="f-2621">11</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 119.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Balances reported within cash and cash equivalents have an original maturity of three months or less. The effective interest rate on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash and cash equivalents at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 236.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 310.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="gsk:EffectiveInterestRateOnCashAndCashEquivalents" scale="-2" id="f-2622">4.8</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: approximately<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="gsk:EffectiveInterestRateOnCashAndCashEquivalents" scale="-2" id="f-2623">4.7</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Cash and cash equivalents <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> earning interest at floating and fixed rates amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 342.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-759" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2624">3,746</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 394.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-761" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2625">1</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 448.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> respectively (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 500.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-760" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2626">2,720</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 107.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-762" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2627">38</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and non-interest bearing holdings amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-763" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2628">123</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-764" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-2629">178</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s policy regarding the credit quality of cash and cash equivalents is set out in Note 44, &#8216;Financial instruments and related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosures&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 274.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Short-term borrowings<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-9" name="gsk:CommercialPapersAuthorised" scale="9" id="f-2630">10</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-765" decimals="-9" name="gsk:CommercialPapersAuthorised" scale="9" id="f-2631">8.0</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 179.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) US commercial paper programme. There was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-766" decimals="INF" name="ifrs-full:CommercialPapersIssued" format="ixt:fixed-zero" scale="0" id="f-2632">no</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US commercial paper in issue at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 130.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-2633">850</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-767" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-2634">667</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)). GSK has a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-768" decimals="-9" name="gsk:CommercialPapersAuthorised" scale="9" id="f-2635">5</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Euro commercial paper programme. There was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 515.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-768" decimals="INF" name="ifrs-full:CommercialPapersIssued" format="ixt:fixed-zero" scale="0" id="f-2636">no</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 525.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Euro commercial paper in issue at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.77999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 283.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-769" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-2637">170</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-769" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-2638">148</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)). GSK has <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-770" decimals="-8" name="gsk:RevolvingCreditFacilities" format="ixt:num-dot-decimal" scale="9" id="f-2639">1.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 464.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-771" name="gsk:RevolvingCreditFacilityTerm" format="ixt-sec:durwordsen" id="f-2640"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 495.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 514.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committed facilities and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-8" name="gsk:RevolvingCreditFacilities" format="ixt:num-dot-decimal" scale="9" id="f-2641">2.2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 188.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-772" decimals="-8" name="gsk:RevolvingCreditFacilities" scale="9" id="f-2642">1.8</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 243.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-773" name="gsk:RevolvingCreditFacilityTerm" format="ixt-sec:durday" id="f-2643">364</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> day<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 273.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> committed facilities. The <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-771" name="gsk:RevolvingCreditFacilityTerm" format="ixt-sec:durwordsen" id="f-2644"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committed facilities were signed in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 331.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February 2022 and extended by <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-771" name="gsk:RevolvingCreditFacilityExtensionTerm" format="ixt-sec:durwordsen" id="f-2645"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in August 2024 to September 2027. The <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-773" name="gsk:RevolvingCreditFacilityTerm" format="ixt-sec:durwordsen" id="f-2646"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">364<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-day<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 391.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> committed facilities were signed in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">September 2024. All<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> facilities were undrawn at 31 December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 300.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There was no commercial paper in issue at 31 December 2024. The weighted average interest rate on commercial paper <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">borrowings at 31 December <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-774" decimals="3" name="gsk:WeightedAverageInterestRateOnBorrowings" scale="-2" id="f-2647">5.1</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The weighted average interest rate on current bank loans and overdrafts at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 406.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-9" decimals="3" name="gsk:WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" scale="-2" id="f-2648">3.4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="gsk:WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" scale="-2" id="f-2649">4.6</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 399.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The average effective pre-swap interest rate of notes classified as short-term at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.77000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-775" decimals="3" name="gsk:AverageEffectivePreSwapInterestRateShortTerm" scale="-2" id="f-2650">3.9</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-776" decimals="3" name="gsk:AverageEffectivePreSwapInterestRateShortTerm" scale="-2" id="f-2651">2.4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 508.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 415.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Long-term borrowings<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 430.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December 2024 GSK had long-term borrowings of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-8" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="9" id="f-2652">14.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 309.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 338.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-8" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="9" id="f-2653">15.2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-777" decimals="-8" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="9" id="f-2654">8.4</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-778" decimals="-8" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="9" id="f-2655">8.7</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 532.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fell due in more than five years. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The average effective pre-swap interest rate of all notes in issue at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 303.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="gsk:AverageEffectivePreSwapInterestRateNotesIssued" scale="-2" id="f-2656">3.8</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.50999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="gsk:AverageEffectivePreSwapInterestRateNotesIssued" scale="-2" id="f-2657">3.7</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 483.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-term borrowings repayable after five years carry interest at effective rates between <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-779" decimals="3" name="gsk:CarryInterestAtEffectiveRates" scale="-2" id="f-2658">1.7</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-780" decimals="3" name="gsk:CarryInterestAtEffectiveRates" scale="-2" id="f-2659">6.4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 440.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-781" decimals="3" name="gsk:CarryInterestAtEffectiveRates" scale="-2" id="f-2660">1.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 488.01pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 504.41pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.77000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-782" decimals="3" name="gsk:CarryInterestAtEffectiveRates" scale="-2" id="f-2661">6.6</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 525.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 493.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with repayment dates ranging from <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 185.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2045<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.85pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 284.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 291.21pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 293.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2045<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2023, through a bilateral buyback of outstanding Sterling Notes, GSK repurchased <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-783" decimals="-6" name="ifrs-full:RepaymentsOfBondsNotesAndDebentures" format="ixt:num-dot-decimal" scale="6" id="f-2662">76</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 454.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-784" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2663">5.250</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium Term Note 2033 and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-785" decimals="-6" name="ifrs-full:RepaymentsOfBondsNotesAndDebentures" format="ixt:num-dot-decimal" scale="6" id="f-2664">69</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-786" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-2665">6.375</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#163; Euro Medium Term Note 2039.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Effective rates shown for 2023 exclude the impact of one-off premiums associated with the repurchase of the Sterling Notes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 551.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Pledged assets<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group held pledged investments in US Treasury Notes with a par value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-787" decimals="-6" name="gsk:PledgedInvestments" scale="6" id="f-2666">26</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 391.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-787" decimals="-6" name="gsk:PledgedInvestments" scale="6" id="f-2667">21</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 465.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-788" decimals="-6" name="gsk:PledgedInvestments" scale="6" id="f-2668">54</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 577.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-788" decimals="-6" name="gsk:PledgedInvestments" scale="6" id="f-2669">42</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)) as security against irrevocable letters of credit issued on the Group&#8217;s behalf in respect of the Group&#8217;s self-insurance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 587.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activity. Provisions in respect of self-insurance are included within the provisions for legal and other disputes discussed in Note 32, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 597.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">'Other provisions&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 613.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The total cash outflow for leases for the year ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 342.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CashOutflowForLeases" format="ixt:num-dot-decimal" scale="6" id="f-2670">256</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CashOutflowForLeases" format="ixt:num-dot-decimal" scale="6" id="f-2671">197</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 645.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfLeaseObligationsExplanatoryTableTextBlock" id="f-2672" continuedAt="f-2672-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maturity<span style="display: inline-block; height: 6.18pt;"></span><span id="iefb21abf5bab402db7fb405a4b02d67b_3291"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 100.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> analysis of discounted lease liabilities recognised on the Group balance sheet is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2672-1"><div style="position: var(--position); top: 661.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><span id="i76a5e5984cbd4e3f891bf60dca713c48_0-0-1-1-821446"></span></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rental payments due within one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-789" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="f-2673">168</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-790" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="f-2674">156</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rental payments due between one and two years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-791" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2675">222</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-792" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2676">214</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rental payments due between two and three years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-793" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2677">146</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-794" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2678">134</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rental payments due between three and four years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-795" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2679">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-796" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2680">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rental payments due between four and five years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-797" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2681">73</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-798" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2682">88</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rental payments due after five years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-777" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2683">384</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-778" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="f-2684">501</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-2685">1,102</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-2686">1,207</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">220<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_475"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEmployeeBenefitsExplanatory" id="f-2687" continuedAt="f-2687-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-2687-1" continuedAt="f-2687-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" id="f-2688" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 17.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 8.72pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension and other post-employment costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 1.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 17.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK pension schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 17.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-799" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2689">120</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 17.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-800" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2690">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 17.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-801" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2691">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 29.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US pension schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 29.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-802" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2692">40</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 29.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-803" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2693">56</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 29.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-804" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2694">48</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other overseas pension schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-805" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2695">151</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-806" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2696">146</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-807" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2697">154</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unfunded post-retirement healthcare schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 53.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-808" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2698">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 53.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-809" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2699">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 53.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-810" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2700">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 65.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2701">368</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 65.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2702">356</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 65.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2703">369</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 77.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Analysed as:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Funded defined benefit/hybrid pension schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-811" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2704">132</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-812" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2705">134</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-813" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2706">152</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unfunded defined benefit pension schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 101.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-814" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2707">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 101.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-815" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2708">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 101.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-816" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2709">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 113.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unfunded post-retirement healthcare schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 113.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-817" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2710">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 113.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-818" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2711">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 113.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-819" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2712">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined benefit schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 125.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2713">218</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 125.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2714">227</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 125.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2715">236</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined contribution pension schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 137.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="6" id="f-2716">150</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 137.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="6" id="f-2717">129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 137.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="6" id="f-2718">133</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 149.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2719">368</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 149.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2720">356</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 149.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss" scale="6" id="f-2721">369</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 17.25pt;"><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 17.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 487.5pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 7.79pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The costs of the defined benefit pension and post-retirement healthcare schemes are charged in the income statement as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 209.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of sales<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-449" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2722">87</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-450" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2723">94</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-820" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2724">104</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 221.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling, general and administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-453" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2725">92</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-454" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2726">91</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 221.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-821" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2727">90</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 233.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 233.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-451" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2728">39</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 233.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-452" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2729">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 233.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-822" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2730">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 245.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2731">218</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 245.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2732">227</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 245.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-2733">236</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK entities operate pension arrangements which cover the Group&#8217;s material obligations to provide pensions to retired employees. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These arrangements have been developed in accordance with local practices in the countries concerned. Pension benefits can be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 440.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided by state schemes; by defined contribution schemes, whereby retirement benefits are determined by the value of funds <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arising from contributions paid in respect of each employee; or by defined benefit schemes, whereby retirement benefits are based <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on factors such as employee pensionable remuneration and length of service. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension costs of defined benefit schemes for accounting purposes have been calculated using the projected unit credit method. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain countries pension benefits are provided on an unfunded basis, some administered by trustee companies. Formal, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independent, actuarial valuations of the Group&#8217;s main plans are undertaken regularly, normally at least every three years. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement movements in the year are recognised through the statement of comprehensive income. Discount rates are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">derived from AA rated corporate bond yields except in countries where there is no deep market in corporate bonds where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government bond yields are used. Discount rates are selected to reflect the term of the expected benefit payments. Projected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflation rates and pension increases are long-term predictions based on the yield gap between long-term index-linked and fixed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest government bonds. In the UK, mortality rates are determined by adjusting the SAPS S3 standard mortality tables to reflect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recent scheme experience. These rates are then projected to reflect improvements in life expectancy in line with the CMI 2023 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projections with a long-term rate of improvement of 1.0% per year for both males and females. In the US, mortality rates are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calculated using the PRI-2012 white collar table adjusted to reflect recent experience. These rates are projected using MP-2020 to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 594.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allow for future improvements in life expectancy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 610.24pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" id="f-2734" continuedAt="f-2734-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The average life expectancy assumed now for an individual at the age of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" format="ixt-sec:duryear" id="f-2735">60</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and projected to apply in 2044 for an individual then at <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2734-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the age of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" format="ixt-sec:duryear" id="f-2736">60</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 636.33pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 78.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 78.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Male<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Female<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Male<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Female<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-823" name="gsk:MalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2737">26.8</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-823" name="gsk:FemalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2738">28.3</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-824" name="gsk:MalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2739">27.4</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-824" name="gsk:FemalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2740">28.8</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Projected for 2044<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-825" name="gsk:MalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2741">27.9</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-825" name="gsk:FemalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2742">29.5</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-826" name="gsk:MalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2743">28.9</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-826" name="gsk:FemalePensionersAverageLifeExpectancyAtSixty" format="ixt-sec:duryear" id="f-2744">30.2</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">221<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-2" continuedAt="f-2687-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The assets of funded schemes are generally held in separately administered trusts, either as specific assets or as a proportion of a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">general fund, or are insurance contracts. Assets are invested in different classes in order to maintain a balance between risk and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">return. Investments are diversified to limit the financial effect of the failure of any individual investment. The target exposure for&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-1" decimals="0" name="gsk:NumberOfUKPensionPlansPhysicalAssetAllocationStrategyApplied" format="ixt-sec:numwordsen" scale="0" id="f-2745">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 73.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-1" decimals="0" name="gsk:NumberOfUKPensionPlans" format="ixt-sec:numwordsen" scale="0" id="f-2746">four</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> UK plans is split <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 177.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-827" decimals="2" name="gsk:AllocationToReturnSeekingAssets" scale="-2" id="f-2747">36</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; to return-seeking assets and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-827" decimals="2" name="gsk:AllocationToLiabilityMatchingAssets" scale="-2" id="f-2748">64</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 324.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to liability-matching assets. During 2019, a buy-in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insurance contract was purchased to cover substantially all of the obligations of the other UK plan. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 501.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the value <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the insurance contract was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:TotalValueOfTheInsuranceContract" scale="6" id="f-2749">340</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:TotalValueOfTheInsuranceContract" scale="6" id="f-2750">387</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 283.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The asset allocation of the US plans is currently set at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-828" decimals="2" name="gsk:AllocationToReturnSeekingAssets" scale="-2" id="f-2751">25</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 510.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> return-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seeking assets and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 128.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-828" decimals="2" name="gsk:AllocationToLiabilityMatchingAssets" scale="-2" id="f-2752">75</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> liability-matching assets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The pension plans are exposed to risk that arises because the market value of the plans&#8217; assets might decline or the estimated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of the plans&#8217; liabilities might increase. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Within the broad investment strategy outlined above, the return-seeking assets are primarily intended to generate future returns <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">while the liability-matching assets are intended to match future pension obligations. Each pool invests across a broad range of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets. The main risks within the portfolios are against credit risk, interest rates, long-term inflation, equities, property, currency and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bank counterparty risk. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The plan liabilities are a series of future cash flows with relatively long duration. On an IAS 19 basis, these cash flows are sensitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to changes in the expected long-term inflation rate and the discount rate (AA corporate bond yield curve) where an increase in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term inflation corresponds with an increase in the liabilities, and an increase in the discount rate corresponds with a decrease <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the liabilities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 325.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The interest rate risk in the US is partially hedged, with the target based on an accounting measure of the plan liabilities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the UK plans, there is an interest rate and inflation hedging strategy in place. The targets are based on an economic measure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the plan liabilities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate-related impacts, along with other environmental, social and governance (ESG) considerations, can be financially material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with regard both to expected returns and to risk implications. The incorporation of such considerations into investment policy is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subject to local regulations and fiduciary obligations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the UK, the defined benefit pension schemes operated for the benefit of former Glaxo Wellcome employees and former <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham employees remain separate. These schemes were closed to new entrants in 2001 and subsequent UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employees are entitled to join a defined contribution scheme. In addition, the Group operates a number of post-retirement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare schemes, the principal one of which is in the US. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The UK defined benefit plans closed to future accrual effective from 31 March 2022. As a result, post closure the accrued benefits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of active participants are revalued in line with inflation (RPI for the legacy Glaxo Wellcome plans and CPI for the legacy SmithKline <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beecham plans subject to the relevant caps for each arrangement) rather than capped pay increases. From 1 April 2022, former <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">defined benefit plans employees were transferred to the defined contribution plans. All defined benefit plan participants who were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">still active at 1 April 2022 received a defined pension contribution of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-829" decimals="0" name="ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="0" id="f-2753">10,000</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> each in 2022. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The cash funding or technical provision d<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 206.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eficits of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-830" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="6" id="f-2754">1,080</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 291.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> identified in the 31 December 2020 pension scheme valuations in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-831" decimals="0" name="gsk:NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" format="ixt-sec:numwordsen" scale="0" id="f-2755">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 73.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK UK defined benefit pension schemes and increased by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-832" decimals="-6" name="gsk:NotionalInterest" format="ixt:num-dot-decimal" scale="6" id="f-2756">7</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> notional interest, were fully paid in 2023, (2023:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-833" decimals="-6" name="ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2757">353</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; 2022: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 126.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-834" decimals="-6" name="ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2758">691</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The contributions were collateralised by the creation of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="partnership" contextRef="c-1" decimals="0" name="gsk:NumberOfScottishLimitedPartnerships" format="ixt-sec:numwordsen" scale="0" id="f-2759">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Scottish Limited Partnerships <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SLPs) during the GSK Consumer Healthcare Holdings Limited demerger, each SLP providing a funding mechanism for each of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-212" decimals="INF" name="gsk:NumberOfPrincipalUKDefinedBenefitPensionSchemes" format="ixt-sec:numwordsen" scale="0" id="f-2760">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 73.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> principal UK defined benefit pension schemes (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="pensionscheme" contextRef="c-835" decimals="INF" name="gsk:NumberOfPrincipalUKDefinedBenefitPensionSchemes" format="ixt-sec:numwordsen" scale="0" id="f-2761">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> benefiting current and former Glaxo Wellcome employees, with the third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 557.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefiting current and former SmithKline Beecham employees)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 287.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The US cash balance pension plan closed to future accrual from 1 January 2021.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.67pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" id="f-2762" continuedAt="f-2762-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has applied the following financial assumptions in assessing the defined benefit liabilities:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2762-1"><div style="position: var(--position); top: 605.56pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 119.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 119.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 77.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% pa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rate of increase of future earnings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2763">3.20</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2764">3.20</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 30.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-2765">3.40</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-837" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2766">5.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-838" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2767">4.60</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-839" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2768">4.80</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2769">5.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2770">5.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-840" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2771">5.30</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2772">3.30</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2773">3.10</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-2774">3.40</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expected pension increases<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-837" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="f-2775">2.90</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-838" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="f-2776">2.90</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-839" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="f-2777">3.10</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="f-2778">2.40</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="f-2779">2.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 54.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="f-2780">2.40</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash balance credit/conversion rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 26.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="gsk:ActuarialAssumptionOfCashBalanceCreditRate" scale="-2" id="f-2781">4.80</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="gsk:ActuarialAssumptionOfCashBalanceCreditRate" scale="-2" id="f-2782">4.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-840" decimals="4" name="gsk:ActuarialAssumptionOfCashBalanceCreditRate" scale="-2" id="f-2783">3.90</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="gsk:ActuarialAssumptionOfCashBalanceCreditRate" scale="-2" id="f-2784">1.10</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="gsk:ActuarialAssumptionOfCashBalanceCreditRate" scale="-2" id="f-2785">0.60</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="gsk:ActuarialAssumptionOfCashBalanceCreditRate" scale="-2" id="f-2786">0.80</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inflation rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129.75pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-837" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2787">2.90</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 169.5pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-838" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2788">2.90</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 209.25pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-839" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2789">3.10</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2790">2.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2791">2.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-840" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2792">2.50</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2793">1.90</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2794">2.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 78.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 22.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-2795">2.30</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 707pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 337.42pt;">Sensitivity analysis detailing the effect of changes in assumptions is provided on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 391.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 14.04pt;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i7116a2801eff4075aa6b58db69a45043_10318">228</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 136.1pt;">. The analysis provided reflects the<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 541.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 2.32pt;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 717.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 319.49pt;">assumption changes which have the most material impact on the results of the Group.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 2.32pt;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">222<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-3" continuedAt="f-2687-4"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" id="f-2796" continuedAt="f-2796-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The amounts recorded in the income statement and statement of comprehensive income for the three years ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 482.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2796-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in relation to the defined benefit pension and post-retirement healthcare schemes were as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 166.07pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Post-retirement<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amounts charged to operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2797">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2798">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2799">94</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2800">97</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2801">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2802">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2803">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2804">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2805">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2806">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net interest (income)/cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2807">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2808">26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2809">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2810">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2811">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gains from settlements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2812">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2813">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2814">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2815">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2816">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2817">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2818">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" format="ixt:fixed-zero" scale="6" id="f-2819">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2820">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" format="ixt:fixed-zero" scale="6" id="f-2821">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2822">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2823">40</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2824">106</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2825">161</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2826">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 129pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement gains/(losses) recorded in the statement of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-841" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2827">237</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-842" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2828">90</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-843" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2829">129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-844" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2830">456</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-845" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2831">50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 326.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Post-retirement<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amounts charged to operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.94pt;"></span></span><span style="left: 39.57pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2832">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2833">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2834">91</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2835">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2836">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost/(credit)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2837">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2838">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2839">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2840">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2841">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net interest (income)/cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2842">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2843">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2844">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2845">46</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2846">47</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gains from settlements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2847">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2848">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2849">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2850">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2851">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2852">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2853">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" format="ixt:fixed-zero" scale="6" id="f-2854">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2855">30</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2856">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2857">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2858">56</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2859">101</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2860">169</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2861">58</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 129pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement gains/(losses) recorded in the statement of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-846" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2862">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-847" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2863">45</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-848" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2864">38</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-849" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2865">111</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-850" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2866">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 486.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.54pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Post-retirement<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 20.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amounts charged to operating profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2867">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2868">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2869">126</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2870">146</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2871">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost/(credit)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2872">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.94pt;"></span></span><span style="left: 39.57pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2873">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.94pt;"></span></span><span style="left: 39.57pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2874">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-2875">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.94pt;"></span></span><span style="left: 39.57pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2876">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net interest (income)/cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2877">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2878">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2879">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2880">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-2881">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gains from settlements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2882">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2883">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2884">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2885">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-2886">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2887">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2888">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.94pt;"></span></span><span style="left: 39.57pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" format="ixt:fixed-zero" scale="6" id="f-2889">&#8212;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2890">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" scale="6" id="f-2891">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2892">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2893">48</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2894">113</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2895">183</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="6" id="f-2896">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 129pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement gains/(losses) recorded in the statement of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 80.36999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-851" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="f-2897">1,169</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-852" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2898">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-853" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2899">261</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-854" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2900">872</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 129pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 14.72pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-855" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-2901">228</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 647.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 251.92pt;">The amounts included within past service costs in the UK included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 305.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 40.44pt;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:AugmentationCostsIncludedInPastServiceCosts" scale="6" id="f-2902">18</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 5.43pt;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 18.72pt;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 370.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 4.96pt;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 35.76pt;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AugmentationCostsIncludedInPastServiceCosts" scale="6" id="f-2903">3</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 28.64pt;">; 2022: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 439.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 35.76pt;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:AugmentationCostsIncludedInPastServiceCosts" scale="6" id="f-2904">6</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 66.03pt;">) of augmentation<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 541.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 2.32pt;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); text-align: justify; text-align-last: var(--justify); top: 657.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre; width: 210.21pt;">costs which arose from Major restructuring programmes.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">223<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-4" continuedAt="f-2687-5"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfBalanceSheetPresentationOfDefinedBenefitPensionAndPostRetirementExplanatoryTableTextBlock" id="f-2905" continuedAt="f-2905-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A summarised balance sheet presentation of the Group defined benefit pension schemes and other post-retirement benefits is set <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2905-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out in the table below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 171.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recognised in other non-current assets:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension schemes in surplus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-856" decimals="-6" name="ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan" scale="6" id="f-2906">898</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-857" decimals="-6" name="ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan" scale="6" id="f-2907">634</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-858" decimals="-6" name="ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan" scale="6" id="f-2908">229</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recognised in pensions and other post-employment benefits:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Pension schemes in deficit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-859" decimals="-6" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="6" id="f-2909">1,001</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-860" decimals="-6" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="6" id="f-2910">1,397</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-861" decimals="-6" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="6" id="f-2911">1,585</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Post-retirement benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-862" decimals="-6" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" scale="6" id="f-2912">863</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-863" decimals="-6" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" scale="6" id="f-2913">943</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-864" decimals="-6" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" scale="6" id="f-2914">994</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-2915">1,864</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-2916">2,340</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-2917">2,579</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the event of a plan wind-up, GSK believes the UK pension scheme rules provide the company with the right to a refund of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">surplus assets following the full settlement of plan liabilities. As a result, the net surplus in the UK defined benefit pension schemes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is recognised in full.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.99pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory" id="f-2918" continuedAt="f-2918-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair values of the assets and liabilities of the UK and US defined benefit pension schemes, together with aggregated data for <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-2918-1" continuedAt="f-2918-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other defined benefit pension schemes in the Group are as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 335.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 89.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 218.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 89.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Equities:<span style="display: inline-block; height: 5.46pt; width: 7.53pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-865" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2919">1,669</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-866" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2920">472</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-867" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2921">364</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-868" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2922">2,505</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-869" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2923">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-870" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2924">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-871" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2925">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-872" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2926">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multi-asset funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2927">923</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2928">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2929">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2930">923</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Property:<span style="display: inline-block; height: 5.46pt; width: 5.87pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-865" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2931">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-866" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2932">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-867" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2933">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-868" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2934">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-869" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2935">407</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-870" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2936">99</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-871" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2937">24</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-872" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2938">530</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Corporate bonds:<span style="display: inline-block; height: 5.46pt; width: 24.4pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-865" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2939">2,104</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-866" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2940">739</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-867" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2941">208</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-868" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2942">3,051</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-869" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2943">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-870" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2944">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-871" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2945">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-872" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2946">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Government bonds:<span style="display: inline-block; height: 5.46pt; width: 6.68pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 102pt; width: 218.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 218.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-865" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2947">4,107</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-866" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" scale="6" id="f-2948">772</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-867" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" scale="6" id="f-2949">489</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-868" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2950">5,368</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Insurance contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2951">883</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2952">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2953">822</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2954">1,705</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other (liabilities)/assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" sign="-" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2955">1,291</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2956">125</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2957">81</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" sign="-" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2958">1,085</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-2959">8,802</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-2960">2,207</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-2961">2,005</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-2962">13,014</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Present value of scheme obligations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-2963">8,241</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-2964">2,596</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-2965">2,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-2966">13,117</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net surplus/(obligation)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2967">561</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2968">389</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2969">275</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2970">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 174pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 174pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-874" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2971">725</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 174pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-875" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" format="ixt:fixed-zero" scale="6" id="f-2972">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 174pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-876" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2973">173</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 174pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-877" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2974">898</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in pensions and other post-employment benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 185.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-878" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2975">164</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 185.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-879" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2976">389</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 185.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-880" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2977">448</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 185.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-881" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="6" id="f-2978">1,001</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 197.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-837" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2979">561</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 197.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-214" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2980">389</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 197.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-218" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2981">275</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 197.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-873" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-2982">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 209.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Actual return/(loss) on plan assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-827" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2983">213</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-828" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2984">132</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-882" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2985">121</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 209.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-883" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-2986">40</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The multi-asset funds comprise investments in pooled investment vehicles that are invested across a range of asset classes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 577.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing diversification within the growth portfolio. The investments in this asset class with a quoted market price were fully&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 587.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redeemed during the year (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 173.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" scale="6" id="f-2987">209</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 603.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The &#8216;Other (liabilities)/assets&#8217; category comprises cash and mark to market values of derivative positions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Index-linked gilts held as part of a UK repo programme are included in government bonds. The related loan of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-884" decimals="-6" name="gsk:LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2988">1,634</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 515pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 130.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-885" decimals="-6" name="gsk:LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2989">1,853</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.33999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 229.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-886" decimals="-6" name="gsk:LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2990">2,376</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is deducted within &#8216;Other assets&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">224<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-5" continuedAt="f-2687-6"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:continuation id="f-2918-2" continuedAt="f-2918-3"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 89.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 89.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Equities:<span style="display: inline-block; height: 5.46pt; width: 7.53pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-887" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2991">1,647</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-888" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2992">447</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-889" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2993">349</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 18.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-890" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-2994">2,443</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-891" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2995">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-892" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-2996">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-893" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2997">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 30.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-894" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2998">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multi-asset funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-2999">852</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3000">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3001">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 42.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3002">852</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Property:<span style="display: inline-block; height: 5.46pt; width: 5.87pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-887" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3003">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-888" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3004">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-889" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3005">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 54.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-890" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3006">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 66.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-891" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3007">467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 66.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-892" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3008">119</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 66.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-893" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3009">24</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 66.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-894" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3010">610</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Corporate bonds:<span style="display: inline-block; height: 5.46pt; width: 24.4pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-887" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3011">2,019</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-888" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3012">698</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-889" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3013">205</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 78.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-890" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3014">2,922</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-891" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3015">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-892" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3016">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-893" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3017">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 90.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-894" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3018">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Government bonds:<span style="display: inline-block; height: 5.46pt; width: 6.68pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-887" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3019">4,897</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-888" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" scale="6" id="f-3020">774</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-889" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" scale="6" id="f-3021">527</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 102.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-890" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3022">6,198</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Insurance contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3023">990</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3024">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3025">771</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 114.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3026">1,761</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other (liabilities)/assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 126.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" sign="-" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3027">1,374</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 126.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3028">104</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 126.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3029">89</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 126.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" sign="-" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3030">1,181</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 138.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3031">9,498</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 138.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3032">2,142</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 138.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3033">1,982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 138.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3034">13,622</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Present value of scheme obligations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 150.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3035">9,222</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 150.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3036">2,757</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 150.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3037">2,406</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 150.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3038">14,385</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net surplus/(obligation)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3039">276</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3040">615</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3041">424</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3042">763</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 6pt; left: 303.75pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.44pt;"></span></span><span style="left: 35.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 6pt; left: 349.5pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.44pt;"></span></span><span style="left: 35.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 6pt; left: 395.25pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.44pt;"></span></span><span style="left: 35.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 6pt; left: 441pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.44pt;"></span></span><span style="left: 35.07pt; position: var(--position);">&#8212;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 180.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-896" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3043">457</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 180.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-897" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" format="ixt:fixed-zero" scale="6" id="f-3044">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 180.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-898" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3045">177</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 180.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-899" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3046">634</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in pensions and other post-employment benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 192.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-900" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3047">181</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 192.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-901" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3048">615</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 192.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-902" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3049">601</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 192.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-903" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="6" id="f-3050">1,397</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 204.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-838" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3051">276</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 204.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-215" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3052">615</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 204.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-219" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3053">424</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 204.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-895" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3054">763</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 222.75pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Actual return on plan assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-904" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3055">647</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-905" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3056">196</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-906" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3057">138</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-907" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3058">981</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><ix:continuation id="f-2918-3"><div style="position: var(--position); top: 374.72pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 89.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 214.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 89.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equities:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 20.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-908" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3059">1,351</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 20.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-909" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3060">437</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 20.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-910" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3061">371</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 20.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-911" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3062">2,159</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 32.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-912" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3063">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 32.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-913" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3064">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 32.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-914" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3065">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 32.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-915" decimals="-6" name="ifrs-full:EquityInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3066">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multi-asset funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 44.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3067">1,101</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 44.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3068">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 44.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3069">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 44.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" name="ifrs-full:InvestmentFundsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3070">1,101</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 56.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-908" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3071">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 56.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-909" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3072">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 56.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-910" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3073">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 56.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-911" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3074">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 68.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-912" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3075">464</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 68.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-913" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3076">140</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 68.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-914" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3077">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 68.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-915" decimals="-6" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3078">605</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: -0.2pt; position: var(--position);">Corporate bonds:<span style="display: inline-block; height: 5.46pt; width: 24.4pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 80.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-908" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3079">1,692</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 80.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-909" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3080">779</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 80.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-910" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3081">124</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 80.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-911" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3082">2,595</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; unlisted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 92.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-912" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3083">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 92.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-913" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3084">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 92.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-914" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3085">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 92.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-915" decimals="-6" name="ifrs-full:DebtInstrumentsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3086">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Government bonds:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 89.25pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 214.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 214.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; listed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-908" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3087">4,048</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-909" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" scale="6" id="f-3088">723</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-910" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" scale="6" id="f-3089">558</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-911" decimals="-6" name="gsk:GovernmentBondsContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3090">5,329</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Insurance contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3091">1,003</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-3092">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3093">691</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-3094">1,694</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other (liabilities)/assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" sign="-" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3095">645</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3096">181</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3097">89</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" sign="-" name="gsk:OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" scale="6" id="f-3098">375</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3099">9,014</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3100">2,260</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3101">1,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3102">13,144</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Present value of scheme obligations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3103">9,117</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3104">3,030</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3105">2,353</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3106">14,500</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net surplus/(obligation)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3107">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3108">770</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3109">483</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="6" id="f-3110">1,356</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 182.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-917" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3111">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 182.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-918" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" format="ixt:fixed-zero" scale="6" id="f-3112">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 182.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-919" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3113">120</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 182.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-920" decimals="-6" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3114">229</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 194.25pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in Pensions and other post-employment benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 194.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-921" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3115">212</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 194.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-922" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3116">770</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 194.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-923" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3117">603</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 194.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-924" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="6" id="f-3118">1,585</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 206.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-839" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3119">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 206.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-840" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3120">770</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 206.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-836" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" scale="6" id="f-3121">483</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 206.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-916" decimals="-6" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="6" id="f-3122">1,356</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 224.25pt; width: 303.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 303.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Actual return on plan assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303.75pt; position: var(--position); top: 224.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-925" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3123">4,710</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 349.5pt; position: var(--position); top: 224.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-926" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3124">253</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 224.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-927" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3125">550</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441pt; position: var(--position); top: 224.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-928" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3126">5,513</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">225<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-6" continuedAt="f-2687-7"><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfMovementsInFairValuesOfAssetsExplanatoryTableTextBlock" id="f-3127" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 15pt;"><td colspan="6" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 15pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 15pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Post-retirement<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movements in fair values of assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 35.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 35.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 35.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 35.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 35.25pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 55.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.66pt;"></span></span><span style="left: 24.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-929" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3128">13,632</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 55.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-930" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3129">2,524</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 55.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-931" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3130">2,906</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 55.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.66pt;"></span></span><span style="left: 24.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-932" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3131">19,062</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 55.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-933" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-3132">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 67.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3133">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 67.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3134">286</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 67.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3135">122</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 67.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3136">408</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 67.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3137">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 79.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3138">271</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 79.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3139">71</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 79.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3140">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 79.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3141">370</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 79.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3142">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 91.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3143">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 91.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3144">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 91.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" format="ixt:fixed-zero" scale="6" id="f-3145">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 91.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3146">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 91.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" format="ixt:fixed-zero" scale="6" id="f-3147">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 103.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 103.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3148">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 103.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3149">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 103.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" sign="-" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3150">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 103.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3151">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 103.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3152">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 115.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 115.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3153">4,981</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 115.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3154">324</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 115.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3155">578</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 115.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3156">5,883</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 115.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3157">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 127.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3158">755</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 127.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3159">50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 127.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3160">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 127.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3161">919</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 127.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3162">117</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 139.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scheme participants&#8217; contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 139.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3163">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 139.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3164">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 139.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3165">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 139.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3166">15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 139.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3167">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 151.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" format="ixt:fixed-zero" scale="6" id="f-3168">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 151.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" format="ixt:fixed-zero" scale="6" id="f-3169">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 151.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" scale="6" id="f-3170">624</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 151.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" scale="6" id="f-3171">624</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 151.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" format="ixt:fixed-zero" scale="6" id="f-3172">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 163.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 163.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-934" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3173">649</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 163.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-935" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3174">326</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 163.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-936" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3175">105</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 163.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-937" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3176">1,080</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 163.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-938" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3177">135</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 175.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-939" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3178">9,014</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 175.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-940" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3179">2,260</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 175.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-941" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3180">1,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 175.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.66pt;"></span></span><span style="left: 24.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-942" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3181">13,144</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 175.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-943" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-3182">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 187.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 187.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3183">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 187.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3184">125</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 187.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3185">84</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 187.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3186">209</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 187.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3187">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 199.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 199.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3188">430</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 199.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3189">111</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 199.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3190">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 199.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3191">601</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 199.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3192">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 211.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3193">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 211.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3194">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 211.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" format="ixt:fixed-zero" scale="6" id="f-3195">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 211.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3196">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 211.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" format="ixt:fixed-zero" scale="6" id="f-3197">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 223.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 223.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3198">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 223.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3199">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 223.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3200">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 223.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3201">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 223.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3202">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 235.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 235.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3203">217</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 235.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3204">85</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 235.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3205">78</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 235.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3206">380</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 235.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3207">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 247.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 247.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3208">363</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 247.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3209">125</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 247.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3210">118</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 247.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3211">606</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 247.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3212">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scheme participants&#8217; contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 259.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3213">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 259.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3214">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 259.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3215">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 259.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3216">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 259.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3217">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 271.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 271.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-944" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3218">512</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 271.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-945" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3219">298</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 271.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-946" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3220">73</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 271.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-947" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3221">883</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 271.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-948" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3222">116</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 283.5pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 283.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-949" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3223">9,498</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 283.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-950" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3224">2,142</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 283.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-951" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3225">1,982</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 283.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.66pt;"></span></span><span style="left: 24.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-952" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3226">13,622</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 283.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-953" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-3227">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 295.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 295.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3228">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 295.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3229">37</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 295.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3230">116</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 295.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3231">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 295.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3232">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 307.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 307.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3233">426</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 307.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3234">102</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 307.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3235">59</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 307.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3236">587</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 307.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3237">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 319.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 319.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3238">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 319.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3239">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 319.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" format="ixt:fixed-zero" scale="6" id="f-3240">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 319.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" scale="6" id="f-3241">23</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 319.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" format="ixt:fixed-zero" scale="6" id="f-3242">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 331.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3243">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 331.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3244">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 331.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" sign="-" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3245">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 331.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" sign="-" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3246">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 331.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3247">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 343.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3248">639</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 343.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3249">30</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 343.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3250">62</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 343.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3251">547</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 343.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3252">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 355.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 355.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3253">63</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 355.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3254">179</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 355.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3255">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 355.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3256">351</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 355.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3257">94</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scheme participants&#8217; contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 367.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3258">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 367.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3259">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 367.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3260">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 367.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3261">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 367.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3262">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 379.5pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 379.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-954" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3263">534</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 379.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-955" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3264">272</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 379.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-956" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3265">101</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 379.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-957" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3266">907</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 379.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-958" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3267">112</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 391.5pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 391.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-959" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3268">8,802</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 391.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-960" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3269">2,207</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 391.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-961" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3270">2,005</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 391.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.66pt;"></span></span><span style="left: 24.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-962" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-3271">13,014</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 391.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-963" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-3272">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2024, the Group made a deficit reduction contribution to the UK pens<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ion schem<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">es of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-964" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" format="ixt:num-dot-decimal" scale="6" id="f-3273">30</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 435.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 468.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-965" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" format="ixt:fixed-zero" scale="6" id="f-3274">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 477.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), eliminating the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deficit identified in the 31 December 2023 triennial funding valuation. The Group also made a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contribution to the US Cash Balance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Plan of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-966" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" format="ixt:num-dot-decimal" scale="6" id="f-3275">150</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-967" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" format="ixt:num-dot-decimal" scale="6" id="f-3276">96</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions for 2025 are estimated to be <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 303.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-239" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" format="ixt:num-dot-decimal" scale="6" id="f-3277">270</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in respect of def<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ined benefit pension schemes and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-968" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" format="ixt:num-dot-decimal" scale="6" id="f-3278">80</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in respect of other post-retirement benefits.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">226<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-7" continuedAt="f-2687-8"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 114.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 130.48pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" id="f-3279" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.119999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pensions<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Post-retirement<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movements in defined benefit obligations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 18.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 18.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 18.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rest of World<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 18.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 18.75pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 39pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Obligations at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 39pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-969" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3280">13,299</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 39pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-970" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3281">3,248</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 39pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-971" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3282">3,644</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 39pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-972" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3283">20,191</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 39pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-973" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3284">1,243</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3285">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3286">371</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3287">124</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3288">495</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 51pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3289">125</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3290">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3291">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3292">126</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3293">146</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 63pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3294">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3295">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3296">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3297">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3298">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3299">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3300">260</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3301">91</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3302">37</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3303">388</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 87pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3304">32</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3305">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3306">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3307">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3308">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 99pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3309">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 111pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3310">3,812</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3311">360</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3312">839</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3313">5,011</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 111pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3314">228</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scheme participants&#8217; contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 123pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3315">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 123pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3316">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 123pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3317">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 123pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3318">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 123pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3319">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 135pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 135pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" format="ixt:fixed-zero" scale="6" id="f-3320">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 135pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" format="ixt:fixed-zero" scale="6" id="f-3321">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 135pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" scale="6" id="f-3322">621</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 135pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" scale="6" id="f-3323">621</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 135pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="gsk:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" scale="6" id="f-3324">83</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 147pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 147pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-974" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3325">649</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 147pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-975" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3326">326</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 147pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-976" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3327">105</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 147pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-977" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3328">1,080</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 147pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-978" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3329">135</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 159pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Obligations at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 159pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-979" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3330">9,117</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 159pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-980" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3331">3,031</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 159pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-981" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3332">2,352</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 159pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-982" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3333">14,500</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 159pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-983" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3334">994</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 171pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 171pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3335">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 171pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3336">166</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 171pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3337">87</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 171pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3338">253</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 171pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3339">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 183pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 183pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3340">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 183pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3341">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 183pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3342">91</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 183pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3343">96</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 183pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3344">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 195pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 195pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3345">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 195pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3346">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 195pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3347">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 195pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3348">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 195pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3349">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 207pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 207pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3350">425</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 207pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3351">145</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 207pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3352">76</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 207pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3353">646</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 207pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3354">47</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 219pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3355">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 219pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3356">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 219pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3357">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 219pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3358">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 219pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3359">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 231pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 231pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3360">189</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 231pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3361">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 231pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3362">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 231pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3363">269</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 231pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3364">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 243pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scheme participants&#8217; contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 243pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3365">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 243pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3366">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 243pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3367">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 243pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3368">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 243pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3369">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 255pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 255pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-984" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3370">512</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 255pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-985" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3371">298</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 255pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-986" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3372">73</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 255pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-987" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3373">883</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 255pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-988" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3374">116</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 267pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Obligations at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 267pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-989" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3375">9,222</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 267pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-990" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3376">2,757</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 267pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-991" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3377">2,406</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 267pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-992" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3378">14,385</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 267pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-993" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3379">943</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 279pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 279pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3380">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 279pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3381">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 279pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3382">133</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 279pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3383">93</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 279pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3384">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 291pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 291pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3385">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 291pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3386">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 291pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3387">94</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 291pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3388">97</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 291pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3389">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 303pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 303pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3390">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 303pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3391">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 303pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3392">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 303pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3393">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 303pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3394">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 315pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 315pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3395">411</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 315pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3396">128</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 315pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3397">73</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 315pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3398">612</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 315pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3399">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 327pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 327pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3400">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 327pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3401">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 327pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3402">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 327pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3403">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 327pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3404">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 339pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 339pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3405">876</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 339pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3406">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 339pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3407">67</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 339pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3408">1,003</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 339pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3409">50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 351pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scheme participants&#8217; contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 351pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3410">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 351pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3411">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 351pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3412">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 351pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3413">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 351pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" sign="-" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3414">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 363pt; width: 236.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benefits paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 363pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-994" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3415">534</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 363pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-995" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3416">272</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 363pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-996" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3417">101</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 363pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-997" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3418">907</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 363pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-998" decimals="-6" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="f-3419">112</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 375pt; width: 236.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 236.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Obligations at <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 375pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-999" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3420">8,241</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 375pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1000" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3421">2,596</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 375pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1001" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3422">2,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 375pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1002" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3423">13,117</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 375pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1003" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3424">863</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">227<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-2687-8" continuedAt="f-2687-9"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" id="f-3425" continuedAt="f-3425-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The defined benefit pension obligation is analysed as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3425-1"><div style="position: var(--position); top: 145.17pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Funded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1004" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3426">12,564</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1005" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3427">13,782</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1006" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3428">13,887</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unfunded<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1007" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3429">553</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1008" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3430">603</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1009" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3431">613</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3432">13,117</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3433">14,385</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3434">14,500</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The liability for the US post-retirement healthcare scheme has been assessed using the same assumptions as for the US pension <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 219.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scheme, together with the assumption for future medical inflation of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 305.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="gsk:ActuarialAssumptionOfExpectedRatesOfMedicalInflation" scale="-2" id="f-3435">6.50</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 355.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="gsk:ActuarialAssumptionOfExpectedRatesOfMedicalInflation" scale="-2" id="f-3436">6.75</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 381.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) in 2024, grading down to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 481.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1010" decimals="2" name="gsk:ActuarialAssumptionOfExpectedRatesOfMedicalInflation" scale="-2" id="f-3437">5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 493.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in 2031 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 229.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">thereafter. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 175.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the US post-retirement healthcare scheme obligation was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1011" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-3438">748</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 440.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 464.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1012" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-3439">785</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 537.1899999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1013" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="f-3440">870</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Post-retirement benefits are unfunded.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.41pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" id="f-3441" continuedAt="f-3441-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The movement in the net defined benefit liability is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3441-1" continuedAt="f-3441-2"><div style="position: var(--position); top: 268.3pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="f-3442">763</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="f-3443">1,356</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-19" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="f-3444">1,129</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3445">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3446">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3447">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3448">97</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3449">96</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3450">146</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Past service cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3451">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3452">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="f-3453">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3454">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3455">45</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="f-3456">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlements and curtailments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3457">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3458">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3459">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurements:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Return on plan assets, excluding amounts included in interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3460">547</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3461">380</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3462">5,883</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain/(loss) from change in demographic assumptions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 116.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3463">90</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 116.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3464">135</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 116.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3465">92</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain/(loss) from change in financial assumptions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 128.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3466">890</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 128.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3467">137</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 128.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="f-3468">5,868</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Experience gain/(loss)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 140.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3469">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 140.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3470">267</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 140.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3471">949</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employer contributions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 152.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3472">351</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 152.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3473">606</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 152.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="f-3474">919</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 164.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to assets held for sale/distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 164.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3475">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 164.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="f-3476">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 164.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3477">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expenses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 176.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3478">23</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 176.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3479">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 176.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" scale="6" id="f-3480">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 188.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 188.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="f-3481">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 188.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="f-3482">763</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 188.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="f-3483">1,356</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.24pt; width: 595.44pt;"><ix:continuation id="f-3441-2" continuedAt="f-3441-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The remeasurements included within post-retirement benefits are detailed below:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation></div><ix:continuation id="f-3441-3"><div style="position: var(--position); top: 489.13pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain from change in demographic assumptions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-968" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3484">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1014" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3485">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1015" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3486">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain/(loss) from change in financial assumptions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-968" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3487">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1014" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3488">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1015" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3489">219</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Experience gain/(loss)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-968" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3490">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1014" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3491">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1015" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="f-3492">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-968" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3493">50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1014" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3494">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1015" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="f-3495">228</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.07pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" id="f-3496" continuedAt="f-3496-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The defined benefit pension obligation analysed by membership category is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3496-1"><div style="position: var(--position); top: 577.96pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1016" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3497">1,418</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1017" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3498">1,508</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1018" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3499">1,390</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1019" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3500">8,147</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1020" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3501">8,730</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1021" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3502">8,540</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1022" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3503">3,552</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1023" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3504">4,147</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1024" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3505">4,570</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1025" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3506">13,117</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1026" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3507">14,385</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1027" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="f-3508">14,500</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.4pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" id="f-3509" continuedAt="f-3509-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The post-retirement benefit obligation analysed by membership category is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3509-1"><div style="position: var(--position); top: 665.29pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1028" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3510">277</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1029" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3511">277</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1030" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3512">306</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1031" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3513">586</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1032" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3514">666</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1033" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3515">688</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1034" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:fixed-zero" scale="6" id="f-3516">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1035" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:fixed-zero" scale="6" id="f-3517">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1036" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:fixed-zero" scale="6" id="f-3518">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1037" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3519">863</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1038" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3520">943</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1039" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="f-3521">994</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.73pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory" id="f-3522" continuedAt="f-3522-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The weighted average duration of the defined benefit obligation is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3522-1"><div style="position: var(--position); top: 752.62pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">years<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-239" name="gsk:WeightedAverageDurationOfDefinedBenefitObligations" format="ixt-sec:duryear" id="f-3523">11</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-240" name="gsk:WeightedAverageDurationOfDefinedBenefitObligations" format="ixt-sec:duryear" id="f-3524">11</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-241" name="gsk:WeightedAverageDurationOfDefinedBenefitObligations" format="ixt-sec:duryear" id="f-3525">12</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Post-retirement benefits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #dbdbdb; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1040" name="gsk:WeightedAverageDurationOfDefinedBenefitObligations" format="ixt-sec:duryear" id="f-3526">9</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1041" name="gsk:WeightedAverageDurationOfDefinedBenefitObligations" format="ixt-sec:duryear" id="f-3527">10</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1042" name="gsk:WeightedAverageDurationOfDefinedBenefitObligations" format="ixt-sec:duryear" id="f-3528">10</ix:nonNumeric><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">228<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-2687-9"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31. Pensions and other post-employment benefits continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sensitivity analysis<span style="display: inline-block; height: 8pt;"></span><span id="i7116a2801eff4075aa6b58db69a45043_10318"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" id="f-3529" continuedAt="f-3529-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The effect of changes in assumptions used on the benefit obligations and on the 2025 annual defined benefit pension and post-<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3529-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retirement costs are detailed below. This information has been determined by taking into account the duration of the liabilities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the overall profile of the plan memberships.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 181.46pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 383.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.25% <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.25% <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Decrease)/increase in annual pension cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3530">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3531">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in annual post-retirement benefits cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3532">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3533">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Decrease)/increase in pension obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3534">309</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3535">320</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Decrease)/increase in post-retirement benefits obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3536">17</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1043" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3537">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.75%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.75%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Decrease)/increase in annual pension cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3538">55</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3539">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 124.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in annual post-retirement benefits cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3540">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3541">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Decrease)/increase in pension obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3542">883</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" format="ixt:num-dot-decimal" scale="6" id="f-3543">1,012</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">(Decrease)/increase in post-retirement benefits obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 148.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3544">49</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 148.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1044" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3545">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 173.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.25%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 173.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.25%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 199.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inflation rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 211.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in annual pension cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 211.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1045" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3546">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 211.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1045" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3547">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 223.5pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in pension obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 223.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1045" decimals="-6" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3548">234</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 223.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1045" decimals="-6" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3549">229</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 235.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.75%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 235.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.75%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 261.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in annual pension cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 261.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1046" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3550">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 261.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1046" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3551">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 273.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in pension obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 273.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1046" decimals="-6" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3552">737</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 273.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1046" decimals="-6" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="6" id="f-3553">646</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 298.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1 year<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Life expectancy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 336.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in annual pension cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 336.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1047" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3554">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in annual post-retirement benefits cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 348.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1047" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3555">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 360.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in pension obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 360.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1047" decimals="-6" name="gsk:IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3556">380</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 372.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Increase in post-retirement benefits obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 372.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1047" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3557">29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 397.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increase<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 423.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rate of future healthcare inflation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 435.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in annual post-retirement benefits cost<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 435.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1048" decimals="-6" name="gsk:IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3558">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><span id="i312420a3d6d442b5a9ced8bc507e3d14_30-0-1-1-824492"></span><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 447.75pt; width: 383.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 383.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in post-retirement benefits obligation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 383.25pt; position: var(--position); top: 447.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1048" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="f-3559">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">229<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_481"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" id="f-3561" continuedAt="f-3561-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #ffffff; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">32. Other provisions<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3561-1" continuedAt="f-3561-2"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherProvisionsExplanatory" id="f-3562" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 262.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.01pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legal<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disputes<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.01pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Major<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restructuring<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.01pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 262.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1050" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3563">267</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1051" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3564">282</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1052" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3565">383</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1053" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3566">307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3567">1,239</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="f-3568">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="f-3569">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="f-3570">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="f-3571">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="f-3572">34</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Charge for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="ifrs-full:AdditionalProvisionsOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3573">2,039</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="6" id="f-3574">195</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="6" id="f-3575">216</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="6" id="f-3576">161</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdditionalProvisionsOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3577">2,611</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reversed unused<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="ifrs-full:UnusedProvisionReversedOtherProvisions" scale="6" id="f-3578">50</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" name="ifrs-full:UnusedProvisionReversedOtherProvisions" scale="6" id="f-3579">51</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" name="ifrs-full:UnusedProvisionReversedOtherProvisions" scale="6" id="f-3580">52</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" name="ifrs-full:UnusedProvisionReversedOtherProvisions" scale="6" id="f-3581">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:UnusedProvisionReversedOtherProvisions" scale="6" id="f-3582">183</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unwinding of discount<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" scale="6" id="f-3583">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" scale="6" id="f-3584">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" format="ixt:fixed-zero" scale="6" id="f-3585">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" format="ixt:fixed-zero" scale="6" id="f-3586">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" scale="6" id="f-3587">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Utilised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="f-3588">885</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="f-3589">149</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="f-3590">123</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="f-3591">70</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3592">1,227</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassifications and other movements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" format="ixt:fixed-zero" scale="6" id="f-3593">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="f-3594">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="f-3595">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="f-3596">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="f-3597">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to pension obligations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="gsk:TransferToPensionObligationsOtherProvisions" format="ixt:fixed-zero" scale="6" id="f-3598">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1055" decimals="-6" name="gsk:TransferToPensionObligationsOtherProvisions" scale="6" id="f-3599">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1056" decimals="-6" name="gsk:TransferToPensionObligationsOtherProvisions" format="ixt:fixed-zero" scale="6" id="f-3600">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1057" decimals="-6" name="gsk:TransferToPensionObligationsOtherProvisions" format="ixt:fixed-zero" scale="6" id="f-3601">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:TransferToPensionObligationsOtherProvisions" scale="6" id="f-3602">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 262.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1058" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3603">1,446</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1059" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3604">273</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1060" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3605">426</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1061" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3606">390</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3607">2,535</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To be settled within one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1058" decimals="-6" name="ifrs-full:OtherShorttermProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3608">1,393</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1059" decimals="-6" name="ifrs-full:OtherShorttermProvisions" scale="6" id="f-3609">178</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1060" decimals="-6" name="ifrs-full:OtherShorttermProvisions" scale="6" id="f-3610">178</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1061" decimals="-6" name="ifrs-full:OtherShorttermProvisions" scale="6" id="f-3611">197</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherShorttermProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3612">1,946</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To be settled after one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1058" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-3613">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1059" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-3614">95</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1060" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-3615">248</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1061" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-3616">193</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherLongtermProvisions" scale="6" id="f-3617">589</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 262.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1058" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3618">1,446</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1059" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3619">273</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1060" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3620">426</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1061" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-3621">390</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3622">2,535</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 354.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Legal and other disputes<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is involved in a substantial number of legal and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other disputes, including notification of possible claims, as set <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 390.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out in Note 47, &#8216;Legal proceedings&#8217;. Provisions for legal and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other disputes include amounts relating to product liability, anti-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trust, government investigations, contract terminations and self <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insurance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group may become involved in significant legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings in respect of which it is not possible to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meaningfully assess whether the outcome will result in a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">probable outflow, or to quantify or reliably estimate the liability, if <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any, that could result from ultimate resolution of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings. In these cases, the Group would provide <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate disclosures about such cases, but no provision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">would be made.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 524.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The net charge for the year of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1054" decimals="-6" name="gsk:AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3623">1,989</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 218.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 534.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reversals and estimated insurance recoveries) <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reflected the &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 107.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1062" decimals="-8" name="gsk:AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" format="ixt:num-dot-decimal" scale="9" id="f-3624">1.8</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> charge for the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 198.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> settlement and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related legal fees<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, as well as provisions for other product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability cases, commercial disputes and various other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government investigations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The discount on the provision is <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 174.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3625">18</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in 2024 (2023:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3626">10</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The discount was calculated using risk-adjusted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projected cash flows and risk-free rates of return.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 627.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In respect of product liability claims related to certain products, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provision is made when there is sufficient history of claims <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 648.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made and settlements to enable management to make a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 658.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable estimate of the provision required to cover unasserted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 668.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">claims, and to determine the probability of the outflow of cash. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The ultimate liability for such matters may vary from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounts provided and is dependent upon the outcome of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 699.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation proceedings, investigations and possible settlement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 709.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">negotiations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 725.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s position could change over time, and, therefore, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 735.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there can be no assurance that any losses that result from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 745.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcome of any legal proceedings will not exceed by a material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 755.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount the amount of the provisions reported in the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 766.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It is in the nature of the Group&#8217;s business that a number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 364.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these matters may be the subject of negotiation and litigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over many years. Litigation proceedings, including the various <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appeal procedures, often take many years to reach resolution, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and out-of-court settlement discussions can also often be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 405.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protracted. Indemnified disputes will result in a provision charge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 415.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and a corresponding receivable.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is in potential settlement discussions in a number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the disputes for which amounts have been provided and, based <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on its current assessment of the progress of these disputes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimates that <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ShorttermLegalProceedingsProvision" format="ixt:num-dot-decimal" scale="6" id="f-3627">1,393</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the amount provided at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 472.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> will be settled within one year, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 482.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related to the resolution of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 404.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> For a discussion of legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issues, see Note 47, &#8216;Legal proceedings&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 508.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Major restructuring programmes<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 524.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="restructuringprogramme" contextRef="c-1" decimals="0" name="gsk:NumberOfMajorRestructuringProgrammes" format="ixt-sec:numwordsen" scale="0" id="f-3628">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> major restructuring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 534.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programmes: the Separation restructuring programme which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 544.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focused on the separation of GSK into <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="company" contextRef="c-1" decimals="0" name="gsk:NumberOfCompaniesSplitInto" format="ixt-sec:numwordsen" scale="0" id="f-3629">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 462.20000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> companies <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now largely complete<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, plus the Significant Acquisitions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programme which is focused on the integration of recent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 591.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Restructuring provisions primarily include severance costs <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">when management has made a formal decision to eliminate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain positions and this has been communicated to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 622.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">groups of employees affected and appropriate consultation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procedures completed, where appropriate. No provision is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 642.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made for staff severance payments that are paid immediately.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 658.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The discount on the provisions increased by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1063" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3630">1</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 536.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 668.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: increased by <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1064" decimals="-5" name="ifrs-full:IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-3631">0.4</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 684.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfer to pension obligations reflects augmentation costs of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 694.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:PensionObligationAugmentationCosts" format="ixt:num-dot-decimal" scale="6" id="f-3632">18</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> relating to defined benefit plans arising from staff <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redundancies, as shown in Note 31, &#8216;Pensions and other post-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 715.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employment benefits&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">230<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-3561-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">32. Other provisions continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Employee-related provisions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee-related provisions include obligations for certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medical benefits to disabled employees and their spouses in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the provision for these benefits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 191.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1065" decimals="-6" name="ifrs-full:ProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-3633">46</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 148.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1066" decimals="-6" name="ifrs-full:ProvisionsForEmployeeBenefits" format="ixt:num-dot-decimal" scale="6" id="f-3634">48</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Other employee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits reflect a variety of provisions for severance costs, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">jubilee awards and other long-service benefits. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Given the nature of these provisions, the amounts are likely to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be settled over many years.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 166.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other provisions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Included in other provisions are provisions for onerous <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts, insurance provisions and a number of other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions including vehicle insurance, environmental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remediation and regulatory matters.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="position: absolute; top: 244.34pt;" id="idc89fa1ee07645df9629d157a4b46752_487"></div><div style="position: var(--position); top: 244.34pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfContingentConsiderationLiabilitiesExplanatory" id="f-3635" continuedAt="f-3635-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33. Contingent consideration liabilities<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3635-1" continuedAt="f-3635-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.78pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" id="f-3636" continuedAt="f-3636-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The consideration for certain acquisitions includes amounts contingent on future events such as development milestones or sales <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3636-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance. The Group has provided for the fair value of this contingent consideration as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 308.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 262.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi-ViiV <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.709999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1067" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3637">5,559</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1068" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3638">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1069" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3639">479</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1070" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3640">38</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-19" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3641">6,076</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement through income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1071" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3642">1,431</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1072" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3643">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1073" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3644">231</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1074" decimals="-6" sign="-" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3645">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3646">1,645</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movement through reserves<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1071" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3647">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1072" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3648">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1073" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3649">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1074" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3650">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3651">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Initial recognition from business combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1071" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3652">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1072" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3653">482</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1073" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3654">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1074" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3655">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3656">482</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: operating cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1071" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-3657">1,031</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1072" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3658">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1073" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" scale="6" id="f-3659">27</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1074" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3660">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-3661">1,058</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1071" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3662">69</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1072" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3663">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1073" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3664">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1074" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3665">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3666">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1075" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3667">5,890</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1076" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3668">501</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1077" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3669">673</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1078" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3670">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3671">7,068</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement through income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1079" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3672">934</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1080" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3673">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1081" decimals="-6" sign="-" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3674">210</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1082" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3675">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3676">768</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movement through reserves<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1079" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3677">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1080" decimals="-6" sign="-" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3678">29</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1081" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3679">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1082" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3680">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3681">29</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: operating cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1079" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-3682">1,106</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1080" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3683">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1081" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" scale="6" id="f-3684">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1082" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3685">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-3686">1,134</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1079" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3687">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1080" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3688">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1081" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3689">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1082" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3690">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3691">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1083" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3692">5,718</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1084" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3693">516</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1085" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3694">424</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1086" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3695">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3696">6,662</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Initial recognition from business combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1087" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3697">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1088" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3698">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1089" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3699">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1090" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3700">104</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3701">104</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement through income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1087" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3702">1,533</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1088" decimals="-6" sign="-" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3703">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1089" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3704">215</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1090" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3705">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3706">1,762</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movement through reserves<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1087" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3707">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1088" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3708">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1089" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="f-3709">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1090" decimals="-6" sign="-" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3710">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3711">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 204pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: operating cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1087" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-3712">1,190</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1088" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3713">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1089" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" scale="6" id="f-3714">45</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1090" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3715">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-3716">1,235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 216pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash payments: investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1087" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3717">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1088" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3718">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1089" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3719">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1090" decimals="-6" name="gsk:ContingentConsiderationPaid" format="ixt:fixed-zero" scale="6" id="f-3720">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ContingentConsiderationPaid" scale="6" id="f-3721">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 228pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1091" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3722">6,061</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1092" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3723">502</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1093" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3724">575</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1094" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-3725">142</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-3726">7,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration payable of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1095" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-3727">96</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 232.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was recognised at acquisition for the purchase of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 419.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1095" decimals="2" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="f-3728">100</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 443.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the equity of Aiolos <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bio, Inc. Further information on the acquisition is provided in Note 41, &#8216;Acquisitions and disposals&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Of the contingent consideration payable at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1096" decimals="-6" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-3729">1,172</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 341.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 370.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1097" decimals="-6" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-3730">1,053</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 421.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is expected to be paid within <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one year. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 90.75999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The considerations payable for the acquisition of the Shionogi-ViiV Healthcare joint venture, Affinivax and the Novartis Vaccines&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business are expected to be paid over a number of years. As a result, the total estimated liabilities are discounted to their present <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">values, shown above. The Shionogi-ViiV Healthcare contingent consideration liability is discounted at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1091" decimals="2" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3731">8</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 445.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1083" decimals="2" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3732">8</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), the Affinivax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 642.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contingent consideration liability is discounted at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 235.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1092" decimals="3" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3733">9.0</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1084" decimals="3" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3734">8.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 302.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and the Novartis Vaccines contingent consideration liability is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discounted at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1098" decimals="3" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3735">8.0</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 130.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1099" decimals="3" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3736">7.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 173.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) for commercialised products and at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 311.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1100" decimals="3" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3737">9.0</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 335.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1101" decimals="3" name="gsk:ContingentConsiderationPayableDiscountedPercentage" scale="-2" id="f-3738">8.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) for pipeline assets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 668.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Shionogi-ViiV Healthcare and Novartis Vaccines contingent consideration liabilities are calculated principally based on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forecast sales performance of specified products over the lives of those products.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 694.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Affinivax contingent consideration is based upon <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 252.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="payment" contextRef="c-1088" decimals="0" name="gsk:NumberOfPotentialMilestonePayments" format="ixt-sec:numwordsen" scale="0" id="f-3739">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> potential milestone payments, each of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1102" decimals="-8" name="ifrs-full:Liabilities" scale="9" id="f-3740">0.6</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1102" decimals="-8" name="ifrs-full:Liabilities" scale="9" id="f-3741">0.5</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 498.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) which will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be paid if certain paediatric clinical development milestones are achieved.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 332pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">231<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-3635-2" continuedAt="f-3635-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">33. Contingent consideration liabilities continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationExplanatoryTableTextBlock" id="f-3742" continuedAt="f-3742-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below shows on an indicative basis the income statement and balance sheet sensitivity to reasonably possible changes <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3742-1" continuedAt="f-3742-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in key inputs to the valuations of the largest contingent consideration liabilities.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 171.26pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 135pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 135pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 118.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 8.72pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in financial liability and loss/(gain) in income <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 17.72pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi-ViiV<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.709999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shionogi-ViiV<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Novartis<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.709999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% increase in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1103" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3743">573</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1104" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3744">83</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1105" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3745">539</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1106" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3746">63</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15% increase in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1107" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3747">857</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1108" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3748">125</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1109" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3749">807</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1110" decimals="-6" name="gsk:IncreaseInSalesForecastAmount" scale="6" id="f-3750">94</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% decrease in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1111" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3751">572</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1112" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3752">83</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1113" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3753">539</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1114" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3754">62</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15% decrease in sales forecasts*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1115" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3755">856</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1116" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3756">125</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1117" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3757">808</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1118" decimals="-6" sign="-" name="gsk:DecreaseInSalesForecastAmount" scale="6" id="f-3758">92</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% increase in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1119" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3759">180</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1120" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3760">38</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1121" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3761">174</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1122" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3762">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1123" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3763">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5% increase in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1124" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3764">267</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1125" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3765">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1126" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3766">55</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1127" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3767">256</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1128" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3768">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1129" decimals="-6" sign="-" name="gsk:IncreaseInDiscountRateAmount" scale="6" id="f-3769">38</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% decrease in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1130" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3770">194</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1131" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3771">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1132" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3772">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1133" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3773">184</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1134" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3774">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1135" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3775">30</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 122.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5% decrease in discount rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1136" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3776">298</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1137" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3777">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1138" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3778">67</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1139" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3779">281</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1140" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3780">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1141" decimals="-6" name="gsk:DecreaseInDiscountRateAmount" scale="6" id="f-3781">47</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1142" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3782">431</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1143" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3783">43</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1144" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3784">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1145" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3785">386</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1146" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3786">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1147" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3787">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 146.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1148" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3788">677</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1149" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3789">68</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1150" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3790">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1151" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3791">604</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1152" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3792">69</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1153" decimals="-6" name="gsk:AppreciationOfUSDollar" scale="6" id="f-3793">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 158.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1154" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3794">368</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1155" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3795">37</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1156" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3796">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1157" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3797">330</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1158" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3798">38</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1159" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3799">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1160" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3800">533</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1161" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3801">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1162" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3802">17</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1163" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3803">478</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1164" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3804">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1165" decimals="-6" name="gsk:DepreciationOfUSDollar" scale="6" id="f-3805">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1166" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3806">77</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1167" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3807">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1168" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3808">91</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1169" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3809">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 194.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1170" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3810">123</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1171" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3811">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1172" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3812">144</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1173" decimals="-6" name="gsk:AppreciationOfEuro" scale="6" id="f-3813">30</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1174" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3814">65</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1175" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3815">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1176" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3816">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1177" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3817">16</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1178" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3818">95</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1179" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3819">27</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1180" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3820">113</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1181" decimals="-6" name="gsk:DepreciationOfEuro" scale="6" id="f-3821">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 230.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% increase in probability of milestone success<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1182" decimals="-6" name="gsk:TenPercentIncreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3822">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1080" decimals="-6" name="gsk:TenPercentIncreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3823">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1183" decimals="-6" name="gsk:TenPercentIncreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3824">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 242.25pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10% decrease in probability of milestone success<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">N/A<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1088" decimals="-6" sign="-" name="gsk:TenPercentDecreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3825">73</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1182" decimals="-6" sign="-" name="gsk:TenPercentDecreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3826">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 33.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n/a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1080" decimals="-6" sign="-" name="gsk:TenPercentDecreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3827">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1183" decimals="-6" sign="-" name="gsk:TenPercentDecreaseInProbabilityOfMilestoneSuccess" scale="6" id="f-3828">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 436.2pt; width: 595.44pt;"><ix:continuation id="f-3742-2"><ix:continuation id="f-3635-3"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">*<span style="display: inline-block; height: 5.09pt; width: 8.65pt;"></span></span><span style="left: 65.2pt; position: var(--position);">The sales forecast is for ViiV Healthcare sales only in respect of the Shionogi-ViiV Healthcare contingent consideration.<span style="display: inline-block; height: 5.09pt;"></span></span></span></ix:continuation></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 429.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="position: absolute; top: 456.8pt;" id="idc89fa1ee07645df9629d157a4b46752_490"></div><div style="position: var(--position); top: 456.8pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory" id="f-3829" continuedAt="f-3829-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">34. Other non-current liabilities<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3829-1" continuedAt="f-3829-2"><div style="position: var(--position); top: 495.24pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" id="f-3830" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accruals<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Accruals" scale="6" id="f-3831">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Accruals" scale="6" id="f-3832">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" scale="6" id="f-3833">165</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" scale="6" id="f-3834">254</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentPayables" scale="6" id="f-3835">929</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentPayables" scale="6" id="f-3836">849</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-3837">1,100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-3838">1,107</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-3829-2">Other payables includes a number of employee-related liabilities including employee savings plans.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 598.77pt;" id="idc89fa1ee07645df9629d157a4b46752_493"></div><div style="position: var(--position); top: 598.77pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfContingentLiabilitiesExplanatory" id="f-3839" continuedAt="f-3839-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">35. Contingent liabilities<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3839-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, contingent liabilities where GSK has a present obligation as a result of a past event, comprising guarantees <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other items arising in the normal course of business, amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" scale="6" id="f-3840">26</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 355.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 379.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 384.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" scale="6" id="f-3841">32</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.3199999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-5" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="6" id="f-3842">0.5</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-5" name="ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" scale="6" id="f-3843">0.2</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 148.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of financial assets were pledged as collateral for contingent liabilities<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Provision is made for the outcome <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of tax, legal and other disputes where it is both probable that the Group will suffer an outflow of funds and it is possible to make a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable estimate of that outflow. If it is not possible to meaningfully assess whether the outcomes will result in a probable outflow, or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to quantify or reliably estimate the liability, if any, no provision is recorded. Descriptions of the significant legal and other disputes to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which the Group is a party are set out in Note 47, &#8216;Legal proceedings&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">232<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_496"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="f-3844" continuedAt="f-3844-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="if7f05fba416046898f9dd6e7a55a209c_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">36. Commitments<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3844-1"><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" id="f-3845" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contractual obligations and commitments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contracted for but not provided in the financial statements:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ContractualCommitmentsForAcquisitionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-3846">19,183</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ContractualCommitmentsForAcquisitionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-3847">16,329</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" scale="6" id="f-3848">754</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" scale="6" id="f-3849">762</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:ContractualObligationsAndCommitmentsOfInvestments" scale="6" id="f-3850">203</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:ContractualObligationsAndCommitmentsOfInvestments" scale="6" id="f-3851">153</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:ContractualObligationsAndCommitments" format="ixt:num-dot-decimal" scale="6" id="f-3852">20,140</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:ContractualObligationsAndCommitments" format="ixt:num-dot-decimal" scale="6" id="f-3853">17,244</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The commitments related to intangible assets include milestone payments, which are dependent on successful clinical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 252.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">development or on meeting specified sales targets, and which represent the maximum that would be paid if all milestones, however <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unlikely, are achieved. The amounts disclosed are not risk-adjusted or discounted. The increase in intangible asset commitments in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is ma<span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 94.99000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">inly attributable to new R&amp;D collaborations and acquisitions, including with Shanghai Hansoh Biomedical Co. Ltd and </span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.57pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">Jiangsu Hengrui Pharmaceuticals Co., Ltd.</span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition, within intangible assets commitments the Group has disclosed <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1184" decimals="-6" name="gsk:ContractualObligationsAndCommitments" format="ixt:num-dot-decimal" scale="6" id="f-3854">38</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 371.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1185" decimals="-6" name="gsk:ContractualObligationsAndCommitments" scale="6" id="f-3855">30</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 439.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) related to nature-based <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carbon credit projects,<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> which aligns with GSK&#8217;s commitments to a net-zero, nature positive world, and within property, plant and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equipment commitments of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1186" decimals="-6" name="gsk:ContractualObligationsAndCommitments" format="ixt:num-dot-decimal" scale="6" id="f-3856">34</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1187" decimals="-6" name="gsk:ContractualObligationsAndCommitments" scale="6" id="f-3857">46</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) related to the transition to a lower-carbon propellant solution.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the previous year, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1185" decimals="-6" name="gsk:ContractualObligationsAndCommitments" scale="6" id="f-3858">30</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> relating to nature-based carbon credits projects was included in purchase commitments and is now <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included in intangible asset commitments. Lease contracts that have not commenced are not disclosed as these are not material. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the Group's commitments related to interest on debt and future finance charges on leases refer to Note 44 'Financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table excludes any amounts already capitalised in the financial statements for the year ended 31 December <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">233<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_499"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfShareCapitalAndSharePremiumExplanatory" id="f-3859" continuedAt="f-3859-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37. Share capital and share premium account<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3859-1" continuedAt="f-3859-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 148.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share Consolidation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 164.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following completion of the Consumer Healthcare business demerger on 18 July 2022, GSK plc Ordinary shares were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 174.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consolidated to maintain share price comparability before and after demerger. The consolidation was approved by GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders at a General Meeting held on 6 July 2022. Shareholders received <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1188" decimals="0" name="gsk:SharesReceivedForEveryFiveExistingShares" scale="0" id="f-3860">4</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> new Ordinary shares with a nominal value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 524.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#188;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 540.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 195.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pence each for every <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1188" decimals="0" name="gsk:SurrenderedSharesForEveryFourNewSharesReceived" scale="0" id="f-3861">5</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 139.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> existing Ordinary shares which had a nominal value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-1188" decimals="2" name="gsk:ParValueOfSharesSurrenderedInLieuOfNewShares" scale="-2" id="f-3862">25</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> pence each. Earnings per share, diluted earnings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 205.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">per share, adjusted earnings per share and dividends per share were retrospectively adjusted to reflect the Share Consolidation in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 215.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 225.92pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfClassesOfShareCapitalAndSharePremiumExplanatoryTableTextBlock" id="f-3863" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 270.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 126.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 0pt; width: 171.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 171.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares of 25p each pre-share consolidation<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 171.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.200000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares of 31&#188;p each post-share consolidation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.299999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">premium<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 18.75pt; width: 126.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 126.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 101.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital issued and fully paid:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 270.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 42.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 73.36pt;"></span></span><span style="left: 75.99pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" format="ixt:num-dot-decimal" scale="0" id="f-3864">5,387,015,059</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1189" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3865">1,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-14" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3866">3,301</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impact of share consolidation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 54.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.9pt;"></span></span><span style="left: 73.53pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" sign="-" name="gsk:IncreaseDecreaseInNumberOfSharesFromShareConsolidation" format="ixt:num-dot-decimal" scale="0" id="f-3867">1,077,403,011</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1190" decimals="-6" name="gsk:IncreaseDecreaseThroughConsolidatingSharesEquity" format="ixt:fixed-zero" scale="6" id="f-3868">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-24" decimals="-6" name="gsk:IncreaseDecreaseThroughConsolidatingSharesEquity" format="ixt:fixed-zero" scale="6" id="f-3869">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issued under employee share schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 66pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 87.83pt;"></span></span><span style="left: 90.46pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="gsk:NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" format="ixt:num-dot-decimal" scale="0" id="f-3870">1,731,293</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1190" decimals="-6" name="ifrs-full:IssueOfEquity" format="ixt:fixed-zero" scale="6" id="f-3871">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-24" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-3872">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 78pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 116.77pt;"></span></span><span style="left: 119.39999999999999pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="gsk:NumberOfTreasurySharesTransferredToEmployeeShareTrusts" format="ixt:fixed-zero" scale="0" id="f-3873">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1190" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" format="ixt:fixed-zero" scale="6" id="f-3874">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-24" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="6" id="f-3875">114</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 270.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 90pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 73.36pt;"></span></span><span style="left: 75.99pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="0" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" format="ixt:num-dot-decimal" scale="0" id="f-3876">4,311,343,341</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1191" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3877">1,347</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-26" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3878">3,440</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issued under employee share schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 102pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 94.02pt;"></span></span><span style="left: 96.64999999999999pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="gsk:NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" format="ixt:num-dot-decimal" scale="0" id="f-3879">802,642</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1192" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-3880">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-37" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-3881">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 114pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 116.77pt;"></span></span><span style="left: 119.39999999999999pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="gsk:NumberOfTreasurySharesTransferredToEmployeeShareTrusts" format="ixt:fixed-zero" scale="0" id="f-3882">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1192" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" format="ixt:fixed-zero" scale="6" id="f-3883">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-37" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="6" id="f-3884">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 270.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 126pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 73.36pt;"></span></span><span style="left: 75.99pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="0" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" format="ixt:num-dot-decimal" scale="0" id="f-3885">4,312,145,983</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1193" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3886">1,348</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-39" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3887">3,451</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issued under employee share schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 138pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 87.83pt;"></span></span><span style="left: 90.46pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="gsk:NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" format="ixt:num-dot-decimal" scale="0" id="f-3888">2,157,751</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1194" decimals="-6" name="ifrs-full:IssueOfEquity" format="ixt:fixed-zero" scale="6" id="f-3889">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-48" decimals="-6" name="ifrs-full:IssueOfEquity" scale="6" id="f-3890">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 270.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 150pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 116.77pt;"></span></span><span style="left: 119.39999999999999pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="gsk:NumberOfTreasurySharesTransferredToEmployeeShareTrusts" format="ixt:fixed-zero" scale="0" id="f-3891">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1194" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" format="ixt:fixed-zero" scale="6" id="f-3892">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 150pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-48" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="6" id="f-3893">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 270.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 270.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270.75pt; position: var(--position); top: 162pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 73.36pt;"></span></span><span style="left: 75.99pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" format="ixt:num-dot-decimal" scale="0" id="f-3894">4,314,303,734</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1195" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3895">1,348</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-50" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="f-3896">3,473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, of the issued share capital, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1196" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3897">64,314,305</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 284.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares were held in the ESOP Trusts, out of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 476.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1197" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3898">63,666,947</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.4499999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares were held for the future exercise of share awards and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1198" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3899">647,358</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares were held for the Executive Supplemental Savings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plan. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 74.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1199" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3900">169,171,555</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 121.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares were held as Treasury shares and<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 279.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1200" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3901">4,080,818,273</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares were in free issue. All issued shares are fully <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">paid and there are <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 133.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares authorised but not in issue. The nominal, carrying and market values of the shares held in the ESOP <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.41pt; width: 595.44pt;"><ix:continuation id="f-3859-2" continuedAt="f-3859-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trusts are disclosed in Note 45, &#8216;Employee share schemes&#8217;<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 274.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-3859-3">.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 477.5pt;" id="idc89fa1ee07645df9629d157a4b46752_505"></div><div style="position: var(--position); top: 477.5pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory" id="f-3903" continuedAt="f-3903-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 480.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 480.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 480.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38. Movements in equity<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-3903-1" continuedAt="f-3903-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained earnings and other reserves amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 245.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:RetainedEarningsAndOtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-3904">8,850</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 297.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 309.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 409.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:RetainedEarningsAndOtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-3905">8,548</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 465.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:RetainedEarningsAndOtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-3906">5,811</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of which<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1201" decimals="-6" name="gsk:RetainedEarningsAndOtherReserves" scale="6" id="f-3907">452</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1202" decimals="-6" name="gsk:RetainedEarningsAndOtherReserves" scale="6" id="f-3908">451</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 233.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 261.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1203" decimals="-6" name="gsk:RetainedEarningsAndOtherReserves" scale="6" id="f-3909">463</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) related to associates and joint ventures. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.03pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" id="f-3910" continuedAt="f-3910-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The cumulative translation exchange in equity is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3910-1"><div style="position: var(--position); top: 554.92pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 10.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 135pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.77pt; width: 135pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net translation exchange included in:<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 10.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 10.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 10.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 10.5pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">translation<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-15" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3911">803</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1204" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3912">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-18" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3913">181</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-19" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3914">993</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3915">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3916">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3917">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3918">85</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of overseas subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3919">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:fixed-zero" scale="6" id="f-3920">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:fixed-zero" scale="6" id="f-3921">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3922">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movement attributable to continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="gsk:MovementInTranslationExchangeAttributableToContinuingOperations" scale="6" id="f-3923">692</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" sign="-" name="gsk:MovementInTranslationExchangeAttributableToContinuingOperations" scale="6" id="f-3924">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="gsk:MovementInTranslationExchangeAttributableToContinuingOperations" scale="6" id="f-3925">209</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:MovementInTranslationExchangeAttributableToContinuingOperations" scale="6" id="f-3926">906</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movement attributable to discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 162.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="gsk:MovementInTranslationExchangeAttributableToDiscontinuedOperations" scale="6" id="f-3927">263</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="gsk:MovementInTranslationExchangeAttributableToDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-3928">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" name="gsk:MovementInTranslationExchangeAttributableToDiscontinuedOperations" scale="6" id="f-3929">112</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:MovementInTranslationExchangeAttributableToDiscontinuedOperations" scale="6" id="f-3930">375</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-27" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3931">429</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1206" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3932">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-30" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3933">97</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 112.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3934">531</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 124.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3935">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3936">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3937">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 124.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3938">47</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of overseas subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3939">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:fixed-zero" scale="6" id="f-3940">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:fixed-zero" scale="6" id="f-3941">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 136.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3942">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-40" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3943">504</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1208" decimals="-6" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3944">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-43" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3945">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3946">612</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3947">380</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3948">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3949">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="6" id="f-3950">396</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of overseas subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3951">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:fixed-zero" scale="6" id="f-3952">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:fixed-zero" scale="6" id="f-3953">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3954">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 201pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-51" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3955">971</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1210" decimals="-6" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3956">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-54" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="6" id="f-3957">126</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 201pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="6" id="f-3958">1,095</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 775.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Includes <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 92.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1211" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-3959">554</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 129.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> reclassification to the consolidated income statement of net exchange gains related to the demerger of the Consumer Healthcare <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 784.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business.<span style="display: inline-block; height: 5.09pt;"></span></span></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">234<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-3903-2" continuedAt="f-3903-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">38. Movements in equity continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory" id="f-3960" continuedAt="f-3960-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of other comprehensive income by equity category is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-3960-1" continuedAt="f-3960-2"><div style="position: var(--position); top: 139.48pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that may be subsequently reclassified to income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-3961">380</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-3962">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-3963">392</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3964">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3965">87</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-3966">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax on fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-3967">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-3968">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of hedging<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 99pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 99pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" scale="6" id="f-3969">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 99pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 99pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" scale="6" id="f-3970">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of cash flow hedges to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-3971">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-3972">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that will not be reclassified to income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets of non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" scale="6" id="f-3973">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" scale="6" id="f-3974">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-3975">100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-3976">100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 155.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 155.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" scale="6" id="f-3977">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 155.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 155.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" scale="6" id="f-3978">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement on defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 166.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-3979">506</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 166.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 166.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 166.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-3980">506</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 177.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on remeasurement defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 177.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-3981">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 177.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 177.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 177.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-3982">122</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 189pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" scale="6" id="f-3983">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 189pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" scale="6" id="f-3984">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 200.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total other comprehensive (expense)/income for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-44" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-3985">83</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-3986">86</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-46" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-3987">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-3988">173</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 355.98pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that may be subsequently reclassified to income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-3989">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-3990">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-3991">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3992">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-3993">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="f-3994">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="f-3995">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax on fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-3996">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-3997">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of cash flow hedges to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-3998">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-3999">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that will not be reclassified to income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets of non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" scale="6" id="f-4000">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" scale="6" id="f-4001">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-4002">244</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-4003">244</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 145.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" scale="6" id="f-4004">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" scale="6" id="f-4005">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement on defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-4006">71</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-4007">71</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on remeasurement defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-4008">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-4009">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 179.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="gsk:OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" scale="6" id="f-4010">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" scale="6" id="f-4011">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 191.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total other comprehensive (expense)/income for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 191.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-32" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4012">45</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 191.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4013">247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 191.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-34" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4014">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 191.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4015">317</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 564.23pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 307.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 307.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Retained<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controlling<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that may be subsequently reclassified to income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets and net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-4016">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-4017">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" scale="6" id="f-4018">113</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements on liquidation or disposal of subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; and associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-4019">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="6" id="f-4020">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="f-4021">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="f-4022">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax on fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-4023">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 89.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="f-4024">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of cash flow hedges to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-4025">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-4026">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Items that will not be reclassified to income statement:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 111.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 111.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 111.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 111.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange movements on overseas net assets of non-controlling interests<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" scale="6" id="f-4027">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" scale="6" id="f-4028">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-4029">754</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" scale="6" id="f-4030">754</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 145.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on fair value movements on equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" scale="6" id="f-4031">56</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" scale="6" id="f-4032">56</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement on defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-4033">786</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="6" id="f-4034">786</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on remeasurement defined benefit plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-4035">211</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" scale="6" id="f-4036">211</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 179.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value movements on cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="gsk:OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" scale="6" id="f-4037">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 179.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" scale="6" id="f-4038">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 190.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive (expense)/income for the year from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncomeFromContinuingOperations" scale="6" id="f-4039">464</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncomeFromContinuingOperations" scale="6" id="f-4040">695</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncomeFromContinuingOperations" scale="6" id="f-4041">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 190.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4042">1,187</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 202.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive (expense)/income for the year from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 202.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" name="ifrs-full:ComprehensiveIncomeFromDiscontinuedOperations" scale="6" id="f-4043">375</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 202.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncomeFromDiscontinuedOperations" scale="6" id="f-4044">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 202.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 202.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ComprehensiveIncomeFromDiscontinuedOperations" scale="6" id="f-4045">356</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 214.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total other comprehensive (expense)/income for the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 214.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-20" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4046">89</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 214.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4047">714</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 214.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-22" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4048">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000; border-top: 0.75pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 214.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4049">831</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">235<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-3903-3" continuedAt="f-3903-4"><ix:continuation id="f-3960-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">38. Movements in equity continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information on net investment hedges is provided in part (d) of Note 44 &#8216;Financial instruments and related disclosures'.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:MovementsInOtherReservesTableTextBlock" id="f-4050" continuedAt="f-4050-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The analysis of other reserves is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-4050-1"><div style="position: var(--position); top: 161.06pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 265.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ESOP Trust<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.029999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge reserve<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.779999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 265.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1212" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4051">28</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1204" decimals="-6" name="ifrs-full:OtherReserves" scale="6" id="f-4052">383</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1213" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4053">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1214" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4054">2,129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-16" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4055">2,463</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1215" decimals="-6" name="gsk:ExchangeAdjustments" scale="6" id="f-4056">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" sign="-" name="gsk:ExchangeAdjustments" scale="6" id="f-4057">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1216" decimals="-6" sign="-" name="gsk:ExchangeAdjustments" scale="6" id="f-4058">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1217" decimals="-6" name="gsk:ExchangeAdjustments" format="ixt:fixed-zero" scale="6" id="f-4059">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="gsk:ExchangeAdjustments" scale="6" id="f-4060">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transferred to retained earnings in the year on disposal of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1215" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4061">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" sign="-" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4062">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1216" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4063">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1217" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4064">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" sign="-" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4065">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Balances derecognised on demerger<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1215" decimals="-6" name="gsk:BalanceAmountDerecognisedOnDemerger" format="ixt:fixed-zero" scale="6" id="f-4066">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="gsk:BalanceAmountDerecognisedOnDemerger" format="ixt:fixed-zero" scale="6" id="f-4067">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1216" decimals="-6" name="gsk:BalanceAmountDerecognisedOnDemerger" scale="6" id="f-4068">169</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1217" decimals="-6" name="gsk:BalanceAmountDerecognisedOnDemerger" format="ixt:fixed-zero" scale="6" id="f-4069">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:BalanceAmountDerecognisedOnDemerger" scale="6" id="f-4070">169</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movement in the year (including tax)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1215" decimals="-6" name="gsk:NetFairValueMovements" format="ixt:fixed-zero" scale="6" id="f-4071">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4072">698</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1216" decimals="-6" sign="-" name="gsk:NetFairValueMovements" scale="6" id="f-4073">141</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1217" decimals="-6" name="gsk:NetFairValueMovements" format="ixt:fixed-zero" scale="6" id="f-4074">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4075">557</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 86.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1215" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4076">1,200</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4077">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1216" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4078">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1217" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4079">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4080">1,200</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 98.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Write-down of shares held by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1215" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-4081">911</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1205" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4082">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1216" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4083">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1217" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4084">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 98.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-23" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-4085">911</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 265.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1218" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4086">353</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1206" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4087">308</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1219" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4088">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1220" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4089">2,129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 110.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-28" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4090">1,448</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 122.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" sign="-" name="gsk:ExchangeAdjustments" scale="6" id="f-4091">26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="gsk:ExchangeAdjustments" scale="6" id="f-4092">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" name="gsk:ExchangeAdjustments" scale="6" id="f-4093">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="gsk:ExchangeAdjustments" format="ixt:fixed-zero" scale="6" id="f-4094">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 122.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="gsk:ExchangeAdjustments" scale="6" id="f-4095">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transferred to Retained earnings in the year on disposals of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4096">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4097">33</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4098">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4099">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 134.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4100">33</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 146.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of cash flow hedges to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4101">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4102">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-4103">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4104">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 146.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-4105">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 158.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging gain/loss transferred to non-financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4106">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4107">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-4108">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4109">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 158.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-4110">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movement in the year (including tax)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" name="gsk:NetFairValueMovements" format="ixt:fixed-zero" scale="6" id="f-4111">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4112">230</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4113">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="gsk:NetFairValueMovements" format="ixt:fixed-zero" scale="6" id="f-4114">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 170.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4115">270</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" scale="6" id="f-4116">285</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4117">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4118">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4119">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" scale="6" id="f-4120">285</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 193.5pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Write-down of shares held by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 193.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1221" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-4121">324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 193.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1207" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4122">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 193.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1222" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4123">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 193.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1223" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4124">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 193.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-35" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-4125">324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 205.5pt; width: 265.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 205.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1224" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4126">288</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 205.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1208" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4127">510</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 205.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1225" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4128">22</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 205.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1226" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4129">2,129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 205.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-41" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4130">1,309</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 217.5pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 217.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:ExchangeAdjustments" scale="6" id="f-4131">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 217.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="gsk:ExchangeAdjustments" format="ixt:fixed-zero" scale="6" id="f-4132">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 217.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" name="gsk:ExchangeAdjustments" format="ixt:fixed-zero" scale="6" id="f-4133">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 217.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:ExchangeAdjustments" format="ixt:fixed-zero" scale="6" id="f-4134">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 217.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:ExchangeAdjustments" scale="6" id="f-4135">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transferred to retained earnings in the year on disposal of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 229.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4136">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 229.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" sign="-" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4137">66</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 229.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4138">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 229.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4139">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 229.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:TransferredToRetainedEarningsOnDisposalOfEquityInvestments" scale="6" id="f-4140">66</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of cash flow hedges to income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 241.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4141">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 241.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4142">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 241.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-4143">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 241.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4144">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 241.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" scale="6" id="f-4145">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging gain/(loss) transferred to non-financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4146">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4147">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" sign="-" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-4148">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4149">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" sign="-" name="gsk:HedgingGainLossTransferredToNonFinancialAssets" scale="6" id="f-4150">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 264.75pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cost of hedging<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:CostOfHedgedItemAttributableToHedgedRisk" format="ixt:fixed-zero" scale="6" id="f-4151">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="gsk:CostOfHedgedItemAttributableToHedgedRisk" format="ixt:fixed-zero" scale="6" id="f-4152">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" name="gsk:CostOfHedgedItemAttributableToHedgedRisk" scale="6" id="f-4153">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:CostOfHedgedItemAttributableToHedgedRisk" format="ixt:fixed-zero" scale="6" id="f-4154">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 264.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:CostOfHedgedItemAttributableToHedgedRisk" scale="6" id="f-4155">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 276pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net fair value movement in the year (including tax)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 276pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:NetFairValueMovements" format="ixt:fixed-zero" scale="6" id="f-4156">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 276pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4157">83</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 276pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" sign="-" name="gsk:NetFairValueMovements" scale="6" id="f-4158">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 276pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:NetFairValueMovements" format="ixt:fixed-zero" scale="6" id="f-4159">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 276pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:NetFairValueMovements" scale="6" id="f-4160">74</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 288pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary shares acquired by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 288pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" scale="6" id="f-4161">459</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 288pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4162">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 288pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4163">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 288pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" format="ixt:fixed-zero" scale="6" id="f-4164">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 288pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" scale="6" id="f-4165">459</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 300pt; width: 265.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Write-down of shares held by ESOP Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 300pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1227" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-4166">362</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 300pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1209" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4167">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 300pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1228" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4168">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 300pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1229" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" format="ixt:fixed-zero" scale="6" id="f-4169">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 300pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-47" decimals="-6" name="gsk:WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" scale="6" id="f-4170">362</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 312pt; width: 265.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 265.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 265.5pt; position: var(--position); top: 312pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1230" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4171">397</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 310.5pt; position: var(--position); top: 312pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1210" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4172">659</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 355.5pt; position: var(--position); top: 312pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1231" decimals="-6" sign="-" name="ifrs-full:OtherReserves" scale="6" id="f-4173">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 400.5pt; position: var(--position); top: 312pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1232" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4174">2,129</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 445.5pt; position: var(--position); top: 312pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-52" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4175">1,054</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other reserves include various non-distributable merger and pre-merger reserves amounting to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 409.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1233" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4176">1,849</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1234" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4177">1,849</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 152.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; 2022: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1235" decimals="-6" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="6" id="f-4178">1,849</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 232.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Other reserves also include the capital redemption reserve created as a result of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the previous <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share buyback programme<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> amounting to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 255.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1236" decimals="-6" name="ifrs-full:OtherReserves" scale="6" id="f-4179">280</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 300.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 311.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 407.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1237" decimals="-6" name="ifrs-full:OtherReserves" scale="6" id="f-4180">280</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 456.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; 2022: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1238" decimals="-6" name="ifrs-full:OtherReserves" scale="6" id="f-4181">280</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 529.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.35pt; width: 595.44pt;"><ix:continuation id="f-3903-4"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which ceased in 2014.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">236<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 123.59pt;" id="idc89fa1ee07645df9629d157a4b46752_508"></div><div style="position: var(--position); top: 123.59pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory" id="f-4182" continuedAt="f-4182-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 490.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 490.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 490.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">39. Non-controlling interests<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4182-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total non-controlling interests includes the following individually material non-controlling interests. Other non-controlling interests <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are individually not material.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 185.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 201.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK holds <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1239" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" id="f-4183">78.3</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the ViiV Healthcare sub-group, giving rise to a material non-controlling interest. <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" id="f-4184" continuedAt="f-4184-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Summarised financial <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-4184-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 211.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information available at the latest practicable date in respect of the ViiV Healthcare sub-group is as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 227.1pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-4185">7,023</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-4186">6,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-4187">5,619</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 33pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 33pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4188">1,619</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 33pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4189">2,034</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 33pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4190">1,528</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other comprehensive income/(expense)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4191">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4192">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="f-4193">94</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 58.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4194">1,626</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 58.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4195">2,015</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 58.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4196">1,622</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 319.74pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 442.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-4197">2,649</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-4198">2,528</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-4199">3,479</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-4200">3,330</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="f-4201">6,128</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="f-4202">5,858</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 8.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 64.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4203">4,218</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 64.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4204">3,881</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4205">8,566</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 76.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4206">8,453</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-4207">12,784</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-4208">12,334</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" sign="-" name="ifrs-full:NetAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4209">6,656</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" sign="-" name="ifrs-full:NetAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4210">6,476</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 437.32pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash inflow from operating activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4211">2,554</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4212">2,192</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4213">3,442</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash outflow from investing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4214">106</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4215">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4216">174</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net cash outflow from financing activities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4217">2,518</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4218">2,463</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4219">2,718</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in cash and bank overdrafts in the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInCashAndBankOverdrafts" scale="6" id="f-4220">70</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInCashAndBankOverdrafts" scale="6" id="f-4221">273</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="gsk:IncreaseDecreaseInCashAndBankOverdrafts" scale="6" id="f-4222">550</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The above financial information relates to the ViiV Healthcare group on a stand-alone basis, before the impact of Group-related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 520.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustments, primarily related to the recognition of preferential dividends. The profit after taxation of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4223">1,619</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 481.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4224">2,034</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 133.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-4225">1,528</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 185.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is stated after charging preferential dividends payable to GSK and Pfizer and after a charge of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RemeasurementsOfContingentConsiderationPayableForAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-4226">1,377</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RemeasurementsOfContingentConsiderationPayableForAcquisition" scale="6" id="f-4227">858</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 206.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RemeasurementsOfContingentConsiderationPayableForAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-4228">1,483</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) for remeasurement of contingent consideration payable.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration is expected to be paid over a number of years. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.34pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" id="f-4229" continuedAt="f-4229-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following amounts attributable to the ViiV Healthcare group are included in GSK&#8217;s financial statements:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-4229-1"><div style="position: var(--position); top: 583.23pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of profit for the year attributable to non-controlling interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" scale="6" id="f-4230">357</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" scale="6" id="f-4231">373</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" scale="6" id="f-4232">415</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid to non-controlling interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1239" decimals="-6" name="ifrs-full:DividendsPaidToNoncontrollingInterests" scale="6" id="f-4233">392</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1240" decimals="-6" name="ifrs-full:DividendsPaidToNoncontrollingInterests" scale="6" id="f-4234">398</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1241" decimals="-6" name="ifrs-full:DividendsPaidToNoncontrollingInterests" scale="6" id="f-4235">480</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interest in the consolidated balance sheet<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1242" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="f-4236">683</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1243" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="f-4237">648</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1244" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="f-4238">611</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="position: absolute; top: 658.87pt;" id="idc89fa1ee07645df9629d157a4b46752_511"></div><div style="position: var(--position); top: 658.87pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="f-4239" continuedAt="f-4239-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40. Related party transactions<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4239-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, a loan of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 174.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1245" decimals="-5" name="gsk:LoansReceivableMadeByEntityRelatedPartyTransactions" scale="6" id="f-4240">0.8</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 241.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 245.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1246" decimals="-5" name="gsk:LoansReceivableMadeByEntityRelatedPartyTransactions" scale="6" id="f-4241">0.8</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 288.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) to Index Ventures and a loan of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1247" decimals="-5" name="gsk:LoansReceivableMadeByEntityRelatedPartyTransactions" scale="6" id="f-4242">2.3</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 454.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 459.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 478.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 482.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1248" decimals="-5" name="gsk:LoansReceivableMadeByEntityRelatedPartyTransactions" scale="6" id="f-4243">0.6</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 525.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ) to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicxi Ventures I LP remained due to GSK. Cash distributions were received from the investment in Medicxi Ventures I LP of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 717.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1247" decimals="-5" name="ifrs-full:InvestmentIncome" scale="6" id="f-4244">15.3</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 100.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: Medicxi Ventures I LP of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1248" decimals="-5" name="ifrs-full:InvestmentIncome" scale="6" id="f-4245">10.7</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 269.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 733.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group had no other significant related party transactions which might reasonably be expected to influence decisions made by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 743.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the users of these Financial Statements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The aggregate compensation of the Directors and GLT is given in Note 9, &#8216;Employee costs&#8217;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 391.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">237<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_514"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory" id="f-4246" continuedAt="f-4246-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">41. Acquisitions and disposals<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4246-1" continuedAt="f-4246-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details o<span style="display: inline-block; height: 6.18pt;"></span><span id="i85a7883afb7a42668794ca0331023acb_11211"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">f the acquisition and disposal of significant subsidiaries, associates, joint ventures and other businesses are given below:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 9 January 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK announced it had entered into an agreement to acquire <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1095" decimals="2" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="f-4247">100</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aiolos<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 412.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Bio, Inc. (Aiolos), a clinical stage <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharmaceutical company focused on addressing the unmet treatment needs of patients with certain respiratory and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflammatory conditions, for a total cash consideration of US<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1095" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4248">1,004</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1095" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4249">800</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 379.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) as adjusted for working capital acquired <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 214.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">paid upon closing and up to US<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 170.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1249" decimals="-6" name="gsk:BusinessCombinationMaximumPotentialMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="f-4250">400</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 220.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1249" decimals="-6" name="gsk:BusinessCombinationMaximumPotentialMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="f-4251">319</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) in certain success-based regulatory milestone payments. The estimated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value of the contingent c<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 158.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">onsideration payable was US<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 267.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1095" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4252">120</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 317.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1095" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4253">96</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In addition, GSK will also be responsible for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">success-based milestone payments as well as tiered royalties owed to Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui). The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisition completed on 14 February 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2024, no sales arising from the Aiolos business were included in Group turnover and no revenue is expected until regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approval is received on the acquired asset.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK continues to support the ongoing development of the acquired asset and consequently this asset will be loss making until <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval on this asset is received. The development of this asset has been integrated into the Group&#8217;s existing R&amp;D <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 307.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities, so it is impracticable to quantify these development costs or the impact on Total profit after taxation for the period ended <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31 December 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 97.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1095" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4254">191</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> has been recognised. The goodwill represents specific synergies available to GSK from the business <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combination. The goodwill has been allocated to the Group&#8217;s R&amp;D segment. None of the goodwill is expected to be deductible for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax purposes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 369.57pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" id="f-4255" continuedAt="f-4255-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 442.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net assets acquired:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4256">886</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.03pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="gsk:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4257">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.03pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="f-4258">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4259">26</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="f-4260">188</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="6" id="f-4261">705</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="f-4262">191</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total consideration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.86pt; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1250" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="6" id="f-4263">896</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 507.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 6 June 2024, GSK announced that it had acquired Elsie Biotechnologies, a San Diego-based private biotechnology company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dedicated to unlocking the full potential of oligonucleotide therapeutics, for a total consideration of up to US<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4264">51</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(approximate<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 102.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ly <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1251" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4265">40</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), including up to US$<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="6" id="f-4266">10</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 241.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million (&#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1251" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="6" id="f-4267">8</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million) in certain success-based development and regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 537.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">milestone payments. The key assets and liabilities recognised at acquisition include goodwill of US$<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="f-4268">23</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 464.90000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1251" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="f-4269">19</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 479.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 547.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intangible assets of US$<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4270">35</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1251" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4271">27</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and a deferred tax liability of US$<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="f-4272">7</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1251" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="f-4273">6</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million). <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 432.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The acquisition is accounted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for as a business combination but is not considered a significant acquisition for the Group. This agreement is not subject to closing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions and the acquisition has been completed.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 584.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business disposals<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK completed no material business disposals in 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 615.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Associates and joint ventures<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK completed <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no material investments<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> or disposals of associates or joint ventures during the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 647.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cash flows<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 663.55pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" id="f-4274" continuedAt="f-4274-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposals<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash consideration paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1252" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" scale="6" id="f-4275">773</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1253" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-4276">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net deferred consideration paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1252" decimals="-6" sign="-" name="gsk:DeferredConsiderationReceivedPaid" scale="6" id="f-4277">57</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1253" decimals="-6" sign="-" name="gsk:DeferredConsiderationReceivedPaid" scale="6" id="f-4278">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1252" decimals="-6" name="gsk:TransactionCostsOnDisposal" scale="6" id="f-4279">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1253" decimals="-6" name="gsk:TransactionCostsOnDisposal" format="ixt:fixed-zero" scale="6" id="f-4280">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents acquired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1252" decimals="-6" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" scale="6" id="f-4281">25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1253" decimals="-6" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" format="ixt:fixed-zero" scale="6" id="f-4282">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash outflow<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1252" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4283">810</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1253" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4284">18</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">238<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4246-2" continuedAt="f-4246-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">41. Acquisitions and disposals continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 155.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business acquisitions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 28 June 2023, GSK completed the acquisition of BELLUS Health Inc. (&#8220;Be<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 342.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">llus"<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) which was effected through a Plan of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arrangement (the &#8220;Arrangement&#8221;) pursuant to the Canada Business Corporations Act. The Arrangement was approved by Bellus&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders on 16 June 2023. Upon completion, GSK acquired all outstanding common shares of Bellus for US<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 471.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1254" decimals="2" name="gsk:AcquisitionOfInterestInSubsidiaryConsiderationPerShare" scale="0" id="f-4285">14.75</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 497.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> per <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">common share in cash, representing a total equity value of US<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1254" decimals="-9" name="ifrs-full:EquityInterestsOfAcquirer" format="ixt:num-dot-decimal" scale="9" id="f-4286">2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1254" decimals="-8" name="ifrs-full:EquityInterestsOfAcquirer" format="ixt:num-dot-decimal" scale="9" id="f-4287">1.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 363.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The acquisition provides GSK access to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development for the first-line <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment of adult patients with refractory chronic cough (RCC). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 238.65pt; width: 595.44pt;"><ix:continuation id="f-4255-1" continuedAt="f-4255-2"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 442.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net assets acquired:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4288">1,438</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-current equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="gsk:NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" scale="6" id="f-4289">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="gsk:RightOfUseAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4290">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="gsk:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4291">96</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investments held as current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="gsk:InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4292">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="f-4293">148</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="gsk:LeaseLiabilitiesRecognizedAsOfAcquisitionDate" scale="6" id="f-4294">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4295">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred tax liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="f-4296">136</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="f-4297">1,496</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-4298">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="f-4299">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total consideration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1255" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4300">1,605</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2023, the provisional values of the identifiable assets and liabilities acquired in the Affinivax, Inc. business combination were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 446.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">updated for the finalisation of the fair value of intangible assets, resulting in an increase in intellectual property of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 472.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 477.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1256" decimals="-6" name="ifrs-full:MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" scale="6" id="f-4301">39</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 486.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million, a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrease to goodwill of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1257" decimals="-6" sign="-" name="ifrs-full:MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" scale="6" id="f-4302">31</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 156.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million and a decrease to deferred tax of &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 315.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1258" decimals="-6" sign="-" name="ifrs-full:MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" scale="6" id="f-4303">8</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 319.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million. The amounts recognised at 31 December 2022 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have not been restated on the basis of materiality. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 482.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business disposals<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK completed no material business disposals in 2023.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 514.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Associates and joint ventures<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 530.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK completed no material investments or disposals of associates or joint ventures during the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 546.14pt; width: 595.44pt;"><ix:continuation id="f-4274-1" continuedAt="f-4274-2"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cash flows<span style="display: inline-block; height: 8pt;"></span></span></ix:continuation></div><ix:continuation id="f-4274-2" continuedAt="f-4274-3"><div style="position: var(--position); top: 562.03pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposals<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash consideration (paid)/received<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1259" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-4304">1,605</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1260" decimals="-6" sign="-" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" scale="6" id="f-4305">68</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net deferred consideration paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1259" decimals="-6" name="gsk:DeferredConsiderationReceivedPaid" format="ixt:fixed-zero" scale="6" id="f-4306">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1260" decimals="-6" sign="-" name="gsk:DeferredConsiderationReceivedPaid" scale="6" id="f-4307">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1259" decimals="-6" name="gsk:TransactionCostsOnDisposal" scale="6" id="f-4308">17</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1260" decimals="-6" name="gsk:TransactionCostsOnDisposal" format="ixt:fixed-zero" scale="6" id="f-4309">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents acquired/(divested)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1259" decimals="-6" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" scale="6" id="f-4310">148</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1260" decimals="-6" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" format="ixt:fixed-zero" scale="6" id="f-4311">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash (outflow)/inflow<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1259" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4312">1,474</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1260" decimals="-6" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4313">49</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">239<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4246-3" continuedAt="f-4246-4"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">41. Acquisitions and disposals continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 161.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Business acquisitions<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 1 July 2022, GSK completed the acquisition of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 241.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1261" decimals="2" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="f-4314">100</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of Sierra Oncology, Inc., a California-based, late-stage biopharmaceutical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company focused on targeted therapies for the treatment of rare forms of cancer, for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1261" decimals="-8" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="9" id="f-4315">1.9</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.78000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1261" decimals="-8" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="9" id="f-4316">1.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The main asset is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">momelotinib which targets the medical needs of myelofibrosis patients with anaemia. Total transaction costs were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 476.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1262" decimals="-6" name="gsk:PaymentsMadeForTransactionCostsAndOther" format="ixt:num-dot-decimal" scale="6" id="f-4317">52</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 15 August 2022, GSK completed the acquisition of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="2" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="f-4318">100</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 278.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of Affinivax, Inc. a clinical-stage biopharmaceutical company based in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cambridge, Boston, Massachusetts focused on pneumococcal vaccine candidates. The consideration for the acquisition comprised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an upfront payment of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-8" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="9" id="f-4319">2.2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 178.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 183.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1263" decimals="-8" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="9" id="f-4320">1.8</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) as adjusted for working capital acquired paid upon closing and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 462.21000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="payment" contextRef="c-1264" decimals="INF" name="gsk:NumberOfPotentialMilestonePayments" format="ixt-sec:numwordsen" scale="0" id="f-4321">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">milestone payments each of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 160.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-8" name="gsk:BusinessCombinationPotentialMilestonePaymentPerTranche" format="ixt:num-dot-decimal" scale="9" id="f-4322">0.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 206.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1263" decimals="-8" name="gsk:BusinessCombinationPotentialMilestonePaymentPerTranche" format="ixt:num-dot-decimal" scale="9" id="f-4323">0.5</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 246.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) to be paid upon the achievement of certain paediatric clinical development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">milestones. The estimated fair value of the contingent consideration payable was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 356.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1263" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4324">482</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The values were provisional and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were subject to change. The total transaction costs were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1264" decimals="-6" name="gsk:PaymentsMadeForTransactionCostsAndOther" format="ixt:num-dot-decimal" scale="6" id="f-4325">71</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 305.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During 2022, no sales arising from the Sierra Oncology or Affinivax businesses were included in Group turnover and no revenue is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected until regulatory approval is received on the acquired assets.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK continues to support the ongoing development of the acquired assets and consequently these assets will be loss making until <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory approval on these assets is received. The development of these assets has been integrated into the Group&#8217;s existing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">R&amp;D activities, so it was impracticable to quantify these development costs or the impact on Total profit after taxation for the period <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ended 31 December 2022.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 352.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 97.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4326">1,127</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1265" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4327">162</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for Sierra Oncology and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 292.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1266" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4328">965</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for Affinivax), which is not expected to be deductible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for tax purposes, has been recognised. The goodwill represents workforce in place, and specific synergies available to GSK from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 373.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the business combinations. The goodwill has been allocated to the Group&#8217;s Commercial Operations and R&amp;D segments (refer to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 19 &#8216;Goodwill&#8217; for allocation methodology). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 399.2pt; width: 595.44pt;"><ix:continuation id="f-4255-2"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 25.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.31pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sierra <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 25.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net assets acquired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4329">1,497</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4330">1,467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 37.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4331">2,964</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Property, plant and equipment<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 49.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-4332">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 49.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" scale="6" id="f-4333">30</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 49.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" scale="6" id="f-4334">30</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Right of use assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="gsk:RightOfUseAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4335">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="gsk:RightOfUseAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4336">52</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 61.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:RightOfUseAssetsRecognisedAsOfAcquisitionDate" scale="6" id="f-4337">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 73.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inventory<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" scale="6" id="f-4338">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-4339">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 73.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" scale="6" id="f-4340">60</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="gsk:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4341">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="gsk:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4342">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 85.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4343">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="f-4344">175</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="f-4345">109</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 97.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="f-4346">284</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="gsk:LeaseLiabilitiesRecognizedAsOfAcquisitionDate" scale="6" id="f-4347">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="gsk:LeaseLiabilitiesRecognizedAsOfAcquisitionDate" scale="6" id="f-4348">55</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 109.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:LeaseLiabilitiesRecognizedAsOfAcquisitionDate" scale="6" id="f-4349">56</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4350">40</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4351">77</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" scale="6" id="f-4352">117</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 133.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="gsk:TaxationRecognizedAsOfAcquisitionDate" scale="6" id="f-4353">259</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="gsk:TaxationRecognizedAsOfAcquisitionDate" scale="6" id="f-4354">236</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 133.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:TaxationRecognizedAsOfAcquisitionDate" scale="6" id="f-4355">495</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="f-4356">1,435</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="f-4357">1,307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 145.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="f-4358">2,742</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Goodwill<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="f-4359">162</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="f-4360">965</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4361">1,127</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="gsk:NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4362">1,597</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="gsk:NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4363">2,272</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-4364">3,869</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total cash<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4365">1,597</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4366">1,790</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-4367">3,387</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of contingent consideration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 192.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1267" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-4368">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 192.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1268" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="6" id="f-4369">482</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="6" id="f-4370">482</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 608.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 24 November 2022 GSK signed an agreement to buy out the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 295.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1269" decimals="2" name="gsk:BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" scale="-2" id="f-4371">25</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> non-controlling interest in Glaxo Saudi Arabia Ltd for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SAR<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 71.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="sar" contextRef="c-1269" decimals="-6" name="gsk:BusinessCombinationConsiderationPayableForStepAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-4372">94</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.74000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1269" decimals="-6" name="gsk:BusinessCombinationConsiderationPayableForStepAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-4373">21</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), paid in 2023.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">240<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4246-4" continuedAt="f-4246-5"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">41. Acquisitions and disposals continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Demerger of <span style="display: inline-block; height: 8pt;"></span><span id="i85a7883afb7a42668794ca0331023acb_11181"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 120.69pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Consumer<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 174.4pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Healthcare business<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">On 18 July 2022, GSK plc separated its Consumer Healthcare business from the GSK Group to form Haleon plc, an independent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">listed company. The separation was effected by way of a demerger of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.23pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1270" decimals="3" name="gsk:PercentageOfOwnershipDivested" scale="-2" id="f-4374">80.1</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.6pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> of GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.27000000000004pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1271" decimals="2" name="gsk:PercentageofGSKHolding" scale="-2" id="f-4375">68</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 383.84000000000003pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> holding in the Consumer Healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">business to GSK shareholders. Following the demerger, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 258.66pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1272" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4376">54.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.03pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> of Haleon plc was held in aggregate by GSK shareholders, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1273" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4377">6.0</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.79pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">held by GSK (including shares received by GSK&#8217;s consolidated ESOP trusts) and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 349.84000000000003pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1274" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4378">7.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.63pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> was held by certain Scottish Limited <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">Partnerships (SLPs) set up to provide collateral for a funding mechanism pursuant to which GSK will provide additional funding for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s UK defined benefit pension schemes (Note 31, 'Pensions and other post-employment benefits'). The aggregate ownership by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">GSK (including ownership by the ESOP trusts and SLPs) after the demerger of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 341.31pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1270" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4379">13.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 364.68pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> was measured at fair value with changes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">through profit or loss. In 2022, Pfizer held <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.17000000000002pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1275" decimals="2" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4380">32</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.74pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;"> of Haleon plc after the demerger<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 341.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under IFRIC 17 &#8216;Distributions of Non-cash Assets to Owners&#8217; a liability and an equity distribution are measured at the fair value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the assets to be distributed when the dividend is appropriately authorised and it is no longer at the entity&#8217;s discretion. The liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and equity movement, and associated gain on distribution were recognised in Q3 2022 when the demerger distribution was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorised and occurred. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The asset distributed was the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 165.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1276" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4381">54.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 189.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ownership of the Consumer Healthcare business. The net carrying amount of the Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare business in the consolidated financial statements, including the retained <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1270" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4382">13.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and net of the amount attributable to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-controlling interest, was approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 215.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1277" decimals="-9" name="gsk:CarryingValueOfInvestmentNetOfNonControllingInterest" format="ixt:num-dot-decimal" scale="9" id="f-4383">11</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 252.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> at the end of June. GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1278" decimals="-8" name="gsk:LiabilityEliminatedOnDemerger" format="ixt:num-dot-decimal" scale="9" id="f-4384">6.3</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> share of the shareholder loans made in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q1 2022 in advance of the pre-separation dividends was eliminated in the consolidated financial statements. The assets distributed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were reduced by Consumer Healthcare transactions up to 18 July that principally included pre-separation dividends declared and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settled after the end of Q2 2022 and before 18 July 2022. Those dividends included: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1271" decimals="-8" name="gsk:DividendFundedByDebtFinancing" format="ixt:num-dot-decimal" scale="9" id="f-4385">10.4</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1271" decimals="-8" name="gsk:DividendFundedByDebtFinancingAttributableToGsk" format="ixt:num-dot-decimal" scale="9" id="f-4386">7.1</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 458.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> attributable to GSK) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of dividends funded by Consumer Healthcare debt that was partially on-lent during Q1 2022 and dividends of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 459.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1271" decimals="-8" name="gsk:DividendsDistributedFromCashBalance" format="ixt:num-dot-decimal" scale="9" id="f-4387">0.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1271" decimals="-8" name="gsk:DividendsDistributedFromCashBalanceAttributableToGsk" format="ixt:num-dot-decimal" scale="9" id="f-4388">0.4</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> attributable to GSK) from available cash balances.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 376.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 130.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1279" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4389">54.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ownership of the Consumer Healthcare business distributed was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1280" decimals="-8" name="gsk:FairValueOfTheAssetsDistributed" format="ixt:num-dot-decimal" scale="9" id="f-4390">15.5</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 443.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. This was measured by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reference to the quoted average Haleon plc share price over the first five days of trading, this being a fair value measured with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">observable inputs which was considered to be representative of the fair value at the distribution date. A gain on distribution of this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value less book value of the attributable net assets of the Consumer Healthcare business of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1279" decimals="-8" name="gsk:GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" format="ixt:num-dot-decimal" scale="9" id="f-4391">7.7</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 450.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was recorded in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income statement in 2022. There was an additional gain of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 273.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1270" decimals="-8" name="gsk:AdditionalGainOnRemeasurementOfRetainedStake" format="ixt:num-dot-decimal" scale="9" id="f-4392">2.4</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to remeasure the retained <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1270" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4393">13.5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> from its book value to fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 85.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1278" decimals="-8" name="gsk:FairValueOfHolding" format="ixt:num-dot-decimal" scale="9" id="f-4394">3.9</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> using the same fair value methodology as used for the distributed shares. The gain on distribution and on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remeasurement of the retained stake upon demerger was presented as part of discontinued operations. Any future gains or losses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the retained stake in Haleon plc will be recognised in continuing operations. In addition, there was a reclassification of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s share of cumulative exchange differences arising on translation of the foreign currency net assets of the divested <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiaries and offsetting net investment hedges from reserves into the income statement of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1281" decimals="-8" name="gsk:ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" format="ixt:num-dot-decimal" scale="9" id="f-4395">0.6</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The total gain on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demerger of Consumer Healthcare was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-8" name="gsk:GainOnDemergerOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="9" id="f-4396">10.1</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.72000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. These transactions were presented in profit from discontinued operations in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 505.03pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" id="f-4397" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 442.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 442.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of the Consumer Healthcare business distributed (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 199.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1279" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4398">54.5</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 220.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:FairValueOfTheConsumerHealthcareBusinessDistributed" format="ixt:num-dot-decimal" scale="6" id="f-4399">15,526</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 442.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of the retained ownership in Haleon plc (<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 167.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1270" decimals="3" name="gsk:PercentageOfOwnershipDistributed" scale="-2" id="f-4400">13.5</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 188.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:FairValueOfTheRetainedOwnershipInHaleonPlc" format="ixt:num-dot-decimal" scale="6" id="f-4401">3,853</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="gsk:TotalfairValueOfDistributedandRetainBusiness" format="ixt:num-dot-decimal" scale="6" id="f-4402">19,379</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying amount of the net assets and liabilities distributed/de-recognised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:CarryingAmountOfTheNetAssetsAndLiabilitiesDistributed" format="ixt:num-dot-decimal" scale="6" id="f-4403">12,887</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying amount of the non-controlling interest de-recognised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CarryingAmountOfTheNciDerecognized" format="ixt:num-dot-decimal" scale="6" id="f-4404">3,038</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gain on demerger before exchange movements and transaction costs<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-4405">9,530</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclassification of exchange movements and net investment hedge movements on disposal of overseas subsidiaries<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" scale="6" id="f-4406">554</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 442.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 442.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total gain on the demerger of Consumer Healthcare<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:GainOnDemergerOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="f-4407">10,084</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consumer Healthcare was presented as a discontinued operation as at 30 June 2022 and disclosed as such in the interim financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements. The Consolidated Income Statement and Consolidated Cash Flow Statement distinguish discontinued operations from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuing operations. Financial information relating to the operations of Consumer Healthcare for the period is set out on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following page and includes financial information until 18 July 2022. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 676.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This financial information differs both in purpose and basis of preparation from the Historical Financial Information and the Interim <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 687.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial Information included in the Haleon prospectus and from that which was published by Haleon plc on 2 March 2023. As a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result, whilst the two sets of financial information are similar, they are not the same because of certain differences in accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and disclosure under IFRS.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">241<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-4246-5"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">41. Acquisitions and disposals continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 136.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" id="f-4408" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total results<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.86pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.66pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:Revenue" format="ixt:num-dot-decimal" scale="6" id="f-4409">5,581</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:OperatingExpense" format="ixt:num-dot-decimal" scale="6" id="f-4410">4,730</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit before tax<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:ProfitLossBeforeTax" scale="6" id="f-4411">851</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 56.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Taxation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 56.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="f-4412">235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax rate %<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 68.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1282" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="f-4413">27.6</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Loss)/profit after taxation from discontinued operations: Consumer Healthcare<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 80.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperations" scale="6" id="f-4414">616</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other gains/(losses) on demerger<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="gsk:OtherGainsLossesOnDemerger" format="ixt:num-dot-decimal" scale="6" id="f-4415">2,433</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Remeasurement of discontinued operations distributed to shareholders on demerger<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 104.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.18pt;"></span></span><span style="left: 22.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="gsk:RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" format="ixt:num-dot-decimal" scale="6" id="f-4416">7,651</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit after taxation on demerger of discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 116.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="gsk:ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-4417">10,700</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-controlling interest in discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 128.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.37pt;"></span></span><span style="left: 29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests" scale="6" id="f-4418">205</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Earnings attributable to shareholders from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 140.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1282" decimals="-6" name="ifrs-full:IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="f-4419">10,495</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Earnings per share from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 152.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbpPerShare" contextRef="c-11" decimals="3" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="-2" id="f-4420">260.6</ix:nonFraction>p<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 327pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Other business disposals<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 342.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There were no other material business disposals in 2022.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 358.78pt; width: 595.44pt;"><ix:continuation id="f-4274-3"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 352.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 23.44pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cash flows<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.780000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposals - <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demerger<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Business <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disposals - <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash consideration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 35.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1283" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-4421">3,392</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 35.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1284" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-4422">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 35.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1285" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-4423">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net deferred consideration paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1283" decimals="-6" name="gsk:DeferredConsiderationReceivedPaid" format="ixt:fixed-zero" scale="6" id="f-4424">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1284" decimals="-6" name="gsk:DeferredConsiderationReceivedPaid" format="ixt:fixed-zero" scale="6" id="f-4425">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 47.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1285" decimals="-6" sign="-" name="gsk:DeferredConsiderationReceivedPaid" scale="6" id="f-4426">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 59.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents (divested)/acquired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 59.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1283" decimals="-6" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" scale="6" id="f-4427">284</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 59.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1284" decimals="-6" sign="-" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" scale="6" id="f-4428">933</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 59.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1285" decimals="-6" sign="-" name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" scale="6" id="f-4429">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 71.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1283" decimals="-6" sign="-" name="gsk:CashOutflowInflowExcludingTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-4430">3,108</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 71.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1284" decimals="-6" sign="-" name="gsk:CashOutflowInflowExcludingTransactionCosts" scale="6" id="f-4431">933</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 71.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1285" decimals="-6" sign="-" name="gsk:CashOutflowInflowExcludingTransactionCosts" scale="6" id="f-4432">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 83.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transaction costs paid<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 83.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1283" decimals="-6" name="gsk:TransactionCostsOnDisposal" scale="6" id="f-4433">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 83.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1284" decimals="-6" name="gsk:TransactionCostsOnDisposal" scale="6" id="f-4434">141</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 83.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1285" decimals="-6" name="gsk:TransactionCostsOnDisposal" format="ixt:fixed-zero" scale="6" id="f-4435">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 95.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash (outflow)/inflow<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 95.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1283" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4436">3,187</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 95.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1284" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4437">1,074</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 95.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1285" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-4438">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash consideratio<span style="display: inline-block; height: 6.18pt;"></span><span id="i85a7883afb7a42668794ca0331023acb_11209"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 121.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">n for business acquisitions included<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 253.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 255.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-4439">5</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 290.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> related to other business acquisition activity.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">242<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_517"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" id="f-4440" continuedAt="f-4440-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 48.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 48.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">42. Adjustments reconciling Total profit after tax to operating <span style="display: inline-block; height: 13.46pt;"></span></span></div><div style="line-height: 18.5pt; position: var(--position); top: 23.9pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4440-1"><div style="position: var(--position); top: 172.83pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" id="f-4441" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total profit after tax from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4442">2,951</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4443">5,308</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProfitLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4444">4,921</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax on profits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 36.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="6" id="f-4445">526</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 36.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="6" id="f-4446">756</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 36.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="6" id="f-4447">707</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share of after-tax (profits)/losses of associates and joint ventures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" scale="6" id="f-4448">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" scale="6" id="f-4449">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" scale="6" id="f-4450">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance expense net of finance income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="6" id="f-4451">547</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="6" id="f-4452">677</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="6" id="f-4453">803</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depreciation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForDepreciationExpense" format="ixt:num-dot-decimal" scale="6" id="f-4454">1,097</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForDepreciationExpense" format="ixt:num-dot-decimal" scale="6" id="f-4455">1,082</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForDepreciationExpense" format="ixt:num-dot-decimal" scale="6" id="f-4456">1,061</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortisation of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-4457">1,454</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-4458">1,212</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 84.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForAmortisationExpense" format="ixt:num-dot-decimal" scale="6" id="f-4459">1,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impairment and assets written off<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:AdjustmentsForImpairmentAndAssetsWrittenOff" scale="6" id="f-4460">408</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AdjustmentsForImpairmentAndAssetsWrittenOff" scale="6" id="f-4461">467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:AdjustmentsForImpairmentAndAssetsWrittenOff" scale="6" id="f-4462">481</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Profit)/loss on sale of businesses<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:AdjustmentsForProfitLossOnSaleOfBusinesses" scale="6" id="f-4463">11</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AdjustmentsForProfitLossOnSaleOfBusinesses" format="ixt:fixed-zero" scale="6" id="f-4464">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:AdjustmentsForProfitLossOnSaleOfBusinesses" scale="6" id="f-4465">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit on sale of intangible assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:AdjustmentsForProfitOnSaleOfIntangibleAssets" scale="6" id="f-4466">170</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:AdjustmentsForProfitOnSaleOfIntangibleAssets" scale="6" id="f-4467">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:AdjustmentsForProfitOnSaleOfIntangibleAssets" scale="6" id="f-4468">185</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit on sale of investments in associates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-4469">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="f-4470">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="f-4471">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 144.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit on sale of equity investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:AdjustmentsForProfitOnSaleOfEquityInvestments" scale="6" id="f-4472">10</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AdjustmentsForProfitOnSaleOfEquityInvestments" format="ixt:fixed-zero" scale="6" id="f-4473">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:AdjustmentsForProfitOnSaleOfEquityInvestments" scale="6" id="f-4474">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 157.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes in working capital:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 169.5pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in inventories<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 169.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="6" id="f-4475">294</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 169.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="6" id="f-4476">424</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 169.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="6" id="f-4477">269</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 182.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in trade receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="6" id="f-4478">298</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="6" id="f-4479">794</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 182.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="6" id="f-4480">158</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 194.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in trade payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="6" id="f-4481">179</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="6" id="f-4482">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 194.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="6" id="f-4483">494</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="6" id="f-4484">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="6" id="f-4485">145</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="6" id="f-4486">458</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration paid (see Note 33)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-4487">1,235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-4488">1,134</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 218.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="6" id="f-4489">1,058</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 230.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-cash increase in contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4490">1,834</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" scale="6" id="f-4491">492</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 230.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-4492">1,628</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 242.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables" scale="6" id="f-4493">610</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables" scale="6" id="f-4494">689</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 242.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables" scale="6" id="f-4495">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in pension and other provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 254.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="6" id="f-4496">999</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 254.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="6" id="f-4497">457</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 254.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="6" id="f-4498">962</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 266.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share-based incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 266.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="6" id="f-4499">344</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 266.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="6" id="f-4500">307</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 266.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="6" id="f-4501">346</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 278.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 278.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForFairValueGainsLosses" scale="6" id="f-4502">39</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 278.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForFairValueGainsLosses" scale="6" id="f-4503">107</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 278.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForFairValueGainsLosses" scale="6" id="f-4504">283</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 290.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 290.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" scale="6" id="f-4505">110</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 290.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" scale="6" id="f-4506">100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 290.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" scale="6" id="f-4507">170</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 302.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating cash flow from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 302.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4508">7,861</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 302.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4509">8,096</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 302.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4510">7,944</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 314.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Operating cash flow from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 314.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-4511">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 314.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-4512">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 314.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" scale="6" id="f-4513">932</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 332.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total cash generated from operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 332.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-4514">7,861</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 332.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-4515">8,096</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 332.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:CashFlowsFromUsedInOperationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-4516">8,876</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">243<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_520"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCashFlowStatementExplanatory" id="f-4517" continuedAt="f-4517-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">43. Reconciliation of net cash flow to movement in net debt<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4517-1" continuedAt="f-4517-2"><div style="position: var(--position); top: 154.08pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" id="f-4518" continuedAt="f-4518-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt, at beginning of year, as adjusted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-4519">15,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-4520">17,197</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-19" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-4521">19,838</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in cash and bank overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" scale="6" id="f-4522">599</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" scale="6" id="f-4523">468</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4524">7,597</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease in liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DecreaseIncreaseInLiquidInvestment" scale="6" id="f-4525">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DecreaseIncreaseInLiquidInvestment" scale="6" id="f-4526">72</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DecreaseIncreaseInLiquidInvestment" scale="6" id="f-4527">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of long-term loans<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 99.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4528">1,615</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4529">2,260</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4530">6,668</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Issue of long-term notes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4531">1,075</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" scale="6" id="f-4532">223</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4533">1,025</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net decrease/(increase) in short-term loans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" scale="6" id="f-4534">811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" scale="6" id="f-4535">333</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4536">1,021</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase in other short-term loans<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 110.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:IncreaseDecreaseInOtherShortTermLoans" scale="6" id="f-4537">266</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:IncreaseDecreaseInOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-4538">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:IncreaseDecreaseInOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-4539">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of other short-term loans<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 120.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RepaymentOfOtherShortTermLoans" scale="6" id="f-4540">81</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RepaymentOfOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-4541">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RepaymentOfOtherShortTermLoans" format="ixt:fixed-zero" scale="6" id="f-4542">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="f-4543">226</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="f-4544">197</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="f-4545">202</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investments/(debt) of subsidiary undertakings acquired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" format="ixt:fixed-zero" scale="6" id="f-4546">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" scale="6" id="f-4547">50</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" scale="6" id="f-4548">24</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:ExchangeOnNetDebt" scale="6" id="f-4549">117</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:ExchangeOnNetDebt" scale="6" id="f-4550">554</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 138.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:ExchangeOnNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4551">1,531</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-cash movements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="gsk:OtherAdjustmentsForNonCashItemsToNetDebt" scale="6" id="f-4552">142</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" sign="-" name="gsk:OtherAdjustmentsForNonCashItemsToNetDebt" scale="6" id="f-4553">474</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:OtherAdjustmentsForNonCashItemsToNetDebt" scale="6" id="f-4554">207</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in net debt from continuing operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DecreaseIncreaseInNetDebtFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4555">1,945</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DecreaseIncreaseInNetDebtFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4556">2,157</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 162.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" sign="-" name="gsk:DecreaseIncreaseInNetDebtFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="f-4557">4,536</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Decrease/(increase) in net debt from discontinued operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:DecreaseIncreaseInNetDebtFromDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-4558">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:DecreaseIncreaseInNetDebtFromDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-4559">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:DecreaseIncreaseInNetDebtFromDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-4560">7,177</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total net debt at end of year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 189.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-4561">13,095</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 189.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-4562">15,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 189.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-31" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="f-4563">17,197</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4518-1"><div style="position: var(--position); top: 366.52pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 474.75pt;"/></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 12.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 12.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 12.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 474.75pt;"><div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 2.63pt; width: 474.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Repayment of long-term loans for <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 104.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 119.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 129.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4564">1,615</ix:nonFraction> million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 172.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 176.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 191.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 195.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4565">2,260</ix:nonFraction> million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 238.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; 2022: <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 261.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4566">6,668</ix:nonFraction> million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) includes the current portion of long-term borrowings <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 11.03pt; width: 474.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 7.4799999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="gsk:RepaymentsOfCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4567">1,615</ix:nonFraction> million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 50.199999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 54.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 69.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 73.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="gsk:RepaymentsOfCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4568">2,116</ix:nonFraction> million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 115.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 119.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 135.14000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 138.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="gsk:RepaymentsOfCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-4569">5,074</ix:nonFraction> million<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 181.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) which was classified as short-term borrowing on the balance sheet and previously presented <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 474.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as repayment of short-term loans<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 12.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 12.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 12.75pt; overflow: hidden; position: var(--position); top: 30pt; width: 474.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 474.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other short-term loans include bank loans presented within short-term borrowings on the balance sheet, with an initial maturity of greater than three <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 474.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">months.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="position: var(--position); top: 425.27pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" id="f-4570" continuedAt="f-4570-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 126.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 37.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Analysis of changes in net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.879999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 0pt; width: 37.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 37.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 37.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Change <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclass-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ifications<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 33.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1286" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4571">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 33.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1287" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4572">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 33.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1287" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4573">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 33.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1287" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4574">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 33.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1287" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4575">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 33.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1287" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4576">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 33.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1287" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4577">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1288" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4578">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 206.25pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 246pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 283.5pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 323.25pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 363pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 402.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 3pt; left: 442.5pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1289" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4579">2,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1290" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4580">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 48.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1290" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4581">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1290" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4582">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1290" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4583">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1290" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4584">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 48.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1290" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4585">988</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 48.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1291" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4586">3,870</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 60.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1292" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4587">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 60.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1293" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4588">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 60.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1293" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4589">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 60.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1293" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4590">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 60.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1293" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4591">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 60.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1293" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4592">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 60.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1293" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4593">389</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 60.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1294" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4594">467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 72.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1295" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4595">2,858</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 72.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1296" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4596">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 72.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1296" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4597">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 72.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1296" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4598">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 72.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1296" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4599">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 72.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1296" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4600">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 72.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1296" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4601">599</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1297" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4602">3,403</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Debt due within one year:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial paper<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1298" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4603">815</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1299" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4604">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 96.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1299" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4605">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1299" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4606">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1299" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4607">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1299" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4608">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 96.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1299" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4609">811</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1300" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4610">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European/US MTN &amp; Bank facilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 108.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1301" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4611">1,651</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 108.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1302" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4612">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 108.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.92pt;"></span></span><span style="left: 23.55pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1302" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4613">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 108.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1302" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4614">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 108.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1302" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4615">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 108.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1302" decimals="-6" sign="-" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4616">1,414</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 108.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1302" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4617">1,615</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1303" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4618">1,419</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 120.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1304" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4619">156</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 120.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1305" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4620">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 120.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1305" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4621">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 120.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1305" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4622">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 120.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1305" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4623">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 120.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1305" decimals="-6" sign="-" name="gsk:ReclassificationOfNetDebt" scale="6" id="f-4624">249</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 120.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1305" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4625">226</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1306" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4626">168</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1307" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4627">113</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1308" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4628">11</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 132.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.38pt;"></span></span><span style="left: 26.009999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1308" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4629">14</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1308" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4630">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1308" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4631">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1308" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4632">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 132.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1308" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4633">185</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1309" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4634">295</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1310" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4635">2,735</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1311" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4636">49</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 144.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1311" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4637">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1311" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4638">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1311" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4639">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1311" decimals="-6" sign="-" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4640">1,663</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1311" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4641">2,467</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1312" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4642">1,882</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Debt due after one year:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European/US MTN &amp; Bank facilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 168.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1313" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4643">14,154</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 168.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1314" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4644">127</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 168.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1314" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4645">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 168.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1314" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4646">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 168.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1314" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4647">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 168.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1314" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4648">1,414</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 168.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1314" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4649">1,075</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1315" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4650">13,703</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1316" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4651">1,051</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1317" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4652">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 180.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.78pt;"></span></span><span style="left: 19.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1317" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4653">137</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1317" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4654">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1317" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4655">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1317" decimals="-6" name="gsk:ReclassificationOfNetDebt" scale="6" id="f-4656">249</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 180.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1317" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4657">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1318" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4658">934</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1319" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4659">15,205</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1320" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4660">132</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 192.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.78pt;"></span></span><span style="left: 19.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1320" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4661">137</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1320" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4662">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1320" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4663">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1320" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4664">1,663</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 192.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1320" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4665">1,075</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1321" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4666">14,637</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 210.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1322" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4667">15,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 210.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1323" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4668">127</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 210.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.78pt;"></span></span><span style="left: 19.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1323" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4669">137</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 210.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1323" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4670">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 210.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1323" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4671">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 210.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1323" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4672">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 210.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1323" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4673">1,970</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 210.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1324" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4674">13,095</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="3" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest payable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 228.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1325" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4675">162</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 228.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1326" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4676">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 228.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.92pt;"></span></span><span style="left: 23.55pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1326" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4677">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 228.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1326" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4678">602</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 228.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1326" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4679">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 228.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1326" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4680">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 228.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1326" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4681">632</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 228.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1327" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4682">162</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1328" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4683">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1329" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4684">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 240.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.52pt;"></span></span><span style="left: 30.15pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1329" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4685">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1329" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4686">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1329" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" scale="6" id="f-4687">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1329" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4688">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 240.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1329" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4689">129</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 240.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1330" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4690">82</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 126.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities from financing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 126.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; activities*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 166.5pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 8.7pt;"></span></span><span style="left: 11.329999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1331" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4691">18,086</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 206.25pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1332" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4692">181</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 246pt; position: var(--position); top: 252.75pt; width: 37.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 37.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.78pt;"></span></span><span style="left: 19.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1332" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4693">167</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 283.5pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1332" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4694">617</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 323.25pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1332" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" scale="6" id="f-4695">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 363pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1332" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4696">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 402.75pt; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1332" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4697">1,895</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1333" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4698">16,763</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4570-1" continuedAt="f-4570-2"><div style="position: var(--position); top: 708.96pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 12pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 474.75pt;"/></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 12pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 12pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 12pt; position: var(--position); top: 0pt; width: 474.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 474.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Excluding cash and cash equivalents, overdrafts and liquid investments.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">244<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-4517-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">43. Reconciliation of net cash flow to movement in net debt continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:continuation id="f-4570-2" continuedAt="f-4570-3"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 129pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 44.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Analysis of changes in net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.879999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Change <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reclass-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ifications<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 44.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 47.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 33.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1334" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4699">67</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 33.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.81pt;"></span></span><span style="left: 34.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1335" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4700">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 33.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1335" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4701">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="gbp" contextRef="c-1335" xsi:nil="true" name="ifrs-full:InterestExpense" id="f-4702"></ix:nonFraction></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="gbp" contextRef="c-1335" xsi:nil="true" name="gsk:ChangeInFairValueOfNetDebt" id="f-4703"></ix:nonFraction></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><ix:nonFraction unitRef="gbp" contextRef="c-1335" xsi:nil="true" name="gsk:ReclassificationOfNetDebt" id="f-4704"></ix:nonFraction></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 33.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1335" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4705">72</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 33.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.13pt;"></span></span><span style="left: 35.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1286" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4706">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 48.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1336" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4707">3,723</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 48.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1337" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4708">105</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 48.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1337" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4709">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 48.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1337" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4710">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 48.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1337" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4711">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 48.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1337" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4712">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 48.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1337" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4713">682</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 48.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.8pt;"></span></span><span style="left: 25.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1289" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4714">2,936</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 60.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1338" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4715">298</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 60.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1339" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4716">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 60.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1339" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4717">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 60.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1339" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4718">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 60.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1339" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4719">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 60.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1339" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4720">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 60.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1339" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4721">214</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 60.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.67pt;"></span></span><span style="left: 33.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1292" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4722">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 72.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1340" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4723">3,425</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1341" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4724">99</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1341" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4725">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1341" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4726">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1341" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4727">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1341" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4728">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 72.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1341" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4729">468</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 72.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.8pt;"></span></span><span style="left: 25.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1295" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4730">2,858</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Debt due within one year:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial paper<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 99.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1342" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4731">1,191</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 99.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1343" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4732">56</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 99.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1343" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4733">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 99.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1343" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4734">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 99.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1343" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4735">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 99.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1343" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4736">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 99.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1343" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4737">320</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 99.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.53pt;"></span></span><span style="left: 29.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1298" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4738">815</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 111.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European/US MTN &amp; Bank facilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 111.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1344" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4739">2,146</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 111.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1345" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4740">48</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 111.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1345" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4741">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 111.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1345" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4742">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 111.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1345" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4743">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 111.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.34pt;"></span></span><span style="left: 19.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1345" decimals="-6" sign="-" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4744">1,669</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 111.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1345" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4745">2,116</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 111.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.34pt;"></span></span><span style="left: 22.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1301" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4746">1,651</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 123.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 123.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1346" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4747">167</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 123.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1347" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4748">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 123.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.81pt;"></span></span><span style="left: 34.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1347" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4749">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 123.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1347" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4750">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 123.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1347" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4751">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 123.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1347" decimals="-6" sign="-" name="gsk:ReclassificationOfNetDebt" scale="6" id="f-4752">195</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 123.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1347" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4753">197</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 123.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.53pt;"></span></span><span style="left: 29.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1304" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4754">156</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 135.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 135.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1348" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4755">150</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 135.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1349" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4756">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 135.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1349" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4757">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 135.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1349" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4758">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 135.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1349" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4759">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 135.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1349" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4760">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 135.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1349" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4761">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 135.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.53pt;"></span></span><span style="left: 29.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1307" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4762">113</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 147.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1350" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4763">3,654</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 147.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1351" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4764">137</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 147.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1351" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4765">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 147.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1351" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4766">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 147.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1351" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4767">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 147.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.34pt;"></span></span><span style="left: 19.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1351" decimals="-6" sign="-" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4768">1,864</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 147.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1351" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4769">2,646</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 147.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.34pt;"></span></span><span style="left: 22.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1310" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4770">2,735</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Debt due after one year:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European/US MTN &amp; Bank facilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1352" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4771">16,194</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 174.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1353" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4772">469</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 174.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1353" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4773">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 174.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1353" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4774">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 174.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1353" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4775">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 174.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1353" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4776">1,669</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 174.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1353" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4777">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 174.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1313" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4778">14,154</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1354" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4779">841</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 186.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.13pt;"></span></span><span style="left: 32.76pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1355" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4780">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 186.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1355" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4781">447</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 186.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1355" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4782">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 186.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1355" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4783">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 186.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1355" decimals="-6" name="gsk:ReclassificationOfNetDebt" scale="6" id="f-4784">195</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 186.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1355" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4785">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 186.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.34pt;"></span></span><span style="left: 22.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1316" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4786">1,051</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 198.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1356" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4787">17,035</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1357" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4788">511</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1357" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4789">447</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1357" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4790">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1357" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4791">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1357" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:num-dot-decimal" scale="6" id="f-4792">1,864</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 198.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1357" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4793">79</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 198.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1319" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4794">15,205</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 216.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 216.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1358" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4795">17,197</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1359" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4796">545</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1359" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4797">396</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1359" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4798">19</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1359" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4799">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1359" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4800">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 216.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1359" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4801">2,027</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 216.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1322" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4802">15,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest payable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 234.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1360" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4803">207</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 234.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1361" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4804">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 234.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.67pt;"></span></span><span style="left: 30.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1361" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4805">29</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 234.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1361" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4806">693</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 234.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1361" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4807">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 234.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1361" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4808">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 234.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1361" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4809">766</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 234.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.53pt;"></span></span><span style="left: 29.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1325" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4810">162</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 246.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 246.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1362" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4811">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 246.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1363" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4812">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 246.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1363" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-4813">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 246.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1363" decimals="-6" name="ifrs-full:InterestExpense" format="ixt:fixed-zero" scale="6" id="f-4814">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 246.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1363" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" scale="6" id="f-4815">343</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 246.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1363" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4816">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 246.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1363" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4817">335</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 246.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.13pt;"></span></span><span style="left: 35.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1328" decimals="-6" sign="-" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="6" id="f-4818">16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 258.75pt; width: 129pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total liabilities from financing<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 129pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; activities*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 129pt; position: var(--position); top: 258.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.7pt;"></span></span><span style="left: 17.33pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1364" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4819">20,888</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 174.75pt; position: var(--position); top: 258.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1365" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4820">649</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 258.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1365" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" scale="6" id="f-4821">476</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 263.25pt; position: var(--position); top: 258.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.53pt;"></span></span><span style="left: 26.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1365" decimals="-6" name="ifrs-full:InterestExpense" scale="6" id="f-4822">712</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 258.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.99pt;"></span></span><span style="left: 28.619999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1365" decimals="-6" name="gsk:ChangeInFairValueOfNetDebt" scale="6" id="f-4823">343</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 351.75pt; position: var(--position); top: 258.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 34.27pt;"></span></span><span style="left: 36.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1365" decimals="-6" name="gsk:ReclassificationOfNetDebt" format="ixt:fixed-zero" scale="6" id="f-4824">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 258.75pt; width: 44.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 44.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.8pt;"></span></span><span style="left: 22.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1365" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4825">2,998</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 258.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1331" decimals="-6" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-4826">18,086</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div><ix:continuation id="f-4570-3"><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 418.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">*<span style="display: inline-block; height: 5.09pt; width: 8.65pt;"></span></span><span style="left: 65.2pt; position: var(--position);">Excluding cash and cash equivalents, overdrafts and liquid investments.<span style="display: inline-block; height: 5.09pt;"></span></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For further information on significant changes in net debt see Note 30, &#8216;Net debt&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">245<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_523"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" id="f-4827" continuedAt="f-4827-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i0c523670d8e84ad8a96288f79dd9015d_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4827-1" continuedAt="f-4827-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The objective of GSK&#8217;s Treasury activities is to minimise the net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost of financial operations and reduce its volatility to benefit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">earnings and cash flows. GSK uses a variety of financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments to finance its operations and derivative financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments to manage market risks from these operations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives principally comprise foreign exchange forward <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts and swaps which are used to swap borrowings and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liquid assets into currencies required for Group purposes as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">well as interest rate swaps which are used to manage exposure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to financial risks from changes in interest rates. These financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments reduce the uncertainty of foreign currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions and interest payments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives are used exclusively for hedging purposes in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relation to underlying business activities and not as trading or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">speculative instruments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 316.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Capital management<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 332.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s financial strategy supports the Group&#8217;s strategic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 342.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">priorities and is regularly reviewed by the Board. GSK manages <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 352.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the capital structure of the Group through an appropriate mix of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debt and equity. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 378.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The capital structure of the Group consists of net debt of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-9" name="ifrs-full:Borrowings" scale="9" id="f-4828">13</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 388.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-9" name="ifrs-full:Borrowings" scale="9" id="f-4829">15</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.28pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(see Note 30, &#8216;Net debt&#8217;) and total <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity, including items related to non-controlling interests, of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 409.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-9" name="ifrs-full:Equity" scale="9" id="f-4830">13</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-9" name="ifrs-full:Equity" scale="9" id="f-4831">13</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ) (see &#8216;Consolidated statement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 419.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in equity&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 155.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_364">184</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Total capital, including that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided by non-controlling interests, is <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 201.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-9" name="gsk:EquityAndDebtNet" format="ixt:num-dot-decimal" scale="9" id="f-4832">26</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.51999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-9" name="gsk:EquityAndDebtNet" format="ixt:num-dot-decimal" scale="9" id="f-4833">28</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group continues to manage its financial policies to a credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profile that particularly targets ratings of at least A2/A (Moody's/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S&amp;P), through the cycle. The Group&#8217;s long-term credit rating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with Standard &amp; Poor&#8217;s is A (stable outlook) and with Moody&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investor Services is A2 (stable outlook). The Group&#8217;s short-term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credit ratings are A-1 and P-1 with Standard &amp; Poor&#8217;s and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Moody&#8217;s respectively. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 532.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Liquidity risk management<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35386"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s policy is to borrow centrally in order to meet anticipated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">funding requirements. The strategy is to diversify liquidity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sources using a range of facilities and to maintain broad access <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to financial markets. Each day, GSK sweeps cash to or from a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of global subsidiaries and central Treasury accounts for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liquidity management purposes. GSK utilises both physical and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">notional cash pool arrangements as appropriate by location <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and currency. For notional cash pools, liquidity is drawn against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">foreign currency balances to provide both local funding and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">central liquidity as required and with balances actively <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managed and maintained to appropriate levels. As balances in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">notional pooling arrangements are not settled across <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies, gross cash and overdraft balances are reported.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 686.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK had <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 176.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-8" name="ifrs-full:ShorttermBorrowings" scale="9" id="f-4834">2.3</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 216.89999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 245.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-8" name="ifrs-full:ShorttermBorrowings" scale="9" id="f-4835">2.8</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 288.24pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of borrowings repayable within one year and held <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1366" decimals="-8" name="gsk:CashAndCashEquivalentsAndLiquidInvestments" format="ixt:num-dot-decimal" scale="9" id="f-4836">3.9</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 279.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1367" decimals="-8" name="gsk:CashAndCashEquivalentsAndLiquidInvestments" format="ixt:num-dot-decimal" scale="9" id="f-4837">3.0</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.88pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of cash and cash equivalents and liquid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 717.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1366" decimals="-8" name="gsk:CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" format="ixt:num-dot-decimal" scale="9" id="f-4838">3.1</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 174.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1367" decimals="-8" name="gsk:CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" format="ixt:num-dot-decimal" scale="9" id="f-4839">2.2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 242.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 245.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.97000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was held <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 727.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">centrally. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has access to short-term finance under a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 479.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-9" name="gsk:CommercialPapersAuthorised" scale="9" id="f-4840">10</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 517.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 522.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-765" decimals="-9" name="gsk:CommercialPapersAuthorised" scale="9" id="f-4841">8</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) US commercial paper programme. There was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 503.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-766" decimals="INF" name="ifrs-full:CommercialPapersIssued" format="ixt:fixed-zero" scale="0" id="f-4842">no</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial paper in issue at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 485.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 490.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 509.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 514.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-4843">850</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-767" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-4844">667</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)). Maximum drawdowns under the US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Paper programme during the year were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1368" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" format="ixt:num-dot-decimal" scale="6" id="f-4845">1,315</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 356.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 361.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1368" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" format="ixt:num-dot-decimal" scale="6" id="f-4846">1,048</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1369" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" format="ixt:num-dot-decimal" scale="6" id="f-4847">3,262</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 496.57000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 501.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1369" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" format="ixt:num-dot-decimal" scale="6" id="f-4848">2,579</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)). GSK has access to short-term finance under a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-768" decimals="-9" name="gsk:CommercialPapersAuthorised" scale="9" id="f-4849">5</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Euro commercial paper programme. There was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 506.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-768" decimals="INF" name="ifrs-full:CommercialPapersIssued" format="ixt:fixed-zero" scale="0" id="f-4850">no</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Euro <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial paper in issue at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 415.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 511.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 515.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-769" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-4851">170</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-769" decimals="-6" name="ifrs-full:CommercialPapersIssued" scale="6" id="f-4852">148</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)). Maximum drawdowns under the Euro <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commerical Paper programme during the year were <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 501.07000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1370" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" scale="6" id="f-4853">170</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1370" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" scale="6" id="f-4854">145</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 409.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8364;<ix:nonFraction unitRef="eur" contextRef="c-1371" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" scale="6" id="f-4855">927</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 454.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 459.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1371" decimals="-6" name="gsk:MaximumDrawdownOfCommercialPapers" scale="6" id="f-4856">800</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 504.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-770" decimals="-8" name="gsk:RevolvingCreditFacilities" scale="9" id="f-4857">1.6</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-771" name="gsk:RevolvingCreditFacilityTerm" format="ixt-sec:durwordsen" id="f-4858"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-8" name="gsk:RevolvingCreditFacilities" scale="9" id="f-4859">2.2</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 494.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-772" decimals="-8" name="gsk:RevolvingCreditFacilities" scale="9" id="f-4860">1.8</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 534.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-773" name="gsk:RevolvingCreditFacilityTerm" format="ixt-sec:durday" id="f-4861">364</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> day<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> committed facilities. These committed facilities were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undrawn at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 420.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. GSK considers this level of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">committed facilities to be adequate, given current liquidity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has a <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 347.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1366" decimals="-9" name="gsk:AmountHeldAtEuropeanMediumTermNoteProgramme" scale="9" id="f-4862">20</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Euro Medium Term Note programme and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 390.33000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1366" decimals="-8" name="gsk:NotesIssuedAtEuropeanMediumTermNoteProgramme" scale="9" id="f-4863">9.2</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of notes were in issue under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this programme. The Group also had <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 444.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1366" decimals="-8" name="gsk:NotesIssuedUnderUsShelfRegistration" scale="9" id="f-4864">7.5</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 484.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1366" decimals="-8" name="gsk:NotesIssuedUnderUsShelfRegistration" format="ixt:num-dot-decimal" scale="9" id="f-4865">5.9</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 529.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of notes in issue at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 448.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> under a US shelf <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">registration. GSK&#8217;s borrowings mature at dates between <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 515.27pt; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 534.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.16pt; position: var(--position); text-decoration: none; white-space: pre;">2045<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The put option owned by Pfizer in ViiV Healthcare is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercisable. In reviewing liquidity requirements GSK considers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that sufficient financing options are available should the put <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">option be exercised.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 449.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Market risk<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 465.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate risk management<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s objective is to minimise the effective net interest cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and to balance the mix of debt at fixed and floating rates over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s main interest rate risk arises from borrowings and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments with floating rates and refinancing of maturing fixed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 536.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate debt where any changes in interest rates will affect future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 546.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows or the fair values of financial instruments. The policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 556.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on interest rate risk management limits the net amount of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 566.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">floating rate debt to a specific cap, reviewed and agreed no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 576.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">less than annually by the Board.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The majority of debt is issued at fixed interest rates and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 602.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in the floating rates of interest do not significantly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 613.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect the Group&#8217;s net interest charge. Short-term borrowings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 623.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including bank facilities are exposed to the risk of future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 633.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in market interest rates as are the majority of cash and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 643.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liquid investments.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">246<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-2" continuedAt="f-4827-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 142.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange risk management <span style="display: inline-block; height: 6.55pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35514"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s objective is to minimise the exposure of overseas <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operating subsidiaries to transaction risk by matching local <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency income with local currency costs where possible. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign currency transaction exposures arising on external and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal trade flows are selectively hedged. GSK&#8217;s internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trading transactions are matched centrally and inter-company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payment terms are managed to reduce foreign currency risk. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where possible, GSK manages the cash surpluses or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 237.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">borrowing requirements of subsidiary companies centrally using <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forward contracts to hedge future repayments back into the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">originating currency. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In order to reduce foreign currency translation exposure, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group seeks to denominate borrowings in the currencies of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principal assets and cash flows. These are primarily <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">denominated in US Dollars, Euros and Sterling. Borrowings can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be swapped into other currencies as required. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings denominated in, or swapped into, foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies that match investments in overseas Group assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may be treated as a hedge against the relevant assets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Forward contracts in major currencies are also used to reduce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exposure to the Group&#8217;s investment in overseas assets (see <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Net investment hedges&#8217; section of this note for further details).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 397.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Credit risk<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Credit risk is the risk that a counterparty will default on its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contractual obligations resulting in financial loss to the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and arises on cash and cash equivalents and favourable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">derivative financial instruments held with banks and financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">institutions as well as credit exposures to wholesale and retail <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customers, including outstanding receivables.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group considers its maximum credit risk at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 482.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to be <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="ifrs-full:MaximumExposureToCreditRisk" format="ixt:num-dot-decimal" scale="6" id="f-4866">9,986</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.32000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 479.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="ifrs-full:MaximumExposureToCreditRisk" format="ixt:num-dot-decimal" scale="6" id="f-4867">9,528</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 531.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which is the total of the Group&#8217;s financial assets with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exception of &#8217;Other investments&#8217; (comprising equity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments) which bear equity risk rather than credit risk. See <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35430">249</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for details on the Group&#8217;s total financial assets. At <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK&#8217;s greatest concentration of credit risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 322.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1374" decimals="-8" name="gsk:CreditExposure1" scale="9" id="f-4868">1.1</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with a wholesaler in the US (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 489.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 494.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1375" decimals="-8" name="gsk:CreditExposure1" scale="9" id="f-4869">1.2</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 534.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with a wholesaler in the US). See page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 451.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35407">247</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 465.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information on the Group&#8217;s credit risk exposure in respect of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="wholesalers" contextRef="c-9" decimals="0" name="gsk:NumberOfLargestUSWholesalers" format="ixt-sec:numwordsen" scale="0" id="f-4870">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 323.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> largest US wholesaler customers. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 263.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There has been no change in the estimation techniques or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant assumptions made during the current and prior <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting periods in assessing the loss allowance for financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets at amortised cost or at FVTOCI.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Treasury-related credit risk<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK sets global counterparty limits for each of GSK&#8217;s banking <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and investment counterparties based on long-term credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ratings from Moody&#8217;s and Standard &amp; Poor&#8217;s. Usage of these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">limits is actively monitored.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK actively manages its exposure to credit risk, reducing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">surplus cash balances wherever possible. This is part of GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 389.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy to regionalise cash management and to concentrate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 400.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash centrally as much as possible. The table below sets out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the credit exposure to counterparties by rating for liquid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investments, cash and cash equivalents and derivatives. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The gross asset position on each derivative contract is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 446.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered for the purpose of this table, although, under ISDA <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 456.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreements, the amount at risk is the net position with each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">counterparty. Table (e) on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35390">257</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sets out the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 477.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial assets and liabilities on an offset basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">247<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-3" continuedAt="f-4827-4"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35486"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 183.73000000000002pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 130.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 140.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1376" decimals="-6" name="gsk:CashHeldAtUnratedOrSubInvestmentRatedCounterparties" scale="6" id="f-4871">24</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 185.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.27999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1377" decimals="-6" name="gsk:CashHeldAtUnratedOrSubInvestmentRatedCounterparties" scale="6" id="f-4872">44</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of cash is categorised as held with unrated or sub-investment grade rated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 141.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">counterparties (lower than BBB-/Baa3). This exposure is concentrated in overseas banks used for local cash management or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment purposes, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">includin<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">g: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 173.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1378" decimals="-6" name="gsk:CashHeldAtUnratedOrSubInvestmentRatedCounterparties" scale="6" id="f-4873">14</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 213.98000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with Halk Bank in the UK; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1379" decimals="-6" name="gsk:CashHeldAtUnratedOrSubInvestmentRatedCounterparties" scale="6" id="f-4874">5</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 348.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in Honduras held with Banco de America Central <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Banco de Honduras; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1380" decimals="-6" name="gsk:CashHeldAtUnratedOrSubInvestmentRatedCounterparties" scale="6" id="f-4875">1</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in Ecuador held with Banco De La Produccion; and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1381" decimals="-6" name="gsk:CashHeldAtUnratedOrSubInvestmentRatedCounterparties" scale="6" id="f-4876">1</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in Brazil held with Banco <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bradesco,&#160; Itau Unibanco, Banco Do Brasil and Caixa Ecomonica Federal. Of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4877">80</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4878">55</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of bank balances <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and deposits held with BBB/Baa rated counterparties, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 255.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1384" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4879">41</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 295.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was held with BBB-/Baa3 rated counterparties, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balances or deposits of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 142.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1385" decimals="-6" name="ifrs-full:BalancesWithBanks" scale="6" id="f-4880">33</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Banca Popolare Di Sondrio in the UK; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1386" decimals="-6" name="ifrs-full:BalancesWithBanks" scale="6" id="f-4881">5</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 380.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with OTP Bank in Russia; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 480.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1387" decimals="-6" name="ifrs-full:BalancesWithBanks" scale="6" id="f-4882">2</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 515.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">State Bank of India in India and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 172.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1388" decimals="-6" name="ifrs-full:BalancesWithBanks" scale="6" id="f-4883">1</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.31pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with Banco De Credito Del Peru in Peru. These banks are used for local investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purposes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK measures expected credit losses over cash and cash equivalents as a function of individual counterparty credit ratings and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">associated 12 month default rates. Expected credit losses over cash and cash equivalents and third-party financial derivatives are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deemed to be immaterial and no such loss has been experienced during <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 324.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 343.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Credit ratings are assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s respectively. Where the opinions of the two rating agencies differ, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK assigns the lower rating of the two to the counterparty. Where local rating agency or Fitch data is the only source available, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the ratings are converted to global ratings equivalent to those of Standard &amp; Poor&#8217;s or Moody&#8217;s using published conversion tables. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These credit ratings form the basis of the assessment of the expected credit loss on Treasury-related balances held at amortised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 305.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost being bank balances and deposits and Government securities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 321.45pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCreditRiskExposureExplanatory" id="f-4884" continuedAt="f-4884-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 217.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 217.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AAA/Aaa<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AA/Aa<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A/A<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BBB/Baa<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BB+/Ba1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.020000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and below<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">/unrated <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bank balances and deposits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1389" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" format="ixt:fixed-zero" scale="6" id="f-4885">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1390" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4886">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1391" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" format="ixt:num-dot-decimal" scale="6" id="f-4887">2,450</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4888">80</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1392" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4889">24</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" format="ixt:num-dot-decimal" scale="6" id="f-4890">2,590</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US Treasury and Treasury repo only money market funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1389" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" scale="6" id="f-4891">300</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1390" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4892">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1391" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4893">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4894">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1392" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4895">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" scale="6" id="f-4896">300</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquidity funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1389" decimals="-6" name="gsk:LiquidityFunds" scale="6" id="f-4897">980</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1390" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4898">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1391" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4899">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4900">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1392" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4901">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="gsk:LiquidityFunds" scale="6" id="f-4902">980</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 69.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Government securities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1389" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4903">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1390" decimals="-6" name="gsk:GovernmentSecurities" scale="6" id="f-4904">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1391" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4905">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4906">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1392" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4907">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="gsk:GovernmentSecurities" scale="6" id="f-4908">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Third-party financial derivatives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1389" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4909">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1390" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4910">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1391" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="f-4911">110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4912">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1392" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4913">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="f-4914">110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1389" decimals="-6" name="gsk:RatedCreditExposures1" format="ixt:num-dot-decimal" scale="6" id="f-4915">1,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1390" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4916">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1391" decimals="-6" name="gsk:RatedCreditExposures1" format="ixt:num-dot-decimal" scale="6" id="f-4917">2,560</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1382" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4918">80</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1392" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4919">24</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1372" decimals="-6" name="gsk:RatedCreditExposures1" format="ixt:num-dot-decimal" scale="6" id="f-4920">4,001</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-4884-1"><div style="position: var(--position); top: 437.89pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 217.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 25.22pt; width: 217.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AAA/Aaa<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AA/Aa<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A/A<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BBB/Baa<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BB+/Ba1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.020000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and below<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">/unrated <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bank balances and deposits<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1393" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" format="ixt:fixed-zero" scale="6" id="f-4921">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1394" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4922">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1395" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" format="ixt:num-dot-decimal" scale="6" id="f-4923">1,815</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4924">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1396" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" scale="6" id="f-4925">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="gsk:BankBalancesAndDepositHeldWithCounterparties" format="ixt:num-dot-decimal" scale="6" id="f-4926">1,942</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US Treasury and Treasury repo only money market funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1393" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" scale="6" id="f-4927">155</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1394" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4928">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1395" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4929">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4930">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1396" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" format="ixt:fixed-zero" scale="6" id="f-4931">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="gsk:UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" scale="6" id="f-4932">155</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquidity funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1393" decimals="-6" name="gsk:LiquidityFunds" scale="6" id="f-4933">839</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1394" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4934">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1395" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4935">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4936">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1396" decimals="-6" name="gsk:LiquidityFunds" format="ixt:fixed-zero" scale="6" id="f-4937">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="gsk:LiquidityFunds" scale="6" id="f-4938">839</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 69.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Government securities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1393" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4939">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1394" decimals="-6" name="gsk:GovernmentSecurities" scale="6" id="f-4940">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1395" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4941">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4942">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1396" decimals="-6" name="gsk:GovernmentSecurities" format="ixt:fixed-zero" scale="6" id="f-4943">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 69.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="gsk:GovernmentSecurities" scale="6" id="f-4944">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Third-party financial derivatives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1393" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4945">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1394" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4946">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1395" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="f-4947">130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4948">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1396" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-4949">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 81.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="f-4950">130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 217.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 217.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1393" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4951">994</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 262.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1394" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4952">70</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1395" decimals="-6" name="gsk:RatedCreditExposures1" format="ixt:num-dot-decimal" scale="6" id="f-4953">1,945</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1383" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4954">55</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1396" decimals="-6" name="gsk:RatedCreditExposures1" scale="6" id="f-4955">44</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 93.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1373" decimals="-6" name="gsk:RatedCreditExposures1" format="ixt:num-dot-decimal" scale="6" id="f-4956">3,108</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 554.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s centrally managed cash reserves amounted to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.64999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1366" decimals="-8" name="gsk:CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" scale="9" id="f-4957">3.1</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1367" decimals="-8" name="gsk:CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" scale="9" id="f-4958">2.2</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 158.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 229.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, all available <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within three months. This includes <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.54000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1397" decimals="-8" name="gsk:CashManagedForSubsidiaryCompany" scale="9" id="f-4959">1.9</ix:nonFraction> billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 251.08999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1398" decimals="-8" name="gsk:CashManagedForSubsidiaryCompany" scale="9" id="f-4960">2.0</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of cash managed by the Group for ViiV Healthcare, a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1399" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-4961">78.3</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1400" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-4962">78.3</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 130.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) owned subsidiary. The Group has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 605.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invested centrally managed liquid assets in bank deposits, Aaa/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AAA rated US Treasury and Treasury repo only money market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">funds and Aaa/AAA rated liquidity funds.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 641.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Wholesale and retail credit risk<span style="display: inline-block; height: 6.55pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35407"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 655.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Outside the US, no customer accounts for more than <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 252.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1401" decimals="2" name="gsk:PercentageOfAccountsReceivableByMajorCustomer" scale="-2" id="f-4963">5</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 665.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s trade receivables balance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 681.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the US, in line with other pharmaceutical companies, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group sells its products through a small number of wholesalers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 701.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in addition to hospitals, pharmacies, physicians and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 711.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">groups. Sales to the three largest wholesalers amounted to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 722pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.50999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1402" decimals="2" name="gsk:ConcentrationsOfRiskRevenuePercentage" scale="-2" id="f-4964">77</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 130.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 149.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1403" decimals="2" name="gsk:ConcentrationsOfRiskRevenuePercentage" scale="-2" id="f-4965">79</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 170.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of the sales of the US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 732.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial Operations business in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 188.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 207.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 748.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had trade receivables due <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 758.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from these <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 95.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="wholesalers" contextRef="c-9" decimals="0" name="gsk:NumberOfLargestUSWholesalers" format="ixt-sec:numwordsen" scale="0" id="f-4966">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> wholesalers totalling <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.26999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1404" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:num-dot-decimal" scale="6" id="f-4967">2,766</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1405" decimals="2" name="gsk:PercentageOfAccountsReceivableByMajorCustomer" scale="-2" id="f-4968">50</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 768.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total trade receivables (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 159.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 164.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1406" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:num-dot-decimal" scale="6" id="f-4969">3,319</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 216.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1407" decimals="2" name="gsk:PercentageOfAccountsReceivableByMajorCustomer" scale="-2" id="f-4970">56</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 245.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 778.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group is exposed to a concentration of credit risk in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 788.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">these wholesalers such that, if one or more of them encounters <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 554.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial difficulty, it could materially and adversely affect the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s financial results.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This concentration of trade receivables is reflective of standard <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market practice in the US pharmaceuticals sector where a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant portion of sales are made to these <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 473.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="wholesalers" contextRef="c-9" decimals="0" name="gsk:NumberOfLargestUSWholesalers" format="ixt-sec:numwordsen" scale="0" id="f-4971">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 492.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wholesalers, as disclosed in Note 6 'Turnover and segment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information'. GSK&#8217;s assessment is that there is limited credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk associated with these customers.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s credit risk monitoring activities relating to these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wholesalers include a review of their quarterly financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information and Standard &amp; Poor&#8217;s credit ratings, development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of GSK internal risk ratings, and establishment and periodic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review of credit limits. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 704pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All new customers are subject to a credit vetting process and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 714.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing customers will be subject to a review at least annually. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 724.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The vetting process and subsequent reviews involve obtaining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 734.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information including the customer&#8217;s status as a government or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 744.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">private sector entity, audited financial statements, credit bureau <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 755pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports, debt rating agency (e.g. Moody&#8217;s, Standard &amp; Poor&#8217;s) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 765.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports, payment performance history (from trade references, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 775.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry credit groups) and bank references. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">248<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-4" continuedAt="f-4827-5"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables consist of amounts due from a large number <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of customers, spread across diverse industries and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">geographical areas. Ongoing credit evaluation is performed on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the financial condition of accounts receivable and, where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate, credit insurance is purchased or factoring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements put in place. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The amount of information obtained is proportional to the level <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of exposure being considered. The information is evaluated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quantitatively (i.e. credit score) and qualitatively (i.e. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgement) in conjunction with the customer&#8217;s credit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements to determine a credit limit.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables are grouped into customer segments that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have similar loss patterns to assess credit risk while other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receivables and other financial assets are assessed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individually. Historical and forward-looking information is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considered to determine the appropriate expected credit loss <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The<span style="display: inline-block; height: 6.18pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35493"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Group believes there is no further credit risk provision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required in excess of the allowance for expected credit losses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(see Note 26, &#8216;Trade and other receivables&#8217;). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 371.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Credit enhancements<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group uses credit enhancements including factoring, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">letters of credit and credit insurance to minimise the credit risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 405.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the trade receivables in the Group. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 275.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1408" decimals="-6" name="ifrs-full:TradeReceivables" scale="6" id="f-4972">307</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1409" decimals="-6" name="ifrs-full:TradeReceivables" scale="6" id="f-4973">421</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of trade receivables were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 426.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insured in order to protect the receivables from loss due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 436.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credit risks such as default, insolvency and bankruptcy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each Group entity assesses the credit risk of its private <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">customers to determine if credit insurance is required. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Factoring arrangements are managed locally by entities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are used to mitigate risk arising from large credit risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concentrations. All factoring arrangements are non-recourse. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 514.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of financial assets and liabilities <span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35434"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 527.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">excluding lease liabilities<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.92999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4ea37a9ed3204b4998a3aab279ebc6c3_3-0-1-1-821446">249</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> presents the carrying amounts and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair values of the Group&#8217;s financial assets and liabilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">excluding lease liabilities at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.42999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair values of the financial assets and liabilities are included <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at the price that would be received to sell an asset or paid to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 610.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfer a liability in an orderly transaction between market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">participants at the measurement date.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following methods and assumptions are used to measure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 150.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the fair values of significant financial instruments carried at fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value on the balance sheet:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments &#8211; equity investments traded in an active <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 186.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market determined by reference to the relevant stock <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange quoted bid price; other equity investments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determined by reference to the current market value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">similar instruments, recent financing rounds or the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discounted cash flows of the underlying net assets<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade receivables carried at fair value &#8211; based on invoiced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 259.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate swaps, foreign exchange forward contracts, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">swaps and options &#8211; based on the present value of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contractual cash &#64258;ows or option valuation models using <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market sourced data (for example exchange rates or interest <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates) at the balance sheet date<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash equivalents carried at fair value &#8211; based on net asset <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 322.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of the funds<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration for business acquisitions and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">divestments &#8211; based on present values of expected future <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following methods and assumptions are used to estimate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the fair values of significant financial instruments which are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 389.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at fair value on the balance sheet:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 405.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Receivables and payables, including put options, carried at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amortised cost &#8211; approximates to the carrying amount<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments &#8211; approximates to the carrying amount<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents carried at amortised cost &#8211; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximates to the carrying amount<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 459.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-term loans &#8211; based on quoted market prices (a level 1 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value measurement) in the case of European and US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medium Term Notes; approximates to the carrying amount in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the case of&#8200;other fixed rate borrowings and floating rate bank <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loans<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term loans, overdrafts and commercial paper &#8211; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximates to the carrying amount because of the short <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">maturity of these instruments.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">249<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-5" continuedAt="f-4827-6"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35430"></span></span></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" id="f-4974" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 252.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.56pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.36pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.16pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><span id="i4ea37a9ed3204b4998a3aab279ebc6c3_3-0-1-1-821446"></span><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets measured at amortised cost:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">b<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1410" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4975">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1410" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-4976">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1411" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4977">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1411" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-4978">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 75.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">b<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 75.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1412" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-4979">3,733</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 75.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1412" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4980">3,733</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 75.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1413" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-4981">3,829</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 75.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1413" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4982">3,829</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liquid investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1414" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4983">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1414" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-4984">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1415" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4985">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 87.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1415" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-4986">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 99.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1416" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-4987">2,590</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 99.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1416" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4988">2,590</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 99.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1417" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-4989">1,942</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 99.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1417" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4990">1,942</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 123.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets measured at fair value through other comprehensive<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; income (FVTOCI):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments designated at FVTOCI<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1418" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4991">843</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1418" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-4992">843</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1419" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4993">931</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1419" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-4994">931</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,b<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1420" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-4995">2,163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1420" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4996">2,163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1421" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-4997">2,541</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1421" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4998">2,541</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets mandatorily measured at fair value through profit or loss<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (FVTPL):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 200.25pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments and other investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1422" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-4999">257</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1422" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5000">257</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1423" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5001">2,410</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1423" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5002">2,410</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 212.25pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,b<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1424" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5003">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1424" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5004">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1425" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5005">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1425" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5006">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 224.25pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 224.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,b<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 224.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1426" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5007">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 224.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1426" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5008">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 224.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1427" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5009">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 224.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1427" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5010">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for trading derivatives that are not in a designated and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; effective hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 236.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,d,e<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 236.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1428" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5011">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 236.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1428" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5012">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 236.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1429" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5013">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 236.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1429" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5014">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 256.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 256.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1430" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5015">1,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 256.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1430" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5016">1,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 256.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1431" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5017">994</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 256.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1431" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5018">994</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 280.5pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments (fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; movements through other comprehensive income)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 280.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,d,e<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 280.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1432" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5019">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 280.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1432" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5020">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 280.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1433" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5021">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 280.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1433" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5022">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 300.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 300.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5023">11,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 300.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5024">11,086</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 300.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5025">12,869</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 300.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5026">12,869</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities measured at amortised cost:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 336.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings excluding obligations under lease liabilities:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; bonds in a designated hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 348.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">d<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 348.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1434" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:num-dot-decimal" scale="6" id="f-5027">5,346</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 348.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1434" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5028">5,278</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 348.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1435" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:num-dot-decimal" scale="6" id="f-5029">5,348</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 348.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1435" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5030">5,233</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 360.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; other bonds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 360.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1436" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:num-dot-decimal" scale="6" id="f-5031">9,774</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 360.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1436" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5032">9,597</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 360.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1437" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:num-dot-decimal" scale="6" id="f-5033">10,456</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 360.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1437" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5034">10,762</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 372.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; bank loans and overdrafts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 372.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1438" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" scale="6" id="f-5035">762</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 372.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1438" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" scale="6" id="f-5036">762</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 372.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1439" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" scale="6" id="f-5037">191</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 372.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1439" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" scale="6" id="f-5038">191</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 384.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; commercial paper in a designated hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 384.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1440" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:fixed-zero" scale="6" id="f-5039">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 384.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1440" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5040">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 384.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1441" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" scale="6" id="f-5041">148</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 384.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1441" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" scale="6" id="f-5042">148</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 396.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; other commercial paper<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 396.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1442" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:fixed-zero" scale="6" id="f-5043">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 396.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1442" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5044">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 396.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1443" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" scale="6" id="f-5045">667</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 396.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1443" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" scale="6" id="f-5046">667</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 408.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;&#160; other borrowings<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 408.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1444" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" scale="6" id="f-5047">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 408.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1444" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" scale="6" id="f-5048">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 408.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1445" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" scale="6" id="f-5049">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 408.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1445" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" scale="6" id="f-5050">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 420.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total borrowings excluding lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 40.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">f<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1446" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:num-dot-decimal" scale="6" id="f-5051">15,884</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1446" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5052">15,639</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1447" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLease" format="ixt:num-dot-decimal" scale="6" id="f-5053">16,811</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 420.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1447" decimals="-6" name="gsk:BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5054">17,002</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 432.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 432.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 432.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1448" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5055">13,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 432.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1448" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5056">13,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 432.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1449" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5057">13,383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 432.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1449" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5058">13,383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 444.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other provisions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 444.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 444.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1450" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5059">182</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 444.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1450" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5060">182</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 444.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1451" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5061">199</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 444.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1451" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5062">199</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 456.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 456.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 456.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1452" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5063">46</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 456.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1452" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5064">46</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 456.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1453" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5065">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 456.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1453" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5066">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 492.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities mandatorily measured at fair value through profit or loss <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 15.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(FVTPL):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 516.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 516.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,c<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 516.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1454" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5067">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 516.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1454" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5068">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 516.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1455" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5069">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 516.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1455" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5070">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 528.75pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for trading derivatives that are not in a designated and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; effective hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 528.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,d,e<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 528.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1456" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5071">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 528.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1456" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5072">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 528.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1457" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5073">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 528.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1457" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5074">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 561pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments (fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; movements through other comprehensive income)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 252.75pt; position: var(--position); top: 561pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a,d,e<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 561pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1432" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5075">157</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 561pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1432" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5076">157</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 561pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1433" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="f-5077">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 561pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1433" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5078">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 581.25pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total financial liabilities excluding lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 581.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5079">36,744</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 581.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5080">36,499</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 581.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5081">37,223</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 581.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5082">37,414</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 605.25pt; width: 252.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 252.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net financial assets and financial liabilities excluding lease liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 605.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" sign="-" name="gsk:NetFinancialAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5083">25,658</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 605.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" sign="-" name="gsk:NetFinancialAssetsLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5084">25,413</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 605.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="gsk:NetFinancialAssetsLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5085">24,354</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 605.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 13.95pt;"></span></span><span style="left: 16.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" sign="-" name="gsk:NetFinancialAssetsLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5086">24,545</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 757.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The valuation methodology used to measure fair value in the above table is described and categorised on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35434">248</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 773.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables, Other non-current assets, Trade and other payables, Other provisions, Contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 783.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities and Other non-current liabilities are reconciled to the relevant Notes on pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35458">251</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35441">252</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">250<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-6" continuedAt="f-4827-7"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fair value of investments in GSK shares<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Employee Share Ownership Plan (ESOP) Trusts held GSK shares with a carrying amount of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" scale="6" id="f-5087">397</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" scale="6" id="f-5088">288</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 150.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and a market value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" scale="6" id="f-5089">866</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 283.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 289.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" scale="6" id="f-5090">853</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) based on quoted market price. The shares are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held by the ESOP Trusts to satisfy future exercises of options and awards under employee incentive schemes. In <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 475.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 494.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carrying amount, which is the lower of cost or expected proceeds, of these shares has been recognised as a deduction from other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 100.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 172.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, GSK held Treasury shares at a cost of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:TreasuryShares" format="ixt:num-dot-decimal" scale="6" id="f-5091">2,958</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:TreasuryShares" format="ixt:num-dot-decimal" scale="6" id="f-5092">3,447</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) which has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deducted from retained earnings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 212.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(a) <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 70.02pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial instruments held at fair value<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following tables categorise the Group&#8217;s financial assets and liabilities held at fair value by the valuation methodology applied in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">determining their fair value. Where possible, quoted prices in active markets are used (Level 1). Where such prices are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available, the asset or liability is classified as Level 2, provided all significant inputs to the valuation model used are based on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">observable market data. If one or more of the significant inputs to the valuation model is not based on observable market data, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instrument is classified as Level 3. Other investments classified as Level 3 in the tables below comprise equity investments in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unlisted entities with which the Group has entered into research collaborations and investments which provide access to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biotechnology developments of potential interest.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 305.04pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueMeasurementExplanatory" id="f-5093" continuedAt="f-5093-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 328.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 328.5pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 328.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 263.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 271.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level 1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level 2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level 3<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets at fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets measured at fair value through other comprehensive income (FVTOCI):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments designated at FVTOCI<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1458" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5094">646</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1459" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5095">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1460" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5096">197</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1461" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5097">843</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1462" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5098">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1463" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5099">2,163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1464" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5100">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1465" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5101">2,163</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets mandatorily measured at fair value through profit or loss (FVTPL):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments and other investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1466" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5102">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1467" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5103">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1468" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5104">257</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1469" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5105">257</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1470" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5106">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1471" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5107">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1472" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5108">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1473" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5109">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1474" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5110">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1475" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5111">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1476" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5112">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1477" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5113">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for trading derivatives that are not in a designated and effective hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1478" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5114">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1479" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5115">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1480" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5116">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1481" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5117">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1482" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5118">1,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1483" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5119">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1484" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5120">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1485" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5121">1,280</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments (fair value movements through OCI)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1486" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5122">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1487" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5123">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1488" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5124">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1489" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5125">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1490" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5126">1,926</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1491" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5127">2,324</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1492" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5128">487</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1493" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5129">4,737</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities at fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities mandatorily measured at fair value through profit or loss (FVTPL):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1494" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5130">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.4pt;"></span></span><span style="left: 32.03pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1495" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5131">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.01pt;"></span></span><span style="left: 12.64pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1496" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5132">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.01pt;"></span></span><span style="left: 12.64pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1497" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5133">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for trading derivatives that are not in a designated and effective hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1498" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5134">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.34pt;"></span></span><span style="left: 22.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1499" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5135">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.4pt;"></span></span><span style="left: 32.03pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1500" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5136">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.34pt;"></span></span><span style="left: 22.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1501" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5137">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments (fair value movements through OCI)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1502" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5138">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1503" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5139">157</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.4pt;"></span></span><span style="left: 32.03pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1504" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5140">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1505" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5141">157</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1490" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5142">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.2pt;"></span></span><span style="left: 18.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1491" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5143">192</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.01pt;"></span></span><span style="left: 12.64pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1492" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5144">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.01pt;"></span></span><span style="left: 12.64pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1493" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5145">7,472</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5093-1" continuedAt="f-5093-2"><div style="position: var(--position); top: 549.73pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 328.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 328.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 9.47pt; width: 328.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level 1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level 2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level 3<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets at fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 18pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 37.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets measured at fair value through other comprehensive income (FVTOCI):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other investments designated at FVTOCI<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1506" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5146">741</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1507" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5147">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1508" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5148">190</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 42pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1509" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5149">931</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1510" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5150">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1511" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5151">2,541</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1512" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5152">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.93pt;"></span></span><span style="left: 17.56pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1513" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5153">2,541</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets mandatorily measured at fair value through profit or loss (FVTPL):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 78pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current equity investments and other investments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1514" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5154">2,204</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1515" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5155">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1516" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5156">206</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 78pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.93pt;"></span></span><span style="left: 17.56pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1517" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5157">2,410</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 90pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1518" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5158">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1519" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5159">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1520" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5160">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 90pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1521" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5161">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 102pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1522" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5162">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1523" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5163">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1524" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5164">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 102pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1525" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5165">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 114pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for trading derivatives that are not in a designated and effective hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1526" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5166">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1527" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5167">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1528" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5168">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1529" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5169">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 126pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash and cash equivalents<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1530" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5170">994</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1531" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5171">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1532" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5172">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 126pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.12pt;"></span></span><span style="left: 23.75pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1533" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5173">994</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments (fair value movements through OCI)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1534" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5174">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.63pt;"></span></span><span style="left: 28.259999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1535" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5175">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1536" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5176">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 138pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.26pt;"></span></span><span style="left: 27.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1537" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5177">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1538" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5178">3,939</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 15.3pt;"></span></span><span style="left: 17.93pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1539" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5179">2,694</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.49pt;"></span></span><span style="left: 24.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1540" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" scale="6" id="f-5180">414</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 150pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.93pt;"></span></span><span style="left: 17.56pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1541" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5181">7,047</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities at fair value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 174pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities mandatorily measured at fair value through profit or loss (FVTPL):<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 186pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1542" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5182">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1543" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5183">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1544" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5184">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 186pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1545" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5185">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 198pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 5.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held for trading derivatives that are not in a designated and effective hedging relationship<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1546" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5186">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1547" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5187">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1548" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5188">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 198pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1549" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5189">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 328.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 328.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments (fair value movements through OCI)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1550" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5190">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1551" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5191">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1552" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5192">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 210pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.17pt;"></span></span><span style="left: 25.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1553" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5193">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.77pt;"></span></span><span style="left: 32.4pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1538" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5194">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 368.25pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.03pt;"></span></span><span style="left: 21.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1539" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-5195">114</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 408pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1540" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5196">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 222pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.84pt;"></span></span><span style="left: 15.469999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1541" decimals="-6" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5197">6,776</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">251<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-7" continuedAt="f-4827-8"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 130.98pt; width: 595.44pt;"><ix:continuation id="f-5093-2" continuedAt="f-5093-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movements in the year for financial instruments measured using Level 3 valuation methods are presented below:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation></div><ix:continuation id="f-5093-3"><div style="position: var(--position); top: 146.87pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.61pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1554" decimals="-6" sign="-" name="gsk:FinancialAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5198">6,248</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1555" decimals="-6" sign="-" name="gsk:FinancialAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5199">6,411</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange adjustments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" sign="-" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" scale="6" id="f-5200">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" format="ixt:fixed-zero" scale="6" id="f-5201">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net losses recognised in the income statement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" name="gsk:GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5202">1,733</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 42pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" scale="6" id="f-5203">863</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net losses recognised in other comprehensive income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" sign="-" name="gsk:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" scale="6" id="f-5204">42</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 54pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" sign="-" name="gsk:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" scale="6" id="f-5205">142</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration related to business acquisitions in the period<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.28pt;"></span></span><span style="left: 26.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="f-5206">104</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 66pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" format="ixt:fixed-zero" scale="6" id="f-5207">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlement of contingent consideration liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" name="gsk:PaymentOfContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5208">1,254</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 78pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:PaymentOfContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5209">1,145</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additions<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" sign="-" name="gsk:AdditionsFairValueMeasurementAssetsAndLiabilities" scale="6" id="f-5210">111</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 90pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" sign="-" name="gsk:AdditionsFairValueMeasurementAssetsAndLiabilities" scale="6" id="f-5211">57</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals and settlements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" name="gsk:DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" scale="6" id="f-5212">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" scale="6" id="f-5213">25</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transfers from Level 3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" name="gsk:TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" format="ixt:fixed-zero" scale="6" id="f-5214">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 114pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" scale="6" id="f-5215">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1558" decimals="-6" sign="-" name="gsk:FinancialAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5216">6,793</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.09pt;"></span></span><span style="left: 20.72pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1554" decimals="-6" sign="-" name="gsk:FinancialAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5217">6,248</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Of the total net losses of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 146.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" name="gsk:GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" format="ixt:num-dot-decimal" scale="6" id="f-5218">1,733</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 226.97000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" scale="6" id="f-5219">863</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 271.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) attributable to Level 3 financial instruments which were recognised in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the income statemen<span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">t, </span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1556" decimals="-6" name="gsk:LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5220">1,733</ix:nonFraction> million</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 190.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-6" name="gsk:LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" scale="6" id="f-5221">857</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) were in respect of financial instruments which were held at the end of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 310.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">year and were reported in Other operating income/expense. Charges of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1559" decimals="-6" name="gsk:RemeasurementGainLossOfTheContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="f-5222">1,533</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 397.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1560" decimals="-6" name="gsk:RemeasurementGainLossOfTheContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="f-5223">934</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 447.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) arose from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remeasurement of the contingent consideration payable for the acquisition of the former Shionogi-ViiV Healthcare joint venture. A <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remeasurement <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charge<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 140.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 152.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1561" decimals="-6" sign="-" name="gsk:RemeasurementGainLossOfTheContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="f-5224">215</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1562" decimals="-6" name="gsk:RemeasurementGainLossOfTheContingentConsiderationPayable" scale="6" id="f-5225">210</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 270.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> gain) arose from remeasurement of the contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable for the acquisition of the Novartis Vaccines business. A gain<span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of </span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 318.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1563" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5226">22</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> (2023: </span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.96000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1564" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5227">44</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> charge</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">) arose</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 481.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remeasurement of the Affinivax contingent consideration liability for the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration payable for the acquisition of Aiolos, amounting to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1095" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5228">96</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, was recognised during the year. Further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information on the Aiolos acquisition is provided in Note 41, &#8216;Acquisitions and disposals&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There were transfers of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1565" decimals="-6" name="ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyLiabilities" format="ixt:fixed-zero" scale="6" id="f-5229">nil</ix:nonFraction></span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 156.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> out of Level 3 financial instruments in the year (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1566" decimals="-6" name="ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5230">9</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 393.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> out of Level 3 financial instruments). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Movements arising on the translation of overseas net assets for consolidation into the Group accounts are recorded as exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustments. Net gains and losses include the impact of other exchange movements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 429.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities measured using Level 3 valuation methods at 31 December included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 381.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1567" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-5231">6,061</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 457.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1568" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-5232">5,718</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 513.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 439.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of contingent consideration payable for the acquisition in 2012 of the former Shionogi-ViiV Healthcare joint venture. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 449.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration is expected to be paid over a number of years and will vary in line with the future performance of specified products <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and movements in certain foreign currencies. A further <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1569" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-5233">575</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 302.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1570" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-5234">424</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is in respect of contingent consideration for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the acquisition in 2015 of the Novartis Vaccines business. This consideration is expected to be paid over a number of years and will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 480.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vary in line with the future performance of specified products, the achievement of certain milestone targets and movements in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 490.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain foreign currencies. Contingent consideration payable for the acquisition of Affinivax in 2022 of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1571" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="f-5235">502</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 503.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1572" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="f-5236">516</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) is recognised at 31 December. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> consideration is expected to be paid over a number of years and will vary in line with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the achievement of certain development milestones and movements in the USD/GBP exchange rate. Sensitivity analysis on these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balances is provided in Note 33, &#8216;Contingent consideration liabilities&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 553pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(b) <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 70.62pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35458"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 214.39pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> and Other non-current assets in scope of IFRS 9<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table reconciles financial instruments within Trade and other receivables and Other non-current assets which fall <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within the scope of IFRS 9 to the relevant balance sheet amounts. The financial assets are predominantly non-interest earning. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-financial instruments include tax receivables, amounts receivable under insurance contracts, pension surplus balances and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prepayments, which are outside the scope of IFRS 9.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 615.38pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" id="f-5237" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 89.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 24.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 29.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 24.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 0pt; width: 108.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 108.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 0pt; width: 109.5pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 109.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 92.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 36pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 89.25pt; position: var(--position); top: 12pt; width: 24.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 12pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTOCI<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 12pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortised<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.01pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 12pt; width: 29.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 12pt; width: 24.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 12pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FVTOCI <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 12pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortised<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.01pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.81pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 457.5pt; position: var(--position); top: 12pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 20.61pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 28.41pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; receivables (Note 26)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 89.25pt; position: var(--position); top: 48pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.18pt;"></span></span><span style="left: 12.809999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1573" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-5238">53</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 48pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1574" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5239">2,163</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 48pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.26pt;"></span></span><span style="left: 12.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1575" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5240">3,733</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 48pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1576" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5241">5,949</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 48pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.01pt;"></span></span><span style="left: 23.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1577" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-5242">887</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 48pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 4.26pt;"></span></span><span style="left: 6.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1578" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5243">6,836</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 48pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.18pt;"></span></span><span style="left: 12.809999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1579" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-5244">23</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 48pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1580" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5245">2,541</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 48pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.26pt;"></span></span><span style="left: 12.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1581" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5246">3,829</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 48pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1582" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5247">6,393</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 48pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.01pt;"></span></span><span style="left: 23.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1583" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-5248">992</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 457.5pt; position: var(--position); top: 48pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1584" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5249">7,385</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 89.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current assets <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 89.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (Note 24)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 89.25pt; position: var(--position); top: 68.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.18pt;"></span></span><span style="left: 12.809999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1573" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" scale="6" id="f-5250">31</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 68.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.6pt;"></span></span><span style="left: 22.23pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1574" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:fixed-zero" scale="6" id="f-5251">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 68.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1575" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" scale="6" id="f-5252">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.18pt;"></span></span><span style="left: 27.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1576" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" scale="6" id="f-5253">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1577" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-5254">1,906</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 68.25pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 4.26pt;"></span></span><span style="left: 6.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1578" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-5255">1,942</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 68.25pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.18pt;"></span></span><span style="left: 12.809999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1585" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" scale="6" id="f-5256">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 68.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.6pt;"></span></span><span style="left: 22.23pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1580" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:fixed-zero" scale="6" id="f-5257">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 68.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.85pt;"></span></span><span style="left: 27.48pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1581" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" scale="6" id="f-5258">9</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.18pt;"></span></span><span style="left: 27.81pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1582" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" scale="6" id="f-5259">27</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 68.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1583" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-5260">1,557</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 457.5pt; position: var(--position); top: 68.25pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1584" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-5261">1,584</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 89.25pt; position: var(--position); top: 88.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.18pt;"></span></span><span style="left: 12.809999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1573" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5262">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 114pt; position: var(--position); top: 88.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1574" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5263">2,163</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 88.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.26pt;"></span></span><span style="left: 12.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1575" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5264">3,738</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 179.25pt; position: var(--position); top: 88.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1576" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5265">5,985</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 219pt; position: var(--position); top: 88.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1577" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5266">2,793</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 88.5pt; width: 29.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 29.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 4.26pt;"></span></span><span style="left: 6.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1578" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5267">8,778</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288pt; position: var(--position); top: 88.5pt; width: 24.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 24.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.18pt;"></span></span><span style="left: 12.809999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1585" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="f-5268">41</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 312.75pt; position: var(--position); top: 88.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1580" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5269">2,541</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 342.75pt; position: var(--position); top: 88.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 10.26pt;"></span></span><span style="left: 12.89pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1581" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5270">3,838</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 88.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1582" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5271">6,420</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 417.75pt; position: var(--position); top: 88.5pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 14.76pt;"></span></span><span style="left: 17.39pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1583" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5272">2,549</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 457.5pt; position: var(--position); top: 88.5pt; width: 30pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 5.01pt;"></span></span><span style="left: 7.64pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1584" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="f-5273">8,969</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 728.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables include trade receivables of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 265.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1578" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5274">5,563</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 316.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 321.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 340.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1584" decimals="-6" name="ifrs-full:TradeReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5275">5,905</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 397.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has portfolios in each of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 739.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the three business models under IFRS <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1586" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-5276">51</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 251.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.17000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 272.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1579" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" scale="6" id="f-5277">23</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 317.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measured at FVTPL<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, is held to sell the contractual cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 749.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows as the receivables will be sold under a factoring arrangement, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 306.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1574" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5278">2,163</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 363.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1580" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5279">2,541</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), measured at FVTOCI, is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 759.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held to either collect or sell the contractual cash flows as the receivables may be sold under a factoring agreement, and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 498.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1587" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5280">3,349</ix:nonFraction> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 769.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 106.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1588" decimals="-6" name="ifrs-full:TradeAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-5281">3,341</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), measured at amortised cost, is held to collect the contractual cash flows and there is no factoring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 779.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreement in place.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="background-image: url('data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIGQ9IiI+PC9wYXRoPjwvc3ZnPg=='); background-size: 595.44pt 841.68pt; height: 841.68pt; position: var(--position); width: 595.44pt;"></div><div style="left: 0pt; position: var(--position); top: 803.13pt;"><div style="width: 487pt;"><div style="line-height: 8.5pt; position: var(--position); top: 0pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 4.017pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">252<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-8" continuedAt="f-4827-9"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(c)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 67.05pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 70.02pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables,<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35441"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 204.16000000000003pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Other provisions, Contingent consideration liabilities and Other <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">non-current liabilities in scope of IFRS 9<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 158.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table reconciles financial instruments within Trade and other payables, Other provisions, Contingent consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities and Other non-current liabilities which fall within the scope of IFRS 9 to the relevant balance sheet amounts. The financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 178.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities are predominantly non-interest bearing. Non-financial instruments include payments on account, tax and social security <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payables and provisions which do not arise from contractual obligations to deliver cash or another financial asset, which are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 199.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outside the scope of IFRS 9. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 215.06pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" id="f-5282" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 483.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 0pt; width: 117pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 117pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 100.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 0pt; width: 117pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 117pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 100.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 33pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 132.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.81pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortised<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.81pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.01pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.81pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.779999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At FVTPL<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.81pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amortised <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 9.81pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.01pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 9.81pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 12pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 17.61pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.779999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 25.41pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 93.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (Note 29)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1589" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:fixed-zero" scale="6" id="f-5283">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 132.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1590" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5284">13,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1591" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5285">13,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1592" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5286">2,175</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1593" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5287">15,335</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1594" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:fixed-zero" scale="6" id="f-5288">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1595" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5289">13,383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1596" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5290">13,383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1597" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5291">2,461</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 45pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1598" decimals="-6" name="ifrs-full:TradeAndOtherPayables" format="ixt:num-dot-decimal" scale="6" id="f-5292">15,844</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 93.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other provisions <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (Note 32)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1589" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:fixed-zero" scale="6" id="f-5293">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 132.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1590" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-5294">182</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1591" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-5295">182</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1592" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-5296">2,353</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1593" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-5297">2,535</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1594" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:fixed-zero" scale="6" id="f-5298">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1595" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-5299">199</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1596" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="f-5300">199</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1597" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-5301">1,040</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 65.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1598" decimals="-6" name="ifrs-full:OtherProvisions" format="ixt:num-dot-decimal" scale="6" id="f-5302">1,239</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 93.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Contingent consideration<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; liabilities (Note 33)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1589" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5303">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 132.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1590" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-5304">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1591" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5305">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1592" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-5306">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1593" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5307">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1594" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5308">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1595" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-5309">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1596" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5310">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1597" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:fixed-zero" scale="6" id="f-5311">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 85.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1598" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-5312">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 93.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other non-current liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (Note 34)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1589" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="6" id="f-5313">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 132.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1590" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="f-5314">46</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1591" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="f-5315">46</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1592" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5316">1,054</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1593" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5317">1,100</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1594" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="6" id="f-5318">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1595" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="f-5319">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1596" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="f-5320">54</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1597" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5321">1,053</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 105.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1598" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5322">1,107</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 93.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1589" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5323">7,280</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 132.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1590" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5324">13,388</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 171.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1591" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5325">20,668</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1592" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5326">5,582</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 249.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1593" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5327">26,250</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 288.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1594" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5328">6,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1595" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5329">13,636</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 366.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1596" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5330">20,298</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 405.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 12.09pt;"></span></span><span style="left: 14.719999999999999pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1597" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5331">4,554</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 444.75pt; position: var(--position); top: 126pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 7.95pt;"></span></span><span style="left: 10.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1598" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5332">24,852</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 363.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(d) <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 70.62pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments and hedging programmes<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives are only used for economic hedging purposes and not as speculative investments and are measured at FVTPL, other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 389.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than designated and effective hedging instruments. Derivatives are presented as current assets or liabilities if they are expected to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 400.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be settled within 12 months after the end of the reporting period, otherwise they are classified as non-current. <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" id="f-5333" continuedAt="f-5333-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 460.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has the <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5333-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following derivative financial instruments:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 426.13pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 311.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 20.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 0pt; width: 78pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 78pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 61.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 78pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 0pt; width: 78pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 78pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 61.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 78pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 18.75pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 18.75pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liabilities<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 18.75pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 18.75pt; width: 39pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Liabilities<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges &#8211; Foreign exchange contracts <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (net principal amount &#8211; <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 81.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1599" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:fixed-zero" scale="6" id="f-5334">nil</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 92.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 118.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1600" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5335">175</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 157.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">))<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 49.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1599" decimals="-6" name="ifrs-full:HedgingInstrumentAssets" format="ixt:fixed-zero" scale="6" id="f-5336">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 49.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1601" decimals="-6" name="ifrs-full:HedgingInstrumentLiabilities" format="ixt:fixed-zero" scale="6" id="f-5337">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 49.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1600" decimals="-6" name="ifrs-full:HedgingInstrumentAssets" format="ixt:fixed-zero" scale="6" id="f-5338">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 49.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.56pt;"></span></span><span style="left: 29.189999999999998pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1602" decimals="-6" name="ifrs-full:HedgingInstrumentLiabilities" scale="6" id="f-5339">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 69.75pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges &#8211; Foreign exchange contracts <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (net principal amount &#8211; <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 81.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1603" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5340">13,206</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 131.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 156.57000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1604" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5341">12,339</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 206.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">))<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 211.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 69.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1603" decimals="-6" name="ifrs-full:HedgingInstrumentAssets" scale="6" id="f-5342">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 69.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1605" decimals="-6" name="ifrs-full:HedgingInstrumentLiabilities" scale="6" id="f-5343">157</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 69.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1604" decimals="-6" name="ifrs-full:HedgingInstrumentAssets" scale="6" id="f-5344">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 69.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1606" decimals="-6" name="ifrs-full:HedgingInstrumentLiabilities" scale="6" id="f-5345">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives designated and effective as hedging instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 90pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1607" decimals="-6" name="ifrs-full:HedgingInstrumentAssets" scale="6" id="f-5346">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 90pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1608" decimals="-6" name="ifrs-full:HedgingInstrumentLiabilities" scale="6" id="f-5347">157</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 90pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1609" decimals="-6" name="ifrs-full:HedgingInstrumentAssets" scale="6" id="f-5348">32</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 90pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1610" decimals="-6" name="ifrs-full:HedgingInstrumentLiabilities" scale="6" id="f-5349">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non current<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 113.25pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (net principal amount &#8211; <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 81.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1611" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5350">35</ix:nonFraction> million<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 116.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 142.13000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1612" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:fixed-zero" scale="6" id="f-5351">nil</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 153.67000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">))<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 113.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1611" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" scale="6" id="f-5352">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 113.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1613" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="f-5353">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 113.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1612" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-5354">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 113.25pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1614" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="f-5355">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 133.5pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Current<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 145.5pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 311.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; (net principal amount &#8211; <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 81.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1615" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5356">8,676</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 127.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 152.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1616" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5357">10,375</ix:nonFraction>&#160;million<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 202.38000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">))<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 145.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1615" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="f-5358">73</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 145.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1617" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="f-5359">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 145.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1616" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="f-5360">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 145.5pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1618" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="f-5361">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Embedded and other derivatives<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 165.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1619" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="f-5362">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 165.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1620" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="f-5363">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 165.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1621" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-5364">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 165.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.02pt;"></span></span><span style="left: 31.65pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1622" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="f-5365">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 177.75pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivatives classified as held for trading<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 177.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1623" decimals="-6" name="ifrs-full:DerivativeFinancialAssetsHeldForTrading" scale="6" id="f-5366">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 177.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1624" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesHeldForTrading" scale="6" id="f-5367">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 177.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.88pt;"></span></span><span style="left: 27.509999999999998pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1625" decimals="-6" name="ifrs-full:DerivativeFinancialAssetsHeldForTrading" scale="6" id="f-5368">98</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 177.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 22.42pt;"></span></span><span style="left: 25.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1626" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesHeldForTrading" scale="6" id="f-5369">78</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 189.75pt; width: 311.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 311.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total derivative instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 311.25pt; position: var(--position); top: 189.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.74pt;"></span></span><span style="left: 23.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:HedgingInstrumentsAndDerivativesAssets" scale="6" id="f-5370">110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 189.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1624" decimals="-6" name="gsk:HedgingInstrumentsAndDerivativesLiabilities" scale="6" id="f-5371">192</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 409.5pt; position: var(--position); top: 189.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.74pt;"></span></span><span style="left: 23.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:HedgingInstrumentsAndDerivativesAssets" scale="6" id="f-5372">130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 448.5pt; position: var(--position); top: 189.75pt; width: 39pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.28pt;"></span></span><span style="left: 20.91pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1626" decimals="-6" name="gsk:HedgingInstrumentsAndDerivativesLiabilities" scale="6" id="f-5373">114</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="6" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 201.75pt; width: 487.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 1.8499999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 7.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Includes options with net principal amount EUR <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 165.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="eur" contextRef="c-1627" decimals="-7" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="9" id="f-5374">1.25</ix:nonFraction> billion<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">253<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-9" continuedAt="f-4827-10"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fair value hedges<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group had no designated fair value hedges.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 161.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 176.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, certain foreign exchange contracts were designated as net investment hedges in respect of the foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency translation risk arising on consolidation of the Group&#8217;s net investment in its European (Euro), American (USD), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Singaporean (SGD), Canadian (CAD), Chinese (CNH) and Japanese (JPY) foreign operations as shown in the table below. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The carrying amount of bonds on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i89066ac732c64b14be7b71b458c956b7_35486">247</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 214.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> included <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1628" decimals="-6" name="gsk:CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" format="ixt:num-dot-decimal" scale="6" id="f-5375">5,346</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 302.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 307.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 326.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 330.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1629" decimals="-6" name="gsk:CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" format="ixt:num-dot-decimal" scale="6" id="f-5376">5,348</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) that were designated as hedging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments in net investment hedges. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 239.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group entered into forward foreign exchange contracts which have been designated as cash flow <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 265.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedges. These were entered into to hedge the foreign exchange exposure arising on cash flows from Euro denominated coupon <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments relating to notes issued under the Group&#8217;s European Medium Term Note programme, and to hedge foreign currency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payments due on acquisitions, and collaboration or licensing arrangements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group manages its cash flow interest rate risk by using floating-to-fixed interest rate swaps. In addition, the Group carries a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance in reserves that arose from pre-hedging fluctuations in long-term interest rates when pricing bonds issued in prior years <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 322.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and in the current year. The balance is reclassified to finance costs over the life of these bonds.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 338pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange risk <span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35515"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the current year, the Group has designated certain foreign exchange forward contracts and swaps as cash flow and net <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 364.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment hedges. Foreign exchange derivative financial assets and liabilities are presented in the line &#8216;Derivative financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">instruments&#8217; (either as assets or liabilities) on the Consolidated balance sheet. The following tables detail the foreign exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forward contracts and swaps outstanding at the end of the reporting period, as well as information on the related hedged items. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 400.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedge effectiveness is determined at the inception of the hedge relationship, and through periodic prospective effectiveness <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessments to ensure that an economic relationship exists between the hedged item and hedging instrument. The Group enters <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">into hedge relationships where the critical terms of the hedging instrument match exactly with the terms of the hedged item, and so <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 430.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a qualitative assessment of effectiveness is performed. If changes in circumstances affect the terms of the hedged item such that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the critical terms no longer match exactly with the critical terms of the hedging instrument, the Group uses the hypothetical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">derivative method to assess effectiveness. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The main source of hedge ineffectiveness in these hedging relationships is the effect of the counterparty and the Group&#8217;s own <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 477.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">credit risk on the fair value of the foreign exchange forward contracts and swaps, which is not reflected in the fair value of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 487.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged item attributable to changes in foreign exchange rates. In 2024 another source of ineffectiveness emerged from these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedging relationships namely the principal amount of USD net investment hedges exceeded the hedged item for a period of ten <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">days owing <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to an adjustment to the USD net assets of the Group because of a change in the provision for the Zantac litigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between quarters but after the financial instruments were entered into with the counterparty. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The ineffectiveness recorded for this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 96.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1630" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectiveness" format="ixt:num-dot-decimal" scale="6" id="f-5377">15</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 143.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1631" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectiveness" format="ixt-sec:numwordsen" scale="0" id="f-5378">No</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 154.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ineffectiveness was recorded from cash flow hedges in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 381.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1632" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectiveness" format="ixt-sec:numwordsen" scale="0" id="f-5379">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 430.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1633" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectiveness" format="ixt-sec:numwordsen" scale="0" id="f-5380">No</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> other ineffectiveness was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recorded from net investment hedges (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 216.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1634" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectiveness" format="ixt-sec:numwordsen" scale="0" id="f-5381">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 554.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2024, the movement in the time value of options recognised in reserves is <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 339.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-5382">4</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (2023: &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" format="ixt:fixed-zero" scale="0" id="f-5383">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 416.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and is accounted for as a cost <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of hedging.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">254<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-10" continuedAt="f-4827-11"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 136.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutHedgedItemsExplanatory" id="f-5384" continuedAt="f-5384-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 258.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 49.22pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 258.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange rate<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 304.5pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 11.25pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net notional<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 11.25pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 11.25pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Periodic <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value for<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> calculating <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 93pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sell foreign currency:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 105pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 3 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 105pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1635" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5385">1.20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 105pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 105pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1636" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5386">8,201</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 105pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1636" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5387">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 105pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1635" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5388">359</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 117pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1637" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5389">197.82</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 117pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JPY<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 117pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1638" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5390">84</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 117pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1638" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5391">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 117pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1637" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5392">13</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1639" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5393">1.29</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">USD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1640" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5394">2,417</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1640" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5395">66</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1639" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5396">56</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1641" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5397">9.26</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CNH<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1642" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5398">61</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1642" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5399">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 140.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1641" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5400">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 to 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1643" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5401">1.31</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">USD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1644" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5402">1,827</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1644" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5403">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1643" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5404">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1645" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5405">1.76</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CAD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1646" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5406">244</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1646" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5407">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 162.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1645" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5408">17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1647" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5409">1.67</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SGD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1648" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5410">164</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1648" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5411">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 174.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1647" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5412">3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1649" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5413">1.17</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1650" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5414">208</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1650" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5415">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 186.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1649" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5416">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 198pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 3 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 210pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 210pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1651" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:fixed-zero" scale="6" id="f-5417">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 210pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1651" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5418">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 210pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1652" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5419">42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 222pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 to 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 222pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 222pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1653" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5420">623</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 222pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1653" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5421">622</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 222pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1654" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5422">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 234pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 234pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JPY<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 234pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1655" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5423">216</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 234pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1655" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5424">216</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 234pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1656" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5425">19</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 246pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 246pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1657" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5426">4,524</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 246pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1657" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5427">4,508</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 246pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1658" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5428">157</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 257.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1659" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5429">18,570</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 257.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1659" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5430">5,468</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 257.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1660" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5431">507</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5384-1" continuedAt="f-5384-2"><div style="position: var(--position); top: 416.11pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 0pt; width: 276.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 276.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedged items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 11.25pt; width: 92.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Periodic change in value <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for calculating hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 11.25pt; width: 92.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cumulative balance in cash <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flow hedge reserve/foreign <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency translation reserve <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for continuing hedges<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 11.25pt; width: 92.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Balance in cash flow hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve arising from hedging <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relationships for which hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting is no longer applied<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 53.25pt; width: 210.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 142.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment in foreign operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 65.25pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 71.53pt;"></span></span><span style="left: 74.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1661" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5432">522</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 65.25pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 71.53pt;"></span></span><span style="left: 74.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1661" decimals="-6" sign="-" name="gsk:ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" scale="6" id="f-5433">208</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 65.25pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1661" decimals="-6" name="gsk:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" format="ixt:fixed-zero" scale="6" id="f-5434">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 504.05pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 258.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 10.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="5" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 0pt; width: 228.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.91pt; width: 228.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 211.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 10.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 49.22pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 258.75pt; overflow: hidden; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange rate<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 304.5pt; overflow: hidden; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net notional<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Periodic <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value for <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calculating <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Buy foreign currency:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 3 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1662" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5435">1.27</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">USD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1663" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5436">145</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1663" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5437">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1662" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5438">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 to 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1664" decimals="2" name="ifrs-full:AverageForeignExchangeRate" format="ixt:fixed-zero" scale="0" id="f-5439">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1665" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:fixed-zero" scale="0" id="f-5440">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1665" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" format="ixt:fixed-zero" scale="0" id="f-5441">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1664" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" format="ixt:fixed-zero" scale="0" id="f-5442">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1666" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5443">1.25</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">USD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1667" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5444">35</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1667" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5445">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1666" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5446">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sell foreign currency:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 152.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 3 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1668" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5447">1.16</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="number" contextRef="c-1669" decimals="-6" sign="-" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5448">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1669" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" format="ixt:fixed-zero" scale="6" id="f-5449">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 152.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1668" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" format="ixt:fixed-zero" scale="6" id="f-5450">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1670" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5451">175</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1670" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5452">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 164.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1671" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5453">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">255<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-11" continuedAt="f-4827-12"><div><ix:continuation id="f-5384-2" continuedAt="f-5384-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 130.98pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 258.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45.75pt;"/></tr><tr style="height: 10.5pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 0pt; width: 45.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 2.91pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 10.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 49.22pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 258.75pt; overflow: hidden; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Average <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange rate<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 304.5pt; overflow: hidden; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net notional<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amount<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 10.5pt; width: 45.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Periodic <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value for <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calculating <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange contracts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sell foreign currency:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 104.25pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 3 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1672" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5454">1.15</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1673" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5455">9,146</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.17pt;"></span></span><span style="left: 31.8pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1673" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5456">12</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 104.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1672" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5457">126</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1674" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5458">181.42</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JPY<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1675" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5459">133</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1675" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5460">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 116.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1674" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5461">28</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1676" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5462">1.27</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">USD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1677" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5463">2,633</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1677" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5464">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 128.25pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1676" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5465">97</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 139.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 139.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1678" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5466">1.67</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 139.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CAD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 139.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1679" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5467">260</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 139.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1679" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5468">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 139.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1678" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5469">10</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 258.75pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.44pt;"></span></span><span style="left: 28.07pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1680" decimals="2" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="f-5470">1.66</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SGD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1681" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5471">167</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1681" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5472">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 151.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1680" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5473">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 163.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Borrowings:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than 3 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 175.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 175.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1682" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5474">148</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 175.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1682" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5475">148</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 175.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.63pt;"></span></span><span style="left: 34.26pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1683" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5476">12</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 187.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 to 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 187.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 187.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1684" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:fixed-zero" scale="0" id="f-5477">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 187.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1684" decimals="-6" name="gsk:HedgingInstrumentAtFairValue" format="ixt:fixed-zero" scale="0" id="f-5478">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 187.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.77pt;"></span></span><span style="left: 38.400000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1685" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" format="ixt:fixed-zero" scale="0" id="f-5479">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 199.5pt; width: 258.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 258.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 6 months<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 199.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 31.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JPY<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 199.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1686" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" scale="6" id="f-5480">236</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 199.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.03pt;"></span></span><span style="left: 27.66pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1686" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" scale="6" id="f-5481">235</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 199.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.31pt;"></span></span><span style="left: 35.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1687" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5482">3</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 211.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 211.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.3pt;"></span></span><span style="left: 23.93pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1688" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5483">5,127</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 211.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1688" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5484">5,113</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 211.5pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1689" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5485">125</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 350.25pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 17.16pt;"></span></span><span style="left: 19.79pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1690" decimals="-6" name="ifrs-full:NominalAmountOfHedgingInstrument" format="ixt:num-dot-decimal" scale="6" id="f-5486">17,850</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 396pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.84pt;"></span></span><span style="left: 21.47pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1690" decimals="-6" sign="-" name="gsk:HedgingInstrumentAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5487">5,498</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 441.75pt; position: var(--position); top: 222.75pt; width: 45.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 27.49pt;"></span></span><span style="left: 30.119999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1691" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5488">402</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 376.42pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 210.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 92.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 0pt; width: 276.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 276.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedged items<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 11.25pt; width: 92.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Periodic change in value <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for calculating hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 47.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 11.25pt; width: 92.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cumulative balance in cash <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flow hedge reserve/foreign <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency translation reserve <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for continuing hedges<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 92.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 11.25pt; width: 92.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Balance in cash flow hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve arising from hedging <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relationships for which hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting is no longer applied<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 80.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variability in cash flows from a highly probable forecast<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; transaction<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 65.25pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1692" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5489">2</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 65.25pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 79.81pt;"></span></span><span style="left: 82.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1692" decimals="-6" sign="-" name="gsk:ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" scale="6" id="f-5490">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 65.25pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1692" decimals="-6" name="gsk:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" format="ixt:fixed-zero" scale="6" id="f-5491">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variability in cash flows from foreign exchange exposure <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; arising on Euro denominated coupon payments relating to<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; debt issued<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 85.5pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1693" decimals="-6" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" format="ixt:fixed-zero" scale="6" id="f-5492">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 85.5pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1693" decimals="-6" name="gsk:ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" format="ixt:fixed-zero" scale="6" id="f-5493">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 85.5pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1693" decimals="-6" name="gsk:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" format="ixt:fixed-zero" scale="6" id="f-5494">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 114.75pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 86.41pt;"></span></span><span style="left: 89.03999999999999pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 114.75pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 86.41pt;"></span></span><span style="left: 89.03999999999999pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 210.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 210.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment in foreign operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 210.75pt; position: var(--position); top: 126.75pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 71.53pt;"></span></span><span style="left: 74.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1694" decimals="-6" sign="-" name="ifrs-full:GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" scale="6" id="f-5495">402</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 303pt; position: var(--position); top: 126.75pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 71.53pt;"></span></span><span style="left: 74.16pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1694" decimals="-6" sign="-" name="gsk:ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" scale="6" id="f-5496">725</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 395.25pt; position: var(--position); top: 126.75pt; width: 92.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 92.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 82.27pt;"></span></span><span style="left: 84.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1694" decimals="-6" name="gsk:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" format="ixt:fixed-zero" scale="6" id="f-5497">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1695" decimals="-6" name="ifrs-full:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" format="ixt:fixed-zero" scale="6" id="f-5498">nil</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 66.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 90.72999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 95.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1696" decimals="-6" name="ifrs-full:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" format="ixt:fixed-zero" scale="6" id="f-5499">nil</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of balances in the cash flow hedge reserve arise from hedging relationships for which hedge accounting is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 536.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no longer applied. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.95pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" id="f-5500" continuedAt="f-5500-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table details the effectiveness of the hedging relationships and the amounts reclassified from the hedging reserve to <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5500-1" continuedAt="f-5500-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 572.35pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 105pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 0pt; width: 54.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 12pt; width: 135pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 135pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount reclassified to profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 12pt; width: 109.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 109.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount reclassified to balance sheet<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 65.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.7100000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gains/(losses) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 65.25pt; left: 150pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 65.25pt; left: 195pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.860000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedged <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future cash <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no longer <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affecting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 330pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.520000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reclassification <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 23.25pt; width: 54.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to hedged <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">item affecting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 43.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 23.25pt; width: 54.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.46pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.799999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in balance <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.26pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet in which <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.06pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reclassification <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.86pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 57.66pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 105pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 32.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 105pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variability in cash flows from a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly probable forecast <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1697" decimals="-6" name="ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax" scale="6" id="f-5501">8</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 195pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 330pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 100.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 42.31pt;"></span></span><span style="left: 44.940000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1698" decimals="-6" sign="-" name="gsk:ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" scale="6" id="f-5502">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 32.25pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 3.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 105pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 105pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment in foreign <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105pt; position: var(--position); top: 147.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1699" decimals="-6" name="ifrs-full:GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" scale="6" id="f-5503">522</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 147.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1699" decimals="-6" sign="-" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" scale="6" id="f-5504">15</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 195pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 147.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 147.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1699" decimals="-6" name="gsk:ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" scale="6" id="f-5505">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 330pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 147.75pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 147.75pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 105pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 105pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Time value of options<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 105pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1700" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" scale="6" id="f-5506">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 150pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 195pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 285pt; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 330pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 375pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 181.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 181.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">256<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-12" continuedAt="f-4827-13"><div><ix:continuation id="f-5500-2" continuedAt="f-5500-3"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 139.98pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 102pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 54.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 0pt; width: 54.75pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 12pt; width: 138pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount reclassified to profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 12pt; width: 109.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 109.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 1.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount reclassified to balance sheet<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.7100000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gains/(losses) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 147pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 192pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.860000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedged <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future cash <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no longer <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 23.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affecting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 23.25pt; width: 48pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item in<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reclassification<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 23.25pt; width: 54.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to hedged <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">item affecting<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 43.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 23.25pt; width: 54.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.799999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in balance <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sheet in which <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reclassification <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 54.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 102pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 102pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variability in cash flows from a <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly probable forecast <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.42pt;"></span></span><span style="left: 31.05pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1692" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax" scale="6" id="f-5507">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 192pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 92.25pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 38.02pt;"></span></span><span style="left: 40.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 92.25pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.63pt;"></span></span><span style="left: 43.260000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1701" decimals="-6" name="gsk:ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" scale="6" id="f-5508">37</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 432.75pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 6pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 102pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Variability in cash flows from <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">foreign exchange exposure <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arising on Euro denominated <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">coupon payments relating to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debt issued<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 32.56pt;"></span></span><span style="left: 35.190000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1693" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax" scale="6" id="f-5509">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 192pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 127.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 327pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 127.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 127.5pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 102pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 186pt; width: 102pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net investment in foreign <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 102pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 102pt; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1702" decimals="-6" name="ifrs-full:GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" scale="6" id="f-5510">402</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 147pt; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 192pt; overflow: hidden; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 11.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 282pt; position: var(--position); top: 186pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.02pt;"></span></span><span style="left: 37.650000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1702" decimals="-6" name="gsk:ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" scale="6" id="f-5511">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 186pt; width: 48pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other income <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 48pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 378pt; position: var(--position); top: 186pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 432.75pt; position: var(--position); top: 186pt; width: 54.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 54.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 44.77pt;"></span></span><span style="left: 47.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 370.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate risk<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 386.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group manages its cash flow interest rate risk by using floating-to-fixed interest rate swaps, where at quarterly intervals the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 396.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">difference between fixed contract rates and floating rate interest amounts calculated by reference to the agreed notional principal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounts are exchanged.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are none of these swaps outstanding at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 227.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 298.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> or at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 320.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 391.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The only impact on these financial statements of interest rate swaps is where the interest rate risk on an element of future debt <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issuance has been managed by entering into forward starting interest rate swaps, effectively to lock in the interest rates on the debt <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 459.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in advance. These were closed out at the time of issuing the debt, and the resulting gain or loss held in the Cash flow hedge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 469.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserve and reclassified to income statement as the interest payments on the debt impacted the income statement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 485.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Forward starting interest rate swaps<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Forward starting interest rate contracts, exchanging floating interest for fixed interest, were designated as cash flow hedges to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedge the interest variability of the interest cash flows associated with future fixed rate debt.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 524.85pt; width: 595.44pt;"><ix:continuation id="f-5384-3" continuedAt="f-5384-4"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate swaps<span style="display: inline-block; height: 6.55pt;"></span></span></ix:continuation></div><ix:continuation id="f-5384-4"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate swap contract assets and liabilities are presented (when applicable) in the line &#8216;Derivative financial instruments&#8217; (either <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as assets or liabilities) on the Consolidated balance sheet.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1703" decimals="-6" name="ifrs-full:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" scale="6" id="f-5512">16</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.97999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1704" decimals="-6" name="ifrs-full:ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" scale="6" id="f-5513">21</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) of balances in the cash flow hedge reserve arise from hedge relationships for which hedge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting is no longer applied.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.52pt; width: 595.44pt;"><ix:continuation id="f-5500-3" continuedAt="f-5500-4"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table<span style="display: inline-block; height: 6.18pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35516"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 123.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> details the effectiveness of the hedging relationships and the amounts reclassified from the hedging reserve to <span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation></div><ix:continuation id="f-5500-4" continuedAt="f-5500-5"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 616.61pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 186pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 0pt; width: 201pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 201pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 184.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 12pt; width: 150.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 150.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount reclassified to profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gains/(losses) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged future <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no longer <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.200000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affecting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reclassification <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 186pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 186pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pre-hedging of long-term interest rates:<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 186pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Matured in the past<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1705" decimals="-6" name="ifrs-full:ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" format="ixt:fixed-zero" scale="6" id="f-5514">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1706" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-5515">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 286.5pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1706" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" format="ixt:fixed-zero" scale="6" id="f-5516">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1706" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" scale="6" id="f-5517">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 437.25pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">257<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-13" continuedAt="f-4827-14"><div><ix:continuation id="f-5500-5"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 120.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 186pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 0pt; width: 201pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 201pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 184.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 12pt; width: 150.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 150.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount reclassified to profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gains/(losses) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reserves<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amount <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recognised in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 286.5pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which hedge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ineffectiveness <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged future <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no longer <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 14.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expected to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occur<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due to <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.200000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedged item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affecting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profit or loss<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 50.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 24pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Line item <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in profit or loss <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.96pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.76pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 5.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reclassification <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.56pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjustment <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 42.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is included<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 81.75pt; width: 186pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cash flow hedges<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 186pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pre-hedging of long-term interest rates:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 186pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 186pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Matured in the past<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 186pt; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1707" decimals="-6" name="ifrs-full:ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" format="ixt:fixed-zero" scale="6" id="f-5518">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 236.25pt; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1708" decimals="-6" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="6" id="f-5519">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 286.5pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 336.75pt; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1708" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" format="ixt:fixed-zero" scale="6" id="f-5520">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1708" decimals="-6" name="ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" scale="6" id="f-5521">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 437.25pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income or <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 21.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expense<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 260.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(e) <span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35390"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 70.02pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Offsetting<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 121.1pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> of financial assets and liabilities<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets and liabilities are offset and the net amount reported in the balance sheet where there is a legally enforceable right <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to offset the recognised amounts, and there is an intention to settle on a net basis or realise the asset and settle the liability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">simultaneously. There are also arrangements that do not meet the criteria for offsetting but still allow for the related amounts to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offset in certain circumstances, such as bankruptcy or the termination of a contract. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 322.66pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory" id="f-5522" continuedAt="f-5522-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following tables set out the financial assets and liabilities that are offset, or subject to enforceable master netting arrangements <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5522-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 332.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other similar agreements but not offset, as at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 310.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 400.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The column &#8216;Net amount&#8217; shows the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact on the Group&#8217;s balance sheet if all offset rights were exercised. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 358.95pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 239.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 239.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 239.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 239.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(liabilities)<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(liabilities)/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 9.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets set off<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 8.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(liabilities) per <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Related <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounts not <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> set off in the <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 7.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance sheet<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 239.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 239.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 239.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 239.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 239.25pt; position: var(--position); top: 54pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1709" decimals="-6" name="ifrs-full:GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5523">5,950</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 54pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1709" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5524">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 54pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1709" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-5525">5,949</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390pt; position: var(--position); top: 54pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1709" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-5526">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 54pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.8pt;"></span></span><span style="left: 28.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1709" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5527">5,949</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 239.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 239.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 239.25pt; position: var(--position); top: 66pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1710" decimals="-6" name="ifrs-full:GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5528">110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 66pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1710" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:fixed-zero" scale="6" id="f-5529">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 66pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.99pt;"></span></span><span style="left: 34.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1710" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" scale="6" id="f-5530">110</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390pt; position: var(--position); top: 66pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.67pt;"></span></span><span style="left: 36.300000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1710" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" scale="6" id="f-5531">89</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 66pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1710" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5532">21</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 239.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 239.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 239.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 239.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 239.25pt; position: var(--position); top: 102pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1711" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5533">13,161</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 102pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1711" decimals="-6" name="ifrs-full:GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5534">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 102pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1711" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-5535">13,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390pt; position: var(--position); top: 102pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1711" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="f-5536">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 102pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1711" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5537">13,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 239.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 239.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 239.25pt; position: var(--position); top: 114pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1712" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5538">192</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 114pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1712" decimals="-6" name="ifrs-full:GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:fixed-zero" scale="6" id="f-5539">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339.75pt; position: var(--position); top: 114pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1712" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" scale="6" id="f-5540">192</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 390pt; position: var(--position); top: 114pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 36.13pt;"></span></span><span style="left: 38.760000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1712" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" scale="6" id="f-5541">89</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 440.25pt; position: var(--position); top: 114pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1712" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5542">103</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 495.64pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 240pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 49.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 49.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 49.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 49.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 49.5pt;"/></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 240pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 240pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 0pt; width: 49.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(liabilities)<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 0pt; width: 49.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(liabilities)/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets offset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 0pt; width: 49.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net financial <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 26.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(liabilities)<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 0pt; width: 49.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Related <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amounts not <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offset<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 0pt; width: 49.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 36.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">balance<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 240pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 240pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 240pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 240pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other receivables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 54pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.05pt;"></span></span><span style="left: 27.68pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1713" decimals="-6" name="ifrs-full:GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5543">6,394</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 54pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.06pt;"></span></span><span style="left: 39.690000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1713" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5544">1</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 54pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.05pt;"></span></span><span style="left: 27.68pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1713" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-5545">6,393</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 54pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.52pt;"></span></span><span style="left: 42.150000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1713" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" format="ixt:fixed-zero" scale="6" id="f-5546">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 54pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 25.05pt;"></span></span><span style="left: 27.68pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1713" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5547">6,393</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 240pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 240pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 66pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.24pt;"></span></span><span style="left: 33.87pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1714" decimals="-6" name="ifrs-full:GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5548">130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 66pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.52pt;"></span></span><span style="left: 42.150000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1714" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:fixed-zero" scale="6" id="f-5549">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 66pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.24pt;"></span></span><span style="left: 33.87pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1714" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" scale="6" id="f-5550">130</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 66pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.78pt;"></span></span><span style="left: 31.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1714" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" scale="6" id="f-5551">108</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 66pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 35.38pt;"></span></span><span style="left: 38.010000000000005pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1714" decimals="-6" name="ifrs-full:NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5552">22</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 240pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 240pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial liabilities<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 240pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 240pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade and other payables<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 102pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.45pt;"></span></span><span style="left: 21.08pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1715" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5553">13,384</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 102pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.52pt;"></span></span><span style="left: 42.150000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1715" decimals="-6" name="ifrs-full:GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5554">1</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 102pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.45pt;"></span></span><span style="left: 21.08pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1715" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" format="ixt:num-dot-decimal" scale="6" id="f-5555">13,383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 102pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.52pt;"></span></span><span style="left: 42.150000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1715" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="f-5556">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 102pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 18.45pt;"></span></span><span style="left: 21.08pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1715" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:num-dot-decimal" scale="6" id="f-5557">13,383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 240pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 240pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instruments<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 240pt; position: var(--position); top: 114pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.78pt;"></span></span><span style="left: 31.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1716" decimals="-6" name="ifrs-full:GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5558">114</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 289.5pt; position: var(--position); top: 114pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.52pt;"></span></span><span style="left: 42.150000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1716" decimals="-6" name="ifrs-full:GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" format="ixt:fixed-zero" scale="6" id="f-5559">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 114pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.78pt;"></span></span><span style="left: 31.41pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1716" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" scale="6" id="f-5560">114</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 388.5pt; position: var(--position); top: 114pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 31.24pt;"></span></span><span style="left: 33.87pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1716" decimals="-6" name="ifrs-full:FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" scale="6" id="f-5561">108</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 114pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.06pt;"></span></span><span style="left: 39.690000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1716" decimals="-6" name="ifrs-full:NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" scale="6" id="f-5562">6</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 632.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amounts which do not meet the criteria for offsetting on the balance sheet but could be settled net in certain circumstances <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 642.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principally relate to derivative transactions under ISDA (International Swaps and Derivatives Association) agreements where each <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">party has the option to settle amounts on a net basis in the event of default of the other party. As there is presently not a legally <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enforceable right of offset, these amounts have not been offset in the balance sheet, but have been presented separately in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 673.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">table above.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">258<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-14" continuedAt="f-4827-15"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(f) Debt interest rate repricing table<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDebtSecuritiesExplanatory" id="f-5563" continuedAt="f-5563-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table sets out the exposure of the Group to interest rates on debt, including commercial paper. The maturity analysis <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5563-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of fixed rate debt is stated by contractual maturity and of floating rate debt by interest rate repricing dates. For the purpose of this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">table, debt is defined as all classes of borrowings other than lease liabilities.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 181.46pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 387pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 25.5pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 12pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.31pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 12pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.11pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 17.91pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.629999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Floating and fixed rate debt less than one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 37.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1717" decimals="-6" name="ifrs-full:CurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5564">2,181</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 37.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1718" decimals="-6" name="ifrs-full:CurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5565">2,657</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between one and two years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 49.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1719" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5566">1,410</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 49.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1720" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5567">1,434</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between two and three years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 61.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1721" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" scale="6" id="f-5568">721</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 61.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1722" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5569">1,475</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 73.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between three and four years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 73.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1723" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5570">2,355</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 73.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1724" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" scale="6" id="f-5571">740</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 85.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between four and five years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 85.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1725" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5572">1,207</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 85.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1726" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5573">2,350</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between five and ten years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 97.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1727" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5574">2,738</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 97.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1728" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5575">3,031</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Greater than ten years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 109.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1729" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5576">5,272</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 109.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 23.34pt;"></span></span><span style="left: 25.97pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1730" decimals="-6" name="ifrs-full:NoncurrentDebtInstrumentsIssued" format="ixt:num-dot-decimal" scale="6" id="f-5577">5,124</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 121.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-5578">15,884</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 121.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-5579">16,811</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 133.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Original issuance profile:<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 145.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fixed rate interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 145.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-761" decimals="-6" name="gsk:InterestBearingDebt" format="ixt:num-dot-decimal" scale="6" id="f-5580">15,126</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 145.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-762" decimals="-6" name="gsk:InterestBearingDebt" format="ixt:num-dot-decimal" scale="6" id="f-5581">15,847</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 157.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Floating rate interest<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 157.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-759" decimals="-6" name="gsk:InterestBearingDebt" scale="6" id="f-5582">756</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 157.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 29.53pt;"></span></span><span style="left: 32.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-760" decimals="-6" name="gsk:InterestBearingDebt" scale="6" id="f-5583">964</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 169.5pt; width: 387pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 387pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non interest bearing<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 169.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 37.81pt;"></span></span><span style="left: 40.440000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="gsk:NonInterestBearingDebt" scale="6" id="f-5584">2</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 169.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 40.27pt;"></span></span><span style="left: 42.900000000000006pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="gsk:NonInterestBearingDebt" format="ixt:fixed-zero" scale="6" id="f-5585">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 387pt; position: var(--position); top: 181.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-5586">15,884</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 437.25pt; position: var(--position); top: 181.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 19.2pt;"></span></span><span style="left: 21.83pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-6" name="ifrs-full:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-5587">16,811</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">259<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-15" continuedAt="f-4827-16"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(g) Sensitivity analysis<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The tables below illustrate the estimated impact on the income statement and equity as a result of hypothetical market movements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in foreign exchange and interest rates in relation to the Group&#8217;s financial instruments. The range of variables chosen for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sensitivity analysis reflects management&#8217;s view of changes which are reasonably possible over a one-year period.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 181.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange sensitivity<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35517"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group operates internationally and is primarily exposed to foreign exchange risk in relation to Sterling against movements in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US Dollar, Euro and Japanese Yen. Foreign exchange risk arises from the translation of financial assets and liabilities which are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 217.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the functional currency of the entity that holds them. Based on the Group&#8217;s net financial assets and liabilities as at 31 December, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 227.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a weakening and strengthening of Sterling against these currencies, with all other variables held constant, is illustrated in the tables <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">below. The tables exclude financial instruments that expose the Group to foreign exchange risk where this risk is fully hedged with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">another financial instrument.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 264.24pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" id="f-5588" continuedAt="f-5588-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income statement impact of non-functional currency foreign exchange exposures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 56.839999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 56.839999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-664" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5589">106</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-665" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5590">61</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-666" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5591">167</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-667" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5592">97</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-672" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5593">42</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-673" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5594">4</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-674" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5595">66</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-675" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5596">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 yen appreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1731" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5597">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1732" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5598">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 yen appreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1733" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5599">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1734" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5600">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5588-1"><div style="position: var(--position); top: 395.23pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income statement impact of non-functional currency foreign exchange exposures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 56.839999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) in<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 56.839999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-668" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5601">91</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-669" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5602">52</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-670" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5603">131</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-671" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5604">76</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-676" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5605">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-677" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5606">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-678" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5607">51</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-679" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" scale="6" id="f-5608">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 yen depreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1735" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5609">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1736" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5610">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 yen depreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1737" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5611">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1738" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" format="ixt:fixed-zero" scale="6" id="f-5612">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The equity impact, shown below, for foreign exchange sensitivity relates to derivative and non-derivative financial instruments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 523.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hedging the Group&#8217;s net investments in its European (Euro) foreign operations and cash flow hedges of its foreign exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exposure arising on Euro denominated coupon payments relating to notes issued under the Group&#8217;s European Medium Term <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note programme.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 559.3pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:ForeignExchangeSensitivityEquityImpactTableTextBlock" id="f-5613" continuedAt="f-5613-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity impact of non-functional currency foreign exchange exposures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 53.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in equity<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 53.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in equity<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-664" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5614">368</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-665" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5615">209</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 53.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 53.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-666" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5616">577</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 53.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-667" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5617">327</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 66pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.34pt;"></span></span><span style="left: 55.970000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-672" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5618">1,188</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 66pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.34pt;"></span></span><span style="left: 55.970000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-673" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5619">1,372</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation in Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.34pt;"></span></span><span style="left: 55.970000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-674" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5620">1,834</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 78.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 53.34pt;"></span></span><span style="left: 55.970000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-675" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5621">2,160</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5613-1"><div style="position: var(--position); top: 675.94pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 17.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity impact of non-functional currency foreign exchange exposures<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 53.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in equity<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 53.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in equity<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 37.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-668" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5622">313</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 37.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-669" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5623">178</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 50.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-670" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5624">453</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 50.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-671" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5625">258</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 63pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-676" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" scale="6" id="f-5626">958</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 63pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 55.8pt;"></span></span><span style="left: 58.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-677" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5627">1,152</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 75.75pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 75.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 55.8pt;"></span></span><span style="left: 58.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-678" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5628">1,384</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 75.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 55.8pt;"></span></span><span style="left: 58.43pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-679" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" format="ixt:num-dot-decimal" scale="6" id="f-5629">1,662</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">260<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-4827-16" continuedAt="f-4827-17"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and related disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk" id="f-5630" continuedAt="f-5630-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The tables below present the Group&#8217;s sensitivity to a weakening and strengthening of Sterling against the relevant currency based <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5630-1" continuedAt="f-5630-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the composition of net debt as shown in Note 30, 'Net debt', adjusted for the effects of foreign exchange derivatives that are not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">part of net debt but affect future foreign currency cash flows.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 165.57pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impact of foreign exchange movements on adjusted net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Increase)/decrease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.549999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in adjusted net debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Increase)/decrease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.549999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in adjusted net debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-664" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5631">555</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-665" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5632">622</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15&#160; cent appreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-666" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5633">870</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-667" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5634">974</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent appreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-672" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5635">178</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-673" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5636">386</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent appreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-674" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5637">279</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-675" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5638">609</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 yen appreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1731" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5639">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1732" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5640">5</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 yen appreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1733" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5641">8</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1734" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5642">7</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 304.61pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Impact of foreign exchange movements on adjusted net debt<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Increase)/decrease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.549999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in adjusted net debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Increase)/decrease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 21.549999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in adjusted net debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-668" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5643">473</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-669" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5644">531</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of the US Dollar<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-670" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5645">684</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-671" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5646">769</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 cent depreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-676" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5647">150</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-677" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5648">325</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 cent depreciation of the Euro<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-678" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5649">217</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.53pt;"></span></span><span style="left: 62.160000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-679" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5650">468</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 yen depreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1735" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5651">5</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1736" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5652">4</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 yen depreciation of the Yen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1737" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5653">7</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1738" decimals="-6" name="gsk:IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" scale="6" id="f-5654">6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 427.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Interest rate sensitivity<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 443.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is exposed to interest rate risk on its outstanding borrowings and investments where any changes in interest rates will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect future cash flows or the fair values of financial instruments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 469.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The majority of debt is issued at fixed interest rates and changes in the floating rates of interest do not significantly affect the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s net interest charge, although the majority of cash and liquid investments earn floating rates of interest.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below hypothetically shows the Group&#8217;s sensitivity to changes in interest rates in relation to Sterling, US Dollar and Euro <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">floating rate financial assets and liabilities. A <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 236.66000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> basis points) or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 312.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">150<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> basis points) movement in EUR, USD or Sterling <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 516.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest rates is <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1739" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughInterestRateMovements" format="ixt:fixed-zero" scale="0" id="f-5655"><ix:nonFraction unitRef="gbp" contextRef="c-1740" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughInterestRateMovements" format="ixt:fixed-zero" scale="0" id="f-5656"><ix:nonFraction unitRef="gbp" contextRef="c-1741" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughInterestRateMovements" format="ixt:fixed-zero" scale="0" id="f-5657"><ix:nonFraction unitRef="gbp" contextRef="c-1742" decimals="-6" name="gsk:IncreaseDecreaseInEquityThroughInterestRateMovements" format="ixt:fixed-zero" scale="0" id="f-5658">not</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> deemed to have a material effect on equity. A <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 296.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 308.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 314.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 328.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> basis points) or <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 389.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">150<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> basis points) decrease in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EUR, USD or Sterling interest rates would have an equal and opposite impact to that<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 368.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shown below<span style="display: inline-block; height: 6.18pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35518"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.59000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 542.36pt; width: 595.44pt;"><ix:continuation id="f-5630-2"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 327pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 0pt; width: 80.25pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 63.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income statement impact of interest rate movements<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 50.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in income<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 11.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 6.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 13.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 50.08pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in income<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 21.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% (100 basis points) increase in Sterling interest rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1743" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5659">72</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 40.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1744" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5660">41</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5% (150 basis points) increase in Sterling interest rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 61.99pt;"></span></span><span style="left: 64.62pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1745" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5661">108</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 52.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1746" decimals="-6" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5662">62</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 64.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% (100 basis points) increase in US Dollar interest rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1747" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5663">43</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 64.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1748" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5664">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5% (150 basis points) increase in US Dollar interest rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1749" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5665">64</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 76.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1750" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5666">51</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1% (100 basis points) increase in Euro interest rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1751" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5667">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 88.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 67.81pt;"></span></span><span style="left: 70.44pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1752" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5668">9</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 100.5pt; width: 327pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 327pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.5% (150 basis points) increase in Euro interest rates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #e6e7e9; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1753" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5669">30</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 407.25pt; position: var(--position); top: 100.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1754" decimals="-6" sign="-" name="gsk:IncreaseDecreaseInIncomeThroughInterestRateMovements" scale="6" id="f-5670">13</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:continuation></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">261<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-4827-17"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">44. Financial instruments and <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 208.95999999999998pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">related<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 244.43pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(h) Contractual cash flows for non-derivative financial liabilities and derivative instruments<span style="display: inline-block; height: 8pt;"></span><span id="i89066ac732c64b14be7b71b458c956b7_35505"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following tables provide an analysis of the anticipated contractual cash flows including interest payable for the Group&#8217;s non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">derivative financial liabilities on an undiscounted basis. For the purpose of this table, debt is defined as all classes of borrowings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">except for lease liabilities. Interest is calculated based on debt held at 31 December without taking account of future issuance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Floating rate interest is estimated using the prevailing interest rate at the balance sheet date. Cash flows in foreign currencies are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">translated using spot rates at 31 December. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 201.86pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities" id="f-5671" continuedAt="f-5671-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 124.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 124.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 124.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 43.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on lease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade payables <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.189999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities not<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.369999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in net debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 43.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due in less than one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1755" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5672">2,181</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1756" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5673">540</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1755" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5674">168</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1755" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5675">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1755" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5676">14,440</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 42pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1755" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5677">17,370</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between one and two years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1757" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5678">1,411</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1758" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5679">500</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1757" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5680">222</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1757" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5681">34</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1757" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5682">1,247</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 54pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1757" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5683">3,414</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between two and three years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1759" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" scale="6" id="f-5684">723</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1760" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5685">484</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1759" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5686">146</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1759" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5687">29</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1759" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5688">1,593</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 66pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1759" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5689">2,975</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between three and four years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1761" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5690">2,362</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1762" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5691">434</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1761" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5692">109</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1761" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5693">23</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1761" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5694">1,461</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 78pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1761" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5695">4,389</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between four and five years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1763" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5696">1,213</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1764" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5697">383</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1763" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5698">73</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1763" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5699">20</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1763" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" scale="6" id="f-5700">913</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 90pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1763" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5701">2,602</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between five and ten years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1765" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5702">2,759</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1766" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-5703">1,646</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1765" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5704">299</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1765" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5705">53</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1765" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5706">2,318</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 102pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1765" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5707">7,075</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Greater than ten years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1767" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5708">5,320</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1768" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-5709">1,251</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1767" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5710">85</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1767" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5711">14</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1767" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5712">1,313</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 114pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1767" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5713">7,983</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross contractual cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1769" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5714">15,969</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1770" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-5715">5,238</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1769" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5716">1,102</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1769" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5717">214</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1769" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5718">23,285</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 424.5pt; overflow: hidden; position: var(--position); top: 126pt; width: 3pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 3pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1769" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5719">45,808</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5671-1"><div style="position: var(--position); top: 350.55pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 124.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 42pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 124.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 33.47pt; width: 124.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 43.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 39.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 34.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 37.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charge <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on lease <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.21pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 13.28pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trade payables <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.01pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.189999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.81pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 22.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities not<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 27.369999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in net debt<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 0pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 26.61pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 43.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 34.41pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 48.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Due in less than one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1771" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5720">2,660</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1772" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5721">547</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1771" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5722">156</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1771" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5723">41</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1771" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5724">14,526</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 42pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1771" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5725">17,930</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between one and two years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1773" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5726">1,436</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1774" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5727">507</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1773" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5728">214</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1773" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5729">36</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1773" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5730">1,469</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 54pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1773" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5731">3,662</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between two and three years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1775" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5732">1,477</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1776" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5733">466</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1775" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5734">134</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1775" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5735">31</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1775" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5736">1,150</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 66pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1775" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5737">3,258</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between three and four years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1777" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" scale="6" id="f-5738">742</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1778" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5739">449</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1777" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5740">114</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1777" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5741">27</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1777" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5742">1,406</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 78pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1777" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5743">2,738</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between four and five years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1779" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5744">2,359</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1780" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="f-5745">399</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1779" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5746">88</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1779" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5747">23</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1779" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" scale="6" id="f-5748">940</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 90pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1779" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5749">3,809</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between five and ten years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1781" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5750">3,054</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1782" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-5751">1,611</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1781" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5752">325</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1781" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5753">75</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1781" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5754">2,037</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 102pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1781" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5755">7,102</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Greater than ten years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1783" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5756">5,172</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1784" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-5757">1,467</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1783" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="f-5758">176</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 43.42pt;"></span></span><span style="left: 46.050000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1783" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5759">21</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1783" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5760">1,043</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 114pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1783" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5761">7,879</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 124.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 124.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross contractual cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 124.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1785" decimals="-6" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5762">16,900</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 184.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1786" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-5763">5,446</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 244.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 33.09pt;"></span></span><span style="left: 35.720000000000006pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1785" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5764">1,207</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 304.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 39.28pt;"></span></span><span style="left: 41.910000000000004pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1785" decimals="-6" name="gsk:FutureFinanceChargeOnFinanceLeases" scale="6" id="f-5765">254</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 364.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1785" decimals="-6" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5766">22,571</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 427.5pt; position: var(--position); top: 126pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.95pt;"></span></span><span style="left: 31.58pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1785" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5767">46,378</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below provides an analysis of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 217.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anticipated contractual cash flows<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 342.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for the Group&#8217;s derivative instruments excluding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity options which do not give rise to cash flows, and other embedded derivatives, which are not material, using undiscounted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash flows. Cash flows in foreign currencies are translated using spot rates at 31 December. The gross cash flows of foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange contracts are presented for the purpose of this table although, in practice, the Group uses standard settlement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 540pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements to reduce its liquidity requirements on these instruments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 555.89pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities" id="f-5768" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 483.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 153.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 3pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><span id="i3b9ac3fc24f54baf9a5671cfa2b8d000_0-0-1-1-821446"></span></td><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 0pt; width: 163.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.79pt; width: 163.5pt;"><span style="color: #000000; font-family: 'GSK Precision', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 143.81pt; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 0pt; width: 163.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.79pt; width: 163.5pt;"><span style="color: #000000; font-family: 'GSK Precision Light', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 144.28pt; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 7.2pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 14.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross cash inflows<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 14.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross cash outflows<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 14.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross cash inflows<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 14.25pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross cash outflows<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 25.5pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange forward <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts and swaps<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 25.5pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange forward <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts and swaps<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 25.5pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange forward <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts and swaps<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 25.5pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 2.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Foreign exchange forward <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contracts and swaps<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 68.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 153.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Less than one year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 51.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.66pt;"></span></span><span style="left: 54.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1787" decimals="-6" name="gsk:ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5769">28,567</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 51.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.2pt;"></span></span><span style="left: 51.830000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1787" decimals="-6" name="gsk:PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5770">28,634</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 51.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.66pt;"></span></span><span style="left: 54.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1788" decimals="-6" name="gsk:ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5771">31,961</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 51.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.2pt;"></span></span><span style="left: 51.830000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1788" decimals="-6" name="gsk:PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5772">31,944</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 153.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Between one and two years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 66.13pt;"></span></span><span style="left: 68.75999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1789" decimals="-6" name="gsk:ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" scale="6" id="f-5773">36</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 63.67pt;"></span></span><span style="left: 66.3pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1789" decimals="-6" name="gsk:PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" scale="6" id="f-5774">35</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1790" decimals="-6" name="gsk:ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:fixed-zero" scale="6" id="f-5775">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 70.27pt;"></span></span><span style="left: 72.89999999999999pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1790" decimals="-6" name="gsk:PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:fixed-zero" scale="6" id="f-5776">&#8211;</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 153.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 153.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gross contractual cash flows<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 153.75pt; position: var(--position); top: 75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.66pt;"></span></span><span style="left: 54.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1791" decimals="-6" name="gsk:ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5777">28,603</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 237pt; position: var(--position); top: 75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.2pt;"></span></span><span style="left: 51.830000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1791" decimals="-6" name="gsk:PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5778">28,669</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 320.25pt; position: var(--position); top: 75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 51.66pt;"></span></span><span style="left: 54.29pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1792" decimals="-6" name="gsk:ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5779">31,961</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 403.5pt; position: var(--position); top: 75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 49.2pt;"></span></span><span style="left: 51.830000000000005pt; position: var(--position);">(<ix:nonFraction unitRef="gbp" contextRef="c-1792" decimals="-6" name="gsk:PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="f-5780">31,944</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">262<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_526"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="f-5781" continuedAt="f-5781-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">45. Employee share schemes<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5781-1" continuedAt="f-5781-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK operates several <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employee s<span style="display: inline-block; height: 6.18pt;"></span><span id="i64d01e803b4c4157a1b84355aaad07bc_4573"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hare schem<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 225.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">es, including the Share Value Plan, whereby awards are granted to employees to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquire shares or ADS in GSK plc at no cost after a <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-242" name="gsk:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-5782"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 247.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 266.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> vesting period and the Performance Share Plan, whereby awards <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are granted to employees to acquire shares or ADS in GSK plc at no cost, subject to&#8239;the achievement by the Group of specified <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance targets. The Group also operates savings-related share option schemes, whereby options are granted to employees <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to acquire shares in GSK plc at a discounted price. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Grants of restricted share awards are normally exercisable at the end of the <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-242" name="gsk:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-5783"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 336.77000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 355.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 375.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> vesting or performance period. Awards are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">normally granted to employees to acquire shares or ADS in GSK plc but in some circumstances may be settled in cash. Grants <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under savings-related share option schemes are normally exercisable after <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-242" name="gsk:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-5784"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 334.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 353.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8217; saving. In accordance with UK practice, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">majority of options under the savings-related share option schemes are granted at a price <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1793" decimals="2" name="gsk:AtPercentageBelowMarketPrice" scale="-2" id="f-5785">20</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> below the market price ruling at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 249.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date of grant.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 265.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The total charge for share-based incentive plans in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 244.79000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 283.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-5786">347</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 327.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.04pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 351.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 356.40000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-10" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-5787">321</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 405.84000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 424.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-5788">314</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). Of this amount, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-242" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-5789">260</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-243" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-5790">244</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 176.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-244" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-5791">243</ix:nonFraction> million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 244.73000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) arose from the Share Value Plan. See Note 9, &#8216;Employee costs&#8217; for further <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">details.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 310.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK share award schemes<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 326.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share Value Plan<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 339.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under the Share Value Plan, share awards are granted to certain employees at no cost. The awards vest after <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 464.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">two and a half<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 516.8199999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.08pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1794" name="gsk:VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" format="ixt-sec:durwordsen" id="f-5792"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 73.00999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> years<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 95.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and there are no performance criteria attached. The fair value of these awards is determined based on the closing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share price on the day of grant, after deducting the expected future dividend yield of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="3" name="gsk:ExpectedFutureDividendYieldPercentageShareGranted" scale="-2" id="f-5793">3.4</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 391.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 410.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 414.71000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-243" decimals="3" name="gsk:ExpectedFutureDividendYieldPercentageShareGranted" scale="-2" id="f-5794">3.8</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 457.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">: <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 461.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="3" name="gsk:ExpectedFutureDividendYieldPercentageShareGranted" scale="-2" id="f-5795">3.2</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 481.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) over the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">duration of the award.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 386.37pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfEmployeeShareValuePlanTableTextBlock" id="f-5796" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 291.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 48.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of shares and ADS issuable<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 0pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 25.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number (000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 340.5pt; position: var(--position); top: 0pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 0pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 6.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number (000)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 0pt; width: 48.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 48.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 20.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 291.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;January 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 18.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1795" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5797">28,244</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 18.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1796" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5798">15,529</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards granted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 30.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-244" decimals="-3" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="3" id="f-5799">10,987</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 340.5pt; position: var(--position); top: 30.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-244" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-5800">13.00</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 30.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1797" decimals="-3" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="3" id="f-5801">6,133</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 30.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1797" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-5802">30.64</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards exercised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 42.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-244" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5803">9,538</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 42.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-1797" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5804">4,919</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards cancelled<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 54.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-244" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5805">1,718</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 54.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-1797" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5806">1,314</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 291.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 66.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1798" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5807">27,975</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 66.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1799" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5808">15,429</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards granted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 78.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-243" decimals="-3" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="3" id="f-5809">11,548</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 340.5pt; position: var(--position); top: 78.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-243" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-5810">12.79</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 78.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1800" decimals="-3" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="3" id="f-5811">6,449</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 78.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1800" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-5812">31.65</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards exercised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 90.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-243" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5813">8,599</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 90.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-1800" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5814">4,856</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards cancelled<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 102.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-243" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5815">1,144</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 102.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.03pt;"></span></span><span style="left: 30.66pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-1800" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="3" id="f-5816">797</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 291.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 114.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1801" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5817">29,780</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 114.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1802" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5818">16,225</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 126.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards granted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 126.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-242" decimals="-3" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="3" id="f-5819">12,023</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 340.5pt; position: var(--position); top: 126.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-242" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-5820">15.17</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 126.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 24.3pt;"></span></span><span style="left: 26.93pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1803" decimals="-3" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="3" id="f-5821">6,431</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 438pt; position: var(--position); top: 126.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1803" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-5822">39.49</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards exercised<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 138.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-242" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5823">9,384</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 138.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-1803" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5824">5,199</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 291.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Awards cancelled<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 150.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 21.84pt;"></span></span><span style="left: 24.47pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-242" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5825">1,225</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 150.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 28.03pt;"></span></span><span style="left: 30.66pt; position: var(--position);">(<ix:nonFraction unitRef="shares" contextRef="c-1803" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="3" id="f-5826">877</ix:nonFraction>)<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 291.75pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 291.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 291.75pt; position: var(--position); top: 162.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1804" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5827">31,194</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 389.25pt; position: var(--position); top: 162.75pt; width: 48.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 48.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.16pt;"></span></span><span style="left: 22.79pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1805" decimals="-3" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-5828">16,580</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 571.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Performance Share Plan<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under the Performance Share Plan, share awards are granted to Directors and senior executives at no cost. The percentage of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each award that vests is based upon the performance of the Group over a defined measurement period with dividends reinvested <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 605.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the same period. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 144.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For awards granted from <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 257.54pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the performance conditions are based on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 417.27000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="performancemeasure" contextRef="c-1806" decimals="0" name="gsk:NumberOfPerformanceMeasures" format="ixt-sec:numwordsen" scale="0" id="f-5829">four</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 431.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> measures over a <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1807" name="gsk:SharePlanPerformanceAssessmentPeriod" format="ixt-sec:durwordsen" id="f-5830"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 518.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 537.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance period. These are adjusted free cash flow (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 262.46pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1808" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5831">30</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 279.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), TSR (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 308.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1809" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5832">30</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 325.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), R&amp;D new product performance (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 453.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1810" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5833">20</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 470.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and pipeline <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">progress (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 91.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1811" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5834">20</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. For awards granted from 2022, the performance conditions are based on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 388.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="performancemeasure" contextRef="c-1812" decimals="0" name="gsk:NumberOfPerformanceMeasures" format="ixt-sec:numwordsen" scale="0" id="f-5835">five</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 401.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> measures over a <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1813" name="gsk:SharePlanPerformanceAssessmentPeriod" format="ixt-sec:durwordsen" id="f-5836"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.15000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 488.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-year<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 636.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance period. These are TSR (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1814" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5837">30</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 210.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), pipeline progress (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 286.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1815" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5838">20</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 303.5pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), profit measure (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 369.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1816" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5839">20</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">), sale measure (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1817" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5840">20</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 466.52000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and ESG <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 646.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1818" decimals="2" name="gsk:PercentageOfPerformanceSharePlan" scale="-2" id="f-5841">10</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 122.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">).&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The fair value of the awards is determined based on the closing share price on the day of grant. For TSR performance elements, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">this is adjusted by the likelihood of that condition being met, as assessed at the time of grant.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, awards were made of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 187.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-245" decimals="-5" name="gsk:NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" scale="6" id="f-5842">4.2</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198.70999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million shares at a weighted fair value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 352.65000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1819" decimals="2" name="gsk:WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" scale="0" id="f-5843">13.65</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 378.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 397.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1820" decimals="-5" name="gsk:NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" scale="6" id="f-5844">0.9</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 408.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million ADS at a weighted fair <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 85.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="gsk:WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" scale="0" id="f-5845">34.26</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, there were outstanding awards over <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1819" decimals="-5" name="gsk:NumberOfAwardsOutstandingInShareBasedPaymentArrangement" scale="6" id="f-5846">13.7</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 354.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million shares and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 426.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1821" decimals="-5" name="gsk:NumberOfAwardsOutstandingInShareBasedPaymentArrangement" scale="6" id="f-5847">2.4</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million ADS.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">263<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-5781-2"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">45. Employee share schemes continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share options and savings-related options<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the purposes of valuing savings-related options to arrive at the share-based payment charge, a Black-Scholes option pricing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">model has been used.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" id="f-5848" continuedAt="f-5848-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 138.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The assumptions used in the model are as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5848-1"><div style="position: var(--position); top: 187.15pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 352.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Grant<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Grant<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 10.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Grant<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk-free interest rate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1822" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-5849">4.24</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1823" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-5850">4.57</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 20.32pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 20.32pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1824" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-5851">3.37</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividend yield<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1822" decimals="3" name="gsk:DividendYieldShareOptionsGranted" scale="-2" id="f-5852">4.3</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1823" decimals="3" name="gsk:DividendYieldShareOptionsGranted" scale="-2" id="f-5853">4.0</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 26.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.46pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.46pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1824" decimals="3" name="gsk:DividendYieldShareOptionsGranted" scale="-2" id="f-5854">3.3</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 38.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Volatility<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.51pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.51pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1822" decimals="2" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-5855">34</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.51pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.51pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1823" decimals="2" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-5856">34</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 26.51pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 26.51pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1824" decimals="2" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-5857">36</ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 352.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expected life<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1822" name="gsk:ExpectedLifeOfShareOptionsGranted" format="ixt-sec:duryear" id="f-5858">3</ix:nonNumeric> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1823" name="gsk:ExpectedLifeOfShareOptionsGranted" format="ixt-sec:duryear" id="f-5859">3</ix:nonNumeric> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 15.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1824" name="gsk:ExpectedLifeOfShareOptionsGranted" format="ixt-sec:duryear" id="f-5860">3</ix:nonNumeric> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 352.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 352.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Savings-related options grant price (including <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 150.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1823" decimals="2" name="gsk:SavingsRelatedOptionsGrantPriceDiscount" scale="-2" id="f-5861"><ix:nonFraction unitRef="number" contextRef="c-1822" decimals="2" name="gsk:SavingsRelatedOptionsGrantPriceDiscount" scale="-2" id="f-5862"><ix:nonFraction unitRef="number" contextRef="c-1824" decimals="2" name="gsk:SavingsRelatedOptionsGrantPriceDiscount" scale="-2" id="f-5863">20</ix:nonFraction></ix:nonFraction></ix:nonFraction>%<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 165.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> discount)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1822" decimals="2" name="gsk:SavingsRelatedOptionsGrantPrice" scale="0" id="f-5864">11.27</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1823" decimals="2" name="gsk:SavingsRelatedOptionsGrantPrice" scale="0" id="f-5865">11.20</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1824" decimals="2" name="gsk:SavingsRelatedOptionsGrantPrice" scale="0" id="f-5866">11.39</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Expected volatility has been based on an evaluation of the historical volatility of the Company&#8217;s share price, particularly over the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">historical period commensurate with the expected term.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 298.18pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" id="f-5867" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Options outstanding for the Share Save Plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.74pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 42.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Savings-related<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.54pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share option schemes<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.599999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">000<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.06pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.86pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 18.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercise<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.419999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">price<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 397.5pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.870000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 46.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1825" decimals="-3" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="3" id="f-5868">5,449</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 46.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1825" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-5869">11.44</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Range of exercise prices on options outstanding at year end<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 58.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.04pt;"></span></span><span style="left: 18.669999999999998pt; position: var(--position);">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1825" decimals="2" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="f-5870">10.34</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 442.5pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: -5.53pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 32.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8212;&#160; &#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1825" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" format="ixt:num-dot-decimal" scale="0" id="f-5871">12.07</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 70.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted average market price on exercise during year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 70.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 16.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1793" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-5872">16.24</ix:nonFraction><span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Weighted average remaining contractual life<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 82.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 10.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1793" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-5873">2.1</ix:nonNumeric> years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 400.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Options over <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1793" decimals="-5" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="6" id="f-5874">1.7</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 115.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million shares were granted during the year under the savings-related share option scheme at a weighted average <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 410.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fair value of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="c-1825" decimals="2" name="gsk:WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" scale="0" id="f-5875">4.03</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 120.58pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 206.58999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 211.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1825" decimals="-5" name="gsk:NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" scale="6" id="f-5876">4.3</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.91000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> million of the savings-related share options were not exercisable. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 426.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There has been no change in the effective exercise price of any outstanding options during the year.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 442.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Employee Share Ownership Plan Trusts<span style="display: inline-block; height: 8pt;"></span><span id="i64d01e803b4c4157a1b84355aaad07bc_4545"></span><span id="i64d01e803b4c4157a1b84355aaad07bc_4574"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group sponsors Employee Share Ownership Plan (ESOP) Trusts to acquire and hold shares in GSK plc to satisfy awards <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">made under employee incentive plans. The trustees of the ESOP Trusts purchase shares with finance provided by the Group by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">way of loans or contributions. The costs of running the ESOP Trusts are charged to the income statement. Shares held by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ESOP Trusts are deducted from other reserves and amortised down to the value of proceeds, if any, receivable from employees on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exercise by a transfer to retained earnings. The trustees have waived their rights to dividends on the shares held by the ESOP <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trusts. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 140.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1196" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5877">64,314,305</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 182.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares were held in the ESOP Trusts, out of which <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 374.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1197" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5878">63,666,947</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 416.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were held for the future exercise <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 535.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of share awards and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 132.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="shares" contextRef="c-1198" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5879">647,358</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares were held for the Executive Supplemental <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.02000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Savings Plan<span style="display: inline-block; height: 6.18pt;"></span><span id="i64d01e803b4c4157a1b84355aaad07bc_4572"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 399.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 551.38pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" id="f-5880" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 397.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares held for share award schemes<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 6.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of shares (000)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1826" decimals="-3" name="gsk:NumberOfSharesHeldForShareAwardSchemes" format="ixt:num-dot-decimal" scale="3" id="f-5881">64,314</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);"><ix:nonFraction unitRef="shares" contextRef="c-1827" decimals="-3" name="gsk:NumberOfSharesHeldForShareAwardSchemes" format="ixt:num-dot-decimal" scale="3" id="f-5882">58,817</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 38.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 50.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominal value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1826" decimals="-6" name="gsk:NominalValueOfSharesHeldForShareAwardSchemes" scale="6" id="f-5883">20</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 50.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 30.88pt;"></span></span><span style="left: 33.51pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1827" decimals="-6" name="gsk:NominalValueOfSharesHeldForShareAwardSchemes" scale="6" id="f-5884">18</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Carrying amount<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1826" decimals="-6" name="gsk:CarryingValueOfSharesHeldForShareAwardSchemes" scale="6" id="f-5885">397</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 62.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1827" decimals="-6" name="gsk:CarryingValueOfSharesHeldForShareAwardSchemes" scale="6" id="f-5886">288</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 397.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 397.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Market value<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1826" decimals="-6" name="gsk:MarketValueOfSharesHeldForShareAwardSchemes" scale="6" id="f-5887">866</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 74.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 26.74pt;"></span></span><span style="left: 29.369999999999997pt; position: var(--position);"><ix:nonFraction unitRef="gbp" contextRef="c-1827" decimals="-6" name="gsk:MarketValueOfSharesHeldForShareAwardSchemes" scale="6" id="f-5888">853</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">264<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_535"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfPrincipalGroupCompaniesTextBlock" id="f-5890" continuedAt="f-5890-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="ie185e4dd03f2448cadabbbc77961fd02_0-0-1-1-823249"></span><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">46. Principal Group companies<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5890-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 142.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" id="f-5891" continuedAt="f-5891-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following represent the principal subsidiaries and their countries of incorporation of the Group at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 427.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-5891-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity share capital of these entities is shown in the percentage columns. All companies are incorporated in their principal country <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of operation except where stated.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 177.99pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 20.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 216pt;"><div><div style="line-height: 11pt; position: var(--position); top: 0.19pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">England<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 0pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 10.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Group Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 12pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1829" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5892">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Operations UK Limited <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 23.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1830" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5893">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 34.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Wellcome UK Limited <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 34.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1831" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5894">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Capital plc&#160; <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 45.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1832" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5895">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Export Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 57pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1833" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5896">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Finance plc<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 68.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1834" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5897">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Finance (No. 2) Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 79.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1835" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5898">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Holdings Limited<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 111.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(a) <span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 90.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1836" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5899">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline IHC Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 102pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1837" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5900">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 113.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property (No.2) Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 113.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1838" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5901">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 124.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property (No.3) Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 124.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1839" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5902">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 135.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property (No.4) Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 135.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1840" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5903">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 147pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property Development Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 147pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1841" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5904">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 158.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 158.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1842" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5905">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 169.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Research &amp; Development Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 169.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1843" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5906">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Services Unlimited<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 118.28999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(a)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 180.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1844" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5907">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline UK Limited <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 192pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1845" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5908">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 203.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline US Trading Limited <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 203.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1846" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5909">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 214.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Setfirst Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 214.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1847" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5910">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 225.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1848" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5911">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 237pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare Finance Limited <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 237pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1849" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5912">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare UK (No.3) Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 248.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1850" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5913">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare UK Limited<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 259.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1851" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5914">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 453.74pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 20.25pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 216pt;"><div><div style="line-height: 11pt; position: var(--position); top: 0.19pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Europe<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 0pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 10.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline AG (Switzerland)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 12pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1852" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5915">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Wellcome Production S.A.S (France)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 23.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1853" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5916">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 34.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline B.V. (Netherlands)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 34.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1854" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5917">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Biologicals SA (Belgium)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 45.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1855" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5918">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline GmbH &amp; Co. KG (Germany)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 57pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1856" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5919">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 68.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Manufacturing SpA (Italy)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 68.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1857" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5920">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Pharma GmbH (Austria)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 79.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1858" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5921">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Pharmaceuticals SA (Belgium)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 90.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1859" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5922">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline S.A. (Spain)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 102pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1860" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5923">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 113.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline S.p.A. (Italy)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 113.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1861" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5924">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 124.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Single Member A.E.B.E. (Greece)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 124.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1862" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5925">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 135.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Trading Services Limited (Republic of Ireland)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 207.01000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(b)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 135.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1863" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5926">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 147pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Capital B.V. (Netherlands)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 103.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(b)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 147pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1864" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5927">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 158.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Services Sp z o.o. (Poland)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 158.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1865" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5928">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 169.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Vaccines GmbH (Germany)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 169.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1866" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5929">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Vaccines S.r.l. (Italy)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 180.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1867" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5930">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JSC GlaxoSmithKline Trading (Russia)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 192pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1868" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5931">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 203.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratoire GlaxoSmithKline (France)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 203.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1869" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5932">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 214.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios ViiV Healthcare, S.L. (Spain)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 214.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1870" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5933">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 225.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare GmbH (Germany)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 225.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1871" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5934">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 237pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare S.r.l. (Italy)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 237pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1872" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5935">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 248.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare SAS (France)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 248.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1873" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5936">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 177.99pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 20.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 216pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 0pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 10.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax, Inc<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 15pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1874" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5937">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aiolos Bio, Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 26.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1875" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5938">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corixa Corporation<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 37.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 4.5pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.5pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1876" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5939">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Capital Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 48.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1877" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5940">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Holdings (Americas) Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 60pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1878" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5941">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline LLC<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 71.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1879" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5942">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human Genome Sciences, Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 82.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1880" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5943">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel Laboratories, Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 93.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1881" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5944">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tesaro, Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 105pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.59pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.59pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1882" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5945">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare Company<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 116.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1883" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5946">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.49pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 316.18pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 216pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 20.25pt;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 216pt;"><div><div style="line-height: 11pt; position: var(--position); top: 3.19pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Others<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 0pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 6.47pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 10.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">%<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 15pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Saudi Arabia Limited (Saudi Arabia)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 15pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1884" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5947">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Life Sciences FZE (United&#160;Arab&#160;Emirates)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 26.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1885" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5948">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Colombia S.A.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 37.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1886" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5949">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Wellcome Manufacturing Pte Ltd (Singapore)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 48.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1887" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5950">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline (Thailand) Limited (Thailand)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 60pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1888" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5951">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Biopharma Argentina S.A.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 71.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1889" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5952">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Australia Pty Ltd (Australia)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 82.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1890" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5953">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 93.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Brasil Limitada (Brazil)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 93.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1891" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5954">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Far East B.V. (Taiwan)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 105pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1892" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5955">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 116.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Ilaclari Sanayi ve Ticaret A.S. (Turkey)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 116.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1893" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5956">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 127.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Inc. (Canada)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 127.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1894" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5957">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 138.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline K.K. (Japan)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 138.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1895" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5958">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Korea Limited (Republic of Korea)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 150pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1896" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5959">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Limited (Hong Kong)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 161.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1897" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5960">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 172.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Mexico S.A. de C.V. (Mexico)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 172.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1898" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5961">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Pakistan Limited (Pakistan)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 183.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1899" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5962">82.6</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 195pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Pharmaceuticals Limited (India)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 195pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 8.76pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 8.76pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1900" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5963">75</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Enterprise Management Co, Ltd (China)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 206.25pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1901" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5964">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 217.5pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Pharma Vietnam Company Limited (Vietnam)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 217.5pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1902" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5965">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ID Biomedical Corporation of Quebec (Canada)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 228.75pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 4.62pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 4.62pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1903" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5966">100</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 240pt; width: 216pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 216pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare K.K (Japan)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 216pt; position: var(--position); top: 240pt; width: 20.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 2.63pt; position: var(--position);"><ix:nonFraction unitRef="number" contextRef="c-1904" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="f-5967">78.3</ix:nonFraction><span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 721.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(a)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directly held wholly-owned subsidiary of GSK plc.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 731.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(b)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Tax resident in UK.<span style="display: inline-block; height: 5.09pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 742.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">The subsidiaries and associates listed above principally affect the figures in the Group&#8217;s financial statements. Each of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 752.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Capital Inc., GlaxoSmithKline Capital plc, GlaxoSmithKline Finance plc, GSK Capital BV and GlaxoSmithKline LLC, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 762.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">is a wholly-owned finance subsidiary of the company, and the Company has fully and unconditionally guaranteed the securities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 772.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.011em; position: var(--position); text-decoration: none; white-space: pre;">issued by each.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">265<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_538"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="gsk:DisclosureOfLegalProceedingsExplanatoryTextBlock" id="f-5968" continuedAt="f-5968-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">47. Legal proceedings<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-5968-1" continuedAt="f-5968-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is involved in significant <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 186.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal and administrative <span style="display: inline-block; height: 6.18pt;"></span><span id="i59a0d33488c04eee9773c8d9f9f1ba75_19134"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 99.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, principally product liability, intellectual property, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax, anti-trust, consumer fraud and governmental investigations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The most significant of these matters, other than tax matters, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are described below. The Group makes provision for these <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings on a regular basis as summarised in Note 2, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Accounting principles and policies&#8217; and Note 32, &#8216;Other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions&#8217;. Note 2 also describes when disclosure is made of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings for which there is no provision. Legal expenses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incurred and provisions related to legal claims are charged to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">selling, general and administration costs. The Group does not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">believe that information about the amount sought by plaintiffs, if <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that is known, would be meaningful with respect to those legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings. This is due to a number of factors, including, but <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not limited to, the stage of proceedings, the entitlement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties to appeal a decision and clarity as to theories of liability, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 315.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">damages and governing law.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 64.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, the Group&#8217;s aggregate provision for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal and other disputes (not including tax matters described in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Note 14, &#8216;Taxation&#8217;) was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-9" decimals="-6" name="ifrs-full:LegalProceedingsProvision" format="ixt:num-dot-decimal" scale="6" id="f-5969">1,446</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. There can be no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assurance that any losses that result from the outcome of any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal proceedings will not materially exceed the amount of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions reported in the Group&#8217;s financial statements. If this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 392.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were to happen, it could have a material adverse impact on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 402.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results of operations of the Group in the reporting period in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which the judgements are incurred or the settlements entered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">into.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 438.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Intellectual property<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intellectual property claims include challenges to the validity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and enforceability of the Group&#8217;s patents on various products or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processes as well as assertions of non-infringement of those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patents. A loss in such cases could result in loss of patent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protection for the product at issue. The consequences of any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such loss could be a significant decrease in sales of that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product and could materially affect future results of operations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the Group.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 541.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Coreg<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In 2014, GSK initiated suit against Teva for inducing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infringement of its patent relating to the use of carvedilol <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 575.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 56.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Coreg<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) in decreasing mortality caused by congestive heart <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">failure. In June 2017, the case proceeded to a jury trial in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 596.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US District Court for the District of Delaware. The jury returned <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 606.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a verdict in GSK&#8217;s favour, awarding GSK lost profits and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 616.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonable royalties for a total award of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 203.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1905" decimals="-4" name="gsk:DamagesAwardedToGSK" format="ixt:num-dot-decimal" scale="6" id="f-5970">235.51</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 259.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. On 29 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">March 2018, the trial judge ruled on post-trial motions filed by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 636.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Teva and found that substantial evidence at trial did not support <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the jury&#8217;s finding of induced infringement, overturning the jury <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">award. GSK appealed, and on 2 October 2020, a divided panel <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Court of Appeals for the Federal Circuit reversed the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">district court&#8217;s ruling and reinstated the jury award in GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 687.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">favour. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 703.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 2 December 2020, Teva filed a petition for rehearing en <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 713.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">banc. The court granted Teva&#8217;s petition, but only for a rehearing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 724.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="member" contextRef="c-1906" decimals="0" name="gsk:NumberOfPanelMembersAtRehearing" format="ixt-sec:numwordsen" scale="0" id="f-5971">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 98.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-member panel that issued the original decision. On <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 734.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5 August 2021, the original panel issued its rehearing opinion <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 744.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where the majority again reinstated the jury&#8217;s damages award <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 754.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1907" decimals="-4" name="gsk:DamagesAwardedToGSK" format="ixt:num-dot-decimal" scale="6" id="f-5972">235.51</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 119.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in GSK&#8217;s favour. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Teva again filed a petition for rehearing en banc which was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rejected by the Court of Appeals for the Federal Circuit on 11 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February 2022. On 11 July 2022, Teva filed a petition for writ of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certiorari with the Supreme Court of the United States seeking <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to overturn the Federal Court decision. On 15 May 2023, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US Supreme Court denied Teva&#8217;s request.&#160; Certain issues <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remain to be resolved at the District Court. On 12 December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, the trial judge ruled that further briefing is needed. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">briefing is to be completed by 24 February 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 249.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">mRNA<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 262.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 25 April 2024, GSK filed a patent infringement suit against <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer Inc. and BioNTech SE in the United States District Court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the District of Delaware alleging infringement of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 495.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1908" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInfringed" format="ixt-sec:numwordsen" scale="0" id="f-5973">five</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 508.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK patents by the COVID-19 vaccine, COMIRNATY&#174;.&#160; On 14 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">August 2024, GSK filed a First Amended Complaint asserting <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 534.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1909" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInfringed" scale="0" id="f-5974">3</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 539.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">additional GSK patents against Pfizer/BioNTech bringing the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">total number of asserted patents to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 436.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1910" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInfringed" scale="0" id="f-5975">8</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; Pfizer/BioNTech filed an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Answer and Counterclaims to GSK&#8217;s First Amended Complaint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on 30 August 2024. Trial has yet to be scheduled.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 12 October 2024, GSK filed <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 423.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1911" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInfringed" format="ixt-sec:numwordsen" scale="0" id="f-5976">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 436.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> separate patent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infringement suits against Moderna, Inc. in the United States <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">District Court for the District of Delaware. The first suit alleges <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 390.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infringement of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1912" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInfringed" scale="0" id="f-5977">7</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 367.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK patents by the COVID-19 vaccine, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SPIKEVAX.&#160; The second suit alleges infringement of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 501.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1913" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInfringed" scale="0" id="f-5978">6</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 505.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patents by the RSV vaccine, mRESVIA.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 2 January 2025, Acuitas Therapeutics Inc. filed a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">declaratory judgment complaint against GSK, seeking <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">judgment that COMIRNATY does not infringe <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.57000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1914" decimals="INF" name="gsk:NumberOfPatentsAllegedlyInvalidlyInfringed" format="ixt-sec:numwordsen" scale="0" id="f-5979">five</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 487.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK patents.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acuitas also seeks a ruling that the patents are invalid.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 473.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">RSV<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 487.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 7 June 2022, Pfizer, Inc. filed suit in the London High Court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 497.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenging the validity and requesting revocation of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1915" decimals="0" name="gsk:NumberOfPatentsRevocationRequested" format="ixt-sec:numwordsen" scale="0" id="f-5980">three</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 519.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 507.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European patents relating to RSV vaccine technology. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 517.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corresponding invalidity suits against additional patents were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 527.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">filed in the District Court of the Hague in the Netherlands in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">January 2023 and in the Enterprise Court of Brussels in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Belgium in March 2023.&#160; In each of those matters GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">counterclaimed that Pfizer&#8217;s RSV vaccine infringes GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patents. On 2 August 2023, GSK filed a patent infringement suit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 578.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against Pfizer in the United States District Court for the District <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of Delaware alleging infringement of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 441.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1916" decimals="0" name="gsk:NumberOfPatents" format="ixt-sec:numwordsen" scale="0" id="f-5981">four</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> US GSK patents by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer&#8217;s RSV vaccine, Abrysvo.&#160; Additional patents have been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">added to the US litigation.&#160; Pfizer counterclaimed in the US that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">all patents are invalid, and that Pfizer&#8217;s product does not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">infringe. On 5 August 2024, GSK filed a patent infringement suit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on a fourth European patent in the European Unified Patent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Court (&#8220;UPC&#8221;) at the D&#252;sseldorf Local Division.&#160; On 14 August <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, Pfizer filed a patent revocation suit against that same <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">European patent in the UPC. <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">266<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-5968-2" continuedAt="f-5968-3"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">47. Legal proceedings continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The trial in the UK action took place in June 2023.&#160; On 7 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">October 2024, the London High Court ruled in Pfizer&#8217;s favour <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and invalidated <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.67pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="patent" contextRef="c-1917" decimals="0" name="gsk:NumberOfPatentsInvalidated" format="ixt-sec:numwordsen" scale="0" id="f-5982">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of GSK&#8217;s patents relating to RSV vaccine <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology. The Court held a hearing on 13 December 2024 at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which GSK sought the Court&#8217;s permission to appeal its 7 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">October 2024 ruling. On 16 January 2025, the court issued a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decision refusing permission to appeal. GSK is seeking <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">permission to appeal from the Court of Appeal.&#160; In the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Netherlands, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="hearing" contextRef="c-1918" decimals="INF" name="gsk:NumberOfSeparateFirstInstanceHearings" format="ixt-sec:numwordsen" scale="0" id="f-5983">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 116.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> separate first-instance hearings were held <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the parties await a decision.&#160; Trial dates have not been set <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in Belgium or the UPC. In the US, the Court has set a trial date <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of 3 August 2026. GSK is seeking monetary compensation from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer for Pfizer&#8217;s infringing sales of Abrysvo. GSK&#8217;s sales of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are not at issue in these litigations.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Product liability<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is currently a defendant in a number of product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability lawsuits.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 322.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Avandia<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 92.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="classaction" contextRef="c-1919" decimals="0" name="gsk:NumberOfClassActionsPending" format="ixt-sec:numwordsen" scale="0" id="f-5984">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> pending US class actions (both filed in 2010) by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">third-party payers which assert claims under the Racketeer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In&#64258;uenced and Corrupt Organizations Act (RICO) and state <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consumer protection laws. In December 2019, the Third Circuit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 377.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Court of Appeals reversed the summary judgements granted in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">favour of the Group and remanded the third-party payer cases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">back to district court. Discovery is complete, and class <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certification and summary judgment briefing has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 417.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">completed. A hearing on certain <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 173.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Daubert<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> motions relating to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 428.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">experts was held on 1 February 2024. On 25 October 2024, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">district court granted GSK&#8217;s motion to exclude Plaintiffs&#8217; expert <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on causation, and excluded a portion of Plaintiffs&#8217; damages <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expert. The Court has scheduled a hearing on Plaintiffs&#8217; motion <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for class certification for 12 March 2025, and a hearing on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s motion for summary judgment for 21 April 2025.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 494.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span><span id="i59a0d33488c04eee9773c8d9f9f1ba75_19113"></span><span id="i59a0d33488c04eee9773c8d9f9f1ba75_19135"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has been named in product liability lawsuits on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">behalf of individuals asserting personal injury claims arising out <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 528.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the use of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 102.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 129.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. The federal cases are part of a <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multidistrict Litigation (MDL) proceeding pending in the United <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">States District Court for the Southern District of Florida. Cases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have also been filed in a number of state courts, the majority of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which are in Delaware.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 585.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As announced on 9 October 2024 GSK reached agreements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 71.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="plaintiff" contextRef="c-1920" decimals="0" name="gsk:LossContingencyNumberOfPlaintiffsInCaseAgreementReached" scale="0" id="f-5985">10</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 80.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> plaintiff firms who together represent <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 220.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1920" decimals="2" name="gsk:PercentageOfPlaintiffsAgreementReached" scale="-2" id="f-5986">93</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 605.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 111.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="plaintiff" contextRef="c-1921" decimals="0" name="gsk:LossContingencyNumberOfPlaintiffsInCase" format="ixt:num-dot-decimal" scale="0" id="f-5987">80,000</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 137.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> claimants) of the Zantac state court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 616.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product liability cases pending against GSK in the United <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">States. Under these agreements, GSK will make an aggregate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 636.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payment of up to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 118.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1920" decimals="-8" name="gsk:LossContingencyDamageAwardedValue" format="ixt:num-dot-decimal" scale="9" id="f-5988">2.2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 158.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to resolve all U.S. state court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 646.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product liability cases handled by these plaintiff firms that meet <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 656.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreed eligibility and participation criteria (the &#8220;State Courts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Settlement&#8221;). The participating plaintiff firms are unanimously <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommending to their clients that they accept the terms of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 687.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">State Courts Settlement, which is expected to be fully <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implemented by the end of H1 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 713.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As of February 2025, the vast majority of the remaining state <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 723.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">court cases have resolved or been dismissed, such that less <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 734pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 72.53999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="number" contextRef="c-1922" decimals="2" name="gsk:PercentageOfStateCasesRemaining" scale="-2" id="f-5989">1</ix:nonFraction>%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 84.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the state court cases remain.&#160; There are no cases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 744.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with trial dates in 2025 and just <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 171.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="case" contextRef="c-1923" decimals="INF" name="gsk:NumberOfPersonalInjuryCasesDefendant" format="ixt-sec:numwordsen" scale="0" id="f-5990">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 184.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> personal injury cases with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 754.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trial dates in 2026, both of which are in Nevada.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 9 October 2024, GSK also reached an agreement in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principle to pay a total of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 398.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$<ix:nonFraction unitRef="usd" contextRef="c-1924" decimals="-6" name="gsk:LossContingencyDamageAwardedValue" format="ixt:num-dot-decimal" scale="6" id="f-5991">70</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to resolve the <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 493.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 520.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> qui <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tam complaint previously filed by Valisure. The agreement in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principle is subject to final approval from the Department of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Justice.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s appeal of the Delaware Superior Court&#8217;s decision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowing Plaintiffs to present expert evidence of general <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">causation on all <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 365.46000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="case" contextRef="c-1925" decimals="0" name="gsk:NumberOfCancerTypes" format="ixt-sec:numwordsen" scale="0" id="f-5992">ten</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 377.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> cancer types to a jury remains pending. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oral argument has been scheduled before the Delaware <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supreme Court on 16 April 2025. As previously disclosed, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="case" contextRef="c-1926" decimals="0" name="gsk:NumberOfProductLiabilityCasesDismissed" format="ixt:num-dot-decimal" scale="0" id="f-5993">14,000</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 385.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> product liability cases were dismissed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following the grant of defendants&#8217; Daubert motions in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">December 2022 in the Federal MDL proceeding. These are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now on appeal by the plaintiffs to the United States Court of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appeals for the Eleventh Circuit, along with appeals in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medical monitoring and consumer class action cases. GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remains confident in its position and will continue to vigorously <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">defend against those appeals.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Outside the US, there are <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 402.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="classaction" contextRef="c-1927" decimals="0" name="gsk:NumberOfClassActionsPending" format="ixt-sec:numwordsen" scale="0" id="f-5994">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 415.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> proposed class actions pending <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against GSK in Ontario and Quebec, Canada along with a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">class action in Israel.&#160; The Ontario action is in the process of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">being discontinued, and the Quebec action remains dormant.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are also approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 415.95000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="classaction" contextRef="c-1928" decimals="0" name="gsk:NumberOfClassActionsPending" scale="0" id="f-5995">120</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 429.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> individual actions that have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been filed in Canada.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 20 March 2020, the New Mexico Attorney General filed a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lawsuit against multiple defendants, including the Group, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alleging violations of state consumer protection and false <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advertising statutes, among other claims. This case remains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 431.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pending. On 11 November 2020, the Mayor &amp; City of Baltimore <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 442.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">filed an action against the Group alleging that <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 475.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 502.83000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased the risk of cancer and/or caused cancer in Baltimore <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, and that the Group failed to warn of or concealed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 472.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those risks. Fact and expert discovery is ongoing. The court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 482.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has set a trial date of 28 September 2026.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 4 February 2025, a putative securities class action lawsuit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">was filed in the US District Court for the Eastern District of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pennsylvania against GSK and certain officers on behalf of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purchasers of GSK publicly traded securities during the period <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5 February 2020 through 14 August 2022. The complaint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alleges that defendants made materially false and/or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">misleading statements or omissions with regard to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 493.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zantac<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 519.1600000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 575.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Zofran<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group was a defendant in over <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 438.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="case" contextRef="c-1929" decimals="0" name="gsk:NumberOfProductLiabilityCases" scale="0" id="f-5996">400</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 452.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> product liability cases <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">involving Zofran pending in a Multidistrict Litigation (MDL) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceeding in the District of Massachusetts. The cases alleged <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that children suffered birth defects due to their mothers&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ingestion of Zofran and/or generic ondansetron for pregnancy- <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related nausea and vomiting. Plaintiffs asserted that the Group <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sold Zofran knowing it was unsafe for pregnant women, failed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to warn of the risks and illegally marketed Zofran &#8220;off-label&#8221; for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use by pregnant women.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 686.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 1 June 2021, the MDL Court granted the Group&#8217;s motion for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 697.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">summary judgment on federal pre-emption grounds. The Court <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 707.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">found that the FDA was fully informed of all relevant safety <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 717.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information regarding Zofran and had repeatedly rejected any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 727.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attempt to add a birth defect warning to the label. At that time, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 737.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Court granted judgment for the Group in all cases pending <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 748.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the MDL (approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 404.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="case" contextRef="c-1930" decimals="0" name="gsk:NumberOfProductLiabilityCases" scale="0" id="f-5997">431</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 418.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> cases) and closed the MDL <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 758.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceeding. Plaintiffs appealed this decision and, on 9 January <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 768.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023, the United States Court of Appeals for the First Circuit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 778.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affirmed the district court&#8217;s decision in favour of the Group.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">267<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><ix:continuation id="f-5968-3" continuedAt="f-5968-4"><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">47. Legal proceedings continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 132.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There remains <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.4pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="case" contextRef="c-1931" decimals="0" name="gsk:NumberOfStateCourtCases" format="ixt-sec:numwordsen" scale="0" id="f-5998">one</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 124.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> state court case and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 204.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="classaction" contextRef="c-1931" decimals="0" name="gsk:NumberOfClassActionsPending" format="ixt-sec:numwordsen" scale="0" id="f-5999">four</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 219.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> proposed class <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions in Canada, which are not currently active and plaintiffs&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">counsel are seeking to discontinue.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 168.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sales and marketing and regulation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 184.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s marketing and promotion of its Pharmaceutical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Vaccine products are the subject of certain governmental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigations and private lawsuits brought by litigants under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 215.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">various theories of law.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 230.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Flovent<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 85.33pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; Arizona Attorney General<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 6 February 2025, the Arizona Attorney General filed a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lawsuit alleging violation of the state consumer protection <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statute. The lawsuit alleges that GSK engaged in deceptive and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unfair practices with respect to <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 169.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flovent<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 290.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK Korea &#8211; Proceedings under Fair Trade Laws<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In August 2020, GSK Korea was indicted under Korea&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Monopoly Regulation and Fair Trade laws in relation to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government tenders of HPV (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 162.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cervarix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.02999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) and PCV (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 237.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Synflorix<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 270.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 335.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines in 2018 and 2019. The prosecutor alleged that GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Korea, through the actions of at least <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 193.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="employee" contextRef="c-1932" decimals="0" name="gsk:NumberOfEmployeesInterferedWithTenderProcess" format="ixt-sec:numwordsen" scale="0" id="f-6000">one</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 207.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of its employees, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 355.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interfered with the tender process under the National <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Immunisation Programme by using &#8220;straw bidders.&#8221;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A former GSK Korea employee was also charged in his <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individual capacity by the prosecutor in relation to the same <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">matter. Further, a number of wholesalers are co-defendants in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the proceedings. On 1 February 2023, the court rendered a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guilty verdict in respect of all defendants. GSK Korea was fined <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">KRW<ix:nonFraction unitRef="krw" contextRef="c-1933" decimals="-6" name="gsk:LossContingenciesDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="f-6001">70</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 108.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> which is approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 198pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1933" decimals="0" name="gsk:LossContingenciesDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="f-6002">45,000</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 228.39999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. In July 2024, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the appellate court rendered a not-guilty verdict for all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">defendants, overturning the lower court&#8217;s decision. The case is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 463.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">now before the Korea Supreme Court.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Korea Fair Trade Commission (KFTC) also commenced <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proceedings regarding the same matter. KFTC hearings took <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">place in July 2023 and GSK Korea was found in violation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable fair trade law. The KFTC imposed a fine of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">KRW<ix:nonFraction unitRef="krw" contextRef="c-1934" decimals="-6" name="gsk:LossContingenciesDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="f-6003">351</ix:nonFraction>&#160;million<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 113.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> which is approximately <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<ix:nonFraction unitRef="gbp" contextRef="c-1934" decimals="0" name="gsk:LossContingenciesDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="f-6004">212,000</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 535.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">US electronic health records subpoena<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 19 March 2023, the Group received a subpoena from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United States Attorney&#8217;s Office for the Western District of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Virginia, which is working with the United States Department of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Justice Civil Division, seeking documents relating to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s electronic health record programmes.&#160; The Group is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cooperating with this enquiry.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 616.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Senate HELP Enquiry<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group received a letter dated 8 January 2024 from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">majority members of the US Senate Health, Education, Labor <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Pensions (&#8220;HELP&#8221;) Committee initiating an investigation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">into the pricing of inhalers for the treatment of asthma and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD. The letter is similar to letters received by a number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 680.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other pharmaceutical companies and requests information on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 690.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pricing, research in the treatment of respiratory diseases, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 700.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patenting and business practices. The Group is cooperating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 711.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 85.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enquiry<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 132.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Anti-trust/competition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 148.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Certain governmental actions and private lawsuits have been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 158.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">brought against the Group alleging violation of competition or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 168.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anti-trust laws.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 184.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Lamictal<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Purported classes of direct purchasers filed suit in the US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">District Court for the District of New Jersey alleging that the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group and Teva Pharmaceuticals unlawfully conspired to delay <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 228.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generic competition for <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 392.08000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lamictal<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, resulting in overcharges to <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the purchasers, by entering into an allegedly anti-competitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reverse payment settlement to resolve patent infringement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 259.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation. A separate count accuses the Group of monopolising <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the market.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 13 December 2018, the trial judge granted plaintiffs&#8217; class <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certification motion, certifying a class of direct purchasers. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 305.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group filed a Rule 23(f) motion in the Court of Appeals for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 315.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Third Circuit, challenging the class certification decision. On 22 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 326.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">April 2020, the Court of Appeals vacated the lower court&#8217;s grant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 336.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of class certification and remanded the issue back to the lower <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">court for further analysis.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 9 October 2020, the district court heard argument on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plaintiffs&#8217; renewed motion for class certification after remand. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 382.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 9 April 2021, the district court denied Plaintiffs&#8217; motion for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 392.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">class certification of the putative direct purchaser class, leaving <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a potential class of brand-only purchasers. Plaintiffs moved to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supplement their expert report and seek additional discovery to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support the addition of certain generic purchasers. On 21 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 433.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">January 2022, the district court denied Plaintiffs&#8217; motion to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 443.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supplement their expert report and seek additional discovery <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and held that the issue of generic purchasers had already been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decided and denied in the court&#8217;s ruling on decertification. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties conducted briefing on class certification as to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 484.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remaining brand-only purchasers, with plaintiffs also seeking to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 494.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">add a smaller category of purchasers.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 1 February 2023, the district court denied Plaintiffs&#8217; renewed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">class certification motion. A series of follow-on complaints have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 531.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been filed in the US District Court for the Eastern District of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pennsylvania by groups of alleged purchasers. The cases have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 551.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been consolidated with the previously pending case in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 561.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">District of New Jersey. Discovery is ongoing.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></ix:continuation></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">268<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 484.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 62.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 70.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 70.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 325.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 484.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 484.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes to the financial statements continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><ix:continuation id="f-5968-4" continuedAt="f-5968-5"><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">47<span style="display: inline-block; height: 8pt;"></span><span id="i59a0d33488c04eee9773c8d9f9f1ba75_19114"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 65.92pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">. Legal proceedings continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 132.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Commercial and corporate<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 148.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group is involved in certain contractual and/or commercial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 158.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disputes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 174.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Zejula Royalty Dispute<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 187.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In October 2012, Tesaro, Inc. (now a wholly owned subsidiary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 197.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of GSK) entered into <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 132.76999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="agreement" contextRef="c-1935" decimals="0" name="gsk:NumberOfWorldwidePatentLicenseAgreements" format="ixt-sec:numwordsen" scale="0" id="f-6005">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 145.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> worldwide patent licence agreements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with AstraZeneca UK Limited related to niraparib (later <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved as <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 102.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 125.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">). In May 2021, AstraZeneca filed a lawsuit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against Tesaro in the High Court, England and Wales alleging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that Tesaro failed to pay some of the royalties due under the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">license agreements. Tesaro has counterclaimed based on a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 259.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calculated overpayment.&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 132.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trial was held in the week of 6 March 2023 and judgment was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entered against the Group on 5 April 2023, ruling that all current <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 152.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uses of <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 334.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generate royalty-bearing sales under the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">wording of the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 359.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="agreement" contextRef="c-1936" decimals="0" name="gsk:NumberOfWorldwidePatentLicenseAgreements" format="ixt-sec:numwordsen" scale="0" id="f-6006">two</ix:nonFraction><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 372.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> licence agreements. On 12 June 2023, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Court of Appeal of England and Wales granted the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">request for permission to appeal the 5 April 2023 judgment.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The appeal was heard on 17 January 2024 and on 9 February <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 203.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 the Court of Appeal ruled in the Group&#8217;s favour, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">overturning the trial court&#8217;s judgment and determining that only <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 224.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 329.03000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> sales for uses falling within the licensed patents could <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be deemed royalty-bearing. AstraZeneca requested permission <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to appeal and on 28 May 2024, the UK Supreme Court rejected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AstraZeneca&#8217;s request. The appropriate quantum of royalties <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following the Court of Appeal&#8217;s judgement may be the subject of <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-5968-5">further proceedings.</ix:continuation>&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 306.86pt;" id="idc89fa1ee07645df9629d157a4b46752_541"></div><div style="position: var(--position); top: 306.86pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" id="f-6007" continuedAt="f-6007-1" escape="true"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">48. Post balance sheet events<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></ix:nonNumeric></div><ix:continuation id="f-6007-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 345.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 13 January 2025, GSK announced it had entered into an agreement to acquire IDRx, Inc. (IDRx) a clinical-stage <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 355.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. The acquisition <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">includes lead molecule, IDRX-42, a highly selective investigational small molecule tyrosine kinase inhibitor (TKI) being developed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as a first- and second-line therapy for the treatment of gastrointestinal stromal tumours.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.79pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">GSK acquired all of the outstanding equity interests (including all options and other incentive equity) in IDRx for up to </span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.99pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">US$</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="usd" contextRef="c-1937" decimals="-7" name="ifrs-full:ConsiderationPaidReceived" format="ixt:num-dot-decimal" scale="9" id="f-6008">1.15</ix:nonFraction>&#160;billion</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.33pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> of total cash consideration, comprising an upfront payment of US$</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="usd" contextRef="c-1938" decimals="-9" name="gsk:UpfrontCashConsiderationPaidReceived" format="ixt:num-dot-decimal" scale="9" id="f-6009">1</ix:nonFraction>&#160;billion</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 386.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> with potential for an additional </span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.19pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">US$</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"><ix:nonFraction unitRef="usd" contextRef="c-1938" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-6010">150</ix:nonFraction>&#160;million</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;"> success-based regulatory approval milestone payment. GSK is also be responsible for success-based milestone </span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.39pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">payments as well as tiered royalties for IDRX-42 owed to Merck KGaA, Darmstadt, Germany. The transaction was subject to </span><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.59pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">customary conditions, including applicable regulatory agency clearances under the Hart-Scott-Rodino Act in the US,</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 483.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsequently closed on 21 February 2025. Given the timing of the closure of the transaction, GSK expects to disclose the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisional accounting for the acquisition in the Q1 2025 Results Announcement.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.88pt; width: 595.44pt;"><span style="background-color: #ffffff; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><span style="background-color: inherit;">On 5 February 2025, GSK</span><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 151.57999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> announced its intention to implement a &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1939" decimals="-9" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="f-6011">2</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 333.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> share buyback programme <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.85pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to be completed over an 18 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 479.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">month period. The programme commenced on 24 February 2025 with an initial tranche of up to &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 413.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonFraction unitRef="gbp" contextRef="c-1940" decimals="-8" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="f-6012">0.7</ix:nonFraction>&#160;billion<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 449.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">269<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 501.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 96.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 6pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 140.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 149.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="4" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 183.75pt; position: var(--position); top: 0pt; width: 318pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 318pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 183.73pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="8" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_550"></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Investor<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="background-color: transparent; height: 841.91pt; left: 0.1pt; opacity: 1; position: var(--position); top: 0.12pt; width: 595.28pt; z-index: -1;"><div><div><div style="position: var(--position);"><img src="gsk-20241231_g49.jpg" alt="AR__main_divider_pages background.jpg" style="height: 841.91pt; width: 595.28pt;"/></div></div></div></div><div style="font-size: 12pt; line-height: 60pt; position: var(--position); top: 182.38pt; width: 595.44pt;"><span style="color: #ffffff; font-family: 'Arial', sans-serif; font-size: 60pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.01em; position: var(--position); text-decoration: none; white-space: pre;">Information<span style="display: inline-block; height: 43.68pt;"></span></span></div><div style="position: var(--position); top: 482.34pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 473.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 207.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 9.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 203.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 26.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 207.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In this section<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of employees<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 14.25pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_565">270</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 14.25pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Insider Trading Policies<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 14.25pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_38219">296</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 30.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical products and intellectual<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.83pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; property<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 32.25pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_571">275</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 32.25pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cyber security<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 32.25pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaba1f3b1f85449a9baa50bb8040a23a3_0-0-1-1-821446">296</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vaccine products and intellectual property <span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 63pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_574">276</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 63pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code of Ethics<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 63pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-1-821446">297</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 81pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 81pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplemental Guarantor Information<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 81pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i37d244f9bf254df68642a97cc2064c35_0-0-1-1-821446">297</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital and control<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_655">286</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 243.75pt; position: var(--position); top: 99pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Principal Accountant Fees and Service<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 99pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105646">297</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 117pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 117pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_661">288</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 243.75pt; overflow: hidden; position: var(--position); top: 117pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder services and contacts<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 117pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if82f25ba1b444b79b54f72c88eb84a57_0-0-1-1-821446">298</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 135pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial calendar 2025<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 135pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_664">289</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 243.75pt; overflow: hidden; position: var(--position); top: 135pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US law and regulation<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 135pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_685">299</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 153pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual General Meeting 2024<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 153pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_667">289</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 243.75pt; overflow: hidden; position: var(--position); top: 153pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public&#160; <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 15.83pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; Accounting Firm<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 153pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_688">301</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax information to shareholders<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 180.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_670">290</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 243.75pt; overflow: hidden; position: var(--position); top: 180.75pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance comparison<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 180.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_691">302</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 243.75pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 195.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_697">303</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 213.75pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles of association of GSK plc<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 213.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i11409e1e32b245dcbff808f3d7d6cd41_0-0-1-5-821446">292</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 243.75pt; overflow: hidden; position: var(--position); top: 213.75pt; width: 203.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 203.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glossary of terms<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447pt; position: var(--position); top: 213.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 6.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_703">311</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 231.75pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Material contracts<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 231.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1ed0f69669d6410b8634beaa3e754e83_0-0-1-5-821446">294</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 249.75pt; width: 207.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 207.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 8.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">American depository shares<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #f36633; border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 207.75pt; position: var(--position); top: 249.75pt; width: 26.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 26.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 5.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2f316a1474164b27aa0dc2bb426300d2_0-0-1-1-821446">295</a><span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">270<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_565"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i3c67e0b4da274536a9fa55dc8874fa09_0-0-1-1-824496"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of employees<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 262.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 262.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 1.34pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 2.63pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Number of employees<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">12,024<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">12,205<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 11.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">11,946<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Europe<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 22.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">32,208<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 22.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">32,675<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 22.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">31,800<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">International<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">24,397<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">25,332<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 33.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">25,654<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">68,629<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">70,212<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 45pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">69,400<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 6.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Manufacturing<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">23,082<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">23,159<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">23,292<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 72.75pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Selling<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">25,047<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">26,193<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">26,310<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Administration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 82.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);">7,806<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 82.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);">7,888<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 82.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 20.55pt;"></span></span><span style="left: 23.18pt; position: var(--position);">7,605<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 262.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 262.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research and development<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">12,694<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">12,972<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">12,193<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">68,629<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">70,212<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 1pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 102pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 16.41pt;"></span></span><span style="left: 19.04pt; position: var(--position);">69,400<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The geographic distribution of employees in the table above is based on the location of GSK&#8217;s subsidiary companies. The number <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of employees is the number of permanent employed staff at the end of the financial period. It excludes those employees who are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employed and managed by GSK on a contract basis.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">271<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipelines, products and intellectual property<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_568"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i1bc4fd6132a8429dba354d6173c8333f_0-0-1-1-824424"></span><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.017em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceuticals and Vaccines product development pipeline<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 147.33pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 232.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 20.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 30pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 182.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 20.25pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 3.29pt; width: 20.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 20.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 30pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.16pt; width: 30pt;"><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 182.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 5.16pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In-license or other alliance relationship with third party<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 20.25pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 30pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#x5E;<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 182.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare, a global specialist HIV company with <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK, Pfizer, Inc. and Shionogi Limited as shareholders, is <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible for developing and delivering HIV medicines<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 20.25pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 30pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BLA<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 182.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biological Licence Application<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 20.25pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 30pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAA<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 51.75pt; width: 182.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Marketing Authorisation Application (Europe)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 20.25pt; overflow: hidden; position: var(--position); top: 63pt; width: 30pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 30pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NDA<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 63pt; width: 182.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 182.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">New Drug Application (US)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 147.33pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 32.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 204pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 32.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 32.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 32.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 204pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 32.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 32.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 32.25pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 204pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.19pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Submitted<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 32.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 32.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 32.25pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 204pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.79pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Evaluation of clinical pharmacology, usually conducted in <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 12.19pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volunteers<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 32.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 32.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 32.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 204pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Determination of dose and initial evaluation of efficacy, conducted <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in a small number of patients<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 32.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 32.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 32.25pt; overflow: hidden; position: var(--position); top: 63pt; width: 204pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.63pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Large comparative study (compound versus placebo and/or <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 11.03pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established treatment) in patients to establish clinical benefit&#160;  and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 19.43pt; width: 204pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">safety<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 246.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAA and NDA/BLA regulatory review milestones shown in the table below are those that have been achieved. Future filing dates <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 256.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are not included in this list.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 269.25pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 417pt; overflow: hidden; position: var(--position); top: 0pt; width: 70.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieved regulatory <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review milestones<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compound<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 129.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mechanism of Action/Vaccine Type<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 162pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indication<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NDA/BLA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 210pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 210pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory Immunology and Inflammation<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-interleukin 5 (IL5) antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 44.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Nov24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="4" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 64.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depemokimab<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 46.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="4" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 64.5pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-acting anti-interleukin 5 (IL5) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Dec24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 55.5pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Dec24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 210pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chronic rhinosinusitis with nasal polyps <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(CRSwNP)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 417pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Dec24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Dec24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Eosinophilic granulomatosis with polyangiitis <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(EGPA)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 88.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hypereosinophilic syndrome (HES)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">camlipixant<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 120pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P2X3 receptor antagonist<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 120pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Refractory chronic cough<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">latozinemab<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 39.879999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-sortilin monoclonal antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Frontotemporal dementia (FTD) due to <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">heterozygous mutations in the progranulin gene<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">linerixibat<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ileal bile acid transporter (IBAT) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cholestatic pruritus in primary biliary cholangitis <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(PBC)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 171.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 171.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beta 2 adrenergic receptor agonist<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 171.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, low carbon version of metered dose <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inhaler<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 171.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: italic; font-weight: normal; left: 28.310000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 42pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 192pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-B lymphocyte stimulator (BLys) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">monoclonal antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 192pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Systemic sclerosis associated interstitial lung <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 210pt; overflow: hidden; position: var(--position); top: 212.25pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 4.22pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interstitial lung disease associated with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 13.22pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connective tissue disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 212.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 234pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK1070806<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 234pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-interleukin 18 (IL18) antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 234pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Atopic dermatitis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 234pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 246pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3915393<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 246pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Transglutaminase 2 (TG2) inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 246pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pulmonary fibrosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 246pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 258pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4527226 (AL101)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 258pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-sortilin monoclonal antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 258pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alzheimer&#8217;s disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 258pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4532990<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 47.209999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HSD17B13 RNA interference<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-alcoholic steatohepatitis/Metabolic <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dysfunction-associated steatohepatitis (NASH/<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MASH)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4532990<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HSD17B13 RNA interference<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alcohol-related liver disease (ALD)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 309.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5784283<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 309.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Long-acting anti-thymic stromal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lymphopoietin (TSLP) monoclonal <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 210pt; overflow: hidden; position: var(--position); top: 309.75pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 309.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belantamab<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 38.669999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B-cell maturation antigen binder<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Systemic lupus erythematosus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3862995<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-interleukin 33 (IL33) antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 355.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3888130<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 355.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-interleukin 7 (IL7) antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 355.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Autoimmune disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 355.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4172239<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DNMT1 inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 210pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sickle cell disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 379.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4347859<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 379.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Interferon pathway modulator<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 379.5pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Systemic lupus erythematosus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 379.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 78.6pt; left: 48.69pt; opacity: 1; position: var(--position); top: 731.48pt; width: 486pt; z-index: 1;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 0pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brand names appearing in italics are trade marks owned by or licensed to the GSK group of companies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 15.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase II/III study. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 26.29pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II study start expected in 2025.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.69pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I study start imminent.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 47.09pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-registrational.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 57.49pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase I/II study<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 67.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has an exclusive global license option to co-develop and commercialise the candidate.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">272<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipelines, products and intellectual property continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceuticals and Vaccines product development pipeline continued <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 123.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 485.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 80.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 414.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 70.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.62pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieved regulatory <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.42pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review milestones<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18pt; width: 80.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.4pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compound<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 18pt; width: 129.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.4pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mechanism of Action/Vaccine Type<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 210pt; overflow: hidden; position: var(--position); top: 18pt; width: 159.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indication<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 18pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 414.75pt; overflow: hidden; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 450pt; overflow: hidden; position: var(--position); top: 18pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.4pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NDA/BLA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 27.75pt; width: 369.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 5.06pt; width: 369.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory Immunology and Inflammation continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4527363<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B-cell modulator<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Systemic lupus erythematosus<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4528287<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 57pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti IL23-IL18 bispecific antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 57pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inflammatory bowel disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 57pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 80.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4771261<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Monoclonal antibody against novel <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">kidney target<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Autosomal dominant polycystic kidney disease <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5462688<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RNA-editing oligonucleotide <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alpha-1 antitrypsin deficiency<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 80.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 80.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5926371<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 80.25pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti CD19-CD20-CD3 trispecific <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 210pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 159.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 159.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Autoimmune disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 369.75pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 11.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 88.47pt; left: 54.66pt; opacity: 1; position: var(--position); top: 715.28pt; width: 486pt; z-index: 2;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 0pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brand names appearing in italics are trade marks owned by or licensed to the GSK group of companies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 15.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase II/III study. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 26.29pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II study start expected in 2025.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.69pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I study start imminent.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 47.09pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-registrational.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 57.49pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase I/II study<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 67.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has an exclusive global license option to co-develop and commercialise the candidate.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div><div style="position: var(--position); top: 254.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 209.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 209.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="5" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 108.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(belantamab <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mafodotin)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 34.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="5" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 108.75pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADC targeting B-cell maturation <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antigen<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2L+ Multiple myeloma combination with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pomalyst and dexamethasone<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 417pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Jun24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Sep24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 36pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2L+ Multiple myeloma combination with Velcade <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and dexamethasone<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 417pt; overflow: hidden; position: var(--position); top: 36pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Jun24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 36pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Sep24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1L Multiple myeloma combination with Revlimid <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and dexamethasone<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multiple myeloma in combination with anti-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer treatments (platform study)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 79.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1L Multiple myeloma combination with Velcade, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revlimid and dexamethasone<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="7" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 105.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (dostarlimab)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 73.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="7" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 105.75pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 123pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-programmed cell death protein 1 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receptor (PD-1) antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 123pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1L primary advanced/recurrent endometrial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 123pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 123pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Jan25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 123pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Aug 24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1L Endometrial cancer combination with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">niraparib<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 143.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 163.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Peri-operative dMMR/MSI-H colon cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 163.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unresected head and neck squamous cell <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">carcinoma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 174.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 195pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-small cell lung cancer<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 86.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(4)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 195pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Neoadjuvant dMMR/MSI-H rectal cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 206.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 217.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Previously untreated MMRp/MSS colon cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 217.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(momelotinib)&#8224;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JAK1, JAK2 and ACVR1 inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Myelofibrosis with anaemia<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Jan24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 228.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Sep23<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 49.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 249pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belrestotug<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 36.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 49.5pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 249pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-TIGIT antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 249pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-small cell lung cancer combination with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">novel immunotherapy combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 249pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Squamous cell carcinoma of the head and neck <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combination with novel immunotherapy <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combinations<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 269.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cobolimab<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 33.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-T-cell immunoglobulin and mucin <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">domain-3 (TIM-3) antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2L Non-small cell lung cancer combination with <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli (dostarlimab) and docetaxel<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 298.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 40.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 318.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 20.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (niraparib)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 55.879999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 40.5pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 318.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Poly (ADP-ribose) polymerase (PARP) <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1/2 inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 318.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1L Maintenance ovarian cancer combination <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with Jemperli (dostarlimab)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 318.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 339pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1L Maintenance non-small cell lung cancer <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">combination with pembrolizumab<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 339pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">273<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipelines, products and intellectual property continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceuticals and Vaccines product development pipeline continued <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 0pt; width: 70.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.74pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieved regulatory <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.54pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review milestones<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 79.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compound<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 129.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mechanism of Action/Vaccine Type<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 162.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indication<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 372pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 417pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 20.25pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NDA/BLA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4381562<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-PVRIG antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 32.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nelistotug<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 31.580000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anti-CD96 antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 43.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belantamab<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B-cell maturation antigen binder<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Multiple myeloma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4418959<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(IDE-275)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 72pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Werner Helicase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 72pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dMMR/MSI-H solid tumours<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4524101<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DNA polymerase theta inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 92.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 103.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5733584<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 103.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADC targeting B7-H4<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 103.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gynaecologic malignancies<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 103.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5764227<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADC targeting B7-H3<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Solid tumours<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 114.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 126pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">XMT-2056 (wholly <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">owned by Mersana <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Therapeutics)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 45.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;(6)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 126pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">STING agonist ADC<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 126pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 126pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 161.25pt; width: 209.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 209.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV&#x5E;<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cabotegravir<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV integrase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 175.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH3810109<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 39.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV broadly neutralizing antibody<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH3739937<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 210pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV maturation inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 210pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 210pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 224.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH4011499<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 224.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV capsid protein inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 224.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 224.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH4524184<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 39.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV integrase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 238.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">VH4527079<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV entry inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 385.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 209.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 209.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infectious Diseases<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 40.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(RSV vaccine)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 47.269999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 40.5pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recombinant protein, adjuvanted<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory syncytial virus prophylaxis in older <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adult population 50-59 years of age<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Jul24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Aug24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 34.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory syncytial virus prophylaxis in adult <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">population 18-49 years of age at increased risk<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 34.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Penmenvy<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Men ABCWY 1<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 51.779999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">st<span style="display: inline-block; height: 3.549pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 55.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Gen)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recombinant protein, outer membrane <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesicle, glycoconjugate vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prevention of invasive disease caused by N. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningitis serogroups A, B, C, W and Y in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adolescents 10-25 years of age<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Approved<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A: Feb25<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 22.5pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gepotidacin<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 37.809999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="2" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 22.5pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 84pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Triazaacenaphthylene bacterial type II <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">topoisomerase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 84pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Uncomplicated urinary tract infection (uUTI)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registration<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 84pt; width: 35.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 35.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S: Jul24<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 95.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Urogenital gonorrhoea (GC)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 95.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">bepirovirsen<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 40.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HBV antisense oligonucleotide<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chronic hepatitis B virus infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 372pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 30pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recombinant protein and outer <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">membrane vesicle vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prevention of invasive disease caused by N. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningitis serogroup B in individuals 2 months <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of age and older (US)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 30pt; left: 372pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ibrexafungerp<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 45.239999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antifungal glucan synthase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Invasive candidiasis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tebipenem pivoxil<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 57.19pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antibacterial carbapenem<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Complicated urinary tract infection (cUTI)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 165.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 5.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Varicella new strain<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 63.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 180pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Live, attenuated vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 180pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 1.22pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active immunization for the prevention of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 10.22pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">varicella in individuals 12 months of age and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 19.22pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">older<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 372pt; overflow: hidden; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase III<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">alpibectir<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 29.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ethionamide booster<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tuberculosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 222pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ganfeborole<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 39.059999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 222pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leucyl t-RNA synthetase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 222pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tuberculosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 222pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Malaria RTS,S <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(fractional dose)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 53.01pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recombinant protein, adjuvanted <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Malaria prophylaxis&#160; (Plasmodium falciparum)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shigella<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 26.220000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Generalized Modules for Membrane <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Antigens (GMMA) vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shigella diarrhea prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 78.6pt; left: 53.94pt; opacity: 1; position: var(--position); top: 716.21pt; width: 486pt; z-index: 3;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 0pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brand names appearing in italics are trade marks owned by or licensed to the GSK group of companies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 15.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase II/III study. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 26.29pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II study start expected in 2025.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.69pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I study start imminent.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 47.09pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-registrational.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 57.49pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase I/II study<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 67.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has an exclusive global license option to co-develop and commercialise the candidate.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">274<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipelines, products and intellectual property continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceuticals and Vaccines product development pipeline continued <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 79.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 129.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 162.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 35.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 417pt; overflow: hidden; position: var(--position); top: 0pt; width: 70.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.99pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Achieved regulatory <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.79pt; width: 70.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">review milestones<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 79.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compound<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 129.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 129.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mechanism of Action/Vaccine Type<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 162.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indication<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 417pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 452.25pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 35.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NDA/BLA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 209.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 209.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infectious Diseases continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CMV<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 16.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjuvanted recombinant subunit <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cytomegalovirus (CMV) infection prophylaxis in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">females 16-49 years of age<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Men ABCWY (2nd <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Gen)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 16.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 63pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Recombinant protein, outer membrane <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vesicle, conjugated vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 63pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prevention of invasive disease caused by N. <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningitis serogroup A,B,C,W and Y in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adolescents and children 6 weeks of age and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">older<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 63pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">iNTS (Typhimurium + <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Enteritidis)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 34.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bivalent Generalized Modules for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Membrane Antigens (GMMA) vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Invasive non-typhoidal salmonella<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">iNTS (S. typhimurium + <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S. enteritidis + <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">S.Typhi)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 27.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bivalent Generalized Modules for <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Membrane Antigens (GMMA) vaccine <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and typhoid conjugate vaccine (TCV)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Invasive non-typhoidal salmonella and typhoid <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fever<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA Seasonal Flu<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 66.77pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active immunization for the prevention of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenza disease in adults 18 years and older<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 171pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA COVID-19<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 57.699999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 171pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 171pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active immunization to prevent COVID-19 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease caused by SARS-CoV-2 in individuals <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12 years and older<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 171pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 200.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Measles, mumps, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rubella &amp; varicella new <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strain vaccine <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 200.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Live, attenuated vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 200.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active immunization for the prevention of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measles, mumps, rubella, and varicella in <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">children 12 months through 12 years of age<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 200.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pneumococcal 24-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">valent - paed<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 42.739999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MAPS Pneumococcal 24-valent paed<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prevention of invasive pneumococcal disease, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pneumonia, and acute otitis media caused by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Streptococcus pneumoniae 24 serotypes <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included in the vaccine in children aged 6 weeks <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 38.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">- 17 years<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 276.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA Flu H5N1 pre-<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pandemic<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 32.059999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 276.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 276.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic preparedness registration for active <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">immunization of adults 18+ YoA for the <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prevention of disease caused by influenza A <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">virus H5N1 subtype contained in the vaccine <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 276.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 315pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">daplusiran + <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tomligisiran<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 37.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 315pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hepatitis B virus-targeted siRNA <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sequential combination<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 315pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chronic hepatitis B virus infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 315pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sanfetrinem cilexetil<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 64.96pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Serine beta lactamase inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tuberculosis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salmonella (typhoid + <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">paratyphoid A)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 47.709999999999994pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bivalent conjugate vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salmonella (typhoid + paratyphoid A) enteric <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fever<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 366.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3772701<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 366.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P. falciparum whole cell inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 366.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Malaria<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 366.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 378pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3882347<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 378pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FimH antagonist<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 378pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Uncomplicated urinary tract infection (uUTI) <span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 378pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 389.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3923868<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 389.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PI4K beta inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 389.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rhinovirus disease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 389.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 400.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK3965193<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 400.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PAPD5/PAPD7 inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 400.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chronic hepatitis B virus infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 400.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK4024484<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P. falciparum whole cell inhibitor<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Malaria<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 423pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5251738<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 423pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">TLR8 agonist<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 423pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chronic hepatitis B virus infection<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 423pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 41.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 434.25pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK5102188<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 44.519999999999996pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 434.25pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjuvanted recombinant subunit <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 434.25pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active immunization for the prevention of urinary <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tract infection (UTI) caused by<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uropathogenic Escherichia coli (UPEC) in 18+ <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 162.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adults at increased risk.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 41.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 434.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 475.5pt; width: 79.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA Seasonal Flu/<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 79.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COVID-19<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 34.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8224;(5)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 79.5pt; overflow: hidden; position: var(--position); top: 475.5pt; width: 129.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 129.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mRNA vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 209.25pt; overflow: hidden; position: var(--position); top: 475.5pt; width: 162.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Active immunization for the prevention of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenza disease and COVID-19 disease <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">caused by SARS-CoV-2 in adults 18 years and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 162.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">older<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 372pt; overflow: hidden; position: var(--position); top: 475.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="background-color: transparent; height: 78.6pt; left: 54.66pt; opacity: 1; position: var(--position); top: 717.71pt; width: 486pt; z-index: 4;"><div><div><div><div style="line-height: 8.5pt; position: var(--position); top: 0pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brand names appearing in italics are trade marks owned by or licensed to the GSK group of companies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 15.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase II/III study. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 26.29pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase II study start expected in 2025.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 36.69pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phase I study start imminent.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 47.09pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-registrational.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 57.49pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(5)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In Phase I/II study<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 67.89pt; width: 486pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(6)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 11.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK has an exclusive global license option to co-develop and commercialise the candidate.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">275<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 21.28pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipelines, products and intellectual property continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_571"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 490.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 490.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 490.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.028em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical products and intellectual property<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 9.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 9.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.16pt; width: 120pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent expiry dates<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 54.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 84.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Products<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 138pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compounds<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 138pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indication(s)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 9.75pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EU<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 21pt; width: 222.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 222.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Specialty Medicines and Intellectual Property<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 222.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Apretude<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabotegravir<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV prevention<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031* <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026-2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 45.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabenuva/Vocabria <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">+ Rekambys<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cabotegravir, rilpivirine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV/AIDS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031* <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026-2038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 67.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rukobia<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fostemsavir<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV/AIDS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 89.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2034<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 111pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dovato<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 111pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir, lamivudine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 111pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV/AIDS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 111pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030-2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 111pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029-2034<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 35.379999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Juluca<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir, rilpivirine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV/AIDS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Triumeq<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir, lamivudine and abacavir<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV/AIDS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 154.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tivicay<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dolutegravir<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HIV/AIDS<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 176.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 198pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory/Immunology<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 210pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Benlysta, Benlysta <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SC and IV)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 210pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belimumab<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 210pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">systemic lupus erythematosus, lupus <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nephritis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 210pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029- 2035<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 210pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2035<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 234pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nucala<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 234pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mepolizumab<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 234pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, CRSwNP, EGPA, HES<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 234pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029-2036<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 234pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028- 2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.25pt; width: 222.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oncology<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blenrep<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">belantamab mafodotin<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relapsed/refractory multiple myeloma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2032 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 259.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2032<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jemperli<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dostarlimab<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dMMR/MSI-H recurrent/ advanced <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">endometrial cancer, dMMR solid tumours<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2035* <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2034-2038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 279.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2036 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ojjaara/Omjjara<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">momelotinib<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">myelofibrosis in patients with anemia<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2035-2040<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2039*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zejula<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">niraparib<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ovarian cancer<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2027-2039<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2032 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029-2037<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 351.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 3pt; width: 222.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pandemic<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Xevudy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sotrovimab<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Early treatment of COVID-19<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2041<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 363.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2041<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 537.52pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 222.75pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 222.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Medicines and Intellectual Property<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 12.75pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.25pt; width: 222.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 27pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Anoro Ellipta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 27pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">umeclidinium bromide/vilanterol <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trifenatate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 27pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 27pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2027<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 27pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2030<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flixotide/Flovent<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fluticasone propionate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Relvar/Breo Ellipta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fluticasone furoate/vilanterol trifenatate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2027-2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 58.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028 <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Seretide/Advair<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">salmeterol xinafoate/fluticasone <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">propionate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 78.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trelegy Ellipta<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 99pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fluticasone furoate/vilanterol trifenatate/<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">umeclidinium bromide<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 99pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">COPD, asthma<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 99pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2027<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 99pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025-2032<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 123pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ventolin<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 123pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Salbutamol sulphate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 123pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Asthma, COPD<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 123pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 123pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 134.25pt; width: 222.75pt;"><div><div style="line-height: 8pt; position: var(--position); top: 5.25pt; width: 222.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other General Medicines<span style="display: inline-block; height: 5.82pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Augmentin<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amoxicillin trihydrate/potassium <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clavulanate<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common bacterial infections<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NA<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 148.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lamictal<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lamotrigine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Epilepsy, bipolar disorder<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 168.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 728.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent expiry dates in normal text relate to the latest expiring new molecular entity patents in the relevant territory. <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 414.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent expiry dates in italics relate to <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 736.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other patents<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 105.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Where appropriate, unless otherwise indicated all patent expiry dates include granted Patent Term Extensions in the US, granted <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 745.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplementary Protection Certificates in EU, and Paediatric Exclusivity periods. Additional exclusivities (for example regulatory data protection) may exist <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 753.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">but are not listed in the table.&#160; (* = date includes pending PTE in US or SPC in EU)<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 763.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 11.34pt;"></span></span><span style="left: 65.2pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 24.66pt;"></span></span><span style="left: 89.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 125.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 161.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 197.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 233.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 269.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 305.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span><span style="left: 341.86pt; position: var(--position);"><span style="display: inline-block; height: 5.09pt; width: 36pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">276<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 7.84pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipelines, products and intellectual property continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 23.84pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical products and intellectual property continued <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 125.59pt;" id="idc89fa1ee07645df9629d157a4b46752_574"></div><div style="position: var(--position); top: 125.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.028em; position: var(--position); text-decoration: none; white-space: pre;">Vaccines and Intellectual Property<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 158.03pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 84.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 138pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 60pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 120pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 120pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent expiry dates<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 54.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">1<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 84.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Products<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 138pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Compounds<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 138pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indication(s)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 60pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EU<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Arexvy<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory syncytial virus vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Respiratory syncytial virus vaccination<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2030<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 22.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2032<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bexsero<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningococcal group-B vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis group B prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 33.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2028<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 45pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Boostrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 45pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diphtheria, tetanus, acellular<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pertussis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 45pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diphtheria, tetanus, acellular<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pertussis booster vaccination<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 45pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 45pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Infanrix/Pediarix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">diphtheria, tetanus, pertussis,<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">polio, hepatitis B, Haemophilus <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenzae type B (EU)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prophylaxis against diphtheria, tetanus, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pertussis, polio, hepatitis B, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Haemophilus influenzae type B (EU)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 74.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 47.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cervarix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HPV 16 &amp; 18 virus like <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particles (VLPs), AS04<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adjuvant (MPL + aluminium<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 29.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hydroxide)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">human papilloma virus<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">type 16 and 18<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Not marketed <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 112.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Fluarix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">split inactivated influenza<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antigens (2 virus subtypes A <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2 subtype B)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seasonal influenza prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 159.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 38.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 198pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">FluLaval<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 198pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">split inactivated influenza <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">antigens (2 virus subtypes A <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and 2 subtype B)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 198pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seasonal influenza prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 198pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 38.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 198pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Menveo<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meningococcal group A, C, W-135 and Y <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conjugate vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meningitis group A, C, W-135<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Y prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 236.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 265.5pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Priorix, Priorix Tetra, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Varilrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 265.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">live attenuated MMR, Varicella and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">MMRV vaccines<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 265.5pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measles, mumps, rubella and <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">chickenpox prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 265.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 265.5pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rotarix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human rotavirus RIX4414 strain<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rotavirus prophylaxis<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 294.75pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expired<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 306pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Synflorix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 306pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conjugated pneumococcal<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">polysaccharide<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 306pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prophylaxis against invasive<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disease, pneumonia, acute otitis media<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 306pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Not marketed <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in US<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 306pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 84.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 84.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: italic; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shingrix<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 84.75pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">zoster vaccine<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recombinant, adjuvanted<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 222.75pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 138pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">herpes zoster<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 138pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(shingles)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 360.75pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2029<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 420.75pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 60pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 60pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2031<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 527.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent expiry dates in normal <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 156.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">text<span style="display: inline-block; height: 5.09pt;"></span><span id="i629949df649b4df6a43ce60f256ec9c6_555"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 167.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> relate to the latest expiring new molecular entity patents in the relevant territory. <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 414.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patent expiry dates in italics relate to <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 536.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: italic; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other patents. <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 109.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where appropriate, unless otherwise indicated all patent expiry dates include granted Patent Term Extensions in the US, granted <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 544.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplementary Protection Certificates in EU, and Paediatric Exclusivity periods. Additional exclusivities (for example regulatory data protection) may exist <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 553.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">but are not listed in the table.&#160; (* = date includes pending PTE in US or SPC in EU)<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">277<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_580"></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 68.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outline<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 93.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> below the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 134.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">principal risks and uncertainties<span style="display: inline-block; height: 6.18pt;"></span><span id="i1077fb2fc11448b385eb927b655df1b8_347"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 251.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to our business, financial condition and operations that may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect our performance and ability to achieve our objectives. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 143.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 77.25999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are the risks that we believe could <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cause<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 230.83999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> our actual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 154.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results to differ materially from expected and historical<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.32999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> results<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We must comply with a broad range of laws and regulations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which apply to the research and development (R&amp;D), <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturing, testing, approval, distribution, sales, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">marketing of pharmaceutical and vaccine products. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect the cost of product development, the time required to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reach the market and the likelihood of doing so successfully on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an uninterrupted basis.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As rules and regulations change, government interpretation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and policy evolves, and our business activities develop, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nature of a particular risk may also alter. Changes to regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regimes may be substantial. Any alteration in, and failure to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comply with, applicable laws and regulations could materially <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and adversely affect our financial results.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Similarly, our global business exposes us to litigation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government investigations, including product liability litigation, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patent and antitrust litigation and sales and marketing litigation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Litigation and government investigations, and the related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions we may make for unfavourable outcomes and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increases in related costs, such as insurance premiums, could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also materially and adversely affect our financial results.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Detail on the status and various uncertainties in our significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 232.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unresolved disputes and potential litigation is set out in Note<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 47 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Legal proceedings&#8217; on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 411.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_538">265</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 290.33pt;" id="idc89fa1ee07645df9629d157a4b46752_586"></div><div style="position: var(--position); top: 290.33pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 8.9pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Patient safety<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 344.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK, including our third parties, fails to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 354.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriately collect, assess, follow up, or report human safety <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 365.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information, including adverse events, from all potential sources <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 375.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or that GSK potentially fails to appropriately act on any relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 385.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">findings that may affect the benefit-to-risk profile of a medicine <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 395.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or vaccine in a timely manner.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 411.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK will not tolerate an unfavourable benefit-to-risk profile for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients who use our products. The most important <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consequence of ineffective pharmacovigilance is the potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for harm to patients, so we uphold stringent procedures for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">managing human safety information, conducting timely safety <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">signal detection and ensuring appropriate measures are in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">place to manage risks to patients. We are dedicated to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adhering fully to pharmacovigilance and other relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations globally. Failure to comply could lead to inspection <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">findings, regulatory scrutiny, civil or criminal sanctions and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">either temporary or permanent revocation of product marketing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorisation. We regularly review and respond to all patient <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">safety risks to limit the potential for reputational damage, loss of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trust from patients and healthcare providers, product-related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">litigation, and reduced shareholder confidence.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 345.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 346.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are accountable for protecting patients and participants in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 356.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">clinical trials who receive our medicines and vaccines, whether <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 366.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they are in development or marketed, from harm. An <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 376.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unforeseen event that unfavourably shifts the benefit-to-risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 387.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profile is not a probable occurrence, but such an event cannot <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 397.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be fully discounted, and more generally, we cannot predict all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances impacting safety and efficacy that could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potentially result in harm to patients. We operate in a complex <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and restrictive pharmacovigilance regulatory environment, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which can be further complicated by differing requirements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">among regulatory agencies. Such regulatory complexity is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">further illustrated by instances of regulatory agencies taking <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decisions on the safety of medicines and vaccines based on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">externally available data that may not be accessible to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 489.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">marketing authorisation holder. This could hinder our ability to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make prompt decisions and take appropriate action in relation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the safety of our products, or to confirm or refute conclusions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">asserted by external parties. This issue could potentially extend <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to next-generation digital health data held by tech companies or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 540.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other data custodians, which may be inaccessible to our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 550.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry and/or regulatory agencies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 566.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Numerous information sources, including publications not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 576.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on robust scientific research, media coverage, social <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 586.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">media, Artificial Intelligence (AI) tools and government health <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 596.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities, could potentially lead to a surge in reports related to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 607.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products and/or adverse events. Such information and reports, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 617.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as well as poor management of patient safety risks generally <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 627.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could lead to harm to our reputation, reduced trust from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients and healthcare providers, and a decline in shareholder <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">confidence, as well as increased regulatory scrutiny. It could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 658.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also increase the number of product-related legal cases, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 668.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including class-action lawsuits which GSK and our industry <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 678.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">frequently encounter.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">278<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 129.28pt;" id="idc89fa1ee07645df9629d157a4b46752_592"></div><div style="position: var(--position); top: 129.28pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product quality<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to ensure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate controls and governance of quality for development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and commercial products are in place; compliance with industry <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 214.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">practices and regulations in manufacturing and distribution <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities; and terms of GSK product licenses and supporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory activities are met.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 250.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A failure to ensure product quality could have far-reaching <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implications for patient safety, cause product launch delays, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug shortages or product recalls, and have regulatory, legal, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and financial consequences.These could materially and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 307.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adversely affect GSK's reputation and financial results<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 254.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The external environment for product quality remains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 191.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenging. The impact of continuing nationalism and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 201.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">geopolitical tensions, and of new and emerging regulations with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 211.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a gradual divergence in regulatory expectations by some health <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities, as well as a strong focus from regulators on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inspections and prevention of drug shortages present a broad <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set of challenges to our sites and functions as they support <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product quality and our licence to operate. The rapid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 262.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advancement and use of digital technologies, particularly the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use of AI and Machine Learning (ML), within an evolving <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory framework, introduce both the opportunity to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accelerate ways of working and the potential to impact product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 303.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quality if not adequately controlled. We need to align to new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 313.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and updated regulatory guidance as it emerges. The threat of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 323.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cyber-attacks and data breaches across the industry could risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 333.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the integrity of product quality data and its audit trail. Attracting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 344.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and retaining key specialised skills to deliver quality innovation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 354.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in manufacturing and development is potentially challenging in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a highly competitive environment and remains a focus for our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 374.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">innovative new platforms.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 406.5pt;" id="idc89fa1ee07645df9629d157a4b46752_598"></div><div style="position: var(--position); top: 406.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial controls and reporting<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 441.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 457.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK fails to comply with current tax laws; fails to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 467.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report accurate financial information in compliance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 477.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounting standards and applicable legislation; or incurs <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 487.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant losses due to treasury activities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 503.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Non-compliance with existing or new financial or ESG reporting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and disclosure requirements, or changes to the recognition of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income and expenses, could expose GSK to litigation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 550.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory action and could materially and adversely affect our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 560.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial results. Failure to comply with changes in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 570.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">substance or application of the laws governing transfer pricing, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 580.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends, tax credits and intellectual property could also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 590.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materially and adversely affect our financial results. Failure to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 601.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comply with applicable laws and regulations could result in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 611.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK being investigated by relevant government agencies and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 621.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities and/or in legal proceedings against us. Government <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 631.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigations and litigation, can be unpredictable and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 641.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regardless of their outcome, may be costly, require significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 652.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management attention, and damage our reputation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 662.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inconsistent application of treasury policies, transactional or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">settlement errors, or counterparty defaults could lead to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 682.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant losses.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 698.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 716.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The laws of various jurisdictions require us to publicly disclose <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 726.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our financial results and any events that could materially affect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 736.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s financial results. Regulators routinely review the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 746.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements of listed companies for compliance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 756.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new, revised, or existing accounting and regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 767.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements. We believe that we comply with the appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 777.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory requirements concerning our financial statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 787.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the disclosure of material information, including any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 797.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions relating to business restructuring such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 441.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquisitions and divestitures. However, should we be subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an investigation into potential non-compliance with accounting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and disclosure requirements, this could lead to restatements of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">previously reported results and significant penalties. Our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury group deals daily in high value transactions, mostly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">foreign exchange and cash management transactions. These <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions involve market volatility and counterparty risk. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group&#8217;s effective tax rate reflects the locations of our activities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the value they generate, which determine the jurisdictions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in which profits arise and the applicable tax rates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These may be higher or lower than the UK statutory rate and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 556.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may reflect regimes that encourage innovation and investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 566.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in R&amp;D by providing tax incentives which, if changed, could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 576.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affect GSK&#8217;s effective tax rate. In addition, the worldwide nature <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 586.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of our operations means that our cross-border supply routes, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 596.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">necessary to ensure supplies of medicines and vaccines, can <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 607.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">result in conflicting claims from tax authorities as to the profits <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 617.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to be taxed in individual countries.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This can lead to double taxation, with the same profits taxed in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">more than one country. The complexity of tax regulations also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">means that we may occasionally disagree with tax authorities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the technical interpretation of a particular area of tax law. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The tax charge included in our financial statements is our best <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 681.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">estimate of tax liability pending any audits by tax authorities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect there to be a continued focus on tax reform, driven <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 701.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by international initiatives set by the OECD, the European <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 711.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commission and the UN, as well as various domestic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 721.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">initiatives. These may result in significant changes to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 732.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">established tax principles and an increase in tax authority <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 742.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disputes. Regardless of their merit or outcomes, these may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 752.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">costly, divert management attention and adversely impact our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 762.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reputation and relationship with key stakeholders. Laws, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 772.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations, orders and other measures restrict dealings with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 783.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain countries, governments, government officials, entities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 793.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and individuals, and the use of financial institutions and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 803.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">movement of funds. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">279<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_604"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 8.9pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Legal matters<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to comply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with certain legal requirements for the development and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management of our pipeline, supply and commercialisation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our products and operation of business, and specifically in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relation to requirements for competition law, anti-bribery and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corruption, and sanctions. Any failure to comply with legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards for these particular areas could lead to increasing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scrutiny and enforcement from government agencies.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to mitigate this risk could subject GSK and associated <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 281.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">persons to governmental investigation, regulatory action, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 291.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">civil and criminal liability. It may hinder GSK&#8217;s ability to supply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its products under certain government contracts. Moreover, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 311.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">failure to manage legal risk could have substantial implications <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 321.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for GSK&#8217;s reputation and the reputation of its senior leadership. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 332.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It could undermine investor confidence in our governance, risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 342.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management and future performance, and negatively affect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 352.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share performance. It could result in substantial financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">penalties and the imposition of additional reporting obligations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 169.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The general landscape for anti-bribery and corruption, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 179.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competitive practices, and sanctions and export controls <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 189.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to be challenging with increased scrutiny from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government agencies. Authorities remain committed to robust <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">foreign bribery investigations and prosecutions, with a particular <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 220.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">focus on the conduct of multi-national companies regardless of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 230.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their location. We have observed evolving trends in relation to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 240.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sanctions, where penalties for violations which were previously <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 251.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">imposed mainly on large international banks are now also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 261.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">imposed on companies across various industries. The financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 271.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">penalties in these cases are often substantial. The&#160; applicable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 281.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">laws are often uncertain, unstable or evolving and can conflict <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 291.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across different markets making it challenging to determine <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exact requirements of local laws in every market.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Developments in the external environment include an increase <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 328.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in transparency and collaboration among enforcement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 338.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities with the aim of reducing bribery and corruption <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 348.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">globally.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 412.07pt;" id="idc89fa1ee07645df9629d157a4b46752_610"></div><div style="position: var(--position); top: 412.07pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commercial practices<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 450.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 466.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially engage in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">commercial activities that fail to comply with laws, regulations, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry codes, and internal controls and requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 502.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 518.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It could materially and adversely affect our ability to deliver our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">strategy and long-term priorities if we fail to engage in activities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that are consistent with: the letter and spirit of the law, industry <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 549.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations, or the Group&#8217;s requirements relating to sales and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 559.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">promotion of medicines and vaccines; appropriate interactions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with healthcare professionals (HCPs), organisations and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients; legitimate and transparent transfers of value; and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pricing and competition&#160; regulations in commercial practices, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 600.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including trade channel activities and business tendering. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 610.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additionally, such a failure may result in incomplete awareness <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 620.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the risk/benefit profile of our products and possibly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 630.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suboptimal treatment of patients and consumers; governmental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investigation, regulatory action and legal proceedings brought <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 651.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against the Group by governmental and private plaintiffs which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could result in government sanctions; and criminal and/or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 671.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial penalties. Any practices that are found to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 681.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">misaligned with our culture could also result in reputational <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 691.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">harm and dilute the trust established with external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 702.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 718.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 735.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We operate in a highly regulated and extremely competitive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 745.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biopharma industry, amongst peers who make significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 756.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product innovations and technical advances and intensify price <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 766.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">competition.&#160; The external environment is challenging. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 776.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governments have increased their focus on initiatives to drive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 786.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">down medicine and vaccines costs for consumers. There is an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 796.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectation there will be continued focus on regulating drug <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 450.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prices . Additional external factors include access limitations to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 460.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our customers, major geopolitical events in key markets, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 470.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">macroeconomic inflationary dynamics, and pricing pressure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">across markets. For example,&#160; in the US, a number of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legislative proposals have been introduced and/or signed into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">law that attempt to lower drug prices, including the Inflation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reduction Act. To achieve our strategic objectives, we must <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 521.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to develop commercially viable new products, sustain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reliable supply, and deliver additional uses for existing products <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that address the needs of patients, consumers, HCPs and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payers. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 568.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financially, new products/indications carry with them an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 578.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uncertainty of future success. Product development is costly, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 588.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">lengthy, and uncertain, and carries the potential for failure at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any stage. Even after successful product development, we face <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">challenges in how we launch, and competitors&#8217; products or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pricing strategies could render our assets less competitive. We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support product innovation through our continued focus on both <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in-person and virtual engagement, with a constant focus on our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient. Once we have an approved medicine or vaccine, it is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 660.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our obligation to provide important information to the healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 670.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">community in various ways, always in a responsible, legal, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 680.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ethical manner.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 696.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Appropriate product promotion ensures HCPs have access to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 706.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the information they need, that patients and consumers have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 716.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the facts about the medicines and vaccines they require, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 727.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that products are prescribed, recommended, or used in a lawful <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 737.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and compliant manner that provides healthcare benefit.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">280<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_616"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scientific and patient engagement<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to engage <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">externally to gain insights, educate and communicate on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">science of our medicines and associated disease areas, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide healthcare and patient support, grants and donations in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a legitimate and transparent manner compliant with laws, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations, industry codes and internal controls and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Without controls in place, GSK is exposed to the risk of real, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">perceived, or disguised promotion, including off-label and prior <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 281.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorisation promotion. This could lead to reputational <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 291.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">damage, competitor complaints, regulatory inspections with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsequent corrective actions, or civil litigation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We must fully and appropriately engage externally to bring <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient benefit, and to advance science and innovation, while <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivering our strategy. Otherwise, we risk reducing the trust of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the public, patients, healthcare professionals, payers, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 358.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulators, and governments.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 169.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Scientific and patient engagements are diverse non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 179.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">promotional activities directed at healthcare professionals, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 189.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patients, payers, and other external stakeholders. Such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">engagements aim to improve patient care through the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exchange or provision of knowledge on the use of our products <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 220.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and related diseases.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We expect our activities to be scientifically sound and accurate, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conducted ethically and transparently, and compliant with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 256.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable codes, laws, and regulations. There are many <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry and local codes and laws and other regulations that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">apply, including in the areas of privacy, data integrity and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmacovigilance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 389.97pt;" id="idc89fa1ee07645df9629d157a4b46752_622"></div><div style="position: var(--position); top: 389.97pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data ethics and privacy<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 424.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to ethically <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">collect; use; re-use through AI, data analytics or automation; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 460.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">secure; share and destroy personal information in accordance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with laws, regulations, and internal controls and requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 487.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">Non-compliance with data privacy laws could lead to harm to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 513.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">individuals and GSK. It could also damage trust between GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 523.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">and individuals, communities, business partners and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">government authorities. Many countries have increased the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">enforcement powers of their data protection authorities, allowing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">them to impose significant fines, restrict cross-border data <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">flows, or temporarily ban data processing. Many new national <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 574.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">laws also enable individuals to bring collective legal actions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.009000000000000001em; position: var(--position); text-decoration: none; white-space: pre;">against companies for failing to follow data privacy laws.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 600.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 613.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data protection and privacy legislation is diverse, with limited <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 623.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global harmonisation or simplification, making it challenging for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 634.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any multi-national company to standardise its approach to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 644.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance. Governments are enforcing compliance with data <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 654.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protection and privacy laws more rigorously.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The approach and focus of data protection and privacy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulators also differs between regions and countries, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">creates further challenges for global organisations seeking to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implement a single harmonised global privacy programme.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increases in the volume of data processed and advances in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technology have resulted in a greater focus on data <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance and the ethical use of personal information, over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 501.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and above compliance with data privacy laws. Companies <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 511.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seeking to foster innovation in AI/ML and other new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technologies are faced with evolving decisions from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">policymakers on how best to promote trust in these systems <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and avoid unintended outcomes or harmful impacts. Regulators <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(including in the EU, UK, US and China) continue to introduce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory developments around the use of AI/ML. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 573.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolving regulatory landscape adds more complexity to our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 583.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 599.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additionally, the geopolitical environment significantly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 609.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influences the evolution of laws concerning the localisation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data, restrictions on international transfers and data security <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(including, in 2024, the proposed BIOSECURE Act in the US). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 640.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This increasing trend for data sovereignty may impact our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ability to innovate and to effectively operate internationally.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">281<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_628"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research practices<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adequately conduct ethical and credible pre-clinical and clinical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">research, collaborate in research activities compliant with laws, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations, and internal controls and requirements.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 214.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 231.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The potential impacts of this risk include harm to human <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 242pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subjects, reputational damage, failure to secure regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 252.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approvals for our products, governmental investigation, legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 262.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions by governmental and private entities (including product <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liability suits and claims for damages), revenue loss due to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 282.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inadequate patent protection or inability to supply our products, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and regulatory action such as fines, penalties, or loss of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product authorisation. Poor data integrity and governance could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compromise GSK&#8217;s R&amp;D efforts and negatively impact our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reputation. Any of these could severely impact our financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results and erode trust among patients and customers.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 349.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 362.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human research is critical to assessing and demonstrating the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 373.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">safety and efficacy of our investigational products, discovering <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new products, and for further evaluating our products post-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approval. This research includes clinical trials involving both <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthy volunteers and patients, and it adheres to stringent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations and the highest ethical, medical, and scientific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards. Our clinical trials reflect the populations affected by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the diseases we are aiming to address. We are committed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ensuring we recruit participants to our clinical trials in line with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the epidemiology of the diseases in question and we ensure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that the patients and people enrolled in our clinical trials <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 475.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">represent the real-world patient/people population affected by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the disease under study and that will use our medicines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines. We are committed to transparency and disclose the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results of our human research externally, regardless of whether <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they cast our products in a positive or negative light, to ensure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 526.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that the scientific community can benefit from our findings.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 541.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additionally, our work with human biological samples is crucial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the discovery, development, and safety monitoring of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 562.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products. We are committed to managing these human <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 572.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">biological samples in accordance with relevant laws, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 582.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations, and ethical principles, and in a manner that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 592.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respects the interests of sample donors. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 608.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Data is pivotal to our R&amp;D strategy, and we continue to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 619.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leverage healthcare technologies and maximise the use of data <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 629.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to serve patients. Governing our data in accordance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 639.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant laws, regulations, contractual obligations, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 649.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expectations, and our culture across data ethics, privacy, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 659.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information and cyber security, and data integrity is essential .<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The external environment is increasingly challenging and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influenced by the regulatory and political environment in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">addition to the rising trend of data sovereignty and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">developing global landscape of quality standards, data <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">protection, privacy and cyber laws with potential impact on how <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we conduct our research in a global setting. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 469.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Research involving <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">animals can raise ethical concerns. In many cases, however, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">research involving animals is the only way to investigate the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effects of a potential new medicine or vaccines in a living body <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 243.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other than in humans. Animal research provides critical <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 253.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information about the causes and mechanisms of diseases and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therefore remains a vital part of our research. We continually <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">seek ways in which we can minimise or find alternatives to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">use of animals in research, development, and testing, while <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complying with regulatory requirements and reducing the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact on the animals used.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biological materials are required for the discovery, research, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and development of our assets. We are committed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 341.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conducting research is compliance with terms and conditions of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 351.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">licenses, agreements, or authorisations under which we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 361.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquire, use, or transfer biological materials and technologies. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Through the Convention on Biological Diversity (CBD) and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nagoya Protocol, the international community has established <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 392.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a global framework regulating access to, and use of, genetic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 402.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resources of non-human origin in research and development. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 412.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We support the equitable access and fairness principles of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access and benefit sharing (ABS) outlined in the CBD and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nagoya Protocol. We also recognise the importance of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 443.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate, effective, and proportionate implementation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures at national and regional levels.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">282<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_634"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Environment, health, and safety (EHS)<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to ensure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate controls and governance of the organisation's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets, facilities, infrastructure, and business activities, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including execution of hazardous activities, handling of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hazardous materials, or release of substances harmful to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment that disrupt supply or harm employees, third <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties or the environment.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 238.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to manage EHS risks could result in significant harm to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 264.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people, the environment and the communities in which we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 275.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operate, fines, inability to meet stakeholder expectations and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 285.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory requirements, litigation or regulatory action, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 295.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">damage to the company&#8217;s reputation. This could materially and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 305.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adversely affect our financial results.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 163.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK is subject to the health, safety and environmental laws of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">various jurisdictions. These laws impose duties to protect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people, the environment and the communities in which we <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 194.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operate. The external regulations continue to arise and evolve, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">notably new sustainability directives from the EU and Canada <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 214.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and proposed rules in the US and evolving PFAS regulations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Developments in AI and data protection have also added both <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opportunities and challenges.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 324.59pt;" id="idc89fa1ee07645df9629d157a4b46752_640"></div><div style="position: var(--position); top: 324.59pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 490.5pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i97793aaf5fcd42f689800beb9dbf6c6d_0-0-1-1-824607"></span><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 490.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 490.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information and cyber security<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 357.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties fail to ensure appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls and governance to identify, protect, detect, respond, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and recover from cyber security incidents in accordance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable laws, regulations, industry standards, internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls, and requirements. This could be due to unauthorised <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access, disclosure, loss, theft, unavailability or corruption of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK's information, key systems, or technology infrastructure.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 450.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to adequately protect our information and systems <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 476.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">against cyber security threats may cause harm to patients, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 486.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">workforce and customers, disruption to our business and/or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">loss of commercial or strategic advantage, regulatory sanction, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or damage to our reputation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 357.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 372.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The external environment remains challenging, with increased <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">geopolitical conflict and digital nationalism, rising frequency of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 393.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">data breaches, and growing sophistication of cyber threat <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 403.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actors. New cyber regulations and privacy laws, along with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 413.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">anonymity provided by cryptocurrencies and the dark web, are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 423.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complicating the environment.&#160; GSK&#8217;s business relies on a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">highly connected information network, making our systems and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 444.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information targets for cyber security threats. This means that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 454.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies&#8217; systems and information have been and will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 464.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to be targeted by cyber security threat actors. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Acceleration in the use of digital, data and analytics, AI/ML and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could computing capabilities to drive GSK&#8217;s pipeline, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 495.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance and productivity requires us to continuously adapt <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 505.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and strengthen our controls and defensive capabilities. We also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 515.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rely on third-party contractors, partners, and suppliers who face <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 525.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">similar cyber security threats. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">283<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_646"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supply continuity<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK or our third parties potentially fail to deliver a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continuous supply of compliant finished product or respond <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectively to a crisis incident in a timely manner to recover and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustain critical supply operations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 208.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We recognise how important continuity of supply of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 234.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products is to the patients who rely on them. Difficulties with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">forecasting demand for our products or their manufacture or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 254.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution can lead to:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Product shortages and product recalls<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regulatory intervention<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reputational harm<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 301.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lost sales revenue<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To respond, we need sophisticated end-to-end supply chain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management combined with robust crisis management and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business continuity plans.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 161.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We operate our supply chains in a continually evolving, highly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 171.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulated environment. There is no single set of global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations which governs the manufacture and distribution of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines, and we must adhere to the requirements in all those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 202.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">markets in which we licence, sell or manufacture our products. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 212.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We rely on our internal Quality Management System and our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 222.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Internal Control Framework to ensure we maintain our licence <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 233.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to operate.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our complex end-to-end supply chains often involve third-party <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 256.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">suppliers, from Active Pharmaceutical Ingredient (API) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manufacturers and raw material suppliers through to third party <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">logistics providers and contract engineering firms. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We continue to operate our global supply chains in a rapidly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changing geopolitical environment. Increasing nationalism and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">friction between the US and China creates divergence from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">global supply strategy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 332.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increasing environmental regulation and reporting across the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 343.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare sector has the potential to increase scrutiny by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 353.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investors, governments and non-governmental organisations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 363.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as net-zero climate targets progress. Evolving regulation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 373.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing scrutiny is being incorporated into public <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 383.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procurement of medicines and vaccines.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 413.93pt;" id="idc89fa1ee07645df9629d157a4b46752_649"></div><div style="position: var(--position); top: 413.93pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Climate change<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 452.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure in the management of: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 484.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; Physical climate and environmental risks; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 500.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; Current and future regulatory requirements for environmental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 510.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance, disclosure and taxes; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; Delivery and performance of management environmental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">objectives leading to: reduced supply chain resilience; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">product life cycle management issues; loss of trust/reputation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with employees, investors, customers, regulators and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">stakeholders,&#160; increased costs; loss of sales or market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 577.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">access; negative impacts on the environment.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 593.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 117.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 608.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We recognise that the way we respond to climate change and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 619.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">manage environmental risks affects our ability to supply <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 629.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products to patients and consumers and could lead to harm to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 639.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the environment and our reputation. For example:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes to regulations governing the supply of high global <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 665.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">warming potential (GWP) substances by the EU, UK and US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 675.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governments will restrict our ability to manufacture metered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 686pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dose inhalers; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 697.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increasing levels of water stress could lead to interruptions to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 707.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">supply of water to our and third-party supply sites; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 718.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Increasing frequency and impact of extreme weather events <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 728.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that could disrupt GSK and third-party supplier sites; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 740pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Future regulatory policy responses to address climate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 750.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">change could lead to the imposition of carbon taxes by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 760.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries where we manufacture and source goods from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 770.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">third parties; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our nature-based projects might not deliver sufficient <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">volumes of carbon credits to meet our needs in a given year, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 472.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requiring us to buy additional credits at higher costs;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to meet fast-evolving regulatory requirements on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosures and environmental compliance could lead to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 504.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory actions or fines;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to meet changing stakeholder expectations such as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from health systems with increasing demands for low carbon <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines, affecting demand for our products, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which may have an adverse impact on our financial results <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and longer-term loss of trust, undermining the credibility of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the compan<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 357.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">y. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 588.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 604.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It is increasingly understood that the interconnected effects of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">climate change, nature loss, and society&#8217;s impact on both are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 624.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influencing human health. Internal and external expectations for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 634.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies to address their impact on the environment are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 645.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing, as are the effects of climate change on operational <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resilience. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regulations on environmental compliance, disclosure and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environmentally related taxation are rapidly evolving in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 691.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions around the world, such as the EU Corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 701.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sustainability Reporting Directive, which&#160; requires increasing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 712.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">levels of disclosure and data assurance. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 727.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our ability to meet our targets of reducing carbon emissions by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 738.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80% and 90% by 2030 and 2045 (in each case, from a 2020 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 748.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">baseline), respectively, is based on successful regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 758.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outcomes from the programme to redevelop our Ventolin <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 768.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inhaler using a lower-carbon propellant.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">284<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pipeline delivery<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 11pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 161.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK fails or has delay in the delivery of our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 171.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline of new medicines, vaccines or other products.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 187.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to ensure appropriate controls and governance over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pipeline delivery risk could cause product launch delays, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adversely impact our ability to deliver new medicines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines to patients, and negatively impact our reputation, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial results and ability to deliver on our strategy.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 260.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The discovery and development of new products and new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 286.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">approved uses for existing products is essential for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 296.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sustained strength of our business. It is crucial to continually <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">replenish the pipeline to offset revenue loss when products lose <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exclusivity or market share, and to respond to emerging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 327.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare and patient needs.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Developing pharmaceutical and vaccine products can be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">complex, risky, costly and lengthy. The regulatory and payer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(such as health insurance companies, governments or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employers that cover costs for prescription medicines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines) landscape continues to evolve and can influence the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug approval process and drug pricing and shapes the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">potential use of our medicines and vaccines in the market. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The use of technology and partnerships are increasingly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 156.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">important in successful R&amp;D execution, adding greater <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 166.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">predictability and pace in pipeline delivery. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Seeking and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 176.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">acquiring external innovation through licensing deals, mergers, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 186.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and acquisitions to access new technologies and high potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">drug candidates is another key driver for pipeline growth. There <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 207.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is, however, increasing competition from companies to secure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the most promising deals. This increased competition could <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adversely impact our ability to support pipeline delivery with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 237.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external opportunities. Additionally, we may miscalculate risks <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or value associated with business development transactions to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">support our pipeline based on information available to us at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time of deal, which could adversely impact our pipeline growth, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business operations, or financial results. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The convergence of science and technology continues to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shape the discovery, development and delivery of medicines <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and vaccines to patients. The biopharma industry and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governments continue to work together to develop a policy and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulatory environment, including a global framework, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will stimulate and protect innovative research and development <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with trust and transparency considering these technology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advances. We invest in data tech, including AI, and platform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">technologies to be faster, more effective and more predictive in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 390.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discovering and developing highly innovative and impactful <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 400.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">medicines and vaccines. We invest in technology to reach <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 411.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">people and patients better and faster and empower our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 421.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scientists to do their best work. Our investments in technology <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 431.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and stakeholder engagement to influence the global framework <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may not achieve intended benefits, adversely impacting our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 451.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial operations, ability to deliver new medicines and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 462.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vaccines to patients, and delivery on our strategy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 493.81pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emerging risks<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 16pt; position: var(--position); top: 520.56pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Skills and capability planning<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 545.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 561.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK potentially fails to ensure adequate skills and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 571.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capability planning to enable delivery of our strategic priorities.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 587.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 603.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Failure to mitigate this risk could impact our reputation, damage <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">trust between GSK and our employees, and our adversely <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">impact our operations and ability to deliver on our strategy. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 639.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Developing and maintaining a skilled and talented workforce <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 665.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with the right capabilities to address our strategic goals impacts <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our&#160; ability to deliver on long term strategic objectives, driving <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increasing need for robust skills and capabilities planning. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Significant advances in science and technology are rapidly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 576.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evolving the skills and capabilities needed for jobs across the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 586.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical and healthcare industry. The talent pool is small <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and highly competitive, with companies increasingly evaluating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how they attract, integrate, incentivise and retain talent over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time and reskill and develop capability internally. It is essential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 627.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">we continue to assess and evolve the skills and capability <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 637.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">needed to achieve our business priorities in a dynamic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">285<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Risk Factors continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 16pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Regulatory environment<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 138.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that GSK fails to adapt to changes in the regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 164.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">environment, new or amended legislation and governmental <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">action in relation to the pharmaceutical and healthcare industry.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 190.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Changes in the regulatory environment, the introduction of new <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 216.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or amended legislation, government spending and policies and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other actions in relation to the pharmaceutical and healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">industry may continue to have an impact on prices for GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products, GSK&#8217;s ability to introduce products to the market, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adversely<span style="display: inline-block; height: 6.18pt;"></span><span id="i27f24adb8ed14564b0e7ab7e0cc1fb14_11163"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.84pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> impact the availability of and access to GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 267.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">products, and increase GSK&#8217;s regulatory burdens and costs, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 277.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which have adversely affected and may adversely affect in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">future GSK&#8217;s business, cash flows, results of operations, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial condition and prospects.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 314.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The pharmaceutical and healthcare industry in which GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operates is subject to an increasing number of extensive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governmental laws and regulations, investigations and legal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions by national and local governmental agencies, in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">countries in which GSK operates.&#160; Legislative and regulatory <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proposals and enactments to reform healthcare insurance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">programs and increasing economic pressure could significantly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 138.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">influence the manner in which GSK&#8217;s products are prescribed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 148.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and purchased.&#160; For example, in the United States, provisions <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 158.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Affordable Care Act have resulted in changes in the way <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 168.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare is paid for by both governmental and private <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 179.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insurers. Certain other U.S. laws, such as the Inflation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 189.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reduction Act and the American Rescue Plan Act, have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">introduced other measures relating to drug prices, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government price-setting for certain drugs, statutory caps on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rebates drug manufacturers pay to Medicaid, and financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 230.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">penalties for drug prices that rise faster than the rate of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 240.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inflation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 256.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In the UK, EU and other international markets, governments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide healthcare at low costs and regulate drug prices, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">patient eligibility and/or reimbursement levels, and have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 286.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">announced or implemented measures, and may implement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 296.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">new or additional measures, to reduce and further control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 307.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">healthcare costs in order to limit government spending and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 317.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control costs.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 333.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition, changes to regulatory authorities&#8217; timing or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirements for approval or clearance of GSK&#8217;s drugs may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have a negative impact on GSK&#8217;s ability to bring new products <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the market, and a rescission of a previous approval may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 374.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">require GSK to withdraw a product from the market.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 16pt; line-height: 16pt; position: var(--position); top: 432.41pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Geopoli<span style="display: inline-block; height: 11.64pt;"></span><span id="i27f24adb8ed14564b0e7ab7e0cc1fb14_11164"></span><span id="i27f24adb8ed14564b0e7ab7e0cc1fb14_11339"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 108.96000000000001pt; position: var(--position); text-decoration: none; white-space: pre;">tical<span style="display: inline-block; height: 11.64pt;"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 16pt; font-style: normal; font-weight: normal; left: 137.39pt; position: var(--position); text-decoration: none; white-space: pre;"> developments<span style="display: inline-block; height: 11.64pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 457.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk definition<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The risk that geopolitical and social tensions, give rise to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restrictive measures that may negatively impact GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 509.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk impact<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Geopolitical and social tensions, such as changes in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government, sovereign risks, acts of war or aggression or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">terrorism, have had and could continue to have a direct and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indirect impact on the pharmaceutical industry and GSK&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 566.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">operations. The introduction of aggressive trade, monetary and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 576.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fiscal policies by governments and/or central banks generally in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 586.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">response to geopolitical and social tensions, or to address <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market-specific factors such as inflation, could lead to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recessions in the jurisdictions in which we operate and raise the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 617.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cost-of-living in those markets, resulting in further pressure on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 627.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">prices for our products and costs.&#160; Any of these developments <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 637.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may materially and adversely affect GSK&#8217;s business, cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">flows, results of operations, financial condition and prospects.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 457.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Context<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Geopolitical and social tensions in recent years have led <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governments to introduce, or threaten to introduce protectionist <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measures, including tariffs and other trade restrictions. For <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">example, the introduction of tariffs or other trade restrictions on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pharmaceutical products or active pharmaceutical ingredients <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">could cause an interruption in or disruption to our supply chain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and our ability to produce and deliver our products, and our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ability to pass on the related costs may be limited due to our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">inability to influence reimbursement mechanisms, challenge <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government limits on drug prices or competitive pressures.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">286<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder information<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_652"></div><div style="position: absolute; top: 114.19pt;" id="idc89fa1ee07645df9629d157a4b46752_655"></div><div style="position: var(--position); top: 114.19pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital and control<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 152.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of our <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 105.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issued share cap<span style="display: inline-block; height: 6.18pt;"></span><span id="i8b8f599eed654c6e85cf442c2fb50161_6087"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 169.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ital and the number of shares <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held in Treasury as at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 136.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 208.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> can be found in Note <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 173.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 63.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to the financial statements, &#8216;Share capital and share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">premium account&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Ordinary Shares are listed on the London Stock Exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(LSE) and are also quoted on the New York Stock Exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(NYSE) in the form of American Depositary Shares (ADS). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 229.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each ADS represents two Ordinary Shares. For details of listed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 239.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debt and where it is listed refer to Note <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.23000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 250.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements, &#8216;Net debt&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Holders of Ordinary Shares and ADS are entitled to receive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 276.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends (when declared) and a copy of the company&#8217;s Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 286.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report (if elected). They are also entitled to attend, speak, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 296.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appoint proxies and exercise voting rights at general meetings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the company.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are no restrictions on the transfer, or limitations on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holding, of Ordinary Shares and ADS and no requirements to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 343.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obtain approval prior to any transfers. No Ordinary Shares or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 353.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS carry any special rights with regard to control of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 363.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company and there are no restrictions on voting rights. Major <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders have the same voting rights per share as all other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders. There are no known arrangements under which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial rights are held by a person other than the holder of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares and no known agreements on restrictions on share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfers or on voting rights.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 430.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares acquired through the Group&#8217;s employee share plans <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rank equally with the other shares in issue and have no special <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 450.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights. The trustees of our Employee Share Ownership Plan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 460.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trusts have waived their rights to dividends on shares of GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plc held by those Trusts.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 487.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Exchange controls and other limitations <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 500.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">affecting holders<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other than certain economic sanctions, which may be in force <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from time to time, there are currently no applicable laws, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 536.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decrees or regulations in force in the UK restricting the import <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 546.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or export of capital or restricting the remittance of dividends or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 556.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other payments to holders of the company&#8217;s shares who are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-residents of the UK. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Similarly, other than certain economic sanctions which may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 593.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in force from time to time, there are no limitations relating only <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 603.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to non-residents of the UK under English law or the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles of Association on the right to be a holder of, and to vote <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in respect of, the company&#8217;s shares.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 152.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Interests in voting rights<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 168.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other than as stated below, as far as as the company is aware, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 178.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">there are no persons with significant direct or indirect holdings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the company. Information provided to the company pursuant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the FCA's Disclosure Guidance and Transparency Rules <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 209.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(DTR 5) is published on a Regulatory Information Service and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 219.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the company&#8217;s website, gsk.com.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 235.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company has received notifications in accordance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 245.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DTR 5 of the following notifiable interests in the voting rights in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company&#8217;s issued share capital:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 271.7pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 53.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 53.25pt; position: var(--position); top: 0pt; width: 90.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 33.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31 December 2024<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 0pt; width: 90.75pt;"><div><div style="line-height: 8.5pt; position: var(--position); top: 2.54pt; width: 90.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 2.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 20 February 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div></td></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 53.25pt; overflow: hidden; position: var(--position); top: 12pt; width: 51pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">No. of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 104.25pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.26pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.010000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 144pt; overflow: hidden; position: var(--position); top: 12pt; width: 51pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">No. of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voting <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 12pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.26pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 12.06pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of total <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.86pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 19.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voting<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 27.66pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 32.010000000000005pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: -5.53pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">BlackRock, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Inc.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 53.25pt; position: var(--position); top: 47.25pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0.73pt; position: var(--position); white-space: pre;">231,975,400<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 42.419999999999995pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 104.25pt; position: var(--position); top: 47.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.44pt; position: var(--position);">5.60<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 32.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 47.25pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0.73pt; position: var(--position); white-space: pre;">231,975,400<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 42.419999999999995pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 47.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.44pt; position: var(--position);">5.60<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 32.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 59.25pt; width: 53.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 53.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dodge &amp; Cox<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 53.25pt; position: var(--position); top: 59.25pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0.73pt; position: var(--position); white-space: pre;">253,464,108<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 42.419999999999995pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 104.25pt; position: var(--position); top: 59.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.44pt; position: var(--position);">6.11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 32.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 144pt; position: var(--position); top: 59.25pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 0.73pt; position: var(--position); white-space: pre;">253,464,108<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 42.419999999999995pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 59.25pt; width: 39.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 15.44pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 15.44pt; position: var(--position);">6.11<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span><span style="left: 32.37pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 347.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Percentage of total voting rights at the date of notification to the company.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 358.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Comprising an indirect interest in <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 418.84999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">229,134,683<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 457.40999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Ordinary Shares and a <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 366.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holding of <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 348.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,840,717<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 378.90999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Qualifying Financial Instruments (Contracts for <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 375.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Difference). <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 385.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Comprising an indirect interest in <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 418.84999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99,377,874<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 453.54999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Ordinary Shares and <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 393.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">154,086,234<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 354.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ADS.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company has not acquired or disposed of any interests in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 424.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its own shares during the period under review.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 440.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 337.91pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">buyback<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 381.92pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> programme<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board has been authorised to issue and allot Ordinary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares under Article 9 of the company&#8217;s Articles of Association. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The power under Article 9 and the authority for the company to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">make purchases of its own shares are subject to shareholder <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">authorities which are sought on an annual basis at our Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 507.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">General Meeting (AGM). Any shares purchased by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 517.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company may be cancelled, held as Treasury shares or used <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for satisfying share options and grants under the Group's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">employee share plans.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our programme covers purchases of shares for cancellation or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to be held as Treasury shares, in accordance with the authority <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">renewed by shareholders at the AGM in May 2024, when the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 584.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company was authorised to purchase a maximum of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 499.26pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 595.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">411,703,340<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 350.93pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> shares. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 610.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In determining specific share repurchase levels, the company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">considers the development of free cash flow during the year. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of shares purchased, cancelled, held as Treasury <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 641.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares and subsequently transferred from Treasury <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 497.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to satisfy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 651.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">awards under the Group&#8217;s employee share plans are disclosed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 661.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in Note<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 331.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 37<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 343.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to the financial statements, &#8216;Share capital and share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 672.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 309.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remium account&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 373.49pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 688pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On 5 February 2025 GSK announced its intention to implement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 698.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a &#163;2 billion share buyback programme to be completed over an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 708.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18 month period. The programme commenced on 24 February <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 718.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025 with an initial tranche of up to &#163;0.7 billion.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">287<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder information continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 30.22pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital and control continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Market capitalisation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The market capitalisation, based on shares in issue excluding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury shares, of GSK at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 229.29000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 248.91000000000003pt; position: var(--position); text-decoration: none; white-space: pre;">&#163;55.8 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">billion. At that date, GSK was the 11th largest company by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">market capitalisation in the FTSE index.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 175.77pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 101.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 101.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share price<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 31.630000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 35.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">24<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="font-size: 12pt; line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 28.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 38.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">At 1 January<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.51<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 18.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16.13<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 30.75pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">At 31 December<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.47<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 30.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.38<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Increase/(decrease)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 28.56pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 28.56pt; position: var(--position);">(9)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 37.62pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 18.23pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 18.23pt; position: var(--position);">(0.06)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 37.620000000000005pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 42.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 24.42pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 24.42pt; position: var(--position);">(12)<span style="display: inline-block; height: 5.46pt;"></span></span><span style="left: 37.620000000000005pt; position: var(--position);">%<span style="display: inline-block; height: 5.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 54.75pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">High during the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18.13<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.36<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 54.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18.31<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 66.75pt; width: 101.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 101.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Low during the year<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 101.25pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.16<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 66.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.96<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 259.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table above sets out middle market closing prices. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s share price decreased by (9)% in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 240.61pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compares with an increase in the FTSE 100 index of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 250.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5.7%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 270.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during the year. The middle market closing share price on 20 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 300.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February 2025 was &#163;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 132.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.47<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 153.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The trading symbol for GSK's Ordinary Shares of 31 &#188; pence <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each on the LSE is GSK and the trading symbol for GSK's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADSs on the NYSE is GSK. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share price trend in the three years ended <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 0pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><div style="left: 304.8pt; position: var(--position); top: 0pt;"><div style="position: var(--position);"><img src="gsk-20241231_g137.gif" alt="5285" style="height: 204.09pt; width: 255.11pt;"/></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 394.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Nature of trading market<span style="display: inline-block; height: 8pt;"></span><span id="i8b8f599eed654c6e85cf442c2fb50161_6088"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 179.55pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 410.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following table sets out, for the periods indicated, the high and low middle market closing prices for the company&#8217;s Ordinary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 421.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares on the LSE and for the ADS on the NYSE.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 436.96pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 40.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 12pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 45.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK&#163; per share <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="2" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 12pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 45.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US$ per share<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="background-color: #ffffff; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">High<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 29.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">High<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 30.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Low<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February 2025*<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.85<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37.70<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">34.84<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">January 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.05<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.94<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">35.50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">32.08<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.83<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">35.99<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.43<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">November 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37.02<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 72pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.35<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">October 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.22<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.93<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40.30<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 84pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">36.76<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 96pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">September 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16.71<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44.26<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 96pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40.56<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 108pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 31 December 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.22<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">40.30<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 108pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.35<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 30 September 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16.71<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.98<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44.26<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38.21<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 132pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 30 June 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18.13<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.26<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">45.78<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 132pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38.50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 31 March 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 24.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">17.11<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">43.58<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 144pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37.51<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 156pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 31 December 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.21<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.82<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37.56<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 156pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">34.17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 168pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 30 September 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.36<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.16<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38.07<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 168pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.81<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 180pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 30 June 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.23<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.46<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38.32<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 180pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.60<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 192pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter ended 31 March 2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15.03<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.77<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">36.43<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 192pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 204pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Year ended 31 December 2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.92<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.20<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">37.92<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 204pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 216pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Year ended 31 December 2021<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16.19<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13.80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44.44<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 216pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38.13<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 228pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Year ended 31 December 2020<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 307.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14.68<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 352.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12.92<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 397.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">39.17<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 442.5pt; position: var(--position); top: 228pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">33.42<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 681.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">* to 20 February 2025<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">288<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_658"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="font-size: 18.5pt; line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Analysis of shareholdings at <span style="display: inline-block; height: 13.46pt;"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: 232.51000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 294pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 58.5pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 12.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounts<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% of total<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 16.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accounts<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 17.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">% if total <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 0pt; width: 58.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 58.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 4.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Number of shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Holding of shares<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Up to 1,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">43,735<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75.37<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 30pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.30<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 30pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12,841,103<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,001 to 5,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10,671<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">18.39<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 41.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.52<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 41.25pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">22,424,074<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5,001 to 100,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2,652<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4.57<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 52.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.16<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 52.5pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">49,934,290<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 63.75pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100,001 to 1,000,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">643<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.11<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 63.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5.27<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 63.75pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">227,421,834<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 75pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Over 1,000,000<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 29.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">326<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.56<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">92.75<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 75pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4,001,682,433<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">58,027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 86.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 86.25pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 8.32pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4,314,303,734<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 97.5pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held by<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 108.75pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); white-space: pre;">Institutional and corporate holders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.61pt; position: var(--position); text-decoration: none; white-space: pre;">2,699<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">4.65<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 108.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.61pt; position: var(--position); text-decoration: none; white-space: pre;">75.33<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 108.75pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 7.93pt; position: var(--position); text-decoration: none; white-space: pre;">3,249,766,038<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Individuals and other corporate bodies<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.44pt; position: var(--position); text-decoration: none; white-space: pre;">55,326<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.61pt; position: var(--position); text-decoration: none; white-space: pre;">95.35<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 120pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">1.26<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 120pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 18.35pt; position: var(--position); text-decoration: none; white-space: pre;">54,190,742<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 131.25pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Guaranty Nominees Limited (ADR programme)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.2pt; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">0.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 131.25pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 23.61pt; position: var(--position); text-decoration: none; white-space: pre;">19.50<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 131.25pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.18pt; position: var(--position); text-decoration: none; white-space: pre;">841,175,799<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 294pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 294pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Held as Treasury shares by GSK<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 142.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 38.23pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 142.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">0.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 142.5pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.92<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 142.5pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 14.51pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">169,171,155<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 294pt; position: var(--position); top: 153.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.44pt; position: var(--position); text-decoration: none; white-space: pre;">58,027<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 339pt; position: var(--position); top: 153.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.44pt; position: var(--position); text-decoration: none; white-space: pre;">100.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 384pt; position: var(--position); top: 153.75pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 19.44pt; position: var(--position); text-decoration: none; white-space: pre;">100.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 429pt; position: var(--position); top: 153.75pt; width: 58.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 7.93pt; position: var(--position); text-decoration: none; white-space: pre;">4,314,303,734<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 321.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JP Morgan Chase Bank NA is the Depositary for the company&#8217;s American Depositary Receipt (ADR) programme. The company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 332.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS are listed on the NYSE. Ordinary Shares representing the company&#8217;s ADR programme, which is managed by the Depositary, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 342.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are registered in the name of Guaranty Nominees Limited. At 20 February 2025, Guaranty Nominees Limited held <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 478pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">850,772,953<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 524.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 352.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary Shares representing <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.43pt; position: var(--position); text-decoration: none; white-space: pre;">20.52%<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 195.22000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the issued share capital (excluding Treasury shares).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 368.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">At 20 February 2025, the number of holders of Ordinary Shares in the US was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 346.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">894<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 360.28000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with holdings of&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 425.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">750,483<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.5pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 457.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary Shares, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 378.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the number of registered holders of ADS was <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 223.41000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14,455<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> with holdings of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 311.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">425,386,476<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ADS. Certain of these Ordinary Shares and ADS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">were held by brokers or other nominees. As a result, the number of holders of record or registered holders in the US is not <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representative of the number of beneficial holders or of the r<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.48pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">esidence of beneficial holder<span style="display: inline-block; height: 6.18pt;"></span><span id="i60c8d07006604afb873c7b5c1a95bed9_901"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 382.90000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 425.01pt;" id="idc89fa1ee07645df9629d157a4b46752_661"></div><div style="position: var(--position); top: 425.01pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 463.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company pays dividends quarterly and continues to return <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash to shareholders through its dividend policy. Dividends <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">remain an essential component of total shareholder return and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK recognises the importance of dividends to shareholders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 509.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From 2022, GSK implemented a progressive dividend policy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 520.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guided by a 40% to 60% pay-out ratio through the investment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 530.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cycle. The dividend policy, the total expected cash distribution, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 540.54pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the respective dividend pay-out ratios for GSK remain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 550.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unchanged.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 566.63pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 236.25pt;"/></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 236.25pt;"><div><div style="line-height: 11pt; position: var(--position); top: 2.63pt; width: 236.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dividends per share<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 592.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The table below sets out the dividend per share and per ADS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 602.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the last five years. The dividend per ADS is translated into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 612.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US dollars at applicable exchange rates.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 628.61pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 236.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 146.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 45pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 146.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 146.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Year <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.83pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pence<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 0pt; width: 45pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.52pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 24.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US$<span style="display: inline-block; height: 4.73pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.2250000000000005pt; font-style: normal; font-weight: normal; left: 37.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -1.6555pt; vertical-align: super; white-space: pre;">(1)<span style="display: inline-block; height: 3.0745000000000005pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 146.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 28.08pt; position: var(--position); white-space: pre;">61<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 36.42pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(2)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 12pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 30.2pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">&#8212; (4)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 146.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.03pt; position: var(--position); text-decoration: none; white-space: pre;">58<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 24pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">1.47<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 146.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2022<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 17.66pt; position: var(--position); white-space: pre;">61.25<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 4.875pt; font-style: normal; font-weight: normal; left: 36.42pt; position: var(--position); top: -1.9109999999999998pt; vertical-align: super; white-space: pre;">(3)<span style="display: inline-block; height: 3.549pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 36pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.05pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">2.00<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 146.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2021<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 48pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">2.16<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 146.25pt;"><div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 146.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2020<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 146.25pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 34.09pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">80<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 191.25pt; position: var(--position); top: 60pt; width: 45pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 45pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 27.78pt; position: var(--position); text-decoration: none; white-space: pre;">2.12<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 7pt; position: var(--position); top: 708.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(1)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An annual fee of $0.03 per ADS (or $0.0075 per ADS per quarter) will be <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 716.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charged by the Depositary. The amounts shown are the dividends paid <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 725.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">per ADS before the annual fee is charged.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 735.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(2)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends declared and paid in respect of <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 194.16000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 209.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> were 15p per share for <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 743.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q1 <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 76.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 91.82000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">, 15p per share for Q2 <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 161.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 176.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and 15p per share for Q3 <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 258.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 273.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. A <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 752.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend of <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 100.6pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16p<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 112.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> per share has been declared for <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 214.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q4<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 223.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 225.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 240.82999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 762.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(3)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adjusted for the Share Consolidation (2022 only; prior years have not <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 771.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been adjusted). <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 781.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(4)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 79.07000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q4<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 88.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 90.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 105.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> ordinary dividend receivable by ADS holders will be <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 789.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calculated based on the exchange rate on 8 April 2025. The cumulative <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 798.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 65.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend receivable by ADS holders for Q1, Q2 and Q3 <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 235.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 250.45999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 266.63pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;1.15<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 283.98pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 473.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The expected dividend for <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 403.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 422.53000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 433.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">64<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.58000000000004pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">p per Ordinary Share. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 489.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details of the dividends declared, the amounts and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.94pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payment dates are given in Note <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 428.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 437.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to the financial statements, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 510.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8216;Dividends&#8217;.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 526.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 328.92pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Dividend calendar<span style="display: inline-block; height: 8pt;"></span></span></div><div style="position: var(--position); top: 541.92pt; width: 595.44pt;"><div style="font-size: 0pt; left: 304.8pt; position: var(--position); top: 0pt; width: 234.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 36.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 49.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 51pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 47.25pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 36.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 36.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 36.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ex-dividend <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 87pt; overflow: hidden; position: var(--position); top: 0pt; width: 49.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS Ex-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividend date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 136.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 51pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 51pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Record date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 187.5pt; overflow: hidden; position: var(--position); top: 0pt; width: 47.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Payment date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 36.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 36.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q4 2024<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 36.75pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 87pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">21 February <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 136.5pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">21 February <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 187.5pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 April<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 36.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 36.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q1 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 36.75pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 May<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 87pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16 May<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 136.5pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">16 May<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 187.5pt; overflow: hidden; position: var(--position); top: 40.5pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10 July<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 36.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 36.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q2 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 36.75pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14 August <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 87pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 August <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 136.5pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">15 August <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 187.5pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9 October<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 36.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 36.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q3 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 36.75pt; overflow: hidden; position: var(--position); top: 84pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">13 November<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 87pt; overflow: hidden; position: var(--position); top: 84pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14 November<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 136.5pt; overflow: hidden; position: var(--position); top: 84pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14 November<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 187.5pt; overflow: hidden; position: var(--position); top: 84pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8 January<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 36.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 36.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Q4 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 36.75pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 50.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">19 February<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 87pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 49.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 49.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 136.5pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 51pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20 February<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 51pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 187.5pt; overflow: hidden; position: var(--position); top: 105.75pt; width: 47.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9 April<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 47.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">289<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_664"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="font-size: 18.5pt; line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial calendar <span style="display: inline-block; height: 13.46pt;"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: 153.27pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 153.33pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 237.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 162pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 75.75pt;"/></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 162pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 162pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 142.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Event <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 162pt; position: var(--position); top: 0pt; width: 75.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 4.41pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 59.53pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Date<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 12pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter 1 results announcement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 162pt; overflow: hidden; position: var(--position); top: 12pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">30 April 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual General Meeting<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 162pt; overflow: hidden; position: var(--position); top: 24pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">7 May 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 36pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter 2 results announcement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 162pt; overflow: hidden; position: var(--position); top: 36pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">30 July 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quarter 3 results announcement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 162pt; overflow: hidden; position: var(--position); top: 48pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">29 October 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preliminary/Quarter 4 Results announcement<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 162pt; overflow: hidden; position: var(--position); top: 60pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 3.47pt; width: 75.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">4 February 2026<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report publication<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 162pt; overflow: hidden; position: var(--position); top: 72pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">February/March 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 162pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 162pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report distribution<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.75pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 162pt; overflow: hidden; position: var(--position); top: 84pt; width: 75.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 75.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">March 2025<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 262.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Information about the company, including the share and ADS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">price, is available on our website at gsk.com. Information made <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available on the website does not constitute part of this Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 305.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Stock Exchange announcement notifications<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 321.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We provide shareholders with a service to receive automatic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 331.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">email notifications when we publish a stock exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">announcement. To receive email notifications, please sign up <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for announcements at gsk.com in the Investors section.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 153.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Results announcements<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 169.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Results announcements are issued to the LSE and are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 179.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available on its news service. They are also sent to the US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 189.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Securities and Exchange Commission (SEC) and the NYSE, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 199.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issued to the media and made available on our website.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 215.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Financial reports <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Annual Report is made available on our website from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date of publication. Shareholders may elect to receive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">notification by email of the publication of Annual Reports by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 262.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">registering on www.investorcentre.co.uk, and may also elect to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receive a printed copy of the Annual Report by contacting our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">registrar, Computershare Investor Services PLC. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Copies of previous Annual Reports are available on our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">website. Printed copies can also be obtained from our registrar <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(see page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if82f25ba1b444b79b54f72c88eb84a57_0-0-1-1-821446">298</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 358.56pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for the contact details). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: absolute; top: 382.45pt;" id="idc89fa1ee07645df9629d157a4b46752_667"></div><div style="position: var(--position); top: 382.45pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="font-size: 18pt; line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual General Meeting <span style="display: inline-block; height: 13.1pt;"></span></span><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: 196.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 420.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Annual General Meeting (AGM) will be held at 2.30pm (UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 431.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time) on Wednesday, 7 May 2025 at The Landmark London, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">222 Marylebone Road, London, NW1 6JQ, United Kingdom <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 451.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and will also be broadcast live for you to join electronically.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The AGM is the company&#8217;s principal forum for communication <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with private shareholders. In addition to the formal AGM <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business, there will be a presentation by the CEO on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance of the Group and its future development. There <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">will be an opportunity for questions to be asked of the Board <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and Chairs of the Board&#8217;s Committees will be available to take <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">questions relating to their roles.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Further details on how to access the AGM electronically or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attend in person, ask questions and vote, can be found in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 564.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">notice of Annual General Meeting <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2025<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 199.14999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> (AGM Notice) which will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be made available on our website at gsk.com on or around 24 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">March 2025.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 601.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investors holding shares through a nominee service should <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrange with that service for them to be appointed as a proxy in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of their shareholding to attend and vote at the meeting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electronically. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 420.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS holders wishing to attend the meeting electronically should <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 431.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">refer to the AGM Notice for details on how to request a proxy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 441.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appointment from the Depositary, JP Morgan Chase Bank NA. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 451.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This will enable them to attend, ask questions and vote <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electronically on the business to be transacted at the meeting. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS holders are reminded that if they do not instruct the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary as to the way in which the shares represented by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their ADS should be voted by completing and returning the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voting card provided by the Depositary, their shares will not be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">voted.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 534.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Documents on display<span style="display: inline-block; height: 8pt;"></span><span id="if8bc787354ec4663b4033dfe884628b8_2037"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 550.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Articles of Association of the company and Directors&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">service contracts or, where applicable, letters of appointment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between Directors and the company or any of its subsidiaries <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(and any side letters relating to severance terms and pension <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 590.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements) are available for inspection at the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 601.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">registered office and will be made available for inspection at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">AGM.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">290<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_670"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax information for shareholders<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A summary of certain UK tax and US federal income tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consequences for holders of shares and ADS who are citizens <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the UK or the US is set out below. It is not a complete <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">analysis of all the possible tax consequences of the purchase, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ownership or sale of these securities. It is intended only as a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">general guide. Holders are advised to consult their advisers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with respect to the tax consequences of the purchase, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 223.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ownership or sale of their shares or ADS and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 233.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consequences under state and local tax laws in the US and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 243.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implications of the current UK/US tax conventions. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US holders of ADS generally will be treated as the owners of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the underlying shares for the purposes of the current UK/US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">double taxation conventions relating to income and gains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Income Tax Convention), estate and gift taxes (Estate and Gift <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax Convention), and for the purposes of the Internal Revenue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code of 1986, as amended.<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 157.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 326.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">UK shareholders <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 342.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This summary only applies to a UK resident shareholder that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 352.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holds shares as capital assets. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 368.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation of dividends <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 82.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 101.52pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">/25 UK tax year, UK resident individuals are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entitled to a dividend tax allowance of up to &#163;500, so that the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">first &#163;500 of dividends received in a tax year will be free of tax. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends in excess of this allowance will be taxed at 8.75% for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 425.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basic rate taxpayers, 33.75% for higher rate tax payers and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 435.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">39.35% for additional rate taxpayers. Note that from 6 April <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 445.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 the dividend allowance was reduced from &#163;1,000 to &#163;500.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK resident shareholders that are corporation taxpayers should <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">note that dividends payable on ordinary shares are generally <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 481.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entitled to exemption from corporation tax.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 497.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation of capital gains <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK resident shareholders may be liable for UK tax on gains on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the disposal of shares or ADS. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 539.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For disposals by individuals in the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 181.7pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200.42000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">/25 UK tax year, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">capital gains tax rate is dependant on the date of sale. Prior to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">30 October 2024, a taxable capital gain accruing on a disposal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of shares or ADS will be taxed at 10% for basic rate taxpayers, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or 20% if, after all allowable deductions, the individual&#8217;s taxable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 590.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income for the year exceeds the basic rate income tax banding. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 600.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disposals made on or after 30 October 2024 the rates are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 611.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">increased to 18% and 24% respectively. Note this is following <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 621.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the use of any exemptions available to the individual taxpayer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such as the annual exempt amount. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation tax payers may be entitled to an indexation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 657.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowance which applies to reduce capital gains to the extent <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 667.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that such gains arise due to inflation. Indexation allowance may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 677.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reduce a chargeable gain but will not create an allowable loss. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 688.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For assets acquired on or before 1 January 2018, legislation in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 698.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Finance Act 2018 freezes the level of indexation allowance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that is given in calculating a company&#8217;s chargeable gains at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 718.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value that would apply to the disposal of an asset in December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 728.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2017. For assets acquired from 1 January 2018 onwards, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 739.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legislation in the Finance Act 2018 removes any indexation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 749.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">allowance on disposal.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Inheritance tax <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Individual (UK-domiciled or otherwise) shareholders may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liable to UK inheritance tax on the transfer of shares or ADS. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exposure to a UK inheritance tax charge typically occurs on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">death of the asset owner. However, transfers of shares (other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">than commercial sales) within seven years of death remain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant to any inheritance tax exposure at death. Further, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfers to a trust arrangement during lifetime can give rise to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an immediate inheritance tax charge.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax may be charged on the amount by which the value of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholder&#8217;s estate is reduced as a result of any transfer by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">way of lifetime gift or other disposal at less than full market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 285.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value. In the case of a bequest on death, tax may be charged <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 295.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on the value of the shares at the date of the shareholder&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 306.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">death. Where an exposure to UK inheritance tax and US estate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 316.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or gift tax exists, careful planning must be undertaken to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 326.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understand the opportunity to utilise the US/UK Estate and Gift <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 336.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Double Tax Convention to manage tax credits and avoid double <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">taxation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 362.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The overall exposure will be dependent on the specific <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 372.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">circumstances of each situation and it is also important to note <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that tax charges may arise in other jurisdictions. Bespoke <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 393.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">advice tailored to an individual&#8217;s personal circumstances should <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 403.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">therefore be obtained from a tax professional. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 419.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Stamp duty and stamp duty reserve tax<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 435.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK stamp duty and/or stamp duty reserve tax (SDRT) will, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 445.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subject to certain exemptions, be payable on the transfer of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares at a rate of 0.5% (rounded up to the nearest &#163;5 in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">case of stamp duty) of the consideration for the transfer. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notwithstanding this, provided that an instrument is executed in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pursuance of the agreement that gave rise to the charge to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SDRT and that instrument is stamped within six years of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 506.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreement (including being stamped as exempt) any SDRT <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 516.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charge should be cancelled and any SDRT which has already <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 527.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">been paid will be repaid. Where listed shares are transferred to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 537.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a company connected to the transferor the chargeable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 547.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration will be deemed to be not less than the market <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 557.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of the shares transferred. This market value override also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applies where non-listed shares are transferred to a company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connected to the transferor where the consideration includes an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 588.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issue of shares. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 604.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">US <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 322.88pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">shareholders<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 390.92pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This summary only applies to a shareholder (who is a citizen or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 630.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resident of the US or a domestic corporation or a person that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is otherwise subject to US federal income tax on a net income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 650.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">basis in respect of the shares or ADS) that holds shares or ADS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 660.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as capital assets, is not resident in the UK for UK tax purposes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and does not hold shares for the purposes of a trade, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">profession or vocation that is carried on in the UK through a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 691.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">branch or agency. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 707.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The summary also does not address the tax treatment of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 717.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holders that are subject to special tax rules, such as banks, tax-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 727.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exempt entities, insurance companies, dealers in securities or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 737.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currencies, persons that hold shares or ADS as part of an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 748.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">integrated investment (including a &#8216;straddle&#8217;) comprised of a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 758.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share or ADS and one or more other positions, and persons <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 768.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that own (directly, indirectly or constructively) 10% or more of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 778.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company&#8217;s stock (by vote or value), nor does it address tax <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 788.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">treatment that may be applicable as a result of international <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 799.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income tax treaties.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">291<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation of dividends <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The gross amount of dividends received is treated as foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">source dividend income for US tax purposes. It is not eligible <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for the dividend received deduction allowed to US corporations. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid in sterling generally will be<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 209.18pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> includable<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 249.31pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> in income <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in a US dollar amount calculated by reference to the exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rate in effect on the day the US holder receive the dividends, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the case of Ordinary Shares, or the date the depositary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">receives the dividends, in the case of ADSs. Subject to certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exceptions for short-term or hedged positions, an individual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eligible US holder will be subject to US taxation at a maximum <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">federal rate of 23.8% plus applicable state and local tax in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of qualified dividends. A qualified dividend as defined <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the US Internal Revenue Service (IRS) is a dividend that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meets the following criteria:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">It must be issued by a US corporation, a corporation <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">incorporated in a US possession, or a corporation that is <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">eligible for the benefits of a comprehensive income tax treaty <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deemed satisfactory, as published by the IRS. <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.26pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The dividends are not of a type listed by the IRS as dividends <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 334.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that do not qualify.<span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.35pt; width: 595.44pt;"><span style="font-family: 'GSK Precision Light', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.<span style="display: inline-block; height: 8.16pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The required dividend holding period has been met. The <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares must have been owned by you for more than 60 days <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the &#8216;holding period&#8217; &#8211; which is defined as the 121-day <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">period that begins 60 days before the ex-dividend date, or <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the day in which the stock trades without the dividend priced <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in. For example, if a stock&#8217;s ex-dividend date is 1 October, <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 411.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the shares must be held for more than 60 days in the period <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 421.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between 2 August and 30 November of that year in order to <span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 431.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">count as a qualified dividend.<span style="display: inline-block; height: 8.16pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends that are not qualified are subject to taxation at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US federal graduated tax rates, at a maximum rate of 40.8%. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Some types of dividends are automatically excluded from being <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">qualified dividends, even if they meet the other requirements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">These include (but are not limited to):<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 504.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capital gains distributions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends on bank deposits<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 526.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends held by a corporation in an Employee Stock <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 537.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ownership Plan (ESOP)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends paid by tax-exempt corporations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US state and local tax rates on qualified and non-qualified <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends may vary and would be assessed in addition to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">federal tax rates communicated above.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 600.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Taxation of capital gains <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Generally, US holders will not be subject to UK capital gains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 626.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tax, but will be subject to US tax on capital gains realised on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 636.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the sale or other disposal of shares or ADS. Such gains will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">long-term capital gains (subject to reduced rates of taxation for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 657.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">individual holders) if the shares or ADS were held for more than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 667.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one year, from the date the shares were vested/released. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 677.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Short-term capital gains can be subject to taxation of rates of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 687.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">up to 40.8%, whereas long-term capital gains may be subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 698pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rates of up to 23.8%. State and local tax rates on capital gains <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may also apply.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Information reporting and backup <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">withholding <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 142.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dividends and payments of the proceeds on a sale of shares or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 152.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADS, paid within the US or through certain US-related financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intermediaries, are subject to information reporting and may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subject to backup withholding unless the US holder is a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporation or other exempt recipient or provides a taxpayer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identification number and certifies that no loss of exemption has <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 203.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">occurred. Non-US holders generally are not subject to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information reporting or backup withholding, but may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required to provide a certification of their non-US status in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connection with payments received. Any amounts withheld will <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be allowed as a refund or credit against a holder&#8217;s US federal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 254.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">income tax liability provided the required information is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 264.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">furnished to the IRS. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 280.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Estate and gift taxes <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under the Estate and Gift Tax Convention, a US shareholder is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not generally subject to UK inheritance tax. However, a US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holder may be subject to US federal estate and gift tax.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 330.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Stamp duty <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK stamp duty and/or SDRT will, subject to certain exemptions, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 356.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be payable on any transfer of shares to the ADS custodian or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">depositary at a rate of 1.5% of the amount of any consideration <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 376.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided (if transferred on sale), or their value (if transferred for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">no consideration). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 402.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">However, no stamp duty or SDRT should be payable on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfer of, or agreement to transfer an ADS or on transfers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">within the clearance service.&#160; Notwithstanding the above, where <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the clearance service operator has made an election under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">s97A Finance Act 1986, broadly the 1.5% stamp duty/SDRT <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 453.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">charge should not arise on the transfer into the clearance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">service, but transfers to, and within, the system (where there is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a change in beneficial ownership) wo<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 442.55pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">uld attract a 0.5% charge<span style="display: inline-block; height: 6.18pt;"></span><span id="i98a746406a444b7985babbff9a78bf40_11036"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 535.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">292<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_673"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i11409e1e32b245dcbff808f3d7d6cd41_0-0-1-5-821446"></span><span id="i11409e1e32b245dcbff808f3d7d6cd41_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles of Association of GSK plc<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.69pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">following<span style="display: inline-block; height: 6.18pt;"></span><span id="i9003e035c1ff401f8e7b8ba700367d24_105515"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 103.34pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> is a summary of certain provisions of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s Articles of Association (the &#8220;Articles&#8221;). This summary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">is qualified in its entirety by reference to the UK Companies Act <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2006 (the &#8220;Companies Act&#8221;) and the current Articles which are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available online on the company&#8217;s website. Any amendment to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Articles may be made in accordance with the provisions of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Companies Act, by way of special resolution.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK plc (the &#8220;company&#8221;) is a public limited company registered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in England and Wales with a registered number 3888792. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company has no statement of objects in the Articles; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordingly, its objects are unrestricted in accordance with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions of the Companies Act.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 285.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(a)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 89.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Directors<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Articles provide for a board of directors, consisting of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(unless otherwise determined by ordinary resolution of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders) not less than two nor more than 24 directors, in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which all the powers of the company (whether relating to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management of the business of the company or not) are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">vested.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A director must not vote on, or count towards the quorum in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relation to, any resolution of the Board relating specifically to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their own appointment (including remuneration) or the terms of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 396.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">their termination of appointment or relating to any contract in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 406.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which they have an interest. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">This prohibition does not apply to any resolution where that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 432.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest cannot reasonably be regarded as likely to give rise to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 442.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a conflict of interest or where that interest arises only from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 452.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain specified matters, including (but not limited to): (a) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 463.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indemnifying the director in respect of obligations incurred at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the request of or for the benefit of the company or any of its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiary undertakings; (b) indemnifying a third party in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 493.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respect of obligations of the company or any of its subsidiary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertakings for which the director has assumed responsibility <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 514.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in whole or in part under an indemnity or guarantee or by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">giving of security; (c) contracts concerning another company in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which the director is the holder of or beneficially interested in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">less than 1% of any class of the equity share capital of such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company; (d) offers of securities by the company or any of its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiary undertakings in which the director will or may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entitled to participate as a holder of securities; (e) employee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">benefits in relation to the company or any of its subsidiary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">undertakings in which the director will share in a similar manner <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to other employees; and (f) the purchase or maintenance of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insurance against any liability for, or for the benefit of, any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 626.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">director or directors or for, or for the benefit of, persons who <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 636.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">include directors.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 652.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors may be elected by ordinary resolution of shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 662.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or appointed by the Board. At each annual general meeting, all <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 672.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the directors at the date of the notice convening the annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 683.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">general meeting shall retire from office and may offer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 693.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">themselves for re-election by members.&#160; No director is required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 703.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to retire by reason of their age, nor do any special formalities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 713.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">apply to the appointment or re-election of any director who is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over any age limit. No shareholding qualification for directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 734.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shall be required. Directors may also be removed before the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 744.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expiration of their term of office in accordance with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 754.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provisions of the Companies Act and the Articles.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 770.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subject to the provisions of the Companies Act, the directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 780.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may exercise all the company&#8217;s powers to borrow money; to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 790.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mortgage or charge all or any of the company&#8217;s undertaking, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 800.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">property (present and future), and uncalled capital; to issue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">debentures and other securities; and to give security either <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outright or as collateral security for any debt, liability or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">obligation of the company or of any third party. The Articles <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide for the provision of benefits, by the payment of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gratuities, pensions or insurance or in any other manner, for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any director or former director or their relations, connected <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 213.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">persons or dependants.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(b)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 340.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Voting<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 248.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All resolutions put to the vote at general meetings, including <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electronic general meetings, will be decided by poll. On a poll, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">every shareholder who is present in person or by proxy shall <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have one vote for every share held. Matters are transacted at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; meetings by the proposing and passing of two <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">kinds of resolution. An ordinary resolution requires the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affirmative vote of a majority of the votes cast by those entitled <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to vote at a meeting at which there is a quorum. A special <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resolution requires the affirmative vote of not less than three <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quarters of the votes cast by those entitled to vote at a meeting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at which there is a quorum. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 366.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The necessary quorum for a meeting of the company is a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 376.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">minimum of two shareholders present in person or by proxy <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and entitled to vote. A shareholder is not entitled to vote any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 397.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share held by them at any general or class meeting if any call <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or other sum then payable remains unpaid or if that shareholder <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has been served with a restriction notice (as defined in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles) after failure to provide the company with information <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concerning interests in those shares required to be provided <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 448.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the Companies Act.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 464.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(c)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 340.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Transfer of shares<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 479.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Any shareholder may transfer their Ordinary Shares which are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 490.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in certificated form by an instrument of transfer in any usual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 500.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">form or in any other form which the Board may approve. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 510.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board may decline to register a transfer of a certificated share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 520.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unless the instrument of transfer (a) is duly stamped or certified <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 530.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or otherwise shown to the satisfaction of the Board to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 541.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exempt from stamp duty, and is accompanied by the relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 551.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">share certificate and such other evidence of the right to transfer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 561.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as the Board may reasonably require, (b) is in respect of only <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 571.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">one class of share, and (c) if to joint transferees, is in favour of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 581.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">not more than four such transferees.&#160; Registration of a transfer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 592.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of an uncertificated share may be refused in the circumstances <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 602.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">set out in the uncertificated securities rules (as defined in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 612.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles) and where, in the case of a transfer to joint holders, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 622.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the number of joint holders to whom the uncertificated share is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to be transferred exceeds four. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 648.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Board may decline to register a transfer of any of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 659.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company&#8217;s certificated shares by a person with a 0.25% <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 669.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest (as defined in the Articles) if such a person has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 679.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">served with a restriction notice (as defined in the Articles) after <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 689.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">failure to provide the company with information concerning <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 699.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interests in those shares required to be provided under the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Companies Act, unless the transfer is shown to the Board to be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 720.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pursuant to an arm&#8217;s length sale (as defined in the Articles). <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">293<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 11pt; position: var(--position); top: 126.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(d)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 89.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Dividends and distribution of assets <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">on liquidation<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subject to the provisions of the Articles and applicable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legislation, the Company in general meeting may declare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dividends on the Ordinary Shares by ordinary resolution, but <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any such dividend may not exceed the amount recommended <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by the Board.&#160; If in their opinion the company&#8217;s financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">position justifies such payments, the directors may, as far as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any applicable legislation allows, pay interim dividends on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares of any class of such amounts and in respect of such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">periods as they think fit. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Except in so far as the rights attaching to, or the terms of issue <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 263.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of, any share otherwise provide, all dividends will be declared, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">apportioned and paid pro rata according to the amounts paid <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">up on the shares during any portion of the period in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which the dividend is paid. As the company has only one class <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 303.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of Ordinary Shares, the holders of such Ordinary Shares will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entitled to participate in any surplus assets on a winding-up in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proportion to their shareholdings.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If shareholders fail to provide the necessary details to enable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payment, or if payment cannot be made using the details <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided by the shareholder, the dividend or other amount <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable will be treated as unclaimed. Any dividend or other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sum unclaimed after a period of six years from the date it was <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">declared or became due for payment is forfeited and reverts to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company unless the Board decides otherwise. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 417.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(e)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 89.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share rights<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subject to any rights attached to existing shares, the company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">may issue (a) shares with such rights and restrictions as the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 453.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company may be ordinary resolution decide or (if there is no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 463.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such resolution or so far as it does not make specific provision) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as the Board may decide, and (b) redeemable shares, and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 484.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board may determine the terms, conditions and manner of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">redemption of any redeemable share so issued. Such rights, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 504.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">restrictions, terms and conditions shall apply to the relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 514.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares as if they were set out in the Articles.&#160; Subject to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Articles, any resolution passed by the shareholders and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders&#8217; rights, the Board may decide how to offer, allot, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">grant options over or otherwise deal with any shares in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 571.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(f)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 89.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Variation of rights and changes in <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 584.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">capital <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 600.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subject to the provisions of any statute (including any orders, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 610.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations or other subordinate legislation made under it) from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 620.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time to time in force concerning companies in so far as it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 631.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applies to the company, the rights attached to any class of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 641.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares may be varied with the written consent of the holders of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 651.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">three quarters in nominal value of the issued shares of that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 661.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">class (excluding any shares of that class held as treasury <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares) or with the sanction of a special resolution passed at a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 682.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">separate meeting of the holders of shares of that class. At <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 692.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">every such separate meeting, the provisions of the Articles <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 702.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relating to general meetings shall apply, except the necessary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 712.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">quorum shall be at least two persons entitled to vote and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 722.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holding or representing as proxy at least one-third in nominal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">value of the issued shares of the relevant class (excluding any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 743.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares of that class held as treasury shares) (but provided that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 753.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at any adjourned meeting one holder of shares of the relevant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 763.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">class present in person or by proxy shall be a quorum).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 779.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If new shares are created or issued which rank equally with any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 789.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other existing shares, or if the company purchases or redeems <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 800pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any of its own shares, the rights of existing shares will not be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regarded as changed or abrogated unless the terms of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">existing shares expressly say otherwise.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While holders of ordinary shares have no pre-emptive rights <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the Articles, the ability of the directors to cause the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company to issue shares, securities convertible into shares or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rights to shares, otherwise than pursuant to an employee share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">scheme, is restricted. Under the Companies Act, the directors <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of a company are, with certain exceptions, unable to allot any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equity securities without express authorisation, which may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 210.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contained in a company&#8217;s articles of association or given by its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 221.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders in a general meeting, but which in either event <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 231.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cannot last for more than five years. Under the Companies Act, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the company may also not allot shares for cash (otherwise than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pursuant to an employee share scheme) without first making an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offer to existing shareholders to allot such shares to them on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the same or more favourable terms in proportion to their <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respective shareholdings, unless this requirement is disapplied <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by a special resolution of the shareholders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Holders of shares are not subject to calls on capital by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company, provided that the amounts required to be paid on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issue have been paid off.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 344.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(g)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 340.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Limitations on rights of non-resident <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 357.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">or foreign shareholders<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 373.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are no limitations imposed by the Articles on the rights of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 383.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">non-resident or foreign shareholders except that there is no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requirement for the company to serve notices on shareholders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 404.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">outside the United Kingdom and the United States, if no postal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 414.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">address in the United States or United Kingdom has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 424.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided to the company. The company may choose not to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 434.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">serve, send or supply any notice to a particular shareholder <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 445.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where it considers this necessary or appropriate to deal with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 455.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal, regulatory or practical problems in, or under the laws of, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 465.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">any territory.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 481.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(h)<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 340.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">General meetings of shareholders<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 497.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company is required by the Companies Act to hold an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 507.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">annual general meeting each year. General meetings of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 517.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders may be called as necessary by the directors and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 527.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">must be called promptly upon receipt of a requisition from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 538.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareholders. Under the Companies Act, an annual general <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 548.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meeting must be called by notice of at least 21 clear days. A <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 558.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">general meeting other than an annual general meeting may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 568.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">called on not less than 14 clear days&#8217; notice provided a special <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 578.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resolution reducing the notice period to 14 clear days has been <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 589.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">passed at the immediately preceding annual general meeting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 599.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or a general meeting held since that annual general meeting. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 609.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The directors may determine that a general meeting shall be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 619.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">held as a physical meeting or in combination with an electronic <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 629.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">platform or platforms that enables members to participate in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 640.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meeting without physically attending (an electronic general <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 650.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">meeting).<span style="display: inline-block; height: 6.18pt;"></span><span id="i9003e035c1ff401f8e7b8ba700367d24_105516"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">294<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i1ed0f69669d6410b8634beaa3e754e83_0-0-1-5-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Material contracts<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Agreements<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 116.58pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> w<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 128.01999999999998pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ith Novartis<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On April 22, 2014, GSK and Novartis AG (&#8220;Novartis&#8221;) entered <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">into a three-part, inter-conditional transaction, in connection <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with which they executed, among other agreements, a share <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and business sale agreement relating to the acquisition by GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the vaccines business of Novartis (the &#8220;Vaccines SAPA&#8221;). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s shareholders approved the transaction on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">December<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> 18, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2014. The transaction closed on March 2, 2015.&#160; GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continues to have obligations to pay further sales and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">milestone-based consideration to Novartis under the Vaccines <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SAPA.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 281.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Agreement with Pfizer<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 294.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On December 19, 2018, GSK, GSK Consumer Healthcare and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer Inc. (&#8220;Pfizer&#8221;) entered into a Stock and Asset Purchase <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreement (the &#8220;Pfizer SAPA&#8221;) pursuant to which the parties <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreed to form a consumer healthcare joint venture (the &#8220;GSK/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 335.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer JV&#8221;) through the acquisition by GSK Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 345.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare from Pfizer of Pfizer&#8217;s consumer healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business and the transfer by GSK to GSK Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare of those parts of the GSK consumer healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business not already part of GSK Consumer Healthcare as of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the date of the Pfizer SAPA (with certain limited exceptions). As <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 396.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consideration for the acquisition of its consumer healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 406.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business, Pfizer received shares in GSK Consumer Healthcare <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representing a 32% ownership interest in the GSK/Pfizer JV. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK retained a controlling interest in GSK Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare of 68%. On July 31, 2019, the parties entered into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an amendment to the Pfizer SAPA, pursuant to which: (i) GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 457.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consumer Healthcare transferred by novation to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Consumer Healthcare Holdings (No. 2) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Limited (&#8220;GSK Consumer Healthcare (No. 2)&#8221;) all rights, title, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">interest, obligations duties and liabilities of GSK Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare under and in respect of the Pfizer SAPA, (ii) the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">parties released GSK Consumer Healthcare from its obligations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the Pfizer SAPA in exchange for GSK Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare (No. 2)&#8217;s assumption thereof and (iii) certain other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amendments to the Pfizer SAPA and other arrangements in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connection with the closing of the transaction, including in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 559.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relation to the delayed legal completion of the transaction in a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 569.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">number of jurisdictions due to regulatory constraints. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 579.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transaction closed on July 31, 2019.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Each of GSK and Pfizer gave customary and broadly reciprocal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">representations and warranties to each other under the Pfizer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SAPA. GSK and Pfizer agreed to indemnify each other and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Consumer Healthcare (No. 2) (as applicable) in respect of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">losses (other than certain losses arising from tax matters, which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are subject to a specific indemnity under the Pfizer SAPA) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relating to: (i) certain liabilities which the parties agreed will be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">retained by GSK or Pfizer; (ii) any breach of their respective <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">covenants or agreements under the Pfizer SAPA or the related <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ancillary agreements implementing the Pfizer SAPA; or (iii) any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">breach of their respective representations and warranties given <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the Pfizer SAPA or the related ancillary agreements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implementing the Pfizer SAPA as of the date of completion of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the transaction. GSK Consumer Healthcare (No. 2) agreed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indemnify GSK and Pfizer in respect of losses (other than <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain losses arising from tax matters, which are subject to a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specific indemnity under the Pfizer SAPA) relating to: (i) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liabilities which GSK Consumer Healthcare (No. 2) agreed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assume in connection with the transaction; (ii) liabilities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 338.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">resulting from the conduct of GSK Consumer Healthcare&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">business other than those liabilities that GSK agreed to retain in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connection with the transaction; and (iii) any breach of GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consumer Healthcare (No.2)&#8217;s post-completion covenants or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 379.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreements under the Pfizer SAPA or the related ancillary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 389.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreements implementing the Pfizer SAPA.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On June 1, 2022, GSK, Pfizer, GSK Consumer Healthcare (No. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2) and Haleon plc (&#8220;Haleon&#8221;) entered into the second <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amendment agreement to the Pfizer SAPA to implement certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">amendments in connection with the demerger of the Consumer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Healthcare business (the &#8220;Demerger&#8221;) and to include Haleon in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Pfizer SAPA indemnity framework by way of a guarantee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 467.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">given by Haleon with respect to the indemnification obligations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of GSK Consumer Healthcare (No. 2) under the Pfizer SAPA.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 493.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Demerger Agreements<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 509.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On June 1, 2022, GSK and Haleon entered into a demerger <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 519.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">agreement (the &#8220;Demerger Agreement&#8221;) to effect the Demerger <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 529.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and to govern aspects of the relationship between GSK and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Haleon following completion of the Demerger. The Demerger <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 549.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreement contains certain customary indemnities under which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK indemnifies Haleon in respect of liabilities, losses <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">demands, claims, costs, taxes and damages arising, directly or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">indirectly, from or in consequence of certain claims. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">On June 1, 2022 GSK, GSK Consumer Healthcare and GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consumer Healthcare (No. 2) entered into an asset transfer <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework agreement (the &#8220;Asset Transfer Framework <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 626.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreement&#8221;), setting out the framework for the transfer of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 637.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain businesses, assets, liabilities and employees that were <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">excluded from the original perimeter of the GSK/Pfizer JV as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 657.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contemplated in the Pfizer SAPA and others that were included <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 667.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the original perimeter of the GSK/Pfizer JV but had not yet <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 677.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legally transferred or to record the transfer of other assets <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 688.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the Pfizer SAPA, in each case from the GSK group to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 698.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Haleon group. The Asset Transfer Framework Agreement also <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 708.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sets out the framework for the transfer of certain businesses, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 718.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets, liabilities and employees from the Haleon group to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 728.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK group.&#160; The Asset Transfer Framework Agreement <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 739.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contained a substantially equivalent indemnity regime to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 749.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pfizer SAPA indemnification regime described above. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 765.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The indemnities given by GSK pursuant to the Pfizer SAPA, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 775.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Demerger Agreement and the Asset Transfer Framework <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 785.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreement, as described above, survived the completion of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 795.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Demerger and continue in perpetuity.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">295<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i2f316a1474164b27aa0dc2bb426300d2_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">American Depositary Shares<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Fees and charges payable by<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 204.33999999999997pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> ADR holders<span style="display: inline-block; height: 8pt;"></span><span id="i9003e035c1ff401f8e7b8ba700367d24_105520"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JPMorgan Chase Bank, N.A. serves as the depositary (the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 177.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Depositary&#8221;) for GSK&#8217;s American Depositary Receipt (&#8220;ADR&#8221;) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">program. On July 29, 2019, GSK and the Depositary amended <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 198.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and restated the deposit agreement and further amended the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 208.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deposit agreement on March 15, 2021 (the &#8220;Deposit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 218.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreement&#8221;) between GSK, the Depositary and owners and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 228.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holders of ADRs. Pursuant to the Deposit Agreement, ADR <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 239.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holders may be required to pay various fees to the Depositary, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 249.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the Depositary may refuse to provide any service for which <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 259.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a fee is assessed until the applicable fee has been paid. In <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 269.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">particular, the Depositary, under the terms of the Deposit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 279.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Agreement, shall charge (i) a fee of $5.00 per 100 American <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary Shares (or portion thereof) for the issuance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery, reduction, cancellation or surrender (as the case may <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">be) of American&#160; Depositary Shares (&#8220;ADSs&#8221;), (ii) a fee of U.S.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$0.05 or less per ADS held (A) upon which any cash <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distribution is made&#160; pursuant to the Deposit Agreement or (B) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 341.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in the case of an elective cash/stock dividend, upon which a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 351.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cash distribution or an issuance of additional ADSs is made as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a result of such elective dividend, (iii) a fee for the distribution <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or sale of securities, such fee being in an amount equal to the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">fee for the execution and delivery of ADSs referred to above <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 392.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which would have been charged as a result of the deposit of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 402.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such securities but which securities or the net cash proceeds <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 412.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from the sale thereof are instead distributed by the Depositary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 422.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to ADR holders entitled thereto, (iv) an aggregate fee of U.S.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 432.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">$0.05 or less per ADS per calendar year (or portion thereof) for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">services performed by the Depositary in administering the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 453.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADRs (which fee may be charged on a periodic basis during <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 463.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">each calendar year and shall be assessed against ADR holders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 473.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as of the record date or record dates set by the Depositary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 483.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">during each calendar year and shall be payable at the sole <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 494.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">discretion of the Depositary by billing such Holders or by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 504.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">deducting such charge from one or more cash dividends or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 514.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other cash distributions), and (v) a fee for the reimbursement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 524.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">such fees, charges and expenses as are incurred by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 534.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary and/or any of its agents (including, without <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 545.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">limitation, the agent or agents of the Depositary (the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 555.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Custodian&#8221;) and expenses incurred on behalf of ADR holders <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 565.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in connection with compliance with foreign exchange control <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 575.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regulations or any law or regulation relating to foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 585.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment) in connection with the servicing of the ordinary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares or other Deposited Securities, the sale of securities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(including, without limitation, Deposited Securities), the delivery <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 616.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of Deposited Securities or otherwise in connection with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 626.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary&#8217;s or its Custodian&#8217;s compliance with applicable law, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 636.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rule or regulation (which fees and charges shall be assessed&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 647.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on a proportionate basis against ADR holders as of the record <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 657.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">date or dates set by the Depositary and shall be payable at the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 667.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sole discretion of the Depositary by billing such ADR holders or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 677.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">by deducting such charge from one or more cash dividends or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 687.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other cash distributions).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 145.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK will pay other charges and out of pocket expenses of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 155.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary and any agent of the Depositary (except the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 165.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Custodian) as specified in written agreements from time to time <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 175.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between GSK and the Depositary, except (i) stock transfer or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other taxes and other governmental charges (which are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 196.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">payable by ADR holders or persons depositing ordinary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 206.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares), (ii) SWIFT, cable, telex and facsimile transmission and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">delivery charges incurred at the request of persons depositing, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or ADR holders delivering ordinary shares, ADRs or Deposited <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Securities (which are payable by such persons or ADR <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">holders), (iii) transfer or registration fees for the registration or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transfer of <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 344.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deposited Securities on any applicable register in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">connection with the deposit or withdrawal of Deposited <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 277.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Securities (which are payable by persons depositing ordinary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 287.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shares or ADR holders withdrawing Deposited Securities) and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(iv) in connection with the conversion of foreign currency into <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 308.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">U.S. dollars, the Depositary shall deduct out of such foreign <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 318.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currency the fees, expenses and other charges charged by it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 328.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and/or its agent&#160; (which may be a division, branch or affiliate) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 338.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">so appointed in connection with such conversion. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 349.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary and/or its agent may act as principal for such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 359.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conversion of foreign currency. Such charges may at any time <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 369.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and from time to time be changed by agreement between GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 379.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the Depositary.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 395.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Direct and indirect payments by the <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 408.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Depositary<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 424.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Depositary anticipates reimbursing GSK for certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 434.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">expenses incurred by GSK that are related to the establishment <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 445.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and maintenance of the ADR program upon such terms and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 455.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">conditions as GSK and the Depositary may agree from time to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 465.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">time. The Depositary may make available to GSK a set amount <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 475.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or a portion of the Depositary fees charged in respect of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 485.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ADR program or otherwise upon such terms and conditions as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 496.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK and the Depositary may agree from time to time. In 2024 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 506.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Depositary made payments of approximately $11.18 million.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Under certain circumstances, including removal of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 532.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Depositary or termination of the ADR program by GSK, GSK is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 542.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required to repay certain amounts paid to GSK and to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 552.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensate the Depositary for payments made or services <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 563.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provided on behalf of GSK.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">296<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 18.5pt; position: var(--position); top: 133.09pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: 51.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Insider Trading Policies<span style="display: inline-block; height: 13.46pt;"></span><span id="i9003e035c1ff401f8e7b8ba700367d24_105518"></span><span id="i9003e035c1ff401f8e7b8ba700367d24_38219"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We are committed to compliance with laws and regulations and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to financial integrity,&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 131.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 167.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-6013">adopted</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> an insider trading policy<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 288.25pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that governs the purchase, sale, and other dispositions of GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">securities by directors, management, and employees that is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 160.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonably designed to promote compliance with applicable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">insider trading laws, rules and regulations, and listing <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards.&#160; A copy of the policy is filed as Exhibit 11.1 to this <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report on Form 20-F.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 217.24pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="iaba1f3b1f85449a9baa50bb8040a23a3_0-0-1-5-824335"></span><span id="iaba1f3b1f85449a9baa50bb8040a23a3_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cyber Security<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 255.68pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-6014" continuedAt="f-6014-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Risk management and strategy <span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-6014-1" continuedAt="f-6014-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 269.17pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-6015" continuedAt="f-6015-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-6016" continuedAt="f-6016-1">We manage cyber security risk using our corporate enterprise </ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-6016-1" continuedAt="f-6016-2"><ix:continuation id="f-6015-1" continuedAt="f-6015-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 279.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risk management and Internal Control Framework (ICF). <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 264.99pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 289.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chief Information Security Officer (CISO)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 205.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> heads our Cyber <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 299.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security Office and is responsible for identifying and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">implementing controls<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 135.59pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> to mitigate and manage cyber security <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">risks, while maintaining a set of key risk indicators and setting <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">tolerances and thresholds that balance risk and business <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.57pt; width: 595.44pt;"><ix:continuation id="f-6015-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">needs.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 79.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> We adhere to widely accepted standards and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">frameworks to benchmark our internal environment and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls, defining our security objectives and desired outcomes. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 371.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As our threat environment evolves, we also utilise external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">frameworks such as the NIST Cyber Security Framework to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">measure cyber readiness and maturity, ISO 27001/27002 for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">general information technology controls, and Sarbanes-Oxley <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(SOX) for assessment of internal controls. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 212.12pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-6017" continuedAt="f-6017-1">Furthermore, we </ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span></div><ix:continuation id="f-6017-1" continuedAt="f-6017-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 422.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">draw on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 86.1pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-6018">third party consultants</ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 168.24pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8217; expertise in processes for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing, identifying and/or managing cyber security risks. <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 442.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">also have a third-party security risk management programme to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 452.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assess cyber security risk when selecting and onboarding third <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></ix:continuation></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 462.97pt; width: 595.44pt;"><ix:continuation id="f-6014-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-6016-2"><ix:continuation id="f-6017-2">parties.</ix:continuation></ix:continuation><span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 81.38pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 478.86pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-6019" continuedAt="f-6019-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Information and Cyber Security Governance<span style="display: inline-block; height: 6.55pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-6019-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 492.35pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-6023" continuedAt="f-6023-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-6021" continuedAt="f-6021-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-6020" continuedAt="f-6020-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-6022" continuedAt="f-6022-1"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Chief Digital and Technology Officer (CDTO) <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 237.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">leads the <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-6023-1" continuedAt="f-6023-2"><ix:continuation id="f-6021-1"><ix:continuation id="f-6020-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.55pt; width: 595.44pt;"><ix:continuation id="f-6022-1" continuedAt="f-6022-2"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Digital and Technology function, including the CIS<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.07999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">O and Cyber <span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-6022-2">Security Office.</ix:continuation><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 110.64pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-6024" continuedAt="f-6024-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 112.96000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our CDTO has over 25 years<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 222.20999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 224.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 231.52999999999997pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> experience as <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></div><ix:continuation id="f-6024-1" continuedAt="f-6024-2"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 522.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">an IT professional, including with GSK since 2018, and is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 533.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsible for Technology and Cyber Security at GSK.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 263.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 543.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CDTO is the Enterprise Risk Owner and&#160; manages and reports <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 553.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-6024-2">regularly on the GSK Information and Cyber Security risk.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 255.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The CISO coordinates risk, develops controls, and monitors the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 265.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">enterprise risk plan. This plan includes a description of the risk, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its external and internal context, our assessment and risk <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 286.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appetite, how we treat and monitor the risk in line with our ICF. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 296.48pt; width: 595.44pt;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-6026" continuedAt="f-6026-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-6025" continuedAt="f-6025-1" escape="true"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">T<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 309.95pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">he Board, Audit &amp; Risk Committee, and Risk Oversight and <span style="display: inline-block; height: 6.18pt;"></span></span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-6026-1"><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 306.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-6025-1">Compliance Council oversee our cyber security risk.</ix:continuation> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 500.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The CISO <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 316.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regularly reports on cyber security risks. This reporting covers <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">external and internal insights, key risk indicators, management <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">actions, updates on implementing the enterprise risk plan, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">escalations.&#160; The Cyber Security Office analyses potential <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 357.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cyber security incidents. Significant cyber security incidents are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 367.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">escalated to the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 366.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-6027" continuedAt="f-6027-1">Chief Compliance Officer, CDTO, GSK </ix:nonNumeric><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 378.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><ix:continuation id="f-6027-1">Leadership Team, and Company Secretary</ix:continuation><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 463.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Material incidents <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 388.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are escalated to the Board and Audit &amp; Risk Committee and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 398.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">appropriate disclosure committee as needed.<span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><ix:continuation id="f-6023-2" continuedAt="f-6023-3"><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 414.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Cyber Security Awareness, Training and Readiness<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our cyber security awareness and training programmes include <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 438.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">phishing simulations, monthly awareness campaigns, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mandatory annual refreshers for all employees. We also run <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">periodic crisis simulation exercises to test our response to <span style="display: inline-block; height: 6.18pt;"></span></span></div></ix:continuation><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.66pt; width: 595.44pt;"><ix:continuation id="f-6023-3"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">cyber security incidents<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 392.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></ix:continuation><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 394.41pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 396.73pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 484.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Compliance<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 355.06pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> with various governmental cyber security <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 495.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">regulations <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 508.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our Cyber Security Office, works to stay abreast of emerging <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government regulations, trends, and compliance expectations <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">regarding cyber security. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">297<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional information continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-1-821446"></span><span id="i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-5-824337"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code of Ethics<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have a number of well-established policies, including our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Code of Conduct ("The Code") for all employees, including the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CEO, CFO and other senior financial officers.&#160; The Code is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">available at https://www.gsk.com/en-gb/company/governance/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance/#the-code. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">During the year no waivers were granted from a provision of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">our code of ethics to our principal executive officer, principal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial officer, principal accounting officer or controller, or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">persons performing similar functions.&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 235.11pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i37d244f9bf254df68642a97cc2064c35_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Supplemental Guarantor Information<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 273.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As of 31 December 2024, GSK plc (the &#8216;Guarantor&#8217;) has fully <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and unconditionally guaranteed certain debt securities (&#8216;Notes&#8217;) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issued by GlaxoSmithKline Capital plc and GlaxoSmithKline <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capital Inc. (the &#8216;Issuers&#8217;) in offerings under the Guarantor's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the Issuers' registration statement on Form F-3, including: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Capital Inc.:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 346.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.625% Notes due 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 358.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.875% Notes due 2028<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5.375% Notes due 2034<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 382.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6.375% Notes due 2038<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 394.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">4.200% Notes due 2043<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Capital plc:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8226;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3.375% Notes due 2029<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 273.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Issuers are 100% owned finance subsidiaries of GSK plc. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 283.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Issuers have no assets or operations other than those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 293.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">related to the issuance, administration and repayment of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 304.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Notes being registered and other non-registered securities <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 314.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guaranteed by GSK plc. GSK plc has fully and unconditionally <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guaranteed the Notes and no other subsidiary of GSK plc <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 334.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provides such guarantee. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Notes are listed on the New York Stock Exchange or the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London Stock Exchange (in the case of 5.375% Notes due <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2034). The guarantee is a full, irrevocable and unconditional <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">guarantee of the principal, interest, premium, if any, and any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other amounts payable in respect of the Notes.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 470.69pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 490.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 97.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 98.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 98.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 98.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 98.25pt;"/></tr><tr style="height: 21.75pt;"><td colspan="5" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i087033d814da4b86806bb66a3591f946_0-0-1-1-825207"></span><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 490.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 490.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Principal Accountant Fees and Services<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 503.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit Fees<span style="display: inline-block; height: 6.18pt;"></span><span id="i9003e035c1ff401f8e7b8ba700367d24_105646"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 94.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> for 2024 and 2023 were paid to Deloitte LLP as follows<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 299.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">:&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 519.02pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 264.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 125.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 69.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 69.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 52.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 69.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.16pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.36pt; width: 69.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 52.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 69.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 58.129999999999995pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;m<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit Fees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 18.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">21.1<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 18.75pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 52.65pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20.4<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 30pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Audit-Related Fees&#185;<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 30pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2.2<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 30pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 56.79pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1.6<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 41.25pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax Fees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 41.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.77pt;"></span></span><span style="left: 62.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 41.25pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.77pt;"></span></span><span style="left: 62.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 52.5pt; width: 125.25pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 125.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">All Other Fees<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 125.25pt; position: var(--position); top: 52.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.77pt;"></span></span><span style="left: 62.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td><td colspan="1" rowspan="1" style="background-color: #ededed; border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 195pt; position: var(--position); top: 52.5pt; width: 69.75pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.72pt; width: 69.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 2.63pt; position: var(--position);"><span style="display: inline-block; height: 5.46pt; width: 59.77pt;"></span></span><span style="left: 62.400000000000006pt; position: var(--position);">&#8211;<span style="display: inline-block; height: 5.46pt; width: 2.46pt;"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 604.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">1 <span style="display: inline-block; height: 4.017pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 58.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The other assurance services provided by the auditor related to agreed upon procedures and other assurance services outside of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 614.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statutory audit requirements. <span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">298<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_679"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="if82f25ba1b444b79b54f72c88eb84a57_0-0-1-1-821446"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder services and contacts<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Registrar<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company&#8217;s registrar is:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 183.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Computershare Investor Services PLC<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 193.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Pavillions, Bridgwater Road Bristol, BS99 6ZY<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 204.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">www.investorcentre.co.uk<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 214.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +44 (0)370 707 1595*<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Computershare provides a range of services for shareholders:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 250.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Individual Savings Accounts (ISAs)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 266.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equiniti Financial Services Limited provide the EQi Flexible ISA <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 276.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to hold GSK shares.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 292.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Details (including information on fees) are available from <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 302.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">www.eqi.co.uk or can be requested by calling the Equiniti <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 313.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Customer Experience Team on 0345 0700 720. Lines are open <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 323.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">8:00am to 5:30pm, UK time Monday to Friday (excluding UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 333.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">public holidays).<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 5.525pt; font-style: normal; font-weight: normal; left: 114.03999999999999pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; top: -2.163pt; vertical-align: super; white-space: pre;">&#8224;<span style="display: inline-block; height: 4.017pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 365.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">ADS Depositary<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The ADR programme is administered by JPMorgan <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chase Bank, N.A.:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regular Correspondence:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EQ Shareowner Services<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P.O. Box 64504<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">St. Paul, MN 55164-0504<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 453.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Delivery of Stock Certificates and Overnight Mail:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 463.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">EQ Shareowner Services<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1110 Centre Pointe Curve, Suite 101<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 484.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mendota Heights, MN 55120-4100<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 500.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">shareowneronline.com/informational/contact-us/<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From the US: +1 877 353 1154<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 520.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">From outside the US: +1 651 453 2128<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 536.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Depositary also provides Global Invest Direct, a direct ADS <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 546.71pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">purchase/sale and dividend reinvestment plan for ADS holders. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 556.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">For details on how to enrol, please visit www.adr.com or call the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 567.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">above helpline number to obtain an enrolment pack. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Contacts<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 167.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Investor relations<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 181.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Investor relations may be contacted as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 197.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">UK<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 210.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street,<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 220.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London, WC1A 1DG<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 230.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +44 (0)20 8047 5000<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 246.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">US<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 260.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2929 Walnut Street<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 270.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Philadelphia PA 19104<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 280.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +1 888 825 5249 (US toll free)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 290.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +1 215 751 4000 (outside the US)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 306.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">GSK Response Center<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 320.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +1 888 825 5249 (US toll free)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.76pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +1 215 751 4600 (outside the US)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 346.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Share scam alert<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 359.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If you receive an unsolicited telephone call offering to sell or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">buy your shares, please take extra care. The caller may be part <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of a highly organised financial scam.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 396.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">If you are a UK shareholder, please contact the Financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 406.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Conduct Authority at www.fca.org.uk/consumers or on its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 416.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">consumer helpline:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 432.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: 0800 111 6768 (in the UK)*<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 448.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tel: +44 207 066 1000 (outside the UK)*<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 511.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">*<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Lines are open from 8.00am to 6.00pm, UK time, Monday to Friday, <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 520.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">except UK public holidays, and 9.00am to 1.00pm on Saturdays.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 541.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">&#8224;<span style="display: inline-block; height: 5.09pt; width: 7.48pt;"></span></span><span style="left: 316.14pt; position: var(--position);">The provision of share dealing details is not intended to be an invitation <span style="display: inline-block; height: 5.09pt;"></span></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 549.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or inducement to engage in an investment activity. Advice on share <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 557.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dealing should be obtained from a stockbroker or independent financial <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 566.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 316.14pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adviser.<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">299<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 24.94pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_685"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US law and regulation<span style="display: inline-block; height: 13.1pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A number of provisions of US law and regulation apply to the <span style="display: inline-block; height: 6.18pt;"></span><span id="ie7bb0cadabf34676b88e6d9dab7f886f_1973"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">company because our shares are quoted on the NYSE in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">form of ADS.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 188.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">NYSE rules<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 204.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In general, the NYSE rules permit the company to follow UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 214.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">corporate governance practices instead of those applied in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 224.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US, provided that we explain any significant variations. This <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 234.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">explanation is in the Corporate Governance comparison on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 244.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 74.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifcc8df5449354dd2b9795314def7a291_4596">302</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 88.94pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. NYSE rules require us to file annual and interim <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 255.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">written affirmations concerning our Audit &amp; Risk Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 265.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(ARC) and our statement on significant differences in corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 275.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 291.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley Act of 2002<span style="display: inline-block; height: 8pt;"></span><span id="ie7bb0cadabf34676b88e6d9dab7f886f_1872"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 307.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Following a number of corporate and accounting scandals in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 317.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the US, Congress passed the Sarbanes-Oxley Act of 2002. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 327.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley is a wide-ranging piece of legislation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 337.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concerned largely with financial reporting and corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 347.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">governance.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 363.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As recommended by the SEC, the company has an established <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 374.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Disclosure Committee. The Committee reports to the CEO, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 384.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CFO and to the ARC. It is chaired by the Company Secretary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 394.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and its members consist of senior managers from finance, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 404.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">legal, corporate communications and investor relations.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 420.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Where appropriate, external legal counsel, the external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 430.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditors, our sponsor bank, and internal experts are invited to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 440.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">attend the Disclosure Committee&#8217;s meetings periodically. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 451.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee has responsibility for considering the materiality of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 461.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information and, on a timely basis, determining the disclosure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 471.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of that information. It has responsibility for the timely filing of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 481.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports with the SEC and the formal review of the Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 491.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report and the Annual Report on Form 20-F. In 2024, the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 502.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Committee met 22 times, including for the purpose of receiving <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 512.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">relevant and appropriate training.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 528.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley requires that the Annual Report on Form 20-F <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 538.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contains a statement as to whether a member of the ARC is an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 548.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audit committee financial expert, as defined in rules under <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 558.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley. Such a statement for the relevant members of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 569.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the ARC (Charles Bancroft) is included in the Board Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 579.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information area of the Corporate Governance report on page<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 282.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 589.46pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">103</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 67.9pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 70.22pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and in his biography on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 180.43pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie03156c997354de09dbceb1686216b85_0-0-1-1-821446">105</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 194.47000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 605.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional disclosure requirements arise under section 302 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 615.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">section 404 of Sarbanes-Oxley in respect of disclosure controls <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and procedures and internal control over financial reporting. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 641.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Section 302: Corporate responsibility for <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 651.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">financial reports<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 667.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley requires the CEO and the CFO to complete <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 677.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">formal certifications, confirming that: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 693.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they have each reviewed the Annual Report on Form 20-F;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 709.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on their knowledge, the Annual Report on Form 20-F <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 719.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">contains no material misstatements or omissions;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">based on their knowledge, the financial statements and other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial information fairly present, in all material respects, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the financial condition, results of operations and cash flows <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as of the dates, and for the periods, presented in the Annual <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report on Form 20-F;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 207.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they are responsible for establishing and maintaining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 218.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosure controls and procedures that ensure that material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 228.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">information is made known to them, and have evaluated the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 238.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effectiveness of these controls and procedures as at the year <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 248.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">end, the results of such evaluation being contained in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 258.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report on Form 20-F;<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 274.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they are responsible for establishing and maintaining internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 284.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control over financial reporting that provides reasonable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 294.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assurance regarding the reliability of financial reporting and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 304.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the preparation of financial statements for external purposes <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in accordance with generally accepted accounting principles; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 330.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">they have disclosed in the Annual Report on Form 20-F any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 340.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in internal controls over financial reporting during <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the period covered by the Annual Report on Form 20-F that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">have materially affected, or are reasonably likely to affect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">materially, the company&#8217;s internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 381.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting; and<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 396.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> they have&#160; disclosed, based on their most recent evaluation <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 407.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of internal control over financial reporting, to the external <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 417.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">auditor and the ARC, all significant deficiencies and material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 427.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">weaknesses in the design or operation of internal controls <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">over financial reporting which are reasonably likely to affect <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adversely the company&#8217;s ability to record, process, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">summarise and report financial information, and any fraud <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(regardless of materiality) involving persons that have a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">significant role in the company&#8217;s internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 313.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group has carried out an evaluation under the supervision <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 510.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and with the participation of its management, including the CEO <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 520.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and CFO, of the effectiveness of the design and operation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 530.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group&#8217;s disclosure controls and procedures as at 31 <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 540.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">December 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 556.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">There are inherent limitations to the effectiveness of any <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 566.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">system of disclosure controls and procedures, including the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 577.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">possibility of human error and the circumvention or overriding of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 587.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the controls and procedures. Accordingly, even effective <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 597.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosure controls and procedures can only provide <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 607.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonable assurance of achieving their control objectives.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Based on the Group&#8217;s evaluation, the CEO and CFO have <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 633.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">concluded that, as at 31 December 2024, the disclosure <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 643.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">controls and procedures were effective to provide reasonable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 654.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assurance that information required to be disclosed in the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 664.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports that the Group files and submits under the US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 674.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Securities Exchange Act of 1934, as amended, is recorded, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 684.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">processed, summarized and reported as and when required <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 694.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and that it is accumulated and communicated to management, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 705.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">including the CEO and CFO, as appropriate, to allow timely <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 715.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">decisions regarding disclosure.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">300<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 10.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US law and regulation continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 120.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Section 404: Management&#8217;s annual report on <span style="display: inline-block; height: 8pt;"></span><span id="ie7bb0cadabf34676b88e6d9dab7f886f_1972"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 133.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">internal control over financial reporting<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In accordance with the requirements of section 404 of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sarbanes-Oxley, the following report is provided by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 169.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">management in respect of the company&#8217;s internal control over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 179.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">under the US Securities Exchange Act of 1934, as amended <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(the Exchange Act)): <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management is responsible for establishing and maintaining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">adequate internal control over financial reporting for the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group. Internal control over financial reporting is designed to <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 246.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide reasonable assurance regarding the reliability of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial reporting and the preparation of financial statements <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 267.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for external purposes in accordance with IFRS. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 278.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management conducted an evaluation of the effectiveness of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 288.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal control over financial reporting based on the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 298.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">framework, Internal Control &#8211; Integrated Framework (2013) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 309.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">issued by the Committee of Sponsoring Organisations of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 319.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treadway Commission (COSO).<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 330.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management has assessed the effectiveness of internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control over financial reporting as at 31 December 2024 and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">has concluded that such internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 361.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting was effective.&#160; In addition, there have been no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 371.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">changes in the Group&#8217;s internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 381.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting during 2024 that have materially affected, or are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 391.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reasonably likely to affect materially, the Group&#8217;s internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 401.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control over financial reporting .<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 413.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deloitte LLP, which has audited the consolidated financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 423.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements of the Group for the year ended 31 December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 433.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, has also assessed the effectiveness of the Group&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 443.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">internal control over financial reporting as at 31 December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 453.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024 under Auditing Standard 2201 of&#160;the Public Company <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 464.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accounting Oversight Board (United&#160;States). Their audit <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 474.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 62.36pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">report is <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 94.99000000000001pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">on<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 104.35pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 127.71pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_688">301</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 141.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Section 13(r) of the Exchange Act<span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 129.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Section 13(r) of the Exchange Act requires issuers to make <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 139.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">specific disclosure in their annual reports of certain types of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 149.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dealings with Iran, including transactions or dealings with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 159.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">government-owned or controlled entities, as well as dealings <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 170.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">with entities sanctioned for activities related to terrorism or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 180.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proliferation of weapons of mass destruction, even when those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 190.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities are not prohibited by US law and do not involve US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 200.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">persons. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 216.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group exported certain medicines to Iran via sales by non-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 226.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US entities that are not subsidiaries of a US entity to a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 236.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">distributor in Iran pursuant to a specific licence issued by the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 247.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Office of Foreign Assets Control. The Group ceased exports <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 257.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and sales to Iran in June 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 273.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group did not regularly receive information regarding the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 283.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">identity of the distributor's downstream customers and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 293.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intermediaries in Iran, and it is possible that these parties <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 303.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">included entities, such as hospitals and pharmacies, that are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 314.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">owned directly or indirectly by the Iranian Government or by <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 324.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">persons or entities sanctioned in connection with terrorism or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 334.46pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">proliferation activities.&#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 350.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As the Group does not regularly receive information regarding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 360.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the identity of its distributor's downstream customers and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 370.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">intermediaries, it cannot establish the proportion of gross <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 380.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenue or sales potentially attributable to entities affiliated with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 391.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Iranian Government or parties sanctioned for disclosable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 401.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">activities. As a result, the Group is reporting the entire gross <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 411.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">revenues &#163;2.6 million and net profits &#163;5.6 million from the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 421.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group's sales to Iran in 2024.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Some hospitals or other medical facilities in Lebanon may be <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 447.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">affiliated with or controlled by Hezbollah or other groups that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 458.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are designated by the United States pursuant to Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 468.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Order 13224. Again, the Group does not deal directly with such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 478.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hospitals or facilities and instead sells through distributors. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 488.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group is unable to establish the proportion of gross revenue or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 498.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sales potentially attributable to reportable activities. As a result, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 509.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the Group is reporting the entire gross revenues &#163;7.3 million <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 519.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and net profits &#163;3.3 million&#160; from the Group's sales to Lebanon <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 529.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in 2024. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 545.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In addition to Section 13(r) of the Exchange Act, US law <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 555.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generally restricts dealings by US persons and dealings that <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 565.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">otherwise are subject to US jurisdiction with certain countries or <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 575.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">territories that are subject to comprehensive sanctions, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 586.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">currently Crimea, Cuba, the so-called Donetsk People's <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 596.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Republic, Iran, the so-called Luhansk People's Republic, North <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 606.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Korea and Syria, as well as with the Government of Venezuela <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 616.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(though not with the country of Venezuela as a whole) and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 626.93pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">certain agencies of the Government of the Russian Federation. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 637.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group engages in some activity in certain such <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 647.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">jurisdictions having assessed applicable licences and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 657.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">exemptions<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 673.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">While we believe the Group complies with all applicable US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 683.62pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">sanctions in all material respects, such laws are complex and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 693.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continue to evolve rapidly.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">301<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 51.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 51.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 21.28pt; width: 486.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_688"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 51.03pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="id049f66b4eaf4c87820773f0dfd5c2be_0-0-1-1-824580"></span><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm <span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 140.14pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.39pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">To the shareholders and the Board of Directors of GSK plc <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 155.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Opinion on Internal Control over Financial <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 168.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Reporting <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 184.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have audited the internal control over financial reporting of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 194.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK plc and subsidiaries (the &#8220;Group&#8221;) as at 31 December <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 205.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024, based on criteria established in<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 192.95999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> I<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 197.60000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nternal Control &#8212; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 215.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Integrated Framework (2013)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 162.74pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> issued by the Committee of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 225.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sponsoring Organizations of the Treadway Commission <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 235.69pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(COSO). In our opinion, the Group maintained, in all material <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 245.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">respects, effective internal control over financial reporting as at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 256.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31 December 2024, based on criteria established in <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 248.13pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 266.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: italic; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Control &#8212; Integrated Framework (2013)<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 202.92000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> issued by COSO.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We have also audited, in accordance with the standards of the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Public Company Accounting Oversight Board (United States) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 302.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(PCAOB), the consolidated financial statements as at and for <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 312.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the year ended 31 December 2024, of the Group and our report <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 322.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dated 3 March 2025, expressed an unqualified opinion on <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 333.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">those financial statements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 349.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Basis for Opinion <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 364.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group&#8217;s management is responsible for maintaining <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effective internal control over financial reporting and for its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessment of the effectiveness of internal control over <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial reporting, included in the accompanying &#8220;Section 404: <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 405.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Management&#8217;s annual report on internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 415.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting&#8221; included on page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 158.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ie7bb0cadabf34676b88e6d9dab7f886f_1972">300</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 172.48000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> of the Form 20-F. Our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibility is to express an opinion on the Group&#8217;s internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control over financial reporting based on our audit. We are a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 446.56pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">public accounting firm registered with the PCAOB and are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required to be independent with respect to the Group in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with the U.S. federal securities laws and the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 477.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">applicable rules and regulations of the Securities and Exchange <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 487.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Commission and the PCAOB. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 503.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We conducted our audit in accordance with the standards of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 513.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the PCAOB. Those standards require that we plan and perform <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 523.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the audit to obtain reasonable assurance about whether <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 533.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">effective internal control over financial reporting was maintained <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in all material respects. Our audit included obtaining an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">understanding of internal control over financial reporting, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assessing the risk that a material weakness exists, testing and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">evaluating the design and operating effectiveness of internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control based on the assessed risk, and performing such other <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procedures as we considered necessary in the circumstances. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">We believe that our audit provides a reasonable basis for our <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">opinion. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 158.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Definition and Limitations of Internal Control <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 171.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">over Financial Reporting<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 187.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A company&#8217;s internal control over financial reporting is a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 197.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">process designed to provide reasonable assurance regarding <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 207.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the reliability of financial reporting and the preparation of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 217.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">financial statements for external purposes in accordance with <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 227.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">generally accepted accounting principles. A company&#8217;s internal <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 238.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">control over financial reporting includes those policies and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 248.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">procedures that (1) pertain to the maintenance of records that, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 258.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">in reasonable detail, accurately and fairly reflect the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 268.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">transactions and dispositions of the assets of the company; (2) <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 278.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">provide reasonable assurance that transactions are recorded <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 289.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">as necessary to permit preparation of financial statements in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 299.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">accordance with generally accepted accounting principles, and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that receipts and expenditures of the company are being made <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 319.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">only in accordance with authorizations of management and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">directors of the company; and (3) provide reasonable <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 340.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assurance regarding prevention or timely detection of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 350.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">unauthorized acquisition, use, or disposition of the company&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 360.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">assets that could have a material effect on the financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 370.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">statements. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 386.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Because of its inherent limitations, internal control over financial <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 396.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reporting may not prevent or detect misstatements. Also, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 407.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">projections of any evaluation of effectiveness to future periods <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.24pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">are subject to the risk that controls may become inadequate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">because of changes in conditions, or that the degree of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance with the policies or procedures may deteriorate. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 485.31pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">/s/ Deloitte LLP <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 501.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London, United Kingdom <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 517.09pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3 March 2025<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">302<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_691"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 21.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance comparison<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 145.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Description<span style="display: inline-block; height: 8pt;"></span><span id="ifcc8df5449354dd2b9795314def7a291_4596"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 113.42pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> of differences <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 190.27999999999997pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">between UK Corporate Governance and New York <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 450.45pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Stock<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 479.97pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;"> Exchange <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 159.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">(&#8220;NYSE&#8221;) requirements.<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 176.07pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160; <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 174.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s pri<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 89.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mary listing is on the <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 168.01999999999998pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">London<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 196.10000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Stock Exchange. GSK is <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">required to comply with the Financial Conduct Authority&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 195.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Listing Rules (Listing Rules) and Disclosure and Transparency <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 205.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rules (DTRs) and report compliance with the UK Corporate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 215.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Governance Code (Code). The Group&#8217;s statement of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 225.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compliance with the Code is set out on<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 197.68pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 200pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 221.04000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ice499ac0d689441e8c4c6946358b1659_8524">112</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 234.45pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 241.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK also has American Depositary Receipts listed on the New <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 252.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">York Stock Exchange (NYSE) and is subject to the application <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 262.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the NYSE Rules. As a foreign private issuer, GSK is exempt <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 272.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">from most of the NYSE Rules that US companies must follow. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">However, GSK is required to disclose any significant ways in <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">which its corporate governance practices differ from those <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 303.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">followed by US companies listed on the NYSE. Significant <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 313.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">differences between GSK&#8217;s current corporate governance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 323.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">practices and the applicable NYSE corporate governance <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 333.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">standards are as follows:<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 349.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Director independence<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK complies with the Code, which requires at least half the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Board, excluding the Chair, to be independent Non-Executive <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directors. The NYSE Rules require the Board to have a <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">majority of independent directors. The Board considers the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 406.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">factors set out in the Code when determining a Director&#8217;s <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 416.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independence. It does not explicitly consider the NYSE <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 426.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independence requirements (which are different from those set <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 436.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">out by the Code). <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 452.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 53.86pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Board Committees<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 468.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s Board Committees are broadly aligned in purpose and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 478.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">composition to those required by the NYSE Rules. The NYSE <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">requires listed US companies to have compensation and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 499.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nominating/corporate governance committees composed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 509.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">entirely of independent directors, as defined under the NYSE <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 519.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rules. The Board&#8217;s Remuneration Committee is composed <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 529.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">solely of independent Non-Executive Directors who are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 539.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independent under the standards of the Code. The <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 550.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominations &amp; Corporate Governance Committee consists of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 560.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">independent Non-Executive Directors and the Board&#8217;s Chair, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 570.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">who was deemed to be independent on appointment according <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 580.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">to the independence standards of the Code. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK complies with the NYSE Rules requirement to have an <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.86pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">audit committee comprised solely of independent directors, as <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 617.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">defined under Rule 10A-3 under the Securities Exchange Act of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 627.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1934, as amended. However, GSK follows the Code <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 174.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">recommendations, rather than the NYSE Rules, regarding the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 185.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">responsibilities of the Board&#8217;s Audit &amp; Risk Committee (except <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 195.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">for applicable mandatory responsibilities under the Sarbanes-<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 205.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oxley Act of 2002, as amended), although both are broadly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 215.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">comparable. The Board has determined that Charles Bancroft, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 225.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chair of the Audit &amp; Risk Committee, has the appropriate <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 236.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">qualifications and background to be an &#8220;Audit Committee <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 246.32pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Financial Expert&#8221; as defined under the US Securities and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 256.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange Commission rules. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 272.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The roles of GSK&#8217;s Board Committees are set out on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 503.17pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">page <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 524.21pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i045a8f02f1c1423cbc8769bc5d57e6df_2741">113</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 537.62pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 282.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of the Annual Report and within each Board Committee&#8217;s terms <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 292.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of reference, available at gsk.com. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 308.7pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Code of Business Conduct and Ethics<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 324.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The NYSE Rules require that listed US companies adopt and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 334.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclose a code of business conduct and ethics for directors, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 344.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">officers and employees, and promptly disclose any waivers of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 355.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the code for directors or executive officers. There is no <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 365.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equivalent recommendation in the Code, but GSK has adopted <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 375.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a Code of Conduct for all employees, including the CEO, CFO <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 385.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and other senior financial officers, which is available at <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 395.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gsk.com.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 411.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Shareholder Approval of Equity-<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 425.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">compensation plans<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The NYSE Rules require that shareholders of listed US <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 451.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies be given the opportunity to vote on all equity <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 461.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">compensation plans and material revisions to those plans <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 471.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(subject to limited exceptions). GSK complies with the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 481.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">equivalent UK requirements, which are similar to the NYSE <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 491.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rules. However, the Board does not explicitly consider the <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 502.17pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NYSE&#8217;s detailed definition of &#8216;material revisions&#8217;. <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 518.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: bold; left: 304.8pt; letter-spacing: -0.008em; position: var(--position); text-decoration: none; white-space: pre;">Corporate Governance Guidelines<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 533.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The NYSE Rules require listed US companies to adopt and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclose corporate governance guidelines. The Listing Rules <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">and the Code require GSK to include an explanation in its <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report of how it applies the principles of the Code and <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">a confirmation that it complies with the Code's provisions or, <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 584.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">where it does not, provide an explanation of how and why it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 595.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">does not comply. In addition, GSK is required to make certain <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 605.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">mandatory corporate governance statements in the Directors&#8217; <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Report in accordance with the Listing Rules and DTRs, which it <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 625.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">does on <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 337.05pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">pages <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 362.3pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5268">173</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 376.34000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 395.02pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5269">174</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 409.06pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.18pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">303<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">Strategic report</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">Corporate governance</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_340">Financial statements</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_553">Investor information</a><span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 3.28pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 39pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39pt; left: 0pt; overflow: hidden; position: var(--position); top: 48pt; width: 487.5pt;"><div><div style="line-height: 11pt; position: var(--position); top: 14.91pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_697"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><span id="i78702b22fa5142c6844bbd70272b0eff_0-0-1-1-823252"></span><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 151.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In accordance with Section 409 of the Companies Act 2006 a full list of subsidiaries, associates, joint ventures and joint <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 162.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">arrangements, the address of the registered office and effective percentage of equity owned, as at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 420.09000000000003pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 491.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> are <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 172.23pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">disclosed below. Unless otherwise stated the share capital disclosed comprises ordinary shares which are indirectly held by GSK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 182.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plc. The percentage held by class of share is stated where this is less than 100%. Unless otherwise stated, all subsidiary <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 192.63pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies have their registered office and are tax resident in their country of incorporation.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 214.52pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 173.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.72pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wholly owned subsidiaries<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14245563&#160;Canada&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 24pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75 Rue Queen, Unit&#233; 1400, Montreal, QC H3C 2N6, Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">14934792&#160;Canada&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 36.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100&#160;Milverton&#160;Drive,&#160;Suite&#160;800&#160;,&#160;Mississauga&#160;ON&#160;L5R&#160;4H1,&#160;Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1506369&#160;Alberta&#160;ULC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 49.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3500&#160;855-2nd&#160;Street&#160;SW,&#160;Calgary&#160;AB&#160;T2P&#160;4J8,&#160;Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Action&#160;Potential&#160;Venture&#160;Capital&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 62.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 81pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Adechsa&#160;GmbH (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 81pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 81pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c/o GlaxoSmithKline AG, Zweigniederlassung Baar/Zug, Neuhofstrasse 4, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6340 Baar, Switzerland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Affinivax,&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 99.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 118.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aiolos Bio, Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 118.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common Stock<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 118.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation Service Company, 251 Little Falls Drive, Wilmington DE 19808, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aiolos Bio Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 137.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 150pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Allen&#160;&amp;&#160;Hanburys&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 150pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 150pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Allen&#160;&amp;&#160;Hanburys&#160;Pharmaceutical&#160;Nigeria&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 162.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">49,&#160;Town&#160;Planning&#160;Way,&#160;Ilupeju,&#160;Lagos,&#160;Nigeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 174pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Allen&#160;Pharmazeutika&#160;Gesellschaft&#160;m.b.H.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 174pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 174pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wienerbergstra&#223;e&#160;7,&#160;Wien,&#160;1100,&#160;Austria,&#160;Austria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beecham Group&#160;p.l.c<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.20&#160;Ordinary&#160;A;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#163;0.05&#160;Ordinary&#160;B<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 186.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 205.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beecham&#160;Pharmaceuticals&#160;(Pte)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 205.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 205.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">38&#160;Quality&#160;Road,&#160;Jurong&#160;Industrial&#160;Estate,&#160;Jurong,&#160;618809,&#160;Singapore<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beecham&#160;Portuguesa-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Produtos&#160;Farmaceuticos&#160;e&#160;Quimicos,&#160;Lda,<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 23.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beecham&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 241.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avenue&#160;Fleming&#160;20,&#160;1300&#160;Wavre,&#160;Belgium<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bellus&#160;Health&#160;Inc<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 267pt; overflow: hidden; position: var(--position); top: 254.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75 Rue Queen, Unit&#233; 1300, Montreal, QC H3C 2N6, Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 266.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biovesta&#160;Ila&#231;lari&#160;Ltd.&#160;Sti. (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 266.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominative<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 266.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Esentepe Mah, Bahar Sk. Ozdilek River Plaza, Vyndham Grand No: 12 Kat: <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">22, Kapi: 58, Sisli, Istanbul 32394, Turkey<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 285pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cascan&#160;GmbH&#160;&amp;&#160;Co.&#160;KG<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 285pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 285pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munich,&#160;Bavaria,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 297.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Cellzome&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 297.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 297.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Meyerhofstrasse&#160;1,&#160;69117,&#160;Heidelberg,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 310.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clarges Pharmaceuticals Trustees Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 310.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 310.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Colleen&#160;Corporation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corixa&#160;Corporation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 343.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 362.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dealcyber&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 362.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 267pt; overflow: hidden; position: var(--position); top: 362.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 374.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Desarrollo&#160;Energia&#160;Solar&#160;Alternativa&#160;S.L.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 374.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 374.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severo&#160;Ochoa,&#160;2,&#160;Parque&#160;Tecnologico&#160;de&#160;Madrid,&#160;Tres&#160;Cantos,&#160;28760,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Madrid,&#160;Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 393pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Duncan&#160;Pharmaceuticals&#160;Philippines&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 393pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 393pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23rd&#160;Floor,&#160;The&#160;Finance&#160;Centre,&#160;26th&#160;Street&#160;Corner&#160;9th&#160;Avenue,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonifacio&#160;Global&#160;City,&#160;Taguig&#160;City,&#160;1634,&#160;Philippines<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Elsie Biotechnologies, Inc<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common Stock<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 411.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation Service Company, 251 Little Falls Drive, Wilmington DE 19808, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 430.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Etex&#160;Farmaceutica&#160;Ltda<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 430.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Social&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 430.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Av.&#160;Andr&#233;s&#160;Bello&#160;2457,&#160;Costanera&#160;Center,&#160;Torre&#160;2,&#160;Piso&#160;20,&#160;Providencia,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Santiago,&#160;7510689,&#160;Chile<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 449.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Group&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 449.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 449.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 468pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Kabushiki&#160;Kaisha (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 468pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 468pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1-8-1&#160;Akasaka&#160;Minato-ku,&#160;Tokyo,&#160;Japan<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 480.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;New&#160;Zealand&#160;Pension&#160;Plan&#160;Trustee&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 480.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 480.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;2&#160;E.2,&#160;Generator&#160;at&#160;GridAKL,&#160;12&#160;Madden&#160;Street,&#160;Wynyard&#160;Quarter,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Auckland,&#160;1010,&#160;New&#160;Zealand<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Operations&#160;UK&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 512.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Saudi&#160;Arabia&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 512.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 512.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PO&#160;Box&#160;22617,&#160;Area&#160;No&#160;56&#160;to&#160;73,&#160;Warehouse&#160;City,&#160;First&#160;Stage&#160;Al&#160;Khomrah,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Jeddah&#160;21416,&#160;Saudi&#160;Arabia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 531pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Verwaltungs&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 531pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 531pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munich,&#160;Bavaria,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 542.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Wellcome&#160;Farmaceutica,&#160;Limitada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 542.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 542.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 561pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Wellcome International B.V. (iii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 561pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 561pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 572.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Wellcome&#160;Manufacturing&#160;Pte&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 572.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 572.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;Pioneer&#160;Sector&#160;1,&#160;Jurong&#160;Industrial&#160;Estate,&#160;Jurong,&#160;628413,&#160;Singapore<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 583.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Wellcome&#160;Production<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 583.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 583.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;rue&#160;Fran&#231;ois&#160;Jacob,&#160;92500,&#160;Rueil-Malmaison,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">304<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 173.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wholly owned subsidiaries continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Wellcome&#160;Vidhyasom&#160;Limited (in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 24pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12th&#160;Floor&#160;Wave&#160;Place,&#160;55&#160;Wireless&#160;Road,&#160;Lumpini,&#160;Pathumwan,&#160;Bangkok,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10330,&#160;Thailand<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Wellcome,&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Poligono&#160;Industrial&#160;Allendeduero,&#160;Avenida&#160;de&#160;Extremadura,&#160;3,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Aranda&#160;de&#160;Duero,&#160;09400,&#160;Burgos,&#160;Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo,&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severo&#160;Ochoa,&#160;2,&#160;Parque&#160;Tecnologico&#160;de&#160;Madrid,&#160;Tres&#160;Cantos,&#160;28760,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Madrid,&#160;Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxochem&#160;Pte&#160;Ltd (iii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;Rochester&#160;Park,&#160;139234,&#160;Singapore<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;-&#160;Produtos&#160;Farmaceuticos,&#160;Limitada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary&#160;Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 91.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(Cambodia)&#160;Co.,&#160;Ltd.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">5th&#160;Floor&#160;DKSH&#160;Building,&#160;No.797&#160;Preah&#160;Monivong&#160;Boulevard&#160;(Co,&#160;Sangkat&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Phsar&#160;Deum&#160;Thakov,&#160;Khan&#160;Chamkarmon,&#160;Phnom&#160;Penh,&#160;Cambodia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 129pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(China)&#160;Investment&#160;Co&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 129pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 129pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Room&#160;901,&#160;902,&#160;903,&#160;905,&#160;908,&#160;909&#160;and&#160;910,&#160;Unit&#160;901,&#160;Floor&#160;9,&#160;No.&#160;56&#160;Mid&#160;4<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">th&#160;East&#160;Ring&#160;Road,&#160;Chaoyang&#160;District,&#160;Beijing,&#160;China<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(China)&#160;R&amp;D&#160;Company&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 147.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">F1-3,&#160;No.18&#160;Building,&#160;999&#160;Huanke&#160;Road,&#160;Pilot&#160;Free&#160;Trade&#160;Zone,&#160;Shanghai,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">201210,&#160;China<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(GSK)&#160;S.R.L.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bucure&#351;ti Sectorul 1, &#350;oseaua BUCURE&#350;TI-PLOIE&#350;TI, Nr. 89A<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Romania<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(Ireland)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12&#160;Riverwalk,&#160;Citywest&#160;Business&#160;Campus,&#160;Dublin&#160;24,&#160;Ireland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(Israel)&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25&#160;Basel&#160;Street,&#160;PO&#160;Box&#160;10283,&#160;Petach-Tikva,&#160;49002,&#160;Israel<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(Private)&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 207.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unit&#160;3,&#160;20&#160;Anthony&#160;Road,&#160;Msasa,&#160;Harare,&#160;Zimbabwe<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(Thailand)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 219pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 219pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12th&#160;Floor&#160;Wave&#160;Place,&#160;55&#160;Wireless&#160;Road,&#160;Lumpini,&#160;Pathumwan,&#160;Bangkok,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">10330,&#160;Thailand<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;AB<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hemvarnsg.&#160;9,&#160;171&#160;54,&#160;Solna,&#160;Sweden<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 249pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;AG<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 249pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 249pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Talstrasse&#160;3&#160;,&#160;3053&#160;Muenchenbuchsee,&#160;Switzerland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Angola&#160;Unipessoal&#160;Limitada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 260.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Luanda,&#160;Bairro&#160;Petrangol,&#160;Estrada&#160;de&#160;Cacuaco&#160;n&#160;&#176;&#160;288,&#160;Angola<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 271.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;AS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 271.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 271.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Drammensveien&#160;288,&#160;Oslo,&#160;NO-0283,&#160;Norway<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Australia&#160;Pty&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 282.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;4&#160;,&#160;436&#160;Johnston&#160;Street&#160;,&#160;Abbotsford,&#160;Victoria,&#160;3067,&#160;Australia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 294pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;B.V.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 294pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 294pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Van&#160;Asch&#160;van,&#160;Wijckstraat&#160;55h,&#160;3811&#160;LP&#160;Amersfoort,&#160;The&#160;Netherlands,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Netherlands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Beteiligungs&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 324pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Biologicals&#160;Kft.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 324pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 324pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2100&#160;G&#246;d&#246;ll&#245;,&#160;Homoki&#160;Nagy&#160;Istv&#225;n&#160;utca&#160;1,&#160;Hungary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Biologicals&#160;S.A.S.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 335.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">637&#160;Rue&#160;des&#160;Aulnois,&#160;Saint-Amand&#160;Les&#160;Eaux,&#160;59230,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Biologicals&#160;SA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary:<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preference<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rue&#160;de&#160;l'Institut&#160;89&#160;B-1330&#160;Rixensart,&#160;Belgium<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 365.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Brasil&#160;Limitada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 365.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quotas<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 365.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Estrada&#160;dos&#160;Banderiantes,&#160;8464,&#160;Rio&#160;de&#160;Janeiro,&#160;22783-110,&#160;Brazil<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 376.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Capital&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 376.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 376.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wilmington&#160;Trust&#160;SP&#160;Services,&#160;Inc.,&#160;1100&#160;N.&#160;Market&#160;Street,&#160;4th&#160;Floor,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wilmington&#160;DE&#160;19890,&#160;United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 395.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Capital&#160;plc<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 395.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 395.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 406.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Caribbean&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 406.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 406.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 417.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Chile&#160;Farmaceutica&#160;Limitada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 417.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Social&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 417.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Av.&#160;Andr&#233;s&#160;Bello&#160;2457,&#160;Torre&#160;2,&#160;piso&#160;20,&#160;Providencia,&#160;Santiago,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Regi&#243;n&#160;Metropolitana,&#160;Chile<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 436.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Colombia&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 436.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 436.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avenida Calle 116, No 7-15, Interior 2 Oficina 601 A, Bogota, 110111, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Colombia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 455.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;doo&#160;Beograd-Novi&#160;Beograd (In liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 455.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 455.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Milutin&#160;Milankovic,&#160;1J,&#160;Novi&#160;Beograd,&#160;Belgrade,&#160;11070,&#160;Serbia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 466.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Ecuador&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 466.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 466.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Av. 6 de diciembre E10-A, y Juan Boussingault, Edificio Torre 6, Piso 4, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Oficina 408, Quito, Ecuador<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 485.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;El&#160;Salvador&#160;S.A.&#160;de&#160;C.V.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 485.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 485.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Municipio&#160;de&#160;San&#160;Salvador,&#160;Departamento&#160;de&#160;San&#160;Salvador,&#160;El&#160;Salvador<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 496.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;EOOD<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 496.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 496.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">119 Oborishte Str., Sofia 1505, Bulgaria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 507.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Export&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 507.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 507.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 519pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Export&#160;Panama&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 519pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 519pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Panama&#160;City,&#160;Republic&#160;of&#160;Panama,&#160;Panama<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Far&#160;East&#160;B.V.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Van&#160;Asch&#160;van&#160;Wijckstraat&#160;55h,&#160;3811&#160;LP,&#160;Amersfoort,&#160;Netherlands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 543pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Finance&#160;plc<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 543pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 543pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 555.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;GmbH&#160;&amp;&#160;Co.&#160;KG<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 555.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 555.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 567pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Guatemala&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 567pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 567pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3ra.&#160;Av.&#160;13-78&#160;Zona&#160;10,&#160;Torre&#160;Citibank,&#160;Nivel&#160;8,&#160;Guatemala&#160;City,&#160;Guatemala<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 579.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Holding&#160;AS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 579.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 579.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Drammensveien&#160;288,&#160;Oslo,&#160;NO-0283,&#160;Norway<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 592.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Holdings&#160;(Americas)&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 592.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 592.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wilmington&#160;Trust&#160;SP&#160;Services&#160;Inc.,&#160;1100&#160;North&#160;Market&#160;Street,&#160;4th&#160;Floor,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wilmington,&#160;Delaware,&#160;19890, United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 611.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Holdings&#160;(One)&#160;Limited (i)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 611.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 611.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 622.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Holdings&#160;Limited (i)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 622.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 622.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Holdings&#160;Pty&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;4&#160;,&#160;436&#160;Johnston&#160;Street&#160;,&#160;Abbotsford,&#160;Victoria,&#160;3067,&#160;Australia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 646.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Honduras&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 646.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 646.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tegucigalpa,&#160;MDC,&#160;Honduras<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 657.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;IHC&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 657.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 657.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 669pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Ilaclari&#160;Sanayi&#160;ve&#160;Ticaret&#160;A.S.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 669pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominative<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 669pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Esentepe Mah, Bahar Sk. Ozdilek River Plaza, Vyndham Grand No: 12 Kat: <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">22, Kapi: 58, Sisli, Istanbul 32394, Turkey<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">305<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 173.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wholly owned subsidiaries continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Class&#160;A&#160;Common;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Class&#160;C&#160;Preference<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 24pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">100&#160;Milverton&#160;Drive,&#160;Suite&#160;800&#160;,&#160;Mississauga&#160;ON&#160;L5R&#160;4H1,&#160;Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Insurance&#160;Ltd.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c/o&#160;Trinity&#160;Corporate&#160;Services&#160;Ltd.,&#160;Trinity&#160;Hall,&#160;43&#160;Cedar&#160;Avenue,&#160;Hamilton,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hamilton,&#160;HM12,&#160;Bermuda<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Intellectual&#160;Property&#160;(No.2)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Intellectual&#160;Property&#160;Development&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Intellectual&#160;Property&#160;Holdings&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 99pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A&#160;Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B&#160;Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 99pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Intellectual&#160;Property&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 117.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Intellectual&#160;Property&#160;Management&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 136.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Investigaci&#243;n&#160;y&#160;Desarrollo,&#160;S.L.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severo&#160;Ochoa&#160;2&#160;Parque&#160;Tecnol&#243;gico&#160;de&#160;Madrid,&#160;Tres&#160;Cantos,&#160;28760,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Madrid, Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 174pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Investments&#160;Pty&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 174pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 174pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;4&#160;,&#160;436&#160;Johnston&#160;Street&#160;,&#160;Abbotsford,&#160;Victoria,&#160;3067,&#160;Australia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;K.K.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1-8-1&#160;Akasaka&#160;Minato-ku,&#160;Tokyo,&#160;Japan<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Korea&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">9F&#160;LS&#160;Yongsan&#160;Tower,&#160;92&#160;Hangang-daero,&#160;Yongsan-gu,&#160;Seoul,&#160;04386,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Korea,&#160;Republic&#160;of<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Latin&#160;America,&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Panama&#160;City,&#160;Republic&#160;of&#160;Panama,&#160;Panama<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 226.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 226.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 226.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Suites 1004-10. 10F, Tower 6, The Gateway, 9 Kanton Road, Tsimshatsui, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Kowloon, Hong Kong<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 245.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;LLC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LLC&#160;Interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 256.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Manufacturing&#160;SpA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Viale&#160;dell&#8217;Agricoltura&#160;7,&#160;37135,&#160;Verona,&#160;Italy<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 286.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Maroc&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 286.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 286.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">42-44&#160;Angle&#160;Bd,&#160;Rachidi&#160;et&#160;Abou&#160;Hamed&#160;El&#160;Glaza,&#160;Casablanca,&#160;Morocco<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 297.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Mercury&#160;Limited (i)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 297.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 297.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 309pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Mexico&#160;S.A.&#160;de&#160;C.V.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 309pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary&#160;A;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary&#160;B<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 309pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Av.&#160;Real&#160;Mayorazgo&#160;130&#160;Piso&#160;20,&#160;Colonia&#160;Xoco,&#160;Alcaldia&#160;Benito&#160;Ju&#225;rez,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ciudad&#160;de&#160;Mexico,&#160;03330,&#160;Mexico<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;NZ&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 327.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;2&#160;E.2,&#160;Generator&#160;@GridAKL,&#160;12&#160;Madden&#160;Street,&#160;Wynyard&#160;Quarter,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Auckland,&#160;1010,&#160;New&#160;Zealand<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Oy<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 346.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Porkkalankatu&#160;20&#160;A,&#160;Helsinki,&#160;00180,&#160;Finland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 357.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Peru&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 357.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 357.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Av.&#160;V&#237;ctor&#160;Andr&#233;s&#160;Bela&#250;nde&#160;N&#176;147,&#160;V&#237;a&#160;Principal&#160; &#176;133,&#160;Piso&#160;7,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Distrito&#160;de&#160;San&#160;Isidro,&#160;Lima,&#160;Per&#250;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 376.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharma&#160;A/S<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 376.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 376.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Vallensb&#230;k&#160;Company&#160;House&#160;III&#160;,&#160;Delta&#160;Park&#160;37,&#160;DK-2665,&#160;Valle,&#160;Denmark<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 387.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharma&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 387.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 387.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wienerbergstra&#223;e&#160;7,&#160;Wien,&#160;1100,&#160;Austria,&#160;Austria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 399pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceutical&#160;Kenya&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 399pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 399pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">P.O&#160;Box&#160;78392-00507,&#160;Likoni&#160;Road,&#160;Nairobi,&#160;Kenya<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 410.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceutical&#160;Nigeria&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 410.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 410.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;Industrial&#160;Avenue,&#160;Ilupeju,&#160;Ikeja,&#160;Lagos,&#160;PM&#160;B&#160;21218,&#160;Nigeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 421.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceutical&#160;Sdn&#160;Bhd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 421.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 421.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">HZ.01,&#160;Horizon&#160;Penthouse,&#160;1&#160;Powerhouse,&#160;1,&#160;Persiaran&#160;Bandar&#160;Utama,&#160;Ban<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">dar&#160;Utama,&#160;47800&#160;Petaling&#160;Jaya,&#160;Selangor,&#160;Malaysia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 440.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceuticals&#160;(Pvt)&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 440.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 440.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">121&#160;Galle&#160;Road,&#160;Kaldemulla,&#160;Moratuwa,&#160;Sri&#160;Lanka<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 451.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceuticals&#160;Costa&#160;Rica&#160;S.A<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 451.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 451.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Autopista&#160;Florencia&#160;del&#160;Castillo,&#160;kil&#243;metro&#160;siete,&#160;Oficentro&#160;TerraCampus,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">edificio&#160;uno,&#160;cuarto&#160;piso,&#160;San&#160;Diego,&#160;Cartago,&#160;30302,&#160;Costa&#160;Rica<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 471.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceuticals&#160;SA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 471.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 471.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avenue Fleming 20, 1300 Wavre, Belgium<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 483pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceuticals&#160;Ukraine&#160;LLC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 483pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chartered&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 483pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pavla&#160;Tychyny&#160;avenue,&#160;1-V,&#160;Kiev,&#160;02152,&#160;Ukraine<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 494.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Philippines&#160;Inc<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 494.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 494.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23rd&#160;Floor,&#160;The&#160;Finance&#160;Centre,&#160;26th&#160;Street&#160;Corner&#160;9th&#160;Avenue,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonifacio&#160;Global&#160;City,&#160;Taguig&#160;City,&#160;1634,&#160;Philippines<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 513pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pte&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 513pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 513pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;Rochester&#160;Park,&#160;139234,&#160;Singapore<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 524.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Puerto&#160;Rico,&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 524.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 524.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CORPORATION&#160;SERVICE&#160;COMPANY&#160;PUERTO&#160;RICO&#160;INC.,&#160;c/o&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">RVM&#160;Professional&#160;Services,&#160;LLC,&#160;A4&#160;Reparto&#160;Mendoza,&#160;Humacao,&#160;00791,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Puerto&#160;Rico<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 550.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Republica Dominicana S..A<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 550.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 550.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Blue Mall Tower, Floor 23 Ave., Winston Churchill 95, Santa Domingo,<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dominican Republic<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 569.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Research&#160;&amp;&#160;Development&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 569.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 267pt; overflow: hidden; position: var(--position); top: 569.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 581.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 581.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 267pt; overflow: hidden; position: var(--position); top: 581.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severo&#160;Ochoa,&#160;2,&#160;Parque&#160;Tecnologico&#160;de&#160;Madrid,&#160;Tres&#160;Cantos,&#160;28760,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Madrid,&#160;Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 599.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;S.p.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 599.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 599.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Viale&#160;dell&#8217;Agricoltura&#160;7,&#160;37135,&#160;Verona,&#160;Italy<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 610.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;s.r.o.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 610.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 610.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hvezdova&#160;1734/2c,&#160;Prague,&#160;4&#160;140&#160;00,&#160;Czech&#160;Republic<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 621.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Services&#160;GmbH&#160;&amp;&#160;Co.&#160;KG<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 621.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 267pt; overflow: hidden; position: var(--position); top: 621.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 633.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Services&#160;Unlimited (i)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 633.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 633.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 645pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Single&#160;Member&#160;A.E.B.E.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 645pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 645pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">266&#160;Kifissias&#160;Avenue,&#160;Halandri,&#160;Athens,&#160;152&#160;32,&#160;Greece<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 656.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;SL&#160;LLC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 656.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LLC Interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 656.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 675pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;SL&#160;LP (ii)(v)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 675pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 675pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 686.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;South&#160;Africa&#160;(Pty)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 686.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 686.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">155 West Street, Sandown, Sandton 2031, South Africa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">306<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/></tr><tr style="height: 14.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 14.25pt; width: 173.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.06pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wholly owned subsidiaries continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Trading&#160;Services&#160;Limited (iii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 26.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12&#160;Riverwalk,&#160;Citywest&#160;Business&#160;Campus,&#160;Dublin&#160;24,&#160;D24 YK11, Ireland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Tunisia&#160;S.A.R.L.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 37.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Immeuble&#160;REGUS,&#160;Lot&#160;B17,&#160;Centre&#160;Urbain&#160;Nord,&#160;Tunis,&#160;Tunisia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;UK&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 48.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 60pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Uruguay&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 60pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered Provisory&#160;Stock<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 60pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Victor Soli&#241;o 349, Montevideo, Montevideo, 11300, Uruguay<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;US&#160;Trading&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 71.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Venezuela&#160;C.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 82.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">calle&#160;Altagracia,&#160;edificio&#160;P&amp;G,&#160;piso&#160;Mezzanina,&#160;torre&#160;Torre&#160;Sur,&#160;Urbanizacion<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;Sorokaima,&#160;La&#160;Trinidad,&#160;Caracas,&#160;1080,&#160;Venezuela<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Vietnam&#160;Limited&#160;Liability&#160;Company (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 101.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The&#160;Metropolitan,&#160;235&#160;Dong&#160;Khoi&#160;Street,&#160;District&#160;1,&#160;7th&#160;Floor&#160;Unit&#160;701,&#160;Ho&#160;C<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">hi&#160;Minh&#160;City,&#160;Vietnam<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 120pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlycoVaxyn&#160;AG (in liquidation) <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 120pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preferred&#160;A;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preferred&#160;B;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.03pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preferred&#160;C<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 120pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Neum&#252;hlequai 6, Z&#252;rich, 8001 Switzerland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 153.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Groupe&#160;GlaxoSmithKline<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 153.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 153.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;rue&#160;Fran&#231;ois&#160;Jacob,&#160;92500,&#160;Rueil-Malmaison,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 165pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Biopharma&#160;Argentina&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 165pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nominative&#160;Non&#160;Endorseable&#160;O<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">rdinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 165pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tucum&#225;n&#160;1,&#160;piso&#160;4,&#160;Buenos&#160;Aires,&#160;C1049AAA,&#160;Argentina<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Capital B.V (iii) (vi)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 183.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 24.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 195pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Capital&#160;K.K.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 195pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 195pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1-8-1&#160;Akasaka&#160;Minato-ku,&#160;Tokyo,&#160;Japan<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Commercial&#160;Sp.&#160;z&#160;o.o.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 219.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ul.&#160;Rzymowskiego&#160;53,&#160;02-697,&#160;Warsaw,&#160;Poland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 231pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;d.o.o.,&#160;Ljubljana<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 231pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 231pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ameri&#353;ka&#160;ulica&#160;8,,&#160;Ljubljana,&#160;1000,&#160;Slovenia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 242.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Enterprise&#160;Management&#160;Co,&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 242.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 242.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Floor&#160;4,&#160;18&#160;Lane&#160;999&#160;Huanke&#160;Road,&#160;No.&#160;1358&#160;Zhongke&#160;Road,&#160;Shanghai,&#160;Ch<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ina<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 261pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Equity&#160;Investments,&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 261pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Units<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 261pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;2595&#160;Interstate&#160;Drive,&#160;Suite&#160;103,&#160;Harrisburg,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PA&#160;17110,&#160;United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 281.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Finance (No.3)&#160;(in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 281.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 281.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c/o BDO LLP, 5 Temple Square, Temple Street, Liverpool, L2 5RH, United <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 300pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Finance&#160;(No&#160;2)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 300pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 300pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 311.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;GP&#160;1&#160;Limited (strike-off requested)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 311.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A&#160;Shares;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B&#160;Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 311.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50&#160;Lothian&#160;Road,&#160;Festival&#160;Square,&#160;Edinburgh,&#160;Scotland,&#160;EH3&#160;9WJ,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 330pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;GP&#160;2&#160;Limited (strike-off requested)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 330pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 330pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50&#160;Lothian&#160;Road,&#160;Festival&#160;Square,&#160;Edinburgh,&#160;Scotland,&#160;EH3&#160;9WJ,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;India&#160;Global&#160;Services&#160;Private&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;1,&#160;2&#160;&amp;&#160;3&#160;Luxor&#160;North&#160;Tower,&#160;Bagmane&#160;Capital&#160;Business&#160;Park&#160;Outer&#160;Ri<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ng&#160;Road,&#160;Bangalore,&#160;Karnataka,&#160;560037,&#160;India<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;International&#160;Holding&#160;and&#160;Finance&#160;BV<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 367.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Van&#160;Asch&#160;van&#160;Wijckstraat&#160;55h,&#160;3811&#160;LP,&#160;Amersfoort,&#160;Netherlands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Kazakhstan&#160;LLP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Participation&#160;Interest<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 378.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nursultan&#160;Nazarbayev&#160;Ave&#160;273,&#160;Business&#160;center&#160;USKO,&#160;3rd&#160;fl.,&#160;Almaty,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">050059,&#160;Kazakhstan<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 397.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Life&#160;Sciences&#160;FZE<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 397.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 397.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LB06015,&#160;Jebel&#160;Ali&#160;Freezone,&#160;Dubai,&#160;United&#160;Arab&#160;Emirates<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 408.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;LP&#160;Limited (i)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 408.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 408.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 420pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Pharma&#160;India&#160;Private&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 420pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 420pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,&#160;Battery&#160;House,&#160;Bhulabhai&#160;Desai&#160;Raod,&#160;Mumbai,&#160;Maharashtra,&#160;400026,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">India<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 438.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Pharma&#160;Vietnam&#160;Company&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 438.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Chartered&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 438.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unit&#160;702/703&#160;7th&#160;Floor,&#160;The&#160;Metropolitan&#160;Tower,&#160;235&#160;Dong&#160;Khoi&#160;Street,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ben&#160;Nghe&#160;Ward,&#160;District&#160;1,&#160;Ho&#160;Chi&#160;Minh,&#160;Vietnam<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 457.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Pharmaceutical&#160;Trading&#160;S.A. (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 457.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 457.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bucure&#351;ti Sectorul 1, &#350;oseaua BUCURE&#350;TI-PLOIE&#350;TI, Nr. 89A<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Romania<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 476.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;PSC&#160;Poland&#160;sp.&#160;z&#160;o.o.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 476.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 476.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ul.&#160;Grunwaldzka&#160;189,&#160;Pozna&#324;,&#160;60-322,&#160;Pol<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 487.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Regional Headquarters Company<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 487.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 487.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Olaya Tower, Prince Mohamed Ibn Abdelaziz Street, Olaya, Riyadh, 12821, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Saudi Arabia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 506.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Services&#160;Sp&#160;z&#160;o.o.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 506.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 506.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ul.&#160;Grunwaldzka&#160;189,&#160;60-322,&#160;Poznan,&#160;Poland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 517.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Vaccines&#160;BV<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 517.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 517.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">De Entree 201,1101 HG, Amsterdam <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 528.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Vaccines&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 528.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 528.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Emil-von-Behring-Str.76,&#160;35041&#160;Marburg,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 540pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Vaccines&#160;Institute&#160;for&#160;Global&#160;Health&#160;S.r.l.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 540pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 540pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Via&#160;Fiorentina&#160;1,&#160;53100,&#160;Siena,&#160;Italy<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 552.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Vaccines&#160;S.r.l.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 552.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 552.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Via&#160;Fiorentina&#160;1,&#160;53100,&#160;Siena,&#160;Italy<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 564pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Vaccines&#160;Vertriebs&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 564pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 564pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rudolf-Diesel-Ring&#160;27,&#160;83607,&#160;Holzkirchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 575.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Human&#160;Genome&#160;Sciences,&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 575.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 575.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 594pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ID&#160;Biomedical&#160;Corporation&#160;of&#160;Quebec<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 594pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 594pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2323,&#160;boul.&#160;Du&#160;Parc&#160;Technologique,&#160;Qu&#233;bec&#160;Qu&#233;bec&#160;G1P&#160;4R8,&#160;Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 605.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Instituto&#160;Luso&#160;Farmaco,&#160;Limitada (in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 605.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 605.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 624pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">InterPharma&#160;Dienstleistungen&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 624pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 624pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wienerbergstra&#223;e&#160;7,&#160;Wien,&#160;1100,&#160;Austria,&#160;Austria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">J&amp;J&#160;Technologies,&#160;LC (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LLC Interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;100&#160;Shockoe&#160;Slip,&#160;2nd&#160;Floor,&#160;Richmond&#160;VA&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3219,,&#160;United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 654pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JSC&#160;GlaxoSmithKline&#160;Trading<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 654pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 654pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leningradskiy&#160;Prospect&#160;37A,&#160;Building&#160;4,&#160;Floor&#160;3,&#160;Premises&#160;XV,&#160;Room&#160;1,&#160;125<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">167,&#160;Moscow,&#160;Russian&#160;Federation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 672.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratoire&#160;GlaxoSmithKline<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 672.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 672.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;rue&#160;Fran&#231;ois&#160;Jacob,&#160;92500,&#160;Rueil-Malmaison,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">307<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 173.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wholly owned subsidiaries continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratoire&#160;Pharmaceutique&#160;Alg&#233;rien&#160;LPA&#160;Production&#160;SPA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 24pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zone&#160;Industrielle&#160;Est,&#160;Boudouaou,&#160;Boumerdes,&#160;Algeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratoire&#160;Pharmaceutique&#160;Alg&#233;rien&#160;SPA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 35.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zone&#160;Industrielle&#160;Est,&#160;Boudouaou,&#160;Boumerdes,&#160;Algeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratoires&#160;Paucourt (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 46.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;rue&#160;Fran&#231;ois&#160;Jacob,&#160;92500,&#160;Rueil-Malmaison,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratoires&#160;Saint-Germain (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;rue&#160;Fran&#231;ois&#160;Jacob,&#160;92500,&#160;Rueil-Malmaison,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 69pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios&#160;Dermatologicos&#160;Darier,&#160;S.A&#160;de&#160;C.V.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 69pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary&#160;A;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary&#160;B<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 69pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Av.&#160;Real&#160;Mayorazgo&#160;130&#160;Piso&#160;20,&#160;Colonia&#160;Xoco,&#160;Alcaldia&#160;Benito&#160;Ju&#225;rez,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ciudad&#160;de&#160;Mexico,&#160;03330,&#160;Mexico<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios&#160;Farmaceuticos&#160;Stiefel&#160;(Portugal)&#160;LTDA (in <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios&#160;Stiefel&#160;de&#160;Venezuela&#160;SA<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 106.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Calle&#160;Altagracia,&#160;edificio&#160;P&amp;G,&#160;nivel&#160;Mezzanina,,&#160;piso&#160;Mezzanina,&#160;local&#160;Torre<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;Sur,&#160;Urbanizacion&#160;Sorokaima,&#160;La&#160;Trinidad,&#160;Caracas,&#160;1080,&#160;Venezuela,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bolivarian&#160;Republic&#160;of<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios&#160;Stiefel&#160;Ltda.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 132.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avenida Doutor Tim&#243;teo Penteado n&#186; 2289, Box XXIII, Vila Hulda, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Guarulhos, S&#227;o Paulo 07094-000, Brazil<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios&#160;Wellcome&#160;De&#160;Portugal&#160;Limitada (in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 151.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Maxinutrition Limited (in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 170.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c/o BDO LLP, 5 Temple Square, Temple Street, Liverpool, L2 5RH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Montrose&#160;Fine&#160;Chemical&#160;Company&#160;Ltd. (in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 181.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c/o BDO LLP, 2 Atlantic Square, 31 York Street, Glasgow, G2 8NJ<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">PT&#160;Glaxo&#160;Wellcome&#160;Indonesia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Class&#160;A;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Class&#160;B<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 192.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">JL.&#160;Pulobuaran&#160;Raya&#160;Kav.III/<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">DD&#160;2,3,4&#160;KWS.&#160;Industri,&#160;Pulogadung,&#160;Jatinegara,&#160;Cakung,&#160;Jakarta&#160;Timur,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Indonesia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 219pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Qeparo Acquisition Co<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 219pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common Stock<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 219pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation Service Company, 251 Little Falls Drive, Wilmington DE 19808, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Setfirst&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 267pt; overflow: hidden; position: var(--position); top: 237.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shanghai GlaxoSmithKline Pharmaceutical Co., Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 249.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Room 803, 804, Building A, 5 Shuntong Road, Lingang New Area, China <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(Shanghai) Pilot Free Trade Zone, Shanghai, China<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sitari&#160;Pharma,&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 268.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 287.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Smith&#160;Kline&#160;&amp;&#160;French&#160;Laboratories&#160;Limited (in liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 287.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 287.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c/o BDO LLP, 5 Temple Square, Temple Street, Liverpool, L2 5RH, United <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 306pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Smith&#160;Kline&#160;&amp;&#160;French&#160;Portuguesa-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Produtos&#160;Farmaceuticos,&#160;LDA (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 306pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 306pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 0pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;(Bangladesh)&#160;Private&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12pt; left: 267pt; overflow: hidden; position: var(--position); top: 324.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">House-2/A,&#160;Road-138,Gulshan-1,&#160;Dhaka,&#160;1212,&#160;Bangladesh<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 336.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;(Cork)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 336.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 336.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12&#160;Riverwalk,&#160;Citywest&#160;Business&#160;Campus,&#160;Dublin&#160;24,&#160;Ireland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 348pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Egypt&#160;L.L.C.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 348pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 348pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amoun&#160;Street,&#160;El&#160;Salam&#160;City,&#160;Cairo,&#160;Egypt<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Farma,&#160;S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 267pt; overflow: hidden; position: var(--position); top: 359.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severo&#160;Ochoa,&#160;2,&#160;Parque&#160;Tecnologico&#160;de&#160;Madrid,&#160;Tres&#160;Cantos,&#160;28760,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Madrid,&#160;Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 377.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Legacy&#160;H&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 377.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 377.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 388.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 388.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 388.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 399.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Pension&#160;Plan&#160;Trustee&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 399.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 399.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 411pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Pharma&#160;GmbH&#160;&amp;&#160;Co&#160;KG<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 411pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 411pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 422.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Pharma&#160;Verwaltungs&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 422.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 422.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 433.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Pharmaceuticals&#160;(Pty)&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 433.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 433.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flushing&#160;Meadows&#160;Building,&#160;The&#160;Campus,&#160;57&#160;Sloane&#160;Street,&#160;Bryanston&#160;202<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,&#160;South&#160;Africa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 452.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SmithKline&#160;Beecham&#160;Senior&#160;Executive&#160;Pension&#160;Plan&#160;Truste<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">e&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 452.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 267pt; overflow: hidden; position: var(--position); top: 452.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 470.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;GmbH&#160;&amp;&#160;Co.&#160;KG<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 470.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership&#160;Capital<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 470.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 481.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Laboratories&#160;Legacy&#160;(Ireland)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 481.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 481.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Unit&#160;2&#160;Building&#160;2500,&#160;Avenue&#160;2000&#160;Cork&#160;Airport&#160;Business&#160;Park,&#160;Cork,&#160;Irelan<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">d<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 500.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Laboratories&#160;Pte&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 500.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 500.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;Pioneer&#160;Sector,&#160;628413,&#160;Singapore<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 511.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Laboratories,&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 511.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 511.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Maroc&#160;SARL<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 530.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">275&#160;Boulevard&#160;Zerktouni,&#160;Casablanca,&#160;Morocco<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 541.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Research&#160;(Australia)&#160;Holdings&#160;Pty&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 541.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.25pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 541.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;4&#160;,&#160;436&#160;Johnston&#160;Street&#160;,&#160;Abbotsford,&#160;Victoria,&#160;3067,&#160;Australia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 552.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Research&#160;Australia&#160;Pty&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 552.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.25pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 552.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;4&#160;,&#160;436&#160;Johnston&#160;Street&#160;,&#160;Abbotsford,&#160;Victoria,&#160;3067,&#160;Australia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 564pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;West&#160;Coast&#160;LLC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 564pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LLC Interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 564pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 582.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Strebor&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 582.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 582.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 601.5pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tesaro&#160;Bio&#160;GmbH (In liquidation)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 601.5pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 601.5pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Poststrasse&#160;6,&#160;6300&#160;Zug,&#160;Switzerland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 612.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tesaro&#160;Bio&#160;Netherlands&#160;B.V<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 612.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 612.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Joop&#160;Geesinkweg&#160;901,&#160;1114&#160;AB,&#160;Amsterdam-Duivendrecht,&#160;Netherlands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 624pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tesaro&#160;Development,&#160;Ltd.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 624pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 624pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Clarendon&#160;House,&#160;2&#160;Church&#160;Street,&#160;Hamilton&#160;HM11,&#160;Bermuda<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tesaro,&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 635.25pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 654pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The&#160;Sydney&#160;Ross&#160;Co. (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 654pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 654pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;Princeton&#160;South&#160;Corporate&#160;Center,&#160;Suite&#160;160<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">,&#160;100&#160;Charles&#160;Ewing&#160;Blvd,&#160;Ewing&#160;NJ&#160;08628,&#160;United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 684pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 153.42pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 173.25pt; position: var(--position); top: 684pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 67.91pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 267pt; position: var(--position); top: 684pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.14pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 161.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">308<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 540.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 84.75pt;"></span></span><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 173.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 93.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 219.75pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 173.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wholly owned subsidiaries continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 24pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UCB&#160;Pharma&#160;Asia&#160;Pacific&#160;Sdn&#160;Bhd (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 24pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 267pt; overflow: hidden; position: var(--position); top: 24pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">12th&#160;Floor,&#160;Menara&#160;Symphony,&#160;No.&#160;5,&#160;Jalan&#160;Prof.&#160;Khoo&#160;Kay&#160;Kim,&#160;Seksyen&#160;1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3,&#160;46200&#160;Petaling&#160;Jaya,&#160;Malaysia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wellcome&#160;Consumer&#160;Healthcare&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 15pt; left: 267pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 173.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 173.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Wellcome&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 173.25pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 93.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 93.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 267pt; overflow: hidden; position: var(--position); top: 57.75pt; width: 219.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 219.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 15.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div><div style="position: var(--position); top: 202.16pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 140.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Effective % <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ownership<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 0pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 270pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 270pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subsidiaries where the effective interest is less than 100%<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amoun&#160;Pharmaceutical&#160;Industries&#160;Co.&#160;S.A.E.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Monetary&#160;Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">90.71%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">El&#160;Salam&#160;City&#160;11491,&#160;PO&#160;Box&#160;3001,&#160;Cairo,&#160;Egypt<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biddle&#160;Sawyer&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">252&#160;Dr&#160;Annie&#160;Besant&#160;Road,&#160;Mumbai,&#160;400030,&#160;India<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">British&#160;Pharma&#160;Group&#160;Limited (i)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 54pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Guarantee<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 54pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">50.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 54pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Galvani&#160;Bioelectronics&#160;Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">55.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 84pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Galvani&#160;Bioelectronics&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 84pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A&#160;Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B&#160;Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 84pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">55.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">-<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 84pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo&#160;Laboratories&#160;(Nigeria)&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99.99%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 102.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">82&#160;Marine&#160;Road,&#160;Apapa,&#160;Lagos,&#160;Nigeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 114pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glaxo-Allenburys&#160;(Nigeria)&#160;Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 114pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 114pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 114pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">41&#160;Creek&#160;Road,&#160;Apapa,&#160;Lagos,&#160;PMB&#160;1401,&#160;Nigeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;(Tianjin)&#160;Co.&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 140.25pt; position: var(--position); top: 125.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 62.72pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 125.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 11.16pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 15.29pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">90.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">No.&#160;65,&#160;the&#160;Fifth&#160;Avenue,&#160;Tai&#160;Feng&#160;Industrial&#160;Park,&#160;Tianjin&#160;Economic&#160;and&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Technological Development Area,&#160;Tianjin,&#160;300457,&#160;China<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 144pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Alg&#233;rie&#160;S.P.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 144pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 144pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99.99%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 144pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Zone&#160;Industrielle&#160;Est,&#160;Boudouaou,&#160;Wilaya&#160;de&#160;Boumerdes,&#160;Algeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Consumer&#160;Nigeria&#160;plc (iv)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">46.42%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 155.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1&#160;Industrial&#160;Avenue,&#160;Ilupeju,&#160;Ikeja,&#160;Lagos,&#160;PM&#160;B&#160;21218,&#160;Nigeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pakistan&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">82.59%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 166.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The&#160;Sykes&#160;Building,&#160;35&#160;Dockyard&#160;Road,&#160;West&#160;Wharf,&#160;Karachi,&#160;74000,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pakistan<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Pharmaceuticals&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">75.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 185.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">252&#160;Dr&#160;Annie&#160;Besant&#160;Road,&#160;Mumbai,,&#160;400030,&#160;India<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;S.A.E.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">91.20%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 196.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Boomerang&#160;Office&#160;Building&#160;-&#160;Land&#160;No.&#160;46,&#160;Zone&#160;(J)&#160;-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;1st&#160;District,&#160;Town&#160;Center&#160;-&#160;5th&#160;Tagammoe,&#160;New&#160;Cairo&#160;City,&#160;Egypt<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Laboratorios&#160;ViiV&#160;Healthcare,&#160;S.L.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 215.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Severo&#160;Ochoa,&#160;2,&#160;Parque&#160;Tecnologico&#160;de&#160;Madrid,&#160;Tres&#160;Cantos,&#160;28760,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Madrid,&#160;Spain<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 234pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Limited Liability Company SmithKline Beecham-<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Biomed O.O.O.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 234pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Participation&#160;Interest<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 234pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">97.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 234pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leningradskiy&#160;Prospect&#160;37A,&#160;Building&#160;4,&#160;Floor&#160;2,&#160;Premises&#160;XIV,&#160;Room&#160;42,&#160;1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25167,&#160;Moscow,&#160;Russian&#160;Federation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Modern&#160;Pharma&#160;Trading&#160;Company&#160;L.L.C.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">98.24%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 252.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amoun&#160;Street,&#160;PO&#160;Box&#160;3001,&#160;El&#160;Salam&#160;City,&#160;Cairo,&#160;11491,&#160;Egypt<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 264pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stiefel&#160;Egypt&#160;LLC (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 264pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 264pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">99.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 264pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Amoun&#160;Street,&#160;PO&#160;Box&#160;3001,&#160;El&#160;Salam&#160;City,&#160;Cairo,&#160;11491,&#160;Egypt<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;(South&#160;Africa)&#160;(Proprietary)&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 275.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Flushing&#160;Meadows&#160;Building,&#160;The&#160;Campus,&#160;57&#160;Sloane&#160;Street,&#160;Bryanston&#160;202<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1,&#160;South&#160;Africa<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 294pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;HealthCare&#160;BV<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 294pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 294pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 294pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Van&#160;Asch&#160;van,&#160;Wijckstraat&#160;55h,&#160;3811&#160;LP&#160;Amersfoort,&#160;The&#160;Netherlands,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Netherlands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Company<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 312.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation&#160;Service&#160;Company,&#160;251&#160;Little&#160;Falls&#160;Drive,&#160;Wilmington&#160;DE&#160;19808,<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#160;United&#160;States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Finance&#160;2&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 331.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 351.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Finance&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 351.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Redeemable&#160;Preference<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 351.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 351.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 370.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 370.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 370.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 370.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Prinzregentenplatz&#160;9,&#160;81675,&#160;Munchen,&#160;Germany<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 381.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;GmbH<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 381.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 381.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 381.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Talstrasse&#160;3&#160;,&#160;3053&#160;Muenchenbuchsee,&#160;Switzerland<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 393pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;K.K.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 393pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 393pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 393pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1-8-1&#160;Akasaka&#160;Minato-ku,&#160;Tokyo,&#160;Japan<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 404.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 404.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A&#160;Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B&#160;Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">C&#160;Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.03pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">D1&#160;Preference;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 33.83pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">D2&#160;Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 41.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Deferred;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 49.43pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">E&#160;5%&#160;Cumulative&#160;Preference<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 404.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 57.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 404.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 462pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Pty&#160;Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 462pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 462pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 462pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Level&#160;4&#160;,&#160;436&#160;Johnston&#160;Street&#160;,&#160;Abbotsford,&#160;Victoria,&#160;3067,&#160;Australia<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 26.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 473.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Puerto&#160;Rico,&#160;LLC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 473.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">LLC Interests<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 473.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 26.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 473.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CORPORATION&#160;SERVICE&#160;COMPANY&#160;PUERTO&#160;RICO&#160;INC.,&#160;c/o&#160;RVM&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Professional&#160;Services,&#160;LLC,&#160;A4&#160;Reparto&#160;Mendoza,&#160;Humacao,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Puerto&#160;Rico,&#160;00791<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;S.r.l.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 499.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Viale&#160;dell&#8217;Agricoltura&#160;7,&#160;37135,&#160;Verona,&#160;Italy<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 510.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;SAS<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 510.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 510.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 510.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23&#160;rue&#160;Fran&#231;ois&#160;Jacob,&#160;92500,&#160;Rueil-Malmaison,&#160;France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 522pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;SRL<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 522pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 522pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 522pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Avenue Fleming 20, 1300 Wavre, Belgium<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 533.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Trading&#160;LLC (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 533.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Participation&#160;Interest<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 533.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 533.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Leningradskiy&#160;Prospect&#160;37A,&#160;Building&#160;4,&#160;Floor&#160;2,&#160;Premises&#160;XIV,&#160;Room&#160;28,&#160;1<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25167,&#160;Moscow,&#160;Russian&#160;Federation<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 552pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;Trading&#160;Services&#160;UK&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 552pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 552pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 552pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 563.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;UK&#160;(No.3)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 563.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 563.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 563.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 582pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;UK&#160;(No.4)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 582pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 582pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 582pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">309<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 140.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 90pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 217.5pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Effective % <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ownership<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 0pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 24pt;"><td colspan="3" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 24pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 270pt;"><div><div style="line-height: 9pt; position: var(--position); top: 3.26pt; width: 270pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subsidiaries where the effective interest is less than 100% <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 270pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;UK&#160;(No.5)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;UK&#160;(No.6)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 61.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;UK&#160;(No.7)&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 80.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#160;Medicines&#160;Research&#160;Centre,&#160;Gunnels&#160;Wood&#160;Road,&#160;Stevenage,&#160;SG1&#160;2<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">NY,&#160;United&#160;Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;UK&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 99pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 99pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 99pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiV&#160;Healthcare&#160;ULC<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 270pt; overflow: hidden; position: var(--position); top: 110.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3500&#160;855-2nd&#160;Street&#160;SW,&#160;Calgary&#160;AB&#160;T2P&#160;4J8,&#160;Canada<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">ViiVHIV&#160;Healthcare&#160;Unipessoal&#160;Lda<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Quota<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 121.5pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Rua&#160;Dr&#160;Antonio&#160;Loureiro&#160;Borges&#160;No&#160;3,&#160;Arquiparque,&#160;Miraflores,&#160;1495-131,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alges,&#160;Portugal<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 140.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 140.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Winster&#160;Pharmaceuticals&#160;Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 140.25pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 90pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 90pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 230.25pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">46.42%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270pt; overflow: hidden; position: var(--position); top: 140.25pt; width: 217.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2A&#160;Association&#160;Avenue,&#160;Ilupeju&#160;Industrial&#160;Estate,&#160;Lagos,&#160;PO&#160;Box&#160;3199,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 217.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Nigeria<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 283.08pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 165.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 216.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Effective % <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ownership<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 0pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Associates<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 18pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 0pt; overflow: hidden; position: var(--position); top: 33pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline&#160;Landholding&#160;Company,&#160;Inc<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 33pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Common<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 231pt; overflow: hidden; position: var(--position); top: 33pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">39.93%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 33pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">23rd&#160;Floor,&#160;The&#160;Finance&#160;Centre,&#160;26th&#160;Street&#160;Corner&#160;9th&#160;Avenue,&#160;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Bonifacio&#160;Global&#160;City,&#160;Taguig&#160;City,&#160;1634,&#160;Philippines<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 21pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 0pt; overflow: hidden; position: var(--position); top: 51pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Index Ventures Life VI (Jersey) LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 51pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(24.94%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 231pt; overflow: hidden; position: var(--position); top: 51pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">24.94%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 21pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 51pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44 Esplanade, St Helier, Jersey, JE4 9WG, Channel Islands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 72pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Kurma Biofund II FCPR<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 72pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(32.06%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 72pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">32.06%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 72pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">24 rue Royale, 5th Floor,&#160; 75008, Paris, France<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Longwood Fund I, LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(35%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">35.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 90.75pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Prudential Tower, Suite 1715, 800 Boylston Street, Boston, MA 02199, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Medicxi Ventures I LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(26.10%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">26.10%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 109.5pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44 Esplanade, St Helier, Jersey, JE4 9WG, Channel Islands<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="4" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 128.25pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other significant holdings<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 39.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Alpheus Medical, Inc.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Series A Preference <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(13.77%)<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Series A-1 <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.03pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Preference (7.27%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">21.04%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 39.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 142.5pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">3510 Hopkins Place, North Oakdale,&#160; Minnesota 55128, United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Global Farm S.A.<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A Shares (0%)<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">B Shares (0%) <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 18.23pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">C Shares (100%) of <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 26.03pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">C Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20% 100% <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">of C Shares<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 33.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 182.25pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Mendoza 1259, Ciudad Aut&#243;noma de Buenos Aires, Argentina<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 216pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Longwood Fund II, LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 216pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(20.00%) <span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 216pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">20.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 216pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Prudential Tower, Suite 1715, 800 Boylston Street, Boston, MA 02199, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Sanderling Ventures VII, L.P. A63<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(25.31%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">25.31%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 234.75pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">1300 S. El Camino Real, Suite 203, San Mateo, CA 94402, United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 253.5pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SR One Capital Fund I-B, LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 253.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(44%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 253.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">44.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 253.5pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation service company, 251 Little Falls Drive, City of Wilmington, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">County of New Castle, Delaware 19808, United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SR One Capital Fund III, LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Parnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(43.5%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">43.50%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 272.25pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation service company, 251 Little Falls, Drive, City of Wilmington, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">County of New Castle, Delaware 19808, United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 291pt; width: 165.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">SR One Capital Opportunities Fund I, LP<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 165.75pt; overflow: hidden; position: var(--position); top: 291pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Partnership Interest <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(24.19%)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 231pt; overflow: hidden; position: var(--position); top: 291pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">24.19%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 18.75pt; left: 270.75pt; overflow: hidden; position: var(--position); top: 291pt; width: 216.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Corporation service company, 251 Little Falls Drive, City of Wilmington, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.43pt; width: 216.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">County of New Castle, Delaware 19808, United States<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">310<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 13.5pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 7.5pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 72.75pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 72.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 327.75pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 486.75pt;"><div><div style="line-height: 11pt; position: var(--position); top: 6.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Other statutory disclosures continued<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 22.72pt; width: 486.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Group companies continued<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="line-height: 8.5pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The following UK registered subsidiaries will take advantage of the audit exemption set out within Section 479A of the Companies <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 123.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Act 2006 for the period ended <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 166.87pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 238.44pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">. Unless otherwise stated, the undertakings listed below are owned, either directly <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 133.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">or indirectly, by GSK plc.<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="position: var(--position); top: 143.99pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 165pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 177.75pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 39.75pt;"/></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Name<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Security<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Effective % <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.75pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Ownership<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 0pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Registered address<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Company <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.75pt; width: 39.75pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); white-space: pre;">Number<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 14.25pt;"><td colspan="2" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 14.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 18.75pt; width: 230.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 230.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK registered subsidiaries exempted from audit<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 33pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Burroughs Wellcome International Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 33pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 33pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 33pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 33pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">543757<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 44.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Domantis Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 44.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 44.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Medicines Research Centre, Gunnels Wood Road, <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.75pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stevenage SG1 2NY, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 44.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">3907643<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 63pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Edinburgh Pharmaceutical Industries Limited (ii)<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 63pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.25pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Preference;<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 63pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 63pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shewalton Road, Irvine, Ayrshire, KA11 5AP, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 63pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SC005534<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 83.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Eskaylab Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 83.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 83.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 83.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 83.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">99025<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 94.5pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Glaxo Wellcome UK Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 94.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 94.5pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 94.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">480080<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 105.75pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Glaxochem (UK) Unlimited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.25pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary B;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.87pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary C<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 105.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 105.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 105.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">4299472<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 133.5pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property (No.3) Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 133.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 133.5pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 133.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">11480952<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 144.75pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property (No.4) Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 144.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 144.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">11721880<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 156pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline Intellectual Property (No.5) Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 156pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 156pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 156pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 156pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">11959399<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 167.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline International Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 167.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 167.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 167.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 167.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">2298366<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 178.5pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">PHIVCO UK II Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 178.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 178.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 178.5pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 178.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">6944229<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 189.75pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">PHIVCO UK Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 189.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 189.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 189.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">6944223<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 201pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham (Export) Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 201pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 201pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 201pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 201pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">2860752<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 212.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham (H) Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 212.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Non-cumulative <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 11.25pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Non-redeemable;<span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 19.87pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 212.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 212.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 212.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">3296131<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 240pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham (Investments) Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 240pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 240pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 240pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 240pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">302065<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 18.75pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 251.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham Marketing and Technical Services <span style="display: inline-block; height: 4.73pt;"></span></span></div><div style="line-height: 6.5pt; position: var(--position); top: 10.75pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 251.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 251.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 251.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">494385<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 270pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham Nominees Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 270pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 270pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 270pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 270pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">503868<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 281.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">SmithKline Beecham Overseas Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 281.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 281.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 281.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 281.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">2552828<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 292.5pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Stiefel Laboratories (U.K.) Ltd<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 292.5pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 292.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 292.5pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 292.5pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">831160<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 303.75pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Tesaro UK Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 303.75pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 303.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 303.75pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 303.75pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">7890847<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 315pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">The Wellcome Foundation Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 315pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 315pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">100.00%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 315pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 315pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">194814<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 326.25pt; width: 165pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 165pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">ViiV Healthcare Overseas Limited<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 165pt; position: var(--position); top: 326.25pt; width: 65.25pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 65.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">Ordinary<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 230.25pt; position: var(--position); top: 326.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">78.30%<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 270pt; position: var(--position); top: 326.25pt; width: 177.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 177.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street, London, WC1A 1DG, United Kingdom<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000; border-top: 0.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;"><div style="left: 447.75pt; position: var(--position); top: 326.25pt; width: 39.75pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 2.63pt; width: 39.75pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 0pt; position: var(--position); text-decoration: none; white-space: pre;">7027385<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 489.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">In accordance with Section 479C of the Companies Act 2006, the company will guarantee debts and liabilities of the above UK <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 8.5pt; position: var(--position); top: 499.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">subsidiary undertakings. As at <span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 167.78pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">31&#160;December 2024<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 239.35000000000002pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> the total sum of these debts and liabilities is &#163;370 million (<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 455.75pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2023<span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 474.47pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> &#8211; &#163;317 million)<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 515.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Key<span style="display: inline-block; height: 5.09pt;"></span><span id="i0a0bc1ef88344c3fbe4978aa0129185c_1516"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 525.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(i)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Directly owned by GSK plc.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 536.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(ii)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Dormant entity.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 546.47pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(iii)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax resident in the UK.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 556.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(iv)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Consolidated as a subsidiary in accordance with Section 1162 (4)(a) of the Companies Act 2006 on the grounds of dominant influence.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 567.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">(v)<span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exempt from the provisions of Regulations 4-6 of the Partnership (Accounts) Regulation 2008, in accordance with the exemptions noted in Regulation 7 of <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 575.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 68.03pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">that Regulation. <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 586.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; letter-spacing: -0.005em; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">(vi)<span style="display: inline-block; height: 5.09pt; width: 1.75pt;"></span></span><span style="left: 65.2pt; position: var(--position);"> Incorporated in the Netherlands<span style="display: inline-block; height: 5.09pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.74pt; position: var(--position); text-decoration: none; white-space: pre;">311<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_703"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 487.5pt;"/></tr><tr style="height: 27.75pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 27.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 487.5pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Glossary of terms<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position: var(--position); top: 151.83pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 180pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 307.5pt;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 180pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Terms used in the Annual Report<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 1pt solid #ffffff; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 0pt; width: 307.5pt;"><div><div style="line-height: 6.5pt; position: var(--position); top: 3.66pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">US equivalent or brief description<span style="display: inline-block; height: 4.73pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Accelerated capital allowances<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 11.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Tax allowance in excess of depreciation arising from the purchase of fixed assets that delay <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the charging and payment of tax. The equivalent of tax depreciation.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">American Depositary Receipt (ADR)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 31.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Receipt evidencing title to an ADS. Each GSK ADR represents two Ordinary Shares<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">American Depositary Shares (ADS)<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 42.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Listed on the New York Stock Exchange; represents two Ordinary Shares<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 54pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 54pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Basic income per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Called up share capital<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 65.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary Shares, issued and fully paid.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">CER growth<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 76.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Growth at constant exchange rates.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The company<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 87.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK plc<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 99pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Currency swap<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 99pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An exchange of two currencies, coupled with a subsequent re-exchange of those currencies, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">at agreed exchange rates and dates<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined benefit plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 119.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension plan with specific employee benefits, often called &#8216;final salary scheme&#8217;.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Defined contribution plan<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 130.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Pension plan with specific contributions and a level of pension dependent upon the growth of <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">the pension fund.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Derivative financial instrument<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 150.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A financial instrument that derives its value from the price or rate of some underlying item<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 162pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted earnings per share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 162pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Diluted income per share.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Employee Share Ownership Plan Trusts<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 173.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Trusts established by the Group to satisfy share-based employee incentive plans<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 184.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Equity Shareholders&#8217; funds<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 184.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shareholders&#8217; equity.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Finance lease<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 195.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Capital lease.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 207pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Freehold<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 207pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ownership with absolute rights in perpetuity<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The Group<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 218.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK plc and its subsidiary undertakings.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 229.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK plc and its subsidiary undertakings.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Hedging<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 240.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The reduction of risk, normally in relation to foreign currency or interest rate movements, by <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">making off-setting commitments.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 261pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Intangible fixed assets<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 261pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Assets without physical substance, such as computer software, brands, licences, patents, <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">know-how and marketing rights purchased from outside parties.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 281.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 281.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A fully paid up ordinary share in the capital of the company.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 292.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 292.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Profit attributable to shareholders<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 303.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Net income<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 315pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share capital<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 315pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Ordinary Shares, capital stock or common stock issued and fully paid.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 326.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share option<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 326.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Stock option.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 337.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Share premium account<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 337.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Additional paid-up capital or paid-in surplus (not distributable).<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Shares in issue<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 348.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The number of shares outstanding.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 360pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Subsidiary<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 360pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">An entity in which GSK exercises control.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 371.25pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury share<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 371.25pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Treasury stock.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 382.5pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Turnover<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 382.5pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Revenue.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr><tr style="height: 29.25pt;"><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 393.75pt; width: 180pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 180pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">UK Corporate Governance Code<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="border-bottom: 0.5pt solid #000000; border-top: 0.5pt solid #000000; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 29.25pt; left: 180pt; overflow: hidden; position: var(--position); top: 393.75pt; width: 307.5pt;"><div><div style="line-height: 7.5pt; position: var(--position); top: 2.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">As required by the UK Listing Authority, the company has disclosed in the Annual Report <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 11.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">how it has applied the best practice corporate governance provisions of the Financial <span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7.5pt; position: var(--position); top: 20.63pt; width: 307.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Reporting Council&#8217;s UK Corporate Governance Code.<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">312<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 486.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 486.75pt;"/></tr><tr style="height: 20.25pt;"><td colspan="1" rowspan="1" style="border-top: 0.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 20.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 0pt; width: 486.75pt;"><div><div style="line-height: 18.5pt; position: var(--position); top: 2.63pt; width: 486.75pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 18.5pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Index<span style="display: inline-block; height: 13.46pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height: 8.5pt; position: var(--position); top: 144.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Access<span style="display: inline-block; height: 6.18pt; width: 199.94pt;"></span></span><span style="left: 281.18pt; position: var(--position);">43<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Accounting principles and policies<span style="display: inline-block; height: 6.18pt; width: 95.21pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_379">187</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 163.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Acquisitions and disposals<span style="display: inline-block; height: 6.18pt; width: 123.04pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_514">237</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Adjustments reconciling Total profit after tax to operating <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">&#160; cash flows<span style="display: inline-block; height: 6.18pt; width: 178.24pt;"></span></span><span style="left: 276.46pt; position: var(--position);">242<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">American depositary shares<span style="display: inline-block; height: 6.18pt; width: 117.36pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105520">295</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Annual General Meeting 2023<span style="display: inline-block; height: 6.18pt; width: 109.82pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_667">289</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 212.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Approach to tax<span style="display: inline-block; height: 6.18pt; width: 167.85pt;"></span></span><span style="left: 281.18pt; position: var(--position);">92<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Articles of Association of GSK plc<span style="display: inline-block; height: 6.18pt; width: 97.08pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105515">292</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Assets held for sale<span style="display: inline-block; height: 6.18pt; width: 148.51pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_463">216</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Associates and joint ventures<span style="display: inline-block; height: 6.18pt; width: 112.17pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_415">203</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Audit &amp; Risk Committee Report<span style="display: inline-block; height: 6.18pt; width: 105.12pt;"></span></span><span style="left: 276.46pt; position: var(--position);">124<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Business model<span style="display: inline-block; height: 6.18pt; width: 172.11pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.9pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_31">2</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Cash and cash equivalents<span style="display: inline-block; height: 6.18pt; width: 120.66pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_460">216</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Cash generation and conversion<span style="display: inline-block; height: 6.18pt; width: 105.09pt;"></span></span><span style="left: 281.18pt; position: var(--position);">86<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">CEO&#8217;s statement<span style="display: inline-block; height: 6.18pt; width: 168.01pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.9pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_46">6</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Chair&#8217;s statement<span style="display: inline-block; height: 6.18pt; width: 165.82pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 285.9pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_40">4</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Chair&#8217;s Governance statement<span style="display: inline-block; height: 6.18pt; width: 108.39pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 277.09pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_265">110</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Chair&#8217;s Remuneration annual statement<span style="display: inline-block; height: 6.18pt; width: 72.86pt;"></span></span><span style="left: 276.46pt; position: var(--position);">133<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Climate-related financial disclosure<span style="display: inline-block; height: 6.18pt; width: 95.7pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.18pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_166">62</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Code of Ethics<span style="display: inline-block; height: 6.18pt; width: 167.39pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-5-824337">297</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Commitments<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 106.24000000000001pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 19.62pt;"></span></span><span style="left: 125.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span><span style="left: 161.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span><span style="left: 197.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span><span style="left: 233.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span><span style="left: 269.86pt; position: var(--position);">&#160; <span style="display: inline-block; height: 6.18pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 274.58pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_496">232</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Consolidated balance sheet<span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #ff0090; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 158.62pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 3.24pt;"></span></span><span style="left: 161.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span><span style="left: 197.86pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 36pt;"></span></span><span style="left: 233.86pt; position: var(--position);">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;  <span style="display: inline-block; height: 6.18pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 273.98pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_361">183</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Consolidated cash flow statement<span style="display: inline-block; height: 6.18pt; width: 95.66pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_367">185</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 378.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Consolidated income statement<span style="display: inline-block; height: 6.18pt; width: 103.68pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_355">182</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Consolidated statement of changes in equity<span style="display: inline-block; height: 6.18pt; width: 55.54pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_364">184</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Consolidated statement of comprehensive income<span style="display: inline-block; height: 6.18pt; width: 34.3pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_358">182</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 408.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Contingent consideration liabilities<span style="display: inline-block; height: 6.18pt; width: 94.29pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_487">230</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 417.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Contingent liabilities<span style="display: inline-block; height: 6.18pt; width: 147.14pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_493">231</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 427.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Corporate governance<span style="display: inline-block; height: 6.18pt; width: 138.12pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_253">103</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 437.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Corporate governance comparison<span style="display: inline-block; height: 6.18pt; width: 91.87pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ifcc8df5449354dd2b9795314def7a291_4596">302</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 447.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Corporate Responsibility Committee Report<span style="display: inline-block; height: 6.18pt; width: 59.51pt;"></span></span><span style="left: 277.09pt; position: var(--position);">117<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 456.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Critical accounting judgements and key sources of <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 466.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">&#160; estimation uncertainty<span style="display: inline-block; height: 6.18pt; width: 135.3pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_382">193</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 476.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Critical accounting policies<span style="display: inline-block; height: 6.18pt; width: 127.31pt;"></span></span><span style="left: 281.18pt; position: var(--position);">94<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 486.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Cyber security<span style="display: inline-block; height: 6.18pt; width: 168.33pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#iaba1f3b1f85449a9baa50bb8040a23a3_0-0-1-5-824335">296</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 496.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Data and engagement<span style="display: inline-block; height: 6.18pt; width: 143.31pt;"></span></span><span style="left: 281.18pt; position: var(--position);">49<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 505.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Demerger of Consumer Healthcare business<span style="display: inline-block; height: 6.18pt; width: 54.6pt;"></span></span><span style="left: 276.46pt; position: var(--position);">238<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 515.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Directors and senior management<span style="display: inline-block; height: 6.18pt; width: 94.71pt;"></span></span><span style="left: 276.46pt; position: var(--position);">156<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 525.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Directors&#8217; interests in shares<span style="display: inline-block; height: 6.18pt; width: 115.8pt;"></span></span><span style="left: 276.46pt; position: var(--position);">154<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 535.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Directors&#8217; report<span style="display: inline-block; height: 6.18pt; width: 162.52pt;"></span></span><span style="left: 276.46pt; position: var(--position);">130<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 544.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Directors&#8217; statement of responsibilities<span style="display: inline-block; height: 6.18pt; width: 79.95pt;"></span></span><span style="left: 276.46pt; position: var(--position);">166<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 554.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Dividends<span style="display: inline-block; height: 6.18pt; width: 185.33pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_424">207</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 564.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Earnings per share<span style="display: inline-block; height: 6.18pt; width: 150.87pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_421">207</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 574.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Employee costs<span style="display: inline-block; height: 6.18pt; width: 162.66pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_403">201</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 583.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Employee share schemes<span style="display: inline-block; height: 6.18pt; width: 124.9pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_526">262</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 593.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Environment<span style="display: inline-block; height: 6.18pt; width: 179.66pt;"></span></span><span style="left: 281.18pt; position: var(--position);">45<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 603.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Ethical standards<span style="display: inline-block; height: 6.18pt; width: 162.2pt;"></span></span><span style="left: 281.18pt; position: var(--position);">48<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 613.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Exchange rates<span style="display: inline-block; height: 6.18pt; width: 163.6pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_388">195</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 623.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Finance expense<span style="display: inline-block; height: 6.18pt; width: 157.94pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_412">203</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 632.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Finance income<span style="display: inline-block; height: 6.18pt; width: 162.67pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_409">203</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 642.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Financial calendar 2025<span style="display: inline-block; height: 6.18pt; width: 132.48pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_664">289</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 652.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Financial instruments and related disclosures<span style="display: inline-block; height: 6.18pt; width: 52.73pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_523">245</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 662.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Financial performance<span style="display: inline-block; height: 6.18pt; width: 143.33pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.18pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_211">81</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 671.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Financial position and resources<span style="display: inline-block; height: 6.18pt; width: 105.58pt;"></span></span><span style="left: 281.18pt; position: var(--position);">87<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 681.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">General Medicines<span style="display: inline-block; height: 6.18pt; width: 144.74pt;"></span></span><span style="left: 269.38pt; position: var(--position);">38,75<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 691.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Glossary of terms<span style="display: inline-block; height: 6.18pt; width: 156.05pt;"></span></span><span style="left: 276.46pt; position: var(--position);">215<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 701.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Goodwill<span style="display: inline-block; height: 6.18pt; width: 190.06pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_433">210</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 710.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Group companies<span style="display: inline-block; height: 6.18pt; width: 155.58pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_697">303</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 720.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Group financial review<span style="display: inline-block; height: 6.18pt; width: 143.34pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 281.18pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 730.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">GSK Leadership Team<span style="display: inline-block; height: 6.18pt; width: 137.33pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_262">108</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 740.3pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Innovation<span style="display: inline-block; height: 6.18pt; width: 188.15pt;"></span></span><span style="left: 281.18pt; position: var(--position);">09<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 750.07pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Insider trading policies<span style="display: inline-block; height: 6.18pt; width: 138.15pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9003e035c1ff401f8e7b8ba700367d24_105518">296</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 759.84pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Inventories<span style="display: inline-block; height: 6.18pt; width: 181.07pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_454">215</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 769.61pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Investments in associates and joint ventures<span style="display: inline-block; height: 6.18pt; width: 56pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_442">213</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 779.38pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Investor relations<span style="display: inline-block; height: 6.18pt; width: 157.95pt;"></span></span><span style="left: 276.46pt; position: var(--position);">303<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 789.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Legal proceedings<span style="display: inline-block; height: 6.18pt; width: 153.23pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_538">265</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 798.92pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 53.86pt; position: var(--position);">Major restructuring costs<span style="display: inline-block; height: 6.18pt; width: 129.63pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 276.46pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_406">202</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 144.33pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Material contracts<span style="display: inline-block; height: 6.18pt; width: 155.59pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1ed0f69669d6410b8634beaa3e754e83_0-0-1-5-821446">294</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 154.1pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Movements in equity<span style="display: inline-block; height: 6.18pt; width: 144.73pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_505">233</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 163.87pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Net debt<span style="display: inline-block; height: 6.18pt; width: 190.51pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_472">218</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 173.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">New accounting requirements<span style="display: inline-block; height: 6.18pt; width: 110.29pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_385">195</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 183.41pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Nominations Committee Report<span style="display: inline-block; height: 6.18pt; width: 104.17pt;"></span></span><span style="left: 527.4pt; position: var(--position);">120<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 193.18pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Non-controlling interests<span style="display: inline-block; height: 6.18pt; width: 131.07pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_508">236</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 202.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Non-controlling interests in ViiV Healthcare<span style="display: inline-block; height: 6.18pt; width: 66.13pt;"></span></span><span style="left: 532.12pt; position: var(--position);">71<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 212.72pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Non-Executive Directors&#8217; fees<span style="display: inline-block; height: 6.18pt; width: 111.08pt;"></span></span><span style="left: 527.4pt; position: var(--position);">152<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 222.49pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Notes to the financial statements<span style="display: inline-block; height: 6.18pt; width: 99.43pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_370">186</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 232.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Operating profit<span style="display: inline-block; height: 6.18pt; width: 164.09pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_397">200</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 242.03pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Other intangible assets<span style="display: inline-block; height: 6.18pt; width: 136.4pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 528.03pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_439">211</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 251.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Other investments<span style="display: inline-block; height: 6.18pt; width: 153.69pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_448">214</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 261.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Other non-current assets<span style="display: inline-block; height: 6.18pt; width: 128.67pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_451">214</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 271.34pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Other non-current liabilities<span style="display: inline-block; height: 6.18pt; width: 121.17pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_490">231</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 281.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Other operating income/(expense)<span style="display: inline-block; height: 6.18pt; width: 93.76pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_394">199</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 290.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Other provisions<span style="display: inline-block; height: 6.18pt; width: 160.78pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_481">229</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 300.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Our culture<span style="display: inline-block; height: 6.18pt; width: 185.32pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 532.12pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_148">56</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 310.42pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Our external environment <span style="display: inline-block; height: 6.18pt; width: 129.16pt;"></span></span><span style="left: 532.12pt; position: var(--position);">12<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 320.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Our long-term priorities<span style="display: inline-block; height: 6.18pt; width: 140.51pt;"></span></span><span style="left: 532.12pt; position: var(--position);">09<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 329.96pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Pensions and other post-employment benefits<span style="display: inline-block; height: 6.18pt; width: 49.87pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_475">220</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 339.73pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;">Pharmaceutical products, competition and intellectual<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 349.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">&#160; property<span style="display: inline-block; height: 6.18pt; width: 186.73pt;"></span></span><span style="left: 527.4pt; position: var(--position);">281<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 359.27pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Pipeline<span style="display: inline-block; height: 6.18pt; width: 192.42pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_568">271</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 369.04pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Post balance sheet events<span style="display: inline-block; height: 6.18pt; width: 123.01pt;"></span></span><span style="left: 527.4pt; position: var(--position);">267<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 378.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Presentation of the financial statements<span style="display: inline-block; height: 6.18pt; width: 73.95pt;"></span></span><span style="left: 527.4pt; position: var(--position);">269<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 388.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Principal accountant fees and services<span style="display: inline-block; height: 6.18pt; width: 77.72pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-5-824337">297</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 398.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Principal Group companies<span style="display: inline-block; height: 6.18pt; width: 120.68pt;"></span></span><span style="left: 527.4pt; position: var(--position);">264<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 410.81pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Property, plant and equipment<span style="display: inline-block; height: 6.18pt; width: 109.5pt;"></span></span><span style="left: 527.4pt; position: var(--position);">208<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 420.58pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Reconciliation of net cash flow to movement in net debt<span style="display: inline-block; height: 6.18pt; width: 14.97pt;"></span></span><span style="left: 527.4pt; position: var(--position);">243<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 430.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Registrar<span style="display: inline-block; height: 6.18pt; width: 188.16pt;"></span></span><span style="left: 527.4pt; position: var(--position);">302<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 440.12pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Related party transactions<span style="display: inline-block; height: 6.18pt; width: 116.89pt;"></span></span><span style="left: 520.32pt; position: var(--position);">&#160; 236 <span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 449.89pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Reliable supply<span style="display: inline-block; height: 6.18pt; width: 169.77pt;"></span></span><span style="left: 532.12pt; position: var(--position);">17<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 459.66pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Remuneration governance<span style="display: inline-block; height: 6.18pt; width: 122.55pt;"></span></span><span style="left: 527.4pt; position: var(--position);">150<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 469.43pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Remuneration report<span style="display: inline-block; height: 6.18pt; width: 144.74pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 479.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Reporting framework<span style="display: inline-block; height: 6.18pt; width: 148.52pt;"></span></span><span style="left: 532.12pt; position: var(--position);">69<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 488.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;">Reports of Independent Registered Public <span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 498.74pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 304.8pt; position: var(--position); text-decoration: none; white-space: pre;">&#160; Accounting Firm&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 507.28pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ida94f57fa3214bf3b03349eb1fd5fbec_0-0-1-1-824708">178</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 521.44pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.18pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 526.1600000000001pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#id049f66b4eaf4c87820773f0dfd5c2be_0-0-1-1-824580">301</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 540.32pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt; width: 1.24pt;"></span></span><span style="left: 541.56pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 508.51pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Responsible business<span style="display: inline-block; height: 6.18pt; width: 144.74pt;"></span></span><span style="left: 532.12pt; position: var(--position);">42<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 518.28pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Right of use assets<span style="display: inline-block; height: 6.18pt; width: 150.39pt;"></span></span><span style="left: 527.4pt; position: var(--position);">209<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 528.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Risk Factors<span style="display: inline-block; height: 6.18pt; width: 175.41pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i1077fb2fc11448b385eb927b655df1b8_347">277</a><span style="display: inline-block; height: 6.18pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 541.56pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt;"></span></span><span style="left: 541.56pt; position: var(--position);"><span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 537.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Risk management<span style="display: inline-block; height: 6.18pt; width: 158.89pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 532.12pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_154">59</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 547.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Science and technology<span style="display: inline-block; height: 6.18pt; width: 137.18pt;"></span></span><span style="left: 532.12pt; position: var(--position);">16<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 557.36pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Science Committee report<span style="display: inline-block; height: 6.18pt; width: 125.08pt;"></span></span><span style="left: 528.03pt; position: var(--position);">118<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 567.13pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Share capital and control<span style="display: inline-block; height: 6.18pt; width: 128.7pt;"></span></span><span style="left: 527.4pt; position: var(--position);">296<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 576.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Share capital and share premium account<span style="display: inline-block; height: 6.18pt; width: 65.45pt;"></span></span><span style="left: 527.4pt; position: var(--position);">233<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 586.67pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Share Consolidation<span style="display: inline-block; height: 6.18pt; width: 146.17pt;"></span></span><span style="left: 527.4pt; position: var(--position);">233<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 596.44pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Shareholder information<span style="display: inline-block; height: 6.18pt; width: 132.01pt;"></span></span><span style="left: 527.4pt; position: var(--position);">296<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 606.21pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Shareholder services and contacts<span style="display: inline-block; height: 6.18pt; width: 92.34pt;"></span></span><span style="left: 527.4pt; position: var(--position);">302<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 615.98pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Specialty Medicines<span style="display: inline-block; height: 6.18pt; width: 140.5pt;"></span></span><span style="left: 520.32pt; position: var(--position);">33,73<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 625.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Stakeholder engagement<span style="display: inline-block; height: 6.18pt; width: 128.37pt;"></span></span><span style="left: 528.03pt; position: var(--position);">112<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 635.52pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Supplemental guarantor information<span style="display: inline-block; height: 6.18pt; width: 87.65pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i99bf9039e6eb4157bd4218c7fa5445f2_0-0-1-5-824337">297</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 645.29pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Task Force on Climate-related Financial Disclosures<span style="display: inline-block; height: 6.18pt; width: 31.51pt;"></span></span><span style="left: 532.12pt; position: var(--position);">55<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 655.06pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Taxation<span style="display: inline-block; height: 6.18pt; width: 190.98pt;"></span></span><span style="left: 527.4pt; position: var(--position);">204<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 664.83pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Tax information for shareholders<span style="display: inline-block; height: 6.18pt; width: 101.32pt;"></span></span><span style="left: 527.4pt; position: var(--position);">299<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 674.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Three-year selected financial data<span style="display: inline-block; height: 6.18pt; width: 94.72pt;"></span></span><span style="left: 527.4pt; position: var(--position);">276<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 684.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">The Board<span style="display: inline-block; height: 6.18pt; width: 182.96pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_259">104</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 694.14pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Trade and other payables<span style="display: inline-block; height: 6.18pt; width: 126.16pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_469">217</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 703.91pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Trade and other receivables<span style="display: inline-block; height: 6.18pt; width: 117.2pt;"></span></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 527.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_457">215</a><span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 713.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Treasury policies<span style="display: inline-block; height: 6.18pt; width: 163.46pt;"></span></span><span style="left: 532.12pt; position: var(--position);">93<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 723.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Trust<span style="display: inline-block; height: 6.18pt; width: 208.28pt;"></span></span><span style="left: 532.12pt; position: var(--position);">09<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 733.22pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Turnover and segment information<span style="display: inline-block; height: 6.18pt; width: 93.13pt;"></span></span><span style="left: 527.4pt; position: var(--position);">195<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 742.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">US law and regulation<span style="display: inline-block; height: 6.18pt; width: 139.57pt;"></span></span><span style="left: 527.4pt; position: var(--position);">304<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 752.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Vaccines<span style="display: inline-block; height: 6.18pt; width: 181.7pt;"></span></span><span style="left: 520.32pt; position: var(--position);">29,74<span style="display: inline-block; height: 6.18pt;"></span></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 762.53pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 304.8pt; position: var(--position);">Vaccine products, competition and intellectual property<span style="display: inline-block; height: 6.18pt; width: 17.49pt;"></span></span><span style="left: 527.4pt; position: var(--position);">284<span style="display: inline-block; height: 6.18pt;"></span></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 487pt;"><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 4.88pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">313<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 487pt;"><div style="position: var(--position); top: 0pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 71.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 66pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 14.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 65.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 8.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 159pt;"/></tr><tr style="height: 23.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 58.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 58.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Strategic report<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 72.75pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 79.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 79.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Corporate governance<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 166.5pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 74.25pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 74.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Financial statements<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="2" rowspan="1" style="border-bottom: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"><div style="height: 11.25pt; left: 255pt; overflow: hidden; position: var(--position); top: 23.25pt; width: 73.5pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 73.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Investor information<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 328.5pt; position: var(--position); top: 23.25pt; width: 159pt;"><div><div style="line-height: 7pt; position: var(--position); top: 2.91pt; width: 159pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 33.55pt; position: var(--position); text-decoration: none; white-space: pre;">GSK 2024 Annual Report on Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div></td></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="border-top: 1.5pt solid #f36633; font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="12" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 36.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 47.25pt; width: 487.5pt;"><div><div style="line-height: 21pt; position: var(--position); top: 15.56pt; width: 487.5pt;"><span style="color: #f36633; font-family: 'Arial', sans-serif; font-size: 21pt; font-style: normal; font-weight: normal; left: -0.2pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">About GSK<span style="display: inline-block; height: 15.28pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_709"></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK<span style="display: inline-block; height: 8pt;"></span><span id="ibb3e9e0c590e476fb58151bf8c774ad2_5654"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 76.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> pl<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 88.37pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">c<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 93.82pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> was incorporated as GlaxoSmithKline <span style="display: inline-block; height: 8pt;"></span></span></div><div style="font-size: 12pt; line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">plc, an <span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 88.88pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">English<span style="display: inline-block; height: 8pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 124.57pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> public limited company on <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 139.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">6 December 1999. We were formed by a merger <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 152.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">between Glaxo Wellcome plc and SmithKline <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 166.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Beecham plc. GSK acquired these two English <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 179.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">companies on 27 December 2000 as part of the <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 192.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">merger arrangements. Effective 15 May 2022 <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 205.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GlaxoSmithKline plc changed its name to <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 218.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK plc. On 18 July 2022, GSK plc separated <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 232.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">its Consumer Healthcare business from the <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 245.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK Group to form Haleon, an independent <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 258.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">listed company.<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 277.48pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Our shares are listed on the London Stock <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 290.68pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Exchange and the New York Stock Exchange.<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 8.5pt; position: var(--position); top: 309.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 8.5pt; font-style: normal; font-weight: normal; left: 53.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">gsk.com<span style="display: inline-block; height: 6.18pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The SEC maintains an Internet site that contains <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 126.59pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">reports, proxy and information statements, and <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 139.79pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">other information regarding issuers that file <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 152.99pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">electronically with the SEC.&#160; The address of that <span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 166.19pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">site is http://www.sec.gov.<span style="display: inline-block; height: 8pt;"></span></span></div><div style="line-height: 11pt; position: var(--position); top: 185.08pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 304.8pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s internet address is gsk.com<span style="display: inline-block; height: 10.56pt;"></span></span><span style="font-family: 'GSK Precision', sans-serif; font-size: 11pt; font-style: normal; font-weight: normal; left: 470.92pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 10.56pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 203.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Brand names appearing in italics throughout this report are trade marks either <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 212.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">owned by and/or licensed to GSK or associated companies. All other trade <span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 220.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">marks are the property of their respective owners.<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 242.57pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Download PDFs:<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7.5pt; position: var(--position); top: 253.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211;<span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 306.11pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;"> Annual Report <span style="display: inline-block; height: 5.46pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 353.86pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.46pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 265.97pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; Form 20-F<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 277.37pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; ESG Performance Report <span style="display: inline-block; height: 5.09pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 388.66pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">2024<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 288.77pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 301.97pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">&#8211; Full-year and Fourth Quarter 2024 Results<span style="display: inline-block; height: 5.09pt;"></span></span></div><div style="font-size: 12pt; line-height: 6pt; position: var(--position); top: 344.11pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Cautionary statement<span style="display: inline-block; height: 4.36pt;"></span><span id="ibb3e9e0c590e476fb58151bf8c774ad2_5653"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 115.08pt; position: var(--position); text-decoration: none; white-space: pre;"> regarding forward-looking statements<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 355.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">This document and the Group&#8217;s other reports published <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 362.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">or filed with or furnished to the US Securities and <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 369.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Exchange Commission (SEC), and any other written <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 377.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">information released, or oral statements made, to the <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 384.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">public in the future by or on behalf of the Group, may <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 391.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">contain forward-looking statements. Forward-looking <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 398.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">statements give the Group&#8217;s current expectations or <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 405.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">forecasts of future events.<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 416pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">An investor can identify these statements by the fact that <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 423.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">they do not relate strictly to historical or current facts. <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 430.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">They use words such as &#8216;anticipate&#8217;, &#8216;estimate&#8217;, &#8216;expect&#8217;, <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 437.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">&#8216;intend&#8217;, &#8216;will&#8217;, &#8216;project&#8217;, &#8216;plan&#8217;, &#8216;believe&#8217;, &#8216;target&#8217; and other <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 444.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">words and terms of similar meaning in connection with <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 452pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">any discussion of future operating or financial <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 459.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">performance. In particular, these include statements <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 466.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">relating to future actions, prospective products or product <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 473.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">approvals, future performance or results of current and <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 480.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">anticipated products, sales efforts, expenses, the <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 488pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">outcome of contingencies such as legal proceedings, <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 495.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">dividend payments and financial results. Other than in <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 502.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">accordance with its legal or regulatory obligations <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 509.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">(including under the Market Abuse Regulation, the UK <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 516.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">Listing Rules and the Disclosure and Transparency Rules <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 524pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">of the Financial Conduct Authority), the Group undertakes <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 531.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">no obligation to update any forward-looking statements, <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 538.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">whether as a result of new information, future events or <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 545.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">otherwise. The reader should, however, consult any <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 552.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">additional disclosures that the Group may make in any <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 560pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">documents which it publishes and/or files with the SEC. <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 567.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">All readers, wherever located, should take note of these <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 574.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">disclosures. Accordingly, no assurance can be given that <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 581.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">any particular expectation will be met and investors are <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 588.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">cautioned not to place undue reliance on the forward-<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 596pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 53.86pt; position: var(--position); text-decoration: none; white-space: pre;">looking statements.<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 355.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">Forward-looking statements are subject to assumptions, <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 362.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">inherent risks and uncertainties, many of which relate to <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 369.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">factors that are beyond the Group&#8217;s control or precise <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 377.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">estimate. The Group cautions investors that a number of <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 384.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">important factors, including those in this document, could <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 391.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">cause actual results to differ materially from those <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 398.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">expressed or implied in any forward-looking statement. <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 405.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">Such factors include, but are not limited to, those <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 413.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">discussed under &#8216;Risk factors&#8217; on pages <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 328.12pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_580">277</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 338.11pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 346.42pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i27f24adb8ed14564b0e7ab7e0cc1fb14_11164">285</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 356.40999999999997pt; position: var(--position); text-decoration: none; white-space: pre;"> of this <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 420.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">Annual Report. Any forward-looking statements made by <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 427.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">or on behalf of the Group speak only as of the date they <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 434.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">are made and are based upon the knowledge and <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 441.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">information available to the Directors on the date of this <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 449.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; position: var(--position); text-decoration: none; white-space: pre;">report.<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 459.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">A number of non-IFRS measures are used to report the <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 466.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">performance of our business. These measures are <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 473.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">defined on pages<span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 266.61pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 268.27pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9510c9847c6040bfa7e14a02ad5607ad_383">79</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 274.93pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 283.24pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i9510c9847c6040bfa7e14a02ad5607ad_1224">79</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 289.9pt; position: var(--position); text-decoration: none; white-space: pre;"> a<span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 294.89pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">nd a reconciliation of Core <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 480.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">results to Total results is set out on pages <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 331.18pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_217">88</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 337.84000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 346.15pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i8e4ae46c605c4ded86b536f771a8d159_0-0-1-1-821446">90</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 352.81pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 490.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">The information in this document does not constitute an <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 498.05pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">offer to sell or an invitation to buy shares in GSK plc or an <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 505.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">invitation or inducement to engage in any other <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 512.45pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">investment activities. Past performance cannot be relied <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 519.65pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">upon as a guide to future performance. Nothing in this <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 526.85pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 221.15pt; letter-spacing: -0.005em; position: var(--position); text-decoration: none; white-space: pre;">Annual Report should be construed as a profit forecast.<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 355.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">Notice regarding limitations on Director Liability <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 362.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: bold; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">under English Law<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 371.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">Under the UK Companies Act 2006, a safe harbour limits <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 378.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">the liability of Directors in respect of statements in and <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 385.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">omissions from the Directors&#8217; Report (for which see page <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 392.95pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_334">173</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 398.43pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 411.74pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5270">174</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 421.73pt; position: var(--position); text-decoration: none; white-space: pre;">), the Strategic report and the Remuneration <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 400.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">report. Under English law the Directors would be liable to <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 407.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">the company, but not to any third party, if one or more of <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 414.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">these reports contained errors as a result of recklessness <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 421.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">or knowing misstatement or dishonest concealment of a <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="font-size: 12pt; line-height: 6pt; position: var(--position); top: 428.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">material fact, but would otherwise not be liable. Pages<span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 531.53pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.36pt;"></span><span id="ibb3e9e0c590e476fb58151bf8c774ad2_9107"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 533.19pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_190">75</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 539.85pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 436.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 395.09pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7689">102</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 405.08pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 408.4pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 418.39pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 426.7pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28335">172</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 436.69pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 440.01pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_334">173</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 450pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 463.31pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#if777c2edb3ef4a46804339e189a6b74e_5267">174</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 473.3pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 476.62pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_424">207</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 486.61pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 494.92pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_430">209</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 504.90999999999997pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 508.23pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_439">211</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 517.78pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 443.35pt; width: 595.44pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ic6350600483b4fcb8853f9457fd6579c_254">212</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 398.43pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 401.75pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_526">262</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 411.74pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 420.05pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i64d01e803b4c4157a1b84355aaad07bc_4572">263</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 430.04pt; position: var(--position); text-decoration: none; white-space: pre;"> and <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 443.35pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_541">268</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 453.34000000000003pt; position: var(--position); text-decoration: none; white-space: pre;"> comprise the Directors&#8217; Report, <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 450.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">pages <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 406.42pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_25">1</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 409.75pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 418.06pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i3c9ab6f3cbe740ac92eb0b39d2bf1e71_7687">102</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 428.05pt; position: var(--position); text-decoration: none; white-space: pre;"> inclusive comprise the Strategic report <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 457.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">and pages <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 418.07pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_292">134</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 428.06pt; position: var(--position); text-decoration: none; white-space: pre;"> to <span style="display: inline-block; height: 4.36pt;"></span></span><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 436.37pt; position: var(--position); text-decoration: none; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i4838aa2af2e84b87bae8d2fc4f9143cf_28334">172</a><span style="display: inline-block; height: 4.36pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 446.36pt; position: var(--position); text-decoration: none; white-space: pre;"> inclusive comprise the <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 464.95pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">Remuneration report, each of which have been drawn up <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 472.15pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">and presented in accordance with and in reliance upon <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 479.35pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">English company law and the liabilities of the Directors in <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 486.55pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">connection with these reports shall be subject to the <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 493.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">limitations and restrictions provided by such law.<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 503.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">Website<span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 512.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">GSK&#8217;s website www.gsk.com gives additional information <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 519.6pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">on the Group. Notwithstanding the references we make in <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 526.8pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">this Annual Report to GSK&#8217;s website, none of the <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 534pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">information made available on the website constitutes <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 541.2pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">part of this Annual Report or shall be deemed to be <span style="display: inline-block; height: 4.36pt;"></span></span></div><div style="line-height: 6pt; position: var(--position); top: 548.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 6pt; font-style: normal; font-weight: normal; left: 388.44pt; position: var(--position); text-decoration: none; white-space: pre;">incorporated by reference herein.<span style="display: inline-block; height: 4.36pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="left: 0pt; position: var(--position); top: -0.04pt; z-index: -9223372036854775806;"><img src="gsk-20241231_g138.jpg" alt="Back.cover (1).jpg" style="height: 841.76pt; width: 595.44pt;"/></div><div style="left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 538pt;"><div style="line-height: 7.5pt; position: var(--position); top: 7.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 291.46pt; position: var(--position); text-decoration: none; white-space: pre;">314<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="left: 0pt; position: var(--position); top: 0pt;"><div style="width: 538pt;"></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_712"></div><div style="line-height: 29pt; position: var(--position); top: 352.93pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'GSK Precision Light', sans-serif; font-size: 29pt; font-style: normal; font-weight: normal; left: 111.13pt; position: var(--position); text-decoration: none; white-space: pre;">We unite science, technology <span style="display: inline-block; height: 27.84pt;"></span></span></div><div style="line-height: 29pt; position: var(--position); top: 387.15pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'GSK Precision Light', sans-serif; font-size: 29pt; font-style: normal; font-weight: normal; left: 144.56pt; position: var(--position); text-decoration: none; white-space: pre;">and talent to get ahead <span style="display: inline-block; height: 27.84pt;"></span></span></div><div style="line-height: 29pt; position: var(--position); top: 421.37pt; width: 595.44pt;"><span style="color: #f36633; font-family: 'GSK Precision Light', sans-serif; font-size: 29pt; font-style: normal; font-weight: normal; left: 171.71pt; position: var(--position); text-decoration: none; white-space: pre;">of disease together.<span style="display: inline-block; height: 27.84pt;"></span></span></div><div style="font-size: 12pt; line-height: 7pt; position: var(--position); top: 704.9pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); text-decoration: none; white-space: pre;">Head Office and Registered Office<span style="display: inline-block; height: 5.09pt;"></span><span id="i0bea432c992c4a71bf59b49d4f20544d_396"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 716.16pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); white-space: pre;">GSK plc<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 726.78pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); text-decoration: none; white-space: pre;">79 New Oxford Street,<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 737.4pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); text-decoration: none; white-space: pre;">London, WC1A 1DG<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 748.02pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); text-decoration: none; white-space: pre;">United Kingdom<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 763.64pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); white-space: pre;">Tel: +44 (0)20 8047 5000<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 7pt; position: var(--position); top: 779.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 28.35pt; position: var(--position); white-space: pre;">Registered number: 3888792<span style="display: inline-block; height: 5.09pt;"></span></span></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 484pt;"><div style="line-height: 7.5pt; position: var(--position); top: 7.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 290.05pt; position: var(--position); text-decoration: none; white-space: pre;">315<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 0pt;"><div style="width: 484pt;"></div></div><div><div style="position: absolute; top: 113.39pt;" id="idc89fa1ee07645df9629d157a4b46752_718"></div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 437.25pt;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.63pt; position: var(--position); text-decoration: none; white-space: pre;">Item 19<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 0pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Exhibits<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 15.75pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">1.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 15.75pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit11-articlesofassoci.htm">Articles of Association of the Registrant as in effect on the date hereof are incorporated by reference to </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit11-articlesofassoci.htm">Exhibit 1.1 to the Registrant&#8217;s Annual Report on Form 20-F filed with the commission on March 5, 2024.</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 413.24pt; position: var(--position); text-decoration: none; white-space: pre;"> <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 42.75pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">2.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 42.75pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a1.htm">Second Amended and Restated Deposit Agreement, dated as of July 21, 2019, among the Registrant and </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a1.htm">JPMorgan Chase Bank, N.A. as Depositary, and the owners and holders from time to time of the American </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a1.htm">Depositary Shares issued thereunder, including the form of American Depositary Receipt, is incorporated by </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.56pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a1.htm">reference to Exhibit (a)(1) to the registration statement on Form F-6 (No. 333-264759) filed with the </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 47.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a1.htm">Commission on May 6, 2022.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 33.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 103.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">2.2<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 103.5pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a2.htm">Amendment No. 1 to Deposit Agreement, dated as of March 15, 2021, including the Form of American </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a2.htm">Depositary Receipt, is incorporated by reference to Exhibit (a)(2) to the registration statement on Form F-6 </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.13pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922057023/tm2214709d1_ex99-a2.htm">(No. 333-264759) filed with the Commission on May 6, 2022.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 140.25pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">2.3<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 140.25pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922061977/tm2214709d3_424b3.htm">Form of American Depositary Share is incorporated by reference to the filing pursuant to Rule 424(b)(3) in </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922061977/tm2214709d3_424b3.htm">connection with the registration statement on Form F-6 (Nos. 333-232726 and 333-264759) filed with the </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000110465922061977/tm2214709d3_424b3.htm">Commission on May 17, 2022.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 178.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">2.4<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 178.5pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit24-descriptionofsec.htm">Description of the Registrant&#8217;s securities registered pursuant to Section 12 of the Securities Exchange Act of </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit24-descriptionofsec.htm">1934.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 205.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">2.5<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 205.5pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">Long Term Debt Instruments: GSK plc is not party to any single instrument relating to long-term debt <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">pursuant to which a total amount of securities exceeding 10% of its total assets (on a consolidated basis) is <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">authorised to be issued. GSK plc hereby agrees to furnish to the Securities and Exchange Commission (the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.56pt; width: 437.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">&#8220;Commission&#8221;), upon its request, a copy of any instrument defining the rights of holders of its long-term debt <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 47.81pt; width: 437.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">or the rights of holders of the long-term debt of any of its subsidiaries for which consolidated or <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 59.06pt; width: 437.25pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: none; white-space: pre;">unconsolidated financial statements are required to be filed with the Commission.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 277.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">4.3<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 277.5pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex43.htm">UK Service Agreement between GlaxoSmithKline Services Unlimited and Emma N. Walmsley dated March </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex43.htm">29, 2017 is incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Annual Report on Form 20-F filed </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex43.htm">with the Commission on March 15, 2019.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 315.75pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">4.4<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 315.75pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit44-juliebrownsservi.htm">UK Service Agreement between GlaxoSmithKline Services Unlimited and Julie Brown dated September&#160; 25, </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit44-juliebrownsservi.htm">2022 is incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Annual Report on Form 20-F filed with </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit44-juliebrownsservi.htm">the commission on March 5, 2024</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 137.57pt; position: var(--position); text-decoration: none; white-space: pre;">.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 69pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 354pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">4.5<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 354pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex49.htm">Share and Business Sale Agreement relating to the Vaccines Group made on April 22, 2014, as amended </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex49.htm">and restated on May 29, 2014, as amended on October 9, 2014, and as further amended and restated on </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex49.htm">March 1, 2015, between Novartis AG and GlaxoSmithKline plc is incorporated by&#160; reference to Exhibit 4.9 of </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.56pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex49.htm">the Registrant&#8217;s Annual Report on Form 20-F&#160; filed with the Commission on March 18, 2016. Confidential </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 47.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex49.htm">portions of this exhibit have been omitted pursuant to a request for confidential treatment and filed </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 59.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex49.htm">separately with the SEC.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 426pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">4.6<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 426pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex410.htm">Stock and Asset Purchase Agreement by and among Pfizer Inc., GlaxoSmithKline plc and GlaxoSmithKline </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex410.htm">Consumer Healthcare Holdings Limited dated as of December 19, 2018 is incorporated by reference to </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex410.htm">Exhibit 4.10 to the Registrant&#8217;s Annual Report on Form 20-F filed with the Commission on March 15, 2019. </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.56pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex410.htm">Confidential portions of this exhibit have been omitted pursuant to a request for confidential treatment and </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 47.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746dex410.htm">filed separately with the SEC.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 486.75pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">4.7<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 486.75pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953dex48.htm">Amendment Agreement dated July 31, 2019 to the Stock and Asset Purchase Agreement by and among </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953dex48.htm">Pfizer Inc., GlaxoSmithKline plc, GlaxoSmithKline Consumer Healthcare Holdings Limited and </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953dex48.htm">GlaxoSmithKline Consumer Healthcare Holdings (No. 2) Limited dated as of July 31, 2019 is incorporated by </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.56pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953dex48.htm">reference to Exhibit 4.8 to the Registrant&#8217;s Annual Report on Form 20-F filed with the Commission on March </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 47.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/d769953dex48.htm">6, 2020.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 57.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 547.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">4.8<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 547.5pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312523067105/d382677dex48.htm">Second Amendment Agreement dated June 1, 2022 to the Stock and Asset Purchase Agreement by and </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312523067105/d382677dex48.htm">among Pfizer Inc., GSK plc, GlaxoSmithKline Consumer Healthcare Holdings Limited and GlaxoSmithKline </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312523067105/d382677dex48.htm">Consumer Healthcare Holdings (No. 2) Limited dated as of 19 December 2018. Certain confidential </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.56pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312523067105/d382677dex48.htm">information contained in this exhibit has been omitted from this exhibit because it is both (i) not material and </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 47.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000119312523067105/d382677dex48.htm">(ii) would likely cause competitive harm to the Registrant if publicly disclosed.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 608.25pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.87pt; position: var(--position); text-decoration: none; white-space: pre;">8.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 608.25pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_535">A list of the Registrant&#8217;s principal subsidiaries as at 31 December 2024 can be found in Note 46 to the </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="#idc89fa1ee07645df9629d157a4b46752_535">financial statements on page 264</a><span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 134.59pt; position: var(--position); text-decoration: none; white-space: pre;">. <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 11.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 635.25pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.7pt; position: var(--position); text-decoration: none; white-space: pre;">11.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 635.25pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.63pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit111-sharedealingcode.htm">GSK plc Code for Dealing in Securities</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 649.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">12.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 649.5pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit121-s302certxemma.htm">Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934 &#8211; Emma </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit121-s302certxemma.htm">Walmsley.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 484pt;"><div style="line-height: 7.5pt; position: var(--position); top: 7.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 290.05pt; position: var(--position); text-decoration: none; white-space: pre;">316<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 0pt;"><div style="width: 484pt;"></div></div><div><div style="position: var(--position); top: 113.39pt; width: 595.44pt;"><div style="font-size: 0pt; left: 53.86pt; position: var(--position); top: 0pt; width: 487.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tbody><tr style="height: 0;"><td colspan="1" rowspan="1" style="padding: 0; width: 50.25pt;"/><td colspan="1" rowspan="1" style="padding: 0; width: 437.25pt;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 0pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">12.2<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 0pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit122-s302certxjulie.htm">Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934 &#8211; Julie </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit122-s302certxjulie.htm">Brown.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 24pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 27pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">13.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 27pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit131-s906certificate.htm">Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit131-s906certificate.htm">1350, Chapter 63 of Title 18, United States Code).</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 54pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">15.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 54pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit151-deloittesconsent.htm">Consent of Deloitte LLP.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 69.75pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 20.12pt; position: var(--position); text-decoration: none; white-space: pre;">17<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 69.75pt; width: 437.25pt;"><div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="exhibit17-subsidiaryissuer.htm">List of Subsidiary Issuers of Guaranteed Securities .</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 36.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 85.5pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 16.37pt; position: var(--position); text-decoration: none; white-space: pre;">97.1<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 50.25pt; position: var(--position); top: 85.5pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 4.31pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit971-clawbackpolicy.htm">GSK Group Clawback Policy for the Recovery of Erroneously Awarded Compensation is incorporated by </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 15.56pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit971-clawbackpolicy.htm">reference to Exhibit 97.1 to the Registrant&#8217;s Annual Report on Form 20-F filed with the Commission on </a><span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 26.81pt; width: 437.25pt;"><span style="color: #0000ff; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: var(--position); text-decoration: underline; white-space: pre;"><a style="-sec-extract: exhibit; color: inherit; text-decoration: inherit; z-index: 1;" href="https://www.sec.gov/Archives/edgar/data/1131399/000113139924000007/exhibit971-clawbackpolicy.htm">March 5, 2024.</a><span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 7.13pt; position: var(--position); text-decoration: none; white-space: pre;">101.INS*&#160; &#160; &#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 125.25pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">XBRL Instance Document<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 141pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.13pt; position: var(--position); text-decoration: none; white-space: pre;">101.SCH*<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 141pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">XBRL Taxonomy Extension Schema Document<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 35.25pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="left: 0pt; position: var(--position); top: 156.75pt; width: 50.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 50.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 5.88pt; position: var(--position); text-decoration: none; white-space: pre;">101.CAL*<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 35.25pt; left: 50.25pt; overflow: hidden; position: var(--position); top: 156.75pt; width: 437.25pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.81pt; width: 437.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF**XBRL Taxonomy Extension Definition <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 14.06pt; width: 437.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Linkbase Document 101.LAB**XBRL Taxonomy Extension Label Linkbase Document 101.PRE**XBRL <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.31pt; width: 437.25pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Taxonomy Extension Presentation<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 12.75pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 12.75pt; left: 0pt; overflow: hidden; position: var(--position); top: 195pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="color: #000000; font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Linkbase Document<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 3pt;"><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/><td colspan="1" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"/></tr><tr style="height: 47.25pt;"><td colspan="2" rowspan="1" style="font-size: 0; text-align: left; vertical-align: top;"><div style="height: 47.25pt; left: 0pt; overflow: hidden; position: var(--position); top: 213.75pt; width: 487.5pt;"><div><div style="line-height: 9pt; position: var(--position); top: 2.63pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">*In accordance with Rule 402 of Regulation S-T, the information in these exhibits shall not be deemed to be &#8220;filed&#8221; for <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 13.88pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 25.13pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">incorporated by reference into any registration statement or other document filed under the Securities Act, or the <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 36.38pt; width: 487.5pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: -0.2pt; position: var(--position); text-decoration: none; white-space: pre;">Exchange Act, except as shall be expressly set forth by specific reference in such filing.<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-family: Arial, Sans Serif; font-size: 0; height: 841.68pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 595.44pt; word-wrap: break-word;"><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 813.33pt;"><div style="width: 484pt;"><div style="line-height: 7.5pt; position: var(--position); top: 7.82pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 290.05pt; position: var(--position); text-decoration: none; white-space: pre;">317<span style="display: inline-block; height: 5.46pt;"></span></span></div></div></div><div style="-sec-extract: summary; left: 0pt; position: var(--position); top: 0pt;"><div style="width: 484pt;"></div></div><div><div style="line-height: 9pt; position: var(--position); top: 113.39pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;">Signature<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 135.01pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;">The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 146.26pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;">authorized the undersigned to sign this Annual Report on its behalf.<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 169.76pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 341.86pt; position: var(--position); text-decoration: none; white-space: pre;">GSK plc<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="font-size: 12pt; line-height: 9pt; position: var(--position); top: 201.25pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 51.03pt; position: var(--position); text-decoration: none; white-space: pre;">March 3<span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 83.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">, <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.50999999999999pt; position: var(--position); text-decoration: none; white-space: pre;">2025&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 213pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 341.86pt; position: var(--position); text-decoration: underline; white-space: pre;">By:&#160; &#160; /s/ Julie Brown&#160; &#160; &#160;  <span style="display: inline-block; height: 6.55pt;"></span></span><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><span style="left: 440.82pt; position: var(--position);">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.55pt; width: 18.04pt;"></span></span><span style="left: 593.86pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 36pt;"></span></span><span style="left: 629.86pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 36pt;"></span></span><span style="left: 665.86pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 36pt;"></span></span><span style="left: 701.86pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 36pt;"></span></span><span style="left: 737.86pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 36pt;"></span></span><span style="left: 773.86pt; position: var(--position);">&#160;  <span style="display: inline-block; height: 6.55pt; width: 28.5pt;"></span></span><span style="left: 809.86pt; position: var(--position);"><span style="display: inline-block; height: 6.55pt; width: 36pt;"></span></span><span style="left: 845.86pt; position: var(--position);">&#160; &#160; &#160; &#160;  <span style="display: inline-block; height: 6.55pt; width: 13.5pt;"></span></span><span style="left: 881.86pt; position: var(--position);">&#160; <span style="display: inline-block; height: 6.55pt; width: 31pt;"></span></span><span style="left: 917.86pt; position: var(--position);">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <span style="display: inline-block; height: 6.55pt; width: 27pt;"></span></span><span style="left: 989.86pt; position: var(--position);">&#160; &#160; &#160; &#160;  <span style="display: inline-block; height: 6.55pt;"></span></span></span></div><div style="line-height: 9pt; position: var(--position); top: 224.75pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 341.86pt; position: var(--position); text-decoration: none; white-space: pre;">Julie Brown<span style="display: inline-block; height: 6.55pt;"></span></span></div><div style="line-height: 9pt; position: var(--position); top: 236.5pt; width: 595.44pt;"><span style="font-family: 'Arial', sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 341.86pt; position: var(--position); text-decoration: none; white-space: pre;">Chief Financial Officer<span style="display: inline-block; height: 6.55pt;"></span></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.4
<SEQUENCE>2
<FILENAME>exhibit24-descriptionofsec.htm
<DESCRIPTION>EX-2.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i507757eb6bb942ca876bce9915745b43_1"></div><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-align:right;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Exhibit 2.4</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">DESCRIPTION OF SECURITIES</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">REGISTERED UNDER SECTION 12 OF<br>THE EXCHANGE ACT</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As of December 31, 2024, GSK plc (&#8220;GSK,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had ordinary shares, American Depositary Receipts and debt securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (the &#8220;Act&#8221;).</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">A. Description of Ordinary Shares</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:139%">This summary of the general terms and provisions of our ordinary shares does not purport to be complete and is subject to and qualified in its entirety by reference to our Articles of Association (the &#8220;Articles&#8221;), which are incorporated herein by reference to the Form 20-F filed on March 3, 2025 (File No.&#160;001-15170).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK has ordinary shares in issue which are in registered form and are governed by the laws of England and Wales.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The holders of ordinary shares have statutory pre-emption rights under the UK Companies Act 2006 (the &#8220;Companies Act&#8221;) on the issuance of new ordinary shares or rights to subscribe for, or to convert into, ordinary shares. Under the Companies Act, such pre-emption rights may be dis-applied by special resolution of the shareholders of GSK. The shareholders of GSK passed a special resolution on May 3, 2023 to allow Directors to be empowered to (i) disapply pre-emption rights in relation to an allotment of equity securities that is otherwise made on a pre-emptive basis in order to deal appropriately with fractional entitlements, jurisdictional issues and other legal, regulatory or practical problems and (ii) allot equity securities for cash and&#47;or to sell ordinary shares held by GSK as treasury shares for cash up to an amount of &#163;64,328,647 in nominal share capital as if pre-emption rights did not apply. This authorization is set to expire at the end of GSK&#8217;s Annual General Meeting held in 2025 (or, if earlier, close of business on June 30, 2025). As at December 31, 2024 there were 4,314,303,734 ordinary shares of 31 1&#8260;4 pence each in issue.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our Articles contain provisions to the following effect&#58;</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Dividends</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">All ordinary shares rank pari passu in respect of dividends and other distributions of profits. Subject to the provisions of the Articles and applicable legislation, GSK at any general meeting may declare dividends on the ordinary shares by ordinary resolution, but such dividends may not exceed the amount recommended by the board of directors of GSK (the &#8220;Board&#8221;). The Board may also pay interim or fixed rate dividends if it appears they are justified by our financial position.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">All unclaimed dividends payable in respect of any share may be invested or otherwise made use of by the Board for the benefit of GSK until claimed. If a dividend is not claimed after 6 years of it being declared or becoming payable, it is forfeited and reverts to us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK may, if authorized by an ordinary resolution, offer any holders of ordinary shares (excluding any member holding shares as treasury shares) the right to elect to receive ordinary shares, credited as fully paid, instead of cash in respect of the whole (or some part, to be determined by the Board) of any dividend specified by the ordinary resolution.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Voting</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Subject to any special terms as to voting upon which any shares may be issued or may at the relevant time be held and to any other provisions of the Articles, members shall be entitled to vote at a general meeting as provided in the Companies Act.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">At any general meeting, a resolution that is put to the vote of the meeting shall be decided on a poll, which shall be taken in such manner as the chair of the meeting shall direct, including by means of electronic vote casters. The result of the vote shall be deemed to be the resolution of the meeting at which the vote was demanded. A vote to elect the chair of the meeting or to adjourn the meeting must be taken immediately at the meeting. Any other vote may be taken at any other time (within 30 days of the meeting) and place determined by the chair. In the case of joint holders, only the vote of the senior holder (as determined by order in the share register) or his or her proxy may be counted. If any sum payable remains unpaid in relation to a member&#8217;s shareholding, that member is not entitled to vote that share or exercise any other right in relation to a meeting of GSK unless the Board determines otherwise. For a proxy vote to be valid, the Board must have received satisfactory evidence such that the authority of the person claiming to exercise the right to vote or such other right has been received by the Company not later than the last time at which appointments of proxy should have been received in order to be valid for use at that meeting or on the holding of that poll.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Any objection or error shall be referred to the chair of the meeting and shall only vitiate the decision of the meeting on any resolution if the chair decides that the objection or error may have affected the decision of the meeting.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Transfers</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Ordinary shares may be held in either certificated or uncertificated form. Certificated ordinary shares shall be transferred in any usual or other form approved by the Board and executed by or on behalf of the transferor. Transfers of uncertificated ordinary shares shall be made in accordance with the Companies Act and Uncertificated Securities Regulations 2001, as amended.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Board is not bound to register (i) a transfer of partly paid ordinary shares, (ii) uncertificated shares in the circumstances set out in the Companies Act and Uncertificated Securities Regulations 2001 and (iii) transfers of uncertificated securities to joint holders where the number of such joint holders exceeds four. The Board may also decline to register an instrument of transfer of certificated ordinary shares unless (i) it is duly stamped, duly certified or otherwise shown to the satisfaction of the Board to be exempt from stamp duty and deposited at the prescribed place and accompanied by the share certificate(s) and such other evidence as reasonably required by the Board to evidence right to transfer, (ii) it is in respect of one class of shares only, and (iii) in the case of a transfer to joint holders, the number of joint holders to whom the share is to be transferred does not exceed four.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Subject to any rights attached to existing shares, any share may be issued on terms that it is, at our option or the option of the holder of such share, redeemable. The directors are authorized to determine the terms, conditions and manner of redemption of any such shares under the Articles.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Calls on capital</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The directors may make calls upon the members in respect of any monies unpaid on their shares. A person upon whom a call is made remains liable even if the shares in respect of which the call is made have been transferred. Interest will be chargeable on any unpaid amount called at a rate determined by the Board (not exceeding the Bank of England base rate by more than 5%).</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If a member fails to pay any call or installment of a call in full (following notice from the Board that such failure will result in forfeiture of the relevant shares), such shares (including any dividends declared but not paid) may be forfeited by a resolution of the Board, and will become the property of GSK. Forfeiture shall not absolve a previous member for amounts payable by him&#47;her (which may continue to accrue interest).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK also has a lien over all of our partly paid shares for all monies payable or called on such shares and over the debts and liabilities of a member to GSK. If any monies which are the subject of the lien remain unpaid after a notice from the Board demanding payment, we may sell such shares.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Other Shareholder Rights</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">On a distribution of capital on a winding-up, the ordinary shares rank pari passu with each other but behind the rights of all of GSK&#8217;s creditors.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Variation of Rights</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The rights attached to any class of shares may be varied either with the consent in writing of the holders of at least 75% in nominal value of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If new shares are created or issued which rank equally with any other existing shares, or if the Company purchases or redeems any of its own shares, the rights of the existing shares will not be regarded as changed or abrogated unless the terms of the existing shares expressly say otherwise.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Limitations on Share Ownership</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">There are no limitations on the rights of shareholders to own ordinary shares. In addition, there are no restrictions imposed by the Articles or (subject to the effect of any economic sanctions or UK or EU merger control laws that may be in force from time to time) by current UK laws which relate to non-residents or foreign shareholders and which limit the rights of such non-residents or foreign shareholders to hold or (when entitled to do so) exercise voting rights on the ordinary shares.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">B. Description of American Depositary Shares</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:139%">This summary of the general terms and provisions of our American Depositary Shares (&#8220;ADSs&#8221;) does not purport to be complete and is subject to and qualified in its entirety by our Form F-6 filed on July 19, 2019, as amended on March 15, 2021 (Commission file No. 333-232726), including the exhibits thereto. In the following description, a &#8220;Holder&#8221; is the person registered with the Depositary (as defined below).</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">American Depositary Receipts (&#8220;ADRs&#8221;) evidencing ADSs are issuable pursuant to an amended and restated deposit agreement dated July 19, 2019, between GSK, and JPMorgan Chase Bank, N.A., as depositary (the &#8220;Depositary&#8221;), and the Holders of the ADRs, as amended on March 15, 2021 (the &#8220;Deposit Agreement&#8221;). The principal executive office of the Depositary is 383 Madison Avenue, Floor 11, New York, New York 10179. Each ADS represents the right to receive two ordinary shares of GSK. An ADR may evidence any number of ADSs.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our American Depositary Receipts are admitted to trading on the New York Stock Exchange under the symbol &#8220;GSK&#8221;.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Voting</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary or, if the deposited securities are registered in the name of or held by its nominee, its nominee, subject to and in accordance with the constituent documents of GSK irrevocably appointed each Holder for the time being on the record date (the &#8220;Voting Record Date&#8221;) fixed by the Depositary in respect of any meeting (at which holders of deposited securities are entitled to vote) as its proxy to attend, vote and speak at the relevant meeting (or any adjournment thereof) in respect of the deposited securities represented by the ADS registered on the books of the Depositary in the name of such Holder on the Voting Record Date. In respect of any such meeting each such Holder can appoint any person as its substitute proxy to attend, vote and speak on behalf of the Holder subject to and in accordance with the provisions of the Deposit Agreement and the constituent documents of GSK.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As soon as practicable after receipt of notice of any meeting at which the holders of deposited securities are entitled to vote, or of solicitation of consents or proxies from holders of deposited securities, the Depositary shall fix the Voting Record Date in respect of such meeting or solicitation. The Depositary or, if GSK so determines, GSK, shall distribute to Holders of record on such Voting Record Date&#58; (a) such information as is contained in such notice of meeting or in the solicitation materials, (b) an ADR proxy card in a form prepared by the Depositary, (c) a statement that each Holder at the close of business on the Voting Record Date will be entitled, subject to any applicable law, GSK&#8217;s constituent documents and the provisions of or governing the deposited securities, either (i) to use such ADR proxy card in order to attend, vote and speak at such meeting as the proxy of the Depositary or its nominee solely with respect to the ordinary shares or other deposited securities represented by ADSs evidenced by such Holder&#8217;s ADRs or (ii) to appoint any other person as the substitute proxy of such Holder, solely with respect to the ordinary shares or other deposited securities represented by ADSs evidenced by such Holder&#8217;s ADRs, or (iii) to renounce the proxy initially provided by the Depositary or its nominee to such Holder or such Holder&#8217;s substitute proxy and to provide voting instructions to the Depositary as to the exercise of the voting rights pertaining to the ordinary shares or other deposited securities represented by ADSs evidenced by their respective ADRs (&#8220;Voting Instructions&#8221;), and (d) if the Depositary is to be given Voting Instructions by such Holder, a brief statement as to the manner in which Voting Instructions may be given to the Depositary. Each Holder shall be solely responsible for the forwarding of voting information to the persons or entities having a beneficial ownership interest in ADSs (the &#8220;Beneficial Owners&#8221;) registered in such Holder&#8217;s name. There is no guarantee that Holders and Beneficial Owners generally or any Holder or Beneficial Owner in particular will receive the notice described above with sufficient time to enable such Holder or Beneficial Owner to return any voting instructions to the Depositary in a timely manner or for the Holder to arrange to attend, vote and&#47;or speak at the relevant meeting. GSK shall provide notice to the Depositary of such vote or meeting in a timely manner and at least 30 days prior to the date of such vote or meeting (unless less than 30 days&#8217; notice of the meeting has been given in accordance with GSK&#8217;s Articles of Association and English law, in which case GSK will provide to the Depositary such advance notice of the meeting as may be possible under the circumstances)&#59; provided that if the Depositary receives less than 30 days&#8217; notice of such vote or meeting, the Depositary shall only make such distribution to the extent it deems it to be practicable.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Upon actual receipt by the ADR department responsible for proxies and voting instructions (including, without limitation, instructions of any entity or entities acting on behalf of the nominee for the Depositary Trust Company (&#8220;DTC&#8221;)) of Voting Instructions of a Holder on the Voting Record Date in the manner and on or before the time established by the Depositary for such purpose, the Depositary shall endeavor, insofar as practicable and permitted under applicable law, the provisions of GSK&#8217;s constituent documents and the provisions of the deposited securities, to vote or cause to be voted the deposited securities represented by the ADSs evidenced by such Holder&#8217;s ADRs in accordance with such Voting Instructions insofar as practicable and permitted under the provisions of or governing deposited securities. The Depositary will not itself exercise any voting discretion in respect of any deposited securities. Ordinary shares or other deposited securities represented by ADSs for which no specific Voting Instructions are received by the Depositary from the Holder shall not be voted by the Depositary but may be directly voted by such Holder in attendance at meetings of shareholders as proxy for the Depositary or its nominee, subject to, and in accordance with, the Deposit Agreement and GSK&#8217;s constituent documents.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Holders and their substitute proxy (other than the Depositary) shall only be permitted to attend, vote and speak at meetings at which holders of deposited securities are entitled to vote as the proxy of the Depositary or its nominee with respect to the whole number of ordinary shares represented by the ADSs evidenced by ADRs held by such Holders on the record date set by the Depositary. For the avoidance of doubt, when the Depositary receives Voting Instructions from a substitute proxy of a Holder (including, without limitation, instructions from Broadridge Financial Solutions or any other entity acting on behalf of participants and&#47;or customers of participants within DTC) or their agents, and such registered Holder has notified the Depositary that it holds ADRs on behalf of such substitute proxies, the Depositary shall treat such Voting Instructions as coming from an entity that holds ADRs on behalf of such substitute proxies and the Depositary shall vote or cause to be voted the deposited securities in accordance with such instructions.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Holders are strongly encouraged to forward their Voting Instructions as soon as possible. Voting Instructions will not be deemed received until such time as the ADR department responsible for proxies and voting has received such Voting Instructions notwithstanding that such Voting Instructions may have been physically received by the Depositary prior to such time.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notwithstanding anything contained in the Deposit Agreement or any ADR, the Depositary may, to the extent not prohibited by any law, rule or regulation or the rules and&#47;or requirements of the stock exchange on which the ADSs are listed, in lieu of distribution of the materials provided to the Depositary in connection with any meeting of or solicitation of consents or proxies from holders of deposited securities, distribute to the Holders a notice, after consulting GSK as to the form of such notice to the extent practicable, that provides Holders with, or otherwise publicizes to Holders, instructions on how to retrieve such materials or receive such materials upon request (i.e., by reference to a website containing the materials for retrieval or a contact for requesting copies of the materials).</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Procedures for Transmitting Notices, Reports and Proxy Soliciting Material</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In addition to the procedures for transmitting notices discussed above under &#8220;Voting&#8221;, the Depositary or its agent will keep, at a designated transfer office (the &#8220;Transfer Office&#8221;), (i) a register (the &#8220;ADR Register&#8221;) for the registration, registration of transfer, combination and split-up of ADRs and</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(ii) facilities for the delivery and receipt of ADRs. Title to an ADR (and to deposited securities represented by the ADSs), when properly endorsed (in the case of ADRs in certificated form) or upon delivery to the Depositary of proper instruments of transfer, is transferable by delivery with the same effect as in the case of negotiable instruments under the laws of the State of New York&#59; provided that the Depositary, notwithstanding any notice to the contrary, may treat the person in whose name such ADR is registered on the ADR Register as the absolute owner hereof for all purposes and neither the Depositary nor GSK will have any obligation or be subject to any liability under the Deposit Agreement or any ADR to any Beneficial Owner, unless such Beneficial Owner is the Holder hereof. Such ADR is transferable on the ADR Register and may be split into other ADRs or combined with other ADRs into one ADR, evidencing the aggregate number of ADSs surrendered for split-up or combination, by the Holder hereof or by duly authorized attorney upon surrender of this ADR at the Transfer Office properly endorsed (in the case of ADRs in certificated form) or upon delivery to the Depositary of proper instruments of transfer and duly stamped as may be required by applicable law&#59; provided that the Depositary may close the ADR Register at any time or from time to time when deemed expedient by it and it shall also close the issuance book portion of the ADR Register when reasonably requested by GSK in order to enable GSK to comply with applicable law. At the request of a Holder, the Depositary shall, for the purpose of substituting a certificated ADR with a Direct Registration ADR (defined below), or vice versa, execute and deliver a certificated ADR or a Direct Registration ADR, as the case may be, for any authorized number of ADSs requested, evidencing the same aggregate number of ADSs as those evidenced by the certificated ADR or Direct Registration ADR, as the case may be, substituted.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Deposit Agreement, the provisions of or governing deposited securities and any written communications from GSK, which are both received by the custodian or its nominee as a holder of deposited securities and made generally available to the holders of deposited securities, are available for inspection by Holders at the offices of the Depositary and its agent or agents (the &#8220;Custodian&#8221;), at the Transfer Office, on the U.S. Securities and Exchange Commission&#8217;s (the &#8220;Commission&#8221;) website, or upon request from the Depositary (which request may be refused by the Depositary at its discretion). The Depositary will distribute copies of such communications (or English translations or summaries thereof) to Holders when furnished by GSK. GSK is subject to the periodic reporting requirements of the Act and accordingly files certain reports with the Commission. Such reports and other information may be inspected and copied through the Commission&#8217;s EDGAR system or at public reference facilities maintained by the Commission located at the date hereof at 100 F Street, NE, Washington, DC 20549.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Direct Registration ADR&#8221; means an ADR, the ownership of which is recorded on the Direct Registration System.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Direct Registration System&#8221; means the system for the uncertificated registration of ownership of securities established by DTC and utilized by the Depositary pursuant to which the Depositary may record the ownership of ADRs without the issuance of a certificate, which ownership shall be evidenced by periodic statements issued by the Depositary to the Holders entitled thereto.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Sale or Exercising of Rights</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary will distribute to each Holder entitled thereto on the record date set by the Depositary therefor at such Holder&#8217;s address shown on the ADR Register, in proportion to the number of deposited securities (on which the following distributions on deposited securities are received by the Custodian) represented by ADSs evidenced by such Holder&#8217;s ADRs&#58; (i) warrants or other instruments in the discretion of the Depositary representing rights to acquire additional ADRs in respect of any rights to subscribe for additional Shares or rights of any nature available to the Depositary as a result of a distribution on deposited securities (&#8220;Rights&#8221;), to the extent that GSK timely furnishes to the Depositary evidence satisfactory to the Depositary that the Depositary may lawfully distribute the same (GSK has no obligation to so furnish such evidence), or (ii) to the extent GSK does not so furnish such evidence and sales of Rights are practicable, any U.S. dollars available to the Depositary from the net proceeds of sales of Rights as in the case of cash, or (iii) to the extent GSK does not so furnish such evidence and such sales cannot practicably be accomplished by reason of the nontransferability of the Rights, limited markets therefor, their short duration or otherwise, nothing (and any Rights may lapse).</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Deposit or Sale of Securities Resulting from Dividends, Splits or Plans of Reorganization</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If GSK makes a dividend payable at the election of the holders of ordinary shares in either cash or additional ordinary shares that it wishes to be made available to the Holders, GSK shall give notice thereof to the Depositary at least 30 days prior to the proposed distribution stating whether or not it wishes such elective distribution to be made available to the Holders. The Depositary shall make such elective distribution available to the Holders only if, among other things, GSK has timely requested that the elective distribution is available to the Holders and the Depositary shall have determined that such distribution is reasonably practicable. If the conditions for making the elective distribution available to the Holders are satisfied, the Depositary will establish procedures to enable the Holders to elect the receipt of either cash or additional ADSs. If the conditions for making the elective distribution available to the Holders are not satisfied, the Depositary will, to the extent permitted by law, distribute either cash or additional ADSs to the Holders on the basis of the same determination as is made in the local market in respect of the ordinary shares for which no election is made. There can be no assurance that Holders generally, or any Holder in particular, will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of ordinary shares.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">To the extent the Depositary deems distribution of securities or property available to the Depositary resulting from any distribution on deposited securities (other than cash, ordinary shares or Rights) not to be equitable and practicable, the Depositary may distribute any U.S. dollars available to the Depositary from net proceeds of sale of such securities or property.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary may, in its discretion, and shall if reasonably requested by GSK, distribute additional or amended ADRs or cash, securities or property to reflect any change in par value, split-up, consolidation, cancellation or other reclassification of deposited securities, any ordinary share distributions or other distributions not distributed to Holders or any cash, securities or property available to the Depositary in respect of deposited securities from (and the Depositary is hereby authorized to surrender any deposited securities to any person and, irrespective of whether such deposited securities are surrendered or otherwise cancelled by operation of law, rule, regulation or otherwise, to sell by public or private sale any property received in connection with) any recapitalization, reorganization, merger, consolidation, liquidation, receivership, bankruptcy or sale of all or substantially all the assets of the Company. To the extent the Depositary does not amend ADRs or make a distribution to Holders to reflect any of the foregoing, or the net proceeds thereof, whatever cash, securities or property results from any of the foregoing shall constitute deposited securities and each ADS evidenced by this ADR shall automatically represent its pro rata interest in the deposited securities as then constituted. Promptly upon the occurrence of any of the aforementioned changes affecting deposited securities, GSK shall notify the Depositary in writing of such occurrence and as soon as practicable after receipt of such notice from GSK, may instruct the Depositary to give notice thereof, at GSK&#8217;s expense, to Holders in accordance with the provisions hereof. Upon receipt of such instruction, the Depositary shall give notice to the Holders in accordance with the terms thereof, as soon as reasonably practicable.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">For all cash dividends and other cash distributions that are made available to the Depositary after the date that will be published on www.adr.com (as updated by the Depositary from time to time, &#8220;ADR.com&#8221;) and communicated to then current Holders by mail, the Depositary will distribute any cash to Holders solely via electronic funds transfer (&#8220;EFT&#8221;), except as otherwise provided in this paragraph. In order to receive such amounts, Holders must provide their bank deposit details to the Depositary in accordance with the instructions provided by the Depositary for this purpose. Subject to the last sentence of this paragraph, all such amounts owing to Holders who do not provide such bank deposit details shall be held by the Depositary on behalf of such Holders until such bank deposit details have been provided. All amounts so held by the Depositary will be reported for tax purposes as if paid to all Holders as of the date that funds are first made available to Holders and will neither accrue interest nor be invested for Holders while they are being held. A Holder will be unable to receive cash dividends or other cash distributions to which it is entitled until such time as such Holder either (i) provides its bank deposit details to the Depositary in accordance with the instructions provided by the Depositary for this purpose, (ii) transfers such Holder&#8217;s ADS position into DTC or (iii) cancels its ADSs (whereupon, in the case of a transfer to DTC or a cancellation, such Holder will receive a check for the aggregate amount of cash dividends and&#47;or cash distributions being held on its behalf).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notwithstanding the foregoing, the Depositary shall, if instructed by GSK, distribute cash dividends and other cash distributions by check or by such other means as GSK and the Depositary may agree.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Foreign Exchange Related Matters</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">To facilitate the administration of various depositary receipt transactions, including disbursement of dividends or other cash distributions and other corporate actions, the Depositary may engage the foreign exchange desk within JPMorgan Chase Bank, N.A. (the &#8220;Bank&#8221;) and&#47;or its affiliates in order to enter into spot foreign exchange transactions to convert foreign currency into U.S. dollars (&#8220;FX Transactions&#8221;). For certain currencies, FX Transactions are entered into with the Bank or an affiliate, as the case may be, acting in a principal capacity. For other currencies, FX Transactions are routed directly to and managed by an unaffiliated local custodian (or other third party local liquidity provider), and neither the Bank nor any of its affiliates is a party to such FX Transactions.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The foreign exchange rate applied to an FX Transaction will be either (a) a published benchmark rate, or (b) a rate determined by a third party local liquidity provider, in each case plus or minus a spread, as applicable. The Depositary will disclose which foreign exchange rate and spread, if any, apply to such currency on ADR.com. Such applicable foreign exchange rate and spread may (and neither the Depositary, the Bank nor any of their affiliates is under any obligation to ensure that such rate does not) differ from rates and spreads at which comparable transactions are entered into with other customers or the range of foreign exchange rates and spreads at which the Bank or any of its affiliates enters into foreign exchange transactions in the relevant currency pair on the date of the FX Transaction. Additionally, the timing of execution of an FX Transaction varies according to local market dynamics, which may include regulatory requirements, market hours and liquidity in the foreign exchange market or other factors. Furthermore, the Bank and its affiliates may manage the associated risks of their position in the market in a manner they deem appropriate without regard to the impact of such activities on GSK, the Depositary, Holders or Beneficial Owners. The spread applied does not reflect any gains or losses that may be earned or incurred by the Bank and its affiliates as a result of risk management or other hedging related activity.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">To the extent the Company provides U.S. dollars to the Depositary, neither the Bank nor any of its affiliates will execute an FX Transaction. In such case, the Depositary will distribute the U.S. dollars received from the Company.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Further details relating to the applicable foreign exchange rate, the applicable spread and the execution of FX Transactions will be provided by the Depositary on ADR.com. The Company, Holders and Beneficial Owners each acknowledge and agree that the terms applicable to FX Transactions disclosed from time to time on ADR.com will apply to any FX Transaction executed pursuant to the Deposit Agreement.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Amendment and Termination of the Deposit Agreement</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The form of ADRs evidencing ADSs and any provisions of the Deposit Agreement relating to those ADRs may be amended by GSK and the Depositary. Any amendment that imposes or increases any fees or charges, other than taxes and other governmental charges, transfer or registration fees, transmission costs, delivery costs or other such expenses, or that otherwise prejudices any substantial existing right of the Holders or Beneficial Owners, will not take effect as to any ADRs until 30 days after notice of the amendment has been given to the Holders. Every Holder and Beneficial Owner of any ADR, at the time an amendment becomes effective, will be deemed to continue to hold such ADR and to consent and agree to the amendment and to be bound by the Deposit Agreement or the ADR as amended. No amendment may impair the right of any Holder to surrender ADRs and receive in return the deposited securities represented by the ADSs. If any governmental body or regulatory body should adopt new laws, rules or regulations which would require amendment or supplement of the Deposit Agreement or the form of ADR to ensure compliance therewith, GSK and the Depositary may amend or supplement the Deposit Agreement and the ADR at any time in accordance with such changed laws, rules or regulations. Such amendment or supplement to the Deposit Agreement in such circumstances may become effective before a notice of such amendment or supplement is given to Holders or within any other period of time as required for compliance.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Whenever GSK directs, the Depositary has agreed to terminate the Deposit Agreement as to ADRs evidencing ADSs by mailing a termination notice to the Holders then outstanding at least 30 days before the date fixed in the notice of termination. The Depositary may likewise terminate the Deposit Agreement as to ADRs evidencing ADSs by mailing a termination notice to GSK and the Holders then outstanding at least 30 days before the date of termination, under the following circumstances&#58; (i) in the event of GSK&#8217;s bankruptcy or insolvency, (ii) if the ordinary shares cease to be listed on an internationally recognized stock exchange, (iii) if GSK effects (or will effect) a redemption of all or substantially all of the deposited securities, or a cash or share distribution representing a return of all or substantially all of the value of the deposited securities, or (iv) there occurs a merger, consolidation, sale of assets or other transaction as a result of which securities or other property are delivered in exchange for or in lieu of deposited securities, except where such transaction was commenced, announced by GSK or notified to the Depositary prior to the effective date of the Deposit Agreement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">After the date so fixed for termination, the Depositary and its agents will perform no further acts under the Deposit Agreement and this ADR, except to receive and hold (or sell) distributions on deposited securities and deliver deposited securities being withdrawn. As soon as practicable after the date so fixed for termination, the Depositary shall use its reasonable efforts to sell the deposited securities and shall thereafter (as long as it may lawfully do so) hold in an account (which may be a segregated or unsegregated account) the net proceeds of such sales, together with any other cash then held by it under the Deposit Agreement, without liability for interest, in trust for the pro rata benefit of the Holders of ADRs not </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">theretofore surrendered. After making such sale, the Depositary shall be discharged from all obligations in respect of the Deposit Agreement and this ADR, except to account for such net proceeds and other cash. After the date so fixed for termination, GSK shall be discharged from all obligations under the Deposit Agreement except for its obligations to the Depositary and its agents.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Rights of Holders to Inspect the Transfer Books of the Depositary and the List of Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary will keep books for the registration and transfer of ADRs as well as facilities for the delivery and receipt of ADRs at the Transfer Office. These books will be open for inspection by Holders at all reasonable times. However, this inspection may not be for the purpose of communicating with Holders in the interest of a business or object other than GSK business or a matter related to the Deposit Agreement or the ADRs.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Restrictions on the Right to Transfer or Withdraw the Underlying Securities</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As a condition precedent to the issue, registration, registration of transfer, split-up or combination of any ADR, the delivery of any distribution in respect thereof, or the withdrawal of any deposited securities, GSK, the Depositary, or custodian may require payment of a sum sufficient to reimburse it for any tax or other governmental charge and any stock transfer or registration fee with respect thereto (including any such tax or charge and fee with respect to ordinary shares or other deposited securities being registered) and payment of any applicable fees as therein provided, may require the production of proof satisfactory to it as to the identity and genuineness of any signature, as well as such other information, including without limitation, information as to citizenship, residence, exchange control approval, beneficial or other ownership of any securities, compliance with applicable law, regulations, provisions of or governing deposited securities and terms of the Deposit Agreement and ADR, as it may deem necessary or proper, and may also require compliance with any regulations the Depositary may establish consistent with the provisions of the Deposit Agreement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The issuance of ADRs, the acceptance of deposits of ordinary shares, the registration, registration of transfer, split-up or combination of ADRs or the withdrawal of deposited securities may be suspended, generally or in particular instances, when the ADR Register or any register for deposited securities is closed or when any such action is deemed advisable by the Depositary or GSK at any time or from time to time.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Limitations on the Depositary&#8217;s Liability</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall not incur any liability to any Holder or Beneficial Owners of ADRs, if by reason of any provision of any present or future law, rule, regulation, fiat, order or decree of the U.S., England, Wales or any other country or jurisdiction, or of any governmental or regulatory authority or any securities exchange or market or automated quotation system, or the provisions of or governing any deposited securities, or by reason of any provision, present or future, of the Company&#8217;s charter, or by reason of any act of God or war or terrorism or other circumstances beyond its control, the Depositary shall be prevented or forbidden from or be subject to any civil or criminal penalty on account of doing or performing any act or thing which by the terms of the Deposit Agreement it is provided shall be done or performed&#59; nor shall the Depositary incur any liability to any Holder or Beneficial Owner of any ADR by reason of any non-performance or delay, caused as aforesaid, in the performance of any act or thing which by the terms of the Deposit Agreement it is provided shall or may be done or performed, or by reason of any exercise of, or failure to exercise, any discretion provided for in the Deposit Agreement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary assumes no obligation nor shall it be subject to any liability under the Deposit Agreement to any Holders or Beneficial Owners of any ADR (including, without limitation, liability with respect to the validity or worth of any deposited securities), except that it agrees to perform its obligations specifically set forth in the Deposit Agreement without gross negligence or willful misconduct. The Depositary shall not be a fiduciary or have any fiduciary duty to Holders or Beneficial Owners.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary and its agents shall not be under any obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any deposited securities or in respect of the ADRs. The Depositary shall not be liable to Holders or Beneficial Owners for any action or non-action by it in reliance upon the advice of or information from the Company, legal counsel, accountants, any person presenting ordinary shares for deposit, any Holder or any other person believed by it to be competent to give such advice or information. The Depositary shall not be liable for the acts or omissions made by, or the insolvency of, any securities depository, clearing agency or settlement system.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall not be responsible for, and shall incur no liability in connection with or arising from, the insolvency of any custodian that is not a branch or affiliate of JPMorgan Chase Bank, N.A. The Depositary shall not have any liability for the price received in connection with any sale of securities, the timing thereof or any delay in action or omission to act nor shall it be responsible for any error or delay in action, omission to act, default or negligence on the part of the party so retained in connection with any such sale or proposed sale. The Depositary shall not be liable for any acts or omissions to act on the part of the custodian, except to the extent that any Holder has incurred liability directly as a result of the custodian having (i) committed fraud or willful misconduct in the provision of custodial services to the Depositary or (ii) failed to use reasonable care in the provision of custodial services to the Depositary as determined in accordance with the standards prevailing in the jurisdiction in which the custodian is located.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary and its respective agents may rely and shall be protected in acting upon any written notice, request, direction, instruction or document believed by it to be genuine and to have been signed, presented or given by the proper party or parties.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall be under no obligation to inform Holders or Beneficial Owners about the requirements of the laws, rules or regulations or any changes therein or thereto of any country or jurisdiction or of any governmental or regulatory authority or any securities exchange or market or automated quotation system.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary and its agents will not be responsible for any failure to carry out any Voting Instructions to vote any of the Deposited Securities, for the manner in which any such vote is cast, any act or omission to act on the part of Holders, Beneficial Owners, the Company or its agents in connection with voting at a meeting, or for the effect of any such vote.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary may rely upon instructions from the Company or its counsel in respect of any approval or license required for any currency conversion, transfer or distribution.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary and its agents may own and deal in any class of securities of the Company and its affiliates and in ADRs.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notwithstanding anything to the contrary set forth in the Deposit Agreement or any ADR, the Depositary shall have no liability or responsibility under the Deposit Agreement, any ADR or any related agreement, for any period prior to the effective date of the Deposit Agreement or for any act or omission of the predecessor to the Depositary or any of its agents (including the Custodian as defined in the Prior Deposit Agreement), under or in connection with this Deposit Agreement, any ADRs or any related agreement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notwithstanding anything to the contrary set forth in the Deposit Agreement or any ADR, the Depositary and its agents may fully respond to any and all demands or requests for information maintained by or on its behalf in connection with the Deposit Agreement, any Holder or Holders, any ADR or ADRs or otherwise related hereto or thereto to the extent such information is requested or required by or pursuant to any lawful authority, including without limitation laws, rules, regulations, administrative or judicial process, banking, securities or other regulators.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall not be liable for the failure by any Holder or Beneficial Owner to obtain the benefits of credits or refunds of non-U.S. tax paid against such Holder&#8217;s or Beneficial Owner&#8217;s income tax liability.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary is under no obligation to provide the Holders and Beneficial Owners, or any of them, with any information about the tax status of the Company. The Depositary shall not incur any liability for any tax or tax consequences that may be incurred by Holders and Beneficial Owners on account of their ownership or disposition of the ADRs or ADSs.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall not incur any liability for the content of any information submitted to it by or on behalf of the Company for distribution to the Holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring an interest in the deposited securities, for the validity or worth of the deposited securities, for the credit-worthiness of any third party, for allowing any rights to lapse upon the terms of the Deposit Agreement or for the failure or timeliness of any notice from the Company.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notwithstanding anything to the contrary set forth in the Deposit Agreement or any ADR, the may use third party delivery services and providers of information regarding matters such as pricing, proxy voting, corporate actions, class action litigation and other services in connection herewith and the Deposit Agreement, and use local agents to provide extraordinary services such as attendance at annual meetings of issuers of securities. Although the Depositary will use reasonable care (and cause their agents to use reasonable care) in the selection and retention of such third party providers and local agents, they will not be responsible for any errors or omissions made by them in providing the relevant information or services.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the Depositary or in connection with any matter arising wholly after the removal or resignation of the Depositary.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">By holding an ADS or an interest therein, Holders and Beneficial Owners each irrevocably agree that any legal suit, action or proceeding against or involving the Depositary, arising out of or based upon the Deposit Agreement, the ADSs or the transactions contemplated herein, therein or hereby, may only be instituted in a state or federal court in New York, New York, and by holding an ADS or an interest therein each irrevocably waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Company has agreed to indemnify the Depositary and its agents under certain circumstances and the Depositary has agreed to indemnify the Company under certain circumstances.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Depositary shall not be liable to Holders or Beneficial Owners for any indirect, special, punitive or consequential damages (including, without limitation, legal fees and expenses) or lost profits, in each case of any form incurred by any person or entity (including, without limitation, Holders and Beneficial Owners), whether or not foreseeable and regardless of the type of action in which such a claim may be brought.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">C. Debt Securities </font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Each series of debt securities listed on the New York Stock Exchange and set forth on the cover page to GSK&#8217;s annual report on Form 20-F for the year ended December 31, 2023 has been issued by either GlaxoSmithKline Capital Inc. (&#8220;GSK Capital Inc.&#8221;) or GlaxoSmithKline Capital plc (&#8220;GSK Capital plc&#8221;) and guaranteed by GSK. Each of these series of notes and related guarantees were issued pursuant to an effective registration statement and a related prospectus and prospectus supplement setting forth the terms of the relevant series of notes and related guarantees.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The following table sets forth the name of the series, interest rate, dates of the registration statements, dates of the base prospectuses and dates of issuance for each relevant series of notes (the &#8220;Notes&#8221;).</font></div><div style="margin-bottom:12pt;padding-right:25.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Series &#47; Interest Rate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Registration Statement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Date of Base Prospectus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Date of Issuance</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">3.375% Notes due 2029</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">333-223982</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 28, 2018</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 25, 2019</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">3.625% Notes due 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">333-223982</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 28, 2018</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">May 15, 2018</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">3.875% Notes due 2028</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">333-223982</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 28, 2018</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">May 15, 2018</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">4.200% Notes due 2043</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">333-172621</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 4, 2011</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 18, 2013</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">6.375% Notes due 2038</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">333-149531</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">March 4, 2008</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">May 13, 2008</font></td></tr></table></div><div style="margin-bottom:5.5pt;padding-right:25.3pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Pursuant to an Agreement of Resignation, Appointment and Acceptance dated April 12, 2017 by and among GSK Capital plc, Law Debenture Trust Company of New York and Deutsche Bank Trust Company Americas, Deutsche Bank Trust Company Americas has become the successor trustee to Law Debenture Trust Company of New York under the indenture dated as of April 6, 2004 among GSK, GSK Capital plc and Law Debenture Trust Company of New York, as amended and supplemented.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Pursuant to an Agreement of Resignation, Appointment and Acceptance dated April 12, 2017 by and among GSK Capital Inc., Law Debenture Trust Company of New York and Deutsche Bank Trust Company Americas, Deutsche Bank Trust Company Americas has become the successor trustee to Law Debenture Trust Company of New York under the indenture dated as of April 6, 2004 among GSK, GSK Capital Inc. and Law Debenture Trust Company of New York, as amended and supplemented.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The paying agent under the indentures governing the Notes is the trustee under the relevant indenture. The address of the trustee and paying agent in relation to the Notes is 60 Wall Street, 16th Floor, New York, NY 10005.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:139%">The summary set out below of the general terms and provisions of the Notes does not purport to be complete and is subject to and qualified by reference to, all of the definitions and provisions of the relevant indenture governing the applicable series of Notes, any supplement to the relevant indenture and the form of the instrument representing each series of Notes. Certain terms, unless otherwise defined herein, have the meaning given to them in the relevant indenture governing the applicable series of Notes.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">1. Notes offered pursuant to the Base Prospectus dated March 28, 2018 </font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">a. Prospectus Supplement (March 19, 2019) &#8211; 3.375% Notes due 2029</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of the Notes</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK Capital plc issued the 3.375% Notes due 2029 (the &#8220;2029 Notes&#8221;) pursuant to an indenture, dated as of April 6, 2004, among GSK, as guarantor, GSK Capital plc, as issuer, and Deutsche Bank Trust Company Americas, as trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017, among GSK Capital plc, Law Debenture Trust Company of New York and Deutsche Bank Trust Company Americas), as amended and supplemented by a first supplemental indenture, dated as of March 21, 2014 and as further amended and supplemented by a second supplemental indenture dated as of May 15, 2018 (for purposes of this description of the 2029 Notes only, the &#8220;Indenture&#8221;). References in this &#8220;Description of the Notes&#8221; to the &#8220;Notes&#8221; refer to the 2029 Notes.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK Capital plc issued the 2029 Notes in the initial aggregate principal amount of 1,000,000,000. The 2029 Notes will mature on June 1, 2029 unless redeemed or purchased prior to such date as described below.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Notes are fully and unconditionally guaranteed by GSK. If, for any reason, GSK Capital plc does not make any required payment in respect of the Notes when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. You will be entitled to payment under the guarantee of GSK without taking any action whatsoever against us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK Capital plc issued the Notes in book-entry form only, in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As used herein, &#8220;business day&#8221; means any day other than a Saturday, a Sunday or a day on which banking institutions in the City of New York or London, England are authorized or obligated by law, regulation or executive order to be closed.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We or any of our subsidiaries may at any time and from time to time purchase the Notes of any series in the open market or by tender or by private agreement, if applicable law allows. The Notes of any such series purchased by us or any of our subsidiaries may be held, resold or surrendered by the purchaser thereof through us to the trustee or any paying agent for cancellation.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Interest</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Notes each bear interest at the applicable interest rate shown in the table above and accrue interest from March 25, 2019, or from the most recent date to which interest has been paid (or provided for), to but not including the next date upon which interest is required to be paid.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Interest is payable on each of the 2029 Notes twice a year, on June 1 and December 1, commencing December 1, 2019, to the person in whose name a 2029 Note, respectively, is registered at the close of business on the May 17 or November 16th that precedes the date on which interest will be paid. Interest on the 2029 Notes will be paid on the basis of a 360-day year consisting of twelve 30-day months.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an interest payment date or redemption date, or the maturity date, for the Notes, as the case may be, would fall on a day that is not a business day, then the required payment will be made on the next succeeding business day, but no additional interest shall be paid unless we fail to make payment on such next succeeding business day.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Subject to certain exceptions, if we are required to withhold or deduct any amount for or on account of any U.K. or U.S. withholding tax from any payment made on the Notes, we will pay additional amounts on those payments so that the amount received by noteholders will equal the amount that would have been received if no such taxes had been applicable. See &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As contemplated by the last paragraph under &#8220;Description of Debt Securities&#8212;Defeasance&#8221; below, the satisfaction of certain conditions will permit us to omit to comply with some or all of our obligations, covenants and agreements under the Indenture with respect to the Notes of any or all series, as applicable. In addition, we may omit to comply with certain covenants through covenant defeasance. We refer you to the information under &#8220;Description of Debt Securities&#8212;Defeasance&#8221; below for more information on how we may do this.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Except as described herein, the Indenture does not contain any covenants or other provisions designed to protect holders of the Notes against a reduction in our creditworthiness in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the Notes, including, among other things, through the incurrence of additional indebtedness.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Payment of Additional Amounts</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The provisions of the Indenture described under &#8220;Description of Debt Securities&#8212;Covenants&#8212;Payment of Additional Amounts&#8221; do not apply to the Notes. The following payment of additional amounts provisions apply to the Notes. </font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments made by us under or with respect to the Notes will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of (i) the government of the United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or (ii) the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as &#8220;Taxes,&#8221; unless we are required to withhold or deduct Taxes by law.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the Notes, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted&#59; provided that no additional amounts will be payable with respect to Taxes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the applicable Notes (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or the United States or any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges,</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">payable other than by withholding from payments of principal of or premium, if any, or interest on the applicable Notes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the presentation of the applicable Notes (where presentation is required) for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed if presentation for payment of the applicable Notes had been made to a paying agent other than the paying agent to which the presentation was made&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed solely by reason of the holder or beneficial owner owning or having owned, actually or constructively, 10% or more of the total combined voting power of all classes of our stock entitled to vote&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for a failure by the holder or beneficial owner (or any financial institution through which the holder or beneficial owner holds any security through which payment on the security is made) to comply with any certification, information, identification, documentation or other reporting requirements (including entering into and complying with an agreement with the U.S. Internal Revenue Service) imposed pursuant to Sections 1471 through 1474 of the U.S. Internal Revenue Code as in effect on the date of issuance of the applicable Notes or any successor or amended version of such provisions&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any combination of the foregoing items&#59;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">nor shall additional amounts be paid with respect to any payment of the principal of or premium, if any, or interest on any Notes to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of such Notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in the Indenture that at least one paying agent for the Notes will be located outside the United Kingdom.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligation to pay additional amounts if and when due will survive the termination of the Indenture and the payment of all amounts in respect of the Notes.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Tax Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In the event of changes in U.K. or U.S. withholding taxes applicable to payments of interest, we may redeem the Notes of a series in whole (but not in part) at any time prior to maturity, at a price equal to 100% of their principal amount plus accrued interest to the redemption date. See &#8220;Description of Debt Securities&#8212;Optional Redemption for Tax Reasons&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Make-Whole Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Prior to March 1, 2029 (the date that is three months prior to the scheduled maturity date for the 2029 Notes) (the &#8220;2029 Notes Par Call Date&#8221;), we may redeem the 2029 Notes, in whole or in part, at our option at any time and from time to time at a redemption price equal to the greater of (i) 100% of the principal amount of the 2029 Notes to be redeemed on that redemption date&#59; and (ii) as determined by the quotation agent (as defined below), the sum of the present values of the remaining scheduled payments of principal of and interest on the 2029 Notes to be redeemed on that redemption date (not including any portion of such payments of interest accrued as of the redemption date) that would be due if the 2029 Notes matured on the 2029 Notes Par Call Date, discounted to the redemption date on a semi-annual basis (assuming a 360 day year consisting of twelve 30 day months) at the Treasury Rate plus 0.150%, plus accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the 2029 Notes Par Call Date, we may redeem the 2029 Notes, in whole or in part, at our option at any time and from time to time at a redemption price equal to 100% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest, if any, thereon to, but excluding, the redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The 2029 Notes Par Call Date is referred to herein as a &#8220;Par Call Date.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notwithstanding the foregoing, installments of interest on the Notes to be redeemed that are due and payable on an interest payment date falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date according to the Notes and the Indenture, as applicable.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Issue&#8221; means the United States Treasury security selected by the quotation agent as having a maturity comparable to the remaining term of the Notes of the applicable series to be redeemed, assuming such Notes matured on the applicable Par Call Date, that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes, assuming such Notes matured on the applicable Par Call Date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the quotation agent for the Notes obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, the quotation.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Quotation agent&#8221; means any Reference Treasury Dealer appointed by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer&#8221; means (i) each of Deutsche Bank Securities Inc., Goldman Sachs &#38; Co. LLC, HSBC Securities (USA) Inc. and Merrill Lynch, Pierce, Fenner &#38; Smith Incorporated (or their respective affiliates that are Primary Treasury Dealers) and their respective successors&#59; provided, however, that if any of the foregoing shall cease to be a primary U.S. government securities dealer in the United States (a &#8220;Primary Treasury Dealer&#8221;), we will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer Quotations&#8221; means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by us, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the quotation agent by such Reference Treasury Dealer at 5&#58;00 p.m., New York City time, on the third business day preceding such redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Treasury Rate&#8221; means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notice of any redemption will be mailed at least 15 days but not more than 60 days before the redemption date to each registered holder of the Notes of the applicable series to be redeemed by us or by the trustee on our behalf. Notice of redemption will be published in a daily newspaper of general circulation in the United States, and we will give notice of any such redemption to any exchange on which such Notes are listed. On and after any redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. On or before the redemption date, we will deposit with a paying agent (or the trustee) money sufficient to pay the redemption price of and accrued interest on the Notes to be redeemed on that date. If less than all of the Notes of the applicable series are to be redeemed, the Notes to be redeemed shall be selected by lot by The Depository Trust Company (&#8220;DTC&#8221;), in the case of Notes represented by a global security, or by the trustee by such method as the trustee deems to be fair and appropriate, in the case of Notes that are not represented by a global security.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Events of Default</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The events of default under the Indenture, as applicable, with respect to the Notes are defined under &#8220;Description of Debt Securities&#8212;Events of Default&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Further Issuances</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We initially offered the 2029 Notes in the aggregate principal amount of $1,000,000,0000. We may from time to time, without the consent of the holders of a series of Notes, create and issue further debt securities of the same series having the same terms and conditions in all respects as the applicable Notes being offered hereby, except for the issue date, the issue price and the first payment of interest thereon. Any such additional debt securities shall be issued under a separate CUSIP or ISIN number unless the additional debt securities are issued pursuant to a &#8220;qualified reopening&#8221; of the original series, are otherwise treated as part of the same &#8220;issue&#8221; of debt instruments as the original series or are issued with no more than a de minimis amount of original discount, in each case for U.S. federal income tax purposes.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We issued the Notes in the form of one or more fully registered global securities. We deposited these global securities with, or on behalf of, DTC and register these securities in the name of DTC&#8217;s nominee. Direct and indirect participants in DTC will record beneficial ownership of the Notes </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">by individual investors. The transfer of ownership of beneficial interests in a global security will be effected only through records maintained by DTC or its nominee, or by participants or persons that hold through participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Investors may elect to hold beneficial interests in the global securities through either DTC, Clearstream Banking S.A. (&#8220;Clearstream&#8221;) or Euroclear Bank SA&#47;NV (&#8220;Euroclear&#8221;) if they are participants in these systems, or indirectly through organizations which are participants in these systems. Beneficial interests in the global securities will be held in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Upon receipt of any payment in respect of a global security, DTC or its nominee will immediately credit participants&#8217; accounts with amounts proportionate to their respective beneficial interests in the principal amount of the global security as shown in the records of DTC or its nominee.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments by participants to owners of beneficial interests in a global security held through participants will be governed by standing instructions and customary practices and will be the responsibility of those participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC holds securities of institutions that have accounts with it or its participants. Through its maintenance of an electronic book-entry system, DTC facilitates the clearance and settlement of securities transactions among its participants and eliminates the need to deliver securities certificates physically. DTC&#8217;s participants include securities brokers and dealers, including the underwriters of this offering, banks, trust companies, clearing corporations and other organizations. DTC is partially owned by some of these participants or their representatives. Access to DTC&#8217;s book-entry system is also available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly. DTC agrees with and represents to its participants that it will administer its book-entry system in accordance with its rules and bylaws and requirements of law. The rules applicable to DTC and its participants are on file with the U.S. Securities and Exchange Commission&#8217;s (the &#8220;Commission&#8221;).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream and Euroclear hold interests on behalf of their participants through customers&#8217; securities accounts in Clearstream&#8217;s and Euroclear&#8217;s names on the books of their respective depositaries, which in turn will hold interests in customers&#8217; securities accounts in the depositaries&#8217; names on the books of DTC. At the date of the prospectus supplement, Citibank, N.A. acts as U.S. depositary for Clearstream and JPMorgan Chase Bank, N.A. acts as</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">U.S. depositary for Euroclear, or, collectively, the &#8220;U.S. Depositaries.&#8221; </font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream holds securities for its participating organizations, or &#8220;Clearstream Participants,&#8221; and facilitates the clearance and settlement of securities transactions between Clearstream Participants through electronic book-entry changes in accounts of Clearstream Participants, thereby eliminating the need for physical movement of certificates. Clearstream provides to Clearstream Participants, among other things, services for safekeeping, administration, clearance and settlement of internationally traded securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream is registered as a bank in Luxembourg and as such is subject to regulation by the Commission de Surveillance du Secteur Financier and the Banque Centrale du Luxembourg, which supervise and oversee the activities of Luxembourg banks. Clearstream Participants are worldwide financial institutions, including underwriters, securities brokers and dealers, banks, trust companies and clearing corporations, and may include the underwriters or their affiliates. Indirect access to Clearstream is available to other institutions that clear through or maintain a custodial relationship with a Clearstream Participant. Clearstream has established an electronic bridge with Euroclear as the operator of the Euroclear System, or the &#8220;Euroclear Operator,&#8221; in Brussels to facilitate settlement of trades between Clearstream and the Euroclear Operator.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to the Notes of a series held beneficially through Clearstream will be credited to cash accounts of Clearstream Participants in accordance with its rules and procedures, to the extent received by the U.S. Depositary for Clearstream.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear holds securities and book-entry interests in securities for participating organizations, or &#8220;Euroclear Participants&#8221; and facilitates the clearance and settlement of securities transactions between Euroclear Participants, and between Euroclear Participants and participants of certain other securities intermediaries through electronic book-entry changes in accounts of such participants or other securities intermediaries. Euroclear provides Euroclear Participants with, among other things, safekeeping, administration, clearance and settlement, securities lending and borrowing, and related services.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear Participants are investment banks, securities brokers and dealers, banks, central banks, supranationals, custodians, investment managers, corporations, trust companies and certain other organizations and may include the underwriters or their affiliates. Non-participants in Euroclear may hold and transfer beneficial interests in a global security through accounts with a Euroclear Participant or any other securities intermediary that holds a book-entry interest in a global security through one or more securities intermediaries standing between such other securities intermediary and Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to Notes of a series held beneficially through Euroclear will be credited to the cash accounts of Euroclear Participants in accordance with the Terms and Conditions, to the extent received by the U.S. Depositary for Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers between Euroclear Participants and Clearstream Participants will be effected in the ordinary way in accordance with their respective rules and operating procedures.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Cross-market transfers between DTC&#8217;s participating organizations, or the &#8220;DTC Participants,&#8221; on the one hand, and Euroclear Participants or Clearstream Participants, on the other hand, will be effected through DTC in accordance with DTC&#8217;s rules on behalf of Euroclear or Clearstream, as the case may be, by its U.S. Depositary&#59; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. Depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the global security in DTC, and making or receiving payment in accordance with normal procedures for same-day fund settlement applicable to DTC. Euroclear Participants and Clearstream Participants may not deliver instructions directly to their respective U.S. Depositaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Due to time zone differences, the securities accounts of a Euroclear Participant or Clearstream Participant purchasing an interest in a global security from a DTC Participant in DTC will be credited, and any such crediting will be reported, to the relevant Euroclear Participant or Clearstream Participant during the securities settlement processing day (which must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a Euroclear Participant or Clearstream Participant to a DTC Participant will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#8217;s settlement date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The information in this section concerning DTC, Euroclear and Clearstream and their book-entry systems has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy or completeness of that information.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">None of us, any of the underwriters and the trustee will have any responsibility for the performance by DTC, Euroclear or Clearstream or their respective participants of their respective obligations under the rules and procedures governing their operations. </font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Although DTC, Clearstream and Euroclear have agreed to the foregoing procedures in order to facilitate transfers of securities among participants of DTC, Clearstream and Euroclear, they are under no obligations to perform or continue to perform such procedures and they may discontinue the procedures at any time.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Same-Day Settlement and Payment</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Initial settlement for the Notes was made in immediately available funds. Secondary market trading between DTC participants will occur in the ordinary way in accordance with DTC rules and will be settled in immediately available funds using DTC&#8217;s Same-Day Funds Settlement System.</font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">b. Prospectus Supplement (May 10, 2018) &#8211;3.625% Notes due 2025 and 3.875% Notes due 2028</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of the Notes</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK Capital Inc. issued the 3.625% Notes due 2025 (&#8220;2025 Notes&#8221;) and the 3.875% Notes due 2028 (&#8220;2028 Notes&#8221;) pursuant to an indenture, dated as of April 6, 2004, among GSK, as guarantor, GSK Capital Inc., as issuer, and Deutsche Bank Trust Company Americas, as trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017, among GSK Capital Inc., Law Debenture Trust Company of New York and Deutsche Bank Trust Company Americas), as amended and supplemented by a first supplemental indenture, dated as of March 18, 2013, as further amended and supplemented by a second supplemental indenture dated as of March 21, 2014 and as further amended and supplemented by a third supplemental indenture which was entered into on May 15, 2018 (for purposes of this description of the 2025 Notes and the 2028 Notes only, the &#8220;GSK Capital Inc. Indenture&#8221;).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK Capital Inc. issued the 2025 Notes in the initial aggregate principal amount of $1,000,000,000. The 2025 Notes will mature on May 15, 2025 unless redeemed or purchased prior to such date as described below. GSK Capital Inc. issued the 2028 Notes in the initial aggregate principal amount of $1,750,000,000. The 2028 Notes will mature on May 15, 2028 unless redeemed or purchased prior to such date as described below.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">References in this &#8220;Description of the Notes&#8221; to the &#8220;Notes&#8221; refer to the 2025 Notes and the 2028 Notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Notes are fully and unconditionally guaranteed by GSK. If, for any reason, GSK Capital Inc does not make any required payment in respect of the Notes when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. You will be entitled to payment under the guarantee of GSK without taking any action whatsoever against us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">GSK Capital Inc. issued the Notes in book-entry form only, in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Business day&#8221; means any day other than a Saturday, a Sunday or a day on which banking institutions in the City of New York or London,</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">England are authorized or obligated by law, regulation or executive order to be closed.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We or any of our subsidiaries may at any time and from time to time purchase the Notes of any series in the open market or by tender or by private agreement, if applicable law allows. The Notes of any such series purchased by us or any of our subsidiaries may be held, resold or surrendered by the purchaser thereof through us to the trustee or any paying agent for cancellation.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Interest</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The Notes each bear interest at the applicable interest rate shown in the table above and accrue interest from May 15, 2018, or from the most recent date to which interest has been paid (or provided for), to but not including the next date upon which interest is required to be paid.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Interest is payable on each of the 2025 Notes and the 2028 Notes twice a year, on May 15 and November 15, commencing November 15, 2018, to the person in whose name a 2025 Note, or a 2028 Note, respectively, is registered at the close of business on the April 30 or October 31 that precedes the date on which interest will be paid. Interest on the Notes is paid on the basis of a 360-day year consisting of twelve 30-day months.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an interest payment date or redemption date, or the maturity date, for any series of Notes, as the case may be, would fall on a day that is not a business day, then the required payment will be made on the next succeeding business day, but no additional interest shall be paid unless we fail to make payment on such next succeeding business day. </font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Subject to certain exceptions, if we are required to withhold or deduct any amount for or on account of any U.K. or U.S. withholding tax from any payment made on the Notes, we will pay additional amounts on those payments so that the amount received by noteholders will equal the amount that would have been received if no such taxes had been applicable. See &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As contemplated by the last paragraph under &#8220;Description of Debt Securities&#8212;Defeasance&#8221; below, the satisfaction of certain conditions will permit us to omit to comply with some or all of our obligations, covenants and agreements under the GSK Capital Inc. Indenture with respect to the Notes of any or all series, as applicable. In addition, we may omit to comply with certain covenants through covenant defeasance. We refer you to the information under &#8220;Description of Debt Securities&#8212;Defeasance&#8221; below for more information on how we may do this.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Except as described herein, the GSK Capital Inc. Indenture does not contain any covenants or other provisions designed to protect holders of the Notes against a reduction in our creditworthiness in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the Notes, including, among other things, through the incurrence of additional indebtedness.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Payment of Additional Amounts</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The provisions of the GSK Capital Inc. Indenture described under &#8220;Description of Debt Securities&#8212;Covenants&#8212;Payment of Additional Amounts&#8221; below do not apply to the Notes. The following payment of additional amounts provisions apply to the Notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments made by us under or with respect to the Notes will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of (i) the government of the United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or (ii) the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as &#8220;Taxes,&#8221; unless we are required to withhold or deduct Taxes by law.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the Notes, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted&#59; provided that no additional amounts will be payable with respect to Taxes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the applicable Notes (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or the United States or any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein&#59;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">payable other than by withholding from payments of principal of or premium, if any, or interest on the applicable Notes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the presentation of the applicable Notes (where presentation is required) for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed if presentation for payment of the applicable Notes had been made to a paying agent other than the paying agent to which the presentation was made&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed solely by reason of the holder or beneficial owner owning or having owned, actually or constructively, 10% or more of the total combined voting power of all classes of our stock entitled to vote&#59; </font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for a failure by the holder or beneficial owner (or any financial institution through which the holder or beneficial owner holds any security through which payment on the security is made) to comply with any certification, information, identification, documentation or other reporting requirements (including entering into and complying with an agreement with the U.S. Internal Revenue Service) imposed pursuant to Sections 1471 through 1474 of the U.S. Internal Revenue Code as in effect on the date of issuance of the applicable Notes or any successor or amended version of such provisions&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any combination of the foregoing items&#59;</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">nor shall additional amounts be paid with respect to any payment of the principal of or premium, if any, or interest on any Notes to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of such Notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in the GSK Capital Inc. Indenture that at least one paying agent for the Notes will be located outside the United Kingdom.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligation to pay additional amounts if and when due will survive the termination of the GSK Capital Inc. Indenture and the payment of all amounts in respect of the Notes.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Tax Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In the event of changes in U.K. or U.S. withholding taxes applicable to payments of interest, we may redeem the Notes of a series in whole (but not in part) at any time prior to maturity, at a price equal to 100% of their principal amount plus accrued interest to the redemption date. See &#8220;Description of Debt Securities&#8212;Optional Redemption for Tax Reasons&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Make-Whole Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may redeem the 2025 Notes and&#47;or the 2028 Notes in whole or in part, at our option at any time and from time to time, prior to maturity, at a redemption price equal to the greater of (i) 100% of the principal amount of the Notes of the applicable series to be redeemed on that redemption date&#59; and (ii) as determined by the quotation agent (as defined below), the sum of the present values of the remaining scheduled payments of principal of and interest on the Notes of the applicable series being redeemed on that redemption date (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360 day year consisting of twelve 30 day months) at the Treasury Rate, plus 0.150% in the case of the 2025 Notes, and 0.150% in the case of the 2028 Notes, plus, in each case, accrued and unpaid interest thereon to, but excluding, the date of redemption. Notwithstanding the foregoing, installments of interest on the Notes to be redeemed that are due and payable on an interest payment date falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date according to the Notes and the GSK Capital Inc. Indenture.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Issue&#8221; means the United States Treasury security selected by the quotation agent as having a maturity comparable to the remaining term (as measured from the date of redemption) of the Notes of the applicable series to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the quotation agent for the Notes obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, the quotation.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Quotation agent&#8221; means any Reference Treasury Dealer appointed by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer&#8221; means (i) each of Citigroup Global Markets Inc., Goldman Sachs &#38; Co. LLC, J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner &#38; Smith Incorporated (or their respective affiliates that are Primary Treasury Dealers) and their respective successors&#59; provided, however, that if any of the foregoing shall cease to be a primary U.S. government securities dealer in the United States (a &#8220;Primary Treasury Dealer&#8221;), we will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer Quotations&#8221; means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by us, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the quotation agent by such Reference Treasury Dealer at 5&#58;00 p.m., New York City time, on the third business day preceding such redemption date. </font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Treasury Rate&#8221; means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notice of any redemption will be mailed at least 15 days but not more than 60 days before the redemption date to each registered holder of the Notes of the applicable series to be redeemed by us or by the trustee on our behalf. Notice of redemption will be published in a daily newspaper of general circulation in the United States, and we will give notice of any such redemption to any exchange on which such Notes are listed. On and after any redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. On or before the redemption date, we will deposit with a paying agent (or the trustee) money sufficient to pay the redemption price of and accrued interest on the Notes to be redeemed on that date. If less than all of the Notes of the applicable series are to be redeemed, the Notes to be redeemed shall be selected by lot by The Depository Trust Company (&#8220;DTC&#8221;), in the case of Notes represented by a global security, or by the trustee by such method as the trustee deems to be fair and appropriate, in the case of Notes that are not represented by a global security.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Events of Default</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The events of default under the GSK Capital Inc. Indenture with respect to the Notes are defined under &#8220;Description of Debt Securities&#8212;Events of Default&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Further Issuances</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We initially offered the 2025 Notes in the aggregate principal amount of $1,000,000,000 and the 2028 Notes in the aggregate principal amount of $1,750,000,000. We may from time to time, without the consent of the holders of a series of Notes, create and issue further debt securities of the same series having the same terms and conditions in all respects as the applicable Notes being offered hereby, except for the issue date, the issue price and the first payment of interest thereon. Any such additional debt securities shall be issued under a separate CUSIP or ISIN number unless the additional debt securities are issued pursuant to a &#8220;qualified reopening&#8221; of the original series, are otherwise treated as part of the same &#8220;issue&#8221; of debt instruments as the original series or are issued with no more than a de minimis amount of original discount, in each case for U.S. federal income tax purposes.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We issued the Notes of each series in the form of one or more fully registered global securities. We deposited these global securities with, or on behalf of, DTC and register these securities in the name of DTC&#8217;s nominee. Direct and indirect participants in DTC will record beneficial ownership of the Notes by individual investors. The transfer of ownership of beneficial interests in a global security will be effected only through records maintained by DTC or its nominee, or by participants or persons that hold through participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Investors may elect to hold beneficial interests in the global securities through either DTC, Clearstream Banking S.A. (&#8220;Clearstream&#8221;) or Euroclear Bank SA&#47;NV (&#8220;Euroclear&#8221;) if they are participants in these systems, or indirectly through organizations which are participants in these systems. Beneficial interests in the global securities will be held in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Upon receipt of any payment in respect of a global security, DTC or its nominee will immediately credit participants&#8217; accounts with amounts proportionate to their respective beneficial interests in the principal amount of the global security as shown in the records of DTC or its nominee.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments by participants to owners of beneficial interests in a global security held through participants will be governed by standing instructions and customary practices and will be the responsibility of those participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC holds securities of institutions that have accounts with it or its participants. Through its maintenance of an electronic book-entry system, DTC facilitates the clearance and settlement of securities transactions among its participants and eliminates the need to deliver securities certificates physically. DTC&#8217;s participants include securities brokers and dealers, including the underwriters of this offering, banks, trust companies, clearing corporations and other organizations. DTC is partially owned by some of these participants or their representatives. Access to DTC&#8217;s book-entry system is also available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly. DTC agrees with and represents to its participants that it will administer its book-entry system in accordance with its rules and bylaws and requirements of law. The rules applicable to DTC and its participants are on file with the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream and Euroclear hold interests on behalf of their participants through customers&#8217; securities accounts in Clearstream&#8217;s and Euroclear&#8217;s names on the books of their respective depositaries, which in turn will hold interests in customers&#8217; securities accounts in the depositaries&#8217; names on the books of DTC. At the date of the prospectus supplement, Citibank, N.A. acts as U.S. depositary for Clearstream and JPMorgan Chase Bank, N.A. acts as</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">U.S. depositary for Euroclear, or, collectively, the &#8220;U.S. Depositaries.&#8221; </font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream holds securities for its participating organizations, or &#8220;Clearstream Participants,&#8221; and facilitates the clearance and settlement of securities transactions between Clearstream Participants through electronic book-entry changes in accounts of Clearstream Participants, thereby eliminating the need for physical movement of certificates. Clearstream provides to Clearstream Participants, among other things, services for safekeeping, administration, clearance and settlement of internationally traded securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream is registered as a bank in Luxembourg and as such is subject to regulation by the Commission de Surveillance du Secteur Financier and the Banque Centrale du Luxembourg, which supervise and oversee the activities of Luxembourg banks. Clearstream Participants are worldwide financial institutions, including underwriters, securities brokers and dealers, banks, trust companies and clearing corporations, and may include the underwriters or their affiliates. Indirect access to Clearstream is available to other institutions that clear through or maintain a custodial relationship with a Clearstream Participant. Clearstream has established an electronic bridge with Euroclear as the operator of the Euroclear System, or the &#8220;Euroclear Operator,&#8221; in Brussels to facilitate settlement of trades between Clearstream and the Euroclear Operator.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to the Notes of a series held beneficially through Clearstream will be credited to cash accounts of Clearstream Participants in accordance with its rules and procedures, to the extent received by the U.S. Depositary for Clearstream.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear holds securities and book-entry interests in securities for participating organizations, or &#8220;Euroclear Participants&#8221; and facilitates the clearance and settlement of securities transactions between Euroclear Participants, and between Euroclear Participants and participants of certain other securities intermediaries through electronic book-entry changes in accounts of such participants or other securities intermediaries. Euroclear provides Euroclear Participants with, among other things, safekeeping, administration, clearance and settlement, securities lending and borrowing, and related services.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear Participants are investment banks, securities brokers and dealers, banks, central banks, supranationals, custodians, investment managers, corporations, trust companies and certain other organizations and may include the underwriters or their affiliates. Non-participants in Euroclear may hold and transfer beneficial interests in a global security through accounts with a Euroclear Participant or any other securities intermediary that holds a book-entry interest in a global security through one or more securities intermediaries standing between such other securities intermediary and Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to Notes of a series held beneficially through Euroclear will be credited to the cash accounts of Euroclear Participants in accordance with the Terms and Conditions, to the extent received by the U.S. Depositary for Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers between Euroclear Participants and Clearstream Participants will be effected in the ordinary way in accordance with their respective rules and operating procedures.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Cross-market transfers between DTC&#8217;s participating organizations, or the &#8220;DTC Participants,&#8221; on the one hand, and Euroclear Participants or Clearstream Participants, on the other hand, will be effected through DTC in accordance with DTC&#8217;s rules on behalf of Euroclear or Clearstream, as the case may be, by its U.S. Depositary&#59; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. Depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the global security in DTC, and making </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">or receiving payment in accordance with normal procedures for same-day fund settlement applicable to DTC. Euroclear Participants and Clearstream Participants may not deliver instructions directly to their respective U.S. Depositaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Due to time zone differences, the securities accounts of a Euroclear Participant or Clearstream Participant purchasing an interest in a global security from a DTC Participant in DTC will be credited, and any such crediting will be reported, to the relevant Euroclear Participant or Clearstream Participant during the securities settlement processing day (which must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a Euroclear Participant or Clearstream Participant to a DTC Participant will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#8217;s settlement date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The information in this section concerning DTC, Euroclear and Clearstream and their book-entry systems has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy or completeness of that information.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">None of us, any of the underwriters and the trustee will have any responsibility for the performance by DTC, Euroclear or Clearstream or their respective participants of their respective obligations under the rules and procedures governing their operations. </font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Although DTC, Clearstream and Euroclear have agreed to the foregoing procedures in order to facilitate transfers of securities among participants of DTC, Clearstream and Euroclear, they are under no obligation to perform or continue to perform such procedures and they may discontinue the procedures at any time.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Same-Day Settlement and Payment</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Initial settlement for the Notes was made in immediately available funds. Secondary market trading between DTC participants will occur in the ordinary way in accordance with DTC rules and will be settled in immediately available funds using DTC&#8217;s Same-Day Funds Settlement System.</font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">c. Base Prospectus &#8211; March 28, 2018</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of Debt Securities</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As used in this &#8220;Description of Debt Securities,&#8221; &#8220;debt securities&#8221; means the debentures, notes, bonds, guarantees and other evidences of indebtedness that GSK issues or that a finance subsidiary issues and GSK fully and unconditionally guarantees and, in each case, the trustee authenticates and delivers under the applicable indenture. The debt securities will be our direct unsecured obligations and will rank equally and ratably without preference among themselves and at least equally with all of our other unsecured and unsubordinated indebtedness.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities will be issued in one or more series under an indenture dated as of March 4, 2008 between GSK and Deutsche Bank Trust Company Americas, as trustee (the &#8220;trustee&#8221;) (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK, the trustee and Law Debenture Trust Company of New York), as supplemented by a first supplemental indenture dated as of March 21, 2014 between GSK and the trustee (for purposes of this &#8220;Description of Debt Securities,&#8221; the &#8220;GSK plc Indenture&#8221;), an indenture dated as of April 6, 2004 among GSK Capital plc, GSK, as guarantor, and the trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK Capital plc, the guarantor, the trustee and Law Debenture Trust Company of New York), as supplemented by a first supplemental indenture dated as of March 21, 2014 among GSK Capital plc, the guarantor and the trustee (for purposes of this &#8220;Description of Debt Securities,&#8221; the &#8220;GSK Capital plc Indenture&#8221;), or an indenture dated as of April 6, 2004 among GSK Capital Inc., the guarantor and the trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017, among GSK Capital Inc., the guarantor, the trustee and Law Debenture Trust Company of New York), as supplemented by a first supplemental indenture dated as of March 18, 2013 among GSK Capital Inc., the guarantor and the trustee and a second supplemental indenture dated as of March 21, 2014 among GSK Capital Inc., the guarantor and the trustee (for purposes of this &#8220;Description of Debt Securities,&#8221; the &#8220;GSK Capital Inc. Indenture&#8221;). Each of the GSK plc Indenture, the GSK Capital plc Indenture and the GSK Capital Inc. Indenture has been qualified under the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). In the following discussion, we sometimes refer to these indentures collectively as the &#8220;indentures.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">This &#8220;Description of Debt Securities&#8221; briefly outlines the provisions of the indentures and is qualified in its entirety by reference to the indentures. The terms of the indentures will include both those stated in the indentures and those made part of the indentures by the Trust Indenture Act.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures have been filed as exhibits to the registration statement of which the base prospectus forms a part, and you should read the indentures for provisions that may be important to you.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures do not contain any covenants or other provisions designed to protect holders of the debt securities against a reduction in the creditworthiness of GSK or the finance subsidiaries in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Issuances in Series</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures do not limit the amount of debt securities that may be issued. The debt securities may be issued in one or more series with the same or various maturities, at a price of 100% of their principal amount or at a premium or a discount. Not all debt securities of any one series need be issued at the same time, and, unless otherwise provided, any series may be reopened, without the consents of the holders of debt securities of that series, for issuances of additional debt securities of that series. Except in the limited circumstances described below under &#8220;&#8212;Covenants&#8212;Limitation on Liens,&#8221; the debt securities will not be secured by any property or assets of GSK, as issuer or guarantor, or the finance subsidiaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The terms of any authorized series of debt securities will be described in a prospectus supplement. These terms will include some or all of the following&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the title, aggregate principal amount and denominations of the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the date or dates on which principal will be payable&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the percentage of the principal amount at which the debt securities will be issued and whether the debt securities will be &#8220;original issue discount&#8221; securities for U.S. federal income tax purposes. If original issue discount debt securities are issued (generally, securities that are issued at a substantial discount below their principal amount), the special U.S. federal income tax and other considerations of a purchase of original issue discount debt securities will be described&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the rate or rates, which may be fixed or variable, at which the debt securities will bear interest&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the interest payment dates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any optional or mandatory redemption terms&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether any sinking fund is required&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the currency in which the debt securities will be denominated or principal, premium or interest will be payable, if other than U.S. dollars&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether the debt securities are to be issued as individual certificates to each holder or in the form of global certificates held by a depositary on behalf of beneficial owners&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">information describing any book-entry features&#59;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the names and duties of any co-trustees, depositaries, authenticating agents, paying agents, transfer agents or registrars for any series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the applicability of the defeasance and covenant defeasance provisions described herein, or any modifications of those provisions&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any deletions from, modifications of or additions to the events of default or covenants with respect to the debt securities&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any other terms, conditions, rights or preferences of the debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities that have a maturity of less than one year from their date of issue and in respect of which the proceeds are to be received by us in the United Kingdom will have a minimum denomination of &#163;100,000 (or its equivalent in another currency).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The prospectus supplement relating to any series of debt securities may add to or change statements contained in the base prospectus. The prospectus supplement may also include, if applicable, a discussion of certain U.S. federal income tax and U.K. income tax considerations.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">GSK Guarantees</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities issued by the GSK Capital Inc. or GSK Capital plc (the &#8220;finance subsidiaries&#8221;) will be fully and unconditionally guaranteed by GSK. If for any reason the applicable finance subsidiary does not make any required payment in respect of its debt securities when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. The holder of a guaranteed debt security will be entitled to payment under the applicable guarantee of GSK without taking any action whatsoever against the finance subsidiary.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Payment and Transfer</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities will be issued only as registered securities, which means that the name of the holder will be entered in a register that will be kept by the trustee or another agent appointed by us. Unless stated otherwise in a prospectus supplement, and except as described under &#8220;&#8212;Book-Entry System&#8221; below, payments of principal, interest and additional amounts, if any, will be made at the office of the paying agent or agents named in the prospectus supplement or by check mailed to you at your address as it appears in the register.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless other procedures are described in a prospectus supplement and except as described under &#8220;&#8212;Book Entry System&#8221; below, you will be able to transfer registered debt securities at the office of the transfer agent or agents named in the prospectus supplement. You may also exchange registered debt securities at the office of the transfer agent for an equal aggregate principal amount of registered debt securities of the same series having the same maturity date, interest rate and other terms as long as the debt securities are issued in authorized denominations.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Neither we nor the trustee will impose any service charge for any transfer or exchange of a debt security&#59; however, we may ask you to pay any taxes or other governmental charges in connection with a transfer or exchange of debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities may be issued under a book-entry system in the form of one or more global securities. The global securities will be registered in the name of a depositary or its nominee and deposited with that depositary or its custodian. Unless stated otherwise in the prospectus supplement, The Depository Trust Company, New York, New York, or DTC, will be the depositary if a depositary is used.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC has advised us as follows&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking organization&#8221; within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code and a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section 17A of the Exchange Act&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC was created to hold securities of its participants and to facilitate the clearance and settlement of securities transactions, such as through transfers and pledges, among its participants in such securities through electronic book-entry changes to accounts of its participants, thereby eliminating the need for physical movement of securities certificates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC&#8217;s participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations, some of whom (and&#47;or their representatives) own DTC&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">access to DTC&#8217;s book-entry system is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the DTC rules applicable to its participants are on file with U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">According to DTC, the foregoing information with respect to DTC has been provided to the financial community for informational purposes only and is not intended to serve as a representation, warranty or contract modification of any kind.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Following the issuance of a global security in registered form, the depositary will credit the accounts of its participants with the debt securities upon our instructions. Only persons who hold directly or indirectly through financial institutions that are participants in the depositary can hold beneficial interests in the global securities. Since the laws of some jurisdictions require certain types of purchasers to take physical delivery of such securities in definitive form, you may encounter difficulties in your ability to own, transfer or pledge beneficial interests in a global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">So long as the depositary or its nominee is the registered owner of a global security, we and the trustee will treat the depositary as the sole owner or holder of the debt securities for purposes of the applicable indenture. Therefore, except as set forth below, you will not be entitled to have debt securities registered in your name or to receive physical delivery of certificates representing the debt securities. Accordingly, you will have to rely on the procedures of the depositary and the participant in the depositary through whom you hold your beneficial interest in order to exercise any rights of a holder under the indenture. We understand that under existing practices, the depositary would act upon the instructions of a participant or authorize that participant to take any action that a holder is entitled to take.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We will make all payments of principal, interest and additional amounts, if any, on the debt securities to the depositary. It is expected that the depositary will then credit participants&#8217; accounts proportionately with these payments on the payment date and that the participants will in turn credit their customers&#8217; accounts in accordance with their customary practices. Neither we nor the trustee will be responsible for making any payments to participants or customers of participants or for maintaining any records relating to the holdings of or payments to participants and their customers, and you will have to rely on the procedures of the depositary and its participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Global securities are generally not transferable. Physical certificates will be issued to beneficial owners in lieu of a global security only in the special situations described in the sixth paragraph under the heading &#8220;Legal Ownership of Debt Securities&#8212;Global Securities&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Consolidation, Merger or Sale</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We and the finance subsidiaries have agreed in the indentures not to consolidate with or merge with or into any other person or convey or transfer all or substantially all of our respective properties and assets to any person (except that the finance subsidiaries may merge into us), unless&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we or the applicable finance subsidiary, as the case may be, are the continuing person, or the successor expressly assumes by supplemental indenture our obligations under the applicable indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the continuing person is a U.S. or U.K. company or is organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and, if it is not a U.S. or U.K. company, the continuing person agrees by supplemental indenture to be bound by a covenant comparable to that described below under &#8220;&#8212;Covenants&#8212; Payment of Additional Amounts&#8221; with respect to taxes imposed in the continuing person&#8217;s jurisdiction of organization (in which case the </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">continuing person will benefit from a redemption option comparable to that described below under &#8220;&#8212;Optional Redemption for Tax Reasons&#8221; in the event of changes in taxes in that jurisdiction after the date of the consolidation, merger or sale)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">immediately after the transaction, no default under the debt securities has occurred and is continuing&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we deliver to the trustee an officer&#8217;s certificate and, if neither we nor the applicable subsidiary are the continuing person, an opinion of counsel, in each case stating, among other things, that the transaction and the supplemental indenture, if required, comply with these provisions and the indenture.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Payment of Additional Amounts</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments made by us under or with respect to the debt securities will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of the government of the United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as &#8220;Taxes,&#8221; unless we are required to withhold or deduct Taxes by law.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the debt securities, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted&#59; provided that no additional amounts will be payable with respect to Taxes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the debt securities (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the United States or, as applicable, any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">payable other than by withholding from payments of principal of or interest on the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the presentation of a debt security (where presentation is required) for payment on a date more than30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed on a payment to an individual and are required to be made pursuant to European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, or any law implementing or complying with, or introduced in order to conform to, such Directive&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed if presentation for payment of the relevant debt securities had been made to a paying agent other than the paying agent to which the presentation was made&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for a failure by the holder or beneficial owner (or any financial institution through which the holder or beneficial owner holds any debt security through which payment on the debt security is made) to comply with any certification, information, identification, documentation or other reporting requirements (including entering into and complying with an agreement with the U.S. Internal Revenue Service or any other governmental authority) imposed pursuant to Sections 1471 through 1474 of the U.S. Internal Revenue Code as in effect on the date of issuance of the Notes or any successor or amended version of such provisions, or any agreement entered into pursuant to Section 1471(b) of the U.S. Internal Revenue Code, or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such Sections of the U.S. Internal Revenue Code (or any law implementing such intergovernmental agreement)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">solely with respect to debt securities issued under the GSK Capital Inc. Indenture, that are imposed solely by reason of the holder or beneficial owner owning or having owned, actually or constructively, 10% or more of the total combined voting power of all classes of the Company&#8217;s stock entitled to vote&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any combination of the foregoing items&#59;</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">nor shall additional amounts be paid with respect to any payment of the principal of or interest on any debt security to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of the debt security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in each indenture that at least one paying agent for each series of debt securities will be located outside the United Kingdom. We have also agreed that if we maintain a paying agent with respect to a particular series of debt securities in any member state of the European Union, we will maintain a paying agent in at least one member state (other than the United Kingdom) that will not be obliged to withhold or deduct taxes pursuant to any law implementing European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, provided there is at least one member state that does not require a paying agent to withhold or deduct pursuant to such Directive.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligation to pay additional amounts if and when due will survive the termination of the indentures and the payment of all amounts in respect of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Limitation on Liens</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in the indentures not to incur or assume (or permit any of our subsidiaries to incur or assume) any lien on or with respect to any of our or our subsidiaries&#8217; property, assets or revenues, present or future, to secure any relevant indebtedness (as this term is defined below) without making (or causing our subsidiaries to make) effective provision for securing the debt securities equally and ratably with such relevant indebtedness as to such property, assets or revenues, for as long as such relevant indebtedness is so secured.</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The restrictions on liens will not apply to&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens arising by operation of law&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens on property, assets or revenues of any person, which liens are existing at the time such person becomes a subsidiary&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens on property, assets or revenues of a person existing at the time such person is merged with or into or consolidated with us or any of our subsidiaries or at the time of a sale, lease or other disposition to us of the properties of a person as an entirety or substantially as an entirety.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">For purposes of the limitation on liens covenant, the term &#8220;relevant indebtedness&#8221; means any of our debt that&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">is in the form of or represented by bonds, notes, loan stock, depositary receipts or other securities issued (otherwise than to constitute or by banks or other lending institutions)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">is denominated in, or confers any right of payment by reference to, any currency other than the currency of the country in which the issuer of the indebtedness has its principal place of business, or is denominated in or by reference to the currency of such country but more than 20% of which is placed or offered for subscription or sale by or on behalf of, or by agreement with, the issuer outside such country&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">at its date of issue is, or is intended by the issuer to become, quoted, listed, traded or dealt in on any stock exchange, over-the-counter market or other securities market.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Additional Covenants</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may be subject to additional covenants, including restrictive covenants in respect of a particular series of debt securities. Such additional covenants will be set forth in the applicable prospectus supplement and, to the extent necessary, in the supplemental indenture or board resolution relating to that series of debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Redemption for Tax Reasons</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may redeem any series of debt securities in whole but not in part at any time, on giving not less than 30 nor more than 60 days&#8217; notice of such redemption, at a redemption price equal to the principal amount plus accrued interest, if any, to the date fixed for redemption (except in the case of discounted debt securities, which may be redeemed at the redemption price specified by the terms of each series of such debt securities), if&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we determine that, as a result of any change in or amendment to the laws or any regulations or rulings promulgated thereunder of the United Kingdom (or of any political subdivision or taxing authority thereof) or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the United States (or of any political subdivision or taxing authority thereof), or any change in the application or official interpretation of such laws, regulations or rulings, or any change in the application or official interpretation of, or any execution of or amendment to, any treaty or treaties affecting taxation to which any such jurisdiction is a party, which change, execution or amendment becomes effective on or after the issue date or such other date specified in the debt securities of that series&#58;</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we would be required to pay additional amounts (as described under &#8220;&#8212;Covenants&#8211;&#8211;Payment of Additional Amounts&#8221; above) with respect to that series of debt securities on the next succeeding interest payment date and the payment of such additional amounts cannot be avoided by the use of reasonable measures available to us&#59; or</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">withholding tax has been or would be required to be withheld with respect to interest income received or receivable by the applicable finance subsidiary directly from the guarantor (or any affiliate) and such withholding tax obligation cannot be avoided by the use of reasonable measures available to the applicable finance subsidiary or the guarantor (or any affiliate)&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we determine, based upon an opinion of independent counsel of recognized standing that, as a result of any action taken by any legislative body of, taxing authority of, or any action brought in a court of competent jurisdiction in, the United Kingdom (or any political subdivision or taxing authority thereof) or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the United States (or any political subdivision or taxing authority thereof) (whether or not such action was taken or brought with respect to GSK, as issuer or guarantor, or the applicable finance subsidiary, as the case may be), which action is taken or brought on or after the issue date or such other date specified in the debt securities of that series, there is a substantial probability that the circumstances described above would exist&#59; provided, however, that such notice of redemption may be given earlier than 90 days prior to the earliest date on which we would be obligated to pay such additional amounts.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We will also pay to each holder, or make available for payment to each such holder, on the redemption date any additional amounts resulting from the payment of such redemption price. Prior to the publication of any notice of redemption, we will deliver to the trustee&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an officer&#8217;s certificate stating that we are entitled to effect a redemption and setting forth a statement of facts showing that the conditions precedent of the right so to redeem have occurred&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an opinion of counsel to the effect that the conditions specified above have been satisfied. Any notice of redemption will be irrevocable once we deliver the officer&#8217;s certificate to the trustee.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Events of Default</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless otherwise specified in a prospectus supplement, an event of default with respect to a series of debt securities occurs upon&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of the principal (or premium, if any) of any debt security of that series when due (including as a sinking fund installment), and, in the case of technical or administrative difficulties, the continuance of that default for more than two business days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of interest on, or any additional amounts payable in respect of, any debt security of that series when due and payable, and the continuance of that default for 30 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in performing any other covenant in the indenture applicable to that series for 90 days after the receipt of written notice specifying such default from the trustee or from the holders of 25% in principal amount of the debt securities of that series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default under any bond, debenture, note or other evidence of indebtedness for money borrowed of GSK or either finance subsidiary, as the case may be (not including any indebtedness for which recourse is limited to property purchased), having in any particular case an outstanding principal amount in excess of &#163;100,000,000 (or its equivalent in any other currency) where any such failure results in such indebtedness being accelerated and becoming due and payable prior to its stated maturity and such acceleration shall not have been rescinded or annulled or such indebtedness shall not have been discharged&#59; provided that there shall not be deemed to be an Event of Default if such acceleration is rescinded or annulled or such payment is made within 10 days after there has been given to GSK and either finance subsidiary by the trustee or to either finance subsidiary, GSK and the trustee by the holders of 25% or more in aggregate principal amount of the debt securities of such series a written notice specifying such default and requiring it to be remedied and stating that such notice is a &#8220;Notice of Default&#8221; hereunder&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">certain events of bankruptcy, insolvency or reorganization of GSK or either finance subsidiary, as the case may be&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">&#9642;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:11.34pt">any other event of default provided with respect to that particular series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Any additional or different events of default applicable to a particular series of debt securities will be described in the prospectus supplement relating to such series.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">An event of default with respect to a particular series of debt securities will not necessarily constitute an event of default with respect to any other series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The trustee may withhold notice to the holders of debt securities of any default (except in the payment of principal, premium or interest) if it, in good faith considers such withholding of notice to be in the best interests of the holders. A default is any event which is an event of default described above or would be an event of default but for the giving of notice or the passage of time.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an event of default occurs and continues, the trustee or the holders of the aggregate principal amount of the debt securities specified below may require us to repay immediately, or accelerate&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the entire principal of the debt securities of such series&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">if the debt securities are original issue discount securities, such portion of the principal as may be described in the applicable prospectus supplement.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If the event of default occurs because of a default in a payment of principal or interest on the debt securities of any series, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of that series can accelerate that series of debt securities. If the event of default occurs because of a failure to perform any other covenant in the applicable indenture or any covenant for the benefit of one or more, but not all, of the series of debt securities, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of all series affected, voting as one class, can accelerate all of the affected series of debt securities. If the event of default occurs because of bankruptcy proceedings, then all of the debt securities under the indenture will be accelerated automatically. Therefore, except in the case of a default on a payment of principal or interest on the debt securities of your series or a default due to our bankruptcy or insolvency, it is possible that you may not be able to accelerate the debt securities of your series because of the failure of holders of other series to take action.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The holders of a majority of the aggregate principal amount of the debt securities of all affected series, voting as one class, can rescind this accelerated payment requirement or waive any past default or event of default or allow noncompliance with any provision of the applicable indenture. However, they cannot waive a default in payment of principal of, premium, if any, or interest on any of the debt securities when due otherwise than as a result of acceleration.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">After an event of default, the trustee must exercise the same degree of care a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee is not obligated to exercise any of its rights or powers under the applicable indenture at the request, order or direction of any holders, unless the holders offer the trustee indemnity satisfactory to it. If they provide this indemnity, the holders of a majority in principal amount of all affected series of debt securities, voting as one class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any power conferred upon the trustee, for any series of debt securities. However, the trustee may refuse to follow any direction that conflicts with law or the indenture or is unduly prejudicial to the rights of other holders.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">No holder will be entitled to pursue any remedy with respect to the indenture unless the trustee fails to act for 60 days after it is given&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">notice of default by that holder&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">a written request to enforce the indenture by the holders of not less than 25% in principal amount of all outstanding debt securities of any affected series&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an indemnity to the trustee, reasonably satisfactory to the trustee&#59;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">and during this 60-day period the holders of a majority in principal amount of all outstanding debt securities of such affected series do not give a direction to the trustee that is inconsistent with the enforcement request. These provisions will not prevent any holder of debt securities from enforcing payment of the principal of (and premium, if any) and interest on the debt securities at the relevant due dates.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an event of default with respect to a series of debt securities occurs and is continuing, the trustee will mail to the holders of those debt securities a notice of the event of default within 90 days after it occurs. However, except in the case of a default in any payment in respect of a series of debt securities, the trustee shall be protected in withholding notice of an event of default if it determines in good faith that this is in the interests of the holders of the relevant debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Modification of the Indentures</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In general, rights and obligations of us and the holders under the indentures may be modified if the holders of a majority in aggregate principal amount of the outstanding debt securities of each series affected by the modification consent to such modification. However, each of the indentures provides that, unless each affected holder agrees, an amendment cannot&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">make any adverse change to any payment term of a debt security such as extending the maturity date, extending the date on which we have to pay interest or make a sinking fund payment, reducing the interest rate, reducing the amount of principal we have to repay, changing the currency in which we have to make any payment of principal, premium or interest, modifying any redemption or repurchase right, or right to convert or exchange any debt security, to the detriment of the holder and impairing any right of a holder to bring suit for payment&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">waive any payment default&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">reduce the percentage of the aggregate principal amount of debt securities needed to make any amendment to the applicable indenture or to waive any covenant or default&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">make any other change to the amendment provisions of the applicable indenture.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">However, if we and the trustee agree, the applicable indenture may be amended without notifying any holders or seeking their consent if the amendment does not materially and adversely affect any holder. We and the trustee are permitted to make modifications and amendments to the applicable indenture without the consent of any holder of debt securities for any of the following purposes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to cure any ambiguity, defect or inconsistency in the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to comply with sections of the indenture governing when we may merge and substitute obligors&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to comply with any requirements of the U.S. Securities and Exchange Commission in connection with the qualification of the indenture under the Trust Indenture Act&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to evidence and provide for the acceptance by a successor trustee of appointment under the indenture with respect to the debt securities of any or all series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to establish the form or forms or terms of the debt securities of any series or of the coupons appertaining to such debt securities as permitted under the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to provide for uncertificated debt securities and to make all appropriate changes for such purpose&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to provide for a further guarantee from a third party on outstanding debt securities of any series and the debt securities of any series that may be issued under the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to change or eliminate any provision of the indenture&#59; provided that any such change or elimination will become effective only when there are no outstanding debt securities of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to supplement any of the provisions of the indenture to such extent as will be necessary to permit or facilitate the defeasance and discharge of any series of debt securities pursuant to the indenture&#59; provided that any such action will not adversely affect the interests of the holders of such or any other series of debt securities in any material respect&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to make any change that does not materially and adversely affect the rights of any holder of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Defeasance</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The term defeasance means discharge from some or all of the obligations under the indentures. If we deposit with the trustee sufficient cash or government securities to pay the principal, interest, any premium and any other sums due to the stated maturity date or a redemption date of the debt securities of a particular series, then at our option&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we will be discharged from our respective obligations with respect to the debt securities of such series&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we will no longer be under any obligation to comply with the restrictive covenants, if any, contained in the applicable indenture and any supplemental indenture or board resolution with respect to the debt securities of such series, and the events of default relating to failures to comply with covenants will no longer apply to us.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this happens, the holders of the debt securities of the affected series will not be entitled to the benefits of the applicable indenture except for registration of transfer and exchange of debt securities and replacement of lost, stolen or mutilated debt securities. Instead, the holders will only be able to rely on the deposited funds or obligations for payment.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We must deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the holders of the debt securities to recognize income, gain or loss for U.S. federal income tax purposes. We may, in lieu of an opinion of counsel, deliver a ruling to such effect received from or published by the U.S. Internal Revenue Service.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Substitution of Issuer</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may at our option at any time, without the consent of any holders of debt securities, cause GSK or any other subsidiary of GSK to assume the obligations of the applicable finance subsidiary under any series of debt securities, provided that the new obligor executes a supplemental indenture in which it agrees to be bound by the terms of those debt securities and the relevant indenture. If the new obligor is not a U.S. or U.K. company, it must be organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and it must also agree in the supplemental indenture to be bound by a covenant comparable to that described above under &#8220;&#8212; Covenants&#8212;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payment of Additional Amounts&#8221; with respect to taxes imposed in its jurisdiction of organization (in which case the new obligor will benefit from a redemption option comparable to that described above under &#8220;&#8212;Optional Redemption for Tax Reasons&#8221; in the event of changes in taxes in that jurisdiction after the date of the substitution). In the case of such a substitution, the applicable finance subsidiary will be relieved of any further obligation under the assumed series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">For U.S. federal income tax purposes, a substitution of obligors as described above generally would be treated as a deemed taxable exchange of debt securities for new debt securities issued by the new obligor. As discussed further in the applicable prospectus supplement, a United States person who holds debt securities or owns a beneficial interest therein generally will recognize capital gain or loss in an amount equal to the difference between the issue price of the new debt securities and such person&#8217;s adjusted tax basis in the debt securities. Such persons should consult their own tax advisors regarding the tax consequences of a deemed taxable exchange in the event of a substitution of obligors.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Information Concerning the Trustee</font></div><div style="margin-top:5.85pt;padding-left:6.65pt;padding-right:25.3pt;text-indent:33.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Deutsche Bank Trust Company Americas, 60 Wall Street, 16th Floor, New York, NY 10005, will be the trustee. The trustee will be required to perform only those duties that are specifically set forth in the indentures, except when a default has occurred and is continuing with respect to the debt </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">ecurities. After a default, the trustee must exercise the same degree of care that a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee will be under no obligation to exercise any of the powers vested in it by the indentures at the request of any holder of debt securities unless the holder offers the trustee indemnity satisfactory to it against the costs, expenses and liabilities that might be incurred by exercising those powers.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Governing Law</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities, the related guarantees and the indentures will be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Legal Ownership of Debt Securities</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">&#8220;Street Name&#8221; and Other Indirect Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We generally will not recognize investors who hold debt securities in accounts at banks or brokers as legal holders of those debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Holding securities in accounts at banks or brokers is called holding in &#8220;street name.&#8221; If an investor holds debt securities in street name, we recognize only the bank or broker or the financial institution the bank or broker uses to hold the debt securities. These intermediary banks, brokers and other financial institutions pass along principal, interest and other payments on the debt securities, either because they agree to do so in their customer agreements or because they are legally required to do so. If you hold debt securities in street name, you should check with your own institution to find out&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it handles payments and notices with respect to securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether it imposes fees or charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it would handle voting if ever required&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how and when you should notify it to exercise on your behalf any rights or options that may exist under the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether and how you can instruct it to send you securities registered in your own name so you can be a direct holder as described below&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it would pursue rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Registered Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligations, as well as the obligations of the trustee and those of any third parties employed by us or the trustee, extend only to persons who are registered as holders of debt securities. As noted above, we do not have obligations directly to you if you hold in street name or through other indirect means, either because you choose to hold debt securities in that manner or because the debt securities are issued in the form of global securities as described below. For example, once we make payment to the registered holder, we have no further responsibility for the payment even if that holder is legally required to pass the payment along to you but does not do so.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Global Securities</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">A global security is a special type of indirectly held security. If we choose to issue debt securities in the form of global securities, the ultimate beneficial owners of the debt securities will be indirect holders. We do this by requiring that the global security be registered in the name of a financial institution we select and by requiring that the debt securities represented by the global security not be registered in the name of any other holder except in the special situations described below. The financial institution that acts as the sole registered holder of the global security is called the depositary. Any person wishing to own a debt security may do so indirectly through an account with a broker, bank or other financial institution that in turn has an account with the depositary. The prospectus supplement will indicate whether your series of debt securities will be issued only as global securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers of debt securities represented by the global security will be made only on the records of the depositary or its nominee by transferring such debt securities from the account of one broker, bank or financial institution to the account of another broker, bank or financial institution. These transfers are made electronically only and are also known as book-entry transfers. Securities in global form are sometimes also referred to as being in book-entry form.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As an indirect holder, your rights relating to a global security will be governed by the account rules of your broker, bank or financial institution and of the depositary, as well as general laws relating to securities transfers. We will not recognize you as a holder of debt securities and instead will deal only with the depositary that holds the global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">You should be aware that if debt securities are issued only in the form of a global security&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">except in very limited circumstances described below, you will not have any right to have debt securities registered in your own name&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you cannot receive physical certificates for your interest in the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you will be a street name holder and must look to your own broker, bank or financial institution for payments on the debt securities and protection of your legal rights relating to the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own securities in the form of physical certificates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary&#8217;s policies will govern payments, transfers, exchanges and other matters relating to your indirect interest in the global security. We and the trustee will have no responsibility for any aspect of the depositary&#8217;s actions or for its records of ownership interests in the global security. We and the trustee also will not supervise the depositary in any way&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary will require that indirect interests in the global security be purchased or sold within its system using same-day funds for settlement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In a few special circumstances described below, the global security will terminate and the indirect interests in it will be exchanged for registered debt securities represented by physical certificates. After that exchange, the choice of whether to hold debt securities in registered form or in street name will be up to you. You must consult your broker, bank or financial institution to find out how to have your interests in debt securities transferred to your name, so that you will be a registered holder of the debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless we specify otherwise in the prospectus supplement, the special circumstances for termination of a global security are&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">when the depositary notifies us that it is unwilling or unable to continue as depositary and we do not or cannot appoint a successor depositary within 90 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary ceases to be a clearing agency registered under the Exchange Act and we do not appoint a successor depositary within 90 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an event of default has occurred and is continuing and beneficial owners representing a majority in principal amount of the applicable series of debt securities have advised the depositary to cease acting as the depositary&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we decide we do not want to have the debt securities of that series represented by a global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The prospectus supplement may also list additional circumstances for terminating a global security that would apply only to the particular series of debt securities covered by the prospectus supplement. When a global security terminates, the depositary (and not us or the trustee) is responsible for deciding the names of the institutions that will be the initial registered holders.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">The Term &#8220;Holder&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In the descriptions of the debt securities included herein, when we refer to the &#8220;holder&#8221; of a given debt security as being entitled to certain rights or payments, or being permitted to take certain actions, we are in all cases referring to the registered holder of the debt security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">While you would be the registered holder if you held a certificated security registered in your name, it is likely that the holder will actually be either the broker, bank or other financial institutions where you have your street name account, or, in the case of a global security, the depositary. If you are an indirect holder, you will need to coordinate with the institution through which you hold your interest in a debt security in order to determine how the provisions involving holders described in the descriptions of the debt securities included herein will actually apply to you. For example, if the debt security in which you hold a beneficial interest in street name can be repaid at the option of the holder, you cannot exercise the option yourself by following the procedures described in the prospectus supplement. Instead, you would need to cause the institution through which you hold your interest to take those actions on your behalf. Your institution may have procedures and deadlines different from or additional to those described in the prospectus supplement relating to the debt security.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">2. Notes offered pursuant to the Base Prospectus dated March 4, 2011 </font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">a. Prospectus Supplement (March 13, 2013) &#8211;4.200% Notes due 2043</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of the Notes</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We issued the 4.200% Notes due 2043 pursuant to an indenture, dated April 6, 2004, among GSK, as guarantor, GSK Capital Inc., as issuer,</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">and Law Debenture Trust Company of New York, the trustee for the notes (as successor to Citibank, N.A., pursuant to an Instrument of Resignation, Appointment and Acceptance dated December 27, 2007 among GSK Capital Inc., GSK, Law Debenture Trust Company of New York and Citibank, N.A.), as supplemented by a first supplemental indenture thereto dated March 18, 2013 (for purposes of this description of the notes only, the &#8220;indenture&#8221;).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">References in this &#8220;Description of the Notes&#8221; to the &#8220;notes&#8221; refer to the 4.200% Notes due 2043. The notes are each a series of our debt securities. GSK Capital Inc. issued the notes in the aggregate principal amount of $500,000,000. The notes will mature on March 18, 2043 unless redeemed or repurchased prior to such date as permitted below. GSK Capital Inc. issued the notes only in book-entry form, in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The notes each bear interest at the applicable interest rate shown in the table above and accrue interest from March 18, 2013, or from the most recent date to which interest has been paid (or provided for), to but not including the next date upon which interest is required to be paid.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Interest is payable on the notes twice a year, on March 18 and September 18, commencing September 18, 2013, to the person in whose name a note is registered at the close of business on the March 3 or September 3 that precedes the date on which interest will be paid. Interest on the notes is paid on the basis of a 360-day year consisting of twelve 30-day months. &#8220;Business day&#8221; means any day other than a Saturday, a Sunday or a day on which banking institutions in the City of New York or London, England are authorized or obligated by law, regulation or executive order to be closed.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an interest payment date or redemption date, or the maturity date, for the notes, as the case may be, would fall on a day that is not a business day, then the interest payment date or redemption date, or the maturity date, as the case may be, will be postponed to the next succeeding business day, but no additional interest shall be paid unless we fail to make payment on such next succeeding business day.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The notes are fully and unconditionally guaranteed by GSK. If, for any reason, GSK Capital Inc. does not make any required payment in respect of the notes when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. You will be entitled to payment under the guarantee of GSK without taking any action whatsoever against us.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Subject to certain exceptions, if we are required to withhold or deduct any amount for or on account of any U.K. or U.S. withholding tax from any payment made on the notes, we will pay additional amounts on those payments so that the amount received by noteholders will equal the amount that would have been received if no such taxes had been applicable. See &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As contemplated by the last paragraph under &#8220;Description of Debt Securities&#8212;Defeasance&#8221; below, the satisfaction of certain conditions will permit us to omit to comply with some or all of our obligations, covenants and agreements under the indenture with respect to the notes. In addition, we may omit to comply with certain covenants through covenant defeasance. We refer you to the information under &#8220;Description of Debt Securities&#8212; Defeasance&#8221; below for more information on how we may do this.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Except as described herein, the indenture for the notes does not contain any covenants or other provisions designed to protect holders of the notes against a reduction in our creditworthiness in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the notes, including, among other things, through the incurrence of additional indebtedness.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Payment of Additional Amounts</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The provisions of the indenture described under &#8220;Description of Debt Securities&#8212;Covenants&#8212;Payment of Additional Amounts&#8221; below do not apply to the notes. The following payment of additional amounts provisions apply to the notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments made by us under or with respect to the notes will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of (i) the government of the United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or (ii) the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as &#8220;Taxes,&#8221; unless we are required to withhold or deduct Taxes by law.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the notes, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted&#59; provided that no additional amounts will be payable with respect to Taxes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the notes (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or the United States or any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges&#59; </font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">payable other than by withholding from payments of principal of or premium, if any, or interest on the notes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the presentation of notes (where presentation is required) for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed on a payment to an individual and are required to be made pursuant to European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, or any law implementing or complying with, or introduced in order to conform to, such Directive&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed if presentation for payment of the relevant notes had been made to a paying agent other than the paying agent to which the presentation was made&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed solely by reason of the holder or beneficial owner owning or having owned, actually or constructively, 10% or more of the total combined voting power of all classes of our stock entitled to vote&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for a failure by the holder or beneficial owner (or any financial institution through which the holder or beneficial owner holds any Security through which payment on the security is made) to comply with any certification, information, identification, documentation or other reporting requirements (including entering into and complying with an agreement with the U.S. Internal Revenue Service) imposed pursuant to Sections 1471 through 1474 of the U.S. Internal Revenue Code as in effect on the date of issuance of the Notes or any successor or amended version of such provisions&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any combination of the foregoing items&#59;</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">nor shall additional amounts be paid with respect to any payment of the principal of or premium, if any, or interest on any notes to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in the indenture that at least one paying agent for the notes will be located outside the United Kingdom. We have also agreed that if we maintain a paying agent with respect to the notes in any member state of the European Union, we will maintain a paying agent in at least one member state that will not be obliged to withhold or deduct taxes pursuant to any law implementing European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, provided there is at least one member state that does not require a paying agent to withhold or deduct pursuant to such Directive.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligation to pay additional amounts if and when due will survive the termination of the indenture and the payment of all amounts in respect of the notes.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Make-Whole Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may redeem the notes, in whole or in part, at our option at any time and from time to time at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed on that redemption date&#59; and (ii) as determined by the quotation agent (as defined below), the sum of the present values of the remaining scheduled payments of principal and interest on the notes being redeemed on that redemption date (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 0.175%, plus accrued and unpaid interest thereon to, but excluding, the date of redemption. Notwithstanding the foregoing, installments of interest on notes to be redeemed that are due and payable on an interest payment date falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date according to the notes and the indenture.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Issue&#8221; means the United States Treasury security selected by the quotation agent as having a maturity comparable to the remaining term (as measured from the date of redemption) of the notes to be redeemed that would be utilized, at the time of selection and in </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the quotation agent for the notes obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, the quotation.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Quotation agent&#8221; means any Reference Treasury Dealer appointed by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer&#8221; means (i) each of Deutsche Bank Securities Inc., Goldman, Sachs &#38; Co., J.P. Morgan Securities LLC and UBS Securities LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors&#59; provided, however, that if any of the foregoing shall cease to be a primary U.S. government securities dealer in the United States (a &#8220;Primary Treasury Dealer&#8221;), we will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer Quotations&#8221; means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by us, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the quotation agent by such Reference Treasury Dealer at 5&#58;00 p.m., New York City time, on the third business day preceding such redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Treasury Rate&#8221; means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each registered holder of the notes to be redeemed by us or by the trustee on our behalf. Notice of redemption will be published in a daily newspaper of general circulation in the United States, and we will give notice of any such redemption to any exchange on which such notes are listed. On and after any redemption date, interest will cease to accrue on the notes or portions thereof called for redemption. On or before the redemption date, we will deposit with a paying agent (or the trustee) money sufficient to pay the redemption price of and accrued interest on the notes to be redeemed on that date. If less than all of the notes are to be redeemed, the notes to be redeemed shall be selected by lot by The Depository Trust Company (&#8220;DTC&#8221;), in the case of notes represented by a global security, or by the trustee by such method as the trustee deems to be fair and appropriate, in the case of notes that are not represented by a global security.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Events of Default</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The definitions of an event of default with respect to a series of debt securities under &#8220;Description of Debt Securities&#8212;Events of Default&#8221; below do not apply to the notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The following are events of default under the indenture with respect to the notes of a series&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of the principal of (or premium, if any, on) any such note when due, and, in the case of technical or administrative difficulties, the continuance of that default for more than two business days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of interest on, or any additional amounts payable in respect of, any such note when due and payable, and the continuance of that default for 30 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in performing any other covenant in the indenture applicable to any such note for 90 days after the receipt of written notice specifying such default from the trustee or from the holders of 25% in principal amount of such notes&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default under any bond, debenture, note or other evidence of indebtedness for money borrowed of GSK or GSK Capital Inc. (not including any indebtedness for which recourse is limited to property purchased), having in any particular case an aggregate outstanding principal amount in excess of &#163;100,000,000 (or its equivalent in any other currency) whether such indebtedness now exists or shall hereafter be created, which default results in such indebtedness becoming or being accelerated and declared due and payable prior to its stated maturity and such acceleration shall not have been rescinded or annulled or such indebtedness shall not have been discharged&#59; provided that there shall not be deemed to be an event of default if such acceleration is rescinded or annulled or such payment is made within 10 days after the receipt of written notice specifying such default from the trustee or from the holders of 25% in principal amount of such notes&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">certain events of bankruptcy, insolvency or reorganization of GSK or GSK Capital Inc.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Because the applicable threshold amount of indebtedness the acceleration of which would give rise to an event of default under the indenture is lower, and the number of days that must pass before the ongoing default in the performance of any covenant under the indenture other than the payment of principal, interest or additional amounts that would give rise to an event of default under the indenture is lower, for each series of debt securities issued under the indenture before the date of the first supplemental indenture, the acceleration of outstanding indebtedness of GSK or GSK Capital Inc. or the ongoing default in the performance of any covenant in the indenture other than payment of principal, premium, interest or additional amounts may constitute an event of default with respect to one or more of such previously issued series, but may not constitute an event of default under the respective terms of the notes offered by the prospectus supplement.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Further Issuances</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We initially offered the notes in the aggregate principal amount of $500,000,000. We may from time to time, without the consent of the holders of a series of notes, create and issue further notes of the same series having the same terms and conditions in all respects as the applicable notes being offered hereby, except for the issue date, the issue price and the first payment of interest thereon. We will not issue any further notes unless such further notes have no more than a de minimis amount of original issue discount or such issuance would constitute a &#8220;qualified reopening&#8221; for U.S. federal income tax purposes. Additional notes issued in this matter will be consolidated with and will form a single series with the notes being offered hereby.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We issued the notes of each series in the form of one or more fully registered global securities. We deposited these global securities with, or on behalf of, DTC and register these securities in the name of DTC&#8217;s nominee. Direct and indirect participants in DTC will record beneficial ownership of the notes by individual investors. The transfer of ownership of beneficial interests in a global security will be effected only through records maintained by DTC or its nominee, or by participants or persons that hold through participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Investors may elect to hold beneficial interests in the global securities through either DTC, Clearstream Banking S.A. (&#8220;Clearstream&#8221;) or Euroclear Bank SA&#47;NV (&#8220;Euroclear&#8221;) if they are participants in these systems, or indirectly through organizations which are participants in these systems. Beneficial interests in the global securities will be held in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Upon receipt of any payment in respect of a global security, DTC or its nominee will immediately credit participants&#8217; accounts with amounts proportionate to their respective beneficial interests in the principal amount of the global security as shown in the records of DTC or its nominee.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments by participants to owners of beneficial interests in a global security held through participants will be governed by standing instructions and customary practices and will be the responsibility of those participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC holds securities of institutions that have accounts with it or its participants. Through its maintenance of an electronic book-entry system, DTC facilitates the clearance and settlement of securities transactions among its participants and eliminates the need to deliver securities certificates physically. DTC&#8217;s participants include securities brokers and dealers, including the underwriters of this offering, banks, trust companies, clearing corporations and other organizations. DTC is partially owned by some of these participants or their representatives. Access to DTC&#8217;s book-entry system is also available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly. DTC agrees with and represents to its participants that it will administer its book-entry system in accordance with its rules and bylaws and requirements of law. The rules applicable to DTC and its participants are on file with the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream and Euroclear hold interests on behalf of their participants through customers&#8217; securities accounts in Clearstream&#8217;s and Euroclear&#8217;s names on the books of their respective depositaries, which in turn will hold interests in customers&#8217; securities accounts in the depositaries&#8217; names on the books of DTC. At the date of the prospectus supplement, Citibank, N.A. acts as U.S. depositary for Clearstream and JPMorgan Chase Bank, N.A. acts as</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">U.S. depositary for Euroclear, or, collectively, the &#8220;U.S. Depositaries.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream holds securities for its participating organizations, or &#8220;Clearstream Participants,&#8221; and facilitates the clearance and settlement of securities transactions between Clearstream Participants through electronic book-entry changes in accounts of Clearstream Participants, thereby eliminating the need for physical movement of certificates. Clearstream provides to Clearstream Participants, among other things, services for safekeeping, administration, clearance and settlement of internationally traded securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream is registered as a bank in Luxembourg and as such is subject to regulation by the Commission de Surveillance du Secteur Financier and the Banque Centrale du Luxembourg, which supervise and oversee the activities of Luxembourg banks. Clearstream Participants are worldwide financial institutions, including underwriters, securities brokers and dealers, banks, trust companies and clearing corporations, and may include the underwriters or their affiliates. Indirect access to Clearstream is available to other institutions that clear through or maintain a custodial relationship with a Clearstream Participant. Clearstream has established an electronic bridge with Euroclear as the operator of the Euroclear system, or the &#8220;Euroclear Operator,&#8221; in Brussels to facilitate settlement of trades between Clearstream and the Euroclear Operator.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to the notes of a series held beneficially through Clearstream will be credited to cash accounts of Clearstream Participants in accordance with its rules and procedures, to the extent received by the U.S. Depositary for Clearstream.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear holds securities and book-entry interests in securities for participating organizations, or &#8220;Euroclear Participants&#8221; and facilitates the clearance and settlement of securities transactions between Euroclear Participants, and between Euroclear Participants and participants of certain other securities intermediaries through electronic book-entry changes in accounts of such participants or other securities intermediaries. Euroclear provides Euroclear Participants with, among other things, safekeeping, administration, clearance and settlement, securities lending and borrowing, and related services.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear Participants are investment banks, securities brokers and dealers, banks, central banks, supranationals, custodians, investment managers, corporations, trust companies and certain other organizations and may include the underwriters or their affiliates. Non-participants in Euroclear may hold and transfer beneficial interests in a global security through accounts with a Euroclear Participant or any other securities intermediary that holds a book-entry interest in a global security through one or more securities intermediaries standing between such other securities intermediary and Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to notes of a series held beneficially through Euroclear will be credited to the cash accounts of Euroclear Participants in accordance with the Terms and Conditions, to the extent received by the U.S. Depositary for Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers between Euroclear Participants and Clearstream Participants will be effected in the ordinary way in accordance with their respective rules and operating procedures.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Cross-market transfers between DTC&#8217;s participating organizations, or the &#8220;DTC Participants,&#8221; on the one hand, and Euroclear Participants or Clearstream Participants, on the other hand, will be effected through DTC in accordance with DTC&#8217;s rules on behalf of Euroclear or Clearstream, as the case may be, by its U.S. Depositary&#59; however, such cross- market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. Depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the global security in DTC, and making or receiving payment in accordance with normal procedures for same-day fund settlement applicable to DTC. Euroclear Participants and Clearstream Participants may not deliver instructions directly to their respective U.S. Depositaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Due to time zone differences, the securities accounts of a Euroclear Participant or Clearstream Participant purchasing an interest in a global security from a DTC Participant in DTC will be credited, and any such crediting will be reported, to the relevant Euroclear Participant or Clearstream Participant during the securities settlement processing day (which must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a Euroclear Participant or Clearstream Participant to a DTC Participant will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#8217;s settlement date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The information in this section concerning DTC, Euroclear and Clearstream and their book-entry systems has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy of that information.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">None of us, any of the underwriters and the trustee will have any responsibility for the performance by DTC, Euroclear or Clearstream or their respective participants of their respective obligations under the rules and procedures governing their operations.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Although DTC, Clearstream and Euroclear have agreed to the foregoing procedures in order to facilitate transfers of securities among participants of DTC, Clearstream and Euroclear, they are under no obligation to perform or continue to perform such procedures and they may discontinue the procedures at any time.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Same-Day Settlement and Payment</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Initial settlement for the notes was made in immediately available funds. Secondary market trading between DTC participants will occur in the ordinary way in accordance with DTC rules and will be settled in immediately available funds using DTC&#8217;s Same-Day Funds Settlement System.</font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:14.73pt;text-decoration:underline">Base Prospectus &#8211; March 4, 2011</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of Debt Securities</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As used in this &#8220;Description of Debt Securities,&#8221; &#8220;debt securities&#8221; means the debentures, notes, bonds, guarantees and other evidences of</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">indebtedness that GSK issues or that GSK Capital Inc. or GSK Capital plc (the &#8220;finance subsidiaries&#8221;) issues and GSK fully and unconditionally guarantees and, in each case, the trustee authenticates and delivers under the applicable indenture. The debt securities will be our direct unsecured obligations and will rank equally and ratably without preference among themselves and at least equally with all of our other unsecured and unsubordinated indebtedness.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities will be issued in one or more series under an indenture between GSK and Law Debenture Trust Company of New York, as trustee, or under indentures among the finance subsidiaries, Law Debenture Trust Company of New York, as trustee (as successor to Citibank, N.A., pursuant to Instruments of Resignation, Appointment and Acceptance among the finance subsidiaries, the guarantor, Law Debenture Trust Company of New York and Citibank, N.A.), and GSK, as guarantor. The indentures applicable to GSK, GSK Capital Inc. and GSK Capital plc will each be qualified under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act. In the following discussion, we sometimes refer to these indentures collectively as the &#8220;indentures.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">This &#8220;Description of Debt Securities&#8221; briefly outlines the provisions of the indentures and is qualified in its entirety by reference to the indentures. The terms of the indentures will include both those stated in the indentures and those made part of the indentures by the Trust Indenture Act. The forms of the indentures have been filed as exhibits to the registration statement of which the base prospectus forms a part, and you should read the indentures for provisions that may be important to you.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures do not contain any covenants or other provisions designed to protect holders of the debt securities against a reduction in the creditworthiness of GSK or the finance subsidiaries in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Issuances in Series</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures do not limit the amount of debt securities that may be issued. The debt securities may be issued in one or more series with the same or various maturities, at a price of 100% of their principal amount or at a premium or a discount. Not all debt securities of any one series need be issued at the same time, and, unless otherwise provided, any series may be reopened, without the consents of the holders of debt securities of that series, for issuances of additional debt securities of that series. Except in the limited circumstances described below under &#8220;&#8212; Covenants &#8212; Limitation on Liens,&#8221; the debt securities will not be secured by any property or assets of GSK, as issuer or guarantor, or the finance subsidiaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The terms of any authorized series of debt securities will be described in a prospectus supplement. These terms will include some or all of the following&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the title, aggregate principal amount and denominations of the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the date or dates on which principal will be payable&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the percentage of the principal amount at which the debt securities will be issued and whether the debt securities will be &#8220;original issue discount&#8221; securities for U.S. federal income tax purposes. If original issue discount debt securities are issued (generally, securities that are issued at a substantial discount below their principal amount), the special U.S. federal income tax and other considerations of a purchase of original issue discount debt securities will be described&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the rate or rates, which may be fixed or variable, at which the debt securities will bear interest&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the interest payment dates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any optional or mandatory redemption terms&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether any sinking fund is required&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the currency in which the debt securities will be denominated or principal, premium or interest will be payable, if other than U.S. dollars&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether the debt securities are to be issued as individual certificates to each holder or in the form of global certificates held by a depositary on behalf of beneficial owners&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">information describing any book-entry features&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the names and duties of any co-trustees, depositaries, authenticating agents, paying agents, transfer agents or registrars for any series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the applicability of the defeasance and covenant defeasance provisions described herein, or any modifications of those provisions&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any deletions from, modifications of or additions to the events of default or covenants with respect to the debt securities&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any other terms, conditions, rights or preferences of the debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities that have a maturity of less than one year from their date of issue and in respect of which the proceeds are to be received by us in the United Kingdom will have a minimum denomination of &#163;100,000 (or its equivalent in another currency).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The prospectus supplement relating to any series of debt securities may add to or change statements contained in the base prospectus. The prospectus supplement may also include, if applicable, a discussion of certain U.S. federal income tax and U.K. income tax considerations.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">GSK Guarantees</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities issued by the finance subsidiaries will be fully and unconditionally guaranteed by GSK. If for any reason the applicable finance subsidiary does not make any required payment in respect of its debt securities when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. The holder of a guaranteed debt security will be entitled to payment under the applicable guarantee of GSK without taking any action whatsoever against the finance subsidiary.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Payment and Transfer</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities will be issued only as registered securities, which means that the name of the holder will be entered in a register that will be kept by the trustee or another agent appointed by us. Unless stated otherwise in a prospectus supplement, and except as described under &#8220;&#8212; Book-Entry System&#8221; below, payments of principal, interest and additional amounts, if any, will be made at the office of the paying agent or agents named in the prospectus supplement or by check mailed to you at your address as it appears in the register.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless other procedures are described in a prospectus supplement and except as described under &#8220;&#8212; Book Entry System&#8221; below, you will be able to transfer registered debt securities at the office of the transfer agent or agents named in the prospectus supplement. You may also exchange registered debt securities at the office of the transfer agent for an equal aggregate principal amount of registered debt securities of the same series having the same maturity date, interest rate and other terms as long as the debt securities are issued in authorized denominations.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Neither we nor the trustee will impose any service charge for any transfer or exchange of a debt security&#59; however, we may ask you to pay any taxes or other governmental charges in connection with a transfer or exchange of debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities may be issued under a book-entry system in the form of one or more global securities. The global securities will be registered in the name of a depositary or its nominee and deposited with that depositary or its custodian. Unless stated otherwise in the prospectus supplement, The Depository Trust Company, New York, New York, or DTC, will be the depositary if a depositary is used.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC has advised us as follows&#58;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking organization&#8221; within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code and a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section 17A of the Exchange Act&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC was created to hold securities of its participants and to facilitate the clearance and settlement of securities transactions, such as through transfers and pledges, among its participants in such securities through electronic book-entry changes to accounts of its participants, thereby eliminating the need for physical movement of securities certificates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC&#8217;s participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations, some of whom (and&#47;or their representatives) own DTC&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">access to DTC&#8217;s book-entry system is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the DTC rules applicable to its participants are on file with the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">According to DTC, the foregoing information with respect to DTC has been provided to the financial community for informational purposes only and is not intended to serve as a representation, warranty or contract modification of any kind.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Following the issuance of a global security in registered form, the depositary will credit the accounts of its participants with the debt securities upon our instructions. Only persons who hold directly or indirectly through financial institutions that are participants in the depositary can hold beneficial interests in the global securities. Since the laws of some jurisdictions require certain types of purchasers to take physical delivery of such securities in definitive form, you may encounter difficulties in your ability to own, transfer or pledge beneficial interests in a global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">So long as the depositary or its nominee is the registered owner of a global security, we and the trustee will treat the depositary as the sole owner or holder of the debt securities for purposes of the applicable indenture. Therefore, except as set forth below, you will not be entitled to have debt securities registered in your name or to receive physical delivery of certificates representing the debt securities. Accordingly, you will have to rely on the procedures of the depositary and the participant in the depositary through whom you hold your beneficial interest in order to exercise any rights of a holder under the indenture. We understand that under existing practices, the depositary would act upon the instructions of a participant or authorize that participant to take any action that a holder is entitled to take.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We will make all payments of principal, interest and additional amounts, if any, on the debt securities to the depositary. It is expected that the depositary will then credit participants&#8217; accounts proportionately with these payments on the payment date and that the participants will in turn credit their customers&#8217; accounts in accordance with their customary practices. Neither we nor the trustee will be responsible for making any payments to participants or customers of participants or for maintaining any records relating to the holdings of participants and their customers, and you will have to rely on the procedures of the depositary and its participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Global securities are generally not transferable. Physical certificates will be issued to beneficial owners in lieu of a global security only in the special situations described in the sixth paragraph under the heading &#8220;Legal Ownership of Debt Securities &#8212; Global Securities&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Consolidation, Merger or Sale</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We and the finance subsidiaries have agreed in the indentures not to consolidate with or merge with or into any other person or convey or transfer all or substantially all of our respective properties and assets to any person (except that the finance subsidiaries may merge into us), unless&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we or the applicable finance subsidiary, as the case may be, are the continuing person, or the successor expressly assumes by supplemental indenture our obligations under the applicable indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:11.37pt">the continuing person is a U.S. or U.K. company or is organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and, if it is not a U.S. or U.K. company, the continuing person agrees by supplemental indenture to be bound by a covenant comparable to that described below under &#8220;&#8212; Covenants &#8212; Payment of Additional Amounts&#8221; with respect to taxes imposed in the continuing person&#8217;s jurisdiction of organization (in which case the continuing person will benefit from a redemption option comparable to that described below under &#8220;&#8212; Optional Redemption for Tax Reasons&#8221; in the event of changes in taxes in that jurisdiction after the date of the consolidation, merger or sale)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:11.37pt">immediately after the transaction, no default under the debt securities has occurred and is continuing&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:11.37pt">we deliver to the trustee an officer&#8217;s certificate and, if neither we nor the applicable subsidiary are the continuing person, an opinion of counsel, in each case stating, among other things, that the transaction and the supplemental indenture, if required, comply with these provisions and the indenture.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Payment of Additional Amounts</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments made by us under or with respect to the debt securities will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of (i) the government of the United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or (ii) the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as &#8220;Taxes,&#8221; unless we are required to withhold or deduct Taxes by law.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the debt securities, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted&#59; provided that no additional amounts will be payable with respect to Taxes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the debt securities (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or the United States or any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">payable other than by withholding from payments of principal of or interest on the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent&#58;</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes&#59; and</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">&#9642;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:11.34pt">at least 30 days before the first payment date with respect to which such additional amounts shall be payable, we have notified such recipient in writing that such recipient is required to comply with such requirement&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the presentation of a debt security (where presentation is required) for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later&#59;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed on a payment to an individual and are required to be made pursuant to European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, or any law implementing or complying with, or introduced in order to conform to, such Directive&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed if presentation for payment of the relevant debt securities had been made to a paying agent other than the paying agent to which the presentation was made&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any combination of the foregoing items&#59;</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">nor shall additional amounts be paid with respect to any payment of the principal of or interest on any debt security to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of the debt security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in each indenture that at least one paying agent for each series of debt securities will be located outside the United Kingdom. We have also agreed that if we maintain a paying agent with respect to a particular series of debt securities in any member state of the European Union, we will maintain a paying agent in at least one member state (other than the United Kingdom) that will not be obliged to withhold or deduct taxes pursuant to any law implementing European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, provided there is at least one member state that does not require a paying agent to withhold or deduct pursuant to such Directive.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligation to pay additional amounts if and when due will survive the termination of the indentures and the payment of all amounts in respect of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Limitation on Liens</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in the indentures not to incur or assume (or permit any of our subsidiaries to incur or assume) any lien on or with respect to any of our or our subsidiaries&#8217; property, assets or revenues, present or future, to secure any relevant indebtedness (as this term is defined below) without making (or causing our subsidiaries to make) effective provision for securing the debt securities equally and ratably with such relevant indebtedness as to such property, assets or revenues, for as long as such relevant indebtedness is so secured.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The restrictions on liens will not apply to&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens arising by operation of law&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens on property, assets or revenues of any person, which liens are existing at the time such person becomes a subsidiary&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens on property, assets or revenues of a person existing at the time such person is merged with or into or consolidated with us or any of our subsidiaries or at the time of a sale, lease or other disposition to us of the properties of a person as an entirety or substantially as an entirety.</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">For purposes of the limitation on liens covenant, the term &#8220;relevant indebtedness&#8221; means any of our debt that&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">is in the form of or represented by bonds, notes, loan stock, depositary receipts or other securities issued (otherwise than to constitute or represent advances made by banks or other lending institutions)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">is denominated in, or confers any right of payment by reference to, any currency other than the currency of the country in which the issuer of the indebtedness has its principal place of business, or is denominated in or by reference to the currency of such country but more than 20% of which is placed or offered for subscription or sale by or on behalf of, or by agreement with, the issuer outside such country&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">at its date of issue is, or is intended by the issuer to become, quoted, listed, traded or dealt in on any stock exchange, over-the-counter market or other securities market.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Additional Covenants</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may be subject to additional covenants, including restrictive covenants in respect of a particular series of debt securities. Such additional covenants will be set forth in the applicable prospectus supplement and, to the extent necessary, in the supplemental indenture or board resolution relating to that series of debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Redemption for Tax Reasons</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may redeem any series of debt securities in whole but not in part at any time, on giving not less than 30 nor more than 60 days&#8217; notice of such redemption, at a redemption price equal to the principal amount plus accrued interest, if any, to the date fixed for redemption (except in the case of discounted debt securities, which may be redeemed at the redemption price specified by the terms of each series of such debt securities), if&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we determine that, as a result of any change in or amendment to the laws or any regulations or rulings promulgated thereunder of the United Kingdom (or of any political subdivision or taxing authority thereof) or the United States (or of any political subdivision or taxing authority thereof), or any change in the application or official interpretation of such laws, regulations or rulings, or any change in the application or official interpretation of, or any execution of or amendment to, any treaty or treaties affecting taxation to which any such jurisdiction is a party, which change, execution or amendment becomes effective on or after the issue date or such other date specified in the debt securities of that series&#58;</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we would be required to pay additional amounts (as described under &#8220;&#8212; Covenants &#8212; Payment of Additional Amounts&#8221; above) with respect to that series of debt securities on the next succeeding interest payment date and the payment of such additional amounts cannot be avoided by the use of reasonable measures available to us&#59; or</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">withholding tax has been or would be required to be withheld with respect to interest income received or receivable by the applicable finance subsidiary directly from the guarantor (or any affiliate) and such withholding tax obligation cannot be avoided by the use of reasonable measures available to the applicable finance subsidiary or the guarantor (or any affiliate)&#59; or</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we determine, based upon an opinion of independent counsel of recognized standing that, as a result of any action taken by any legislative body of, taxing authority of, or any action brought in a court of competent jurisdiction in, the United Kingdom (or any political subdivision or taxing authority thereof) or the United States (or any political subdivision or taxing authority thereof) (whether or not such action was taken or brought with respect to GSK, as issuer or guarantor, or the applicable finance subsidiary, as the case may be), which action is taken or brought on or after the issue date or such other date specified in the debt securities of that series, there is a substantial probability that the circumstances described above would exist&#59; provided, however, that no such notice of redemption may be given earlier than 90 days prior to the earliest date on which we would be obligated to pay such additional amounts.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We will also pay to each holder, or make available for payment to each such holder, on the redemption date any additional amounts resulting from the payment of such redemption price. Prior to the publication of any notice of redemption, we will deliver to the trustee&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an officer&#8217;s certificate stating that we are entitled to effect a redemption and setting forth a statement of facts showing that the conditions precedent of the right so to redeem have occurred&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an opinion of counsel to the effect that the conditions specified above have been satisfied.</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">Any notice of redemption will be irrevocable once we deliver the officer&#8217;s certificate to the trustee.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Events of Default</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless otherwise specified in a prospectus supplement, an event of default with respect to a series of debt securities occurs upon&#58;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of the principal (or premium, if any) of any debt security of that series when due (including as a sinking fund installment), and, in the case of technical or administrative difficulties, the continuance of that default for more than two business days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of interest on, or any additional amounts payable in respect of, any debt security of that series when due and payable, and the continuance of that default for 30 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in performing any other covenant in the indenture applicable to that series for 60 days after the receipt of written notice specifying such default from the trustee or from the holders of 25% in principal amount of the debt securities of that series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default under any bond, debenture, note or other evidence of indebtedness for money borrowed of GSK or either finance subsidiary, as the case may be (not including any indebtedness for which recourse is limited to property purchased), having in any particular case an outstanding principal amount in excess of $25,000,000 (or its equivalent in any other currency) where any such failure results in such indebtedness being accelerated and becoming due and payable prior to its stated maturity and such acceleration shall not have been rescinded or annulled or such indebtedness shall not have been discharged&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">certain events of bankruptcy, insolvency or reorganization of GSK or either finance subsidiary, as the case may be&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any other event of default provided with respect to that particular series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Any additional or different events of default applicable to a particular series of debt securities will be described in the prospectus supplement relating to such series.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">An event of default with respect to a particular series of debt securities will not necessarily constitute an event of default with respect to any other series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The trustee may withhold notice to the holders of debt securities of any default (except in the payment of principal, premium or interest) if it, in good faith, considers such withholding of notice to be in the best interests of the holders. A default is any event which is an event of default described above or would be an event of default but for the giving of notice or the passage of time.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an event of default occurs and continues, the trustee or the holders of the aggregate principal amount of the debt securities specified below may require us to repay immediately, or accelerate&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the entire principal of the debt securities of such series&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">if the debt securities are original issue discount securities, such portion of the principal as may be described in the applicable prospectus supplement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If the event of default occurs because of a default in a payment of principal or interest on the debt securities of any series, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of that series can accelerate that series of debt securities. If the event of default occurs because of a failure to perform any other covenant in the applicable indenture or any covenant for the benefit of one or more, but not all, of the series of debt securities, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of all series affected, voting as one class, can accelerate all of the affected series of debt securities. If the event of default occurs because of bankruptcy proceedings, then all of the debt securities under the indenture will be accelerated automatically. Therefore, except in the case of a default on a payment of principal or interest on the debt securities of your series or a default due to our bankruptcy or insolvency, it is possible that you may not be able to accelerate the debt securities of your series because of the failure of holders of other series to take action.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The holders of a majority of the aggregate principal amount of the debt securities of all affected series, voting as one class, can rescind this accelerated payment requirement or waive any past default or event of default or allow noncompliance with any provision of the applicable indenture. However, they cannot waive a default in payment of principal of, premium, if any, or interest on any of the debt securities when due otherwise than as a result of acceleration.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">After an event of default, the trustee must exercise the same degree of care a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee is not obligated to exercise any of its rights or powers under the applicable indenture at the request, order or direction of any holders, unless the holders offer the trustee reasonable indemnity. If they provide this reasonable indemnity, the holders of a majority in principal amount of all affected series of debt securities, voting as one class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any power conferred upon the trustee, for any series of debt securities. However, the trustee may refuse to follow any direction that conflicts with law or the indenture or is unduly prejudicial to the rights of other holders.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">No holder will be entitled to pursue any remedy with respect to the indenture unless the trustee fails to act for 60 days after it is given&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">notice of default by that holder&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">a written request to enforce the indenture by the holders of not less than 25% in principal amount of all outstanding debt securities of any affected series&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an indemnity to the trustee, satisfactory to the trustee&#59;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">and during this 60-day period the holders of a majority in principal amount of all outstanding debt securities of such affected series do not give a direction to the trustee that is inconsistent with the enforcement request. These provisions will not prevent any holder of debt securities from enforcing payment of the principal of (and premium, if any) and interest on the debt securities at the relevant due dates.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an event of default with respect to a series of debt securities occurs and is continuing, the trustee will mail to the holders of those debt securities a notice of the event of default within 90 days after it occurs. However, except in the case of a default in any payment in respect of a series of debt securities, the trustee shall be protected in withholding notice of an event of default if it determines in good faith that this is in the interests of the holders of the relevant debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Modification of the Indentures</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In general, rights and obligations of us and the holders under the indentures may be modified if the holders of a majority in aggregate principal amount of the outstanding debt securities of each series affected by the modification consent to such modification. However, each of the indentures provides that, unless each affected holder agrees, an amendment cannot&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">make any adverse change to any payment term of a debt security such as extending the maturity date, extending the date on which we have to pay interest or make a sinking fund payment, reducing the interest rate, reducing the amount of principal we have to repay, changing the currency in which we have to make any payment of principal, premium or interest, modifying any redemption or repurchase right, or right to convert or exchange any debt security, to the detriment of the holder and impairing any right of a holder to bring suit for payment&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">waive any payment default&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">reduce the percentage of the aggregate principal amount of debt securities needed to make any amendment to the applicable indenture or to waive any covenant or default&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">make any other change to the amendment provisions of the applicable indenture.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">However, if we and the trustee agree, the applicable indenture may be amended without notifying any holders or seeking their consent if the amendment does not materially and adversely affect any holder. We and the trustee are permitted to make modifications and amendments to the applicable indenture without the consent of any holder of debt securities for any of the following purposes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to cure any ambiguity, defect or inconsistency in the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to comply with sections of the indenture governing when we may merge and substitute obligors&#59;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to comply with any requirements of the U.S. Securities and Exchange Commission in connection with the qualification of the indenture under the Trust Indenture Act&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to evidence and provide for the acceptance by a successor trustee of appointment under the indenture with respect to the debt securities of any or all series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to establish the form or forms or terms of the debt securities of any series or of the coupons appertaining to such debt securities as permitted under the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to provide for uncertificated debt securities and to make all appropriate changes for such purpose&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to provide for a further guarantee from a third party on outstanding debt securities of any series and the debt securities of any series that may be issued under the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to change or eliminate any provision of the indenture&#59; provided that any such change or elimination will become effective only when there are no outstanding debt securities of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to supplement any of the provisions of the indenture to such extent as will be necessary to permit or facilitate the defeasance and discharge of any series of debt securities pursuant to the indenture&#59; provided that any such action will not adversely affect the interests of the holders of such or any other series of debt securities in any material respect&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to make any change that does not materially and adversely affect the rights of any holder of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Defeasance</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The term defeasance means discharge from some or all of the obligations under the indentures. If we deposit with the trustee sufficient cash or government securities to pay the principal, interest, any premium and any other sums due to the stated maturity date or a redemption date of the debt securities of a particular series, then at our option&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we will be discharged from our respective obligations with respect to the debt securities of such series&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we will no longer be under any obligation to comply with the restrictive covenants, if any, contained in the applicable indenture and any supplemental indenture or board resolution with respect to the debt securities of such series, and the events of default relating to failures to comply with covenants will no longer apply to us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this happens, the holders of the debt securities of the affected series will not be entitled to the benefits of the applicable indenture except for registration of transfer and exchange of debt securities and replacement of lost, stolen or mutilated debt securities. Instead, the holders will only be able to rely on the deposited funds or obligations for payment.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We must deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the holders of the debt securities to recognize income, gain or loss for U.S. federal income tax purposes. We may, in lieu of an opinion of counsel, deliver a ruling to such effect received from or published by the U.S. Internal Revenue Service.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Substitution of Issuer</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may at our option at any time, without the consent of any holders of debt securities, cause GSK or any other subsidiary of GSK to assume the obligations of the applicable finance subsidiary under any series of debt securities, provided that the new obligor executes a supplemental indenture in which it agrees to be bound by the terms of those debt securities and the relevant indenture. If the new obligor is not a U.S. or U.K. company, it must be organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and it must also agree in the supplemental indenture to be bound by a covenant comparable to that described above under &#8220;&#8212; Covenants &#8212; Payment of Additional Amounts&#8221; with respect to taxes imposed in its jurisdiction of organization (in which case the new obligor will benefit from a redemption option comparable to that described above under &#8220;&#8212; Optional Redemption for Tax Reasons&#8221; in the event of changes in taxes in that jurisdiction after the date of the substitution). In the case of such substitution, the applicable finance subsidiary will be relieved of any further obligation under the assumed series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">For U.S. federal income tax purposes, a substitution of obligors as described above generally would be treated as a deemed taxable exchange of debt securities for new debt securities issued by the new obligor. As discussed further in the applicable prospectus supplement, a United States person who holds debt securities or owns a beneficial interest therein generally will recognize capital gain or loss in an amount equal to the difference between the issue price of the new debt securities and such person&#8217;s adjusted tax basis in the debt securities. Such persons should consult their own tax advisors regarding the tax consequences of a deemed taxable exchange in the event of a substitution of obligors.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Information Concerning the Trustee</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Law Debenture Trust Company of New York will be the trustee. The trustee will be required to perform only those duties that are specifically set forth in the indentures, except when a default has occurred and is continuing with respect to the debt securities. After a default, the trustee must exercise the same degree of care that a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee will be under no obligation to exercise any of the powers vested in it by the indentures at the request of any holder of debt securities unless the holder offers the trustee reasonable indemnity against the costs, expenses and liabilities that might be incurred by exercising those powers.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Governing Law</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities, the related guarantees and the indentures will be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Legal Ownership of Debt Securities</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">&#8220;Street Name&#8221; and Other Indirect Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We generally will not recognize investors who hold debt securities in accounts at banks or brokers as legal holders of those debt securities. Holding securities in accounts at banks or brokers is called holding in &#8220;street name.&#8221; If an investor holds debt securities in street name, we recognize only the bank or broker or the financial institution the bank or broker uses to hold the debt securities. These intermediary banks, brokers and other financial institutions pass along principal, interest and other payments on the debt securities, either because they agree to do so in their customer agreements or because they are legally required to do so. If you hold debt securities in street name, you should check with your own institution to find out&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it handles payments and notices with respect to securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether it imposes fees or charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it would handle voting if ever required&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how and when you should notify it to exercise on your behalf any rights or options that may exist under the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether and how you can instruct it to send you securities registered in your own name so you can be a direct holder as described below&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it would pursue rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Registered Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligations, as well as the obligations of the trustee and those of any third parties employed by us or the trustee, extend only to persons who are registered as holders of debt securities. As noted above, we do not have obligations to you if you hold in street name or through other indirect means, either because you choose to hold debt securities in that manner or because the debt securities are issued in the form of global securities as described below. For example, once we make payment to the registered holder, we have no further responsibility for the payment even if that holder is legally required to pass the payment along to you as a street name customer but does not do so.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Global Securities</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">A global security is a special type of indirectly held security. If we choose to issue debt securities in the form of global securities, the ultimate beneficial owners of the debt securities will be indirect holders. We do this by requiring that the global security be registered in the name of a financial institution we select and by requiring that the debt securities represented by the global security not be registered in the name of any other holder except in the special situations described below. The financial institution that acts as the sole registered holder of the global security is called the depositary. Any person wishing to own a debt security may do so indirectly through an account with a broker, bank or other financial institution that in turn has an account with the depositary. The prospectus supplement will indicate whether your series of debt securities will be issued only as global securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers of debt securities represented by the global security will be made only on the records of the depositary or its nominee by transferring such debt securities from the account of one broker, bank or financial institution to the account of another broker, bank or financial institution. These transfers are made electronically only and are also known as book- entry transfers. Securities in global form are sometimes also referred to as being in book-entry form.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As an indirect holder, your rights relating to a global security will be governed by the account rules of your broker, bank or financial institution and of the depositary, as well as general laws relating to securities transfers. We will not recognize you as a holder of debt securities and instead will deal only with the depositary that holds the global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">You should be aware that if debt securities are issued only in the form of a global security&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you cannot have debt securities registered in your own name&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you cannot receive physical certificates for your interest in the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you will be a street name holder and must look to your own broker, bank or financial institution for payments on the debt securities and protection of your legal rights relating to the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own securities in the form of physical certificates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary&#8217;s policies will govern payments, transfers, exchanges and other matters relating to your indirect interest in the global security. We and the trustee will have no responsibility for any aspect of the depositary&#8217;s actions or for its records of ownership interests in the global security. We and the trustee also will not supervise the depositary in any way&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary will require that indirect interests in the global security be purchased or sold within its system using same-day funds for settlement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In a few special situations described below, the global security will terminate and the indirect interests in it will be exchanged for registered debt securities represented by physical certificates. After that exchange, the choice of whether to hold debt securities in registered form or in street name will be up to you. You must consult your broker, bank or financial institution to find out how to have your interests in debt securities transferred to your name, so that you will be a registered holder.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless we specify otherwise in the prospectus supplement, the special situations for termination of a global security are&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">when the depositary notifies us that it is unwilling or unable to continue as depositary and we do not or cannot appoint a successor depositary within 90 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary ceases to be a clearing agency registered under the Exchange Act and we do not appoint a successor depositary within 90 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an event of default has occurred and is continuing and beneficial owners representing a majority in principal amount of the applicable series of debt securities have advised the depositary to cease acting as the depositary&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we decide we do not want to have the debt securities of that series represented by a global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of debt securities covered by the prospectus supplement. When a global security terminates, the depositary (and not us or the trustee) is responsible for deciding the names of the institutions that will be the initial registered holders.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">The Term &#8220;Holder&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In the descriptions of the debt securities included herein, when we refer to the &#8220;holder&#8221; of a given debt security as being entitled to certain rights or payments, or being permitted to take certain actions, we are in all cases referring to the registered holder of the debt security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">While you would be the registered holder if you held a certificated security registered in your name, it is likely that the holder will actually be either the broker, bank or other financial institution where you have your street name account, or, in the case of a global security, the depositary. If you are an indirect holder, you will need to coordinate with the institution through which you hold your interest in a debt security in order to determine how the provisions involving holders described in this prospectus and any prospectus supplement will actually apply to you. For example, if the debt security in which you hold a beneficial interest in street name can be repaid at the option of the holder, you cannot exercise the option yourself by following the procedures described in the prospectus supplement. Instead, you would need to cause the institution through which you hold your interest to take those actions on your behalf. Your institution may have procedures and deadlines different from or additional to those described in the prospectus supplement relating to the debt security.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">3. Notes offered pursuant to the Base Prospectus dated March 4, 2008</font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">a. Prospectus Supplement (May 6, 2008) &#8211; 6.375% Notes due 2038</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of the Notes</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We issued the 6.375% Notes due 2038 pursuant to an indenture, dated April 6, 2004, among GSK, as guarantor, GSK Capital Inc., as issuer, and Law Debenture Trust Company of New York, the trustee for the notes (as successor to Citibank, N.A., pursuant to an Instrument of Resignation, Appointment and Acceptance dated December 27, 2007 among GSK Capital Inc., GSK, Law Debenture Trust Company of New York and Citibank, N.A.) (for purposes of this description of the 6.375% Notes due 2038 only, the &#8220;indenture&#8221;). References in this &#8220;Description of the Notes&#8221; to the &#8220;notes&#8221; refer to the 6.375% Notes due 2038. The notes are a series of our debt securities. GSK Capital Inc. issued the notes in the aggregate principal amount of $2,750,000,000. The notes will mature on May 15, 2038. GSK Capital Inc. issued the notes only in book-entry form, in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The notes are fully and unconditionally guaranteed by GSK. If, for any reason, GSK Capital Inc. does not make any required payment in respect of the notes when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. You will be entitled to payment under the guarantee of GSK without taking any action whatsoever against us.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Interest Payments</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The notes bear interest at the applicable interest rate shown in the table above and accrued interest from May 13, 2008, or from the most recent date to which interest has been paid (or provided for), to but not including the next date upon which interest is required to be paid.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Interest is payable on the notes twice a year, on May 15 and November 15, commencing November 15, 2008, to the person in whose name a note is registered at the close of business on the May 1 or November 1 that precedes the date on which interest will be paid. Interest on the notes are paid on the basis of a 360-day year consisting of twelve 30-day months. &#8220;Business day&#8221; means any day other than a Saturday, a Sunday or a day on which banking institutions in the City of New York or London, England are authorized or obligated by law, regulation or executive order to be closed.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an interest payment date or redemption date, or the maturity date, for the notes, as the case may be, would fall on a day that is not a business day, then the interest payment date or redemption date, or the maturity date, as the case may be, will be postponed to the next succeeding business day, but no additional interest shall be paid unless we fail to make payment on such next succeeding business day.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Subject to certain exceptions, if we are required to withhold or deduct any amount for or on account of any U.K. or U.S. withholding tax from any payment made on the notes, we will pay additional amounts on those payments so that the amount received by noteholders will equal the amount that would have been received if no such taxes had been applicable. See &#8220;Description of Debt Securities &#8212; Covenants &#8212; Payment of Additional Amounts&#8221; below.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As contemplated by the last paragraph under &#8220;Description of Debt Securities &#8212; Defeasance&#8221; below, the satisfaction of certain conditions will permit us to omit to comply with some or all of our obligations, covenants and agreements under the indenture with respect to the notes. In addition, we may omit to comply with certain covenants through covenant defeasance. We refer you to the information under &#8220;Description of Debt Securities &#8212; Defeasance&#8221; below for more information on how we may do this.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Except as described herein, the indenture for the notes does not contain any covenants or other provisions designed to protect holders of the notes against a reduction in our creditworthiness in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the notes, including, among other things, through the incurrence of additional indebtedness.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Make-Whole Redemption</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may redeem the notes, in whole or in part, at our option at any time and from time to time at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed on that redemption date&#59; and (ii) as determined by the quotation agent (as defined below), the sum of the present values of the remaining scheduled payments of principal and interest on the notes being redeemed on that redemption date (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 0.25%, plus accrued and unpaid interest thereon to, but excluding, the date of redemption. Notwithstanding the foregoing, installments of interest on notes to be redeemed that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date according to the notes and the indenture.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Issue&#8221; means the United States Treasury security selected by the quotation agent as having a maturity comparable to the remaining term (as measured from the date of redemption) of the notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the notes.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the quotation agent for the notes obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, the quotation. &#8220;Quotation agent&#8221; means any Reference Treasury Dealer appointed by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer&#8221; means (i) each of Citigroup Global Markets Inc., J.P. Morgan Securities Inc. and Lehman Brothers Inc. (or their respective affiliates that are Primary Treasury Dealers) and their respective successors&#59; provided, however, that if any of the foregoing shall cease to be a primary U.S. government securities dealer in New York City (a &#8220;Primary Treasury Dealer&#8221;), we will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Reference Treasury Dealer Quotations&#8221; means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by us, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the quotation agent by such Reference Treasury Dealer at 5&#58;00 p.m., New York City time, on the third business day preceding such redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8220;Treasury Rate&#8221; means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that redemption date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each registered holder of the notes to be redeemed by us or by the trustee on our behalf. Notice of redemption will be published in a daily newspaper of general circulation in the United States, and we will give notice of any such redemption to any exchange on which the notes are listed. On and after any redemption date, interest will cease to accrue on the notes or portions thereof called for redemption. On or before the redemption date, we will deposit with a paying agent (or the trustee) money sufficient to pay the redemption price of and accrued interest on the notes to be redeemed on that date. If less than all of the notes are to be redeemed, the notes to be redeemed shall be selected by lot by The Depository Trust Company (&#8220;DTC&#8221;), in the case of notes represented by a global security, or by the trustee by such method as the trustee deems to be fair and appropriate, in the case of notes that are not represented by a global security.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Further Issuances</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We initially offered the notes in the aggregate principal amount of $2,750,000,000. We may from time to time, without the consent of the holders of a series of notes, create and issue further notes of the same series having the same terms and conditions in all respects as the applicable notes being offered hereby, except for the issue date, the issue price and the first payment of interest thereon. We will not issue any further notes unless such further notes have no more than a de minimis amount of original issue discount or such issuance would constitute a &#8220;qualified reopening&#8221; for U.S. federal income tax purposes. Additional notes issued in this manner will be consolidated with and will form a single series with the notes being offered hereby.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We issued the notes of each series in the form of one or more fully registered global securities. We deposited these global securities with, or on behalf of, DTC and register these securities in the name of DTC&#8217;s nominee. Direct and indirect participants in DTC will record beneficial ownership of the notes by individual investors. The transfer of ownership of beneficial interests in a global security will be effected only through records maintained by DTC or its nominee, or by participants or persons that hold through participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Investors may elect to hold beneficial interests in the global securities through either DTC, Clearstream Banking S.A. (&#8220;Clearstream&#8221;) or Euroclear Bank SA&#47;NV (&#8220;Euroclear&#8221;) if they are participants in these systems, or indirectly through organizations which are participants in these systems. Beneficial interests in the global securities will be held in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Upon receipt of any payment in respect of a global security, DTC or its nominee will immediately credit participants&#8217; accounts with amounts proportionate to their respective beneficial interests in the principal amount of the global security as shown in the records of DTC or its nominee.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments by participants to owners of beneficial interests in a global security held through participants will be governed by standing instructions and customary practices and will be the responsibility of those participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC holds securities of institutions that have accounts with it or its participants. Through its maintenance of an electronic book-entry system, DTC facilitates the clearance and settlement of securities transactions among its participants and eliminates the need to deliver securities certificates physically. DTC&#8217;s participants include securities brokers and dealers, including the underwriters of this offering, banks, trust companies, clearing corporations and other organizations. DTC is owned by a number of its participants and by the New York Stock Exchange, Inc., the American Stock Exchange, Inc. and the National Association of Securities Dealers, Inc. Access to DTC&#8217;s book- entry system is also available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly. DTC agrees with and represents to its participants that it will administer its book-entry system in accordance with its rules and bylaws and requirements of law. The rules applicable to DTC and its participants are on file with the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream and Euroclear hold interests on behalf of their participants through customers&#8217; securities accounts in Clearstream&#8217;s and Euroclear&#8217;s names on the books of their respective depositaries, which in turn will hold interests in customers&#8217; securities accounts in the depositaries&#8217; names on the books of DTC. At the date of the prospectus supplement, Citibank, N.A. acts as U.S. depositary for Clearstream and JPMorgan Chase Bank, N.A. acts as</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">U.S. depositary for Euroclear, or, collectively, the &#8220;U.S. Depositaries.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream holds securities for its participating organizations, or &#8220;Clearstream Participants,&#8221; and facilitates the clearance and settlement of securities transactions between Clearstream Participants through electronic book-entry changes in accounts of Clearstream Participants, thereby eliminating the need for physical movement of certificates. Clearstream provides to Clearstream Participants, among other things, services for safekeeping, administration, clearance and settlement of internationally traded securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Clearstream is registered as a bank in Luxembourg and as such is subject to regulation by the Commission de Surveillance du Secteur Financier and the Banque Centrale du Luxembourg, which supervise and oversee the activities of Luxembourg banks. Clearstream Participants are worldwide financial institutions, including underwriters, securities brokers and dealers, banks, trust companies and clearing corporations, and may include the underwriters or their affiliates. Indirect access to Clearstream is available to other institutions that clear through or maintain a custodial relationship with a Clearstream Participant. Clearstream has established an electronic bridge with Euroclear as the operator of the Euroclear System, or the &#8220;Euroclear Operator,&#8221; in Brussels to facilitate settlement of trades between Clearstream and the Euroclear Operator.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to the notes of a series held beneficially through Clearstream will be credited to cash accounts of Clearstream Participants in accordance with its rules and procedures, to the extent received by the U.S. Depositary for Clearstream.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear holds securities and book-entry interests in securities for participating organizations, or &#8220;Euroclear Participants&#8221; and facilitates the clearance and settlement of securities transactions between Euroclear Participants, and between Euroclear Participants and participants of certain other securities intermediaries through electronic book-entry changes in accounts of such participants or other securities intermediaries. Euroclear provides Euroclear Participants with, among other things, safekeeping, administration, clearance and settlement, securities lending and borrowing, and related services.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Euroclear Participants are investment banks, securities brokers and dealers, banks, central banks, supranationals, custodians, investment managers, corporations, trust companies and certain other organizations and may include the underwriters or their affiliates. Non-participants in Euroclear may hold and transfer beneficial interests in a global security through accounts with a Euroclear Participant or any other securities intermediary that holds a book-entry interest in a global security through one or more securities intermediaries standing between such other securities intermediary and Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Distributions with respect to notes of a series held beneficially through Euroclear will be credited to the cash accounts of Euroclear Participants in accordance with the Terms and Conditions, to the extent received by the U.S. Depositary for Euroclear.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers between Euroclear Participants and Clearstream Participants will be effected in the ordinary way in accordance with their respective rules and operating procedures.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Cross-market transfers between DTC&#8217;s participating organizations, or the &#8220;DTC Participants,&#8221; on the one hand, and Euroclear Participants or Clearstream Participants, on the other hand, will be effected through DTC in accordance with DTC&#8217;s rules on behalf of Euroclear or Clearstream, as the case may be, by its U.S. Depositary&#59; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. Depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the global security in DTC, and making or receiving payment in accordance with normal procedures for same-day fund settlement applicable to DTC. Euroclear Participants and Clearstream Participants may not deliver instructions directly to their respective U.S. Depositaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Due to time zone differences, the securities accounts of a Euroclear Participant or Clearstream Participant purchasing an interest in a global security from a DTC Participant in DTC will be credited, and any such crediting will be reported to the relevant Euroclear Participant or Clearstream Participant during the securities settlement processing day (which must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a Euroclear Participant or Clearstream Participant to a DTC Participant will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#8217;s settlement date.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The information in this section concerning DTC, Euroclear and Clearstream and their book-entry systems has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy of that information.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">None of us, any of the underwriters and the trustee will have any responsibility for the performance by Euroclear or Clearstream or their respective participants of their respective obligations under the rules and procedures governing their operations.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Although DTC, Clearstream and Euroclear have agreed to the foregoing procedures in order to facilitate transfers of securities among participants of DTC, Clearstream and Euroclear, they are under no obligation to perform or continue to perform such procedures and they may discontinue the procedures at any time.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Same-Day Settlement and Payment</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Initial settlement for the notes was made in immediately available funds. Secondary market trading between DTC participants will occur in the ordinary way in accordance with DTC rules and will be settled in immediately available funds using DTC&#8217;s Same-Day Funds Settlement System.</font></div><div style="padding-left:14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">b. Base Prospectus &#8211; March 4, 2008</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Description of Debt Securities</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As used in this &#8220;Description of Debt Securities,&#8221; &#8220;debt securities&#8221; means the debentures, notes, bonds, guarantees and other evidences of indebtedness that GSK issues or that GSK Capital Inc. or GSK Capital plc (the &#8220;finance subsidiaries&#8221;) issues and GSK fully and unconditionally guarantees and, in each case, the trustee authenticates and delivers under the applicable indenture. The debt securities will be our direct unsecured obligations and will rank equally and ratably without preference among themselves and at least equally with all of our other unsecured and unsubordinated indebtedness.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities will be issued in one or more series under an indenture between GSK and Law Debenture Trust Company of New York, as trustee, or under indentures among the finance subsidiaries, Law Debenture Trust Company of New York, as trustee (as successor to Citibank, N.A., pursuant to Instruments of Resignation, Appointment and Acceptance among the finance subsidiaries, the guarantor, Law Debenture Trust Company of New York and Citibank, N.A.), and GSK, as guarantor. The indentures applicable to GSK, GSK Capital Inc. and GSK Capital plc will each be qualified under the Trust Indenture Act of 1939, as amended. In the following discussion, we sometimes refer to these indentures collectively as the &#8220;indentures.&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">This &#8220;Description of Debt Securities&#8221; briefly outlines the provisions of the indentures. The terms of the indentures will include both those stated in the indentures and those made part of the indentures by the Trust Indenture Act. The forms of the indentures have been filed as exhibits to the registration statement of which this &#8220;Description of Debt Securities&#8221; forms a part, and you should read the indentures for provisions that may be important to you.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures do not contain any covenants or other provisions designed to protect holders of the debt securities against a reduction in the creditworthiness of GSK or the finance subsidiaries in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Issuances in Series</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The indentures do not limit the amount of debt securities that may be issued. The debt securities may be issued in one or more series with the same or various maturities, at a price of 100% of their principal amount or at a premium or a discount. Not all debt securities of any one series need be issued at the same time, and, unless otherwise provided, any series may be reopened, without the consents of the holders of debt securities of that series, for issuances of additional debt securities of that series. Except in the limited circumstances described below under &#8220;&#8212; Covenants &#8212; Limitation on Liens,&#8221; the debt securities will not be secured by any property or assets of GSK, as issuer or guarantor, or the finance subsidiaries.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The terms of any authorized series of debt securities will be described in a prospectus supplement. These terms will include some or all of the following&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the title, aggregate principal amount and denominations of the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the date or dates on which principal will be payable&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the percentage of the principal amount at which the debt securities will be issued and whether the debt securities will be &#8220;original issue discount&#8221; securities for U.S. federal income tax purposes. If original issue discount debt securities are issued (generally, securities that are issued at a substantial discount below their principal amount), the special U.S. federal income tax and other considerations of a purchase of original issue discount debt securities will be described&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the rate or rates, which may be fixed or variable, at which the debt securities will bear interest&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the interest payment dates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any optional or mandatory redemption terms&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether any sinking fund is required&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the currency in which the debt securities will be denominated or principal, premium or interest will be payable, if other than U.S. dollars&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether the debt securities are to be issued as individual certificates to each holder or in the form of global certificates held by a depositary on behalf of beneficial owners&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">information describing any book-entry features&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the names and duties of any co-trustees, depositaries, authenticating agents, paying agents, transfer agents or registrars for any series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the applicability of the defeasance and covenant defeasance provisions described herein, or any modifications of those provisions&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any deletions from, modifications of or additions to the events of default or covenants with respect to the debt securities&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any other terms, conditions, rights or preferences of the debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities that have a maturity of less than one year from their date of issue and in respect of which the proceeds are to be received by us in the United Kingdom will have a minimum denomination of &#163;100,000 (or its equivalent in another currency).</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The prospectus supplement relating to any series of debt securities may add to or change statements contained in the base prospectus. The prospectus supplement may also include, if applicable, a discussion of certain U.S. federal income tax and U.K. income tax considerations.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">GSK Guarantees</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities issued by the finance subsidiaries will be fully and unconditionally guaranteed by GSK. If for any reason the applicable finance subsidiary does not make any required payment in respect of its debt securities when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. The holder of a guaranteed debt security will be entitled to payment under the applicable guarantee of GSK without taking any action whatsoever against the finance subsidiary.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Payment and Transfer</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities will be issued only as registered securities, which means that the name of the holder will be entered in a register that will be kept by the trustee or another agent appointed by us. Unless stated otherwise in a prospectus supplement, and except as described under &#8220;&#8212; Book-Entry System&#8221; below, payments of principal, interest and additional amounts, if any, will be made at the office of the paying agent or agents named in the prospectus supplement or by check mailed to you at your address as it appears in the register.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless other procedures are described in a prospectus supplement and except as described under &#8220;&#8212; Book Entry System&#8221; below, you will be able to transfer registered debt securities at the office of the transfer agent or agents named in the prospectus supplement. You may also </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">exchange registered debt securities at the office of the transfer agent for an equal aggregate principal amount of registered debt securities of the same series having the same maturity date, interest rate and other terms as long as the debt securities are issued in authorized denominations.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Neither we nor the trustee will impose any service charge for any transfer or exchange of a debt security&#59; however, we may ask you to pay any taxes or other governmental charges in connection with a transfer or exchange of debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Book-Entry System</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Debt securities may be issued under a book-entry system in the form of one or more global securities. The global securities will be registered in the name of a depositary or its nominee and deposited with that depositary or its custodian. Unless stated otherwise in the prospectus supplement, The Depository Trust Company, New York, New York, or DTC, will be the depositary if a depositary is used.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">DTC has advised us as follows&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking organization&#8221; within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code and a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section 17A of the Exchange Act&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC was created to hold securities of its participants and to facilitate the clearance and settlement of securities transactions, such as through transfers and pledges, among its participants in such securities through electronic book-entry changes to accounts of its participants, thereby eliminating the need for physical movement of securities certificates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">DTC&#8217;s participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations, some of whom (and&#47;or their representatives) own DTC&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">access to DTC&#8217;s book-entry system is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">According to DTC, the foregoing information with respect to DTC has been provided to the financial community for informational purposes only and is not intended to serve as a representation, warranty or contract modification of any kind.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Following the issuance of a global security in registered form, the depositary will credit the accounts of its participants with the debt securities upon our instructions. Only persons who hold directly or indirectly through financial institutions that are participants in the depositary can hold beneficial interests in the global securities. Since the laws of some jurisdictions require certain types of purchasers to take physical delivery of such securities in definitive form, you may encounter difficulties in your ability to own, transfer or pledge beneficial interests in a global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">So long as the depositary or its nominee is the registered owner of a global security, we and the trustee will treat the depositary as the sole owner or holder of the debt securities for purposes of the applicable indenture. Therefore, except as set forth below, you will not be entitled to have debt securities registered in your name or to receive physical delivery of certificates representing the debt securities. Accordingly, you will have to rely on the procedures of the depositary and the participant in the depositary through whom you hold your beneficial interest in order to exercise any rights of a holder under the indenture. We understand that under existing practices, the depositary would act upon the instructions of a participant or authorize that participant to take any action that a holder is entitled to take.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We will make all payments of principal, interest and additional amounts, if any, on the debt securities to the depositary. It is expected that the depositary will then credit participants&#8217; accounts proportionately with these payments on the payment date and that the participants will in turn credit their customers&#8217; accounts in accordance with their customary practices. Neither we nor the trustee will be responsible for making any payments to participants or customers of participants or for maintaining any records relating to the holdings of participants and their customers, and you will have to rely on the procedures of the depositary and its participants.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Global securities are generally not transferable. Physical certificates will be issued to beneficial owners in lieu of a global security only in the special situations described in the sixth paragraph under the heading &#8220;Legal Ownership of Debt Securities &#8212; Global Securities&#8221; below.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Consolidation, Merger or Sale</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We and the finance subsidiaries have agreed in the indentures not to consolidate with or merge with or into any other person or convey or transfer all or substantially all of our respective properties and assets to any person (except that the finance subsidiaries may merge into us), unless&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we or the applicable finance subsidiary, as the case may be, are the continuing person, or the successor expressly assumes by supplemental indenture our obligations under the applicable indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the continuing person is a U.S. or U.K. company or is organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and, if it is not a U.S. or U.K. company, the continuing person agrees by supplemental indenture to be bound by a covenant comparable to that described below under &#8220;&#8212; Covenants &#8212; Payment of Additional Amounts&#8221; with respect to taxes imposed in the continuing person&#8217;s jurisdiction of organization (in which case the continuing person will benefit from a redemption option comparable to that described below under &#8220;&#8212; Optional Redemption for Tax Reasons&#8221; in the event of changes in taxes in that jurisdiction after the date of the consolidation, merger or sale)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">immediately after the transaction, no default under the debt securities has occurred and is continuing&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we deliver to the trustee an officer&#8217;s certificate and, if neither we nor the applicable subsidiary are the continuing person, an opinion of counsel, in each case stating, among other things, that the transaction and the supplemental indenture, if required, comply with these provisions and the indenture.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Covenants</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Payment of Additional Amounts</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Payments made by us under or with respect to the debt securities will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of (i) the government of the United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or (ii) the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as &#8220;Taxes,&#8221; unless we are required to withhold or deduct Taxes by law.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the debt securities, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted&#59; provided that no additional amounts will be payable with respect to Taxes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the debt securities (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or the United States or any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein&#59;</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">payable other than by withholding from payments of principal of or interest on the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent&#58;</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes&#59; and</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">&#9642;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:11.34pt">at least 30 days before the first payment date with respect to which such additional amounts shall be payable, we have notified such recipient in writing that such recipient is required to comply with such requirement&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed but for the presentation of a debt security (where presentation is required) for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that are imposed on a payment to an individual and are required to be made pursuant to European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, or any law implementing or complying with, or introduced in order to conform to, such Directive&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">that would not have been imposed if presentation for payment of the relevant debt securities had been made to a paying agent other than the paying agent to which the presentation was made&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any combination of the foregoing items&#59;</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">nor shall additional amounts be paid with respect to any payment of the principal of or interest on any debt security to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of the debt security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in each indenture that at least one paying agent for each series of debt securities will be located outside the United Kingdom. We have also agreed that if we maintain a paying agent with respect to a particular series of debt securities in any member state of the European Union, we will maintain a paying agent in at least one member state (other than the United Kingdom) that will not be obliged to withhold or deduct taxes pursuant to any law implementing European Council Directive 2003&#47;48&#47;EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, provided there is at least one member state that does not require a paying agent to withhold or deduct pursuant to such Directive.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligation to pay additional amounts if and when due will survive the termination of the indentures and the payment of all amounts in respect of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Limitation on Liens</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We have agreed in the indentures not to incur or assume (or permit any of our subsidiaries to incur or assume) any lien on or with respect to any of our or our subsidiaries&#8217; property, assets or revenues, present or future, to secure any relevant indebtedness (as this term is defined below) without making (or causing our subsidiaries to make) effective provision for securing the debt securities equally and ratably with such relevant indebtedness as to such property, assets or revenues, for as long as such relevant indebtedness is so secured.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The restrictions on liens will not apply to&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens arising by operation of law&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens on property, assets or revenues of any person, which liens are existing at the time such person becomes a subsidiary&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">liens on property, assets or revenues of a person existing at the time such person is merged with or into or consolidated with us or any of our subsidiaries or at the time of a sale, lease or other disposition to us of the properties of a person as an entirety or substantially as an entirety.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">For purposes of the limitation on liens covenant, the term &#8220;relevant indebtedness&#8221; means any of our debt that&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">is in the form of or represented by bonds, notes, loan stock, depositary receipts or other securities issued (otherwise than to constitute or represent advances made by banks or other lending institutions)&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">is denominated in, or confers any right of payment by reference to, any currency other than the currency of the country in which the issuer of the indebtedness has its principal place of business, or is denominated in or by reference to the currency of such country but more than 20% of which is placed or offered for subscription or sale by or on behalf of, or by agreement with, the issuer outside such country&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">at its date of issue is, or is intended by the issuer to become, quoted, listed, traded or dealt in on any stock exchange, over-the-counter market or other securities market.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Additional Covenants</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may be subject to additional covenants, including restrictive covenants in respect of a particular series of debt securities. Such additional covenants will be set forth in the applicable prospectus supplement and, to the extent necessary, in the supplemental indenture or board resolution relating to that series of debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Optional Redemption for Tax Reasons</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may redeem any series of debt securities in whole but not in part at any time, on giving not less than 30 nor more than 60 days&#8217; notice of such redemption, at a redemption price equal to the principal amount plus accrued interest, if any, to the date fixed for redemption (except in the case of discounted debt securities, which may be redeemed at the redemption price specified by the terms of each series of such debt securities), if&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we determine that, as a result of any change in or amendment to the laws or any regulations or rulings promulgated thereunder of the United Kingdom (or of any political subdivision or taxing authority thereof) or the United States (or of any political subdivision or taxing authority thereof), or any change in the application or official interpretation of such laws, regulations or rulings, or any change in the application or official interpretation of, or any execution of or amendment to, any treaty or treaties affecting taxation to which any such jurisdiction is a party, which change, execution or amendment becomes effective on or after the issue date or such other date specified in the debt securities of that series&#58;</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we would be required to pay additional amounts (as described under &#8220;&#8212; Covenants &#8212; Payment of Additional Amounts&#8221; above) with respect to that series of debt securities on the next succeeding interest payment date and the payment of such additional amounts cannot be avoided by the use of reasonable measures available to us&#59; or</font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">withholding tax has been or would be required to be withheld with respect to interest income received or receivable by the applicable finance subsidiary directly from the guarantor (or any affiliate) and such withholding tax obligation cannot be avoided by the use of reasonable measures available to the applicable finance subsidiary or the guarantor (or any affiliate)&#59; or </font></div><div style="padding-left:56.69pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we determine, based upon an opinion of independent counsel of recognized standing that, as a result of any action taken by any legislative body of, taxing authority of, or any action brought in a court of competent jurisdiction in, the United Kingdom (or any political subdivision or taxing authority thereof) or the United States (or any political subdivision or taxing authority thereof) (whether or not such action was taken or brought with respect to GSK, as issuer or guarantor, or the applicable finance subsidiary, as the case may be), which action is taken or brought on or after the issue date or such other date specified in the debt securities of that series, there is a substantial probability that the circumstances described above would exist&#59; provided, however, that no such notice of </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:56.69pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">redemption may be given earlier than 90 days prior to the earliest date on which we would be obligated to pay such additional amounts.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We will also pay to each holder, or make available for payment to each such holder, on the redemption date any additional amounts resulting from the payment of such redemption price. Prior to the publication of any notice of redemption, we will deliver to the trustee&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an officer&#8217;s certificate stating that we are entitled to effect a redemption and setting forth a statement of facts showing that the conditions precedent of the right so to redeem have occurred&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an opinion of counsel to the effect that the conditions specified above have been satisfied. Any notice of redemption will be irrevocable once we deliver the officer&#8217;s certificate to the trustee.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Events of Default</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless otherwise specified in a prospectus supplement, an event of default with respect to a series of debt securities occurs upon&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of the principal (or premium, if any) of any debt security of that series when due (including as a sinking fund installment), and, in the case of technical or administrative difficulties, the continuance of that default for more than two business days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in payment of interest on, or any additional amounts payable in respect of, any debt security of that series when due and payable, and the continuance of that default for 30 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default in performing any other covenant in the indenture applicable to that series for 60 days after the receipt of written notice from the trustee or from the holders of 25% in principal amount of the debt securities of that series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">default under any bond, debenture, note or other evidence of indebtedness for money borrowed of GSK or either finance subsidiary, as the case may be (not including any indebtedness for which recourse is limited to property purchased), having in any particular case an outstanding principal amount in excess of $25,000,000 (or its equivalent in any other currency) where any such failure results in such indebtedness being accelerated and becoming due and payable prior to its stated maturity and such acceleration shall not have been rescinded or annulled or such indebtedness shall not have been discharged&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">certain events of bankruptcy, insolvency or reorganization of GSK or either finance subsidiary, as the case may be&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">any other event of default provided with respect to that particular series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Any additional or different events of default applicable to a particular series of debt securities will be described in the prospectus supplement relating to such series.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">An event of default with respect to a particular series of debt securities will not necessarily constitute an event of default with respect to any other series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The trustee may withhold notice to the holders of debt securities of any default (except in the payment of principal, premium or interest) if it, in good faith, considers such withholding of notice to be in the best interests of the holders. A default is any event which is an event of default described above or would be an event of default but for the giving of notice or the passage of time.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an event of default occurs and continues, the trustee or the holders of the aggregate principal amount of the debt securities specified below may require us to repay immediately, or accelerate&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the entire principal of the debt securities of such series&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">if the debt securities are original issue discount securities, such portion of the principal as may be described in the applicable prospectus supplement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If the event of default occurs because of a default in a payment of principal or interest on the debt securities of any series, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of that series can accelerate that series of debt securities. If the event of default occurs because of a failure to perform any other covenant in the applicable indenture or any covenant for the benefit of one or more, but not all, of the series of debt securities, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of all series affected, voting as one class, can accelerate all of the affected series of debt securities. If the event of default occurs because of bankruptcy proceedings, then all of the debt securities under the indenture will be accelerated automatically. Therefore, except in the case of a default on a payment of principal or interest on the debt securities of your series or a default due to our bankruptcy or insolvency, it is possible that you may not be able to accelerate the debt securities of your series because of the failure of holders of other series to take action.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The holders of a majority of the aggregate principal amount of the debt securities of all affected series, voting as one class, can rescind this accelerated payment requirement or waive any past default or event of default or allow noncompliance with any provision of the applicable indenture. However, they cannot waive a default in payment of principal of, premium, if any, or interest on any of the debt securities when due otherwise than as a result of acceleration.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">After an event of default, the trustee must exercise the same degree of care a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee is not obligated to exercise any of its rights or powers under the applicable indenture at the request, order or direction of any holders, unless the holders offer the trustee reasonable indemnity. If they provide this reasonable indemnity, the holders of a majority in principal amount of all affected series of debt securities, voting as one class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any power conferred upon the trustee, for any series of debt securities. However, the trustee may refuse to follow any direction that conflicts with law or the indenture or is unduly prejudicial to the rights of other holders.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">No holder will be entitled to pursue any remedy with respect to the indenture unless the trustee fails to act for 60 days after it is given&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">notice of default by that holder&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">a written request to enforce the indenture by the holders of not less than 25% in principal amount of all outstanding debt securities of any affected series&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an indemnity to the trustee, satisfactory to the trustee&#59;</font></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">and during this 60-day period the holders of a majority in principal amount of all outstanding debt securities of such affected series do not give a direction to the trustee that is inconsistent with the enforcement request. These provisions will not prevent any holder of debt securities from enforcing payment of the principal of (and premium, if any) and interest on the debt securities at the relevant due dates.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an event of default with respect to a series of debt securities occurs and is continuing, the trustee will mail to the holders of those debt securities a notice of the event of default within 90 days after it occurs. However, except in the case of a default in any payment in respect of a series of debt securities, the trustee shall be protected in withholding notice of an event of default if it determines in good faith that this is in the interests of the holders of the relevant debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Modification of the Indentures</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In general, rights and obligations of us and the holders under the indentures may be modified if the holders of a majority in aggregate principal amount of the outstanding debt securities of each series affected by the modification consent to such modification. However, each of the indentures provides that, unless each affected holder agrees, an amendment cannot&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">make any adverse change to any payment term of a debt security such as extending the maturity date, extending the date on which we have to pay interest or make a sinking fund payment, reducing the interest rate, reducing the amount of principal we have to repay, changing the currency in which we have to make any payment of principal, premium or interest, modifying any redemption or repurchase </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="padding-left:42.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%">right, or right to convert or exchange any debt security, to the detriment of the holder and impairing any right of a holder to bring suit for payment&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">waive any payment default&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">reduce the percentage of the aggregate principal amount of debt securities needed to make any amendment to the applicable indenture or to waive any covenant or default&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">make any other change to the amendment provisions of the applicable indenture.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">However, if we and the trustee agree, the applicable indenture may be amended without notifying any holders or seeking their consent if the amendment does not materially and adversely affect any holder. We and the trustee are permitted to make modifications and amendments to the applicable indenture without the consent of any holder of debt securities for any of the following purposes&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to cure any ambiguity, defect or inconsistency in the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to comply with sections of the indenture governing when we may merge and substituted obligors&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to comply with any requirements of the U.S. Securities and Exchange Commission in connection with the qualification of the indenture under the Trust Indenture Act&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to evidence and provide for the acceptance by a successor trustee of appointment under the indenture with respect to the debt securities of any or all series&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to establish the form or forms or terms of the debt securities of any series or of the coupons appertaining to such debt securities as permitted under the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to provide for uncertificated debt securities and to make all appropriate changes for such purpose&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to provide for a further guarantee from a third party on outstanding debt securities of any series and the debt securities of any series that may be issued under the indenture&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to change or eliminate any provision of the indenture&#59; provided that any such change or elimination will become effective only when there are no outstanding debt securities of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to supplement any of the provisions of the indenture to such extent as will be necessary to permit or facilitate the defeasance and discharge of any series of debt securities pursuant to the indenture&#59; provided that any such action will not adversely affect the interests of the holders of such or any other series of debt securities in any material respect&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">to make any change that does not materially and adversely affect the rights of any holder of the debt securities.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Defeasance</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The term defeasance means discharge from some or all of the obligations under the indentures. If we deposit with the trustee sufficient cash or government securities to pay the principal, interest, any premium and any other sums due to the stated maturity date or a redemption date of the debt securities of a particular series, then at our option&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we will be discharged from our respective obligations with respect to the debt securities of such series&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we will no longer be under any obligation to comply with the restrictive covenants, if any, contained in the applicable indenture and any supplemental indenture or board resolution with respect to the debt securities of such series, and the events of default relating to failures to comply with covenants will no longer apply to us.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this happens, the holders of the debt securities of the affected series will not be entitled to the benefits of the applicable indenture except for registration of transfer and exchange of debt securities and replacement of lost, stolen or mutilated debt securities. Instead, the holders will only be able to rely on the deposited funds or obligations for payment.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We must deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the holders of the debt securities to recognize income, gain or loss for U.S. federal income tax purposes. We may, in lieu of an opinion of counsel, deliver a ruling to such effect received from or published by the U.S. Internal Revenue Service.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Substitution of Issuer</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We may at our option at any time, without the consent of any holders of debt securities, cause GSK or any other subsidiary of GSK to assume the obligations of the applicable finance subsidiary under any series of debt securities, provided that the new obligor executes a supplemental indenture in which it agrees to be bound by the terms of those debt securities and the relevant indenture. If the new obligor is not a U.S. or U.K. company, it must be organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and it must also agree in the supplemental indenture to be bound by a covenant comparable to that described above under &#8220;&#8212; Covenants &#8212; Payment of Additional Amounts&#8221; with respect to taxes imposed in its jurisdiction of organization (in which case the new obligor will benefit from a redemption option comparable to that described above under &#8220;&#8212; Optional Redemption for Tax Reasons&#8221; in the event of changes in taxes in that jurisdiction after the date of the substitution). In the case of such a substitution, the applicable finance subsidiary will be relieved of any further obligation under the assumed series of debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">For U.S. federal income tax purposes, a substitution of obligors as described above generally would be treated as a deemed taxable exchange of debt securities for new debt securities issued by the new obligor. As discussed further in the applicable prospectus supplement, a United States person who holds debt securities or owns a beneficial interest therein generally will recognize capital gain or loss in an amount equal to the difference between the issue price of the new debt securities and such person&#8217;s adjusted tax basis in the debt securities. Such persons should consult their own tax advisors regarding the tax consequences of a deemed taxable exchange in the event of a substitution of obligors.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Information Concerning the Trustee</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Law Debenture Trust Company of New York will be the trustee. The trustee will be required to perform only those duties that are specifically set forth in the indentures, except when a default has occurred and is continuing with respect to the debt securities. After a default, the trustee must exercise the same degree of care that a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee will be under no obligation to exercise any of the powers vested in it by the indentures at the request of any holder of debt securities unless the holder offers the trustee reasonable indemnity against the costs, expenses and liabilities that might be incurred by exercising those powers.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Governing Law</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The debt securities, the related guarantees and the indentures will be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Legal Ownership of Debt Securities</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">&#8220;Street Name&#8221; and Other Indirect Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">We generally will not recognize investors who hold debt securities in accounts at banks or brokers as legal holders of those debt securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Holding securities in accounts at banks or brokers is called holding in &#8220;street name.&#8221; If an investor holds debt securities in street name, we recognize only the bank or broker or the financial institution the bank or broker uses to hold the debt securities. These intermediary banks, brokers </font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">and other financial institutions pass along principal, interest and other payments on the debt securities, either because they agree to do so in their customer agreements or because they are legally required to do so. If you hold debt securities in street name, you should check with your own institution to find out&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it handles payments and notices with respect to securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether it imposes fees or charges&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it would handle voting if ever required&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how and when you should notify it to exercise on your behalf any rights or options that may exist under the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">whether and how you can instruct it to send you securities registered in your own name so you can be a direct holder as described below&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">how it would pursue rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Registered Holders</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Our obligations, as well as the obligations of the trustee and those of any third parties employed by us or the trustee, extend only to persons who are registered as holders of debt securities. As noted above, we do not have obligations to you if you hold in street name or through other indirect means, either because you choose to hold debt securities in that manner or because the debt securities are issued in the form of global securities as described below. For example, once we make payment to the registered holder, we have no further responsibility for the payment even if that holder is legally required to pass the payment along to you as a street name customer but does not do so.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Global Securities</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">A global security is a special type of indirectly held security. If we choose to issue debt securities in the form of global securities, the ultimate beneficial owners of the debt securities will be indirect holders. We do this by requiring that the global security be registered in the name of a financial institution we select and by requiring that the debt securities represented by the global security not be registered in the name of any other holder except in the special situations described below. The financial institution that acts as the sole registered holder of the global security is called the depositary. Any person wishing to own a debt security may do so indirectly through an account with a broker, bank or other financial institution that in turn has an account with the depositary. The prospectus supplement will indicate whether your series of debt securities will be issued only as global securities.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Transfers of debt securities represented by the global security will be made only on the records of the depositary or its nominee by transferring such debt securities from the account of one broker, bank or financial institution to the account of another broker, bank or financial institution. These transfers are made electronically only and are also known as book- entry transfers. Securities in global form are sometimes also referred to as being in book-entry form.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">As an indirect holder, your rights relating to a global security will be governed by the account rules of your broker, bank or financial institution and of the depositary, as well as general laws relating to securities transfers. We will not recognize you as a holder of debt securities and instead will deal only with the depositary that holds the global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">You should be aware that if debt securities are issued only in the form of a global security&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you cannot have debt securities registered in your own name&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you cannot receive physical certificates for your interest in the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you will be a street name holder and must look to your own broker, bank or financial institution for payments on the debt securities and protection of your legal rights relating to the debt securities&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">you may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own securities in the form of physical certificates&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary&#8217;s policies will govern payments, transfers, exchanges and other matters relating to your indirect interest in the global security. We and the trustee will have no responsibility for any aspect of the depositary&#8217;s actions or for its records of ownership interests in the global security. We and the trustee also will not supervise the depositary in any way&#59; and</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary will require that indirect interests in the global security be purchased or sold within its system using same-day funds for settlement.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In a few special situations described below, the global security will terminate and the indirect interests in it will be exchanged for registered debt securities represented by physical certificates. After that exchange, the choice of whether to hold debt securities in registered form or in street name will be up to you. You must consult your broker, bank or financial institution to find out how to have your interests in debt securities transferred to your name, so that you will be a registered holder.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Unless we specify otherwise in the prospectus supplement, the special situations for termination of a global security are&#58;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">when the depositary notifies us that it is unwilling or unable to continue as depositary and we do not or cannot appoint a successor depositary within 90 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">the depositary ceases to be a clearing agency registered under the Exchange Act and we do not appoint a successor depositary within 90 days&#59;</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">an event of default has occurred and is continuing and beneficial owners representing a majority in principal amount of the applicable series of debt securities have advised the depositary to cease acting as the depositary&#59; or</font></div><div style="padding-left:42.52pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:105%;padding-left:10.67pt">we decide we do not want to have the debt securities of that series represented by a global security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">The prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of debt securities covered by the prospectus supplement. When a global security terminates, the depositary (and not us or the trustee) is responsible for deciding the names of the institutions that will be the initial registered holders.</font></div><div style="margin-bottom:5.5pt;margin-top:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:139%">The Term &#8220;Holder&#8221;</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">In the descriptions of the debt securities included herein, when we refer to the &#8220;holder&#8221; of a given debt security as being entitled to certain rights or payments, or being permitted to take certain actions, we are in all cases referring to the registered holder of the debt security.</font></div><div style="margin-bottom:5.5pt;text-indent:28.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:139%">While you would be the registered holder if you held a certificated security registered in your name, it is likely that the holder will actually be either the broker, bank or other financial institution where you have your street name account, or, in the case of a global security, the depositary. If you are an indirect holder, you will need to coordinate with the institution through which you hold your interest in a debt security in order to determine how the provisions involving holders described in this prospectus and any prospectus supplement will actually apply to you. For example, if the debt security in which you hold a beneficial interest in street name can be repaid at the option of the holder, you cannot exercise the option yourself by following the procedures described in the prospectus supplement. Instead, you would need to cause the institution through which you hold your interest to take those actions on your behalf. Your institution may have procedures and deadlines different from or additional to those described in the prospectus supplement relating to the debt security.</font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>3
<FILENAME>exhibit111-sharedealingcode.htm
<DESCRIPTION>EX-11.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i9d2daf0a8f8e408cbd2ebf4a67588575_1"></div><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Procedure for Dealing in Securities </font></div><div><font style="color:#ff6600;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">GSK Corporate</font></div><div><font style="color:#ff6600;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SOP_606739 (6.0)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#007bc3;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Why do we have this SOP&#63;</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#007bc3;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What does this SOP cover&#63;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#635a54;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This SOP covers&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.9pt">Disclosure and control of inside information</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.9pt">The selective disclosure of inside information</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.9pt">Dealing in GSK equity and debt securities</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#635a54;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This SOP supports </font><font style="color:#635a54;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">POL-GSK-008, the Code for Dealing in GSK Securities (&#8220;the Code&#8221;)</font><font style="color:#635a54;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#007bc3;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Why should you read this&#63;</font></div><div><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This SOP gives guidance on GSK&#8217;s standards of practice and procedures when dealing in securities of GSK, or securities of companies that GSK is doing business with and imposes restrictions on dealing that go beyond those imposed by law. Failure to comply with this SOP and the Code may result in disciplinary action and may also constitute a civil or criminal offence.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#be0077;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What do you need to do&#63;</font></td></tr></table></div><div style="margin-top:3pt"><font style="font-family:'Wingdings',sans-serif;font-size:13pt;font-weight:400;line-height:120%"></font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You need to comply with the Code and this SOP if you are deemed to have access to inside information.<br></font></div><div style="margin-bottom:3pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This SOP applies to </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">all employees and complementary workers</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the GSK Group who have access to inside information due to their office or employment or involvement in a business transaction or situation, and who are included on Insider Lists, including&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">The Directors of GSK</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">Members of the GSK Leadership Team (&#8220;GLT&#8221;)</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">The Company Secretary of GSK</font></div><div style="margin-bottom:3pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">together Persons Discharging Managerial Responsibility (&#8220;PDMRs&#8221;)</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">Members of the Disclosure Committee, GSK&#8217;s Investor Relations team and individuals designated by GLT members, </font></div><div style="margin-bottom:3pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">together </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designated Employees</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;DEs&#8221;)</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">The </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Persons Closely Associated</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (&#8220;PCAs&#8221;) of PDMRs and DEs,  </font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:14.67pt">Project Insiders </font></div><div><font style="font-family:'Wingdings',sans-serif;font-size:13pt;font-weight:400;line-height:120%"></font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Management</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of GSK, </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GSK functions</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GSK business units</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are ultimately responsible for ensuring this procedure is communicated to all their employees. <br></font></div><div><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Secretariat </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is responsible for monitoring the implementation and communication of the Code. </font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#be0077;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">How do you do it&#63;</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">1</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inside Information</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.20500000000000002em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.225em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.20500000000000002em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">precise</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.20500000000000002em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nature,</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.21em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">which</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.20500000000000002em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.21em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">not</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.21em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">been made public, relating, directly or indirectly, to GSK or any GSK Securities, and</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.115em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">which, if</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.075em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">it</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.06em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">were</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.06em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">made</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.055em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">public,</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.06em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">would</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.055em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">be</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.055em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">likely</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.045em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.055em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">have</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.055em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.07em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">significant</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.06em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">effect</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.06em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">on</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.04em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.04em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">price</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.055em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.075em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:0.01em;line-height:120%">any</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> GSK</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;letter-spacing:-0.02em;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the course of an ongoing process (such as a significant transaction or investigation), inside information may arise at different stages. As a result, an assessment of whether inside information arises must be examined at each stage. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Delaying Disclosure</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK is required to disclose inside information as soon as possible, but may delay disclosure if each of the following conditions is met&#58;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Immediate disclosure is likely to prejudice GSK&#8217;s legitimate interests&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The delay of the disclosure is not likely to mislead the public&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">GSK is able to ensure the confidentiality of that information.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A short delay is permissible for GSK to clarify whether information is, in fact, inside information. Once inside information is identified, a delay will not be permitted solely to ascertain the precise implications of the information &#8211; in these circumstances a holding announcement should be issued.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Results</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK will generally be able to delay disclosure of information that is generated in the process of the preparing quarterly financial results. However, if it is determined that the financial results are outside the market&#8217;s expectations, an immediate announcement will be required. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Record-keeping and notifying the FCA</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK must highlight in its announcement that the information communicated is inside information, post the information on its website and keep it there for five years. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inside information must be located in an easily identifiable section of GSK&#8217;s website, be presented in chronological order and indicate the date and time of disclosure.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a decision to delay disclosure is made, GSK must maintain records of the decision to delay disclosure, including the dates and times when&#58;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">the inside information first existed within GSK&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">the decision to delay disclosure was made&#59; and</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">GSK is likely to disclose the inside information. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK must also keep a record of the basis on which it made each decision to delay disclosure, including reviews subsequently undertaken to ensure that the conditions that justified the delay remained and the grounds for concluding that the confidentiality of the information would be maintained. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When the delayed information is announced, GSK must notify the FCA that disclosure was delayed. The FCA is then entitled to request an explanation of the decision behind the delay. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"></font><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If you think you are in possession of inside information, but have not been notified that you are on an insider list, or you think you should be added to an insider list, you should contact a member of Corporate Secretariat. If you think that you are in possession of inside information which has not yet been reviewed by the Disclosure Committee and you are not aware that an insider project list exists, you should contact the Company Secretary immediately.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.75pt solid #be0077;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:133%">2</font></td><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.75pt solid #be0077;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Insider Lists</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK must maintain lists of individuals with inside information which must be properly updated as and when individuals become, or cease to be, insiders. Insider lists are kept for a period of five years and will be provided to the FCA on request. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under current regulation, insider lists need to contain Sensitive Personally Identifiable Information (&#8220;SPII&#8221;) for individuals on insider lists as follows&#58; full name (including former names), job title, date of birth, national identification number, work and home addresses and telephone numbers. GSK maintains &#8220;permanent insider&#8221; lists (PDMRs, DEs, and PDMR PCAs) and project insider lists. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK must take reasonable steps to ensure that insiders acknowledge in writing their duties as insiders and their awareness of the sanctions applicable to insider dealing and unlawful disclosure of inside information. GSK must also maintain an electronic copy of its insider list.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK&#8217;s insider lists are maintained using the Insidertrack tool, managed by Corporate Secretariat, which can be accessed by individuals who wish to review their list membership, and to update and supplement SPII.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"></font><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">If you are on an insider list you must not deal in GSK securities. If you are a Designated Employee you must always seek consent to deal &#8211; such clearance will not be given in a financial results closed period, and&#47;or whilst you are on an insider list.</font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:133%">3</font></td><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selective Disclosure of information</font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK may make selective disclosure in situations including&#58;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Communicating information to key investors prior to announcement in order to gauge their interest in a possible transaction&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Conducting discussions with key investors about the terms of a potential acquisition, including its potential size or pricing&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Contacting key investors to obtain financial commitments from them to participate in debt issuance or additional equity offering&#59; and</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Discussing a transaction or other situation with rating agencies ahead of announcement. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Before disclosing information, GSK must assess whether it constitutes inside information and make a written record of its conclusion. The FCA may request a copy of such record. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This assessment and record-keeping procedure must be carried out every time GSK makes selective disclosure, even if there is no disclosure of inside information.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When carrying out a selective disclosure, GSK must&#58;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Obtain, via email or telephone, the consent of the proposed recipient to receive the information &#8211; if the proposed recipient does not consent, the Company must not disclose the information&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Inform the recipient that (i) they are prohibited from using the information to acquire, dispose of or amend an order that has been placed for financial instruments, on the basis of the information provided and (ii) they must keep the information confidential&#59;</font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">For each disclosure of information, draw up a list of those who have agreed and those who have not agreed to receive the information (together with dates and times of communications)&#59; </font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Maintain records of the selective disclosure for at least five years and use recorded telephone lines when obtaining the consent of the recipient (or, if no consent is given or this is not possible, keep minutes of the discussion signed by both parties)&#59; </font></div><div style="margin-bottom:6pt;padding-left:20.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">Notify the recipient when the information ceases to be inside information (even if it has been publicly announced) and retain a record of the decisions which led to the assessment that the information is no longer inside information for five years. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"></font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If you are involved in projects where GSK is doing business with other companies you must be aware of these procedures, and you must take care not to inadvertently share GSK information that might be inside information, or disclose information that might be inside information for the company GSK is doing business with. If in doubt, please contact Corporate Secretariat or the Company Secretary.</font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:133%">4</font></td><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#be0077;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dealing in securities, closed periods and notifications</font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dealings</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dealings subject to the Code include subscriptions to share capital issuances or debt instrument issuances and transactions executed by a third party under an individual portfolio, or asset management mandate on behalf or for a relevant employee. The full revised list can be viewed in Appendix 1 to this SOP. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notification and clearance will be required for a transaction which is undertaken by a third party for the account of the relevant employee, even where the third party is exercising full discretion (i.e. not acting on the instruction of the employee). Transactions which are undertaken under a trading plan or saving scheme, or by a &#8220;family office&#8221;, a trust, a discretionary portfolio arrangement and all other investment vehicles, are therefore likely to require notification and clearance. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No notification will be required for transactions in financial instruments which are linked to shares or debt instruments where either&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The financial instrument is a unit or share in a collective investment undertaking whose exposure to GSK shares or debt instruments does not exceed 20% of the assets held by the collective investment undertaking&#59; or</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The financial instrument provides exposure to a portfolio of assets in which the exposure to GSK shares or debt instruments does not exceed 20% of the portfolio&#8217;s assets. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In practice, this should exclude notification and clearance being required for dealings carried out by pension funds and other collective investment vehicles in which the relevant employee is invested. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Closed Periods</font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK adopts the following closed periods</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The period from the end of the financial year up to and including the preliminary results announcement&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The period from the end of each of the other financial quarters up to and including the relevant quarterly results announcement, or, if longer, the period of 30 calendar days immediately preceding such announcement. </font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Clearance</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PDMRs and DEs will be required at all times to seek clearance to deal. This can be done via the Insidertrack tool https&#58;&#47;&#47;insiders.gsk.com&#47; managed by Corporate Secretariat. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the case of a PDMR or DE, clearance will not be given where any matter exists which constitutes inside information. In the case of an employee who only appears on an insider list, clearance will not be given whilst they remain on that list. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dealings may be permitted during a closed period or a period where inside information exists if&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">There are exceptional circumstances, such as severe financial difficulty, which require the immediate sale of shares&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The dealing is pursuant to an employee share scheme where the terms of the award or grant of GSK securities have been agreed before the start of the relevant period and cannot be changed&#59; or</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">The relevant employee is acquiring GSK securities under an employee saving scheme and he or she has entered into the scheme before the start of the relevant period, does not alter the terms of his or her participation during the period and the arrangements for the purchase of securities are either clearly set out and cannot be altered or are planned to occur at a fixed date. </font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.5pt solid #be0077;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #be0077;border-top:0.5pt solid #be0077;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A PDMR or DE may be permitted to deal during a closed period if&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">He or she is taking up an entitlement in respect of a rights issue&#59; or</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-.</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.51pt">He or she is transferring GSK securities between two of his or her accounts, provided that such a transfer does not result in a change in price of the securities. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"></font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">All relevant employees should consult the Code, which contains a more detailed explanation of when the exceptions apply or seek advice from GSK&#8217;s Corporate Secretariat as to when dealing will be permitted</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notifications</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PDMRs and their PCAs are required to notify GSK and the FCA of every transaction conducted on their own account relating to GSK shares or debt instruments. The time period for notification is within two business days of the transaction, although in practice the notification will be made by Corporate Secretariat on behalf of PDMRs or their PCA to the FCA.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GSK must announce information relating to transactions that are notified to it by PDMRs and their PCAs promptly and within three business days of the transaction. </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the Code, PDMRs must also seek to prohibit their PCAs from dealing without prior clearance to Deal, which will not be granted during a Closed Period. </font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#be0077;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Training &#38; Communication</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GSK Internal Guides</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Training and induction on this SOP for PDMRs is handled by the Company Secretary. The Corporate Secretariat team provides training and communication required under this SOP for all other employees</font><font style="color:#635a54;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and complementary workers </font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily through the Insidertrack tool, and whenever appropriate, training and support in person.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#be0077;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Monitoring</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management Monitoring (MM)&#58;  </font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As identified in this SOP, Corporate Secretariat is required to assess and monitor controls to ensure they are in place, in use and effective. Corporate Secretariat is ensuring that MM is appropriate, proportionate, solution focused, and documented. Corporate Secretariat will record MM activities and retain results to evidence that key controls in this SOP are in place. .<br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Independent Business Monitoring (IBM)&#58;  </font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Secretariat, supported by Ethics and Compliance, are accountable for ensuring that a fit for purpose and structured monitoring programme is in place, in line with the risk associated with the business activity. Controls included within this written standard may be subject to Independent Business Monitoring procedures.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ff6600;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;If you have concerns</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you have&#160;concerns&#160;about how to apply this procedure you should bring them to the attention of a manager, supervisor&#160;or a member of Corporate Secretariat. If you see any violations of this company procedure, please report it through the appropriate Speak Up channels. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To find your local Speak Up integrity line number or to report online, please visit&#58; </font><font style="color:#ff6600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.gsk.com&#47;speakup</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you feel you are unable to comply with this guideline or the mandatory controls it supports, please contact the document author and your</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#ff6600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;letter-spacing:-0.02em;line-height:120%;text-decoration:underline">Ethics &#38; Compliance Business Partner</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#9a8b7d;border-bottom:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Administration</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Governance Board Approval&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">GSK plc Board of Directors</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Governance<br>Approval Date&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">18-December-2018</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Owner&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Victoria Whyte, SVP &#38; Company Secretary</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Author&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard Webster, Interim Director, </font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governance, Plc &#38; Shareholder Services</font></div></td></tr><tr style="height:28pt"><td colspan="3" rowspan="2" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">History&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This procedure supersedes and replaces </font><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOP_606739 (5.0) - Procedure for Dealing in Securities SOP-GSK-008</font></div></td></tr><tr style="height:78pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes since last revision</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">Update to GSK Connect link in Code for Dealing in Securities</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">Amendment to Code for Dealing in Securities page numbers in contents page.</font></div></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Previous<br>Versions&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26-Apr-2019&#58; SOP_606739&#47; SOP-GSK-008 v5</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16-May-2018&#58; SOP_606739 &#47; SOP-GSK-008 v4</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20-Feb-2018&#58; SOP_606739 &#47; SOP-GSK-008 v3</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#605552;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">03-Jul-2016&#58; SOP_606739 &#47; SOP-GSK-008 v2</font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">See CDMS for Document Effective Date</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9d2daf0a8f8e408cbd2ebf4a67588575_4"></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">GSK plc</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">________________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Code for Dealing in Securities</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">DETAILED GUIDANCE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">________________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Contents</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Page</font></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Purpose</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Definitions</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Scope</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Responsibilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Dealing by PDMRs and Restricted Persons</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">6.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Clearance to Deal</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">13</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">7.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Dealing by PCAs</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">8.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Investment Managers</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">9.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Circumstances for refusal</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Exceptional circumstances</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">11.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Employee share or saving schemes</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">16</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">12.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Entitlements in respect of rights issues and other offers</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">17</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">13.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Transfers between accounts</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">17</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">14.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Saving schemes</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">17</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">15.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Acting as a trustee</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">16.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notifiable Transactions</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">17.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Sanction</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">19</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">18.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Communication of issues</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">19</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Schedule 1&#58; Dealings</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">20</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Schedule 2&#58; Notification template</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">22</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CODE FOR DEALING IN SECURITIES</font></div><div style="text-align:center"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DETAILED GUIDANCE</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;PURPOSE</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of this Dealing Code (the &#8220;Code&#8221;) is to give clear guidance to officers, employees and complementary workers of GSK plc (&#8220;GSK&#8221;) and its subsidiaries and subsidiary undertakings on the standards of practice and pre-clearance procedures to be followed when dealing in the securities of GSK or the securities of any company with which GSK is doing business.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">This Code imposes dealing restrictions which go beyond those imposed by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Its purpose is to ensure that directors and other persons discharging managerial responsibilities comply with their obligations under the Market Abuse Regulation and that they do not abuse, and do not place themselves under suspicion of abusing, inside information that they may be thought to have. This means that there will be certain times when such persons cannot deal in the securities of GSK.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure by any person who is subject to this Code to observe and comply with its requirements may result in disciplinary action. Depending on the circumstances, such non- compliance may also constitute a civil and&#47;or criminal offence.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;DEFINITIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Code the following definitions apply unless the context requires otherwise&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Closed Period</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of the following periods&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the period from the end of the relevant financial year up to and including the time of the preliminary announcement of GSK&#8217;s annual results or, if longer, the period of 30 calendar days immediately preceding (and including) the time of any such announcement&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the period from the end of the relevant financial quarter up to and including the time of the announcement of GSK&#8217;s first, second or third quarter results or, if longer, the period of 30 calendar days immediately preceding (and including) the time of any such announcement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dealing</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, in respect of any person, the conducting of any transaction on his or her own account or for the account of a third party, directly or indirectly, relating to GSK Securities or on the price of related derivatives (and related terms, such as &#8220;Deal&#8221;, &#8220;Deals&#8221; and &#8220;Dealt&#8221;, shall be interpreted accordingly)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designated Employee</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an employee or a complementary worker of GSK who is not a PDMR but who has regular access to Inside Information and has received a notification from Corporate Secretariat that they are a Designated Employee for the purposes of this Code&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disregarded Undertaking</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a collective investment undertaking or portfolio of assets which satisfies the following two conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;it is either&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;a collective investment undertaking or portfolio of assets in respect of which the relevant Restricted Person or PCA has ascertained that the exposure to GSK Securities does not exceed 20% of the assets held by that collective investment undertaking or portfolio of assets&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;a collective investment undertaking or portfolio of assets whose exposure to GSK Securities cannot be ascertained by the relevant Restricted Person or PCA&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the relevant Restricted Person or PCA is unable to determine or influence the investment strategy or transactions of that collective investment undertaking or portfolio of assets&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Scheme</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a scheme for encouraging or facilitating the holding of GSK Securities by or for the benefit of&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;one or more of the bona fide employees or former employees of GSK (or of any of GSK&#8217;s subsidiaries or subsidiary undertakings)&#59; and&#47;or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;one or more of the spouses, civil partners, surviving spouses, surviving civil partners or minor children or step-children of such employees or former employees&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GSK Securities</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any publicly traded or quoted shares or debt instruments of GSK (or of any of GSK&#8217;s subsidiaries or subsidiary undertakings) or derivatives or other financial instruments linked to any of them&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inside Information</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means information of a precise nature, which has not been made public, relating, directly or indirectly, to GSK or any GSK Securities, and which, if it were made public, would be likely to have a significant effect on the price of any GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given in paragraph 5.4&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Manager</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an investment professional who manages investments with or without discretion&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Abuse Regulation</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the EU Market Abuse Regulation (596&#47;2014)&#59; &#8220;Notifiable Transaction&#8221; has the meaning given in paragraph 16.2&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PCA</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of a person means a person closely associated with that person, being any of&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;a spouse or civil partner&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;a child or stepchild under the age of 18 years who is unmarried and does not have a civil partner&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;a relative who has shared the same household for at least one year on the date of the relevant Dealing&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;a legal person, trust or partnership, the managerial responsibilities of which are discharged by a Restricted Person&#47;Insider&#47;Designated Employee or by a person referred to in paragraphs (A), (B), or (C) of this definition, which is directly or indirectly controlled by such a person, which is set up for the benefit of such a </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">person or which has economic interests which are substantially equivalent to those of such a person&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PDMR</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person discharging managerial responsibilities in respect of GSK, being either&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;a director of GSK&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;a member of GSK&#8217;s GSK Leadership Team&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the Company Secretary of GSK.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prohibited Period</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of the following periods&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;any Closed Period&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;any period when there exists any matter which constitutes Inside Information&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Person</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who is&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;a PDMR&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;a Designated Employee&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;an Insider (on the basis set out in paragraph 5.4)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;SCOPE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Code applies to certain officers, employees and complementary workers of GSK (and its subsidiaries and subsidiary undertakings) who have access to Inside Information due to their office or employment or involvement in a business transaction or situation, and who are included on insider lists, including&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;PDMRs&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Designated Employees&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Insiders&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;PCAs and Investment Managers of PDMRs and Designated Employees.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;RESPONSIBILITIES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;All officers, employees and complementary workers of GSK (and its subsidiaries and subsidiary undertakings) are individually responsible for their compliance with this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;Senior management of GSK are ultimately responsible for ensuring this Code is communicated to all officers, employees and complementary workers.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;DEALING BY PDMRS AND DESIGNATED EMPLOYEES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;A PDMR or Designated Employee must not Deal in any GSK Securities without obtaining clearance to Deal in advance in accordance with paragraph 6.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;Schedule 1 contains a non-exhaustive list of transactions which could constitute Dealing for the purpose of this Code. Any individual who is uncertain as to whether or not any particular transaction requires clearance should consult the Company Secretary.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;Irrespective of whether permission to Deal has been granted to an individual, he or she remains subject to the insider dealing prohibitions set out in the Market Abuse Regulation and the Criminal Justice Act 1993. Nothing in this Code sanctions a breach of the prohibitions of insider dealing or of unlawful disclosure of inside information under the Market Abuse Regulation, the provisions of the Criminal Justice Act 1993 relating to insider dealing and the improper disclosure of information or any other relevant legal or regulatory requirements.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;&#160;&#160;&#160;Individuals who are notified in writing that he or she is on an insider list (&#8220;Insiders&#8221;) become prohibited from Dealing in GSK Securities and will be subject to the requirements of this Code until such time as he or she receives written notification from Corporate Secretariat that they are no longer included on the relevant Insider List (unless at that time the individual has been notified that he or she is on another insider list).</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;&#160;&#160;&#160;Individuals should note that this Code applies differently to PDMRs, Designated Employees and Insiders. They should be mindful that their categorisation may change from time to time (for example a Designated Employee may be included on an insider list and therefore become an Insider) and should ensure that they comply with all relevant provisions of this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;CLEARANCE TO DEAL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">6.1&#160;&#160;&#160;&#160;PDMRs</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chairman, the Chief Executive Officer, the Chief Financial Officer, Senior Independent Non-Executive Director (&#8220;SID&#8221;) and the Company Secretary are each authorised to give consent to deal to Restricted Persons and the Company Secretary as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">DEALINGS BY&#58;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">REQUIRE CLEARANCE BY&#58;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Chair</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Chief Executive Officer or the SID</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Chief Executive Officer</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chair or the SID</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Other Directors or the Company Secretary</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of the Chairman,</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Chief Executive Officer or the Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">GLT members</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of the Chair, the Chief Executive Officer, the Chief Financial Officer or the Company Secretary</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">6.2&#160;&#160;&#160;&#160;Designated Employees</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designated Employees must not Deal in any GSK Securities without first notifying the Company Secretary in writing and receiving clearance to Deal from him or her.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">6.3&#160;&#160;&#160;&#160;Clearance process</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;All applications for Dealing clearance must be made through the Company Secretary&#8217;s office using the electronic consent to deal tool available on the Corporate Secretariat Community accessible on </font><font style="color:#ff6600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">mygsk.com</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Secretariat will maintain a record of the response to any Dealing request made by a PDMR or Designated Employee and of any clearance given.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Corporate Secretariat will aim to respond to all Dealing requests within 24 hours, but it may take up to five business days to respond. A response to a request for clearance to Deal and clearance (if any) must be given to the relevant Restricted Person within five business days of the request being made and must be given in writing. If a response is not given within that time limit, then clearance to Deal shall be deemed not to have been given.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;An individual who is given clearance to Deal in accordance with this paragraph 6 must Deal as soon as possible and in any event within two business days of clearance being received.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;Following any Dealing, a PDMR must also comply with paragraph 7 where applicable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;No person may give himself or herself clearance to Deal.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;DEALING BY PCAS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;PDMRs must&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;provide GSK with a list of their PCAs and notify GSK of any changes that need to be made to that list&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B) &#160;&#160;&#160;&#160;inform their PCAs that they are subject to Dealing restrictions under this Code&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;take reasonable steps to prevent any Dealings in GSK Securities by or on behalf of his or her PCAs on considerations of a short-term nature&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;ensure that their PCAs do not Deal in GSK Securities without obtaining prior clearance to Deal.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;The relevant PDMR must submit an application for clearance to deal on behalf of the relevant PCA in accordance with paragraph 6.1.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;&#160;&#160;&#160;Designated Employees are required to obtain clearance to Deal under this Code on behalf of their PCAs. GSK requires Designated Employees to remind their PCAs that it is a criminal offence to Deal in GSK Securities if they are in possession of Inside Information and therefore, Designated Employees must always seek consent to deal on behalf of their PCAs in accordance with paragraph 6.2.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;&#160;&#160;&#160;PDMRs and Designated Employees must not disclose Inside Information (including the fact that the Company is in a Closed Period) or any other confidential information to their PCAs when informing them that they are subject to Dealing restrictions under this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;INVESTMENT MANAGERS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1&#160;&#160;&#160;&#160;It is GSK&#8217;s policy that PDMRs and their PCAs should instruct their Investment Manager not to invest on GSK Securities, whether or not discretionary. However, this policy does not restrict an Investment Manager acting on behalf of a PDMR or a PCA of a PDMR from buying and selling units or shares in, or financial instruments which provide an exposure to, a Disregarded Undertaking, provided that consent to Deal is obtained in accordance with paragraph 8.3 below.</font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.2&#160;&#160;&#160;&#160;If a PDMR or any of his or her PCAs has funds under management with an Investment Manager which includes GSK Securities when he or she becomes a PDMR, he or she shall use reasonable endeavours to freeze such GSK Securities as soon as reasonably practicable while they remain a PDMR.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;&#160;&#160;&#160;Notwithstanding paragraph 8.1, if it is necessary for an Investment Manager of a PDMR to Deal in GSK Securities, the relevant PDMR must first obtain clearance to Deal in accordance with paragraph 6.1.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;&#160;&#160;&#160;Investment Managers of Designated Employees are not required to obtain clearance to Deal under this Code. However, GSK requires Designated Employees to remind Investment Managers who manage funds on their behalf that it is a criminal offence to Deal in GSK Securities if they are in possession of Inside Information and requires that Designated Employees seek to prohibit their Investment Managers from Dealing during a Closed Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;CIRCUMSTANCES FOR REFUSAL</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;A Restricted Person must not be given clearance to Deal in any GSK Securities during a Prohibited Period unless paragraph 10 applies or the relevant Dealing may be permitted in accordance with paragraph 11 to paragraph 13 (inclusive).</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;The Market Abuse Regulation may also allow clearance to be given during a Prohibited Period for other Dealings relating to (inclusive) employee share or savings schemes, or transactions where the beneficial interest in the relevant GSK Security does not change. GSK will ordinarily seek legal advice before clearing any such Dealing.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;A Restricted Person must not be given clearance to Deal in any GSK Securities on considerations of a short-term nature. An investment with a maturity of one year or less will always be considered to be of a short-term nature.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.4&#160;&#160;&#160;&#160;The provisions of this paragraph 9 apply equally to clearances to Deal which are sought by Restricted Persons in relation to Dealings by their PCAs or Investment Managers.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;EXCEPTIONAL CIRCUMSTANCES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1&#160;&#160;&#160;&#160;A Restricted Person may be given clearance to sell (but not to purchase) GSK&#8217;s shares or ADSs (but not other GSK Securities) during a Prohibited Period if he or she is in severe financial difficulty or there are other exceptional circumstances which require the immediate sale of shares. Where clearance is granted, the Restricted Person will only be allowed to sell shares to the extent necessary to obtain the required financial resources.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;&#160;&#160;&#160;Any request to Deal by reason of exceptional circumstances must be accompanied by a written statement which describes the exceptional character of the circumstances and explains the transaction envisaged and why that transaction could not be executed at a time other than during the Prohibited Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3&#160;&#160;&#160;&#160;Circumstances will only be considered to be &#8220;exceptional&#8221; for the purposes of paragraph 10.1 if they are extremely urgent, unforeseen and compelling and where their cause is external to the relevant Restricted Person and he or she has no control over them. When considering whether or not the circumstances are exceptional, GSK will take into account (among other things) the extent to which the Restricted Person&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;is facing a legally enforceable commitment or claim, such as a court order, to sell the relevant shares or ADSs&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;could not reasonably satisfy a financial commitment (entered into before the start of the relevant Prohibited Period) to a third party (including a tax authority) otherwise than by selling the relevant shares or ADSs.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4&#160;&#160;&#160;&#160;The determination of whether or not a Restricted Person is in severe financial difficulty or that there are other exceptional circumstances which require the immediate sale of GSK shares or ADSs will be made by&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Chair&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;if the Chair is not present or if the Chair is the Restricted Person, by the Chief Executive Officer.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;EMPLOYEE SHARE OR SAVING SCHEMES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">11.1&#160;&#160;&#160;&#160;Non-discretionary awards and grants</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards or grants of GSK Securities to a Restricted Person under an Employee Scheme can be made by GSK during a Prohibited Period if&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Employee Scheme and its terms have been previously approved by GSK&#8217;s shareholders where required and otherwise approved by the board&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the terms of the Employee Scheme specify the timing of the award or grant and the amount of GSK Securities awarded or granted, or the basis on which such amount is to be calculated, and do not allow the exercise of discretion&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the Restricted Person does not have any discretion as to the acceptance of GSK Securities awarded or granted.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the preceding paragraph, levels of vesting (even on a discretionary basis) of awards of GSK Securities to a Restricted Person under an Employee Scheme can be made by GSK during a Close Period, provided that, if GSK is in a Prohibited Period, GSK may only make such vesting determinations if it can be shown that the remuneration committee&#8217;s actions were not affected by the Inside Information. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">11.2&#160;&#160;&#160;&#160;Pre-planned awards and grants</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards or grants of GSK Securities to a Restricted Person under an Employee Scheme can be made by GSK during a Prohibited Period if the frequency and timing of the awards or grants, their conditions, the amount of GSK Securities to be awarded or granted and the group of recipients are determined in accordance with a framework established before the start of the Prohibited Period such that Inside Information cannot influence any such award or grant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">11.3&#160;&#160;&#160;&#160;Pre-approved exercise or conversion</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the period for the exercise of options or other rights, assigned to a Restricted Person under an Employee Scheme is due to expire within a Prohibited Period, then such exercise (as well as sales of shares acquired pursuant to such exercise) may be permitted during a Prohibited Period if&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Restricted Person notifies GSK of his or her election to exercise (and if relevant, sell) at least four months before the expiry date and such election is irrevocable&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the Restricted Person received clearance in accordance with paragraph 6 to exercise prior to making such irrevocable notification.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">11.4&#160;&#160;&#160;&#160;Employee saving schemes</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of GSK Securities by a Restricted Person under an employee saving scheme (e.g. a HMRC registered Sharesave scheme) may be permitted during a Prohibited Period if&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Restricted Person has entered into the saving scheme before the start of the Prohibited Period, except when he or she cannot enter into the scheme at another time due to the commencement date of his or her employment&#59;</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the Restricted Person does not alter the terms of his or her participation in the saving scheme or cancel such participation during the Prohibited Period&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the arrangements for the purchase of GSK Securities are either clearly set under the scheme terms and the Restricted Person cannot alter them during the Prohibited Period or are planned under the saving scheme to occur at a fixed date which falls in the Prohibited Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;ENTITLEMENTS IN RESPECT OF RIGHTS ISSUES AND OTHER OFFERS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;&#160;&#160;&#160;The following Dealings may be permitted during a Closed Period&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;an undertaking or election to take up entitlements under a rights issue or other offer (including an offer for GSK Securities in lieu of a cash dividend)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the take up of entitlements under a rights issue or other offer (including an offer of GSK Securities in lieu of a cash dividend)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;allowing entitlements to lapse under a rights issue or other offer (including an offer of GSK Securities in lieu of a cash dividend)&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;the sale of sufficient entitlements nil-paid to take up the balance of the entitlements under a rights issue,</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that the Restricted Person does not have access to any information that constitutes Inside Information and explains the reasons why such Dealing cannot take place at another time and GSK is satisfied with that explanation.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2&#160;&#160;&#160;&#160;At any time other than during a Closed Period, the transactions contemplated by paragraphs 12.1 (A) to (D) (inclusive) will not constitute Dealing for the purposes of this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;TRANSFERS BETWEEN ACCOUNTS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;&#160;&#160;&#160;A Restricted Person may be permitted to transfer GSK Securities between two accounts of that Restricted Person during a Closed Period, provided that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Restricted Person does not have access to any information that constitutes Inside Information&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the Restricted Person explains the reasons why the transfer cannot take place at another time and GSK is satisfied with that explanation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;such a transfer does not result in a change in price of the relevant GSK Securities.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2&#160;&#160;&#160;&#160;The transfer of GSK Securities between a Restricted Person and another person (including any PCA of that Restricted Person) is not permitted during a Closed Period.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.3&#160;&#160;&#160;&#160;At any time other than during a Closed Period, the transfer of GSK Securities between two accounts of a Restricted Person which does not result in a change in price of the relevant GSK Securities will not constitute Dealing for the purposes of this Code.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;SAVING SCHEMES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1&#160;&#160;&#160;&#160;A Restricted Person may participate in a share scheme under which only GSK Securities are purchased pursuant to a regular standing order or direct debit or by regular deduction from that Restricted Person&#8217;s salary, or where GSK Securities are acquired by way of a standing election to re-invest dividends or other distributions received, or are acquired as part payment of that Restricted Person&#8217;s remuneration or any scheme which is a HMRC registered Sharesave scheme  without clearance under paragraph 6 if&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Restricted Person does not enter into the scheme during a Prohibited Period, unless the scheme involves the part payment of remuneration in the form of GSK Securities and is entered into upon the commencement of that Restricted Person&#8217;s employment or, if the Restricted Person is a non- executive director, his or her appointment to the board&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the Restricted Person does not carry out the purchase of GSK Securities under the scheme during a Prohibited Period, unless paragraph 11.4 applies&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;before entering into the scheme, cancelling the scheme or varying the terms of his or her participation or carrying out sales of GSK Securities within the scheme, the Restricted Person obtains clearance in accordance with paragraph 6.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.2&#160;&#160;&#160;&#160; For the purposes of paragraph 14.1(C), an application by a Restricted Person to enter into a share scheme may be treated as an application for dealing clearance under paragraph 6 and the acceptance of an application by a Restricted Person to enter into a scheme may be treated as clearance to deal under paragraph 6.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3 &#160;&#160;&#160;&#160;For the avoidance of doubt, except in a Prohibited Period where paragraph 11.4 shall apply, the exercise by a Restricted Person of an option to acquire GSK Securities under a HMRC Sharesave scheme shall not constitute Dealing for the purposes of this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;ACTING AS A TRUSTEE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.1&#160;&#160;&#160;&#160;Where a Restricted Person acts as a trustee, Dealing in GSK Securities by that trust during a Prohibited Period does not require clearance under paragraph 6 if&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Restricted Person is not a beneficiary of the trust&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the decision to Deal is taken by the other trustees or by Investment Managers on behalf of the trustees independently of the Restricted Person.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;&#160;&#160;&#160;The other trustees or Investment Managers acting on behalf of the other trustees will be assumed to have acted independently where the decision to deal&#58;</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;was taken without consultation with, or other involvement of, the Restricted Person&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;was delegated to a committee of which the Restricted Person is not a member.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;NOTIFIABLE TRANSACTIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;&#160;&#160;&#160;PDMRs must notify GSK in writing of every Notifiable Transaction in GSK Securities conducted for his or her account. Such notification must be made using the notification template in Schedule 2 and must be sent to the Company Secretary or their designated appointee as soon as practicable and in any event within two business days of the transaction date.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.2&#160;&#160;&#160;&#160;A &#8220;Notifiable Transaction&#8221; is any transaction relating to GSK Securities conducted for the account of a PDMR or their PCA, whether the transaction was conducted by such PDMR or PCA or on his or her behalf by a third party. In determining whether or not a transaction is a &#8220;Notifiable Transaction&#8221;, the following guidance should be considered&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the venue or place where a transaction is conducted is irrelevant for the purposes of determining whether or not that transaction is a &#8220;Notifiable Transaction&#8221;&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;a transaction relating to GSK Securities which is undertaken by a third party for the account of a PDMR or a PCA of a PDMR is a Notifiable Transaction, even where that third party is exercising full discretion (i.e. where no instruction is given by the PDMR or PCA of a PDMR) and therefore transactions relating to GSK Securities which are undertaken under a Trading Plan or saving scheme, or by a &#8220;family office&#8221;, a trust, a discretionary portfolio arrangement and all other investment vehicles, are likely to qualify as &#8220;Notifiable Transactions&#8221;&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;paragraph 1 of Schedule 1 contains a non-exhaustive list of transactions which could constitute Notifiable Transactions&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;the transactions described in paragraphs 2(C), 2(D) and 2(H) of Schedule 1 could also be Notifiable Transactions.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.3&#160;&#160;&#160;&#160;Any PDMR who is uncertain as to whether or not a particular transaction constitutes a Notifiable Transaction should consult the Company Secretary.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.4&#160;&#160;&#160;&#160;GSK will make the relevant regulatory notifications and announcements in respect of Notifiable Transactions on behalf of PDMRs and PCAs as soon as practicable after it receives the notification of a transaction.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;SANCTION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure by any officer, employee or contractor to observe the GSK standards of practice and prior consent requirements may result in disciplinary action, up to and including termination of office, employment or contract. Depending on the circumstances, it may also constitute a civil and&#47;or a criminal offence.</font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;COMMUNICATION OF ISSUES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;&#160;&#160;&#160;If a Restricted Person or an Insider becomes aware of a breach of this Code, irrespective of whether the breach is by themselves or by one of their PCAs, they must notify the Company Secretary immediately and without delay.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.2&#160;&#160;&#160;&#160;General queries concerning this Code should be directed, in the first instance, to the Company Secretary.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule 1</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEALINGS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Transactions that could constitute Dealing</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this Code, and subject to paragraph 2 of this Schedule, the following is a non-exhaustive list of transactions which could constitute Dealing&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the pledging or lending of GSK Securities (although a pledge, or a similar security interest, of GSK Securities in connection with the depositing of GSK Securities in a custody account is not &#8220;Dealing&#8221;, unless and until such pledge or other security interest is designated to secure a specific credit facility)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;transactions in GSK Securities undertaken by Investment Managers or any other persons professionally arranging or executing transactions on behalf of a Restricted Person or a PCA, including where discretion is exercised&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;transactions in GSK Securities made under a life insurance policy, where (i) the policyholder is a Restricted Person or a PCA&#59; (ii) the investment risk is borne by the policyholder&#59; and (iii) the policyholder has the power or discretion to make investment decisions regarding specific instruments in that life insurance policy or to execute transactions regarding specific instruments for that life insurance policy&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;an acquisition, disposal, short sale, subscription or exchange of GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;the acceptance or exercise of an option over GSK Securities, including of a share option granted as part of a remuneration package, and the disposal of shares stemming from the exercise of a share option&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)&#160;&#160;&#160;&#160;entering into or exercise of equity swaps related to GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)&#160;&#160;&#160;&#160;transactions in or related to derivatives over GSK Securities, including cash-settled transactions&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)&#160;&#160;&#160;&#160;entering into a contract for difference on GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)&#160;&#160;&#160;&#160;the acquisition, disposal or exercise of rights in relation to GSK Securities, including put and call options and warrants&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)&#160;&#160;&#160;&#160;subscription to a share capital increase or debt instrument issuance of GSK&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)&#160;&#160;&#160;&#160;transactions in derivatives and financial instruments linked to a debt instrument of GSK including credit default swaps&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)&#160;&#160;&#160;&#160;conditional transactions relating to GSK Securities.&#59;</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(M)&#160;&#160;&#160;&#160;automatic or non-automatic conversion of a Company Security into another Company Security, including the exchange of convertible bonds to shares&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(N)&#160;&#160;&#160;&#160;subject to paragraphs 2(D) and 2(E) of this Schedule, transactions executed in index- related products, baskets and derivatives transacting in GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(O)&#160;&#160;&#160;&#160;subject to paragraphs 2(D) and 2(E) of this Schedule, transactions executed in shares or units of investment funds which transact in GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(P)&#160;&#160;&#160;&#160;subject to paragraphs 2(D) and 2(E) of this Schedule, transactions executed by the manager of an investment fund in which the Restricted Person or PCA has invested and which transacts in GSK Securities&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Q)&#160;&#160;&#160;&#160;transactions executed by an Investment Manager or other third party under an individual portfolio or asset management mandate on behalf or for the benefit of the Restricted Person or PCA&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(R)&#160;&#160;&#160;&#160;borrowing or lending of shares or debt instruments of GSK or derivatives or other financial instruments linked thereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Transactions that do not constitute Dealing</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following transactions do not constitute Dealing for the purposes of this Code but may still&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;constitute dealing for the purposes of the insider dealing and market abuse regimes&#59; and&#47;or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;give rise to a notification obligation under paragraph 16 of this Code&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the cancellation or surrender of an option under an Employee Scheme&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the automatic vesting of a conditional award under an Employee Scheme&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the transfer of GSK Securities by an independent trustee of an Employee Scheme to a beneficiary who is not a Restricted Person&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;bona fide gifts and donations of GSK Securities received, or an inheritance of GSK Securities received&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;buying and selling units or shares in, or financial instruments which provide an exposure to, a Disregarded Undertaking&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)&#160;&#160;&#160;&#160;transactions in GSK Securities by a Disregarded Undertaking&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)&#160;&#160;&#160;&#160;at any time other than during a Closed Period, transactions which paragraphs 12.2 and 13.3 specify do not constitute &#8220;Dealings&#8221;&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)&#160;&#160;&#160;&#160;at any time other than during a Closed Period, undertakings to accept, or the acceptance of, a takeover offer&#59;</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)&#160;&#160;&#160;&#160;transactions in GSK Securities pursuant to a saving scheme in accordance with paragraph 14 (Saving schemes)&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)&#160;&#160;&#160;&#160;transactions in GSK Securities by the trustees of a trust in accordance with paragraph 15 (Acting as a trustee)&#59; and</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)&#160;&#160;&#160;&#160;conditional transactions relating to GSK Securities. The completion of such transactions upon the fulfilment of the conditions (provided no further action is required by the Restricted Person) does not constitute </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dealing and therefore does not require clearance, but such completion could constitute a Notifiable Transaction.</font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9d2daf0a8f8e408cbd2ebf4a67588575_7"></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule 2</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTIFICATION TEMPLATE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please send your completed form to &#91;name&#93; (&#91;email address&#93;). If you require any assistance in completing this form, please contact &#91;name&#93;.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.263%"><tr><td style="width:1.0%"></td><td style="width:5.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1.</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Details of the Restricted Person &#47; person closely associated with them (&#8220;PCA&#8221;)</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Name</font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Include first name(s) and last name(s).&#93;</font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;If the PCA is a legal person, state its full name including legal form as provided for in the register where it is incorporated, if applicable.&#93;</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2.</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Reason for the notification </font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Position &#47; status </font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;For Restricted Person, state job title e.g. CEO, CFO.&#93; </font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;For PCAs, state that the notification concerns a PCA and the name and position of the relevant Restricted Person.&#93;</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Details of the transaction(s)&#58; section to be repeated for (i) each type of instrument&#59; (ii) each type of transaction&#59; (iii) each date&#59; and (iv) each place where transactions have been conducted</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a) </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Description of the financial instrument, type of instrument </font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;State the nature of the instrument e.g. a share, a debt instrument, a derivative or a financial instrument linked to a share or debt instrument.&#93;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">b)</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nature of the transaction</font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Description of the transaction type.&#93;</font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Please indicate whether the transaction is linked to the exercise of a share option programme.&#93;</font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.263%"><tr><td style="width:1.0%"></td><td style="width:5.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.001%"></td><td style="width:0.1%"></td></tr><tr style="height:237pt"><td colspan="3" rowspan="7" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">c) </font></div></td><td colspan="3" rowspan="7" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Price(s) and volume(s)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Where more than one transaction of the same nature (purchases, sales etc.) of the same financial instrument are executed on the same day and at the same place of transaction, prices and volumes of these transactions should be reported in the table above, using as many lines as needed.&#93; </font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;In each case, please specify the currency and the metric for quantity.&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:237pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Price(s) </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Volume(s)</font></div></td></tr><tr style="height:237pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr style="height:237pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr style="height:237pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr style="height:237pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr style="height:237pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.263%"><tr><td style="width:1.0%"></td><td style="width:5.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">d)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aggregated information </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">Aggregated volume </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.67pt">Price </font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Please aggregate the volumes of multiple transactions when these transactions&#58; </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.67pt">relate to the same financial instrument&#59; </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.67pt">are of the same nature&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.67pt">are executed on the same day&#59; and </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.67pt">are executed at the same place of transaction.&#93; </font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Please state the metric for quantity.&#93;</font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Please provide&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.67pt">in the case of a single transaction, the price of the single transaction&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.67pt">in the case where the volumes of multiple transactions are aggregated, the weighted average price of the aggregated transactions.&#93; </font></div><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Please state the currency.&#93;</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">e) </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date of the transaction</font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Date of the particular day of execution of the notified transaction, using the date format&#58; YYYY-MM-DD and please specify the time zone.&#93;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">f)</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Place of the transaction </font></div></td><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#5f5f5f;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">&#91;Please name the trading venue where the transaction was executed. If the transaction was not executed on any trading venue, please state &#8216;outside a trading venue&#8217; in this box.&#93;</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>exhibit121-s302certxemma.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1bbfab3909044205a028b2d924364684_1"></div><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Exhibit 12.1</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Section 302 Certificate</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Form of Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934</font></div><div style="margin-bottom:6pt;margin-top:10.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">I, Emma Walmsley, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">I have reviewed this Annual Report on Form 20-F of GSK plc&#59;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:7.17pt">evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:0.1pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.770%"><tr><td style="width:1.0%"></td><td style="width:46.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Date&#58; March 3, 2025</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#47;s&#47; Emma Walmsley</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.05pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Emma Walmsley</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-right:5.9pt"><font><br></font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>exhibit122-s302certxjulie.htm
<DESCRIPTION>EX-12.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if4f4ea728f4849c880e6fc7c64abc503_1"></div><div style="min-height:70.87pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Exhibit 12.2</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Section 302 Certificate</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Form of Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">I, Julie Brown, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">I have reviewed this Annual Report on Form 20-F of GSK plc&#59;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:7.17pt">evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:14.17pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:28.35pt;text-indent:-14.17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;padding-left:6.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.770%"><tr><td style="width:1.0%"></td><td style="width:46.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Date&#58; March 3, 2025</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#47;s&#47; Julie Brown</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Julie Brown</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-right:5.9pt"><font><br></font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>exhibit131-s906certificate.htm
<DESCRIPTION>EX-13.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8b35fcda9ea945ca98adf49b4ea3b443_1"></div><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Exhibit 13.1</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Section 906 Certificate</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of GSK plc, a public limited company incorporated under English law (the &#8220;company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">The Annual Report on Form 20-F for the year ended December 31, 2024 (the &#8220;Form 20-F&#8221;) of the company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the company.</font></div><div style="margin-bottom:6pt;margin-top:0.15pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.770%"><tr><td style="width:1.0%"></td><td style="width:46.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Date&#58; March 3, 2025</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#47;s&#47; Emma Walmsley</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Emma Walmsley</font></div><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Chief Executive Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Date&#58; March 3, 2025</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#47;s&#47; Julie Brown</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Julie Brown</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:6pt;padding-right:5.9pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>7
<FILENAME>exhibit151-deloittesconsent.htm
<DESCRIPTION>EX-15.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i9a23fd951b7f46fdbc14d7343f95ee3f_1"></div><div style="min-height:70.87pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Exhibit 15.1</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">We consent to the incorporation by reference in Registration Statement Nos. 333-278205, 333-278205-01 and 333-278205-02  on Form F-3 of GSK plc, GlaxoSmithKline Capital Inc. and GlaxoSmithKline Capital plc and Registration Statement Nos. 333-88966, 333-100388, 333-162702, and 333-235651 on Form S-8 of GSK plc, of our reports dated 3 March 2025, relating to the financial statements of GSK plc and the effectiveness of GSK plc&#8217;s internal control over financial reporting appearing in this Annual Report on Form 20-F for the year ended 31 December 2024.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">London, United Kingdom</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">3 March 2025</font></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-right:456.95pt"><font><br></font></div><div style="height:42.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-17
<SEQUENCE>8
<FILENAME>exhibit17-subsidiaryissuer.htm
<DESCRIPTION>EX-17
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i0a3db2732e4d4184807dcfe9fa1c9c1a_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 17</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">List of Subsidiary Issuers of Guaranteed Securities</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each of the following subsidiaries of GSK plc (the &#8220;Guarantor&#8221;) is issuer of the following outstanding securities, which are fully and unconditionally guaranteed by the Guarantor&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GlaxoSmithKline Capital Inc.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.625% Notes due 2025 </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875% Notes due 2028</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.375% Notes due 2034</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.375% Notes due 2038</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.200% Notes due 2043</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GlaxoSmithKline Capital plc</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375% Notes due 2029</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>gsk-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3a546e24-b21d-4f2c-8496-4bed728e8d38,g:19b91481-759e-443e-bc09-8752e6669383-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gsk="http://www.gsk.com/20241231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gsk.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:import namespace="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gsk-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gsk-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gsk-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gsk-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.gsk.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.gsk.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedincomestatement" roleURI="http://www.gsk.com/role/Consolidatedincomestatement">
        <link:definition>9952151 - Statement - Consolidated income statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedstatementofcomprehensiveincome" roleURI="http://www.gsk.com/role/Consolidatedstatementofcomprehensiveincome">
        <link:definition>9952152 - Statement - Consolidated statement of comprehensive income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedstatementofcomprehensiveincomeAlternatecalculation" roleURI="http://www.gsk.com/role/ConsolidatedstatementofcomprehensiveincomeAlternatecalculation">
        <link:definition>9952153 - Statement - Consolidated statement of comprehensive income - Alternate calculation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedbalancesheet" roleURI="http://www.gsk.com/role/Consolidatedbalancesheet">
        <link:definition>9952154 - Statement - Consolidated balance sheet</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedstatementofchangesinequity" roleURI="http://www.gsk.com/role/Consolidatedstatementofchangesinequity">
        <link:definition>9952155 - Statement - Consolidated statement of changes in equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedcashflowstatement" roleURI="http://www.gsk.com/role/Consolidatedcashflowstatement">
        <link:definition>9952156 - Statement - Consolidated cash flow statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedincomestatement_1" roleURI="http://www.gsk.com/role/Consolidatedincomestatement_1">
        <link:definition>9952157 - Statement - Consolidated income statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedincomestatement_2" roleURI="http://www.gsk.com/role/Consolidatedincomestatement_2">
        <link:definition>9952157 - Statement - Consolidated income statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Presentationofthefinancialstatements" roleURI="http://www.gsk.com/role/Presentationofthefinancialstatements">
        <link:definition>9952158 - Disclosure - Presentation of the financial statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountingprinciplesandpolicies" roleURI="http://www.gsk.com/role/Accountingprinciplesandpolicies">
        <link:definition>9952159 - Disclosure - Accounting principles and policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Criticalaccountingjudgementsandkeysourcesofestimationuncertainty" roleURI="http://www.gsk.com/role/Criticalaccountingjudgementsandkeysourcesofestimationuncertainty">
        <link:definition>9952160 - Disclosure - Critical accounting judgements and key sources of estimation uncertainty</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Newaccountingrequirements" roleURI="http://www.gsk.com/role/Newaccountingrequirements">
        <link:definition>9952161 - Disclosure - New accounting requirements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Exchangerates" roleURI="http://www.gsk.com/role/Exchangerates">
        <link:definition>9952162 - Disclosure - Exchange rates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Turnoverandsegmentinformation" roleURI="http://www.gsk.com/role/Turnoverandsegmentinformation">
        <link:definition>9952163 - Disclosure - Turnover and segment information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otheroperatingincomeexpense" roleURI="http://www.gsk.com/role/Otheroperatingincomeexpense">
        <link:definition>9952164 - Disclosure - Other operating income/(expense)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operatingprofit" roleURI="http://www.gsk.com/role/Operatingprofit">
        <link:definition>9952165 - Disclosure - Operating profit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Employeecosts" roleURI="http://www.gsk.com/role/Employeecosts">
        <link:definition>9952166 - Disclosure - Employee costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Majorrestructuringcosts" roleURI="http://www.gsk.com/role/Majorrestructuringcosts">
        <link:definition>9952167 - Disclosure - Major restructuring costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financeincome" roleURI="http://www.gsk.com/role/Financeincome">
        <link:definition>9952168 - Disclosure - Finance income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financeexpense" roleURI="http://www.gsk.com/role/Financeexpense">
        <link:definition>9952169 - Disclosure - Finance expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Associatesandjointventures" roleURI="http://www.gsk.com/role/Associatesandjointventures">
        <link:definition>9952170 - Disclosure - Associates and joint ventures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Taxation" roleURI="http://www.gsk.com/role/Taxation">
        <link:definition>9952171 - Disclosure - Taxation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Earningspershare" roleURI="http://www.gsk.com/role/Earningspershare">
        <link:definition>9952172 - Disclosure - Earnings per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Dividends" roleURI="http://www.gsk.com/role/Dividends">
        <link:definition>9952173 - Disclosure - Dividends</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Propertyplantandequipment" roleURI="http://www.gsk.com/role/Propertyplantandequipment">
        <link:definition>9952174 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Rightofuseassets" roleURI="http://www.gsk.com/role/Rightofuseassets">
        <link:definition>9952175 - Disclosure - Right of use assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.gsk.com/role/Goodwill">
        <link:definition>9952176 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otherintangibleassets" roleURI="http://www.gsk.com/role/Otherintangibleassets">
        <link:definition>9952177 - Disclosure - Other intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investmentsinassociatesandjointventures" roleURI="http://www.gsk.com/role/Investmentsinassociatesandjointventures">
        <link:definition>9952178 - Disclosure - Investments in associates and joint ventures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Currentequityinvestments" roleURI="http://www.gsk.com/role/Currentequityinvestments">
        <link:definition>9952179 - Disclosure - Current equity investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otherinvestments" roleURI="http://www.gsk.com/role/Otherinvestments">
        <link:definition>9952180 - Disclosure - Other investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Othernoncurrentassets" roleURI="http://www.gsk.com/role/Othernoncurrentassets">
        <link:definition>9952181 - Disclosure - Other non-current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.gsk.com/role/Inventories">
        <link:definition>9952182 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Tradeandotherreceivables" roleURI="http://www.gsk.com/role/Tradeandotherreceivables">
        <link:definition>9952183 - Disclosure - Trade and other receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Cashandcashequivalents" roleURI="http://www.gsk.com/role/Cashandcashequivalents">
        <link:definition>9952184 - Disclosure - Cash and cash equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Assetsheldforsale" roleURI="http://www.gsk.com/role/Assetsheldforsale">
        <link:definition>9952185 - Disclosure - Assets held for sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Tradeandotherpayables" roleURI="http://www.gsk.com/role/Tradeandotherpayables">
        <link:definition>9952186 - Disclosure - Trade and other payables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netdebt" roleURI="http://www.gsk.com/role/Netdebt">
        <link:definition>9952187 - Disclosure - Net debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Pensionsandotherpostemploymentbenefits" roleURI="http://www.gsk.com/role/Pensionsandotherpostemploymentbenefits">
        <link:definition>9952188 - Disclosure - Pensions and other post-employment benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otherprovisions" roleURI="http://www.gsk.com/role/Otherprovisions">
        <link:definition>9952189 - Disclosure - Other provisions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingentconsiderationliabilities" roleURI="http://www.gsk.com/role/Contingentconsiderationliabilities">
        <link:definition>9952190 - Disclosure - Contingent consideration liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Othernoncurrentliabilities" roleURI="http://www.gsk.com/role/Othernoncurrentliabilities">
        <link:definition>9952191 - Disclosure - Other non-current liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingentliabilities" roleURI="http://www.gsk.com/role/Contingentliabilities">
        <link:definition>9952192 - Disclosure - Contingent liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitments" roleURI="http://www.gsk.com/role/Commitments">
        <link:definition>9952193 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Sharecapitalandsharepremiumaccount" roleURI="http://www.gsk.com/role/Sharecapitalandsharepremiumaccount">
        <link:definition>9952194 - Disclosure - Share capital and share premium account</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Movementsinequity" roleURI="http://www.gsk.com/role/Movementsinequity">
        <link:definition>9952195 - Disclosure - Movements in equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Noncontrollinginterests" roleURI="http://www.gsk.com/role/Noncontrollinginterests">
        <link:definition>9952196 - Disclosure - Non-controlling interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Relatedpartytransactions" roleURI="http://www.gsk.com/role/Relatedpartytransactions">
        <link:definition>9952197 - Disclosure - Related party transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitionsanddisposals" roleURI="http://www.gsk.com/role/Acquisitionsanddisposals">
        <link:definition>9952198 - Disclosure - Acquisitions and disposals</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdjustmentsreconcilingTotalprofitaftertaxtooperatingcashflows" roleURI="http://www.gsk.com/role/AdjustmentsreconcilingTotalprofitaftertaxtooperatingcashflows">
        <link:definition>9952199 - Disclosure - Adjustments reconciling Total profit after tax to operating cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reconciliationofnetcashflowtomovementinnetdebt" roleURI="http://www.gsk.com/role/Reconciliationofnetcashflowtomovementinnetdebt">
        <link:definition>9952200 - Disclosure - Reconciliation of net cash flow to movement in net debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialinstrumentsandrelateddisclosures" roleURI="http://www.gsk.com/role/Financialinstrumentsandrelateddisclosures">
        <link:definition>9952201 - Disclosure - Financial instruments and related disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Employeeshareschemes" roleURI="http://www.gsk.com/role/Employeeshareschemes">
        <link:definition>9952202 - Disclosure - Employee share schemes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalGroupcompanies" roleURI="http://www.gsk.com/role/PrincipalGroupcompanies">
        <link:definition>9952203 - Disclosure - Principal Group companies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Legalproceedings" roleURI="http://www.gsk.com/role/Legalproceedings">
        <link:definition>9952204 - Disclosure - Legal proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Postbalancesheetevents" roleURI="http://www.gsk.com/role/Postbalancesheetevents">
        <link:definition>9952205 - Disclosure - Post balance sheet events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesandpoliciesPolicies" roleURI="http://www.gsk.com/role/AccountingprinciplesandpoliciesPolicies">
        <link:definition>9955511 - Disclosure - Accounting principles and policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesandpoliciesTables" roleURI="http://www.gsk.com/role/AccountingprinciplesandpoliciesTables">
        <link:definition>9955512 - Disclosure - Accounting principles and policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ExchangeratesTables" roleURI="http://www.gsk.com/role/ExchangeratesTables">
        <link:definition>9955513 - Disclosure - Exchange rates (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationTables" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationTables">
        <link:definition>9955514 - Disclosure - Turnover and segment information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingincomeexpenseTables" roleURI="http://www.gsk.com/role/OtheroperatingincomeexpenseTables">
        <link:definition>9955515 - Disclosure - Other operating income/(expense) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingprofitTables" roleURI="http://www.gsk.com/role/OperatingprofitTables">
        <link:definition>9955516 - Disclosure - Operating profit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeecostsTables" roleURI="http://www.gsk.com/role/EmployeecostsTables">
        <link:definition>9955517 - Disclosure - Employee costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MajorrestructuringcostsTables" roleURI="http://www.gsk.com/role/MajorrestructuringcostsTables">
        <link:definition>9955518 - Disclosure - Major restructuring costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinanceincomeTables" roleURI="http://www.gsk.com/role/FinanceincomeTables">
        <link:definition>9955519 - Disclosure - Finance income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinanceexpenseTables" roleURI="http://www.gsk.com/role/FinanceexpenseTables">
        <link:definition>9955520 - Disclosure - Finance expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssociatesandjointventuresTables" roleURI="http://www.gsk.com/role/AssociatesandjointventuresTables">
        <link:definition>9955521 - Disclosure - Associates and joint ventures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationTables" roleURI="http://www.gsk.com/role/TaxationTables">
        <link:definition>9955522 - Disclosure - Taxation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareTables" roleURI="http://www.gsk.com/role/EarningspershareTables">
        <link:definition>9955523 - Disclosure - Earnings per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsTables" roleURI="http://www.gsk.com/role/DividendsTables">
        <link:definition>9955524 - Disclosure - Dividends (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentTables" roleURI="http://www.gsk.com/role/PropertyplantandequipmentTables">
        <link:definition>9955525 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofuseassetsTables" roleURI="http://www.gsk.com/role/RightofuseassetsTables">
        <link:definition>9955526 - Disclosure - Right of use assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.gsk.com/role/GoodwillTables">
        <link:definition>9955527 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherintangibleassetsTables" roleURI="http://www.gsk.com/role/OtherintangibleassetsTables">
        <link:definition>9955528 - Disclosure - Other intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinassociatesandjointventuresTables" roleURI="http://www.gsk.com/role/InvestmentsinassociatesandjointventuresTables">
        <link:definition>9955529 - Disclosure - Investments in associates and joint ventures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CurrentequityinvestmentsTables" roleURI="http://www.gsk.com/role/CurrentequityinvestmentsTables">
        <link:definition>9955530 - Disclosure - Current equity investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherinvestmentsTables" roleURI="http://www.gsk.com/role/OtherinvestmentsTables">
        <link:definition>9955531 - Disclosure - Other investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentassetsTables" roleURI="http://www.gsk.com/role/OthernoncurrentassetsTables">
        <link:definition>9955532 - Disclosure - Other non-current assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.gsk.com/role/InventoriesTables">
        <link:definition>9955533 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherreceivablesTables" roleURI="http://www.gsk.com/role/TradeandotherreceivablesTables">
        <link:definition>9955534 - Disclosure - Trade and other receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsTables" roleURI="http://www.gsk.com/role/CashandcashequivalentsTables">
        <link:definition>9955535 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsheldforsaleTables" roleURI="http://www.gsk.com/role/AssetsheldforsaleTables">
        <link:definition>9955536 - Disclosure - Assets held for sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherpayablesTables" roleURI="http://www.gsk.com/role/TradeandotherpayablesTables">
        <link:definition>9955537 - Disclosure - Trade and other payables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdebtTables" roleURI="http://www.gsk.com/role/NetdebtTables">
        <link:definition>9955538 - Disclosure - Net debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsTables" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsTables">
        <link:definition>9955539 - Disclosure - Pensions and other post-employment benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherprovisionsTables" roleURI="http://www.gsk.com/role/OtherprovisionsTables">
        <link:definition>9955540 - Disclosure - Other provisions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentconsiderationliabilitiesTables" roleURI="http://www.gsk.com/role/ContingentconsiderationliabilitiesTables">
        <link:definition>9955541 - Disclosure - Contingent consideration liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentliabilitiesTables" roleURI="http://www.gsk.com/role/OthernoncurrentliabilitiesTables">
        <link:definition>9955542 - Disclosure - Other non-current liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsTables" roleURI="http://www.gsk.com/role/CommitmentsTables">
        <link:definition>9955543 - Disclosure - Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharecapitalandsharepremiumaccountTables" roleURI="http://www.gsk.com/role/SharecapitalandsharepremiumaccountTables">
        <link:definition>9955544 - Disclosure - Share capital and share premium account (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MovementsinequityTables" roleURI="http://www.gsk.com/role/MovementsinequityTables">
        <link:definition>9955545 - Disclosure - Movements in equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollinginterestsTables" roleURI="http://www.gsk.com/role/NoncontrollinginterestsTables">
        <link:definition>9955546 - Disclosure - Non-controlling interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddisposalsTables" roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsTables">
        <link:definition>9955547 - Disclosure - Acquisitions and disposals (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdjustmentsreconcilingTotalprofitaftertaxtooperatingcashflowsTables" roleURI="http://www.gsk.com/role/AdjustmentsreconcilingTotalprofitaftertaxtooperatingcashflowsTables">
        <link:definition>9955548 - Disclosure - Adjustments reconciling Total profit after tax to operating cash flows (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReconciliationofnetcashflowtomovementinnetdebtTables" roleURI="http://www.gsk.com/role/ReconciliationofnetcashflowtomovementinnetdebtTables">
        <link:definition>9955549 - Disclosure - Reconciliation of net cash flow to movement in net debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresTables" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresTables">
        <link:definition>9955550 - Disclosure - Financial instruments and related disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeshareschemesTables" roleURI="http://www.gsk.com/role/EmployeeshareschemesTables">
        <link:definition>9955551 - Disclosure - Employee share schemes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalGroupcompaniesTables" roleURI="http://www.gsk.com/role/PrincipalGroupcompaniesTables">
        <link:definition>9955552 - Disclosure - Principal Group companies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PresentationofthefinancialstatementsDetails" roleURI="http://www.gsk.com/role/PresentationofthefinancialstatementsDetails">
        <link:definition>9955553 - Disclosure - Presentation of the financial statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesandPoliciesAdditionalInformationDetails" roleURI="http://www.gsk.com/role/AccountingprinciplesandPoliciesAdditionalInformationDetails">
        <link:definition>9955554 - Disclosure - Accounting principles and Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingprinciplesandPoliciesSummaryofExpectedUsefulLivesofPropertyPlantandEquipmentDetails" roleURI="http://www.gsk.com/role/AccountingprinciplesandPoliciesSummaryofExpectedUsefulLivesofPropertyPlantandEquipmentDetails">
        <link:definition>9955555 - Disclosure - Accounting principles and Policies - Summary of Expected Useful Lives of Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CriticalaccountingjudgementsandkeysourcesofestimationuncertaintyDetails" roleURI="http://www.gsk.com/role/CriticalaccountingjudgementsandkeysourcesofestimationuncertaintyDetails">
        <link:definition>9955556 - Disclosure - Critical accounting judgements and key sources of estimation uncertainty (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ExchangeratesDetails" roleURI="http://www.gsk.com/role/ExchangeratesDetails">
        <link:definition>9955557 - Disclosure - Exchange rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationAdditionalInformationDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationAdditionalInformationDetails">
        <link:definition>9955558 - Disclosure - Turnover and segment information - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationTurnoverbySegmentDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationTurnoverbySegmentDetails">
        <link:definition>9955559 - Disclosure - Turnover and segment information - Turnover by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationTurnoverbyProductServiceDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationTurnoverbyProductServiceDetails">
        <link:definition>9955560 - Disclosure - Turnover and segment information - Turnover by Product &amp; Service (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationSegmentProfitDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationSegmentProfitDetails">
        <link:definition>9955561 - Disclosure - Turnover and segment information - Segment Profit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationDepreciationandamortisationbysegmentDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationDepreciationandamortisationbysegmentDetails">
        <link:definition>9955562 - Disclosure - Turnover and segment information - Depreciation and amortisation by segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationPPEandintangibleassetimpairmentandreversalsbysegmentDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationPPEandintangibleassetimpairmentandreversalsbysegmentDetails">
        <link:definition>9955563 - Disclosure - Turnover and segment information - PP&amp;E and intangible asset impairment and reversals by segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails">
        <link:definition>9955564 - Disclosure - Turnover and segment information - Net operating assets by segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TurnoverandsegmentinformationSummaryofGeographicalInformationDetails" roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationSummaryofGeographicalInformationDetails">
        <link:definition>9955565 - Disclosure - Turnover and segment information - Summary of Geographical Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails" roleURI="http://www.gsk.com/role/OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails">
        <link:definition>9955566 - Disclosure - Other operating income/(expense) - Information about Other Operating Income Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingincomeexpenseAdditionalInformationDetails" roleURI="http://www.gsk.com/role/OtheroperatingincomeexpenseAdditionalInformationDetails">
        <link:definition>9955567 - Disclosure - Other operating income/(expense) - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingprofitSummaryofInformationAboutProfitLossDetails" roleURI="http://www.gsk.com/role/OperatingprofitSummaryofInformationAboutProfitLossDetails">
        <link:definition>9955568 - Disclosure - Operating profit - Summary of Information About Profit Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingprofitAdditionalInformationDetails" roleURI="http://www.gsk.com/role/OperatingprofitAdditionalInformationDetails">
        <link:definition>9955569 - Disclosure - Operating profit - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingprofitSummaryofAuditorsRemunerationDetails" roleURI="http://www.gsk.com/role/OperatingprofitSummaryofAuditorsRemunerationDetails">
        <link:definition>9955570 - Disclosure - Operating profit - Summary of Auditors Remuneration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeecostsSummaryofEmployeeCostsDetails" roleURI="http://www.gsk.com/role/EmployeecostsSummaryofEmployeeCostsDetails">
        <link:definition>9955571 - Disclosure - Employee costs - Summary of Employee Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeecostsSummaryofCostofSharebasedIncentivePlansDetails" roleURI="http://www.gsk.com/role/EmployeecostsSummaryofCostofSharebasedIncentivePlansDetails">
        <link:definition>9955572 - Disclosure - Employee costs - Summary of Cost of Share-based Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails" roleURI="http://www.gsk.com/role/EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails">
        <link:definition>9955573 - Disclosure - Employee costs - Disclosure of Average Monthly Number of Persons Employed by the Group (Including Directors) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeecostsSummaryofCompensationoftheDirectorsandSeniorManagementDetails" roleURI="http://www.gsk.com/role/EmployeecostsSummaryofCompensationoftheDirectorsandSeniorManagementDetails">
        <link:definition>9955574 - Disclosure - Employee costs - Summary of Compensation of the Directors and Senior Management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MajorrestructuringcostsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/MajorrestructuringcostsAdditionalInformationDetails">
        <link:definition>9955575 - Disclosure - Major restructuring costs - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails" roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails">
        <link:definition>9955576 - Disclosure - Major restructuring costs - Summary of Analysis of Costs Charged to Operating Profit From Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails" roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails">
        <link:definition>9955577 - Disclosure - Major restructuring costs - Summary of Major restructuring charges from continuing operations by programme (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails" roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails">
        <link:definition>9955578 - Disclosure - Major restructuring costs - Summary of Major Restructuring Charges from Continuing Operations by Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinanceincomeDetails" roleURI="http://www.gsk.com/role/FinanceincomeDetails">
        <link:definition>9955579 - Disclosure - Finance income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinanceExpenseDetails" roleURI="http://www.gsk.com/role/FinanceExpenseDetails">
        <link:definition>9955580 - Disclosure - Finance Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssociatesandjointventuresSummaryofAfterTaxProfitsandLossesofAssociatesandJointVenturesDetails" roleURI="http://www.gsk.com/role/AssociatesandjointventuresSummaryofAfterTaxProfitsandLossesofAssociatesandJointVenturesDetails">
        <link:definition>9955581 - Disclosure - Associates and joint ventures - Summary of After Tax Profits and Losses of Associates and Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssociatesandjointventuresSummaryofAggregatedFinancialInformationDetails" roleURI="http://www.gsk.com/role/AssociatesandjointventuresSummaryofAggregatedFinancialInformationDetails">
        <link:definition>9955582 - Disclosure - Associates and joint ventures - Summary of Aggregated Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssociatesandjointventuresAdditionalInformationDetails" roleURI="http://www.gsk.com/role/AssociatesandjointventuresAdditionalInformationDetails">
        <link:definition>9955583 - Disclosure - Associates and joint ventures - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationSummaryofTaxationChargeBasedonProfitsDetails" roleURI="http://www.gsk.com/role/TaxationSummaryofTaxationChargeBasedonProfitsDetails">
        <link:definition>9955584 - Disclosure - Taxation - Summary of Taxation Charge Based on Profits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationAdditionalInformationDetails" roleURI="http://www.gsk.com/role/TaxationAdditionalInformationDetails">
        <link:definition>9955585 - Disclosure - Taxation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationSummaryofReconciliationofTaxChargeDetails" roleURI="http://www.gsk.com/role/TaxationSummaryofReconciliationofTaxChargeDetails">
        <link:definition>9955586 - Disclosure - Taxation - Summary of Reconciliation of Tax Charge (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationSummaryofTaxonItemsChargedtoEquityandStatementofComprehensiveIncomeDetails" roleURI="http://www.gsk.com/role/TaxationSummaryofTaxonItemsChargedtoEquityandStatementofComprehensiveIncomeDetails">
        <link:definition>9955587 - Disclosure - Taxation - Summary of Tax on Items Charged to Equity and Statement of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationSummaryofMovementinDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.gsk.com/role/TaxationSummaryofMovementinDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955588 - Disclosure - Taxation - Summary of Movement in Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationSummaryofNetDeferredTaxAssetDetails" roleURI="http://www.gsk.com/role/TaxationSummaryofNetDeferredTaxAssetDetails">
        <link:definition>9955589 - Disclosure - Taxation - Summary of Net Deferred Tax Asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TaxationSummaryofTemporaryDifferenceUnusedTaxLossesandUnusedTaxCreditsDetails" roleURI="http://www.gsk.com/role/TaxationSummaryofTemporaryDifferenceUnusedTaxLossesandUnusedTaxCreditsDetails">
        <link:definition>9955590 - Disclosure - Taxation - Summary of Temporary Difference Unused Tax Losses and Unused Tax Credits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareSummaryofBasicandDilutedEarningsPerShareDetails" roleURI="http://www.gsk.com/role/EarningspershareSummaryofBasicandDilutedEarningsPerShareDetails">
        <link:definition>9955591 - Disclosure - Earnings per share - Summary of Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareScheduleofNumbersofSharesEarningsPerShareDetails" roleURI="http://www.gsk.com/role/EarningspershareScheduleofNumbersofSharesEarningsPerShareDetails">
        <link:definition>9955592 - Disclosure - Earnings per share - Schedule of Numbers of Shares Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsSummaryofInterimFinancialReportingDetails" roleURI="http://www.gsk.com/role/DividendsSummaryofInterimFinancialReportingDetails">
        <link:definition>9955593 - Disclosure - Dividends - Summary of Interim Financial Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/DividendsAdditionalInformationDetails">
        <link:definition>9955594 - Disclosure - Dividends - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsSummaryofDividendstoShareholdersDetails" roleURI="http://www.gsk.com/role/DividendsSummaryofDividendstoShareholdersDetails">
        <link:definition>9955595 - Disclosure - Dividends - Summary of Dividends to Shareholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentSummaryofPropertyPlantandEquipmentDetails" roleURI="http://www.gsk.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentDetails">
        <link:definition>9955596 - Disclosure - Property, plant and equipment - Summary of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentAdditionalInformationDetails" roleURI="http://www.gsk.com/role/PropertyplantandequipmentAdditionalInformationDetails">
        <link:definition>9955597 - Disclosure - Property, plant and equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofuseassetsDetails" roleURI="http://www.gsk.com/role/RightofuseassetsDetails">
        <link:definition>9955598 - Disclosure - Right of use assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillSummaryofChangesinGoodwillDetails" roleURI="http://www.gsk.com/role/GoodwillSummaryofChangesinGoodwillDetails">
        <link:definition>9955599 - Disclosure - Goodwill - Summary of Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillSummaryofGoodwillAllocatedtoSegmentsDetails" roleURI="http://www.gsk.com/role/GoodwillSummaryofGoodwillAllocatedtoSegmentsDetails">
        <link:definition>9955600 - Disclosure - Goodwill - Summary of Goodwill Allocated to Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAdditionalInformationDetails" roleURI="http://www.gsk.com/role/GoodwillAdditionalInformationDetails">
        <link:definition>9955601 - Disclosure - Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofDiscountedCashFlowModelsUsedinImpairmentTestsDetails" roleURI="http://www.gsk.com/role/GoodwillScheduleofDiscountedCashFlowModelsUsedinImpairmentTestsDetails">
        <link:definition>9955602 - Disclosure - Goodwill - Schedule of Discounted Cash Flow Models Used in Impairment Tests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherintangibleassetsSummaryofOtherIntangibleAssetsDetails" roleURI="http://www.gsk.com/role/OtherintangibleassetsSummaryofOtherIntangibleAssetsDetails">
        <link:definition>9955603 - Disclosure - Other intangible assets - Summary of Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherintangibleassetsAdditionalinformationDetails" roleURI="http://www.gsk.com/role/OtherintangibleassetsAdditionalinformationDetails">
        <link:definition>9955604 - Disclosure - Other intangible assets - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherintangibleassetsScheduleofAmortisationandImpairmentLossesNetofReversalsDetails" roleURI="http://www.gsk.com/role/OtherintangibleassetsScheduleofAmortisationandImpairmentLossesNetofReversalsDetails">
        <link:definition>9955605 - Disclosure - Other intangible assets - Schedule of Amortisation and Impairment Losses, Net of Reversals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherintangibleassetsSummaryofBookValuesofLargestIndividualItemsDetails" roleURI="http://www.gsk.com/role/OtherintangibleassetsSummaryofBookValuesofLargestIndividualItemsDetails">
        <link:definition>9955606 - Disclosure - Other intangible assets - Summary of Book Values of Largest Individual Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinAssociatesandJointVenturesSummaryofInvestmentsinAssociatesandJointVenturesDetails" roleURI="http://www.gsk.com/role/InvestmentsinAssociatesandJointVenturesSummaryofInvestmentsinAssociatesandJointVenturesDetails">
        <link:definition>9955607 - Disclosure - Investments in Associates and Joint Ventures - Summary of Investments in Associates and Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinAssociatesandJointVenturesAdditionalInformationDetails" roleURI="http://www.gsk.com/role/InvestmentsinAssociatesandJointVenturesAdditionalInformationDetails">
        <link:definition>9955608 - Disclosure - Investments in Associates and Joint Ventures - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CurrentEquityInvestmentsDetails" roleURI="http://www.gsk.com/role/CurrentEquityInvestmentsDetails">
        <link:definition>9955609 - Disclosure - Current Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInvestmentsScheduleofOtherInvestmentsDetails" roleURI="http://www.gsk.com/role/OtherInvestmentsScheduleofOtherInvestmentsDetails">
        <link:definition>9955610 - Disclosure - Other Investments - Schedule of Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInvestmentsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/OtherInvestmentsAdditionalInformationDetails">
        <link:definition>9955611 - Disclosure - Other Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNonCurrentAssetsSummaryofOtherNonCurrentAssetsDetails" roleURI="http://www.gsk.com/role/OtherNonCurrentAssetsSummaryofOtherNonCurrentAssetsDetails">
        <link:definition>9955612 - Disclosure - Other Non-Current Assets - Summary of Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNonCurrentAssetsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/OtherNonCurrentAssetsAdditionalInformationDetails">
        <link:definition>9955613 - Disclosure - Other Non-Current Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.gsk.com/role/InventoriesDetails">
        <link:definition>9955614 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherreceivablesSummaryofTradeandOtherReceivablesDetails" roleURI="http://www.gsk.com/role/TradeandotherreceivablesSummaryofTradeandOtherReceivablesDetails">
        <link:definition>9955615 - Disclosure - Trade and other receivables - Summary of Trade and Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherreceivablesAdditionalInformationDetails" roleURI="http://www.gsk.com/role/TradeandotherreceivablesAdditionalInformationDetails">
        <link:definition>9955616 - Disclosure - Trade and other receivables - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherreceivablesSummaryofLossAllowanceDetails" roleURI="http://www.gsk.com/role/TradeandotherreceivablesSummaryofLossAllowanceDetails">
        <link:definition>9955617 - Disclosure - Trade and other receivables - Summary of Loss Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsSummaryofCashandCashEquivalentsDetails" roleURI="http://www.gsk.com/role/CashandcashequivalentsSummaryofCashandCashEquivalentsDetails">
        <link:definition>9955618 - Disclosure - Cash and cash equivalents - Summary of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/CashandcashequivalentsAdditionalInformationDetails">
        <link:definition>9955619 - Disclosure - Cash and cash equivalents - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsheldforSaleDetails" roleURI="http://www.gsk.com/role/AssetsheldforSaleDetails">
        <link:definition>9955620 - Disclosure - Assets held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherpayablesSummaryofTradeandOtherPayablesDetails" roleURI="http://www.gsk.com/role/TradeandotherpayablesSummaryofTradeandOtherPayablesDetails">
        <link:definition>9955621 - Disclosure - Trade and other payables - Summary of Trade and Other Payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherpayablesAdditionalInformationDetails" roleURI="http://www.gsk.com/role/TradeandotherpayablesAdditionalInformationDetails">
        <link:definition>9955622 - Disclosure - Trade and other payables - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeandotherpayablesSummaryofIncreaseDecreaseinFinancialLiabilityandLossGaininIncomeStatementDetails" roleURI="http://www.gsk.com/role/TradeandotherpayablesSummaryofIncreaseDecreaseinFinancialLiabilityandLossGaininIncomeStatementDetails">
        <link:definition>9955623 - Disclosure - Trade and other payables - Summary of Increase/(Decrease) in Financial Liability and Loss/(Gain) in Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdebtScheduleofCurrentAssetsShortandLongTermBorrowingsDetails" roleURI="http://www.gsk.com/role/NetdebtScheduleofCurrentAssetsShortandLongTermBorrowingsDetails">
        <link:definition>9955624 - Disclosure - Net debt - Schedule of Current Assets, Short and Long Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdebtAdditionalInformationDetails" roleURI="http://www.gsk.com/role/NetdebtAdditionalInformationDetails">
        <link:definition>9955625 - Disclosure - Net debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdebtScheduleofFinanceLeaseObligationsDetails" roleURI="http://www.gsk.com/role/NetdebtScheduleofFinanceLeaseObligationsDetails">
        <link:definition>9955626 - Disclosure - Net debt - Schedule of Finance Lease Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails">
        <link:definition>9955627 - Disclosure - Pensions and other post-employment benefits - Summary of Pension and Other Post-employment Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofAverageLifeExpectancyAssumedDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAverageLifeExpectancyAssumedDetails">
        <link:definition>9955628 - Disclosure - Pensions and other post-employment benefits - Summary of Average Life Expectancy Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsAdditionalInformationDetails">
        <link:definition>9955629 - Disclosure - Pensions and other post-employment benefits - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostemploymentBenefitsSummaryofFinancialAssumptionsinAssessingDefinedBenefitLiabilitiesDetails" roleURI="http://www.gsk.com/role/PensionsandOtherPostemploymentBenefitsSummaryofFinancialAssumptionsinAssessingDefinedBenefitLiabilitiesDetails">
        <link:definition>9955630 - Disclosure - Pensions and Other Post-employment Benefits - Summary of Financial Assumptions in Assessing Defined Benefit Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails">
        <link:definition>9955631 - Disclosure - Pensions and other post-employment benefits - Summary of Amounts Recorded in Income Statement and Statement of Comprehensive Income Related to Defined Benefit Pension and Post-retirement Healthcare Schemes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofBalanceSheetPresentationofGroupDefinedBenefitPensionSchemesandOtherPostretirementBenefitsDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofBalanceSheetPresentationofGroupDefinedBenefitPensionSchemesandOtherPostretirementBenefitsDetails">
        <link:definition>9955632 - Disclosure - Pensions and other post-employment benefits - Summary of Balance Sheet Presentation of Group Defined Benefit Pension Schemes and Other Post-retirement Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails">
        <link:definition>9955633 - Disclosure - Pensions and other post-employment benefits - Fair Values of Assets and Liabilities of UK and US Defined Benefit Pension Schemes Together with Aggregated Data for Other Defined Benefit Pension Schemes in Group (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofMovementsinFairValuesofAssetsDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofMovementsinFairValuesofAssetsDetails">
        <link:definition>9955634 - Disclosure - Pensions and other post-employment benefits - Summary of Movements in Fair Values of Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationsDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationsDetails">
        <link:definition>9955635 - Disclosure - Pensions and other post-employment benefits - Summary of Movement in Defined Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofAnalysisofDefinedBenefitPensionObligationDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAnalysisofDefinedBenefitPensionObligationDetails">
        <link:definition>9955636 - Disclosure - Pensions and other post-employment benefits - Summary of Analysis of Defined Benefit Pension Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsMovementInBenefitLiabilityDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsMovementInBenefitLiabilityDetails">
        <link:definition>9955637 - Disclosure - Pensions and other post-employment benefits - Movement In Benefit Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails">
        <link:definition>9955638 - Disclosure - Pensions and other post-employment benefits - Summary of Remeasurements Within Post-Retirement Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofDefinedBenefitPensionObligationAnalysedbyMembershipCategoryDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofDefinedBenefitPensionObligationAnalysedbyMembershipCategoryDetails">
        <link:definition>9955639 - Disclosure - Pensions and other post-employment benefits - Summary of Defined Benefit Pension Obligation Analysed by Membership Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofPostRetirementBenefitObligationAnalysedbyMembershipCategoryDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPostRetirementBenefitObligationAnalysedbyMembershipCategoryDetails">
        <link:definition>9955640 - Disclosure - Pensions and other post-employment benefits - Summary of Post-Retirement Benefit Obligation Analysed by Membership Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofWeightedAverageDurationDefinedBenefitObligationDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofWeightedAverageDurationDefinedBenefitObligationDetails">
        <link:definition>9955641 - Disclosure - Pensions and other post-employment benefits - Summary of Weighted Average Duration Defined Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandotherpostemploymentbenefitsSummaryofChangesinAssumptionsUsedonBenefitObligationsDefinedBenefitPensionandPostRetirementCostsDetails" roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofChangesinAssumptionsUsedonBenefitObligationsDefinedBenefitPensionandPostRetirementCostsDetails">
        <link:definition>9955642 - Disclosure - Pensions and other post-employment benefits - Summary of Changes in Assumptions Used on Benefit Obligations, Defined Benefit Pension and Post Retirement Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherprovisionsSummaryofOtherProvisionsDetails" roleURI="http://www.gsk.com/role/OtherprovisionsSummaryofOtherProvisionsDetails">
        <link:definition>9955643 - Disclosure - Other provisions - Summary of Other Provisions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherprovisionsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/OtherprovisionsAdditionalInformationDetails">
        <link:definition>9955644 - Disclosure - Other provisions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentconsiderationliabilitiesSummaryofFairValueContingentConsiderationDetails" roleURI="http://www.gsk.com/role/ContingentconsiderationliabilitiesSummaryofFairValueContingentConsiderationDetails">
        <link:definition>9955645 - Disclosure - Contingent consideration liabilities - Summary of Fair Value Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationLiabilitiesAdditionalInformationDetails" roleURI="http://www.gsk.com/role/ContingentConsiderationLiabilitiesAdditionalInformationDetails">
        <link:definition>9955646 - Disclosure - Contingent Consideration Liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentconsiderationliabilitiesDisclosureofsensitivityofkeymodelinputtomeasurecontingentconsiderationDetails" roleURI="http://www.gsk.com/role/ContingentconsiderationliabilitiesDisclosureofsensitivityofkeymodelinputtomeasurecontingentconsiderationDetails">
        <link:definition>9955647 - Disclosure - Contingent consideration liabilities - Disclosure of sensitivity of key model input to measure contingent consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentLiabilitiesDetails" roleURI="http://www.gsk.com/role/OtherNoncurrentLiabilitiesDetails">
        <link:definition>9955648 - Disclosure - Other Non-current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentliabilitiesDetails" roleURI="http://www.gsk.com/role/ContingentliabilitiesDetails">
        <link:definition>9955649 - Disclosure - Contingent liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsScheduleofContractualObligationsandCommitmentsDetails" roleURI="http://www.gsk.com/role/CommitmentsScheduleofContractualObligationsandCommitmentsDetails">
        <link:definition>9955650 - Disclosure - Commitments - Schedule of Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/CommitmentsAdditionalInformationDetails">
        <link:definition>9955651 - Disclosure - Commitments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharecapitalandsharepremiumaccountAdditionalInformationDetails" roleURI="http://www.gsk.com/role/SharecapitalandsharepremiumaccountAdditionalInformationDetails">
        <link:definition>9955652 - Disclosure - Share capital and share premium account - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharecapitalandsharepremiumaccountSummaryofShareCapitalandSharePremiumDetails" roleURI="http://www.gsk.com/role/SharecapitalandsharepremiumaccountSummaryofShareCapitalandSharePremiumDetails">
        <link:definition>9955653 - Disclosure - Share capital and share premium account - Summary of Share Capital and Share Premium (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MovementsinEquityAdditionalInformationDetails" roleURI="http://www.gsk.com/role/MovementsinEquityAdditionalInformationDetails">
        <link:definition>9955654 - Disclosure - Movements in Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MovementsinEquitySummaryofCumulativeTranslationExchangeinEquityDetails" roleURI="http://www.gsk.com/role/MovementsinEquitySummaryofCumulativeTranslationExchangeinEquityDetails">
        <link:definition>9955655 - Disclosure - Movements in Equity - Summary of Cumulative Translation Exchange in Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails" roleURI="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails">
        <link:definition>9955656 - Disclosure - Movements in Equity - Analysis of Other Comprehensive Income by Equity Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MovementsinEquityAnalysisofOtherReservesDetails" roleURI="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherReservesDetails">
        <link:definition>9955657 - Disclosure - Movements in Equity - Analysis of Other Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollinginterestsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/NoncontrollinginterestsAdditionalInformationDetails">
        <link:definition>9955658 - Disclosure - Non-controlling interests - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollinginterestsSummarisedFinancialInformationofViiVHealthcareGroupandGSKConsumerHealthcareJointVentureDetails" roleURI="http://www.gsk.com/role/NoncontrollinginterestsSummarisedFinancialInformationofViiVHealthcareGroupandGSKConsumerHealthcareJointVentureDetails">
        <link:definition>9955659 - Disclosure - Non-controlling interests - Summarised Financial Information of ViiV Healthcare Group and GSK Consumer Healthcare Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollinginterestsAmountsAttributableToJointVenturesIncludedinGSKResultsDetails" roleURI="http://www.gsk.com/role/NoncontrollinginterestsAmountsAttributableToJointVenturesIncludedinGSKResultsDetails">
        <link:definition>9955660 - Disclosure - Non-controlling interests - Amounts Attributable To Joint Ventures Included in GSK Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartytransactionsDetails" roleURI="http://www.gsk.com/role/RelatedpartytransactionsDetails">
        <link:definition>9955661 - Disclosure - Related party transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddisposalsAdditionalInformationDetails" roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsAdditionalInformationDetails">
        <link:definition>9955662 - Disclosure - Acquisitions and disposals - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails" roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails">
        <link:definition>9955663 - Disclosure - Acquisitions and disposals - Summary of Fair Values of the Assets Acquired in Business Combinations, Including Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddisposalsSummaryofCashFlowsDetails" roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofCashFlowsDetails">
        <link:definition>9955664 - Disclosure - Acquisitions and disposals - Summary of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails" roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails">
        <link:definition>9955665 - Disclosure - Acquisitions and disposals - Summary of Fair Value and Carrying amounts of Demergers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails" roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails">
        <link:definition>9955666 - Disclosure - Acquisitions and disposals - Summary of Financial Information Relating to Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdjustmentsreconcilingTotalprofitaftertaxtooperatingcashflowsDetails" roleURI="http://www.gsk.com/role/AdjustmentsreconcilingTotalprofitaftertaxtooperatingcashflowsDetails">
        <link:definition>9955667 - Disclosure - Adjustments reconciling Total profit after tax to operating cash flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReconciliationofnetcashflowtomovementinnetdebtSummaryofNetDebtDetails" roleURI="http://www.gsk.com/role/ReconciliationofnetcashflowtomovementinnetdebtSummaryofNetDebtDetails">
        <link:definition>9955668 - Disclosure - Reconciliation of net cash flow to movement in net debt - Summary of Net Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReconciliationofnetcashflowtomovementinnetdebtSummaryofAnalysisofChangesinNetDebtDetails" roleURI="http://www.gsk.com/role/ReconciliationofnetcashflowtomovementinnetdebtSummaryofAnalysisofChangesinNetDebtDetails">
        <link:definition>9955669 - Disclosure - Reconciliation of net cash flow to movement in net debt - Summary of Analysis of Changes in Net Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresAdditionalInformationCapitalandRiskManagementDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationCapitalandRiskManagementDetails">
        <link:definition>9955670 - Disclosure - Financial instruments and related disclosures - Additional Information Capital and Risk Management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails">
        <link:definition>9955671 - Disclosure - Financial instruments and related disclosures - Summary of External Credit Exposure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails">
        <link:definition>9955672 - Disclosure - Financial instruments and related disclosures - Summary of Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueofFinancialInstrumentsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueofFinancialInstrumentsDetails">
        <link:definition>9955673 - Disclosure - Financial instruments and related disclosures - Additional Information Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofFairValueofFinancialInstrumentsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFairValueofFinancialInstrumentsDetails">
        <link:definition>9955674 - Disclosure - Financial instruments and related disclosures - Summary of Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofMovementinFinancialInstrumentsMeasuredUsingLevel3ValuationMethodDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofMovementinFinancialInstrumentsMeasuredUsingLevel3ValuationMethodDetails">
        <link:definition>9955675 - Disclosure - Financial instruments and related disclosures - Summary of Movement in Financial Instruments Measured Using Level 3 Valuation Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentsandotherreceivablesandothernoncurrentassetsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentsandotherreceivablesandothernoncurrentassetsDetails">
        <link:definition>9955676 - Disclosure - Financial instruments and related disclosures - Reconciliation of financial instruments and other receivables and other non-current assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails">
        <link:definition>9955677 - Disclosure - Financial instruments and related disclosures - Reconciliation of financial instruments within Trade and other payables, Other provisions, Other non-current liabilities and Contingent consideration liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresFairValuesofDerivativesHeldDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresFairValuesofDerivativesHeldDetails">
        <link:definition>9955678 - Disclosure - Financial instruments and related disclosures - Fair Values of Derivatives Held (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueHedgesDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueHedgesDetails">
        <link:definition>9955679 - Disclosure - Financial instruments and related disclosures - Additional Information Fair Value Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofDetailedInformationofForeignExchangeForwardContractsSwapsOutstandingandRelatedHedgedItemsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofDetailedInformationofForeignExchangeForwardContractsSwapsOutstandingandRelatedHedgedItemsDetails">
        <link:definition>9955680 - Disclosure - Financial instruments and related disclosures - Summary of Detailed Information of Foreign Exchange Forward Contracts, Swaps Outstanding and Related Hedged Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofEffectivenessofHedgingRelationshipsandAmountsReclassifiedfromHedgingReservetoProfitorLossDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofEffectivenessofHedgingRelationshipsandAmountsReclassifiedfromHedgingReservetoProfitorLossDetails">
        <link:definition>9955681 - Disclosure - Financial instruments and related disclosures - Summary of Effectiveness of Hedging Relationships and Amounts Reclassified from Hedging Reserve to Profit or Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresEffectivenessofHedgingRelationshipsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresEffectivenessofHedgingRelationshipsDetails">
        <link:definition>9955682 - Disclosure - Financial instruments and related disclosures - Effectiveness of Hedging Relationships (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails">
        <link:definition>9955683 - Disclosure - Financial instruments and related disclosures - Schedule of Offsetting of Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresScheduleofDebtInterestRateRepricingDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofDebtInterestRateRepricingDetails">
        <link:definition>9955684 - Disclosure - Financial instruments and related disclosures - Schedule of Debt Interest Rate Repricing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresImpactofNonfunctionalCurrencyForeignExchangeExposuresDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresImpactofNonfunctionalCurrencyForeignExchangeExposuresDetails">
        <link:definition>9955685 - Disclosure - Financial instruments and related disclosures - Impact of Non-functional Currency Foreign Exchange Exposures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresImpactofInterestRateCurrencyMovementsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresImpactofInterestRateCurrencyMovementsDetails">
        <link:definition>9955686 - Disclosure - Financial instruments and related disclosures - Impact of Interest Rate Currency Movements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryofAnticipatedcontractualcashflowsincludinginterestpayablefortheNonDerivativeFinancialliabilitiesonundiscountedbasisDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofAnticipatedcontractualcashflowsincludinginterestpayablefortheNonDerivativeFinancialliabilitiesonundiscountedbasisDetails">
        <link:definition>9955687 - Disclosure - Financial instruments and related disclosures - Summary of Anticipated contractual cash flows including interest payable for the Non-Derivative Financial liabilities on undiscounted basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrelateddisclosuresSummaryAnticipatedContractualCashFlowsforDerivativeInstrumentsExcludingEmbeddedDerivativesandEquityOptionsUsingUndiscountedCashFlowsDetails" roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryAnticipatedContractualCashFlowsforDerivativeInstrumentsExcludingEmbeddedDerivativesandEquityOptionsUsingUndiscountedCashFlowsDetails">
        <link:definition>9955688 - Disclosure - Financial instruments and related disclosures - Summary Anticipated Contractual Cash Flows for Derivative Instruments, Excluding Embedded Derivatives and Equity Options, Using Undiscounted Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeshareschemesAdditionalInformationDetails" roleURI="http://www.gsk.com/role/EmployeeshareschemesAdditionalInformationDetails">
        <link:definition>9955689 - Disclosure - Employee share schemes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeshareschemesScheduleofNumberofSharesandADSIssuableDetails" roleURI="http://www.gsk.com/role/EmployeeshareschemesScheduleofNumberofSharesandADSIssuableDetails">
        <link:definition>9955690 - Disclosure - Employee share schemes - Schedule of Number of Shares and ADS Issuable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeshareschemesSummaryofValuationModelUsedtoValuingSavingRelatedOptiontoArriveattheShareBasedPaymentChargeDetails" roleURI="http://www.gsk.com/role/EmployeeshareschemesSummaryofValuationModelUsedtoValuingSavingRelatedOptiontoArriveattheShareBasedPaymentChargeDetails">
        <link:definition>9955691 - Disclosure - Employee share schemes - Summary of Valuation Model Used to Valuing Saving - Related Option to Arrive at the Share Based Payment Charge (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeshareschemesSummaryofOptionOutstandingDetails" roleURI="http://www.gsk.com/role/EmployeeshareschemesSummaryofOptionOutstandingDetails">
        <link:definition>9955692 - Disclosure - Employee share schemes - Summary of Option Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeshareschemesSummaryofSharesHeldforShareAwardSchemesDetails" roleURI="http://www.gsk.com/role/EmployeeshareschemesSummaryofSharesHeldforShareAwardSchemesDetails">
        <link:definition>9955693 - Disclosure - Employee share schemes - Summary of Shares Held for Share Award Schemes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalGroupcompaniesDetails" roleURI="http://www.gsk.com/role/PrincipalGroupcompaniesDetails">
        <link:definition>9955694 - Disclosure - Principal Group companies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedingsDetails" roleURI="http://www.gsk.com/role/LegalProceedingsDetails">
        <link:definition>9955695 - Disclosure - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostbalancesheeteventsDetails" roleURI="http://www.gsk.com/role/PostbalancesheeteventsDetails">
        <link:definition>9955696 - Disclosure - Post balance sheet events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="gsk_TitleOfEachClassAxis" abstract="true" name="TitleOfEachClassAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TitleOfEachClassDomain" abstract="true" name="TitleOfEachClassDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AmericanDepositarySharesMember" abstract="true" name="AmericanDepositarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointSixTwoFiveNotesDue2025Member" abstract="true" name="ThreePointSixTwoFiveNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointEightSevenFiveNotesDue2028Member" abstract="true" name="ThreePointEightSevenFiveNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointThreeSevenFiveNotesDue2029Member" abstract="true" name="ThreePointThreeSevenFiveNotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SixPointThreeSevenFiveNotesDue2038Member" abstract="true" name="SixPointThreeSevenFiveNotesDue2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FourPointTwoZeroZeroNotesDue2043Member" abstract="true" name="FourPointTwoZeroZeroNotesDue2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" abstract="false" name="ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" abstract="false" name="RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations" abstract="false" name="ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" abstract="false" name="ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" abstract="false" name="ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" abstract="false" name="FairValueMovementsOnCashFlowHedgesNotReclassified" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" abstract="false" name="OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations" abstract="false" name="OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LiquidInvestments" abstract="false" name="LiquidInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ContingentConsiderationLiabilities" abstract="false" name="ContingentConsiderationLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NonCashDistributionToNonControllingInterests" abstract="false" name="NonCashDistributionToNonControllingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" abstract="false" name="IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" abstract="false" name="IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" abstract="false" name="IncreaseDecreaseThroughDisposalOfEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" abstract="false" name="ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" abstract="false" name="WriteDownOfSharesHeldByEmployeeStockOwnershipPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_SharesAcquiredByEsopTrusts" abstract="false" name="SharesAcquiredByEsopTrusts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_HedgingGainLossTransferredToNonFinancialAssets" abstract="false" name="HedgingGainLossTransferredToNonFinancialAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" abstract="false" name="CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" abstract="false" name="IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInLiquidInvestments" abstract="false" name="IncreaseDecreaseInLiquidInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" abstract="false" name="CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" abstract="false" name="OutflowOfCashThroughCCLClassifiedAsInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" abstract="false" name="DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ProceedsRepaymentsFromOfShortTermLoans" abstract="false" name="ProceedsRepaymentsFromOfShortTermLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInOtherShortTermLoans" abstract="false" name="IncreaseDecreaseInOtherShortTermLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RepaymentOfOtherShortTermLoans" abstract="false" name="RepaymentOfOtherShortTermLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" abstract="false" name="DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AccountingPrinciplesAndPoliciesAbstract" abstract="true" name="AccountingPrinciplesAndPoliciesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfEmployeeCostsExplanatory" abstract="false" name="DisclosureOfEmployeeCostsExplanatory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfMajorRestructuringCostsExplanatory" abstract="false" name="DisclosureOfMajorRestructuringCostsExplanatory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfAssociatesAndJointVenturesExplanatoryTextBlock" abstract="false" name="DisclosureOfAssociatesAndJointVenturesExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDividendsAbstract" abstract="true" name="DisclosureOfDividendsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" abstract="false" name="DisclosureOfCurrentEquityInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfNetDebtAbstract" abstract="true" name="DisclosureOfNetDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfContingentConsiderationAbstract" abstract="true" name="DisclosureOfContingentConsiderationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" abstract="false" name="DisclosureOfContingentConsiderationLiabilitiesExplanatory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_OtherNonCurrentLiabilitiesAbstract" abstract="true" name="OtherNonCurrentLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfShareCapitalAndSharePremiumExplanatory" abstract="false" name="DisclosureOfShareCapitalAndSharePremiumExplanatory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfNonControllingInterestsAbstract" abstract="true" name="DisclosureOfNonControllingInterestsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" abstract="false" name="DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" abstract="false" name="DisclosureOfPrincipalGroupCompaniesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" abstract="false" name="DisclosureOfLegalProceedingsExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DescriptionOfAccountingPolicyForCurrentEquityInvestmentsExplanatoryPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForCurrentEquityInvestmentsExplanatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DescriptionOfAccountingPolicyForOtherInvestmentPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForOtherInvestmentPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" abstract="false" name="DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" abstract="false" name="SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfTurnoverBySegmentExplanatoryTableTextBlock" abstract="false" name="DisclosureOfTurnoverBySegmentExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfNumberOfEmployeesTableTextBlock" abstract="false" name="DisclosureOfNumberOfEmployeesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" abstract="false" name="DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfMajorRestructuringCostsChargedToOperatingProfitExplanatoryTableTextBlock" abstract="false" name="DisclosureOfMajorRestructuringCostsChargedToOperatingProfitExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfRestructuringCostsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" abstract="false" name="DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfIncomeTaxExpenseBenefitsTableTextBlock" abstract="false" name="DisclosureOfIncomeTaxExpenseBenefitsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" abstract="false" name="DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" abstract="false" name="DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" abstract="false" name="DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="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" abstract="false" name="DisclosureOfInterimDividendExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDividendsPaidTableTextBlock" abstract="false" name="DisclosureOfDividendsPaidTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfAllocationOfGoodwillToSegmentsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfAllocationOfGoodwillToSegmentsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" abstract="false" name="DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" abstract="false" name="DisclosureOfScheduleOfOtherInvestmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" abstract="false" name="SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationOfInventoriesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" abstract="false" name="CategoriesOfTradeAndOtherReceivablesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" abstract="false" name="DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" abstract="false" name="SummaryOfTradePayablesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" abstract="false" name="DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfLeaseObligationsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" abstract="false" name="DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" abstract="false" name="DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfBalanceSheetPresentationOfDefinedBenefitPensionAndPostRetirementExplanatoryTableTextBlock" abstract="false" name="DisclosureOfBalanceSheetPresentationOfDefinedBenefitPensionAndPostRetirementExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfMovementsInFairValuesOfAssetsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfMovementsInFairValuesOfAssetsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" abstract="false" name="DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" abstract="false" name="SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" abstract="false" name="DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" abstract="false" name="DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationExplanatoryTableTextBlock" abstract="false" name="DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfClassesOfShareCapitalAndSharePremiumExplanatoryTableTextBlock" abstract="false" name="DisclosureOfClassesOfShareCapitalAndSharePremiumExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" abstract="false" name="DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_MovementsInOtherReservesTableTextBlock" abstract="false" name="MovementsInOtherReservesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" abstract="false" name="ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" abstract="false" name="DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" abstract="false" name="DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" abstract="false" name="FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" abstract="false" name="ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" abstract="false" name="DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" abstract="false" name="DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" abstract="false" name="ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="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" abstract="false" name="ForeignExchangeSensitivityEquityImpactTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" abstract="false" name="DisclosureOfEmployeeShareValuePlanTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" abstract="false" name="DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" abstract="false" name="DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="gsk_NumberOfTherapeuticAreas" abstract="false" name="NumberOfTherapeuticAreas" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" abstract="true" name="DisclosureOfAccountingPrinciplesAndPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ERPSoftwareSystemsMember" abstract="true" name="ERPSoftwareSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherComputerSoftwareMember" abstract="true" name="OtherComputerSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PharmaceuticalsMember" abstract="true" name="PharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_VaccinesMember" abstract="true" name="VaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RemainingBookValueMember" abstract="true" name="RemainingBookValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="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" abstract="true" name="DisclosureOfAccountingPrinciplesAndPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" abstract="false" name="ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RevenueFromCoPromotionalActivities" abstract="false" name="RevenueFromCoPromotionalActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" abstract="false" name="ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AmortisableProportionOverExclusivityPeriod" abstract="false" name="AmortisableProportionOverExclusivityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_FreeholdBuildingsMember" abstract="true" name="FreeholdBuildingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LeaseholdLandAndBuildingsMember" abstract="true" name="LeaseholdLandAndBuildingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PlantAndMachineryMember" abstract="true" name="PlantAndMachineryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EquipmentAndVehiclesMember" abstract="true" name="EquipmentAndVehiclesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SegmentConsolidationItemAxis" abstract="true" name="SegmentConsolidationItemAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_SegmentConsolidationItemDomain" abstract="true" name="SegmentConsolidationItemDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_USPharmaceuticalsAndVaccinesMember" abstract="true" name="USPharmaceuticalsAndVaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" abstract="true" name="EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ActuarialAssumptionPercentageRateAxis" abstract="true" name="ActuarialAssumptionPercentageRateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ActuarialAssumptionPercentageRateDomain" abstract="true" name="ActuarialAssumptionPercentageRateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ActuarialAssumptionPercentageRateChangeMember" abstract="true" name="ActuarialAssumptionPercentageRateChangeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" abstract="true" name="ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShionogiViiVHealthcareJointVentureMember" abstract="true" name="ShionogiViiVHealthcareJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SensitivityAnalysisForActuarialAssumptionsMember" abstract="true" name="SensitivityAnalysisForActuarialAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LicencesAndFranchisesAmortisedBrandsMember" abstract="true" name="LicencesAndFranchisesAmortisedBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CustomerReturnsDiscountsAndRebates" abstract="false" name="CustomerReturnsDiscountsAndRebates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" abstract="false" name="CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_UncertainTaxPositionsRecognised" abstract="false" name="UncertainTaxPositionsRecognised" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LegalCosts" abstract="false" name="LegalCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" abstract="false" name="GainLossOnContingentConsiderationAndPutOptionLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfPensionSchemesInSurplus" abstract="false" name="NumberOfPensionSchemesInSurplus" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_DefinedBenefitPlanSurplusNet" abstract="false" name="DefinedBenefitPlanSurplusNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PensionSurplus" abstract="false" name="PensionSurplus" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfCountriesWithPensionSurpluses" abstract="false" name="NumberOfCountriesWithPensionSurpluses" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_PercentageOfDecreaseInDiscountRate" abstract="false" name="PercentageOfDecreaseInDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_IncreaseInPlanDeficit" abstract="false" name="IncreaseInPlanDeficit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseInAnnualPensionCost" abstract="false" name="IncreaseInAnnualPensionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PercentageOfIncreaseInDiscountRate" abstract="false" name="PercentageOfIncreaseInDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_DecreaseInPlanDeficit" abstract="false" name="DecreaseInPlanDeficit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseInAnnualPensionCost" abstract="false" name="DecreaseInAnnualPensionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfForeignExchangeRatesTable" abstract="true" name="DisclosureOfForeignExchangeRatesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfForeignExchangeRatesLineItems" abstract="true" name="DisclosureOfForeignExchangeRatesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_Wholesalers1Member" abstract="true" name="Wholesalers1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_Wholesalers2Member" abstract="true" name="Wholesalers2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_Wholesalers3Member" abstract="true" name="Wholesalers3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShionogiViivHealthcareMember" abstract="true" name="ShionogiViivHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PfizerMember" abstract="true" name="PfizerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NumberOfReportableOperatingSegments" abstract="false" name="NumberOfReportableOperatingSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfProductGroups" abstract="false" name="NumberOfProductGroups" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfUSWholesalers" abstract="false" name="NumberOfUSWholesalers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_RevenueFromChangesToEstimatesOfRARAccruals" abstract="false" name="RevenueFromChangesToEstimatesOfRARAccruals" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" abstract="false" name="ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" abstract="false" name="MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" abstract="false" name="RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PutOption" abstract="false" name="PutOption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CommercialOperationsMember" abstract="true" name="CommercialOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShinglesMember" abstract="true" name="ShinglesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MeningitisMember" abstract="true" name="MeningitisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RSVArexvyMember" abstract="true" name="RSVArexvyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InfluenzaMember" abstract="true" name="InfluenzaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EstablishedVaccinesMember" abstract="true" name="EstablishedVaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" abstract="true" name="MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PandemicVaccinesMember" abstract="true" name="PandemicVaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HIVMember" abstract="true" name="HIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ImmunoInflammationRespiratoryAndOtherMember" abstract="true" name="ImmunoInflammationRespiratoryAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OncologyMember" abstract="true" name="OncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" abstract="true" name="HIVOncologyImmunoInflammationRespiratoryAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PandemicMember" abstract="true" name="PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SpecialtyMedicineMember" abstract="true" name="SpecialtyMedicineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RespiratoryMember" abstract="true" name="RespiratoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherGeneralMedicinesMember" abstract="true" name="OtherGeneralMedicinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GeneralMedicinesMember" abstract="true" name="GeneralMedicinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ResearchAndDevelopmentMember" abstract="true" name="ResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GainLossOnDisposalOfInterestInAssociates" abstract="false" name="GainLossOnDisposalOfInterestInAssociates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetOperatingAssets" abstract="false" name="NetOperatingAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_InvestmentsInJointVenturesAndAssociates" abstract="false" name="InvestmentsInJointVenturesAndAssociates" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrentAndDeferredTaxation" abstract="false" name="CurrentAndDeferredTaxation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CustomerMember" abstract="true" name="CustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GileadSciencesIncMember" abstract="true" name="GileadSciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UpfrontSettlementIncome" abstract="false" name="UpfrontSettlementIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisposalOfBusinessesAndAssets" abstract="false" name="DisposalOfBusinessesAndAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" abstract="false" name="RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MiscellaneousOtherIncomeExpense" abstract="false" name="MiscellaneousOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_UpfrontPayment" abstract="false" name="UpfrontPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PercentageOfRoyaltyPayableOnFutureSales" abstract="false" name="PercentageOfRoyaltyPayableOnFutureSales" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_InvestmentAxis" abstract="true" name="InvestmentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_InvestmentDomain" abstract="true" name="InvestmentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HaleonPlcMember" abstract="true" name="HaleonPlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NovartisVaccinesMember" abstract="true" name="NovartisVaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" abstract="false" name="GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" abstract="false" name="ImpairmentOfRightOfUseAssetsNetOfReversals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ImpairmentOfIntangibleAssetsNetOfReversal" abstract="false" name="ImpairmentOfIntangibleAssetsNetOfReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" abstract="false" name="ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfOperatingProfitTable" abstract="true" name="DisclosureOfOperatingProfitTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" abstract="true" name="LiquidationOrDisposalOfOverseasSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LiquidationOrDisposalOfInterestInAssociatesMember" abstract="true" name="LiquidationOrDisposalOfInterestInAssociatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PurposeAxis" abstract="true" name="PurposeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_PurposeDomain" abstract="true" name="PurposeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" abstract="true" name="ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfOperatingProfitLineItems" abstract="true" name="DisclosureOfOperatingProfitLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfAuditorsRemunerationTable" abstract="true" name="DisclosureOfAuditorsRemunerationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfAuditorsRemunerationLineItems" abstract="true" name="DisclosureOfAuditorsRemunerationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AuditorsRemunerationForOtherAssuranceServices" abstract="false" name="AuditorsRemunerationForOtherAssuranceServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" abstract="false" name="AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PostEmploymentBenefitExpense" abstract="false" name="PostEmploymentBenefitExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ShareValuePlanMember" abstract="true" name="ShareValuePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PerformanceSharePlansMember" abstract="true" name="PerformanceSharePlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShareOptionPlanMember" abstract="true" name="ShareOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CashSettledAndOtherPlansMember" abstract="true" name="CashSettledAndOtherPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" abstract="true" name="ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfEmployeeCostsAndNumbersTable" abstract="true" name="DisclosureOfEmployeeCostsAndNumbersTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ManufacturingMember" abstract="true" name="ManufacturingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SellingGeneralAndAdministrationMember" abstract="true" name="SellingGeneralAndAdministrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" abstract="true" name="DisclosureOfEmployeeCostsAndNumbersLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AverageNumberOfEmployeesFromContinuingOperations" abstract="false" name="AverageNumberOfEmployeesFromContinuingOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" abstract="false" name="AverageNumberOfEmployeesFromDiscontinuingOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" abstract="false" name="KeyManagementPersonnelCompensationSocialSecurityCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfRestructuringCostsTable" abstract="true" name="DisclosureOfRestructuringCostsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ArrangementTypeAxis" abstract="true" name="ArrangementTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ArrangementTypeDomain" abstract="true" name="ArrangementTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SeparationRestructuringProgrammeMember" abstract="true" name="SeparationRestructuringProgrammeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfRestructuringCostsLineItems" abstract="true" name="DisclosureOfRestructuringCostsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_MajorRestructuringCostThreshold" abstract="false" name="MajorRestructuringCostThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfCompaniesSplitInto" abstract="false" name="NumberOfCompaniesSplitInto" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_TotalRestructuringCosts" abstract="false" name="TotalRestructuringCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ProvisionReversalRestructuring" abstract="false" name="ProvisionReversalRestructuring" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AssetImpairmentsCredit" abstract="false" name="AssetImpairmentsCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherNonCashCreditCharges" abstract="false" name="OtherNonCashCreditCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RestructuringNumberOfCompaniesSeparatedInto" abstract="false" name="RestructuringNumberOfCompaniesSeparatedInto" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" abstract="false" name="IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherCostsCashSettlement" abstract="false" name="OtherCostsCashSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_SignificantAcquisitionsMember" abstract="true" name="SignificantAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LegacyProgrammesMember" abstract="true" name="LegacyProgrammesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CashRestructuringCharges" abstract="false" name="CashRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NonCashRestructuringCharges" abstract="false" name="NonCashRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RestructuringCosts1" abstract="false" name="RestructuringCosts1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RestructuringCostsAxis" abstract="true" name="RestructuringCostsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_RestructuringCostsDomain" abstract="true" name="RestructuringCostsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CostOfMajorRestructuringMember" abstract="true" name="CostOfMajorRestructuringMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CostChargedToOperatingProfit" abstract="false" name="CostChargedToOperatingProfit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RetranslationOfLoan" abstract="false" name="RetranslationOfLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" abstract="false" name="ReclassificationAdjustmentsOnHedgesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherAssociatesMember" abstract="true" name="OtherAssociatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SalesToAssociatesAndJointVentures" abstract="false" name="SalesToAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncomeTaxExpenseBenefitsTable" abstract="true" name="IncomeTaxExpenseBenefitsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_IncomeTaxExpenseBenefitsLineItems" abstract="true" name="IncomeTaxExpenseBenefitsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_CurrentTaxExpenseIncomeAbstract" abstract="true" name="CurrentTaxExpenseIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" abstract="false" name="TaxRateEffectOfReassessmentsOfPriorYearEstimates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" abstract="false" name="TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_TaxRateEffectOfResearchAndDevelopmentCredits" abstract="false" name="TaxRateEffectOfResearchAndDevelopmentCredits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" abstract="false" name="TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_TaxRateEffectOfChangeInTaxRate" abstract="false" name="TaxRateEffectOfChangeInTaxRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" abstract="false" name="TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_OverseasMember" abstract="true" name="OverseasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ProvisionsForUncertainTaxPosition" abstract="false" name="ProvisionsForUncertainTaxPosition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_UnremittedEarnings" abstract="false" name="UnremittedEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_UnremittedProfitsForWhichDeferredTaxNotProvided" abstract="false" name="UnremittedProfitsForWhichDeferredTaxNotProvided" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DeferredTaxAssetsRecognizedOnTradingLosses" abstract="false" name="DeferredTaxAssetsRecognizedOnTradingLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" abstract="false" name="TaxEffectOfBenefitOfIntellectualPropertyIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxEffectOfResearchAndDevelopmentCredits" abstract="false" name="TaxEffectOfResearchAndDevelopmentCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" abstract="false" name="TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" abstract="false" name="TaxEffectOfReassessmentsOfPriorYearEstimates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" abstract="false" name="TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxEffectOfChangeInTaxRate" abstract="false" name="TaxEffectOfChangeInTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrentTaxationAbstract" abstract="true" name="CurrentTaxationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" abstract="false" name="CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" abstract="false" name="CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" abstract="false" name="CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" abstract="false" name="CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" abstract="true" name="DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" abstract="false" name="DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" abstract="false" name="DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" abstract="false" name="DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" abstract="false" name="DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AcceleratedCapitalAllowancesMember" abstract="true" name="AcceleratedCapitalAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IntraGroupProfitMember" abstract="true" name="IntraGroupProfitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PensionsAndOtherPostEmploymentBenefitsMember" abstract="true" name="PensionsAndOtherPostEmploymentBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShareOptionAndAwardSchemesMember" abstract="true" name="ShareOptionAndAwardSchemesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TaxReformsPeriodOfApplicationAxis" abstract="true" name="TaxReformsPeriodOfApplicationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TaxReformsPeriodOfApplicationDomain" abstract="true" name="TaxReformsPeriodOfApplicationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OriginationAndReversalOfTemporaryDifferencesMember" abstract="true" name="OriginationAndReversalOfTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" abstract="true" name="MovementInDeferredTaxAssetsAndLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" abstract="false" name="DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" abstract="false" name="IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_WithinTenYearsMember" abstract="true" name="WithinTenYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AvailableIndefinitelyMember" abstract="true" name="AvailableIndefinitelyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TaxLosses" abstract="false" name="TaxLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" abstract="false" name="UnrecognisedDeferredTaxAssetOnTradingLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CapitalLosses" abstract="false" name="CapitalLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" abstract="false" name="UnrecognisedDeferredTaxAssetOnCapitalLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfDividendsTable" abstract="true" name="DisclosureOfDividendsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_FirstInterimMember" abstract="true" name="FirstInterimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SecondInterimMember" abstract="true" name="SecondInterimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThirdInterimMember" abstract="true" name="ThirdInterimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FourthInterimMember" abstract="true" name="FourthInterimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfDividendsLineItems" abstract="true" name="DisclosureOfDividendsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AdditionalProvisionForDividendPayable" abstract="false" name="AdditionalProvisionForDividendPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" abstract="false" name="DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashDividendsPaidToShareholdersRecognizedInYear" abstract="false" name="CashDividendsPaidToShareholdersRecognizedInYear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DividendsRecognisedInYear" abstract="false" name="DividendsRecognisedInYear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PropertyPlantAndEquipmentAndVehiclesMember" abstract="true" name="PropertyPlantAndEquipmentAndVehiclesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NetBookValueMember" abstract="true" name="NetBookValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LowerCarbonPropellantMember" abstract="true" name="LowerCarbonPropellantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MajorRestructuringProgrammesMember" abstract="true" name="MajorRestructuringProgrammesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" abstract="false" name="WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" abstract="false" name="WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_DisclosureOfRightOfUseAssetsTable" abstract="true" name="DisclosureOfRightOfUseAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_PlantAndEquipmentMember" abstract="true" name="PlantAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfRightOfUseAssetsLineItems" abstract="true" name="DisclosureOfRightOfUseAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" abstract="false" name="IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" abstract="false" name="CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" abstract="false" name="IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" abstract="false" name="IntangibleAssetsForWhichImpairmentsHaveBeenCharged" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" abstract="false" name="IntangibleAssetsForWhichImpairmentsHaveBeenReversed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TesaroAssetsMember" abstract="true" name="TesaroAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MeningitisPortfolioMember" abstract="true" name="MeningitisPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AffinivaxAssetsMember" abstract="true" name="AffinivaxAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CamlipixantMember" abstract="true" name="CamlipixantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MomelotinibMember" abstract="true" name="MomelotinibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DolutegravirIncludingCabotegravirMember" abstract="true" name="DolutegravirIncludingCabotegravirMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AiolosAcquisitionMember" abstract="true" name="AiolosAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_CureVacAssetsMember" abstract="true" name="CureVacAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IteosAssetsMember" abstract="true" name="IteosAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AlectorAssetsMember" abstract="true" name="AlectorAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BenlystaMember" abstract="true" name="BenlystaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShingrixMember" abstract="true" name="ShingrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HansohPharmaAssetsMember" abstract="true" name="HansohPharmaAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ChimagenMember" abstract="true" name="ChimagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_RSVMember" abstract="true" name="RSVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BMSAssetsMember" abstract="true" name="BMSAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SperoMember" abstract="true" name="SperoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_WaveLifeSciencesMember" abstract="true" name="WaveLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ArrowheadMember" abstract="true" name="ArrowheadMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UCBMember" abstract="true" name="UCBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DTMember" abstract="true" name="DTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RelvarBreoAnoroMember" abstract="true" name="RelvarBreoAnoroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_StiefelTradeNameMember" abstract="true" name="StiefelTradeNameMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FluarixFluLavalMember" abstract="true" name="FluarixFluLavalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OkairosMember" abstract="true" name="OkairosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OthersMember" abstract="true" name="OthersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" abstract="false" name="AdditionsInInvestmentsInAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisposalsInAssociatesAndJointVentures" abstract="false" name="DisposalsInAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" abstract="false" name="DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" abstract="false" name="FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FlagshipPioneeringMember" abstract="true" name="FlagshipPioneeringMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" abstract="true" name="CurrentEquityInvestmentsMeasuredAsFVTPLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" abstract="false" name="NetFairValueMovementsThroughProfitOrLossCurrentInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" abstract="false" name="DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" abstract="true" name="InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherInvestmentsNoncurrentMember" abstract="true" name="OtherInvestmentsNoncurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" abstract="false" name="IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdditionsToOtherInvestments" abstract="false" name="AdditionsToOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" abstract="false" name="NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" abstract="false" name="NetFairValueMovementsThroughProfitOrLossOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" abstract="false" name="DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisposalsAndSettlementsOtherInvestments" abstract="false" name="DisposalsAndSettlementsOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" abstract="true" name="EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" abstract="true" name="EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CrisprTherapeuticsMember" abstract="true" name="CrisprTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SROneCapitalFundIBLPMember" abstract="true" name="SROneCapitalFundIBLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" abstract="false" name="AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ListedInvestments" abstract="false" name="ListedInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_InvestmentFairValue" abstract="false" name="InvestmentFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReceivablesRelatedToInsuranceContracts" abstract="false" name="ReceivablesRelatedToInsuranceContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfOtherNoncurrentAssetsTable" abstract="true" name="DisclosureOfOtherNoncurrentAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_OtherNonCurrentReceivablesMember" abstract="true" name="OtherNonCurrentReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RemainingBalanceMember" abstract="true" name="RemainingBalanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfOtherNonCurrentAssetsLineItems" abstract="true" name="DisclosureOfOtherNonCurrentAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_OtherNoncurrentNatureBasedCarbonReceivables" abstract="false" name="OtherNoncurrentNatureBasedCarbonReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_EmployeeLoansAndAdvances" abstract="false" name="EmployeeLoansAndAdvances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfTradeAndOtherReceivablesTable" abstract="true" name="DisclosureOfTradeAndOtherReceivablesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AssociatesAndJointVenturesMember" abstract="true" name="AssociatesAndJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherReceivableMember" abstract="true" name="OtherReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfTradeAndOtherReceivablesLineItems" abstract="true" name="DisclosureOfTradeAndOtherReceivablesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_RoyaltiesReceivable" abstract="false" name="RoyaltiesReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" abstract="false" name="IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" abstract="false" name="IncreaseDecreaseThroughUtilisationFinancialAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AssetsHeldForSaleTable" abstract="true" name="AssetsHeldForSaleTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AssetsHeldForSaleLineItems" abstract="true" name="AssetsHeldForSaleLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_OtherAssetsNet" abstract="false" name="OtherAssetsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_WagesAndSalariesPayable" abstract="false" name="WagesAndSalariesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PutOptionPayable" abstract="false" name="PutOptionPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CustomerReturnAndRebateAccruals" abstract="false" name="CustomerReturnAndRebateAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherAccruals" abstract="false" name="OtherAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfTradeAndOtherPayablesTable" abstract="true" name="DisclosureOfTradeAndOtherPayablesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_SegmentConsolidationItemMember" abstract="true" name="SegmentConsolidationItemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfTradeAndOtherPayablesLineItems" abstract="true" name="DisclosureOfTradeAndOtherPayablesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="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" abstract="false" name="InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" abstract="true" name="CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" abstract="true" name="CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" abstract="true" name="CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" abstract="true" name="CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" abstract="true" name="CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" abstract="true" name="CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" abstract="true" name="CurrencyRiskTenCentAppreciationOfUSDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" abstract="true" name="CurrencyRiskFifteenCentAppreciationOfUsDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember" abstract="true" name="CurrencyRiskTenCentDepreciationOfUSDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" abstract="true" name="CurrencyRiskFifteenCentDepreciationOfUsDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskTenCentAppreciationOfEuroMember" abstract="true" name="CurrencyRiskTenCentAppreciationOfEuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" abstract="true" name="CurrencyRiskFifteenCentAppreciationOfEuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskTenCentDepreciationOfEuroMember" abstract="true" name="CurrencyRiskTenCentDepreciationOfEuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" abstract="true" name="CurrencyRiskFifteenCentDepreciationOfEuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInFinancialLiability" abstract="false" name="IncreaseDecreaseInFinancialLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfDebtTable" abstract="true" name="DisclosureOfDebtTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_Debt1Member" abstract="true" name="Debt1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NewYorkStockExchangeMember" abstract="true" name="NewYorkStockExchangeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LondonStockExchangeMember" abstract="true" name="LondonStockExchangeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember" abstract="true" name="ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" abstract="true" name="OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" abstract="true" name="FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" abstract="true" name="ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" abstract="true" name="OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" abstract="true" name="OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" abstract="true" name="ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" abstract="true" name="ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" abstract="true" name="ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" abstract="true" name="ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember" abstract="true" name="OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" abstract="true" name="ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" abstract="true" name="OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" abstract="true" name="OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" abstract="true" name="TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" abstract="true" name="ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember" abstract="true" name="FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" abstract="true" name="FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" abstract="true" name="OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember" abstract="true" name="ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" abstract="true" name="SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" abstract="true" name="SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" abstract="true" name="FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" abstract="true" name="FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" abstract="true" name="FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherLongtermBorrowingsMember" abstract="true" name="OtherLongtermBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfDebtLineItems" abstract="true" name="DisclosureOfDebtLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_LiquidInvestmentsCurrent" abstract="false" name="LiquidInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_BankLoansOverdraftsAndOther" abstract="false" name="BankLoansOverdraftsAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LongTermBorrowingsAbstract" abstract="true" name="LongTermBorrowingsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ShortTermNotesMember" abstract="true" name="ShortTermNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NonInterestBearingMember" abstract="true" name="NonInterestBearingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CommercialPaperDebtMember" abstract="true" name="CommercialPaperDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" abstract="true" name="FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" abstract="true" name="SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LetterOfCreditHeldMember" abstract="true" name="LetterOfCreditHeldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UsCommercialPaperProgramMember" abstract="true" name="UsCommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EuroCommercialPaperProgramMember" abstract="true" name="EuroCommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" abstract="false" name="EffectiveInterestRateOnAvailableForSaleFinancialInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_EffectiveInterestRateOnCashAndCashEquivalents" abstract="false" name="EffectiveInterestRateOnCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_CommercialPapersAuthorised" abstract="false" name="CommercialPapersAuthorised" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RevolvingCreditFacilities" abstract="false" name="RevolvingCreditFacilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RevolvingCreditFacilityTerm" abstract="false" name="RevolvingCreditFacilityTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_RevolvingCreditFacilityExtensionTerm" abstract="false" name="RevolvingCreditFacilityExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_WeightedAverageInterestRateOnBorrowings" abstract="false" name="WeightedAverageInterestRateOnBorrowings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" abstract="false" name="WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_AverageEffectivePreSwapInterestRateShortTerm" abstract="false" name="AverageEffectivePreSwapInterestRateShortTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_AverageEffectivePreSwapInterestRateNotesIssued" abstract="false" name="AverageEffectivePreSwapInterestRateNotesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_CarryInterestAtEffectiveRates" abstract="false" name="CarryInterestAtEffectiveRates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_PledgedInvestments" abstract="false" name="PledgedInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" abstract="true" name="DisclosureOfDefinedBenefitPensionAndPostRetirementTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_UkDefinedBenefitAndDefinedContributionPlansMember" abstract="true" name="UkDefinedBenefitAndDefinedContributionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UsDefinedBenefitAndDefinedContributionPlansMember" abstract="true" name="UsDefinedBenefitAndDefinedContributionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherOverseasPensionPlansMember" abstract="true" name="OtherOverseasPensionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UnfundedPostRetirementHealthcareSchemesMember" abstract="true" name="UnfundedPostRetirementHealthcareSchemesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DefinedBenefitHybridPensionSchemeMember" abstract="true" name="DefinedBenefitHybridPensionSchemeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" abstract="true" name="DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_CurrentPeriodMember" abstract="true" name="CurrentPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ProjectedPeriodMember" abstract="true" name="ProjectedPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MalePensionersAverageLifeExpectancyAtSixty" abstract="false" name="MalePensionersAverageLifeExpectancyAtSixty" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_FemalePensionersAverageLifeExpectancyAtSixty" abstract="false" name="FemalePensionersAverageLifeExpectancyAtSixty" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_UKDefinedBenefitPlansMember" abstract="true" name="UKDefinedBenefitPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoWellcomeMember" abstract="true" name="GlaxoWellcomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SmithKlineBeechamLimitedMember" abstract="true" name="SmithKlineBeechamLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_USCashBalancePlanMember" abstract="true" name="USCashBalancePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_PostRetirementBenefitsMember" abstract="true" name="PostRetirementBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TransfereeAxis" abstract="true" name="TransfereeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TransfereeDomain" abstract="true" name="TransfereeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SLPPartneshipsMember" abstract="true" name="SLPPartneshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" abstract="true" name="GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TwoThousandThirtyOneAndThereafterMember" abstract="true" name="TwoThousandThirtyOneAndThereafterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NumberOfUKPensionPlansPhysicalAssetAllocationStrategyApplied" abstract="false" name="NumberOfUKPensionPlansPhysicalAssetAllocationStrategyApplied" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfUKPensionPlans" abstract="false" name="NumberOfUKPensionPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_AllocationToReturnSeekingAssets" abstract="false" name="AllocationToReturnSeekingAssets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_AllocationToLiabilityMatchingAssets" abstract="false" name="AllocationToLiabilityMatchingAssets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_TotalValueOfTheInsuranceContract" abstract="false" name="TotalValueOfTheInsuranceContract" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" abstract="false" name="NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NotionalInterest" abstract="false" name="NotionalInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfScottishLimitedPartnerships" abstract="false" name="NumberOfScottishLimitedPartnerships" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" abstract="false" name="NumberOfPrincipalUKDefinedBenefitPensionSchemes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_AugmentationCostsIncludedInPastServiceCosts" abstract="false" name="AugmentationCostsIncludedInPastServiceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" abstract="false" name="FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" abstract="false" name="LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="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" abstract="false" name="ActuarialAssumptionOfExpectedRatesOfMedicalInflation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" abstract="true" name="DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" abstract="true" name="DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ActuarialAssumptionOfCashBalanceCreditRate" abstract="false" name="ActuarialAssumptionOfCashBalanceCreditRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" abstract="true" name="ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" abstract="false" name="IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NoncurrentAssetsOtherMember" abstract="true" name="NoncurrentAssetsOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GroupMember" abstract="true" name="GroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ListedMember" abstract="true" name="ListedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_UnlistedMember" abstract="true" name="UnlistedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_GovernmentBondsContributedToFairValueOfPlanAssets" abstract="false" name="GovernmentBondsContributedToFairValueOfPlanAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" abstract="false" name="OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RemeasurementsAbstract" abstract="true" name="RemeasurementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" abstract="false" name="IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DefinedBenefitObligationActiveMember" abstract="true" name="DefinedBenefitObligationActiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DefinedBenefitObligationRetiredMember" abstract="true" name="DefinedBenefitObligationRetiredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DefinedBenefitObligationDeferredMember" abstract="true" name="DefinedBenefitObligationDeferredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" abstract="true" name="DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_PostRetirementBenefitMember" abstract="true" name="PostRetirementBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" abstract="true" name="DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_WeightedAverageDurationOfDefinedBenefitObligations" abstract="false" name="WeightedAverageDurationOfDefinedBenefitObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_ChangeInAssumptionsAxis" abstract="true" name="ChangeInAssumptionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ChangeInAssumptionsDomain" abstract="true" name="ChangeInAssumptionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ZeroPointTwoFivePercentMember" abstract="true" name="ZeroPointTwoFivePercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ZeroPointSevenFivePercentMember" abstract="true" name="ZeroPointSevenFivePercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_OneYearMember" abstract="true" name="OneYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_OnePercentMember" abstract="true" name="OnePercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" abstract="false" name="IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" abstract="false" name="IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" abstract="false" name="IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" abstract="false" name="IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" abstract="false" name="IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" abstract="false" name="IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LegalAndOtherDisputesMember" abstract="true" name="LegalAndOtherDisputesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EmployeeRelatedProvisionsMember" abstract="true" name="EmployeeRelatedProvisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherProvisionMember" abstract="true" name="OtherProvisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TransferToPensionObligationsOtherProvisions" abstract="false" name="TransferToPensionObligationsOtherProvisions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MajorRestructuringProvisionsMember" abstract="true" name="MajorRestructuringProvisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ZantacMember" abstract="true" name="ZantacMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TitleOfIndividual1Axis" abstract="true" name="TitleOfIndividual1Axis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TitleOfIndividual1Domain" abstract="true" name="TitleOfIndividual1Domain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisabledEmployeesMember" abstract="true" name="DisabledEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" abstract="false" name="AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfMajorRestructuringProgrammes" abstract="false" name="NumberOfMajorRestructuringProgrammes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_PensionObligationAugmentationCosts" abstract="false" name="PensionObligationAugmentationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AffinivaxMember" abstract="true" name="AffinivaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NovartisMember" abstract="true" name="NovartisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherBusinessMember" abstract="true" name="OtherBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" abstract="false" name="RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" abstract="false" name="ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" abstract="false" name="AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ContingentConsiderationPaid" abstract="false" name="ContingentConsiderationPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfFairValueOfContingentConsiderationTable" abstract="true" name="DisclosureOfFairValueOfContingentConsiderationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AiolosBioInc.Member" abstract="true" name="AiolosBioInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CommercialisedProductsMember" abstract="true" name="CommercialisedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PipelineAssetsMember" abstract="true" name="PipelineAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" abstract="true" name="DisclosureOfFairValueOfContingentConsiderationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ContingentConsiderationPayableDiscountedPercentage" abstract="false" name="ContingentConsiderationPayableDiscountedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_NumberOfPotentialMilestonePayments" abstract="false" name="NumberOfPotentialMilestonePayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" abstract="true" name="DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="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" abstract="true" name="OtherRiskTenPercentageIncreaseInSalesForecastsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" abstract="true" name="OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="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" abstract="true" name="OtherRiskTenPercentageDecreaseInSalesForecastsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" abstract="true" name="OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" abstract="true" name="OtherRiskOnePercentageIncreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" abstract="true" name="OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" abstract="true" name="OtherRiskOnePercentageDecreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" abstract="true" name="OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" abstract="true" name="IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_IncreaseInSalesForecastAmount" abstract="false" name="IncreaseInSalesForecastAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseInSalesForecastAmount" abstract="false" name="DecreaseInSalesForecastAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseInDiscountRateAmount" abstract="false" name="IncreaseInDiscountRateAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseInDiscountRateAmount" abstract="false" name="DecreaseInDiscountRateAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AppreciationOfUSDollar" abstract="false" name="AppreciationOfUSDollar" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DepreciationOfUSDollar" abstract="false" name="DepreciationOfUSDollar" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AppreciationOfEuro" abstract="false" name="AppreciationOfEuro" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DepreciationOfEuro" abstract="false" name="DepreciationOfEuro" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" abstract="false" name="TenPercentIncreaseInProbabilityOfMilestoneSuccess" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TenPercentDecreaseInProbabilityOfMilestoneSuccess" abstract="false" name="TenPercentDecreaseInProbabilityOfMilestoneSuccess" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ContractualObligationsAndCommitmentsOfInvestments" abstract="false" name="ContractualObligationsAndCommitmentsOfInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ContractualObligationsAndCommitments" abstract="false" name="ContractualObligationsAndCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CategoriesOfCommitmentsAxis" abstract="true" name="CategoriesOfCommitmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_CategoriesOfCommitmentsDomain" abstract="true" name="CategoriesOfCommitmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CarbonRemovalProjectsMember" abstract="true" name="CarbonRemovalProjectsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" abstract="true" name="ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EmployeeShareOwnershipPlanMember" abstract="true" name="EmployeeShareOwnershipPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember" abstract="true" name="EmployeeShareOwnershipPlanHeldForFutureExerciseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ExecutiveSupplementalSavingsPlanMember" abstract="true" name="ExecutiveSupplementalSavingsPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FreeIssueMember" abstract="true" name="FreeIssueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SharesReceivedForEveryFiveExistingShares" abstract="false" name="SharesReceivedForEveryFiveExistingShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gsk_SurrenderedSharesForEveryFourNewSharesReceived" abstract="false" name="SurrenderedSharesForEveryFourNewSharesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" abstract="false" name="ParValueOfSharesSurrenderedInLieuOfNewShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" abstract="false" name="IncreaseDecreaseInNumberOfSharesFromShareConsolidation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" abstract="false" name="NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" abstract="false" name="NumberOfTreasurySharesTransferredToEmployeeShareTrusts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" abstract="false" name="IncreaseDecreaseThroughConsolidatingSharesEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MiscellaneousComponentsOfEquityAxis" abstract="true" name="MiscellaneousComponentsOfEquityAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_MiscellaneousComponentsOfEquityDomain" abstract="true" name="MiscellaneousComponentsOfEquityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NonDistributableMergerAndPreMergerReservesMember" abstract="true" name="NonDistributableMergerAndPreMergerReservesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RetainedEarningsAndOtherReserves" abstract="false" name="RetainedEarningsAndOtherReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueReserveMember" abstract="true" name="FairValueReserveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EventAxis" abstract="true" name="EventAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_EventDomain" abstract="true" name="EventDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DemergerMember" abstract="true" name="DemergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ContinuingAndDiscontinuedOperationAxis" abstract="true" name="ContinuingAndDiscontinuedOperationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ContinuingAndDiscontinuedOperationDomain" abstract="true" name="ContinuingAndDiscontinuedOperationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ConsumerHealthcareBusinessMember" abstract="true" name="ConsumerHealthcareBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MovementInTranslationExchangeAttributableToContinuingOperations" abstract="false" name="MovementInTranslationExchangeAttributableToContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" abstract="false" name="MovementInTranslationExchangeAttributableToDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" abstract="false" name="ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" abstract="false" name="ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" abstract="false" name="OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" abstract="false" name="OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_EsopTrustMember" abstract="true" name="EsopTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ExchangeAdjustments" abstract="false" name="ExchangeAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" abstract="false" name="TransferredToRetainedEarningsOnDisposalOfEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_BalanceAmountDerecognisedOnDemerger" abstract="false" name="BalanceAmountDerecognisedOnDemerger" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CostOfHedgedItemAttributableToHedgedRisk" abstract="false" name="CostOfHedgedItemAttributableToHedgedRisk" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetFairValueMovements" abstract="false" name="NetFairValueMovements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" abstract="false" name="OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfNoncontrollingInterestsTable" abstract="true" name="DisclosureOfNoncontrollingInterestsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_ViiVHealthCareMember" abstract="true" name="ViiVHealthCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfNoncontrollingInterestsLineItems" abstract="true" name="DisclosureOfNoncontrollingInterestsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" abstract="false" name="RemeasurementsOfContingentConsiderationPayableForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInCashAndBankOverdrafts" abstract="false" name="IncreaseDecreaseInCashAndBankOverdrafts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisclosureOfNonControllingInterestsLineItems" abstract="true" name="DisclosureOfNonControllingInterestsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_IndexVenturesMember" abstract="true" name="IndexVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MedicxiVenturesILimitedPartnerMember" abstract="true" name="MedicxiVenturesILimitedPartnerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" abstract="false" name="LoansReceivableMadeByEntityRelatedPartyTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ElsieBiotechnologiesMember" abstract="true" name="ElsieBiotechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_BellusMember" abstract="true" name="BellusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AffinivaxIncMember" abstract="true" name="AffinivaxIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SierraOncologyIncMember" abstract="true" name="SierraOncologyIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSaudiArabiaLimitedMember" abstract="true" name="GlaxoSaudiArabiaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DeferredTaxationMember" abstract="true" name="DeferredTaxationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskAggregateHoldingMember" abstract="true" name="GskAggregateHoldingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskShareholdersMember" abstract="true" name="GskShareholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskAndGsksConsolidatedEsotTrustsMember" abstract="true" name="GskAndGsksConsolidatedEsotTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ScottishLimitedPartnershipsMember" abstract="true" name="ScottishLimitedPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskHoldingMember" abstract="true" name="GskHoldingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BusinessCombinationMaximumPotentialMilestonePayment" abstract="false" name="BusinessCombinationMaximumPotentialMilestonePayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" abstract="false" name="AcquisitionOfInterestInSubsidiaryConsiderationPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="gsk_PaymentsMadeForTransactionCostsAndOther" abstract="false" name="PaymentsMadeForTransactionCostsAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" abstract="false" name="BusinessCombinationPotentialMilestonePaymentPerTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" abstract="false" name="BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_BusinessCombinationConsiderationPayableForStepAcquisition" abstract="false" name="BusinessCombinationConsiderationPayableForStepAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PercentageOfOwnershipDivested" abstract="false" name="PercentageOfOwnershipDivested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_PercentageofGSKHolding" abstract="false" name="PercentageofGSKHolding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_PercentageOfOwnershipDistributed" abstract="false" name="PercentageOfOwnershipDistributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="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" abstract="false" name="CarryingValueOfInvestmentNetOfNonControllingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LiabilityEliminatedOnDemerger" abstract="false" name="LiabilityEliminatedOnDemerger" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DividendFundedByDebtFinancing" abstract="false" name="DividendFundedByDebtFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DividendFundedByDebtFinancingAttributableToGsk" abstract="false" name="DividendFundedByDebtFinancingAttributableToGsk" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DividendsDistributedFromCashBalance" abstract="false" name="DividendsDistributedFromCashBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="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" abstract="false" name="DividendsDistributedFromCashBalanceAttributableToGsk" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueOfTheAssetsDistributed" abstract="false" name="FairValueOfTheAssetsDistributed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" abstract="false" name="GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdditionalGainOnRemeasurementOfRetainedStake" abstract="false" name="AdditionalGainOnRemeasurementOfRetainedStake" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueOfHolding" abstract="false" name="FairValueOfHolding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" abstract="false" name="ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainOnDemergerOfDiscontinuedOperation" abstract="false" name="GainOnDemergerOfDiscontinuedOperation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_SierraOncologyMember" abstract="true" name="SierraOncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NetAssetsAcquiredAbstract" abstract="true" name="NetAssetsAcquiredAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" abstract="false" name="NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" abstract="false" name="RightOfUseAssetsRecognisedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" abstract="false" name="TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" abstract="false" name="InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate" abstract="false" name="LeaseLiabilitiesRecognizedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TaxationRecognizedAsOfAcquisitionDate" abstract="false" name="TaxationRecognizedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" abstract="false" name="NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TotalForAllBusinessDivesturesMember" abstract="true" name="TotalForAllBusinessDivesturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TotalForAllBusinessDivesturesDemergerMember" abstract="true" name="TotalForAllBusinessDivesturesDemergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_TotalForAllBusinessDivesturesOtherMember" abstract="true" name="TotalForAllBusinessDivesturesOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_DeferredConsiderationReceivedPaid" abstract="false" name="DeferredConsiderationReceivedPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashOutflowInflowExcludingTransactionCosts" abstract="false" name="CashOutflowInflowExcludingTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TransactionCostsOnDisposal" abstract="false" name="TransactionCostsOnDisposal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" abstract="false" name="FairValueOfTheConsumerHealthcareBusinessDistributed" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" abstract="false" name="FairValueOfTheRetainedOwnershipInHaleonPlc" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TotalfairValueOfDistributedandRetainBusiness" abstract="false" name="TotalfairValueOfDistributedandRetainBusiness" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CarryingAmountOfTheNetAssetsAndLiabilitiesDistributed" abstract="false" name="CarryingAmountOfTheNetAssetsAndLiabilitiesDistributed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CarryingAmountOfTheNciDerecognized" abstract="false" name="CarryingAmountOfTheNciDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" abstract="false" name="GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" abstract="false" name="ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherGainsLossesOnDemerger" abstract="false" name="OtherGainsLossesOnDemerger" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" abstract="false" name="ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" abstract="false" name="AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" abstract="false" name="AdjustmentsForImpairmentAndAssetsWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" abstract="false" name="AdjustmentsForProfitLossOnSaleOfBusinesses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" abstract="false" name="AdjustmentsForProfitOnSaleOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" abstract="false" name="AdjustmentsForProfitOnSaleOfEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ChangesInWorkingCapitalAbstract" abstract="true" name="ChangesInWorkingCapitalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" abstract="false" name="AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" abstract="false" name="CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashFlowsFromUsedInOperationsBeforeTax" abstract="false" name="CashFlowsFromUsedInOperationsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" abstract="false" name="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseIncreaseInLiquidInvestment" abstract="false" name="DecreaseIncreaseInLiquidInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" abstract="false" name="NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ExchangeOnNetDebt" abstract="false" name="ExchangeOnNetDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_OtherAdjustmentsForNonCashItemsToNetDebt" abstract="false" name="OtherAdjustmentsForNonCashItemsToNetDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" abstract="false" name="DecreaseIncreaseInNetDebtFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DecreaseIncreaseInNetDebtFromDiscontinuedOperations" abstract="false" name="DecreaseIncreaseInNetDebtFromDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" abstract="false" name="RepaymentsOfCurrentPortionOfNoncurrentBorrowings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LiquidInvestmentsMember" abstract="true" name="LiquidInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LiquidInvestmentsCashAndCashEquivalentsMember" abstract="true" name="LiquidInvestmentsCashAndCashEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CashAndCashEquivalentMember" abstract="true" name="CashAndCashEquivalentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BankOverdrafts1Member" abstract="true" name="BankOverdrafts1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DerivativeFinancialInstrumentsMember" abstract="true" name="DerivativeFinancialInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" abstract="true" name="EuropeanUsMediumTermNotesAndBankFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherCurrentDebtMember" abstract="true" name="OtherCurrentDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NetDebtMember" abstract="true" name="NetDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AccruedInterestMember" abstract="true" name="AccruedInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ChangeInFairValueOfNetDebt" abstract="false" name="ChangeInFairValueOfNetDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationOfNetDebt" abstract="false" name="ReclassificationOfNetDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_WholesaleAndRetailCreditRiskMember" abstract="true" name="WholesaleAndRetailCreditRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EuroCommercialPaperProgrammeMember" abstract="true" name="EuroCommercialPaperProgrammeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LowerThanBBBBaa3Member" abstract="true" name="LowerThanBBBBaa3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BbbOrBaaMember" abstract="true" name="BbbOrBaaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BBB-OrBaaThreeRatedMember" abstract="true" name="BBB-OrBaaThreeRatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_WholesalerInTheUsMember" abstract="true" name="WholesalerInTheUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SaudiBritishBankMember" abstract="true" name="SaudiBritishBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HalkBankMember" abstract="true" name="HalkBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" abstract="true" name="UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BancoBradescoItauUniBancoBancoDoBrasilAndCaixaEconomicaFederalMember" abstract="true" name="BancoBradescoItauUniBancoBancoDoBrasilAndCaixaEconomicaFederalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BancoDeLaProduccionMember" abstract="true" name="BancoDeLaProduccionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" abstract="true" name="BancoDeAmericaCentralAndBancoDeHondurasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_NonUsaMember" abstract="true" name="NonUsaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BancaPopolareDiSondrioMember" abstract="true" name="BancaPopolareDiSondrioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_OTPBankMember" abstract="true" name="OTPBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_StateBankOfIndiaMember" abstract="true" name="StateBankOfIndiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BancoDeCreditoDelPeruMember" abstract="true" name="BancoDeCreditoDelPeruMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_InLineWithOtherPharmaceuticalCompaniesMember" abstract="true" name="InLineWithOtherPharmaceuticalCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DueFromThreeWholesalersMember" abstract="true" name="DueFromThreeWholesalersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GroupCreditEnhancementsAndCreditInsuranceMember" abstract="true" name="GroupCreditEnhancementsAndCreditInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EquityAndDebtNet" abstract="false" name="EquityAndDebtNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashAndCashEquivalentsAndLiquidInvestments" abstract="false" name="CashAndCashEquivalentsAndLiquidInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" abstract="false" name="CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MaximumDrawdownOfCommercialPapers" abstract="false" name="MaximumDrawdownOfCommercialPapers" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" abstract="false" name="AmountHeldAtEuropeanMediumTermNoteProgramme" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" abstract="false" name="NotesIssuedAtEuropeanMediumTermNoteProgramme" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NotesIssuedUnderUsShelfRegistration" abstract="false" name="NotesIssuedUnderUsShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CreditExposure1" abstract="false" name="CreditExposure1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfLargestUSWholesalers" abstract="false" name="NumberOfLargestUSWholesalers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" abstract="false" name="CashHeldAtUnratedOrSubInvestmentRatedCounterparties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_BankBalancesAndDepositHeldWithCounterparties" abstract="false" name="BankBalancesAndDepositHeldWithCounterparties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashReserves" abstract="false" name="CashReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CashManagedForSubsidiaryCompany" abstract="false" name="CashManagedForSubsidiaryCompany" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PercentageOfAccountsReceivableByMajorCustomer" abstract="false" name="PercentageOfAccountsReceivableByMajorCustomer" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_ConcentrationsOfRiskRevenuePercentage" abstract="false" name="ConcentrationsOfRiskRevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_AAAOrAaaMember" abstract="true" name="AAAOrAaaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AaOrAaMember" abstract="true" name="AaOrAaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AorAMember" abstract="true" name="AorAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BBPlusOrBaOneMember" abstract="true" name="BBPlusOrBaOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" abstract="false" name="UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LiquidityFunds" abstract="false" name="LiquidityFunds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GovernmentSecurities" abstract="false" name="GovernmentSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RatedCreditExposures1" abstract="false" name="RatedCreditExposures1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TradeAndOtherReceivableMember" abstract="true" name="TradeAndOtherReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CashAndCashEquivalentsFinancialAssetsMember" abstract="true" name="CashAndCashEquivalentsFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherFinancialInvestmentsMember" abstract="true" name="OtherFinancialInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrentEquityAndOtherInvestmentsMember" abstract="true" name="CurrentEquityAndOtherInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" abstract="true" name="HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" abstract="true" name="DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" abstract="true" name="FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BondsInDesignatedHedgingRelationshipMember" abstract="true" name="BondsInDesignatedHedgingRelationshipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherBondsMember" abstract="true" name="OtherBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BankLoansAndOverdraftsMember" abstract="true" name="BankLoansAndOverdraftsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CommercialPaperInADesignatedHedgingRelationshipMember" abstract="true" name="CommercialPaperInADesignatedHedgingRelationshipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherCommercialPaperMember" abstract="true" name="OtherCommercialPaperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherBorrowingMember" abstract="true" name="OtherBorrowingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ContingentConsiderationLiabilitiesMember" abstract="true" name="ContingentConsiderationLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TradeAndOtherPayableMember" abstract="true" name="TradeAndOtherPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OtherNonCurrentLiabilitiesMember" abstract="true" name="OtherNonCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BorrowingsExcludingObligationsUnderFinanceLease" abstract="false" name="BorrowingsExcludingObligationsUnderFinanceLease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" abstract="false" name="BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetFinancialAssetsLiabilities" abstract="false" name="NetFinancialAssetsLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetFinancialAssetsLiabilitiesAtFairValue" abstract="false" name="NetFinancialAssetsLiabilitiesAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NovartisVaccinesBusinessMember" abstract="true" name="NovartisVaccinesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AffinivaxAcquisitionMember" abstract="true" name="AffinivaxAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FinancialLiabilitiesOneMember" abstract="true" name="FinancialLiabilitiesOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" abstract="true" name="TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AmortizedCostMember" abstract="true" name="AmortizedCostMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" abstract="false" name="CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" abstract="false" name="FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" abstract="false" name="GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" abstract="false" name="LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" abstract="false" name="RemeasurementGainLossOfTheContingentConsiderationPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" abstract="true" name="FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" abstract="true" name="DisclosureOfFinancialAssetsAndLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" abstract="true" name="DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_FinancialAssetsAndLiabilities" abstract="false" name="FinancialAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" abstract="false" name="IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" abstract="false" name="GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" abstract="false" name="GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PaymentOfContingentConsiderationLiabilities" abstract="false" name="PaymentOfContingentConsiderationLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" abstract="false" name="AdditionsFairValueMeasurementAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" abstract="false" name="DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" abstract="false" name="TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_FinancialInstrumentsMember" abstract="true" name="FinancialInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NonFinancialInstrumentsMember" abstract="true" name="NonFinancialInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" abstract="true" name="DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" abstract="true" name="TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ForeignExchangeContractsMember" abstract="true" name="ForeignExchangeContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EmbeddedAndOtherDerivativesMember" abstract="true" name="EmbeddedAndOtherDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_NetInvestmentHedgesMember" abstract="true" name="NetInvestmentHedgesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HedgingInstrumentsAndDerivativesAssets" abstract="false" name="HedgingInstrumentsAndDerivativesAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_HedgingInstrumentsAndDerivativesLiabilities" abstract="false" name="HedgingInstrumentsAndDerivativesLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NetInvestmentHedgedMember" abstract="true" name="NetInvestmentHedgedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ForeignExchangeRiskMember" abstract="true" name="ForeignExchangeRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" abstract="true" name="InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" abstract="true" name="InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" abstract="true" name="InterestRateRiskOnePercentMovementInUSDInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" abstract="true" name="InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateSensitivityMember" abstract="true" name="InterestRateSensitivityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" abstract="false" name="CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="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" abstract="false" name="IncreaseDecreaseInEquityThroughInterestRateMovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_SellForeignCurrencyLessThanThreeMonthsMember" abstract="true" name="SellForeignCurrencyLessThanThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SellForeignCurrencyThreeToSixMonthsMember" abstract="true" name="SellForeignCurrencyThreeToSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_SellForeignCurrencyOverSixMonthsMember" abstract="true" name="SellForeignCurrencyOverSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BorrowingsLessThanThreeMonthsMember" abstract="true" name="BorrowingsLessThanThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BorrowingThreeToSixMonthsMember" abstract="true" name="BorrowingThreeToSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BorrowingsOverSixMonthsMember" abstract="true" name="BorrowingsOverSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BuyForeignCurrencyLessThanThreeMonthsMember" abstract="true" name="BuyForeignCurrencyLessThanThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BuyForeignCurrencyThreeToSixMonthsMember" abstract="true" name="BuyForeignCurrencyThreeToSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_BuyForeignCurrencyOverSixMonthsMember" abstract="true" name="BuyForeignCurrencyOverSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" abstract="true" name="VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" abstract="true" name="VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HedgingInstrumentAtFairValue" abstract="false" name="HedgingInstrumentAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" abstract="false" name="ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" abstract="false" name="ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" abstract="false" name="ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" abstract="false" name="ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PreHedgingOfLongTermInterestRatesMember" abstract="true" name="PreHedgingOfLongTermInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MaturedInThePastPeriodMember" abstract="true" name="MaturedInThePastPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DerivativeFinancialAssetsMember" abstract="true" name="DerivativeFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TradesAndOtherPayablesMember" abstract="true" name="TradesAndOtherPayablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DerivativeFinancialLiabilitiesMember" abstract="true" name="DerivativeFinancialLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems" abstract="true" name="DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_FloatingAndFixedRateDebtMember" abstract="true" name="FloatingAndFixedRateDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DisclosureOfDebtInterestRateRepricingLineItems" abstract="true" name="DisclosureOfDebtInterestRateRepricingLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gsk_InterestBearingDebt" abstract="false" name="InterestBearingDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NonInterestBearingDebt" abstract="false" name="NonInterestBearingDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CurrencyRiskTenYenAppreciationOfYenMember" abstract="true" name="CurrencyRiskTenYenAppreciationOfYenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" abstract="true" name="CurrencyRiskFifteenYenAppreciationOfYenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskTenYenDepreciationOfYenMember" abstract="true" name="CurrencyRiskTenYenDepreciationOfYenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" abstract="true" name="CurrencyRiskFifteenYenDepreciationOfYenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" abstract="false" name="IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" abstract="false" name="IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" abstract="false" name="IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" abstract="true" name="InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" abstract="true" name="InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" abstract="true" name="InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" abstract="true" name="InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" abstract="true" name="InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" abstract="true" name="InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="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" abstract="false" name="IncreaseDecreaseInIncomeThroughInterestRateMovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NonDerivativesFinancialLiabilitiesMember" abstract="true" name="NonDerivativesFinancialLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FutureFinanceChargeOnFinanceLeases" abstract="false" name="FutureFinanceChargeOnFinanceLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_ForeignExchangeForwardContractsAndSwapsMember" abstract="true" name="ForeignExchangeForwardContractsAndSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" abstract="false" name="ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" abstract="false" name="PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_SavingsRelatedShareOptionSchemesMember" abstract="true" name="SavingsRelatedShareOptionSchemesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_FreeCashFlowMember" abstract="true" name="FreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TsrMember" abstract="true" name="TsrMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_RAndDNewProductPerformanceMember" abstract="true" name="RAndDNewProductPerformanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_PipelineProgressMember" abstract="true" name="PipelineProgressMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ProfitMeasureMember" abstract="true" name="ProfitMeasureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SaleMeasureMember" abstract="true" name="SaleMeasureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ESGEnvironmentMember" abstract="true" name="ESGEnvironmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_AwardType1Axis" abstract="true" name="AwardType1Axis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_AwardType1Domain" abstract="true" name="AwardType1Domain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" abstract="false" name="VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_AtPercentageBelowMarketPrice" abstract="false" name="AtPercentageBelowMarketPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_ExpectedFutureDividendYieldPercentageShareGranted" abstract="false" name="ExpectedFutureDividendYieldPercentageShareGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_NumberOfPerformanceMeasures" abstract="false" name="NumberOfPerformanceMeasures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_SharePlanPerformanceAssessmentPeriod" abstract="false" name="SharePlanPerformanceAssessmentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_PercentageOfPerformanceSharePlan" abstract="false" name="PercentageOfPerformanceSharePlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" abstract="false" name="NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" abstract="false" name="WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" abstract="false" name="WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" abstract="false" name="NumberOfAwardsOutstandingInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" abstract="false" name="NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="gsk_ShareOptionsAndSavingsRelatedOptionsMember" abstract="true" name="ShareOptionsAndSavingsRelatedOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DividendYieldShareOptionsGranted" abstract="false" name="DividendYieldShareOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_ExpectedLifeOfShareOptionsGranted" abstract="false" name="ExpectedLifeOfShareOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gsk_SavingsRelatedOptionsGrantPriceDiscount" abstract="false" name="SavingsRelatedOptionsGrantPriceDiscount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="gsk_SavingsRelatedOptionsGrantPrice" abstract="false" name="SavingsRelatedOptionsGrantPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="gsk_NumberOfSharesHeldForShareAwardSchemes" abstract="false" name="NumberOfSharesHeldForShareAwardSchemes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gsk_NominalValueOfSharesHeldForShareAwardSchemes" abstract="false" name="NominalValueOfSharesHeldForShareAwardSchemes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_CarryingValueOfSharesHeldForShareAwardSchemes" abstract="false" name="CarryingValueOfSharesHeldForShareAwardSchemes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_MarketValueOfSharesHeldForShareAwardSchemes" abstract="false" name="MarketValueOfSharesHeldForShareAwardSchemes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfSharesHeldForShareOptionSchemes" abstract="false" name="NumberOfSharesHeldForShareOptionSchemes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="gsk_GlaxoGroupLimitedMember" abstract="true" name="GlaxoGroupLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoOperationsUkLimitedMember" abstract="true" name="GlaxoOperationsUkLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoWellcomeUkLimitedMember" abstract="true" name="GlaxoWellcomeUkLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineCapitalPLCMember" abstract="true" name="GlaxoSmithKlineCapitalPLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineExportLimitedMember" abstract="true" name="GlaxoSmithKlineExportLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineFinancePLCMember" abstract="true" name="GlaxoSmithKlineFinancePLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKFinanceNo2LimitedMember" abstract="true" name="GSKFinanceNo2LimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineHoldingsLimitedMember" abstract="true" name="GlaxoSmithKlineHoldingsLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIhcLimitedMember" abstract="true" name="GlaxosmithklineIhcLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIntellectualPropertyNo.2LimitedMember" abstract="true" name="GlaxosmithklineIntellectualPropertyNo.2LimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" abstract="true" name="GlaxosmithklineIntellectualPropertyNo.3LimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" abstract="true" name="GlaxosmithklineIntellectualPropertyNo.4LimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" abstract="true" name="GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIntellectualPropertyLimitedMember" abstract="true" name="GlaxosmithklineIntellectualPropertyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" abstract="true" name="GlaxoSmithKlineResearchAndDevelopmentLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineServicesUnlimitedMember" abstract="true" name="GlaxoSmithKlineServicesUnlimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" abstract="true" name="GlaxoSmithKlineUnitedKingdomLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineUsTradingLimitedMember" abstract="true" name="GlaxosmithklineUsTradingLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_SetFirstLimitedMember" abstract="true" name="SetFirstLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViivHealthcareFinanceLimitedMember" abstract="true" name="ViivHealthcareFinanceLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" abstract="true" name="ViivHealthcareUnitedKingdomNo.3LimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViiVHealthCareUnitedKingdomLimitedMember" abstract="true" name="ViiVHealthCareUnitedKingdomLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineAgMember" abstract="true" name="GlaxosmithklineAgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoWellcomeProductionS.A.SMember" abstract="true" name="GlaxoWellcomeProductionS.A.SMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineB.v.Member" abstract="true" name="GlaxosmithklineB.v.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineBiologicalsSAMember" abstract="true" name="GlaxoSmithKlineBiologicalsSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineGmbHAndCoKGMember" abstract="true" name="GlaxoSmithKlineGmbHAndCoKGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineManufacturingSpAMember" abstract="true" name="GlaxoSmithKlineManufacturingSpAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklinePharmaGmbhMember" abstract="true" name="GlaxosmithklinePharmaGmbhMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlinePharmaceuticalsSAMember" abstract="true" name="GlaxoSmithKlinePharmaceuticalsSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineSAMember" abstract="true" name="GlaxoSmithKlineSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineSPAMember" abstract="true" name="GlaxoSmithKlineSPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" abstract="true" name="GlaxosmithklineSingleMemberA.e.b.e.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineTradingServicesLimitedMember" abstract="true" name="GlaxoSmithKlineTradingServicesLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskCapitalB.v.Member" abstract="true" name="GskCapitalB.v.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKServicesSPZOOMember" abstract="true" name="GSKServicesSPZOOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKVaccinesGmbHMember" abstract="true" name="GSKVaccinesGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKVaccinesSRLMember" abstract="true" name="GSKVaccinesSRLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_JscGlaxosmithklineTradingMember" abstract="true" name="JscGlaxosmithklineTradingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LaboratoireGlaxoSmithKlineMember" abstract="true" name="LaboratoireGlaxoSmithKlineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_LaboratoriosViiVHealthCareSLMember" abstract="true" name="LaboratoriosViiVHealthCareSLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViivHealthcareGmbhMember" abstract="true" name="ViivHealthcareGmbhMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViivHealthcareSRLItalyMember" abstract="true" name="ViivHealthcareSRLItalyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViiVHealthcareSASMember" abstract="true" name="ViiVHealthcareSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CorixaCorporationMember" abstract="true" name="CorixaCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineCapitalIncMember" abstract="true" name="GlaxoSmithKlineCapitalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineHoldingsIncMember" abstract="true" name="GlaxoSmithKlineHoldingsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineLLCMember" abstract="true" name="GlaxoSmithKlineLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_HumanGenomeSciencesIncMember" abstract="true" name="HumanGenomeSciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_StiefelLaboratoriesIncMember" abstract="true" name="StiefelLaboratoriesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_TesaroMember" abstract="true" name="TesaroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViiVHealthcareCompanyMember" abstract="true" name="ViiVHealthcareCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKLifeSciencesFZEMember" abstract="true" name="GSKLifeSciencesFZEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineColombiaS.A.Member" abstract="true" name="GlaxoSmithKlineColombiaS.A.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_GlaxoWellcomeManufacturingPteLtdMember" abstract="true" name="GlaxoWellcomeManufacturingPteLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineThailandLimitedMember" abstract="true" name="GlaxosmithklineThailandLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKBiopharmaArgentinaS.A.Member" abstract="true" name="GSKBiopharmaArgentinaS.A.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineAustraliaPtyLtdMember" abstract="true" name="GlaxoSmithKlineAustraliaPtyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineBrasilLimitadaMember" abstract="true" name="GlaxoSmithKlineBrasilLimitadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineFarEastB.v.Member" abstract="true" name="GlaxosmithklineFarEastB.v.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" abstract="true" name="GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineIncMember" abstract="true" name="GlaxoSmithKlineIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineKKMember" abstract="true" name="GlaxoSmithKlineKKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineKoreaLimitedMember" abstract="true" name="GlaxoSmithKlineKoreaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlineLimitedMember" abstract="true" name="GlaxoSmithKlineLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" abstract="true" name="GlaxosmithklineMexicoS.a.DeC.v.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxoSmithKlinePakistanLimitedMember" abstract="true" name="GlaxoSmithKlinePakistanLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" abstract="true" name="GlaxosmithklinePharmaceuticalsLimitedIndiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskEnterpriseManagementCoLtdMember" abstract="true" name="GskEnterpriseManagementCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GskPharmaVietnamCompanyLimitedMember" abstract="true" name="GskPharmaVietnamCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_IDBiomedicalCorporationOfQuebecMember" abstract="true" name="IDBiomedicalCorporationOfQuebecMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ViivHealthcareK.kMember" abstract="true" name="ViivHealthcareK.kMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_EnglandMember" abstract="true" name="EnglandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_CoregMember" abstract="true" name="CoregMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_MRNAMember" abstract="true" name="MRNAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_AvandiaMember" abstract="true" name="AvandiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ZantacQuiTamMember" abstract="true" name="ZantacQuiTamMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ZofranMember" abstract="true" name="ZofranMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_ZejulaRoyaltyDisputeMember" abstract="true" name="ZejulaRoyaltyDisputeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_OntarioAndQuebecMember" abstract="true" name="OntarioAndQuebecMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_VaccineAxis" abstract="true" name="VaccineAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_VaccineDomain" abstract="true" name="VaccineDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_SpikevaxMember" abstract="true" name="SpikevaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_MRESVIAMember" abstract="true" name="MRESVIAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ComirnatyMember" abstract="true" name="ComirnatyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_ConclusionOfMajorLitigationMember" abstract="true" name="ConclusionOfMajorLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_GSKKoreaMember" abstract="true" name="GSKKoreaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_GSKGroupMember" abstract="true" name="GSKGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gsk_DamagesAwardedToGSK" abstract="false" name="DamagesAwardedToGSK" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfPanelMembersAtRehearing" abstract="false" name="NumberOfPanelMembersAtRehearing" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfPatentsAllegedlyInfringed" abstract="false" name="NumberOfPatentsAllegedlyInfringed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" abstract="false" name="NumberOfPatentsAllegedlyInvalidlyInfringed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfPatentsRevocationRequested" abstract="false" name="NumberOfPatentsRevocationRequested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfPatents" abstract="false" name="NumberOfPatents" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfPatentsInvalidated" abstract="false" name="NumberOfPatentsInvalidated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfSeparateFirstInstanceHearings" abstract="false" name="NumberOfSeparateFirstInstanceHearings" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfClassActionsPending" abstract="false" name="NumberOfClassActionsPending" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" abstract="false" name="LossContingencyNumberOfPlaintiffsInCaseAgreementReached" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_PercentageOfPlaintiffsAgreementReached" abstract="false" name="PercentageOfPlaintiffsAgreementReached" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="gsk_LossContingencyNumberOfPlaintiffsInCase" abstract="false" name="LossContingencyNumberOfPlaintiffsInCase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_LossContingencyDamageAwardedValue" abstract="false" name="LossContingencyDamageAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfCancerTypes" abstract="false" name="NumberOfCancerTypes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_PercentageOfStateCasesRemaining" abstract="false" name="PercentageOfStateCasesRemaining" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="gsk_NumberOfPersonalInjuryCasesDefendant" abstract="false" name="NumberOfPersonalInjuryCasesDefendant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfProductLiabilityCasesDismissed" abstract="false" name="NumberOfProductLiabilityCasesDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfProductLiabilityCases" abstract="false" name="NumberOfProductLiabilityCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfStateCourtCases" abstract="false" name="NumberOfStateCourtCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_NumberOfEmployeesInterferedWithTenderProcess" abstract="false" name="NumberOfEmployeesInterferedWithTenderProcess" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_LossContingenciesDamagesSoughtValue" abstract="false" name="LossContingenciesDamagesSoughtValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gsk_NumberOfWorldwidePatentLicenseAgreements" abstract="false" name="NumberOfWorldwidePatentLicenseAgreements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gsk_IDRxInc.Member" abstract="true" name="IDRxInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_TrancheAxis" abstract="true" name="TrancheAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gsk_TrancheDomain" abstract="true" name="TrancheDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_FirstTrancheMember" abstract="true" name="FirstTrancheMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gsk_UpfrontCashConsiderationPaidReceived" abstract="false" name="UpfrontCashConsiderationPaidReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>gsk-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3a546e24-b21d-4f2c-8496-4bed728e8d38,g:19b91481-759e-443e-bc09-8752e6669383-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedincomestatement" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedincomestatement"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedincomestatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_0aa6b206-aef1-4ae3-8881-5fbcf36fd04b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_d34896e7-18a9-458d-b85a-03a28f3393fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_0aa6b206-aef1-4ae3-8881-5fbcf36fd04b" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_d34896e7-18a9-458d-b85a-03a28f3393fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_666e52a1-4de4-4773-aa6d-420aff68fbdf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_0aa6b206-aef1-4ae3-8881-5fbcf36fd04b" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_666e52a1-4de4-4773-aa6d-420aff68fbdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_7016c2f6-3ead-4c5a-be7d-706e0af431b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_f56cb62e-6029-4416-84b2-e997f179edeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_7016c2f6-3ead-4c5a-be7d-706e0af431b5" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_f56cb62e-6029-4416-84b2-e997f179edeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_16191b13-ea11-4972-b18d-972fa8e3fd31" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_7016c2f6-3ead-4c5a-be7d-706e0af431b5" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_16191b13-ea11-4972-b18d-972fa8e3fd31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_d570a791-e773-4b65-9343-bf01f2b27b6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_d3a710d0-4d95-4b1c-b3b6-a2aaba50bd18" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_d570a791-e773-4b65-9343-bf01f2b27b6c" xlink:to="loc_ifrs-full_CostOfSales_d3a710d0-4d95-4b1c-b3b6-a2aaba50bd18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_0ebfcb22-abb5-4898-94b5-f61eec6a4b6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_d570a791-e773-4b65-9343-bf01f2b27b6c" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_0ebfcb22-abb5-4898-94b5-f61eec6a4b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_4011822b-8c0e-480d-b29e-2648bf8aa438" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_ddcbbfef-6a45-4aa9-8608-c9770b313279" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_4011822b-8c0e-480d-b29e-2648bf8aa438" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_ddcbbfef-6a45-4aa9-8608-c9770b313279" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_a44d4dbf-72f0-4456-8603-2b9cb8b0b2a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_4011822b-8c0e-480d-b29e-2648bf8aa438" xlink:to="loc_ifrs-full_FinanceIncome_a44d4dbf-72f0-4456-8603-2b9cb8b0b2a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_2f860d9a-4ac3-482d-8fbc-04ba21e07ac2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_4011822b-8c0e-480d-b29e-2648bf8aa438" xlink:to="loc_ifrs-full_FinanceCosts_2f860d9a-4ac3-482d-8fbc-04ba21e07ac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_b54bc807-b7d6-4d52-a3f5-ea33544b314b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_4011822b-8c0e-480d-b29e-2648bf8aa438" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_b54bc807-b7d6-4d52-a3f5-ea33544b314b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfNoncurrentAssets_7dcaf317-0280-40cd-b922-b0b39e52f526" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_4011822b-8c0e-480d-b29e-2648bf8aa438" xlink:to="loc_ifrs-full_GainsLossesOnDisposalsOfNoncurrentAssets_7dcaf317-0280-40cd-b922-b0b39e52f526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_444cfcda-53ac-499b-a73d-4ae19908de36" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_086dd2d5-3921-4a68-8b37-9b4c797df377" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_444cfcda-53ac-499b-a73d-4ae19908de36" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_086dd2d5-3921-4a68-8b37-9b4c797df377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_297881a5-d1cb-46a5-a959-3d1fcfbe504f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_444cfcda-53ac-499b-a73d-4ae19908de36" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_297881a5-d1cb-46a5-a959-3d1fcfbe504f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1ff783b6-2b42-4f03-9efd-c8dc5637a157" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_dd6c22e3-f02f-4892-9b16-d5332207298d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1ff783b6-2b42-4f03-9efd-c8dc5637a157" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_dd6c22e3-f02f-4892-9b16-d5332207298d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_3d33b707-1159-4e8c-955d-4e81ecd84ba2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1ff783b6-2b42-4f03-9efd-c8dc5637a157" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_3d33b707-1159-4e8c-955d-4e81ecd84ba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromRoyalties_e16de2ef-a397-45f2-8277-6dfb6e5e3cf2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1ff783b6-2b42-4f03-9efd-c8dc5637a157" xlink:to="loc_ifrs-full_RevenueFromRoyalties_e16de2ef-a397-45f2-8277-6dfb6e5e3cf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_d7a9a775-77c3-4108-ae05-e50b7881522d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1ff783b6-2b42-4f03-9efd-c8dc5637a157" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_d7a9a775-77c3-4108-ae05-e50b7881522d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_010ceee7-9947-433c-abdd-33a44643b61c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1ff783b6-2b42-4f03-9efd-c8dc5637a157" xlink:to="loc_ifrs-full_GrossProfit_010ceee7-9947-433c-abdd-33a44643b61c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_9abb58eb-7df6-47cf-b798-2a1592957570" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_cf37695d-23f1-48e1-82cd-ec10f53280d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_9abb58eb-7df6-47cf-b798-2a1592957570" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_cf37695d-23f1-48e1-82cd-ec10f53280d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_85d8eaa8-2547-4f2f-b623-69265a7a3964" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_9abb58eb-7df6-47cf-b798-2a1592957570" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_85d8eaa8-2547-4f2f-b623-69265a7a3964" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedstatementofcomprehensiveincome" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedstatementofcomprehensiveincome"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedstatementofcomprehensiveincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToInvestmentsInEquityInstrumentsOfOtherComprehensiveIncome_3b75945c-e05f-4cab-be4e-16f2f78d60b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToInvestmentsInEquityInstrumentsOfOtherComprehensiveIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:to="loc_ifrs-full_IncomeTaxRelatingToInvestmentsInEquityInstrumentsOfOtherComprehensiveIncome_3b75945c-e05f-4cab-be4e-16f2f78d60b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_2bf92cd7-cc60-47a5-81e3-bf0290cbd5b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_2bf92cd7-cc60-47a5-81e3-bf0290cbd5b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments_cfe3badf-7e58-452a-b2e3-ee05b14dd50b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments_cfe3badf-7e58-452a-b2e3-ee05b14dd50b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_066560aa-5114-459a-b670-b01fcc471548" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:to="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_066560aa-5114-459a-b670-b01fcc471548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified_dc96a44b-35d5-47ce-b7a4-1f0383faa43f" xlink:href="gsk-20241231.xsd#gsk_FairValueMovementsOnCashFlowHedgesNotReclassified"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:to="loc_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified_dc96a44b-35d5-47ce-b7a4-1f0383faa43f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests_4a41c6f3-294b-49fe-831d-8fdbc2f724a1" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_08c36092-24e2-4f71-8640-5ed43eb46b2c" xlink:to="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests_4a41c6f3-294b-49fe-831d-8fdbc2f724a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_4b1b27e2-58ba-427a-a36d-328aec17a0a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_3d56748f-75ee-458e-b316-d84fbcf6b2e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_4b1b27e2-58ba-427a-a36d-328aec17a0a4" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_3d56748f-75ee-458e-b316-d84fbcf6b2e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_0afd5708-2aa4-4874-ac3d-e268dd43d95d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_4b1b27e2-58ba-427a-a36d-328aec17a0a4" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_0afd5708-2aa4-4874-ac3d-e268dd43d95d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_8af17754-d22c-43e3-b8b3-1215aeccb35e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_8af17754-d22c-43e3-b8b3-1215aeccb35e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations_4ddd8612-09fc-4d2a-a318-3e2b9dccfb30" xlink:href="gsk-20241231.xsd#gsk_ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:to="loc_gsk_ExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperations_4ddd8612-09fc-4d2a-a318-3e2b9dccfb30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_eb19e5c7-e87c-499b-9f38-b9373198e641" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:to="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_eb19e5c7-e87c-499b-9f38-b9373198e641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_97e58ba4-c2ef-474c-969d-971463b8e406" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_97e58ba4-c2ef-474c-969d-971463b8e406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations_b7c82b81-a0c0-4f62-b1f2-2898a769a203" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:to="loc_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations_b7c82b81-a0c0-4f62-b1f2-2898a769a203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_937a26f2-e260-4e93-9f8b-43f2674171a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_33b3e8b0-d766-48a1-8b9c-ab29b9bc8cfb" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_937a26f2-e260-4e93-9f8b-43f2674171a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_705f313f-82fb-4b58-ad90-4834f99ad541" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_f7d876b8-24ca-44bb-8d2d-c937adcf9ea1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_705f313f-82fb-4b58-ad90-4834f99ad541" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_f7d876b8-24ca-44bb-8d2d-c937adcf9ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_747d45b1-8ba4-40e8-b039-9ba5f945ac57" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_705f313f-82fb-4b58-ad90-4834f99ad541" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_747d45b1-8ba4-40e8-b039-9ba5f945ac57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/ConsolidatedstatementofcomprehensiveincomeAlternatecalculation" xlink:type="simple" xlink:href="gsk-20241231.xsd#ConsolidatedstatementofcomprehensiveincomeAlternatecalculation"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/ConsolidatedstatementofcomprehensiveincomeAlternatecalculation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_4229e862-9360-48cf-bc7c-743781a30b6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_24b180f0-976d-4b9d-abd9-bf763efe3b66" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_4229e862-9360-48cf-bc7c-743781a30b6b" xlink:to="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_24b180f0-976d-4b9d-abd9-bf763efe3b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations_558a9f7d-5bb5-4b62-a269-000544e0c06f" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_4229e862-9360-48cf-bc7c-743781a30b6b" xlink:to="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromDiscontinuedOperations_558a9f7d-5bb5-4b62-a269-000544e0c06f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_014dcfe6-6c55-4c75-8088-b9c6af3e5841" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_4229e862-9360-48cf-bc7c-743781a30b6b" xlink:to="loc_ifrs-full_ProfitLoss_014dcfe6-6c55-4c75-8088-b9c6af3e5841" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedbalancesheet" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedbalancesheet"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedbalancesheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_e551b897-0a83-4406-8de2-1200d53b2604" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_e551b897-0a83-4406-8de2-1200d53b2604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_baa9a9e4-2068-4e43-a11d-933745be68ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_DeferredTaxAssets_baa9a9e4-2068-4e43-a11d-933745be68ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_9c32b914-36b4-4395-af56-d982fdaa172e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_9c32b914-36b4-4395-af56-d982fdaa172e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_341e7dc5-fd48-4a29-8f2b-45b1abeed623" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_341e7dc5-fd48-4a29-8f2b-45b1abeed623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_21b14ae1-daf0-47be-af46-11f75685f606" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_21b14ae1-daf0-47be-af46-11f75685f606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_cefa6ceb-8fe0-4d3d-9d67-0276203aafd0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_cefa6ceb-8fe0-4d3d-9d67-0276203aafd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_b18340d0-6faa-456b-9d9d-a1efe0df333f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_Goodwill_b18340d0-6faa-456b-9d9d-a1efe0df333f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_3e342aa8-f977-4350-b450-57aca2887296" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_RightofuseAssets_3e342aa8-f977-4350-b450-57aca2887296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_2abd9e3a-4ec2-4ef7-94bc-42c56089edb1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_73d7c2f3-550d-495b-a5e9-889c9d67eab7" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_2abd9e3a-4ec2-4ef7-94bc-42c56089edb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions_114796f9-7dcc-4748-9047-0eb590f04990" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:to="loc_ifrs-full_OtherShorttermProvisions_114796f9-7dcc-4748-9047-0eb590f04990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilities_655cfa01-5fa4-4c72-b83e-7b8194f7592a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:to="loc_ifrs-full_CurrentTaxLiabilities_655cfa01-5fa4-4c72-b83e-7b8194f7592a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_4c004976-718d-4437-b467-263adc963af4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_4c004976-718d-4437-b467-263adc963af4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_3c30d15a-cdca-4800-97bd-f121adb2ec3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_3c30d15a-cdca-4800-97bd-f121adb2ec3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_cad4c5c1-55e4-40d9-90e3-2e3ed257513c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:to="loc_ifrs-full_ShorttermBorrowings_cad4c5c1-55e4-40d9-90e3-2e3ed257513c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationLiabilities_0b0db771-3452-47a2-9932-f107b52edcb5" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_9f96e394-6c74-4f36-a2a3-bc2e6bb2f014" xlink:to="loc_gsk_ContingentConsiderationLiabilities_0b0db771-3452-47a2-9932-f107b52edcb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_096a076a-d653-4b85-8bc4-82dab180c041" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_LongtermBorrowings_096a076a-d653-4b85-8bc4-82dab180c041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_161eb8b1-c106-4278-9c46-d2ef9ec101a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_161eb8b1-c106-4278-9c46-d2ef9ec101a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_f05888b3-c2c0-4089-8d24-569119055872" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_f05888b3-c2c0-4089-8d24-569119055872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_18753e88-e034-4db3-a518-24966bfd0f16" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_18753e88-e034-4db3-a518-24966bfd0f16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_84fd7bcc-0237-4eed-9b7e-43691daccebb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_84fd7bcc-0237-4eed-9b7e-43691daccebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_efb5f5b5-ba4a-410c-a75b-85451d9c54f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_efb5f5b5-ba4a-410c-a75b-85451d9c54f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_6de28617-0340-4aa5-a20b-21e43319bb71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_956d7c5d-7071-4c96-a236-6f470829927b" xlink:to="loc_ifrs-full_OtherLongtermProvisions_6de28617-0340-4aa5-a20b-21e43319bb71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_76056212-6f27-47d9-a31d-16c659be050f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_e4c1d767-9d22-47f9-80bd-319c9ef903eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_76056212-6f27-47d9-a31d-16c659be050f" xlink:to="loc_ifrs-full_SharePremium_e4c1d767-9d22-47f9-80bd-319c9ef903eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings_4d431329-ed30-42d4-8fec-458f4adf8f4e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_76056212-6f27-47d9-a31d-16c659be050f" xlink:to="loc_ifrs-full_RetainedEarnings_4d431329-ed30-42d4-8fec-458f4adf8f4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_246c8c14-afae-4519-8433-dd3dd5b81dfc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_76056212-6f27-47d9-a31d-16c659be050f" xlink:to="loc_ifrs-full_OtherReserves_246c8c14-afae-4519-8433-dd3dd5b81dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_6d64a1dd-dbb6-4b43-b5f5-8e4920e6bc56" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_76056212-6f27-47d9-a31d-16c659be050f" xlink:to="loc_ifrs-full_IssuedCapital_6d64a1dd-dbb6-4b43-b5f5-8e4920e6bc56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_2b7b29fe-3e39-4daa-bab5-549b1f5a7977" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_ca6ddda0-acd6-4c68-92fb-6241a653a9b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_2b7b29fe-3e39-4daa-bab5-549b1f5a7977" xlink:to="loc_ifrs-full_CurrentAssets_ca6ddda0-acd6-4c68-92fb-6241a653a9b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_0fad10b5-00c3-415a-b45f-73e671607499" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_2b7b29fe-3e39-4daa-bab5-549b1f5a7977" xlink:to="loc_ifrs-full_NoncurrentAssets_0fad10b5-00c3-415a-b45f-73e671607499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_ec5c78ff-c2a1-4b55-afcb-09ea3849b003" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_55675005-718f-40bc-a8c4-010af2a2c927" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_ec5c78ff-c2a1-4b55-afcb-09ea3849b003" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_55675005-718f-40bc-a8c4-010af2a2c927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests_7a119079-a9c4-4561-83bc-3951542ef344" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_ec5c78ff-c2a1-4b55-afcb-09ea3849b003" xlink:to="loc_ifrs-full_NoncontrollingInterests_7a119079-a9c4-4561-83bc-3951542ef344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_36ba62e6-9416-4e16-b133-084714481e0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_36ba62e6-9416-4e16-b133-084714481e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_e7792a11-1fdd-4658-aa6e-a7beb7827a73" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_e7792a11-1fdd-4658-aa6e-a7beb7827a73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestments_6c44d520-ba7d-467d-a11a-9b76f66708a6" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_gsk_LiquidInvestments_6c44d520-ba7d-467d-a11a-9b76f66708a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_b35f1f16-a573-4560-9d03-daa30a959cf0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_CashAndCashEquivalents_b35f1f16-a573-4560-9d03-daa30a959cf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_ba0562ef-afe2-4341-b029-2fc07111d7ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_ba0562ef-afe2-4341-b029-2fc07111d7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssets_0d683c56-bb41-42ec-bb03-8960fb80c02b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_CurrentTaxAssets_0d683c56-bb41-42ec-bb03-8960fb80c02b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets_67871fa6-2715-42da-a836-1e047ae296da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialAssets_67871fa6-2715-42da-a836-1e047ae296da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_0c288555-bbb3-46dc-9be0-80f8fea9a373" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_4001b8b7-a3df-4e99-b7e3-8bfd05c34986" xlink:to="loc_ifrs-full_Inventories_0c288555-bbb3-46dc-9be0-80f8fea9a373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_601f6e5c-165b-4c9f-8cba-818b47c9ce8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_c1a94bc6-7d7c-448e-be00-5c9a06f2197b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_601f6e5c-165b-4c9f-8cba-818b47c9ce8f" xlink:to="loc_ifrs-full_CurrentLiabilities_c1a94bc6-7d7c-448e-be00-5c9a06f2197b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_7d69b3ce-788f-4e6e-ace3-25f1b0ad18ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_601f6e5c-165b-4c9f-8cba-818b47c9ce8f" xlink:to="loc_ifrs-full_NoncurrentLiabilities_7d69b3ce-788f-4e6e-ace3-25f1b0ad18ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities_bb553c00-a526-44d3-8c99-8c973bb2f100" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_fcefd1c9-e8d4-450a-a2d1-c0bc7e9b4c86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_bb553c00-a526-44d3-8c99-8c973bb2f100" xlink:to="loc_ifrs-full_Assets_fcefd1c9-e8d4-450a-a2d1-c0bc7e9b4c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_eed6961f-33a0-437f-84a3-860056e8bfea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_bb553c00-a526-44d3-8c99-8c973bb2f100" xlink:to="loc_ifrs-full_Liabilities_eed6961f-33a0-437f-84a3-860056e8bfea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedstatementofchangesinequity" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedstatementofchangesinequity"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedstatementofchangesinequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_1c73fade-3550-49d7-9367-503e7943c54d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_dc13f49f-20e5-42f5-9fc3-27d30e5d8800" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_1c73fade-3550-49d7-9367-503e7943c54d" xlink:to="loc_ifrs-full_ProfitLoss_dc13f49f-20e5-42f5-9fc3-27d30e5d8800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_dcd0dd40-2e0a-42ce-a117-dd5eb83dcc21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_1c73fade-3550-49d7-9367-503e7943c54d" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_dcd0dd40-2e0a-42ce-a117-dd5eb83dcc21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedcashflowstatement" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedcashflowstatement"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedcashflowstatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_931d9728-2658-436e-960f-fb554c940dff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_931d9728-2658-436e-960f-fb554c940dff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInLiquidInvestments_3b79c41d-c521-4b73-b398-dfc73a3fef86" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInLiquidInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_gsk_IncreaseDecreaseInLiquidInvestments_3b79c41d-c521-4b73-b398-dfc73a3fef86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities_4f49396b-9dbd-435b-b1e1-01ba5da404dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities_4f49396b-9dbd-435b-b1e1-01ba5da404dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_5ac95d8e-fefd-423c-b631-921728406f70" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_5ac95d8e-fefd-423c-b631-921728406f70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_2088917a-9e43-4674-bc05-e14fc4da539c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_2088917a-9e43-4674-bc05-e14fc4da539c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_2ff659fb-7fb8-499c-ab00-d02cfd5de448" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_2ff659fb-7fb8-499c-ab00-d02cfd5de448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_44b4d667-a11b-4782-89d7-1e547d37407a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_44b4d667-a11b-4782-89d7-1e547d37407a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities_f327cf16-38f6-4a21-9629-0f48f59d44be" xlink:href="gsk-20241231.xsd#gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities_f327cf16-38f6-4a21-9629-0f48f59d44be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_7f47aff0-47a1-4756-a217-a0209070cc53" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_7f47aff0-47a1-4756-a217-a0209070cc53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_23df33e4-612c-44cd-8e1e-bd41cbe30d6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_23df33e4-612c-44cd-8e1e-bd41cbe30d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_a50858df-78fa-4cb1-ab37-85663ca7ea80" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_a50858df-78fa-4cb1-ab37-85663ca7ea80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_dd8b7096-1e07-4126-9cb9-819c46f86ba3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_dd8b7096-1e07-4126-9cb9-819c46f86ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_f6780689-b968-4bf5-b2e5-aff610828b21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_f6780689-b968-4bf5-b2e5-aff610828b21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_afcce24d-d32b-4f9c-b358-7f4602468967" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_afcce24d-d32b-4f9c-b358-7f4602468967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities_ef7501f8-a375-4268-a357-46517a95c102" xlink:href="gsk-20241231.xsd#gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities_ef7501f8-a375-4268-a357-46517a95c102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests_bdb88a98-9c1e-49bc-a1e5-73e07c0cb9fe" xlink:href="gsk-20241231.xsd#gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_a56feeb0-dc27-44ec-b4f2-adad836a4358" xlink:to="loc_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests_bdb88a98-9c1e-49bc-a1e5-73e07c0cb9fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_f77c0f91-0a6a-4f5d-9b3c-1e66893511ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_f77c0f91-0a6a-4f5d-9b3c-1e66893511ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_982d69ec-a9f5-462b-bcd1-643b01e036d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_982d69ec-a9f5-462b-bcd1-643b01e036d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_24c34a46-1b5b-40fb-907d-b3ef266d73ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_24c34a46-1b5b-40fb-907d-b3ef266d73ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_bc99cd33-c36a-4718-b29a-5bc4f1bdee32" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_bc99cd33-c36a-4718-b29a-5bc4f1bdee32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RepaymentOfOtherShortTermLoans_2e826260-4d50-40c9-8012-8c96142de31e" xlink:href="gsk-20241231.xsd#gsk_RepaymentOfOtherShortTermLoans"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_gsk_RepaymentOfOtherShortTermLoans_2e826260-4d50-40c9-8012-8c96142de31e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_7e0b933a-8e74-4b8b-a45a-18ad136b508c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_7e0b933a-8e74-4b8b-a45a-18ad136b508c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_df513766-55fc-49c9-b2c8-6fd3eb6c0ed1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_df513766-55fc-49c9-b2c8-6fd3eb6c0ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_1da9abbd-b4db-4fba-aa29-46000b4ab012" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_1da9abbd-b4db-4fba-aa29-46000b4ab012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProceedsRepaymentsFromOfShortTermLoans_eefd8d74-4973-4d07-9d50-354383d984f3" xlink:href="gsk-20241231.xsd#gsk_ProceedsRepaymentsFromOfShortTermLoans"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_gsk_ProceedsRepaymentsFromOfShortTermLoans_eefd8d74-4973-4d07-9d50-354383d984f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities_75b9fcd0-4b22-4840-b885-923fb37538cf" xlink:href="gsk-20241231.xsd#gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities_75b9fcd0-4b22-4840-b885-923fb37538cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInOtherShortTermLoans_d8b4eeef-9ecd-4595-9b8a-5f92956ccff9" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInOtherShortTermLoans"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_gsk_IncreaseDecreaseInOtherShortTermLoans_d8b4eeef-9ecd-4595-9b8a-5f92956ccff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_d9f187e0-4df5-4afb-bb4b-5355523ffda8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fe3a574-91da-4e96-87cc-637e366256ce" xlink:to="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_d9f187e0-4df5-4afb-bb4b-5355523ffda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_f2b99a7d-e2a4-459d-aeec-ee80f42c230d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_5194ebfb-624c-459a-996c-d40483f4c880" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_f2b99a7d-e2a4-459d-aeec-ee80f42c230d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_5194ebfb-624c-459a-996c-d40483f4c880" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_d18ee601-283a-4aa1-ac3b-ad30db1c91c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_f2b99a7d-e2a4-459d-aeec-ee80f42c230d" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_d18ee601-283a-4aa1-ac3b-ad30db1c91c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_dce1592e-519d-472e-8129-b7b15125bd63" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_f92bfa1e-17a7-45b0-bb7d-ec80dbdfbcb9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_dce1592e-519d-472e-8129-b7b15125bd63" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_f92bfa1e-17a7-45b0-bb7d-ec80dbdfbcb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_68f6ba8b-1fa9-4e39-ab3c-db1b66336d68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_dce1592e-519d-472e-8129-b7b15125bd63" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_68f6ba8b-1fa9-4e39-ab3c-db1b66336d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_1618f4bd-c7f1-431a-81a6-9f5bc631fad2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_a26f1090-222e-4a95-88c8-9b681622bec3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_1618f4bd-c7f1-431a-81a6-9f5bc631fad2" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_a26f1090-222e-4a95-88c8-9b681622bec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_df41106e-8189-4066-a134-3a5785f02e90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_1618f4bd-c7f1-431a-81a6-9f5bc631fad2" xlink:to="loc_ifrs-full_CashAndCashEquivalents_df41106e-8189-4066-a134-3a5785f02e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_4f4a70e1-d629-4f28-bdf8-fefde7406ebe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations_176f178f-9925-46c9-a0c0-7e825ccedd67" xlink:href="gsk-20241231.xsd#gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_4f4a70e1-d629-4f28-bdf8-fefde7406ebe" xlink:to="loc_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations_176f178f-9925-46c9-a0c0-7e825ccedd67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations_27355311-6fc1-4e58-a859-67e123639ea2" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_4f4a70e1-d629-4f28-bdf8-fefde7406ebe" xlink:to="loc_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations_27355311-6fc1-4e58-a859-67e123639ea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_43dea341-13cd-44d4-8bca-8ddc5f24ec57" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_5c621ce7-9417-4629-bf44-758e733cfe0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_43dea341-13cd-44d4-8bca-8ddc5f24ec57" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_5c621ce7-9417-4629-bf44-758e733cfe0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_d54d6810-1d1c-4807-bf02-6c0a9c0fb979" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_43dea341-13cd-44d4-8bca-8ddc5f24ec57" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_d54d6810-1d1c-4807-bf02-6c0a9c0fb979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_fdad92f2-7697-4904-bf94-c8cd92b1e55b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_fa68648f-1f5f-46ab-b595-99b78581b2fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_fdad92f2-7697-4904-bf94-c8cd92b1e55b" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_fa68648f-1f5f-46ab-b595-99b78581b2fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_038b8f38-0961-4a4f-a601-c5f49323b74d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_fdad92f2-7697-4904-bf94-c8cd92b1e55b" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_038b8f38-0961-4a4f-a601-c5f49323b74d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1d633aa1-0d75-4dbb-97da-a8e2e450d6c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fa15de1-e10c-4472-bc5f-4ac3d685d54e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1d633aa1-0d75-4dbb-97da-a8e2e450d6c2" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0fa15de1-e10c-4472-bc5f-4ac3d685d54e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1dea18c7-68a3-4974-8bd0-a00fe0fe5ed1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1d633aa1-0d75-4dbb-97da-a8e2e450d6c2" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1dea18c7-68a3-4974-8bd0-a00fe0fe5ed1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedincomestatement_1" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedincomestatement_1"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedincomestatement_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_d3dacbcd-aed0-4fdf-b1ed-5160cdbc8ddf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger_f0cc1803-406a-4670-94e7-60d93fadf0aa" xlink:href="gsk-20241231.xsd#gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_d3dacbcd-aed0-4fdf-b1ed-5160cdbc8ddf" xlink:to="loc_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger_f0cc1803-406a-4670-94e7-60d93fadf0aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_b0fb8d88-fc53-4b19-86f5-0684ca25b10c" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_d3dacbcd-aed0-4fdf-b1ed-5160cdbc8ddf" xlink:to="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_b0fb8d88-fc53-4b19-86f5-0684ca25b10c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_824a28f0-63ea-47d3-ac19-c4b2b375834c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_825d1e9a-abc5-447e-b239-8d56869e8c1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_824a28f0-63ea-47d3-ac19-c4b2b375834c" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_825d1e9a-abc5-447e-b239-8d56869e8c1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeFromContinuingOperationsAttributableToOwnersOfParent_3d46bde8-6f27-48d3-80f0-6cd7415af806" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromContinuingOperationsAttributableToOwnersOfParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_824a28f0-63ea-47d3-ac19-c4b2b375834c" xlink:to="loc_ifrs-full_IncomeFromContinuingOperationsAttributableToOwnersOfParent_3d46bde8-6f27-48d3-80f0-6cd7415af806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests_3bb430a7-c594-402b-a6b8-3db3674d2d9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_824a28f0-63ea-47d3-ac19-c4b2b375834c" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests_3bb430a7-c594-402b-a6b8-3db3674d2d9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_6d5fd1c5-ec58-4a99-8b73-b4743a7f7eb7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_824a28f0-63ea-47d3-ac19-c4b2b375834c" xlink:to="loc_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_6d5fd1c5-ec58-4a99-8b73-b4743a7f7eb7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedincomestatement_2" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedincomestatement_2"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/Consolidatedincomestatement_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_52c700e1-275b-4c8c-a9fb-606c3c611647" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_1af66c4c-7c6d-423e-908f-b36ff958a6a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_52c700e1-275b-4c8c-a9fb-606c3c611647" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_1af66c4c-7c6d-423e-908f-b36ff958a6a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_6326e23b-af55-4b0b-986f-c26c38f38085" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_52c700e1-275b-4c8c-a9fb-606c3c611647" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_6326e23b-af55-4b0b-986f-c26c38f38085" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_3227623a-7351-4027-a99c-f3f9dd1977ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_3227623a-7351-4027-a99c-f3f9dd1977ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_e9e27d94-fb8c-4d80-9f3e-902902e8dc24" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_e9e27d94-fb8c-4d80-9f3e-902902e8dc24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_56c47741-81f4-4713-9f8c-e56d3398e751" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_56c47741-81f4-4713-9f8c-e56d3398e751" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetOperatingAssets_8d362a91-505e-48e8-b3e2-725d7825c210" xlink:href="gsk-20241231.xsd#gsk_NetOperatingAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_gsk_NetOperatingAssets_8d362a91-505e-48e8-b3e2-725d7825c210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDebt_4ee43fce-b16b-44c1-955a-566306ddb7a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_ifrs-full_NetDebt_4ee43fce-b16b-44c1-955a-566306ddb7a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsInJointVenturesAndAssociates_27693203-09b6-4e2b-8a42-f9b261d095ee" xlink:href="gsk-20241231.xsd#gsk_InvestmentsInJointVenturesAndAssociates"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_gsk_InvestmentsInJointVenturesAndAssociates_27693203-09b6-4e2b-8a42-f9b261d095ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentAndDeferredTaxation_ae3b4f7d-80c8-4f72-a0b2-c5b7a8a2353b" xlink:href="gsk-20241231.xsd#gsk_CurrentAndDeferredTaxation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetAssetsLiabilities_91bd7705-dc85-4f43-b1fc-2bffdb401207" xlink:to="loc_gsk_CurrentAndDeferredTaxation_ae3b4f7d-80c8-4f72-a0b2-c5b7a8a2353b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments_0777ad80-88b9-4810-a222-29ce85969981" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments_0777ad80-88b9-4810-a222-29ce85969981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalOfBusinessesAndAssets_693f97d1-6999-4fda-86df-dc9d65f56ced" xlink:href="gsk-20241231.xsd#gsk_DisposalOfBusinessesAndAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_gsk_DisposalOfBusinessesAndAssets_693f97d1-6999-4fda-86df-dc9d65f56ced" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_c6f46df3-ae65-402f-b29d-b5c90f12d2d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_c6f46df3-ae65-402f-b29d-b5c90f12d2d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_77450c90-8d82-483d-bdfe-d1cff0cad712" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_77450c90-8d82-483d-bdfe-d1cff0cad712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_9a4d5521-67f2-4032-932a-d45dca389616" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_9a4d5521-67f2-4032-932a-d45dca389616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UpfrontSettlementIncome_66b98852-23e8-42ee-8408-3b51b0f32c6d" xlink:href="gsk-20241231.xsd#gsk_UpfrontSettlementIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_gsk_UpfrontSettlementIncome_66b98852-23e8-42ee-8408-3b51b0f32c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousOtherIncomeExpense_1298cbf7-0503-4dec-bcdd-56e85be42e2b" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousOtherIncomeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_2c30cf72-0d0b-4aac-99bd-5888cdabae23" xlink:to="loc_gsk_MiscellaneousOtherIncomeExpense_1298cbf7-0503-4dec-bcdd-56e85be42e2b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OperatingprofitSummaryofAuditorsRemunerationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OperatingprofitSummaryofAuditorsRemunerationDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/OperatingprofitSummaryofAuditorsRemunerationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_f92df20b-9c13-48ec-bf37-6625d41f2c6f" xlink:href="gsk-20241231.xsd#gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_ede92a02-58b9-45b3-a98c-bba7131e3056" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_f92df20b-9c13-48ec-bf37-6625d41f2c6f" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_ede92a02-58b9-45b3-a98c-bba7131e3056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditorsRemunerationForOtherAssuranceServices_7fe64ffe-f2ff-48a8-8201-addc2ed14cf2" xlink:href="gsk-20241231.xsd#gsk_AuditorsRemunerationForOtherAssuranceServices"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_f92df20b-9c13-48ec-bf37-6625d41f2c6f" xlink:to="loc_gsk_AuditorsRemunerationForOtherAssuranceServices_7fe64ffe-f2ff-48a8-8201-addc2ed14cf2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeecostsSummaryofEmployeeCostsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeecostsSummaryofEmployeeCostsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/EmployeecostsSummaryofEmployeeCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_1e93c178-6253-476c-a9dc-f79d47027215" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries_e5a5d964-54b5-433d-809f-ca92f9935056" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_1e93c178-6253-476c-a9dc-f79d47027215" xlink:to="loc_ifrs-full_WagesAndSalaries_e5a5d964-54b5-433d-809f-ca92f9935056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SocialSecurityContributions_34ddfcd1-b1fe-4f58-b6bb-19f78ef59c57" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SocialSecurityContributions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_1e93c178-6253-476c-a9dc-f79d47027215" xlink:to="loc_ifrs-full_SocialSecurityContributions_34ddfcd1-b1fe-4f58-b6bb-19f78ef59c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostEmploymentBenefitExpense_35bc08db-673b-4dbd-8948-324a65642e75" xlink:href="gsk-20241231.xsd#gsk_PostEmploymentBenefitExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_1e93c178-6253-476c-a9dc-f79d47027215" xlink:to="loc_gsk_PostEmploymentBenefitExpense_35bc08db-673b-4dbd-8948-324a65642e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_5aee65ba-a464-4eca-b8a6-ee32388fc483" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_1e93c178-6253-476c-a9dc-f79d47027215" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_5aee65ba-a464-4eca-b8a6-ee32388fc483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TerminationBenefitsExpense_40f3da51-e292-4e6b-9630-b749ee293c7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TerminationBenefitsExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_1e93c178-6253-476c-a9dc-f79d47027215" xlink:to="loc_ifrs-full_TerminationBenefitsExpense_40f3da51-e292-4e6b-9630-b749ee293c7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_c1e5733f-02f1-4baa-96ef-d8fdb985a349" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_7ff99187-bb51-42a4-bbd5-b31473c4b1c9" xlink:href="gsk-20241231.xsd#gsk_AverageNumberOfEmployeesFromDiscontinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageNumberOfEmployees_c1e5733f-02f1-4baa-96ef-d8fdb985a349" xlink:to="loc_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_7ff99187-bb51-42a4-bbd5-b31473c4b1c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageNumberOfEmployeesFromContinuingOperations_cd58265b-18db-4fa4-8c7d-2da790b5c79c" xlink:href="gsk-20241231.xsd#gsk_AverageNumberOfEmployeesFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageNumberOfEmployees_c1e5733f-02f1-4baa-96ef-d8fdb985a349" xlink:to="loc_gsk_AverageNumberOfEmployeesFromContinuingOperations_cd58265b-18db-4fa4-8c7d-2da790b5c79c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeecostsSummaryofCompensationoftheDirectorsandSeniorManagementDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeecostsSummaryofCompensationoftheDirectorsandSeniorManagementDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/EmployeecostsSummaryofCompensationoftheDirectorsandSeniorManagementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_529fb8d9-80a7-49b5-a917-cbc43198b72f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_7df59993-4e38-41fb-8f13-8da8b095a66b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_529fb8d9-80a7-49b5-a917-cbc43198b72f" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_7df59993-4e38-41fb-8f13-8da8b095a66b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts_8a254a86-2840-4af7-b5b8-e369fbbb2580" xlink:href="gsk-20241231.xsd#gsk_KeyManagementPersonnelCompensationSocialSecurityCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_529fb8d9-80a7-49b5-a917-cbc43198b72f" xlink:to="loc_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts_8a254a86-2840-4af7-b5b8-e369fbbb2580" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_741f5d36-a5e0-40df-b7c3-dc668c294e06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_529fb8d9-80a7-49b5-a917-cbc43198b72f" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_741f5d36-a5e0-40df-b7c3-dc668c294e06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_9180cc30-f5d2-4d1f-b2d0-e4e195e0a3fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_529fb8d9-80a7-49b5-a917-cbc43198b72f" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_9180cc30-f5d2-4d1f-b2d0-e4e195e0a3fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalRestructuringCosts_588c4788-9558-4932-8bbc-888dbc75605f" xlink:href="gsk-20241231.xsd#gsk_TotalRestructuringCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherMaterialNoncashItems_038d6fd0-8885-450e-80d2-5d74107b2396" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherMaterialNoncashItems"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalRestructuringCosts_588c4788-9558-4932-8bbc-888dbc75605f" xlink:to="loc_ifrs-full_OtherMaterialNoncashItems_038d6fd0-8885-450e-80d2-5d74107b2396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_a333f4f4-9013-4502-93d6-03e7da807985" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfProvisionsForCostOfRestructuring"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalRestructuringCosts_588c4788-9558-4932-8bbc-888dbc75605f" xlink:to="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_a333f4f4-9013-4502-93d6-03e7da807985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCostsCashSettlement_b888e94b-562d-48a1-9d92-6319dbcf8028" xlink:href="gsk-20241231.xsd#gsk_OtherCostsCashSettlement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalRestructuringCosts_588c4788-9558-4932-8bbc-888dbc75605f" xlink:to="loc_gsk_OtherCostsCashSettlement_b888e94b-562d-48a1-9d92-6319dbcf8028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_dec2f7dd-c985-4a65-a4bb-83851564493c" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalRestructuringCosts_588c4788-9558-4932-8bbc-888dbc75605f" xlink:to="loc_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_dec2f7dd-c985-4a65-a4bb-83851564493c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3ac16fa0-edaf-475c-9e31-6e5f9971fc7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalRestructuringCosts_588c4788-9558-4932-8bbc-888dbc75605f" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3ac16fa0-edaf-475c-9e31-6e5f9971fc7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCosts1_ed1ef3a5-4b1b-4ac4-a1df-f8245766ac8f" xlink:href="gsk-20241231.xsd#gsk_RestructuringCosts1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashRestructuringCharges_3a79b7f1-3d15-4cd6-81de-61c994893ea0" xlink:href="gsk-20241231.xsd#gsk_CashRestructuringCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RestructuringCosts1_ed1ef3a5-4b1b-4ac4-a1df-f8245766ac8f" xlink:to="loc_gsk_CashRestructuringCharges_3a79b7f1-3d15-4cd6-81de-61c994893ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCashRestructuringCharges_90087e09-c322-4964-b604-81c9fa9a2ad8" xlink:href="gsk-20241231.xsd#gsk_NonCashRestructuringCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RestructuringCosts1_ed1ef3a5-4b1b-4ac4-a1df-f8245766ac8f" xlink:to="loc_gsk_NonCashRestructuringCharges_90087e09-c322-4964-b604-81c9fa9a2ad8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostChargedToOperatingProfit_95da2638-e7d1-4e98-aa35-2902dfda5dc9" xlink:href="gsk-20241231.xsd#gsk_CostChargedToOperatingProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_14327ead-6bba-4d3e-b666-d9045918ce46" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CostChargedToOperatingProfit_95da2638-e7d1-4e98-aa35-2902dfda5dc9" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_14327ead-6bba-4d3e-b666-d9045918ce46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_db506b91-f004-4d8a-b3e9-eed05b41c888" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CostChargedToOperatingProfit_95da2638-e7d1-4e98-aa35-2902dfda5dc9" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_db506b91-f004-4d8a-b3e9-eed05b41c888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_d835c29f-fcfd-4493-8195-8ad2ebec4b34" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CostChargedToOperatingProfit_95da2638-e7d1-4e98-aa35-2902dfda5dc9" xlink:to="loc_ifrs-full_CostOfSales_d835c29f-fcfd-4493-8195-8ad2ebec4b34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_efe8a0d5-cbe0-4e28-acbb-0a0c62c2592b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CostChargedToOperatingProfit_95da2638-e7d1-4e98-aa35-2902dfda5dc9" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_efe8a0d5-cbe0-4e28-acbb-0a0c62c2592b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinanceincomeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinanceincomeDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/FinanceincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_690d0b40-ddb4-448e-94d8-545f82855bd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost_a6c9883b-f47e-4f66-9561-aab794f69ed7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_690d0b40-ddb4-448e-94d8-545f82855bd1" xlink:to="loc_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost_a6c9883b-f47e-4f66-9561-aab794f69ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncome_e0d0d132-09a6-480a-95f8-d154c225a009" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_690d0b40-ddb4-448e-94d8-545f82855bd1" xlink:to="loc_ifrs-full_OtherFinanceIncome_e0d0d132-09a6-480a-95f8-d154c225a009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_5f1eb513-dd0c-4f38-9f9e-8296716cd058" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_690d0b40-ddb4-448e-94d8-545f82855bd1" xlink:to="loc_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_5f1eb513-dd0c-4f38-9f9e-8296716cd058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss_ed25c1af-9162-46b7-9f72-bc166998fc89" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_690d0b40-ddb4-448e-94d8-545f82855bd1" xlink:to="loc_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss_ed25c1af-9162-46b7-9f72-bc166998fc89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinanceExpenseDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinanceExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/FinanceExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_96ae6774-5e75-4e5c-91d0-e115fe5d3f9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_96ae6774-5e75-4e5c-91d0-e115fe5d3f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue_6890cd25-ed55-468a-8b0c-05e02bdabb81" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue_6890cd25-ed55-468a-8b0c-05e02bdabb81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_3dc90626-b067-42bc-88fc-d2535dcd1441" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_3dc90626-b067-42bc-88fc-d2535dcd1441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost_53ad67b8-2931-4956-94eb-5b31ae47b37a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost_53ad67b8-2931-4956-94eb-5b31ae47b37a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_a7cb4568-ef13-4bff-9462-cff1c292cd62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_a7cb4568-ef13-4bff-9462-cff1c292cd62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RetranslationOfLoan_abdb1acd-b9ca-4851-a2b1-a163d715b263" xlink:href="gsk-20241231.xsd#gsk_RetranslationOfLoan"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_gsk_RetranslationOfLoan_abdb1acd-b9ca-4851-a2b1-a163d715b263" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax_1caaa945-0214-44fc-85b5-15072b1a75db" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentsOnHedgesNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_578d4356-0e8b-4ff9-a88f-1456aa9c9549" xlink:to="loc_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax_1caaa945-0214-44fc-85b5-15072b1a75db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofTaxationChargeBasedonProfitsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofTaxationChargeBasedonProfitsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TaxationSummaryofTaxationChargeBasedonProfitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8a2e65c2-c98f-45dd-b502-9221b41d4503" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_c36708cd-8419-430c-a314-6a781101a55f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8a2e65c2-c98f-45dd-b502-9221b41d4503" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_c36708cd-8419-430c-a314-6a781101a55f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_597afea5-973e-497d-8a61-865c1cdcc7f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8a2e65c2-c98f-45dd-b502-9221b41d4503" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_597afea5-973e-497d-8a61-865c1cdcc7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_c09c3dae-4b01-46a0-bb2b-1752822428ff" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_c09c3dae-4b01-46a0-bb2b-1752822428ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_ed868789-b2ca-4f85-b697-9771422c0690" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_ed868789-b2ca-4f85-b697-9771422c0690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_6aa6dc66-dab3-4edd-bd2b-71827697be94" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_ifrs-full_ApplicableTaxRate_6aa6dc66-dab3-4edd-bd2b-71827697be94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_dc1c3485-c9fd-4faa-9678-4a10db5f6e44" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfResearchAndDevelopmentCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_dc1c3485-c9fd-4faa-9678-4a10db5f6e44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_6d82a5fd-c4c9-4d5b-99e7-47804648ce00" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_6d82a5fd-c4c9-4d5b-99e7-47804648ce00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_923a3d69-947b-41bc-970a-92af805916b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_923a3d69-947b-41bc-970a-92af805916b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_49e3a543-a939-4937-a4fe-d8ffe9f4e6a0" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_49e3a543-a939-4937-a4fe-d8ffe9f4e6a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfChangeInTaxRate_c7eb278d-8792-43c4-8d62-6a1df83af33d" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfChangeInTaxRate"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_gsk_TaxRateEffectOfChangeInTaxRate_c7eb278d-8792-43c4-8d62-6a1df83af33d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_e5acc3d3-96fb-4a38-9163-7955c6c05c90" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_af6068d5-f28e-4797-a8b2-887b891e90cc" xlink:to="loc_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_e5acc3d3-96fb-4a38-9163-7955c6c05c90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_3304eac3-95ea-4dac-976e-d94a5be9e217" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_dcf8566f-d6ec-4409-8d06-70d7510e2999" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_3304eac3-95ea-4dac-976e-d94a5be9e217" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_dcf8566f-d6ec-4409-8d06-70d7510e2999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_b8ca1998-ac92-481b-9dbb-6aed9b5468bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_3304eac3-95ea-4dac-976e-d94a5be9e217" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_b8ca1998-ac92-481b-9dbb-6aed9b5468bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofReconciliationofTaxChargeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofReconciliationofTaxChargeDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TaxationSummaryofReconciliationofTaxChargeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_50a3a281-d52e-4593-8769-2368b8f62dba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_50a3a281-d52e-4593-8769-2368b8f62dba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_f2768cbe-2d98-4099-8687-526d4207e7c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_f2768cbe-2d98-4099-8687-526d4207e7c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfChangeInTaxRate_20423213-41de-40a4-801d-0ed310415633" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfChangeInTaxRate"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_gsk_TaxEffectOfChangeInTaxRate_20423213-41de-40a4-801d-0ed310415633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_630d641b-769c-4941-96be-c307abde8f0b" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_630d641b-769c-4941-96be-c307abde8f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfResearchAndDevelopmentCredits_bca8602e-1f7e-4da3-8836-9a7305c7066f" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfResearchAndDevelopmentCredits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_gsk_TaxEffectOfResearchAndDevelopmentCredits_bca8602e-1f7e-4da3-8836-9a7305c7066f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_25e6c788-1b74-425e-8fbc-13ed17028701" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_25e6c788-1b74-425e-8fbc-13ed17028701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_de2e230c-c78e-46e4-87d4-ebb5ea753d4e" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_de2e230c-c78e-46e4-87d4-ebb5ea753d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_31e33bf3-3cc2-42a1-84e9-49503c642ff3" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfReassessmentsOfPriorYearEstimates"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_31e33bf3-3cc2-42a1-84e9-49503c642ff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_3655173b-6f98-42e4-ac9c-175b1295df73" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_093202be-1c3d-4627-a4c5-b85c1db158ca" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_3655173b-6f98-42e4-ac9c-175b1295df73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofTaxonItemsChargedtoEquityandStatementofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofTaxonItemsChargedtoEquityandStatementofComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TaxationSummaryofTaxonItemsChargedtoEquityandStatementofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_eaa46d43-c3a2-476e-b43f-a93d0781a50d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_8f66b0a8-4744-410a-b756-556d76cb3237" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_eaa46d43-c3a2-476e-b43f-a93d0781a50d" xlink:to="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_8f66b0a8-4744-410a-b756-556d76cb3237" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_f2a7d27f-a9c9-44bf-af90-5e6a22243c37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_eaa46d43-c3a2-476e-b43f-a93d0781a50d" xlink:to="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_f2a7d27f-a9c9-44bf-af90-5e6a22243c37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_89e89d4c-109c-40a3-bc44-6078967219ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_2c0bc250-e17a-4214-9b95-793d737873b9" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_89e89d4c-109c-40a3-bc44-6078967219ac" xlink:to="loc_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_2c0bc250-e17a-4214-9b95-793d737873b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome_24126063-f8d2-4559-b700-1c48b1d8d5af" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_89e89d4c-109c-40a3-bc44-6078967219ac" xlink:to="loc_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome_24126063-f8d2-4559-b700-1c48b1d8d5af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_3675cfbe-1bce-4bdf-82e5-4b7455e09a20" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_89e89d4c-109c-40a3-bc44-6078967219ac" xlink:to="loc_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_3675cfbe-1bce-4bdf-82e5-4b7455e09a20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_46863501-233a-4f57-8776-aad525b595f8" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_89e89d4c-109c-40a3-bc44-6078967219ac" xlink:to="loc_gsk_DeferredTaxRelatingToFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_46863501-233a-4f57-8776-aad525b595f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_86c2502b-592d-4691-9768-3a3c65d3521b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_52614c98-c466-4f5f-ba42-c81c90347884" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_86c2502b-592d-4691-9768-3a3c65d3521b" xlink:to="loc_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_52614c98-c466-4f5f-ba42-c81c90347884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_0ee1328c-0c2b-4ac6-be95-d592411b1a3c" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_86c2502b-592d-4691-9768-3a3c65d3521b" xlink:to="loc_gsk_CurrentTaxOnDefinedBenefitPlansChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_0ee1328c-0c2b-4ac6-be95-d592411b1a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_984a8654-5958-41b9-bb7e-72aafda48c75" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_86c2502b-592d-4691-9768-3a3c65d3521b" xlink:to="loc_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_984a8654-5958-41b9-bb7e-72aafda48c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_6c40cbeb-3552-4406-92f4-bfbfa36d39fc" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_86c2502b-592d-4691-9768-3a3c65d3521b" xlink:to="loc_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_6c40cbeb-3552-4406-92f4-bfbfa36d39fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofNetDeferredTaxAssetDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofNetDeferredTaxAssetDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TaxationSummaryofNetDeferredTaxAssetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_94f91878-3b5f-48bb-ae63-5c905f06d223" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_32e14634-f15b-4363-981f-1cb6e90a93cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_94f91878-3b5f-48bb-ae63-5c905f06d223" xlink:to="loc_ifrs-full_DeferredTaxAssets_32e14634-f15b-4363-981f-1cb6e90a93cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_8e65d961-8078-48ea-b6f7-f835769db2c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_94f91878-3b5f-48bb-ae63-5c905f06d223" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_8e65d961-8078-48ea-b6f7-f835769db2c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EarningspershareScheduleofNumbersofSharesEarningsPerShareDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EarningspershareScheduleofNumbersofSharesEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/EarningspershareScheduleofNumbersofSharesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_e31be1b6-cc4f-4ecc-8959-a7be2c17f032" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_92f22729-c173-411b-8c66-8257eb0b7536" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_e31be1b6-cc4f-4ecc-8959-a7be2c17f032" xlink:to="loc_ifrs-full_WeightedAverageShares_92f22729-c173-411b-8c66-8257eb0b7536" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_69e8e941-8dca-445c-bf24-2a5cc4810f4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_e31be1b6-cc4f-4ecc-8959-a7be2c17f032" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_69e8e941-8dca-445c-bf24-2a5cc4810f4b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/DividendsSummaryofDividendstoShareholdersDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#DividendsSummaryofDividendstoShareholdersDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/DividendsSummaryofDividendstoShareholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsRecognisedInYear_259e9067-9302-4d5c-9de9-3174b2884427" xlink:href="gsk-20241231.xsd#gsk_DividendsRecognisedInYear"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear_ad12752e-1616-4afb-8694-8e8b5e152b70" xlink:href="gsk-20241231.xsd#gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_DividendsRecognisedInYear_259e9067-9302-4d5c-9de9-3174b2884427" xlink:to="loc_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear_ad12752e-1616-4afb-8694-8e8b5e152b70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashDividendsPaidToShareholdersRecognizedInYear_9e8e2999-1483-44cd-9660-4ca280a95247" xlink:href="gsk-20241231.xsd#gsk_CashDividendsPaidToShareholdersRecognizedInYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_DividendsRecognisedInYear_259e9067-9302-4d5c-9de9-3174b2884427" xlink:to="loc_gsk_CashDividendsPaidToShareholdersRecognizedInYear_9e8e2999-1483-44cd-9660-4ca280a95247" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherNonCurrentAssetsSummaryofOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherNonCurrentAssetsSummaryofOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/OtherNonCurrentAssetsSummaryofOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_792f2044-5723-488f-a5d2-fd8d447e74f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReceivablesRelatedToInsuranceContracts_b3afddae-e8ea-4909-9776-4510bf9b3a1d" xlink:href="gsk-20241231.xsd#gsk_ReceivablesRelatedToInsuranceContracts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_792f2044-5723-488f-a5d2-fd8d447e74f1" xlink:to="loc_gsk_ReceivablesRelatedToInsuranceContracts_b3afddae-e8ea-4909-9776-4510bf9b3a1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan_6e27d786-5f2d-411c-89b8-11f157cacf7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_792f2044-5723-488f-a5d2-fd8d447e74f1" xlink:to="loc_ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan_6e27d786-5f2d-411c-89b8-11f157cacf7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_c2b53223-77e3-4b12-bd93-b5ad4ff379b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_792f2044-5723-488f-a5d2-fd8d447e74f1" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_c2b53223-77e3-4b12-bd93-b5ad4ff379b8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/InventoriesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_ac700f7d-d740-4ac0-afa3-2c7d87bbb4af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress_6555b292-79df-4432-9389-02ff7c6574e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WorkInProgress"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_ac700f7d-d740-4ac0-afa3-2c7d87bbb4af" xlink:to="loc_ifrs-full_WorkInProgress_6555b292-79df-4432-9389-02ff7c6574e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods_f3a04e2c-72a3-4d34-8457-0f2303ef4e65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinishedGoods"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_ac700f7d-d740-4ac0-afa3-2c7d87bbb4af" xlink:to="loc_ifrs-full_FinishedGoods_f3a04e2c-72a3-4d34-8457-0f2303ef4e65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_0d60a6a4-40be-44ef-a506-271e0318137f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_ac700f7d-d740-4ac0-afa3-2c7d87bbb4af" xlink:to="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_0d60a6a4-40be-44ef-a506-271e0318137f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TradeandotherreceivablesSummaryofTradeandOtherReceivablesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TradeandotherreceivablesSummaryofTradeandOtherReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TradeandotherreceivablesSummaryofTradeandOtherReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivables_54897483-db05-46a6-a132-8dc4ce051f26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:to="loc_ifrs-full_TradeReceivables_54897483-db05-46a6-a132-8dc4ce051f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccruedIncomeOtherThanContractAssets_3cfc458b-cb7d-4a7b-acfe-20c61bbe2c97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:to="loc_ifrs-full_AccruedIncomeOtherThanContractAssets_3cfc458b-cb7d-4a7b-acfe-20c61bbe2c97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Prepayments_211c03ea-dd3d-42b2-bffd-d3c574282256" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:to="loc_ifrs-full_Prepayments_211c03ea-dd3d-42b2-bffd-d3c574282256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivable_38eaed46-cbeb-4eec-974e-31a4ddb45440" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:to="loc_ifrs-full_InterestReceivable_38eaed46-cbeb-4eec-974e-31a4ddb45440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeLoansAndAdvances_7124158a-f3f3-454f-9c73-da4aee2fb6be" xlink:href="gsk-20241231.xsd#gsk_EmployeeLoansAndAdvances"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:to="loc_gsk_EmployeeLoansAndAdvances_7124158a-f3f3-454f-9c73-da4aee2fb6be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReceivables_036ba503-1b86-4cfc-8b3b-6439c6cf79bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_a2a6ade4-2180-443a-9e02-f08d39bca2d9" xlink:to="loc_ifrs-full_OtherReceivables_036ba503-1b86-4cfc-8b3b-6439c6cf79bb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/CashandcashequivalentsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#CashandcashequivalentsSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/CashandcashequivalentsSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_e53c59ae-dd8a-4f19-aefe-6b1f8eaf1ebd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_dd03d038-da8f-4388-86bf-b818b02e3ce2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_e53c59ae-dd8a-4f19-aefe-6b1f8eaf1ebd" xlink:to="loc_ifrs-full_CashEquivalents_dd03d038-da8f-4388-86bf-b818b02e3ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_300dd84c-d014-4d86-bb8a-6db03bf94c91" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_e53c59ae-dd8a-4f19-aefe-6b1f8eaf1ebd" xlink:to="loc_ifrs-full_Cash_300dd84c-d014-4d86-bb8a-6db03bf94c91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AssetsheldforSaleDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AssetsheldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/AssetsheldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_203e728e-f7d3-4cc7-8677-49af6c02f997" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_31b6d016-2faf-4217-9756-2855799b5879" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_203e728e-f7d3-4cc7-8677-49af6c02f997" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_31b6d016-2faf-4217-9756-2855799b5879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAssetsNet_cbad1fa4-1979-496b-8305-b3c10c6fd506" xlink:href="gsk-20241231.xsd#gsk_OtherAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_203e728e-f7d3-4cc7-8677-49af6c02f997" xlink:to="loc_gsk_OtherAssetsNet_cbad1fa4-1979-496b-8305-b3c10c6fd506" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TradeandotherpayablesSummaryofTradeandOtherPayablesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TradeandotherpayablesSummaryofTradeandOtherPayablesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/TradeandotherpayablesSummaryofTradeandOtherPayablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_9fccc596-104b-4cca-9406-db0c30b873da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_9fccc596-104b-4cca-9406-db0c30b873da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WagesAndSalariesPayable_984a5aa1-41b5-4531-844c-e2d47af7b586" xlink:href="gsk-20241231.xsd#gsk_WagesAndSalariesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_gsk_WagesAndSalariesPayable_984a5aa1-41b5-4531-844c-e2d47af7b586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_11a2648a-552d-4331-af46-c0ddad856780" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_11a2648a-552d-4331-af46-c0ddad856780" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PutOptionPayable_b67e0861-da4d-4740-9cd6-12ae869bf010" xlink:href="gsk-20241231.xsd#gsk_PutOptionPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_gsk_PutOptionPayable_b67e0861-da4d-4740-9cd6-12ae869bf010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentPayables_1c770bb9-f50e-45ed-806b-c79050f31302" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_ifrs-full_OtherCurrentPayables_1c770bb9-f50e-45ed-806b-c79050f31302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_b04c869b-23d6-4e9b-bc53-14dd5775c770" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_ifrs-full_ContractLiabilities_b04c869b-23d6-4e9b-bc53-14dd5775c770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnAndRebateAccruals_c09c2faf-a2ae-4f37-bd0f-72fb554c9b22" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnAndRebateAccruals"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_gsk_CustomerReturnAndRebateAccruals_c09c2faf-a2ae-4f37-bd0f-72fb554c9b22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAccruals_872c1535-b39b-40a2-9e5a-5010a59f5bbe" xlink:href="gsk-20241231.xsd#gsk_OtherAccruals"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_67bf4eed-497a-44c0-aed4-99015926410e" xlink:to="loc_gsk_OtherAccruals_872c1535-b39b-40a2-9e5a-5010a59f5bbe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_8630118f-f7a3-43e3-bc09-a6cc7962f8b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_71f4ffe6-2d15-40cd-91e4-c994b7ec61a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_8630118f-f7a3-43e3-bc09-a6cc7962f8b3" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_71f4ffe6-2d15-40cd-91e4-c994b7ec61a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_d478b779-ca14-4a3c-8350-53bfe514b023" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_8630118f-f7a3-43e3-bc09-a6cc7962f8b3" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_d478b779-ca14-4a3c-8350-53bfe514b023" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_b5c06491-9162-47cb-a31c-f08736320a71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_7f03beaf-eea4-4922-a1b1-144105ce45eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_b5c06491-9162-47cb-a31c-f08736320a71" xlink:to="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_7f03beaf-eea4-4922-a1b1-144105ce45eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_d25d6dc8-8b09-48ae-b6f2-462a2b82fec3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_b5c06491-9162-47cb-a31c-f08736320a71" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_d25d6dc8-8b09-48ae-b6f2-462a2b82fec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_4f865461-204e-4d38-b704-b6169c7509c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_b5c06491-9162-47cb-a31c-f08736320a71" xlink:to="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_4f865461-204e-4d38-b704-b6169c7509c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_be2c5fa9-e20d-4bad-956b-540af9bb7c45" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_b5c06491-9162-47cb-a31c-f08736320a71" xlink:to="loc_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_be2c5fa9-e20d-4bad-956b-540af9bb7c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_a66fe3fc-2cd7-4f01-bd21-5076dbbe580f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_b5c06491-9162-47cb-a31c-f08736320a71" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_a66fe3fc-2cd7-4f01-bd21-5076dbbe580f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan_4f4f9ffb-9254-4f41-9896-c8722ea7f147" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_4cdb83a6-f011-4f67-ab8b-135569012672" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SurplusDeficitInPlan_4f4f9ffb-9254-4f41-9896-c8722ea7f147" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_4cdb83a6-f011-4f67-ab8b-135569012672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_b4765cbd-6370-410d-a7f9-a180568e45df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SurplusDeficitInPlan_4f4f9ffb-9254-4f41-9896-c8722ea7f147" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_b4765cbd-6370-410d-a7f9-a180568e45df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_8131eaee-3287-42ac-ad93-44bf20a7b03b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_6697fcc4-2591-4220-985e-4e5d4684200d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_8131eaee-3287-42ac-ad93-44bf20a7b03b" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_6697fcc4-2591-4220-985e-4e5d4684200d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_44620992-d120-4698-9efd-fed914b91c4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_8131eaee-3287-42ac-ad93-44bf20a7b03b" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_44620992-d120-4698-9efd-fed914b91c4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_547eeb63-dfb3-45a4-ac41-4ed2791111ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_8131eaee-3287-42ac-ad93-44bf20a7b03b" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_547eeb63-dfb3-45a4-ac41-4ed2791111ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherprovisionsSummaryofOtherProvisionsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherprovisionsSummaryofOtherProvisionsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/OtherprovisionsSummaryofOtherProvisionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_3c377efc-287b-4ce7-bbc3-2d1b50ae79bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions_b56c0ecc-267c-4de4-bb65-08b87f20c914" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherProvisions_3c377efc-287b-4ce7-bbc3-2d1b50ae79bc" xlink:to="loc_ifrs-full_OtherShorttermProvisions_b56c0ecc-267c-4de4-bb65-08b87f20c914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_cd5a81d9-9fb8-4547-9659-40e59a304f11" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherProvisions_3c377efc-287b-4ce7-bbc3-2d1b50ae79bc" xlink:to="loc_ifrs-full_OtherLongtermProvisions_cd5a81d9-9fb8-4547-9659-40e59a304f11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherNoncurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherNoncurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/OtherNoncurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_db9ddd25-d04a-4af0-a0d2-0ca1694ad11d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Accruals_b5ba5e9e-266f-4b91-befb-3ee03b68da15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Accruals"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_db9ddd25-d04a-4af0-a0d2-0ca1694ad11d" xlink:to="loc_ifrs-full_Accruals_b5ba5e9e-266f-4b91-befb-3ee03b68da15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities_04021f15-9c2a-4e22-86ea-f2d5b2ae223c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_db9ddd25-d04a-4af0-a0d2-0ca1694ad11d" xlink:to="loc_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities_04021f15-9c2a-4e22-86ea-f2d5b2ae223c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentPayables_76bd2499-0e8e-459c-984a-654cb8ff47ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentPayables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_db9ddd25-d04a-4af0-a0d2-0ca1694ad11d" xlink:to="loc_ifrs-full_OtherNoncurrentPayables_76bd2499-0e8e-459c-984a-654cb8ff47ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/CommitmentsScheduleofContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#CommitmentsScheduleofContractualObligationsandCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/CommitmentsScheduleofContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContractualObligationsAndCommitments_e3e7d67d-2c01-457e-81bf-8c5f03af46de" xlink:href="gsk-20241231.xsd#gsk_ContractualObligationsAndCommitments"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets_a85a84ae-6f6a-4989-8605-b603abefed06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_ContractualObligationsAndCommitments_e3e7d67d-2c01-457e-81bf-8c5f03af46de" xlink:to="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets_a85a84ae-6f6a-4989-8605-b603abefed06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_7a02c4cf-8435-4b66-a9b9-0cc93b348347" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_ContractualObligationsAndCommitments_e3e7d67d-2c01-457e-81bf-8c5f03af46de" xlink:to="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_7a02c4cf-8435-4b66-a9b9-0cc93b348347" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContractualObligationsAndCommitmentsOfInvestments_c47f3bec-b3c0-4bd5-ba08-13a8bb6a7596" xlink:href="gsk-20241231.xsd#gsk_ContractualObligationsAndCommitmentsOfInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_ContractualObligationsAndCommitments_e3e7d67d-2c01-457e-81bf-8c5f03af46de" xlink:to="loc_gsk_ContractualObligationsAndCommitmentsOfInvestments_c47f3bec-b3c0-4bd5-ba08-13a8bb6a7596" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_d075e319-df61-4a6c-a609-6addedac1d38" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_d075e319-df61-4a6c-a609-6addedac1d38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_2d9a5e13-0873-4615-b0fa-256c83d28fda" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_2d9a5e13-0873-4615-b0fa-256c83d28fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_f28e5b94-5e17-48c9-952a-b7bf712b08c5" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_f28e5b94-5e17-48c9-952a-b7bf712b08c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_257baad6-fe5b-4c17-aeb6-dc5b05ae1e71" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_257baad6-fe5b-4c17-aeb6-dc5b05ae1e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_1fdcde81-0959-48ff-bcce-300799d3693b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_1fdcde81-0959-48ff-bcce-300799d3693b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_5c5586b7-d6c6-4812-92ca-808e7c521a34" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_5c5586b7-d6c6-4812-92ca-808e7c521a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_5d9ff894-4a23-4866-837c-1fdd37d5f19e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_5d9ff894-4a23-4866-837c-1fdd37d5f19e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_718f1f09-e281-408c-ae43-33d31ca26659" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_718f1f09-e281-408c-ae43-33d31ca26659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_54d19798-9ba0-47af-9a34-e364c697259f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_54d19798-9ba0-47af-9a34-e364c697259f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_5d708e3b-c8b6-4039-b7e6-d6873da0af87" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_5d708e3b-c8b6-4039-b7e6-d6873da0af87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_d4c4703a-88bb-4aff-919d-029e1437a830" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_66a7f245-a58c-4dad-9bc8-7b3d7d36366a" xlink:to="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_d4c4703a-88bb-4aff-919d-029e1437a830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_6cbfb9c4-d272-46a7-b637-228cbd3c0cde" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_e2f0d737-eeb0-4376-8a07-7614a60df0fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_6cbfb9c4-d272-46a7-b637-228cbd3c0cde" xlink:to="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_e2f0d737-eeb0-4376-8a07-7614a60df0fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations_d8790f36-d839-4a74-9659-0ed23f2eaacd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_6cbfb9c4-d272-46a7-b637-228cbd3c0cde" xlink:to="loc_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations_d8790f36-d839-4a74-9659-0ed23f2eaacd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate_8602aa22-27a3-42a9-8afd-c7e33a43acbe" xlink:href="gsk-20241231.xsd#gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate_8602aa22-27a3-42a9-8afd-c7e33a43acbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_961b04ec-a0c9-41e9-90de-ed487319f6f5" xlink:href="gsk-20241231.xsd#gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_961b04ec-a0c9-41e9-90de-ed487319f6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_c1562820-6486-4fa9-98be-5754988389d6" xlink:href="gsk-20241231.xsd#gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_c1562820-6486-4fa9-98be-5754988389d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_7b300e84-77ad-4fde-8744-3687c324e13f" xlink:href="gsk-20241231.xsd#gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_7b300e84-77ad-4fde-8744-3687c324e13f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_45e734db-f1ef-4dd2-aa0a-73579654a08f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_45e734db-f1ef-4dd2-aa0a-73579654a08f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_e1ed1ae6-a781-4b3b-927e-3c48727f55c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_e1ed1ae6-a781-4b3b-927e-3c48727f55c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_ad9e2a6f-7d36-49d7-a6ab-b19a44397f4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_ad9e2a6f-7d36-49d7-a6ab-b19a44397f4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxationRecognizedAsOfAcquisitionDate_386307cd-457f-4195-a48a-eaf7e3310c28" xlink:href="gsk-20241231.xsd#gsk_TaxationRecognizedAsOfAcquisitionDate"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_gsk_TaxationRecognizedAsOfAcquisitionDate_386307cd-457f-4195-a48a-eaf7e3310c28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_ae799179-7821-4f80-937c-5330fef62f75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_ae799179-7821-4f80-937c-5330fef62f75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_12aaf5b6-8dc2-4ebf-bf69-fccd2321e7be" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_12aaf5b6-8dc2-4ebf-bf69-fccd2321e7be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_98796e3d-0bd3-4131-a778-ad029d42e39b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_98796e3d-0bd3-4131-a778-ad029d42e39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_1d41f8fc-fda5-468f-ae2c-d9e79627956a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0aec7c1c-bf0f-4b37-82ce-eaea9c7e48ba" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_1d41f8fc-fda5-468f-ae2c-d9e79627956a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_65ff739e-33a3-4682-a5ef-0f539dfe612c" xlink:href="gsk-20241231.xsd#gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_60064d64-c5fc-48f5-baaa-218aa9d01b2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_65ff739e-33a3-4682-a5ef-0f539dfe612c" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_60064d64-c5fc-48f5-baaa-218aa9d01b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_00b5f3c4-13a1-4075-aed3-ef2608f6b491" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_65ff739e-33a3-4682-a5ef-0f539dfe612c" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_00b5f3c4-13a1-4075-aed3-ef2608f6b491" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofCashFlowsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_eee6c8a3-b142-4577-a716-54e316170bc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_58a8faae-89e7-45fb-a701-f2209716491d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_eee6c8a3-b142-4577-a716-54e316170bc7" xlink:to="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_58a8faae-89e7-45fb-a701-f2209716491d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredConsiderationReceivedPaid_05afcbbc-1c4c-4a36-a501-090714b9d7d1" xlink:href="gsk-20241231.xsd#gsk_DeferredConsiderationReceivedPaid"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_eee6c8a3-b142-4577-a716-54e316170bc7" xlink:to="loc_gsk_DeferredConsiderationReceivedPaid_05afcbbc-1c4c-4a36-a501-090714b9d7d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransactionCostsOnDisposal_6a90c7fb-5e4f-4bec-939a-c90bd77bb108" xlink:href="gsk-20241231.xsd#gsk_TransactionCostsOnDisposal"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_eee6c8a3-b142-4577-a716-54e316170bc7" xlink:to="loc_gsk_TransactionCostsOnDisposal_6a90c7fb-5e4f-4bec-939a-c90bd77bb108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_12b9a72b-0f9e-4be6-8ae2-6c973bcf56d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_eee6c8a3-b142-4577-a716-54e316170bc7" xlink:to="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_12b9a72b-0f9e-4be6-8ae2-6c973bcf56d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashOutflowInflowExcludingTransactionCosts_412667ff-482a-4381-9e1e-1f59a37a1d52" xlink:href="gsk-20241231.xsd#gsk_CashOutflowInflowExcludingTransactionCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_21ed2360-e47f-4088-a8f3-5d0ea6201190" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CashOutflowInflowExcludingTransactionCosts_412667ff-482a-4381-9e1e-1f59a37a1d52" xlink:to="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_21ed2360-e47f-4088-a8f3-5d0ea6201190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_99439517-131e-4228-b9f8-c6ee0a17b3e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CashOutflowInflowExcludingTransactionCosts_412667ff-482a-4381-9e1e-1f59a37a1d52" xlink:to="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_99439517-131e-4228-b9f8-c6ee0a17b3e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredConsiderationReceivedPaid_bc5d3f19-a9ae-436c-b272-99f8b17f9a5c" xlink:href="gsk-20241231.xsd#gsk_DeferredConsiderationReceivedPaid"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_CashOutflowInflowExcludingTransactionCosts_412667ff-482a-4381-9e1e-1f59a37a1d52" xlink:to="loc_gsk_DeferredConsiderationReceivedPaid_bc5d3f19-a9ae-436c-b272-99f8b17f9a5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalfairValueOfDistributedandRetainBusiness_47495f43-b4bd-4e66-a1af-c04b183efd50" xlink:href="gsk-20241231.xsd#gsk_TotalfairValueOfDistributedandRetainBusiness"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_67471e28-4330-41a0-8306-5a623cf0951d" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheConsumerHealthcareBusinessDistributed"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalfairValueOfDistributedandRetainBusiness_47495f43-b4bd-4e66-a1af-c04b183efd50" xlink:to="loc_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_67471e28-4330-41a0-8306-5a623cf0951d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_4df274fc-d7a9-4d43-8908-cbdca2b7de34" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheRetainedOwnershipInHaleonPlc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_TotalfairValueOfDistributedandRetainBusiness_47495f43-b4bd-4e66-a1af-c04b183efd50" xlink:to="loc_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_4df274fc-d7a9-4d43-8908-cbdca2b7de34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerOfDiscontinuedOperation_09660ef4-24ae-46e1-b8f3-cf716fd86b64" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerOfDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_8f44da9e-8ac7-4060-9e5e-44a55d883d72" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_GainOnDemergerOfDiscontinuedOperation_09660ef4-24ae-46e1-b8f3-cf716fd86b64" xlink:to="loc_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_8f44da9e-8ac7-4060-9e5e-44a55d883d72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_c8f0290a-164d-4973-a636-64e445dad815" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_GainOnDemergerOfDiscontinuedOperation_09660ef4-24ae-46e1-b8f3-cf716fd86b64" xlink:to="loc_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_c8f0290a-164d-4973-a636-64e445dad815" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_eaf6cf26-6e61-4c2d-9f6a-9a795ab23977" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_483bb1a3-f643-4748-b82c-be6ade8f5102" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_eaf6cf26-6e61-4c2d-9f6a-9a795ab23977" xlink:to="loc_ifrs-full_Revenue_483bb1a3-f643-4748-b82c-be6ade8f5102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_7f5c2dfd-1550-41a5-9db7-7e44e3891af1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_eaf6cf26-6e61-4c2d-9f6a-9a795ab23977" xlink:to="loc_ifrs-full_OperatingExpense_7f5c2dfd-1550-41a5-9db7-7e44e3891af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_bac6681d-56f2-47e4-9378-26158d2b8040" xlink:href="gsk-20241231.xsd#gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_89aea404-8d25-494d-a134-cdf7ac133c88" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_bac6681d-56f2-47e4-9378-26158d2b8040" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_89aea404-8d25-494d-a134-cdf7ac133c88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherGainsLossesOnDemerger_dbf09fa5-2333-4220-b418-74ee1f1f7c5a" xlink:href="gsk-20241231.xsd#gsk_OtherGainsLossesOnDemerger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_bac6681d-56f2-47e4-9378-26158d2b8040" xlink:to="loc_gsk_OtherGainsLossesOnDemerger_dbf09fa5-2333-4220-b418-74ee1f1f7c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_11658b08-368e-43b7-8a16-ac4418c855fd" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_bac6681d-56f2-47e4-9378-26158d2b8040" xlink:to="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_11658b08-368e-43b7-8a16-ac4418c855fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RatedCreditExposures1_5551470b-9243-46f0-bc94-38cc68cd2522" xlink:href="gsk-20241231.xsd#gsk_RatedCreditExposures1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidityFunds_12ee3967-c536-48b7-9a8b-f77a12b2f8fa" xlink:href="gsk-20241231.xsd#gsk_LiquidityFunds"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RatedCreditExposures1_5551470b-9243-46f0-bc94-38cc68cd2522" xlink:to="loc_gsk_LiquidityFunds_12ee3967-c536-48b7-9a8b-f77a12b2f8fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_3df3a52f-4a13-4e56-9678-3685c7636352" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RatedCreditExposures1_5551470b-9243-46f0-bc94-38cc68cd2522" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_3df3a52f-4a13-4e56-9678-3685c7636352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankBalancesAndDepositHeldWithCounterparties_f6e2d305-e29b-4ae5-986d-34a67318a698" xlink:href="gsk-20241231.xsd#gsk_BankBalancesAndDepositHeldWithCounterparties"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RatedCreditExposures1_5551470b-9243-46f0-bc94-38cc68cd2522" xlink:to="loc_gsk_BankBalancesAndDepositHeldWithCounterparties_f6e2d305-e29b-4ae5-986d-34a67318a698" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_902b3180-665a-47fe-a0c6-10c86881604f" xlink:href="gsk-20241231.xsd#gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RatedCreditExposures1_5551470b-9243-46f0-bc94-38cc68cd2522" xlink:to="loc_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_902b3180-665a-47fe-a0c6-10c86881604f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GovernmentSecurities_834593e1-db58-43e5-bead-291c2e1325c8" xlink:href="gsk-20241231.xsd#gsk_GovernmentSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_RatedCreditExposures1_5551470b-9243-46f0-bc94-38cc68cd2522" xlink:to="loc_gsk_GovernmentSecurities_834593e1-db58-43e5-bead-291c2e1325c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFinancialAssetsLiabilities_4162c4e0-0313-42c4-bcc9-e46894da4cfd" xlink:href="gsk-20241231.xsd#gsk_NetFinancialAssetsLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_ac4df3f7-fa7c-40ef-b6bc-c458256a85c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_NetFinancialAssetsLiabilities_4162c4e0-0313-42c4-bcc9-e46894da4cfd" xlink:to="loc_ifrs-full_FinancialAssets_ac4df3f7-fa7c-40ef-b6bc-c458256a85c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_6b48dbbc-d0a2-4de0-8fd0-d3d0a91c2ee5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gsk_NetFinancialAssetsLiabilities_4162c4e0-0313-42c4-bcc9-e46894da4cfd" xlink:to="loc_ifrs-full_FinancialLiabilities_6b48dbbc-d0a2-4de0-8fd0-d3d0a91c2ee5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_c8cbb110-ba32-4fb7-8d42-228d77586ef3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_7769fa6a-e4ce-439d-8a16-c20ffd8627b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_c8cbb110-ba32-4fb7-8d42-228d77586ef3" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_7769fa6a-e4ce-439d-8a16-c20ffd8627b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_754c3fc8-7ff8-4eb5-99d8-c124a8c05603" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_c8cbb110-ba32-4fb7-8d42-228d77586ef3" xlink:to="loc_ifrs-full_OtherProvisions_754c3fc8-7ff8-4eb5-99d8-c124a8c05603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayables_a31d17b7-05fd-465c-bd73-b7b0df34a13b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_c8cbb110-ba32-4fb7-8d42-228d77586ef3" xlink:to="loc_ifrs-full_TradeAndOtherPayables_a31d17b7-05fd-465c-bd73-b7b0df34a13b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_c062e24d-a8ce-4ab6-9312-55ff680df720" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialLiabilities_c8cbb110-ba32-4fb7-8d42-228d77586ef3" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_c062e24d-a8ce-4ab6-9312-55ff680df720" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_9d80ee01-54f1-4485-afbb-3120754cf1f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_e50c3db8-d35c-4f35-b035-3c6b7fb02967" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_9d80ee01-54f1-4485-afbb-3120754cf1f5" xlink:to="loc_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_e50c3db8-d35c-4f35-b035-3c6b7fb02967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_362bc3d5-09f1-41af-be20-345bfb50eb4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_9d80ee01-54f1-4485-afbb-3120754cf1f5" xlink:to="loc_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_362bc3d5-09f1-41af-be20-345bfb50eb4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_8bb9703d-7224-4f90-9c3b-a726201dd796" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities_7506102a-dd39-4eb0-a998-15394c494421" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_8bb9703d-7224-4f90-9c3b-a726201dd796" xlink:to="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities_7506102a-dd39-4eb0-a998-15394c494421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_88a31d03-80b0-4d53-bac8-50f62ef99efa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_8bb9703d-7224-4f90-9c3b-a726201dd796" xlink:to="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_88a31d03-80b0-4d53-bac8-50f62ef99efa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_f3b87e88-277a-497a-ba35-63ba6e96166e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets_41162dcc-5e99-42fb-a48c-7c5a36e63d85" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_f3b87e88-277a-497a-ba35-63ba6e96166e" xlink:to="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets_41162dcc-5e99-42fb-a48c-7c5a36e63d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_22f7daee-2e51-4bf0-b57a-ebc447cd8cd6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_f3b87e88-277a-497a-ba35-63ba6e96166e" xlink:to="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_22f7daee-2e51-4bf0-b57a-ebc447cd8cd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_cd5aa82c-e452-4a39-91ca-55eb4aa3918b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_c7e33542-31e3-4f11-b7d9-0350102c68b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_cd5aa82c-e452-4a39-91ca-55eb4aa3918b" xlink:to="loc_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_c7e33542-31e3-4f11-b7d9-0350102c68b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_9950464f-99c1-4720-ba24-972c9b90df23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_cd5aa82c-e452-4a39-91ca-55eb4aa3918b" xlink:to="loc_ifrs-full_GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_9950464f-99c1-4720-ba24-972c9b90df23" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>gsk-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3a546e24-b21d-4f2c-8496-4bed728e8d38,g:19b91481-759e-443e-bc09-8752e6669383-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.gsk.com/role/CoverPage" xlink:type="simple" xlink:href="gsk-20241231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_8a717f30-25b7-4ef2-82fc-05f457a41cc7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentInformationTable_8a717f30-25b7-4ef2-82fc-05f457a41cc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_35021176-35ac-4ddf-9a1c-f433729f71f1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_8a717f30-25b7-4ef2-82fc-05f457a41cc7" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_35021176-35ac-4ddf-9a1c-f433729f71f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_35021176-35ac-4ddf-9a1c-f433729f71f1_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_35021176-35ac-4ddf-9a1c-f433729f71f1" xlink:to="loc_dei_AddressTypeDomain_35021176-35ac-4ddf-9a1c-f433729f71f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_264975ea-70ed-4b6c-87cb-b5ad3858848e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_35021176-35ac-4ddf-9a1c-f433729f71f1" xlink:to="loc_dei_AddressTypeDomain_264975ea-70ed-4b6c-87cb-b5ad3858848e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_6ac9bcba-3d27-47e2-9b73-cda34c857eb0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_264975ea-70ed-4b6c-87cb-b5ad3858848e" xlink:to="loc_dei_BusinessContactMember_6ac9bcba-3d27-47e2-9b73-cda34c857eb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfEachClassAxis_261b788c-0f31-4f52-bb9b-f78a937c5a52" xlink:href="gsk-20241231.xsd#gsk_TitleOfEachClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_8a717f30-25b7-4ef2-82fc-05f457a41cc7" xlink:to="loc_gsk_TitleOfEachClassAxis_261b788c-0f31-4f52-bb9b-f78a937c5a52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfEachClassDomain_261b788c-0f31-4f52-bb9b-f78a937c5a52_default" xlink:href="gsk-20241231.xsd#gsk_TitleOfEachClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_TitleOfEachClassAxis_261b788c-0f31-4f52-bb9b-f78a937c5a52" xlink:to="loc_gsk_TitleOfEachClassDomain_261b788c-0f31-4f52-bb9b-f78a937c5a52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:href="gsk-20241231.xsd#gsk_TitleOfEachClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_TitleOfEachClassAxis_261b788c-0f31-4f52-bb9b-f78a937c5a52" xlink:to="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmericanDepositarySharesMember_5034fb22-6b73-4773-b279-80c00a5c8bdf" xlink:href="gsk-20241231.xsd#gsk_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:to="loc_gsk_AmericanDepositarySharesMember_5034fb22-6b73-4773-b279-80c00a5c8bdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointSixTwoFiveNotesDue2025Member_dd873a22-b9ee-4b63-a4d2-3c9d904e0a46" xlink:href="gsk-20241231.xsd#gsk_ThreePointSixTwoFiveNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:to="loc_gsk_ThreePointSixTwoFiveNotesDue2025Member_dd873a22-b9ee-4b63-a4d2-3c9d904e0a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointEightSevenFiveNotesDue2028Member_e9d38cb6-e288-4634-9ea3-545b3f818845" xlink:href="gsk-20241231.xsd#gsk_ThreePointEightSevenFiveNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:to="loc_gsk_ThreePointEightSevenFiveNotesDue2028Member_e9d38cb6-e288-4634-9ea3-545b3f818845" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointThreeSevenFiveNotesDue2029Member_6019b601-0118-4741-af35-23492f77491c" xlink:href="gsk-20241231.xsd#gsk_ThreePointThreeSevenFiveNotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:to="loc_gsk_ThreePointThreeSevenFiveNotesDue2029Member_6019b601-0118-4741-af35-23492f77491c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFiveNotesDue2038Member_a359ecf8-7b31-4d84-954f-08645882046f" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFiveNotesDue2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:to="loc_gsk_SixPointThreeSevenFiveNotesDue2038Member_a359ecf8-7b31-4d84-954f-08645882046f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointTwoZeroZeroNotesDue2043Member_67a6cc68-3a05-48be-8f34-fd4eb0b806d6" xlink:href="gsk-20241231.xsd#gsk_FourPointTwoZeroZeroNotesDue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfEachClassDomain_18c9a8cf-4391-41f8-8fe6-f339e29e4255" xlink:to="loc_gsk_FourPointTwoZeroZeroNotesDue2043Member_67a6cc68-3a05-48be-8f34-fd4eb0b806d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_766b544a-9f5c-4eb1-88a8-570442d14673" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentType_766b544a-9f5c-4eb1-88a8-570442d14673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_a08f5690-40f0-4bcf-8785-f276f8ba5ad5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentRegistrationStatement_a08f5690-40f0-4bcf-8785-f276f8ba5ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_9edffe63-afd6-4913-99ac-399dd242568c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentAnnualReport_9edffe63-afd6-4913-99ac-399dd242568c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0cc8359c-84a9-4eeb-8f35-851934c24ce6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentPeriodEndDate_0cc8359c-84a9-4eeb-8f35-851934c24ce6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_635c732f-a68a-42c4-9e93-170f7927ab22" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_CurrentFiscalYearEndDate_635c732f-a68a-42c4-9e93-170f7927ab22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7dfc8c83-019d-42fa-8f4a-ade622c8e202" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentFiscalYearFocus_7dfc8c83-019d-42fa-8f4a-ade622c8e202" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_01f59162-862a-4e68-9f66-704f0b1a1496" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentTransitionReport_01f59162-862a-4e68-9f66-704f0b1a1496" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_28a24def-e12d-43a3-beeb-77cb69589c5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentShellCompanyReport_28a24def-e12d-43a3-beeb-77cb69589c5c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_03a8b2d2-fa1b-4dd1-bfd4-4d7b33387076" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityFileNumber_03a8b2d2-fa1b-4dd1-bfd4-4d7b33387076" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b55731fd-537e-4184-9636-a382875e61a9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityRegistrantName_b55731fd-537e-4184-9636-a382875e61a9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2055221d-035a-4efb-aada-c94f401ec325" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2055221d-035a-4efb-aada-c94f401ec325" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e180e615-0c3f-4130-b798-7073852a6108" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityAddressAddressLine1_e180e615-0c3f-4130-b798-7073852a6108" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9aea47b1-9dab-46b1-96a6-4de0f89d8b1b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityAddressCityOrTown_9aea47b1-9dab-46b1-96a6-4de0f89d8b1b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6a21f448-939c-4be9-ade1-0d231415b5b5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityAddressPostalZipCode_6a21f448-939c-4be9-ade1-0d231415b5b5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_05222c9d-c601-4390-beee-0ab109f677a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityAddressCountry_05222c9d-c601-4390-beee-0ab109f677a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_15633850-56ad-4bc1-af3b-f768ec7bf323" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_ContactPersonnelName_15633850-56ad-4bc1-af3b-f768ec7bf323" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d797933e-5036-46e4-a59d-423bf17e35fb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_CityAreaCode_d797933e-5036-46e4-a59d-423bf17e35fb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7a33cdd2-b91b-4dde-a72a-8cd3f3df24dd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_LocalPhoneNumber_7a33cdd2-b91b-4dde-a72a-8cd3f3df24dd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_3d5b652a-3422-4e0f-828a-00ae0294f42c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_ContactPersonnelEmailAddress_3d5b652a-3422-4e0f-828a-00ae0294f42c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2f553815-5a96-456c-9627-45a83a2ce48c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_Security12bTitle_2f553815-5a96-456c-9627-45a83a2ce48c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b966cdde-989e-4695-a41d-fe206911ec0a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_TradingSymbol_b966cdde-989e-4695-a41d-fe206911ec0a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_36b3706b-cf0c-436f-aed8-47bd0cfe1361" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_SecurityExchangeName_36b3706b-cf0c-436f-aed8-47bd0cfe1361" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_009084f4-03ce-4b8a-9d7e-7c21e8ee9782" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_009084f4-03ce-4b8a-9d7e-7c21e8ee9782" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_b320f102-9ffd-41c2-9c24-9a7ee5300eca" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_b320f102-9ffd-41c2-9c24-9a7ee5300eca" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_8516b140-f772-4e37-b38b-d26de33a7811" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityVoluntaryFilers_8516b140-f772-4e37-b38b-d26de33a7811" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0f18c145-6bad-4654-9aa7-4f2f96c4a55e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityCurrentReportingStatus_0f18c145-6bad-4654-9aa7-4f2f96c4a55e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_44c41897-6bd7-4417-8e68-e5a519111b0d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityInteractiveDataCurrent_44c41897-6bd7-4417-8e68-e5a519111b0d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9d113d30-78a9-46f0-a182-ebd7bef3ee76" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityFilerCategory_9d113d30-78a9-46f0-a182-ebd7bef3ee76" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a2357cb2-cc03-43e4-82f7-ba9db0830cfa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityEmergingGrowthCompany_a2357cb2-cc03-43e4-82f7-ba9db0830cfa" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_822d5f6e-8378-4ab9-8507-67439b800282" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_IcfrAuditorAttestationFlag_822d5f6e-8378-4ab9-8507-67439b800282" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8ee399fa-a858-4948-ac66-c720cded5d35" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8ee399fa-a858-4948-ac66-c720cded5d35" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_e5eeec3b-9671-4e28-bd9f-b6ee44fc386a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentAccountingStandard_e5eeec3b-9671-4e28-bd9f-b6ee44fc386a" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_11e55732-e19f-4fb9-948b-1bb57f83c5ec" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityShellCompany_11e55732-e19f-4fb9-948b-1bb57f83c5ec" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_58d13974-a349-45b3-8f90-2b8c7baffd22" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_AmendmentFlag_58d13974-a349-45b3-8f90-2b8c7baffd22" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f721f364-84aa-4bf9-a5a0-a9515a24e652" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f721f364-84aa-4bf9-a5a0-a9515a24e652" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_80931d60-bc95-4e0b-a2ac-4f3688450b94" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_7278858a-d6fc-4346-a21f-28f0bbf89498" xlink:to="loc_dei_EntityCentralIndexKey_80931d60-bc95-4e0b-a2ac-4f3688450b94" xlink:type="arc" order="35"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/Consolidatedstatementofchangesinequity" xlink:type="simple" xlink:href="gsk-20241231.xsd#Consolidatedstatementofchangesinequity"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/Consolidatedstatementofchangesinequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_9ce429d1-050b-4f4a-8213-21ed38403700" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_9ce429d1-050b-4f4a-8213-21ed38403700" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_67745faa-e69e-4417-882e-fceae85724ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_9ce429d1-050b-4f4a-8213-21ed38403700" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_67745faa-e69e-4417-882e-fceae85724ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_67745faa-e69e-4417-882e-fceae85724ed_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_67745faa-e69e-4417-882e-fceae85724ed" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_67745faa-e69e-4417-882e-fceae85724ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_4a0c73cb-9727-4761-9115-ea2f5474ec1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_67745faa-e69e-4417-882e-fceae85724ed" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_4a0c73cb-9727-4761-9115-ea2f5474ec1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_47ad102e-da45-4560-a142-c9869a6af720" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_4a0c73cb-9727-4761-9115-ea2f5474ec1e" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_47ad102e-da45-4560-a142-c9869a6af720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_c2591b66-b88c-44d9-adb0-92a789cafe96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_47ad102e-da45-4560-a142-c9869a6af720" xlink:to="loc_ifrs-full_IssuedCapitalMember_c2591b66-b88c-44d9-adb0-92a789cafe96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_c718fee1-a218-4d91-931c-5740e9ee7c2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_47ad102e-da45-4560-a142-c9869a6af720" xlink:to="loc_ifrs-full_SharePremiumMember_c718fee1-a218-4d91-931c-5740e9ee7c2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_6f5b85f1-010d-437b-882b-3b350b133a44" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_47ad102e-da45-4560-a142-c9869a6af720" xlink:to="loc_ifrs-full_RetainedEarningsMember_6f5b85f1-010d-437b-882b-3b350b133a44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_22e6c0b1-f639-4fd0-8436-582a41887a98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_47ad102e-da45-4560-a142-c9869a6af720" xlink:to="loc_ifrs-full_OtherReservesMember_22e6c0b1-f639-4fd0-8436-582a41887a98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_bb5fb6a5-1365-4091-9fe2-024da970ea03" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_4a0c73cb-9727-4761-9115-ea2f5474ec1e" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_bb5fb6a5-1365-4091-9fe2-024da970ea03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_8b236c92-e880-4b1a-900b-2d14fcc86e01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_Equity_8b236c92-e880-4b1a-900b-2d14fcc86e01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_3209ba47-a9bc-4b21-95cd-2de7a0a4810f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_ProfitLoss_3209ba47-a9bc-4b21-95cd-2de7a0a4810f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_b6304228-3e47-4a12-a15c-ed025c16f625" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_b6304228-3e47-4a12-a15c-ed025c16f625" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_bc7aa346-4a0f-4506-9762-172d2bd8a574" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_ComprehensiveIncome_bc7aa346-4a0f-4506-9762-172d2bd8a574" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_8de7f1fd-90ac-4a59-8c80-8f5e000073e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_8de7f1fd-90ac-4a59-8c80-8f5e000073e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCashDistributionToNonControllingInterests_b6ac1388-ebf4-4319-a7b4-a369016c240b" xlink:href="gsk-20241231.xsd#gsk_NonCashDistributionToNonControllingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_NonCashDistributionToNonControllingInterests_b6ac1388-ebf4-4319-a7b4-a369016c240b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity_645a0ec5-69dc-4a1d-83c5-9a36356eab8a" xlink:href="gsk-20241231.xsd#gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity_645a0ec5-69dc-4a1d-83c5-9a36356eab8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests_5f7f0af3-9ae1-456b-8ae9-048633193e20" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests_5f7f0af3-9ae1-456b-8ae9-048633193e20" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_68e4bfbd-5c45-4178-a658-e35041f343dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_68e4bfbd-5c45-4178-a658-e35041f343dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaid_0fb0f866-747f-445a-8007-874180a3d1c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_DividendsPaid_0fb0f866-747f-445a-8007-874180a3d1c0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_748c956f-68f4-44fe-a7e6-6ff2c396cbec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_748c956f-68f4-44fe-a7e6-6ff2c396cbec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments_93cab4c6-1d67-4b8c-8c95-e30085bfff45" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments_93cab4c6-1d67-4b8c-8c95-e30085bfff45" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments_b93bd845-b310-432b-969c-656551ce0526" xlink:href="gsk-20241231.xsd#gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments_b93bd845-b310-432b-969c-656551ce0526" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_3f3ecdb4-a392-4e48-8451-add1c52a8b10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_IssueOfEquity_3f3ecdb4-a392-4e48-8451-add1c52a8b10" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan_2e781446-9848-49c0-9326-664390a44072" xlink:href="gsk-20241231.xsd#gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan_2e781446-9848-49c0-9326-664390a44072" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SharesAcquiredByEsopTrusts_fbbfcbaf-0dd6-415a-90d2-5d56e332b247" xlink:href="gsk-20241231.xsd#gsk_SharesAcquiredByEsopTrusts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_SharesAcquiredByEsopTrusts_fbbfcbaf-0dd6-415a-90d2-5d56e332b247" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_45a959e4-f085-40fe-a276-8ddd2bde9ec4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_45a959e4-f085-40fe-a276-8ddd2bde9ec4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_30684620-b072-467a-a55f-5fc492d7495a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_30684620-b072-467a-a55f-5fc492d7495a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingGainLossTransferredToNonFinancialAssets_e71a17f6-7397-482a-a7ff-947fd9ef879e" xlink:href="gsk-20241231.xsd#gsk_HedgingGainLossTransferredToNonFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_fdc1020b-2ac8-408d-bf4e-aecca2faea09" xlink:to="loc_gsk_HedgingGainLossTransferredToNonFinancialAssets_e71a17f6-7397-482a-a7ff-947fd9ef879e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_382cc821-a750-4843-83e1-83d89021676b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AccountingprinciplesandPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AccountingprinciplesandPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AccountingprinciplesandPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:href="gsk-20241231.xsd#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"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_fc661fad-d25b-40a9-a128-55a0debc5cf8" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:to="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_fc661fad-d25b-40a9-a128-55a0debc5cf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_671fb4a2-0255-40e5-897e-f1e3c5ac50ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_fc661fad-d25b-40a9-a128-55a0debc5cf8" xlink:to="loc_ifrs-full_RangeAxis_671fb4a2-0255-40e5-897e-f1e3c5ac50ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_671fb4a2-0255-40e5-897e-f1e3c5ac50ff_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_671fb4a2-0255-40e5-897e-f1e3c5ac50ff" xlink:to="loc_ifrs-full_RangeDomain_671fb4a2-0255-40e5-897e-f1e3c5ac50ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_7f126f8a-9e7e-48da-b76e-c1108c11762f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_671fb4a2-0255-40e5-897e-f1e3c5ac50ff" xlink:to="loc_ifrs-full_RangeDomain_7f126f8a-9e7e-48da-b76e-c1108c11762f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_4f100da8-414d-4591-8dcf-750015ab6d2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_7f126f8a-9e7e-48da-b76e-c1108c11762f" xlink:to="loc_ifrs-full_BottomOfRangeMember_4f100da8-414d-4591-8dcf-750015ab6d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_dfefb4b2-c3eb-4fdf-937e-57a88f106077" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_7f126f8a-9e7e-48da-b76e-c1108c11762f" xlink:to="loc_ifrs-full_TopOfRangeMember_dfefb4b2-c3eb-4fdf-937e-57a88f106077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ff5e87cf-550f-47ee-9483-3688e148a42c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_fc661fad-d25b-40a9-a128-55a0debc5cf8" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ff5e87cf-550f-47ee-9483-3688e148a42c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_ff5e87cf-550f-47ee-9483-3688e148a42c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ff5e87cf-550f-47ee-9483-3688e148a42c" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_ff5e87cf-550f-47ee-9483-3688e148a42c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8043e9aa-aec6-44df-a833-6535da2847e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ff5e87cf-550f-47ee-9483-3688e148a42c" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8043e9aa-aec6-44df-a833-6535da2847e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_3a8c3c7b-d25d-48a1-9312-fffb25334b05" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesAndFranchisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8043e9aa-aec6-44df-a833-6535da2847e1" xlink:to="loc_ifrs-full_LicencesAndFranchisesMember_3a8c3c7b-d25d-48a1-9312-fffb25334b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ERPSoftwareSystemsMember_c0b7187f-6646-48e8-8ce8-d4e70e725f7a" xlink:href="gsk-20241231.xsd#gsk_ERPSoftwareSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8043e9aa-aec6-44df-a833-6535da2847e1" xlink:to="loc_gsk_ERPSoftwareSystemsMember_c0b7187f-6646-48e8-8ce8-d4e70e725f7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComputerSoftwareMember_1657f1c2-5cd7-49da-b70f-afb6a965851d" xlink:href="gsk-20241231.xsd#gsk_OtherComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_8043e9aa-aec6-44df-a833-6535da2847e1" xlink:to="loc_gsk_OtherComputerSoftwareMember_1657f1c2-5cd7-49da-b70f-afb6a965851d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_7f1dd340-9f8d-4cf3-8b9b-da76cb2c2e4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_fc661fad-d25b-40a9-a128-55a0debc5cf8" xlink:to="loc_ifrs-full_SegmentsAxis_7f1dd340-9f8d-4cf3-8b9b-da76cb2c2e4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_7f1dd340-9f8d-4cf3-8b9b-da76cb2c2e4d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_7f1dd340-9f8d-4cf3-8b9b-da76cb2c2e4d" xlink:to="loc_ifrs-full_SegmentsDomain_7f1dd340-9f8d-4cf3-8b9b-da76cb2c2e4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_cbc45c2a-8130-4d86-a686-61f5de70fc08" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_7f1dd340-9f8d-4cf3-8b9b-da76cb2c2e4d" xlink:to="loc_ifrs-full_SegmentsDomain_cbc45c2a-8130-4d86-a686-61f5de70fc08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PharmaceuticalsMember_b24bc699-c905-4dee-b28c-e70e1c269eb7" xlink:href="gsk-20241231.xsd#gsk_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_cbc45c2a-8130-4d86-a686-61f5de70fc08" xlink:to="loc_gsk_PharmaceuticalsMember_b24bc699-c905-4dee-b28c-e70e1c269eb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccinesMember_a2606811-049b-4f94-b396-ad6655ee9dfd" xlink:href="gsk-20241231.xsd#gsk_VaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_cbc45c2a-8130-4d86-a686-61f5de70fc08" xlink:to="loc_gsk_VaccinesMember_a2606811-049b-4f94-b396-ad6655ee9dfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9b0569b5-69a0-4597-821b-05e6731ca87c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_fc661fad-d25b-40a9-a128-55a0debc5cf8" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9b0569b5-69a0-4597-821b-05e6731ca87c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_9b0569b5-69a0-4597-821b-05e6731ca87c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9b0569b5-69a0-4597-821b-05e6731ca87c" xlink:to="loc_ifrs-full_CarryingAmountMember_9b0569b5-69a0-4597-821b-05e6731ca87c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_efd447cf-8344-4fd6-b781-30a922f4f718" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9b0569b5-69a0-4597-821b-05e6731ca87c" xlink:to="loc_ifrs-full_CarryingAmountMember_efd447cf-8344-4fd6-b781-30a922f4f718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemainingBookValueMember_373c62e7-abb5-42a9-ab11-0ff953527375" xlink:href="gsk-20241231.xsd#gsk_RemainingBookValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_efd447cf-8344-4fd6-b781-30a922f4f718" xlink:to="loc_gsk_RemainingBookValueMember_373c62e7-abb5-42a9-ab11-0ff953527375" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales_21b286dc-7056-4fca-90bc-00b2c31b5c43" xlink:href="gsk-20241231.xsd#gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:to="loc_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales_21b286dc-7056-4fca-90bc-00b2c31b5c43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevenueFromCoPromotionalActivities_15c0fa1b-77ba-43f7-8564-4f203e7a6556" xlink:href="gsk-20241231.xsd#gsk_RevenueFromCoPromotionalActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:to="loc_gsk_RevenueFromCoPromotionalActivities_15c0fa1b-77ba-43f7-8564-4f203e7a6556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments_8a14e63d-f8b2-4cbb-bea1-8a291e5f06b6" xlink:href="gsk-20241231.xsd#gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:to="loc_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments_8a14e63d-f8b2-4cbb-bea1-8a291e5f06b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_cd4c0f06-daad-454f-a663-d34317d661be" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_cd4c0f06-daad-454f-a663-d34317d661be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmortisableProportionOverExclusivityPeriod_d50ccc0a-1be6-40fe-9a5d-39865265872b" xlink:href="gsk-20241231.xsd#gsk_AmortisableProportionOverExclusivityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7e22c30e-e404-4c87-a4d1-7e0d84c6ec6a" xlink:to="loc_gsk_AmortisableProportionOverExclusivityPeriod_d50ccc0a-1be6-40fe-9a5d-39865265872b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AccountingprinciplesandPoliciesSummaryofExpectedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AccountingprinciplesandPoliciesSummaryofExpectedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AccountingprinciplesandPoliciesSummaryofExpectedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_99a850ee-40cd-45b4-b8a5-2d2c559f9153" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_73e7c361-8b6b-44b0-a8e9-e52f48f7c8de" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_99a850ee-40cd-45b4-b8a5-2d2c559f9153" xlink:to="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_73e7c361-8b6b-44b0-a8e9-e52f48f7c8de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_c16e5cd6-6c6b-4abb-8e39-69114d533dd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_73e7c361-8b6b-44b0-a8e9-e52f48f7c8de" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_c16e5cd6-6c6b-4abb-8e39-69114d533dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_c16e5cd6-6c6b-4abb-8e39-69114d533dd4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_c16e5cd6-6c6b-4abb-8e39-69114d533dd4" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_c16e5cd6-6c6b-4abb-8e39-69114d533dd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_62eb4017-67bc-4dc8-b214-9112856d2b30" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_c16e5cd6-6c6b-4abb-8e39-69114d533dd4" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_62eb4017-67bc-4dc8-b214-9112856d2b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FreeholdBuildingsMember_dc5d63bb-72b2-4940-a414-c0279d97abda" xlink:href="gsk-20241231.xsd#gsk_FreeholdBuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_62eb4017-67bc-4dc8-b214-9112856d2b30" xlink:to="loc_gsk_FreeholdBuildingsMember_dc5d63bb-72b2-4940-a414-c0279d97abda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LeaseholdLandAndBuildingsMember_cdd4b09b-c484-4bd6-a35d-815791c38a91" xlink:href="gsk-20241231.xsd#gsk_LeaseholdLandAndBuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_62eb4017-67bc-4dc8-b214-9112856d2b30" xlink:to="loc_gsk_LeaseholdLandAndBuildingsMember_cdd4b09b-c484-4bd6-a35d-815791c38a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PlantAndMachineryMember_92d451c2-091a-4fdd-9f83-01455cee3b44" xlink:href="gsk-20241231.xsd#gsk_PlantAndMachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_62eb4017-67bc-4dc8-b214-9112856d2b30" xlink:to="loc_gsk_PlantAndMachineryMember_92d451c2-091a-4fdd-9f83-01455cee3b44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquipmentAndVehiclesMember_a739deb9-7643-4133-82ea-bfd052024046" xlink:href="gsk-20241231.xsd#gsk_EquipmentAndVehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_62eb4017-67bc-4dc8-b214-9112856d2b30" xlink:to="loc_gsk_EquipmentAndVehiclesMember_a739deb9-7643-4133-82ea-bfd052024046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_3cad90da-e5cf-4c6b-9320-fd9c82d45939" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_73e7c361-8b6b-44b0-a8e9-e52f48f7c8de" xlink:to="loc_ifrs-full_RangeAxis_3cad90da-e5cf-4c6b-9320-fd9c82d45939" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_3cad90da-e5cf-4c6b-9320-fd9c82d45939_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_3cad90da-e5cf-4c6b-9320-fd9c82d45939" xlink:to="loc_ifrs-full_RangeDomain_3cad90da-e5cf-4c6b-9320-fd9c82d45939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_75484f28-1c5e-494b-8cd6-ec6677f571c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_3cad90da-e5cf-4c6b-9320-fd9c82d45939" xlink:to="loc_ifrs-full_RangeDomain_75484f28-1c5e-494b-8cd6-ec6677f571c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_dd813c56-ed28-409c-9ad0-9bfee859ea16" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_75484f28-1c5e-494b-8cd6-ec6677f571c9" xlink:to="loc_ifrs-full_BottomOfRangeMember_dd813c56-ed28-409c-9ad0-9bfee859ea16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_265487a8-76a4-4448-81a3-12949f132064" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_75484f28-1c5e-494b-8cd6-ec6677f571c9" xlink:to="loc_ifrs-full_TopOfRangeMember_265487a8-76a4-4448-81a3-12949f132064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_6eebaa78-9208-4ba0-b3c3-1ec5ca145684" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_99a850ee-40cd-45b4-b8a5-2d2c559f9153" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_6eebaa78-9208-4ba0-b3c3-1ec5ca145684" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/CriticalaccountingjudgementsandkeysourcesofestimationuncertaintyDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#CriticalaccountingjudgementsandkeysourcesofestimationuncertaintyDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/CriticalaccountingjudgementsandkeysourcesofestimationuncertaintyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis_de0dcbf8-4348-41eb-8803-8af5108ed8bc" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_gsk_SegmentConsolidationItemAxis_de0dcbf8-4348-41eb-8803-8af5108ed8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_de0dcbf8-4348-41eb-8803-8af5108ed8bc_default" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_SegmentConsolidationItemAxis_de0dcbf8-4348-41eb-8803-8af5108ed8bc" xlink:to="loc_gsk_SegmentConsolidationItemDomain_de0dcbf8-4348-41eb-8803-8af5108ed8bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_27f53ac1-4a9c-4a35-b043-e7b0102c49d4" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_SegmentConsolidationItemAxis_de0dcbf8-4348-41eb-8803-8af5108ed8bc" xlink:to="loc_gsk_SegmentConsolidationItemDomain_27f53ac1-4a9c-4a35-b043-e7b0102c49d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_USPharmaceuticalsAndVaccinesMember_6a456906-d7ab-48f7-a00a-16f7f0ec13ce" xlink:href="gsk-20241231.xsd#gsk_USPharmaceuticalsAndVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_27f53ac1-4a9c-4a35-b043-e7b0102c49d4" xlink:to="loc_gsk_USPharmaceuticalsAndVaccinesMember_6a456906-d7ab-48f7-a00a-16f7f0ec13ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_7caf3801-3048-48bf-bc64-f7a20dfcc1c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_7caf3801-3048-48bf-bc64-f7a20dfcc1c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_7caf3801-3048-48bf-bc64-f7a20dfcc1c6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_7caf3801-3048-48bf-bc64-f7a20dfcc1c6" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_7caf3801-3048-48bf-bc64-f7a20dfcc1c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_c14b4d91-d36c-4181-9f6b-caa15d648b59" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_7caf3801-3048-48bf-bc64-f7a20dfcc1c6" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_c14b4d91-d36c-4181-9f6b-caa15d648b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_094bf0d5-3c65-44ff-a74f-f4e805f1b1c8" xlink:href="gsk-20241231.xsd#gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_c14b4d91-d36c-4181-9f6b-caa15d648b59" xlink:to="loc_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_094bf0d5-3c65-44ff-a74f-f4e805f1b1c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateAxis_6127b587-bee6-41b1-baef-f19c58b91c5e" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_gsk_ActuarialAssumptionPercentageRateAxis_6127b587-bee6-41b1-baef-f19c58b91c5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateDomain_6127b587-bee6-41b1-baef-f19c58b91c5e_default" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateAxis_6127b587-bee6-41b1-baef-f19c58b91c5e" xlink:to="loc_gsk_ActuarialAssumptionPercentageRateDomain_6127b587-bee6-41b1-baef-f19c58b91c5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateDomain_bf3776fd-cc3f-4cba-ae79-f73f9f847251" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateAxis_6127b587-bee6-41b1-baef-f19c58b91c5e" xlink:to="loc_gsk_ActuarialAssumptionPercentageRateDomain_bf3776fd-cc3f-4cba-ae79-f73f9f847251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateChangeMember_502690ac-506c-4c96-a308-479b3d2e42e0" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateChangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateDomain_bf3776fd-cc3f-4cba-ae79-f73f9f847251" xlink:to="loc_gsk_ActuarialAssumptionPercentageRateChangeMember_502690ac-506c-4c96-a308-479b3d2e42e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember_44f6fc81-d8a4-4897-a8f6-3c1d3852d0a0" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateDomain_bf3776fd-cc3f-4cba-ae79-f73f9f847251" xlink:to="loc_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember_44f6fc81-d8a4-4897-a8f6-3c1d3852d0a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_798608e8-61bb-4d4c-96f8-48180c36254b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_ifrs-full_JointVenturesAxis_798608e8-61bb-4d4c-96f8-48180c36254b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_798608e8-61bb-4d4c-96f8-48180c36254b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_798608e8-61bb-4d4c-96f8-48180c36254b" xlink:to="loc_ifrs-full_JointVenturesDomain_798608e8-61bb-4d4c-96f8-48180c36254b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_1074838b-3211-4393-b654-831361995af9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_798608e8-61bb-4d4c-96f8-48180c36254b" xlink:to="loc_ifrs-full_JointVenturesDomain_1074838b-3211-4393-b654-831361995af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViiVHealthcareJointVentureMember_edb6996d-e32c-4f78-bde3-bdd246b5c1e3" xlink:href="gsk-20241231.xsd#gsk_ShionogiViiVHealthcareJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_1074838b-3211-4393-b654-831361995af9" xlink:to="loc_gsk_ShionogiViiVHealthcareJointVentureMember_edb6996d-e32c-4f78-bde3-bdd246b5c1e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_36bc99cb-0237-4e0e-ab86-140f14d09364" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_36bc99cb-0237-4e0e-ab86-140f14d09364" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_36bc99cb-0237-4e0e-ab86-140f14d09364_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_36bc99cb-0237-4e0e-ab86-140f14d09364" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_36bc99cb-0237-4e0e-ab86-140f14d09364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_81edbeb7-7ce3-4c54-9a95-06281c4aece0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_36bc99cb-0237-4e0e-ab86-140f14d09364" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_81edbeb7-7ce3-4c54-9a95-06281c4aece0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SensitivityAnalysisForActuarialAssumptionsMember_336d4a33-e9b7-4e7d-a4ea-d19bf15106e9" xlink:href="gsk-20241231.xsd#gsk_SensitivityAnalysisForActuarialAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_81edbeb7-7ce3-4c54-9a95-06281c4aece0" xlink:to="loc_gsk_SensitivityAnalysisForActuarialAssumptionsMember_336d4a33-e9b7-4e7d-a4ea-d19bf15106e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_cf11252b-c0bf-4be2-8581-f53bd2f691fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_cf11252b-c0bf-4be2-8581-f53bd2f691fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_cf11252b-c0bf-4be2-8581-f53bd2f691fa_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_cf11252b-c0bf-4be2-8581-f53bd2f691fa" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_cf11252b-c0bf-4be2-8581-f53bd2f691fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_fcfbfe33-1202-4726-9403-370a7418c521" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_cf11252b-c0bf-4be2-8581-f53bd2f691fa" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_fcfbfe33-1202-4726-9403-370a7418c521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsMember_db5e8d8b-7e7a-46f9-aa80-94189118c5e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_fcfbfe33-1202-4726-9403-370a7418c521" xlink:to="loc_ifrs-full_BusinessCombinationsMember_db5e8d8b-7e7a-46f9-aa80-94189118c5e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d5655924-4f5a-4644-9ead-4827e8d8562c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d5655924-4f5a-4644-9ead-4827e8d8562c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_d5655924-4f5a-4644-9ead-4827e8d8562c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d5655924-4f5a-4644-9ead-4827e8d8562c" xlink:to="loc_ifrs-full_CarryingAmountMember_d5655924-4f5a-4644-9ead-4827e8d8562c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_93614261-96f6-4c76-9945-e02590f868a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_d5655924-4f5a-4644-9ead-4827e8d8562c" xlink:to="loc_ifrs-full_CarryingAmountMember_93614261-96f6-4c76-9945-e02590f868a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_83390cdf-4bec-463d-bda3-d4c315f0eb4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_93614261-96f6-4c76-9945-e02590f868a8" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_83390cdf-4bec-463d-bda3-d4c315f0eb4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_4fa22774-bd0d-4197-8608-3a2f67079365" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_f79634f1-1bc3-4c4f-9024-5efe89979998" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_4fa22774-bd0d-4197-8608-3a2f67079365" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_4fa22774-bd0d-4197-8608-3a2f67079365_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_4fa22774-bd0d-4197-8608-3a2f67079365" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_4fa22774-bd0d-4197-8608-3a2f67079365_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_5d37e5a4-6794-497e-9723-1cf161683ba0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_4fa22774-bd0d-4197-8608-3a2f67079365" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_5d37e5a4-6794-497e-9723-1cf161683ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LicencesAndFranchisesAmortisedBrandsMember_8bf71ba2-3431-4440-9bd9-4c2b3c55a595" xlink:href="gsk-20241231.xsd#gsk_LicencesAndFranchisesAmortisedBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_5d37e5a4-6794-497e-9723-1cf161683ba0" xlink:to="loc_gsk_LicencesAndFranchisesAmortisedBrandsMember_8bf71ba2-3431-4440-9bd9-4c2b3c55a595" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_4bf2c7e2-e7ce-4295-971e-0e97ced61ee3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_Revenue_4bf2c7e2-e7ce-4295-971e-0e97ced61ee3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnsDiscountsAndRebates_b5bcf871-2502-46f8-9173-cf77929d5bf3" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnsDiscountsAndRebates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_CustomerReturnsDiscountsAndRebates_b5bcf871-2502-46f8-9173-cf77929d5bf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment_dd76d96b-dca8-4feb-b51f-bedb892a249f" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment_dd76d96b-dca8-4feb-b51f-bedb892a249f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_89e74548-2ece-49c1-b9dd-adbf3694e58f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_89e74548-2ece-49c1-b9dd-adbf3694e58f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilities_d035d962-1c42-4bc8-ab11-cec76e733942" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_CurrentTaxLiabilities_d035d962-1c42-4bc8-ab11-cec76e733942" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_511aaaec-b8b2-40fe-b66a-b5cc5e88b5a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_511aaaec-b8b2-40fe-b66a-b5cc5e88b5a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssets_7f9aa84e-6c55-448b-89d6-ee7fd3350c96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_CurrentTaxAssets_7f9aa84e-6c55-448b-89d6-ee7fd3350c96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UncertainTaxPositionsRecognised_9161044b-64dc-4941-aee3-af4b97fd4617" xlink:href="gsk-20241231.xsd#gsk_UncertainTaxPositionsRecognised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_UncertainTaxPositionsRecognised_9161044b-64dc-4941-aee3-af4b97fd4617" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegalCosts_f40fccdc-a5c7-4683-a1a6-b57316d90b71" xlink:href="gsk-20241231.xsd#gsk_LegalCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_LegalCosts_f40fccdc-a5c7-4683-a1a6-b57316d90b71" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalProceedingsProvision_612a0236-5da8-4766-8d8d-ac686799f94f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_LegalProceedingsProvision_612a0236-5da8-4766-8d8d-ac686799f94f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities_80bba817-da69-4450-9fed-14cffce69b7a" xlink:href="gsk-20241231.xsd#gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities_80bba817-da69-4450-9fed-14cffce69b7a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_bcfe61fd-3ec0-498b-806e-bcad452e95e5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_bcfe61fd-3ec0-498b-806e-bcad452e95e5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPensionSchemesInSurplus_cfe85da0-66fa-4dca-8f7d-ea1b75a1e0e4" xlink:href="gsk-20241231.xsd#gsk_NumberOfPensionSchemesInSurplus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_NumberOfPensionSchemesInSurplus_cfe85da0-66fa-4dca-8f7d-ea1b75a1e0e4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitPlanSurplusNet_ae161592-ff7e-48c3-91c3-0ebd024b6350" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitPlanSurplusNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_DefinedBenefitPlanSurplusNet_ae161592-ff7e-48c3-91c3-0ebd024b6350" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionSurplus_b32b2a53-186c-4893-b21f-05b270a6abd8" xlink:href="gsk-20241231.xsd#gsk_PensionSurplus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_PensionSurplus_b32b2a53-186c-4893-b21f-05b270a6abd8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCountriesWithPensionSurpluses_7b018738-33b6-49c1-a45b-f7d209e87c57" xlink:href="gsk-20241231.xsd#gsk_NumberOfCountriesWithPensionSurpluses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_NumberOfCountriesWithPensionSurpluses_7b018738-33b6-49c1-a45b-f7d209e87c57" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfDecreaseInDiscountRate_9af8f76c-3c5c-4e6d-b80a-301d9190d016" xlink:href="gsk-20241231.xsd#gsk_PercentageOfDecreaseInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_PercentageOfDecreaseInDiscountRate_9af8f76c-3c5c-4e6d-b80a-301d9190d016" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInPlanDeficit_0ab836f7-9d8c-4fdb-b693-c6b7d610344a" xlink:href="gsk-20241231.xsd#gsk_IncreaseInPlanDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_IncreaseInPlanDeficit_0ab836f7-9d8c-4fdb-b693-c6b7d610344a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInAnnualPensionCost_4ad4931a-13f1-41cb-b279-e536ac789807" xlink:href="gsk-20241231.xsd#gsk_IncreaseInAnnualPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_IncreaseInAnnualPensionCost_4ad4931a-13f1-41cb-b279-e536ac789807" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfIncreaseInDiscountRate_28841dc8-282f-4345-9159-9363a0c696b8" xlink:href="gsk-20241231.xsd#gsk_PercentageOfIncreaseInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_PercentageOfIncreaseInDiscountRate_28841dc8-282f-4345-9159-9363a0c696b8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInPlanDeficit_37a4e574-bdc6-42cb-a403-954ee9e7a638" xlink:href="gsk-20241231.xsd#gsk_DecreaseInPlanDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_DecreaseInPlanDeficit_37a4e574-bdc6-42cb-a403-954ee9e7a638" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInAnnualPensionCost_219211f1-30fb-4165-874b-44915dc0385a" xlink:href="gsk-20241231.xsd#gsk_DecreaseInAnnualPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_gsk_DecreaseInAnnualPensionCost_219211f1-30fb-4165-874b-44915dc0385a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_18658756-6446-4c15-9a2a-dd63cca61865" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_751201df-0ff3-4256-8887-33d96afc9d07" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_18658756-6446-4c15-9a2a-dd63cca61865" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/ExchangeratesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#ExchangeratesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/ExchangeratesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfForeignExchangeRatesLineItems_ea3920d3-1b13-4f64-b9be-949f9041298f" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfForeignExchangeRatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfForeignExchangeRatesTable_d6fe2fcc-e6a6-418a-a196-f5fc54237738" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfForeignExchangeRatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfForeignExchangeRatesLineItems_ea3920d3-1b13-4f64-b9be-949f9041298f" xlink:to="loc_gsk_DisclosureOfForeignExchangeRatesTable_d6fe2fcc-e6a6-418a-a196-f5fc54237738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_8031acd9-923f-4dd0-9a83-c83c4d6b82b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfForeignExchangeRatesTable_d6fe2fcc-e6a6-418a-a196-f5fc54237738" xlink:to="loc_srt_CurrencyAxis_8031acd9-923f-4dd0-9a83-c83c4d6b82b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8031acd9-923f-4dd0-9a83-c83c4d6b82b4_default" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_8031acd9-923f-4dd0-9a83-c83c4d6b82b4" xlink:to="loc_currency_AllCurrenciesDomain_8031acd9-923f-4dd0-9a83-c83c4d6b82b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_446b63ea-03cc-441d-9153-2324746051fa" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_8031acd9-923f-4dd0-9a83-c83c4d6b82b4" xlink:to="loc_currency_AllCurrenciesDomain_446b63ea-03cc-441d-9153-2324746051fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_9d885d2e-5a5f-449f-a59f-95d1db97f3d3" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_446b63ea-03cc-441d-9153-2324746051fa" xlink:to="loc_currency_USD_9d885d2e-5a5f-449f-a59f-95d1db97f3d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_cc994e90-70e1-453a-b851-95806099a5fd" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_446b63ea-03cc-441d-9153-2324746051fa" xlink:to="loc_currency_EUR_cc994e90-70e1-453a-b851-95806099a5fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_be985f04-04f8-4145-b018-10be867312cd" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_446b63ea-03cc-441d-9153-2324746051fa" xlink:to="loc_currency_JPY_be985f04-04f8-4145-b018-10be867312cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageForeignExchangeRate_5dba753e-3cb6-41dd-9d75-362b9208b9ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfForeignExchangeRatesLineItems_ea3920d3-1b13-4f64-b9be-949f9041298f" xlink:to="loc_ifrs-full_AverageForeignExchangeRate_5dba753e-3cb6-41dd-9d75-362b9208b9ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_02d0b8fe-909b-43e4-94af-6b161ced3002" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfForeignExchangeRatesLineItems_ea3920d3-1b13-4f64-b9be-949f9041298f" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_02d0b8fe-909b-43e4-94af-6b161ced3002" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1b715738-1499-4c58-8117-fc9f29403ff6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1b715738-1499-4c58-8117-fc9f29403ff6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_96e7d16a-66b0-4a1c-8442-5e6e935cb304" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1b715738-1499-4c58-8117-fc9f29403ff6" xlink:to="loc_srt_MajorCustomersAxis_96e7d16a-66b0-4a1c-8442-5e6e935cb304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_96e7d16a-66b0-4a1c-8442-5e6e935cb304_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_96e7d16a-66b0-4a1c-8442-5e6e935cb304" xlink:to="loc_srt_NameOfMajorCustomerDomain_96e7d16a-66b0-4a1c-8442-5e6e935cb304_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0fe17284-71e3-4d30-b80c-576cce42a5cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_96e7d16a-66b0-4a1c-8442-5e6e935cb304" xlink:to="loc_srt_NameOfMajorCustomerDomain_0fe17284-71e3-4d30-b80c-576cce42a5cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Wholesalers1Member_46dce195-7b94-4846-906d-60fa2d74e6e7" xlink:href="gsk-20241231.xsd#gsk_Wholesalers1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0fe17284-71e3-4d30-b80c-576cce42a5cd" xlink:to="loc_gsk_Wholesalers1Member_46dce195-7b94-4846-906d-60fa2d74e6e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Wholesalers2Member_360348ee-4caa-4a32-a9cf-8c9256f504b8" xlink:href="gsk-20241231.xsd#gsk_Wholesalers2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0fe17284-71e3-4d30-b80c-576cce42a5cd" xlink:to="loc_gsk_Wholesalers2Member_360348ee-4caa-4a32-a9cf-8c9256f504b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Wholesalers3Member_aaf7c693-a2eb-4bc3-ad89-cd37d33376af" xlink:href="gsk-20241231.xsd#gsk_Wholesalers3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0fe17284-71e3-4d30-b80c-576cce42a5cd" xlink:to="loc_gsk_Wholesalers3Member_aaf7c693-a2eb-4bc3-ad89-cd37d33376af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_114dfe95-3c1b-48fb-b572-a2dabd576438" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1b715738-1499-4c58-8117-fc9f29403ff6" xlink:to="loc_ifrs-full_GeographicalAreasAxis_114dfe95-3c1b-48fb-b572-a2dabd576438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_114dfe95-3c1b-48fb-b572-a2dabd576438_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_114dfe95-3c1b-48fb-b572-a2dabd576438" xlink:to="loc_ifrs-full_GeographicalAreasDomain_114dfe95-3c1b-48fb-b572-a2dabd576438_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_f7e22a19-55bf-423c-b277-cbd1ba87705f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_114dfe95-3c1b-48fb-b572-a2dabd576438" xlink:to="loc_ifrs-full_GeographicalAreasDomain_f7e22a19-55bf-423c-b277-cbd1ba87705f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52e99c8a-c678-4ac3-a1a3-52e4fcba3551" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_f7e22a19-55bf-423c-b277-cbd1ba87705f" xlink:to="loc_country_US_52e99c8a-c678-4ac3-a1a3-52e4fcba3551" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_a6358346-88e8-4441-a450-1743529be103" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1b715738-1499-4c58-8117-fc9f29403ff6" xlink:to="loc_ifrs-full_SegmentsAxis_a6358346-88e8-4441-a450-1743529be103" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_a6358346-88e8-4441-a450-1743529be103_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_a6358346-88e8-4441-a450-1743529be103" xlink:to="loc_ifrs-full_SegmentsDomain_a6358346-88e8-4441-a450-1743529be103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_dd0e060a-dd32-4190-8f73-f3b4cd6c224e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_a6358346-88e8-4441-a450-1743529be103" xlink:to="loc_ifrs-full_SegmentsDomain_dd0e060a-dd32-4190-8f73-f3b4cd6c224e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViivHealthcareMember_fc79eab7-ae47-47d7-a292-e7fde061a202" xlink:href="gsk-20241231.xsd#gsk_ShionogiViivHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_dd0e060a-dd32-4190-8f73-f3b4cd6c224e" xlink:to="loc_gsk_ShionogiViivHealthcareMember_fc79eab7-ae47-47d7-a292-e7fde061a202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4d77e868-4daf-435c-8439-b65b72aaf2a2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1b715738-1499-4c58-8117-fc9f29403ff6" xlink:to="loc_dei_LegalEntityAxis_4d77e868-4daf-435c-8439-b65b72aaf2a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4d77e868-4daf-435c-8439-b65b72aaf2a2_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4d77e868-4daf-435c-8439-b65b72aaf2a2" xlink:to="loc_dei_EntityDomain_4d77e868-4daf-435c-8439-b65b72aaf2a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d7ebe833-a3d8-46f2-80cf-b8f59a0f55e8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4d77e868-4daf-435c-8439-b65b72aaf2a2" xlink:to="loc_dei_EntityDomain_d7ebe833-a3d8-46f2-80cf-b8f59a0f55e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PfizerMember_cf7d3ca2-2700-49df-9eee-083a2dd44d83" xlink:href="gsk-20241231.xsd#gsk_PfizerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d7ebe833-a3d8-46f2-80cf-b8f59a0f55e8" xlink:to="loc_gsk_PfizerMember_cf7d3ca2-2700-49df-9eee-083a2dd44d83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfReportableOperatingSegments_246aa5fa-8f44-4478-93fc-ca9e910e95ef" xlink:href="gsk-20241231.xsd#gsk_NumberOfReportableOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_NumberOfReportableOperatingSegments_246aa5fa-8f44-4478-93fc-ca9e910e95ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfProductGroups_1bb096cb-0fbe-49b6-90ad-2724f6f2ad6a" xlink:href="gsk-20241231.xsd#gsk_NumberOfProductGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_NumberOfProductGroups_1bb096cb-0fbe-49b6-90ad-2724f6f2ad6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUSWholesalers_ca607508-178a-4257-9392-dc0d0d98b07f" xlink:href="gsk-20241231.xsd#gsk_NumberOfUSWholesalers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_NumberOfUSWholesalers_ca607508-178a-4257-9392-dc0d0d98b07f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_e7d58399-4cb6-4879-ae48-684a7959499b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_e7d58399-4cb6-4879-ae48-684a7959499b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevenueFromChangesToEstimatesOfRARAccruals_eba12aa2-c7cf-43d4-99bc-8c3337f73de0" xlink:href="gsk-20241231.xsd#gsk_RevenueFromChangesToEstimatesOfRARAccruals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_RevenueFromChangesToEstimatesOfRARAccruals_eba12aa2-c7cf-43d4-99bc-8c3337f73de0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit_f37c885b-a5f5-4062-89e6-a98ad45df416" xlink:href="gsk-20241231.xsd#gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit_f37c885b-a5f5-4062-89e6-a98ad45df416" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_091a59d6-8c18-44f3-b48d-eb1ae5cd1c41" xlink:href="gsk-20241231.xsd#gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_091a59d6-8c18-44f3-b48d-eb1ae5cd1c41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_72b5ecf1-183b-441e-8ca7-84940332523e" xlink:href="gsk-20241231.xsd#gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_72b5ecf1-183b-441e-8ca7-84940332523e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_3dbb59fb-1d37-45b5-aab9-db42bec35365" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_3dbb59fb-1d37-45b5-aab9-db42bec35365" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PutOption_4cf6b1c8-15af-4ddf-8938-7c516a3d467e" xlink:href="gsk-20241231.xsd#gsk_PutOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_abbd4fc4-d298-43b9-9946-377a09734a79" xlink:to="loc_gsk_PutOption_4cf6b1c8-15af-4ddf-8938-7c516a3d467e" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationTurnoverbySegmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationTurnoverbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationTurnoverbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_081dff24-b547-4bf5-8356-4069dc2c19a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_de6fcffa-1716-49dc-81df-b4b0abf16132" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_081dff24-b547-4bf5-8356-4069dc2c19a7" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_de6fcffa-1716-49dc-81df-b4b0abf16132" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_7d5e1d68-8440-4b06-a032-741171e1109e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_de6fcffa-1716-49dc-81df-b4b0abf16132" xlink:to="loc_ifrs-full_SegmentsAxis_7d5e1d68-8440-4b06-a032-741171e1109e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_7d5e1d68-8440-4b06-a032-741171e1109e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_7d5e1d68-8440-4b06-a032-741171e1109e" xlink:to="loc_ifrs-full_SegmentsDomain_7d5e1d68-8440-4b06-a032-741171e1109e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_3663e432-e40b-4ef6-bb42-de3a76bc01dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_7d5e1d68-8440-4b06-a032-741171e1109e" xlink:to="loc_ifrs-full_SegmentsDomain_3663e432-e40b-4ef6-bb42-de3a76bc01dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_98f1893c-0178-49a0-b8cc-cee6cfb40cdd" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_3663e432-e40b-4ef6-bb42-de3a76bc01dc" xlink:to="loc_gsk_CommercialOperationsMember_98f1893c-0178-49a0-b8cc-cee6cfb40cdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_06022a03-491e-48c5-8d93-8d5950c41e67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_081dff24-b547-4bf5-8356-4069dc2c19a7" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_06022a03-491e-48c5-8d93-8d5950c41e67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationTurnoverbyProductServiceDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationTurnoverbyProductServiceDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationTurnoverbyProductServiceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_027b9755-fbc7-4f62-a357-dc2dd3b335e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesTable_a81c0ccd-0291-4e75-8a47-77cf074def12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_027b9755-fbc7-4f62-a357-dc2dd3b335e9" xlink:to="loc_ifrs-full_DisclosureOfProductsAndServicesTable_a81c0ccd-0291-4e75-8a47-77cf074def12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_1a5ab943-86e3-4474-8a89-6cca42b0cec3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable_a81c0ccd-0291-4e75-8a47-77cf074def12" xlink:to="loc_ifrs-full_SegmentsAxis_1a5ab943-86e3-4474-8a89-6cca42b0cec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_1a5ab943-86e3-4474-8a89-6cca42b0cec3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_1a5ab943-86e3-4474-8a89-6cca42b0cec3" xlink:to="loc_ifrs-full_SegmentsDomain_1a5ab943-86e3-4474-8a89-6cca42b0cec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_fc4707f4-0f56-4663-915c-c8be3bd2dd61" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_1a5ab943-86e3-4474-8a89-6cca42b0cec3" xlink:to="loc_ifrs-full_SegmentsDomain_fc4707f4-0f56-4663-915c-c8be3bd2dd61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_c25f7250-4ae6-4fe8-984e-140d1b58805a" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_fc4707f4-0f56-4663-915c-c8be3bd2dd61" xlink:to="loc_gsk_CommercialOperationsMember_c25f7250-4ae6-4fe8-984e-140d1b58805a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_eeb5c439-4bd4-4d21-b1f8-c23c5e6ec260" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable_a81c0ccd-0291-4e75-8a47-77cf074def12" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_eeb5c439-4bd4-4d21-b1f8-c23c5e6ec260" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_eeb5c439-4bd4-4d21-b1f8-c23c5e6ec260_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_eeb5c439-4bd4-4d21-b1f8-c23c5e6ec260" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_eeb5c439-4bd4-4d21-b1f8-c23c5e6ec260_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_eeb5c439-4bd4-4d21-b1f8-c23c5e6ec260" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShinglesMember_27546887-422e-4c09-b1cc-7af2bb73b291" xlink:href="gsk-20241231.xsd#gsk_ShinglesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_ShinglesMember_27546887-422e-4c09-b1cc-7af2bb73b291" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MeningitisMember_f791f1e3-1a85-4e83-9e77-3c905f8a5c99" xlink:href="gsk-20241231.xsd#gsk_MeningitisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_MeningitisMember_f791f1e3-1a85-4e83-9e77-3c905f8a5c99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RSVArexvyMember_72092559-f448-471a-8b86-fb817e5c48c1" xlink:href="gsk-20241231.xsd#gsk_RSVArexvyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_RSVArexvyMember_72092559-f448-471a-8b86-fb817e5c48c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InfluenzaMember_e1208c18-0c92-4b98-9f8a-fbbb325cf34e" xlink:href="gsk-20241231.xsd#gsk_InfluenzaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_InfluenzaMember_e1208c18-0c92-4b98-9f8a-fbbb325cf34e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EstablishedVaccinesMember_15dfbda6-c399-4c44-8af2-c67740d34fd2" xlink:href="gsk-20241231.xsd#gsk_EstablishedVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_EstablishedVaccinesMember_15dfbda6-c399-4c44-8af2-c67740d34fd2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember_2ba41b6b-7fb7-4cc1-ae27-4bdaa17668b8" xlink:href="gsk-20241231.xsd#gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember_2ba41b6b-7fb7-4cc1-ae27-4bdaa17668b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PandemicVaccinesMember_d9eb0589-7513-4d66-9c30-a04c7c80d323" xlink:href="gsk-20241231.xsd#gsk_PandemicVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_PandemicVaccinesMember_d9eb0589-7513-4d66-9c30-a04c7c80d323" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccinesMember_eb53a79b-d439-4e98-82aa-9659c3799153" xlink:href="gsk-20241231.xsd#gsk_VaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_VaccinesMember_eb53a79b-d439-4e98-82aa-9659c3799153" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HIVMember_1eaad850-7861-4052-b523-b2bce18f16fe" xlink:href="gsk-20241231.xsd#gsk_HIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_HIVMember_1eaad850-7861-4052-b523-b2bce18f16fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ImmunoInflammationRespiratoryAndOtherMember_3723b6b9-83b9-4032-b2eb-12f041f390f1" xlink:href="gsk-20241231.xsd#gsk_ImmunoInflammationRespiratoryAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_ImmunoInflammationRespiratoryAndOtherMember_3723b6b9-83b9-4032-b2eb-12f041f390f1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OncologyMember_ff11584e-ca64-4ceb-b443-929c97d6bc00" xlink:href="gsk-20241231.xsd#gsk_OncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_OncologyMember_ff11584e-ca64-4ceb-b443-929c97d6bc00" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember_fd7035be-8076-499d-8fa6-f50bc000b82d" xlink:href="gsk-20241231.xsd#gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember_fd7035be-8076-499d-8fa6-f50bc000b82d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PandemicMember_60063f70-88e6-4141-8417-edaa602bc73d" xlink:href="gsk-20241231.xsd#gsk_PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_PandemicMember_60063f70-88e6-4141-8417-edaa602bc73d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SpecialtyMedicineMember_0f565980-c719-4852-942d-4180706c935f" xlink:href="gsk-20241231.xsd#gsk_SpecialtyMedicineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_SpecialtyMedicineMember_0f565980-c719-4852-942d-4180706c935f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RespiratoryMember_b0d48fb3-da8c-4146-8175-2326184e1200" xlink:href="gsk-20241231.xsd#gsk_RespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_RespiratoryMember_b0d48fb3-da8c-4146-8175-2326184e1200" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherGeneralMedicinesMember_b0452c69-3486-4866-90e3-1dbc736adcf0" xlink:href="gsk-20241231.xsd#gsk_OtherGeneralMedicinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_OtherGeneralMedicinesMember_b0452c69-3486-4866-90e3-1dbc736adcf0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GeneralMedicinesMember_930a2185-20cf-48b3-ab2f-62abe63f4bfe" xlink:href="gsk-20241231.xsd#gsk_GeneralMedicinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_7ac4e90f-31b0-48b0-acde-81a2067ce55e" xlink:to="loc_gsk_GeneralMedicinesMember_930a2185-20cf-48b3-ab2f-62abe63f4bfe" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_3b3f497d-ee4d-4470-a724-1c96f42b2d35" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_027b9755-fbc7-4f62-a357-dc2dd3b335e9" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_3b3f497d-ee4d-4470-a724-1c96f42b2d35" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationSegmentProfitDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationSegmentProfitDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationSegmentProfitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_5dd6f7fd-0fc0-4bb6-88c7-e82e1fc5d132" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_5dd6f7fd-0fc0-4bb6-88c7-e82e1fc5d132" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis_3d7db27f-1c85-48c2-acda-31b5d7fe9f4f" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_5dd6f7fd-0fc0-4bb6-88c7-e82e1fc5d132" xlink:to="loc_gsk_SegmentConsolidationItemAxis_3d7db27f-1c85-48c2-acda-31b5d7fe9f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_3d7db27f-1c85-48c2-acda-31b5d7fe9f4f_default" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_SegmentConsolidationItemAxis_3d7db27f-1c85-48c2-acda-31b5d7fe9f4f" xlink:to="loc_gsk_SegmentConsolidationItemDomain_3d7db27f-1c85-48c2-acda-31b5d7fe9f4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_cf4dd172-1c63-4c46-84d3-a5769998a5bc" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_SegmentConsolidationItemAxis_3d7db27f-1c85-48c2-acda-31b5d7fe9f4f" xlink:to="loc_gsk_SegmentConsolidationItemDomain_cf4dd172-1c63-4c46-84d3-a5769998a5bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_5a001234-02df-4a02-ba13-e02b7d600a09" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_cf4dd172-1c63-4c46-84d3-a5769998a5bc" xlink:to="loc_ifrs-full_OperatingSegmentsMember_5a001234-02df-4a02-ba13-e02b7d600a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_79ca410b-c510-4d14-a09e-a298ec866a38" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_cf4dd172-1c63-4c46-84d3-a5769998a5bc" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_79ca410b-c510-4d14-a09e-a298ec866a38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_9e058126-8e04-4335-8948-97d233ba4fd2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_cf4dd172-1c63-4c46-84d3-a5769998a5bc" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_9e058126-8e04-4335-8948-97d233ba4fd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_9fe14d47-f465-408a-beca-0c0afd772df2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_5dd6f7fd-0fc0-4bb6-88c7-e82e1fc5d132" xlink:to="loc_ifrs-full_SegmentsAxis_9fe14d47-f465-408a-beca-0c0afd772df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_9fe14d47-f465-408a-beca-0c0afd772df2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_9fe14d47-f465-408a-beca-0c0afd772df2" xlink:to="loc_ifrs-full_SegmentsDomain_9fe14d47-f465-408a-beca-0c0afd772df2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_f7ee426b-737d-4811-8e32-1c5a6e71c1a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_9fe14d47-f465-408a-beca-0c0afd772df2" xlink:to="loc_ifrs-full_SegmentsDomain_f7ee426b-737d-4811-8e32-1c5a6e71c1a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_e0d4e354-8cd4-467f-8579-3e0995afdfb8" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_f7ee426b-737d-4811-8e32-1c5a6e71c1a3" xlink:to="loc_gsk_CommercialOperationsMember_e0d4e354-8cd4-467f-8579-3e0995afdfb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_e9399a56-f5a1-429e-9ab8-95bffec3a454" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_f7ee426b-737d-4811-8e32-1c5a6e71c1a3" xlink:to="loc_gsk_ResearchAndDevelopmentMember_e9399a56-f5a1-429e-9ab8-95bffec3a454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_c5de775d-6c4c-44b0-b08e-27c36c10e2b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_c5de775d-6c4c-44b0-b08e-27c36c10e2b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_bebd8730-df6b-478b-bab2-a967311c7f7d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_FinanceIncome_bebd8730-df6b-478b-bab2-a967311c7f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_a8ea03ce-1ea1-4445-9da7-5fb3b3435848" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_FinanceCosts_a8ea03ce-1ea1-4445-9da7-5fb3b3435848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnDisposalOfInterestInAssociates_8a406268-ad19-4750-8c5a-7b4adfd28725" xlink:href="gsk-20241231.xsd#gsk_GainLossOnDisposalOfInterestInAssociates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_gsk_GainLossOnDisposalOfInterestInAssociates_8a406268-ad19-4750-8c5a-7b4adfd28725" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_912570f6-6dd6-4115-a615-03ee9f0c7fb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_912570f6-6dd6-4115-a615-03ee9f0c7fb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_7074b500-1900-455b-8eab-b31a5b5d8e53" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_7074b500-1900-455b-8eab-b31a5b5d8e53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_c8473dca-0d0c-40c0-adb3-9a01b2888b8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_c8473dca-0d0c-40c0-adb3-9a01b2888b8e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_e0e3bd76-efcb-4bce-a23d-58021a388767" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_2af23ad3-222b-4d2f-a080-b5917fc7e5fa" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_e0e3bd76-efcb-4bce-a23d-58021a388767" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationDepreciationandamortisationbysegmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationDepreciationandamortisationbysegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationDepreciationandamortisationbysegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_78e88287-6538-4d94-933f-f0b0a7864772" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_aa4d28f6-5257-4337-9b33-74346215830f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_78e88287-6538-4d94-933f-f0b0a7864772" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_aa4d28f6-5257-4337-9b33-74346215830f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis_8ad310ad-b218-4672-8f3a-f748c3c97626" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_aa4d28f6-5257-4337-9b33-74346215830f" xlink:to="loc_gsk_SegmentConsolidationItemAxis_8ad310ad-b218-4672-8f3a-f748c3c97626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_8ad310ad-b218-4672-8f3a-f748c3c97626_default" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_SegmentConsolidationItemAxis_8ad310ad-b218-4672-8f3a-f748c3c97626" xlink:to="loc_gsk_SegmentConsolidationItemDomain_8ad310ad-b218-4672-8f3a-f748c3c97626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_0093c6c4-2754-42d1-8eda-7ede2e06c837" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_SegmentConsolidationItemAxis_8ad310ad-b218-4672-8f3a-f748c3c97626" xlink:to="loc_gsk_SegmentConsolidationItemDomain_0093c6c4-2754-42d1-8eda-7ede2e06c837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_4ea9a71e-d767-4dcb-bef0-8e8577ffde21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_0093c6c4-2754-42d1-8eda-7ede2e06c837" xlink:to="loc_ifrs-full_OperatingSegmentsMember_4ea9a71e-d767-4dcb-bef0-8e8577ffde21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_8b178cf4-6090-4e33-9fdc-1c491dc9ea36" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_0093c6c4-2754-42d1-8eda-7ede2e06c837" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_8b178cf4-6090-4e33-9fdc-1c491dc9ea36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_be0cd56c-c9ac-4814-b349-f3e81985458b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_0093c6c4-2754-42d1-8eda-7ede2e06c837" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_be0cd56c-c9ac-4814-b349-f3e81985458b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_e5af6105-73ab-440a-b873-9f35b60a1991" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_aa4d28f6-5257-4337-9b33-74346215830f" xlink:to="loc_ifrs-full_SegmentsAxis_e5af6105-73ab-440a-b873-9f35b60a1991" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_e5af6105-73ab-440a-b873-9f35b60a1991_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_e5af6105-73ab-440a-b873-9f35b60a1991" xlink:to="loc_ifrs-full_SegmentsDomain_e5af6105-73ab-440a-b873-9f35b60a1991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_0389fbf0-61f7-4e90-a90b-2ef0fd015c13" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_e5af6105-73ab-440a-b873-9f35b60a1991" xlink:to="loc_ifrs-full_SegmentsDomain_0389fbf0-61f7-4e90-a90b-2ef0fd015c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_f2c76786-9fa2-4b01-a2c9-589cfca70d87" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_0389fbf0-61f7-4e90-a90b-2ef0fd015c13" xlink:to="loc_gsk_CommercialOperationsMember_f2c76786-9fa2-4b01-a2c9-589cfca70d87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_509bfaf0-b7cf-4608-bafc-497745662cb7" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_0389fbf0-61f7-4e90-a90b-2ef0fd015c13" xlink:to="loc_gsk_ResearchAndDevelopmentMember_509bfaf0-b7cf-4608-bafc-497745662cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_72b2f4b6-8537-4c08-a59c-2048c07fe8d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_78e88287-6538-4d94-933f-f0b0a7864772" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_72b2f4b6-8537-4c08-a59c-2048c07fe8d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationPPEandintangibleassetimpairmentandreversalsbysegmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationPPEandintangibleassetimpairmentandreversalsbysegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationPPEandintangibleassetimpairmentandreversalsbysegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_73dac892-2226-4634-bf79-bd4fc4d7a10a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_653c97a7-6f62-4dfa-90fa-d5678375fa11" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_73dac892-2226-4634-bf79-bd4fc4d7a10a" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_653c97a7-6f62-4dfa-90fa-d5678375fa11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis_0cee20a6-a44e-4010-9045-675b340395b1" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_653c97a7-6f62-4dfa-90fa-d5678375fa11" xlink:to="loc_gsk_SegmentConsolidationItemAxis_0cee20a6-a44e-4010-9045-675b340395b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_0cee20a6-a44e-4010-9045-675b340395b1_default" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_SegmentConsolidationItemAxis_0cee20a6-a44e-4010-9045-675b340395b1" xlink:to="loc_gsk_SegmentConsolidationItemDomain_0cee20a6-a44e-4010-9045-675b340395b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_6a40ca25-c3a0-470f-9d7c-f766b3d57992" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_SegmentConsolidationItemAxis_0cee20a6-a44e-4010-9045-675b340395b1" xlink:to="loc_gsk_SegmentConsolidationItemDomain_6a40ca25-c3a0-470f-9d7c-f766b3d57992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_55740483-1a31-4b2b-845f-f7362cbf5220" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_6a40ca25-c3a0-470f-9d7c-f766b3d57992" xlink:to="loc_ifrs-full_OperatingSegmentsMember_55740483-1a31-4b2b-845f-f7362cbf5220" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_8cafd7f4-69d6-413f-a063-cbba62c8b2e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_6a40ca25-c3a0-470f-9d7c-f766b3d57992" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_8cafd7f4-69d6-413f-a063-cbba62c8b2e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_a8c0baba-738e-43db-ade1-6c9c090c6887" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_6a40ca25-c3a0-470f-9d7c-f766b3d57992" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_a8c0baba-738e-43db-ade1-6c9c090c6887" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_f8d34e59-cbaa-46e2-b568-6d39eaed2a4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_653c97a7-6f62-4dfa-90fa-d5678375fa11" xlink:to="loc_ifrs-full_SegmentsAxis_f8d34e59-cbaa-46e2-b568-6d39eaed2a4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_f8d34e59-cbaa-46e2-b568-6d39eaed2a4b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_f8d34e59-cbaa-46e2-b568-6d39eaed2a4b" xlink:to="loc_ifrs-full_SegmentsDomain_f8d34e59-cbaa-46e2-b568-6d39eaed2a4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_dc7b7afa-86c5-432d-ad2b-bf6ff3cd34e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_f8d34e59-cbaa-46e2-b568-6d39eaed2a4b" xlink:to="loc_ifrs-full_SegmentsDomain_dc7b7afa-86c5-432d-ad2b-bf6ff3cd34e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_2f4abc7e-74e2-42b2-b2c2-c61ad7a6cdc9" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_dc7b7afa-86c5-432d-ad2b-bf6ff3cd34e4" xlink:to="loc_gsk_CommercialOperationsMember_2f4abc7e-74e2-42b2-b2c2-c61ad7a6cdc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_a0fef616-07a3-469f-b484-79939bc092c4" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_dc7b7afa-86c5-432d-ad2b-bf6ff3cd34e4" xlink:to="loc_gsk_ResearchAndDevelopmentMember_a0fef616-07a3-469f-b484-79939bc092c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_3692a047-6a3f-4ec1-b192-3e1191b756b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_73dac892-2226-4634-bf79-bd4fc4d7a10a" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_3692a047-6a3f-4ec1-b192-3e1191b756b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_69265b1a-b214-4031-92e6-5489feabeeaf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_73dac892-2226-4634-bf79-bd4fc4d7a10a" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_69265b1a-b214-4031-92e6-5489feabeeaf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationNetoperatingassetsbysegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1e15a2f6-8874-4931-a104-7684611c9975" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1e15a2f6-8874-4931-a104-7684611c9975" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis_676865d6-271c-4fef-93ce-1e5db19ca7c3" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1e15a2f6-8874-4931-a104-7684611c9975" xlink:to="loc_gsk_SegmentConsolidationItemAxis_676865d6-271c-4fef-93ce-1e5db19ca7c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_676865d6-271c-4fef-93ce-1e5db19ca7c3_default" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_SegmentConsolidationItemAxis_676865d6-271c-4fef-93ce-1e5db19ca7c3" xlink:to="loc_gsk_SegmentConsolidationItemDomain_676865d6-271c-4fef-93ce-1e5db19ca7c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_d218bc5b-ec6d-4c25-ae1e-eddc597e2c8b" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_SegmentConsolidationItemAxis_676865d6-271c-4fef-93ce-1e5db19ca7c3" xlink:to="loc_gsk_SegmentConsolidationItemDomain_d218bc5b-ec6d-4c25-ae1e-eddc597e2c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_eb14de9c-f100-47c5-8227-46b5128b86b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_d218bc5b-ec6d-4c25-ae1e-eddc597e2c8b" xlink:to="loc_ifrs-full_OperatingSegmentsMember_eb14de9c-f100-47c5-8227-46b5128b86b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_f8d61821-4fdd-472c-9b22-45d659befa1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_d218bc5b-ec6d-4c25-ae1e-eddc597e2c8b" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_f8d61821-4fdd-472c-9b22-45d659befa1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_7b611a62-123c-4489-a579-6134eba645f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1e15a2f6-8874-4931-a104-7684611c9975" xlink:to="loc_ifrs-full_SegmentsAxis_7b611a62-123c-4489-a579-6134eba645f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_7b611a62-123c-4489-a579-6134eba645f1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_7b611a62-123c-4489-a579-6134eba645f1" xlink:to="loc_ifrs-full_SegmentsDomain_7b611a62-123c-4489-a579-6134eba645f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_72bfdb09-fdf6-406d-bc40-6c75d489c0ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_7b611a62-123c-4489-a579-6134eba645f1" xlink:to="loc_ifrs-full_SegmentsDomain_72bfdb09-fdf6-406d-bc40-6c75d489c0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_eb0c9106-d83f-44d7-b860-d2b16def5fa0" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_72bfdb09-fdf6-406d-bc40-6c75d489c0ca" xlink:to="loc_gsk_CommercialOperationsMember_eb0c9106-d83f-44d7-b860-d2b16def5fa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_04a68e52-83a0-46ab-9f92-fd71e2958465" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_72bfdb09-fdf6-406d-bc40-6c75d489c0ca" xlink:to="loc_gsk_ResearchAndDevelopmentMember_04a68e52-83a0-46ab-9f92-fd71e2958465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetOperatingAssets_0e0efa5f-8ae7-4cdd-a6cc-39d5ca74f626" xlink:href="gsk-20241231.xsd#gsk_NetOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_gsk_NetOperatingAssets_0e0efa5f-8ae7-4cdd-a6cc-39d5ca74f626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDebt_2d947e27-7a21-499e-89ba-f979e7b88546" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_ifrs-full_NetDebt_2d947e27-7a21-499e-89ba-f979e7b88546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsInJointVenturesAndAssociates_fd54706a-4207-4879-b782-77a527ef19b7" xlink:href="gsk-20241231.xsd#gsk_InvestmentsInJointVenturesAndAssociates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_gsk_InvestmentsInJointVenturesAndAssociates_fd54706a-4207-4879-b782-77a527ef19b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_7da30153-d9ca-45b6-96a6-9a2df805988c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_7da30153-d9ca-45b6-96a6-9a2df805988c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_ee94d5a0-bdf5-477d-a477-faf164a75ca1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_ee94d5a0-bdf5-477d-a477-faf164a75ca1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentAndDeferredTaxation_9a0454ec-456e-4c47-b6d7-d6368aa44e64" xlink:href="gsk-20241231.xsd#gsk_CurrentAndDeferredTaxation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_gsk_CurrentAndDeferredTaxation_9a0454ec-456e-4c47-b6d7-d6368aa44e64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_3a98b604-8311-4da5-afb6-45748c44db7c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_3a98b604-8311-4da5-afb6-45748c44db7c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities_83578246-6d8b-43b5-9773-00fa59b3342f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_46229355-128e-49c3-b88b-623681d933c7" xlink:to="loc_ifrs-full_NetAssetsLiabilities_83578246-6d8b-43b5-9773-00fa59b3342f" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TurnoverandsegmentinformationSummaryofGeographicalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TurnoverandsegmentinformationSummaryofGeographicalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TurnoverandsegmentinformationSummaryofGeographicalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_38c9a40a-d245-48a2-96d6-675bd6f25582" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_b45b7028-509a-400a-a214-f7510906793a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_38c9a40a-d245-48a2-96d6-675bd6f25582" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_b45b7028-509a-400a-a214-f7510906793a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_bca8dfae-b6e2-4aee-881e-7aabc3715905" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_b45b7028-509a-400a-a214-f7510906793a" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_bca8dfae-b6e2-4aee-881e-7aabc3715905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_bca8dfae-b6e2-4aee-881e-7aabc3715905_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_bca8dfae-b6e2-4aee-881e-7aabc3715905" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_bca8dfae-b6e2-4aee-881e-7aabc3715905_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2f8059af-ac15-4f30-b505-246ed085b079" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_bca8dfae-b6e2-4aee-881e-7aabc3715905" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2f8059af-ac15-4f30-b505-246ed085b079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerMember_554171d0-93b3-4fff-a2b0-a00f9cf2502b" xlink:href="gsk-20241231.xsd#gsk_CustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2f8059af-ac15-4f30-b505-246ed085b079" xlink:to="loc_gsk_CustomerMember_554171d0-93b3-4fff-a2b0-a00f9cf2502b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_ecb957c3-86cc-447f-8c0f-25f5482ac7e5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_b45b7028-509a-400a-a214-f7510906793a" xlink:to="loc_ifrs-full_GeographicalAreasAxis_ecb957c3-86cc-447f-8c0f-25f5482ac7e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_ecb957c3-86cc-447f-8c0f-25f5482ac7e5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_ecb957c3-86cc-447f-8c0f-25f5482ac7e5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_ecb957c3-86cc-447f-8c0f-25f5482ac7e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_9d56bca7-4efd-4da4-8ab1-36e20c12f9bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_ecb957c3-86cc-447f-8c0f-25f5482ac7e5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_9d56bca7-4efd-4da4-8ab1-36e20c12f9bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_a0c7f3be-9e1f-4dff-af7f-132f4f823997" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9d56bca7-4efd-4da4-8ab1-36e20c12f9bc" xlink:to="loc_country_GB_a0c7f3be-9e1f-4dff-af7f-132f4f823997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a0dfebb3-5d43-4e2d-8353-257c6690ddd4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9d56bca7-4efd-4da4-8ab1-36e20c12f9bc" xlink:to="loc_country_US_a0dfebb3-5d43-4e2d-8353-257c6690ddd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BE_4e5c1439-7202-481e-ae5b-79027eca9daf" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_BE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9d56bca7-4efd-4da4-8ab1-36e20c12f9bc" xlink:to="loc_country_BE_4e5c1439-7202-481e-ae5b-79027eca9daf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember_d47a4989-34e5-4021-8b8a-2b1e839efca2" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9d56bca7-4efd-4da4-8ab1-36e20c12f9bc" xlink:to="loc_gsk_RestOfWorldMember_d47a4989-34e5-4021-8b8a-2b1e839efca2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_ff447702-7313-4eca-8e4f-57f247d038e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_38c9a40a-d245-48a2-96d6-675bd6f25582" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_ff447702-7313-4eca-8e4f-57f247d038e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_0bfad3fe-bf21-4ed1-af95-a5da548316ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_38c9a40a-d245-48a2-96d6-675bd6f25582" xlink:to="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_0bfad3fe-bf21-4ed1-af95-a5da548316ba" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtheroperatingincomeexpenseInformationaboutOtherOperatingIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f7c0cca3-c9bb-4ffd-8395-4f5c1af1ba6f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f7c0cca3-c9bb-4ffd-8395-4f5c1af1ba6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2f57b322-b971-487f-8064-feb138e06c81" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_f7c0cca3-c9bb-4ffd-8395-4f5c1af1ba6f" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2f57b322-b971-487f-8064-feb138e06c81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2f57b322-b971-487f-8064-feb138e06c81_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2f57b322-b971-487f-8064-feb138e06c81" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2f57b322-b971-487f-8064-feb138e06c81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15c107d5-1853-4ca6-8a7d-42807e22c2bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2f57b322-b971-487f-8064-feb138e06c81" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15c107d5-1853-4ca6-8a7d-42807e22c2bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GileadSciencesIncMember_34d072da-a114-4f0f-bc04-c2c4b6528977" xlink:href="gsk-20241231.xsd#gsk_GileadSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15c107d5-1853-4ca6-8a7d-42807e22c2bb" xlink:to="loc_gsk_GileadSciencesIncMember_34d072da-a114-4f0f-bc04-c2c4b6528977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UpfrontSettlementIncome_f938b0ab-e546-4b02-8401-125842854498" xlink:href="gsk-20241231.xsd#gsk_UpfrontSettlementIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_gsk_UpfrontSettlementIncome_f938b0ab-e546-4b02-8401-125842854498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments_3e58c258-a2c6-417e-8dd8-176b3f7e57e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments_3e58c258-a2c6-417e-8dd8-176b3f7e57e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalOfBusinessesAndAssets_9aa3a221-d829-4e67-8fcc-22b2fd9277cd" xlink:href="gsk-20241231.xsd#gsk_DisposalOfBusinessesAndAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_gsk_DisposalOfBusinessesAndAssets_9aa3a221-d829-4e67-8fcc-22b2fd9277cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_67ac7c7a-c46a-4f02-9700-6ebbcccd59c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_67ac7c7a-c46a-4f02-9700-6ebbcccd59c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_48e1da7b-e2af-4ab0-b55e-8c6abdea6a85" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_48e1da7b-e2af-4ab0-b55e-8c6abdea6a85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_c6ecbabf-fccc-400c-a6e6-933f43eee16f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_c6ecbabf-fccc-400c-a6e6-933f43eee16f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousOtherIncomeExpense_bea66d5c-05a0-40fb-96c0-ea0feacdf43c" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_gsk_MiscellaneousOtherIncomeExpense_bea66d5c-05a0-40fb-96c0-ea0feacdf43c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_dd1a85e3-35c7-4611-af0b-5eeff2162ae6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_dd1a85e3-35c7-4611-af0b-5eeff2162ae6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UpfrontPayment_e2773276-73de-47c9-ba2b-60e5d2a7cbd6" xlink:href="gsk-20241231.xsd#gsk_UpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_gsk_UpfrontPayment_e2773276-73de-47c9-ba2b-60e5d2a7cbd6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfRoyaltyPayableOnFutureSales_d2c84be8-68bb-464f-be9a-9f661c4d39ee" xlink:href="gsk-20241231.xsd#gsk_PercentageOfRoyaltyPayableOnFutureSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7dcbf365-c5da-40a0-a697-2e2d34540278" xlink:to="loc_gsk_PercentageOfRoyaltyPayableOnFutureSales_d2c84be8-68bb-464f-be9a-9f661c4d39ee" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtheroperatingincomeexpenseAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtheroperatingincomeexpenseAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtheroperatingincomeexpenseAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_186fa8d9-b671-4f50-a2df-5fd67db9241a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_0471192b-0092-484c-8f59-6da27172f5c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_186fa8d9-b671-4f50-a2df-5fd67db9241a" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_0471192b-0092-484c-8f59-6da27172f5c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentAxis_8bf90614-82eb-4de2-a5b3-824f2b893189" xlink:href="gsk-20241231.xsd#gsk_InvestmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_0471192b-0092-484c-8f59-6da27172f5c0" xlink:to="loc_gsk_InvestmentAxis_8bf90614-82eb-4de2-a5b3-824f2b893189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentDomain_8bf90614-82eb-4de2-a5b3-824f2b893189_default" xlink:href="gsk-20241231.xsd#gsk_InvestmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_InvestmentAxis_8bf90614-82eb-4de2-a5b3-824f2b893189" xlink:to="loc_gsk_InvestmentDomain_8bf90614-82eb-4de2-a5b3-824f2b893189_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentDomain_3168832a-9ed4-467d-a789-62de2f52529b" xlink:href="gsk-20241231.xsd#gsk_InvestmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_InvestmentAxis_8bf90614-82eb-4de2-a5b3-824f2b893189" xlink:to="loc_gsk_InvestmentDomain_3168832a-9ed4-467d-a789-62de2f52529b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HaleonPlcMember_930241dd-8e08-4a27-9dfa-c4e2e37762b8" xlink:href="gsk-20241231.xsd#gsk_HaleonPlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_InvestmentDomain_3168832a-9ed4-467d-a789-62de2f52529b" xlink:to="loc_gsk_HaleonPlcMember_930241dd-8e08-4a27-9dfa-c4e2e37762b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1de699eb-5af6-4829-b178-02c944c375ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_0471192b-0092-484c-8f59-6da27172f5c0" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1de699eb-5af6-4829-b178-02c944c375ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1de699eb-5af6-4829-b178-02c944c375ba_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1de699eb-5af6-4829-b178-02c944c375ba" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1de699eb-5af6-4829-b178-02c944c375ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_0baa98d4-abb2-4ce7-ae64-e5970e725289" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1de699eb-5af6-4829-b178-02c944c375ba" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_0baa98d4-abb2-4ce7-ae64-e5970e725289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViivHealthcareMember_8664cdd6-7b07-4bc0-bb5f-20babde2dd24" xlink:href="gsk-20241231.xsd#gsk_ShionogiViivHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_0baa98d4-abb2-4ce7-ae64-e5970e725289" xlink:to="loc_gsk_ShionogiViivHealthcareMember_8664cdd6-7b07-4bc0-bb5f-20babde2dd24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisVaccinesMember_b9bb86a5-e677-451e-86b1-2e7db8da8690" xlink:href="gsk-20241231.xsd#gsk_NovartisVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_0baa98d4-abb2-4ce7-ae64-e5970e725289" xlink:to="loc_gsk_NovartisVaccinesMember_b9bb86a5-e677-451e-86b1-2e7db8da8690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss_0b0255cd-0fe0-4714-8ea4-e43d6fa4636a" xlink:href="gsk-20241231.xsd#gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_186fa8d9-b671-4f50-a2df-5fd67db9241a" xlink:to="loc_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss_0b0255cd-0fe0-4714-8ea4-e43d6fa4636a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_0ecfccca-d334-47f6-b1f7-7daf49cac3d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_186fa8d9-b671-4f50-a2df-5fd67db9241a" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_0ecfccca-d334-47f6-b1f7-7daf49cac3d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceived_6d25466a-377e-490c-b018-9b9d95a17220" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_186fa8d9-b671-4f50-a2df-5fd67db9241a" xlink:to="loc_ifrs-full_DividendsReceived_6d25466a-377e-490c-b018-9b9d95a17220" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OperatingprofitAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OperatingprofitAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OperatingprofitAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOperatingProfitLineItems_6c7eca88-583d-49e4-91b4-2ba1a43a3bec" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOperatingProfitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOperatingProfitTable_733d7d99-9281-4b63-86a8-d8a2b5a2fadb" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOperatingProfitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfOperatingProfitLineItems_6c7eca88-583d-49e4-91b4-2ba1a43a3bec" xlink:to="loc_gsk_DisclosureOfOperatingProfitTable_733d7d99-9281-4b63-86a8-d8a2b5a2fadb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0ad36a88-20a1-4181-935f-6680eab6ea4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfOperatingProfitTable_733d7d99-9281-4b63-86a8-d8a2b5a2fadb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0ad36a88-20a1-4181-935f-6680eab6ea4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0ad36a88-20a1-4181-935f-6680eab6ea4d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0ad36a88-20a1-4181-935f-6680eab6ea4d" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0ad36a88-20a1-4181-935f-6680eab6ea4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d7cf423a-6ab9-4749-991a-76e393f2ee2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0ad36a88-20a1-4181-935f-6680eab6ea4d" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d7cf423a-6ab9-4749-991a-76e393f2ee2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember_a1881d55-cbcf-4e3b-a038-f23c410c66c9" xlink:href="gsk-20241231.xsd#gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_d7cf423a-6ab9-4749-991a-76e393f2ee2d" xlink:to="loc_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember_a1881d55-cbcf-4e3b-a038-f23c410c66c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_a2548984-2ea5-428b-8250-c3c39e587676" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfOperatingProfitTable_733d7d99-9281-4b63-86a8-d8a2b5a2fadb" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_a2548984-2ea5-428b-8250-c3c39e587676" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_a2548984-2ea5-428b-8250-c3c39e587676_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_a2548984-2ea5-428b-8250-c3c39e587676" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_a2548984-2ea5-428b-8250-c3c39e587676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_90f57bf3-5999-463e-bc08-91f017b177cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_a2548984-2ea5-428b-8250-c3c39e587676" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_90f57bf3-5999-463e-bc08-91f017b177cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidationOrDisposalOfInterestInAssociatesMember_6d63b29a-9b4d-458b-8e70-3719d7e61e4b" xlink:href="gsk-20241231.xsd#gsk_LiquidationOrDisposalOfInterestInAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_90f57bf3-5999-463e-bc08-91f017b177cf" xlink:to="loc_gsk_LiquidationOrDisposalOfInterestInAssociatesMember_6d63b29a-9b4d-458b-8e70-3719d7e61e4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PurposeAxis_75d6f95f-51cf-4c12-a491-43f3684aaa92" xlink:href="gsk-20241231.xsd#gsk_PurposeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfOperatingProfitTable_733d7d99-9281-4b63-86a8-d8a2b5a2fadb" xlink:to="loc_gsk_PurposeAxis_75d6f95f-51cf-4c12-a491-43f3684aaa92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PurposeDomain_75d6f95f-51cf-4c12-a491-43f3684aaa92_default" xlink:href="gsk-20241231.xsd#gsk_PurposeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_PurposeAxis_75d6f95f-51cf-4c12-a491-43f3684aaa92" xlink:to="loc_gsk_PurposeDomain_75d6f95f-51cf-4c12-a491-43f3684aaa92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PurposeDomain_61b9ac8e-58ed-439b-9547-238b36c25f66" xlink:href="gsk-20241231.xsd#gsk_PurposeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_PurposeAxis_75d6f95f-51cf-4c12-a491-43f3684aaa92" xlink:to="loc_gsk_PurposeDomain_61b9ac8e-58ed-439b-9547-238b36c25f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember_3919bfc7-89b5-4084-8d80-60aab3d110f2" xlink:href="gsk-20241231.xsd#gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_PurposeDomain_61b9ac8e-58ed-439b-9547-238b36c25f66" xlink:to="loc_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember_3919bfc7-89b5-4084-8d80-60aab3d110f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_4e5a8d84-18f2-4ed7-a30f-f777466df3f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOperatingProfitLineItems_6c7eca88-583d-49e4-91b4-2ba1a43a3bec" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_4e5a8d84-18f2-4ed7-a30f-f777466df3f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnDisposalOfInterestInAssociates_db0b9d32-13fc-4aa7-9074-039785bbd404" xlink:href="gsk-20241231.xsd#gsk_GainLossOnDisposalOfInterestInAssociates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOperatingProfitLineItems_6c7eca88-583d-49e4-91b4-2ba1a43a3bec" xlink:to="loc_gsk_GainLossOnDisposalOfInterestInAssociates_db0b9d32-13fc-4aa7-9074-039785bbd404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_afa2fe5a-33bc-4fea-9455-7f83e8dbb4b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOperatingProfitLineItems_6c7eca88-583d-49e4-91b4-2ba1a43a3bec" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_afa2fe5a-33bc-4fea-9455-7f83e8dbb4b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_1fac2a84-f926-4f6a-8be8-0a5b383098c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOperatingProfitLineItems_6c7eca88-583d-49e4-91b4-2ba1a43a3bec" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_1fac2a84-f926-4f6a-8be8-0a5b383098c6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OperatingprofitSummaryofAuditorsRemunerationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OperatingprofitSummaryofAuditorsRemunerationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OperatingprofitSummaryofAuditorsRemunerationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAuditorsRemunerationLineItems_01d14dc5-2547-4dc5-9eac-cf2690f00f21" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAuditorsRemunerationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAuditorsRemunerationTable_1b7e10a9-3b81-479d-8ea3-bc880fab76ab" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAuditorsRemunerationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfAuditorsRemunerationLineItems_01d14dc5-2547-4dc5-9eac-cf2690f00f21" xlink:to="loc_gsk_DisclosureOfAuditorsRemunerationTable_1b7e10a9-3b81-479d-8ea3-bc880fab76ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1f353d48-53ce-40a8-85a5-1696f6e67dd0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAuditorsRemunerationTable_1b7e10a9-3b81-479d-8ea3-bc880fab76ab" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1f353d48-53ce-40a8-85a5-1696f6e67dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1f353d48-53ce-40a8-85a5-1696f6e67dd0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1f353d48-53ce-40a8-85a5-1696f6e67dd0" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1f353d48-53ce-40a8-85a5-1696f6e67dd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5e838975-2fe0-487b-bb07-61606a5bc1b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1f353d48-53ce-40a8-85a5-1696f6e67dd0" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5e838975-2fe0-487b-bb07-61606a5bc1b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParentMember_c24e9fbb-118f-43fb-a497-2ba52cef8cb1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5e838975-2fe0-487b-bb07-61606a5bc1b7" xlink:to="loc_ifrs-full_ParentMember_c24e9fbb-118f-43fb-a497-2ba52cef8cb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubsidiariesMember_92825af3-5b9a-4ecb-9f89-c186ed1a5387" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5e838975-2fe0-487b-bb07-61606a5bc1b7" xlink:to="loc_ifrs-full_SubsidiariesMember_92825af3-5b9a-4ecb-9f89-c186ed1a5387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_a8b68c3b-d1b5-410c-8930-abeb7c14c08a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfAuditorsRemunerationTable_1b7e10a9-3b81-479d-8ea3-bc880fab76ab" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_a8b68c3b-d1b5-410c-8930-abeb7c14c08a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_a8b68c3b-d1b5-410c-8930-abeb7c14c08a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_a8b68c3b-d1b5-410c-8930-abeb7c14c08a" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_a8b68c3b-d1b5-410c-8930-abeb7c14c08a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_0ab1cbd1-6d5e-4de4-b269-9447ae5d1908" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_a8b68c3b-d1b5-410c-8930-abeb7c14c08a" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_0ab1cbd1-6d5e-4de4-b269-9447ae5d1908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_0f9bc946-cb27-4da9-af7b-727ccba530ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0ab1cbd1-6d5e-4de4-b269-9447ae5d1908" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_0f9bc946-cb27-4da9-af7b-727ccba530ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationAbstract_d221cdcb-4101-445d-ad1d-4b557312a6e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfAuditorsRemunerationLineItems_01d14dc5-2547-4dc5-9eac-cf2690f00f21" xlink:to="loc_ifrs-full_AuditorsRemunerationAbstract_d221cdcb-4101-445d-ad1d-4b557312a6e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_67f5e0d8-4266-4cb7-803e-fb47378fabab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_d221cdcb-4101-445d-ad1d-4b557312a6e6" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_67f5e0d8-4266-4cb7-803e-fb47378fabab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditorsRemunerationForOtherAssuranceServices_2b28bebc-fcd6-421b-9c85-579834b36125" xlink:href="gsk-20241231.xsd#gsk_AuditorsRemunerationForOtherAssuranceServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_d221cdcb-4101-445d-ad1d-4b557312a6e6" xlink:to="loc_gsk_AuditorsRemunerationForOtherAssuranceServices_2b28bebc-fcd6-421b-9c85-579834b36125" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_9aa46760-ee6b-4ca0-8bc4-01c0fff29966" xlink:href="gsk-20241231.xsd#gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_d221cdcb-4101-445d-ad1d-4b557312a6e6" xlink:to="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_9aa46760-ee6b-4ca0-8bc4-01c0fff29966" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeecostsSummaryofCostofSharebasedIncentivePlansDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeecostsSummaryofCostofSharebasedIncentivePlansDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeecostsSummaryofCostofSharebasedIncentivePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems_d300909a-1cd4-493c-a9c4-ee819fd5d173" xlink:href="gsk-20241231.xsd#gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f8f1fe87-e66d-46a5-ac1b-6d1f30c50958" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems_d300909a-1cd4-493c-a9c4-ee819fd5d173" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f8f1fe87-e66d-46a5-ac1b-6d1f30c50958" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8484c74d-1188-4008-bb43-43c881f7aeda" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_f8f1fe87-e66d-46a5-ac1b-6d1f30c50958" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8484c74d-1188-4008-bb43-43c881f7aeda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8484c74d-1188-4008-bb43-43c881f7aeda_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8484c74d-1188-4008-bb43-43c881f7aeda" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_8484c74d-1188-4008-bb43-43c881f7aeda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_b4f3da00-074d-4565-80db-a08a2dded618" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8484c74d-1188-4008-bb43-43c881f7aeda" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_b4f3da00-074d-4565-80db-a08a2dded618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareValuePlanMember_8feb370d-95dc-42d8-8701-e7702d7b0a13" xlink:href="gsk-20241231.xsd#gsk_ShareValuePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_b4f3da00-074d-4565-80db-a08a2dded618" xlink:to="loc_gsk_ShareValuePlanMember_8feb370d-95dc-42d8-8701-e7702d7b0a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PerformanceSharePlansMember_7cfeea8b-1a8a-4131-b021-abc51e1e4f27" xlink:href="gsk-20241231.xsd#gsk_PerformanceSharePlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_b4f3da00-074d-4565-80db-a08a2dded618" xlink:to="loc_gsk_PerformanceSharePlansMember_7cfeea8b-1a8a-4131-b021-abc51e1e4f27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOptionPlanMember_c9d5ae0b-a6ed-41fa-a176-110537ce80b2" xlink:href="gsk-20241231.xsd#gsk_ShareOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_b4f3da00-074d-4565-80db-a08a2dded618" xlink:to="loc_gsk_ShareOptionPlanMember_c9d5ae0b-a6ed-41fa-a176-110537ce80b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashSettledAndOtherPlansMember_cfcbfd77-e2d4-492b-bf5a-3cd2d6e61588" xlink:href="gsk-20241231.xsd#gsk_CashSettledAndOtherPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_b4f3da00-074d-4565-80db-a08a2dded618" xlink:to="loc_gsk_CashSettledAndOtherPlansMember_cfcbfd77-e2d4-492b-bf5a-3cd2d6e61588" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8da8f2df-49d5-40d6-99d5-8e9eb05237de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems_d300909a-1cd4-493c-a9c4-ee819fd5d173" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8da8f2df-49d5-40d6-99d5-8e9eb05237de" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeecostsDisclosureofAverageMonthlyNumberofPersonsEmployedbytheGroupIncludingDirectorsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_d9a90704-9982-4fc5-8db8-a4c52a3b9b94" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfEmployeeCostsAndNumbersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfEmployeeCostsAndNumbersTable_e93dfb91-d4db-40e9-86b2-9b157adb4aa3" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfEmployeeCostsAndNumbersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_d9a90704-9982-4fc5-8db8-a4c52a3b9b94" xlink:to="loc_gsk_DisclosureOfEmployeeCostsAndNumbersTable_e93dfb91-d4db-40e9-86b2-9b157adb4aa3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_92e06633-f4a5-41f8-8308-db21cf4f91b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfEmployeeCostsAndNumbersTable_e93dfb91-d4db-40e9-86b2-9b157adb4aa3" xlink:to="loc_ifrs-full_SegmentsAxis_92e06633-f4a5-41f8-8308-db21cf4f91b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_92e06633-f4a5-41f8-8308-db21cf4f91b6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_92e06633-f4a5-41f8-8308-db21cf4f91b6" xlink:to="loc_ifrs-full_SegmentsDomain_92e06633-f4a5-41f8-8308-db21cf4f91b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_ac0d6a23-74b7-4c98-a3fc-4d83333f2411" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_92e06633-f4a5-41f8-8308-db21cf4f91b6" xlink:to="loc_ifrs-full_SegmentsDomain_ac0d6a23-74b7-4c98-a3fc-4d83333f2411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ManufacturingMember_01cc8936-6477-4e54-88dd-62a850292b5a" xlink:href="gsk-20241231.xsd#gsk_ManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_ac0d6a23-74b7-4c98-a3fc-4d83333f2411" xlink:to="loc_gsk_ManufacturingMember_01cc8936-6477-4e54-88dd-62a850292b5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellingGeneralAndAdministrationMember_e4edb029-cdb5-4c01-8f17-05a94c8a5c63" xlink:href="gsk-20241231.xsd#gsk_SellingGeneralAndAdministrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_ac0d6a23-74b7-4c98-a3fc-4d83333f2411" xlink:to="loc_gsk_SellingGeneralAndAdministrationMember_e4edb029-cdb5-4c01-8f17-05a94c8a5c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_39984691-839b-4dbb-acf0-26d60469e2ce" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_ac0d6a23-74b7-4c98-a3fc-4d83333f2411" xlink:to="loc_gsk_ResearchAndDevelopmentMember_39984691-839b-4dbb-acf0-26d60469e2ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageNumberOfEmployeesFromContinuingOperations_f38493f1-9dfe-45ea-a5b3-9c90a6187b72" xlink:href="gsk-20241231.xsd#gsk_AverageNumberOfEmployeesFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_d9a90704-9982-4fc5-8db8-a4c52a3b9b94" xlink:to="loc_gsk_AverageNumberOfEmployeesFromContinuingOperations_f38493f1-9dfe-45ea-a5b3-9c90a6187b72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_10eb47fe-5f1d-4c93-9a08-a8afe5b71398" xlink:href="gsk-20241231.xsd#gsk_AverageNumberOfEmployeesFromDiscontinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_d9a90704-9982-4fc5-8db8-a4c52a3b9b94" xlink:to="loc_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_10eb47fe-5f1d-4c93-9a08-a8afe5b71398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_21d5dc42-c479-4a44-83b5-913926b7a1ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_d9a90704-9982-4fc5-8db8-a4c52a3b9b94" xlink:to="loc_ifrs-full_AverageNumberOfEmployees_21d5dc42-c479-4a44-83b5-913926b7a1ee" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsTable_f6a69f46-930c-43b3-9a26-8f25acacb3b1" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_DisclosureOfRestructuringCostsTable_f6a69f46-930c-43b3-9a26-8f25acacb3b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c704473c-0071-4c53-bf9a-decf9b2f450a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRestructuringCostsTable_f6a69f46-930c-43b3-9a26-8f25acacb3b1" xlink:to="loc_srt_RangeAxis_c704473c-0071-4c53-bf9a-decf9b2f450a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c704473c-0071-4c53-bf9a-decf9b2f450a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c704473c-0071-4c53-bf9a-decf9b2f450a" xlink:to="loc_srt_RangeMember_c704473c-0071-4c53-bf9a-decf9b2f450a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0bfc250-2e8d-4c48-af9c-09c2c4159560" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c704473c-0071-4c53-bf9a-decf9b2f450a" xlink:to="loc_srt_RangeMember_f0bfc250-2e8d-4c48-af9c-09c2c4159560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_46e1c9f5-ea6b-4474-91bb-b53ac2f112fa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0bfc250-2e8d-4c48-af9c-09c2c4159560" xlink:to="loc_srt_MinimumMember_46e1c9f5-ea6b-4474-91bb-b53ac2f112fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeAxis_cab47a34-9ef6-4df6-bda8-91d7be1fb175" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRestructuringCostsTable_f6a69f46-930c-43b3-9a26-8f25acacb3b1" xlink:to="loc_gsk_ArrangementTypeAxis_cab47a34-9ef6-4df6-bda8-91d7be1fb175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain_cab47a34-9ef6-4df6-bda8-91d7be1fb175_default" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ArrangementTypeAxis_cab47a34-9ef6-4df6-bda8-91d7be1fb175" xlink:to="loc_gsk_ArrangementTypeDomain_cab47a34-9ef6-4df6-bda8-91d7be1fb175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain_be8ba135-73f1-4d26-bed5-3344a69d6e16" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ArrangementTypeAxis_cab47a34-9ef6-4df6-bda8-91d7be1fb175" xlink:to="loc_gsk_ArrangementTypeDomain_be8ba135-73f1-4d26-bed5-3344a69d6e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SeparationRestructuringProgrammeMember_44db5369-ed2d-4683-987b-ca78ecb7148e" xlink:href="gsk-20241231.xsd#gsk_SeparationRestructuringProgrammeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ArrangementTypeDomain_be8ba135-73f1-4d26-bed5-3344a69d6e16" xlink:to="loc_gsk_SeparationRestructuringProgrammeMember_44db5369-ed2d-4683-987b-ca78ecb7148e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MajorRestructuringCostThreshold_ff2f1410-9fbb-427c-b731-f8ece67ccf44" xlink:href="gsk-20241231.xsd#gsk_MajorRestructuringCostThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_MajorRestructuringCostThreshold_ff2f1410-9fbb-427c-b731-f8ece67ccf44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCompaniesSplitInto_a30dea05-6863-4016-be17-ba0ca1e5a38a" xlink:href="gsk-20241231.xsd#gsk_NumberOfCompaniesSplitInto"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_NumberOfCompaniesSplitInto_a30dea05-6863-4016-be17-ba0ca1e5a38a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalRestructuringCosts_aef8ef74-5f39-46a3-a5d4-0eb4590e82d2" xlink:href="gsk-20241231.xsd#gsk_TotalRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_TotalRestructuringCosts_aef8ef74-5f39-46a3-a5d4-0eb4590e82d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProvisionReversalRestructuring_e0abd8e7-40c0-4e8b-a7c4-7db730bbd9dc" xlink:href="gsk-20241231.xsd#gsk_ProvisionReversalRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_ProvisionReversalRestructuring_e0abd8e7-40c0-4e8b-a7c4-7db730bbd9dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssetImpairmentsCredit_68bf7a01-ece7-4b10-abed-551260fb473c" xlink:href="gsk-20241231.xsd#gsk_AssetImpairmentsCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_AssetImpairmentsCredit_68bf7a01-ece7-4b10-abed-551260fb473c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNonCashCreditCharges_74b8ffeb-8a1a-473b-809f-2750e95a6afb" xlink:href="gsk-20241231.xsd#gsk_OtherNonCashCreditCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_OtherNonCashCreditCharges_74b8ffeb-8a1a-473b-809f-2750e95a6afb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringNumberOfCompaniesSeparatedInto_886e1a14-1d3a-4c43-815d-330cd80f8e6f" xlink:href="gsk-20241231.xsd#gsk_RestructuringNumberOfCompaniesSeparatedInto"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_398c22f1-4ae5-4c9a-a743-7a4f171f5442" xlink:to="loc_gsk_RestructuringNumberOfCompaniesSeparatedInto_886e1a14-1d3a-4c43-815d-330cd80f8e6f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsSummaryofAnalysisofCostsChargedtoOperatingProfitFromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsTable_f68d4cea-6f4d-4c07-adbc-05c3b5935633" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_gsk_DisclosureOfRestructuringCostsTable_f68d4cea-6f4d-4c07-adbc-05c3b5935633" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeAxis_d5a2b2ea-4d03-407b-be5e-e81eb933d451" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRestructuringCostsTable_f68d4cea-6f4d-4c07-adbc-05c3b5935633" xlink:to="loc_gsk_ArrangementTypeAxis_d5a2b2ea-4d03-407b-be5e-e81eb933d451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain_d5a2b2ea-4d03-407b-be5e-e81eb933d451_default" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ArrangementTypeAxis_d5a2b2ea-4d03-407b-be5e-e81eb933d451" xlink:to="loc_gsk_ArrangementTypeDomain_d5a2b2ea-4d03-407b-be5e-e81eb933d451_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain_4c214d45-e4eb-43a6-a2ab-9ce215717272" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ArrangementTypeAxis_d5a2b2ea-4d03-407b-be5e-e81eb933d451" xlink:to="loc_gsk_ArrangementTypeDomain_4c214d45-e4eb-43a6-a2ab-9ce215717272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SeparationRestructuringProgrammeMember_e78982f1-e585-46c6-a533-4be3e10ff2a4" xlink:href="gsk-20241231.xsd#gsk_SeparationRestructuringProgrammeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ArrangementTypeDomain_4c214d45-e4eb-43a6-a2ab-9ce215717272" xlink:to="loc_gsk_SeparationRestructuringProgrammeMember_e78982f1-e585-46c6-a533-4be3e10ff2a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_04abfef0-3487-459c-98a5-8e23e9ae836f" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_04abfef0-3487-459c-98a5-8e23e9ae836f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_50219b52-7d78-4783-bc58-ac7fee340bb1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfProvisionsForCostOfRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_50219b52-7d78-4783-bc58-ac7fee340bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_997c57f4-939b-4724-bb36-ae0d95d8fec2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_997c57f4-939b-4724-bb36-ae0d95d8fec2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherMaterialNoncashItems_30cba61c-f2e6-4f12-82c9-e132256e5999" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherMaterialNoncashItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_ifrs-full_OtherMaterialNoncashItems_30cba61c-f2e6-4f12-82c9-e132256e5999" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCostsCashSettlement_65d05127-fa6b-4e5d-a982-3baf3503e546" xlink:href="gsk-20241231.xsd#gsk_OtherCostsCashSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_gsk_OtherCostsCashSettlement_65d05127-fa6b-4e5d-a982-3baf3503e546" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalRestructuringCosts_77e2dc96-2ccd-428e-834b-7ef26c6c44a3" xlink:href="gsk-20241231.xsd#gsk_TotalRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_1c1733e5-a18f-4376-94ab-7cabccbb54b5" xlink:to="loc_gsk_TotalRestructuringCosts_77e2dc96-2ccd-428e-834b-7ef26c6c44a3" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorrestructuringchargesfromcontinuingoperationsbyprogrammeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsLineItems_9a16cb6d-dbd9-42bf-90c9-6432732b9c58" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsTable_c259f001-abc8-4640-ad27-ebdc2d45585d" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_9a16cb6d-dbd9-42bf-90c9-6432732b9c58" xlink:to="loc_gsk_DisclosureOfRestructuringCostsTable_c259f001-abc8-4640-ad27-ebdc2d45585d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeAxis_4f796910-8a01-4d40-9ec7-db7a9df3eaf4" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRestructuringCostsTable_c259f001-abc8-4640-ad27-ebdc2d45585d" xlink:to="loc_gsk_ArrangementTypeAxis_4f796910-8a01-4d40-9ec7-db7a9df3eaf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain_4f796910-8a01-4d40-9ec7-db7a9df3eaf4_default" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ArrangementTypeAxis_4f796910-8a01-4d40-9ec7-db7a9df3eaf4" xlink:to="loc_gsk_ArrangementTypeDomain_4f796910-8a01-4d40-9ec7-db7a9df3eaf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain_7b7e03ba-b8ed-4016-901f-49bb92ff29a1" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ArrangementTypeAxis_4f796910-8a01-4d40-9ec7-db7a9df3eaf4" xlink:to="loc_gsk_ArrangementTypeDomain_7b7e03ba-b8ed-4016-901f-49bb92ff29a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SeparationRestructuringProgrammeMember_cd5a0ac1-b0ea-48bd-b758-7ec8996b9df2" xlink:href="gsk-20241231.xsd#gsk_SeparationRestructuringProgrammeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ArrangementTypeDomain_7b7e03ba-b8ed-4016-901f-49bb92ff29a1" xlink:to="loc_gsk_SeparationRestructuringProgrammeMember_cd5a0ac1-b0ea-48bd-b758-7ec8996b9df2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SignificantAcquisitionsMember_200f83ae-4e49-4f65-b321-0fd8555dd43b" xlink:href="gsk-20241231.xsd#gsk_SignificantAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ArrangementTypeDomain_7b7e03ba-b8ed-4016-901f-49bb92ff29a1" xlink:to="loc_gsk_SignificantAcquisitionsMember_200f83ae-4e49-4f65-b321-0fd8555dd43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegacyProgrammesMember_eb9350c3-1182-41a9-80c0-b8e9b73a6516" xlink:href="gsk-20241231.xsd#gsk_LegacyProgrammesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ArrangementTypeDomain_7b7e03ba-b8ed-4016-901f-49bb92ff29a1" xlink:to="loc_gsk_LegacyProgrammesMember_eb9350c3-1182-41a9-80c0-b8e9b73a6516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashRestructuringCharges_72c5eb26-28fa-48de-b875-de972d1bba33" xlink:href="gsk-20241231.xsd#gsk_CashRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_9a16cb6d-dbd9-42bf-90c9-6432732b9c58" xlink:to="loc_gsk_CashRestructuringCharges_72c5eb26-28fa-48de-b875-de972d1bba33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCashRestructuringCharges_a4037241-52a5-4100-8c0f-1f2c8324af70" xlink:href="gsk-20241231.xsd#gsk_NonCashRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_9a16cb6d-dbd9-42bf-90c9-6432732b9c58" xlink:to="loc_gsk_NonCashRestructuringCharges_a4037241-52a5-4100-8c0f-1f2c8324af70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCosts1_06b1b6ce-e45c-4c60-85d9-0bd38b0b9976" xlink:href="gsk-20241231.xsd#gsk_RestructuringCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_9a16cb6d-dbd9-42bf-90c9-6432732b9c58" xlink:to="loc_gsk_RestructuringCosts1_06b1b6ce-e45c-4c60-85d9-0bd38b0b9976" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MajorrestructuringcostsSummaryofMajorRestructuringChargesfromContinuingOperationsbyIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsTable_2e083a93-6af8-49f3-bf01-e184f72e547d" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:to="loc_gsk_DisclosureOfRestructuringCostsTable_2e083a93-6af8-49f3-bf01-e184f72e547d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCostsAxis_118e346f-97cd-422e-9c90-5b665a66f4c8" xlink:href="gsk-20241231.xsd#gsk_RestructuringCostsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRestructuringCostsTable_2e083a93-6af8-49f3-bf01-e184f72e547d" xlink:to="loc_gsk_RestructuringCostsAxis_118e346f-97cd-422e-9c90-5b665a66f4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCostsDomain_118e346f-97cd-422e-9c90-5b665a66f4c8_default" xlink:href="gsk-20241231.xsd#gsk_RestructuringCostsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_RestructuringCostsAxis_118e346f-97cd-422e-9c90-5b665a66f4c8" xlink:to="loc_gsk_RestructuringCostsDomain_118e346f-97cd-422e-9c90-5b665a66f4c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCostsDomain_c8f84817-0409-463c-bc3d-25494f796d89" xlink:href="gsk-20241231.xsd#gsk_RestructuringCostsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_RestructuringCostsAxis_118e346f-97cd-422e-9c90-5b665a66f4c8" xlink:to="loc_gsk_RestructuringCostsDomain_c8f84817-0409-463c-bc3d-25494f796d89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostOfMajorRestructuringMember_b68f2dab-192b-4117-9060-4e461359b88a" xlink:href="gsk-20241231.xsd#gsk_CostOfMajorRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_RestructuringCostsDomain_c8f84817-0409-463c-bc3d-25494f796d89" xlink:to="loc_gsk_CostOfMajorRestructuringMember_b68f2dab-192b-4117-9060-4e461359b88a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_ff491c08-3c05-4d7c-9c76-97b3b51fb70b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:to="loc_ifrs-full_CostOfSales_ff491c08-3c05-4d7c-9c76-97b3b51fb70b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_e69ffba1-3073-4667-9841-69fd6288839d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_e69ffba1-3073-4667-9841-69fd6288839d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_f2880200-1143-468d-aa55-b038cf2ef66f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_f2880200-1143-468d-aa55-b038cf2ef66f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_24491079-2f88-458d-9de3-680ef67451e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_24491079-2f88-458d-9de3-680ef67451e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostChargedToOperatingProfit_784af770-105b-4f66-aadf-df8f79a67275" xlink:href="gsk-20241231.xsd#gsk_CostChargedToOperatingProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems_dbf80a9d-d2d4-45f3-9577-0800d658fd46" xlink:to="loc_gsk_CostChargedToOperatingProfit_784af770-105b-4f66-aadf-df8f79a67275" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AssociatesandjointventuresSummaryofAfterTaxProfitsandLossesofAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AssociatesandjointventuresSummaryofAfterTaxProfitsandLossesofAssociatesandJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AssociatesandjointventuresSummaryofAfterTaxProfitsandLossesofAssociatesandJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_463dc636-1b61-402e-91fa-c025216aa009" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_3bcaa01f-3228-4434-94fc-14b9ccb194c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_463dc636-1b61-402e-91fa-c025216aa009" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_3bcaa01f-3228-4434-94fc-14b9ccb194c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1e870c68-54bb-43b2-a7bf-019dd14e125b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_3bcaa01f-3228-4434-94fc-14b9ccb194c5" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1e870c68-54bb-43b2-a7bf-019dd14e125b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_1e870c68-54bb-43b2-a7bf-019dd14e125b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1e870c68-54bb-43b2-a7bf-019dd14e125b" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_1e870c68-54bb-43b2-a7bf-019dd14e125b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_21df9839-8121-4af7-9d57-b810a23430af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1e870c68-54bb-43b2-a7bf-019dd14e125b" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_21df9839-8121-4af7-9d57-b810a23430af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember_dd759d35-14e6-4806-bf43-967a34696268" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_21df9839-8121-4af7-9d57-b810a23430af" xlink:to="loc_ifrs-full_AssociatesMember_dd759d35-14e6-4806-bf43-967a34696268" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_1f5c3a72-2d29-4b30-8b6a-31ea4a2c9c7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_3bcaa01f-3228-4434-94fc-14b9ccb194c5" xlink:to="loc_ifrs-full_JointVenturesAxis_1f5c3a72-2d29-4b30-8b6a-31ea4a2c9c7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_1f5c3a72-2d29-4b30-8b6a-31ea4a2c9c7a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_1f5c3a72-2d29-4b30-8b6a-31ea4a2c9c7a" xlink:to="loc_ifrs-full_JointVenturesDomain_1f5c3a72-2d29-4b30-8b6a-31ea4a2c9c7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_c39d8510-b50e-476d-924c-6ed33a0567ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_1f5c3a72-2d29-4b30-8b6a-31ea4a2c9c7a" xlink:to="loc_ifrs-full_JointVenturesDomain_c39d8510-b50e-476d-924c-6ed33a0567ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_eed61f69-7714-47e3-bcd4-67ad2a94259b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_c39d8510-b50e-476d-924c-6ed33a0567ce" xlink:to="loc_ifrs-full_JointVenturesMember_eed61f69-7714-47e3-bcd4-67ad2a94259b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_6417492e-84cd-4eca-9b07-d5e02947f14d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_463dc636-1b61-402e-91fa-c025216aa009" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_6417492e-84cd-4eca-9b07-d5e02947f14d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AssociatesandjointventuresSummaryofAggregatedFinancialInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AssociatesandjointventuresSummaryofAggregatedFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AssociatesandjointventuresSummaryofAggregatedFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_be705916-5d06-48c6-800c-50daf6cc2260" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_783571c9-d904-4877-869a-8293b43f0ab4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_be705916-5d06-48c6-800c-50daf6cc2260" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_783571c9-d904-4877-869a-8293b43f0ab4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c89bd048-4fa3-4060-acb6-7c0c26748abb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_783571c9-d904-4877-869a-8293b43f0ab4" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c89bd048-4fa3-4060-acb6-7c0c26748abb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_c89bd048-4fa3-4060-acb6-7c0c26748abb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c89bd048-4fa3-4060-acb6-7c0c26748abb" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_c89bd048-4fa3-4060-acb6-7c0c26748abb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_208d7613-bd19-4046-8fbf-94b689c40b8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c89bd048-4fa3-4060-acb6-7c0c26748abb" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_208d7613-bd19-4046-8fbf-94b689c40b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAssociatesMember_a21b40f9-a7bd-4b8a-8227-61094da3ed95" xlink:href="gsk-20241231.xsd#gsk_OtherAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_208d7613-bd19-4046-8fbf-94b689c40b8a" xlink:to="loc_gsk_OtherAssociatesMember_a21b40f9-a7bd-4b8a-8227-61094da3ed95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_f54a33d9-cf8b-4143-a7dc-09f39aa48b96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_be705916-5d06-48c6-800c-50daf6cc2260" xlink:to="loc_ifrs-full_ProfitLoss_f54a33d9-cf8b-4143-a7dc-09f39aa48b96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_0f97e60e-9324-41f0-9cb7-f6a4296cb364" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_be705916-5d06-48c6-800c-50daf6cc2260" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_0f97e60e-9324-41f0-9cb7-f6a4296cb364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_8f72b302-0d9d-45dd-8e9c-1b9927e0004a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_be705916-5d06-48c6-800c-50daf6cc2260" xlink:to="loc_ifrs-full_ComprehensiveIncome_8f72b302-0d9d-45dd-8e9c-1b9927e0004a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofTaxationChargeBasedonProfitsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofTaxationChargeBasedonProfitsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TaxationSummaryofTaxationChargeBasedonProfitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsLineItems_d6a013a8-8518-4b46-aaea-778be73f2aae" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsTable_bb7b0c18-567d-458e-b212-f1463aa8f4fa" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_d6a013a8-8518-4b46-aaea-778be73f2aae" xlink:to="loc_gsk_IncomeTaxExpenseBenefitsTable_bb7b0c18-567d-458e-b212-f1463aa8f4fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5ef83a61-bb6f-41e2-aadb-7b1ff7eda386" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsTable_bb7b0c18-567d-458e-b212-f1463aa8f4fa" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5ef83a61-bb6f-41e2-aadb-7b1ff7eda386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5ef83a61-bb6f-41e2-aadb-7b1ff7eda386_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5ef83a61-bb6f-41e2-aadb-7b1ff7eda386" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5ef83a61-bb6f-41e2-aadb-7b1ff7eda386_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_b5a35091-c047-4a43-b692-12c968d58db5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5ef83a61-bb6f-41e2-aadb-7b1ff7eda386" xlink:to="loc_ifrs-full_GeographicalAreasDomain_b5a35091-c047-4a43-b692-12c968d58db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_3ea37cab-8bf5-4fa9-be33-3975006a92a7" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b5a35091-c047-4a43-b692-12c968d58db5" xlink:to="loc_country_GB_3ea37cab-8bf5-4fa9-be33-3975006a92a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignCountriesMember_0881b7ec-2e69-4400-903f-17f5124c868f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b5a35091-c047-4a43-b692-12c968d58db5" xlink:to="loc_ifrs-full_ForeignCountriesMember_0881b7ec-2e69-4400-903f-17f5124c868f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxExpenseIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_d6a013a8-8518-4b46-aaea-778be73f2aae" xlink:to="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_71bcfba1-94b0-4875-8454-b1f65e8c370b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_71bcfba1-94b0-4875-8454-b1f65e8c370b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_af633fcb-e938-4727-a22a-5b1cc6e66640" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_af633fcb-e938-4727-a22a-5b1cc6e66640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_40c4ba4e-e67d-4930-af83-95d7c2007a1a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_40c4ba4e-e67d-4930-af83-95d7c2007a1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_3d406a3e-61e5-4dc7-b28a-78f9715d357a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_3d406a3e-61e5-4dc7-b28a-78f9715d357a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_7483ce75-31d6-4184-b75f-c8b5c5ae5be5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CurrentTaxExpenseIncomeAbstract_90db00ea-0488-4055-b7fc-823081a523f1" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_7483ce75-31d6-4184-b75f-c8b5c5ae5be5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TaxationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsTable_64e281a2-e90f-4d1d-b6cb-f42faedc1fc0" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_gsk_IncomeTaxExpenseBenefitsTable_64e281a2-e90f-4d1d-b6cb-f42faedc1fc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_af0c18fc-ab7c-41ac-b170-92ff88ba4ebb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsTable_64e281a2-e90f-4d1d-b6cb-f42faedc1fc0" xlink:to="loc_ifrs-full_GeographicalAreasAxis_af0c18fc-ab7c-41ac-b170-92ff88ba4ebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_af0c18fc-ab7c-41ac-b170-92ff88ba4ebb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_af0c18fc-ab7c-41ac-b170-92ff88ba4ebb" xlink:to="loc_ifrs-full_GeographicalAreasDomain_af0c18fc-ab7c-41ac-b170-92ff88ba4ebb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202e5ad6-b74d-4ba6-833f-a98caf52ad66" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_af0c18fc-ab7c-41ac-b170-92ff88ba4ebb" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202e5ad6-b74d-4ba6-833f-a98caf52ad66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_e011c6fe-518e-4238-a044-a3ad14d2d08f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202e5ad6-b74d-4ba6-833f-a98caf52ad66" xlink:to="loc_country_GB_e011c6fe-518e-4238-a044-a3ad14d2d08f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_3a9d1c27-eda1-4e11-a50b-e77290ceb0ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsTable_64e281a2-e90f-4d1d-b6cb-f42faedc1fc0" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_3a9d1c27-eda1-4e11-a50b-e77290ceb0ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_3a9d1c27-eda1-4e11-a50b-e77290ceb0ec_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_3a9d1c27-eda1-4e11-a50b-e77290ceb0ec" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_3a9d1c27-eda1-4e11-a50b-e77290ceb0ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_c4400d98-f8e6-47c7-8c43-68f0b53bad3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_3a9d1c27-eda1-4e11-a50b-e77290ceb0ec" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_c4400d98-f8e6-47c7-8c43-68f0b53bad3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OverseasMember_146d8f39-6f7d-4c01-b2e1-dfc422927f5e" xlink:href="gsk-20241231.xsd#gsk_OverseasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_c4400d98-f8e6-47c7-8c43-68f0b53bad3f" xlink:to="loc_gsk_OverseasMember_146d8f39-6f7d-4c01-b2e1-dfc422927f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_f0dd5001-b3cf-4b29-8834-122efc9bb4c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_f0dd5001-b3cf-4b29-8834-122efc9bb4c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefund_ca34dc8a-5ba4-41a8-828f-c62ce2668aea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefund_ca34dc8a-5ba4-41a8-828f-c62ce2668aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes_15f615e9-bc3b-49f3-ade8-e8b31d82b76a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes_15f615e9-bc3b-49f3-ade8-e8b31d82b76a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProvisionsForUncertainTaxPosition_8251205e-805d-41eb-b429-7ee79a649c7a" xlink:href="gsk-20241231.xsd#gsk_ProvisionsForUncertainTaxPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_gsk_ProvisionsForUncertainTaxPosition_8251205e-805d-41eb-b429-7ee79a649c7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_998fbfd2-7e86-47b2-8f1b-07d3c7e5caae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_998fbfd2-7e86-47b2-8f1b-07d3c7e5caae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnremittedEarnings_d6865a43-9a85-4063-9781-bcd34dfc091e" xlink:href="gsk-20241231.xsd#gsk_UnremittedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_gsk_UnremittedEarnings_d6865a43-9a85-4063-9781-bcd34dfc091e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnremittedProfitsForWhichDeferredTaxNotProvided_5b13d3fa-01f4-442f-aed0-7b574af58d13" xlink:href="gsk-20241231.xsd#gsk_UnremittedProfitsForWhichDeferredTaxNotProvided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_gsk_UnremittedProfitsForWhichDeferredTaxNotProvided_5b13d3fa-01f4-442f-aed0-7b574af58d13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxAssetsRecognizedOnTradingLosses_c4eaffb2-b2e1-44ff-b86d-543f54b19fb8" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxAssetsRecognizedOnTradingLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_f4667720-37af-48fb-9726-84689e65687e" xlink:to="loc_gsk_DeferredTaxAssetsRecognizedOnTradingLosses_c4eaffb2-b2e1-44ff-b86d-543f54b19fb8" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofReconciliationofTaxChargeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofReconciliationofTaxChargeDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TaxationSummaryofReconciliationofTaxChargeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsTable_b9c7bbc2-47c6-48ca-882e-5d2f4477f118" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_IncomeTaxExpenseBenefitsTable_b9c7bbc2-47c6-48ca-882e-5d2f4477f118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4c53a25a-a7f4-4b8b-9668-43350f57b2c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsTable_b9c7bbc2-47c6-48ca-882e-5d2f4477f118" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4c53a25a-a7f4-4b8b-9668-43350f57b2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_4c53a25a-a7f4-4b8b-9668-43350f57b2c6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4c53a25a-a7f4-4b8b-9668-43350f57b2c6" xlink:to="loc_ifrs-full_GeographicalAreasDomain_4c53a25a-a7f4-4b8b-9668-43350f57b2c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_df20df85-e548-4e4c-9376-a4a057194469" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4c53a25a-a7f4-4b8b-9668-43350f57b2c6" xlink:to="loc_ifrs-full_GeographicalAreasDomain_df20df85-e548-4e4c-9376-a4a057194469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_402321d4-0846-4e29-afaf-1e0e93cce6d3" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_df20df85-e548-4e4c-9376-a4a057194469" xlink:to="loc_country_GB_402321d4-0846-4e29-afaf-1e0e93cce6d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_9f2b07dc-6216-40c6-8475-bf1adbc1975f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_9f2b07dc-6216-40c6-8475-bf1adbc1975f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_71a2e5fe-2a7a-4a84-ab70-bb4bea45f162" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_71a2e5fe-2a7a-4a84-ab70-bb4bea45f162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_e7de4281-a88c-4870-a921-f3fe19e8570f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_ApplicableTaxRate_e7de4281-a88c-4870-a921-f3fe19e8570f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_cd3e73d5-6531-44ac-ad8a-eb75de1931f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_cd3e73d5-6531-44ac-ad8a-eb75de1931f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_532ca0db-2f7a-445c-92cc-3e45e80f7cf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_532ca0db-2f7a-445c-92cc-3e45e80f7cf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_dec5a38a-f09e-4065-bbac-f5e0e64834cf" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_dec5a38a-f09e-4065-bbac-f5e0e64834cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_8abeed4c-f652-4922-96df-37d74b837087" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_8abeed4c-f652-4922-96df-37d74b837087" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfResearchAndDevelopmentCredits_e288f123-0fdf-4788-9439-413848796e57" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfResearchAndDevelopmentCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxEffectOfResearchAndDevelopmentCredits_e288f123-0fdf-4788-9439-413848796e57" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_e9297b44-b1f2-4193-91fa-53625f9d41dc" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfResearchAndDevelopmentCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_e9297b44-b1f2-4193-91fa-53625f9d41dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_5522e70b-0c18-46ca-a5a4-32d9001d84a3" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_5522e70b-0c18-46ca-a5a4-32d9001d84a3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_6d8d12db-a54a-49aa-9ebc-84eae1e28028" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_6d8d12db-a54a-49aa-9ebc-84eae1e28028" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_2792e9a1-d37d-41b7-8687-1829416bf382" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_2792e9a1-d37d-41b7-8687-1829416bf382" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_2293d6f1-e3aa-4a99-a6fb-a9518b267667" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_2293d6f1-e3aa-4a99-a6fb-a9518b267667" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_e1fb59a0-5f23-4053-862d-1bb439758db1" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfReassessmentsOfPriorYearEstimates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_e1fb59a0-5f23-4053-862d-1bb439758db1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_dfa27dc2-797d-4f88-8286-4a3f81b466b5" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_dfa27dc2-797d-4f88-8286-4a3f81b466b5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_4404bf38-1e5c-48c5-8ed6-ff4eccb1ac49" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_4404bf38-1e5c-48c5-8ed6-ff4eccb1ac49" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_bd26e185-e414-4846-ab57-b1c7a67b796e" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_bd26e185-e414-4846-ab57-b1c7a67b796e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfChangeInTaxRate_d096dc61-cb42-49b3-bc5b-1269d0ce8dcb" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfChangeInTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxEffectOfChangeInTaxRate_d096dc61-cb42-49b3-bc5b-1269d0ce8dcb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfChangeInTaxRate_8fe31dd1-c72c-4e3e-848c-4aa300f19413" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfChangeInTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_gsk_TaxRateEffectOfChangeInTaxRate_8fe31dd1-c72c-4e3e-848c-4aa300f19413" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_b961c1fb-e5ee-4558-b2c8-2a3be3a12a56" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_b961c1fb-e5ee-4558-b2c8-2a3be3a12a56" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_0d95c71f-d55c-4f9e-aaa6-ff32c3caa11e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems_b88d992b-15e3-409e-b2ec-903f333755f4" xlink:to="loc_ifrs-full_AverageEffectiveTaxRate_0d95c71f-d55c-4f9e-aaa6-ff32c3caa11e" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofMovementinDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofMovementinDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TaxationSummaryofMovementinDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems_050199a0-913e-4d60-b6c3-f92c757ece6e" xlink:href="gsk-20241231.xsd#gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems_050199a0-913e-4d60-b6c3-f92c757ece6e" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_3ce6a08a-27b0-458e-84ec-b97a5f15ee3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_3ce6a08a-27b0-458e-84ec-b97a5f15ee3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3ce6a08a-27b0-458e-84ec-b97a5f15ee3f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_3ce6a08a-27b0-458e-84ec-b97a5f15ee3f" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3ce6a08a-27b0-458e-84ec-b97a5f15ee3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_9ecf000a-ba6b-489d-a4db-a132fe760e72" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_3ce6a08a-27b0-458e-84ec-b97a5f15ee3f" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_9ecf000a-ba6b-489d-a4db-a132fe760e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AcceleratedCapitalAllowancesMember_c645e91e-8288-4b21-8668-1d7e0a2048d9" xlink:href="gsk-20241231.xsd#gsk_AcceleratedCapitalAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_9ecf000a-ba6b-489d-a4db-a132fe760e72" xlink:to="loc_gsk_AcceleratedCapitalAllowancesMember_c645e91e-8288-4b21-8668-1d7e0a2048d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_47bbe5cb-4015-408b-b31f-36186eba8aeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_9ecf000a-ba6b-489d-a4db-a132fe760e72" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_47bbe5cb-4015-408b-b31f-36186eba8aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_f4453141-a086-42c8-b632-5f66419ad4e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_9ecf000a-ba6b-489d-a4db-a132fe760e72" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_f4453141-a086-42c8-b632-5f66419ad4e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_cb32a10c-4417-4a61-b247-d49bd4c73272" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_cb32a10c-4417-4a61-b247-d49bd4c73272" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_cb32a10c-4417-4a61-b247-d49bd4c73272_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_cb32a10c-4417-4a61-b247-d49bd4c73272" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_cb32a10c-4417-4a61-b247-d49bd4c73272_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_7f8872a9-a5e0-4b26-9d89-f8733aaf0a51" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_cb32a10c-4417-4a61-b247-d49bd4c73272" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_7f8872a9-a5e0-4b26-9d89-f8733aaf0a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_cbee3d11-bc57-4471-af30-24c6f80a8e95" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_7f8872a9-a5e0-4b26-9d89-f8733aaf0a51" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_cbee3d11-bc57-4471-af30-24c6f80a8e95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_b3c6bcfe-59d5-4c77-8468-0461734a0b54" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_b3c6bcfe-59d5-4c77-8468-0461734a0b54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_b3c6bcfe-59d5-4c77-8468-0461734a0b54_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_b3c6bcfe-59d5-4c77-8468-0461734a0b54" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_b3c6bcfe-59d5-4c77-8468-0461734a0b54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_e6c83126-aaec-4420-8d19-9d2828fc4212" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_b3c6bcfe-59d5-4c77-8468-0461734a0b54" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_e6c83126-aaec-4420-8d19-9d2828fc4212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationMember_2f5a26fe-f0d4-491d-8ef9-602853dded94" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_e6c83126-aaec-4420-8d19-9d2828fc4212" xlink:to="loc_ifrs-full_ContingentConsiderationMember_2f5a26fe-f0d4-491d-8ef9-602853dded94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsAxis_e8faec9e-c509-43f0-83cc-762d29c37428" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_ifrs-full_JointOperationsAxis_e8faec9e-c509-43f0-83cc-762d29c37428" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsDomain_e8faec9e-c509-43f0-83cc-762d29c37428_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointOperationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointOperationsAxis_e8faec9e-c509-43f0-83cc-762d29c37428" xlink:to="loc_ifrs-full_JointOperationsDomain_e8faec9e-c509-43f0-83cc-762d29c37428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsDomain_2763e05f-cbbe-48f7-9218-657a62091022" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointOperationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointOperationsAxis_e8faec9e-c509-43f0-83cc-762d29c37428" xlink:to="loc_ifrs-full_JointOperationsDomain_2763e05f-cbbe-48f7-9218-657a62091022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IntraGroupProfitMember_2add5995-b36c-4592-b5ae-a60dfcb7f069" xlink:href="gsk-20241231.xsd#gsk_IntraGroupProfitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointOperationsDomain_2763e05f-cbbe-48f7-9218-657a62091022" xlink:to="loc_gsk_IntraGroupProfitMember_2add5995-b36c-4592-b5ae-a60dfcb7f069" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_e5caa43d-f805-426b-8aba-ad10b7b5ae14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_e5caa43d-f805-426b-8aba-ad10b7b5ae14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_e5caa43d-f805-426b-8aba-ad10b7b5ae14_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_e5caa43d-f805-426b-8aba-ad10b7b5ae14" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_e5caa43d-f805-426b-8aba-ad10b7b5ae14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_0ee17ebb-4c50-412f-8b3c-060a179b1818" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_e5caa43d-f805-426b-8aba-ad10b7b5ae14" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_0ee17ebb-4c50-412f-8b3c-060a179b1818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember_243495a1-eb78-41bf-9081-59f6ca50715c" xlink:href="gsk-20241231.xsd#gsk_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0ee17ebb-4c50-412f-8b3c-060a179b1818" xlink:to="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember_243495a1-eb78-41bf-9081-59f6ca50715c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0c7b49db-2c75-4026-8c1d-d73123e8cdd9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0c7b49db-2c75-4026-8c1d-d73123e8cdd9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0c7b49db-2c75-4026-8c1d-d73123e8cdd9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0c7b49db-2c75-4026-8c1d-d73123e8cdd9" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0c7b49db-2c75-4026-8c1d-d73123e8cdd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_182a520b-8c15-486d-bac7-400ad4dff603" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0c7b49db-2c75-4026-8c1d-d73123e8cdd9" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_182a520b-8c15-486d-bac7-400ad4dff603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOptionAndAwardSchemesMember_88cdcbfb-587e-4392-91ad-70b742416d1c" xlink:href="gsk-20241231.xsd#gsk_ShareOptionAndAwardSchemesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_182a520b-8c15-486d-bac7-400ad4dff603" xlink:to="loc_gsk_ShareOptionAndAwardSchemesMember_88cdcbfb-587e-4392-91ad-70b742416d1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxReformsPeriodOfApplicationAxis_aa68b055-48ca-4526-a422-5a568827c084" xlink:href="gsk-20241231.xsd#gsk_TaxReformsPeriodOfApplicationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0518c445-2565-4e4f-9aac-cbe36b3b426d" xlink:to="loc_gsk_TaxReformsPeriodOfApplicationAxis_aa68b055-48ca-4526-a422-5a568827c084" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxReformsPeriodOfApplicationDomain_aa68b055-48ca-4526-a422-5a568827c084_default" xlink:href="gsk-20241231.xsd#gsk_TaxReformsPeriodOfApplicationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_TaxReformsPeriodOfApplicationAxis_aa68b055-48ca-4526-a422-5a568827c084" xlink:to="loc_gsk_TaxReformsPeriodOfApplicationDomain_aa68b055-48ca-4526-a422-5a568827c084_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxReformsPeriodOfApplicationDomain_aade65ab-671b-423b-b725-cc5d60b58c6c" xlink:href="gsk-20241231.xsd#gsk_TaxReformsPeriodOfApplicationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_TaxReformsPeriodOfApplicationAxis_aa68b055-48ca-4526-a422-5a568827c084" xlink:to="loc_gsk_TaxReformsPeriodOfApplicationDomain_aade65ab-671b-423b-b725-cc5d60b58c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OriginationAndReversalOfTemporaryDifferencesMember_f81c14c2-ee3d-45b6-859f-af85d0e5bf0a" xlink:href="gsk-20241231.xsd#gsk_OriginationAndReversalOfTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TaxReformsPeriodOfApplicationDomain_aade65ab-671b-423b-b725-cc5d60b58c6c" xlink:to="loc_gsk_OriginationAndReversalOfTemporaryDifferencesMember_f81c14c2-ee3d-45b6-859f-af85d0e5bf0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems_050199a0-913e-4d60-b6c3-f92c757ece6e" xlink:to="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_0ae8c3d4-b8dd-4f6f-bf20-ec5f6d03de21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_0ae8c3d4-b8dd-4f6f-bf20-ec5f6d03de21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_c2de0fdd-c452-422d-bd62-c7986410417e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_c2de0fdd-c452-422d-bd62-c7986410417e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_2d554388-a402-4dc3-b1d6-a9c5dafcbcb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_2d554388-a402-4dc3-b1d6-a9c5dafcbcb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_252acd8e-8b25-4d40-a5eb-05da0d4760b8" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:to="loc_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_252acd8e-8b25-4d40-a5eb-05da0d4760b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_38735be6-3221-4305-a461-c2928ade9443" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_38735be6-3221-4305-a461-c2928ade9443" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation_2206d41c-3209-4a84-b572-7e848963cb5f" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_7988d495-f537-4237-9f07-c0ee52a66473" xlink:to="loc_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation_2206d41c-3209-4a84-b572-7e848963cb5f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_59146c7c-119a-4590-9b3e-09a8ec64d3ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TaxationSummaryofTemporaryDifferenceUnusedTaxLossesandUnusedTaxCreditsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TaxationSummaryofTemporaryDifferenceUnusedTaxLossesandUnusedTaxCreditsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TaxationSummaryofTemporaryDifferenceUnusedTaxLossesandUnusedTaxCreditsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_065ad8e8-2fe0-46e2-97fb-80301f99887a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_80b0027d-6089-4e40-b89f-9222d696e07b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_065ad8e8-2fe0-46e2-97fb-80301f99887a" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_80b0027d-6089-4e40-b89f-9222d696e07b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_6148322f-2251-41ed-af83-aac6dbe3551b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_80b0027d-6089-4e40-b89f-9222d696e07b" xlink:to="loc_ifrs-full_MaturityAxis_6148322f-2251-41ed-af83-aac6dbe3551b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_6148322f-2251-41ed-af83-aac6dbe3551b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_6148322f-2251-41ed-af83-aac6dbe3551b" xlink:to="loc_ifrs-full_MaturityDomain_6148322f-2251-41ed-af83-aac6dbe3551b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_7df6c6c3-0921-4cb6-94f3-65d28a15c0fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_6148322f-2251-41ed-af83-aac6dbe3551b" xlink:to="loc_ifrs-full_MaturityDomain_7df6c6c3-0921-4cb6-94f3-65d28a15c0fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WithinTenYearsMember_ec505135-969e-4909-afb2-53aa5fa2414d" xlink:href="gsk-20241231.xsd#gsk_WithinTenYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_7df6c6c3-0921-4cb6-94f3-65d28a15c0fb" xlink:to="loc_gsk_WithinTenYearsMember_ec505135-969e-4909-afb2-53aa5fa2414d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_985d8e6e-5de2-4086-9430-e13e0427ebe4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTenYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_7df6c6c3-0921-4cb6-94f3-65d28a15c0fb" xlink:to="loc_ifrs-full_LaterThanTenYearsMember_985d8e6e-5de2-4086-9430-e13e0427ebe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AvailableIndefinitelyMember_09200c61-12bc-4ca0-97da-87fd29482b46" xlink:href="gsk-20241231.xsd#gsk_AvailableIndefinitelyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_7df6c6c3-0921-4cb6-94f3-65d28a15c0fb" xlink:to="loc_gsk_AvailableIndefinitelyMember_09200c61-12bc-4ca0-97da-87fd29482b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxLosses_f8ce35a3-4bc8-46d0-bc3c-44904c75a576" xlink:href="gsk-20241231.xsd#gsk_TaxLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_065ad8e8-2fe0-46e2-97fb-80301f99887a" xlink:to="loc_gsk_TaxLosses_f8ce35a3-4bc8-46d0-bc3c-44904c75a576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses_6777269f-7a45-471f-a48c-6b2d7825682d" xlink:href="gsk-20241231.xsd#gsk_UnrecognisedDeferredTaxAssetOnTradingLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_065ad8e8-2fe0-46e2-97fb-80301f99887a" xlink:to="loc_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses_6777269f-7a45-471f-a48c-6b2d7825682d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CapitalLosses_a052dad2-afc1-44b9-a8c5-b7bf9e298f73" xlink:href="gsk-20241231.xsd#gsk_CapitalLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_065ad8e8-2fe0-46e2-97fb-80301f99887a" xlink:to="loc_gsk_CapitalLosses_a052dad2-afc1-44b9-a8c5-b7bf9e298f73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses_6401db34-67ce-4514-9a84-46f07ba73913" xlink:href="gsk-20241231.xsd#gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_065ad8e8-2fe0-46e2-97fb-80301f99887a" xlink:to="loc_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses_6401db34-67ce-4514-9a84-46f07ba73913" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/DividendsSummaryofInterimFinancialReportingDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#DividendsSummaryofInterimFinancialReportingDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/DividendsSummaryofInterimFinancialReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDividendsLineItems_99ff5774-7f95-4627-a7d1-942a6a2dd4de" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDividendsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDividendsTable_2e4528f3-8b28-4005-8459-ff3d45af7c38" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDividendsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDividendsLineItems_99ff5774-7f95-4627-a7d1-942a6a2dd4de" xlink:to="loc_gsk_DisclosureOfDividendsTable_2e4528f3-8b28-4005-8459-ff3d45af7c38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_b59da3c5-a8ab-4e4e-b60c-b2c7ec7b6114" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDividendsTable_2e4528f3-8b28-4005-8459-ff3d45af7c38" xlink:to="loc_ifrs-full_MaturityAxis_b59da3c5-a8ab-4e4e-b60c-b2c7ec7b6114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_b59da3c5-a8ab-4e4e-b60c-b2c7ec7b6114_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_b59da3c5-a8ab-4e4e-b60c-b2c7ec7b6114" xlink:to="loc_ifrs-full_MaturityDomain_b59da3c5-a8ab-4e4e-b60c-b2c7ec7b6114_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_6ae4cadf-f0f8-499d-99b4-7521c95dc66f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_b59da3c5-a8ab-4e4e-b60c-b2c7ec7b6114" xlink:to="loc_ifrs-full_MaturityDomain_6ae4cadf-f0f8-499d-99b4-7521c95dc66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FirstInterimMember_8c4f619f-0840-48d2-a48a-d58f943940b3" xlink:href="gsk-20241231.xsd#gsk_FirstInterimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6ae4cadf-f0f8-499d-99b4-7521c95dc66f" xlink:to="loc_gsk_FirstInterimMember_8c4f619f-0840-48d2-a48a-d58f943940b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SecondInterimMember_cc43116c-adeb-49c8-a2d2-de18dda05c46" xlink:href="gsk-20241231.xsd#gsk_SecondInterimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6ae4cadf-f0f8-499d-99b4-7521c95dc66f" xlink:to="loc_gsk_SecondInterimMember_cc43116c-adeb-49c8-a2d2-de18dda05c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThirdInterimMember_a1cf8ac5-9be3-4d61-89f0-ec61f1971f25" xlink:href="gsk-20241231.xsd#gsk_ThirdInterimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6ae4cadf-f0f8-499d-99b4-7521c95dc66f" xlink:to="loc_gsk_ThirdInterimMember_a1cf8ac5-9be3-4d61-89f0-ec61f1971f25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourthInterimMember_f81554ad-f8d4-4985-b436-a48acbc63cfc" xlink:href="gsk-20241231.xsd#gsk_FourthInterimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6ae4cadf-f0f8-499d-99b4-7521c95dc66f" xlink:to="loc_gsk_FourthInterimMember_f81554ad-f8d4-4985-b436-a48acbc63cfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_52cdb596-3f4f-421d-b517-3dafbe12c4b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDividendsLineItems_99ff5774-7f95-4627-a7d1-942a6a2dd4de" xlink:to="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_52cdb596-3f4f-421d-b517-3dafbe12c4b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinaryShares_5296c120-2149-4149-bf2f-1784cd52a715" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOrdinaryShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDividendsLineItems_99ff5774-7f95-4627-a7d1-942a6a2dd4de" xlink:to="loc_ifrs-full_DividendsPaidOrdinaryShares_5296c120-2149-4149-bf2f-1784cd52a715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDividendPayables_ebc4c3f6-023c-4c96-8d16-571ba83aebf2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDividendPayables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDividendsLineItems_99ff5774-7f95-4627-a7d1-942a6a2dd4de" xlink:to="loc_ifrs-full_CurrentDividendPayables_ebc4c3f6-023c-4c96-8d16-571ba83aebf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionalProvisionForDividendPayable_a315e17e-b6ab-45d8-aa32-6351de2b1528" xlink:href="gsk-20241231.xsd#gsk_AdditionalProvisionForDividendPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDividendsLineItems_99ff5774-7f95-4627-a7d1-942a6a2dd4de" xlink:to="loc_gsk_AdditionalProvisionForDividendPayable_a315e17e-b6ab-45d8-aa32-6351de2b1528" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PropertyplantandequipmentSummaryofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_9225332e-3416-4a9b-930a-2799c24d907d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_9225332e-3416-4a9b-930a-2799c24d907d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1d491757-f13f-45c5-8786-9a4abfed5ac9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_9225332e-3416-4a9b-930a-2799c24d907d" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1d491757-f13f-45c5-8786-9a4abfed5ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_1d491757-f13f-45c5-8786-9a4abfed5ac9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1d491757-f13f-45c5-8786-9a4abfed5ac9" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_1d491757-f13f-45c5-8786-9a4abfed5ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_3f586c25-67c8-4d77-a417-7489df92cdc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1d491757-f13f-45c5-8786-9a4abfed5ac9" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_3f586c25-67c8-4d77-a417-7489df92cdc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember_a3866b27-04a5-48af-ab07-7ccdd503d2cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_3f586c25-67c8-4d77-a417-7489df92cdc8" xlink:to="loc_ifrs-full_LandAndBuildingsMember_a3866b27-04a5-48af-ab07-7ccdd503d2cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PropertyPlantAndEquipmentAndVehiclesMember_6300b8d4-0af9-4f03-9651-fc1169fdb8ea" xlink:href="gsk-20241231.xsd#gsk_PropertyPlantAndEquipmentAndVehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_3f586c25-67c8-4d77-a417-7489df92cdc8" xlink:to="loc_gsk_PropertyPlantAndEquipmentAndVehiclesMember_6300b8d4-0af9-4f03-9651-fc1169fdb8ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConstructionInProgressMember_db283842-b663-4f86-ac01-c6ec30e0a013" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_3f586c25-67c8-4d77-a417-7489df92cdc8" xlink:to="loc_ifrs-full_ConstructionInProgressMember_db283842-b663-4f86-ac01-c6ec30e0a013" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6665441e-3fac-49f0-813e-327b3d97c697" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_9225332e-3416-4a9b-930a-2799c24d907d" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6665441e-3fac-49f0-813e-327b3d97c697" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_6665441e-3fac-49f0-813e-327b3d97c697_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6665441e-3fac-49f0-813e-327b3d97c697" xlink:to="loc_ifrs-full_CarryingAmountMember_6665441e-3fac-49f0-813e-327b3d97c697_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_8a1178be-f2e4-4f18-9845-41dbc11e2e59" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6665441e-3fac-49f0-813e-327b3d97c697" xlink:to="loc_ifrs-full_CarryingAmountMember_8a1178be-f2e4-4f18-9845-41dbc11e2e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_d98a1b32-5955-40d7-ac25-53c66e931a13" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_8a1178be-f2e4-4f18-9845-41dbc11e2e59" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_d98a1b32-5955-40d7-ac25-53c66e931a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_270d3e94-23cb-4777-b711-7f4a5d96c092" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_8a1178be-f2e4-4f18-9845-41dbc11e2e59" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_270d3e94-23cb-4777-b711-7f4a5d96c092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_85a9fb00-84dc-4bb1-a035-973495025349" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_8a1178be-f2e4-4f18-9845-41dbc11e2e59" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_85a9fb00-84dc-4bb1-a035-973495025349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_22e1cc76-3d27-4843-85c2-67df399d32b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_8a1178be-f2e4-4f18-9845-41dbc11e2e59" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_22e1cc76-3d27-4843-85c2-67df399d32b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_c4887a1b-3eba-4a7a-85a9-4d8af8418ec7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_c4887a1b-3eba-4a7a-85a9-4d8af8418ec7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_e0b4fc03-7e7e-4d53-bf44-f7aecfb01d5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_e0b4fc03-7e7e-4d53-bf44-f7aecfb01d5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_3ea94769-3fcf-4d30-b0d7-4127ccdc881e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_3ea94769-3fcf-4d30-b0d7-4127ccdc881e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_15412837-a0a9-4ee0-8da3-2a3b0fbf5f75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_15412837-a0a9-4ee0-8da3-2a3b0fbf5f75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_9711500d-3f2a-4ca6-8230-04fc3b70e45a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_9711500d-3f2a-4ca6-8230-04fc3b70e45a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_579b7f51-910f-471f-97c5-13a1fb8b9e2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_579b7f51-910f-471f-97c5-13a1fb8b9e2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_8f35747c-badc-4249-8233-f4c81200ea6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_8f35747c-badc-4249-8233-f4c81200ea6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_b65077b6-c132-4143-bb35-ffd687b9edff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_b65077b6-c132-4143-bb35-ffd687b9edff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_f0e90b65-c457-42d1-b79c-f5362b7098fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_f0e90b65-c457-42d1-b79c-f5362b7098fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_70d03536-c501-4da1-bc80-836881f6f347" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_c3fdcb5f-2557-40a0-81c3-12a2fc0eb8d6" xlink:to="loc_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_70d03536-c501-4da1-bc80-836881f6f347" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_19df2dce-3c81-468d-919f-e5cd7cb2ec82" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PropertyplantandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PropertyplantandequipmentAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PropertyplantandequipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c6a8fe80-fd20-4b87-b83e-29044996bdef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c6a8fe80-fd20-4b87-b83e-29044996bdef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_b85c38e0-a6bc-4839-9289-577620a842a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c6a8fe80-fd20-4b87-b83e-29044996bdef" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_b85c38e0-a6bc-4839-9289-577620a842a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_b85c38e0-a6bc-4839-9289-577620a842a8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_b85c38e0-a6bc-4839-9289-577620a842a8" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_b85c38e0-a6bc-4839-9289-577620a842a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_b2df89b3-ff89-4941-b759-7f8bb8bfdf0b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_b85c38e0-a6bc-4839-9289-577620a842a8" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_b2df89b3-ff89-4941-b759-7f8bb8bfdf0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_eafcd1db-5b7f-4416-bb62-a6ea1e720311" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_b2df89b3-ff89-4941-b759-7f8bb8bfdf0b" xlink:to="loc_ifrs-full_ComputerSoftwareMember_eafcd1db-5b7f-4416-bb62-a6ea1e720311" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8b2ffa61-a973-4f59-b71b-b3e5d8a5bb46" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c6a8fe80-fd20-4b87-b83e-29044996bdef" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8b2ffa61-a973-4f59-b71b-b3e5d8a5bb46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_8b2ffa61-a973-4f59-b71b-b3e5d8a5bb46_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8b2ffa61-a973-4f59-b71b-b3e5d8a5bb46" xlink:to="loc_ifrs-full_CarryingAmountMember_8b2ffa61-a973-4f59-b71b-b3e5d8a5bb46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_494d0c02-ebfc-4b19-892d-efdc82dc0934" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8b2ffa61-a973-4f59-b71b-b3e5d8a5bb46" xlink:to="loc_ifrs-full_CarryingAmountMember_494d0c02-ebfc-4b19-892d-efdc82dc0934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_53eb093a-2224-41d8-bee2-d9cf75824a88" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_494d0c02-ebfc-4b19-892d-efdc82dc0934" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_53eb093a-2224-41d8-bee2-d9cf75824a88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_e19b340d-3d12-43d6-866e-cad481165e41" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_494d0c02-ebfc-4b19-892d-efdc82dc0934" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_e19b340d-3d12-43d6-866e-cad481165e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetBookValueMember_fc0fe13c-8113-472d-893a-3d90bbefcf62" xlink:href="gsk-20241231.xsd#gsk_NetBookValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_494d0c02-ebfc-4b19-892d-efdc82dc0934" xlink:to="loc_gsk_NetBookValueMember_fc0fe13c-8113-472d-893a-3d90bbefcf62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_45efdffb-e699-4da1-98e4-42651f287e67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c6a8fe80-fd20-4b87-b83e-29044996bdef" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_45efdffb-e699-4da1-98e4-42651f287e67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_45efdffb-e699-4da1-98e4-42651f287e67_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_45efdffb-e699-4da1-98e4-42651f287e67" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_45efdffb-e699-4da1-98e4-42651f287e67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_74235fca-2656-4114-a0cf-412135cb97f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_45efdffb-e699-4da1-98e4-42651f287e67" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_74235fca-2656-4114-a0cf-412135cb97f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LowerCarbonPropellantMember_27a2de3a-fa6b-4d19-aa38-7f1a66cf801e" xlink:href="gsk-20241231.xsd#gsk_LowerCarbonPropellantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_74235fca-2656-4114-a0cf-412135cb97f1" xlink:to="loc_gsk_LowerCarbonPropellantMember_27a2de3a-fa6b-4d19-aa38-7f1a66cf801e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c2faed0d-a5be-494d-80fc-b71379973d36" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c6a8fe80-fd20-4b87-b83e-29044996bdef" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c2faed0d-a5be-494d-80fc-b71379973d36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_c2faed0d-a5be-494d-80fc-b71379973d36_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c2faed0d-a5be-494d-80fc-b71379973d36" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_c2faed0d-a5be-494d-80fc-b71379973d36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_78ee1a37-0eea-4d20-bd86-e1e0a71d274e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_c2faed0d-a5be-494d-80fc-b71379973d36" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_78ee1a37-0eea-4d20-bd86-e1e0a71d274e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember_c9d173e4-9ce0-435b-b16d-c2ab1744a6cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_78ee1a37-0eea-4d20-bd86-e1e0a71d274e" xlink:to="loc_ifrs-full_CostOfSalesMember_c9d173e4-9ce0-435b-b16d-c2ab1744a6cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_244f734c-d8fc-4ff7-848b-319ce0ce5744" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_78ee1a37-0eea-4d20-bd86-e1e0a71d274e" xlink:to="loc_gsk_ResearchAndDevelopmentMember_244f734c-d8fc-4ff7-848b-319ce0ce5744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_70efabd2-47f6-4946-a39f-8a0ab19b5537" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_78ee1a37-0eea-4d20-bd86-e1e0a71d274e" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_70efabd2-47f6-4946-a39f-8a0ab19b5537" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MajorRestructuringProgrammesMember_072e1369-63bf-49dc-9239-9a79e6fd88af" xlink:href="gsk-20241231.xsd#gsk_MajorRestructuringProgrammesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_78ee1a37-0eea-4d20-bd86-e1e0a71d274e" xlink:to="loc_gsk_MajorRestructuringProgrammesMember_072e1369-63bf-49dc-9239-9a79e6fd88af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_31d4863f-7489-45c9-8f53-49c4d97698c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_31d4863f-7489-45c9-8f53-49c4d97698c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_e2c47dc9-4c89-4419-95df-dc79b603f52f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_e2c47dc9-4c89-4419-95df-dc79b603f52f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage_6dcf1a12-fe8e-47ed-ba7d-ef30d0cd0071" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage_6dcf1a12-fe8e-47ed-ba7d-ef30d0cd0071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage_22741212-29f6-4620-94d9-939f238f7036" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage_22741212-29f6-4620-94d9-939f238f7036" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_ef4f3f12-841d-4ae7-a08f-b77b0a0b8500" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_ef4f3f12-841d-4ae7-a08f-b77b0a0b8500" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c588fd94-e9ff-4027-91b7-bf199a7b505a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c588fd94-e9ff-4027-91b7-bf199a7b505a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_35f8f938-b3fd-4284-807e-d4187a2d5dc0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_35f8f938-b3fd-4284-807e-d4187a2d5dc0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_3b42d49e-d5ef-4801-a5c9-889a9d34bd97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_28a32c35-e64d-4c82-997a-de526451f92a" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_3b42d49e-d5ef-4801-a5c9-889a9d34bd97" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/RightofuseassetsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#RightofuseassetsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/RightofuseassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRightOfUseAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRightOfUseAssetsTable_1b2a351c-bb8b-4235-aced-9ea30f6c5021" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRightOfUseAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_gsk_DisclosureOfRightOfUseAssetsTable_1b2a351c-bb8b-4235-aced-9ea30f6c5021" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_63ce8e79-0eba-432f-9961-b624e97520df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsTable_1b2a351c-bb8b-4235-aced-9ea30f6c5021" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_63ce8e79-0eba-432f-9961-b624e97520df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_63ce8e79-0eba-432f-9961-b624e97520df_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_63ce8e79-0eba-432f-9961-b624e97520df" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_63ce8e79-0eba-432f-9961-b624e97520df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_1b3f12eb-d442-4e94-a753-9fc8f72547eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_63ce8e79-0eba-432f-9961-b624e97520df" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_1b3f12eb-d442-4e94-a753-9fc8f72547eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember_0d7fc5e2-15ae-4ed8-a015-f04c7df00aa0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_1b3f12eb-d442-4e94-a753-9fc8f72547eb" xlink:to="loc_ifrs-full_LandAndBuildingsMember_0d7fc5e2-15ae-4ed8-a015-f04c7df00aa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PlantAndEquipmentMember_e2f2de0c-9f89-4405-bc91-9d1075156a3e" xlink:href="gsk-20241231.xsd#gsk_PlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_1b3f12eb-d442-4e94-a753-9fc8f72547eb" xlink:to="loc_gsk_PlantAndEquipmentMember_e2f2de0c-9f89-4405-bc91-9d1075156a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_VehiclesMember_01a732d9-25ac-4b6b-8c3c-e68fa6d115c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_1b3f12eb-d442-4e94-a753-9fc8f72547eb" xlink:to="loc_ifrs-full_VehiclesMember_01a732d9-25ac-4b6b-8c3c-e68fa6d115c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_6bd83aa4-8a4a-48a0-9fa0-8d9634d11540" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsTable_1b2a351c-bb8b-4235-aced-9ea30f6c5021" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_6bd83aa4-8a4a-48a0-9fa0-8d9634d11540" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_6bd83aa4-8a4a-48a0-9fa0-8d9634d11540_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_6bd83aa4-8a4a-48a0-9fa0-8d9634d11540" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_6bd83aa4-8a4a-48a0-9fa0-8d9634d11540_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1ce144b9-1a7c-4593-ba6c-05d3b6cf8d15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_6bd83aa4-8a4a-48a0-9fa0-8d9634d11540" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1ce144b9-1a7c-4593-ba6c-05d3b6cf8d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_62864a0e-b80d-4bcd-8f2b-809bede95e67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1ce144b9-1a7c-4593-ba6c-05d3b6cf8d15" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_62864a0e-b80d-4bcd-8f2b-809bede95e67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_de51f461-51ba-480f-91fb-43561dc23157" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_RightofuseAssets_de51f461-51ba-480f-91fb-43561dc23157" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets_66b60a8b-1665-403b-9150-836db296e489" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets_66b60a8b-1665-403b-9150-836db296e489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets_32ae7ece-da21-428a-959f-d83b40e63ff5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets_32ae7ece-da21-428a-959f-d83b40e63ff5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets_8be542d9-d2aa-4fde-8ed7-aa1f651a9e97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets_8be542d9-d2aa-4fde-8ed7-aa1f651a9e97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_fb90aebf-0d5d-4f5c-81fe-8a8e1ad6efdc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_fb90aebf-0d5d-4f5c-81fe-8a8e1ad6efdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsRightofuseAssets_f3540680-db55-42ec-94af-d0da513b6e06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_DisposalsRightofuseAssets_f3540680-db55-42ec-94af-d0da513b6e06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets_0ec330fc-3bf6-4328-84e2-3450513398e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets_0ec330fc-3bf6-4328-84e2-3450513398e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets_74f21b00-a5c3-4d3a-8499-9549e1d581c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets_74f21b00-a5c3-4d3a-8499-9549e1d581c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets_6376a1a3-ff72-49e4-86e4-1c5dad87032b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems_6abc7f5e-f4be-4a5a-9eb8-4c59e65f2c28" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets_6376a1a3-ff72-49e4-86e4-1c5dad87032b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_d91265eb-9971-4a0e-8802-a245b898ad1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/GoodwillSummaryofChangesinGoodwillDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#GoodwillSummaryofChangesinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/GoodwillSummaryofChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_0a9dafd6-9b3e-4736-a9bf-141699233e9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_71f4c3b8-15e6-4220-9ba6-c9fd163b1904" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_0a9dafd6-9b3e-4736-a9bf-141699233e9d" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_71f4c3b8-15e6-4220-9ba6-c9fd163b1904" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6492ff26-4c14-4ddf-8579-a67a1b7ca08f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_71f4c3b8-15e6-4220-9ba6-c9fd163b1904" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6492ff26-4c14-4ddf-8579-a67a1b7ca08f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_6492ff26-4c14-4ddf-8579-a67a1b7ca08f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6492ff26-4c14-4ddf-8579-a67a1b7ca08f" xlink:to="loc_ifrs-full_CarryingAmountMember_6492ff26-4c14-4ddf-8579-a67a1b7ca08f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_6cd96d0d-acce-4d9e-940b-65515cc860da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6492ff26-4c14-4ddf-8579-a67a1b7ca08f" xlink:to="loc_ifrs-full_CarryingAmountMember_6cd96d0d-acce-4d9e-940b-65515cc860da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_99ae1e5b-3420-4869-93ae-0fa7e66548eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_6cd96d0d-acce-4d9e-940b-65515cc860da" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_99ae1e5b-3420-4869-93ae-0fa7e66548eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_bd1c2934-13c8-40e0-8b43-f02a6c92e6a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_0a9dafd6-9b3e-4736-a9bf-141699233e9d" xlink:to="loc_ifrs-full_Goodwill_bd1c2934-13c8-40e0-8b43-f02a6c92e6a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill_5b56ea33-ed2b-4272-94b6-36a10bf86176" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_0a9dafd6-9b3e-4736-a9bf-141699233e9d" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill_5b56ea33-ed2b-4272-94b6-36a10bf86176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalRecognitionGoodwill_669df079-3064-4450-8873-59f84dd133a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_0a9dafd6-9b3e-4736-a9bf-141699233e9d" xlink:to="loc_ifrs-full_AdditionalRecognitionGoodwill_669df079-3064-4450-8873-59f84dd133a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest_91b62225-abbf-49f2-8c7f-aab4fff09641" xlink:href="gsk-20241231.xsd#gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_0a9dafd6-9b3e-4736-a9bf-141699233e9d" xlink:to="loc_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest_91b62225-abbf-49f2-8c7f-aab4fff09641" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_22b4425b-217d-45f5-b19f-64714fa5dc1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/GoodwillSummaryofGoodwillAllocatedtoSegmentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#GoodwillSummaryofGoodwillAllocatedtoSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/GoodwillSummaryofGoodwillAllocatedtoSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_c63fee5f-ed35-41a6-9339-b48a4e507ff2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_515cdf03-30ee-4a9c-90e3-d3613824490f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_c63fee5f-ed35-41a6-9339-b48a4e507ff2" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_515cdf03-30ee-4a9c-90e3-d3613824490f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_47b82c4b-4341-4e7c-8d7f-5c8b6278be28" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_515cdf03-30ee-4a9c-90e3-d3613824490f" xlink:to="loc_ifrs-full_SegmentsAxis_47b82c4b-4341-4e7c-8d7f-5c8b6278be28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_47b82c4b-4341-4e7c-8d7f-5c8b6278be28_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_47b82c4b-4341-4e7c-8d7f-5c8b6278be28" xlink:to="loc_ifrs-full_SegmentsDomain_47b82c4b-4341-4e7c-8d7f-5c8b6278be28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_9fbe4052-09db-4aba-889e-245828aeea39" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_47b82c4b-4341-4e7c-8d7f-5c8b6278be28" xlink:to="loc_ifrs-full_SegmentsDomain_9fbe4052-09db-4aba-889e-245828aeea39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_82246d75-d047-483f-a121-4c9f1ab46689" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_9fbe4052-09db-4aba-889e-245828aeea39" xlink:to="loc_gsk_CommercialOperationsMember_82246d75-d047-483f-a121-4c9f1ab46689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_7d106fe7-1c2d-445b-8240-f5f414c7a114" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_9fbe4052-09db-4aba-889e-245828aeea39" xlink:to="loc_gsk_ResearchAndDevelopmentMember_7d106fe7-1c2d-445b-8240-f5f414c7a114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_aeafd902-9ee6-4ba7-87c4-3a193dbcd6f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_c63fee5f-ed35-41a6-9339-b48a4e507ff2" xlink:to="loc_ifrs-full_Goodwill_aeafd902-9ee6-4ba7-87c4-3a193dbcd6f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/GoodwillScheduleofDiscountedCashFlowModelsUsedinImpairmentTestsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#GoodwillScheduleofDiscountedCashFlowModelsUsedinImpairmentTestsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/GoodwillScheduleofDiscountedCashFlowModelsUsedinImpairmentTestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_56205278-9543-4078-ad04-e997c6871c0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_d5791574-17cd-4e13-bdac-cfa7160b219a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_56205278-9543-4078-ad04-e997c6871c0e" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_d5791574-17cd-4e13-bdac-cfa7160b219a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_fec9ed84-5373-4d99-ac5f-2a71e8df31d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_d5791574-17cd-4e13-bdac-cfa7160b219a" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_fec9ed84-5373-4d99-ac5f-2a71e8df31d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_fec9ed84-5373-4d99-ac5f-2a71e8df31d4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_fec9ed84-5373-4d99-ac5f-2a71e8df31d4" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_fec9ed84-5373-4d99-ac5f-2a71e8df31d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_bbb7db15-7eff-468d-b913-a7e6ddc88e78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_fec9ed84-5373-4d99-ac5f-2a71e8df31d4" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_bbb7db15-7eff-468d-b913-a7e6ddc88e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember_9da5f172-0b00-4f44-b391-e2eeecee9252" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_bbb7db15-7eff-468d-b913-a7e6ddc88e78" xlink:to="loc_gsk_CommercialOperationsMember_9da5f172-0b00-4f44-b391-e2eeecee9252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_55f89181-2e05-41ab-9768-799b2fd7495c" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_bbb7db15-7eff-468d-b913-a7e6ddc88e78" xlink:to="loc_gsk_ResearchAndDevelopmentMember_55f89181-2e05-41ab-9768-799b2fd7495c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows_af004dc9-3b7f-46c5-89f6-73332b0db0ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_56205278-9543-4078-ad04-e997c6871c0e" xlink:to="loc_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows_af004dc9-3b7f-46c5-89f6-73332b0db0ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_086876bc-7868-418f-b8a5-0eebdb89cdf8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_56205278-9543-4078-ad04-e997c6871c0e" xlink:to="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_086876bc-7868-418f-b8a5-0eebdb89cdf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_fc84890c-965a-460b-98cf-9d47803c6072" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_56205278-9543-4078-ad04-e997c6871c0e" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_fc84890c-965a-460b-98cf-9d47803c6072" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherintangibleassetsSummaryofOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherintangibleassetsSummaryofOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherintangibleassetsSummaryofOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_f0eaf1ac-62e9-4cad-83b1-1a7b7b6964ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_f0eaf1ac-62e9-4cad-83b1-1a7b7b6964ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_c6d9fc3c-37c9-44f1-8e80-b19b9998bfeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_f0eaf1ac-62e9-4cad-83b1-1a7b7b6964ed" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_c6d9fc3c-37c9-44f1-8e80-b19b9998bfeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_c6d9fc3c-37c9-44f1-8e80-b19b9998bfeb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_c6d9fc3c-37c9-44f1-8e80-b19b9998bfeb" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_c6d9fc3c-37c9-44f1-8e80-b19b9998bfeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_378bf961-d886-4811-94b7-572ff9b7ad0c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_c6d9fc3c-37c9-44f1-8e80-b19b9998bfeb" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_378bf961-d886-4811-94b7-572ff9b7ad0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_c120b59f-f2ec-4109-91e9-80f2e312745c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_378bf961-d886-4811-94b7-572ff9b7ad0c" xlink:to="loc_ifrs-full_ComputerSoftwareMember_c120b59f-f2ec-4109-91e9-80f2e312745c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LicencesAndFranchisesAmortisedBrandsMember_a5f8e985-45db-483d-85a5-cb3f8cf4440c" xlink:href="gsk-20241231.xsd#gsk_LicencesAndFranchisesAmortisedBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_378bf961-d886-4811-94b7-572ff9b7ad0c" xlink:to="loc_gsk_LicencesAndFranchisesAmortisedBrandsMember_a5f8e985-45db-483d-85a5-cb3f8cf4440c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9203025d-0e1a-417b-9820-d4ef9ca1dd84" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_f0eaf1ac-62e9-4cad-83b1-1a7b7b6964ed" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9203025d-0e1a-417b-9820-d4ef9ca1dd84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_9203025d-0e1a-417b-9820-d4ef9ca1dd84_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9203025d-0e1a-417b-9820-d4ef9ca1dd84" xlink:to="loc_ifrs-full_CarryingAmountMember_9203025d-0e1a-417b-9820-d4ef9ca1dd84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_bd435a6a-70ee-439a-a33f-5a905505fd55" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9203025d-0e1a-417b-9820-d4ef9ca1dd84" xlink:to="loc_ifrs-full_CarryingAmountMember_bd435a6a-70ee-439a-a33f-5a905505fd55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_f42575e7-2fd9-4df1-b379-fec0b68f9567" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_bd435a6a-70ee-439a-a33f-5a905505fd55" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_f42575e7-2fd9-4df1-b379-fec0b68f9567" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_09fcfa4d-49f9-44d3-94b5-a32d3236f6e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_bd435a6a-70ee-439a-a33f-5a905505fd55" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_09fcfa4d-49f9-44d3-94b5-a32d3236f6e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_69d858e5-aa81-4143-868f-ddc3073dd978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_bd435a6a-70ee-439a-a33f-5a905505fd55" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_69d858e5-aa81-4143-868f-ddc3073dd978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_dfdc5a9c-835a-4358-bcfa-4502b26c036d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_bd435a6a-70ee-439a-a33f-5a905505fd55" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_dfdc5a9c-835a-4358-bcfa-4502b26c036d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_708a127e-5950-49b7-b5fd-9d46417cbea9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_708a127e-5950-49b7-b5fd-9d46417cbea9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_205d1fd9-a26b-47cf-a4fc-6d3203d5ac20" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_205d1fd9-a26b-47cf-a4fc-6d3203d5ac20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill_88451419-7c1a-4683-af04-8db84b3c49a0" xlink:href="gsk-20241231.xsd#gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill_88451419-7c1a-4683-af04-8db84b3c49a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_327103d3-7e6c-4c97-96ad-2425ed6940c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_327103d3-7e6c-4c97-96ad-2425ed6940c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1270207d-cde4-4eb4-8ed0-84c6aac9f6af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1270207d-cde4-4eb4-8ed0-84c6aac9f6af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_6adec0b2-5c14-417e-8788-45c999ee098f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_6adec0b2-5c14-417e-8788-45c999ee098f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_f6832c8d-ab54-4fca-aeac-7aad25fd74a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_f6832c8d-ab54-4fca-aeac-7aad25fd74a8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_edfacf6c-7204-406c-9574-0c70a66db827" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_edfacf6c-7204-406c-9574-0c70a66db827" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_6cb5a7cb-ab17-4089-953d-af2c45653489" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_6cb5a7cb-ab17-4089-953d-af2c45653489" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill_3c8c82ff-1688-4323-9a0d-b968dcc6270b" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill_3c8c82ff-1688-4323-9a0d-b968dcc6270b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_0b8a6055-102a-4e99-a6a6-da4de4fba82a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_9d8f93df-a08c-45fb-ada9-c86ee138568a" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_0b8a6055-102a-4e99-a6a6-da4de4fba82a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_50fa709c-6f51-494c-803b-ca7c13dfd9ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherintangibleassetsAdditionalinformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherintangibleassetsAdditionalinformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherintangibleassetsAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_ad786d17-d4fd-4258-b155-7da8af9a7e69" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_47d2aad1-74d7-484d-8314-beb1cc88b9d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_ad786d17-d4fd-4258-b155-7da8af9a7e69" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_47d2aad1-74d7-484d-8314-beb1cc88b9d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MethodsOfGenerationAxis_e4cdf01d-3bf7-446d-80ad-1f2e4efdb1a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodsOfGenerationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_47d2aad1-74d7-484d-8314-beb1cc88b9d8" xlink:to="loc_ifrs-full_MethodsOfGenerationAxis_e4cdf01d-3bf7-446d-80ad-1f2e4efdb1a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MethodsOfGenerationDomain_e4cdf01d-3bf7-446d-80ad-1f2e4efdb1a9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodsOfGenerationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_e4cdf01d-3bf7-446d-80ad-1f2e4efdb1a9" xlink:to="loc_ifrs-full_MethodsOfGenerationDomain_e4cdf01d-3bf7-446d-80ad-1f2e4efdb1a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MethodsOfGenerationDomain_667ee955-3e27-4049-9386-24c5eff1f037" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodsOfGenerationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_e4cdf01d-3bf7-446d-80ad-1f2e4efdb1a9" xlink:to="loc_ifrs-full_MethodsOfGenerationDomain_667ee955-3e27-4049-9386-24c5eff1f037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InternallyGeneratedMember_ef2fb8b5-4abf-466b-b61c-fce5d11a5912" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InternallyGeneratedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MethodsOfGenerationDomain_667ee955-3e27-4049-9386-24c5eff1f037" xlink:to="loc_ifrs-full_InternallyGeneratedMember_ef2fb8b5-4abf-466b-b61c-fce5d11a5912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_83d8ae31-c326-4719-8018-8e6e18668c47" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_ad786d17-d4fd-4258-b155-7da8af9a7e69" xlink:to="loc_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_83d8ae31-c326-4719-8018-8e6e18668c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftware_0f5c5770-4e3e-4845-983a-4d3e3017d450" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_ad786d17-d4fd-4258-b155-7da8af9a7e69" xlink:to="loc_ifrs-full_ComputerSoftware_0f5c5770-4e3e-4845-983a-4d3e3017d450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged_21b8aff5-d1e0-4f5e-94e3-848e83caecc1" xlink:href="gsk-20241231.xsd#gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_ad786d17-d4fd-4258-b155-7da8af9a7e69" xlink:to="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged_21b8aff5-d1e0-4f5e-94e3-848e83caecc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed_ed8b333d-2f52-452a-827c-444230f1f9b9" xlink:href="gsk-20241231.xsd#gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_ad786d17-d4fd-4258-b155-7da8af9a7e69" xlink:to="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed_ed8b333d-2f52-452a-827c-444230f1f9b9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherintangibleassetsScheduleofAmortisationandImpairmentLossesNetofReversalsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherintangibleassetsScheduleofAmortisationandImpairmentLossesNetofReversalsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherintangibleassetsScheduleofAmortisationandImpairmentLossesNetofReversalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_d38cb73a-c141-46ec-84d2-ccac469880c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_89667ea3-e456-4c69-9414-41b0c3097190" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_d38cb73a-c141-46ec-84d2-ccac469880c0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_89667ea3-e456-4c69-9414-41b0c3097190" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_bc4e5da6-4962-4f33-b4e6-91b19968080d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_89667ea3-e456-4c69-9414-41b0c3097190" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_bc4e5da6-4962-4f33-b4e6-91b19968080d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_bc4e5da6-4962-4f33-b4e6-91b19968080d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_bc4e5da6-4962-4f33-b4e6-91b19968080d" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_bc4e5da6-4962-4f33-b4e6-91b19968080d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_41a2d571-2efc-4269-a300-8e0966e6b18f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_bc4e5da6-4962-4f33-b4e6-91b19968080d" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_41a2d571-2efc-4269-a300-8e0966e6b18f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember_18456999-7612-4ed9-859b-80c8104aa8f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_41a2d571-2efc-4269-a300-8e0966e6b18f" xlink:to="loc_ifrs-full_CostOfSalesMember_18456999-7612-4ed9-859b-80c8104aa8f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_e8e78969-4223-4779-9fba-84fe92ff7af5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_41a2d571-2efc-4269-a300-8e0966e6b18f" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_e8e78969-4223-4779-9fba-84fe92ff7af5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_9a69d57c-2b54-4eb7-a621-1075e3fc0ef7" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_41a2d571-2efc-4269-a300-8e0966e6b18f" xlink:to="loc_gsk_ResearchAndDevelopmentMember_9a69d57c-2b54-4eb7-a621-1075e3fc0ef7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_b692cac6-3ef2-458d-8030-6e356383b968" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_d38cb73a-c141-46ec-84d2-ccac469880c0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_b692cac6-3ef2-458d-8030-6e356383b968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_9aed9bd2-c57b-4fa9-886c-8b01c8eb838a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_d38cb73a-c141-46ec-84d2-ccac469880c0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_9aed9bd2-c57b-4fa9-886c-8b01c8eb838a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherintangibleassetsSummaryofBookValuesofLargestIndividualItemsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherintangibleassetsSummaryofBookValuesofLargestIndividualItemsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherintangibleassetsSummaryofBookValuesofLargestIndividualItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_582d2bce-a4a4-437a-bd35-84905dbbf640" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_84ceee99-9188-4ced-894b-299997e20500" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_582d2bce-a4a4-437a-bd35-84905dbbf640" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_84ceee99-9188-4ced-894b-299997e20500" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_72fc57b8-47aa-4656-bdbd-2c53796145ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_84ceee99-9188-4ced-894b-299997e20500" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_72fc57b8-47aa-4656-bdbd-2c53796145ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_72fc57b8-47aa-4656-bdbd-2c53796145ca_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_72fc57b8-47aa-4656-bdbd-2c53796145ca" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_72fc57b8-47aa-4656-bdbd-2c53796145ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_fa56bcf5-f234-4df7-8078-f979e46aecb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_72fc57b8-47aa-4656-bdbd-2c53796145ca" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_fa56bcf5-f234-4df7-8078-f979e46aecb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_60da0092-f5e9-45be-a2ef-74e1847c805c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesAndFranchisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_fa56bcf5-f234-4df7-8078-f979e46aecb2" xlink:to="loc_ifrs-full_LicencesAndFranchisesMember_60da0092-f5e9-45be-a2ef-74e1847c805c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsMaterialToEntityAxis_369afd52-072d-44cd-a146-92ebda39fbb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsMaterialToEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_84ceee99-9188-4ced-894b-299997e20500" xlink:to="loc_ifrs-full_IntangibleAssetsMaterialToEntityAxis_369afd52-072d-44cd-a146-92ebda39fbb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_369afd52-072d-44cd-a146-92ebda39fbb0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsMaterialToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityAxis_369afd52-072d-44cd-a146-92ebda39fbb0" xlink:to="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_369afd52-072d-44cd-a146-92ebda39fbb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsMaterialToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityAxis_369afd52-072d-44cd-a146-92ebda39fbb0" xlink:to="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TesaroAssetsMember_aed45aa1-da8f-4977-afda-c831dbe21ea7" xlink:href="gsk-20241231.xsd#gsk_TesaroAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_TesaroAssetsMember_aed45aa1-da8f-4977-afda-c831dbe21ea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MeningitisPortfolioMember_91d4e0be-788a-4e9d-a76f-7b6973a6144e" xlink:href="gsk-20241231.xsd#gsk_MeningitisPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_MeningitisPortfolioMember_91d4e0be-788a-4e9d-a76f-7b6973a6144e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxAssetsMember_35138bac-09b9-4c9b-b23c-2107213a6829" xlink:href="gsk-20241231.xsd#gsk_AffinivaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_AffinivaxAssetsMember_35138bac-09b9-4c9b-b23c-2107213a6829" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CamlipixantMember_ddae8ce0-e0f6-42d8-9124-3d04ba2818a0" xlink:href="gsk-20241231.xsd#gsk_CamlipixantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_CamlipixantMember_ddae8ce0-e0f6-42d8-9124-3d04ba2818a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MomelotinibMember_0f8508c6-e3e6-4fbf-b30c-68a9fbd8ce61" xlink:href="gsk-20241231.xsd#gsk_MomelotinibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_MomelotinibMember_0f8508c6-e3e6-4fbf-b30c-68a9fbd8ce61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DolutegravirIncludingCabotegravirMember_6c839cc1-3f10-48e0-99ff-a8cf55bceeb2" xlink:href="gsk-20241231.xsd#gsk_DolutegravirIncludingCabotegravirMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_DolutegravirIncludingCabotegravirMember_6c839cc1-3f10-48e0-99ff-a8cf55bceeb2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosAcquisitionMember_0605b621-b1cc-4fe9-995c-2712a7fe55e3" xlink:href="gsk-20241231.xsd#gsk_AiolosAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_AiolosAcquisitionMember_0605b621-b1cc-4fe9-995c-2712a7fe55e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CureVacAssetsMember_b6912340-71a6-4a69-888e-d4c7fe027370" xlink:href="gsk-20241231.xsd#gsk_CureVacAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_CureVacAssetsMember_b6912340-71a6-4a69-888e-d4c7fe027370" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IteosAssetsMember_4eafd276-03b5-48ef-8d47-ce9aed9dcd62" xlink:href="gsk-20241231.xsd#gsk_IteosAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_IteosAssetsMember_4eafd276-03b5-48ef-8d47-ce9aed9dcd62" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AlectorAssetsMember_711d6c9e-1b68-47b1-ad01-766ddcd446ac" xlink:href="gsk-20241231.xsd#gsk_AlectorAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_AlectorAssetsMember_711d6c9e-1b68-47b1-ad01-766ddcd446ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BenlystaMember_17cf4d81-553f-49f6-a8b8-5b840a2da4b3" xlink:href="gsk-20241231.xsd#gsk_BenlystaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_BenlystaMember_17cf4d81-553f-49f6-a8b8-5b840a2da4b3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShingrixMember_b86cb4f8-ef5d-466d-8576-4900ecca1742" xlink:href="gsk-20241231.xsd#gsk_ShingrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_ShingrixMember_b86cb4f8-ef5d-466d-8576-4900ecca1742" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HansohPharmaAssetsMember_2d18b4ab-a3d0-4a27-9fd7-cf77585670e7" xlink:href="gsk-20241231.xsd#gsk_HansohPharmaAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_HansohPharmaAssetsMember_2d18b4ab-a3d0-4a27-9fd7-cf77585670e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChimagenMember_aea4af96-c81a-4f8c-b912-ef59ca76b962" xlink:href="gsk-20241231.xsd#gsk_ChimagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_ChimagenMember_aea4af96-c81a-4f8c-b912-ef59ca76b962" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RSVMember_7adfa7c0-77f7-4951-bf76-f76e93b2d032" xlink:href="gsk-20241231.xsd#gsk_RSVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_RSVMember_7adfa7c0-77f7-4951-bf76-f76e93b2d032" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BMSAssetsMember_49ae87ae-79d0-4462-a1e3-5d3fe1ddc6b0" xlink:href="gsk-20241231.xsd#gsk_BMSAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_BMSAssetsMember_49ae87ae-79d0-4462-a1e3-5d3fe1ddc6b0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SperoMember_41ea2547-d134-4e00-b548-0733bcfcc142" xlink:href="gsk-20241231.xsd#gsk_SperoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_SperoMember_41ea2547-d134-4e00-b548-0733bcfcc142" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WaveLifeSciencesMember_253199b8-20dc-48cf-8cac-963caa9c295e" xlink:href="gsk-20241231.xsd#gsk_WaveLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_WaveLifeSciencesMember_253199b8-20dc-48cf-8cac-963caa9c295e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrowheadMember_ef8cc294-2da9-44d2-9f02-d8344671de0b" xlink:href="gsk-20241231.xsd#gsk_ArrowheadMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_ArrowheadMember_ef8cc294-2da9-44d2-9f02-d8344671de0b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UCBMember_092c8930-cf8d-4a18-8e89-7546ebe2fd8c" xlink:href="gsk-20241231.xsd#gsk_UCBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_UCBMember_092c8930-cf8d-4a18-8e89-7546ebe2fd8c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DTMember_fa7d763f-1660-472b-a77a-91096b93583d" xlink:href="gsk-20241231.xsd#gsk_DTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_DTMember_fa7d763f-1660-472b-a77a-91096b93583d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RelvarBreoAnoroMember_f08be36e-5ea6-4cbc-b371-73943cc900a7" xlink:href="gsk-20241231.xsd#gsk_RelvarBreoAnoroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_RelvarBreoAnoroMember_f08be36e-5ea6-4cbc-b371-73943cc900a7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_StiefelTradeNameMember_957c9fe0-91fa-473e-9520-13cbf20ca1be" xlink:href="gsk-20241231.xsd#gsk_StiefelTradeNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_StiefelTradeNameMember_957c9fe0-91fa-473e-9520-13cbf20ca1be" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FluarixFluLavalMember_64fa8f39-b3ec-4e7e-8676-af1b0b8eb9fb" xlink:href="gsk-20241231.xsd#gsk_FluarixFluLavalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_FluarixFluLavalMember_64fa8f39-b3ec-4e7e-8676-af1b0b8eb9fb" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OkairosMember_20297e30-03f2-4af5-baed-4529e042bba1" xlink:href="gsk-20241231.xsd#gsk_OkairosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_OkairosMember_20297e30-03f2-4af5-baed-4529e042bba1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OthersMember_84003ea2-639c-4bf0-a0c7-6abae549e12e" xlink:href="gsk-20241231.xsd#gsk_OthersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityDomain_aa6aee82-6223-4b42-a385-d07d670ac738" xlink:to="loc_gsk_OthersMember_84003ea2-639c-4bf0-a0c7-6abae549e12e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_293a19b3-b7fa-4b75-a236-fd9e7ee96dc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_582d2bce-a4a4-437a-bd35-84905dbbf640" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_293a19b3-b7fa-4b75-a236-fd9e7ee96dc3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/InvestmentsinAssociatesandJointVenturesSummaryofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#InvestmentsinAssociatesandJointVenturesSummaryofInvestmentsinAssociatesandJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/InvestmentsinAssociatesandJointVenturesSummaryofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ece215cd-00ba-48d0-b55a-25575fda36d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ece215cd-00ba-48d0-b55a-25575fda36d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_af74820e-7205-44d0-a113-7ab2c8ab598a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ece215cd-00ba-48d0-b55a-25575fda36d2" xlink:to="loc_ifrs-full_JointVenturesAxis_af74820e-7205-44d0-a113-7ab2c8ab598a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_af74820e-7205-44d0-a113-7ab2c8ab598a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_af74820e-7205-44d0-a113-7ab2c8ab598a" xlink:to="loc_ifrs-full_JointVenturesDomain_af74820e-7205-44d0-a113-7ab2c8ab598a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_66731ac6-f810-4306-8b85-1840bf23a024" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_af74820e-7205-44d0-a113-7ab2c8ab598a" xlink:to="loc_ifrs-full_JointVenturesDomain_66731ac6-f810-4306-8b85-1840bf23a024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_e0808103-07e4-4065-846f-e80e1b2a6f98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_66731ac6-f810-4306-8b85-1840bf23a024" xlink:to="loc_ifrs-full_JointVenturesMember_e0808103-07e4-4065-846f-e80e1b2a6f98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2ca84f06-c3d8-485d-b51f-ab5fba7f38e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ece215cd-00ba-48d0-b55a-25575fda36d2" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2ca84f06-c3d8-485d-b51f-ab5fba7f38e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2ca84f06-c3d8-485d-b51f-ab5fba7f38e6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2ca84f06-c3d8-485d-b51f-ab5fba7f38e6" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_2ca84f06-c3d8-485d-b51f-ab5fba7f38e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_a94b7a73-e21d-46b4-bf1e-1b815f468f8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2ca84f06-c3d8-485d-b51f-ab5fba7f38e6" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_a94b7a73-e21d-46b4-bf1e-1b815f468f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember_99365f84-2910-4de1-9451-ebc368e6a0e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_a94b7a73-e21d-46b4-bf1e-1b815f468f8f" xlink:to="loc_ifrs-full_AssociatesMember_99365f84-2910-4de1-9451-ebc368e6a0e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_23cb7cc1-8679-455c-84e5-8ba73c8039f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_23cb7cc1-8679-455c-84e5-8ba73c8039f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_b9479b78-2ed5-4dac-b160-06d19eb26b04" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_b9479b78-2ed5-4dac-b160-06d19eb26b04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_60d3d769-2118-4b10-8632-05f9247bee7e" xlink:href="gsk-20241231.xsd#gsk_AdditionsInInvestmentsInAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_60d3d769-2118-4b10-8632-05f9247bee7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalsInAssociatesAndJointVentures_048c4d88-946b-497c-8024-584b2003d1e2" xlink:href="gsk-20241231.xsd#gsk_DisposalsInAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_gsk_DisposalsInAssociatesAndJointVentures_048c4d88-946b-497c-8024-584b2003d1e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures_054ac371-7da7-4225-a61e-020775793949" xlink:href="gsk-20241231.xsd#gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures_054ac371-7da7-4225-a61e-020775793949" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures_87bf9e11-77b4-42e0-babc-c282aea33cc0" xlink:href="gsk-20241231.xsd#gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures_87bf9e11-77b4-42e0-babc-c282aea33cc0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_750786cf-32df-42e4-b978-6ad0d6e0b43b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_270f1ccc-6f12-4d4f-9e16-4b0ea5d16b68" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_750786cf-32df-42e4-b978-6ad0d6e0b43b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_a1c3fc44-b352-4876-ba07-c0a9d48ff4db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/InvestmentsinAssociatesandJointVenturesAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#InvestmentsinAssociatesandJointVenturesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/InvestmentsinAssociatesandJointVenturesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_1bd35b2d-88c7-4823-aeeb-929b9d5b3c1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_36f6fa18-ad7b-44bc-89f5-82224734c928" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_1bd35b2d-88c7-4823-aeeb-929b9d5b3c1c" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_36f6fa18-ad7b-44bc-89f5-82224734c928" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1b3195a0-ef2c-498c-8aac-268694e03d6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_36f6fa18-ad7b-44bc-89f5-82224734c928" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1b3195a0-ef2c-498c-8aac-268694e03d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_1b3195a0-ef2c-498c-8aac-268694e03d6a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1b3195a0-ef2c-498c-8aac-268694e03d6a" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_1b3195a0-ef2c-498c-8aac-268694e03d6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_9b04648c-e7c6-4b9d-8c4b-b902224dbe76" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1b3195a0-ef2c-498c-8aac-268694e03d6a" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_9b04648c-e7c6-4b9d-8c4b-b902224dbe76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FlagshipPioneeringMember_0d463359-6fff-4c5f-ad20-5a487bc00a5d" xlink:href="gsk-20241231.xsd#gsk_FlagshipPioneeringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_9b04648c-e7c6-4b9d-8c4b-b902224dbe76" xlink:to="loc_gsk_FlagshipPioneeringMember_0d463359-6fff-4c5f-ad20-5a487bc00a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_df3bac4d-2644-45d1-8713-0f1bf8fd4ab6" xlink:href="gsk-20241231.xsd#gsk_AdditionsInInvestmentsInAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_1bd35b2d-88c7-4823-aeeb-929b9d5b3c1c" xlink:to="loc_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_df3bac4d-2644-45d1-8713-0f1bf8fd4ab6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/CurrentEquityInvestmentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#CurrentEquityInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/CurrentEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_966d6a1a-5d04-4bc7-a1b5-5337d22c4a26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable_6f9cc640-da61-47d6-a0b7-02804e5cb3e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_966d6a1a-5d04-4bc7-a1b5-5337d22c4a26" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable_6f9cc640-da61-47d6-a0b7-02804e5cb3e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_4837ae24-146e-4dac-9923-349a23ba07b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable_6f9cc640-da61-47d6-a0b7-02804e5cb3e2" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_4837ae24-146e-4dac-9923-349a23ba07b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_4837ae24-146e-4dac-9923-349a23ba07b9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_4837ae24-146e-4dac-9923-349a23ba07b9" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_4837ae24-146e-4dac-9923-349a23ba07b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ba6edd1a-c9da-4be9-ae91-10c185b94847" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_4837ae24-146e-4dac-9923-349a23ba07b9" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ba6edd1a-c9da-4be9-ae91-10c185b94847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_2b83ed66-58c8-4137-8935-7fe8547424bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ba6edd1a-c9da-4be9-ae91-10c185b94847" xlink:to="loc_ifrs-full_EquityInvestmentsMember_2b83ed66-58c8-4137-8935-7fe8547424bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e33a4a82-3db9-4e72-9c23-ef8f67371fe0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable_6f9cc640-da61-47d6-a0b7-02804e5cb3e2" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e33a4a82-3db9-4e72-9c23-ef8f67371fe0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_e33a4a82-3db9-4e72-9c23-ef8f67371fe0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e33a4a82-3db9-4e72-9c23-ef8f67371fe0" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_e33a4a82-3db9-4e72-9c23-ef8f67371fe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_7701ada2-3241-4d98-9ba0-78ccfa1cb39c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e33a4a82-3db9-4e72-9c23-ef8f67371fe0" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_7701ada2-3241-4d98-9ba0-78ccfa1cb39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember_4555186b-7dfe-4d02-8ab2-28235d3fca39" xlink:href="gsk-20241231.xsd#gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_7701ada2-3241-4d98-9ba0-78ccfa1cb39c" xlink:to="loc_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember_4555186b-7dfe-4d02-8ab2-28235d3fca39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_7c27c6c1-6bbf-446e-8372-99a319114327" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_966d6a1a-5d04-4bc7-a1b5-5337d22c4a26" xlink:to="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_7c27c6c1-6bbf-446e-8372-99a319114327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments_96ceb9a3-13be-428a-ad44-a6b102326305" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_966d6a1a-5d04-4bc7-a1b5-5337d22c4a26" xlink:to="loc_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments_96ceb9a3-13be-428a-ad44-a6b102326305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss_34d3c175-4439-4239-9f9b-6891ad4ce8bf" xlink:href="gsk-20241231.xsd#gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_966d6a1a-5d04-4bc7-a1b5-5337d22c4a26" xlink:to="loc_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss_34d3c175-4439-4239-9f9b-6891ad4ce8bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_c66c9aeb-cbf9-4e3b-a358-697cac0ec318" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_966d6a1a-5d04-4bc7-a1b5-5337d22c4a26" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_c66c9aeb-cbf9-4e3b-a358-697cac0ec318" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_31d1d5a0-90ec-4c04-9613-ebe5ad9f0c3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherInvestmentsScheduleofOtherInvestmentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherInvestmentsScheduleofOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherInvestmentsScheduleofOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_9a8ead4a-9882-4ce7-a287-7fcbf37f3bb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_9a8ead4a-9882-4ce7-a287-7fcbf37f3bb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8495f986-4fa2-4824-bbb5-b496e20d597c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_9a8ead4a-9882-4ce7-a287-7fcbf37f3bb6" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8495f986-4fa2-4824-bbb5-b496e20d597c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8495f986-4fa2-4824-bbb5-b496e20d597c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8495f986-4fa2-4824-bbb5-b496e20d597c" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8495f986-4fa2-4824-bbb5-b496e20d597c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_71c0af5e-027f-4ee8-956b-37f114f21852" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8495f986-4fa2-4824-bbb5-b496e20d597c" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_71c0af5e-027f-4ee8-956b-37f114f21852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_dd013c3b-11a0-43bb-b76f-e5c02abd466e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_71c0af5e-027f-4ee8-956b-37f114f21852" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_dd013c3b-11a0-43bb-b76f-e5c02abd466e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_c57ba38e-a8c3-4346-965d-ffd5c500d3d6" xlink:href="gsk-20241231.xsd#gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_71c0af5e-027f-4ee8-956b-37f114f21852" xlink:to="loc_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_c57ba38e-a8c3-4346-965d-ffd5c500d3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_e1e29d18-c082-4250-9773-45036cfc3388" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_9a8ead4a-9882-4ce7-a287-7fcbf37f3bb6" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_e1e29d18-c082-4250-9773-45036cfc3388" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_e1e29d18-c082-4250-9773-45036cfc3388_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_e1e29d18-c082-4250-9773-45036cfc3388" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_e1e29d18-c082-4250-9773-45036cfc3388_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_9530ee75-06ad-4110-8195-216d848904d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_e1e29d18-c082-4250-9773-45036cfc3388" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_9530ee75-06ad-4110-8195-216d848904d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherInvestmentsNoncurrentMember_b6caf6de-db01-4ffe-a28c-8fe1d930c0b7" xlink:href="gsk-20241231.xsd#gsk_OtherInvestmentsNoncurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_9530ee75-06ad-4110-8195-216d848904d4" xlink:to="loc_gsk_OtherInvestmentsNoncurrentMember_b6caf6de-db01-4ffe-a28c-8fe1d930c0b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_368be87f-475e-42f8-931e-b1e9117426e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_368be87f-475e-42f8-931e-b1e9117426e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments_252a8234-7c15-4b34-b960-a7b6e4a8d627" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments_252a8234-7c15-4b34-b960-a7b6e4a8d627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsToOtherInvestments_aa71567a-d099-445a-8133-1fc392ab7e95" xlink:href="gsk-20241231.xsd#gsk_AdditionsToOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_gsk_AdditionsToOtherInvestments_aa71567a-d099-445a-8133-1fc392ab7e95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome_a4dfc9cf-21ee-4b0a-8327-819845430382" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome_a4dfc9cf-21ee-4b0a-8327-819845430382" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments_a8752479-3593-4e2a-b854-572fb43728bf" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments_a8752479-3593-4e2a-b854-572fb43728bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_64866234-404e-4b3f-879a-e361b82f3563" xlink:href="gsk-20241231.xsd#gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_64866234-404e-4b3f-879a-e361b82f3563" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalsAndSettlementsOtherInvestments_3a26fe49-e0a9-4fd9-827c-eb24fc48baab" xlink:href="gsk-20241231.xsd#gsk_DisposalsAndSettlementsOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_82937e65-64cc-46af-b78f-d105dc0186a6" xlink:to="loc_gsk_DisposalsAndSettlementsOtherInvestments_3a26fe49-e0a9-4fd9-827c-eb24fc48baab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_5c168571-d54a-4375-b92d-9585ea75a424" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherInvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherInvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_a2991efb-7d84-41a5-86b6-478e538f15cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_a2991efb-7d84-41a5-86b6-478e538f15cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_a2991efb-7d84-41a5-86b6-478e538f15cb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_a2991efb-7d84-41a5-86b6-478e538f15cb" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_a2991efb-7d84-41a5-86b6-478e538f15cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_a5a50d40-8916-4895-8d1e-39ce12acc2de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_a2991efb-7d84-41a5-86b6-478e538f15cb" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_a5a50d40-8916-4895-8d1e-39ce12acc2de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_325dfa18-f3ff-4860-a1a9-34a772ab9d5f" xlink:href="gsk-20241231.xsd#gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_a5a50d40-8916-4895-8d1e-39ce12acc2de" xlink:to="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_325dfa18-f3ff-4860-a1a9-34a772ab9d5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember_1b226d53-5b62-4023-a334-0544c4d9cbaf" xlink:href="gsk-20241231.xsd#gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_a5a50d40-8916-4895-8d1e-39ce12acc2de" xlink:to="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember_1b226d53-5b62-4023-a334-0544c4d9cbaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c1b9404b-8db0-4d62-ae64-0d7ace1eae6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c1b9404b-8db0-4d62-ae64-0d7ace1eae6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_c1b9404b-8db0-4d62-ae64-0d7ace1eae6b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c1b9404b-8db0-4d62-ae64-0d7ace1eae6b" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_c1b9404b-8db0-4d62-ae64-0d7ace1eae6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_ad39bc11-2017-43eb-812d-38f8d419e529" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c1b9404b-8db0-4d62-ae64-0d7ace1eae6b" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_ad39bc11-2017-43eb-812d-38f8d419e529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WaveLifeSciencesMember_e3b1ce39-cf0d-4da9-a2c5-9a3a4435fee6" xlink:href="gsk-20241231.xsd#gsk_WaveLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_ad39bc11-2017-43eb-812d-38f8d419e529" xlink:to="loc_gsk_WaveLifeSciencesMember_e3b1ce39-cf0d-4da9-a2c5-9a3a4435fee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CrisprTherapeuticsMember_6f301fdc-84a5-4c66-b42e-c07f1f173113" xlink:href="gsk-20241231.xsd#gsk_CrisprTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_ad39bc11-2017-43eb-812d-38f8d419e529" xlink:to="loc_gsk_CrisprTherapeuticsMember_6f301fdc-84a5-4c66-b42e-c07f1f173113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a9a586d4-b6b8-40ff-be29-2a20d5303a1d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a9a586d4-b6b8-40ff-be29-2a20d5303a1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a9a586d4-b6b8-40ff-be29-2a20d5303a1d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a9a586d4-b6b8-40ff-be29-2a20d5303a1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a9a586d4-b6b8-40ff-be29-2a20d5303a1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ea525d8f-bf82-493a-baf8-b04f5ea5a10e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a9a586d4-b6b8-40ff-be29-2a20d5303a1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ea525d8f-bf82-493a-baf8-b04f5ea5a10e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SROneCapitalFundIBLPMember_ee4f397a-c874-406e-a805-b99883ad6b7f" xlink:href="gsk-20241231.xsd#gsk_SROneCapitalFundIBLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ea525d8f-bf82-493a-baf8-b04f5ea5a10e" xlink:to="loc_gsk_SROneCapitalFundIBLPMember_ee4f397a-c874-406e-a805-b99883ad6b7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e66e0c2f-d81d-4184-9db5-e42a59df8e53" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e66e0c2f-d81d-4184-9db5-e42a59df8e53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_e66e0c2f-d81d-4184-9db5-e42a59df8e53_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e66e0c2f-d81d-4184-9db5-e42a59df8e53" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_e66e0c2f-d81d-4184-9db5-e42a59df8e53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_aa829e8c-cd06-4434-9da9-a31de3496ac7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e66e0c2f-d81d-4184-9db5-e42a59df8e53" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_aa829e8c-cd06-4434-9da9-a31de3496ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_3cd3d36b-4f0c-4da8-a246-21994b16d371" xlink:href="gsk-20241231.xsd#gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_aa829e8c-cd06-4434-9da9-a31de3496ac7" xlink:to="loc_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_3cd3d36b-4f0c-4da8-a246-21994b16d371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_8011bbbe-7344-4c16-af46-8e6ce6c39ed0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_42157d9a-e922-4733-aa1d-872a7248e00a" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_8011bbbe-7344-4c16-af46-8e6ce6c39ed0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_8011bbbe-7344-4c16-af46-8e6ce6c39ed0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_8011bbbe-7344-4c16-af46-8e6ce6c39ed0" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_8011bbbe-7344-4c16-af46-8e6ce6c39ed0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_7eaee107-9890-4d38-ae58-a65098e13de8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_8011bbbe-7344-4c16-af46-8e6ce6c39ed0" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_7eaee107-9890-4d38-ae58-a65098e13de8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherInvestmentsNoncurrentMember_ac5be1af-d874-4ae7-9c89-81ed9c102508" xlink:href="gsk-20241231.xsd#gsk_OtherInvestmentsNoncurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_7eaee107-9890-4d38-ae58-a65098e13de8" xlink:to="loc_gsk_OtherInvestmentsNoncurrentMember_ac5be1af-d874-4ae7-9c89-81ed9c102508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments_e89a5c17-6e20-4bba-84b6-0e55a232fadd" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments_e89a5c17-6e20-4bba-84b6-0e55a232fadd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ListedInvestments_4f2932ba-4161-42b9-9d32-b1ff55167a07" xlink:href="gsk-20241231.xsd#gsk_ListedInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_gsk_ListedInvestments_4f2932ba-4161-42b9-9d32-b1ff55167a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentFairValue_565d2f8e-5dd0-40f7-82d2-3f8545992611" xlink:href="gsk-20241231.xsd#gsk_InvestmentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_gsk_InvestmentFairValue_565d2f8e-5dd0-40f7-82d2-3f8545992611" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAtDateOfDerecognition_f1cf5d04-3489-4ca7-97e0-df1a0fcf6515" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAtDateOfDerecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAtDateOfDerecognition_f1cf5d04-3489-4ca7-97e0-df1a0fcf6515" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_47309eea-64b4-4624-8cb1-ae33ac7e061f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_47309eea-64b4-4624-8cb1-ae33ac7e061f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_78fc53cf-8fd6-416c-bd93-0a25cc320e03" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_aa0a0a33-ebbb-41ac-b28e-dfb9d7e7c27f" xlink:to="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_78fc53cf-8fd6-416c-bd93-0a25cc320e03" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherNonCurrentAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherNonCurrentAssetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherNonCurrentAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_37a37ea9-4c50-4453-b8ff-5f5cb4bd1239" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOtherNoncurrentAssetsTable_0f588509-8221-4241-a775-55d7814321d2" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_37a37ea9-4c50-4453-b8ff-5f5cb4bd1239" xlink:to="loc_gsk_DisclosureOfOtherNoncurrentAssetsTable_0f588509-8221-4241-a775-55d7814321d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d3ea681f-db82-4eb1-afe2-7e5d325570f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfOtherNoncurrentAssetsTable_0f588509-8221-4241-a775-55d7814321d2" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d3ea681f-db82-4eb1-afe2-7e5d325570f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_d3ea681f-db82-4eb1-afe2-7e5d325570f1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d3ea681f-db82-4eb1-afe2-7e5d325570f1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_d3ea681f-db82-4eb1-afe2-7e5d325570f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_59202d06-2956-4770-a826-327c877ce33a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d3ea681f-db82-4eb1-afe2-7e5d325570f1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_59202d06-2956-4770-a826-327c877ce33a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNonCurrentReceivablesMember_b21a08bd-8f67-4263-911f-02bed8d4802b" xlink:href="gsk-20241231.xsd#gsk_OtherNonCurrentReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_59202d06-2956-4770-a826-327c877ce33a" xlink:to="loc_gsk_OtherNonCurrentReceivablesMember_b21a08bd-8f67-4263-911f-02bed8d4802b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_f1f04020-2316-4043-9773-997c75206b02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfOtherNoncurrentAssetsTable_0f588509-8221-4241-a775-55d7814321d2" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_f1f04020-2316-4043-9773-997c75206b02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f1f04020-2316-4043-9773-997c75206b02_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_f1f04020-2316-4043-9773-997c75206b02" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f1f04020-2316-4043-9773-997c75206b02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5e939f5d-8efb-4edb-90dd-0688be810236" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_f1f04020-2316-4043-9773-997c75206b02" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5e939f5d-8efb-4edb-90dd-0688be810236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_53e05aba-df67-4f1a-b5e5-8cc5d0d502ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5e939f5d-8efb-4edb-90dd-0688be810236" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_53e05aba-df67-4f1a-b5e5-8cc5d0d502ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemainingBalanceMember_34e03448-ff0a-4495-a31c-850952f83059" xlink:href="gsk-20241231.xsd#gsk_RemainingBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5e939f5d-8efb-4edb-90dd-0688be810236" xlink:to="loc_gsk_RemainingBalanceMember_34e03448-ff0a-4495-a31c-850952f83059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_f67a3464-e374-488e-b32e-39bbdb867153" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_37a37ea9-4c50-4453-b8ff-5f5cb4bd1239" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_f67a3464-e374-488e-b32e-39bbdb867153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_9a2e22fb-991e-4c4f-9033-737425a9991e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_37a37ea9-4c50-4453-b8ff-5f5cb4bd1239" xlink:to="loc_ifrs-full_FinancialAssets_9a2e22fb-991e-4c4f-9033-737425a9991e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNoncurrentNatureBasedCarbonReceivables_af039893-a23a-4b7e-8f11-e554170d133e" xlink:href="gsk-20241231.xsd#gsk_OtherNoncurrentNatureBasedCarbonReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_37a37ea9-4c50-4453-b8ff-5f5cb4bd1239" xlink:to="loc_gsk_OtherNoncurrentNatureBasedCarbonReceivables_af039893-a23a-4b7e-8f11-e554170d133e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TradeandotherreceivablesAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TradeandotherreceivablesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TradeandotherreceivablesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherReceivablesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherReceivablesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9c42388e-96b3-417f-90d9-bee8959a3921" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9c42388e-96b3-417f-90d9-bee8959a3921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_9c42388e-96b3-417f-90d9-bee8959a3921_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9c42388e-96b3-417f-90d9-bee8959a3921" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_9c42388e-96b3-417f-90d9-bee8959a3921_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_9a6e16da-ee58-4709-8325-85f4381b5365" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9c42388e-96b3-417f-90d9-bee8959a3921" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_9a6e16da-ee58-4709-8325-85f4381b5365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssociatesAndJointVenturesMember_cf713fc2-575b-425d-9541-f48c04f1789e" xlink:href="gsk-20241231.xsd#gsk_AssociatesAndJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_9a6e16da-ee58-4709-8325-85f4381b5365" xlink:to="loc_gsk_AssociatesAndJointVenturesMember_cf713fc2-575b-425d-9541-f48c04f1789e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d7d98136-5165-4fc9-8ac2-30c6c5ced585" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d7d98136-5165-4fc9-8ac2-30c6c5ced585" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_d7d98136-5165-4fc9-8ac2-30c6c5ced585_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d7d98136-5165-4fc9-8ac2-30c6c5ced585" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_d7d98136-5165-4fc9-8ac2-30c6c5ced585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_811048cc-d138-4658-8bed-1a24033355ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_d7d98136-5165-4fc9-8ac2-30c6c5ced585" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_811048cc-d138-4658-8bed-1a24033355ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember_9a7720a5-7ce4-4e7e-abfd-42304131380a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_811048cc-d138-4658-8bed-1a24033355ce" xlink:to="loc_ifrs-full_TradeReceivablesMember_9a7720a5-7ce4-4e7e-abfd-42304131380a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherReceivableMember_54474536-688d-4a5b-9ffd-01c062855dfc" xlink:href="gsk-20241231.xsd#gsk_OtherReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_811048cc-d138-4658-8bed-1a24033355ce" xlink:to="loc_gsk_OtherReceivableMember_54474536-688d-4a5b-9ffd-01c062855dfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis_5bf27432-dbe0-43ca-a161-1b54ee2778cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:to="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis_5bf27432-dbe0-43ca-a161-1b54ee2778cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_5bf27432-dbe0-43ca-a161-1b54ee2778cc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis_5bf27432-dbe0-43ca-a161-1b54ee2778cc" xlink:to="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_5bf27432-dbe0-43ca-a161-1b54ee2778cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_aa9c2707-6294-4825-8a6f-ad64683d705b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis_5bf27432-dbe0-43ca-a161-1b54ee2778cc" xlink:to="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_aa9c2707-6294-4825-8a6f-ad64683d705b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsCreditimpairedMember_a1f1a6f0-e28b-40d9-94d4-75db23970b57" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsCreditimpairedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_aa9c2707-6294-4825-8a6f-ad64683d705b" xlink:to="loc_ifrs-full_FinancialInstrumentsCreditimpairedMember_a1f1a6f0-e28b-40d9-94d4-75db23970b57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_825f8a43-bfa3-40f2-8389-1b725abab430" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_825f8a43-bfa3-40f2-8389-1b725abab430" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_825f8a43-bfa3-40f2-8389-1b725abab430_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_825f8a43-bfa3-40f2-8389-1b725abab430" xlink:to="loc_ifrs-full_CarryingAmountMember_825f8a43-bfa3-40f2-8389-1b725abab430_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_1f9bfc6f-04a8-4fd9-94dc-cdad863a098a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_825f8a43-bfa3-40f2-8389-1b725abab430" xlink:to="loc_ifrs-full_CarryingAmountMember_1f9bfc6f-04a8-4fd9-94dc-cdad863a098a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_37f851e3-c9c6-4493-a703-4a0f688ed543" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1f9bfc6f-04a8-4fd9-94dc-cdad863a098a" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_37f851e3-c9c6-4493-a703-4a0f688ed543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8104e051-f0fe-4cc6-8059-98930d79441e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_b8ade056-37c8-46e4-aef1-442dd0c70639" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8104e051-f0fe-4cc6-8059-98930d79441e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8104e051-f0fe-4cc6-8059-98930d79441e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8104e051-f0fe-4cc6-8059-98930d79441e" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8104e051-f0fe-4cc6-8059-98930d79441e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_65d3b5e6-f96d-48fa-8798-7f5ca4e6f2ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_8104e051-f0fe-4cc6-8059-98930d79441e" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_65d3b5e6-f96d-48fa-8798-7f5ca4e6f2ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_fd01f5d7-c1ae-4d07-81a7-215a552da4d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_65d3b5e6-f96d-48fa-8798-7f5ca4e6f2ab" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_fd01f5d7-c1ae-4d07-81a7-215a552da4d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivables_e5af0938-128a-44d1-9a31-5076b934c8ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_ifrs-full_TradeReceivables_e5af0938-128a-44d1-9a31-5076b934c8ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReceivables_26ea3961-ec4e-438c-8dc5-610cd279887f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_ifrs-full_OtherReceivables_26ea3961-ec4e-438c-8dc5-610cd279887f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax_e15614f9-e773-4332-982e-e69d286d16c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax_e15614f9-e773-4332-982e-e69d286d16c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RoyaltiesReceivable_0cbbb8a6-c54e-47a3-81b6-372e2d470ad3" xlink:href="gsk-20241231.xsd#gsk_RoyaltiesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_gsk_RoyaltiesReceivable_0cbbb8a6-c54e-47a3-81b6-372e2d470ad3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_1fd94f69-a6b1-465a-b4b4-fd62dee06757" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_1fd94f69-a6b1-465a-b4b4-fd62dee06757" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_c0ffbdf5-9cfc-4a39-89af-0a823e599b33" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_ifrs-full_FinancialAssets_c0ffbdf5-9cfc-4a39-89af-0a823e599b33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFinancialAssets_77d5a734-7643-43a7-ade3-1f9b3bad1a45" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_d32b7028-f10e-4012-becc-c4506e445756" xlink:to="loc_ifrs-full_IncreaseDecreaseInFinancialAssets_77d5a734-7643-43a7-ade3-1f9b3bad1a45" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TradeandotherreceivablesSummaryofLossAllowanceDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TradeandotherreceivablesSummaryofLossAllowanceDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TradeandotherreceivablesSummaryofLossAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherReceivablesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_abbed150-730c-4b2b-8e1c-24ec3e2c56fd" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherReceivablesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_abbed150-730c-4b2b-8e1c-24ec3e2c56fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_e7430bb3-0ff3-4f00-bdca-8fe9b4029d14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_abbed150-730c-4b2b-8e1c-24ec3e2c56fd" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_e7430bb3-0ff3-4f00-bdca-8fe9b4029d14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_e7430bb3-0ff3-4f00-bdca-8fe9b4029d14_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_e7430bb3-0ff3-4f00-bdca-8fe9b4029d14" xlink:to="loc_ifrs-full_CarryingAmountMember_e7430bb3-0ff3-4f00-bdca-8fe9b4029d14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_3acb16c9-4b81-43cd-b775-52316840f1aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_e7430bb3-0ff3-4f00-bdca-8fe9b4029d14" xlink:to="loc_ifrs-full_CarryingAmountMember_3acb16c9-4b81-43cd-b775-52316840f1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_cf0a00db-be97-4d91-b69f-7bf0e8854766" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_3acb16c9-4b81-43cd-b775-52316840f1aa" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_cf0a00db-be97-4d91-b69f-7bf0e8854766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_bc1c53f5-3744-45b2-85d7-e233a91f1a9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable_abbed150-730c-4b2b-8e1c-24ec3e2c56fd" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_bc1c53f5-3744-45b2-85d7-e233a91f1a9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_bc1c53f5-3744-45b2-85d7-e233a91f1a9f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_bc1c53f5-3744-45b2-85d7-e233a91f1a9f" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_bc1c53f5-3744-45b2-85d7-e233a91f1a9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_efdf7437-e3ef-42ab-be6f-92343da51763" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_bc1c53f5-3744-45b2-85d7-e233a91f1a9f" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_efdf7437-e3ef-42ab-be6f-92343da51763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember_36779e07-0954-464e-9bce-ae67c78bfa80" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_efdf7437-e3ef-42ab-be6f-92343da51763" xlink:to="loc_ifrs-full_TradeReceivablesMember_36779e07-0954-464e-9bce-ae67c78bfa80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_35d571cd-dbd7-4e23-8d1d-75ddd9cd100f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_ifrs-full_FinancialAssets_35d571cd-dbd7-4e23-8d1d-75ddd9cd100f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_a813f9a1-3c9f-4450-82b9-6953850a889e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_a813f9a1-3c9f-4450-82b9-6953850a889e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_4bc4d5b8-28ab-429b-9a96-e696d6a3d771" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_4bc4d5b8-28ab-429b-9a96-e696d6a3d771" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets_e95c04b7-2fd1-4c03-9b78-740186d5ac56" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets_e95c04b7-2fd1-4c03-9b78-740186d5ac56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets_0a6233fd-6b9a-406a-a918-7f6cb85f4c8f" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets_0a6233fd-6b9a-406a-a918-7f6cb85f4c8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets_ff718d88-f49a-4a0b-8267-e5e7e8c00bec" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughUtilisationFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_63e09e26-02bb-4945-8646-2bf5c0ef4864" xlink:to="loc_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets_ff718d88-f49a-4a0b-8267-e5e7e8c00bec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_a03e5266-70cc-4f80-8959-6cfbf46dd11a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AssetsheldforSaleDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AssetsheldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AssetsheldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssetsHeldForSaleLineItems_761a6eed-3699-4762-9203-289f07f5b5f8" xlink:href="gsk-20241231.xsd#gsk_AssetsHeldForSaleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssetsHeldForSaleTable_5ba99dc4-b371-4de9-8c79-64d501a0d88d" xlink:href="gsk-20241231.xsd#gsk_AssetsHeldForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_AssetsHeldForSaleLineItems_761a6eed-3699-4762-9203-289f07f5b5f8" xlink:to="loc_gsk_AssetsHeldForSaleTable_5ba99dc4-b371-4de9-8c79-64d501a0d88d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_8109fac0-8431-49e2-ba84-a62c1e9ac74d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_AssetsHeldForSaleTable_5ba99dc4-b371-4de9-8c79-64d501a0d88d" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_8109fac0-8431-49e2-ba84-a62c1e9ac74d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_8109fac0-8431-49e2-ba84-a62c1e9ac74d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_8109fac0-8431-49e2-ba84-a62c1e9ac74d" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_8109fac0-8431-49e2-ba84-a62c1e9ac74d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_bdab6762-6308-44fa-bc70-5feece5dde81" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_8109fac0-8431-49e2-ba84-a62c1e9ac74d" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_bdab6762-6308-44fa-bc70-5feece5dde81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_fb464d5c-4c50-4bc6-8769-bd48d0cb4f00" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_bdab6762-6308-44fa-bc70-5feece5dde81" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_fb464d5c-4c50-4bc6-8769-bd48d0cb4f00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_146524d2-b791-4195-be1e-6f9695c366dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_AssetsHeldForSaleLineItems_761a6eed-3699-4762-9203-289f07f5b5f8" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_146524d2-b791-4195-be1e-6f9695c366dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAssetsNet_e95c7928-ef39-4951-8513-f5f410d1a0d5" xlink:href="gsk-20241231.xsd#gsk_OtherAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_AssetsHeldForSaleLineItems_761a6eed-3699-4762-9203-289f07f5b5f8" xlink:to="loc_gsk_OtherAssetsNet_e95c7928-ef39-4951-8513-f5f410d1a0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_a00241c6-b8dd-4404-a267-6c9dce181c39" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_AssetsHeldForSaleLineItems_761a6eed-3699-4762-9203-289f07f5b5f8" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_a00241c6-b8dd-4404-a267-6c9dce181c39" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TradeandotherpayablesAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TradeandotherpayablesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TradeandotherpayablesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems_e2db3cfc-1c61-4246-b622-ea4f2166ce2c" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherPayablesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherPayablesTable_181f900a-6ec2-43a9-9b13-e065949a9493" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherPayablesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems_e2db3cfc-1c61-4246-b622-ea4f2166ce2c" xlink:to="loc_gsk_DisclosureOfTradeAndOtherPayablesTable_181f900a-6ec2-43a9-9b13-e065949a9493" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c4d42f5d-73a0-4b90-8974-e83fe368cb47" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesTable_181f900a-6ec2-43a9-9b13-e065949a9493" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c4d42f5d-73a0-4b90-8974-e83fe368cb47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_c4d42f5d-73a0-4b90-8974-e83fe368cb47_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c4d42f5d-73a0-4b90-8974-e83fe368cb47" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_c4d42f5d-73a0-4b90-8974-e83fe368cb47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5baafedf-ef73-43ec-925c-e570057410c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c4d42f5d-73a0-4b90-8974-e83fe368cb47" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5baafedf-ef73-43ec-925c-e570057410c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssociatesAndJointVenturesMember_79bb0487-16bc-419b-8cb0-5089afd24235" xlink:href="gsk-20241231.xsd#gsk_AssociatesAndJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5baafedf-ef73-43ec-925c-e570057410c1" xlink:to="loc_gsk_AssociatesAndJointVenturesMember_79bb0487-16bc-419b-8cb0-5089afd24235" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_6ddbbdfe-d208-4aac-9e2c-02404f75768e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesTable_181f900a-6ec2-43a9-9b13-e065949a9493" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_6ddbbdfe-d208-4aac-9e2c-02404f75768e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_6ddbbdfe-d208-4aac-9e2c-02404f75768e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_6ddbbdfe-d208-4aac-9e2c-02404f75768e" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_6ddbbdfe-d208-4aac-9e2c-02404f75768e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_9c00f692-4eba-4de3-a6da-a7b3ae75a938" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_6ddbbdfe-d208-4aac-9e2c-02404f75768e" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_9c00f692-4eba-4de3-a6da-a7b3ae75a938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_314cb622-564c-4da3-9188-1924dd517159" xlink:href="gsk-20241231.xsd#gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_9c00f692-4eba-4de3-a6da-a7b3ae75a938" xlink:to="loc_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_314cb622-564c-4da3-9188-1924dd517159" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis_77ab2036-6089-485c-a78b-143b71f417e2" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesTable_181f900a-6ec2-43a9-9b13-e065949a9493" xlink:to="loc_gsk_SegmentConsolidationItemAxis_77ab2036-6089-485c-a78b-143b71f417e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_77ab2036-6089-485c-a78b-143b71f417e2_default" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_SegmentConsolidationItemAxis_77ab2036-6089-485c-a78b-143b71f417e2" xlink:to="loc_gsk_SegmentConsolidationItemDomain_77ab2036-6089-485c-a78b-143b71f417e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain_59432c26-4c19-4c8d-812a-706e2ec66011" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_SegmentConsolidationItemAxis_77ab2036-6089-485c-a78b-143b71f417e2" xlink:to="loc_gsk_SegmentConsolidationItemDomain_59432c26-4c19-4c8d-812a-706e2ec66011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemMember_8b2d33c7-7f04-45f7-9813-a813b8225157" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemDomain_59432c26-4c19-4c8d-812a-706e2ec66011" xlink:to="loc_gsk_SegmentConsolidationItemMember_8b2d33c7-7f04-45f7-9813-a813b8225157" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_USPharmaceuticalsAndVaccinesMember_ab59c77b-717b-4e5d-97a9-aac382fdaf38" xlink:href="gsk-20241231.xsd#gsk_USPharmaceuticalsAndVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_SegmentConsolidationItemMember_8b2d33c7-7f04-45f7-9813-a813b8225157" xlink:to="loc_gsk_USPharmaceuticalsAndVaccinesMember_ab59c77b-717b-4e5d-97a9-aac382fdaf38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_e3d792d8-d2bd-4aea-bb5b-377e11c9ec90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems_e2db3cfc-1c61-4246-b622-ea4f2166ce2c" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_e3d792d8-d2bd-4aea-bb5b-377e11c9ec90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAndOperatingIncome_f6fb3f2d-74dc-44d6-9e73-045079e7d877" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems_e2db3cfc-1c61-4246-b622-ea4f2166ce2c" xlink:to="loc_ifrs-full_RevenueAndOperatingIncome_f6fb3f2d-74dc-44d6-9e73-045079e7d877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnAndRebateAccruals_bc1ae16e-b6d5-475b-a77d-ff03e0484bb2" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnAndRebateAccruals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems_e2db3cfc-1c61-4246-b622-ea4f2166ce2c" xlink:to="loc_gsk_CustomerReturnAndRebateAccruals_bc1ae16e-b6d5-475b-a77d-ff03e0484bb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost_252c456e-087d-4358-a6b0-fd501153f41d" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems_e2db3cfc-1c61-4246-b622-ea4f2166ce2c" xlink:to="loc_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost_252c456e-087d-4358-a6b0-fd501153f41d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/TradeandotherpayablesSummaryofIncreaseDecreaseinFinancialLiabilityandLossGaininIncomeStatementDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#TradeandotherpayablesSummaryofIncreaseDecreaseinFinancialLiabilityandLossGaininIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/TradeandotherpayablesSummaryofIncreaseDecreaseinFinancialLiabilityandLossGaininIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationLineItems_dcf023f9-4ce8-4096-aa19-b2a5414dad59" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable_3d8d74e2-6d93-464a-8600-e1e9a376589f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationLineItems_dcf023f9-4ce8-4096-aa19-b2a5414dad59" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable_3d8d74e2-6d93-464a-8600-e1e9a376589f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1912491a-ac06-43d4-996f-99758bab6931" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable_3d8d74e2-6d93-464a-8600-e1e9a376589f" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1912491a-ac06-43d4-996f-99758bab6931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_1912491a-ac06-43d4-996f-99758bab6931_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1912491a-ac06-43d4-996f-99758bab6931" xlink:to="loc_ifrs-full_TypesOfRisksDomain_1912491a-ac06-43d4-996f-99758bab6931_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1912491a-ac06-43d4-996f-99758bab6931" xlink:to="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_470c0ab2-5ae1-4df8-ae2d-867724497b18" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_470c0ab2-5ae1-4df8-ae2d-867724497b18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_dbc9f617-6d2b-43d3-9739-99de36558476" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_dbc9f617-6d2b-43d3-9739-99de36558476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_bfc02b87-9a44-46f2-afad-02bf326b57cc" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskTenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_bfc02b87-9a44-46f2-afad-02bf326b57cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_612b9286-4dd4-49ac-bbd2-cb3e4232d687" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_612b9286-4dd4-49ac-bbd2-cb3e4232d687" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember_f4395168-dac6-4a1a-bd0a-f47aca9d0bab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_ifrs-full_DiscountRateMeasurementInputMember_f4395168-dac6-4a1a-bd0a-f47aca9d0bab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember_4281bd99-6b49-4ab5-948b-488430094e1f" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember_4281bd99-6b49-4ab5-948b-488430094e1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember_9c9c960f-f159-46b5-bba8-9d6f7f996728" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember_9c9c960f-f159-46b5-bba8-9d6f7f996728" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_6a511c05-dbb6-4e01-a6ae-43041bcc8b98" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_6a511c05-dbb6-4e01-a6ae-43041bcc8b98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_24687d13-0671-4807-b37c-c51b88f99ab9" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_24687d13-0671-4807-b37c-c51b88f99ab9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember_376f7870-befb-461c-b427-a2d7a51bc280" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember_376f7870-befb-461c-b427-a2d7a51bc280" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_b91a6b03-a4ee-4038-bcd3-4026306d62c3" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_b91a6b03-a4ee-4038-bcd3-4026306d62c3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_f786cafd-2dcb-484e-8a8c-3278dfd2ac63" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_f786cafd-2dcb-484e-8a8c-3278dfd2ac63" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_1ad2beb2-6a00-4333-9eda-4b8a324a2a6c" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_1ad2beb2-6a00-4333-9eda-4b8a324a2a6c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_05b6639d-e5ad-4021-832b-88a1f3bf284a" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_05b6639d-e5ad-4021-832b-88a1f3bf284a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_0ac40c7e-5313-4813-a0e0-195bc3bd5049" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f23994f6-af7b-4b7c-8320-56c4da8357a2" xlink:to="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_0ac40c7e-5313-4813-a0e0-195bc3bd5049" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInFinancialLiability_73289577-dbbf-4080-85d3-fc671490f177" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInFinancialLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationLineItems_dcf023f9-4ce8-4096-aa19-b2a5414dad59" xlink:to="loc_gsk_IncreaseDecreaseInFinancialLiability_73289577-dbbf-4080-85d3-fc671490f177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c8154bc4-bbe4-447f-8cb6-519ff2e12831" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationLineItems_dcf023f9-4ce8-4096-aa19-b2a5414dad59" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c8154bc4-bbe4-447f-8cb6-519ff2e12831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_82d7ed71-e77e-4de9-95cb-db2efbaf6bca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationLineItems_dcf023f9-4ce8-4096-aa19-b2a5414dad59" xlink:to="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_82d7ed71-e77e-4de9-95cb-db2efbaf6bca" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/NetdebtScheduleofCurrentAssetsShortandLongTermBorrowingsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#NetdebtScheduleofCurrentAssetsShortandLongTermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/NetdebtScheduleofCurrentAssetsShortandLongTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtLineItems_d1573d19-c44d-4bc2-946c-eb39f9192a35" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtTable_8579de35-45c5-4494-8f35-3c98fc35a5e7" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDebtLineItems_d1573d19-c44d-4bc2-946c-eb39f9192a35" xlink:to="loc_gsk_DisclosureOfDebtTable_8579de35-45c5-4494-8f35-3c98fc35a5e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_70bf20f6-0c76-4fde-a4a2-11049f44afcc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_8579de35-45c5-4494-8f35-3c98fc35a5e7" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_70bf20f6-0c76-4fde-a4a2-11049f44afcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_70bf20f6-0c76-4fde-a4a2-11049f44afcc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_70bf20f6-0c76-4fde-a4a2-11049f44afcc" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_70bf20f6-0c76-4fde-a4a2-11049f44afcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_cb209eef-dc74-4504-95a0-d9fb29ea4df7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_70bf20f6-0c76-4fde-a4a2-11049f44afcc" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_cb209eef-dc74-4504-95a0-d9fb29ea4df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Debt1Member_cc1c6af2-49b9-4849-a4b4-10ce82769923" xlink:href="gsk-20241231.xsd#gsk_Debt1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_cb209eef-dc74-4504-95a0-d9fb29ea4df7" xlink:to="loc_gsk_Debt1Member_cc1c6af2-49b9-4849-a4b4-10ce82769923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_c3a130b2-ace0-4d3d-86ad-9fe12cf799e6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_8579de35-45c5-4494-8f35-3c98fc35a5e7" xlink:to="loc_dei_EntityListingsExchangeAxis_c3a130b2-ace0-4d3d-86ad-9fe12cf799e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_c3a130b2-ace0-4d3d-86ad-9fe12cf799e6_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_c3a130b2-ace0-4d3d-86ad-9fe12cf799e6" xlink:to="loc_dei_ExchangeDomain_c3a130b2-ace0-4d3d-86ad-9fe12cf799e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_64ca4705-3d11-4dad-8f09-ceb6874bbba8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_c3a130b2-ace0-4d3d-86ad-9fe12cf799e6" xlink:to="loc_dei_ExchangeDomain_64ca4705-3d11-4dad-8f09-ceb6874bbba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NewYorkStockExchangeMember_4c2c6434-3017-45cc-8da3-f1c8d936c64c" xlink:href="gsk-20241231.xsd#gsk_NewYorkStockExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_64ca4705-3d11-4dad-8f09-ceb6874bbba8" xlink:to="loc_gsk_NewYorkStockExchangeMember_4c2c6434-3017-45cc-8da3-f1c8d936c64c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LondonStockExchangeMember_1fe6a120-aaa2-4d18-9529-d0c11b433eaa" xlink:href="gsk-20241231.xsd#gsk_LondonStockExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_64ca4705-3d11-4dad-8f09-ceb6874bbba8" xlink:to="loc_gsk_LondonStockExchangeMember_1fe6a120-aaa2-4d18-9529-d0c11b433eaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_d1f1711f-7237-4eb3-80b3-8db571aabbea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_8579de35-45c5-4494-8f35-3c98fc35a5e7" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_d1f1711f-7237-4eb3-80b3-8db571aabbea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_d1f1711f-7237-4eb3-80b3-8db571aabbea_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_d1f1711f-7237-4eb3-80b3-8db571aabbea" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_d1f1711f-7237-4eb3-80b3-8db571aabbea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_d1f1711f-7237-4eb3-80b3-8db571aabbea" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember_c83b9e08-7b2c-423b-84cd-9ceb2f0e0805" xlink:href="gsk-20241231.xsd#gsk_ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePercentUSMediumTermNoteTwoThousandTwentyFourMember_c83b9e08-7b2c-423b-84cd-9ceb2f0e0805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember_054ef40b-a628-40ae-bd98-7bd7e468614f" xlink:href="gsk-20241231.xsd#gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember_054ef40b-a628-40ae-bd98-7bd7e468614f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember_475ce8fe-bc71-4997-bbb4-217c0c730e46" xlink:href="gsk-20241231.xsd#gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember_475ce8fe-bc71-4997-bbb4-217c0c730e46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember_15366f0a-3f17-4221-8ea1-e596bef41adf" xlink:href="gsk-20241231.xsd#gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember_15366f0a-3f17-4221-8ea1-e596bef41adf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember_d7a35846-bec0-4f37-9013-4bd00e08e2a6" xlink:href="gsk-20241231.xsd#gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember_d7a35846-bec0-4f37-9013-4bd00e08e2a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember_d11a0a4f-0ab7-4519-8f3a-3d52f08f2dc6" xlink:href="gsk-20241231.xsd#gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember_d11a0a4f-0ab7-4519-8f3a-3d52f08f2dc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember_498196eb-05b5-4313-b94b-2a3f57a9cb40" xlink:href="gsk-20241231.xsd#gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember_498196eb-05b5-4313-b94b-2a3f57a9cb40" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember_e4739cd7-0c47-4344-b316-ff9b53ed30ba" xlink:href="gsk-20241231.xsd#gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember_e4739cd7-0c47-4344-b316-ff9b53ed30ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember_cbf66c1c-553e-4038-a493-afcafe4b3603" xlink:href="gsk-20241231.xsd#gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember_cbf66c1c-553e-4038-a493-afcafe4b3603" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember_20b78cb5-c2d7-42aa-ac39-b17cedd771a0" xlink:href="gsk-20241231.xsd#gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember_20b78cb5-c2d7-42aa-ac39-b17cedd771a0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember_04edf584-fc2e-422e-b4be-52d60f194c8a" xlink:href="gsk-20241231.xsd#gsk_OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointTwoFiveEuroMediumTermNoteTwoThousandTwentyEightMember_04edf584-fc2e-422e-b4be-52d60f194c8a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember_602a606c-9380-465e-aa02-0700d3c809c4" xlink:href="gsk-20241231.xsd#gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember_602a606c-9380-465e-aa02-0700d3c809c4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember_50c341ac-4b40-478d-a29b-b9f1be170bde" xlink:href="gsk-20241231.xsd#gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember_50c341ac-4b40-478d-a29b-b9f1be170bde" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember_68fd29bf-c83a-4a20-b607-c9b5eaea5c20" xlink:href="gsk-20241231.xsd#gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember_68fd29bf-c83a-4a20-b607-c9b5eaea5c20" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember_76988069-afc9-4568-86c3-aeb6a6cbdc0a" xlink:href="gsk-20241231.xsd#gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember_76988069-afc9-4568-86c3-aeb6a6cbdc0a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember_4dfc60e1-773c-4c4c-89ff-a6c8d6d6091e" xlink:href="gsk-20241231.xsd#gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember_4dfc60e1-773c-4c4c-89ff-a6c8d6d6091e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember_2382ad26-0f21-48fe-9071-579635bdebb4" xlink:href="gsk-20241231.xsd#gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember_2382ad26-0f21-48fe-9071-579635bdebb4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember_3de1ca6d-51b9-478c-85f7-af81a4a084fd" xlink:href="gsk-20241231.xsd#gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember_3de1ca6d-51b9-478c-85f7-af81a4a084fd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember_9d8d86e3-0254-4667-baef-323f6eb073f7" xlink:href="gsk-20241231.xsd#gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember_9d8d86e3-0254-4667-baef-323f6eb073f7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember_34f65c50-587e-4f79-8226-2dbf0f860164" xlink:href="gsk-20241231.xsd#gsk_ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_ThreePointTwoFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtySixMember_34f65c50-587e-4f79-8226-2dbf0f860164" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember_5a5c8b4d-bf01-4526-a02f-f49be6179395" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember_5a5c8b4d-bf01-4526-a02f-f49be6179395" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_c8e948e4-91b9-43c0-bd1b-897f7e89830c" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_c8e948e4-91b9-43c0-bd1b-897f7e89830c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember_b40cad04-0c86-43e5-b7a7-121daaef6269" xlink:href="gsk-20241231.xsd#gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember_b40cad04-0c86-43e5-b7a7-121daaef6269" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember_aac72fb9-184c-411d-bc5d-30019169f021" xlink:href="gsk-20241231.xsd#gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember_aac72fb9-184c-411d-bc5d-30019169f021" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember_36a3ce8b-2667-4cc4-89fb-ad0f2bc288b6" xlink:href="gsk-20241231.xsd#gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember_36a3ce8b-2667-4cc4-89fb-ad0f2bc288b6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherLongtermBorrowingsMember_366ff279-583c-47e2-bf86-edff38598a09" xlink:href="gsk-20241231.xsd#gsk_OtherLongtermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73da41ca-e4e2-4ad1-a605-eb0a2b235315" xlink:to="loc_gsk_OtherLongtermBorrowingsMember_366ff279-583c-47e2-bf86-edff38598a09" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_a35651de-53e6-405c-90da-f859c911a978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_d1573d19-c44d-4bc2-946c-eb39f9192a35" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_a35651de-53e6-405c-90da-f859c911a978" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsCurrent_4acf714d-ccf0-4032-8fdb-ad5b713a77aa" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a35651de-53e6-405c-90da-f859c911a978" xlink:to="loc_gsk_LiquidInvestmentsCurrent_4acf714d-ccf0-4032-8fdb-ad5b713a77aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_84aac3ee-0382-49eb-9c70-4405e8a49b67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a35651de-53e6-405c-90da-f859c911a978" xlink:to="loc_ifrs-full_CashAndCashEquivalents_84aac3ee-0382-49eb-9c70-4405e8a49b67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_c2b01304-dacf-4ded-bce8-980ed4f664d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a35651de-53e6-405c-90da-f859c911a978" xlink:to="loc_ifrs-full_CurrentAssets_c2b01304-dacf-4ded-bce8-980ed4f664d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_d1573d19-c44d-4bc2-946c-eb39f9192a35" xlink:to="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued_26c908f8-df44-4ab6-a39a-24e30f4b2b2c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:to="loc_ifrs-full_CommercialPapersIssued_26c908f8-df44-4ab6-a39a-24e30f4b2b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankLoansOverdraftsAndOther_f0fb4a28-f099-4007-af05-24ee8dbaf000" xlink:href="gsk-20241231.xsd#gsk_BankLoansOverdraftsAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:to="loc_gsk_BankLoansOverdraftsAndOther_f0fb4a28-f099-4007-af05-24ee8dbaf000" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_6ede3402-8422-425c-aace-820e4c249985" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:to="loc_ifrs-full_BorrowingsInterestRate_6ede3402-8422-425c-aace-820e4c249985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_157f8a81-ad3b-4565-a037-efaa54d00346" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_157f8a81-ad3b-4565-a037-efaa54d00346" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_ef12df2e-f299-4445-ae1a-6e3d6955dec3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsAbstract_74956f9f-9cd1-48ab-9d3c-ba6fae815a61" xlink:to="loc_ifrs-full_ShorttermBorrowings_ef12df2e-f299-4445-ae1a-6e3d6955dec3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LongTermBorrowingsAbstract_561996d0-f9df-47b2-a9e5-03763d076b07" xlink:href="gsk-20241231.xsd#gsk_LongTermBorrowingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_d1573d19-c44d-4bc2-946c-eb39f9192a35" xlink:to="loc_gsk_LongTermBorrowingsAbstract_561996d0-f9df-47b2-a9e5-03763d076b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_129a5a1f-16bd-4b19-a4d6-1f7a474d69b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_LongTermBorrowingsAbstract_561996d0-f9df-47b2-a9e5-03763d076b07" xlink:to="loc_ifrs-full_LongtermBorrowings_129a5a1f-16bd-4b19-a4d6-1f7a474d69b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_603542eb-a313-42c1-8401-3526fdd611a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_LongTermBorrowingsAbstract_561996d0-f9df-47b2-a9e5-03763d076b07" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_603542eb-a313-42c1-8401-3526fdd611a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_5877ecf5-7a10-4765-9857-e2821a7e157e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_d1573d19-c44d-4bc2-946c-eb39f9192a35" xlink:to="loc_ifrs-full_Borrowings_5877ecf5-7a10-4765-9857-e2821a7e157e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/NetdebtAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#NetdebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/NetdebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_e146a4fb-71e5-4aeb-a015-e632660efd7d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_ifrs-full_MaturityAxis_e146a4fb-71e5-4aeb-a015-e632660efd7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_e146a4fb-71e5-4aeb-a015-e632660efd7d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_e146a4fb-71e5-4aeb-a015-e632660efd7d" xlink:to="loc_ifrs-full_MaturityDomain_e146a4fb-71e5-4aeb-a015-e632660efd7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_9fe96964-28d1-4c00-b938-72230292f906" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_e146a4fb-71e5-4aeb-a015-e632660efd7d" xlink:to="loc_ifrs-full_MaturityDomain_9fe96964-28d1-4c00-b938-72230292f906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_5b89f10f-a039-427b-a7f9-8dd8d24e5608" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_9fe96964-28d1-4c00-b938-72230292f906" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_5b89f10f-a039-427b-a7f9-8dd8d24e5608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_6697565e-ceab-41e1-9ed4-bdf52a06e88e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_9fe96964-28d1-4c00-b938-72230292f906" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_6697565e-ceab-41e1-9ed4-bdf52a06e88e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShortTermNotesMember_c5446c42-eb82-42dd-8ce9-c8bfd534d8fa" xlink:href="gsk-20241231.xsd#gsk_ShortTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_9fe96964-28d1-4c00-b938-72230292f906" xlink:to="loc_gsk_ShortTermNotesMember_c5446c42-eb82-42dd-8ce9-c8bfd534d8fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_550c1d52-16f4-4274-90e4-ce3eae5ee032" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_9fe96964-28d1-4c00-b938-72230292f906" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_550c1d52-16f4-4274-90e4-ce3eae5ee032" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_3ad5823e-f9eb-4861-a93b-0e97f7372b70" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_3ad5823e-f9eb-4861-a93b-0e97f7372b70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_3ad5823e-f9eb-4861-a93b-0e97f7372b70_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_3ad5823e-f9eb-4861-a93b-0e97f7372b70" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_3ad5823e-f9eb-4861-a93b-0e97f7372b70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_3ad5823e-f9eb-4861-a93b-0e97f7372b70" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonInterestBearingMember_a982695f-0d25-4427-adb5-5faf2cb0ca89" xlink:href="gsk-20241231.xsd#gsk_NonInterestBearingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_NonInterestBearingMember_a982695f-0d25-4427-adb5-5faf2cb0ca89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPaperDebtMember_63a36703-6521-43af-bb1f-30aab4f38d45" xlink:href="gsk-20241231.xsd#gsk_CommercialPaperDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_CommercialPaperDebtMember_63a36703-6521-43af-bb1f-30aab4f38d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember_e05567dc-b579-4655-ac5f-60c18b1c8c97" xlink:href="gsk-20241231.xsd#gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeMember_e05567dc-b579-4655-ac5f-60c18b1c8c97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember_8e2768fb-e4e1-4854-b89b-f7d9799c3d0a" xlink:href="gsk-20241231.xsd#gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember_8e2768fb-e4e1-4854-b89b-f7d9799c3d0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_1da0dd1d-c283-4208-baf3-2f6b442db3e4" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_1da0dd1d-c283-4208-baf3-2f6b442db3e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember_7ac29605-5085-485b-9fa7-e234dcac31ee" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember_7ac29605-5085-485b-9fa7-e234dcac31ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LetterOfCreditHeldMember_cdef8c22-b2f3-4005-b8ef-f62f811779b8" xlink:href="gsk-20241231.xsd#gsk_LetterOfCreditHeldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_088bb04a-ed8f-448e-9405-3ef9ad57c191" xlink:to="loc_gsk_LetterOfCreditHeldMember_cdef8c22-b2f3-4005-b8ef-f62f811779b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_a217262f-eba5-4617-a46d-03d576380260" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_a217262f-eba5-4617-a46d-03d576380260" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_a217262f-eba5-4617-a46d-03d576380260_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_a217262f-eba5-4617-a46d-03d576380260" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_a217262f-eba5-4617-a46d-03d576380260_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_30a002ec-2dad-4966-963b-e60018554d4e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_a217262f-eba5-4617-a46d-03d576380260" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_30a002ec-2dad-4966-963b-e60018554d4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember_3c154426-1376-4fbd-b752-59c72375bfe0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_30a002ec-2dad-4966-963b-e60018554d4e" xlink:to="loc_ifrs-full_FloatingInterestRateMember_3c154426-1376-4fbd-b752-59c72375bfe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_5dfe6707-cb67-4427-9afe-9bb247179f33" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_30a002ec-2dad-4966-963b-e60018554d4e" xlink:to="loc_ifrs-full_FixedInterestRateMember_5dfe6707-cb67-4427-9afe-9bb247179f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_b7045aa3-75f0-4bd3-8bdb-d5f94347a2d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_ifrs-full_RangeAxis_b7045aa3-75f0-4bd3-8bdb-d5f94347a2d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_b7045aa3-75f0-4bd3-8bdb-d5f94347a2d5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_b7045aa3-75f0-4bd3-8bdb-d5f94347a2d5" xlink:to="loc_ifrs-full_RangeDomain_b7045aa3-75f0-4bd3-8bdb-d5f94347a2d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_d1610bf7-7a3a-4722-83ff-84ab74db274c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_b7045aa3-75f0-4bd3-8bdb-d5f94347a2d5" xlink:to="loc_ifrs-full_RangeDomain_d1610bf7-7a3a-4722-83ff-84ab74db274c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_9c910620-dbae-410d-9404-11253b8f4730" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_d1610bf7-7a3a-4722-83ff-84ab74db274c" xlink:to="loc_ifrs-full_BottomOfRangeMember_9c910620-dbae-410d-9404-11253b8f4730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_fc68953b-b257-44d4-a76a-332ed6b99bc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_d1610bf7-7a3a-4722-83ff-84ab74db274c" xlink:to="loc_ifrs-full_TopOfRangeMember_fc68953b-b257-44d4-a76a-332ed6b99bc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_04f9789c-aa65-4c76-8884-51fb295a8ea4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_04f9789c-aa65-4c76-8884-51fb295a8ea4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_04f9789c-aa65-4c76-8884-51fb295a8ea4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_04f9789c-aa65-4c76-8884-51fb295a8ea4" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_04f9789c-aa65-4c76-8884-51fb295a8ea4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_261f0f17-d960-4bf7-83eb-65de476825b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_04f9789c-aa65-4c76-8884-51fb295a8ea4" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_261f0f17-d960-4bf7-83eb-65de476825b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsCommercialPaperProgramMember_749af630-9573-417d-aef6-7e037906156d" xlink:href="gsk-20241231.xsd#gsk_UsCommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_261f0f17-d960-4bf7-83eb-65de476825b2" xlink:to="loc_gsk_UsCommercialPaperProgramMember_749af630-9573-417d-aef6-7e037906156d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EuroCommercialPaperProgramMember_bb21574c-0fe5-49b0-a765-3ea74ed048b8" xlink:href="gsk-20241231.xsd#gsk_EuroCommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_261f0f17-d960-4bf7-83eb-65de476825b2" xlink:to="loc_gsk_EuroCommercialPaperProgramMember_bb21574c-0fe5-49b0-a765-3ea74ed048b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_9da0bc4f-3a9e-409b-b406-340ba8ff9ff5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_ifrs-full_TypesOfRisksAxis_9da0bc4f-3a9e-409b-b406-340ba8ff9ff5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_9da0bc4f-3a9e-409b-b406-340ba8ff9ff5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_9da0bc4f-3a9e-409b-b406-340ba8ff9ff5" xlink:to="loc_ifrs-full_TypesOfRisksDomain_9da0bc4f-3a9e-409b-b406-340ba8ff9ff5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_77135217-54bb-42fe-bc09-c82ffbcf7303" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_9da0bc4f-3a9e-409b-b406-340ba8ff9ff5" xlink:to="loc_ifrs-full_TypesOfRisksDomain_77135217-54bb-42fe-bc09-c82ffbcf7303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiquidityRiskMember_ac73ff85-fdfd-4542-9c30-97fa2f29a351" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_77135217-54bb-42fe-bc09-c82ffbcf7303" xlink:to="loc_ifrs-full_LiquidityRiskMember_ac73ff85-fdfd-4542-9c30-97fa2f29a351" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_97c1caf5-73b6-44fe-bc50-3d96e48e4276" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDebtTable_46b4fc5a-85cb-434f-89cb-6be007e685da" xlink:to="loc_dei_EntityListingsExchangeAxis_97c1caf5-73b6-44fe-bc50-3d96e48e4276" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_97c1caf5-73b6-44fe-bc50-3d96e48e4276_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_97c1caf5-73b6-44fe-bc50-3d96e48e4276" xlink:to="loc_dei_ExchangeDomain_97c1caf5-73b6-44fe-bc50-3d96e48e4276_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_21e6dc68-de90-416a-afca-e59eb6a11432" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_97c1caf5-73b6-44fe-bc50-3d96e48e4276" xlink:to="loc_dei_ExchangeDomain_21e6dc68-de90-416a-afca-e59eb6a11432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LondonStockExchangeMember_20cc5b85-d3ed-4516-9744-af8c6ad7576f" xlink:href="gsk-20241231.xsd#gsk_LondonStockExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_21e6dc68-de90-416a-afca-e59eb6a11432" xlink:to="loc_gsk_LondonStockExchangeMember_20cc5b85-d3ed-4516-9744-af8c6ad7576f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments_22260c90-4834-4d6f-b1df-2d55a425fbf4" xlink:href="gsk-20241231.xsd#gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments_22260c90-4834-4d6f-b1df-2d55a425fbf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestments_98af9925-f011-41d7-b894-9a6070197f74" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_LiquidInvestments_98af9925-f011-41d7-b894-9a6070197f74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EffectiveInterestRateOnCashAndCashEquivalents_60a8c17b-97f6-4a44-94bb-f8d99e8a051d" xlink:href="gsk-20241231.xsd#gsk_EffectiveInterestRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_EffectiveInterestRateOnCashAndCashEquivalents_60a8c17b-97f6-4a44-94bb-f8d99e8a051d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1c75ef76-55cf-4015-aa0c-817830012d9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1c75ef76-55cf-4015-aa0c-817830012d9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPapersAuthorised_ae4322ae-c1ec-4090-a7fd-1d09d3057b1a" xlink:href="gsk-20241231.xsd#gsk_CommercialPapersAuthorised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_CommercialPapersAuthorised_ae4322ae-c1ec-4090-a7fd-1d09d3057b1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued_f2838b7b-963c-410a-8c76-4e481f790b86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_ifrs-full_CommercialPapersIssued_f2838b7b-963c-410a-8c76-4e481f790b86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilities_743c5fd0-b458-4ba0-af18-c950ad536cde" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_RevolvingCreditFacilities_743c5fd0-b458-4ba0-af18-c950ad536cde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilityTerm_68d2f169-6da9-41bf-94aa-977652a19d02" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_RevolvingCreditFacilityTerm_68d2f169-6da9-41bf-94aa-977652a19d02" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilityExtensionTerm_64963914-d9a8-487f-b69d-5c77ddc357a9" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilityExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_RevolvingCreditFacilityExtensionTerm_64963914-d9a8-487f-b69d-5c77ddc357a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageInterestRateOnBorrowings_f99840e5-c4ce-4f02-bc78-323d7f8c34d3" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageInterestRateOnBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_WeightedAverageInterestRateOnBorrowings_f99840e5-c4ce-4f02-bc78-323d7f8c34d3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts_c375c372-3e7b-4a96-8a08-8512b314a1b1" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts_c375c372-3e7b-4a96-8a08-8512b314a1b1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageEffectivePreSwapInterestRateShortTerm_7804f84e-e5d9-4b5c-ad97-5c302da41865" xlink:href="gsk-20241231.xsd#gsk_AverageEffectivePreSwapInterestRateShortTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_AverageEffectivePreSwapInterestRateShortTerm_7804f84e-e5d9-4b5c-ad97-5c302da41865" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_ac11c5b0-7a3d-4113-8b11-bfa7c2700d6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_ifrs-full_LongtermBorrowings_ac11c5b0-7a3d-4113-8b11-bfa7c2700d6b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageEffectivePreSwapInterestRateNotesIssued_475178a7-5970-4e3b-b72b-55d969eccf8c" xlink:href="gsk-20241231.xsd#gsk_AverageEffectivePreSwapInterestRateNotesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_AverageEffectivePreSwapInterestRateNotesIssued_475178a7-5970-4e3b-b72b-55d969eccf8c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryInterestAtEffectiveRates_ceb2587c-13bb-4e43-bf68-9c91f1e8a92a" xlink:href="gsk-20241231.xsd#gsk_CarryInterestAtEffectiveRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_CarryInterestAtEffectiveRates_ceb2587c-13bb-4e43-bf68-9c91f1e8a92a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_094f5b79-d10e-450e-99b7-6cbb973c2819" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_094f5b79-d10e-450e-99b7-6cbb973c2819" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_c13faa95-a7d9-44e8-8390-dad5eeed0719" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_ifrs-full_BorrowingsInterestRate_c13faa95-a7d9-44e8-8390-dad5eeed0719" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PledgedInvestments_c518607b-5c8b-4478-8e0d-8ee86f3ace02" xlink:href="gsk-20241231.xsd#gsk_PledgedInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_gsk_PledgedInvestments_c518607b-5c8b-4478-8e0d-8ee86f3ace02" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases_f2cfd9bb-8c06-415c-af8f-e7b9e60bca5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtLineItems_a2cfa55d-b29f-44de-be5f-928d2d20e66b" xlink:to="loc_ifrs-full_CashOutflowForLeases_f2cfd9bb-8c06-415c-af8f-e7b9e60bca5d" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/NetdebtScheduleofFinanceLeaseObligationsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#NetdebtScheduleofFinanceLeaseObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/NetdebtScheduleofFinanceLeaseObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_e0523171-97db-40b1-ad2f-f965e584fc24" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_e64e204e-ac2e-41f6-9bae-823ffae13d97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_e0523171-97db-40b1-ad2f-f965e584fc24" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_e64e204e-ac2e-41f6-9bae-823ffae13d97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_1eef1167-fe38-4ce6-aeb1-d435ec90b5b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_e64e204e-ac2e-41f6-9bae-823ffae13d97" xlink:to="loc_ifrs-full_MaturityAxis_1eef1167-fe38-4ce6-aeb1-d435ec90b5b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_1eef1167-fe38-4ce6-aeb1-d435ec90b5b6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1eef1167-fe38-4ce6-aeb1-d435ec90b5b6" xlink:to="loc_ifrs-full_MaturityDomain_1eef1167-fe38-4ce6-aeb1-d435ec90b5b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1eef1167-fe38-4ce6-aeb1-d435ec90b5b6" xlink:to="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1c1702e3-d4a7-47c9-be5f-cc9d1c6d77f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1c1702e3-d4a7-47c9-be5f-cc9d1c6d77f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_6730642d-268a-43fc-bb96-5d6812b6d751" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_6730642d-268a-43fc-bb96-5d6812b6d751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_e0080f35-225d-4c6e-a505-e6d2e8554690" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_e0080f35-225d-4c6e-a505-e6d2e8554690" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_fd1f5bb4-367d-4c1a-a504-83e2f4ce42e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_fd1f5bb4-367d-4c1a-a504-83e2f4ce42e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_3a1f7b53-89df-4fdf-88c9-cb70046d1586" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_3a1f7b53-89df-4fdf-88c9-cb70046d1586" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_e89a9aec-104c-4e2c-9e7d-3a14688f95c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_159e71d3-1828-47b1-883b-8bd30352296f" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_e89a9aec-104c-4e2c-9e7d-3a14688f95c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_21fc4f13-a3ce-4854-b2e0-a949790726a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_e0523171-97db-40b1-ad2f-f965e584fc24" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_21fc4f13-a3ce-4854-b2e0-a949790726a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_40692af8-0957-411e-93ef-86a9053a07dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_e0523171-97db-40b1-ad2f-f965e584fc24" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_40692af8-0957-411e-93ef-86a9053a07dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_092bfa26-889d-4e32-8f90-c004143f00a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_e0523171-97db-40b1-ad2f-f965e584fc24" xlink:to="loc_ifrs-full_LeaseLiabilities_092bfa26-889d-4e32-8f90-c004143f00a5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPensionandOtherPostemploymentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_c567599f-d0a8-4d35-b295-354917592670" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_635dbe9c-f219-47a3-8e0b-136a5d37206c" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_c567599f-d0a8-4d35-b295-354917592670" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_635dbe9c-f219-47a3-8e0b-136a5d37206c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_2d7e59c6-6cd6-442b-a12f-a6862bdccb56" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_635dbe9c-f219-47a3-8e0b-136a5d37206c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_2d7e59c6-6cd6-442b-a12f-a6862bdccb56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_2d7e59c6-6cd6-442b-a12f-a6862bdccb56_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_2d7e59c6-6cd6-442b-a12f-a6862bdccb56" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_2d7e59c6-6cd6-442b-a12f-a6862bdccb56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_0e818992-a5ad-478d-a8c2-2a458fe3b8d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_2d7e59c6-6cd6-442b-a12f-a6862bdccb56" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_0e818992-a5ad-478d-a8c2-2a458fe3b8d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UkDefinedBenefitAndDefinedContributionPlansMember_d95c0554-214c-4bd5-978b-d70d80950ce0" xlink:href="gsk-20241231.xsd#gsk_UkDefinedBenefitAndDefinedContributionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0e818992-a5ad-478d-a8c2-2a458fe3b8d4" xlink:to="loc_gsk_UkDefinedBenefitAndDefinedContributionPlansMember_d95c0554-214c-4bd5-978b-d70d80950ce0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsDefinedBenefitAndDefinedContributionPlansMember_39bd0473-c76d-4245-bf96-0c10ccdc0c48" xlink:href="gsk-20241231.xsd#gsk_UsDefinedBenefitAndDefinedContributionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0e818992-a5ad-478d-a8c2-2a458fe3b8d4" xlink:to="loc_gsk_UsDefinedBenefitAndDefinedContributionPlansMember_39bd0473-c76d-4245-bf96-0c10ccdc0c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherOverseasPensionPlansMember_36b2de8b-ce84-484c-a108-9edbff967baa" xlink:href="gsk-20241231.xsd#gsk_OtherOverseasPensionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0e818992-a5ad-478d-a8c2-2a458fe3b8d4" xlink:to="loc_gsk_OtherOverseasPensionPlansMember_36b2de8b-ce84-484c-a108-9edbff967baa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnfundedPostRetirementHealthcareSchemesMember_55ca1b52-9d6a-49e3-9847-92c364aaca97" xlink:href="gsk-20241231.xsd#gsk_UnfundedPostRetirementHealthcareSchemesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0e818992-a5ad-478d-a8c2-2a458fe3b8d4" xlink:to="loc_gsk_UnfundedPostRetirementHealthcareSchemesMember_55ca1b52-9d6a-49e3-9847-92c364aaca97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_84662769-db43-4355-b7a5-b980e4895450" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_635dbe9c-f219-47a3-8e0b-136a5d37206c" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_84662769-db43-4355-b7a5-b980e4895450" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_84662769-db43-4355-b7a5-b980e4895450_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_84662769-db43-4355-b7a5-b980e4895450" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_84662769-db43-4355-b7a5-b980e4895450_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_8ddafefb-2daf-4efe-82eb-0268a9965589" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_84662769-db43-4355-b7a5-b980e4895450" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_8ddafefb-2daf-4efe-82eb-0268a9965589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitHybridPensionSchemeMember_8e80cac9-766c-49d4-8fd9-e6a04e6182bf" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitHybridPensionSchemeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_8ddafefb-2daf-4efe-82eb-0268a9965589" xlink:to="loc_gsk_DefinedBenefitHybridPensionSchemeMember_8e80cac9-766c-49d4-8fd9-e6a04e6182bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_0a289862-1ca9-42da-b036-bf288f87b2b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_8ddafefb-2daf-4efe-82eb-0268a9965589" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_0a289862-1ca9-42da-b036-bf288f87b2b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember_72f74322-68d7-4a4b-8b4c-944de8ecee15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_8ddafefb-2daf-4efe-82eb-0268a9965589" xlink:to="loc_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember_72f74322-68d7-4a4b-8b4c-944de8ecee15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_fa46bae0-29b0-4855-9e01-c2fe6d2c3191" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_635dbe9c-f219-47a3-8e0b-136a5d37206c" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_fa46bae0-29b0-4855-9e01-c2fe6d2c3191" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_fa46bae0-29b0-4855-9e01-c2fe6d2c3191_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_fa46bae0-29b0-4855-9e01-c2fe6d2c3191" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_fa46bae0-29b0-4855-9e01-c2fe6d2c3191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_e92e8ab5-5984-4071-be52-4d4302b12648" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_fa46bae0-29b0-4855-9e01-c2fe6d2c3191" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_e92e8ab5-5984-4071-be52-4d4302b12648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_19265efe-5340-4a23-b2c7-ba94af91dc27" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_e92e8ab5-5984-4071-be52-4d4302b12648" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_19265efe-5340-4a23-b2c7-ba94af91dc27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_9960934a-30cc-4858-8859-e7c851db8899" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_e92e8ab5-5984-4071-be52-4d4302b12648" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_9960934a-30cc-4858-8859-e7c851db8899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_13d527a3-6699-4030-87b9-1d1c1eae4bdd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_635dbe9c-f219-47a3-8e0b-136a5d37206c" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_13d527a3-6699-4030-87b9-1d1c1eae4bdd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_13d527a3-6699-4030-87b9-1d1c1eae4bdd_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_13d527a3-6699-4030-87b9-1d1c1eae4bdd" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_13d527a3-6699-4030-87b9-1d1c1eae4bdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_5d486aa8-26f5-4f70-8fa7-18b0d2327a03" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_13d527a3-6699-4030-87b9-1d1c1eae4bdd" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_5d486aa8-26f5-4f70-8fa7-18b0d2327a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember_2ea3d9b5-657d-40e9-9a51-f0035798d4a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_5d486aa8-26f5-4f70-8fa7-18b0d2327a03" xlink:to="loc_ifrs-full_CostOfSalesMember_2ea3d9b5-657d-40e9-9a51-f0035798d4a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_59de749a-0f40-42ef-97d3-d7e29aa21816" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_5d486aa8-26f5-4f70-8fa7-18b0d2327a03" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_59de749a-0f40-42ef-97d3-d7e29aa21816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember_1a5ef95c-6fd4-4a48-a8ea-1d5fa45ea470" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_5d486aa8-26f5-4f70-8fa7-18b0d2327a03" xlink:to="loc_gsk_ResearchAndDevelopmentMember_1a5ef95c-6fd4-4a48-a8ea-1d5fa45ea470" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_a2aca34b-8381-4104-bf73-04e347ff5e9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_c567599f-d0a8-4d35-b295-354917592670" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_a2aca34b-8381-4104-bf73-04e347ff5e9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_5b739292-9909-422c-a920-3aaca4213634" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_c567599f-d0a8-4d35-b295-354917592670" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_5b739292-9909-422c-a920-3aaca4213634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_ecea7e12-7cd1-4ab1-aebd-577668c0f666" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_c567599f-d0a8-4d35-b295-354917592670" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_ecea7e12-7cd1-4ab1-aebd-577668c0f666" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAverageLifeExpectancyAssumedDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofAverageLifeExpectancyAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAverageLifeExpectancyAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_0171f108-f499-44a7-bc0e-d2e535b5efbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_2927994b-86eb-4980-9282-a6fe42f145a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_0171f108-f499-44a7-bc0e-d2e535b5efbd" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_2927994b-86eb-4980-9282-a6fe42f145a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_393a127e-4b7a-41a7-86c4-0c6934a5d3c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_2927994b-86eb-4980-9282-a6fe42f145a9" xlink:to="loc_ifrs-full_GeographicalAreasAxis_393a127e-4b7a-41a7-86c4-0c6934a5d3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_393a127e-4b7a-41a7-86c4-0c6934a5d3c0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_393a127e-4b7a-41a7-86c4-0c6934a5d3c0" xlink:to="loc_ifrs-full_GeographicalAreasDomain_393a127e-4b7a-41a7-86c4-0c6934a5d3c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_c7cd6458-ddad-4226-a107-d20ba98249e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_393a127e-4b7a-41a7-86c4-0c6934a5d3c0" xlink:to="loc_ifrs-full_GeographicalAreasDomain_c7cd6458-ddad-4226-a107-d20ba98249e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_44e6db8b-ada6-47fe-b636-27b21dfd9964" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_c7cd6458-ddad-4226-a107-d20ba98249e6" xlink:to="loc_ifrs-full_CountryOfDomicileMember_44e6db8b-ada6-47fe-b636-27b21dfd9964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_db8f876d-d6a0-46b5-8670-65fab2688ea4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_c7cd6458-ddad-4226-a107-d20ba98249e6" xlink:to="loc_country_US_db8f876d-d6a0-46b5-8670-65fab2688ea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_e0814ebb-fa61-4283-a9a8-014bdaa10a18" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_2927994b-86eb-4980-9282-a6fe42f145a9" xlink:to="loc_ifrs-full_MaturityAxis_e0814ebb-fa61-4283-a9a8-014bdaa10a18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_e0814ebb-fa61-4283-a9a8-014bdaa10a18_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_e0814ebb-fa61-4283-a9a8-014bdaa10a18" xlink:to="loc_ifrs-full_MaturityDomain_e0814ebb-fa61-4283-a9a8-014bdaa10a18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_8a1fc958-26fa-4457-b216-ddc08d7d5a96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_e0814ebb-fa61-4283-a9a8-014bdaa10a18" xlink:to="loc_ifrs-full_MaturityDomain_8a1fc958-26fa-4457-b216-ddc08d7d5a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentPeriodMember_aa8485af-615d-4d51-b4da-33acae361abe" xlink:href="gsk-20241231.xsd#gsk_CurrentPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_8a1fc958-26fa-4457-b216-ddc08d7d5a96" xlink:to="loc_gsk_CurrentPeriodMember_aa8485af-615d-4d51-b4da-33acae361abe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProjectedPeriodMember_955ef91e-e52a-49fe-bf3b-435de62630aa" xlink:href="gsk-20241231.xsd#gsk_ProjectedPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_8a1fc958-26fa-4457-b216-ddc08d7d5a96" xlink:to="loc_gsk_ProjectedPeriodMember_955ef91e-e52a-49fe-bf3b-435de62630aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019_d87d7709-6189-46ab-ad89-9778978f7fb7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_0171f108-f499-44a7-bc0e-d2e535b5efbd" xlink:to="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019_d87d7709-6189-46ab-ad89-9778978f7fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MalePensionersAverageLifeExpectancyAtSixty_27f4aec8-70c7-485d-bc8b-8a27a1729122" xlink:href="gsk-20241231.xsd#gsk_MalePensionersAverageLifeExpectancyAtSixty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_0171f108-f499-44a7-bc0e-d2e535b5efbd" xlink:to="loc_gsk_MalePensionersAverageLifeExpectancyAtSixty_27f4aec8-70c7-485d-bc8b-8a27a1729122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FemalePensionersAverageLifeExpectancyAtSixty_28b0cf93-4ee6-498a-8d41-f2f14dece503" xlink:href="gsk-20241231.xsd#gsk_FemalePensionersAverageLifeExpectancyAtSixty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_0171f108-f499-44a7-bc0e-d2e535b5efbd" xlink:to="loc_gsk_FemalePensionersAverageLifeExpectancyAtSixty_28b0cf93-4ee6-498a-8d41-f2f14dece503" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_ac8ea5c0-4ce4-44fb-b258-6fceffeada92" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:to="loc_ifrs-full_GeographicalAreasAxis_ac8ea5c0-4ce4-44fb-b258-6fceffeada92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_ac8ea5c0-4ce4-44fb-b258-6fceffeada92_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_ac8ea5c0-4ce4-44fb-b258-6fceffeada92" xlink:to="loc_ifrs-full_GeographicalAreasDomain_ac8ea5c0-4ce4-44fb-b258-6fceffeada92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_78eb479f-90f3-4597-bfdc-cc51a540b7e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_ac8ea5c0-4ce4-44fb-b258-6fceffeada92" xlink:to="loc_ifrs-full_GeographicalAreasDomain_78eb479f-90f3-4597-bfdc-cc51a540b7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_9623321d-dd40-4712-b46a-024719466669" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_78eb479f-90f3-4597-bfdc-cc51a540b7e6" xlink:to="loc_ifrs-full_CountryOfDomicileMember_9623321d-dd40-4712-b46a-024719466669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e1abea45-287f-4db3-9c7e-171849f67a35" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_78eb479f-90f3-4597-bfdc-cc51a540b7e6" xlink:to="loc_country_US_e1abea45-287f-4db3-9c7e-171849f67a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_80b3650b-fdd3-4ac2-850a-3872c80001ea" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_78eb479f-90f3-4597-bfdc-cc51a540b7e6" xlink:to="loc_country_GB_80b3650b-fdd3-4ac2-850a-3872c80001ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_1597a2cf-4e12-4712-82ce-27a615943d93" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_1597a2cf-4e12-4712-82ce-27a615943d93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_1597a2cf-4e12-4712-82ce-27a615943d93_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_1597a2cf-4e12-4712-82ce-27a615943d93" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_1597a2cf-4e12-4712-82ce-27a615943d93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_1597a2cf-4e12-4712-82ce-27a615943d93" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UKDefinedBenefitPlansMember_6d71cd7e-dc52-43dd-bb33-c79b9746d0cd" xlink:href="gsk-20241231.xsd#gsk_UKDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_gsk_UKDefinedBenefitPlansMember_6d71cd7e-dc52-43dd-bb33-c79b9746d0cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeMember_704f351a-1e94-4261-9824-9dd11ff12029" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_gsk_GlaxoWellcomeMember_704f351a-1e94-4261-9824-9dd11ff12029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SmithKlineBeechamLimitedMember_06899b43-49a4-4740-a501-1843aef36d5a" xlink:href="gsk-20241231.xsd#gsk_SmithKlineBeechamLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_gsk_SmithKlineBeechamLimitedMember_06899b43-49a4-4740-a501-1843aef36d5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_USCashBalancePlanMember_904d6b51-3624-49ad-a79f-4a1b2bb0b96e" xlink:href="gsk-20241231.xsd#gsk_USCashBalancePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_gsk_USCashBalancePlanMember_904d6b51-3624-49ad-a79f-4a1b2bb0b96e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_bf011347-192a-4b57-820d-3fc350f4d5f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_bf011347-192a-4b57-820d-3fc350f4d5f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_a1f54f3f-e0d2-41e3-b025-ed3260ca3306" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_gsk_PostRetirementBenefitsMember_a1f54f3f-e0d2-41e3-b025-ed3260ca3306" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_2d657145-f065-4b38-b9fc-d96c0a8a6f8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_736ede75-7fb8-4593-8b21-c92fd03cd9a8" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_2d657145-f065-4b38-b9fc-d96c0a8a6f8e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_ac2ff5c0-a060-48cf-8d7a-121687dadf4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_ac2ff5c0-a060-48cf-8d7a-121687dadf4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_ac2ff5c0-a060-48cf-8d7a-121687dadf4a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ac2ff5c0-a060-48cf-8d7a-121687dadf4a" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_ac2ff5c0-a060-48cf-8d7a-121687dadf4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_1cb23e53-ae40-44b0-aecc-577a998f072c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ac2ff5c0-a060-48cf-8d7a-121687dadf4a" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_1cb23e53-ae40-44b0-aecc-577a998f072c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssetsMember_aaef1fd2-b2ef-4676-9d5f-4293ca0ef7d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_1cb23e53-ae40-44b0-aecc-577a998f072c" xlink:to="loc_ifrs-full_OtherAssetsMember_aaef1fd2-b2ef-4676-9d5f-4293ca0ef7d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeAxis_4ed36b7b-d962-4f1d-8e4b-7e1dca87fa63" xlink:href="gsk-20241231.xsd#gsk_TransfereeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:to="loc_gsk_TransfereeAxis_4ed36b7b-d962-4f1d-8e4b-7e1dca87fa63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeDomain_4ed36b7b-d962-4f1d-8e4b-7e1dca87fa63_default" xlink:href="gsk-20241231.xsd#gsk_TransfereeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_TransfereeAxis_4ed36b7b-d962-4f1d-8e4b-7e1dca87fa63" xlink:to="loc_gsk_TransfereeDomain_4ed36b7b-d962-4f1d-8e4b-7e1dca87fa63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeDomain_d8713e99-596d-46f2-8423-fa6886744e67" xlink:href="gsk-20241231.xsd#gsk_TransfereeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_TransfereeAxis_4ed36b7b-d962-4f1d-8e4b-7e1dca87fa63" xlink:to="loc_gsk_TransfereeDomain_d8713e99-596d-46f2-8423-fa6886744e67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SLPPartneshipsMember_b668f043-0af2-450d-86f5-756b1d4b027c" xlink:href="gsk-20241231.xsd#gsk_SLPPartneshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TransfereeDomain_d8713e99-596d-46f2-8423-fa6886744e67" xlink:to="loc_gsk_SLPPartneshipsMember_b668f043-0af2-450d-86f5-756b1d4b027c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_e4f2bd19-1d10-4fa0-b0e1-e4f31c330deb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_e4f2bd19-1d10-4fa0-b0e1-e4f31c330deb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_e4f2bd19-1d10-4fa0-b0e1-e4f31c330deb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_e4f2bd19-1d10-4fa0-b0e1-e4f31c330deb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_e4f2bd19-1d10-4fa0-b0e1-e4f31c330deb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_b9d1c248-69a7-4b4a-90a3-41661a4fbecc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_e4f2bd19-1d10-4fa0-b0e1-e4f31c330deb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_b9d1c248-69a7-4b4a-90a3-41661a4fbecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_57aac944-0fa5-4f89-b5e6-2c0ac17b92bc" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_b9d1c248-69a7-4b4a-90a3-41661a4fbecc" xlink:to="loc_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_57aac944-0fa5-4f89-b5e6-2c0ac17b92bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c653e44d-06f0-4f8a-96d5-4339ba7f7dd5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_398b46e3-e42a-4894-b14f-adcea5c252c7" xlink:to="loc_srt_StatementScenarioAxis_c653e44d-06f0-4f8a-96d5-4339ba7f7dd5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c653e44d-06f0-4f8a-96d5-4339ba7f7dd5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c653e44d-06f0-4f8a-96d5-4339ba7f7dd5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c653e44d-06f0-4f8a-96d5-4339ba7f7dd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8271b38e-15d3-4abc-a7eb-e6f72f07ad8e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c653e44d-06f0-4f8a-96d5-4339ba7f7dd5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8271b38e-15d3-4abc-a7eb-e6f72f07ad8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TwoThousandThirtyOneAndThereafterMember_c9e52e9a-0956-4f23-989f-ec82fcf4f517" xlink:href="gsk-20241231.xsd#gsk_TwoThousandThirtyOneAndThereafterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_8271b38e-15d3-4abc-a7eb-e6f72f07ad8e" xlink:to="loc_gsk_TwoThousandThirtyOneAndThereafterMember_c9e52e9a-0956-4f23-989f-ec82fcf4f517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUKPensionPlansPhysicalAssetAllocationStrategyApplied_74756000-6cf9-4cd0-91c7-313241610e40" xlink:href="gsk-20241231.xsd#gsk_NumberOfUKPensionPlansPhysicalAssetAllocationStrategyApplied"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_NumberOfUKPensionPlansPhysicalAssetAllocationStrategyApplied_74756000-6cf9-4cd0-91c7-313241610e40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUKPensionPlans_62aa01bf-7783-4517-bf31-6659e92fb95f" xlink:href="gsk-20241231.xsd#gsk_NumberOfUKPensionPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_NumberOfUKPensionPlans_62aa01bf-7783-4517-bf31-6659e92fb95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AllocationToReturnSeekingAssets_ab82f398-c129-42f9-b495-50de5c79258b" xlink:href="gsk-20241231.xsd#gsk_AllocationToReturnSeekingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_AllocationToReturnSeekingAssets_ab82f398-c129-42f9-b495-50de5c79258b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AllocationToLiabilityMatchingAssets_913d955c-6f9e-4ab3-835d-b07a8766faf7" xlink:href="gsk-20241231.xsd#gsk_AllocationToLiabilityMatchingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_AllocationToLiabilityMatchingAssets_913d955c-6f9e-4ab3-835d-b07a8766faf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalValueOfTheInsuranceContract_fb17cb14-b841-46df-92aa-ac9c7ac32bcd" xlink:href="gsk-20241231.xsd#gsk_TotalValueOfTheInsuranceContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_TotalValueOfTheInsuranceContract_fb17cb14-b841-46df-92aa-ac9c7ac32bcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset_0e870a7b-711c-403e-b763-a5a00fd629a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset_0e870a7b-711c-403e-b763-a5a00fd629a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan_a08acf74-72da-47ce-927d-a9f15d7c1cb9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_ifrs-full_SurplusDeficitInPlan_a08acf74-72da-47ce-927d-a9f15d7c1cb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits_713f1d95-19e9-4e12-84b6-c7c8460147fe" xlink:href="gsk-20241231.xsd#gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits_713f1d95-19e9-4e12-84b6-c7c8460147fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NotionalInterest_1b3547c5-c68a-4df0-82e1-686b9554889d" xlink:href="gsk-20241231.xsd#gsk_NotionalInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_NotionalInterest_1b3547c5-c68a-4df0-82e1-686b9554889d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_f9994778-15ea-4e36-9aa8-9b95699387a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_f9994778-15ea-4e36-9aa8-9b95699387a0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfScottishLimitedPartnerships_bde15d81-4995-4357-a3a1-6cef6fb1a815" xlink:href="gsk-20241231.xsd#gsk_NumberOfScottishLimitedPartnerships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_NumberOfScottishLimitedPartnerships_bde15d81-4995-4357-a3a1-6cef6fb1a815" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes_60023005-9fa8-48be-8bdd-1e7af35db428" xlink:href="gsk-20241231.xsd#gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes_60023005-9fa8-48be-8bdd-1e7af35db428" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AugmentationCostsIncludedInPastServiceCosts_1fc9246f-0659-4328-9179-559e145684a3" xlink:href="gsk-20241231.xsd#gsk_AugmentationCostsIncludedInPastServiceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_AugmentationCostsIncludedInPastServiceCosts_1fc9246f-0659-4328-9179-559e145684a3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished_ddbdf72c-a203-4d05-89e1-98aca999ad71" xlink:href="gsk-20241231.xsd#gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished_ddbdf72c-a203-4d05-89e1-98aca999ad71" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets_fc7942d2-a232-43bb-9cae-d01e172adb56" xlink:href="gsk-20241231.xsd#gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets_fc7942d2-a232-43bb-9cae-d01e172adb56" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions_dfe35ea9-eb83-4796-8f8b-2d600eed2a33" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions_dfe35ea9-eb83-4796-8f8b-2d600eed2a33" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_9f7ed160-3ae3-4e35-ad25-aa53bdea902d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_9f7ed160-3ae3-4e35-ad25-aa53bdea902d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation_17c08be9-742d-49a6-8872-ef1f0d01df31" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation_17c08be9-742d-49a6-8872-ef1f0d01df31" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_d4964983-da1a-45df-ad2a-67970a618969" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_1d08225d-7fdb-4de0-9467-b160551f2db2" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_d4964983-da1a-45df-ad2a-67970a618969" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandOtherPostemploymentBenefitsSummaryofFinancialAssumptionsinAssessingDefinedBenefitLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandOtherPostemploymentBenefitsSummaryofFinancialAssumptionsinAssessingDefinedBenefitLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandOtherPostemploymentBenefitsSummaryofFinancialAssumptionsinAssessingDefinedBenefitLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable_e3fa0bcb-5596-475e-9dde-71106c535900" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable_e3fa0bcb-5596-475e-9dde-71106c535900" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_64989494-d4e1-4741-bbe3-79488567795c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable_e3fa0bcb-5596-475e-9dde-71106c535900" xlink:to="loc_ifrs-full_GeographicalAreasAxis_64989494-d4e1-4741-bbe3-79488567795c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_64989494-d4e1-4741-bbe3-79488567795c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_64989494-d4e1-4741-bbe3-79488567795c" xlink:to="loc_ifrs-full_GeographicalAreasDomain_64989494-d4e1-4741-bbe3-79488567795c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_020425d0-d4f7-42f9-84c1-c898735169ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_64989494-d4e1-4741-bbe3-79488567795c" xlink:to="loc_ifrs-full_GeographicalAreasDomain_020425d0-d4f7-42f9-84c1-c898735169ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_f7eb44ee-da24-4bea-9c8e-a34dec1fce0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_020425d0-d4f7-42f9-84c1-c898735169ec" xlink:to="loc_ifrs-full_CountryOfDomicileMember_f7eb44ee-da24-4bea-9c8e-a34dec1fce0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_57b701a0-c5ee-4d81-a349-8772da3e5694" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_020425d0-d4f7-42f9-84c1-c898735169ec" xlink:to="loc_country_US_57b701a0-c5ee-4d81-a349-8772da3e5694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember_dbcfca1c-392f-47e3-bae3-0384849ba976" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_020425d0-d4f7-42f9-84c1-c898735169ec" xlink:to="loc_gsk_RestOfWorldMember_dbcfca1c-392f-47e3-bae3-0384849ba976" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_f8ead787-58e8-4c77-b026-4229a27d39e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_f8ead787-58e8-4c77-b026-4229a27d39e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_6852ab6a-eef6-4736-9fa9-acb79e2ca6e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_6852ab6a-eef6-4736-9fa9-acb79e2ca6e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_62f163fa-81f3-43dd-b727-e0fbe1bb30c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_62f163fa-81f3-43dd-b727-e0fbe1bb30c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionOfCashBalanceCreditRate_b8e8908a-6c54-44ba-b340-7e03638544ac" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionOfCashBalanceCreditRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:to="loc_gsk_ActuarialAssumptionOfCashBalanceCreditRate_b8e8908a-6c54-44ba-b340-7e03638544ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_bcd38c5f-4723-4aac-b86a-3c5dddc50b07" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_1e890e1e-b18d-47d3-9341-019a62d92ee1" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_bcd38c5f-4723-4aac-b86a-3c5dddc50b07" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAmountsRecordedinIncomeStatementandStatementofComprehensiveIncomeRelatedtoDefinedBenefitPensionandPostretirementHealthcareSchemesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_eba52be6-d68d-4875-a599-e7682a6f8864" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_eba52be6-d68d-4875-a599-e7682a6f8864" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_a6213f3d-e521-4dcf-9e78-a5188c39b00e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_eba52be6-d68d-4875-a599-e7682a6f8864" xlink:to="loc_ifrs-full_GeographicalAreasAxis_a6213f3d-e521-4dcf-9e78-a5188c39b00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_a6213f3d-e521-4dcf-9e78-a5188c39b00e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a6213f3d-e521-4dcf-9e78-a5188c39b00e" xlink:to="loc_ifrs-full_GeographicalAreasDomain_a6213f3d-e521-4dcf-9e78-a5188c39b00e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_59179b26-304a-4081-b9e1-4bbaba32f880" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a6213f3d-e521-4dcf-9e78-a5188c39b00e" xlink:to="loc_ifrs-full_GeographicalAreasDomain_59179b26-304a-4081-b9e1-4bbaba32f880" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_2c4b0547-6786-4b33-ada1-03a23b2ff7ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_59179b26-304a-4081-b9e1-4bbaba32f880" xlink:to="loc_ifrs-full_CountryOfDomicileMember_2c4b0547-6786-4b33-ada1-03a23b2ff7ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_32e6df97-f335-4328-a092-9204e875c85e" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_59179b26-304a-4081-b9e1-4bbaba32f880" xlink:to="loc_country_US_32e6df97-f335-4328-a092-9204e875c85e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember_040391dd-fa6d-46ac-9e37-edd862124d8c" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_59179b26-304a-4081-b9e1-4bbaba32f880" xlink:to="loc_gsk_RestOfWorldMember_040391dd-fa6d-46ac-9e37-edd862124d8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_3ea98909-bb83-4c02-a373-74b235f00cc5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_eba52be6-d68d-4875-a599-e7682a6f8864" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_3ea98909-bb83-4c02-a373-74b235f00cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_3ea98909-bb83-4c02-a373-74b235f00cc5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_3ea98909-bb83-4c02-a373-74b235f00cc5" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_3ea98909-bb83-4c02-a373-74b235f00cc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_0daf908b-2980-495f-a0d2-deb9e1c180b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_3ea98909-bb83-4c02-a373-74b235f00cc5" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_0daf908b-2980-495f-a0d2-deb9e1c180b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_615a4641-6502-42b9-bc0f-2af333ae87c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0daf908b-2980-495f-a0d2-deb9e1c180b2" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_615a4641-6502-42b9-bc0f-2af333ae87c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_c7cff86a-fbd4-4e2f-a5fe-600136537c98" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_0daf908b-2980-495f-a0d2-deb9e1c180b2" xlink:to="loc_gsk_PostRetirementBenefitsMember_c7cff86a-fbd4-4e2f-a5fe-600136537c98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5f53c296-687c-4580-9cd9-e2ad6c938f2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_eba52be6-d68d-4875-a599-e7682a6f8864" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5f53c296-687c-4580-9cd9-e2ad6c938f2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_5f53c296-687c-4580-9cd9-e2ad6c938f2e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5f53c296-687c-4580-9cd9-e2ad6c938f2e" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_5f53c296-687c-4580-9cd9-e2ad6c938f2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6930a314-3abf-43a7-80d9-99c603245dc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5f53c296-687c-4580-9cd9-e2ad6c938f2e" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6930a314-3abf-43a7-80d9-99c603245dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember_7022be07-716c-4bb8-81c4-f12acd5c1d78" xlink:href="gsk-20241231.xsd#gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_6930a314-3abf-43a7-80d9-99c603245dc9" xlink:to="loc_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember_7022be07-716c-4bb8-81c4-f12acd5c1d78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_5c8b4e82-6fe1-4c44-9ebf-e450ad8bd4b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_5c8b4e82-6fe1-4c44-9ebf-e450ad8bd4b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_eaf0ce05-dff0-4d56-9ddf-b35065258184" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_eaf0ce05-dff0-4d56-9ddf-b35065258184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_6aec96ab-6e31-4e5e-a29e-1b3274a1b012" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_6aec96ab-6e31-4e5e-a29e-1b3274a1b012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_e061a588-1b75-4de3-a8fd-9f73cc7d0588" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_e061a588-1b75-4de3-a8fd-9f73cc7d0588" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_7f6bacde-9963-412e-910f-5c2b0e9a422c" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_7f6bacde-9963-412e-910f-5c2b0e9a422c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_79655fb2-0c54-4708-99d6-510fb1d08287" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_79655fb2-0c54-4708-99d6-510fb1d08287" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_d04ac1b4-ca6d-4d47-9f51-35e28ca211d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_b42b6630-3bbd-4bfe-ac36-828dca745b84" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_d04ac1b4-ca6d-4d47-9f51-35e28ca211d1" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofBalanceSheetPresentationofGroupDefinedBenefitPensionSchemesandOtherPostretirementBenefitsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofBalanceSheetPresentationofGroupDefinedBenefitPensionSchemesandOtherPostretirementBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofBalanceSheetPresentationofGroupDefinedBenefitPensionSchemesandOtherPostretirementBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_aa6bb600-9cf3-4d63-a0dd-732dc421a0ff" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_00fe7bf1-2268-401e-9ca2-5b4fd010225e" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_aa6bb600-9cf3-4d63-a0dd-732dc421a0ff" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_00fe7bf1-2268-401e-9ca2-5b4fd010225e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_f05b1ebf-c5c2-4e78-9c43-3e5a86dccb75" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_00fe7bf1-2268-401e-9ca2-5b4fd010225e" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_f05b1ebf-c5c2-4e78-9c43-3e5a86dccb75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_f05b1ebf-c5c2-4e78-9c43-3e5a86dccb75_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_f05b1ebf-c5c2-4e78-9c43-3e5a86dccb75" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_f05b1ebf-c5c2-4e78-9c43-3e5a86dccb75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_b2a41c89-ea41-4c5b-9f9e-e918370ba23b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_f05b1ebf-c5c2-4e78-9c43-3e5a86dccb75" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_b2a41c89-ea41-4c5b-9f9e-e918370ba23b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NoncurrentAssetsOtherMember_92f485ea-465e-46b1-b5b8-4c6241ff6abb" xlink:href="gsk-20241231.xsd#gsk_NoncurrentAssetsOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_b2a41c89-ea41-4c5b-9f9e-e918370ba23b" xlink:to="loc_gsk_NoncurrentAssetsOtherMember_92f485ea-465e-46b1-b5b8-4c6241ff6abb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember_36ee4f67-4081-4503-813d-97c00f29f9ae" xlink:href="gsk-20241231.xsd#gsk_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_b2a41c89-ea41-4c5b-9f9e-e918370ba23b" xlink:to="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember_36ee4f67-4081-4503-813d-97c00f29f9ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_76941696-502d-4ae7-b4f5-a0ee7d9dc25c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_00fe7bf1-2268-401e-9ca2-5b4fd010225e" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_76941696-502d-4ae7-b4f5-a0ee7d9dc25c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_76941696-502d-4ae7-b4f5-a0ee7d9dc25c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_76941696-502d-4ae7-b4f5-a0ee7d9dc25c" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_76941696-502d-4ae7-b4f5-a0ee7d9dc25c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_b0b81ec3-1eba-4071-beae-b3c72aab0d3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_76941696-502d-4ae7-b4f5-a0ee7d9dc25c" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_b0b81ec3-1eba-4071-beae-b3c72aab0d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_8381a7fb-1ebc-47b4-92aa-80b25f8abc12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_b0b81ec3-1eba-4071-beae-b3c72aab0d3f" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_8381a7fb-1ebc-47b4-92aa-80b25f8abc12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_3a57e662-1592-4d29-8f4c-18f33683ef85" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_b0b81ec3-1eba-4071-beae-b3c72aab0d3f" xlink:to="loc_gsk_PostRetirementBenefitsMember_3a57e662-1592-4d29-8f4c-18f33683ef85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan_0bd186da-22dc-473a-9187-ed8027a73e14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_aa6bb600-9cf3-4d63-a0dd-732dc421a0ff" xlink:to="loc_ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan_0bd186da-22dc-473a-9187-ed8027a73e14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_278fe6f3-087b-4c52-bf72-29ebd9d32896" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_aa6bb600-9cf3-4d63-a0dd-732dc421a0ff" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_278fe6f3-087b-4c52-bf72-29ebd9d32896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_7b11ce3d-989a-4e04-91b4-7a4fff97f727" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_aa6bb600-9cf3-4d63-a0dd-732dc421a0ff" xlink:to="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_7b11ce3d-989a-4e04-91b4-7a4fff97f727" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsFairValuesofAssetsandLiabilitiesofUKandUSDefinedBenefitPensionSchemesTogetherwithAggregatedDataforOtherDefinedBenefitPensionSchemesinGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_c719b866-027c-4e58-bf80-4cbe1a03dad1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_ifrs-full_GeographicalAreasAxis_c719b866-027c-4e58-bf80-4cbe1a03dad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_c719b866-027c-4e58-bf80-4cbe1a03dad1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_c719b866-027c-4e58-bf80-4cbe1a03dad1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_c719b866-027c-4e58-bf80-4cbe1a03dad1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_9446edd9-6fd5-4ae6-a306-702c9444c038" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_c719b866-027c-4e58-bf80-4cbe1a03dad1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_9446edd9-6fd5-4ae6-a306-702c9444c038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_e8161936-cde9-442b-bc99-b4d8ca3aad3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9446edd9-6fd5-4ae6-a306-702c9444c038" xlink:to="loc_ifrs-full_CountryOfDomicileMember_e8161936-cde9-442b-bc99-b4d8ca3aad3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_56085736-4ae7-4abc-b3aa-c55ebcac42fb" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9446edd9-6fd5-4ae6-a306-702c9444c038" xlink:to="loc_country_US_56085736-4ae7-4abc-b3aa-c55ebcac42fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember_9f51b362-d405-4771-bbc9-5a8ac7a9cec8" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_9446edd9-6fd5-4ae6-a306-702c9444c038" xlink:to="loc_gsk_RestOfWorldMember_9f51b362-d405-4771-bbc9-5a8ac7a9cec8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_f3e6c020-203b-473d-a73d-c452a04906da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_f3e6c020-203b-473d-a73d-c452a04906da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_f3e6c020-203b-473d-a73d-c452a04906da_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_f3e6c020-203b-473d-a73d-c452a04906da" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_f3e6c020-203b-473d-a73d-c452a04906da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7d0f6e62-aed0-47b2-8dc8-ae6199e64f1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_f3e6c020-203b-473d-a73d-c452a04906da" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7d0f6e62-aed0-47b2-8dc8-ae6199e64f1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GroupMember_fd2c49f1-24ea-48b1-b857-039b608d3e7c" xlink:href="gsk-20241231.xsd#gsk_GroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7d0f6e62-aed0-47b2-8dc8-ae6199e64f1c" xlink:to="loc_gsk_GroupMember_fd2c49f1-24ea-48b1-b857-039b608d3e7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_787f2a7b-4442-4285-8fbc-d957b6a00c58" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_787f2a7b-4442-4285-8fbc-d957b6a00c58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_787f2a7b-4442-4285-8fbc-d957b6a00c58_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_787f2a7b-4442-4285-8fbc-d957b6a00c58" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_787f2a7b-4442-4285-8fbc-d957b6a00c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_b671e5a2-b188-4cea-8cc3-6563996e89b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_787f2a7b-4442-4285-8fbc-d957b6a00c58" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_b671e5a2-b188-4cea-8cc3-6563996e89b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NoncurrentAssetsOtherMember_292fa87b-614b-4de0-9321-3040b347e0de" xlink:href="gsk-20241231.xsd#gsk_NoncurrentAssetsOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_b671e5a2-b188-4cea-8cc3-6563996e89b8" xlink:to="loc_gsk_NoncurrentAssetsOtherMember_292fa87b-614b-4de0-9321-3040b347e0de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember_5d698b4c-ae30-42ec-a4f4-55ef462fbf10" xlink:href="gsk-20241231.xsd#gsk_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_b671e5a2-b188-4cea-8cc3-6563996e89b8" xlink:to="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember_5d698b4c-ae30-42ec-a4f4-55ef462fbf10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeAxis_71976680-5876-49c2-a4e1-3f3a8fe6eddd" xlink:href="gsk-20241231.xsd#gsk_TransfereeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_gsk_TransfereeAxis_71976680-5876-49c2-a4e1-3f3a8fe6eddd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeDomain_71976680-5876-49c2-a4e1-3f3a8fe6eddd_default" xlink:href="gsk-20241231.xsd#gsk_TransfereeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_TransfereeAxis_71976680-5876-49c2-a4e1-3f3a8fe6eddd" xlink:to="loc_gsk_TransfereeDomain_71976680-5876-49c2-a4e1-3f3a8fe6eddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeDomain_f52a08f6-b957-4c77-82fd-c9987c92b52d" xlink:href="gsk-20241231.xsd#gsk_TransfereeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_TransfereeAxis_71976680-5876-49c2-a4e1-3f3a8fe6eddd" xlink:to="loc_gsk_TransfereeDomain_f52a08f6-b957-4c77-82fd-c9987c92b52d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SLPPartneshipsMember_dfba52f8-89dc-4a97-bca8-5e2e88db60af" xlink:href="gsk-20241231.xsd#gsk_SLPPartneshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TransfereeDomain_f52a08f6-b957-4c77-82fd-c9987c92b52d" xlink:to="loc_gsk_SLPPartneshipsMember_dfba52f8-89dc-4a97-bca8-5e2e88db60af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_4b1eff6b-5a19-42cb-b235-e196fab467b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_4b1eff6b-5a19-42cb-b235-e196fab467b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_4b1eff6b-5a19-42cb-b235-e196fab467b1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4b1eff6b-5a19-42cb-b235-e196fab467b1" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_4b1eff6b-5a19-42cb-b235-e196fab467b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_1db74bfe-d5a4-4188-bb3c-51314b5e3cd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4b1eff6b-5a19-42cb-b235-e196fab467b1" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_1db74bfe-d5a4-4188-bb3c-51314b5e3cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UKDefinedBenefitPlansMember_a6cc6c27-e5e5-4cfc-bda4-218810c6c75f" xlink:href="gsk-20241231.xsd#gsk_UKDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1db74bfe-d5a4-4188-bb3c-51314b5e3cd1" xlink:to="loc_gsk_UKDefinedBenefitPlansMember_a6cc6c27-e5e5-4cfc-bda4-218810c6c75f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_02162524-1974-4c76-88ea-15e5e1f7d3c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_02162524-1974-4c76-88ea-15e5e1f7d3c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_02162524-1974-4c76-88ea-15e5e1f7d3c7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_02162524-1974-4c76-88ea-15e5e1f7d3c7" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_02162524-1974-4c76-88ea-15e5e1f7d3c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_f537bb70-a691-4b99-a285-73562fa58315" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_02162524-1974-4c76-88ea-15e5e1f7d3c7" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_f537bb70-a691-4b99-a285-73562fa58315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_f302cd91-f059-4532-9c23-007b7d1ebf14" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_f537bb70-a691-4b99-a285-73562fa58315" xlink:to="loc_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_f302cd91-f059-4532-9c23-007b7d1ebf14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_5d34d70b-220d-44cd-861e-705fb90e6738" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_065d54a1-63da-4a05-acf2-48371fee6cfa" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_5d34d70b-220d-44cd-861e-705fb90e6738" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_5d34d70b-220d-44cd-861e-705fb90e6738_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_5d34d70b-220d-44cd-861e-705fb90e6738" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_5d34d70b-220d-44cd-861e-705fb90e6738_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_841a0704-b6ac-4e79-8537-2ad93e701efe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_5d34d70b-220d-44cd-861e-705fb90e6738" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_841a0704-b6ac-4e79-8537-2ad93e701efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ListedMember_1afe801a-5ca9-40cc-a714-8506824f4902" xlink:href="gsk-20241231.xsd#gsk_ListedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_841a0704-b6ac-4e79-8537-2ad93e701efe" xlink:to="loc_gsk_ListedMember_1afe801a-5ca9-40cc-a714-8506824f4902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnlistedMember_2f2a523b-efdb-408b-b03e-614a16c91994" xlink:href="gsk-20241231.xsd#gsk_UnlistedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_841a0704-b6ac-4e79-8537-2ad93e701efe" xlink:to="loc_gsk_UnlistedMember_2f2a523b-efdb-408b-b03e-614a16c91994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets_3dee09d6-6d6e-4149-8fbe-f0a627e6d9da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets_3dee09d6-6d6e-4149-8fbe-f0a627e6d9da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets_ba3315d0-c490-41aa-ab13-df19f6eba95b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets_ba3315d0-c490-41aa-ab13-df19f6eba95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_0cf19c58-26a7-44fd-a4ac-2d6c2fab1fd9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_0cf19c58-26a7-44fd-a4ac-2d6c2fab1fd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets_371ac534-af8b-4df6-abce-abed0a37c7c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets_371ac534-af8b-4df6-abce-abed0a37c7c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GovernmentBondsContributedToFairValueOfPlanAssets_ca6fbfb8-b782-416d-9c93-1affff434c2f" xlink:href="gsk-20241231.xsd#gsk_GovernmentBondsContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_gsk_GovernmentBondsContributedToFairValueOfPlanAssets_ca6fbfb8-b782-416d-9c93-1affff434c2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_76481a4e-4b19-4dd7-adaf-47d8fa607119" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_76481a4e-4b19-4dd7-adaf-47d8fa607119" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets_7eda3efd-8614-42c5-9065-f2d22659ee67" xlink:href="gsk-20241231.xsd#gsk_OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_gsk_OtherLiabilitiesAssetsAmountContributedToFairValueOfPlanAssets_7eda3efd-8614-42c5-9065-f2d22659ee67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_abad538c-0ee4-4576-86b3-2abac24c74f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_abad538c-0ee4-4576-86b3-2abac24c74f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_3b9e2eba-f1a5-4aba-a654-8b32e83dce4e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_3b9e2eba-f1a5-4aba-a654-8b32e83dce4e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan_4d9afb70-7555-47df-b700-7fc35ae54283" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_SurplusDeficitInPlan_4d9afb70-7555-47df-b700-7fc35ae54283" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c357cd5a-3ebd-42b3-a303-a92b64d15846" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f3154283-5e7c-4ba9-afce-5fbbee7f9f1b" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c357cd5a-3ebd-42b3-a303-a92b64d15846" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofMovementsinFairValuesofAssetsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofMovementsinFairValuesofAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofMovementsinFairValuesofAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_8b19d16b-0510-4425-92a0-e18a9913cb90" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_8b19d16b-0510-4425-92a0-e18a9913cb90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4c6b604d-d39e-4810-b0e2-45c1ed32803a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_8b19d16b-0510-4425-92a0-e18a9913cb90" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4c6b604d-d39e-4810-b0e2-45c1ed32803a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_4c6b604d-d39e-4810-b0e2-45c1ed32803a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4c6b604d-d39e-4810-b0e2-45c1ed32803a" xlink:to="loc_ifrs-full_GeographicalAreasDomain_4c6b604d-d39e-4810-b0e2-45c1ed32803a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_8df7d19d-f934-468e-912e-063406a08a90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4c6b604d-d39e-4810-b0e2-45c1ed32803a" xlink:to="loc_ifrs-full_GeographicalAreasDomain_8df7d19d-f934-468e-912e-063406a08a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_fab669f0-74b4-4351-9c84-95080772bcf6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_8df7d19d-f934-468e-912e-063406a08a90" xlink:to="loc_ifrs-full_CountryOfDomicileMember_fab669f0-74b4-4351-9c84-95080772bcf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_613ecc54-157a-4a1c-a562-efbc64ac3aa1" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_8df7d19d-f934-468e-912e-063406a08a90" xlink:to="loc_country_US_613ecc54-157a-4a1c-a562-efbc64ac3aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember_3d58630a-8ff6-46f4-b178-b3ee92f3748f" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_8df7d19d-f934-468e-912e-063406a08a90" xlink:to="loc_gsk_RestOfWorldMember_3d58630a-8ff6-46f4-b178-b3ee92f3748f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_751872f9-0ef1-4e50-b860-df3e9daf68ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_8b19d16b-0510-4425-92a0-e18a9913cb90" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_751872f9-0ef1-4e50-b860-df3e9daf68ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_751872f9-0ef1-4e50-b860-df3e9daf68ea_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_751872f9-0ef1-4e50-b860-df3e9daf68ea" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_751872f9-0ef1-4e50-b860-df3e9daf68ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_fb566724-a138-489c-8096-9a304549c1cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_751872f9-0ef1-4e50-b860-df3e9daf68ea" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_fb566724-a138-489c-8096-9a304549c1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_2781b668-d528-4026-87d8-597ad5d72b29" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_fb566724-a138-489c-8096-9a304549c1cf" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_2781b668-d528-4026-87d8-597ad5d72b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_32f45c63-5f2b-42d0-ac2b-509eb173cf0a" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_fb566724-a138-489c-8096-9a304549c1cf" xlink:to="loc_gsk_PostRetirementBenefitsMember_32f45c63-5f2b-42d0-ac2b-509eb173cf0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5a4d31f0-b049-4f86-b798-abe450521d26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_8b19d16b-0510-4425-92a0-e18a9913cb90" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5a4d31f0-b049-4f86-b798-abe450521d26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_5a4d31f0-b049-4f86-b798-abe450521d26_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5a4d31f0-b049-4f86-b798-abe450521d26" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_5a4d31f0-b049-4f86-b798-abe450521d26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_286bfb4b-68f9-44f5-a67d-317ae7f60531" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_5a4d31f0-b049-4f86-b798-abe450521d26" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_286bfb4b-68f9-44f5-a67d-317ae7f60531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember_760eb434-2299-4d10-a75e-cb1ad96ed773" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_286bfb4b-68f9-44f5-a67d-317ae7f60531" xlink:to="loc_ifrs-full_PlanAssetsMember_760eb434-2299-4d10-a75e-cb1ad96ed773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_a6d03086-d686-43af-9e3c-62a89230a1d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_a6d03086-d686-43af-9e3c-62a89230a1d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_cab57e84-2c53-4124-93ae-b17a617eb8e5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_cab57e84-2c53-4124-93ae-b17a617eb8e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_819ea5aa-92ec-49e9-b17e-1cd0bddae472" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_819ea5aa-92ec-49e9-b17e-1cd0bddae472" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses_2dfa119e-fa15-4b44-97a0-3b4a7279b608" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses_2dfa119e-fa15-4b44-97a0-3b4a7279b608" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_04fe7782-baea-44be-94ef-4089abdf6721" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_04fe7782-baea-44be-94ef-4089abdf6721" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_7ebb4b82-15ea-4fbf-87c4-7fda7539609b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_7ebb4b82-15ea-4fbf-87c4-7fda7539609b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_e96139ff-c059-4275-87d8-685bb595b88a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_e96139ff-c059-4275-87d8-685bb595b88a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_2cecb1f3-2059-4695-a6ed-b22e91eee451" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_2cecb1f3-2059-4695-a6ed-b22e91eee451" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_daf14dc9-c593-42bb-9fa4-9881b31b2a89" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_daf14dc9-c593-42bb-9fa4-9881b31b2a89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_ca91a94a-d8eb-4667-a3cd-1952feaf3b15" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_d63328b0-d339-432f-8c66-9783e6f957c6" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_ca91a94a-d8eb-4667-a3cd-1952feaf3b15" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_ade54f3a-a0a6-42a4-8a9e-a8c4f287502c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_53e874b9-a5aa-4cc5-a2a2-4f8f04580eeb" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_53e874b9-a5aa-4cc5-a2a2-4f8f04580eeb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_a35baa0b-5357-4287-9d84-5442ce76eabb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_53e874b9-a5aa-4cc5-a2a2-4f8f04580eeb" xlink:to="loc_ifrs-full_GeographicalAreasAxis_a35baa0b-5357-4287-9d84-5442ce76eabb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_a35baa0b-5357-4287-9d84-5442ce76eabb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a35baa0b-5357-4287-9d84-5442ce76eabb" xlink:to="loc_ifrs-full_GeographicalAreasDomain_a35baa0b-5357-4287-9d84-5442ce76eabb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_3a72c8de-46cf-43af-954f-feca0dbdb1ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a35baa0b-5357-4287-9d84-5442ce76eabb" xlink:to="loc_ifrs-full_GeographicalAreasDomain_3a72c8de-46cf-43af-954f-feca0dbdb1ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember_d04c81d6-6caf-43bf-a823-c7bf40ef0446" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_3a72c8de-46cf-43af-954f-feca0dbdb1ba" xlink:to="loc_ifrs-full_CountryOfDomicileMember_d04c81d6-6caf-43bf-a823-c7bf40ef0446" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dee62835-9bd0-41fb-8a77-23edf72551fe" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_3a72c8de-46cf-43af-954f-feca0dbdb1ba" xlink:to="loc_country_US_dee62835-9bd0-41fb-8a77-23edf72551fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember_5cdc9586-9e52-485d-b09b-7c6dd862679f" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_3a72c8de-46cf-43af-954f-feca0dbdb1ba" xlink:to="loc_gsk_RestOfWorldMember_5cdc9586-9e52-485d-b09b-7c6dd862679f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c841a266-72e3-459c-81a2-68ce4927d089" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_53e874b9-a5aa-4cc5-a2a2-4f8f04580eeb" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c841a266-72e3-459c-81a2-68ce4927d089" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_c841a266-72e3-459c-81a2-68ce4927d089_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c841a266-72e3-459c-81a2-68ce4927d089" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_c841a266-72e3-459c-81a2-68ce4927d089_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_ce25dd97-0636-42b8-a2d0-873f24f59256" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c841a266-72e3-459c-81a2-68ce4927d089" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_ce25dd97-0636-42b8-a2d0-873f24f59256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_0670ac70-4df2-4ff3-9fa5-b710824d60b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_ce25dd97-0636-42b8-a2d0-873f24f59256" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_0670ac70-4df2-4ff3-9fa5-b710824d60b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_cd52aeb2-f785-416e-bd9c-3e38c704937e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_53e874b9-a5aa-4cc5-a2a2-4f8f04580eeb" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_cd52aeb2-f785-416e-bd9c-3e38c704937e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_cd52aeb2-f785-416e-bd9c-3e38c704937e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cd52aeb2-f785-416e-bd9c-3e38c704937e" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_cd52aeb2-f785-416e-bd9c-3e38c704937e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_165b8788-17fb-4e6d-9dab-0da6b8842d85" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cd52aeb2-f785-416e-bd9c-3e38c704937e" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_165b8788-17fb-4e6d-9dab-0da6b8842d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_d3d929ef-f104-4a4f-a8dd-b39eed4d1c04" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_165b8788-17fb-4e6d-9dab-0da6b8842d85" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_d3d929ef-f104-4a4f-a8dd-b39eed4d1c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_e61eda2a-0f35-40cb-9e6b-cd6f30c2832f" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_165b8788-17fb-4e6d-9dab-0da6b8842d85" xlink:to="loc_gsk_PostRetirementBenefitsMember_e61eda2a-0f35-40cb-9e6b-cd6f30c2832f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_d7310bf5-aac0-4025-9925-8712a0216446" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_d7310bf5-aac0-4025-9925-8712a0216446" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_b17257c6-cffd-4dd4-9dd6-6216ee4037ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_b17257c6-cffd-4dd4-9dd6-6216ee4037ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_7412b93f-f65b-4751-9639-fbf1479b1290" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_7412b93f-f65b-4751-9639-fbf1479b1290" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_ec276b74-ffdd-44af-bf16-7e97d65fd891" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_ec276b74-ffdd-44af-bf16-7e97d65fd891" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_bdb4e939-68f1-475f-87dd-13f4eb0a100a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_bdb4e939-68f1-475f-87dd-13f4eb0a100a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_2a128741-e58c-4f61-a2fc-ee71282be221" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_2a128741-e58c-4f61-a2fc-ee71282be221" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_1d7d7b8a-333c-4c5f-abaf-e6ba7383a96f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_1d7d7b8a-333c-4c5f-abaf-e6ba7383a96f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_e27334ce-2b00-4d7a-a957-ba261e4951aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_e27334ce-2b00-4d7a-a957-ba261e4951aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_4d191ea7-a96c-4bf9-8789-90ae40f204bb" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_4d191ea7-a96c-4bf9-8789-90ae40f204bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_89f6b7f4-9548-47ba-b7ca-d7e9dc594112" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_f2fef02b-65eb-4120-8460-1f2da6d73b39" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_89f6b7f4-9548-47ba-b7ca-d7e9dc594112" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_2b7593a0-d4e8-4201-8658-09904591c824" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAnalysisofDefinedBenefitPensionObligationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofAnalysisofDefinedBenefitPensionObligationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofAnalysisofDefinedBenefitPensionObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_d6429d94-8c50-43ca-8742-e88a9191a837" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_f1c9dfa1-bcbd-4222-a996-ab47bcdc5e26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_d6429d94-8c50-43ca-8742-e88a9191a837" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_f1c9dfa1-bcbd-4222-a996-ab47bcdc5e26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_9fdfe082-3d2c-4699-86cb-595cbb932556" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_f1c9dfa1-bcbd-4222-a996-ab47bcdc5e26" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_9fdfe082-3d2c-4699-86cb-595cbb932556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_9fdfe082-3d2c-4699-86cb-595cbb932556_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_9fdfe082-3d2c-4699-86cb-595cbb932556" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_9fdfe082-3d2c-4699-86cb-595cbb932556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_90d72362-54b0-41f3-8fa1-583773914a2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_9fdfe082-3d2c-4699-86cb-595cbb932556" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_90d72362-54b0-41f3-8fa1-583773914a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_bf6e36ef-a03a-4932-a098-e51795e2a539" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_90d72362-54b0-41f3-8fa1-583773914a2e" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_bf6e36ef-a03a-4932-a098-e51795e2a539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_d6e2b0cd-a907-49ac-9c7b-cbffa79f892b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_90d72362-54b0-41f3-8fa1-583773914a2e" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_d6e2b0cd-a907-49ac-9c7b-cbffa79f892b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_c94143f8-bc30-4ea1-a857-96192fd6d267" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_d6429d94-8c50-43ca-8742-e88a9191a837" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_c94143f8-bc30-4ea1-a857-96192fd6d267" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofRemeasurementsWithinPostRetirementBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_7f257876-f927-4a79-a303-983620661fc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_9304b19d-7ebe-45fc-98f2-75e76c3dd8c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_7f257876-f927-4a79-a303-983620661fc3" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_9304b19d-7ebe-45fc-98f2-75e76c3dd8c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_7513eabd-3be4-4881-9803-16edd6bdc23b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_9304b19d-7ebe-45fc-98f2-75e76c3dd8c2" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_7513eabd-3be4-4881-9803-16edd6bdc23b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_7513eabd-3be4-4881-9803-16edd6bdc23b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_7513eabd-3be4-4881-9803-16edd6bdc23b" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_7513eabd-3be4-4881-9803-16edd6bdc23b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_624a2322-0e54-4c82-8aa4-f319c5dcd7c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_7513eabd-3be4-4881-9803-16edd6bdc23b" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_624a2322-0e54-4c82-8aa4-f319c5dcd7c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_89724621-229f-43e1-b741-c04dbc9e40b0" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_624a2322-0e54-4c82-8aa4-f319c5dcd7c4" xlink:to="loc_gsk_PostRetirementBenefitsMember_89724621-229f-43e1-b741-c04dbc9e40b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_90187cf0-f1d8-488d-b4b1-71e39400fed0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_7f257876-f927-4a79-a303-983620661fc3" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_90187cf0-f1d8-488d-b4b1-71e39400fed0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_9cfb94f3-f413-4348-bba1-214f6e026fa2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_7f257876-f927-4a79-a303-983620661fc3" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_9cfb94f3-f413-4348-bba1-214f6e026fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_c26c8a28-0a62-4b0e-b3a5-3d1fcf922d9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_7f257876-f927-4a79-a303-983620661fc3" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_c26c8a28-0a62-4b0e-b3a5-3d1fcf922d9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_0c2ac5bc-b17e-42cc-b06e-7465d331e29e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_7f257876-f927-4a79-a303-983620661fc3" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_0c2ac5bc-b17e-42cc-b06e-7465d331e29e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofDefinedBenefitPensionObligationAnalysedbyMembershipCategoryDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofDefinedBenefitPensionObligationAnalysedbyMembershipCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofDefinedBenefitPensionObligationAnalysedbyMembershipCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_6a4f285c-88c2-49d2-ba17-43df6ef5cc60" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e27ffbff-619c-4761-9254-159aa6ea3871" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_6a4f285c-88c2-49d2-ba17-43df6ef5cc60" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e27ffbff-619c-4761-9254-159aa6ea3871" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_260a3dff-4aba-426e-85a4-fffd9ebd1e65" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e27ffbff-619c-4761-9254-159aa6ea3871" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_260a3dff-4aba-426e-85a4-fffd9ebd1e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_260a3dff-4aba-426e-85a4-fffd9ebd1e65_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_260a3dff-4aba-426e-85a4-fffd9ebd1e65" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_260a3dff-4aba-426e-85a4-fffd9ebd1e65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_4cf49889-3f84-4f8d-b082-3b221c719437" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_260a3dff-4aba-426e-85a4-fffd9ebd1e65" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_4cf49889-3f84-4f8d-b082-3b221c719437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationActiveMember_93612c9e-f253-4003-98e3-71452ae1d71f" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationActiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_4cf49889-3f84-4f8d-b082-3b221c719437" xlink:to="loc_gsk_DefinedBenefitObligationActiveMember_93612c9e-f253-4003-98e3-71452ae1d71f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationRetiredMember_110ad70e-4518-4fd9-930c-0dc61c7ddca9" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationRetiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_4cf49889-3f84-4f8d-b082-3b221c719437" xlink:to="loc_gsk_DefinedBenefitObligationRetiredMember_110ad70e-4518-4fd9-930c-0dc61c7ddca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationDeferredMember_5d520439-0c46-4dc4-b375-12a47ce9d48b" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationDeferredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_4cf49889-3f84-4f8d-b082-3b221c719437" xlink:to="loc_gsk_DefinedBenefitObligationDeferredMember_5d520439-0c46-4dc4-b375-12a47ce9d48b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_ed1919da-4066-4ecd-aaee-ca120a704012" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e27ffbff-619c-4761-9254-159aa6ea3871" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_ed1919da-4066-4ecd-aaee-ca120a704012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_ed1919da-4066-4ecd-aaee-ca120a704012_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_ed1919da-4066-4ecd-aaee-ca120a704012" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_ed1919da-4066-4ecd-aaee-ca120a704012_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_66b37a1d-5db5-49df-9f0a-9cdd1bc13b26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_ed1919da-4066-4ecd-aaee-ca120a704012" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_66b37a1d-5db5-49df-9f0a-9cdd1bc13b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_d6680534-848f-493d-86ef-caff8f52d65a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_66b37a1d-5db5-49df-9f0a-9cdd1bc13b26" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_d6680534-848f-493d-86ef-caff8f52d65a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_3f7767af-0ae6-478a-aa78-29d0800082cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_6a4f285c-88c2-49d2-ba17-43df6ef5cc60" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_3f7767af-0ae6-478a-aa78-29d0800082cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPostRetirementBenefitObligationAnalysedbyMembershipCategoryDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofPostRetirementBenefitObligationAnalysedbyMembershipCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofPostRetirementBenefitObligationAnalysedbyMembershipCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_aec37cf2-043e-45df-96cd-a52a6dd0ef07" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_9991a251-3187-43de-b701-666c45a024a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_aec37cf2-043e-45df-96cd-a52a6dd0ef07" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_9991a251-3187-43de-b701-666c45a024a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_440412d6-234e-4d5e-baf0-5381eda0163c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_9991a251-3187-43de-b701-666c45a024a6" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_440412d6-234e-4d5e-baf0-5381eda0163c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_440412d6-234e-4d5e-baf0-5381eda0163c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_440412d6-234e-4d5e-baf0-5381eda0163c" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_440412d6-234e-4d5e-baf0-5381eda0163c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_426274ef-1f15-4a0c-8aba-763485071ef5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_440412d6-234e-4d5e-baf0-5381eda0163c" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_426274ef-1f15-4a0c-8aba-763485071ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationActiveMember_44760f0c-3b3b-4a40-a1ca-0fc5974d075c" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationActiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_426274ef-1f15-4a0c-8aba-763485071ef5" xlink:to="loc_gsk_DefinedBenefitObligationActiveMember_44760f0c-3b3b-4a40-a1ca-0fc5974d075c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationRetiredMember_c9fceb66-f50e-4d3f-a149-8800d34a1719" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationRetiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_426274ef-1f15-4a0c-8aba-763485071ef5" xlink:to="loc_gsk_DefinedBenefitObligationRetiredMember_c9fceb66-f50e-4d3f-a149-8800d34a1719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationDeferredMember_de5803c7-f6a5-46fc-b6b1-3386f4fed8e9" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationDeferredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_426274ef-1f15-4a0c-8aba-763485071ef5" xlink:to="loc_gsk_DefinedBenefitObligationDeferredMember_de5803c7-f6a5-46fc-b6b1-3386f4fed8e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_cc784e9b-5f23-4270-9118-66b1e8930f48" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_9991a251-3187-43de-b701-666c45a024a6" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_cc784e9b-5f23-4270-9118-66b1e8930f48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_cc784e9b-5f23-4270-9118-66b1e8930f48_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cc784e9b-5f23-4270-9118-66b1e8930f48" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_cc784e9b-5f23-4270-9118-66b1e8930f48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_8b70db0f-702e-40f1-b21d-042c4683610f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cc784e9b-5f23-4270-9118-66b1e8930f48" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_8b70db0f-702e-40f1-b21d-042c4683610f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember_c163246a-5e47-42b1-b440-d7d2dd962251" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_8b70db0f-702e-40f1-b21d-042c4683610f" xlink:to="loc_gsk_PostRetirementBenefitsMember_c163246a-5e47-42b1-b440-d7d2dd962251" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_b768dbfd-7a01-4803-824b-4ce1dcb396fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_aec37cf2-043e-45df-96cd-a52a6dd0ef07" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_b768dbfd-7a01-4803-824b-4ce1dcb396fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofWeightedAverageDurationDefinedBenefitObligationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofWeightedAverageDurationDefinedBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofWeightedAverageDurationDefinedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems_8d3947c5-1a22-4951-80a1-78ebf81a4d1c" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable_72a78b12-621d-4e73-abc6-19b469257951" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems_8d3947c5-1a22-4951-80a1-78ebf81a4d1c" xlink:to="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable_72a78b12-621d-4e73-abc6-19b469257951" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_b956d618-207f-4881-b32e-fa689d9c671d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable_72a78b12-621d-4e73-abc6-19b469257951" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_b956d618-207f-4881-b32e-fa689d9c671d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_b956d618-207f-4881-b32e-fa689d9c671d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_b956d618-207f-4881-b32e-fa689d9c671d" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_b956d618-207f-4881-b32e-fa689d9c671d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_ec15175e-6aa3-422a-a0eb-dbebe4b389fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_b956d618-207f-4881-b32e-fa689d9c671d" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_ec15175e-6aa3-422a-a0eb-dbebe4b389fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember_41a47760-2827-4621-9a3d-99e17c0b56db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_ec15175e-6aa3-422a-a0eb-dbebe4b389fa" xlink:to="loc_ifrs-full_PensionDefinedBenefitPlansMember_41a47760-2827-4621-9a3d-99e17c0b56db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitMember_15c0eafe-2e7a-4575-b854-c12a384f3cee" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_ec15175e-6aa3-422a-a0eb-dbebe4b389fa" xlink:to="loc_gsk_PostRetirementBenefitMember_15c0eafe-2e7a-4575-b854-c12a384f3cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageDurationOfDefinedBenefitObligations_bd10d71b-31ea-4158-9181-501cfe579896" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageDurationOfDefinedBenefitObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems_8d3947c5-1a22-4951-80a1-78ebf81a4d1c" xlink:to="loc_gsk_WeightedAverageDurationOfDefinedBenefitObligations_bd10d71b-31ea-4158-9181-501cfe579896" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofChangesinAssumptionsUsedonBenefitObligationsDefinedBenefitPensionandPostRetirementCostsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PensionsandotherpostemploymentbenefitsSummaryofChangesinAssumptionsUsedonBenefitObligationsDefinedBenefitPensionandPostRetirementCostsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PensionsandotherpostemploymentbenefitsSummaryofChangesinAssumptionsUsedonBenefitObligationsDefinedBenefitPensionandPostRetirementCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_b396de4a-c8e0-4e65-a72b-9efea9adff26" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_b396de4a-c8e0-4e65-a72b-9efea9adff26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_eee4b378-01b8-4872-bf6a-86076a6d60ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_b396de4a-c8e0-4e65-a72b-9efea9adff26" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_eee4b378-01b8-4872-bf6a-86076a6d60ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_eee4b378-01b8-4872-bf6a-86076a6d60ea_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_eee4b378-01b8-4872-bf6a-86076a6d60ea" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_eee4b378-01b8-4872-bf6a-86076a6d60ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_8c0ac480-6492-46d0-87b6-922484db7a08" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_eee4b378-01b8-4872-bf6a-86076a6d60ea" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_8c0ac480-6492-46d0-87b6-922484db7a08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ba83f1c5-5828-4a69-ab31-1b2792d24e08" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_8c0ac480-6492-46d0-87b6-922484db7a08" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ba83f1c5-5828-4a69-ab31-1b2792d24e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_894d7dc3-7936-4bab-bd2d-4856eafae191" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_8c0ac480-6492-46d0-87b6-922484db7a08" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_894d7dc3-7936-4bab-bd2d-4856eafae191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_723ddc79-7562-4953-b33b-deb603e12403" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_8c0ac480-6492-46d0-87b6-922484db7a08" xlink:to="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_723ddc79-7562-4953-b33b-deb603e12403" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_e813d8fa-93e7-4b47-997d-588e12d5f05c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_8c0ac480-6492-46d0-87b6-922484db7a08" xlink:to="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_e813d8fa-93e7-4b47-997d-588e12d5f05c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInAssumptionsAxis_3fa6c290-fe30-46f9-9756-ede78ca6fb3b" xlink:href="gsk-20241231.xsd#gsk_ChangeInAssumptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_b396de4a-c8e0-4e65-a72b-9efea9adff26" xlink:to="loc_gsk_ChangeInAssumptionsAxis_3fa6c290-fe30-46f9-9756-ede78ca6fb3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInAssumptionsDomain_3fa6c290-fe30-46f9-9756-ede78ca6fb3b_default" xlink:href="gsk-20241231.xsd#gsk_ChangeInAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ChangeInAssumptionsAxis_3fa6c290-fe30-46f9-9756-ede78ca6fb3b" xlink:to="loc_gsk_ChangeInAssumptionsDomain_3fa6c290-fe30-46f9-9756-ede78ca6fb3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInAssumptionsDomain_a673831b-1e5c-40cd-8b94-6c8a25ed0967" xlink:href="gsk-20241231.xsd#gsk_ChangeInAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ChangeInAssumptionsAxis_3fa6c290-fe30-46f9-9756-ede78ca6fb3b" xlink:to="loc_gsk_ChangeInAssumptionsDomain_a673831b-1e5c-40cd-8b94-6c8a25ed0967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZeroPointTwoFivePercentMember_48ba6a94-e4a0-4832-8695-f40185e85773" xlink:href="gsk-20241231.xsd#gsk_ZeroPointTwoFivePercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ChangeInAssumptionsDomain_a673831b-1e5c-40cd-8b94-6c8a25ed0967" xlink:to="loc_gsk_ZeroPointTwoFivePercentMember_48ba6a94-e4a0-4832-8695-f40185e85773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZeroPointSevenFivePercentMember_f97bb057-0f46-4889-9293-a02d777b111a" xlink:href="gsk-20241231.xsd#gsk_ZeroPointSevenFivePercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ChangeInAssumptionsDomain_a673831b-1e5c-40cd-8b94-6c8a25ed0967" xlink:to="loc_gsk_ZeroPointSevenFivePercentMember_f97bb057-0f46-4889-9293-a02d777b111a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OneYearMember_9b6f6e3c-2a57-4995-87b9-40ad2f806560" xlink:href="gsk-20241231.xsd#gsk_OneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ChangeInAssumptionsDomain_a673831b-1e5c-40cd-8b94-6c8a25ed0967" xlink:to="loc_gsk_OneYearMember_9b6f6e3c-2a57-4995-87b9-40ad2f806560" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePercentMember_17530960-ff23-4669-b726-2940e35e4d5a" xlink:href="gsk-20241231.xsd#gsk_OnePercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ChangeInAssumptionsDomain_a673831b-1e5c-40cd-8b94-6c8a25ed0967" xlink:to="loc_gsk_OnePercentMember_17530960-ff23-4669-b726-2940e35e4d5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption_7998be4f-2fa9-473d-b9fb-f392a1e8d522" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption_7998be4f-2fa9-473d-b9fb-f392a1e8d522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption_8101932c-d822-43b7-b5b7-dcf2e88a6120" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption_8101932c-d822-43b7-b5b7-dcf2e88a6120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption_fe5534b5-dceb-4fea-a747-2adafb15f46f" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption_fe5534b5-dceb-4fea-a747-2adafb15f46f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption_32d22562-d2e7-427f-a805-b09705e03c57" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption_32d22562-d2e7-427f-a805-b09705e03c57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_54ad46b3-fc1d-4ec8-97de-d6d52516020b" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_54ad46b3-fc1d-4ec8-97de-d6d52516020b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_8abb0f31-31f1-4820-b6f8-625b6a644022" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_8abb0f31-31f1-4820-b6f8-625b6a644022" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_2ad58a7d-156f-409c-a87d-aa5a980d29d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_2ad58a7d-156f-409c-a87d-aa5a980d29d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c6adebf9-91ef-4eea-a09a-d9de111c3018" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_5669e6ce-5e6a-4266-bcc7-a2ceb2d4dc32" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c6adebf9-91ef-4eea-a09a-d9de111c3018" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherprovisionsSummaryofOtherProvisionsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherprovisionsSummaryofOtherProvisionsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherprovisionsSummaryofOtherProvisionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1bb6fed7-bb1c-4b0e-8934-ca6f742c7e96" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1bb6fed7-bb1c-4b0e-8934-ca6f742c7e96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_3ed64a5b-816e-49ea-8e63-c328340b1d6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1bb6fed7-bb1c-4b0e-8934-ca6f742c7e96" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_3ed64a5b-816e-49ea-8e63-c328340b1d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_3ed64a5b-816e-49ea-8e63-c328340b1d6a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_3ed64a5b-816e-49ea-8e63-c328340b1d6a" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_3ed64a5b-816e-49ea-8e63-c328340b1d6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_6e1bdaee-04a3-4870-a842-bc4504e4b13c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_3ed64a5b-816e-49ea-8e63-c328340b1d6a" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_6e1bdaee-04a3-4870-a842-bc4504e4b13c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegalAndOtherDisputesMember_3f998055-4144-4d7b-947c-c8154e4bfdee" xlink:href="gsk-20241231.xsd#gsk_LegalAndOtherDisputesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_6e1bdaee-04a3-4870-a842-bc4504e4b13c" xlink:to="loc_gsk_LegalAndOtherDisputesMember_3f998055-4144-4d7b-947c-c8154e4bfdee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember_ff9c1544-bf91-4e82-91be-de47b7534f7d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_6e1bdaee-04a3-4870-a842-bc4504e4b13c" xlink:to="loc_ifrs-full_RestructuringProvisionMember_ff9c1544-bf91-4e82-91be-de47b7534f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeRelatedProvisionsMember_34cca1c4-8b05-4321-8b8a-e0c30392720a" xlink:href="gsk-20241231.xsd#gsk_EmployeeRelatedProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_6e1bdaee-04a3-4870-a842-bc4504e4b13c" xlink:to="loc_gsk_EmployeeRelatedProvisionsMember_34cca1c4-8b05-4321-8b8a-e0c30392720a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherProvisionMember_ec8becd9-3ac3-4289-9e64-0774203159ec" xlink:href="gsk-20241231.xsd#gsk_OtherProvisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_6e1bdaee-04a3-4870-a842-bc4504e4b13c" xlink:to="loc_gsk_OtherProvisionMember_ec8becd9-3ac3-4289-9e64-0774203159ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_faa2396d-504e-40de-a282-d2146b99f74c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_OtherProvisions_faa2396d-504e-40de-a282-d2146b99f74c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_c9a5da3d-a9cc-4a18-ae2a-e4effe556a8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_c9a5da3d-a9cc-4a18-ae2a-e4effe556a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalProvisionsOtherProvisions_422f3bb2-fded-49aa-add9-f6960cfed8fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_AdditionalProvisionsOtherProvisions_422f3bb2-fded-49aa-add9-f6960cfed8fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedProvisionReversedOtherProvisions_2ff6035e-3305-42d7-a79d-fa0ac8906676" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_UnusedProvisionReversedOtherProvisions_2ff6035e-3305-42d7-a79d-fa0ac8906676" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions_23e65d44-f275-41d5-860f-409c9fd32dc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions_23e65d44-f275-41d5-860f-409c9fd32dc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_491a0179-7dad-4d00-a387-2773dd517c1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_491a0179-7dad-4d00-a387-2773dd517c1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_b36145e0-d15b-4c56-83ee-444ba991aa52" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_b36145e0-d15b-4c56-83ee-444ba991aa52" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransferToPensionObligationsOtherProvisions_e2b8ecf6-8d53-4c09-be3b-d3aa0c529447" xlink:href="gsk-20241231.xsd#gsk_TransferToPensionObligationsOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_gsk_TransferToPensionObligationsOtherProvisions_e2b8ecf6-8d53-4c09-be3b-d3aa0c529447" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_3c9b06ac-a103-41b8-be3d-c927438f818f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions_0bba1c7c-3256-45b3-a214-24315b7e1ab8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_OtherShorttermProvisions_0bba1c7c-3256-45b3-a214-24315b7e1ab8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_c8a1e75d-7022-4229-a2b8-25e09500d20e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_1b504e71-eb6f-4a99-8052-b5c6e2f0bbd6" xlink:to="loc_ifrs-full_OtherLongtermProvisions_c8a1e75d-7022-4229-a2b8-25e09500d20e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_67e27ea8-a8c2-4e29-904f-aabf335c352f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/OtherprovisionsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#OtherprovisionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/OtherprovisionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_3a095c20-008b-4c73-a8d8-33761bfc18c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_3a095c20-008b-4c73-a8d8-33761bfc18c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_641771a0-101a-4db8-a7e7-af64fd3c7fb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_3a095c20-008b-4c73-a8d8-33761bfc18c8" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_641771a0-101a-4db8-a7e7-af64fd3c7fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_641771a0-101a-4db8-a7e7-af64fd3c7fb4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_641771a0-101a-4db8-a7e7-af64fd3c7fb4" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_641771a0-101a-4db8-a7e7-af64fd3c7fb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_cec27da6-131a-401f-be49-f98f83693b9b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_641771a0-101a-4db8-a7e7-af64fd3c7fb4" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_cec27da6-131a-401f-be49-f98f83693b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegalAndOtherDisputesMember_f97fcdf5-39c2-42f0-a4a7-1b27ab31863a" xlink:href="gsk-20241231.xsd#gsk_LegalAndOtherDisputesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_cec27da6-131a-401f-be49-f98f83693b9b" xlink:to="loc_gsk_LegalAndOtherDisputesMember_f97fcdf5-39c2-42f0-a4a7-1b27ab31863a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MajorRestructuringProvisionsMember_1065d93e-3b2a-4de8-b073-4c1c7a693996" xlink:href="gsk-20241231.xsd#gsk_MajorRestructuringProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_cec27da6-131a-401f-be49-f98f83693b9b" xlink:to="loc_gsk_MajorRestructuringProvisionsMember_1065d93e-3b2a-4de8-b073-4c1c7a693996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_81e59d93-745a-458f-8022-26cbd0664309" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_3a095c20-008b-4c73-a8d8-33761bfc18c8" xlink:to="loc_srt_LitigationCaseAxis_81e59d93-745a-458f-8022-26cbd0664309" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_81e59d93-745a-458f-8022-26cbd0664309_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_81e59d93-745a-458f-8022-26cbd0664309" xlink:to="loc_srt_LitigationCaseTypeDomain_81e59d93-745a-458f-8022-26cbd0664309_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a4dcf0f8-e1a8-4a8e-95b1-f121910b5cc6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_81e59d93-745a-458f-8022-26cbd0664309" xlink:to="loc_srt_LitigationCaseTypeDomain_a4dcf0f8-e1a8-4a8e-95b1-f121910b5cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZantacMember_747fc515-5d08-4710-919b-f970bb013223" xlink:href="gsk-20241231.xsd#gsk_ZantacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a4dcf0f8-e1a8-4a8e-95b1-f121910b5cc6" xlink:to="loc_gsk_ZantacMember_747fc515-5d08-4710-919b-f970bb013223" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfIndividual1Axis_bc00c2e6-036c-4968-9769-a81368db71a5" xlink:href="gsk-20241231.xsd#gsk_TitleOfIndividual1Axis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_3a095c20-008b-4c73-a8d8-33761bfc18c8" xlink:to="loc_gsk_TitleOfIndividual1Axis_bc00c2e6-036c-4968-9769-a81368db71a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfIndividual1Domain_bc00c2e6-036c-4968-9769-a81368db71a5_default" xlink:href="gsk-20241231.xsd#gsk_TitleOfIndividual1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_TitleOfIndividual1Axis_bc00c2e6-036c-4968-9769-a81368db71a5" xlink:to="loc_gsk_TitleOfIndividual1Domain_bc00c2e6-036c-4968-9769-a81368db71a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfIndividual1Domain_bbec8001-2db6-43df-aa21-62e52145cd58" xlink:href="gsk-20241231.xsd#gsk_TitleOfIndividual1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_TitleOfIndividual1Axis_bc00c2e6-036c-4968-9769-a81368db71a5" xlink:to="loc_gsk_TitleOfIndividual1Domain_bbec8001-2db6-43df-aa21-62e52145cd58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisabledEmployeesMember_ac1cd71b-1cb1-4348-b530-999b0f677681" xlink:href="gsk-20241231.xsd#gsk_DisabledEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TitleOfIndividual1Domain_bbec8001-2db6-43df-aa21-62e52145cd58" xlink:to="loc_gsk_DisabledEmployeesMember_ac1cd71b-1cb1-4348-b530-999b0f677681" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions_b4aac6ef-b24d-4892-b312-6e7f3348ae13" xlink:href="gsk-20241231.xsd#gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions_b4aac6ef-b24d-4892-b312-6e7f3348ae13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions_cb79d9e5-060a-4233-917d-da9e42cfaaba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions_cb79d9e5-060a-4233-917d-da9e42cfaaba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermLegalProceedingsProvision_8b5b4815-b2ca-4cda-9976-8ce059455e17" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermLegalProceedingsProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_ifrs-full_ShorttermLegalProceedingsProvision_8b5b4815-b2ca-4cda-9976-8ce059455e17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfMajorRestructuringProgrammes_14f92a14-ae65-4fd8-9e2a-3f8d8e303249" xlink:href="gsk-20241231.xsd#gsk_NumberOfMajorRestructuringProgrammes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_gsk_NumberOfMajorRestructuringProgrammes_14f92a14-ae65-4fd8-9e2a-3f8d8e303249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCompaniesSplitInto_5e6f9ffb-54af-4353-ac9f-2ebaaa888c3c" xlink:href="gsk-20241231.xsd#gsk_NumberOfCompaniesSplitInto"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_gsk_NumberOfCompaniesSplitInto_5e6f9ffb-54af-4353-ac9f-2ebaaa888c3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionObligationAugmentationCosts_8ce36c70-9f59-4158-b73e-3b565e598b01" xlink:href="gsk-20241231.xsd#gsk_PensionObligationAugmentationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_gsk_PensionObligationAugmentationCosts_8ce36c70-9f59-4158-b73e-3b565e598b01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionsForEmployeeBenefits_2db74473-537c-43de-8479-812328ab8bb7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsForEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_77155d1f-5b9f-4ec6-a06c-bd6bdef900d5" xlink:to="loc_ifrs-full_ProvisionsForEmployeeBenefits_2db74473-537c-43de-8479-812328ab8bb7" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/ContingentconsiderationliabilitiesSummaryofFairValueContingentConsiderationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#ContingentconsiderationliabilitiesSummaryofFairValueContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/ContingentconsiderationliabilitiesSummaryofFairValueContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_dd8c0f41-bbd4-4aff-8786-74a5ba2b4c62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_dd8c0f41-bbd4-4aff-8786-74a5ba2b4c62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c317808b-bc5a-4f9b-8c85-8740aec76f26" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_dd8c0f41-bbd4-4aff-8786-74a5ba2b4c62" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c317808b-bc5a-4f9b-8c85-8740aec76f26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_c317808b-bc5a-4f9b-8c85-8740aec76f26_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c317808b-bc5a-4f9b-8c85-8740aec76f26" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_c317808b-bc5a-4f9b-8c85-8740aec76f26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_72f0a100-408a-48c7-aeab-ed59a1f9b2e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_c317808b-bc5a-4f9b-8c85-8740aec76f26" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_72f0a100-408a-48c7-aeab-ed59a1f9b2e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViivHealthcareMember_051991c8-be01-471c-8238-76f28cbfdde3" xlink:href="gsk-20241231.xsd#gsk_ShionogiViivHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_72f0a100-408a-48c7-aeab-ed59a1f9b2e3" xlink:to="loc_gsk_ShionogiViivHealthcareMember_051991c8-be01-471c-8238-76f28cbfdde3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxMember_8d287565-92b3-4ed1-8f5a-cb1a96802b6e" xlink:href="gsk-20241231.xsd#gsk_AffinivaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_72f0a100-408a-48c7-aeab-ed59a1f9b2e3" xlink:to="loc_gsk_AffinivaxMember_8d287565-92b3-4ed1-8f5a-cb1a96802b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisMember_d0b9795d-596b-4709-be1f-2cb995558778" xlink:href="gsk-20241231.xsd#gsk_NovartisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_72f0a100-408a-48c7-aeab-ed59a1f9b2e3" xlink:to="loc_gsk_NovartisMember_d0b9795d-596b-4709-be1f-2cb995558778" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherBusinessMember_49d98814-41ce-4bf2-8f48-533f43331210" xlink:href="gsk-20241231.xsd#gsk_OtherBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_72f0a100-408a-48c7-aeab-ed59a1f9b2e3" xlink:to="loc_gsk_OtherBusinessMember_49d98814-41ce-4bf2-8f48-533f43331210" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_4d104a30-5116-4f5d-b0c3-0f918ff8847a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_4d104a30-5116-4f5d-b0c3-0f918ff8847a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_e2168581-bdb6-478e-a609-47e3f9138d73" xlink:href="gsk-20241231.xsd#gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_e2168581-bdb6-478e-a609-47e3f9138d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination_777f1504-ff97-43d5-a209-c5165f2d0167" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination_777f1504-ff97-43d5-a209-c5165f2d0167" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_3ad38e2e-2a27-4c0f-93c7-6606037a4691" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_3ad38e2e-2a27-4c0f-93c7-6606037a4691" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid_1cdf4977-dc4d-459b-8351-5908a40b0607" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid_1cdf4977-dc4d-459b-8351-5908a40b0607" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationPaid_c2e7b715-2a60-4fd9-8f0c-55e7d99a5985" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_9be0960e-46a1-4485-9ba8-90e652f820ba" xlink:to="loc_gsk_ContingentConsiderationPaid_c2e7b715-2a60-4fd9-8f0c-55e7d99a5985" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_c22f1d56-4ba3-4f51-9a68-ab35c46e8e86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/ContingentConsiderationLiabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#ContingentConsiderationLiabilitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/ContingentConsiderationLiabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueOfContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable_1f8f14c1-e003-455a-99ab-9a799c878b42" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueOfContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:to="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable_1f8f14c1-e003-455a-99ab-9a799c878b42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e0e28e25-c9c9-4ae5-82a8-ed33b3531025" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable_1f8f14c1-e003-455a-99ab-9a799c878b42" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e0e28e25-c9c9-4ae5-82a8-ed33b3531025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_e0e28e25-c9c9-4ae5-82a8-ed33b3531025_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e0e28e25-c9c9-4ae5-82a8-ed33b3531025" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_e0e28e25-c9c9-4ae5-82a8-ed33b3531025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6d984305-19a2-418d-a80b-1974e55b7dad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e0e28e25-c9c9-4ae5-82a8-ed33b3531025" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6d984305-19a2-418d-a80b-1974e55b7dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViivHealthcareMember_b60ba9fc-4084-4a2c-80f0-a718e2e16a3f" xlink:href="gsk-20241231.xsd#gsk_ShionogiViivHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6d984305-19a2-418d-a80b-1974e55b7dad" xlink:to="loc_gsk_ShionogiViivHealthcareMember_b60ba9fc-4084-4a2c-80f0-a718e2e16a3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxMember_10f9c403-78db-4f5d-9bd3-2453ae1cca35" xlink:href="gsk-20241231.xsd#gsk_AffinivaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6d984305-19a2-418d-a80b-1974e55b7dad" xlink:to="loc_gsk_AffinivaxMember_10f9c403-78db-4f5d-9bd3-2453ae1cca35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisVaccinesMember_316a96a9-5f2b-4aba-a61e-749c077902b6" xlink:href="gsk-20241231.xsd#gsk_NovartisVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6d984305-19a2-418d-a80b-1974e55b7dad" xlink:to="loc_gsk_NovartisVaccinesMember_316a96a9-5f2b-4aba-a61e-749c077902b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_e02dcc60-02de-45de-b0e5-fd65fce3ac3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable_1f8f14c1-e003-455a-99ab-9a799c878b42" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_e02dcc60-02de-45de-b0e5-fd65fce3ac3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_e02dcc60-02de-45de-b0e5-fd65fce3ac3b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_e02dcc60-02de-45de-b0e5-fd65fce3ac3b" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_e02dcc60-02de-45de-b0e5-fd65fce3ac3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_37048beb-a014-4f74-91c6-f0f7bfdac565" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_e02dcc60-02de-45de-b0e5-fd65fce3ac3b" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_37048beb-a014-4f74-91c6-f0f7bfdac565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member_842b6f64-5a15-4943-840c-ae9004666d20" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_37048beb-a014-4f74-91c6-f0f7bfdac565" xlink:to="loc_gsk_AiolosBioInc.Member_842b6f64-5a15-4943-840c-ae9004666d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialisedProductsMember_790d980f-3ac4-480f-8a4e-6f97b0f492c5" xlink:href="gsk-20241231.xsd#gsk_CommercialisedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_37048beb-a014-4f74-91c6-f0f7bfdac565" xlink:to="loc_gsk_CommercialisedProductsMember_790d980f-3ac4-480f-8a4e-6f97b0f492c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PipelineAssetsMember_7ee2fa5d-7f01-4acb-8c22-cf73909f6420" xlink:href="gsk-20241231.xsd#gsk_PipelineAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_37048beb-a014-4f74-91c6-f0f7bfdac565" xlink:to="loc_gsk_PipelineAssetsMember_7ee2fa5d-7f01-4acb-8c22-cf73909f6420" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_86e87fda-1169-4a8f-a977-0aeab461947c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable_1f8f14c1-e003-455a-99ab-9a799c878b42" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_86e87fda-1169-4a8f-a977-0aeab461947c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_86e87fda-1169-4a8f-a977-0aeab461947c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_86e87fda-1169-4a8f-a977-0aeab461947c" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_86e87fda-1169-4a8f-a977-0aeab461947c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_716b98c1-5b1a-4f53-b8c6-389ce3df681c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_86e87fda-1169-4a8f-a977-0aeab461947c" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_716b98c1-5b1a-4f53-b8c6-389ce3df681c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationMember_a739e56b-f1dc-48ec-ac83-2b57487449c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_716b98c1-5b1a-4f53-b8c6-389ce3df681c" xlink:to="loc_ifrs-full_ContingentConsiderationMember_a739e56b-f1dc-48ec-ac83-2b57487449c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_da95f5d1-bc90-48cd-a2dd-8519092379b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_da95f5d1-bc90-48cd-a2dd-8519092379b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_a05917c2-0451-4fd8-bc6f-a8cb997e14b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_a05917c2-0451-4fd8-bc6f-a8cb997e14b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_714a337b-4da5-4133-925a-0631a7d988db" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:to="loc_ifrs-full_Liabilities_714a337b-4da5-4133-925a-0631a7d988db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationPayableDiscountedPercentage_ea620229-a4a2-4a79-bbaa-0fc6056fde58" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationPayableDiscountedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:to="loc_gsk_ContingentConsiderationPayableDiscountedPercentage_ea620229-a4a2-4a79-bbaa-0fc6056fde58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPotentialMilestonePayments_3be08ba2-e40b-40b4-bea8-5263a3ce167f" xlink:href="gsk-20241231.xsd#gsk_NumberOfPotentialMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_52b22306-1cc9-408a-9fb6-ba9e45be3091" xlink:to="loc_gsk_NumberOfPotentialMilestonePayments_3be08ba2-e40b-40b4-bea8-5263a3ce167f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/ContingentconsiderationliabilitiesDisclosureofsensitivityofkeymodelinputtomeasurecontingentconsiderationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#ContingentconsiderationliabilitiesDisclosureofsensitivityofkeymodelinputtomeasurecontingentconsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/ContingentconsiderationliabilitiesDisclosureofsensitivityofkeymodelinputtomeasurecontingentconsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_f94f25d6-b45b-4bf8-b27c-bf40bd43814a" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_f94f25d6-b45b-4bf8-b27c-bf40bd43814a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_361c317f-5dbc-44e8-a8d7-4665c615eea8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_f94f25d6-b45b-4bf8-b27c-bf40bd43814a" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_361c317f-5dbc-44e8-a8d7-4665c615eea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_361c317f-5dbc-44e8-a8d7-4665c615eea8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_361c317f-5dbc-44e8-a8d7-4665c615eea8" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_361c317f-5dbc-44e8-a8d7-4665c615eea8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_aec0e7f7-9a5a-438c-baee-d2d9fd9e83b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_361c317f-5dbc-44e8-a8d7-4665c615eea8" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_aec0e7f7-9a5a-438c-baee-d2d9fd9e83b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViivHealthcareMember_b4b17bd4-f033-4d24-b96f-7abd07358d0c" xlink:href="gsk-20241231.xsd#gsk_ShionogiViivHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_aec0e7f7-9a5a-438c-baee-d2d9fd9e83b5" xlink:to="loc_gsk_ShionogiViivHealthcareMember_b4b17bd4-f033-4d24-b96f-7abd07358d0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxMember_00e7f667-25c4-4fd9-a52a-9fd3a3888766" xlink:href="gsk-20241231.xsd#gsk_AffinivaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_aec0e7f7-9a5a-438c-baee-d2d9fd9e83b5" xlink:to="loc_gsk_AffinivaxMember_00e7f667-25c4-4fd9-a52a-9fd3a3888766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisVaccinesMember_38ac4304-19b6-4b0c-affd-e561914c957a" xlink:href="gsk-20241231.xsd#gsk_NovartisVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_aec0e7f7-9a5a-438c-baee-d2d9fd9e83b5" xlink:to="loc_gsk_NovartisVaccinesMember_38ac4304-19b6-4b0c-affd-e561914c957a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_b6b2bf6f-03d2-49af-824b-a9a37f800ab5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_f94f25d6-b45b-4bf8-b27c-bf40bd43814a" xlink:to="loc_ifrs-full_TypesOfRisksAxis_b6b2bf6f-03d2-49af-824b-a9a37f800ab5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_b6b2bf6f-03d2-49af-824b-a9a37f800ab5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_b6b2bf6f-03d2-49af-824b-a9a37f800ab5" xlink:to="loc_ifrs-full_TypesOfRisksDomain_b6b2bf6f-03d2-49af-824b-a9a37f800ab5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_b6b2bf6f-03d2-49af-824b-a9a37f800ab5" xlink:to="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember_883a4a00-68c7-46c0-b0f6-64c431966386" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember_883a4a00-68c7-46c0-b0f6-64c431966386" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember_01cbe608-b7cd-4681-ae06-925096ab3972" xlink:href="gsk-20241231.xsd#gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember_01cbe608-b7cd-4681-ae06-925096ab3972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember_35d19f03-cfbf-486f-9598-7971e3ddf1fe" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember_35d19f03-cfbf-486f-9598-7971e3ddf1fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember_a1d1dc4a-17fc-4026-86ca-74c665ba04ab" xlink:href="gsk-20241231.xsd#gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember_a1d1dc4a-17fc-4026-86ca-74c665ba04ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember_669880be-4946-4a98-88e3-4f197840b843" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember_669880be-4946-4a98-88e3-4f197840b843" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember_f3f9c98d-d6c7-4290-bae2-e2e7f1e41193" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember_f3f9c98d-d6c7-4290-bae2-e2e7f1e41193" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember_395d0dcb-a65d-46c8-9026-88228ee33ce4" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember_395d0dcb-a65d-46c8-9026-88228ee33ce4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember_db65252b-1423-4c43-9845-3acc46b0f502" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember_db65252b-1423-4c43-9845-3acc46b0f502" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_514ff64c-5b7c-41f1-8467-5e98e5f634ce" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_514ff64c-5b7c-41f1-8467-5e98e5f634ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_bc0ecaeb-386c-43c4-a819-e93178a6be66" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_bc0ecaeb-386c-43c4-a819-e93178a6be66" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember_05736297-267a-45f4-a8ab-e3a0cde159a8" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember_05736297-267a-45f4-a8ab-e3a0cde159a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_a6bc6e82-7c2e-4960-88bc-48bd34db998f" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_a6bc6e82-7c2e-4960-88bc-48bd34db998f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_070e38c5-bf79-4df6-9fe9-72f31f49c921" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_070e38c5-bf79-4df6-9fe9-72f31f49c921" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_06ebd151-836b-47a8-ba98-6024de57ebc6" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_06ebd151-836b-47a8-ba98-6024de57ebc6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_66461ea6-b8fb-4b7a-be9b-5ed6a6cf120e" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_66461ea6-b8fb-4b7a-be9b-5ed6a6cf120e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_ad51a9b8-79fe-4948-84d1-47843a7d0bd8" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_dab31f05-6ed6-4244-88c0-91ef2b6eeb5d" xlink:to="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_ad51a9b8-79fe-4948-84d1-47843a7d0bd8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInSalesForecastAmount_e4159eb8-2b46-4edf-bc2b-f34ab8bd0f2a" xlink:href="gsk-20241231.xsd#gsk_IncreaseInSalesForecastAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_IncreaseInSalesForecastAmount_e4159eb8-2b46-4edf-bc2b-f34ab8bd0f2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInSalesForecastAmount_4ddd02df-6057-4a96-9c5d-3be52dcb1e30" xlink:href="gsk-20241231.xsd#gsk_DecreaseInSalesForecastAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_DecreaseInSalesForecastAmount_4ddd02df-6057-4a96-9c5d-3be52dcb1e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInDiscountRateAmount_06c79861-f0ab-4fd7-855c-e62d55255047" xlink:href="gsk-20241231.xsd#gsk_IncreaseInDiscountRateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_IncreaseInDiscountRateAmount_06c79861-f0ab-4fd7-855c-e62d55255047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInDiscountRateAmount_1eb706c7-aee8-40d2-a411-9d7a95157a4c" xlink:href="gsk-20241231.xsd#gsk_DecreaseInDiscountRateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_DecreaseInDiscountRateAmount_1eb706c7-aee8-40d2-a411-9d7a95157a4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AppreciationOfUSDollar_46a94a09-0646-41f3-a265-75b2f8eba59c" xlink:href="gsk-20241231.xsd#gsk_AppreciationOfUSDollar"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_AppreciationOfUSDollar_46a94a09-0646-41f3-a265-75b2f8eba59c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DepreciationOfUSDollar_04ba97d4-cc90-49a2-927c-1713ab7ad0ba" xlink:href="gsk-20241231.xsd#gsk_DepreciationOfUSDollar"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_DepreciationOfUSDollar_04ba97d4-cc90-49a2-927c-1713ab7ad0ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AppreciationOfEuro_e163b250-46d7-4542-a4cd-b4f691e65d63" xlink:href="gsk-20241231.xsd#gsk_AppreciationOfEuro"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_AppreciationOfEuro_e163b250-46d7-4542-a4cd-b4f691e65d63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DepreciationOfEuro_13f61804-3a48-4d25-a01d-2b3934cdcd79" xlink:href="gsk-20241231.xsd#gsk_DepreciationOfEuro"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_DepreciationOfEuro_13f61804-3a48-4d25-a01d-2b3934cdcd79" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess_2dda01f4-7117-4d99-9242-1b299505443d" xlink:href="gsk-20241231.xsd#gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess_2dda01f4-7117-4d99-9242-1b299505443d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TenPercentDecreaseInProbabilityOfMilestoneSuccess_bd39fcd6-014c-4d4d-8a43-35bf4ea784b4" xlink:href="gsk-20241231.xsd#gsk_TenPercentDecreaseInProbabilityOfMilestoneSuccess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_373716a7-03bc-4094-a852-dfe90094b41a" xlink:to="loc_gsk_TenPercentDecreaseInProbabilityOfMilestoneSuccess_bd39fcd6-014c-4d4d-8a43-35bf4ea784b4" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/CommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#CommitmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/CommitmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_d3488250-0639-4fc2-9d63-41440e39d178" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_6db9223c-f72b-4adb-9ef5-da6274987b34" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_d3488250-0639-4fc2-9d63-41440e39d178" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_6db9223c-f72b-4adb-9ef5-da6274987b34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CategoriesOfCommitmentsAxis_cde0f037-4845-47f3-950e-aeaea5b9001f" xlink:href="gsk-20241231.xsd#gsk_CategoriesOfCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_6db9223c-f72b-4adb-9ef5-da6274987b34" xlink:to="loc_gsk_CategoriesOfCommitmentsAxis_cde0f037-4845-47f3-950e-aeaea5b9001f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CategoriesOfCommitmentsDomain_cde0f037-4845-47f3-950e-aeaea5b9001f_default" xlink:href="gsk-20241231.xsd#gsk_CategoriesOfCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_CategoriesOfCommitmentsAxis_cde0f037-4845-47f3-950e-aeaea5b9001f" xlink:to="loc_gsk_CategoriesOfCommitmentsDomain_cde0f037-4845-47f3-950e-aeaea5b9001f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CategoriesOfCommitmentsDomain_a89f4400-39c0-4ce5-a94f-abb092c644d4" xlink:href="gsk-20241231.xsd#gsk_CategoriesOfCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_CategoriesOfCommitmentsAxis_cde0f037-4845-47f3-950e-aeaea5b9001f" xlink:to="loc_gsk_CategoriesOfCommitmentsDomain_a89f4400-39c0-4ce5-a94f-abb092c644d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarbonRemovalProjectsMember_7f3286ad-9d07-4bc3-a962-63c112c74f96" xlink:href="gsk-20241231.xsd#gsk_CarbonRemovalProjectsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CategoriesOfCommitmentsDomain_a89f4400-39c0-4ce5-a94f-abb092c644d4" xlink:to="loc_gsk_CarbonRemovalProjectsMember_7f3286ad-9d07-4bc3-a962-63c112c74f96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LowerCarbonPropellantMember_9ba0d39a-f76f-43a4-94df-f8f64d1b09c6" xlink:href="gsk-20241231.xsd#gsk_LowerCarbonPropellantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_CategoriesOfCommitmentsDomain_a89f4400-39c0-4ce5-a94f-abb092c644d4" xlink:to="loc_gsk_LowerCarbonPropellantMember_9ba0d39a-f76f-43a4-94df-f8f64d1b09c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContractualObligationsAndCommitments_f7e550db-aeb1-489c-8155-4559522fd8bc" xlink:href="gsk-20241231.xsd#gsk_ContractualObligationsAndCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_d3488250-0639-4fc2-9d63-41440e39d178" xlink:to="loc_gsk_ContractualObligationsAndCommitments_f7e550db-aeb1-489c-8155-4559522fd8bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/SharecapitalandsharepremiumaccountAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#SharecapitalandsharepremiumaccountAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/SharecapitalandsharepremiumaccountAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0b15a764-e0fd-4a99-b108-c040312bcc02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0b15a764-e0fd-4a99-b108-c040312bcc02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1113372a-6ccd-4369-8183-d6d821cac594" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0b15a764-e0fd-4a99-b108-c040312bcc02" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1113372a-6ccd-4369-8183-d6d821cac594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1113372a-6ccd-4369-8183-d6d821cac594_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1113372a-6ccd-4369-8183-d6d821cac594" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1113372a-6ccd-4369-8183-d6d821cac594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_9d85e375-d41d-4148-9422-17c068feddbc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1113372a-6ccd-4369-8183-d6d821cac594" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_9d85e375-d41d-4148-9422-17c068feddbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_79bf7fd0-026a-4c80-808d-50641788bd3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_9d85e375-d41d-4148-9422-17c068feddbc" xlink:to="loc_ifrs-full_OrdinarySharesMember_79bf7fd0-026a-4c80-808d-50641788bd3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_423c6ca7-5a85-4040-bce6-1d0a8f62b3df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0b15a764-e0fd-4a99-b108-c040312bcc02" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_423c6ca7-5a85-4040-bce6-1d0a8f62b3df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_423c6ca7-5a85-4040-bce6-1d0a8f62b3df_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_423c6ca7-5a85-4040-bce6-1d0a8f62b3df" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_423c6ca7-5a85-4040-bce6-1d0a8f62b3df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_423c6ca7-5a85-4040-bce6-1d0a8f62b3df" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember_d94662c8-262d-49cb-9cc7-c0adb66e0b8c" xlink:href="gsk-20241231.xsd#gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:to="loc_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember_d94662c8-262d-49cb-9cc7-c0adb66e0b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeShareOwnershipPlanMember_ded26c72-1b2c-4865-884a-8510bdac1e1b" xlink:href="gsk-20241231.xsd#gsk_EmployeeShareOwnershipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:to="loc_gsk_EmployeeShareOwnershipPlanMember_ded26c72-1b2c-4865-884a-8510bdac1e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember_413d2fc2-8d8b-4d82-b1c7-6a1e3816136e" xlink:href="gsk-20241231.xsd#gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_EmployeeShareOwnershipPlanMember_ded26c72-1b2c-4865-884a-8510bdac1e1b" xlink:to="loc_gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember_413d2fc2-8d8b-4d82-b1c7-6a1e3816136e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExecutiveSupplementalSavingsPlanMember_6f272bce-d5a1-468d-82b0-74fde6d4d6a8" xlink:href="gsk-20241231.xsd#gsk_ExecutiveSupplementalSavingsPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:to="loc_gsk_ExecutiveSupplementalSavingsPlanMember_6f272bce-d5a1-468d-82b0-74fde6d4d6a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_19a43458-f2c9-402c-97a5-782ef7ca8e5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:to="loc_ifrs-full_TreasurySharesMember_19a43458-f2c9-402c-97a5-782ef7ca8e5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FreeIssueMember_d7853754-faff-4df2-93c7-b2d7f0c62a8d" xlink:href="gsk-20241231.xsd#gsk_FreeIssueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_c1424a6a-3d4d-4d1c-842b-60f998d81adc" xlink:to="loc_gsk_FreeIssueMember_d7853754-faff-4df2-93c7-b2d7f0c62a8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SharesReceivedForEveryFiveExistingShares_ec79a69e-8562-4491-8177-bc0d6402958f" xlink:href="gsk-20241231.xsd#gsk_SharesReceivedForEveryFiveExistingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:to="loc_gsk_SharesReceivedForEveryFiveExistingShares_ec79a69e-8562-4491-8177-bc0d6402958f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_a4507d43-4ff5-439b-ab55-337127af0157" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:to="loc_ifrs-full_ParValuePerShare_a4507d43-4ff5-439b-ab55-337127af0157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SurrenderedSharesForEveryFourNewSharesReceived_9c3f2137-2369-4a9c-ba56-ec5f08dd8440" xlink:href="gsk-20241231.xsd#gsk_SurrenderedSharesForEveryFourNewSharesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:to="loc_gsk_SurrenderedSharesForEveryFourNewSharesReceived_9c3f2137-2369-4a9c-ba56-ec5f08dd8440" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares_b4df72ec-18f8-4534-b1c1-d8c2443089be" xlink:href="gsk-20241231.xsd#gsk_ParValueOfSharesSurrenderedInLieuOfNewShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:to="loc_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares_b4df72ec-18f8-4534-b1c1-d8c2443089be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_c0f68fb8-6f3c-4f53-83a5-e0063d1acbbf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_d2a1c72c-637c-47c4-b4f9-ebf82cf34f97" xlink:to="loc_ifrs-full_NumberOfSharesIssued_c0f68fb8-6f3c-4f53-83a5-e0063d1acbbf" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/SharecapitalandsharepremiumaccountSummaryofShareCapitalandSharePremiumDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#SharecapitalandsharepremiumaccountSummaryofShareCapitalandSharePremiumDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/SharecapitalandsharepremiumaccountSummaryofShareCapitalandSharePremiumDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4ba758c1-2a6f-4322-a3e3-bc2cd723b2c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4ba758c1-2a6f-4322-a3e3-bc2cd723b2c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_7ba143c4-fe57-4197-b9b1-7ef854c4a4f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4ba758c1-2a6f-4322-a3e3-bc2cd723b2c0" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_7ba143c4-fe57-4197-b9b1-7ef854c4a4f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_7ba143c4-fe57-4197-b9b1-7ef854c4a4f6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_7ba143c4-fe57-4197-b9b1-7ef854c4a4f6" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_7ba143c4-fe57-4197-b9b1-7ef854c4a4f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_5b914e6c-cec0-474e-8e20-235c343fba87" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_7ba143c4-fe57-4197-b9b1-7ef854c4a4f6" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_5b914e6c-cec0-474e-8e20-235c343fba87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_356797e5-310d-4329-b981-c74cbde0db24" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_5b914e6c-cec0-474e-8e20-235c343fba87" xlink:to="loc_ifrs-full_IssuedCapitalMember_356797e5-310d-4329-b981-c74cbde0db24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_d1b3c3b4-80bb-4bef-b31b-cda9b7479681" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_5b914e6c-cec0-474e-8e20-235c343fba87" xlink:to="loc_ifrs-full_SharePremiumMember_d1b3c3b4-80bb-4bef-b31b-cda9b7479681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_4d7f2470-fb60-4cf0-ac7a-7b7f1c0acb90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4ba758c1-2a6f-4322-a3e3-bc2cd723b2c0" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_4d7f2470-fb60-4cf0-ac7a-7b7f1c0acb90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_4d7f2470-fb60-4cf0-ac7a-7b7f1c0acb90_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4d7f2470-fb60-4cf0-ac7a-7b7f1c0acb90" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_4d7f2470-fb60-4cf0-ac7a-7b7f1c0acb90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_3175926d-0957-42dd-a84a-ca2c4784c1da" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4d7f2470-fb60-4cf0-ac7a-7b7f1c0acb90" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_3175926d-0957-42dd-a84a-ca2c4784c1da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_d69464d7-2095-433b-a98b-3dbadbe2b573" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_3175926d-0957-42dd-a84a-ca2c4784c1da" xlink:to="loc_ifrs-full_OrdinarySharesMember_d69464d7-2095-433b-a98b-3dbadbe2b573" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssuedAndFullyPaid_d9f770eb-619b-4ee6-bfb4-407da2bc8ba7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_ifrs-full_NumberOfSharesIssuedAndFullyPaid_d9f770eb-619b-4ee6-bfb4-407da2bc8ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation_8c3e8ae1-0fab-4bc9-bfab-f46b9b866342" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation_8c3e8ae1-0fab-4bc9-bfab-f46b9b866342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes_587b356f-572b-4f06-9295-5a4047d1e4cb" xlink:href="gsk-20241231.xsd#gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes_587b356f-572b-4f06-9295-5a4047d1e4cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts_beb85173-fe24-47e1-837c-d06ffc45879f" xlink:href="gsk-20241231.xsd#gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts_beb85173-fe24-47e1-837c-d06ffc45879f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssuedAndFullyPaid_a34713b4-ee2c-476a-9e6a-fffbd371dfad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_ef57a4ab-e2a3-40c2-bcd5-4de5a0d3010f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_ifrs-full_Equity_ef57a4ab-e2a3-40c2-bcd5-4de5a0d3010f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity_dfa93a5a-5160-4690-9753-29dce0d853c0" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughConsolidatingSharesEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity_dfa93a5a-5160-4690-9753-29dce0d853c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_afa8266e-8fdb-48ff-8dd0-f4abcc6e5660" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_ifrs-full_IssueOfEquity_afa8266e-8fdb-48ff-8dd0-f4abcc6e5660" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_21bd492c-b623-4937-acd4-b751649e9a4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_a325c216-0f57-442a-aae9-65819aa68eaf" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_21bd492c-b623-4937-acd4-b751649e9a4a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_0f8a7e45-4781-4598-99c3-aad09b58c95a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MovementsinEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MovementsinEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MovementsinEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_9d2a3c56-e17a-4a71-ba8b-18c6e099325c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_6ed67e48-972a-4612-ba1a-cbc9efe75469" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_9d2a3c56-e17a-4a71-ba8b-18c6e099325c" xlink:to="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_6ed67e48-972a-4612-ba1a-cbc9efe75469" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_4de3314d-dd85-4b27-8a05-43a7bc65b38a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_6ed67e48-972a-4612-ba1a-cbc9efe75469" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_4de3314d-dd85-4b27-8a05-43a7bc65b38a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_4de3314d-dd85-4b27-8a05-43a7bc65b38a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_4de3314d-dd85-4b27-8a05-43a7bc65b38a" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_4de3314d-dd85-4b27-8a05-43a7bc65b38a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_7f3c087b-f2bb-4e42-ab24-14d4c83effb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_4de3314d-dd85-4b27-8a05-43a7bc65b38a" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_7f3c087b-f2bb-4e42-ab24-14d4c83effb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssociatesAndJointVenturesMember_7fadc530-9ee9-4d91-8674-dc7e131bb0da" xlink:href="gsk-20241231.xsd#gsk_AssociatesAndJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_7f3c087b-f2bb-4e42-ab24-14d4c83effb2" xlink:to="loc_gsk_AssociatesAndJointVenturesMember_7fadc530-9ee9-4d91-8674-dc7e131bb0da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousComponentsOfEquityAxis_1a052af5-cb57-42c3-8a4b-fe488eae6099" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_6ed67e48-972a-4612-ba1a-cbc9efe75469" xlink:to="loc_gsk_MiscellaneousComponentsOfEquityAxis_1a052af5-cb57-42c3-8a4b-fe488eae6099" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousComponentsOfEquityDomain_1a052af5-cb57-42c3-8a4b-fe488eae6099_default" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_MiscellaneousComponentsOfEquityAxis_1a052af5-cb57-42c3-8a4b-fe488eae6099" xlink:to="loc_gsk_MiscellaneousComponentsOfEquityDomain_1a052af5-cb57-42c3-8a4b-fe488eae6099_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousComponentsOfEquityDomain_ce282fef-3da2-4f32-ae4e-ad0e9f03dcea" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_MiscellaneousComponentsOfEquityAxis_1a052af5-cb57-42c3-8a4b-fe488eae6099" xlink:to="loc_gsk_MiscellaneousComponentsOfEquityDomain_ce282fef-3da2-4f32-ae4e-ad0e9f03dcea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonDistributableMergerAndPreMergerReservesMember_af61b328-3709-483a-9fe9-6c3247c55d03" xlink:href="gsk-20241231.xsd#gsk_NonDistributableMergerAndPreMergerReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_MiscellaneousComponentsOfEquityDomain_ce282fef-3da2-4f32-ae4e-ad0e9f03dcea" xlink:to="loc_gsk_NonDistributableMergerAndPreMergerReservesMember_af61b328-3709-483a-9fe9-6c3247c55d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalRedemptionReserveMember_460528a2-bb93-4506-ae41-0ec197f6c0c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalRedemptionReserveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_MiscellaneousComponentsOfEquityDomain_ce282fef-3da2-4f32-ae4e-ad0e9f03dcea" xlink:to="loc_ifrs-full_CapitalRedemptionReserveMember_460528a2-bb93-4506-ae41-0ec197f6c0c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RetainedEarningsAndOtherReserves_b82529f7-ac64-4b35-993d-b0573e3d8ce8" xlink:href="gsk-20241231.xsd#gsk_RetainedEarningsAndOtherReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_9d2a3c56-e17a-4a71-ba8b-18c6e099325c" xlink:to="loc_gsk_RetainedEarningsAndOtherReserves_b82529f7-ac64-4b35-993d-b0573e3d8ce8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_db343607-0543-42bb-811a-f86c071a635b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_9d2a3c56-e17a-4a71-ba8b-18c6e099325c" xlink:to="loc_ifrs-full_OtherReserves_db343607-0543-42bb-811a-f86c071a635b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MovementsinEquitySummaryofCumulativeTranslationExchangeinEquityDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MovementsinEquitySummaryofCumulativeTranslationExchangeinEquityDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MovementsinEquitySummaryofCumulativeTranslationExchangeinEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_cb9fe4f1-785a-418d-bed7-22483c116978" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:to="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_cb9fe4f1-785a-418d-bed7-22483c116978" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_0b55ab78-aa27-43d9-a28a-c81f6f03d875" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_cb9fe4f1-785a-418d-bed7-22483c116978" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_0b55ab78-aa27-43d9-a28a-c81f6f03d875" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_0b55ab78-aa27-43d9-a28a-c81f6f03d875_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_0b55ab78-aa27-43d9-a28a-c81f6f03d875" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_0b55ab78-aa27-43d9-a28a-c81f6f03d875_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_529d16d1-3a14-4596-89e1-f8ea49dab392" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_0b55ab78-aa27-43d9-a28a-c81f6f03d875" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_529d16d1-3a14-4596-89e1-f8ea49dab392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_738ff808-b39d-44de-9c17-d663a964cf0b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_529d16d1-3a14-4596-89e1-f8ea49dab392" xlink:to="loc_ifrs-full_RetainedEarningsMember_738ff808-b39d-44de-9c17-d663a964cf0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueReserveMember_06777504-8e09-4051-baee-9bbf77d5939b" xlink:href="gsk-20241231.xsd#gsk_FairValueReserveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_529d16d1-3a14-4596-89e1-f8ea49dab392" xlink:to="loc_gsk_FairValueReserveMember_06777504-8e09-4051-baee-9bbf77d5939b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_b0417399-567a-4241-9a51-4278d70331d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_529d16d1-3a14-4596-89e1-f8ea49dab392" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_b0417399-567a-4241-9a51-4278d70331d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EventAxis_3987496a-808e-43df-8894-831f641ac835" xlink:href="gsk-20241231.xsd#gsk_EventAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_cb9fe4f1-785a-418d-bed7-22483c116978" xlink:to="loc_gsk_EventAxis_3987496a-808e-43df-8894-831f641ac835" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EventDomain_3987496a-808e-43df-8894-831f641ac835_default" xlink:href="gsk-20241231.xsd#gsk_EventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_EventAxis_3987496a-808e-43df-8894-831f641ac835" xlink:to="loc_gsk_EventDomain_3987496a-808e-43df-8894-831f641ac835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EventDomain_43820706-8823-4ce1-a3a7-d8fc3a2853a1" xlink:href="gsk-20241231.xsd#gsk_EventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_EventAxis_3987496a-808e-43df-8894-831f641ac835" xlink:to="loc_gsk_EventDomain_43820706-8823-4ce1-a3a7-d8fc3a2853a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DemergerMember_476e40ae-25d7-4b68-bb76-20e8fa3e7dc9" xlink:href="gsk-20241231.xsd#gsk_DemergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_EventDomain_43820706-8823-4ce1-a3a7-d8fc3a2853a1" xlink:to="loc_gsk_DemergerMember_476e40ae-25d7-4b68-bb76-20e8fa3e7dc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationAxis_14bcd3e4-fb33-4ce7-9d40-620ec581f96f" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_cb9fe4f1-785a-418d-bed7-22483c116978" xlink:to="loc_gsk_ContinuingAndDiscontinuedOperationAxis_14bcd3e4-fb33-4ce7-9d40-620ec581f96f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationDomain_14bcd3e4-fb33-4ce7-9d40-620ec581f96f_default" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationAxis_14bcd3e4-fb33-4ce7-9d40-620ec581f96f" xlink:to="loc_gsk_ContinuingAndDiscontinuedOperationDomain_14bcd3e4-fb33-4ce7-9d40-620ec581f96f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationDomain_53d37483-5097-40e6-848d-deb602838b94" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationAxis_14bcd3e4-fb33-4ce7-9d40-620ec581f96f" xlink:to="loc_gsk_ContinuingAndDiscontinuedOperationDomain_53d37483-5097-40e6-848d-deb602838b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConsumerHealthcareBusinessMember_d76cd4f5-1a0f-47ab-b7b5-ed7a7d593070" xlink:href="gsk-20241231.xsd#gsk_ConsumerHealthcareBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationDomain_53d37483-5097-40e6-848d-deb602838b94" xlink:to="loc_gsk_ConsumerHealthcareBusinessMember_d76cd4f5-1a0f-47ab-b7b5-ed7a7d593070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_97a69149-ce07-4e6c-8bfb-455a5ad8521e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_cb9fe4f1-785a-418d-bed7-22483c116978" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_97a69149-ce07-4e6c-8bfb-455a5ad8521e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingOperationsMember_97a69149-ce07-4e6c-8bfb-455a5ad8521e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_97a69149-ce07-4e6c-8bfb-455a5ad8521e" xlink:to="loc_ifrs-full_ContinuingOperationsMember_97a69149-ce07-4e6c-8bfb-455a5ad8521e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingOperationsMember_50960953-fa90-4169-b870-a08b433883d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_97a69149-ce07-4e6c-8bfb-455a5ad8521e" xlink:to="loc_ifrs-full_ContinuingOperationsMember_50960953-fa90-4169-b870-a08b433883d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_7e441b05-d387-40a7-8e43-c4246840972b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContinuingOperationsMember_50960953-fa90-4169-b870-a08b433883d5" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_7e441b05-d387-40a7-8e43-c4246840972b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_d22d89fc-05c0-4622-a59d-6c088a51b84f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_d22d89fc-05c0-4622-a59d-6c088a51b84f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_c9c5f2e0-e9c4-4393-a59e-575943f77765" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_c9c5f2e0-e9c4-4393-a59e-575943f77765" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_47a167c5-a00f-44c8-88b8-111061938247" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_47a167c5-a00f-44c8-88b8-111061938247" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementInTranslationExchangeAttributableToContinuingOperations_d41db43a-8ba6-40f8-9793-87ff3bfc53be" xlink:href="gsk-20241231.xsd#gsk_MovementInTranslationExchangeAttributableToContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:to="loc_gsk_MovementInTranslationExchangeAttributableToContinuingOperations_d41db43a-8ba6-40f8-9793-87ff3bfc53be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations_2b6b7687-a038-43b5-b573-80158ea64e33" xlink:href="gsk-20241231.xsd#gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_32cc1431-7a88-46b8-9d72-5b219201ede2" xlink:to="loc_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations_2b6b7687-a038-43b5-b573-80158ea64e33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_8806d414-45d2-4847-bb98-88fdea92475c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherComprehensiveIncomebyEquityCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_90c740d6-5bdf-467e-ab39-a411395cd3f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:to="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_90c740d6-5bdf-467e-ab39-a411395cd3f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_4758907a-d22c-4c2a-ba2b-73e8a87d3314" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_90c740d6-5bdf-467e-ab39-a411395cd3f3" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_4758907a-d22c-4c2a-ba2b-73e8a87d3314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_4758907a-d22c-4c2a-ba2b-73e8a87d3314_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_4758907a-d22c-4c2a-ba2b-73e8a87d3314" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_4758907a-d22c-4c2a-ba2b-73e8a87d3314_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_a8969b79-e5e6-49a5-9b1d-34d2b1b44b0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_4758907a-d22c-4c2a-ba2b-73e8a87d3314" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_a8969b79-e5e6-49a5-9b1d-34d2b1b44b0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_aa2dfda6-4cef-4fa8-8e77-81f8d0475c4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a8969b79-e5e6-49a5-9b1d-34d2b1b44b0f" xlink:to="loc_ifrs-full_RetainedEarningsMember_aa2dfda6-4cef-4fa8-8e77-81f8d0475c4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_4e1c083e-b27c-4913-a93c-09be60663e5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a8969b79-e5e6-49a5-9b1d-34d2b1b44b0f" xlink:to="loc_ifrs-full_OtherReservesMember_4e1c083e-b27c-4913-a93c-09be60663e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_95009c3d-356e-48ce-ab6a-f84d5d6693c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a8969b79-e5e6-49a5-9b1d-34d2b1b44b0f" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_95009c3d-356e-48ce-ab6a-f84d5d6693c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_b0515e49-113a-48fd-a55e-08daee3987ae" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:to="loc_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_b0515e49-113a-48fd-a55e-08daee3987ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_e3de3282-2a3d-4dff-8118-3c5dadb0167e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_e3de3282-2a3d-4dff-8118-3c5dadb0167e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_1bc1f9d8-d399-4366-96c6-3605cf1d46d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_1bc1f9d8-d399-4366-96c6-3605cf1d46d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_da5d6fe4-df9d-4337-b14f-3fd460e6e092" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_da5d6fe4-df9d-4337-b14f-3fd460e6e092" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_2dfd208d-d5bc-4e9c-a9c6-7e91a9c2328e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:to="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_2dfd208d-d5bc-4e9c-a9c6-7e91a9c2328e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_3419855f-5f53-4999-9540-fee811bbc6b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_945cb408-bfb3-4c5e-be98-d19359560c84" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_3419855f-5f53-4999-9540-fee811bbc6b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_c9ca30cc-e975-4ff7-aad7-f106be5364e5" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:to="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_c9ca30cc-e975-4ff7-aad7-f106be5364e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_4516cccb-333b-4454-8673-be7fe4e6c5fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_4516cccb-333b-4454-8673-be7fe4e6c5fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_8bf2e289-7a52-4e41-b99c-e13bd94cb42b" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:to="loc_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_8bf2e289-7a52-4e41-b99c-e13bd94cb42b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_e1be3ef5-b086-4495-b47b-465f37c08713" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_e1be3ef5-b086-4495-b47b-465f37c08713" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_674a5c67-8833-4c31-8a16-a1be470f5add" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:to="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_674a5c67-8833-4c31-8a16-a1be470f5add" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_89d157df-f62c-4390-b6de-bd5c668559ce" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_78011aa3-fb21-4f3d-b823-ec0cd6377993" xlink:to="loc_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_89d157df-f62c-4390-b6de-bd5c668559ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_da9bfe92-9fda-45f9-8bec-26f4d8c648fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:to="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations_da9bfe92-9fda-45f9-8bec-26f4d8c648fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations_eb380079-a38e-41d2-92ab-72ee4524887f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:to="loc_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations_eb380079-a38e-41d2-92ab-72ee4524887f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_fc94e16a-d491-420a-b731-411e18225a4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1593c28f-2705-44e7-9663-39e82724675c" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_fc94e16a-d491-420a-b731-411e18225a4b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherReservesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#MovementsinEquityAnalysisofOtherReservesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/MovementsinEquityAnalysisofOtherReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_e50e9369-e24f-4b63-ba30-919e3733abbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_e50e9369-e24f-4b63-ba30-919e3733abbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_310f6b6e-5c18-484d-9643-130c1d22cdce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable_e50e9369-e24f-4b63-ba30-919e3733abbd" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_310f6b6e-5c18-484d-9643-130c1d22cdce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_310f6b6e-5c18-484d-9643-130c1d22cdce_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_310f6b6e-5c18-484d-9643-130c1d22cdce" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_310f6b6e-5c18-484d-9643-130c1d22cdce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_310f6b6e-5c18-484d-9643-130c1d22cdce" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EsopTrustMember_b59a5d51-9027-4e47-9fa0-7764c28baea7" xlink:href="gsk-20241231.xsd#gsk_EsopTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:to="loc_gsk_EsopTrustMember_b59a5d51-9027-4e47-9fa0-7764c28baea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueReserveMember_3ccbed69-34b7-489b-a032-6b500d73b0c3" xlink:href="gsk-20241231.xsd#gsk_FairValueReserveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:to="loc_gsk_FairValueReserveMember_3ccbed69-34b7-489b-a032-6b500d73b0c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesMember_52bad1e6-4c88-4b96-a52c-50d48f551ba7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:to="loc_ifrs-full_ReserveOfCashFlowHedgesMember_52bad1e6-4c88-4b96-a52c-50d48f551ba7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherReservesMember_7406f04d-907e-4bda-a293-ce6136927ab0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:to="loc_ifrs-full_MiscellaneousOtherReservesMember_7406f04d-907e-4bda-a293-ce6136927ab0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_002ae16f-d763-4c91-87d3-60f430908d4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a6155230-8127-4e1b-8207-12aa5d44e63a" xlink:to="loc_ifrs-full_OtherReservesMember_002ae16f-d763-4c91-87d3-60f430908d4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_6854aab9-e211-49a3-b239-c8a7ad371d5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_ifrs-full_OtherReserves_6854aab9-e211-49a3-b239-c8a7ad371d5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeAdjustments_bddb6015-717b-4994-857e-c42d4a56cf9c" xlink:href="gsk-20241231.xsd#gsk_ExchangeAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_ExchangeAdjustments_bddb6015-717b-4994-857e-c42d4a56cf9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments_e3c5f27f-f4c9-4e31-a8ec-75e2380e2e6c" xlink:href="gsk-20241231.xsd#gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments_e3c5f27f-f4c9-4e31-a8ec-75e2380e2e6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BalanceAmountDerecognisedOnDemerger_1dfc32be-fdce-47c4-99f9-86b79d5ac007" xlink:href="gsk-20241231.xsd#gsk_BalanceAmountDerecognisedOnDemerger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_BalanceAmountDerecognisedOnDemerger_1dfc32be-fdce-47c4-99f9-86b79d5ac007" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_8aa7688e-0de1-4a88-af0a-9fae0be5eae0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_8aa7688e-0de1-4a88-af0a-9fae0be5eae0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingGainLossTransferredToNonFinancialAssets_b8dde26b-faaa-4a39-a96f-854289c07a49" xlink:href="gsk-20241231.xsd#gsk_HedgingGainLossTransferredToNonFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_HedgingGainLossTransferredToNonFinancialAssets_b8dde26b-faaa-4a39-a96f-854289c07a49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostOfHedgedItemAttributableToHedgedRisk_eabdab67-ce0b-4495-823c-970b62c31efd" xlink:href="gsk-20241231.xsd#gsk_CostOfHedgedItemAttributableToHedgedRisk"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_CostOfHedgedItemAttributableToHedgedRisk_eabdab67-ce0b-4495-823c-970b62c31efd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovements_3b9a8516-a256-4f47-a7e8-03afa141df84" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_NetFairValueMovements_3b9a8516-a256-4f47-a7e8-03afa141df84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves_7ca06975-9da1-4f03-8b18-5aa314770a1f" xlink:href="gsk-20241231.xsd#gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves_7ca06975-9da1-4f03-8b18-5aa314770a1f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan_c872f3d6-562d-4b04-92ef-65410492e345" xlink:href="gsk-20241231.xsd#gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_19e96284-4444-4f83-a53e-147bb12507d9" xlink:to="loc_gsk_WriteDownOfSharesHeldByEmployeeStockOwnershipPlan_c872f3d6-562d-4b04-92ef-65410492e345" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_15469825-b3df-480e-bd55-af91da30660c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/NoncontrollinginterestsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#NoncontrollinginterestsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/NoncontrollinginterestsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_c15f5f06-03db-40f8-9df6-c62fccb2027e" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNoncontrollingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNoncontrollingInterestsTable_15e6deb9-27cd-483b-9c4d-8ceca6a91d60" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNoncontrollingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_c15f5f06-03db-40f8-9df6-c62fccb2027e" xlink:to="loc_gsk_DisclosureOfNoncontrollingInterestsTable_15e6deb9-27cd-483b-9c4d-8ceca6a91d60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_8d6175ea-088a-4255-b062-6382eca25525" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsTable_15e6deb9-27cd-483b-9c4d-8ceca6a91d60" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_8d6175ea-088a-4255-b062-6382eca25525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_8d6175ea-088a-4255-b062-6382eca25525_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_8d6175ea-088a-4255-b062-6382eca25525" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_8d6175ea-088a-4255-b062-6382eca25525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_04a0ca96-90f5-44a9-a253-3f9ec6c46f1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_8d6175ea-088a-4255-b062-6382eca25525" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_04a0ca96-90f5-44a9-a253-3f9ec6c46f1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthCareMember_ab8eebf9-e280-48ad-97e7-99348f46c032" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_04a0ca96-90f5-44a9-a253-3f9ec6c46f1d" xlink:to="loc_gsk_ViiVHealthCareMember_ab8eebf9-e280-48ad-97e7-99348f46c032" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_cfe3349a-fe67-4ebb-a07c-68caeb1f63e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_c15f5f06-03db-40f8-9df6-c62fccb2027e" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_cfe3349a-fe67-4ebb-a07c-68caeb1f63e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_9f68d98d-11d6-475b-8a53-a8d3834b7336" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_c15f5f06-03db-40f8-9df6-c62fccb2027e" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_9f68d98d-11d6-475b-8a53-a8d3834b7336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition_b1c93c65-bd96-4ac0-8c36-42f41fe583e6" xlink:href="gsk-20241231.xsd#gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_c15f5f06-03db-40f8-9df6-c62fccb2027e" xlink:to="loc_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition_b1c93c65-bd96-4ac0-8c36-42f41fe583e6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/NoncontrollinginterestsSummarisedFinancialInformationofViiVHealthcareGroupandGSKConsumerHealthcareJointVentureDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#NoncontrollinginterestsSummarisedFinancialInformationofViiVHealthcareGroupandGSKConsumerHealthcareJointVentureDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/NoncontrollinginterestsSummarisedFinancialInformationofViiVHealthcareGroupandGSKConsumerHealthcareJointVentureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNoncontrollingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNoncontrollingInterestsTable_747038f5-ffe7-47cb-88e1-2b3473c18a64" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNoncontrollingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_gsk_DisclosureOfNoncontrollingInterestsTable_747038f5-ffe7-47cb-88e1-2b3473c18a64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_52d03a21-c3bb-46f7-a499-2b5c72cd2075" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsTable_747038f5-ffe7-47cb-88e1-2b3473c18a64" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_52d03a21-c3bb-46f7-a499-2b5c72cd2075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_52d03a21-c3bb-46f7-a499-2b5c72cd2075_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_52d03a21-c3bb-46f7-a499-2b5c72cd2075" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_52d03a21-c3bb-46f7-a499-2b5c72cd2075_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_80150e24-a0ea-4653-9278-27a2722cbb11" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_52d03a21-c3bb-46f7-a499-2b5c72cd2075" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_80150e24-a0ea-4653-9278-27a2722cbb11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthCareMember_7afbf068-c8e9-4983-9f55-972747e5ae64" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_80150e24-a0ea-4653-9278-27a2722cbb11" xlink:to="loc_gsk_ViiVHealthCareMember_7afbf068-c8e9-4983-9f55-972747e5ae64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_52397528-f54e-449f-8036-4780600551ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_Revenue_52397528-f54e-449f-8036-4780600551ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_a438964f-d476-454c-a2bb-456e191a59d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_a438964f-d476-454c-a2bb-456e191a59d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_bcaad539-aa03-4ffa-af8d-43c82359710d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_bcaad539-aa03-4ffa-af8d-43c82359710d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_3598dfd5-14ff-48d2-b328-cc1e7f3388ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_3598dfd5-14ff-48d2-b328-cc1e7f3388ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_ea0244bf-c1ad-438c-8c54-0605e4fe1d62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_NoncurrentAssets_ea0244bf-c1ad-438c-8c54-0605e4fe1d62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_7896377f-19a5-4781-8dae-0dd8329e3b3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_CurrentAssets_7896377f-19a5-4781-8dae-0dd8329e3b3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_67d3973e-7598-4fd8-bd3c-d02e84a416bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_Assets_67d3973e-7598-4fd8-bd3c-d02e84a416bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_1c7e894c-18ac-46f9-bf79-d325e6d1f2ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_CurrentLiabilities_1c7e894c-18ac-46f9-bf79-d325e6d1f2ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_f14a00ad-13d6-4829-b19e-789b53d1f2ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_NoncurrentLiabilities_f14a00ad-13d6-4829-b19e-789b53d1f2ed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_3316f0ee-c207-4c8c-b2b4-c3a33270dd9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_Liabilities_3316f0ee-c207-4c8c-b2b4-c3a33270dd9a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities_fab2c357-550a-4359-b73c-350789515bd9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_NetAssetsLiabilities_fab2c357-550a-4359-b73c-350789515bd9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_76360e02-4df2-4b95-8bef-6845417701a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_76360e02-4df2-4b95-8bef-6845417701a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_97cd3e77-207e-41ec-a53f-5ad128019cae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_97cd3e77-207e-41ec-a53f-5ad128019cae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_c99c1079-d9e4-4d13-accf-2f01b56b793b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_c99c1079-d9e4-4d13-accf-2f01b56b793b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInCashAndBankOverdrafts_10ff581e-3dc9-4c77-8249-ffa865447a18" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInCashAndBankOverdrafts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems_ed979287-b938-45d1-9de3-29d96ad5b3b7" xlink:to="loc_gsk_IncreaseDecreaseInCashAndBankOverdrafts_10ff581e-3dc9-4c77-8249-ffa865447a18" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/NoncontrollinginterestsAmountsAttributableToJointVenturesIncludedinGSKResultsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#NoncontrollinginterestsAmountsAttributableToJointVenturesIncludedinGSKResultsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/NoncontrollinginterestsAmountsAttributableToJointVenturesIncludedinGSKResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNonControllingInterestsLineItems_bcf99af0-656a-4b53-9359-83b77a757f49" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNonControllingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNoncontrollingInterestsTable_9086f7b1-8492-4aea-9075-29674d503d18" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNoncontrollingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfNonControllingInterestsLineItems_bcf99af0-656a-4b53-9359-83b77a757f49" xlink:to="loc_gsk_DisclosureOfNoncontrollingInterestsTable_9086f7b1-8492-4aea-9075-29674d503d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_d431d0c6-1f0e-4f64-8cc1-07c6fa8a84d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsTable_9086f7b1-8492-4aea-9075-29674d503d18" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_d431d0c6-1f0e-4f64-8cc1-07c6fa8a84d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_d431d0c6-1f0e-4f64-8cc1-07c6fa8a84d4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_d431d0c6-1f0e-4f64-8cc1-07c6fa8a84d4" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_d431d0c6-1f0e-4f64-8cc1-07c6fa8a84d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_b2b027e0-e6b0-43e1-be89-d02687c41730" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_d431d0c6-1f0e-4f64-8cc1-07c6fa8a84d4" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_b2b027e0-e6b0-43e1-be89-d02687c41730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthCareMember_e879ae4e-507d-4895-b9c6-93752f5e7ab3" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_b2b027e0-e6b0-43e1-be89-d02687c41730" xlink:to="loc_gsk_ViiVHealthCareMember_e879ae4e-507d-4895-b9c6-93752f5e7ab3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_fe33e4b2-3d20-4d2d-8e49-11839948f71b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNonControllingInterestsLineItems_bcf99af0-656a-4b53-9359-83b77a757f49" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_fe33e4b2-3d20-4d2d-8e49-11839948f71b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterests_3c6f4e0a-4630-4b25-99d8-352d1dc3fbe1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNonControllingInterestsLineItems_bcf99af0-656a-4b53-9359-83b77a757f49" xlink:to="loc_ifrs-full_DividendsPaidToNoncontrollingInterests_3c6f4e0a-4630-4b25-99d8-352d1dc3fbe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests_9ea67f15-d79d-4ac1-8de1-cf18d7e01b1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfNonControllingInterestsLineItems_bcf99af0-656a-4b53-9359-83b77a757f49" xlink:to="loc_ifrs-full_NoncontrollingInterests_9ea67f15-d79d-4ac1-8de1-cf18d7e01b1d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/RelatedpartytransactionsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#RelatedpartytransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/RelatedpartytransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_be427ae1-590b-4f77-98fe-9007838509d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_40d7df33-541a-4cde-ae0d-2cab2f688136" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_be427ae1-590b-4f77-98fe-9007838509d6" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_40d7df33-541a-4cde-ae0d-2cab2f688136" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8a1e3d63-c7af-48a4-8e1e-f1a8502a8e41" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_40d7df33-541a-4cde-ae0d-2cab2f688136" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8a1e3d63-c7af-48a4-8e1e-f1a8502a8e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_8a1e3d63-c7af-48a4-8e1e-f1a8502a8e41_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8a1e3d63-c7af-48a4-8e1e-f1a8502a8e41" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_8a1e3d63-c7af-48a4-8e1e-f1a8502a8e41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7a59c769-a73f-409f-9ce5-0a0666f130e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8a1e3d63-c7af-48a4-8e1e-f1a8502a8e41" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7a59c769-a73f-409f-9ce5-0a0666f130e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IndexVenturesMember_af2ba641-599a-4293-b75e-2eb312c2cdeb" xlink:href="gsk-20241231.xsd#gsk_IndexVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7a59c769-a73f-409f-9ce5-0a0666f130e6" xlink:to="loc_gsk_IndexVenturesMember_af2ba641-599a-4293-b75e-2eb312c2cdeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MedicxiVenturesILimitedPartnerMember_995f4ce0-3c0f-4c7a-ba0a-e1f85774bd26" xlink:href="gsk-20241231.xsd#gsk_MedicxiVenturesILimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_7a59c769-a73f-409f-9ce5-0a0666f130e6" xlink:to="loc_gsk_MedicxiVenturesILimitedPartnerMember_995f4ce0-3c0f-4c7a-ba0a-e1f85774bd26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions_f8377711-4464-4974-9185-524320ab2e90" xlink:href="gsk-20241231.xsd#gsk_LoansReceivableMadeByEntityRelatedPartyTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_be427ae1-590b-4f77-98fe-9007838509d6" xlink:to="loc_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions_f8377711-4464-4974-9185-524320ab2e90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentIncome_8bea1838-38f3-4025-aef6-004356535435" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_be427ae1-590b-4f77-98fe-9007838509d6" xlink:to="loc_ifrs-full_InvestmentIncome_8bea1838-38f3-4025-aef6-004356535435" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_d4baff6b-de14-4822-9e76-f57826837b2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_d4baff6b-de14-4822-9e76-f57826837b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_d4baff6b-de14-4822-9e76-f57826837b2d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_d4baff6b-de14-4822-9e76-f57826837b2d" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_d4baff6b-de14-4822-9e76-f57826837b2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_d4baff6b-de14-4822-9e76-f57826837b2d" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member_b1f6d8af-7022-4ffc-a2ae-4236f0da9f46" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:to="loc_gsk_AiolosBioInc.Member_b1f6d8af-7022-4ffc-a2ae-4236f0da9f46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ElsieBiotechnologiesMember_bacb4cab-578b-44f9-b669-d47f37d46b92" xlink:href="gsk-20241231.xsd#gsk_ElsieBiotechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:to="loc_gsk_ElsieBiotechnologiesMember_bacb4cab-578b-44f9-b669-d47f37d46b92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BellusMember_7d4a75c5-9290-4b1a-ad55-29c8f7123fad" xlink:href="gsk-20241231.xsd#gsk_BellusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:to="loc_gsk_BellusMember_7d4a75c5-9290-4b1a-ad55-29c8f7123fad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxIncMember_76851ed7-e1dd-47cd-ad4f-d2484ad83600" xlink:href="gsk-20241231.xsd#gsk_AffinivaxIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:to="loc_gsk_AffinivaxIncMember_76851ed7-e1dd-47cd-ad4f-d2484ad83600" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SierraOncologyIncMember_68128ad1-b4fa-41c3-96d1-f7053ebcd6f1" xlink:href="gsk-20241231.xsd#gsk_SierraOncologyIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:to="loc_gsk_SierraOncologyIncMember_68128ad1-b4fa-41c3-96d1-f7053ebcd6f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSaudiArabiaLimitedMember_3c924529-a3d3-4109-9b1f-d74c653d8da3" xlink:href="gsk-20241231.xsd#gsk_GlaxoSaudiArabiaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_20606008-f6ff-44f1-a119-56a4b402a8d2" xlink:to="loc_gsk_GlaxoSaudiArabiaLimitedMember_3c924529-a3d3-4109-9b1f-d74c653d8da3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_ec153fd7-b1c0-4de9-8b47-ec2941f35327" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_ec153fd7-b1c0-4de9-8b47-ec2941f35327" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_ec153fd7-b1c0-4de9-8b47-ec2941f35327_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ec153fd7-b1c0-4de9-8b47-ec2941f35327" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_ec153fd7-b1c0-4de9-8b47-ec2941f35327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_eab5dbd2-f8a4-47bd-83d4-d925228dcde6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ec153fd7-b1c0-4de9-8b47-ec2941f35327" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_eab5dbd2-f8a4-47bd-83d4-d925228dcde6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_4fe733cd-2fda-4423-9cc8-c359d19fd666" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_eab5dbd2-f8a4-47bd-83d4-d925228dcde6" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_4fe733cd-2fda-4423-9cc8-c359d19fd666" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_ddd09f4b-ef17-493d-bf87-5cb72b331b9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_eab5dbd2-f8a4-47bd-83d4-d925228dcde6" xlink:to="loc_ifrs-full_GoodwillMember_ddd09f4b-ef17-493d-bf87-5cb72b331b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_3f873346-ab76-4ec7-ad14-b68ae155b60d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_3f873346-ab76-4ec7-ad14-b68ae155b60d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_3f873346-ab76-4ec7-ad14-b68ae155b60d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_3f873346-ab76-4ec7-ad14-b68ae155b60d" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_3f873346-ab76-4ec7-ad14-b68ae155b60d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_80ae862f-8587-41d7-b42f-413057e01b4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_3f873346-ab76-4ec7-ad14-b68ae155b60d" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_80ae862f-8587-41d7-b42f-413057e01b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxationMember_89c6215b-cbb5-46fb-875c-3ce94cb8dffd" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_80ae862f-8587-41d7-b42f-413057e01b4a" xlink:to="loc_gsk_DeferredTaxationMember_89c6215b-cbb5-46fb-875c-3ce94cb8dffd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentAxis_b8f4087d-1854-4b46-b377-5e9e6ea68e5f" xlink:href="gsk-20241231.xsd#gsk_InvestmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_gsk_InvestmentAxis_b8f4087d-1854-4b46-b377-5e9e6ea68e5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentDomain_b8f4087d-1854-4b46-b377-5e9e6ea68e5f_default" xlink:href="gsk-20241231.xsd#gsk_InvestmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_InvestmentAxis_b8f4087d-1854-4b46-b377-5e9e6ea68e5f" xlink:to="loc_gsk_InvestmentDomain_b8f4087d-1854-4b46-b377-5e9e6ea68e5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentDomain_8774bc0e-a75c-48af-9cec-efcf8ef4d50e" xlink:href="gsk-20241231.xsd#gsk_InvestmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_InvestmentAxis_b8f4087d-1854-4b46-b377-5e9e6ea68e5f" xlink:to="loc_gsk_InvestmentDomain_8774bc0e-a75c-48af-9cec-efcf8ef4d50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HaleonPlcMember_fd89a9e2-b9da-44de-b206-5472546b3577" xlink:href="gsk-20241231.xsd#gsk_HaleonPlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_InvestmentDomain_8774bc0e-a75c-48af-9cec-efcf8ef4d50e" xlink:to="loc_gsk_HaleonPlcMember_fd89a9e2-b9da-44de-b206-5472546b3577" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_2468c82f-14b4-4a07-a03f-e00ffe19af96" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_srt_OwnershipAxis_2468c82f-14b4-4a07-a03f-e00ffe19af96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2468c82f-14b4-4a07-a03f-e00ffe19af96_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_2468c82f-14b4-4a07-a03f-e00ffe19af96" xlink:to="loc_srt_OwnershipDomain_2468c82f-14b4-4a07-a03f-e00ffe19af96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_2468c82f-14b4-4a07-a03f-e00ffe19af96" xlink:to="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskAggregateHoldingMember_c02ed824-b83d-44d6-9a7f-a3462b367ba3" xlink:href="gsk-20241231.xsd#gsk_GskAggregateHoldingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:to="loc_gsk_GskAggregateHoldingMember_c02ed824-b83d-44d6-9a7f-a3462b367ba3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskShareholdersMember_a1429f7c-dcaf-4192-8536-44710493c649" xlink:href="gsk-20241231.xsd#gsk_GskShareholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:to="loc_gsk_GskShareholdersMember_a1429f7c-dcaf-4192-8536-44710493c649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskAndGsksConsolidatedEsotTrustsMember_1af41055-e3c3-4fc3-b664-0fe81b21dfa9" xlink:href="gsk-20241231.xsd#gsk_GskAndGsksConsolidatedEsotTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:to="loc_gsk_GskAndGsksConsolidatedEsotTrustsMember_1af41055-e3c3-4fc3-b664-0fe81b21dfa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ScottishLimitedPartnershipsMember_6f7ff4de-dcc9-4369-8192-dc5cc6d682f6" xlink:href="gsk-20241231.xsd#gsk_ScottishLimitedPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:to="loc_gsk_ScottishLimitedPartnershipsMember_6f7ff4de-dcc9-4369-8192-dc5cc6d682f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskHoldingMember_a17a7d66-289b-41a9-bb2d-985176777674" xlink:href="gsk-20241231.xsd#gsk_GskHoldingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f9f481cf-69e2-4056-b1ac-3a72efa10d99" xlink:to="loc_gsk_GskHoldingMember_a17a7d66-289b-41a9-bb2d-985176777674" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationAxis_55fd746e-2194-4450-a63b-c2e118243c05" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_gsk_ContinuingAndDiscontinuedOperationAxis_55fd746e-2194-4450-a63b-c2e118243c05" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationDomain_55fd746e-2194-4450-a63b-c2e118243c05_default" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationAxis_55fd746e-2194-4450-a63b-c2e118243c05" xlink:to="loc_gsk_ContinuingAndDiscontinuedOperationDomain_55fd746e-2194-4450-a63b-c2e118243c05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationDomain_cbd4379e-b2f1-4bd9-96a7-4996dc22198c" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationAxis_55fd746e-2194-4450-a63b-c2e118243c05" xlink:to="loc_gsk_ContinuingAndDiscontinuedOperationDomain_cbd4379e-b2f1-4bd9-96a7-4996dc22198c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConsumerHealthcareBusinessMember_2b043fbe-9b59-49e9-a035-5e76f2ffd218" xlink:href="gsk-20241231.xsd#gsk_ConsumerHealthcareBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationDomain_cbd4379e-b2f1-4bd9-96a7-4996dc22198c" xlink:to="loc_gsk_ConsumerHealthcareBusinessMember_2b043fbe-9b59-49e9-a035-5e76f2ffd218" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_aa6fc47c-87b7-407a-8b58-1b6c39d8fdac" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_761132f1-cdd7-4782-9a22-299ae63b5e35" xlink:to="loc_dei_LegalEntityAxis_aa6fc47c-87b7-407a-8b58-1b6c39d8fdac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_aa6fc47c-87b7-407a-8b58-1b6c39d8fdac_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_aa6fc47c-87b7-407a-8b58-1b6c39d8fdac" xlink:to="loc_dei_EntityDomain_aa6fc47c-87b7-407a-8b58-1b6c39d8fdac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9507dabf-4592-4ad4-9e94-b1932c21b7af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_aa6fc47c-87b7-407a-8b58-1b6c39d8fdac" xlink:to="loc_dei_EntityDomain_9507dabf-4592-4ad4-9e94-b1932c21b7af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PfizerMember_383640f0-75be-4742-baa2-292f30d0e72c" xlink:href="gsk-20241231.xsd#gsk_PfizerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9507dabf-4592-4ad4-9e94-b1932c21b7af" xlink:to="loc_gsk_PfizerMember_383640f0-75be-4742-baa2-292f30d0e72c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_03dcbe48-580b-4328-a1a6-b8f9d084a90b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_03dcbe48-580b-4328-a1a6-b8f9d084a90b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_da5ce64b-300f-4704-9420-5d8efc67993c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_da5ce64b-300f-4704-9420-5d8efc67993c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationMaximumPotentialMilestonePayment_c43a70ec-3abe-423f-9727-04c851c249e7" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationMaximumPotentialMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_BusinessCombinationMaximumPotentialMilestonePayment_c43a70ec-3abe-423f-9727-04c851c249e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_559b8652-387c-4c45-808a-3068afc43a1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_559b8652-387c-4c45-808a-3068afc43a1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1a5e8d14-6f35-43f9-ab5c-f8159733737a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1a5e8d14-6f35-43f9-ab5c-f8159733737a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_ab87c531-c7ad-45c1-8f81-2ae3e52e7a79" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_ab87c531-c7ad-45c1-8f81-2ae3e52e7a79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2d61c285-4533-44aa-9ed1-0c55937a783a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2d61c285-4533-44aa-9ed1-0c55937a783a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_6ca851ed-3385-42f0-9536-e167d5edede7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_6ca851ed-3385-42f0-9536-e167d5edede7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare_252b0ccd-552c-402f-b54c-aaa69a39987f" xlink:href="gsk-20241231.xsd#gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare_252b0ccd-552c-402f-b54c-aaa69a39987f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_601b2d32-66a2-4fe2-b209-4d468f78c68d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_601b2d32-66a2-4fe2-b209-4d468f78c68d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration_5df96c84-f6ed-4771-872d-a479e7d6da98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration_5df96c84-f6ed-4771-872d-a479e7d6da98" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred_f102e54f-1898-4f4e-a4ee-75751d2ad3d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_CashTransferred_f102e54f-1898-4f4e-a4ee-75751d2ad3d5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PaymentsMadeForTransactionCostsAndOther_524c97dc-57bb-4af2-b754-daf880367380" xlink:href="gsk-20241231.xsd#gsk_PaymentsMadeForTransactionCostsAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_PaymentsMadeForTransactionCostsAndOther_524c97dc-57bb-4af2-b754-daf880367380" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPotentialMilestonePayments_bc9d942e-a3a8-46a9-a97b-f2a50d2bdca8" xlink:href="gsk-20241231.xsd#gsk_NumberOfPotentialMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_NumberOfPotentialMilestonePayments_bc9d942e-a3a8-46a9-a97b-f2a50d2bdca8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche_a83f29af-5595-412c-b4d0-23eb1f564a5f" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationPotentialMilestonePaymentPerTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche_a83f29af-5595-412c-b4d0-23eb1f564a5f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired_d938b875-b657-489f-b349-424cfdb1341d" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired_d938b875-b657-489f-b349-424cfdb1341d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationConsiderationPayableForStepAcquisition_e7776292-306f-489d-b8bc-802a5343b7a3" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationConsiderationPayableForStepAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_BusinessCombinationConsiderationPayableForStepAcquisition_e7776292-306f-489d-b8bc-802a5343b7a3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfOwnershipDivested_9aacbd0c-f633-4d1b-9fb0-767739eb2c60" xlink:href="gsk-20241231.xsd#gsk_PercentageOfOwnershipDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_PercentageOfOwnershipDivested_9aacbd0c-f633-4d1b-9fb0-767739eb2c60" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageofGSKHolding_e278de5d-97a9-4f48-aea3-8536248f9e77" xlink:href="gsk-20241231.xsd#gsk_PercentageofGSKHolding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_PercentageofGSKHolding_e278de5d-97a9-4f48-aea3-8536248f9e77" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfOwnershipDistributed_58f2523c-8139-4b43-9c23-7ca6ee602425" xlink:href="gsk-20241231.xsd#gsk_PercentageOfOwnershipDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_PercentageOfOwnershipDistributed_58f2523c-8139-4b43-9c23-7ca6ee602425" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest_b391de6b-054a-408a-80fa-81bc00bb1e4a" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest_b391de6b-054a-408a-80fa-81bc00bb1e4a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiabilityEliminatedOnDemerger_7524392b-e95e-4e0a-95dc-c471c400b308" xlink:href="gsk-20241231.xsd#gsk_LiabilityEliminatedOnDemerger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_LiabilityEliminatedOnDemerger_7524392b-e95e-4e0a-95dc-c471c400b308" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendFundedByDebtFinancing_7c8c88b7-a6c3-4216-889f-41af5b976970" xlink:href="gsk-20241231.xsd#gsk_DividendFundedByDebtFinancing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_DividendFundedByDebtFinancing_7c8c88b7-a6c3-4216-889f-41af5b976970" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendFundedByDebtFinancingAttributableToGsk_03cf16e7-f146-49af-a002-f9af182fd93d" xlink:href="gsk-20241231.xsd#gsk_DividendFundedByDebtFinancingAttributableToGsk"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_DividendFundedByDebtFinancingAttributableToGsk_03cf16e7-f146-49af-a002-f9af182fd93d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsDistributedFromCashBalance_05e734d5-f235-43ec-b68d-15c963f35c1a" xlink:href="gsk-20241231.xsd#gsk_DividendsDistributedFromCashBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_DividendsDistributedFromCashBalance_05e734d5-f235-43ec-b68d-15c963f35c1a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsDistributedFromCashBalanceAttributableToGsk_f9e619f0-40d1-4b04-a8ba-4733db456bb8" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_DividendsDistributedFromCashBalanceAttributableToGsk_f9e619f0-40d1-4b04-a8ba-4733db456bb8" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheAssetsDistributed_06c7de99-e5d5-4df1-b04f-4728ad7ae580" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheAssetsDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_FairValueOfTheAssetsDistributed_06c7de99-e5d5-4df1-b04f-4728ad7ae580" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount_8f1de395-2c9a-4eae-b945-c7858eb7c9a2" xlink:href="gsk-20241231.xsd#gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount_8f1de395-2c9a-4eae-b945-c7858eb7c9a2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionalGainOnRemeasurementOfRetainedStake_54386d7b-39b2-41d0-ad1c-d0be79eb9fba" xlink:href="gsk-20241231.xsd#gsk_AdditionalGainOnRemeasurementOfRetainedStake"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_AdditionalGainOnRemeasurementOfRetainedStake_54386d7b-39b2-41d0-ad1c-d0be79eb9fba" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfHolding_198360ef-d4e4-4987-9c30-6f34ebae7b0f" xlink:href="gsk-20241231.xsd#gsk_FairValueOfHolding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_FairValueOfHolding_198360ef-d4e4-4987-9c30-6f34ebae7b0f" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves_9a183fdf-1768-4caa-9fd9-6a179195cdfe" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves_9a183fdf-1768-4caa-9fd9-6a179195cdfe" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerOfDiscontinuedOperation_764b8d00-3f10-4a07-b3b0-4a259f4cdcbd" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_gsk_GainOnDemergerOfDiscontinuedOperation_764b8d00-3f10-4a07-b3b0-4a259f4cdcbd" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_bfabf687-5b35-4925-907b-a3059f84e50f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3fef6a87-9c96-475e-9462-f9f0cbd75819" xlink:to="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_bfabf687-5b35-4925-907b-a3059f84e50f" xlink:type="arc" order="32"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValuesoftheAssetsAcquiredinBusinessCombinationsIncludingGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b923d3aa-a98b-4adb-b25c-d76a4c0763ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b923d3aa-a98b-4adb-b25c-d76a4c0763ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_ef1849ca-356d-443e-9620-54de53fd53d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b923d3aa-a98b-4adb-b25c-d76a4c0763ee" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_ef1849ca-356d-443e-9620-54de53fd53d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_ef1849ca-356d-443e-9620-54de53fd53d1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_ef1849ca-356d-443e-9620-54de53fd53d1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_ef1849ca-356d-443e-9620-54de53fd53d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_412459ee-354b-4ec0-aa8a-72e5d46d10fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_ef1849ca-356d-443e-9620-54de53fd53d1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_412459ee-354b-4ec0-aa8a-72e5d46d10fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member_1c239d2c-f30a-4b79-add3-62c3d3be0a47" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_412459ee-354b-4ec0-aa8a-72e5d46d10fd" xlink:to="loc_gsk_AiolosBioInc.Member_1c239d2c-f30a-4b79-add3-62c3d3be0a47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BellusMember_ec4aa5e2-ebb9-4817-bbc3-41e3b607ee1e" xlink:href="gsk-20241231.xsd#gsk_BellusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_412459ee-354b-4ec0-aa8a-72e5d46d10fd" xlink:to="loc_gsk_BellusMember_ec4aa5e2-ebb9-4817-bbc3-41e3b607ee1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SierraOncologyMember_885783fd-604c-4599-b052-48377263022a" xlink:href="gsk-20241231.xsd#gsk_SierraOncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_412459ee-354b-4ec0-aa8a-72e5d46d10fd" xlink:to="loc_gsk_SierraOncologyMember_885783fd-604c-4599-b052-48377263022a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxMember_dd5a7529-f169-46d0-9ee2-654325b6247a" xlink:href="gsk-20241231.xsd#gsk_AffinivaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_412459ee-354b-4ec0-aa8a-72e5d46d10fd" xlink:to="loc_gsk_AffinivaxMember_dd5a7529-f169-46d0-9ee2-654325b6247a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:href="gsk-20241231.xsd#gsk_NetAssetsAcquiredAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_c613595c-c49a-43b1-b6a7-b866dd8be1c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_c613595c-c49a-43b1-b6a7-b866dd8be1c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_33e58a4a-3621-4614-b1d1-ff69faa384cc" xlink:href="gsk-20241231.xsd#gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_33e58a4a-3621-4614-b1d1-ff69faa384cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_bea635d3-69e9-43bc-bde9-48720a519629" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_bea635d3-69e9-43bc-bde9-48720a519629" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_d4d9fbbc-d62a-45ac-847a-2770d14e0fc4" xlink:href="gsk-20241231.xsd#gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_d4d9fbbc-d62a-45ac-847a-2770d14e0fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_bf983814-d691-431a-a391-4d8b0de7957e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_bf983814-d691-431a-a391-4d8b0de7957e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_1135d9cd-90ea-42a8-97ce-4d69ea35e41a" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_1135d9cd-90ea-42a8-97ce-4d69ea35e41a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_bc76917e-567a-49ab-889c-320eef4eb16e" xlink:href="gsk-20241231.xsd#gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_bc76917e-567a-49ab-889c-320eef4eb16e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_46b31020-104d-4b44-ac81-3a518aed9fd6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_46b31020-104d-4b44-ac81-3a518aed9fd6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate_200cb463-e919-4c7c-9653-d356e5b24f04" xlink:href="gsk-20241231.xsd#gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_gsk_LeaseLiabilitiesRecognizedAsOfAcquisitionDate_200cb463-e919-4c7c-9653-d356e5b24f04" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_47f02cd2-87af-4a00-b27b-f993eaa4b28a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_47f02cd2-87af-4a00-b27b-f993eaa4b28a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_4c68ab9a-68b9-4fb3-a2ef-ddc8171c4040" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_4c68ab9a-68b9-4fb3-a2ef-ddc8171c4040" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxationRecognizedAsOfAcquisitionDate_8381a162-cd82-4d19-ae3c-596b32911946" xlink:href="gsk-20241231.xsd#gsk_TaxationRecognizedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_gsk_TaxationRecognizedAsOfAcquisitionDate_8381a162-cd82-4d19-ae3c-596b32911946" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_7631537d-1cd4-4ca9-a9b1-39d9c4ca0e5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_NetAssetsAcquiredAbstract_277b2485-8d41-409e-ba36-7336003a5c5d" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_7631537d-1cd4-4ca9-a9b1-39d9c4ca0e5f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_928ddd2d-5c1d-47aa-9ded-8057ffe10605" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_928ddd2d-5c1d-47aa-9ded-8057ffe10605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_ed8ddd6a-89ad-4949-bd4f-6948e2402e9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_ed8ddd6a-89ad-4949-bd4f-6948e2402e9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_d003bc60-cf2a-4ec0-94f6-e801fa624662" xlink:href="gsk-20241231.xsd#gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_d003bc60-cf2a-4ec0-94f6-e801fa624662" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_b313575b-d6ad-4f70-a2fa-abdb508de261" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_b313575b-d6ad-4f70-a2fa-abdb508de261" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_c6e215d1-c196-4697-aa4b-1d8d7c995da1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_b60c549a-233e-40f7-a095-6931fdbe72e7" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_c6e215d1-c196-4697-aa4b-1d8d7c995da1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofCashFlowsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_f1d1ccaa-fea4-420f-8fd1-ed18e519c4f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_f1d1ccaa-fea4-420f-8fd1-ed18e519c4f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_f0e281f2-3252-4690-a2c9-26188448eac8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_f1d1ccaa-fea4-420f-8fd1-ed18e519c4f1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_f0e281f2-3252-4690-a2c9-26188448eac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_f0e281f2-3252-4690-a2c9-26188448eac8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_f0e281f2-3252-4690-a2c9-26188448eac8" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_f0e281f2-3252-4690-a2c9-26188448eac8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_534921c4-d4fa-4dec-b2d6-93fc03b4bb2c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_f0e281f2-3252-4690-a2c9-26188448eac8" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_534921c4-d4fa-4dec-b2d6-93fc03b4bb2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsMember_f54fc8bf-edd7-43c4-a1b9-9959ba65ab99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_534921c4-d4fa-4dec-b2d6-93fc03b4bb2c" xlink:to="loc_ifrs-full_BusinessCombinationsMember_f54fc8bf-edd7-43c4-a1b9-9959ba65ab99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalForAllBusinessDivesturesMember_a6744569-e604-400f-9a82-1fff4f74bba6" xlink:href="gsk-20241231.xsd#gsk_TotalForAllBusinessDivesturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_534921c4-d4fa-4dec-b2d6-93fc03b4bb2c" xlink:to="loc_gsk_TotalForAllBusinessDivesturesMember_a6744569-e604-400f-9a82-1fff4f74bba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalForAllBusinessDivesturesDemergerMember_49f295e9-646a-40c2-bb90-bff67821b93c" xlink:href="gsk-20241231.xsd#gsk_TotalForAllBusinessDivesturesDemergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TotalForAllBusinessDivesturesMember_a6744569-e604-400f-9a82-1fff4f74bba6" xlink:to="loc_gsk_TotalForAllBusinessDivesturesDemergerMember_49f295e9-646a-40c2-bb90-bff67821b93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalForAllBusinessDivesturesOtherMember_1a112c73-1066-4c91-9b8e-5ccc278cf360" xlink:href="gsk-20241231.xsd#gsk_TotalForAllBusinessDivesturesOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TotalForAllBusinessDivesturesMember_a6744569-e604-400f-9a82-1fff4f74bba6" xlink:to="loc_gsk_TotalForAllBusinessDivesturesOtherMember_1a112c73-1066-4c91-9b8e-5ccc278cf360" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_dc6d2f61-a619-4cee-8579-ddc8df29c015" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_dc6d2f61-a619-4cee-8579-ddc8df29c015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredConsiderationReceivedPaid_496d2c76-fcd8-4334-98c5-04c1ad4b36ba" xlink:href="gsk-20241231.xsd#gsk_DeferredConsiderationReceivedPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_gsk_DeferredConsiderationReceivedPaid_496d2c76-fcd8-4334-98c5-04c1ad4b36ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_6dadff12-162f-40f6-ac7e-d566fe5209bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_6dadff12-162f-40f6-ac7e-d566fe5209bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashOutflowInflowExcludingTransactionCosts_0fe4a534-dcb8-443a-9332-f9221b5a1444" xlink:href="gsk-20241231.xsd#gsk_CashOutflowInflowExcludingTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_gsk_CashOutflowInflowExcludingTransactionCosts_0fe4a534-dcb8-443a-9332-f9221b5a1444" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransactionCostsOnDisposal_d7a77c4c-cf9a-4044-ad9b-78039b54c254" xlink:href="gsk-20241231.xsd#gsk_TransactionCostsOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_gsk_TransactionCostsOnDisposal_d7a77c4c-cf9a-4044-ad9b-78039b54c254" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_2017ca41-2835-4bcc-831f-bcd6428f8920" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_cca986f0-9d76-4d71-a4f1-e82b91ba8314" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_2017ca41-2835-4bcc-831f-bcd6428f8920" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFairValueandCarryingamountsofDemergersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_04d7678b-24a9-4639-9ac6-32e0a9271289" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_04d7678b-24a9-4639-9ac6-32e0a9271289" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentAxis_0fd020f7-b177-4355-b5e8-2fd5c0bfeb4d" xlink:href="gsk-20241231.xsd#gsk_InvestmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_04d7678b-24a9-4639-9ac6-32e0a9271289" xlink:to="loc_gsk_InvestmentAxis_0fd020f7-b177-4355-b5e8-2fd5c0bfeb4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentDomain_0fd020f7-b177-4355-b5e8-2fd5c0bfeb4d_default" xlink:href="gsk-20241231.xsd#gsk_InvestmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_InvestmentAxis_0fd020f7-b177-4355-b5e8-2fd5c0bfeb4d" xlink:to="loc_gsk_InvestmentDomain_0fd020f7-b177-4355-b5e8-2fd5c0bfeb4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentDomain_a4a3a0b5-0564-4403-b146-08915ba7d53b" xlink:href="gsk-20241231.xsd#gsk_InvestmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_InvestmentAxis_0fd020f7-b177-4355-b5e8-2fd5c0bfeb4d" xlink:to="loc_gsk_InvestmentDomain_a4a3a0b5-0564-4403-b146-08915ba7d53b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HaleonPlcMember_8cfaa7bd-2af4-4943-ab99-72643988d22c" xlink:href="gsk-20241231.xsd#gsk_HaleonPlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_InvestmentDomain_a4a3a0b5-0564-4403-b146-08915ba7d53b" xlink:to="loc_gsk_HaleonPlcMember_8cfaa7bd-2af4-4943-ab99-72643988d22c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6f03ca39-5e48-414f-98c4-f48459c4e779" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_04d7678b-24a9-4639-9ac6-32e0a9271289" xlink:to="loc_srt_OwnershipAxis_6f03ca39-5e48-414f-98c4-f48459c4e779" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6f03ca39-5e48-414f-98c4-f48459c4e779_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_6f03ca39-5e48-414f-98c4-f48459c4e779" xlink:to="loc_srt_OwnershipDomain_6f03ca39-5e48-414f-98c4-f48459c4e779_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_13e044aa-a7f2-4ee7-8483-a1ed42be4874" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_6f03ca39-5e48-414f-98c4-f48459c4e779" xlink:to="loc_srt_OwnershipDomain_13e044aa-a7f2-4ee7-8483-a1ed42be4874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskHoldingMember_41fd729e-b12b-4fdc-975b-46e33e0a5581" xlink:href="gsk-20241231.xsd#gsk_GskHoldingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_13e044aa-a7f2-4ee7-8483-a1ed42be4874" xlink:to="loc_gsk_GskHoldingMember_41fd729e-b12b-4fdc-975b-46e33e0a5581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskAggregateHoldingMember_183c7d77-8264-42d5-8c00-185174e5dbd2" xlink:href="gsk-20241231.xsd#gsk_GskAggregateHoldingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_13e044aa-a7f2-4ee7-8483-a1ed42be4874" xlink:to="loc_gsk_GskAggregateHoldingMember_183c7d77-8264-42d5-8c00-185174e5dbd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfOwnershipDistributed_29845eaf-c139-4235-9936-4984bac52ded" xlink:href="gsk-20241231.xsd#gsk_PercentageOfOwnershipDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_PercentageOfOwnershipDistributed_29845eaf-c139-4235-9936-4984bac52ded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_6a5d205c-6e0b-4d6f-9da3-aed5dfe324af" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheConsumerHealthcareBusinessDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_6a5d205c-6e0b-4d6f-9da3-aed5dfe324af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_98497c2a-14c6-47f6-9dfd-6e1922e3e819" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheRetainedOwnershipInHaleonPlc"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_98497c2a-14c6-47f6-9dfd-6e1922e3e819" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalfairValueOfDistributedandRetainBusiness_16d9779f-5573-4791-b80d-aaf2f0d11773" xlink:href="gsk-20241231.xsd#gsk_TotalfairValueOfDistributedandRetainBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_TotalfairValueOfDistributedandRetainBusiness_16d9779f-5573-4791-b80d-aaf2f0d11773" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingAmountOfTheNetAssetsAndLiabilitiesDistributed_e7ac7aef-272e-452f-85b8-a063e1206fcf" xlink:href="gsk-20241231.xsd#gsk_CarryingAmountOfTheNetAssetsAndLiabilitiesDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_CarryingAmountOfTheNetAssetsAndLiabilitiesDistributed_e7ac7aef-272e-452f-85b8-a063e1206fcf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingAmountOfTheNciDerecognized_b0f049e3-eeef-47a3-acad-f98879bdf255" xlink:href="gsk-20241231.xsd#gsk_CarryingAmountOfTheNciDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_CarryingAmountOfTheNciDerecognized_b0f049e3-eeef-47a3-acad-f98879bdf255" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_e8a14796-e42f-48d0-83fd-fd87e7cd01dd" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_e8a14796-e42f-48d0-83fd-fd87e7cd01dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_ecbe84dc-b7c3-4e98-b21a-8441e98eb56b" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_ecbe84dc-b7c3-4e98-b21a-8441e98eb56b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerOfDiscontinuedOperation_fef083fb-3d66-4db2-98dc-4efc8b8b07a1" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_93112e57-0e32-45c6-a1c7-b2032128f741" xlink:to="loc_gsk_GainOnDemergerOfDiscontinuedOperation_fef083fb-3d66-4db2-98dc-4efc8b8b07a1" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/AcquisitionsanddisposalsSummaryofFinancialInformationRelatingtoDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f61a41f-353e-4ac5-835d-b001ecacf2d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f61a41f-353e-4ac5-835d-b001ecacf2d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_104abb7e-8676-4876-8053-f75694f5b0c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f61a41f-353e-4ac5-835d-b001ecacf2d1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_104abb7e-8676-4876-8053-f75694f5b0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingOperationsMember_104abb7e-8676-4876-8053-f75694f5b0c1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_104abb7e-8676-4876-8053-f75694f5b0c1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_104abb7e-8676-4876-8053-f75694f5b0c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingOperationsMember_a982c714-c014-4fd4-ba84-9bde5a32c77e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_104abb7e-8676-4876-8053-f75694f5b0c1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_a982c714-c014-4fd4-ba84-9bde5a32c77e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_477c108d-0a19-4dd0-b7d8-418ea62318a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContinuingOperationsMember_a982c714-c014-4fd4-ba84-9bde5a32c77e" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_477c108d-0a19-4dd0-b7d8-418ea62318a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_d60dc489-d17f-46a5-92e4-ef1af12556fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_Revenue_d60dc489-d17f-46a5-92e4-ef1af12556fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_c489d2bd-e597-4523-a4a1-c0e972e7b483" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_OperatingExpense_c489d2bd-e597-4523-a4a1-c0e972e7b483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_87fefd48-9da3-4bfb-ac88-deb2327093c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_87fefd48-9da3-4bfb-ac88-deb2327093c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_d9853d24-7b08-4f77-aab0-75cfffc82ef9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_d9853d24-7b08-4f77-aab0-75cfffc82ef9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_76e007f1-bc5b-46f7-ba74-5db9ae22167f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_ApplicableTaxRate_76e007f1-bc5b-46f7-ba74-5db9ae22167f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_475d81c5-ea7d-4f94-90f1-f50191b4cf90" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_475d81c5-ea7d-4f94-90f1-f50191b4cf90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherGainsLossesOnDemerger_ef988cc8-d72d-4f37-bb70-6bd30ebab9d7" xlink:href="gsk-20241231.xsd#gsk_OtherGainsLossesOnDemerger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_gsk_OtherGainsLossesOnDemerger_ef988cc8-d72d-4f37-bb70-6bd30ebab9d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_fcb23452-be46-42e3-9000-ad95b9ec2ced" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_fcb23452-be46-42e3-9000-ad95b9ec2ced" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_9fd781ae-e877-4057-9e67-3ef38343e719" xlink:href="gsk-20241231.xsd#gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_9fd781ae-e877-4057-9e67-3ef38343e719" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests_95f1db10-6424-4f45-a8b9-48d86d14e58b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests_95f1db10-6424-4f45-a8b9-48d86d14e58b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_0b96894c-ee0c-434d-b271-6518f7120faa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_0b96894c-ee0c-434d-b271-6518f7120faa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_816d5794-f3b3-491a-9c3f-b223ef5fdc78" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_3e01e341-4bd1-4640-94c7-63dcf6c4d55d" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_816d5794-f3b3-491a-9c3f-b223ef5fdc78" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/ReconciliationofnetcashflowtomovementinnetdebtSummaryofAnalysisofChangesinNetDebtDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#ReconciliationofnetcashflowtomovementinnetdebtSummaryofAnalysisofChangesinNetDebtDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/ReconciliationofnetcashflowtomovementinnetdebtSummaryofAnalysisofChangesinNetDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_abcefe32-d8cc-4241-8ff4-3aaee51ef906" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_abcefe32-d8cc-4241-8ff4-3aaee51ef906" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ec3ed047-a726-4509-a10f-1283be748c89" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_abcefe32-d8cc-4241-8ff4-3aaee51ef906" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ec3ed047-a726-4509-a10f-1283be748c89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ec3ed047-a726-4509-a10f-1283be748c89_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ec3ed047-a726-4509-a10f-1283be748c89" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ec3ed047-a726-4509-a10f-1283be748c89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_2b135f27-e9a5-47b4-96f6-cbf27c6e0bcc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ec3ed047-a726-4509-a10f-1283be748c89" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_2b135f27-e9a5-47b4-96f6-cbf27c6e0bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsMember_02091a91-0c56-4f85-b3b4-040190c475af" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_2b135f27-e9a5-47b4-96f6-cbf27c6e0bcc" xlink:to="loc_gsk_LiquidInvestmentsMember_02091a91-0c56-4f85-b3b4-040190c475af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_9f7b10a1-ba8b-458b-a317-9b42fcf084bf" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_2b135f27-e9a5-47b4-96f6-cbf27c6e0bcc" xlink:to="loc_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_9f7b10a1-ba8b-458b-a317-9b42fcf084bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentMember_da2ddbd4-e35e-48db-ba25-aa2e044ccea9" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_9f7b10a1-ba8b-458b-a317-9b42fcf084bf" xlink:to="loc_gsk_CashAndCashEquivalentMember_da2ddbd4-e35e-48db-ba25-aa2e044ccea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankOverdrafts1Member_9b9b7a19-aa0b-406c-905f-91945e5ff79d" xlink:href="gsk-20241231.xsd#gsk_BankOverdrafts1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_9f7b10a1-ba8b-458b-a317-9b42fcf084bf" xlink:to="loc_gsk_BankOverdrafts1Member_9b9b7a19-aa0b-406c-905f-91945e5ff79d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativeFinancialInstrumentsMember_b61764a1-1b7c-4f6f-b983-b5b913bc74f4" xlink:href="gsk-20241231.xsd#gsk_DerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_2b135f27-e9a5-47b4-96f6-cbf27c6e0bcc" xlink:to="loc_gsk_DerivativeFinancialInstrumentsMember_b61764a1-1b7c-4f6f-b983-b5b913bc74f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_43a40fc2-ed59-4be9-941a-13a917994274" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_abcefe32-d8cc-4241-8ff4-3aaee51ef906" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_43a40fc2-ed59-4be9-941a-13a917994274" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_43a40fc2-ed59-4be9-941a-13a917994274_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_43a40fc2-ed59-4be9-941a-13a917994274" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_43a40fc2-ed59-4be9-941a-13a917994274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_377e55f9-ded5-46d3-b009-64c77cb991ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_43a40fc2-ed59-4be9-941a-13a917994274" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_377e55f9-ded5-46d3-b009-64c77cb991ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPaperDebtMember_2193646c-687f-4ddb-9f5b-c2a9783b2c32" xlink:href="gsk-20241231.xsd#gsk_CommercialPaperDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_377e55f9-ded5-46d3-b009-64c77cb991ac" xlink:to="loc_gsk_CommercialPaperDebtMember_2193646c-687f-4ddb-9f5b-c2a9783b2c32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember_1dcbbdd5-44ab-478c-b441-db66806459f3" xlink:href="gsk-20241231.xsd#gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_377e55f9-ded5-46d3-b009-64c77cb991ac" xlink:to="loc_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember_1dcbbdd5-44ab-478c-b441-db66806459f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_696654f4-864a-48fb-8394-2c4ea3f1b12f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_377e55f9-ded5-46d3-b009-64c77cb991ac" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_696654f4-864a-48fb-8394-2c4ea3f1b12f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCurrentDebtMember_fa6ab0d7-9593-4024-9f81-69d780cfa5cd" xlink:href="gsk-20241231.xsd#gsk_OtherCurrentDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_377e55f9-ded5-46d3-b009-64c77cb991ac" xlink:to="loc_gsk_OtherCurrentDebtMember_fa6ab0d7-9593-4024-9f81-69d780cfa5cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_8afa4223-a30e-42ed-9f04-196c0ff1a8cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_abcefe32-d8cc-4241-8ff4-3aaee51ef906" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_8afa4223-a30e-42ed-9f04-196c0ff1a8cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_8afa4223-a30e-42ed-9f04-196c0ff1a8cc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_8afa4223-a30e-42ed-9f04-196c0ff1a8cc" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_8afa4223-a30e-42ed-9f04-196c0ff1a8cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_8afa4223-a30e-42ed-9f04-196c0ff1a8cc" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_b002db05-05b9-4412-a955-f5608962eb22" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_b002db05-05b9-4412-a955-f5608962eb22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_11dc6910-f2fb-4b33-b5aa-0ad7bb8e4dd3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_11dc6910-f2fb-4b33-b5aa-0ad7bb8e4dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetDebtMember_271cf599-4c06-46ce-859b-97789f8975e8" xlink:href="gsk-20241231.xsd#gsk_NetDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:to="loc_gsk_NetDebtMember_271cf599-4c06-46ce-859b-97789f8975e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AccruedInterestMember_2598a6f5-9889-4015-8c5c-2d105aba25e4" xlink:href="gsk-20241231.xsd#gsk_AccruedInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:to="loc_gsk_AccruedInterestMember_2598a6f5-9889-4015-8c5c-2d105aba25e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember_ea442017-3387-45be-9272-bf06847759d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0aef4832-931e-47f3-bf7d-f03113f11c3d" xlink:to="loc_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember_ea442017-3387-45be-9272-bf06847759d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_ea646f19-d3b0-49b3-883b-ed8d66110025" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_ea646f19-d3b0-49b3-883b-ed8d66110025" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_9a98af70-166b-419b-ba8e-5a1299657f94" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_9a98af70-166b-419b-ba8e-5a1299657f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_854f6b6f-fcc3-43b9-abd2-fcab4ba64edb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_854f6b6f-fcc3-43b9-abd2-fcab4ba64edb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_11a3361e-8d8c-4242-8cae-aa2d46d9ea0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_ifrs-full_InterestExpense_11a3361e-8d8c-4242-8cae-aa2d46d9ea0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInFairValueOfNetDebt_af505ae1-1c9f-4d11-a16d-4f7d2a15ae00" xlink:href="gsk-20241231.xsd#gsk_ChangeInFairValueOfNetDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_gsk_ChangeInFairValueOfNetDebt_af505ae1-1c9f-4d11-a16d-4f7d2a15ae00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfNetDebt_c82d3566-da78-4bf0-b2be-9d44653f2cd3" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfNetDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_gsk_ReclassificationOfNetDebt_c82d3566-da78-4bf0-b2be-9d44653f2cd3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_bb9720dc-5a2a-4e1b-999d-bbecf0aef133" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_d74c9dad-566a-4756-9721-814bdd8574d2" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_bb9720dc-5a2a-4e1b-999d-bbecf0aef133" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_0dd443e9-125b-436f-a426-f4135be57f6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationCapitalandRiskManagementDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresAdditionalInformationCapitalandRiskManagementDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationCapitalandRiskManagementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_99c95429-d136-42f4-a89a-8144b6269561" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_MaturityAxis_99c95429-d136-42f4-a89a-8144b6269561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_99c95429-d136-42f4-a89a-8144b6269561_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_99c95429-d136-42f4-a89a-8144b6269561" xlink:to="loc_ifrs-full_MaturityDomain_99c95429-d136-42f4-a89a-8144b6269561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_6230f3a0-6b3f-428e-aec3-87084abd7889" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_99c95429-d136-42f4-a89a-8144b6269561" xlink:to="loc_ifrs-full_MaturityDomain_6230f3a0-6b3f-428e-aec3-87084abd7889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_0602dbfb-cd41-4819-8ecf-f433bfa83b0c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6230f3a0-6b3f-428e-aec3-87084abd7889" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_0602dbfb-cd41-4819-8ecf-f433bfa83b0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_cd39ec66-4fb5-4419-92a4-35df7aa19e47" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6230f3a0-6b3f-428e-aec3-87084abd7889" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_cd39ec66-4fb5-4419-92a4-35df7aa19e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanThreeMonthsMember_1d7ee538-933d-42ac-b31c-a1c7a30e7161" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_6230f3a0-6b3f-428e-aec3-87084abd7889" xlink:to="loc_ifrs-full_NotLaterThanThreeMonthsMember_1d7ee538-933d-42ac-b31c-a1c7a30e7161" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_484351ff-e132-420c-95a0-f116a76adcd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_TypesOfRisksAxis_484351ff-e132-420c-95a0-f116a76adcd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_484351ff-e132-420c-95a0-f116a76adcd4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_484351ff-e132-420c-95a0-f116a76adcd4" xlink:to="loc_ifrs-full_TypesOfRisksDomain_484351ff-e132-420c-95a0-f116a76adcd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_9f191090-8f28-4844-8644-b40d3068b819" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_484351ff-e132-420c-95a0-f116a76adcd4" xlink:to="loc_ifrs-full_TypesOfRisksDomain_9f191090-8f28-4844-8644-b40d3068b819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiquidityRiskMember_00977423-2db5-4a8b-a844-3911b1e07f2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_9f191090-8f28-4844-8644-b40d3068b819" xlink:to="loc_ifrs-full_LiquidityRiskMember_00977423-2db5-4a8b-a844-3911b1e07f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditRiskMember_921c6932-1f30-4288-964d-da4395aedd4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_9f191090-8f28-4844-8644-b40d3068b819" xlink:to="loc_ifrs-full_CreditRiskMember_921c6932-1f30-4288-964d-da4395aedd4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WholesaleAndRetailCreditRiskMember_596ce43b-6c19-4225-a841-30a33f1cf087" xlink:href="gsk-20241231.xsd#gsk_WholesaleAndRetailCreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_9f191090-8f28-4844-8644-b40d3068b819" xlink:to="loc_gsk_WholesaleAndRetailCreditRiskMember_596ce43b-6c19-4225-a841-30a33f1cf087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_478c8bde-ea23-4a36-9928-575e8d9756d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_478c8bde-ea23-4a36-9928-575e8d9756d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_478c8bde-ea23-4a36-9928-575e8d9756d0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_478c8bde-ea23-4a36-9928-575e8d9756d0" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_478c8bde-ea23-4a36-9928-575e8d9756d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_09b5f50a-b522-4484-99e0-57b501a7766a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_478c8bde-ea23-4a36-9928-575e8d9756d0" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_09b5f50a-b522-4484-99e0-57b501a7766a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsCommercialPaperProgramMember_0a2a6ed2-9ab9-46bd-86cf-0618d2b3d55d" xlink:href="gsk-20241231.xsd#gsk_UsCommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_09b5f50a-b522-4484-99e0-57b501a7766a" xlink:to="loc_gsk_UsCommercialPaperProgramMember_0a2a6ed2-9ab9-46bd-86cf-0618d2b3d55d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EuroCommercialPaperProgrammeMember_33162c9d-246c-467f-ba50-45d050eaa943" xlink:href="gsk-20241231.xsd#gsk_EuroCommercialPaperProgrammeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_09b5f50a-b522-4484-99e0-57b501a7766a" xlink:to="loc_gsk_EuroCommercialPaperProgrammeMember_33162c9d-246c-467f-ba50-45d050eaa943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesAxis_d208c901-2af4-4e97-9f2a-8b574c36f41f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_ExternalCreditGradesAxis_d208c901-2af4-4e97-9f2a-8b574c36f41f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesDomain_d208c901-2af4-4e97-9f2a-8b574c36f41f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_d208c901-2af4-4e97-9f2a-8b574c36f41f" xlink:to="loc_ifrs-full_ExternalCreditGradesDomain_d208c901-2af4-4e97-9f2a-8b574c36f41f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesDomain_b9b2cb6f-e155-4178-8d08-1dc8850e859e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_d208c901-2af4-4e97-9f2a-8b574c36f41f" xlink:to="loc_ifrs-full_ExternalCreditGradesDomain_b9b2cb6f-e155-4178-8d08-1dc8850e859e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesMember_ffc0c09f-d582-4bfe-8e05-24b56c836c6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_b9b2cb6f-e155-4178-8d08-1dc8850e859e" xlink:to="loc_ifrs-full_ExternalCreditGradesMember_ffc0c09f-d582-4bfe-8e05-24b56c836c6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LowerThanBBBBaa3Member_2723380c-58a2-4792-9009-a643153a2f9c" xlink:href="gsk-20241231.xsd#gsk_LowerThanBBBBaa3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_b9b2cb6f-e155-4178-8d08-1dc8850e859e" xlink:to="loc_gsk_LowerThanBBBBaa3Member_2723380c-58a2-4792-9009-a643153a2f9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BbbOrBaaMember_09042767-1e1a-4efb-93fe-0e1542415e7c" xlink:href="gsk-20241231.xsd#gsk_BbbOrBaaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_b9b2cb6f-e155-4178-8d08-1dc8850e859e" xlink:to="loc_gsk_BbbOrBaaMember_09042767-1e1a-4efb-93fe-0e1542415e7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BBB-OrBaaThreeRatedMember_c97b1e84-2332-4ce8-b1b4-cba64c8d8bc6" xlink:href="gsk-20241231.xsd#gsk_BBB-OrBaaThreeRatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_b9b2cb6f-e155-4178-8d08-1dc8850e859e" xlink:to="loc_gsk_BBB-OrBaaThreeRatedMember_c97b1e84-2332-4ce8-b1b4-cba64c8d8bc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_4093a863-f77c-470a-8ff6-9804ca4d7a49" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_JointVenturesAxis_4093a863-f77c-470a-8ff6-9804ca4d7a49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_4093a863-f77c-470a-8ff6-9804ca4d7a49_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_4093a863-f77c-470a-8ff6-9804ca4d7a49" xlink:to="loc_ifrs-full_JointVenturesDomain_4093a863-f77c-470a-8ff6-9804ca4d7a49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_4093a863-f77c-470a-8ff6-9804ca4d7a49" xlink:to="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WholesalerInTheUsMember_65d5d341-f42a-415b-8d19-7a479b5ca935" xlink:href="gsk-20241231.xsd#gsk_WholesalerInTheUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_WholesalerInTheUsMember_65d5d341-f42a-415b-8d19-7a479b5ca935" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SaudiBritishBankMember_699fd5dc-0458-42b6-812c-0405e62c8296" xlink:href="gsk-20241231.xsd#gsk_SaudiBritishBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_SaudiBritishBankMember_699fd5dc-0458-42b6-812c-0405e62c8296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HalkBankMember_28527a95-acbc-4d47-989e-8956c7650bde" xlink:href="gsk-20241231.xsd#gsk_HalkBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_HalkBankMember_28527a95-acbc-4d47-989e-8956c7650bde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember_9bf1f2f4-bbfd-4c4f-83bd-4a8249b024e7" xlink:href="gsk-20241231.xsd#gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember_9bf1f2f4-bbfd-4c4f-83bd-4a8249b024e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancoBradescoItauUniBancoBancoDoBrasilAndCaixaEconomicaFederalMember_dcfccf7c-1a44-4f8e-bc6c-772489e04d01" xlink:href="gsk-20241231.xsd#gsk_BancoBradescoItauUniBancoBancoDoBrasilAndCaixaEconomicaFederalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_BancoBradescoItauUniBancoBancoDoBrasilAndCaixaEconomicaFederalMember_dcfccf7c-1a44-4f8e-bc6c-772489e04d01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancoDeLaProduccionMember_e1b42dfb-4864-4f7c-991f-10dba31b4f19" xlink:href="gsk-20241231.xsd#gsk_BancoDeLaProduccionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_BancoDeLaProduccionMember_e1b42dfb-4864-4f7c-991f-10dba31b4f19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember_ac98a8c1-8cd1-45a5-bc2a-9083594c7d4d" xlink:href="gsk-20241231.xsd#gsk_BancoDeAmericaCentralAndBancoDeHondurasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_83dbc791-2c79-45b9-afad-501421f480ff" xlink:to="loc_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember_ac98a8c1-8cd1-45a5-bc2a-9083594c7d4d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_14d3c1cc-6791-4e36-8f49-2525becacf1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_GeographicalAreasAxis_14d3c1cc-6791-4e36-8f49-2525becacf1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_14d3c1cc-6791-4e36-8f49-2525becacf1c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_14d3c1cc-6791-4e36-8f49-2525becacf1c" xlink:to="loc_ifrs-full_GeographicalAreasDomain_14d3c1cc-6791-4e36-8f49-2525becacf1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_14d3c1cc-6791-4e36-8f49-2525becacf1c" xlink:to="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SA_c67b8f94-6a7f-4a1e-9544-68df8e41d766" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_SA_c67b8f94-6a7f-4a1e-9544-68df8e41d766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_14317edf-5552-423b-b7d8-59df52c95fb6" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_GB_14317edf-5552-423b-b7d8-59df52c95fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NG_f29dcabb-de00-4374-824b-98297f8f688e" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_NG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_NG_f29dcabb-de00-4374-824b-98297f8f688e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_78c9b49b-9a74-4696-ae80-39e303f0a9fd" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_BR_78c9b49b-9a74-4696-ae80-39e303f0a9fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_EC_53a76369-a80c-49e8-b48e-f49fc925834f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_EC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_EC_53a76369-a80c-49e8-b48e-f49fc925834f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonUsaMember_64b0f5e8-4585-400a-9d29-6238c7623431" xlink:href="gsk-20241231.xsd#gsk_NonUsaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_gsk_NonUsaMember_64b0f5e8-4585-400a-9d29-6238c7623431" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e74e22da-2351-400c-8a09-8774a156a29b" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_US_e74e22da-2351-400c-8a09-8774a156a29b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_HN_2b539b03-7a37-4732-bbd6-b32d4b0dde7f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_HN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_b7383263-a05b-4c4e-92b9-04ee41ac1a12" xlink:to="loc_country_HN_2b539b03-7a37-4732-bbd6-b32d4b0dde7f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ec7e0127-fbfb-45df-93b6-9c5b46404be7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_CounterpartiesAxis_ec7e0127-fbfb-45df-93b6-9c5b46404be7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_ec7e0127-fbfb-45df-93b6-9c5b46404be7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_ec7e0127-fbfb-45df-93b6-9c5b46404be7" xlink:to="loc_ifrs-full_CounterpartiesDomain_ec7e0127-fbfb-45df-93b6-9c5b46404be7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_189ff568-bab5-47ca-82bb-f9240d380139" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_ec7e0127-fbfb-45df-93b6-9c5b46404be7" xlink:to="loc_ifrs-full_CounterpartiesDomain_189ff568-bab5-47ca-82bb-f9240d380139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancaPopolareDiSondrioMember_e1707ee4-64bf-449c-9353-abb76d204cd6" xlink:href="gsk-20241231.xsd#gsk_BancaPopolareDiSondrioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_189ff568-bab5-47ca-82bb-f9240d380139" xlink:to="loc_gsk_BancaPopolareDiSondrioMember_e1707ee4-64bf-449c-9353-abb76d204cd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OTPBankMember_a2c6c2eb-2b0b-4eb9-be34-0003d46496fa" xlink:href="gsk-20241231.xsd#gsk_OTPBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_189ff568-bab5-47ca-82bb-f9240d380139" xlink:to="loc_gsk_OTPBankMember_a2c6c2eb-2b0b-4eb9-be34-0003d46496fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_StateBankOfIndiaMember_ec1636a0-19a6-4930-b732-6523a4d54959" xlink:href="gsk-20241231.xsd#gsk_StateBankOfIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_189ff568-bab5-47ca-82bb-f9240d380139" xlink:to="loc_gsk_StateBankOfIndiaMember_ec1636a0-19a6-4930-b732-6523a4d54959" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancoDeCreditoDelPeruMember_ddc95053-d0a7-45c3-9254-5a86d9163810" xlink:href="gsk-20241231.xsd#gsk_BancoDeCreditoDelPeruMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_189ff568-bab5-47ca-82bb-f9240d380139" xlink:to="loc_gsk_BancoDeCreditoDelPeruMember_ddc95053-d0a7-45c3-9254-5a86d9163810" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_ab530dee-252c-4ecd-92b1-282861182126" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_ab530dee-252c-4ecd-92b1-282861182126" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_ab530dee-252c-4ecd-92b1-282861182126_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_ab530dee-252c-4ecd-92b1-282861182126" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_ab530dee-252c-4ecd-92b1-282861182126_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_42e33e10-d68d-4d9c-ada7-513e84f07f10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_ab530dee-252c-4ecd-92b1-282861182126" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_42e33e10-d68d-4d9c-ada7-513e84f07f10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthCareMember_5190d580-2a87-46da-b45b-d382b1e7bc56" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_42e33e10-d68d-4d9c-ada7-513e84f07f10" xlink:to="loc_gsk_ViiVHealthCareMember_5190d580-2a87-46da-b45b-d382b1e7bc56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_c804a953-4ad3-46cf-8848-5ae94a5aeeed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_RangeAxis_c804a953-4ad3-46cf-8848-5ae94a5aeeed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_c804a953-4ad3-46cf-8848-5ae94a5aeeed_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_c804a953-4ad3-46cf-8848-5ae94a5aeeed" xlink:to="loc_ifrs-full_RangeDomain_c804a953-4ad3-46cf-8848-5ae94a5aeeed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_4f2a5428-7393-47e1-b0de-e4f5886d1906" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_c804a953-4ad3-46cf-8848-5ae94a5aeeed" xlink:to="loc_ifrs-full_RangeDomain_4f2a5428-7393-47e1-b0de-e4f5886d1906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_038f92c5-fd9e-4406-8329-ce3d017ca6f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_4f2a5428-7393-47e1-b0de-e4f5886d1906" xlink:to="loc_ifrs-full_TopOfRangeMember_038f92c5-fd9e-4406-8329-ce3d017ca6f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_54019660-8925-49c4-a101-7e63383446e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_SegmentsAxis_54019660-8925-49c4-a101-7e63383446e2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_54019660-8925-49c4-a101-7e63383446e2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_54019660-8925-49c4-a101-7e63383446e2" xlink:to="loc_ifrs-full_SegmentsDomain_54019660-8925-49c4-a101-7e63383446e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_71f420d6-a10c-4547-a884-4dad38de9a62" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_54019660-8925-49c4-a101-7e63383446e2" xlink:to="loc_ifrs-full_SegmentsDomain_71f420d6-a10c-4547-a884-4dad38de9a62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InLineWithOtherPharmaceuticalCompaniesMember_790cdada-1ccb-47a8-b58b-bf9ab5379975" xlink:href="gsk-20241231.xsd#gsk_InLineWithOtherPharmaceuticalCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_71f420d6-a10c-4547-a884-4dad38de9a62" xlink:to="loc_gsk_InLineWithOtherPharmaceuticalCompaniesMember_790cdada-1ccb-47a8-b58b-bf9ab5379975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_2d03cc9d-c198-4449-8682-66f860bf8095" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_2d03cc9d-c198-4449-8682-66f860bf8095" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_2d03cc9d-c198-4449-8682-66f860bf8095_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_2d03cc9d-c198-4449-8682-66f860bf8095" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_2d03cc9d-c198-4449-8682-66f860bf8095_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_bf98ef9b-171d-4ecc-8b37-28fc033300b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_2d03cc9d-c198-4449-8682-66f860bf8095" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_bf98ef9b-171d-4ecc-8b37-28fc033300b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DueFromThreeWholesalersMember_750af2c7-e3b9-4a34-a866-ffb2fd56c85d" xlink:href="gsk-20241231.xsd#gsk_DueFromThreeWholesalersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_bf98ef9b-171d-4ecc-8b37-28fc033300b9" xlink:to="loc_gsk_DueFromThreeWholesalersMember_750af2c7-e3b9-4a34-a866-ffb2fd56c85d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InsuranceContractsAxis_9f0df4d9-a837-475f-aa6a-f2e1c989f123" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InsuranceContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_8301c7c0-3f5b-409d-adaf-88891a0812a5" xlink:to="loc_ifrs-full_InsuranceContractsAxis_9f0df4d9-a837-475f-aa6a-f2e1c989f123" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InsuranceContractsDomain_9f0df4d9-a837-475f-aa6a-f2e1c989f123_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InsuranceContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_InsuranceContractsAxis_9f0df4d9-a837-475f-aa6a-f2e1c989f123" xlink:to="loc_ifrs-full_InsuranceContractsDomain_9f0df4d9-a837-475f-aa6a-f2e1c989f123_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InsuranceContractsDomain_487320b6-4e9b-45fe-bf10-81b6014f5a98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InsuranceContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_InsuranceContractsAxis_9f0df4d9-a837-475f-aa6a-f2e1c989f123" xlink:to="loc_ifrs-full_InsuranceContractsDomain_487320b6-4e9b-45fe-bf10-81b6014f5a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GroupCreditEnhancementsAndCreditInsuranceMember_56107084-fac5-46b4-9920-5c2553a10eca" xlink:href="gsk-20241231.xsd#gsk_GroupCreditEnhancementsAndCreditInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InsuranceContractsDomain_487320b6-4e9b-45fe-bf10-81b6014f5a98" xlink:to="loc_gsk_GroupCreditEnhancementsAndCreditInsuranceMember_56107084-fac5-46b4-9920-5c2553a10eca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_860a441e-8b24-497a-85d7-d9ea4efafac4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_Borrowings_860a441e-8b24-497a-85d7-d9ea4efafac4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_6277ae6c-5db6-48f7-b417-0dd045303c10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_Equity_6277ae6c-5db6-48f7-b417-0dd045303c10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquityAndDebtNet_b63f1ae6-502b-4c8b-896a-70bcd06709ec" xlink:href="gsk-20241231.xsd#gsk_EquityAndDebtNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_EquityAndDebtNet_b63f1ae6-502b-4c8b-896a-70bcd06709ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_20ddff8a-30fe-4e5c-a219-46847a18e075" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_ShorttermBorrowings_20ddff8a-30fe-4e5c-a219-46847a18e075" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsAndLiquidInvestments_eee69962-f662-473e-b3e1-54386e9f0061" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsAndLiquidInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CashAndCashEquivalentsAndLiquidInvestments_eee69962-f662-473e-b3e1-54386e9f0061" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally_265d4efd-2be4-4775-957d-069ae56f02d4" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally_265d4efd-2be4-4775-957d-069ae56f02d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPapersAuthorised_19c5a301-738c-48d2-b810-1a72eec7866d" xlink:href="gsk-20241231.xsd#gsk_CommercialPapersAuthorised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CommercialPapersAuthorised_19c5a301-738c-48d2-b810-1a72eec7866d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued_40533c13-36c5-4e9f-9cee-cd3240bdb377" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_CommercialPapersIssued_40533c13-36c5-4e9f-9cee-cd3240bdb377" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MaximumDrawdownOfCommercialPapers_be51d0a5-e338-4475-8dde-5f43287e38eb" xlink:href="gsk-20241231.xsd#gsk_MaximumDrawdownOfCommercialPapers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_MaximumDrawdownOfCommercialPapers_be51d0a5-e338-4475-8dde-5f43287e38eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilities_7e26ebf6-da41-42d6-a121-764c88520cbc" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_RevolvingCreditFacilities_7e26ebf6-da41-42d6-a121-764c88520cbc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilityTerm_4b133343-ada9-4007-9e63-4afff6043e2e" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_RevolvingCreditFacilityTerm_4b133343-ada9-4007-9e63-4afff6043e2e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme_4c10cbdf-b696-4d78-a69e-2bd78526fe2d" xlink:href="gsk-20241231.xsd#gsk_AmountHeldAtEuropeanMediumTermNoteProgramme"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme_4c10cbdf-b696-4d78-a69e-2bd78526fe2d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme_0f4d869a-3703-4ded-91dc-fb3dcebbbd8c" xlink:href="gsk-20241231.xsd#gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme_0f4d869a-3703-4ded-91dc-fb3dcebbbd8c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NotesIssuedUnderUsShelfRegistration_951985bc-c5e7-41d5-93ea-231bb9a220f7" xlink:href="gsk-20241231.xsd#gsk_NotesIssuedUnderUsShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_NotesIssuedUnderUsShelfRegistration_951985bc-c5e7-41d5-93ea-231bb9a220f7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_bd25ad19-7917-4f05-92ab-30fbc02a6f53" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_bd25ad19-7917-4f05-92ab-30fbc02a6f53" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CreditExposure1_804f4f13-1a69-4c2b-af0f-a03b0a343c56" xlink:href="gsk-20241231.xsd#gsk_CreditExposure1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CreditExposure1_804f4f13-1a69-4c2b-af0f-a03b0a343c56" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfLargestUSWholesalers_f575bc4d-91ab-4eff-a1ac-1d7c7a715f7e" xlink:href="gsk-20241231.xsd#gsk_NumberOfLargestUSWholesalers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_NumberOfLargestUSWholesalers_f575bc4d-91ab-4eff-a1ac-1d7c7a715f7e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties_bdb6182f-7c96-4256-9fd3-f49c3f3c9ac6" xlink:href="gsk-20241231.xsd#gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties_bdb6182f-7c96-4256-9fd3-f49c3f3c9ac6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankBalancesAndDepositHeldWithCounterparties_faed65cd-0aef-4925-a6fd-b5c8908eaf5e" xlink:href="gsk-20241231.xsd#gsk_BankBalancesAndDepositHeldWithCounterparties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_BankBalancesAndDepositHeldWithCounterparties_faed65cd-0aef-4925-a6fd-b5c8908eaf5e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BalancesWithBanks_bcfd2d77-23f7-4617-80e3-85c04626b2c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_BalancesWithBanks_bcfd2d77-23f7-4617-80e3-85c04626b2c1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashReserves_8fa9de7d-8601-4e47-8944-cc207fb04f87" xlink:href="gsk-20241231.xsd#gsk_CashReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CashReserves_8fa9de7d-8601-4e47-8944-cc207fb04f87" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashManagedForSubsidiaryCompany_92588814-9227-443c-bb8d-ed3d51be2d61" xlink:href="gsk-20241231.xsd#gsk_CashManagedForSubsidiaryCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_CashManagedForSubsidiaryCompany_92588814-9227-443c-bb8d-ed3d51be2d61" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_5cadc8c1-b5e8-4e82-846e-3949ca121bb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_5cadc8c1-b5e8-4e82-846e-3949ca121bb6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfAccountsReceivableByMajorCustomer_3e42bcaf-d47e-4249-83fd-b01b8e59209f" xlink:href="gsk-20241231.xsd#gsk_PercentageOfAccountsReceivableByMajorCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_PercentageOfAccountsReceivableByMajorCustomer_3e42bcaf-d47e-4249-83fd-b01b8e59209f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConcentrationsOfRiskRevenuePercentage_3a73064c-7af8-48ad-846b-dae0afd6e2dc" xlink:href="gsk-20241231.xsd#gsk_ConcentrationsOfRiskRevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_gsk_ConcentrationsOfRiskRevenuePercentage_3a73064c-7af8-48ad-846b-dae0afd6e2dc" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivables_79999841-63c0-4290-abe0-ac5d66a04f14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_TradeReceivables_79999841-63c0-4290-abe0-ac5d66a04f14" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditExposure_1d79c101-9148-4fc6-b60c-4c624ce963cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_e4db9cfd-f8f8-433f-83c9-d612f7e1f6f0" xlink:to="loc_ifrs-full_CreditExposure_1d79c101-9148-4fc6-b60c-4c624ce963cf" xlink:type="arc" order="26"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofExternalCreditExposureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExternalCreditExposuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_23159eed-9927-49d7-9b74-b351489bd3d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_23159eed-9927-49d7-9b74-b351489bd3d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesAxis_b6da8d7a-7721-4776-8d78-f747d31561ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_23159eed-9927-49d7-9b74-b351489bd3d0" xlink:to="loc_ifrs-full_ExternalCreditGradesAxis_b6da8d7a-7721-4776-8d78-f747d31561ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesDomain_b6da8d7a-7721-4776-8d78-f747d31561ca_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_b6da8d7a-7721-4776-8d78-f747d31561ca" xlink:to="loc_ifrs-full_ExternalCreditGradesDomain_b6da8d7a-7721-4776-8d78-f747d31561ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis_b6da8d7a-7721-4776-8d78-f747d31561ca" xlink:to="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AAAOrAaaMember_640af6cc-07ec-45bb-a16f-5d2a1abf2c59" xlink:href="gsk-20241231.xsd#gsk_AAAOrAaaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:to="loc_gsk_AAAOrAaaMember_640af6cc-07ec-45bb-a16f-5d2a1abf2c59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AaOrAaMember_accc72d8-bc1b-4323-93cc-06707787321a" xlink:href="gsk-20241231.xsd#gsk_AaOrAaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:to="loc_gsk_AaOrAaMember_accc72d8-bc1b-4323-93cc-06707787321a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AorAMember_5b5d692e-1dc2-414a-99dd-04e03df50d32" xlink:href="gsk-20241231.xsd#gsk_AorAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:to="loc_gsk_AorAMember_5b5d692e-1dc2-414a-99dd-04e03df50d32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BbbOrBaaMember_8b79377f-5193-4fa1-af71-12ad535c9465" xlink:href="gsk-20241231.xsd#gsk_BbbOrBaaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:to="loc_gsk_BbbOrBaaMember_8b79377f-5193-4fa1-af71-12ad535c9465" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BBPlusOrBaOneMember_47f8a99c-9cd0-452d-966e-c6fc46bb7877" xlink:href="gsk-20241231.xsd#gsk_BBPlusOrBaOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain_125b2515-eff9-4060-8f20-bb56ed5f09f3" xlink:to="loc_gsk_BBPlusOrBaOneMember_47f8a99c-9cd0-452d-966e-c6fc46bb7877" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_2d3ab4d4-2c4b-4818-88b8-f24b022566eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_23159eed-9927-49d7-9b74-b351489bd3d0" xlink:to="loc_ifrs-full_TypesOfRisksAxis_2d3ab4d4-2c4b-4818-88b8-f24b022566eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_2d3ab4d4-2c4b-4818-88b8-f24b022566eb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_2d3ab4d4-2c4b-4818-88b8-f24b022566eb" xlink:to="loc_ifrs-full_TypesOfRisksDomain_2d3ab4d4-2c4b-4818-88b8-f24b022566eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_ba6e50a2-4046-49ed-a5b8-dea817fc44b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_2d3ab4d4-2c4b-4818-88b8-f24b022566eb" xlink:to="loc_ifrs-full_TypesOfRisksDomain_ba6e50a2-4046-49ed-a5b8-dea817fc44b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditRiskMember_7a86e93b-a2ba-42e5-9b82-5542f59b8010" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_ba6e50a2-4046-49ed-a5b8-dea817fc44b0" xlink:to="loc_ifrs-full_CreditRiskMember_7a86e93b-a2ba-42e5-9b82-5542f59b8010" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankBalancesAndDepositHeldWithCounterparties_a51de1e9-db02-4ab8-b143-68e8a94f1c4f" xlink:href="gsk-20241231.xsd#gsk_BankBalancesAndDepositHeldWithCounterparties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_gsk_BankBalancesAndDepositHeldWithCounterparties_a51de1e9-db02-4ab8-b143-68e8a94f1c4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_5834392b-324e-4d8a-bbe4-ff9848d18733" xlink:href="gsk-20241231.xsd#gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_5834392b-324e-4d8a-bbe4-ff9848d18733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidityFunds_d4204790-d7ba-4c8b-b7c8-73f7bc84e88c" xlink:href="gsk-20241231.xsd#gsk_LiquidityFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_gsk_LiquidityFunds_d4204790-d7ba-4c8b-b7c8-73f7bc84e88c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GovernmentSecurities_82ed9852-9f8b-42c5-b7ca-fa53ad474d5a" xlink:href="gsk-20241231.xsd#gsk_GovernmentSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_gsk_GovernmentSecurities_82ed9852-9f8b-42c5-b7ca-fa53ad474d5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_f1e6d75d-09f3-4b04-93af-9a06f2e0cafa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_f1e6d75d-09f3-4b04-93af-9a06f2e0cafa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RatedCreditExposures1_def46bea-f63c-4484-9c55-4ef2cf48629d" xlink:href="gsk-20241231.xsd#gsk_RatedCreditExposures1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_de48f322-ef18-4357-ad51-38b1c5ca8174" xlink:to="loc_gsk_RatedCreditExposures1_def46bea-f63c-4484-9c55-4ef2cf48629d" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_902395fa-e476-44da-8d8b-b3a0052ae9a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_902395fa-e476-44da-8d8b-b3a0052ae9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_902395fa-e476-44da-8d8b-b3a0052ae9a1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_902395fa-e476-44da-8d8b-b3a0052ae9a1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_902395fa-e476-44da-8d8b-b3a0052ae9a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_902395fa-e476-44da-8d8b-b3a0052ae9a1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NoncurrentAssetsOtherMember_5ba1e821-b685-4f2c-940a-bbbcd007b03a" xlink:href="gsk-20241231.xsd#gsk_NoncurrentAssetsOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_NoncurrentAssetsOtherMember_5ba1e821-b685-4f2c-940a-bbbcd007b03a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivableMember_4c17aebf-238b-4590-8aa6-2ab3947475dd" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_TradeAndOtherReceivableMember_4c17aebf-238b-4590-8aa6-2ab3947475dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsMember_f750845b-ccd8-4104-bb60-faee84415c13" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_LiquidInvestmentsMember_f750845b-ccd8-4104-bb60-faee84415c13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsFinancialAssetsMember_cbb6accc-316e-4e11-91f4-a48045e9e64d" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_CashAndCashEquivalentsFinancialAssetsMember_cbb6accc-316e-4e11-91f4-a48045e9e64d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherFinancialInvestmentsMember_62689f4b-7190-4bec-a2db-6f72fdb056d6" xlink:href="gsk-20241231.xsd#gsk_OtherFinancialInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_OtherFinancialInvestmentsMember_62689f4b-7190-4bec-a2db-6f72fdb056d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentEquityAndOtherInvestmentsMember_b6b8155d-e47e-4cae-85ef-1e3d27615435" xlink:href="gsk-20241231.xsd#gsk_CurrentEquityAndOtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_CurrentEquityAndOtherInvestmentsMember_b6b8155d-e47e-4cae-85ef-1e3d27615435" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_635a4cda-3445-4f41-942b-9024ba8f782d" xlink:href="gsk-20241231.xsd#gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_635a4cda-3445-4f41-942b-9024ba8f782d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_e388788d-c0a1-4500-a09b-c8d8af31c715" xlink:href="gsk-20241231.xsd#gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_55d5c853-e199-48a5-90c5-7164371afcf9" xlink:to="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_e388788d-c0a1-4500-a09b-c8d8af31c715" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_54b0a38a-827b-44f7-9cfc-bc980deb3f9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_54b0a38a-827b-44f7-9cfc-bc980deb3f9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_54b0a38a-827b-44f7-9cfc-bc980deb3f9c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_54b0a38a-827b-44f7-9cfc-bc980deb3f9c" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_54b0a38a-827b-44f7-9cfc-bc980deb3f9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8bd2b1a6-f4e0-4075-a7e0-e602445177a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_54b0a38a-827b-44f7-9cfc-bc980deb3f9c" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8bd2b1a6-f4e0-4075-a7e0-e602445177a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_6aee130c-1b0c-4319-a323-57b663758610" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8bd2b1a6-f4e0-4075-a7e0-e602445177a6" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_6aee130c-1b0c-4319-a323-57b663758610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_fab5630d-6862-475f-9841-a36ef28a2cb3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8bd2b1a6-f4e0-4075-a7e0-e602445177a6" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_fab5630d-6862-475f-9841-a36ef28a2cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_6a097137-c300-4c23-bade-5c18dd6305d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8bd2b1a6-f4e0-4075-a7e0-e602445177a6" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_6a097137-c300-4c23-bade-5c18dd6305d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_12e0a7d7-0c59-4df5-aabf-3d8e037e8907" xlink:href="gsk-20241231.xsd#gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_8bd2b1a6-f4e0-4075-a7e0-e602445177a6" xlink:to="loc_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_12e0a7d7-0c59-4df5-aabf-3d8e037e8907" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_50dfd6df-0b23-411e-92de-86e11e47193f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_50dfd6df-0b23-411e-92de-86e11e47193f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_50dfd6df-0b23-411e-92de-86e11e47193f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_50dfd6df-0b23-411e-92de-86e11e47193f" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_50dfd6df-0b23-411e-92de-86e11e47193f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_50dfd6df-0b23-411e-92de-86e11e47193f" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BondsInDesignatedHedgingRelationshipMember_5b57bcc6-a62f-49bd-9a74-8113677cd528" xlink:href="gsk-20241231.xsd#gsk_BondsInDesignatedHedgingRelationshipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:to="loc_gsk_BondsInDesignatedHedgingRelationshipMember_5b57bcc6-a62f-49bd-9a74-8113677cd528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherBondsMember_d181e9d4-3415-4f20-b4bf-675b5e310535" xlink:href="gsk-20241231.xsd#gsk_OtherBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:to="loc_gsk_OtherBondsMember_d181e9d4-3415-4f20-b4bf-675b5e310535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankLoansAndOverdraftsMember_16ebaef0-e258-4ccb-ba10-89f33a3497f1" xlink:href="gsk-20241231.xsd#gsk_BankLoansAndOverdraftsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:to="loc_gsk_BankLoansAndOverdraftsMember_16ebaef0-e258-4ccb-ba10-89f33a3497f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPaperInADesignatedHedgingRelationshipMember_85306265-a034-4e5d-bd74-90d6d9b53b48" xlink:href="gsk-20241231.xsd#gsk_CommercialPaperInADesignatedHedgingRelationshipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:to="loc_gsk_CommercialPaperInADesignatedHedgingRelationshipMember_85306265-a034-4e5d-bd74-90d6d9b53b48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCommercialPaperMember_1af3f8dd-ea9a-4b8e-afbb-5ed36e0f8407" xlink:href="gsk-20241231.xsd#gsk_OtherCommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:to="loc_gsk_OtherCommercialPaperMember_1af3f8dd-ea9a-4b8e-afbb-5ed36e0f8407" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherBorrowingMember_75d086c7-adb4-4736-9604-e1e5200a1943" xlink:href="gsk-20241231.xsd#gsk_OtherBorrowingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5c1c0b04-58cc-4dd3-bd2f-e868f68fd143" xlink:to="loc_gsk_OtherBorrowingMember_75d086c7-adb4-4736-9604-e1e5200a1943" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba0170dc-78f7-4c7d-8007-643e5983e0d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba0170dc-78f7-4c7d-8007-643e5983e0d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ba0170dc-78f7-4c7d-8007-643e5983e0d8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba0170dc-78f7-4c7d-8007-643e5983e0d8" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ba0170dc-78f7-4c7d-8007-643e5983e0d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b4368c6e-f7e4-4370-a5da-57ccb5f5c636" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ba0170dc-78f7-4c7d-8007-643e5983e0d8" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b4368c6e-f7e4-4370-a5da-57ccb5f5c636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_22b5565f-466e-4f46-b99a-43c00286fa82" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b4368c6e-f7e4-4370-a5da-57ccb5f5c636" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_22b5565f-466e-4f46-b99a-43c00286fa82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationLiabilitiesMember_1f13b32f-3039-4b0c-9a28-68819472eb5b" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_b4368c6e-f7e4-4370-a5da-57ccb5f5c636" xlink:to="loc_gsk_ContingentConsiderationLiabilitiesMember_1f13b32f-3039-4b0c-9a28-68819472eb5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_363d0f24-36c5-4554-a85b-8f626692aad2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ec279edb-db0d-4a6d-8f2d-3855fdbf2ebd" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_363d0f24-36c5-4554-a85b-8f626692aad2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_363d0f24-36c5-4554-a85b-8f626692aad2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_363d0f24-36c5-4554-a85b-8f626692aad2" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_363d0f24-36c5-4554-a85b-8f626692aad2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_80e8c346-d651-4312-9311-680b1dcca33c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_363d0f24-36c5-4554-a85b-8f626692aad2" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_80e8c346-d651-4312-9311-680b1dcca33c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherPayableMember_38959e42-7c2f-4e72-94ec-823293ea9bef" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_80e8c346-d651-4312-9311-680b1dcca33c" xlink:to="loc_gsk_TradeAndOtherPayableMember_38959e42-7c2f-4e72-94ec-823293ea9bef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember_ea881112-28c1-480f-b88c-d956829ac113" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_80e8c346-d651-4312-9311-680b1dcca33c" xlink:to="loc_ifrs-full_MiscellaneousOtherProvisionsMember_ea881112-28c1-480f-b88c-d956829ac113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNonCurrentLiabilitiesMember_caed1252-a305-44dc-aade-396f20d2564d" xlink:href="gsk-20241231.xsd#gsk_OtherNonCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_80e8c346-d651-4312-9311-680b1dcca33c" xlink:to="loc_gsk_OtherNonCurrentLiabilitiesMember_caed1252-a305-44dc-aade-396f20d2564d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_928a0496-5c2f-468f-b908-2b00abb0f503" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_ifrs-full_FinancialAssets_928a0496-5c2f-468f-b908-2b00abb0f503" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_0ba06ad0-bc2a-4637-9058-d2b37b66df99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_0ba06ad0-bc2a-4637-9058-d2b37b66df99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsExcludingObligationsUnderFinanceLease_dc1de721-edd3-4516-97a4-97b1d6d5fd11" xlink:href="gsk-20241231.xsd#gsk_BorrowingsExcludingObligationsUnderFinanceLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_gsk_BorrowingsExcludingObligationsUnderFinanceLease_dc1de721-edd3-4516-97a4-97b1d6d5fd11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue_5ff33cae-8b93-4f04-9a55-e6fa760b68a7" xlink:href="gsk-20241231.xsd#gsk_BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_gsk_BorrowingsExcludingObligationsUnderFinanceLeaseAtFairValue_5ff33cae-8b93-4f04-9a55-e6fa760b68a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_5ebe7b7f-4cfb-4930-9962-19f059c38ccb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_ifrs-full_FinancialLiabilities_5ebe7b7f-4cfb-4930-9962-19f059c38ccb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_994997d0-a7a8-475c-92c0-b10f73311714" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_994997d0-a7a8-475c-92c0-b10f73311714" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFinancialAssetsLiabilities_b3c82d67-cfd7-4262-b491-7598f66923d0" xlink:href="gsk-20241231.xsd#gsk_NetFinancialAssetsLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_gsk_NetFinancialAssetsLiabilities_b3c82d67-cfd7-4262-b491-7598f66923d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFinancialAssetsLiabilitiesAtFairValue_2369aca8-9e4b-4184-b17e-1acfd1167dcb" xlink:href="gsk-20241231.xsd#gsk_NetFinancialAssetsLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_1df1f278-0fdb-484b-a84b-c4da2fcef25c" xlink:to="loc_gsk_NetFinancialAssetsLiabilitiesAtFairValue_2369aca8-9e4b-4184-b17e-1acfd1167dcb" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_d0b52379-fc17-4fe0-a809-c19073797a4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_d0b52379-fc17-4fe0-a809-c19073797a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_d0b52379-fc17-4fe0-a809-c19073797a4f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_d0b52379-fc17-4fe0-a809-c19073797a4f" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_d0b52379-fc17-4fe0-a809-c19073797a4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_dda18cf2-07e6-4062-b6eb-bc5b5140fce6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_d0b52379-fc17-4fe0-a809-c19073797a4f" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_dda18cf2-07e6-4062-b6eb-bc5b5140fce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_3ab8c6fa-32ff-43e9-bb57-17cca3919d83" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_dda18cf2-07e6-4062-b6eb-bc5b5140fce6" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_3ab8c6fa-32ff-43e9-bb57-17cca3919d83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_f896eeb4-b593-4540-863f-246dc1c37316" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:to="loc_ifrs-full_JointVenturesAxis_f896eeb4-b593-4540-863f-246dc1c37316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_f896eeb4-b593-4540-863f-246dc1c37316_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_f896eeb4-b593-4540-863f-246dc1c37316" xlink:to="loc_ifrs-full_JointVenturesDomain_f896eeb4-b593-4540-863f-246dc1c37316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesDomain_fb6f1994-985f-407b-9be7-f6502af2340a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_f896eeb4-b593-4540-863f-246dc1c37316" xlink:to="loc_ifrs-full_JointVenturesDomain_fb6f1994-985f-407b-9be7-f6502af2340a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViiVHealthcareJointVentureMember_53fa0205-8d18-4be5-b9d6-5e6af59fe97d" xlink:href="gsk-20241231.xsd#gsk_ShionogiViiVHealthcareJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_fb6f1994-985f-407b-9be7-f6502af2340a" xlink:to="loc_gsk_ShionogiViiVHealthcareJointVentureMember_53fa0205-8d18-4be5-b9d6-5e6af59fe97d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisVaccinesBusinessMember_568e0f49-0f9d-4aec-bdf2-507b5b45d242" xlink:href="gsk-20241231.xsd#gsk_NovartisVaccinesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_fb6f1994-985f-407b-9be7-f6502af2340a" xlink:to="loc_gsk_NovartisVaccinesBusinessMember_568e0f49-0f9d-4aec-bdf2-507b5b45d242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_eb7cdf24-cb4b-4c61-bf2b-015cc204cea8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_eb7cdf24-cb4b-4c61-bf2b-015cc204cea8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_eb7cdf24-cb4b-4c61-bf2b-015cc204cea8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_eb7cdf24-cb4b-4c61-bf2b-015cc204cea8" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_eb7cdf24-cb4b-4c61-bf2b-015cc204cea8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_e7fb1d04-9772-4942-b524-455350fe2958" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_eb7cdf24-cb4b-4c61-bf2b-015cc204cea8" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_e7fb1d04-9772-4942-b524-455350fe2958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxAcquisitionMember_3fc18bdc-72ef-4842-8b9f-776d1f6aec0f" xlink:href="gsk-20241231.xsd#gsk_AffinivaxAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_e7fb1d04-9772-4942-b524-455350fe2958" xlink:to="loc_gsk_AffinivaxAcquisitionMember_3fc18bdc-72ef-4842-8b9f-776d1f6aec0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxMember_cd6cf50b-be71-49ce-83ae-d35ea8149858" xlink:href="gsk-20241231.xsd#gsk_AffinivaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_e7fb1d04-9772-4942-b524-455350fe2958" xlink:to="loc_gsk_AffinivaxMember_cd6cf50b-be71-49ce-83ae-d35ea8149858" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member_12fef191-4f2a-4976-bfda-d60b07cf16f1" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_e7fb1d04-9772-4942-b524-455350fe2958" xlink:to="loc_gsk_AiolosBioInc.Member_12fef191-4f2a-4976-bfda-d60b07cf16f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_7a7312de-9419-4506-bbca-5377e78b8d08" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_7a7312de-9419-4506-bbca-5377e78b8d08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_7a7312de-9419-4506-bbca-5377e78b8d08_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_7a7312de-9419-4506-bbca-5377e78b8d08" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_7a7312de-9419-4506-bbca-5377e78b8d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_070e0bd3-5c35-43d2-983e-cdd57ad24dfa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_7a7312de-9419-4506-bbca-5377e78b8d08" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_070e0bd3-5c35-43d2-983e-cdd57ad24dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialLiabilitiesOneMember_ea3824d1-6be0-4ae5-892e-0340814e6e70" xlink:href="gsk-20241231.xsd#gsk_FinancialLiabilitiesOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_070e0bd3-5c35-43d2-983e-cdd57ad24dfa" xlink:to="loc_gsk_FinancialLiabilitiesOneMember_ea3824d1-6be0-4ae5-892e-0340814e6e70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ce872092-d8b4-4ed3-b9f2-03ff55ed8c6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ce872092-d8b4-4ed3-b9f2-03ff55ed8c6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ce872092-d8b4-4ed3-b9f2-03ff55ed8c6a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ce872092-d8b4-4ed3-b9f2-03ff55ed8c6a" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ce872092-d8b4-4ed3-b9f2-03ff55ed8c6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f0afac21-1d8b-482c-9a6b-e44329e91cdc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ce872092-d8b4-4ed3-b9f2-03ff55ed8c6a" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f0afac21-1d8b-482c-9a6b-e44329e91cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_5bcaa24c-bc0a-4394-8161-2410aa04949d" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f0afac21-1d8b-482c-9a6b-e44329e91cdc" xlink:to="loc_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_5bcaa24c-bc0a-4394-8161-2410aa04949d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember_c532192d-439b-4747-8b4f-f65067cb991b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f0afac21-1d8b-482c-9a6b-e44329e91cdc" xlink:to="loc_ifrs-full_TradeReceivablesMember_c532192d-439b-4747-8b4f-f65067cb991b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_21184f12-ddda-4b9a-93e6-3b3efda25ee2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_b8045675-8aa6-4b4c-99cd-7d8b5f44c4a2" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_21184f12-ddda-4b9a-93e6-3b3efda25ee2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_21184f12-ddda-4b9a-93e6-3b3efda25ee2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_21184f12-ddda-4b9a-93e6-3b3efda25ee2" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_21184f12-ddda-4b9a-93e6-3b3efda25ee2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_22120555-b048-43b0-8865-f5b96a204c09" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_21184f12-ddda-4b9a-93e6-3b3efda25ee2" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_22120555-b048-43b0-8865-f5b96a204c09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_fb03e30a-47b2-483d-9518-2e89d0e98ec8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_22120555-b048-43b0-8865-f5b96a204c09" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_fb03e30a-47b2-483d-9518-2e89d0e98ec8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_39efd71c-61f1-490b-98bc-19b089358f0c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_22120555-b048-43b0-8865-f5b96a204c09" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_39efd71c-61f1-490b-98bc-19b089358f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmortizedCostMember_fffd4aa7-ec4a-4507-b458-3a25a1d33a00" xlink:href="gsk-20241231.xsd#gsk_AmortizedCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_22120555-b048-43b0-8865-f5b96a204c09" xlink:to="loc_gsk_AmortizedCostMember_fffd4aa7-ec4a-4507-b458-3a25a1d33a00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_b791aefa-6f57-4047-b04d-0e0eae32b730" xlink:href="gsk-20241231.xsd#gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_b791aefa-6f57-4047-b04d-0e0eae32b730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_4e88d6fc-2876-44f4-a09d-0755855e24bf" xlink:href="gsk-20241231.xsd#gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_4e88d6fc-2876-44f4-a09d-0755855e24bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasuryShares_8bcce96f-9edd-414c-81e7-241f5e06ea67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_TreasuryShares_8bcce96f-9edd-414c-81e7-241f5e06ea67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement_d88feb29-6aab-4b3a-9594-2da53410d5bb" xlink:href="gsk-20241231.xsd#gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement_d88feb29-6aab-4b3a-9594-2da53410d5bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense_459079ab-321e-4e40-a87d-51e01fa92e59" xlink:href="gsk-20241231.xsd#gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense_459079ab-321e-4e40-a87d-51e01fa92e59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable_4ba95d84-6e54-4d0e-90c4-968924efa2b3" xlink:href="gsk-20241231.xsd#gsk_RemeasurementGainLossOfTheContingentConsiderationPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable_4ba95d84-6e54-4d0e-90c4-968924efa2b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_f5f8dc0c-3db1-449a-856e-6cfaf61f2a3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_f5f8dc0c-3db1-449a-856e-6cfaf61f2a3d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_969e350b-4f82-417c-919f-79a747af7b67" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_969e350b-4f82-417c-919f-79a747af7b67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities_24a1f2ac-4881-49f7-89d2-7ffe6c07be2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities_24a1f2ac-4881-49f7-89d2-7ffe6c07be2d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_53098cf8-dccf-43c8-8175-32494e147a8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_53098cf8-dccf-43c8-8175-32494e147a8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivables_12230bed-6e5d-42ca-bb82-6a94522059df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_TradeReceivables_12230bed-6e5d-42ca-bb82-6a94522059df" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_54cc29d9-1b9f-4d0f-9d4d-fd03f7eaa1ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cbe45928-4f6e-456d-85c5-9daa648903cd" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_54cc29d9-1b9f-4d0f-9d4d-fd03f7eaa1ca" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofFairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_3090ba3e-c35d-4eb5-9833-9f1e8e37cda5" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_3090ba3e-c35d-4eb5-9833-9f1e8e37cda5" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_d07ef177-9eab-47d6-a7e0-05e01f0697eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:to="loc_ifrs-full_MeasurementAxis_d07ef177-9eab-47d6-a7e0-05e01f0697eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_d07ef177-9eab-47d6-a7e0-05e01f0697eb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_d07ef177-9eab-47d6-a7e0-05e01f0697eb" xlink:to="loc_ifrs-full_MeasurementDomain_d07ef177-9eab-47d6-a7e0-05e01f0697eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_2f87b512-1338-4a96-8878-30257242d38c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_d07ef177-9eab-47d6-a7e0-05e01f0697eb" xlink:to="loc_ifrs-full_MeasurementDomain_2f87b512-1338-4a96-8878-30257242d38c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_83228c3d-7d6a-4d10-97fd-b43b26983671" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_2f87b512-1338-4a96-8878-30257242d38c" xlink:to="loc_ifrs-full_AtFairValueMember_83228c3d-7d6a-4d10-97fd-b43b26983671" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_e19460c0-c2ae-462b-a26d-44e3a4d19d37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_e19460c0-c2ae-462b-a26d-44e3a4d19d37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_e19460c0-c2ae-462b-a26d-44e3a4d19d37_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_e19460c0-c2ae-462b-a26d-44e3a4d19d37" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_e19460c0-c2ae-462b-a26d-44e3a4d19d37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_5d7e067e-f5d6-4140-b4f3-9a2c9d213d6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_e19460c0-c2ae-462b-a26d-44e3a4d19d37" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_5d7e067e-f5d6-4140-b4f3-9a2c9d213d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_fe7597c9-e58b-4458-b60b-b617ba146a58" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_5d7e067e-f5d6-4140-b4f3-9a2c9d213d6a" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_fe7597c9-e58b-4458-b60b-b617ba146a58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_8beb7c93-d8c8-4cad-a147-796da6ef437c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_5d7e067e-f5d6-4140-b4f3-9a2c9d213d6a" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_8beb7c93-d8c8-4cad-a147-796da6ef437c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_11e91dd3-621e-4a8a-9f44-63f81e772f08" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_5d7e067e-f5d6-4140-b4f3-9a2c9d213d6a" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_11e91dd3-621e-4a8a-9f44-63f81e772f08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_215801ca-f4f4-4255-8aae-af04e5b519e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_215801ca-f4f4-4255-8aae-af04e5b519e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_215801ca-f4f4-4255-8aae-af04e5b519e1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_215801ca-f4f4-4255-8aae-af04e5b519e1" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_215801ca-f4f4-4255-8aae-af04e5b519e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_4b8d48eb-daec-4cb7-be45-0b0e43e92f86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_215801ca-f4f4-4255-8aae-af04e5b519e1" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_4b8d48eb-daec-4cb7-be45-0b0e43e92f86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_c8baa7e2-22b1-43fd-8e0c-756b22b5dc39" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_4b8d48eb-daec-4cb7-be45-0b0e43e92f86" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_c8baa7e2-22b1-43fd-8e0c-756b22b5dc39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_bd4caaf6-f5a6-4f46-8731-d1eaedef99dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_4b8d48eb-daec-4cb7-be45-0b0e43e92f86" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_bd4caaf6-f5a6-4f46-8731-d1eaedef99dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_d3d885d7-dd38-42c2-982f-f894d4ccb468" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_d3d885d7-dd38-42c2-982f-f894d4ccb468" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_d3d885d7-dd38-42c2-982f-f894d4ccb468_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_d3d885d7-dd38-42c2-982f-f894d4ccb468" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_d3d885d7-dd38-42c2-982f-f894d4ccb468_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2e922ea-2f5f-4788-a619-246498689157" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_d3d885d7-dd38-42c2-982f-f894d4ccb468" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2e922ea-2f5f-4788-a619-246498689157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_d07c24ee-315d-4b54-9e93-e3faeaf4f45c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2e922ea-2f5f-4788-a619-246498689157" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_d07c24ee-315d-4b54-9e93-e3faeaf4f45c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember_4c1c5f50-8ff5-4061-8d4d-5eb2110fdbe7" xlink:href="gsk-20241231.xsd#gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2e922ea-2f5f-4788-a619-246498689157" xlink:to="loc_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember_4c1c5f50-8ff5-4061-8d4d-5eb2110fdbe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3973f270-85ee-45d0-91bc-278d6bbb6a0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3973f270-85ee-45d0-91bc-278d6bbb6a0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3973f270-85ee-45d0-91bc-278d6bbb6a0a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3973f270-85ee-45d0-91bc-278d6bbb6a0a" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3973f270-85ee-45d0-91bc-278d6bbb6a0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_827d0566-8f60-4c00-ab35-f441d233bb68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3973f270-85ee-45d0-91bc-278d6bbb6a0a" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_827d0566-8f60-4c00-ab35-f441d233bb68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_92678c22-d1f6-41eb-9c48-49a1941d5d03" xlink:href="gsk-20241231.xsd#gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_827d0566-8f60-4c00-ab35-f441d233bb68" xlink:to="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_92678c22-d1f6-41eb-9c48-49a1941d5d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_81462e20-489c-46a4-81b7-416bebb17d38" xlink:href="gsk-20241231.xsd#gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_827d0566-8f60-4c00-ab35-f441d233bb68" xlink:to="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_81462e20-489c-46a4-81b7-416bebb17d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationLiabilitiesMember_9976d244-610c-452c-bfae-11b1bd9b8a7a" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_827d0566-8f60-4c00-ab35-f441d233bb68" xlink:to="loc_gsk_ContingentConsiderationLiabilitiesMember_9976d244-610c-452c-bfae-11b1bd9b8a7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ff0a7266-4b65-4a00-948c-6a0de01a4c5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e7a36a24-abaa-4d99-8030-f15f64f26f8c" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ff0a7266-4b65-4a00-948c-6a0de01a4c5f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ff0a7266-4b65-4a00-948c-6a0de01a4c5f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ff0a7266-4b65-4a00-948c-6a0de01a4c5f" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ff0a7266-4b65-4a00-948c-6a0de01a4c5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ff0a7266-4b65-4a00-948c-6a0de01a4c5f" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherFinancialInvestmentsMember_22d21bda-13b6-47af-80ef-f0bc2de7cd81" xlink:href="gsk-20241231.xsd#gsk_OtherFinancialInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_OtherFinancialInvestmentsMember_22d21bda-13b6-47af-80ef-f0bc2de7cd81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivableMember_f478b3d7-5d90-4628-82bb-9982fe0ad803" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_TradeAndOtherReceivableMember_f478b3d7-5d90-4628-82bb-9982fe0ad803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentEquityAndOtherInvestmentsMember_86a57ee1-487c-44bb-b26e-0cf94a232682" xlink:href="gsk-20241231.xsd#gsk_CurrentEquityAndOtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_CurrentEquityAndOtherInvestmentsMember_86a57ee1-487c-44bb-b26e-0cf94a232682" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NoncurrentAssetsOtherMember_feef9c0d-0146-42fb-a36b-a91c6ad9301c" xlink:href="gsk-20241231.xsd#gsk_NoncurrentAssetsOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_NoncurrentAssetsOtherMember_feef9c0d-0146-42fb-a36b-a91c6ad9301c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_a7f28299-142a-4169-a3cb-93484e1047a1" xlink:href="gsk-20241231.xsd#gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_a7f28299-142a-4169-a3cb-93484e1047a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsFinancialAssetsMember_e7acbd91-a7e6-46f1-904a-9e271800d157" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_CashAndCashEquivalentsFinancialAssetsMember_e7acbd91-a7e6-46f1-904a-9e271800d157" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_4e8275df-9e7f-4675-90b9-e2e64c63ed68" xlink:href="gsk-20241231.xsd#gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_d75e512b-f43d-411f-b0ac-f0d18a8c9934" xlink:to="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_4e8275df-9e7f-4675-90b9-e2e64c63ed68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_f23ece7f-836d-4954-a3d6-fdaf97ac27bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_3090ba3e-c35d-4eb5-9833-9f1e8e37cda5" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_f23ece7f-836d-4954-a3d6-fdaf97ac27bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_e2f87418-f979-463d-9102-a68bb77fee68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_3090ba3e-c35d-4eb5-9833-9f1e8e37cda5" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_e2f87418-f979-463d-9102-a68bb77fee68" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofMovementinFinancialInstrumentsMeasuredUsingLevel3ValuationMethodDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofMovementinFinancialInstrumentsMeasuredUsingLevel3ValuationMethodDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofMovementinFinancialInstrumentsMeasuredUsingLevel3ValuationMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_eff75358-ccee-4d72-ab68-84a83415a75f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_eff75358-ccee-4d72-ab68-84a83415a75f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_a316599d-79bd-427d-b9e3-36ccb62083ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_eff75358-ccee-4d72-ab68-84a83415a75f" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_a316599d-79bd-427d-b9e3-36ccb62083ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_a316599d-79bd-427d-b9e3-36ccb62083ad_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_a316599d-79bd-427d-b9e3-36ccb62083ad" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_a316599d-79bd-427d-b9e3-36ccb62083ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_369766d8-d8ad-4dcd-ac7a-525b9835128a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_a316599d-79bd-427d-b9e3-36ccb62083ad" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_369766d8-d8ad-4dcd-ac7a-525b9835128a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_53a1138e-c95a-4162-84b7-02a3f1223c70" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_369766d8-d8ad-4dcd-ac7a-525b9835128a" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_53a1138e-c95a-4162-84b7-02a3f1223c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_3607a691-330a-4ba0-a43c-768c2ef024f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_eff75358-ccee-4d72-ab68-84a83415a75f" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_3607a691-330a-4ba0-a43c-768c2ef024f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_3607a691-330a-4ba0-a43c-768c2ef024f5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_3607a691-330a-4ba0-a43c-768c2ef024f5" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_3607a691-330a-4ba0-a43c-768c2ef024f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_d50f0c57-341d-4300-8766-9c62f903a7d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_3607a691-330a-4ba0-a43c-768c2ef024f5" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_d50f0c57-341d-4300-8766-9c62f903a7d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member_e1c1c801-271d-46b0-8639-99e4978bdcf5" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_d50f0c57-341d-4300-8766-9c62f903a7d7" xlink:to="loc_gsk_AiolosBioInc.Member_e1c1c801-271d-46b0-8639-99e4978bdcf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialAssetsAndLiabilities_52cf37b3-dae3-4d10-bb69-995211283794" xlink:href="gsk-20241231.xsd#gsk_FinancialAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_FinancialAssetsAndLiabilities_52cf37b3-dae3-4d10-bb69-995211283794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities_3c4ed480-1f4c-4482-8a34-7acba87027eb" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities_3c4ed480-1f4c-4482-8a34-7acba87027eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities_4504c575-1afc-4631-832e-10c8c3ffbe23" xlink:href="gsk-20241231.xsd#gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities_4504c575-1afc-4631-832e-10c8c3ffbe23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities_4bde1dc6-65e7-463e-b3ac-0e60732e120c" xlink:href="gsk-20241231.xsd#gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities_4bde1dc6-65e7-463e-b3ac-0e60732e120c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_2284d3f9-40c5-4ab0-948b-e184b8bc952b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_2284d3f9-40c5-4ab0-948b-e184b8bc952b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PaymentOfContingentConsiderationLiabilities_d5bcbd91-a33e-4dc0-b3a3-316d0869339c" xlink:href="gsk-20241231.xsd#gsk_PaymentOfContingentConsiderationLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_PaymentOfContingentConsiderationLiabilities_d5bcbd91-a33e-4dc0-b3a3-316d0869339c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities_b048cb95-5f82-492c-b26b-e56fc57c7370" xlink:href="gsk-20241231.xsd#gsk_AdditionsFairValueMeasurementAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities_b048cb95-5f82-492c-b26b-e56fc57c7370" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities_2a4dab8c-3c22-43f2-8340-d3545752be54" xlink:href="gsk-20241231.xsd#gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities_2a4dab8c-3c22-43f2-8340-d3545752be54" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities_cab8d6b7-9f08-499f-9289-59ac7b033357" xlink:href="gsk-20241231.xsd#gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_2f9e6d4c-ef50-4dc8-83e5-a5a77c7d73a1" xlink:to="loc_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities_cab8d6b7-9f08-499f-9289-59ac7b033357" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialAssetsAndLiabilities_b21a4cb4-43bc-4412-8a96-481d944d824e" xlink:href="gsk-20241231.xsd#gsk_FinancialAssetsAndLiabilities"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentsandotherreceivablesandothernoncurrentassetsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentsandotherreceivablesandothernoncurrentassetsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentsandotherreceivablesandothernoncurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_8e5690fa-98e9-4369-b1a8-7f76c916b823" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a6bd2196-8470-4044-bcea-e8ad019aec10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_8e5690fa-98e9-4369-b1a8-7f76c916b823" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a6bd2196-8470-4044-bcea-e8ad019aec10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_be526273-f554-4d2a-bcf2-93b6f3eec10e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a6bd2196-8470-4044-bcea-e8ad019aec10" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_be526273-f554-4d2a-bcf2-93b6f3eec10e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_be526273-f554-4d2a-bcf2-93b6f3eec10e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_be526273-f554-4d2a-bcf2-93b6f3eec10e" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_be526273-f554-4d2a-bcf2-93b6f3eec10e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_be526273-f554-4d2a-bcf2-93b6f3eec10e" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_be5ecd86-9fba-4a4a-9b28-12a007c7e3c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_be5ecd86-9fba-4a4a-9b28-12a007c7e3c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_a24020cb-834c-48a7-addb-d5f6cd88f366" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_a24020cb-834c-48a7-addb-d5f6cd88f366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_a443ceb2-be30-4958-9e6f-220f21deab69" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_a443ceb2-be30-4958-9e6f-220f21deab69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialInstrumentsMember_934f24a4-f712-4cd4-93de-a802e90db7a9" xlink:href="gsk-20241231.xsd#gsk_FinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:to="loc_gsk_FinancialInstrumentsMember_934f24a4-f712-4cd4-93de-a802e90db7a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonFinancialInstrumentsMember_cac68494-fda5-42ed-ba11-fa1e2f0c44c7" xlink:href="gsk-20241231.xsd#gsk_NonFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_f7a44f9b-750b-417d-9a3c-d3fb187135ad" xlink:to="loc_gsk_NonFinancialInstrumentsMember_cac68494-fda5-42ed-ba11-fa1e2f0c44c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ef1f7791-e662-4a3d-8fbc-c8fb063ef389" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a6bd2196-8470-4044-bcea-e8ad019aec10" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ef1f7791-e662-4a3d-8fbc-c8fb063ef389" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ef1f7791-e662-4a3d-8fbc-c8fb063ef389_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ef1f7791-e662-4a3d-8fbc-c8fb063ef389" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_ef1f7791-e662-4a3d-8fbc-c8fb063ef389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_82235ca6-afee-4bdd-8996-ae6eb5a23d60" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_ef1f7791-e662-4a3d-8fbc-c8fb063ef389" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_82235ca6-afee-4bdd-8996-ae6eb5a23d60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_0345304d-6452-4540-a42c-ce8297e8f95c" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_82235ca6-afee-4bdd-8996-ae6eb5a23d60" xlink:to="loc_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_0345304d-6452-4540-a42c-ce8297e8f95c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_48ab5abe-a101-4815-be45-a260ef9f4402" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_8e5690fa-98e9-4369-b1a8-7f76c916b823" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_48ab5abe-a101-4815-be45-a260ef9f4402" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_9680ac5d-1355-4684-abc4-4007382fc1cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_8e5690fa-98e9-4369-b1a8-7f76c916b823" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_9680ac5d-1355-4684-abc4-4007382fc1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_fc9b4eda-e593-412a-8f27-e10fc9e3aee6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_8e5690fa-98e9-4369-b1a8-7f76c916b823" xlink:to="loc_ifrs-full_FinancialAssets_fc9b4eda-e593-412a-8f27-e10fc9e3aee6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresReconciliationoffinancialinstrumentswithinTradeandotherpayablesOtherprovisionsOthernoncurrentliabilitiesandContingentconsiderationliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9808d3f4-210e-4997-a310-871a9c9a78fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9808d3f4-210e-4997-a310-871a9c9a78fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_e980fb8e-fc01-42b4-b0c4-c9c9bf5b7e5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9808d3f4-210e-4997-a310-871a9c9a78fd" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_e980fb8e-fc01-42b4-b0c4-c9c9bf5b7e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_e980fb8e-fc01-42b4-b0c4-c9c9bf5b7e5a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_e980fb8e-fc01-42b4-b0c4-c9c9bf5b7e5a" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_e980fb8e-fc01-42b4-b0c4-c9c9bf5b7e5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_0d118554-6f18-4125-8d58-f1261a0cc0f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_e980fb8e-fc01-42b4-b0c4-c9c9bf5b7e5a" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_0d118554-6f18-4125-8d58-f1261a0cc0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_3567f4c7-daf9-4ace-acd6-a8ec9796ff8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_0d118554-6f18-4125-8d58-f1261a0cc0f0" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_3567f4c7-daf9-4ace-acd6-a8ec9796ff8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_779cdfd1-fb4e-41aa-b413-31924ce38c63" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_0d118554-6f18-4125-8d58-f1261a0cc0f0" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_779cdfd1-fb4e-41aa-b413-31924ce38c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialInstrumentsMember_854b3161-db63-4433-bd8f-3ba068e62c9d" xlink:href="gsk-20241231.xsd#gsk_FinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_0d118554-6f18-4125-8d58-f1261a0cc0f0" xlink:to="loc_gsk_FinancialInstrumentsMember_854b3161-db63-4433-bd8f-3ba068e62c9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonFinancialInstrumentsMember_dfe0fbdc-9472-491c-994c-6de8d47117e0" xlink:href="gsk-20241231.xsd#gsk_NonFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_0d118554-6f18-4125-8d58-f1261a0cc0f0" xlink:to="loc_gsk_NonFinancialInstrumentsMember_dfe0fbdc-9472-491c-994c-6de8d47117e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cd37dd11-53b5-4bf9-a9e6-58d3dfedb46f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9808d3f4-210e-4997-a310-871a9c9a78fd" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cd37dd11-53b5-4bf9-a9e6-58d3dfedb46f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_cd37dd11-53b5-4bf9-a9e6-58d3dfedb46f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cd37dd11-53b5-4bf9-a9e6-58d3dfedb46f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_cd37dd11-53b5-4bf9-a9e6-58d3dfedb46f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3801682c-d203-4f59-a33a-b24e366f526c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_cd37dd11-53b5-4bf9-a9e6-58d3dfedb46f" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3801682c-d203-4f59-a33a-b24e366f526c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member_45d8c852-9c89-48a1-b141-81a5c1f4f7da" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_3801682c-d203-4f59-a33a-b24e366f526c" xlink:to="loc_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member_45d8c852-9c89-48a1-b141-81a5c1f4f7da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayables_012578c8-8d1f-47cb-942d-fb553519ced1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:to="loc_ifrs-full_TradeAndOtherPayables_012578c8-8d1f-47cb-942d-fb553519ced1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_280a7851-0edf-42d3-9299-3de15ee1600a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:to="loc_ifrs-full_OtherProvisions_280a7851-0edf-42d3-9299-3de15ee1600a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_adaf7895-6cff-4d89-992b-983c5dc9080f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_adaf7895-6cff-4d89-992b-983c5dc9080f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_0085929a-c96d-4181-9994-8b1e275b6b99" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_0085929a-c96d-4181-9994-8b1e275b6b99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_687b0cf0-9019-4625-a504-cef485a4936b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9a16081a-b75b-4f88-8168-f4fbce727feb" xlink:to="loc_ifrs-full_FinancialLiabilities_687b0cf0-9019-4625-a504-cef485a4936b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresFairValuesofDerivativesHeldDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresFairValuesofDerivativesHeldDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresFairValuesofDerivativesHeldDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_c216c8fc-a13d-4297-9fe1-02317961f42b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_c216c8fc-a13d-4297-9fe1-02317961f42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_c216c8fc-a13d-4297-9fe1-02317961f42b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_c216c8fc-a13d-4297-9fe1-02317961f42b" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_c216c8fc-a13d-4297-9fe1-02317961f42b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6d99b1f4-6974-4325-b6c3-0d9a2db1187e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_c216c8fc-a13d-4297-9fe1-02317961f42b" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6d99b1f4-6974-4325-b6c3-0d9a2db1187e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_405e8b62-1c99-4e97-8b5c-17f1f92bfa0c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6d99b1f4-6974-4325-b6c3-0d9a2db1187e" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_405e8b62-1c99-4e97-8b5c-17f1f92bfa0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember_272deb11-6721-48a7-9c15-80af7f35df61" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6d99b1f4-6974-4325-b6c3-0d9a2db1187e" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember_272deb11-6721-48a7-9c15-80af7f35df61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_58c24fba-51cc-4b0f-977f-4120e3a79e51" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_58c24fba-51cc-4b0f-977f-4120e3a79e51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_58c24fba-51cc-4b0f-977f-4120e3a79e51_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_58c24fba-51cc-4b0f-977f-4120e3a79e51" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_58c24fba-51cc-4b0f-977f-4120e3a79e51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_773611f5-bae5-4d5e-96ea-ad8914038162" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_58c24fba-51cc-4b0f-977f-4120e3a79e51" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_773611f5-bae5-4d5e-96ea-ad8914038162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeContractsMember_1ae43274-d52c-42fc-a1e3-e185d0a85713" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_773611f5-bae5-4d5e-96ea-ad8914038162" xlink:to="loc_gsk_ForeignExchangeContractsMember_1ae43274-d52c-42fc-a1e3-e185d0a85713" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmbeddedAndOtherDerivativesMember_b9d86088-7907-4d54-84c2-56cf5fc51140" xlink:href="gsk-20241231.xsd#gsk_EmbeddedAndOtherDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_773611f5-bae5-4d5e-96ea-ad8914038162" xlink:to="loc_gsk_EmbeddedAndOtherDerivativesMember_b9d86088-7907-4d54-84c2-56cf5fc51140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionContractMember_c949a7e6-8ce0-4c70-9a6c-51711e37ce1a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_773611f5-bae5-4d5e-96ea-ad8914038162" xlink:to="loc_ifrs-full_OptionContractMember_c949a7e6-8ce0-4c70-9a6c-51711e37ce1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_2378190f-292c-4304-a063-8de8286e7160" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:to="loc_ifrs-full_MaturityAxis_2378190f-292c-4304-a063-8de8286e7160" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_2378190f-292c-4304-a063-8de8286e7160_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_2378190f-292c-4304-a063-8de8286e7160" xlink:to="loc_ifrs-full_MaturityDomain_2378190f-292c-4304-a063-8de8286e7160_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_5701286f-0b36-4c87-b3ab-b62af711b516" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_2378190f-292c-4304-a063-8de8286e7160" xlink:to="loc_ifrs-full_MaturityDomain_5701286f-0b36-4c87-b3ab-b62af711b516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_d8199701-dfbc-4264-a33f-bce060257a10" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_5701286f-0b36-4c87-b3ab-b62af711b516" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_d8199701-dfbc-4264-a33f-bce060257a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_e8716051-0c87-4d48-bc06-594aae092a05" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_5701286f-0b36-4c87-b3ab-b62af711b516" xlink:to="loc_ifrs-full_LaterThanOneYearMember_e8716051-0c87-4d48-bc06-594aae092a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_1bb33078-37d6-463c-99c4-4f69e472e7d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_1bb33078-37d6-463c-99c4-4f69e472e7d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_1bb33078-37d6-463c-99c4-4f69e472e7d7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_1bb33078-37d6-463c-99c4-4f69e472e7d7" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_1bb33078-37d6-463c-99c4-4f69e472e7d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_b93c201a-7dde-4023-a792-e1d9903ce542" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_1bb33078-37d6-463c-99c4-4f69e472e7d7" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_b93c201a-7dde-4023-a792-e1d9903ce542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetInvestmentHedgesMember_dc5d242f-0d8d-43a7-8691-575020810539" xlink:href="gsk-20241231.xsd#gsk_NetInvestmentHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_b93c201a-7dde-4023-a792-e1d9903ce542" xlink:to="loc_gsk_NetInvestmentHedgesMember_dc5d242f-0d8d-43a7-8691-575020810539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_48846b32-7eb6-4aaf-8295-e42234a3d686" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_b93c201a-7dde-4023-a792-e1d9903ce542" xlink:to="loc_ifrs-full_CashFlowHedgesMember_48846b32-7eb6-4aaf-8295-e42234a3d686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_9989b320-c774-41ef-95bf-4c510903fe74" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_ab7b8ed2-30e5-4d47-a466-3ede7a895e47" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_9989b320-c774-41ef-95bf-4c510903fe74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_9989b320-c774-41ef-95bf-4c510903fe74_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_9989b320-c774-41ef-95bf-4c510903fe74" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_9989b320-c774-41ef-95bf-4c510903fe74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_04389b6d-39e7-4e8c-b803-3c7665c44ea3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_9989b320-c774-41ef-95bf-4c510903fe74" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_04389b6d-39e7-4e8c-b803-3c7665c44ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember_f9e67427-e3f7-4c0e-8f3c-bfc5909bc79d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_04389b6d-39e7-4e8c-b803-3c7665c44ea3" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember_f9e67427-e3f7-4c0e-8f3c-bfc5909bc79d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember_baadf00b-c4e1-4f5e-a938-3cde3151f9ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_04389b6d-39e7-4e8c-b803-3c7665c44ea3" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember_baadf00b-c4e1-4f5e-a938-3cde3151f9ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NominalAmountOfHedgingInstrument_9c91fcd7-fe9c-422b-8ad3-bff04eeeb629" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NominalAmountOfHedgingInstrument"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_NominalAmountOfHedgingInstrument_9c91fcd7-fe9c-422b-8ad3-bff04eeeb629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentAssets_ab48032d-cad6-458f-ab58-fa09bec38729" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_HedgingInstrumentAssets_ab48032d-cad6-458f-ab58-fa09bec38729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentLiabilities_0b44de82-f869-49a6-9b46-588710a835ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_HedgingInstrumentLiabilities_0b44de82-f869-49a6-9b46-588710a835ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_58b7b66d-9828-40ad-96a0-233e3e2951ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_58b7b66d-9828-40ad-96a0-233e3e2951ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_41c3387e-fa1d-4a35-bfc6-dca7661fec39" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_41c3387e-fa1d-4a35-bfc6-dca7661fec39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets_a5866dc6-5ced-439b-acc9-30ac6a03d38e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialAssets_a5866dc6-5ced-439b-acc9-30ac6a03d38e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_7835b147-218a-441a-ab32-d408fe21ae23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_7835b147-218a-441a-ab32-d408fe21ae23" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssetsHeldForTrading_3e653389-ed6a-434e-a8fa-e94b8f603c59" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssetsHeldForTrading"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_DerivativeFinancialAssetsHeldForTrading_3e653389-ed6a-434e-a8fa-e94b8f603c59" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading_1faf3a28-f294-40aa-b3a1-e1b58cf934ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading_1faf3a28-f294-40aa-b3a1-e1b58cf934ed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingInstrumentsAndDerivativesAssets_6b50d229-382f-439d-92a9-1c229a69bcb5" xlink:href="gsk-20241231.xsd#gsk_HedgingInstrumentsAndDerivativesAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_gsk_HedgingInstrumentsAndDerivativesAssets_6b50d229-382f-439d-92a9-1c229a69bcb5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingInstrumentsAndDerivativesLiabilities_9b550ec0-bce3-4d76-9bef-ec3f6a154aae" xlink:href="gsk-20241231.xsd#gsk_HedgingInstrumentsAndDerivativesLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_72ee7d8c-221d-4d9d-b448-589fef53a155" xlink:to="loc_gsk_HedgingInstrumentsAndDerivativesLiabilities_9b550ec0-bce3-4d76-9bef-ec3f6a154aae" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueHedgesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresAdditionalInformationFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_bdeae2e1-1261-433f-81f9-900b0f075c23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_bdeae2e1-1261-433f-81f9-900b0f075c23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_bdeae2e1-1261-433f-81f9-900b0f075c23_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_bdeae2e1-1261-433f-81f9-900b0f075c23" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_bdeae2e1-1261-433f-81f9-900b0f075c23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_227d4292-bb91-4d84-b72b-d9dd4206974b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_bdeae2e1-1261-433f-81f9-900b0f075c23" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_227d4292-bb91-4d84-b72b-d9dd4206974b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BondsInDesignatedHedgingRelationshipMember_404da8c2-17c4-42ad-a4ae-1b7bde248e8d" xlink:href="gsk-20241231.xsd#gsk_BondsInDesignatedHedgingRelationshipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_227d4292-bb91-4d84-b72b-d9dd4206974b" xlink:to="loc_gsk_BondsInDesignatedHedgingRelationshipMember_404da8c2-17c4-42ad-a4ae-1b7bde248e8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_5d1a4e36-2a43-42e9-9244-e59965c861cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_5d1a4e36-2a43-42e9-9244-e59965c861cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_5d1a4e36-2a43-42e9-9244-e59965c861cc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_5d1a4e36-2a43-42e9-9244-e59965c861cc" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_5d1a4e36-2a43-42e9-9244-e59965c861cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_ab74e79a-2552-4c95-a41e-8d2c95ad3e28" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_5d1a4e36-2a43-42e9-9244-e59965c861cc" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_ab74e79a-2552-4c95-a41e-8d2c95ad3e28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetInvestmentHedgedMember_d86a8bb5-f8b2-4a34-ba83-deb131e4f9cf" xlink:href="gsk-20241231.xsd#gsk_NetInvestmentHedgedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_ab74e79a-2552-4c95-a41e-8d2c95ad3e28" xlink:to="loc_gsk_NetInvestmentHedgedMember_d86a8bb5-f8b2-4a34-ba83-deb131e4f9cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_c04fb7a8-8fef-4c6a-956a-36e33695def6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_ab74e79a-2552-4c95-a41e-8d2c95ad3e28" xlink:to="loc_ifrs-full_CashFlowHedgesMember_c04fb7a8-8fef-4c6a-956a-36e33695def6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember_3a11deef-e7b1-469c-9785-cefba1df285d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_ab74e79a-2552-4c95-a41e-8d2c95ad3e28" xlink:to="loc_ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember_3a11deef-e7b1-469c-9785-cefba1df285d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_e94f2020-eafa-4cce-8624-bc536a7a7384" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:to="loc_ifrs-full_TypesOfRisksAxis_e94f2020-eafa-4cce-8624-bc536a7a7384" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_e94f2020-eafa-4cce-8624-bc536a7a7384_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_e94f2020-eafa-4cce-8624-bc536a7a7384" xlink:to="loc_ifrs-full_TypesOfRisksDomain_e94f2020-eafa-4cce-8624-bc536a7a7384_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_e94f2020-eafa-4cce-8624-bc536a7a7384" xlink:to="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeRiskMember_5af363a4-168f-45b6-85bb-333e1301d313" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:to="loc_gsk_ForeignExchangeRiskMember_5af363a4-168f-45b6-85bb-333e1301d313" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember_d46f5dc1-b9bb-4b25-90c5-8f4c0391ed4a" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:to="loc_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember_d46f5dc1-b9bb-4b25-90c5-8f4c0391ed4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember_7ddf6038-1bb5-41c2-8738-a033e20b2365" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:to="loc_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember_7ddf6038-1bb5-41c2-8738-a033e20b2365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember_b4ce4983-0194-4f87-a495-162e67c12a19" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:to="loc_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember_b4ce4983-0194-4f87-a495-162e67c12a19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember_b3f3cd94-8216-492f-a9dd-c1b98348ed3d" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_949ac0fc-195a-47c8-b044-65618e027407" xlink:to="loc_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember_b3f3cd94-8216-492f-a9dd-c1b98348ed3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_50b0d2d2-73bd-4f32-8507-21e5aa822102" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_50b0d2d2-73bd-4f32-8507-21e5aa822102" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_50b0d2d2-73bd-4f32-8507-21e5aa822102_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_50b0d2d2-73bd-4f32-8507-21e5aa822102" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_50b0d2d2-73bd-4f32-8507-21e5aa822102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_dc4dd61e-a5ca-48e7-8773-b54c80c92e3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_50b0d2d2-73bd-4f32-8507-21e5aa822102" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_dc4dd61e-a5ca-48e7-8773-b54c80c92e3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeContractsMember_cb2c357f-6f04-45ca-91f3-90f60f5a6137" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_dc4dd61e-a5ca-48e7-8773-b54c80c92e3c" xlink:to="loc_gsk_ForeignExchangeContractsMember_cb2c357f-6f04-45ca-91f3-90f60f5a6137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateSwapContractMember_87427cb1-fe2f-42bb-9ae3-36a43240577b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateSwapContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_dc4dd61e-a5ca-48e7-8773-b54c80c92e3c" xlink:to="loc_ifrs-full_InterestRateSwapContractMember_87427cb1-fe2f-42bb-9ae3-36a43240577b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_6b79c9ba-4d76-492c-a698-001a0e7e09f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_6b79c9ba-4d76-492c-a698-001a0e7e09f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_6b79c9ba-4d76-492c-a698-001a0e7e09f4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_6b79c9ba-4d76-492c-a698-001a0e7e09f4" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_6b79c9ba-4d76-492c-a698-001a0e7e09f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_4e4b9bdc-fe3d-4517-9dee-917a498d1a86" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_6b79c9ba-4d76-492c-a698-001a0e7e09f4" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_4e4b9bdc-fe3d-4517-9dee-917a498d1a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateSensitivityMember_6f03b28b-9e9a-4ae4-9f4b-4e6f8ba312d0" xlink:href="gsk-20241231.xsd#gsk_InterestRateSensitivityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_4e4b9bdc-fe3d-4517-9dee-917a498d1a86" xlink:to="loc_gsk_InterestRateSensitivityMember_6f03b28b-9e9a-4ae4-9f4b-4e6f8ba312d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_40edffd0-dfc9-4605-bf38-20abf8961263" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_faa1c9c1-1f98-4f9c-b14e-3c74de3b814c" xlink:to="loc_srt_LitigationCaseAxis_40edffd0-dfc9-4605-bf38-20abf8961263" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_40edffd0-dfc9-4605-bf38-20abf8961263_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_40edffd0-dfc9-4605-bf38-20abf8961263" xlink:to="loc_srt_LitigationCaseTypeDomain_40edffd0-dfc9-4605-bf38-20abf8961263_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fac9fbcd-5291-4049-ad68-5ea27fc22590" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_40edffd0-dfc9-4605-bf38-20abf8961263" xlink:to="loc_srt_LitigationCaseTypeDomain_fac9fbcd-5291-4049-ad68-5ea27fc22590" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZantacMember_d7bc83b7-0e53-4e60-a51e-be675f5c2870" xlink:href="gsk-20241231.xsd#gsk_ZantacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_fac9fbcd-5291-4049-ad68-5ea27fc22590" xlink:to="loc_gsk_ZantacMember_d7bc83b7-0e53-4e60-a51e-be675f5c2870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments_283d3c7d-9745-46e1-aee2-e2b3e924768c" xlink:href="gsk-20241231.xsd#gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:to="loc_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments_283d3c7d-9745-46e1-aee2-e2b3e924768c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnHedgeIneffectiveness_4a7c9b89-7dad-4cf5-a377-61635e7769ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:to="loc_ifrs-full_GainLossOnHedgeIneffectiveness_4a7c9b89-7dad-4cf5-a377-61635e7769ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied_281f6d4d-37e3-4b31-9831-83ffeadf2bbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:to="loc_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied_281f6d4d-37e3-4b31-9831-83ffeadf2bbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements_4ad93d75-532f-436d-aeb2-e9cf98a24e0f" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:to="loc_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements_4ad93d75-532f-436d-aeb2-e9cf98a24e0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_00c81c87-6861-4cf8-bedb-f729e6bd985a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_462e283a-6374-4198-a565-916b7f5cc3ee" xlink:to="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_00c81c87-6861-4cf8-bedb-f729e6bd985a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofDetailedInformationofForeignExchangeForwardContractsSwapsOutstandingandRelatedHedgedItemsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofDetailedInformationofForeignExchangeForwardContractsSwapsOutstandingandRelatedHedgedItemsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofDetailedInformationofForeignExchangeForwardContractsSwapsOutstandingandRelatedHedgedItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_61efe8a6-c350-4fcf-9034-b07b8adf8f8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_61efe8a6-c350-4fcf-9034-b07b8adf8f8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_3c5e42c0-5077-4cad-bcb3-1e1fa9ffcc3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_61efe8a6-c350-4fcf-9034-b07b8adf8f8a" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_3c5e42c0-5077-4cad-bcb3-1e1fa9ffcc3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_3c5e42c0-5077-4cad-bcb3-1e1fa9ffcc3d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_3c5e42c0-5077-4cad-bcb3-1e1fa9ffcc3d" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_3c5e42c0-5077-4cad-bcb3-1e1fa9ffcc3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_903b3ec5-047b-497b-a93c-9238733aebc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_3c5e42c0-5077-4cad-bcb3-1e1fa9ffcc3d" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_903b3ec5-047b-497b-a93c-9238733aebc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_8a7dc327-339d-4952-8a81-1a61251816aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_903b3ec5-047b-497b-a93c-9238733aebc7" xlink:to="loc_ifrs-full_CashFlowHedgesMember_8a7dc327-339d-4952-8a81-1a61251816aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetInvestmentHedgesMember_90385e47-c035-495d-981f-a3fe55436f5c" xlink:href="gsk-20241231.xsd#gsk_NetInvestmentHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_903b3ec5-047b-497b-a93c-9238733aebc7" xlink:to="loc_gsk_NetInvestmentHedgesMember_90385e47-c035-495d-981f-a3fe55436f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_e93a3242-d81f-478e-bc56-2413952d6502" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_61efe8a6-c350-4fcf-9034-b07b8adf8f8a" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_e93a3242-d81f-478e-bc56-2413952d6502" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_e93a3242-d81f-478e-bc56-2413952d6502_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_e93a3242-d81f-478e-bc56-2413952d6502" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_e93a3242-d81f-478e-bc56-2413952d6502_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_c099a51c-09e8-49e2-9c18-23d2117ba4c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_e93a3242-d81f-478e-bc56-2413952d6502" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_c099a51c-09e8-49e2-9c18-23d2117ba4c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeContractsMember_f464cf14-0fed-48f6-8a12-22cb0309cca9" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_c099a51c-09e8-49e2-9c18-23d2117ba4c1" xlink:to="loc_gsk_ForeignExchangeContractsMember_f464cf14-0fed-48f6-8a12-22cb0309cca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis_6ab1d588-de6d-4955-9c2c-05a0cb580a3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_61efe8a6-c350-4fcf-9034-b07b8adf8f8a" xlink:to="loc_ifrs-full_HedgedItemsAxis_6ab1d588-de6d-4955-9c2c-05a0cb580a3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain_6ab1d588-de6d-4955-9c2c-05a0cb580a3e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgedItemsAxis_6ab1d588-de6d-4955-9c2c-05a0cb580a3e" xlink:to="loc_ifrs-full_HedgedItemsDomain_6ab1d588-de6d-4955-9c2c-05a0cb580a3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgedItemsAxis_6ab1d588-de6d-4955-9c2c-05a0cb580a3e" xlink:to="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellForeignCurrencyLessThanThreeMonthsMember_bfe51e8f-1de2-4d93-a32c-3dcaed0cc225" xlink:href="gsk-20241231.xsd#gsk_SellForeignCurrencyLessThanThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_SellForeignCurrencyLessThanThreeMonthsMember_bfe51e8f-1de2-4d93-a32c-3dcaed0cc225" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellForeignCurrencyThreeToSixMonthsMember_40170ca0-1112-4538-979a-f5c2e69b75cb" xlink:href="gsk-20241231.xsd#gsk_SellForeignCurrencyThreeToSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_SellForeignCurrencyThreeToSixMonthsMember_40170ca0-1112-4538-979a-f5c2e69b75cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellForeignCurrencyOverSixMonthsMember_e064c5e5-0ca2-44e3-a039-c53f8550a96c" xlink:href="gsk-20241231.xsd#gsk_SellForeignCurrencyOverSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_SellForeignCurrencyOverSixMonthsMember_e064c5e5-0ca2-44e3-a039-c53f8550a96c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsLessThanThreeMonthsMember_d92660b9-cc82-4b38-ae41-9445f014e039" xlink:href="gsk-20241231.xsd#gsk_BorrowingsLessThanThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_BorrowingsLessThanThreeMonthsMember_d92660b9-cc82-4b38-ae41-9445f014e039" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingThreeToSixMonthsMember_c8e109a8-be43-416d-a573-ffa57655da1c" xlink:href="gsk-20241231.xsd#gsk_BorrowingThreeToSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_BorrowingThreeToSixMonthsMember_c8e109a8-be43-416d-a573-ffa57655da1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsOverSixMonthsMember_566b2cc8-bb31-4364-a47e-4e2440f45290" xlink:href="gsk-20241231.xsd#gsk_BorrowingsOverSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_BorrowingsOverSixMonthsMember_566b2cc8-bb31-4364-a47e-4e2440f45290" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BuyForeignCurrencyLessThanThreeMonthsMember_84cc8af4-6006-4d81-8969-5f62c44cea6b" xlink:href="gsk-20241231.xsd#gsk_BuyForeignCurrencyLessThanThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_BuyForeignCurrencyLessThanThreeMonthsMember_84cc8af4-6006-4d81-8969-5f62c44cea6b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BuyForeignCurrencyThreeToSixMonthsMember_ac8d4403-10c6-4326-8835-d8d02e6247b9" xlink:href="gsk-20241231.xsd#gsk_BuyForeignCurrencyThreeToSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_BuyForeignCurrencyThreeToSixMonthsMember_ac8d4403-10c6-4326-8835-d8d02e6247b9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BuyForeignCurrencyOverSixMonthsMember_7764d5fd-a2ce-424c-a71d-8d9aae135463" xlink:href="gsk-20241231.xsd#gsk_BuyForeignCurrencyOverSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_BuyForeignCurrencyOverSixMonthsMember_7764d5fd-a2ce-424c-a71d-8d9aae135463" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_99cb6f28-eac3-4bc4-8e33-52fd5b0f620e" xlink:href="gsk-20241231.xsd#gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_99cb6f28-eac3-4bc4-8e33-52fd5b0f620e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_37c07718-a3bd-4882-96b3-f06fdf127cb6" xlink:href="gsk-20241231.xsd#gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_2bdfbf54-b8ab-4c15-b89f-defb97cd86b9" xlink:to="loc_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_37c07718-a3bd-4882-96b3-f06fdf127cb6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_d763ba6a-2f0f-4ecf-932f-9d071f3ebd96" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_61efe8a6-c350-4fcf-9034-b07b8adf8f8a" xlink:to="loc_srt_CurrencyAxis_d763ba6a-2f0f-4ecf-932f-9d071f3ebd96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_d763ba6a-2f0f-4ecf-932f-9d071f3ebd96_default" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_d763ba6a-2f0f-4ecf-932f-9d071f3ebd96" xlink:to="loc_currency_AllCurrenciesDomain_d763ba6a-2f0f-4ecf-932f-9d071f3ebd96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_d763ba6a-2f0f-4ecf-932f-9d071f3ebd96" xlink:to="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_870dbd33-fc38-47d4-9556-e0e1142e1104" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:to="loc_currency_EUR_870dbd33-fc38-47d4-9556-e0e1142e1104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_b9433fc2-ac8d-4c09-931d-589a7998080e" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:to="loc_currency_JPY_b9433fc2-ac8d-4c09-931d-589a7998080e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_c17c24c1-9fbf-489f-b08f-24c091476569" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:to="loc_currency_USD_c17c24c1-9fbf-489f-b08f-24c091476569" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_2c4770f4-57f7-4790-a43f-a1b4721a8976" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:to="loc_currency_CNY_2c4770f4-57f7-4790-a43f-a1b4721a8976" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_ce1ebf30-4a53-4d03-900a-4a7911f46247" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:to="loc_currency_CAD_ce1ebf30-4a53-4d03-900a-4a7911f46247" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_5ed6f59b-a2e1-4ce0-a079-480117eec65d" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_fe37866c-e347-474f-9853-1064643b7c4b" xlink:to="loc_currency_SGD_5ed6f59b-a2e1-4ce0-a079-480117eec65d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageForeignExchangeRate_4191c11a-0736-4a27-92fe-7d7a6ea46053" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_ifrs-full_AverageForeignExchangeRate_4191c11a-0736-4a27-92fe-7d7a6ea46053" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NominalAmountOfHedgingInstrument_405950ce-461e-4d64-9863-41f3d7a2b5a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NominalAmountOfHedgingInstrument"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_ifrs-full_NominalAmountOfHedgingInstrument_405950ce-461e-4d64-9863-41f3d7a2b5a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingInstrumentAtFairValue_0fa73790-ebf6-4ee9-a698-ca575b03134b" xlink:href="gsk-20241231.xsd#gsk_HedgingInstrumentAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_gsk_HedgingInstrumentAtFairValue_0fa73790-ebf6-4ee9-a698-ca575b03134b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness_e036137b-a324-488f-a3aa-ec9b4b1ddd9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness_e036137b-a324-488f-a3aa-ec9b4b1ddd9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges_0909c877-9272-4fbb-9b82-d9f414642114" xlink:href="gsk-20241231.xsd#gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges_0909c877-9272-4fbb-9b82-d9f414642114" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1_aa2c0baf-78d2-41ba-bdad-b83bc55d7f2f" xlink:href="gsk-20241231.xsd#gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_30983bc2-4890-49a9-ae27-1c309c9b7691" xlink:to="loc_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1_aa2c0baf-78d2-41ba-bdad-b83bc55d7f2f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofEffectivenessofHedgingRelationshipsandAmountsReclassifiedfromHedgingReservetoProfitorLossDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofEffectivenessofHedgingRelationshipsandAmountsReclassifiedfromHedgingReservetoProfitorLossDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofEffectivenessofHedgingRelationshipsandAmountsReclassifiedfromHedgingReservetoProfitorLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d4b557f2-7141-4336-9301-f68fba7bbd1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d4b557f2-7141-4336-9301-f68fba7bbd1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_4bded42d-904d-42bb-91a2-90580f0c802f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d4b557f2-7141-4336-9301-f68fba7bbd1f" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_4bded42d-904d-42bb-91a2-90580f0c802f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_4bded42d-904d-42bb-91a2-90580f0c802f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_4bded42d-904d-42bb-91a2-90580f0c802f" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_4bded42d-904d-42bb-91a2-90580f0c802f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_4f946ac8-c316-4d89-a182-b38857ceee98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_4bded42d-904d-42bb-91a2-90580f0c802f" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_4f946ac8-c316-4d89-a182-b38857ceee98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_2f2b4967-c380-48a2-8cdb-f801b2e2a376" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_4f946ac8-c316-4d89-a182-b38857ceee98" xlink:to="loc_ifrs-full_CashFlowHedgesMember_2f2b4967-c380-48a2-8cdb-f801b2e2a376" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember_c5e3198a-ca83-45eb-a615-b9dc74bbb3c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_4f946ac8-c316-4d89-a182-b38857ceee98" xlink:to="loc_ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember_c5e3198a-ca83-45eb-a615-b9dc74bbb3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember_ac5f362e-a7ac-4679-aaaa-637add73cde1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_4f946ac8-c316-4d89-a182-b38857ceee98" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember_ac5f362e-a7ac-4679-aaaa-637add73cde1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis_3d7d18bf-f238-4a1c-98a4-430349b64c7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d4b557f2-7141-4336-9301-f68fba7bbd1f" xlink:to="loc_ifrs-full_HedgedItemsAxis_3d7d18bf-f238-4a1c-98a4-430349b64c7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain_3d7d18bf-f238-4a1c-98a4-430349b64c7a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgedItemsAxis_3d7d18bf-f238-4a1c-98a4-430349b64c7a" xlink:to="loc_ifrs-full_HedgedItemsDomain_3d7d18bf-f238-4a1c-98a4-430349b64c7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain_46e52cef-f5c0-4c15-af42-26be0d0ac73f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgedItemsAxis_3d7d18bf-f238-4a1c-98a4-430349b64c7a" xlink:to="loc_ifrs-full_HedgedItemsDomain_46e52cef-f5c0-4c15-af42-26be0d0ac73f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_dbe32c44-026e-4f70-ac62-fe565063d34f" xlink:href="gsk-20241231.xsd#gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_46e52cef-f5c0-4c15-af42-26be0d0ac73f" xlink:to="loc_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_dbe32c44-026e-4f70-ac62-fe565063d34f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_772b5ad6-a973-4434-8fa0-df6a8842b625" xlink:href="gsk-20241231.xsd#gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_46e52cef-f5c0-4c15-af42-26be0d0ac73f" xlink:to="loc_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_772b5ad6-a973-4434-8fa0-df6a8842b625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax_3ddb0e34-87ae-4601-8037-91341253c5fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax_3ddb0e34-87ae-4601-8037-91341253c5fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax_e22c91c6-5389-4c02-b06d-b0f053e523fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax_e22c91c6-5389-4c02-b06d-b0f053e523fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_acacafd2-0803-41da-bc66-9a5058f7c18b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_acacafd2-0803-41da-bc66-9a5058f7c18b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_46760e64-1071-4e7a-abf5-87ca469f443a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_46760e64-1071-4e7a-abf5-87ca469f443a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax_744e2ac5-2ed8-4cbd-995a-c39ea6d24a3e" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_gsk_ReclassificationAdjustmentsOnNetInvestmentHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax_744e2ac5-2ed8-4cbd-995a-c39ea6d24a3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax_cb4b7de4-755f-48a0-bc8c-542f3dfe0945" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_95262503-b3aa-408d-964e-0516f5db1b92" xlink:to="loc_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax_cb4b7de4-755f-48a0-bc8c-542f3dfe0945" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresEffectivenessofHedgingRelationshipsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresEffectivenessofHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresEffectivenessofHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_732544d6-204a-4446-b2b2-9037fe5e6211" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d1712182-e9a5-4686-90c6-af6182403417" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_732544d6-204a-4446-b2b2-9037fe5e6211" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d1712182-e9a5-4686-90c6-af6182403417" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis_223e35e6-16e1-4a3c-a1cc-c672cd0f011a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d1712182-e9a5-4686-90c6-af6182403417" xlink:to="loc_ifrs-full_HedgedItemsAxis_223e35e6-16e1-4a3c-a1cc-c672cd0f011a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain_223e35e6-16e1-4a3c-a1cc-c672cd0f011a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgedItemsAxis_223e35e6-16e1-4a3c-a1cc-c672cd0f011a" xlink:to="loc_ifrs-full_HedgedItemsDomain_223e35e6-16e1-4a3c-a1cc-c672cd0f011a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain_6bac3518-f673-41d1-be55-688b5989bf6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgedItemsAxis_223e35e6-16e1-4a3c-a1cc-c672cd0f011a" xlink:to="loc_ifrs-full_HedgedItemsDomain_6bac3518-f673-41d1-be55-688b5989bf6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PreHedgingOfLongTermInterestRatesMember_0801a6d7-d288-4ecf-9146-ed80f75d99c5" xlink:href="gsk-20241231.xsd#gsk_PreHedgingOfLongTermInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_6bac3518-f673-41d1-be55-688b5989bf6a" xlink:to="loc_gsk_PreHedgingOfLongTermInterestRatesMember_0801a6d7-d288-4ecf-9146-ed80f75d99c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastDueStatusAxis_f23a8562-c4ef-4feb-b0c9-5ea2eb91a64b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_d1712182-e9a5-4686-90c6-af6182403417" xlink:to="loc_ifrs-full_PastDueStatusAxis_f23a8562-c4ef-4feb-b0c9-5ea2eb91a64b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastDueStatusDomain_f23a8562-c4ef-4feb-b0c9-5ea2eb91a64b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_PastDueStatusAxis_f23a8562-c4ef-4feb-b0c9-5ea2eb91a64b" xlink:to="loc_ifrs-full_PastDueStatusDomain_f23a8562-c4ef-4feb-b0c9-5ea2eb91a64b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastDueStatusDomain_cde48ee0-0a32-4ad3-aff5-08a0616242d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_PastDueStatusAxis_f23a8562-c4ef-4feb-b0c9-5ea2eb91a64b" xlink:to="loc_ifrs-full_PastDueStatusDomain_cde48ee0-0a32-4ad3-aff5-08a0616242d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MaturedInThePastPeriodMember_9656a1e2-2e22-4382-81ca-656595847d97" xlink:href="gsk-20241231.xsd#gsk_MaturedInThePastPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PastDueStatusDomain_cde48ee0-0a32-4ad3-aff5-08a0616242d1" xlink:to="loc_gsk_MaturedInThePastPeriodMember_9656a1e2-2e22-4382-81ca-656595847d97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments_aa299459-b4cd-42bd-9efc-84e3646bc4a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_732544d6-204a-4446-b2b2-9037fe5e6211" xlink:to="loc_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments_aa299459-b4cd-42bd-9efc-84e3646bc4a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_7ca43561-80a8-47b9-82d6-4a00f82ff31c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_732544d6-204a-4446-b2b2-9037fe5e6211" xlink:to="loc_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_7ca43561-80a8-47b9-82d6-4a00f82ff31c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax_cc4ebebe-8c89-4a33-9f03-666e869adbe1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_732544d6-204a-4446-b2b2-9037fe5e6211" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax_cc4ebebe-8c89-4a33-9f03-666e869adbe1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax_e4794bae-2068-4e1a-82a6-d01f958366bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_732544d6-204a-4446-b2b2-9037fe5e6211" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax_e4794bae-2068-4e1a-82a6-d01f958366bc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofOffsettingofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_bc1cf1a4-6cdb-47cb-a70e-7b0837778345" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_bc1cf1a4-6cdb-47cb-a70e-7b0837778345" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsAxis_845609bd-afc2-46f1-8d07-921ee233638c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_bc1cf1a4-6cdb-47cb-a70e-7b0837778345" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsAxis_845609bd-afc2-46f1-8d07-921ee233638c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain_845609bd-afc2-46f1-8d07-921ee233638c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis_845609bd-afc2-46f1-8d07-921ee233638c" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsDomain_845609bd-afc2-46f1-8d07-921ee233638c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain_90754cdd-f91c-4be7-b9c3-c80a368ca5de" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis_845609bd-afc2-46f1-8d07-921ee233638c" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsDomain_90754cdd-f91c-4be7-b9c3-c80a368ca5de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivableMember_cb8f5e2f-c014-4193-8ea0-f8696f7df5ea" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain_90754cdd-f91c-4be7-b9c3-c80a368ca5de" xlink:to="loc_gsk_TradeAndOtherReceivableMember_cb8f5e2f-c014-4193-8ea0-f8696f7df5ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativeFinancialAssetsMember_076d4a74-de1b-4874-8087-e4930e78c4cb" xlink:href="gsk-20241231.xsd#gsk_DerivativeFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain_90754cdd-f91c-4be7-b9c3-c80a368ca5de" xlink:to="loc_gsk_DerivativeFinancialAssetsMember_076d4a74-de1b-4874-8087-e4930e78c4cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialLiabilitiesAxis_2e273695-2469-4355-b46b-c58205620959" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_bc1cf1a4-6cdb-47cb-a70e-7b0837778345" xlink:to="loc_ifrs-full_TypesOfFinancialLiabilitiesAxis_2e273695-2469-4355-b46b-c58205620959" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain_2e273695-2469-4355-b46b-c58205620959_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfFinancialLiabilitiesAxis_2e273695-2469-4355-b46b-c58205620959" xlink:to="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain_2e273695-2469-4355-b46b-c58205620959_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain_cd168071-4376-4451-9cd3-7c74d511af36" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfFinancialLiabilitiesAxis_2e273695-2469-4355-b46b-c58205620959" xlink:to="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain_cd168071-4376-4451-9cd3-7c74d511af36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradesAndOtherPayablesMember_0698847f-e622-47bd-a096-0477708ebcce" xlink:href="gsk-20241231.xsd#gsk_TradesAndOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain_cd168071-4376-4451-9cd3-7c74d511af36" xlink:to="loc_gsk_TradesAndOtherPayablesMember_0698847f-e622-47bd-a096-0477708ebcce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativeFinancialLiabilitiesMember_7a86347b-2c67-4f84-bd78-82ad70026046" xlink:href="gsk-20241231.xsd#gsk_DerivativeFinancialLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain_cd168071-4376-4451-9cd3-7c74d511af36" xlink:to="loc_gsk_DerivativeFinancialLiabilitiesMember_7a86347b-2c67-4f84-bd78-82ad70026046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_bb10f74c-59ee-478c-a3c2-a41344ae0f98" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_bb10f74c-59ee-478c-a3c2-a41344ae0f98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_86966f39-b9da-451e-ac27-aa75555314b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_86966f39-b9da-451e-ac27-aa75555314b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_06c2db54-6b7a-4337-aa2a-56a8dd034f48" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_06c2db54-6b7a-4337-aa2a-56a8dd034f48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets_e3c2d818-2c6f-4134-86bc-f4c8ce08ea27" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets_e3c2d818-2c6f-4134-86bc-f4c8ce08ea27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_2fe01dd5-a0e7-4f94-ad5f-6351a18c7e04" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_2fe01dd5-a0e7-4f94-ad5f-6351a18c7e04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_ab0e9182-ce2e-4114-ae0f-d1cdcdb5b843" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_GrossFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_ab0e9182-ce2e-4114-ae0f-d1cdcdb5b843" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_c581685f-f872-447f-bfe4-cc02ab602149" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_c581685f-f872-447f-bfe4-cc02ab602149" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_14c9f971-54f5-4419-aa6b-0f08ab4c27f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_14c9f971-54f5-4419-aa6b-0f08ab4c27f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities_c5940d91-c798-4b0b-9463-b22e37b091f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities_c5940d91-c798-4b0b-9463-b22e37b091f1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_36782cd5-6d2b-4e5f-a7c3-1310e81920d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_8a6aeac3-dad1-4008-bc87-71d6a42a5106" xlink:to="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_36782cd5-6d2b-4e5f-a7c3-1310e81920d8" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofDebtInterestRateRepricingDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresScheduleofDebtInterestRateRepricingDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresScheduleofDebtInterestRateRepricingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtInterestRateRepricingLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_43aeb72e-6b6d-45a2-ac22-7d8577848c1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_43aeb72e-6b6d-45a2-ac22-7d8577848c1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_49f8e150-1d69-4849-b029-fe5cb0889b69" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_43aeb72e-6b6d-45a2-ac22-7d8577848c1b" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_49f8e150-1d69-4849-b029-fe5cb0889b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_49f8e150-1d69-4849-b029-fe5cb0889b69_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_49f8e150-1d69-4849-b029-fe5cb0889b69" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_49f8e150-1d69-4849-b029-fe5cb0889b69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_bf2c4054-2fc6-4103-a678-f6c6295c9669" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_49f8e150-1d69-4849-b029-fe5cb0889b69" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_bf2c4054-2fc6-4103-a678-f6c6295c9669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FloatingAndFixedRateDebtMember_9f15e36b-4476-4543-88d5-2cf2aebea7b4" xlink:href="gsk-20241231.xsd#gsk_FloatingAndFixedRateDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_bf2c4054-2fc6-4103-a678-f6c6295c9669" xlink:to="loc_gsk_FloatingAndFixedRateDebtMember_9f15e36b-4476-4543-88d5-2cf2aebea7b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_0e1d1a6e-346d-4cbc-99f2-7f914c3d6f5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_bf2c4054-2fc6-4103-a678-f6c6295c9669" xlink:to="loc_ifrs-full_FixedInterestRateMember_0e1d1a6e-346d-4cbc-99f2-7f914c3d6f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember_af28cb43-0964-4a02-9bd9-2d09d3b31bc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_bf2c4054-2fc6-4103-a678-f6c6295c9669" xlink:to="loc_ifrs-full_FloatingInterestRateMember_af28cb43-0964-4a02-9bd9-2d09d3b31bc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_cd6267ba-d66b-4336-aa7a-82ab4a896ffd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_43aeb72e-6b6d-45a2-ac22-7d8577848c1b" xlink:to="loc_ifrs-full_MaturityAxis_cd6267ba-d66b-4336-aa7a-82ab4a896ffd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_cd6267ba-d66b-4336-aa7a-82ab4a896ffd_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_cd6267ba-d66b-4336-aa7a-82ab4a896ffd" xlink:to="loc_ifrs-full_MaturityDomain_cd6267ba-d66b-4336-aa7a-82ab4a896ffd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_cd6267ba-d66b-4336-aa7a-82ab4a896ffd" xlink:to="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_82c0a2a2-c3a0-45b3-9839-c56e20ea52d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanOneYearMember_82c0a2a2-c3a0-45b3-9839-c56e20ea52d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_82bd8e65-cbbf-4183-83bd-5f24b85720d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_82bd8e65-cbbf-4183-83bd-5f24b85720d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_29271b5b-5191-4e38-ac23-22b057326de8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_29271b5b-5191-4e38-ac23-22b057326de8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_c21fbd84-025f-482c-a56c-c0023bbebea6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_c21fbd84-025f-482c-a56c-c0023bbebea6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_08c42f1c-5b47-4a83-82b0-409082837ca6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_08c42f1c-5b47-4a83-82b0-409082837ca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_be917b8c-669e-4592-8ab1-5c0bc99b759f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_be917b8c-669e-4592-8ab1-5c0bc99b759f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_ba2db4b3-1eaa-4d3d-b719-f55b01f58947" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTenYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_83a9650b-e73b-480e-aaaa-6b4690a813ae" xlink:to="loc_ifrs-full_LaterThanTenYearsMember_ba2db4b3-1eaa-4d3d-b719-f55b01f58947" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDebtInstrumentsIssued_6cc210be-cbcc-4e8a-87cb-ef3d7d52e86d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:to="loc_ifrs-full_CurrentDebtInstrumentsIssued_6cc210be-cbcc-4e8a-87cb-ef3d7d52e86d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDebtInstrumentsIssued_9b3328b2-2058-4c25-a9b3-1d79e0e09c9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDebtInstrumentsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:to="loc_ifrs-full_NoncurrentDebtInstrumentsIssued_9b3328b2-2058-4c25-a9b3-1d79e0e09c9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtSecurities_e4fe1f05-b78a-4e06-ac49-1ede3243ea63" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:to="loc_ifrs-full_DebtSecurities_e4fe1f05-b78a-4e06-ac49-1ede3243ea63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestBearingDebt_126634e1-309b-4d03-aa49-08ce0c8e96c3" xlink:href="gsk-20241231.xsd#gsk_InterestBearingDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:to="loc_gsk_InterestBearingDebt_126634e1-309b-4d03-aa49-08ce0c8e96c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonInterestBearingDebt_bdaa5fc6-9d95-479d-a23a-b4c1717b6db3" xlink:href="gsk-20241231.xsd#gsk_NonInterestBearingDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_DisclosureOfDebtInterestRateRepricingLineItems_44cacb78-7551-4f7a-aeb2-c6576d09dac0" xlink:to="loc_gsk_NonInterestBearingDebt_bdaa5fc6-9d95-479d-a23a-b4c1717b6db3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresImpactofNonfunctionalCurrencyForeignExchangeExposuresDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresImpactofNonfunctionalCurrencyForeignExchangeExposuresDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresImpactofNonfunctionalCurrencyForeignExchangeExposuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_dae41688-a4c8-4b83-94fc-31e98710632a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9bb7dbd0-0b2c-4430-82c0-7ad02f1c519d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_dae41688-a4c8-4b83-94fc-31e98710632a" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9bb7dbd0-0b2c-4430-82c0-7ad02f1c519d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_5d3be393-85d9-40a8-8161-00b44beb32e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_9bb7dbd0-0b2c-4430-82c0-7ad02f1c519d" xlink:to="loc_ifrs-full_TypesOfRisksAxis_5d3be393-85d9-40a8-8161-00b44beb32e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_5d3be393-85d9-40a8-8161-00b44beb32e8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_5d3be393-85d9-40a8-8161-00b44beb32e8" xlink:to="loc_ifrs-full_TypesOfRisksDomain_5d3be393-85d9-40a8-8161-00b44beb32e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_5d3be393-85d9-40a8-8161-00b44beb32e8" xlink:to="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_aeffab25-3f43-47e2-ae4e-233714f41cf7" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_aeffab25-3f43-47e2-ae4e-233714f41cf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_a6ef7135-3d65-4d6f-b32d-ae739cfa676b" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_a6ef7135-3d65-4d6f-b32d-ae739cfa676b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_2e70cdfe-8f80-4915-a303-16de031fbbeb" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_2e70cdfe-8f80-4915-a303-16de031fbbeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_a2f3ad13-d31b-4320-b296-cd6fff781391" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_a2f3ad13-d31b-4320-b296-cd6fff781391" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenYenAppreciationOfYenMember_b409bc11-ed9f-4beb-93ec-e1f4502de66e" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenYenAppreciationOfYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskTenYenAppreciationOfYenMember_b409bc11-ed9f-4beb-93ec-e1f4502de66e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember_2b244095-7e18-4b2f-afd4-43c5926cae34" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenYenAppreciationOfYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember_2b244095-7e18-4b2f-afd4-43c5926cae34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember_fb8a0f78-0cfc-4acd-9aff-5389897a85da" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskTenCentDepreciationOfUSDollarMember_fb8a0f78-0cfc-4acd-9aff-5389897a85da" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_7eaadd61-7543-4043-aa45-828788df685c" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_7eaadd61-7543-4043-aa45-828788df685c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_4d551393-76e0-4662-96f2-6f2c83a064a4" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_4d551393-76e0-4662-96f2-6f2c83a064a4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_ac125ae0-6f52-4992-994d-0c516fc590c6" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_ac125ae0-6f52-4992-994d-0c516fc590c6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenYenDepreciationOfYenMember_3428ad2e-05ab-4efb-89ca-7dfc12a98f8f" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenYenDepreciationOfYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskTenYenDepreciationOfYenMember_3428ad2e-05ab-4efb-89ca-7dfc12a98f8f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember_53a9bb3f-962e-4543-964f-ab83c0ac1e1b" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenYenDepreciationOfYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_f29bf984-50ce-4832-8efc-472c1bece260" xlink:to="loc_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember_53a9bb3f-962e-4543-964f-ab83c0ac1e1b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures_0ec8cae1-c2f0-41fc-ae78-e4379c58aa73" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_dae41688-a4c8-4b83-94fc-31e98710632a" xlink:to="loc_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures_0ec8cae1-c2f0-41fc-ae78-e4379c58aa73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures_90f1d75b-40fc-4cae-ad00-63a57bce3bd7" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_dae41688-a4c8-4b83-94fc-31e98710632a" xlink:to="loc_gsk_IncreaseDecreaseInEquityThroughForeignCurrencyExchangeExposures_90f1d75b-40fc-4cae-ad00-63a57bce3bd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures_8164c25b-22c7-4eff-b03d-4a14e16bc23a" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_dae41688-a4c8-4b83-94fc-31e98710632a" xlink:to="loc_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures_8164c25b-22c7-4eff-b03d-4a14e16bc23a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresImpactofInterestRateCurrencyMovementsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresImpactofInterestRateCurrencyMovementsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresImpactofInterestRateCurrencyMovementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_23444205-8e21-4c53-8285-f8747a4d1299" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a21bca98-0c69-4773-a4b6-7b36e5023a21" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_23444205-8e21-4c53-8285-f8747a4d1299" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a21bca98-0c69-4773-a4b6-7b36e5023a21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_031db856-7a59-4ad8-972b-403ac6ae830c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_a21bca98-0c69-4773-a4b6-7b36e5023a21" xlink:to="loc_ifrs-full_TypesOfRisksAxis_031db856-7a59-4ad8-972b-403ac6ae830c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_031db856-7a59-4ad8-972b-403ac6ae830c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_031db856-7a59-4ad8-972b-403ac6ae830c" xlink:to="loc_ifrs-full_TypesOfRisksDomain_031db856-7a59-4ad8-972b-403ac6ae830c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_031db856-7a59-4ad8-972b-403ac6ae830c" xlink:to="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember_5c76c43f-0d5d-4208-a331-5cfd04306427" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:to="loc_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember_5c76c43f-0d5d-4208-a331-5cfd04306427" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember_a3577a36-d5e8-4a9e-8b90-84300b6aacc5" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:to="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember_a3577a36-d5e8-4a9e-8b90-84300b6aacc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember_ef2319bd-4342-40b7-9431-996122766616" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:to="loc_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember_ef2319bd-4342-40b7-9431-996122766616" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember_6ddf542c-2407-48ad-a8c1-9cb2ae1ef978" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:to="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember_6ddf542c-2407-48ad-a8c1-9cb2ae1ef978" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember_c15fa4c6-3c28-4006-a059-7dee2d7e4c21" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:to="loc_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember_c15fa4c6-3c28-4006-a059-7dee2d7e4c21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember_f4f8c0ae-8a1e-4b49-8b2f-c161718fe584" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_0ba13b45-21bd-45f0-9a3a-669256eef99d" xlink:to="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember_f4f8c0ae-8a1e-4b49-8b2f-c161718fe584" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements_c8e539d8-2eb4-4842-81fd-0247977d64fe" xlink:href="gsk-20241231.xsd#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"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_23444205-8e21-4c53-8285-f8747a4d1299" xlink:to="loc_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements_c8e539d8-2eb4-4842-81fd-0247977d64fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofAnticipatedcontractualcashflowsincludinginterestpayablefortheNonDerivativeFinancialliabilitiesonundiscountedbasisDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryofAnticipatedcontractualcashflowsincludinginterestpayablefortheNonDerivativeFinancialliabilitiesonundiscountedbasisDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryofAnticipatedcontractualcashflowsincludinginterestpayablefortheNonDerivativeFinancialliabilitiesonundiscountedbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_58a60ccd-342f-4351-bbbd-b15fcdcd0066" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_58a60ccd-342f-4351-bbbd-b15fcdcd0066" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_7cb012d4-d0e7-4328-aea7-910469cf6f14" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_58a60ccd-342f-4351-bbbd-b15fcdcd0066" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_7cb012d4-d0e7-4328-aea7-910469cf6f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_7cb012d4-d0e7-4328-aea7-910469cf6f14_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_7cb012d4-d0e7-4328-aea7-910469cf6f14" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_7cb012d4-d0e7-4328-aea7-910469cf6f14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_47c30eb2-d5aa-455b-8f5f-ea471f44eaf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_7cb012d4-d0e7-4328-aea7-910469cf6f14" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_47c30eb2-d5aa-455b-8f5f-ea471f44eaf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonDerivativesFinancialLiabilitiesMember_2d3f0511-7025-429c-b5a9-5836f6e2da55" xlink:href="gsk-20241231.xsd#gsk_NonDerivativesFinancialLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_47c30eb2-d5aa-455b-8f5f-ea471f44eaf4" xlink:to="loc_gsk_NonDerivativesFinancialLiabilitiesMember_2d3f0511-7025-429c-b5a9-5836f6e2da55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_2607283f-0803-44e8-99d8-426c4f514f3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_58a60ccd-342f-4351-bbbd-b15fcdcd0066" xlink:to="loc_ifrs-full_MaturityAxis_2607283f-0803-44e8-99d8-426c4f514f3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_2607283f-0803-44e8-99d8-426c4f514f3b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_2607283f-0803-44e8-99d8-426c4f514f3b" xlink:to="loc_ifrs-full_MaturityDomain_2607283f-0803-44e8-99d8-426c4f514f3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_2607283f-0803-44e8-99d8-426c4f514f3b" xlink:to="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_68fb7a84-c039-4f0f-af58-bce3d2981294" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_68fb7a84-c039-4f0f-af58-bce3d2981294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_f736b4e2-991c-4635-8baf-f1ac7ae740ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_f736b4e2-991c-4635-8baf-f1ac7ae740ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_fdce0df7-8c25-43fe-b4e5-256fbe6c03df" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_fdce0df7-8c25-43fe-b4e5-256fbe6c03df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_c8859e4b-baa9-4740-aee2-17aa6db7ba4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_c8859e4b-baa9-4740-aee2-17aa6db7ba4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_2f725cc7-86c5-4f99-b59f-b56aae486cbe" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_2f725cc7-86c5-4f99-b59f-b56aae486cbe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_2c22d5f2-f430-4869-aa0f-da1008c98f3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_2c22d5f2-f430-4869-aa0f-da1008c98f3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_74e2d785-afca-49a0-9404-5439da01091f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTenYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_d9a04c0d-ac8e-4661-b76c-eed90e1d95bd" xlink:to="loc_ifrs-full_LaterThanTenYearsMember_74e2d785-afca-49a0-9404-5439da01091f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_87546e0c-e47d-4ee4-bc1d-43e79c6f1b27" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_87546e0c-e47d-4ee4-bc1d-43e79c6f1b27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_3587628c-4bfe-4f53-a26e-0f79fd716f37" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_3587628c-4bfe-4f53-a26e-0f79fd716f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_e908c4dd-8147-4529-87d6-0a5640ec4898" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_ifrs-full_LeaseLiabilities_e908c4dd-8147-4529-87d6-0a5640ec4898" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FutureFinanceChargeOnFinanceLeases_e560ddd2-c47c-4979-8e65-e153616c7040" xlink:href="gsk-20241231.xsd#gsk_FutureFinanceChargeOnFinanceLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_gsk_FutureFinanceChargeOnFinanceLeases_e560ddd2-c47c-4979-8e65-e153616c7040" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_63b82e2f-7352-4532-afd3-ca08c2d85364" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_63b82e2f-7352-4532-afd3-ca08c2d85364" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_8080b5a9-a7da-46dd-a62d-93177f1ffaff" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_4b15c268-a6d4-4858-aadc-f0e0d27458bc" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_8080b5a9-a7da-46dd-a62d-93177f1ffaff" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryAnticipatedContractualCashFlowsforDerivativeInstrumentsExcludingEmbeddedDerivativesandEquityOptionsUsingUndiscountedCashFlowsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#FinancialinstrumentsandrelateddisclosuresSummaryAnticipatedContractualCashFlowsforDerivativeInstrumentsExcludingEmbeddedDerivativesandEquityOptionsUsingUndiscountedCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/FinancialinstrumentsandrelateddisclosuresSummaryAnticipatedContractualCashFlowsforDerivativeInstrumentsExcludingEmbeddedDerivativesandEquityOptionsUsingUndiscountedCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0fe82672-f084-47a2-89cd-e10848c81418" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_c35f50f9-37b2-42c4-a2a4-b0d3184605e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0fe82672-f084-47a2-89cd-e10848c81418" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_c35f50f9-37b2-42c4-a2a4-b0d3184605e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_bddbff0c-ead8-46d1-9605-72904d97ad6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_c35f50f9-37b2-42c4-a2a4-b0d3184605e7" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_bddbff0c-ead8-46d1-9605-72904d97ad6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_bddbff0c-ead8-46d1-9605-72904d97ad6a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_bddbff0c-ead8-46d1-9605-72904d97ad6a" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_bddbff0c-ead8-46d1-9605-72904d97ad6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_e1b0a1ce-06cd-494e-a1d9-0d948502472e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_bddbff0c-ead8-46d1-9605-72904d97ad6a" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_e1b0a1ce-06cd-494e-a1d9-0d948502472e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember_c338590c-f396-4e60-8e75-a73d326d7e5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_e1b0a1ce-06cd-494e-a1d9-0d948502472e" xlink:to="loc_ifrs-full_DerivativesMember_c338590c-f396-4e60-8e75-a73d326d7e5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_ba64e9cc-e4c3-4dfa-ad4d-41478a379d08" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_c35f50f9-37b2-42c4-a2a4-b0d3184605e7" xlink:to="loc_ifrs-full_MaturityAxis_ba64e9cc-e4c3-4dfa-ad4d-41478a379d08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_ba64e9cc-e4c3-4dfa-ad4d-41478a379d08_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_ba64e9cc-e4c3-4dfa-ad4d-41478a379d08" xlink:to="loc_ifrs-full_MaturityDomain_ba64e9cc-e4c3-4dfa-ad4d-41478a379d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_a03d5a6c-0748-4834-aefe-8b0a8f31e74f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_ba64e9cc-e4c3-4dfa-ad4d-41478a379d08" xlink:to="loc_ifrs-full_MaturityDomain_a03d5a6c-0748-4834-aefe-8b0a8f31e74f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_42d0aac3-7e40-4235-a6af-d2f430c41d06" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_a03d5a6c-0748-4834-aefe-8b0a8f31e74f" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_42d0aac3-7e40-4235-a6af-d2f430c41d06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_eaaa61c1-38a0-4030-ac46-5e5fe0964ca1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_a03d5a6c-0748-4834-aefe-8b0a8f31e74f" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_eaaa61c1-38a0-4030-ac46-5e5fe0964ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_d2bab54e-ef23-4ab9-b4c0-bf22f7477ea2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_c35f50f9-37b2-42c4-a2a4-b0d3184605e7" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_d2bab54e-ef23-4ab9-b4c0-bf22f7477ea2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_d2bab54e-ef23-4ab9-b4c0-bf22f7477ea2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_d2bab54e-ef23-4ab9-b4c0-bf22f7477ea2" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_d2bab54e-ef23-4ab9-b4c0-bf22f7477ea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_b4d16465-d8c2-4a2d-a27f-c8304254c789" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_d2bab54e-ef23-4ab9-b4c0-bf22f7477ea2" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_b4d16465-d8c2-4a2d-a27f-c8304254c789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeForwardContractsAndSwapsMember_4429a159-3cf0-4556-8ba4-ee4363db13a0" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeForwardContractsAndSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_b4d16465-d8c2-4a2d-a27f-c8304254c789" xlink:to="loc_gsk_ForeignExchangeForwardContractsAndSwapsMember_4429a159-3cf0-4556-8ba4-ee4363db13a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_1d933d2d-70df-4f9f-8d8f-f9ed639616e0" xlink:href="gsk-20241231.xsd#gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0fe82672-f084-47a2-89cd-e10848c81418" xlink:to="loc_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_1d933d2d-70df-4f9f-8d8f-f9ed639616e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_682f67e4-553f-4217-a284-52c1946cafac" xlink:href="gsk-20241231.xsd#gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0fe82672-f084-47a2-89cd-e10848c81418" xlink:to="loc_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_682f67e4-553f-4217-a284-52c1946cafac" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeeshareschemesAdditionalInformationDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeeshareschemesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeeshareschemesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e8c2f323-80da-4c6a-b3bd-d9635d5b387a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e8c2f323-80da-4c6a-b3bd-d9635d5b387a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cd3c60a0-ec4c-4718-8ac1-f53a05341901" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e8c2f323-80da-4c6a-b3bd-d9635d5b387a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cd3c60a0-ec4c-4718-8ac1-f53a05341901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cd3c60a0-ec4c-4718-8ac1-f53a05341901_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cd3c60a0-ec4c-4718-8ac1-f53a05341901" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_cd3c60a0-ec4c-4718-8ac1-f53a05341901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_cd3c60a0-ec4c-4718-8ac1-f53a05341901" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareValuePlanMember_2b22ce08-0c45-4a55-9f68-de7bd433b940" xlink:href="gsk-20241231.xsd#gsk_ShareValuePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_ShareValuePlanMember_2b22ce08-0c45-4a55-9f68-de7bd433b940" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedShareOptionSchemesMember_cae95628-f778-4a9e-ac77-25043c1798d6" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedShareOptionSchemesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_SavingsRelatedShareOptionSchemesMember_cae95628-f778-4a9e-ac77-25043c1798d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PerformanceSharePlansMember_d70507d3-ce43-4fb4-82c8-b65a5e89c5db" xlink:href="gsk-20241231.xsd#gsk_PerformanceSharePlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_PerformanceSharePlansMember_d70507d3-ce43-4fb4-82c8-b65a5e89c5db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FreeCashFlowMember_6e2272d0-a24c-480b-bb26-1cba7878cd66" xlink:href="gsk-20241231.xsd#gsk_FreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_FreeCashFlowMember_6e2272d0-a24c-480b-bb26-1cba7878cd66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TsrMember_5eb293cb-37e8-4260-acec-de737194b845" xlink:href="gsk-20241231.xsd#gsk_TsrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_TsrMember_5eb293cb-37e8-4260-acec-de737194b845" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RAndDNewProductPerformanceMember_9bb759e7-ab78-4ff1-931e-993ea3afe938" xlink:href="gsk-20241231.xsd#gsk_RAndDNewProductPerformanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_RAndDNewProductPerformanceMember_9bb759e7-ab78-4ff1-931e-993ea3afe938" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PipelineProgressMember_fb2bba5e-2e0d-490a-ae46-45bdd16ae698" xlink:href="gsk-20241231.xsd#gsk_PipelineProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_PipelineProgressMember_fb2bba5e-2e0d-490a-ae46-45bdd16ae698" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitMeasureMember_35f17a38-5597-4454-b674-354bf6cb8935" xlink:href="gsk-20241231.xsd#gsk_ProfitMeasureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_ProfitMeasureMember_35f17a38-5597-4454-b674-354bf6cb8935" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SaleMeasureMember_1e0700db-b786-4860-8101-ad70d74e5f89" xlink:href="gsk-20241231.xsd#gsk_SaleMeasureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_SaleMeasureMember_1e0700db-b786-4860-8101-ad70d74e5f89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ESGEnvironmentMember_aca131b3-09b7-47ac-8703-3c2e687ad3d7" xlink:href="gsk-20241231.xsd#gsk_ESGEnvironmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_ff4ed913-8ea2-4fd1-b11b-a1e7f4edec1e" xlink:to="loc_gsk_ESGEnvironmentMember_aca131b3-09b7-47ac-8703-3c2e687ad3d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Axis_3b59feac-4421-476b-91f5-f4a1669f21d8" xlink:href="gsk-20241231.xsd#gsk_AwardType1Axis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e8c2f323-80da-4c6a-b3bd-d9635d5b387a" xlink:to="loc_gsk_AwardType1Axis_3b59feac-4421-476b-91f5-f4a1669f21d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Domain_3b59feac-4421-476b-91f5-f4a1669f21d8_default" xlink:href="gsk-20241231.xsd#gsk_AwardType1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_AwardType1Axis_3b59feac-4421-476b-91f5-f4a1669f21d8" xlink:to="loc_gsk_AwardType1Domain_3b59feac-4421-476b-91f5-f4a1669f21d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Domain_3effd394-c9eb-4916-8f6b-afa957d0ff86" xlink:href="gsk-20241231.xsd#gsk_AwardType1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_AwardType1Axis_3b59feac-4421-476b-91f5-f4a1669f21d8" xlink:to="loc_gsk_AwardType1Domain_3effd394-c9eb-4916-8f6b-afa957d0ff86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmericanDepositarySharesMember_69c53844-6221-4078-9739-0fb5d14b9631" xlink:href="gsk-20241231.xsd#gsk_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_AwardType1Domain_3effd394-c9eb-4916-8f6b-afa957d0ff86" xlink:to="loc_gsk_AmericanDepositarySharesMember_69c53844-6221-4078-9739-0fb5d14b9631" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_115b21cc-7e13-48e8-ae64-f83b0a14bc69" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e8c2f323-80da-4c6a-b3bd-d9635d5b387a" xlink:to="loc_ifrs-full_RangeAxis_115b21cc-7e13-48e8-ae64-f83b0a14bc69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_115b21cc-7e13-48e8-ae64-f83b0a14bc69_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_115b21cc-7e13-48e8-ae64-f83b0a14bc69" xlink:to="loc_ifrs-full_RangeDomain_115b21cc-7e13-48e8-ae64-f83b0a14bc69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_aeb726cd-bae3-4c53-b9ce-0bc206261948" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_115b21cc-7e13-48e8-ae64-f83b0a14bc69" xlink:to="loc_ifrs-full_RangeDomain_aeb726cd-bae3-4c53-b9ce-0bc206261948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_82f72c34-5909-445d-a479-fdadaa39fe50" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_aeb726cd-bae3-4c53-b9ce-0bc206261948" xlink:to="loc_ifrs-full_BottomOfRangeMember_82f72c34-5909-445d-a479-fdadaa39fe50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_c7d87329-71f5-4b75-8648-88d51dd4f9e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_aeb726cd-bae3-4c53-b9ce-0bc206261948" xlink:to="loc_ifrs-full_TopOfRangeMember_c7d87329-71f5-4b75-8648-88d51dd4f9e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_3300cbe5-ebd9-4ebf-910a-e1832898d2e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e8c2f323-80da-4c6a-b3bd-d9635d5b387a" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_3300cbe5-ebd9-4ebf-910a-e1832898d2e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_3300cbe5-ebd9-4ebf-910a-e1832898d2e3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_3300cbe5-ebd9-4ebf-910a-e1832898d2e3" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_3300cbe5-ebd9-4ebf-910a-e1832898d2e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_cfa185ae-706c-4f55-9b9f-706b0f0fe031" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_3300cbe5-ebd9-4ebf-910a-e1832898d2e3" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_cfa185ae-706c-4f55-9b9f-706b0f0fe031" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeShareOwnershipPlanMember_8409dc5a-8bce-4b5d-aee4-cc7dd57635fc" xlink:href="gsk-20241231.xsd#gsk_EmployeeShareOwnershipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cfa185ae-706c-4f55-9b9f-706b0f0fe031" xlink:to="loc_gsk_EmployeeShareOwnershipPlanMember_8409dc5a-8bce-4b5d-aee4-cc7dd57635fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember_5c714b2c-9e59-47e5-a7a7-39a2d0e776cf" xlink:href="gsk-20241231.xsd#gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cfa185ae-706c-4f55-9b9f-706b0f0fe031" xlink:to="loc_gsk_EmployeeShareOwnershipPlanHeldForFutureExerciseMember_5c714b2c-9e59-47e5-a7a7-39a2d0e776cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExecutiveSupplementalSavingsPlanMember_0460c3f4-b04b-4470-92e2-7c74d9e429e4" xlink:href="gsk-20241231.xsd#gsk_ExecutiveSupplementalSavingsPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_cfa185ae-706c-4f55-9b9f-706b0f0fe031" xlink:to="loc_gsk_ExecutiveSupplementalSavingsPlanMember_0460c3f4-b04b-4470-92e2-7c74d9e429e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_35e83295-3bae-436e-9c12-ff4e0d446fda" xlink:href="gsk-20241231.xsd#gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_35e83295-3bae-436e-9c12-ff4e0d446fda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AtPercentageBelowMarketPrice_59e83b65-7946-4df9-a62a-450473b4f1b4" xlink:href="gsk-20241231.xsd#gsk_AtPercentageBelowMarketPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_AtPercentageBelowMarketPrice_59e83b65-7946-4df9-a62a-450473b4f1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_a550bfaf-dd9a-4b0f-a4ce-32f6a7afe236" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_a550bfaf-dd9a-4b0f-a4ce-32f6a7afe236" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExpectedFutureDividendYieldPercentageShareGranted_0027bd70-19d0-450f-8981-d1094718b392" xlink:href="gsk-20241231.xsd#gsk_ExpectedFutureDividendYieldPercentageShareGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_ExpectedFutureDividendYieldPercentageShareGranted_0027bd70-19d0-450f-8981-d1094718b392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPerformanceMeasures_1b2ffdad-e4e0-4130-be50-769a3ad9803c" xlink:href="gsk-20241231.xsd#gsk_NumberOfPerformanceMeasures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_NumberOfPerformanceMeasures_1b2ffdad-e4e0-4130-be50-769a3ad9803c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SharePlanPerformanceAssessmentPeriod_d1a650d3-2e2e-4c78-be5a-b1c45ce6a158" xlink:href="gsk-20241231.xsd#gsk_SharePlanPerformanceAssessmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_SharePlanPerformanceAssessmentPeriod_d1a650d3-2e2e-4c78-be5a-b1c45ce6a158" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfPerformanceSharePlan_bfaecfca-c90c-4280-b3f3-0d6bc589f403" xlink:href="gsk-20241231.xsd#gsk_PercentageOfPerformanceSharePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_PercentageOfPerformanceSharePlan_bfaecfca-c90c-4280-b3f3-0d6bc589f403" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement_45f1dffb-8ae2-442a-ab29-ab6ee6134e89" xlink:href="gsk-20241231.xsd#gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement_45f1dffb-8ae2-442a-ab29-ab6ee6134e89" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement_887e4dff-17d0-40b2-9cdd-f0a6e1beec61" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement_887e4dff-17d0-40b2-9cdd-f0a6e1beec61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare_f89c5846-8dff-47e9-8ba1-5b6402cfc06e" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare_f89c5846-8dff-47e9-8ba1-5b6402cfc06e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement_832cf7b0-7cfa-4704-8b52-456e157b198d" xlink:href="gsk-20241231.xsd#gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement_832cf7b0-7cfa-4704-8b52-456e157b198d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_d637eaca-9014-4902-8290-e0ca3555fd81" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_d637eaca-9014-4902-8290-e0ca3555fd81" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement_f26cc2d9-fb8c-4dea-a659-f38bbff2d462" xlink:href="gsk-20241231.xsd#gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement_f26cc2d9-fb8c-4dea-a659-f38bbff2d462" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_d948d467-1dcc-435a-86d9-55b484570393" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2099f803-da7f-4cdb-9a66-16576829b5e4" xlink:to="loc_ifrs-full_NumberOfSharesIssued_d948d467-1dcc-435a-86d9-55b484570393" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeeshareschemesScheduleofNumberofSharesandADSIssuableDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeeshareschemesScheduleofNumberofSharesandADSIssuableDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeeshareschemesScheduleofNumberofSharesandADSIssuableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_be86adb2-2723-48f6-af8b-77a162de64e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_be86adb2-2723-48f6-af8b-77a162de64e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e55317d2-0361-4161-8a16-dafb7b052c5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_be86adb2-2723-48f6-af8b-77a162de64e9" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e55317d2-0361-4161-8a16-dafb7b052c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e55317d2-0361-4161-8a16-dafb7b052c5d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e55317d2-0361-4161-8a16-dafb7b052c5d" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_e55317d2-0361-4161-8a16-dafb7b052c5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_23b357d4-9396-49bf-bcff-2a66d567f918" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e55317d2-0361-4161-8a16-dafb7b052c5d" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_23b357d4-9396-49bf-bcff-2a66d567f918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareValuePlanMember_40651b1f-aec4-4318-91fa-1629a13f6e71" xlink:href="gsk-20241231.xsd#gsk_ShareValuePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_23b357d4-9396-49bf-bcff-2a66d567f918" xlink:to="loc_gsk_ShareValuePlanMember_40651b1f-aec4-4318-91fa-1629a13f6e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Axis_892594f3-2c81-44be-a612-f22ab0e8e4a9" xlink:href="gsk-20241231.xsd#gsk_AwardType1Axis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_be86adb2-2723-48f6-af8b-77a162de64e9" xlink:to="loc_gsk_AwardType1Axis_892594f3-2c81-44be-a612-f22ab0e8e4a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Domain_892594f3-2c81-44be-a612-f22ab0e8e4a9_default" xlink:href="gsk-20241231.xsd#gsk_AwardType1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_AwardType1Axis_892594f3-2c81-44be-a612-f22ab0e8e4a9" xlink:to="loc_gsk_AwardType1Domain_892594f3-2c81-44be-a612-f22ab0e8e4a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Domain_348a0c86-3fc4-41b7-af58-d4f2cb825041" xlink:href="gsk-20241231.xsd#gsk_AwardType1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_AwardType1Axis_892594f3-2c81-44be-a612-f22ab0e8e4a9" xlink:to="loc_gsk_AwardType1Domain_348a0c86-3fc4-41b7-af58-d4f2cb825041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmericanDepositarySharesMember_e979f4ff-e370-4537-92d1-e21687b7380b" xlink:href="gsk-20241231.xsd#gsk_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_AwardType1Domain_348a0c86-3fc4-41b7-af58-d4f2cb825041" xlink:to="loc_gsk_AmericanDepositarySharesMember_e979f4ff-e370-4537-92d1-e21687b7380b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0c9ddfcd-b805-474f-af9c-a8b8003a362e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0c9ddfcd-b805-474f-af9c-a8b8003a362e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_10aa01e5-34b0-451f-90b2-cdf9e0b19038" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_10aa01e5-34b0-451f-90b2-cdf9e0b19038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_08c9a762-8f24-4751-b3ec-9690ceb9e2af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_08c9a762-8f24-4751-b3ec-9690ceb9e2af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_c06cd81d-8dfa-43a1-9ecd-7e0c43e0a7af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_c06cd81d-8dfa-43a1-9ecd-7e0c43e0a7af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_142924d0-49b9-4113-87c6-8a656db7ee93" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_2839723c-6ea7-4211-801f-f9a64ea03250" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_d9abdd79-da63-4b15-8cac-d6ba45829158" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_2839723c-6ea7-4211-801f-f9a64ea03250" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeeshareschemesSummaryofValuationModelUsedtoValuingSavingRelatedOptiontoArriveattheShareBasedPaymentChargeDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeeshareschemesSummaryofValuationModelUsedtoValuingSavingRelatedOptiontoArriveattheShareBasedPaymentChargeDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeeshareschemesSummaryofValuationModelUsedtoValuingSavingRelatedOptiontoArriveattheShareBasedPaymentChargeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_cbb49e61-d177-42d0-9a16-64b31adda49b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_cbb49e61-d177-42d0-9a16-64b31adda49b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_002d6711-cd48-4677-84fd-9169221e2f72" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_cbb49e61-d177-42d0-9a16-64b31adda49b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_002d6711-cd48-4677-84fd-9169221e2f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_002d6711-cd48-4677-84fd-9169221e2f72_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_002d6711-cd48-4677-84fd-9169221e2f72" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_002d6711-cd48-4677-84fd-9169221e2f72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_92da6547-e4ad-468e-9591-819e7e7d5239" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_002d6711-cd48-4677-84fd-9169221e2f72" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_92da6547-e4ad-468e-9591-819e7e7d5239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOptionsAndSavingsRelatedOptionsMember_461d89c7-382a-42d3-96af-3f78158c1006" xlink:href="gsk-20241231.xsd#gsk_ShareOptionsAndSavingsRelatedOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_92da6547-e4ad-468e-9591-819e7e7d5239" xlink:to="loc_gsk_ShareOptionsAndSavingsRelatedOptionsMember_461d89c7-382a-42d3-96af-3f78158c1006" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_658a1339-b073-4916-adf2-7df91a6d0c68" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_658a1339-b073-4916-adf2-7df91a6d0c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendYieldShareOptionsGranted_e37b53b9-a042-44d8-9c72-121bc73e6cfa" xlink:href="gsk-20241231.xsd#gsk_DividendYieldShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_gsk_DividendYieldShareOptionsGranted_e37b53b9-a042-44d8-9c72-121bc73e6cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_d132fd01-8d83-46a9-85c0-adc0baf12537" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_d132fd01-8d83-46a9-85c0-adc0baf12537" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExpectedLifeOfShareOptionsGranted_70cc7729-85db-47cd-9916-f989b5412da7" xlink:href="gsk-20241231.xsd#gsk_ExpectedLifeOfShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_gsk_ExpectedLifeOfShareOptionsGranted_70cc7729-85db-47cd-9916-f989b5412da7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedOptionsGrantPriceDiscount_fd306a95-032e-47f5-beb4-51bc202ee3b8" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedOptionsGrantPriceDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_gsk_SavingsRelatedOptionsGrantPriceDiscount_fd306a95-032e-47f5-beb4-51bc202ee3b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedOptionsGrantPrice_525f5672-6fd1-4611-aea7-505b1f872605" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedOptionsGrantPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_6e59c379-d62d-4294-b99a-b96294242b60" xlink:to="loc_gsk_SavingsRelatedOptionsGrantPrice_525f5672-6fd1-4611-aea7-505b1f872605" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeeshareschemesSummaryofOptionOutstandingDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeeshareschemesSummaryofOptionOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeeshareschemesSummaryofOptionOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4f655bf8-8d20-4569-a412-ecac03177965" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4f655bf8-8d20-4569-a412-ecac03177965" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_72c385f5-384c-41e1-8a08-8c98cbe6ca0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_4f655bf8-8d20-4569-a412-ecac03177965" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_72c385f5-384c-41e1-8a08-8c98cbe6ca0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_72c385f5-384c-41e1-8a08-8c98cbe6ca0a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_72c385f5-384c-41e1-8a08-8c98cbe6ca0a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_72c385f5-384c-41e1-8a08-8c98cbe6ca0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_125e7e15-9398-44fe-bd28-f1e3d49a7c23" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_72c385f5-384c-41e1-8a08-8c98cbe6ca0a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_125e7e15-9398-44fe-bd28-f1e3d49a7c23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedShareOptionSchemesMember_7aa82ec9-ec44-4194-83f8-f7db25be284e" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedShareOptionSchemesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_125e7e15-9398-44fe-bd28-f1e3d49a7c23" xlink:to="loc_gsk_SavingsRelatedShareOptionSchemesMember_7aa82ec9-ec44-4194-83f8-f7db25be284e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_37a74cfc-4802-4ba5-8cc0-6ec53e7b11b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_37a74cfc-4802-4ba5-8cc0-6ec53e7b11b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_8bd71de8-7d20-4aaa-8626-98ed3ba5b6ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_8bd71de8-7d20-4aaa-8626-98ed3ba5b6ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_21a52b71-cfe6-4b70-ad61-84d2810c7903" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_21a52b71-cfe6-4b70-ad61-84d2810c7903" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_00732a45-8303-400f-953f-b5c00d8825fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_00732a45-8303-400f-953f-b5c00d8825fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_d7a027d8-bc19-405a-9a7f-673f00d75c43" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_d7a027d8-bc19-405a-9a7f-673f00d75c43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_5c01527b-c28e-4ad8-b47f-b010da9bcbe2" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ce08915d-2a4d-413d-a52d-8821e3fa3600" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_5c01527b-c28e-4ad8-b47f-b010da9bcbe2" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/EmployeeshareschemesSummaryofSharesHeldforShareAwardSchemesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#EmployeeshareschemesSummaryofSharesHeldforShareAwardSchemesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/EmployeeshareschemesSummaryofSharesHeldforShareAwardSchemesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1692a23d-7c8d-49cb-b275-f41968e68807" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1692a23d-7c8d-49cb-b275-f41968e68807" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_5041866d-6886-4593-998e-3dd159c3d4af" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1692a23d-7c8d-49cb-b275-f41968e68807" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_5041866d-6886-4593-998e-3dd159c3d4af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5041866d-6886-4593-998e-3dd159c3d4af_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_5041866d-6886-4593-998e-3dd159c3d4af" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5041866d-6886-4593-998e-3dd159c3d4af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_24f5b4d0-c909-470c-b441-2ca4f8c7817e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_5041866d-6886-4593-998e-3dd159c3d4af" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_24f5b4d0-c909-470c-b441-2ca4f8c7817e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeShareOwnershipPlanMember_b737c89d-fab0-4803-a13f-92528586c1b9" xlink:href="gsk-20241231.xsd#gsk_EmployeeShareOwnershipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_24f5b4d0-c909-470c-b441-2ca4f8c7817e" xlink:to="loc_gsk_EmployeeShareOwnershipPlanMember_b737c89d-fab0-4803-a13f-92528586c1b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSharesHeldForShareAwardSchemes_f4136b95-ffc9-4fc7-b31d-7a5efe3fe6d4" xlink:href="gsk-20241231.xsd#gsk_NumberOfSharesHeldForShareAwardSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:to="loc_gsk_NumberOfSharesHeldForShareAwardSchemes_f4136b95-ffc9-4fc7-b31d-7a5efe3fe6d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NominalValueOfSharesHeldForShareAwardSchemes_64cc9c1e-264c-4962-9dd9-4153ee0c72dc" xlink:href="gsk-20241231.xsd#gsk_NominalValueOfSharesHeldForShareAwardSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:to="loc_gsk_NominalValueOfSharesHeldForShareAwardSchemes_64cc9c1e-264c-4962-9dd9-4153ee0c72dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfSharesHeldForShareAwardSchemes_7fae8e13-f960-4cb9-aaf1-4b21ffb2a7e7" xlink:href="gsk-20241231.xsd#gsk_CarryingValueOfSharesHeldForShareAwardSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:to="loc_gsk_CarryingValueOfSharesHeldForShareAwardSchemes_7fae8e13-f960-4cb9-aaf1-4b21ffb2a7e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MarketValueOfSharesHeldForShareAwardSchemes_c9738359-b068-457f-9b0f-aed4a3ec5cab" xlink:href="gsk-20241231.xsd#gsk_MarketValueOfSharesHeldForShareAwardSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:to="loc_gsk_MarketValueOfSharesHeldForShareAwardSchemes_c9738359-b068-457f-9b0f-aed4a3ec5cab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSharesHeldForShareOptionSchemes_94458a35-13e9-4a6e-943e-c0fc9e77778e" xlink:href="gsk-20241231.xsd#gsk_NumberOfSharesHeldForShareOptionSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7cd43d9a-25de-462a-b312-7909b0aa22c4" xlink:to="loc_gsk_NumberOfSharesHeldForShareOptionSchemes_94458a35-13e9-4a6e-943e-c0fc9e77778e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PrincipalGroupcompaniesDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PrincipalGroupcompaniesDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PrincipalGroupcompaniesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_79aa97c3-4d7b-493a-9b54-91dc100ee7be" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_fb90d34c-d1d5-4ee6-9d49-7aba2dc25470" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_79aa97c3-4d7b-493a-9b54-91dc100ee7be" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_fb90d34c-d1d5-4ee6-9d49-7aba2dc25470" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_9b10058b-adfa-4073-92ad-202b532cd9fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_fb90d34c-d1d5-4ee6-9d49-7aba2dc25470" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_9b10058b-adfa-4073-92ad-202b532cd9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_9b10058b-adfa-4073-92ad-202b532cd9fc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_9b10058b-adfa-4073-92ad-202b532cd9fc" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_9b10058b-adfa-4073-92ad-202b532cd9fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_9b10058b-adfa-4073-92ad-202b532cd9fc" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoGroupLimitedMember_1209579c-d629-4a0d-99f9-17035f14af7a" xlink:href="gsk-20241231.xsd#gsk_GlaxoGroupLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoGroupLimitedMember_1209579c-d629-4a0d-99f9-17035f14af7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoOperationsUkLimitedMember_c2532b47-6683-4d21-91f9-15772e1c2964" xlink:href="gsk-20241231.xsd#gsk_GlaxoOperationsUkLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoOperationsUkLimitedMember_c2532b47-6683-4d21-91f9-15772e1c2964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeUkLimitedMember_b4533b82-7a10-4622-b913-90f779bd8209" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeUkLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoWellcomeUkLimitedMember_b4533b82-7a10-4622-b913-90f779bd8209" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineCapitalPLCMember_954d327d-ccc9-42a4-b9b4-910b9ae5b3cc" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineCapitalPLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineCapitalPLCMember_954d327d-ccc9-42a4-b9b4-910b9ae5b3cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineExportLimitedMember_009a44e7-0265-4144-95e1-82fb5dcee0c8" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineExportLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineExportLimitedMember_009a44e7-0265-4144-95e1-82fb5dcee0c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineFinancePLCMember_8bfac180-3592-4a1e-8710-7e570a6ae87e" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineFinancePLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineFinancePLCMember_8bfac180-3592-4a1e-8710-7e570a6ae87e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKFinanceNo2LimitedMember_679aad93-9ade-4265-a1d7-69b549b3af63" xlink:href="gsk-20241231.xsd#gsk_GSKFinanceNo2LimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GSKFinanceNo2LimitedMember_679aad93-9ade-4265-a1d7-69b549b3af63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineHoldingsLimitedMember_afea6780-b1dc-4cd5-b244-a1375872d905" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineHoldingsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineHoldingsLimitedMember_afea6780-b1dc-4cd5-b244-a1375872d905" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIhcLimitedMember_8f3a385c-c794-4990-9956-f94327e0bc20" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIhcLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIhcLimitedMember_8f3a385c-c794-4990-9956-f94327e0bc20" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyNo.2LimitedMember_2a568eb1-2850-4930-854a-b85a00c368d2" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyNo.2LimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIntellectualPropertyNo.2LimitedMember_2a568eb1-2850-4930-854a-b85a00c368d2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember_7049302d-489d-49bc-ab19-84c2803536bc" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember_7049302d-489d-49bc-ab19-84c2803536bc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember_d083a077-4c1f-461b-a9a2-2563f7d76113" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember_d083a077-4c1f-461b-a9a2-2563f7d76113" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember_a1a38cea-f59d-4e21-9042-c7b3f7f2fec9" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember_a1a38cea-f59d-4e21-9042-c7b3f7f2fec9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyLimitedMember_7731eb2d-8db7-4f5a-909c-5fa38c005562" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIntellectualPropertyLimitedMember_7731eb2d-8db7-4f5a-909c-5fa38c005562" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember_5dbd66c7-e21b-45f4-9d76-35cf6f84ad5a" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember_5dbd66c7-e21b-45f4-9d76-35cf6f84ad5a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineServicesUnlimitedMember_2444c3ad-7336-4fa5-b8b1-a7404c29479d" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineServicesUnlimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineServicesUnlimitedMember_2444c3ad-7336-4fa5-b8b1-a7404c29479d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember_5f71b0cf-0bd5-41c7-8f67-2e2e54b180b4" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineUnitedKingdomLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember_5f71b0cf-0bd5-41c7-8f67-2e2e54b180b4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineUsTradingLimitedMember_7292943b-bd9e-4613-b803-04b9bd6ad3d4" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineUsTradingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineUsTradingLimitedMember_7292943b-bd9e-4613-b803-04b9bd6ad3d4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SetFirstLimitedMember_0864c115-fe8e-470d-97b8-8717f3bc169a" xlink:href="gsk-20241231.xsd#gsk_SetFirstLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_SetFirstLimitedMember_0864c115-fe8e-470d-97b8-8717f3bc169a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SmithKlineBeechamLimitedMember_c3dab2c0-8227-4e54-a26e-8d189c033518" xlink:href="gsk-20241231.xsd#gsk_SmithKlineBeechamLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_SmithKlineBeechamLimitedMember_c3dab2c0-8227-4e54-a26e-8d189c033518" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareFinanceLimitedMember_81be2d6d-47d9-4795-b6c4-6b662934a3eb" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareFinanceLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViivHealthcareFinanceLimitedMember_81be2d6d-47d9-4795-b6c4-6b662934a3eb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember_be4e543c-0436-44fb-94c0-95d43e656134" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember_be4e543c-0436-44fb-94c0-95d43e656134" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthCareUnitedKingdomLimitedMember_d2458641-c19d-48b0-93d5-a1033232e341" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthCareUnitedKingdomLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViiVHealthCareUnitedKingdomLimitedMember_d2458641-c19d-48b0-93d5-a1033232e341" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineAgMember_77edd98b-c4ef-47ac-8728-014016ab1c51" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineAgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineAgMember_77edd98b-c4ef-47ac-8728-014016ab1c51" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeProductionS.A.SMember_ece6077f-daf5-435c-a1eb-aa9c1d7074d1" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeProductionS.A.SMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoWellcomeProductionS.A.SMember_ece6077f-daf5-435c-a1eb-aa9c1d7074d1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineB.v.Member_ad42d70e-1de1-4962-a3b8-a963e6b8d958" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineB.v.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineB.v.Member_ad42d70e-1de1-4962-a3b8-a963e6b8d958" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineBiologicalsSAMember_8e46a637-d065-4d8d-86b3-a60c6205c35d" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineBiologicalsSAMember_8e46a637-d065-4d8d-86b3-a60c6205c35d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineGmbHAndCoKGMember_c673fe04-bacf-49d7-ae5b-32a69ee3b016" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineGmbHAndCoKGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineGmbHAndCoKGMember_c673fe04-bacf-49d7-ae5b-32a69ee3b016" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineManufacturingSpAMember_90bc71c5-f7a6-41d3-902f-f21dc4a4ae06" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineManufacturingSpAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineManufacturingSpAMember_90bc71c5-f7a6-41d3-902f-f21dc4a4ae06" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklinePharmaGmbhMember_baeb0034-2cd1-4e12-b1e2-9ab85312c15a" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklinePharmaGmbhMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklinePharmaGmbhMember_baeb0034-2cd1-4e12-b1e2-9ab85312c15a" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlinePharmaceuticalsSAMember_fd5c2aed-5d1c-48a2-849b-82041ea6bb5c" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlinePharmaceuticalsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlinePharmaceuticalsSAMember_fd5c2aed-5d1c-48a2-849b-82041ea6bb5c" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineSAMember_4952139b-b9b7-43ad-8fad-29012af01700" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineSAMember_4952139b-b9b7-43ad-8fad-29012af01700" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineSPAMember_a7733fb2-be2d-4d06-85b9-42ae70f623e7" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineSPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineSPAMember_a7733fb2-be2d-4d06-85b9-42ae70f623e7" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member_8e972d2b-715d-46d3-bec3-e13800071d54" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineSingleMemberA.e.b.e.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member_8e972d2b-715d-46d3-bec3-e13800071d54" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineTradingServicesLimitedMember_20bc8e97-2cf0-4e88-aa7b-d4a3e0008e92" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineTradingServicesLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineTradingServicesLimitedMember_20bc8e97-2cf0-4e88-aa7b-d4a3e0008e92" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskCapitalB.v.Member_ed205d8b-337d-41d2-ad60-02357407fa5d" xlink:href="gsk-20241231.xsd#gsk_GskCapitalB.v.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GskCapitalB.v.Member_ed205d8b-337d-41d2-ad60-02357407fa5d" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKServicesSPZOOMember_b913e4aa-4f32-4fb4-b488-fb8808a29da7" xlink:href="gsk-20241231.xsd#gsk_GSKServicesSPZOOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GSKServicesSPZOOMember_b913e4aa-4f32-4fb4-b488-fb8808a29da7" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKVaccinesGmbHMember_1e1c773c-baac-4d3c-a7e3-56efabced899" xlink:href="gsk-20241231.xsd#gsk_GSKVaccinesGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GSKVaccinesGmbHMember_1e1c773c-baac-4d3c-a7e3-56efabced899" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKVaccinesSRLMember_9ac1569f-26a3-4b9f-b420-ebd29d20b5d3" xlink:href="gsk-20241231.xsd#gsk_GSKVaccinesSRLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GSKVaccinesSRLMember_9ac1569f-26a3-4b9f-b420-ebd29d20b5d3" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_JscGlaxosmithklineTradingMember_c7f5adb6-c03b-44ae-9f3a-0e7cd41c09ee" xlink:href="gsk-20241231.xsd#gsk_JscGlaxosmithklineTradingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_JscGlaxosmithklineTradingMember_c7f5adb6-c03b-44ae-9f3a-0e7cd41c09ee" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LaboratoireGlaxoSmithKlineMember_f612676a-a596-4b55-9ff7-b92df4bd907b" xlink:href="gsk-20241231.xsd#gsk_LaboratoireGlaxoSmithKlineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_LaboratoireGlaxoSmithKlineMember_f612676a-a596-4b55-9ff7-b92df4bd907b" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LaboratoriosViiVHealthCareSLMember_e5ce012d-3706-4a57-bae0-6f128626ea5e" xlink:href="gsk-20241231.xsd#gsk_LaboratoriosViiVHealthCareSLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_LaboratoriosViiVHealthCareSLMember_e5ce012d-3706-4a57-bae0-6f128626ea5e" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareGmbhMember_3c9be1d3-e724-4b8f-b1ac-01ae782faca5" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareGmbhMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViivHealthcareGmbhMember_3c9be1d3-e724-4b8f-b1ac-01ae782faca5" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareSRLItalyMember_9eeb0ed1-d76c-497d-b7e2-dd745d400b50" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareSRLItalyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViivHealthcareSRLItalyMember_9eeb0ed1-d76c-497d-b7e2-dd745d400b50" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthcareSASMember_9aa9413e-15f3-49a3-94b9-665f03ad47c3" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthcareSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViiVHealthcareSASMember_9aa9413e-15f3-49a3-94b9-665f03ad47c3" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxIncMember_48a42fcf-0c03-4124-b342-b2fa0a9b6221" xlink:href="gsk-20241231.xsd#gsk_AffinivaxIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_AffinivaxIncMember_48a42fcf-0c03-4124-b342-b2fa0a9b6221" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member_dd8b4931-696d-420a-84c3-a756169dc8ce" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_AiolosBioInc.Member_dd8b4931-696d-420a-84c3-a756169dc8ce" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CorixaCorporationMember_bf23cb42-78c6-4b97-9b31-1011a6f05099" xlink:href="gsk-20241231.xsd#gsk_CorixaCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_CorixaCorporationMember_bf23cb42-78c6-4b97-9b31-1011a6f05099" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineCapitalIncMember_731fe99f-2695-409f-b4f9-34f1b7c818ed" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineCapitalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineCapitalIncMember_731fe99f-2695-409f-b4f9-34f1b7c818ed" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineHoldingsIncMember_b401784f-e9f8-484c-996a-81ea619f8171" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineHoldingsIncMember_b401784f-e9f8-484c-996a-81ea619f8171" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineLLCMember_c05da510-e6ac-43e0-bae0-be063ee873cd" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineLLCMember_c05da510-e6ac-43e0-bae0-be063ee873cd" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HumanGenomeSciencesIncMember_93bd3de8-12b2-49e5-899b-8690a9636436" xlink:href="gsk-20241231.xsd#gsk_HumanGenomeSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_HumanGenomeSciencesIncMember_93bd3de8-12b2-49e5-899b-8690a9636436" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_StiefelLaboratoriesIncMember_d7ea5004-ff73-4ec7-858d-42aefec65272" xlink:href="gsk-20241231.xsd#gsk_StiefelLaboratoriesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_StiefelLaboratoriesIncMember_d7ea5004-ff73-4ec7-858d-42aefec65272" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TesaroMember_6d7ffa50-310f-4b89-af91-2adba58b7a1c" xlink:href="gsk-20241231.xsd#gsk_TesaroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_TesaroMember_6d7ffa50-310f-4b89-af91-2adba58b7a1c" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthcareCompanyMember_169ccbcd-4eb0-49a6-a2e0-0c569c76d49d" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthcareCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViiVHealthcareCompanyMember_169ccbcd-4eb0-49a6-a2e0-0c569c76d49d" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSaudiArabiaLimitedMember_f15c20ba-9a97-493d-a6ec-33f1b6b435ae" xlink:href="gsk-20241231.xsd#gsk_GlaxoSaudiArabiaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSaudiArabiaLimitedMember_f15c20ba-9a97-493d-a6ec-33f1b6b435ae" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKLifeSciencesFZEMember_b34dc8d4-905b-4d55-afaf-51d461cdcb39" xlink:href="gsk-20241231.xsd#gsk_GSKLifeSciencesFZEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GSKLifeSciencesFZEMember_b34dc8d4-905b-4d55-afaf-51d461cdcb39" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineColombiaS.A.Member_aa10b0fb-b131-4144-88cf-3719136ac29f" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineColombiaS.A.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineColombiaS.A.Member_aa10b0fb-b131-4144-88cf-3719136ac29f" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeManufacturingPteLtdMember_6786acfe-388e-4633-b26c-f6fcbb7d9a29" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeManufacturingPteLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoWellcomeManufacturingPteLtdMember_6786acfe-388e-4633-b26c-f6fcbb7d9a29" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineThailandLimitedMember_dcb2f773-e446-4b2f-a767-a0c24419c4d9" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineThailandLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineThailandLimitedMember_dcb2f773-e446-4b2f-a767-a0c24419c4d9" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKBiopharmaArgentinaS.A.Member_e9307b86-f092-472f-a723-2c1e96386e81" xlink:href="gsk-20241231.xsd#gsk_GSKBiopharmaArgentinaS.A.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GSKBiopharmaArgentinaS.A.Member_e9307b86-f092-472f-a723-2c1e96386e81" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineAustraliaPtyLtdMember_4339b594-d4c8-4411-8a7e-0f92428a13be" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineAustraliaPtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineAustraliaPtyLtdMember_4339b594-d4c8-4411-8a7e-0f92428a13be" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineBrasilLimitadaMember_7af6a598-100f-4ea7-aa74-22b85c5e66c5" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineBrasilLimitadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineBrasilLimitadaMember_7af6a598-100f-4ea7-aa74-22b85c5e66c5" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineFarEastB.v.Member_2fee4d6c-6c78-44f3-9ddb-ba511d4d6c43" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineFarEastB.v.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineFarEastB.v.Member_2fee4d6c-6c78-44f3-9ddb-ba511d4d6c43" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member_f4fd2206-dab7-431f-8fc4-bb6095b677a2" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member_f4fd2206-dab7-431f-8fc4-bb6095b677a2" xlink:type="arc" order="64"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineIncMember_5a933026-49c4-4e23-b9c0-f8c78cc7f86e" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineIncMember_5a933026-49c4-4e23-b9c0-f8c78cc7f86e" xlink:type="arc" order="65"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineKKMember_6a0f1bc9-a3a6-4d5c-bfef-d0690541a76b" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineKKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineKKMember_6a0f1bc9-a3a6-4d5c-bfef-d0690541a76b" xlink:type="arc" order="66"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineKoreaLimitedMember_39791dad-7e1d-4fb1-bdca-e42e9d23e409" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineKoreaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineKoreaLimitedMember_39791dad-7e1d-4fb1-bdca-e42e9d23e409" xlink:type="arc" order="67"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineLimitedMember_63dfbaa8-4643-4bb2-af9b-ba360d1fa995" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlineLimitedMember_63dfbaa8-4643-4bb2-af9b-ba360d1fa995" xlink:type="arc" order="68"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member_7279f3c3-b16f-4fa1-bc16-8a434627bff7" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineMexicoS.a.DeC.v.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member_7279f3c3-b16f-4fa1-bc16-8a434627bff7" xlink:type="arc" order="69"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlinePakistanLimitedMember_9c5d98f5-bc95-4b14-b144-7c5f00548120" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlinePakistanLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxoSmithKlinePakistanLimitedMember_9c5d98f5-bc95-4b14-b144-7c5f00548120" xlink:type="arc" order="70"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember_b3920637-6501-40a7-ba82-c88f65c5254b" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember_b3920637-6501-40a7-ba82-c88f65c5254b" xlink:type="arc" order="71"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskEnterpriseManagementCoLtdMember_b6a2f7cc-f9fa-47f1-be6d-f1e30ac34f81" xlink:href="gsk-20241231.xsd#gsk_GskEnterpriseManagementCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GskEnterpriseManagementCoLtdMember_b6a2f7cc-f9fa-47f1-be6d-f1e30ac34f81" xlink:type="arc" order="72"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskPharmaVietnamCompanyLimitedMember_09a5c2df-fc58-4c48-9c6b-feffbd4356b5" xlink:href="gsk-20241231.xsd#gsk_GskPharmaVietnamCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_GskPharmaVietnamCompanyLimitedMember_09a5c2df-fc58-4c48-9c6b-feffbd4356b5" xlink:type="arc" order="73"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IDBiomedicalCorporationOfQuebecMember_8793260a-4a9c-4128-8459-8a6452b3fe23" xlink:href="gsk-20241231.xsd#gsk_IDBiomedicalCorporationOfQuebecMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_IDBiomedicalCorporationOfQuebecMember_8793260a-4a9c-4128-8459-8a6452b3fe23" xlink:type="arc" order="74"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareK.kMember_e64fc4ce-7995-4de2-a385-a963979c4c77" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareK.kMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_8f4a795e-bb6f-4ebf-8da0-caa619ac9b02" xlink:to="loc_gsk_ViivHealthcareK.kMember_e64fc4ce-7995-4de2-a385-a963979c4c77" xlink:type="arc" order="75"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_d7727021-59c4-4b23-840e-114dea3d847e" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_fb90d34c-d1d5-4ee6-9d49-7aba2dc25470" xlink:to="loc_ifrs-full_GeographicalAreasAxis_d7727021-59c4-4b23-840e-114dea3d847e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_d7727021-59c4-4b23-840e-114dea3d847e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_d7727021-59c4-4b23-840e-114dea3d847e" xlink:to="loc_ifrs-full_GeographicalAreasDomain_d7727021-59c4-4b23-840e-114dea3d847e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_d7727021-59c4-4b23-840e-114dea3d847e" xlink:to="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EnglandMember_5c5a54de-7ddb-4c53-b619-5bcbca43adf7" xlink:href="gsk-20241231.xsd#gsk_EnglandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_gsk_EnglandMember_5c5a54de-7ddb-4c53-b619-5bcbca43adf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_2b223bb9-25cd-4c95-ae4a-d09d4a02d4eb" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_CH_2b223bb9-25cd-4c95-ae4a-d09d4a02d4eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_72e03bd3-0e4b-402c-8000-1d4ddea0a366" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_FR_72e03bd3-0e4b-402c-8000-1d4ddea0a366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_4826eda5-2c43-4641-87d2-5a6c07228e50" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_NL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_NL_4826eda5-2c43-4641-87d2-5a6c07228e50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BE_7c80db68-ac96-4209-a984-673ef4f94895" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_BE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_BE_7c80db68-ac96-4209-a984-673ef4f94895" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT_035afeb1-e6f7-43e1-a698-99f531d768c7" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_IT_035afeb1-e6f7-43e1-a698-99f531d768c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_02c584ce-7018-4535-8bb1-f6e226913d61" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_DE_02c584ce-7018-4535-8bb1-f6e226913d61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AT_d1b2a58b-6af5-4bd3-93f0-64735ba1a3a0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_AT_d1b2a58b-6af5-4bd3-93f0-64735ba1a3a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_20e5ce5f-9949-4adf-9341-2302f61ac223" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_ES"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_ES_20e5ce5f-9949-4adf-9341-2302f61ac223" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GR_51f24be8-0bf3-43d2-afb2-d9ed273eee46" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_GR_51f24be8-0bf3-43d2-afb2-d9ed273eee46" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_5851afc0-e1dd-4548-a638-14d64b3b8565" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_IE_5851afc0-e1dd-4548-a638-14d64b3b8565" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PL_74771fd4-a861-45ed-8b3c-0c18fd09f21a" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_PL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_PL_74771fd4-a861-45ed-8b3c-0c18fd09f21a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_RU_3b671ce4-9d74-489c-841c-96b8461dcd75" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_RU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_RU_3b671ce4-9d74-489c-841c-96b8461dcd75" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0c4e3234-8280-4551-8556-d81735d6d58e" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_US_0c4e3234-8280-4551-8556-d81735d6d58e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SA_f7392304-999a-46ce-a304-88963c7c1f0f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_SA_f7392304-999a-46ce-a304-88963c7c1f0f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AE_974ec1ba-6c79-43a2-86c3-ce0d26379437" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_AE_974ec1ba-6c79-43a2-86c3-ce0d26379437" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CO_37079a09-dee3-496e-a4de-60c07be2e6cd" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_CO_37079a09-dee3-496e-a4de-60c07be2e6cd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_0be4ad60-3b6e-489a-bec1-0f1d9f47bc27" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_SG_0be4ad60-3b6e-489a-bec1-0f1d9f47bc27" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TH_b84fd62e-819c-42d7-a195-c049ca6d36e4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_TH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_TH_b84fd62e-819c-42d7-a195-c049ca6d36e4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AR_9c6999fd-91ce-457c-a46b-b3becc2546c1" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_AR_9c6999fd-91ce-457c-a46b-b3becc2546c1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_582fb751-9a5c-4343-b7e8-aafd6ba8b025" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_AU_582fb751-9a5c-4343-b7e8-aafd6ba8b025" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_da8f721c-e4a6-46b0-9ec4-33fd8901efff" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_BR_da8f721c-e4a6-46b0-9ec4-33fd8901efff" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_73db9181-e179-40a1-92a7-be21b609727d" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_TW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_TW_73db9181-e179-40a1-92a7-be21b609727d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR_1308c41d-f9d1-4a3a-8a17-dbd648cd538a" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_TR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_TR_1308c41d-f9d1-4a3a-8a17-dbd648cd538a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_85642d15-6901-47eb-a5e4-6ded2bfe2fe5" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_CA_85642d15-6901-47eb-a5e4-6ded2bfe2fe5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8110d8cd-1fbe-402c-9d36-ae40532e90e9" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_JP_8110d8cd-1fbe-402c-9d36-ae40532e90e9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_550182f6-12e7-4781-b173-f6c3d6e8070a" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_KR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_KR_550182f6-12e7-4781-b173-f6c3d6e8070a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_HK_9081eb88-cfa4-41db-8acd-8387ec9edf03" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_HK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_HK_9081eb88-cfa4-41db-8acd-8387ec9edf03" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_MX_1eb74869-e329-4e88-aeed-62e2a4a92087" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_MX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_MX_1eb74869-e329-4e88-aeed-62e2a4a92087" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PK_4466cfc5-60dc-4d24-84a3-a7122a34b622" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_PK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_PK_4466cfc5-60dc-4d24-84a3-a7122a34b622" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_765ff897-1bcc-4e78-b812-d76d7803f524" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_IN_765ff897-1bcc-4e78-b812-d76d7803f524" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_d5e3e23e-e530-410a-bd96-a7485ee2244d" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_CN_d5e3e23e-e530-410a-bd96-a7485ee2244d" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_VN_5b72b91a-32f1-4e33-93f4-c500f0dbf4ab" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_VN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_21ee6d5b-1f4a-450d-9876-4a04bc050070" xlink:to="loc_country_VN_5b72b91a-32f1-4e33-93f4-c500f0dbf4ab" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1aa4819e-f5af-4063-8545-22a897074ff9" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_79aa97c3-4d7b-493a-9b54-91dc100ee7be" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1aa4819e-f5af-4063-8545-22a897074ff9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#LegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/LegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_88a79b2e-112d-4f2c-84de-e9ce3ace5edd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:to="loc_srt_LitigationCaseAxis_88a79b2e-112d-4f2c-84de-e9ce3ace5edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_88a79b2e-112d-4f2c-84de-e9ce3ace5edd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_88a79b2e-112d-4f2c-84de-e9ce3ace5edd" xlink:to="loc_srt_LitigationCaseTypeDomain_88a79b2e-112d-4f2c-84de-e9ce3ace5edd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_88a79b2e-112d-4f2c-84de-e9ce3ace5edd" xlink:to="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CoregMember_460edb56-992f-4017-b368-6902c637c851" xlink:href="gsk-20241231.xsd#gsk_CoregMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_CoregMember_460edb56-992f-4017-b368-6902c637c851" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MRNAMember_3d7fcfcf-4d9d-4a0d-bf41-0d00f4fa365d" xlink:href="gsk-20241231.xsd#gsk_MRNAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_MRNAMember_3d7fcfcf-4d9d-4a0d-bf41-0d00f4fa365d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RSVMember_7513e10f-f8cc-4ac0-a5c8-655a74f377a1" xlink:href="gsk-20241231.xsd#gsk_RSVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_RSVMember_7513e10f-f8cc-4ac0-a5c8-655a74f377a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AvandiaMember_ef6f97eb-a10e-42aa-abc7-29a7ea0bab10" xlink:href="gsk-20241231.xsd#gsk_AvandiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_AvandiaMember_ef6f97eb-a10e-42aa-abc7-29a7ea0bab10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZantacMember_5c95bc01-8595-4281-902d-046a0716503b" xlink:href="gsk-20241231.xsd#gsk_ZantacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_ZantacMember_5c95bc01-8595-4281-902d-046a0716503b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZantacQuiTamMember_0869e580-17e1-41de-9710-8067637a9065" xlink:href="gsk-20241231.xsd#gsk_ZantacQuiTamMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_ZantacQuiTamMember_0869e580-17e1-41de-9710-8067637a9065" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZofranMember_4a4513bf-f7d4-4a95-a415-f535b9ae458e" xlink:href="gsk-20241231.xsd#gsk_ZofranMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_ZofranMember_4a4513bf-f7d4-4a95-a415-f535b9ae458e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZejulaRoyaltyDisputeMember_7af202b1-e96f-4b04-8a0b-c93f5b1e1ea5" xlink:href="gsk-20241231.xsd#gsk_ZejulaRoyaltyDisputeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c00bc1b-ee10-44f1-9983-8b736fd28f71" xlink:to="loc_gsk_ZejulaRoyaltyDisputeMember_7af202b1-e96f-4b04-8a0b-c93f5b1e1ea5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1e6cc2dc-25b9-4382-9c29-1e8aee2a0ea1" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1e6cc2dc-25b9-4382-9c29-1e8aee2a0ea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1e6cc2dc-25b9-4382-9c29-1e8aee2a0ea1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1e6cc2dc-25b9-4382-9c29-1e8aee2a0ea1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1e6cc2dc-25b9-4382-9c29-1e8aee2a0ea1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_ee6e9440-83a0-488a-b36d-058fc3785ec7" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1e6cc2dc-25b9-4382-9c29-1e8aee2a0ea1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_ee6e9440-83a0-488a-b36d-058fc3785ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_9221bf72-4535-48e5-b40c-f8275ced1dca" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_ee6e9440-83a0-488a-b36d-058fc3785ec7" xlink:to="loc_stpr_DE_9221bf72-4535-48e5-b40c-f8275ced1dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4c6f09b0-8ef3-409f-96c9-afd40131e245" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_ee6e9440-83a0-488a-b36d-058fc3785ec7" xlink:to="loc_country_US_4c6f09b0-8ef3-409f-96c9-afd40131e245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OntarioAndQuebecMember_774baadf-2f69-4837-b550-4c69720c4e1c" xlink:href="gsk-20241231.xsd#gsk_OntarioAndQuebecMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_ee6e9440-83a0-488a-b36d-058fc3785ec7" xlink:to="loc_gsk_OntarioAndQuebecMember_774baadf-2f69-4837-b550-4c69720c4e1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_ed49deaf-8aa4-4550-b7af-c31de81f7f86" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_ee6e9440-83a0-488a-b36d-058fc3785ec7" xlink:to="loc_country_CA_ed49deaf-8aa4-4550-b7af-c31de81f7f86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccineAxis_ebb37d4d-71c9-4d7b-82a0-6866c0ebcd28" xlink:href="gsk-20241231.xsd#gsk_VaccineAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:to="loc_gsk_VaccineAxis_ebb37d4d-71c9-4d7b-82a0-6866c0ebcd28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccineDomain_ebb37d4d-71c9-4d7b-82a0-6866c0ebcd28_default" xlink:href="gsk-20241231.xsd#gsk_VaccineDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_VaccineAxis_ebb37d4d-71c9-4d7b-82a0-6866c0ebcd28" xlink:to="loc_gsk_VaccineDomain_ebb37d4d-71c9-4d7b-82a0-6866c0ebcd28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccineDomain_39ca1575-6dbd-412b-bd0e-8b3afff9325c" xlink:href="gsk-20241231.xsd#gsk_VaccineDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_VaccineAxis_ebb37d4d-71c9-4d7b-82a0-6866c0ebcd28" xlink:to="loc_gsk_VaccineDomain_39ca1575-6dbd-412b-bd0e-8b3afff9325c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SpikevaxMember_1103327e-9e73-4a0f-83b7-2b361b6dba5a" xlink:href="gsk-20241231.xsd#gsk_SpikevaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_VaccineDomain_39ca1575-6dbd-412b-bd0e-8b3afff9325c" xlink:to="loc_gsk_SpikevaxMember_1103327e-9e73-4a0f-83b7-2b361b6dba5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MRESVIAMember_ede33a8f-fc2d-4501-81f3-5b7b443e665a" xlink:href="gsk-20241231.xsd#gsk_MRESVIAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_VaccineDomain_39ca1575-6dbd-412b-bd0e-8b3afff9325c" xlink:to="loc_gsk_MRESVIAMember_ede33a8f-fc2d-4501-81f3-5b7b443e665a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ComirnatyMember_be45af12-87b3-4694-91e9-f232ad5a77ec" xlink:href="gsk-20241231.xsd#gsk_ComirnatyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_VaccineDomain_39ca1575-6dbd-412b-bd0e-8b3afff9325c" xlink:to="loc_gsk_ComirnatyMember_be45af12-87b3-4694-91e9-f232ad5a77ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0b79fe72-715f-4b1d-ab7d-21ad976f7310" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0b79fe72-715f-4b1d-ab7d-21ad976f7310" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0b79fe72-715f-4b1d-ab7d-21ad976f7310_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0b79fe72-715f-4b1d-ab7d-21ad976f7310" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0b79fe72-715f-4b1d-ab7d-21ad976f7310_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_29d61330-ede3-4986-a119-0ef86d5c7346" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0b79fe72-715f-4b1d-ab7d-21ad976f7310" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_29d61330-ede3-4986-a119-0ef86d5c7346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConclusionOfMajorLitigationMember_31c1bfae-bbea-4f6d-a859-e97b928bb9e1" xlink:href="gsk-20241231.xsd#gsk_ConclusionOfMajorLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_29d61330-ede3-4986-a119-0ef86d5c7346" xlink:to="loc_gsk_ConclusionOfMajorLitigationMember_31c1bfae-bbea-4f6d-a859-e97b928bb9e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1384983b-b35c-491b-b03b-53f2bf90fe57" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:to="loc_srt_RangeAxis_1384983b-b35c-491b-b03b-53f2bf90fe57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1384983b-b35c-491b-b03b-53f2bf90fe57_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1384983b-b35c-491b-b03b-53f2bf90fe57" xlink:to="loc_srt_RangeMember_1384983b-b35c-491b-b03b-53f2bf90fe57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e71eb073-8da9-4710-8c62-6091383d6ecf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1384983b-b35c-491b-b03b-53f2bf90fe57" xlink:to="loc_srt_RangeMember_e71eb073-8da9-4710-8c62-6091383d6ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a0167dfa-07f9-41d4-b1d1-d96a4db80821" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e71eb073-8da9-4710-8c62-6091383d6ecf" xlink:to="loc_srt_MinimumMember_a0167dfa-07f9-41d4-b1d1-d96a4db80821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsolidatedStructuredEntitiesAxis_a79ded28-3092-4cdb-8c36-c79c27aa7460" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_9b39d7f0-8240-4c9d-b04c-c4379ccaadd1" xlink:to="loc_ifrs-full_ConsolidatedStructuredEntitiesAxis_a79ded28-3092-4cdb-8c36-c79c27aa7460" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain_a79ded28-3092-4cdb-8c36-c79c27aa7460_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ConsolidatedStructuredEntitiesAxis_a79ded28-3092-4cdb-8c36-c79c27aa7460" xlink:to="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain_a79ded28-3092-4cdb-8c36-c79c27aa7460_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain_bc58e73d-c53d-42a7-999d-1a2cb786be34" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ConsolidatedStructuredEntitiesAxis_a79ded28-3092-4cdb-8c36-c79c27aa7460" xlink:to="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain_bc58e73d-c53d-42a7-999d-1a2cb786be34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKKoreaMember_71fe827b-b06a-42bf-b3bb-935f366528e2" xlink:href="gsk-20241231.xsd#gsk_GSKKoreaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain_bc58e73d-c53d-42a7-999d-1a2cb786be34" xlink:to="loc_gsk_GSKKoreaMember_71fe827b-b06a-42bf-b3bb-935f366528e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKGroupMember_30fb9751-91b8-45a0-88e5-a29dea1cfb02" xlink:href="gsk-20241231.xsd#gsk_GSKGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain_bc58e73d-c53d-42a7-999d-1a2cb786be34" xlink:to="loc_gsk_GSKGroupMember_30fb9751-91b8-45a0-88e5-a29dea1cfb02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalProceedingsProvision_31c450fa-6e51-4d63-ac57-67558bfab64c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_ifrs-full_LegalProceedingsProvision_31c450fa-6e51-4d63-ac57-67558bfab64c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DamagesAwardedToGSK_5d61df80-878f-4119-acd7-c980f219bbf8" xlink:href="gsk-20241231.xsd#gsk_DamagesAwardedToGSK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_DamagesAwardedToGSK_5d61df80-878f-4119-acd7-c980f219bbf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPanelMembersAtRehearing_53099bfe-5fe4-4df0-910d-04d3297ecb60" xlink:href="gsk-20241231.xsd#gsk_NumberOfPanelMembersAtRehearing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPanelMembersAtRehearing_53099bfe-5fe4-4df0-910d-04d3297ecb60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsAllegedlyInfringed_3b0e5452-6f51-4bca-b559-0958726a4db7" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsAllegedlyInfringed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPatentsAllegedlyInfringed_3b0e5452-6f51-4bca-b559-0958726a4db7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed_d78a0328-a1c0-4fd6-b39a-ef5430f3a9eb" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsAllegedlyInvalidlyInfringed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed_d78a0328-a1c0-4fd6-b39a-ef5430f3a9eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsRevocationRequested_5b60d05b-f37a-4959-81f2-d147e14acd01" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsRevocationRequested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPatentsRevocationRequested_5b60d05b-f37a-4959-81f2-d147e14acd01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatents_5649c27a-bbc0-4263-a611-7dcffe43a278" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPatents_5649c27a-bbc0-4263-a611-7dcffe43a278" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsInvalidated_edecc973-347f-4f6f-b91b-f79945b32b4b" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsInvalidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPatentsInvalidated_edecc973-347f-4f6f-b91b-f79945b32b4b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSeparateFirstInstanceHearings_f283729c-262a-45d8-a8fd-835788fc9d19" xlink:href="gsk-20241231.xsd#gsk_NumberOfSeparateFirstInstanceHearings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfSeparateFirstInstanceHearings_f283729c-262a-45d8-a8fd-835788fc9d19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfClassActionsPending_c1b1ddc8-b5e6-4743-ad40-f9a7e3392e88" xlink:href="gsk-20241231.xsd#gsk_NumberOfClassActionsPending"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfClassActionsPending_c1b1ddc8-b5e6-4743-ad40-f9a7e3392e88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached_3e52543a-1ddd-4394-af14-7969a6a19412" xlink:href="gsk-20241231.xsd#gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached_3e52543a-1ddd-4394-af14-7969a6a19412" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfPlaintiffsAgreementReached_03a33d39-6d24-4de9-af1d-ed4eb16454f5" xlink:href="gsk-20241231.xsd#gsk_PercentageOfPlaintiffsAgreementReached"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_PercentageOfPlaintiffsAgreementReached_03a33d39-6d24-4de9-af1d-ed4eb16454f5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingencyNumberOfPlaintiffsInCase_93ed424a-25ec-4ac7-b020-8f9ce5e61962" xlink:href="gsk-20241231.xsd#gsk_LossContingencyNumberOfPlaintiffsInCase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_LossContingencyNumberOfPlaintiffsInCase_93ed424a-25ec-4ac7-b020-8f9ce5e61962" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingencyDamageAwardedValue_b2ab042f-9934-4679-9e5e-c3c090aa4088" xlink:href="gsk-20241231.xsd#gsk_LossContingencyDamageAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_LossContingencyDamageAwardedValue_b2ab042f-9934-4679-9e5e-c3c090aa4088" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCancerTypes_8fba8c69-5c32-4f95-a691-351634ce31b7" xlink:href="gsk-20241231.xsd#gsk_NumberOfCancerTypes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfCancerTypes_8fba8c69-5c32-4f95-a691-351634ce31b7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfStateCasesRemaining_34368a72-16be-4c41-a7ce-1e3d280ca8b7" xlink:href="gsk-20241231.xsd#gsk_PercentageOfStateCasesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_PercentageOfStateCasesRemaining_34368a72-16be-4c41-a7ce-1e3d280ca8b7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPersonalInjuryCasesDefendant_6e0b1aa2-2d0b-4358-8442-82f4580325fa" xlink:href="gsk-20241231.xsd#gsk_NumberOfPersonalInjuryCasesDefendant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfPersonalInjuryCasesDefendant_6e0b1aa2-2d0b-4358-8442-82f4580325fa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfProductLiabilityCasesDismissed_6ae0b472-e28c-4c34-bcd1-f118d2521449" xlink:href="gsk-20241231.xsd#gsk_NumberOfProductLiabilityCasesDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfProductLiabilityCasesDismissed_6ae0b472-e28c-4c34-bcd1-f118d2521449" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfProductLiabilityCases_5e3cd9e5-e978-4036-93ef-0a8be7740288" xlink:href="gsk-20241231.xsd#gsk_NumberOfProductLiabilityCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfProductLiabilityCases_5e3cd9e5-e978-4036-93ef-0a8be7740288" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfStateCourtCases_e4742609-c689-42da-939b-6a7059b79a54" xlink:href="gsk-20241231.xsd#gsk_NumberOfStateCourtCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfStateCourtCases_e4742609-c689-42da-939b-6a7059b79a54" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfEmployeesInterferedWithTenderProcess_86d28f4a-bd0c-4853-be6d-695751bbd18f" xlink:href="gsk-20241231.xsd#gsk_NumberOfEmployeesInterferedWithTenderProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfEmployeesInterferedWithTenderProcess_86d28f4a-bd0c-4853-be6d-695751bbd18f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingenciesDamagesSoughtValue_79f79e6f-7a1e-4ea3-aff9-284193969da5" xlink:href="gsk-20241231.xsd#gsk_LossContingenciesDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_LossContingenciesDamagesSoughtValue_79f79e6f-7a1e-4ea3-aff9-284193969da5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfWorldwidePatentLicenseAgreements_c182ce71-c847-42bc-96d0-919e2b5c1b92" xlink:href="gsk-20241231.xsd#gsk_NumberOfWorldwidePatentLicenseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_6bfd8aec-df89-4599-a584-fef454561a5f" xlink:to="loc_gsk_NumberOfWorldwidePatentLicenseAgreements_c182ce71-c847-42bc-96d0-919e2b5c1b92" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gsk.com/role/PostbalancesheeteventsDetails" xlink:type="simple" xlink:href="gsk-20241231.xsd#PostbalancesheeteventsDetails"/>
  <link:definitionLink xlink:role="http://www.gsk.com/role/PostbalancesheeteventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ac57a407-d5a3-4bd0-9b2c-9856d4378011" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_3da41129-8077-4dc7-985b-7610e4ac7c01" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ac57a407-d5a3-4bd0-9b2c-9856d4378011" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_3da41129-8077-4dc7-985b-7610e4ac7c01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_f5515d32-f8cc-4949-a46a-3670211a4cae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_3da41129-8077-4dc7-985b-7610e4ac7c01" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_f5515d32-f8cc-4949-a46a-3670211a4cae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_f5515d32-f8cc-4949-a46a-3670211a4cae_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_f5515d32-f8cc-4949-a46a-3670211a4cae" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_f5515d32-f8cc-4949-a46a-3670211a4cae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_35d00d29-a65a-49b6-9ff5-67b8f063774c" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_f5515d32-f8cc-4949-a46a-3670211a4cae" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_35d00d29-a65a-49b6-9ff5-67b8f063774c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IDRxInc.Member_5618dd13-a9b5-4a20-898b-e4b6de00f7b5" xlink:href="gsk-20241231.xsd#gsk_IDRxInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_35d00d29-a65a-49b6-9ff5-67b8f063774c" xlink:to="loc_gsk_IDRxInc.Member_5618dd13-a9b5-4a20-898b-e4b6de00f7b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4fb07f83-98a6-48a9-9592-3b0a2a0561ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_3da41129-8077-4dc7-985b-7610e4ac7c01" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4fb07f83-98a6-48a9-9592-3b0a2a0561ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_4fb07f83-98a6-48a9-9592-3b0a2a0561ae_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4fb07f83-98a6-48a9-9592-3b0a2a0561ae" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_4fb07f83-98a6-48a9-9592-3b0a2a0561ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_43155153-ff84-49cc-8e5d-c32e1fbd88b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4fb07f83-98a6-48a9-9592-3b0a2a0561ae" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_43155153-ff84-49cc-8e5d-c32e1fbd88b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorBusinessCombinationMember_2554e20a-f7bd-4018-88e4-16f657d23649" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorBusinessCombinationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_43155153-ff84-49cc-8e5d-c32e1fbd88b0" xlink:to="loc_ifrs-full_MajorBusinessCombinationMember_2554e20a-f7bd-4018-88e4-16f657d23649" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_bf93cd2d-6574-4292-a5fb-1a1212576e5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_43155153-ff84-49cc-8e5d-c32e1fbd88b0" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_bf93cd2d-6574-4292-a5fb-1a1212576e5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TrancheAxis_d32878d1-3c7b-42cc-bf6b-4411580dc476" xlink:href="gsk-20241231.xsd#gsk_TrancheAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_3da41129-8077-4dc7-985b-7610e4ac7c01" xlink:to="loc_gsk_TrancheAxis_d32878d1-3c7b-42cc-bf6b-4411580dc476" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TrancheDomain_d32878d1-3c7b-42cc-bf6b-4411580dc476_default" xlink:href="gsk-20241231.xsd#gsk_TrancheDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gsk_TrancheAxis_d32878d1-3c7b-42cc-bf6b-4411580dc476" xlink:to="loc_gsk_TrancheDomain_d32878d1-3c7b-42cc-bf6b-4411580dc476_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TrancheDomain_5d740728-5140-4c9d-b0c3-8c91ba733ce6" xlink:href="gsk-20241231.xsd#gsk_TrancheDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gsk_TrancheAxis_d32878d1-3c7b-42cc-bf6b-4411580dc476" xlink:to="loc_gsk_TrancheDomain_5d740728-5140-4c9d-b0c3-8c91ba733ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FirstTrancheMember_f2a7c5b9-d8df-4667-85eb-ba2e69201263" xlink:href="gsk-20241231.xsd#gsk_FirstTrancheMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gsk_TrancheDomain_5d740728-5140-4c9d-b0c3-8c91ba733ce6" xlink:to="loc_gsk_FirstTrancheMember_f2a7c5b9-d8df-4667-85eb-ba2e69201263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_e70b7798-e415-4e77-8e95-c558330eacc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ac57a407-d5a3-4bd0-9b2c-9856d4378011" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_e70b7798-e415-4e77-8e95-c558330eacc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UpfrontCashConsiderationPaidReceived_38b21be3-f0c2-416c-b763-00c03639d9f7" xlink:href="gsk-20241231.xsd#gsk_UpfrontCashConsiderationPaidReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ac57a407-d5a3-4bd0-9b2c-9856d4378011" xlink:to="loc_gsk_UpfrontCashConsiderationPaidReceived_38b21be3-f0c2-416c-b763-00c03639d9f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_1a00bb77-f489-4ca1-b1e0-eae00768b605" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ac57a407-d5a3-4bd0-9b2c-9856d4378011" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_1a00bb77-f489-4ca1-b1e0-eae00768b605" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_c1c3112f-7933-4fce-aba0-3ff753e2bff2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ac57a407-d5a3-4bd0-9b2c-9856d4378011" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_c1c3112f-7933-4fce-aba0-3ff753e2bff2" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>gsk-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3a546e24-b21d-4f2c-8496-4bed728e8d38,g:19b91481-759e-443e-bc09-8752e6669383-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_gsk_OtherLongtermBorrowingsMember_cb11d6c5-88da-4bd8-846e-6371c5f7ef30_terseLabel_en-US" xlink:label="lab_gsk_OtherLongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term borrowings</link:label>
    <link:label id="lab_gsk_OtherLongtermBorrowingsMember_label_en-US" xlink:label="lab_gsk_OtherLongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other LongTerm Borrowings [member]</link:label>
    <link:label id="lab_gsk_OtherLongtermBorrowingsMember_documentation_en-US" xlink:label="lab_gsk_OtherLongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other long term borrowings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherLongtermBorrowingsMember" xlink:href="gsk-20241231.xsd#gsk_OtherLongtermBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherLongtermBorrowingsMember" xlink:to="lab_gsk_OtherLongtermBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts_8aba4fea-a913-4ef6-a546-62411b72bdf0_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average interest rate on current bank loans and overdrafts</link:label>
    <link:label id="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts_label_en-US" xlink:label="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Interest Rate On Current Bank Loans And Overdrafts</link:label>
    <link:label id="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts_documentation_en-US" xlink:label="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average interest rate on current bank loans and overdrafts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" xlink:to="lab_gsk_WeightedAverageInterestRateOnCurrentBankLoansAndOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5022476c-067f-4c32-b762-a5e37f93c8be_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures_6a43b129-99d8-4c20-b476-6a1a6dc8273c_negatedLabel_en-US" xlink:label="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Distributions received</link:label>
    <link:label id="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures_label_en-US" xlink:label="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distributions Received in Investments in Associates and Joint Ventures</link:label>
    <link:label id="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distributions received in investments in associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" xlink:href="gsk-20241231.xsd#gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" xlink:to="lab_gsk_DistributionsReceivedInInvestmentsInAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_e15779e5-6a63-456d-b18a-302354a8a180_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfCountriesWithPensionSurpluses_607b544d-8345-49dc-b904-e18481853c98_terseLabel_en-US" xlink:label="lab_gsk_NumberOfCountriesWithPensionSurpluses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of countries with pension surpluses</link:label>
    <link:label id="lab_gsk_NumberOfCountriesWithPensionSurpluses_label_en-US" xlink:label="lab_gsk_NumberOfCountriesWithPensionSurpluses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Countries With Pension Surpluses</link:label>
    <link:label id="lab_gsk_NumberOfCountriesWithPensionSurpluses_documentation_en-US" xlink:label="lab_gsk_NumberOfCountriesWithPensionSurpluses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Countries With Pension Surpluses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCountriesWithPensionSurpluses" xlink:href="gsk-20241231.xsd#gsk_NumberOfCountriesWithPensionSurpluses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfCountriesWithPensionSurpluses" xlink:to="lab_gsk_NumberOfCountriesWithPensionSurpluses" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember_e1542eb7-d3b8-4d1d-ade3-5a2c4ce980cb_terseLabel_en-US" xlink:label="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options and savings-related options</link:label>
    <link:label id="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember_label_en-US" xlink:label="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Options And Savings Related Options [member]</link:label>
    <link:label id="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember_documentation_en-US" xlink:label="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share options and savings related options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOptionsAndSavingsRelatedOptionsMember" xlink:href="gsk-20241231.xsd#gsk_ShareOptionsAndSavingsRelatedOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShareOptionsAndSavingsRelatedOptionsMember" xlink:to="lab_gsk_ShareOptionsAndSavingsRelatedOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_a82520bc-e1e5-4242-b05e-ee95d99adf6b_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_57295861-eaec-499e-9538-18074c1698ab_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other operating income/(expense)</link:label>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_e6d73641-5031-4636-9385-4527c021810b_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other operating income expense</link:label>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_be76e549-bb6f-4816-9ec4-8df4a1b83066_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other operating expense</link:label>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_label_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other operating income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AffinivaxAcquisitionMember_283a9731-87d0-45fe-9644-7e66d9cbf3ef_terseLabel_en-US" xlink:label="lab_gsk_AffinivaxAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affinivax Assets</link:label>
    <link:label id="lab_gsk_AffinivaxAcquisitionMember_label_en-US" xlink:label="lab_gsk_AffinivaxAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affinivax Acquisition [Member]</link:label>
    <link:label id="lab_gsk_AffinivaxAcquisitionMember_documentation_en-US" xlink:label="lab_gsk_AffinivaxAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Affinivax Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxAcquisitionMember" xlink:href="gsk-20241231.xsd#gsk_AffinivaxAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AffinivaxAcquisitionMember" xlink:to="lab_gsk_AffinivaxAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments_fb64ec60-495d-476d-bb27-d1dd46e757b5_negatedLabel_en-US" xlink:label="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Profit on sale of equity investments</link:label>
    <link:label id="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments_label_en-US" xlink:label="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Profit On Sale Of Equity Investments</link:label>
    <link:label id="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for profit on sale of equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForProfitOnSaleOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" xlink:to="lab_gsk_AdjustmentsForProfitOnSaleOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_d59fb2c4-7897-4a1e-8207-c5ff19a08bfc_totalLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred taxation</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax relating to items credited (charged) directly to equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:to="lab_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets_c2e02f97-64bf-4297-a95a-d9bac1737125_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transfer to assets held for sale</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers, financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_c572b69f-66e1-4371-b452-ac453bbc4b31_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions/disposals</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through business combinations, deferred tax liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests_e10db3db-ef53-4fea-967b-ed14575d0ec0_terseLabel_en-US" xlink:label="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share transactions with non-controlling interests</link:label>
    <link:label id="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests_label_en-US" xlink:label="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Inflows (Outflows) From Share Transactions With Non-Controlling Interests</link:label>
    <link:label id="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests_documentation_en-US" xlink:label="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Inflows (Outflows) From Share Transactions With Non-Controlling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" xlink:href="gsk-20241231.xsd#gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" xlink:to="lab_gsk_CashInflowsOutflowsFromShareTransactionsWithNonControllingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CamlipixantMember_ac8db5b5-03af-4043-bedc-28dc60d9da19_terseLabel_en-US" xlink:label="lab_gsk_CamlipixantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Camlipixant</link:label>
    <link:label id="lab_gsk_CamlipixantMember_label_en-US" xlink:label="lab_gsk_CamlipixantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Camlipixant [Member]</link:label>
    <link:label id="lab_gsk_CamlipixantMember_documentation_en-US" xlink:label="lab_gsk_CamlipixantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Camlipixant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CamlipixantMember" xlink:href="gsk-20241231.xsd#gsk_CamlipixantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CamlipixantMember" xlink:to="lab_gsk_CamlipixantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TransactionCostsOnDisposal_321405ce-316d-434b-8dbd-6efaef06f1d1_negatedTerseLabel_en-US" xlink:label="lab_gsk_TransactionCostsOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_gsk_TransactionCostsOnDisposal_label_en-US" xlink:label="lab_gsk_TransactionCostsOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction Costs On Disposal</link:label>
    <link:label id="lab_gsk_TransactionCostsOnDisposal_documentation_en-US" xlink:label="lab_gsk_TransactionCostsOnDisposal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transaction costs on disposal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransactionCostsOnDisposal" xlink:href="gsk-20241231.xsd#gsk_TransactionCostsOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TransactionCostsOnDisposal" xlink:to="lab_gsk_TransactionCostsOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8afaa35d-eb65-43ec-a389-155f5bad9647_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_5606c817-a2b7-4189-ab24-f743654521eb_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets measured at amortised cost:</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at amortised cost, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OrdinarySharesMember_3be987e1-9f95-4883-9019-1cff7b286d14_terseLabel_en-US" xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_ifrs-full_OrdinarySharesMember_label_en-US" xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary shares [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember" xlink:to="lab_ifrs-full_OrdinarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember_1ded8661-9227-48c5-b79d-4084d08cbd6f_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Australia Pty Ltd (Australia)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Australia Pty Ltd [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Australia Pty Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineAustraliaPtyLtdMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineAustraliaPtyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineAustraliaPtyLtdMember" xlink:to="lab_gsk_GlaxoSmithKlineAustraliaPtyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_1dae5938-8f2e-4769-93c0-b8c6bd2cf4a4_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPotentialMilestonePayments_20efce02-926a-4469-8131-c33df5f78176_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of potential milestone payments</link:label>
    <link:label id="lab_gsk_NumberOfPotentialMilestonePayments_label_en-US" xlink:label="lab_gsk_NumberOfPotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Potential Milestone Payments</link:label>
    <link:label id="lab_gsk_NumberOfPotentialMilestonePayments_documentation_en-US" xlink:label="lab_gsk_NumberOfPotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Potential Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPotentialMilestonePayments" xlink:href="gsk-20241231.xsd#gsk_NumberOfPotentialMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPotentialMilestonePayments" xlink:to="lab_gsk_NumberOfPotentialMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_2d484060-1507-458b-a640-2d73b02887c9_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RatedCreditExposures1_b61ff29e-bf40-481f-8622-a04fe7a195db_totalLabel_en-US" xlink:label="lab_gsk_RatedCreditExposures1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_gsk_RatedCreditExposures1_label_en-US" xlink:label="lab_gsk_RatedCreditExposures1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rated Credit Exposures1</link:label>
    <link:label id="lab_gsk_RatedCreditExposures1_documentation_en-US" xlink:label="lab_gsk_RatedCreditExposures1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rated Credit Exposures1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RatedCreditExposures1" xlink:href="gsk-20241231.xsd#gsk_RatedCreditExposures1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RatedCreditExposures1" xlink:to="lab_gsk_RatedCreditExposures1" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LicencesAndFranchisesMember_e57c6413-e05c-49fd-aa35-30dc0667ae79_terseLabel_en-US" xlink:label="lab_ifrs-full_LicencesAndFranchisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Licences and franchises</link:label>
    <link:label id="lab_ifrs-full_LicencesAndFranchisesMember_label_en-US" xlink:label="lab_ifrs-full_LicencesAndFranchisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licences and franchises [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesAndFranchisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesAndFranchisesMember" xlink:to="lab_ifrs-full_LicencesAndFranchisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems_e800c2b2-5b6f-4e8b-a851-b85d8a412724_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Information About Maturity Profile of Defined Benefit Obligation [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Information About Maturity Profile of Defined Benefit Obligation [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of Information About Maturity Profile of Defined Benefit Obligation [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" xlink:to="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements_e7d3571f-b4c9-4ae0-bf72-18ef1d996f70_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact on equity through interest rate movements</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Equity Through Interest Rate Movements</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Equity Through Interest Rate Movements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements" xlink:to="lab_gsk_IncreaseDecreaseInEquityThroughInterestRateMovements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccruedIncomeOtherThanContractAssets_fc8f28e0-9854-4a4f-9d12-0885996b0b3e_terseLabel_en-US" xlink:label="lab_ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued income</link:label>
    <link:label id="lab_ifrs-full_AccruedIncomeOtherThanContractAssets_label_en-US" xlink:label="lab_ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued income other than contract assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:to="lab_ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss_a307bc22-8f9e-4d0e-9ad5-cfd55c0ce966_negatedTerseLabel_en-US" xlink:label="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Disposals and settlements</link:label>
    <link:label id="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal And Settlements In Financial Assets At Fair Value Through Profit Or Loss</link:label>
    <link:label id="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss_documentation_en-US" xlink:label="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal And Settlements In Financial Assets At Fair Value Through Profit Or Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="gsk-20241231.xsd#gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="lab_gsk_DisposalAndSettlementsInFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SharesAcquiredByEsopTrusts_23a273e8-a03c-4721-9f91-60b85baa286c_terseLabel_en-US" xlink:label="lab_gsk_SharesAcquiredByEsopTrusts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares acquired by ESOP Trusts</link:label>
    <link:label id="lab_gsk_SharesAcquiredByEsopTrusts_label_en-US" xlink:label="lab_gsk_SharesAcquiredByEsopTrusts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired By ESOP Trusts</link:label>
    <link:label id="lab_gsk_SharesAcquiredByEsopTrusts_documentation_en-US" xlink:label="lab_gsk_SharesAcquiredByEsopTrusts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares acquired by ESOP trusts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SharesAcquiredByEsopTrusts" xlink:href="gsk-20241231.xsd#gsk_SharesAcquiredByEsopTrusts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SharesAcquiredByEsopTrusts" xlink:to="lab_gsk_SharesAcquiredByEsopTrusts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember_f669b4d3-80bf-4d8c-a49d-9c730b1343f6_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Services Unlimited</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Services Unlimited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Services Unlimited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineServicesUnlimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineServicesUnlimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineServicesUnlimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineServicesUnlimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DemergerMember_3835e4a1-49a4-424b-8c26-072706c9c2e5_terseLabel_en-US" xlink:label="lab_gsk_DemergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Demerger</link:label>
    <link:label id="lab_gsk_DemergerMember_label_en-US" xlink:label="lab_gsk_DemergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Demerger [Member]</link:label>
    <link:label id="lab_gsk_DemergerMember_documentation_en-US" xlink:label="lab_gsk_DemergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Demerger [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DemergerMember" xlink:href="gsk-20241231.xsd#gsk_DemergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DemergerMember" xlink:to="lab_gsk_DemergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidOrdinaryShares_f34edc04-802d-4904-9a4a-02616a750ce9_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaidOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total dividend</link:label>
    <link:label id="lab_ifrs-full_DividendsPaidOrdinaryShares_label_en-US" xlink:label="lab_ifrs-full_DividendsPaidOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends paid, ordinary shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOrdinaryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidOrdinaryShares" xlink:to="lab_ifrs-full_DividendsPaidOrdinaryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfProductLiabilityCases_278603ec-411e-47ae-8b59-cc2950187698_terseLabel_en-US" xlink:label="lab_gsk_NumberOfProductLiabilityCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of product liability cases</link:label>
    <link:label id="lab_gsk_NumberOfProductLiabilityCases_label_en-US" xlink:label="lab_gsk_NumberOfProductLiabilityCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Product Liability Cases</link:label>
    <link:label id="lab_gsk_NumberOfProductLiabilityCases_documentation_en-US" xlink:label="lab_gsk_NumberOfProductLiabilityCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Product Liability Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfProductLiabilityCases" xlink:href="gsk-20241231.xsd#gsk_NumberOfProductLiabilityCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfProductLiabilityCases" xlink:to="lab_gsk_NumberOfProductLiabilityCases" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember_f318788e-7eba-4fc7-b63b-c240444592ac_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.50% (150 basis points) decrease in discount rate</link:label>
    <link:label id="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk One Fifty Basis Points Decrease In Discount Rate [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk One Fifty Basis Points Decrease In Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" xlink:to="lab_gsk_CurrencyRiskOneFiftyBasisPointsDecreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_4d40b414-c3f1-4291-9563-b1398f452894_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BBPlusOrBaOneMember_87fae9a9-e0b9-47b0-ad27-086c3e30de40_terseLabel_en-US" xlink:label="lab_gsk_BBPlusOrBaOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BB+/Ba1 and below/unrated</link:label>
    <link:label id="lab_gsk_BBPlusOrBaOneMember_label_en-US" xlink:label="lab_gsk_BBPlusOrBaOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BB Plus Or Ba One [member]</link:label>
    <link:label id="lab_gsk_BBPlusOrBaOneMember_documentation_en-US" xlink:label="lab_gsk_BBPlusOrBaOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BB+/Ba1 and Below/Unrated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BBPlusOrBaOneMember" xlink:href="gsk-20241231.xsd#gsk_BBPlusOrBaOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BBPlusOrBaOneMember" xlink:to="lab_gsk_BBPlusOrBaOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_3b8c43d3-29ec-4df3-823e-8371e361e518_negatedLabel_en-US" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Distributions to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends recognised as distributions to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:to="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKGroupMember_b92d41ca-88bc-4d29-b438-0410dfd9836b_terseLabel_en-US" xlink:label="lab_gsk_GSKGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Group</link:label>
    <link:label id="lab_gsk_GSKGroupMember_label_en-US" xlink:label="lab_gsk_GSKGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Group [Member]</link:label>
    <link:label id="lab_gsk_GSKGroupMember_documentation_en-US" xlink:label="lab_gsk_GSKGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKGroupMember" xlink:href="gsk-20241231.xsd#gsk_GSKGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKGroupMember" xlink:to="lab_gsk_GSKGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RestructuringCosts1_e6f7e380-0306-4d97-a970-d438d44dcc51_totalLabel_en-US" xlink:label="lab_gsk_RestructuringCosts1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_gsk_RestructuringCosts1_label_en-US" xlink:label="lab_gsk_RestructuringCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs1</link:label>
    <link:label id="lab_gsk_RestructuringCosts1_documentation_en-US" xlink:label="lab_gsk_RestructuringCosts1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring costs1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCosts1" xlink:href="gsk-20241231.xsd#gsk_RestructuringCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RestructuringCosts1" xlink:to="lab_gsk_RestructuringCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_e6ec441d-1109-4105-96af-bfecdfa741c3_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_5f0dc470-ccc5-4642-bea0-88612a0ffe3d_negatedLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WorkInProgress_1227d741-2691-4914-b36c-a6714c5c0847_terseLabel_en-US" xlink:label="lab_ifrs-full_WorkInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_ifrs-full_WorkInProgress_label_en-US" xlink:label="lab_ifrs-full_WorkInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current work in progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WorkInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress" xlink:to="lab_ifrs-full_WorkInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_9c8b01a7-c049-4ff1-9187-df643c0e3dee_terseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Re-assessments of prior year current tax estimates (in percent)</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect of Reassessments of Prior Year Estimates</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax rate effect of reassessments of prior year estimates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" xlink:to="lab_gsk_TaxRateEffectOfReassessmentsOfPriorYearEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock_1330cc2e-2386-47af-ae52-38f658a1e0fd_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary Information about Other Operating Expense</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Other Operating Income Expense Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other operating income (expense).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExpenseExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_f584fc5d-f449-4a4b-b888-9b7d833ba178_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Presentation of the financial statements</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SharesReceivedForEveryFiveExistingShares_6f8845dc-73b3-411f-bcf6-1e38b792c3b3_terseLabel_en-US" xlink:label="lab_gsk_SharesReceivedForEveryFiveExistingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share received for every five existing shares (in shares)</link:label>
    <link:label id="lab_gsk_SharesReceivedForEveryFiveExistingShares_label_en-US" xlink:label="lab_gsk_SharesReceivedForEveryFiveExistingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Received For Every Five Existing Shares</link:label>
    <link:label id="lab_gsk_SharesReceivedForEveryFiveExistingShares_documentation_en-US" xlink:label="lab_gsk_SharesReceivedForEveryFiveExistingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares received for every five existing shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SharesReceivedForEveryFiveExistingShares" xlink:href="gsk-20241231.xsd#gsk_SharesReceivedForEveryFiveExistingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SharesReceivedForEveryFiveExistingShares" xlink:to="lab_gsk_SharesReceivedForEveryFiveExistingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinishedGoods_c586e1f1-ff8d-4070-a96f-9fee5147e1d3_terseLabel_en-US" xlink:label="lab_ifrs-full_FinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_ifrs-full_FinishedGoods_label_en-US" xlink:label="lab_ifrs-full_FinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current finished goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods" xlink:to="lab_ifrs-full_FinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HedgingInstrumentAtFairValue_1bc6c20f-0431-4054-a463-e984fec26a96_terseLabel_en-US" xlink:label="lab_gsk_HedgingInstrumentAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying&#8232;amount</link:label>
    <link:label id="lab_gsk_HedgingInstrumentAtFairValue_label_en-US" xlink:label="lab_gsk_HedgingInstrumentAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Instrument, At Fair Value</link:label>
    <link:label id="lab_gsk_HedgingInstrumentAtFairValue_documentation_en-US" xlink:label="lab_gsk_HedgingInstrumentAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hedging Instrument, At Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingInstrumentAtFairValue" xlink:href="gsk-20241231.xsd#gsk_HedgingInstrumentAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HedgingInstrumentAtFairValue" xlink:to="lab_gsk_HedgingInstrumentAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonDistributableMergerAndPreMergerReservesMember_342cdc27-0147-4ff8-87c1-5da944d5a15e_verboseLabel_en-US" xlink:label="lab_gsk_NonDistributableMergerAndPreMergerReservesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non distributable merger and pre merger reserves</link:label>
    <link:label id="lab_gsk_NonDistributableMergerAndPreMergerReservesMember_label_en-US" xlink:label="lab_gsk_NonDistributableMergerAndPreMergerReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Distributable Merger And Pre-Merger Reserves [Member]</link:label>
    <link:label id="lab_gsk_NonDistributableMergerAndPreMergerReservesMember_documentation_en-US" xlink:label="lab_gsk_NonDistributableMergerAndPreMergerReservesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-distributable merger and pre-merger reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonDistributableMergerAndPreMergerReservesMember" xlink:href="gsk-20241231.xsd#gsk_NonDistributableMergerAndPreMergerReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonDistributableMergerAndPreMergerReservesMember" xlink:to="lab_gsk_NonDistributableMergerAndPreMergerReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AffinivaxMember_cd658601-c92b-408a-ab7e-4461f55e39b7_terseLabel_en-US" xlink:label="lab_gsk_AffinivaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affinivax</link:label>
    <link:label id="lab_gsk_AffinivaxMember_label_en-US" xlink:label="lab_gsk_AffinivaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affinivax [Member]</link:label>
    <link:label id="lab_gsk_AffinivaxMember_documentation_en-US" xlink:label="lab_gsk_AffinivaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Affinivax [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxMember" xlink:href="gsk-20241231.xsd#gsk_AffinivaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AffinivaxMember" xlink:to="lab_gsk_AffinivaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_1cb5d026-dca0-41d2-a9fa-4673c432d38d_negatedLabel_en-US" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of long-term loans</link:label>
    <link:label id="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_3dec8882-97a3-4506-bb43-cc08e5692fe4_terseLabel_en-US" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment of long-term loans</link:label>
    <link:label id="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DiscountRateMeasurementInputMember_982832e8-a5a6-4848-a11b-7d0b1bd900e6_terseLabel_en-US" xlink:label="lab_ifrs-full_DiscountRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate, measurement input</link:label>
    <link:label id="lab_ifrs-full_DiscountRateMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_DiscountRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount rate, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscountRateMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscountRateMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscountRateMeasurementInputMember" xlink:to="lab_ifrs-full_DiscountRateMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesDemergerMember_4b67201f-9429-42b3-a774-4580f1def88e_terseLabel_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesDemergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business disposals - demerger</link:label>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesDemergerMember_label_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesDemergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total For All Business Divestures, Demerger [Member]</link:label>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesDemergerMember_documentation_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesDemergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total For All Business Divestures, Demerger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalForAllBusinessDivesturesDemergerMember" xlink:href="gsk-20241231.xsd#gsk_TotalForAllBusinessDivesturesDemergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TotalForAllBusinessDivesturesDemergerMember" xlink:to="lab_gsk_TotalForAllBusinessDivesturesDemergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherNonCurrentReceivablesMember_b19f3e73-1f58-4042-b9aa-bbb6eda260c5_terseLabel_en-US" xlink:label="lab_gsk_OtherNonCurrentReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non current receivables</link:label>
    <link:label id="lab_gsk_OtherNonCurrentReceivablesMember_label_en-US" xlink:label="lab_gsk_OtherNonCurrentReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Non Current Receivables [member]</link:label>
    <link:label id="lab_gsk_OtherNonCurrentReceivablesMember_documentation_en-US" xlink:label="lab_gsk_OtherNonCurrentReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other non current receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNonCurrentReceivablesMember" xlink:href="gsk-20241231.xsd#gsk_OtherNonCurrentReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherNonCurrentReceivablesMember" xlink:to="lab_gsk_OtherNonCurrentReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CostOfSales_7444404f-a30f-4263-8c67-fe5444b13351_negatedLabel_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_ifrs-full_CostOfSales_6c7f015e-c6c5-4d95-9a95-7981aecaef30_terseLabel_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_ifrs-full_CostOfSales_label_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales" xlink:to="lab_ifrs-full_CostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock_105fef0d-f156-445e-b5d3-905cb7f74dbc_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Compensation of the Directors and Senior Management</link:label>
    <link:label id="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation of Directors and Senior Management Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of compensation of directors and senior management.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfCompensationOfDirectorsAndSeniorManagementExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RetainedEarningsAndOtherReserves_0da4abe6-bc7d-4a66-ae84-eeccb5b6619c_terseLabel_en-US" xlink:label="lab_gsk_RetainedEarningsAndOtherReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings and other reserves</link:label>
    <link:label id="lab_gsk_RetainedEarningsAndOtherReserves_label_en-US" xlink:label="lab_gsk_RetainedEarningsAndOtherReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings And Other Reserves</link:label>
    <link:label id="lab_gsk_RetainedEarningsAndOtherReserves_documentation_en-US" xlink:label="lab_gsk_RetainedEarningsAndOtherReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Retained earnings and other reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RetainedEarningsAndOtherReserves" xlink:href="gsk-20241231.xsd#gsk_RetainedEarningsAndOtherReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RetainedEarningsAndOtherReserves" xlink:to="lab_gsk_RetainedEarningsAndOtherReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reserves within equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:to="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BankBalancesAndDepositHeldWithCounterparties_f95d2cc8-31a7-4d69-bc53-a2292b1f1f7b_terseLabel_en-US" xlink:label="lab_gsk_BankBalancesAndDepositHeldWithCounterparties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank balances and deposits</link:label>
    <link:label id="lab_gsk_BankBalancesAndDepositHeldWithCounterparties_label_en-US" xlink:label="lab_gsk_BankBalancesAndDepositHeldWithCounterparties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank Balances And Deposit Held With Counterparties</link:label>
    <link:label id="lab_gsk_BankBalancesAndDepositHeldWithCounterparties_documentation_en-US" xlink:label="lab_gsk_BankBalancesAndDepositHeldWithCounterparties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bank balances and deposit held with counter parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankBalancesAndDepositHeldWithCounterparties" xlink:href="gsk-20241231.xsd#gsk_BankBalancesAndDepositHeldWithCounterparties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BankBalancesAndDepositHeldWithCounterparties" xlink:to="lab_gsk_BankBalancesAndDepositHeldWithCounterparties" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_5b9d055c-95e6-4c25-9f50-d389e0b23a08_verboseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net interest (income)/cost</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_3d728fa4-a262-43b1-8629-f2330c01efba_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_5ed17eb3-98f9-4d19-9143-8e1ebb97c365_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7a4ba84d-eb4c-4d2d-a78f-15507c6f8ef9_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TsrMember_53d4a4fb-da2b-4b62-902d-115b7e05cbda_terseLabel_en-US" xlink:label="lab_gsk_TsrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TSR</link:label>
    <link:label id="lab_gsk_TsrMember_label_en-US" xlink:label="lab_gsk_TsrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TSR [Member]</link:label>
    <link:label id="lab_gsk_TsrMember_documentation_en-US" xlink:label="lab_gsk_TsrMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TSR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TsrMember" xlink:href="gsk-20241231.xsd#gsk_TsrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TsrMember" xlink:to="lab_gsk_TsrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LossContingenciesDamagesSoughtValue_5f7d5925-25af-4bab-b520-a5b04a22869f_terseLabel_en-US" xlink:label="lab_gsk_LossContingenciesDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency, damages sought, value</link:label>
    <link:label id="lab_gsk_LossContingenciesDamagesSoughtValue_label_en-US" xlink:label="lab_gsk_LossContingenciesDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies, Damages Sought, Value</link:label>
    <link:label id="lab_gsk_LossContingenciesDamagesSoughtValue_documentation_en-US" xlink:label="lab_gsk_LossContingenciesDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingencies, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingenciesDamagesSoughtValue" xlink:href="gsk-20241231.xsd#gsk_LossContingenciesDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LossContingenciesDamagesSoughtValue" xlink:to="lab_gsk_LossContingenciesDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_f86421e5-a384-44c7-9a4a-74233170c026_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in trade payables</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetAssetsAcquiredAbstract_b2d3dde4-d063-4b9a-8510-f371487691e0_verboseLabel_en-US" xlink:label="lab_gsk_NetAssetsAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net assets acquired:</link:label>
    <link:label id="lab_gsk_NetAssetsAcquiredAbstract_label_en-US" xlink:label="lab_gsk_NetAssetsAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Assets Acquired [Abstract]</link:label>
    <link:label id="lab_gsk_NetAssetsAcquiredAbstract_documentation_en-US" xlink:label="lab_gsk_NetAssetsAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Assets Acquired [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetAssetsAcquiredAbstract" xlink:href="gsk-20241231.xsd#gsk_NetAssetsAcquiredAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetAssetsAcquiredAbstract" xlink:to="lab_gsk_NetAssetsAcquiredAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfFinancialAssetsAxis_2b8a74e9-7808-49bd-b13a-ea504b639285_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_TypesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EmbeddedAndOtherDerivativesMember_31645888-494f-4f4f-93a7-00e3a6548007_terseLabel_en-US" xlink:label="lab_gsk_EmbeddedAndOtherDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Embedded and other derivatives</link:label>
    <link:label id="lab_gsk_EmbeddedAndOtherDerivativesMember_label_en-US" xlink:label="lab_gsk_EmbeddedAndOtherDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Embedded And Other Derivatives [member]</link:label>
    <link:label id="lab_gsk_EmbeddedAndOtherDerivativesMember_documentation_en-US" xlink:label="lab_gsk_EmbeddedAndOtherDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Embedded and other derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmbeddedAndOtherDerivativesMember" xlink:href="gsk-20241231.xsd#gsk_EmbeddedAndOtherDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EmbeddedAndOtherDerivativesMember" xlink:to="lab_gsk_EmbeddedAndOtherDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare_1ba32a67-2f9c-41bf-85ba-5b8c40dcc7ce_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of awards (in dollars per share)</link:label>
    <link:label id="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare_label_en-US" xlink:label="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Fair Value at Measurement Date Share Awards Granted Per share</link:label>
    <link:label id="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare_documentation_en-US" xlink:label="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average fair value at measurement date share awards granted per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" xlink:to="lab_gsk_WeightedAverageFairValueAtMeasurementDateShareAwardsGrantedPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_c62ad69e-2a88-4e19-ab93-c676358c9d85_totalLabel_en-US" xlink:label="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total audit services, audit-related and other assurance services</link:label>
    <link:label id="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_label_en-US" xlink:label="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditors Remuneration For Audit Related And Other Assurance Services</link:label>
    <link:label id="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices_documentation_en-US" xlink:label="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditors remuneration for audit related and other assurance services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" xlink:href="gsk-20241231.xsd#gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" xlink:to="lab_gsk_AuditorsRemunerationForAuditRelatedAndOtherAssuranceServices" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember_8c8580b3-566d-418e-979e-9d670366abde_terseLabel_en-US" xlink:label="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange forward contracts and swaps</link:label>
    <link:label id="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember_label_en-US" xlink:label="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward Contracts and Swaps [member]</link:label>
    <link:label id="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember_documentation_en-US" xlink:label="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward Contracts and Swaps [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeForwardContractsAndSwapsMember" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeForwardContractsAndSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ForeignExchangeForwardContractsAndSwapsMember" xlink:to="lab_gsk_ForeignExchangeForwardContractsAndSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions_41ae196d-6e38-4ab9-baf3-241db494fd16_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount on the provisions</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through change in discount rate, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityInvestmentsMember_a3608e1d-e145-4fd4-98ab-60519ab80344_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_ifrs-full_EquityInvestmentsMember_label_en-US" xlink:label="lab_ifrs-full_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity investments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInvestmentsMember" xlink:to="lab_ifrs-full_EquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_fbfc4cd3-f867-40cf-bd54-4634248dbec3_terseLabel_en-US" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_4bd07f3c-e8e2-4869-abbc-0af5d58fa4b5_negatedLabel_en-US" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Charge for the year</link:label>
    <link:label id="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ForeignCountriesMember_e6fc24bc-e3e4-4d9f-a129-472d33344b55_terseLabel_en-US" xlink:label="lab_ifrs-full_ForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of World current year charge</link:label>
    <link:label id="lab_ifrs-full_ForeignCountriesMember_label_en-US" xlink:label="lab_ifrs-full_ForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign countries [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignCountriesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignCountriesMember" xlink:to="lab_ifrs-full_ForeignCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember_8efaac81-73c2-438e-ab92-b9372604f3a1_terseLabel_en-US" xlink:label="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquidation or disposal of overseas subsidiary</link:label>
    <link:label id="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember_label_en-US" xlink:label="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquidation Or Disposal Of Overseas Subsidiary [member]</link:label>
    <link:label id="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember_documentation_en-US" xlink:label="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liquidation or disposal of overseas subsidiary.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" xlink:href="gsk-20241231.xsd#gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" xlink:to="lab_gsk_LiquidationOrDisposalOfOverseasSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NovartisVaccinesMember_12dcc854-5886-468f-a2f6-f79abe8c0db3_terseLabel_en-US" xlink:label="lab_gsk_NovartisVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novartis vaccines</link:label>
    <link:label id="lab_gsk_NovartisVaccinesMember_label_en-US" xlink:label="lab_gsk_NovartisVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Vaccines [member]</link:label>
    <link:label id="lab_gsk_NovartisVaccinesMember_documentation_en-US" xlink:label="lab_gsk_NovartisVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Novartis vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisVaccinesMember" xlink:href="gsk-20241231.xsd#gsk_NovartisVaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NovartisVaccinesMember" xlink:to="lab_gsk_NovartisVaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesAbstract_cb70b77b-9d82-4786-b5a1-c623a10858ae_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract" xlink:to="lab_ifrs-full_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EquipmentAndVehiclesMember_3ca655eb-643c-4fe5-bc2f-a59a7f5b1938_terseLabel_en-US" xlink:label="lab_gsk_EquipmentAndVehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment and vehicles</link:label>
    <link:label id="lab_gsk_EquipmentAndVehiclesMember_label_en-US" xlink:label="lab_gsk_EquipmentAndVehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment And Vehicles [member]</link:label>
    <link:label id="lab_gsk_EquipmentAndVehiclesMember_documentation_en-US" xlink:label="lab_gsk_EquipmentAndVehiclesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equipment and vehicles.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquipmentAndVehiclesMember" xlink:href="gsk-20241231.xsd#gsk_EquipmentAndVehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EquipmentAndVehiclesMember" xlink:to="lab_gsk_EquipmentAndVehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_35abc429-5cbf-4031-80b3-00a7b873c888_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for derivative financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EmployeeLoansAndAdvances_b556d554-c5af-4c21-9528-9c41095e3682_terseLabel_en-US" xlink:label="lab_gsk_EmployeeLoansAndAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee loans and advances</link:label>
    <link:label id="lab_gsk_EmployeeLoansAndAdvances_label_en-US" xlink:label="lab_gsk_EmployeeLoansAndAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Loans And Advances</link:label>
    <link:label id="lab_gsk_EmployeeLoansAndAdvances_documentation_en-US" xlink:label="lab_gsk_EmployeeLoansAndAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee loans and advances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeLoansAndAdvances" xlink:href="gsk-20241231.xsd#gsk_EmployeeLoansAndAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EmployeeLoansAndAdvances" xlink:to="lab_gsk_EmployeeLoansAndAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_c6ee338f-707c-4094-8da9-601221665708_negatedLabel_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals and asset write-offs</link:label>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals and retirements, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess_451cc6f9-65ce-44fd-afb3-4365288bb092_terseLabel_en-US" xlink:label="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of employees interfered with tender process</link:label>
    <link:label id="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess_label_en-US" xlink:label="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Employees Interfered With Tender Process</link:label>
    <link:label id="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess_documentation_en-US" xlink:label="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Employees Interfered With Tender Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfEmployeesInterferedWithTenderProcess" xlink:href="gsk-20241231.xsd#gsk_NumberOfEmployeesInterferedWithTenderProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfEmployeesInterferedWithTenderProcess" xlink:to="lab_gsk_NumberOfEmployeesInterferedWithTenderProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SavingsRelatedOptionsGrantPrice_a4c24f82-0d02-44fe-b1c1-e8e0cda195d6_terseLabel_en-US" xlink:label="lab_gsk_SavingsRelatedOptionsGrantPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Savings related options grant price (in pound per share)</link:label>
    <link:label id="lab_gsk_SavingsRelatedOptionsGrantPrice_label_en-US" xlink:label="lab_gsk_SavingsRelatedOptionsGrantPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Savings Related Options Grant Price</link:label>
    <link:label id="lab_gsk_SavingsRelatedOptionsGrantPrice_documentation_en-US" xlink:label="lab_gsk_SavingsRelatedOptionsGrantPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Savings related options grant price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedOptionsGrantPrice" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedOptionsGrantPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SavingsRelatedOptionsGrantPrice" xlink:to="lab_gsk_SavingsRelatedOptionsGrantPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_10b989cf-bedc-456a-84fc-d5ac267188ea_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net cash inflow/(outflow) from investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_10d2d3f2-e5b8-40d5-b04c-7c2a02003154_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash outflow from investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses_0d070acf-557e-48c0-88c7-26d67160fe32_negatedLabel_en-US" xlink:label="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">(Profit)/loss on sale of businesses</link:label>
    <link:label id="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses_label_en-US" xlink:label="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Profit (Loss) On Sale Of Businesses</link:label>
    <link:label id="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for profit on sale of businesses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForProfitLossOnSaleOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" xlink:to="lab_gsk_AdjustmentsForProfitLossOnSaleOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfRisksAxis_8508c7d3-aa13-454f-b779-89849b76cff0_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfRisksAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of risks [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfRisksAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfRisksAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of risks [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis" xlink:to="lab_ifrs-full_TypesOfRisksAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_e3ddbccc-0ecb-43aa-8828-28f635238402_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Auditors Remuneration</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of auditors' remuneration [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAuditorsRemunerationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InsuranceContractsDomain_f4787348-5670-4b48-bdaa-eb9a964158cd_terseLabel_en-US" xlink:label="lab_ifrs-full_InsuranceContractsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance contracts [domain]</link:label>
    <link:label id="lab_ifrs-full_InsuranceContractsDomain_label_en-US" xlink:label="lab_ifrs-full_InsuranceContractsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance contracts [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InsuranceContractsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InsuranceContractsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InsuranceContractsDomain" xlink:to="lab_ifrs-full_InsuranceContractsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities_f291932f-6675-4c93-8779-279c964a8c75_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Exchange Adjustments Of Fair Value Measurement Assets And Liabilities</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease through exchange adjustments of fair value measurement assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" xlink:to="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfFairValueMeasurementAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_51406e21-1b8f-4ca3-8490-74b1a6d1ead6_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross financial assets/(liabilities), assets</link:label>
    <link:label id="lab_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_label_en-US" xlink:label="lab_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross financial assets subject to offsetting, enforceable master netting arrangements or similar agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:to="lab_ifrs-full_GrossFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_4774e42c-24aa-4290-b9b8-4cf631d49912_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_2f98a9aa-07f5-49f6-93c7-058eb519a93f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OperatingSegmentsMember_08e223dd-0bb4-4c6c-846f-59260c8b4f81_terseLabel_en-US" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment profit</link:label>
    <link:label id="lab_ifrs-full_OperatingSegmentsMember_81bc439c-dd00-4df5-80a0-6c6e22ba7445_verboseLabel_en-US" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment depreciation and amortisation</link:label>
    <link:label id="lab_ifrs-full_OperatingSegmentsMember_label_en-US" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating segments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingSegmentsMember" xlink:to="lab_ifrs-full_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AmericanDepositarySharesMember_a0f84227-cb99-450c-9f63-4ebab61d06c4_terseLabel_en-US" xlink:label="lab_gsk_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_gsk_AmericanDepositarySharesMember_fc74ba54-ffee-40c1-bb92-e471a51b2448_verboseLabel_en-US" xlink:label="lab_gsk_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">American depositary shares</link:label>
    <link:label id="lab_gsk_AmericanDepositarySharesMember_label_en-US" xlink:label="lab_gsk_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:label id="lab_gsk_AmericanDepositarySharesMember_documentation_en-US" xlink:label="lab_gsk_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmericanDepositarySharesMember" xlink:href="gsk-20241231.xsd#gsk_AmericanDepositarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AmericanDepositarySharesMember" xlink:to="lab_gsk_AmericanDepositarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LondonStockExchangeMember_86d2904b-8126-494e-aad0-a2ed02471aa1_terseLabel_en-US" xlink:label="lab_gsk_LondonStockExchangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">London Stock Exchange</link:label>
    <link:label id="lab_gsk_LondonStockExchangeMember_label_en-US" xlink:label="lab_gsk_LondonStockExchangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">London Stock Exchange [member]</link:label>
    <link:label id="lab_gsk_LondonStockExchangeMember_documentation_en-US" xlink:label="lab_gsk_LondonStockExchangeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">London Stock Exchange [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LondonStockExchangeMember" xlink:href="gsk-20241231.xsd#gsk_LondonStockExchangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LondonStockExchangeMember" xlink:to="lab_gsk_LondonStockExchangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations_51b6f2b2-b623-48bd-848c-c385e067d44f_terseLabel_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flow from continuing operations</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations_label_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flows From (Used In) Operations Before Tax, Continuing Operations</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations_documentation_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash from used in operations before taxes continuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" xlink:href="gsk-20241231.xsd#gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" xlink:to="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgingInstrumentLiabilities_7175f920-06f7-49b3-b6e0-9bc34678645a_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Hedging instrument, liabilities</link:label>
    <link:label id="lab_ifrs-full_HedgingInstrumentLiabilities_label_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging instrument, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentLiabilities" xlink:to="lab_ifrs-full_HedgingInstrumentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level2OfFairValueHierarchyMember_e6baecb7-b015-4db2-b1c7-59c7e8f0b21f_terseLabel_en-US" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_ifrs-full_Level2OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory_83c71c2f-e942-41d0-842f-df50743e6264_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major restructuring costs</link:label>
    <link:label id="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory_label_en-US" xlink:label="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of major restructuring costs [text block]</link:label>
    <link:label id="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory_documentation_en-US" xlink:label="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of major restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfMajorRestructuringCostsExplanatory" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfMajorRestructuringCostsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfMajorRestructuringCostsExplanatory" xlink:to="lab_gsk_DisclosureOfMajorRestructuringCostsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_dd794f6f-0a82-4fc9-9bd3-f062a330b77b_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_b4145230-369f-4f10-b5a1-9784e2bdc2c4_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pensions and other post-employment benefits</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BBB-OrBaaThreeRatedMember_12cdf0b8-5411-4fcc-a41d-662ecb793c42_terseLabel_en-US" xlink:label="lab_gsk_BBB-OrBaaThreeRatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BBB -/ Baa3 Rated</link:label>
    <link:label id="lab_gsk_BBB-OrBaaThreeRatedMember_label_en-US" xlink:label="lab_gsk_BBB-OrBaaThreeRatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BBB -Or Baa Three Rated [member]</link:label>
    <link:label id="lab_gsk_BBB-OrBaaThreeRatedMember_documentation_en-US" xlink:label="lab_gsk_BBB-OrBaaThreeRatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BBB -/ Baa3 rated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BBB-OrBaaThreeRatedMember" xlink:href="gsk-20241231.xsd#gsk_BBB-OrBaaThreeRatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BBB-OrBaaThreeRatedMember" xlink:to="lab_gsk_BBB-OrBaaThreeRatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember_4ad53e50-373f-4c1a-ac3e-3e646fcc2185_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% (100 basis points) movement in EUR or Sterling interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Percent Movement In EUR Or Sterling Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1% (100 basis points) movement in EUR or Sterling interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePercentMovementInEUROrSterlingInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseInDiscountRateAmount_6eb070c7-ada8-4c63-b2b5-399a14a3d041_terseLabel_en-US" xlink:label="lab_gsk_IncreaseInDiscountRateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in discount rate</link:label>
    <link:label id="lab_gsk_IncreaseInDiscountRateAmount_label_en-US" xlink:label="lab_gsk_IncreaseInDiscountRateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase In Discount Rate Amount</link:label>
    <link:label id="lab_gsk_IncreaseInDiscountRateAmount_documentation_en-US" xlink:label="lab_gsk_IncreaseInDiscountRateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase in discount rate amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInDiscountRateAmount" xlink:href="gsk-20241231.xsd#gsk_IncreaseInDiscountRateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseInDiscountRateAmount" xlink:to="lab_gsk_IncreaseInDiscountRateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OneYearMember_b9693a7c-272d-4b22-a72d-54a423496b91_terseLabel_en-US" xlink:label="lab_gsk_OneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One year increase</link:label>
    <link:label id="lab_gsk_OneYearMember_label_en-US" xlink:label="lab_gsk_OneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Year [Member]</link:label>
    <link:label id="lab_gsk_OneYearMember_documentation_en-US" xlink:label="lab_gsk_OneYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OneYearMember" xlink:href="gsk-20241231.xsd#gsk_OneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OneYearMember" xlink:to="lab_gsk_OneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_aa00028a-dfd7-4114-8ed0-06a73f821838_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified_6fb26301-7907-431e-93e9-bd4674a3c74c_verboseLabel_en-US" xlink:label="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on cash flow hedges</link:label>
    <link:label id="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified_label_en-US" xlink:label="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Movements On Cash Flow Hedges Not Reclassified</link:label>
    <link:label id="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified_documentation_en-US" xlink:label="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value movements on cash flow hedges not reclassified.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" xlink:href="gsk-20241231.xsd#gsk_FairValueMovementsOnCashFlowHedgesNotReclassified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" xlink:to="lab_gsk_FairValueMovementsOnCashFlowHedgesNotReclassified" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfHedgesAxis_8efe428b-eb4a-47b1-8b95-d9423ebfffc9_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of hedges [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfHedgesAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of hedges [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfHedgesAxis" xlink:to="lab_ifrs-full_TypesOfHedgesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_a878a0aa-a11d-4e72-a801-1f3c058db2fa_terseLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit schemes</link:label>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense in profit or loss, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilitiesMember_03c5f52a-288f-461f-b057-6e48179ebd9d_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilitiesMember_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilities_8c94b0db-36b6-4a22-9d36-d07ac2e7f129_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_d87f6ff5-43fa-46a4-b232-5e121f3e6c4b_negatedLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_6aedeb0f-1946-45d6-a69d-519eb48dfb98_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurements of assets and liabilities [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurements of assets and liabilities [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurements of assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" xlink:to="lab_gsk_DisclosureOfFairValueMeasurementsOfAssetsAndLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AtPercentageBelowMarketPrice_95bdff91-1f29-4684-be02-be9d5d13d7c9_terseLabel_en-US" xlink:label="lab_gsk_AtPercentageBelowMarketPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options granted at percentage below market price</link:label>
    <link:label id="lab_gsk_AtPercentageBelowMarketPrice_label_en-US" xlink:label="lab_gsk_AtPercentageBelowMarketPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At Percentage Below Market Price</link:label>
    <link:label id="lab_gsk_AtPercentageBelowMarketPrice_documentation_en-US" xlink:label="lab_gsk_AtPercentageBelowMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At percentage below market price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AtPercentageBelowMarketPrice" xlink:href="gsk-20241231.xsd#gsk_AtPercentageBelowMarketPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AtPercentageBelowMarketPrice" xlink:to="lab_gsk_AtPercentageBelowMarketPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement_9c9bf7ba-e02d-4c1d-86e8-0d44c470c7ef_terseLabel_en-US" xlink:label="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net losses on financial instruments held</link:label>
    <link:label id="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement_label_en-US" xlink:label="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains Losses Attributable To Level 3 Of Fair Value Hierarchy Recognised In Income statement</link:label>
    <link:label id="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement_documentation_en-US" xlink:label="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gains losses attributable to level 3 of fair value hierarchy recognised in income statement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" xlink:href="gsk-20241231.xsd#gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" xlink:to="lab_gsk_GainsLossesAttributableToLevel3OfFairValueHierarchyRecognisedInIncomeStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember_b035cb00-29c0-4fb4-8982-de13db76f96e_terseLabel_en-US" xlink:label="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.375% &#8364; Euro Medium Term Note 2029</link:label>
    <link:label id="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember_label_en-US" xlink:label="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Three Seven Five Percent Euro Medium Term Notes Two Thousand Twenty Nine [Member]</link:label>
    <link:label id="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember_documentation_en-US" xlink:label="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1.375% European Medium Term Note 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" xlink:href="gsk-20241231.xsd#gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" xlink:to="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNotesTwoThousandTwentyNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments_af8bf0c7-568a-4e89-9a70-43ad97448362_terseLabel_en-US" xlink:label="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability on leases with annual payments</link:label>
    <link:label id="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments_label_en-US" xlink:label="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Threshold For Applying Implicit Rate Of Interest To Annual Lease Payments</link:label>
    <link:label id="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments_documentation_en-US" xlink:label="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Threshold for applying implicit rate of interest to annual lease payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" xlink:href="gsk-20241231.xsd#gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" xlink:to="lab_gsk_ThresholdForApplyingImplicitRateOfInterestToAnnualLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_a8864e42-a8fd-4932-a21e-0643a52e5c89_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember_b56bc418-5fce-4af9-bc26-43cb9a06c267_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) movement in USD interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Point Five Percent Movement In USD Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) movement in USD interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePointFivePercentMovementInUSDInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContractualObligationsAndCommitments_56a04422-1b08-48d2-8219-80e98b4af397_totalLabel_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total contractual obligations and commitments</link:label>
    <link:label id="lab_gsk_ContractualObligationsAndCommitments_88de4cc8-ae5c-47ff-885a-edd5283f54e3_terseLabel_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual obligations and commitments</link:label>
    <link:label id="lab_gsk_ContractualObligationsAndCommitments_label_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligations And Commitments</link:label>
    <link:label id="lab_gsk_ContractualObligationsAndCommitments_documentation_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual obligations and commitments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContractualObligationsAndCommitments" xlink:href="gsk-20241231.xsd#gsk_ContractualObligationsAndCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContractualObligationsAndCommitments" xlink:to="lab_gsk_ContractualObligationsAndCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration_91be1ba0-5852-4f11-9465-4bd7178864e8_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement period increase (decrease) recognised for particular assets, liabilities, non-controlling interests or items of consideration</link:label>
    <link:label id="lab_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration_label_en-US" xlink:label="lab_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement period adjustments recognised for particular assets, liabilities, non-controlling interests or items of consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" xlink:to="lab_ifrs-full_MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_8a51f02b-1ed0-4480-aaf4-3ec6685b0abe_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares acquired by ESOP Trusts</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through treasury share transactions, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets_82ea9ca0-379c-4220-865e-8fd0998cef0d_terseLabel_en-US" xlink:label="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets_label_en-US" xlink:label="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual commitments for acquisition of intangible assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets" xlink:to="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PurposeDomain_9b603a70-7dd7-4f8d-8415-588b9d05b388_terseLabel_en-US" xlink:label="lab_gsk_PurposeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purpose [Domain]</link:label>
    <link:label id="lab_gsk_PurposeDomain_label_en-US" xlink:label="lab_gsk_PurposeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purpose [Domain]</link:label>
    <link:label id="lab_gsk_PurposeDomain_documentation_en-US" xlink:label="lab_gsk_PurposeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purpose [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PurposeDomain" xlink:href="gsk-20241231.xsd#gsk_PurposeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PurposeDomain" xlink:to="lab_gsk_PurposeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CategoriesOfCommitmentsDomain_f66c7803-5507-4902-b25e-e8fafe209326_terseLabel_en-US" xlink:label="lab_gsk_CategoriesOfCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories Of Commitments [Domain]</link:label>
    <link:label id="lab_gsk_CategoriesOfCommitmentsDomain_label_en-US" xlink:label="lab_gsk_CategoriesOfCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories Of Commitments [Domain]</link:label>
    <link:label id="lab_gsk_CategoriesOfCommitmentsDomain_documentation_en-US" xlink:label="lab_gsk_CategoriesOfCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Categories Of Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CategoriesOfCommitmentsDomain" xlink:href="gsk-20241231.xsd#gsk_CategoriesOfCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CategoriesOfCommitmentsDomain" xlink:to="lab_gsk_CategoriesOfCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_e31c67ba-94da-4a2d-9911-3798d545d556_terseLabel_en-US" xlink:label="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion of consideration paid (received) consisting of cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_49ae9d57-554b-4157-8755-335c376f2d3b_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration (paid)/received</link:label>
    <link:label id="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion of consideration paid (received) consisting of cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:to="lab_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger_8a9f2d30-0505-4447-a9dc-23e14ce591e6_terseLabel_en-US" xlink:label="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit after taxation from discontinued operations and other gains/(losses) from the demerger</link:label>
    <link:label id="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger_label_en-US" xlink:label="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit After Taxation From Discontinued Operations And Other Gains (Losses) From The Demerger</link:label>
    <link:label id="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger_documentation_en-US" xlink:label="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" xlink:href="gsk-20241231.xsd#gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" xlink:to="lab_gsk_ProfitAfterTaxationFromDiscontinuedOperationsAndOtherGainsLossesFromTheDemerger" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ViiVHealthcareSASMember_ab3651ad-1f72-482f-9aef-49eba83701c6_terseLabel_en-US" xlink:label="lab_gsk_ViiVHealthcareSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare SAS (France)</link:label>
    <link:label id="lab_gsk_ViiVHealthcareSASMember_label_en-US" xlink:label="lab_gsk_ViiVHealthcareSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vii V Healthcare SAS [member]</link:label>
    <link:label id="lab_gsk_ViiVHealthcareSASMember_documentation_en-US" xlink:label="lab_gsk_ViiVHealthcareSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ViiV Healthcare SAS.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthcareSASMember" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthcareSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ViiVHealthcareSASMember" xlink:to="lab_gsk_ViiVHealthcareSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_c3135fbe-641f-4826-9e86-acdef542e196_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Present value of scheme obligations</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_c21d1942-6b50-40e3-816a-85ce8031e381_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Defined benefit obligation, at present value at the beginning of the period</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_65018ef6-d6ac-4928-a5ea-20d932faea1b_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Defined benefit obligation, at present value at the end of the period</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_07e91fa5-317c-4505-a023-74609f6b481a_negatedLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Defined benefit obligation</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_df71736d-1985-4682-a3e2-ad761a3b93a1_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Obligations ending balance</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_5c2772da-5fc2-423a-82dc-ca3f4ce825d6_verboseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Obligations ending balance</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit obligation, at present value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember_70611b3f-22f1-42c4-b8fd-3510dac71be1_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property (No.4) Limited</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property (No.4) Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property (No.4) Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" xlink:to="lab_gsk_GlaxosmithklineIntellectualPropertyNo.4LimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally_7ee3b214-d084-45c5-876c-8368dc106c2f_terseLabel_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents held centrally</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally_label_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents And Liquid Investments Held Centrally</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally_documentation_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents And Liquid Investments Held Centrally</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" xlink:to="lab_gsk_CashAndCashEquivalentsAndLiquidInvestmentsHeldCentrally" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses_1b141545-5bda-4a32-9492-84f7f3aec843_terseLabel_en-US" xlink:label="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets recognized on trading losses</link:label>
    <link:label id="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses_label_en-US" xlink:label="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Recognized On Trading Losses</link:label>
    <link:label id="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses_documentation_en-US" xlink:label="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets recognized on trading losses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxAssetsRecognizedOnTradingLosses" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxAssetsRecognizedOnTradingLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredTaxAssetsRecognizedOnTradingLosses" xlink:to="lab_gsk_DeferredTaxAssetsRecognizedOnTradingLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PfizerMember_55ecf37d-e180-43c0-816e-4ab0bf6da6f1_terseLabel_en-US" xlink:label="lab_gsk_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pfizer</link:label>
    <link:label id="lab_gsk_PfizerMember_label_en-US" xlink:label="lab_gsk_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pfizer [member]</link:label>
    <link:label id="lab_gsk_PfizerMember_documentation_en-US" xlink:label="lab_gsk_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pfizer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PfizerMember" xlink:href="gsk-20241231.xsd#gsk_PfizerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PfizerMember" xlink:to="lab_gsk_PfizerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherNonCashCreditCharges_f8edd71e-63a5-46cd-92db-9da75d0efab0_negatedLabel_en-US" xlink:label="lab_gsk_OtherNonCashCreditCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other&#160;non-cash&#160;credit</link:label>
    <link:label id="lab_gsk_OtherNonCashCreditCharges_label_en-US" xlink:label="lab_gsk_OtherNonCashCreditCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Non Cash Credit/(Charges)</link:label>
    <link:label id="lab_gsk_OtherNonCashCreditCharges_documentation_en-US" xlink:label="lab_gsk_OtherNonCashCreditCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other&#160;non cash&#160;credit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNonCashCreditCharges" xlink:href="gsk-20241231.xsd#gsk_OtherNonCashCreditCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherNonCashCreditCharges" xlink:to="lab_gsk_OtherNonCashCreditCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock_26aa1ac0-219e-4580-a382-7cc61a39530e_terseLabel_en-US" xlink:label="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Trade and Other Receivables</link:label>
    <link:label id="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock_label_en-US" xlink:label="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories Of Trade And Other Receivables [Table Text Block]</link:label>
    <link:label id="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Categories Of Trade And Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" xlink:to="lab_gsk_CategoriesOfTradeAndOtherReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock_c1ceb281-398c-4d18-acf6-998d889ca749_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Reconciliation of Tax Charge Calculated at the UK Statutory Rate on the Group Profit Before Tax with the Actual Tax Charge</link:label>
    <link:label id="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of actual tax charge and profit charged at uk tax rate explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of reconciliation of actual tax charge and profit charged at UK tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfReconciliationOfActualTaxChargeAndProfitChargedAtUkTaxRateExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss_3681af31-4794-4de8-9fef-09beb36c7277_terseLabel_en-US" xlink:label="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on remeasurement of investments measured at fair value through profit or loss</link:label>
    <link:label id="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On RemeasurementOof Investments Measured At Fair Value Through Profit Or Loss</link:label>
    <link:label id="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss_documentation_en-US" xlink:label="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain or loss on remeasurement of investments measured at fair value through profit or loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="gsk-20241231.xsd#gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" xlink:to="lab_gsk_GainLossOnRemeasurementOofInvestmentsMeasuredAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProjectedPeriodMember_a0ff6b6b-a82a-4104-8e67-4fc8e3792d0d_terseLabel_en-US" xlink:label="lab_gsk_ProjectedPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Projected for 2044</link:label>
    <link:label id="lab_gsk_ProjectedPeriodMember_label_en-US" xlink:label="lab_gsk_ProjectedPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Projected Period [member]</link:label>
    <link:label id="lab_gsk_ProjectedPeriodMember_documentation_en-US" xlink:label="lab_gsk_ProjectedPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Projected period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProjectedPeriodMember" xlink:href="gsk-20241231.xsd#gsk_ProjectedPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProjectedPeriodMember" xlink:to="lab_gsk_ProjectedPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_b104a1e9-54d8-46cf-9546-50ae2f88f3c9_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based incentive plans</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TitleOfIndividual1Domain_bb4b8dde-6967-4b98-a25a-ce6f09863e0c_terseLabel_en-US" xlink:label="lab_gsk_TitleOfIndividual1Domain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of individual 1 [Domain]</link:label>
    <link:label id="lab_gsk_TitleOfIndividual1Domain_label_en-US" xlink:label="lab_gsk_TitleOfIndividual1Domain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of individual 1 [Domain]</link:label>
    <link:label id="lab_gsk_TitleOfIndividual1Domain_documentation_en-US" xlink:label="lab_gsk_TitleOfIndividual1Domain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Title of individual 1 [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfIndividual1Domain" xlink:href="gsk-20241231.xsd#gsk_TitleOfIndividual1Domain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TitleOfIndividual1Domain" xlink:to="lab_gsk_TitleOfIndividual1Domain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_f96098b5-9a75-4194-ab66-c76e66f7cf83_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of accounting principles and policies [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_label_en-US" xlink:label="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of accounting principles and policies [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting principles and policies [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" xlink:to="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory_38d1d54f-2b8a-4f69-807b-83855adeaaf3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Detailed Information of Foreign Exchange Forward Contracts, Swaps Outstanding and Related Hedged Items</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about hedged items [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_73a4f237-90e3-42a6-9c10-9c98f275e776_negatedLabel_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administration</link:label>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_ddbb36f3-8dbe-4642-8aaf-d615c7edd63d_terseLabel_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administration</link:label>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_f65a391c-53f7-4312-a7df-1d8b26a186eb_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected volatility, share options granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable_5ab298af-7537-498f-a7df-23d71e0ccd33_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plan actuarial assumptions [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plan actuarial assumptions [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plan actuarial assumptions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_14446a7a-a012-4031-8674-7e43ca9014ab_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in associate</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in associate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_42b76066-92f1-44ef-974a-45fdb4c45863_totalLabel_en-US" xlink:label="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Profit after taxation on demerger of discontinued operations</link:label>
    <link:label id="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_label_en-US" xlink:label="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit after taxation on demerger of discontinued operations</link:label>
    <link:label id="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations_documentation_en-US" xlink:label="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Profit after taxation on demerger of discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" xlink:href="gsk-20241231.xsd#gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" xlink:to="lab_gsk_ProfitAfterTaxationOnDemergerOfDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RightofuseAssets_3255ee37-32c8-47d4-9fad-ef4858095687_terseLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_7b425ba3-6614-461f-96e0-d10f86f574aa_periodStartLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Net book value, beginning of the year</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_ef97430e-1e15-4c0a-bdbc-37903726a3b1_periodEndLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Net book value, end of the year</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets" xlink:to="lab_ifrs-full_RightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_73b72e55-b581-4de1-86a0-b265b7ae301c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Liabilities_3b88ac99-6773-4a21-bfb4-08428f7cd1e6_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_ifrs-full_Liabilities_90401d4a-9ce5-4710-8a83-b1ff4084c143_terseLabel_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_ifrs-full_Liabilities_label_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities" xlink:to="lab_ifrs-full_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember_b205dc50-f0cd-4b61-9510-1e11d2738956_terseLabel_en-US" xlink:label="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting accountant work performed in connection with consumer healthcare demerger</link:label>
    <link:label id="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember_label_en-US" xlink:label="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Accountant Work Performed In Connection With Consumer Healthcare Demerger [Member]</link:label>
    <link:label id="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember_documentation_en-US" xlink:label="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reporting Accountant Work Performed In Connection With Consumer Healthcare Demerger [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" xlink:href="gsk-20241231.xsd#gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" xlink:to="lab_gsk_ReportingAccountantWorkPerformedInConnectionWithConsumerHealthcareDemergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember_b4e5f483-e250-45e3-9210-60334d2378dc_terseLabel_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.375% US$ US Medium Term Note 2029</link:label>
    <link:label id="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember_label_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Three Seven Five Percent US Medium Term Note Two Thousand Twenty Nine [Member]</link:label>
    <link:label id="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember_documentation_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three Point Three Seven Five Percent US Medium Term Note Two Thousand Twenty Nine.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" xlink:href="gsk-20241231.xsd#gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" xlink:to="lab_gsk_ThreePointThreeSevenFivePercentUsMediumTermNoteTwoThousandTwentyNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZantacQuiTamMember_b31c6fcb-f305-45c6-9bef-dfa14a4a4b4d_terseLabel_en-US" xlink:label="lab_gsk_ZantacQuiTamMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zantac Qui Tam</link:label>
    <link:label id="lab_gsk_ZantacQuiTamMember_label_en-US" xlink:label="lab_gsk_ZantacQuiTamMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zantac Qui Tam [Member]</link:label>
    <link:label id="lab_gsk_ZantacQuiTamMember_documentation_en-US" xlink:label="lab_gsk_ZantacQuiTamMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zantac Qui Tam</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZantacQuiTamMember" xlink:href="gsk-20241231.xsd#gsk_ZantacQuiTamMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZantacQuiTamMember" xlink:to="lab_gsk_ZantacQuiTamMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CustomerReturnsDiscountsAndRebates_3c003b56-ce1a-44cb-8e04-e3199837521e_terseLabel_en-US" xlink:label="lab_gsk_CustomerReturnsDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incidental deductions to turnover</link:label>
    <link:label id="lab_gsk_CustomerReturnsDiscountsAndRebates_label_en-US" xlink:label="lab_gsk_CustomerReturnsDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Returns Discounts And Rebates</link:label>
    <link:label id="lab_gsk_CustomerReturnsDiscountsAndRebates_documentation_en-US" xlink:label="lab_gsk_CustomerReturnsDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer returns discounts and rebates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnsDiscountsAndRebates" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnsDiscountsAndRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CustomerReturnsDiscountsAndRebates" xlink:to="lab_gsk_CustomerReturnsDiscountsAndRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_81e1a969-e59f-4662-befe-57feb76ac703_terseLabel_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for basis of consolidation [Policy Text Block]</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The description of the entity's accounting policy for basis of consolidation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:href="gsk-20241231.xsd#gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:to="lab_gsk_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilities_e176b4cc-d0c5-45d7-a245-8dc4fe4a430a_negatedLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilities_105d3dd9-2ce3-4a70-973a-3af949f3ef79_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities" xlink:to="lab_ifrs-full_FinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UKDefinedBenefitPlansMember_9f348a95-ccbb-46fc-ad08-e7bbf385c0bd_terseLabel_en-US" xlink:label="lab_gsk_UKDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK defined benefit plans</link:label>
    <link:label id="lab_gsk_UKDefinedBenefitPlansMember_label_en-US" xlink:label="lab_gsk_UKDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UK Defined Benefit Plans [Member]</link:label>
    <link:label id="lab_gsk_UKDefinedBenefitPlansMember_documentation_en-US" xlink:label="lab_gsk_UKDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">UK defined benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UKDefinedBenefitPlansMember" xlink:href="gsk-20241231.xsd#gsk_UKDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UKDefinedBenefitPlansMember" xlink:to="lab_gsk_UKDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_a595da7c-0fe8-422a-9c24-7e4eeba683e9_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_2a85c2e8-9411-4185-aa2b-fd5fc6639f73_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfEmployeeCostsExplanatory_9a806583-315b-4203-b5dc-7ca85a31a2bb_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee costs</link:label>
    <link:label id="lab_gsk_DisclosureOfEmployeeCostsExplanatory_label_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of employee costs [text block]</link:label>
    <link:label id="lab_gsk_DisclosureOfEmployeeCostsExplanatory_documentation_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of employee costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfEmployeeCostsExplanatory" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfEmployeeCostsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfEmployeeCostsExplanatory" xlink:to="lab_gsk_DisclosureOfEmployeeCostsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_6be8d5d7-f507-4d1e-9e9c-927bd8da8e7f_terseLabel_en-US" xlink:label="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_label_en-US" xlink:label="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax On Share Based Payments Charged Or Credited Directly To Equity And Comprehensive Income</link:label>
    <link:label id="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax on share based payments charged or credited directly to equity and comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:to="lab_gsk_DeferredTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashReserves_cf91f6a1-be08-4abc-acd5-d43278ab8e87_terseLabel_en-US" xlink:label="lab_gsk_CashReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash reserves</link:label>
    <link:label id="lab_gsk_CashReserves_label_en-US" xlink:label="lab_gsk_CashReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Reserves</link:label>
    <link:label id="lab_gsk_CashReserves_documentation_en-US" xlink:label="lab_gsk_CashReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashReserves" xlink:href="gsk-20241231.xsd#gsk_CashReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashReserves" xlink:to="lab_gsk_CashReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_982a1925-b85f-435b-ab7b-8f10d4f10b65_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_2bc52191-9174-4196-b250-619d08deda9d_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [domain]</link:label>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_label_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember_19961429-116e-4780-b408-7f7ab7cf7ee3_verboseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Trading Services Limited (Republic of Ireland)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Trading Services Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Trading Services Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineTradingServicesLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineTradingServicesLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineTradingServicesLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineTradingServicesLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_5dd23232-557f-4228-aa2f-46e840e61de9_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of intangible assets</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of intangible assets, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements_23f5ef87-0dba-43ec-bcbf-637ee1825451_verboseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in income</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Income Through Interest Rate Movements</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) in income through interest rate movements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements" xlink:to="lab_gsk_IncreaseDecreaseInIncomeThroughInterestRateMovements" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome_f49a51bc-e332-47e2-a995-cbbed48d8132_terseLabel_en-US" xlink:label="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net fair value movements through other comprehensive income</link:label>
    <link:label id="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome_label_en-US" xlink:label="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Fair Value Movements Investments Through Other Comprehensive Income</link:label>
    <link:label id="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net fair value movements investments through other comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" xlink:to="lab_gsk_NetFairValueMovementsInvestmentsThroughOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_d72885a5-4279-47a2-98ca-fb138d477fc9_periodStartLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and bank overdrafts at the beginning of year</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_a83ca691-8bb4-42a2-978a-a8ad5af3a1bb_periodEndLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and bank overdrafts at the end of year</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_c19b20e5-13b6-41ef-983b-3b44726efe03_totalLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash and bank overdrafts</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents if different from statement of financial position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonUsaMember_36604981-39f2-4424-9f0d-f130fc0b7864_terseLabel_en-US" xlink:label="lab_gsk_NonUsaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non USA</link:label>
    <link:label id="lab_gsk_NonUsaMember_label_en-US" xlink:label="lab_gsk_NonUsaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non USA .[member]</link:label>
    <link:label id="lab_gsk_NonUsaMember_documentation_en-US" xlink:label="lab_gsk_NonUsaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non USA .[member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonUsaMember" xlink:href="gsk-20241231.xsd#gsk_NonUsaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonUsaMember" xlink:to="lab_gsk_NonUsaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_6c5435e5-792a-4502-b0bb-414f545c8c84_terseLabel_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share (pence) from continuing operations (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_27054c68-5503-44fb-83fe-ad83082c550b_verboseLabel_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share from continuing operations (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share from continuing operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess_e0375674-6f88-4c5e-a4f9-dfc1def50837_terseLabel_en-US" xlink:label="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10% increase in probability of milestone success</link:label>
    <link:label id="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess_label_en-US" xlink:label="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ten Percent Increase In Probability Of Milestone Success</link:label>
    <link:label id="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess_documentation_en-US" xlink:label="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase in probability of milestone success.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" xlink:href="gsk-20241231.xsd#gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" xlink:to="lab_gsk_TenPercentIncreaseInProbabilityOfMilestoneSuccess" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember_1fc57f32-71b1-4de0-aac1-7169be7ef6b0_terseLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unfunded post-retirement healthcare schemes</link:label>
    <link:label id="lab_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment medical defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_PostemploymentMedicalDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill_5368e7d8-9ff0-42da-8e3b-b56c0ce61d41_terseLabel_en-US" xlink:label="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalised development costs</link:label>
    <link:label id="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalised Development Costs, Intangible Assets Other Than Goodwill</link:label>
    <link:label id="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill_documentation_en-US" xlink:label="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalised development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" xlink:href="gsk-20241231.xsd#gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_gsk_CapitalisedDevelopmentCostsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember_b616abb9-b3b0-4b71-9f9e-cddbed58fc52_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time value of options</link:label>
    <link:label id="lab_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember_label_en-US" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of change in value of time value of options [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk_ba07e93f-13b6-4b3d-9b10-8d76fd6da866_terseLabel_en-US" xlink:label="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends&#8203; distributed from&#8203; cash balance attributable to GSK</link:label>
    <link:label id="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk_label_en-US" xlink:label="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Distributed From Cash Balance Attributable To GSK</link:label>
    <link:label id="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk_documentation_en-US" xlink:label="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividends&#8203; distributed from&#8203; cash balance attributable to GSK.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsDistributedFromCashBalanceAttributableToGsk" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DividendsDistributedFromCashBalanceAttributableToGsk" xlink:to="lab_gsk_DividendsDistributedFromCashBalanceAttributableToGsk" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_42012b8d-b39d-42ce-8df8-42fad7955f60_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about hedged items [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about hedged items [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TerminationBenefitsExpense_f60a429c-9ff9-4725-a137-a1150ce28509_terseLabel_en-US" xlink:label="lab_ifrs-full_TerminationBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance and other costs from integration and restructuring activities</link:label>
    <link:label id="lab_ifrs-full_TerminationBenefitsExpense_label_en-US" xlink:label="lab_ifrs-full_TerminationBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Termination benefits expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TerminationBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TerminationBenefitsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TerminationBenefitsExpense" xlink:to="lab_ifrs-full_TerminationBenefitsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_1242ddc8-d76a-4798-b8ef-b695bc82072f_terseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement</link:label>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_990d9736-bebf-4845-8b4e-54e82ed7e671_totalLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesMember_f810facd-691c-41cd-8160-c67ce327469e_terseLabel_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business disposals</link:label>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesMember_label_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total For All Business Divestures [Member]</link:label>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesMember_documentation_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total For All Business Divestures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalForAllBusinessDivesturesMember" xlink:href="gsk-20241231.xsd#gsk_TotalForAllBusinessDivesturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TotalForAllBusinessDivesturesMember" xlink:to="lab_gsk_TotalForAllBusinessDivesturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_df4c022b-2894-490b-9e03-7ad51ebe5641_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock_31adada8-befa-41cb-8a3f-5f14749f3274_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Investments</link:label>
    <link:label id="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Schedule of Other Investment [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of schedule of other investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" xlink:to="lab_gsk_DisclosureOfScheduleOfOtherInvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_VaccineAxis_9e95c566-5547-40f1-8040-2407ca3686b2_terseLabel_en-US" xlink:label="lab_gsk_VaccineAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vaccine [Axis]</link:label>
    <link:label id="lab_gsk_VaccineAxis_label_en-US" xlink:label="lab_gsk_VaccineAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vaccine [Axis]</link:label>
    <link:label id="lab_gsk_VaccineAxis_documentation_en-US" xlink:label="lab_gsk_VaccineAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vaccine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccineAxis" xlink:href="gsk-20241231.xsd#gsk_VaccineAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_VaccineAxis" xlink:to="lab_gsk_VaccineAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock_19bf269b-06d7-4e54-be2b-e83e7433aeaf_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Financial Assumptions in Assessing Defined Benefit Liabilities</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Defined Benefit Plan Actuarial Assumptions [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plan actuarial assumptions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_6029f262-4840-4d0b-a5d2-f19f5303e8f8_terseLabel_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bottom of range</link:label>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bottom of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_87badc70-48fb-483d-b120-fb64e3862905_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15 cent appreciation of the Euro</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_744d3345-4059-4875-80ee-e502ae9ea2e3_verboseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">15 cent appreciation of Euro</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Appreciation Of Euro [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Appreciation Of Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:to="lab_gsk_CurrencyRiskFifteenCentAppreciationOfEuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_40f6efa5-c027-4e17-89e0-089eacf389a9_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPerformanceMeasures_a82d7488-563a-40bc-887f-1e3a96e79a53_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPerformanceMeasures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of performance measures</link:label>
    <link:label id="lab_gsk_NumberOfPerformanceMeasures_label_en-US" xlink:label="lab_gsk_NumberOfPerformanceMeasures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Performance Measures</link:label>
    <link:label id="lab_gsk_NumberOfPerformanceMeasures_documentation_en-US" xlink:label="lab_gsk_NumberOfPerformanceMeasures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Performance Measures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPerformanceMeasures" xlink:href="gsk-20241231.xsd#gsk_NumberOfPerformanceMeasures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPerformanceMeasures" xlink:to="lab_gsk_NumberOfPerformanceMeasures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MethodsOfGenerationDomain_db46d2cd-7864-4620-b72d-c9a7a2329fbe_terseLabel_en-US" xlink:label="lab_ifrs-full_MethodsOfGenerationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Methods of generation</link:label>
    <link:label id="lab_ifrs-full_MethodsOfGenerationDomain_label_en-US" xlink:label="lab_ifrs-full_MethodsOfGenerationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Methods of generation [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MethodsOfGenerationDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodsOfGenerationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MethodsOfGenerationDomain" xlink:to="lab_ifrs-full_MethodsOfGenerationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock_08ec0a13-02ae-484c-988e-4fb112beac17_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal proceedings</link:label>
    <link:label id="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Legal Proceedings Explanatory [Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of legal proceedings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" xlink:to="lab_gsk_DisclosureOfLegalProceedingsExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0ec4331e-4e06-4a19-b3df-f9071c29018e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Movement In Net Debt [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_05ecfcee-a72a-4624-8024-e57c335d4fd6_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Life expectancy</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of life expectancy after retirement [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ea176a19-7beb-4aa8-bcbe-8a3bdfe45fdd_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2f2ff7df-70c4-4c64-a8ac-2905511a428d_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_a5007abf-1d5e-416f-bfd8-cfa4a77f9697_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfForeignExchangeRatesTable_64d444a0-e9c4-40e5-b9dc-bab9e08b0402_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Foreign Exchange Rates [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfForeignExchangeRatesTable_label_en-US" xlink:label="lab_gsk_DisclosureOfForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Foreign Exchange Rates [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfForeignExchangeRatesTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Foreign Exchange Rates [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfForeignExchangeRatesTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfForeignExchangeRatesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfForeignExchangeRatesTable" xlink:to="lab_gsk_DisclosureOfForeignExchangeRatesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceIncome_6d36a6ef-328c-4027-bd81-f9e65aa5fc76_terseLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance income</link:label>
    <link:label id="lab_ifrs-full_FinanceIncome_29c40636-7d7b-4639-abeb-c19ef75b97f3_totalLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Finance income</link:label>
    <link:label id="lab_ifrs-full_FinanceIncome_label_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="lab_ifrs-full_FinanceIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_281de453-ca42-426e-b7f9-9d5e40e9525a_terseLabel_en-US" xlink:label="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investments measured at fair value through other comprehensive income (FVTOCI)</link:label>
    <link:label id="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Investments Measured At Fair Value Through Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_documentation_en-US" xlink:label="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity investments measured at fair value through other comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:href="gsk-20241231.xsd#gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UnremittedEarnings_0bb831ba-a6e5-4d5e-9ab7-8393956ec4af_terseLabel_en-US" xlink:label="lab_gsk_UnremittedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unremitted profits</link:label>
    <link:label id="lab_gsk_UnremittedEarnings_label_en-US" xlink:label="lab_gsk_UnremittedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unremitted Earnings</link:label>
    <link:label id="lab_gsk_UnremittedEarnings_documentation_en-US" xlink:label="lab_gsk_UnremittedEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unremitted earnings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnremittedEarnings" xlink:href="gsk-20241231.xsd#gsk_UnremittedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UnremittedEarnings" xlink:to="lab_gsk_UnremittedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InsuranceContractsAxis_32abea42-3f71-44c9-9502-b0af692146f6_terseLabel_en-US" xlink:label="lab_ifrs-full_InsuranceContractsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance contracts [axis]</link:label>
    <link:label id="lab_ifrs-full_InsuranceContractsAxis_label_en-US" xlink:label="lab_ifrs-full_InsuranceContractsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance contracts [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InsuranceContractsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InsuranceContractsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InsuranceContractsAxis" xlink:to="lab_ifrs-full_InsuranceContractsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfFinancialLiabilitiesDomain_38f2c760-14b6-4ab1-af2d-6eabb0a16b8f_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of financial liabilities</link:label>
    <link:label id="lab_ifrs-full_TypesOfFinancialLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of financial liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfFinancialLiabilitiesDomain" xlink:to="lab_ifrs-full_TypesOfFinancialLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DefinedBenefitObligationDeferredMember_4d3c002a-66eb-4888-9435-c702adb51381_terseLabel_en-US" xlink:label="lab_gsk_DefinedBenefitObligationDeferredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_gsk_DefinedBenefitObligationDeferredMember_label_en-US" xlink:label="lab_gsk_DefinedBenefitObligationDeferredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Obligation Deferred [member]</link:label>
    <link:label id="lab_gsk_DefinedBenefitObligationDeferredMember_documentation_en-US" xlink:label="lab_gsk_DefinedBenefitObligationDeferredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined benefit obligation deferred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationDeferredMember" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationDeferredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DefinedBenefitObligationDeferredMember" xlink:to="lab_gsk_DefinedBenefitObligationDeferredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_40619365-84ed-41e9-81b1-4dff2d93c1b0_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged_29fd4396-3b35-4df8-b045-726e78f1c6b3_terseLabel_en-US" xlink:label="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, for which impairments have been charged</link:label>
    <link:label id="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged_label_en-US" xlink:label="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, For Which Impairments Have Been Charged</link:label>
    <link:label id="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged_documentation_en-US" xlink:label="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible assets, for which impairments have been charged.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" xlink:href="gsk-20241231.xsd#gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" xlink:to="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenCharged" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_10660636-7dab-4221-b507-4ccc92a5b6f1_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts_a72ce9ca-c87e-4687-af3b-612260261728_totalLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in cash and bank overdrafts in the year</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Cash And Bank Overdrafts</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and bank overdrafts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInCashAndBankOverdrafts" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInCashAndBankOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInCashAndBankOverdrafts" xlink:to="lab_gsk_IncreaseDecreaseInCashAndBankOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_672b13c0-4426-43cf-89d9-53fc417b7411_totalLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Pension and other post-employment costs</link:label>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract_abeeaa86-da9b-468c-af60-781e6176380c_terseLabel_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxation</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Relating To Items Charged Or Credited Directly To Equity And Comprehensive Income [abstract]</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax relating to items charged or credited directly to equity and comprehensive income [abstract].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" xlink:to="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease_e37baa79-4774-4941-a73f-996e5fdab719_negatedLabel_en-US" xlink:label="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Borrowings excluding obligations under finance lease</link:label>
    <link:label id="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease_label_en-US" xlink:label="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings Excluding Obligations Under Finance Lease</link:label>
    <link:label id="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease_documentation_en-US" xlink:label="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings excluding obligations under finance lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsExcludingObligationsUnderFinanceLease" xlink:href="gsk-20241231.xsd#gsk_BorrowingsExcludingObligationsUnderFinanceLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BorrowingsExcludingObligationsUnderFinanceLease" xlink:to="lab_gsk_BorrowingsExcludingObligationsUnderFinanceLease" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities_d5699480-2d17-409a-9fd5-4c54f6bc333d_terseLabel_en-US" xlink:label="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend and distributions from investments</link:label>
    <link:label id="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends and Distributions Received, Classified As Investing Activities</link:label>
    <link:label id="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities_documentation_en-US" xlink:label="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividends and Distributions Received, Classified As Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" xlink:href="gsk-20241231.xsd#gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" xlink:to="lab_gsk_DividendsAndDistributionsReceivedClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare_3bc9199e-79bb-42b6-88de-2945f65ea2a7_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend per share (pence) (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare_label_en-US" xlink:label="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends paid, ordinary shares per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CapitalCommitmentsAbstract_label_en-US" xlink:label="lab_ifrs-full_CapitalCommitmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital commitments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalCommitmentsAbstract" xlink:to="lab_ifrs-full_CapitalCommitmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member_d0914dc3-b70b-4783-b291-96b71a63d288_terseLabel_en-US" xlink:label="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.875% Notes due 2028</link:label>
    <link:label id="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member_label_en-US" xlink:label="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Eight Seven Five Notes due 2028 [Member]</link:label>
    <link:label id="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member_documentation_en-US" xlink:label="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.875% Notes due 2028.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointEightSevenFiveNotesDue2028Member" xlink:href="gsk-20241231.xsd#gsk_ThreePointEightSevenFiveNotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointEightSevenFiveNotesDue2028Member" xlink:to="lab_gsk_ThreePointEightSevenFiveNotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPatentsAllegedlyInfringed_c54abd5d-d1fd-409b-bb6a-fc009bf49f95_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPatentsAllegedlyInfringed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents allegedly infringed</link:label>
    <link:label id="lab_gsk_NumberOfPatentsAllegedlyInfringed_label_en-US" xlink:label="lab_gsk_NumberOfPatentsAllegedlyInfringed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Patents Allegedly Infringed</link:label>
    <link:label id="lab_gsk_NumberOfPatentsAllegedlyInfringed_documentation_en-US" xlink:label="lab_gsk_NumberOfPatentsAllegedlyInfringed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Patents Allegedly Infringed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsAllegedlyInfringed" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsAllegedlyInfringed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPatentsAllegedlyInfringed" xlink:to="lab_gsk_NumberOfPatentsAllegedlyInfringed" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContinuingAndDiscontinuedOperationDomain_c531d9d2-ab7e-46ca-acc9-2510ae16693b_terseLabel_en-US" xlink:label="lab_gsk_ContinuingAndDiscontinuedOperationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing And Discontinued Operation [Domain]</link:label>
    <link:label id="lab_gsk_ContinuingAndDiscontinuedOperationDomain_label_en-US" xlink:label="lab_gsk_ContinuingAndDiscontinuedOperationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing And Discontinued Operation [Domain]</link:label>
    <link:label id="lab_gsk_ContinuingAndDiscontinuedOperationDomain_documentation_en-US" xlink:label="lab_gsk_ContinuingAndDiscontinuedOperationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Continuing And Discontinued Operation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationDomain" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationDomain" xlink:to="lab_gsk_ContinuingAndDiscontinuedOperationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_0bc2021e-c48b-49e5-92a8-e568c2f283a1_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenditure</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for expenses [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountMember_c5ee4221-c481-4786-ac1b-48fdff5b1cab_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember" xlink:to="lab_ifrs-full_CarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_9ddd0c49-9b08-49ae-be52-ef35704dd637_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Movement In Net Debt [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_c1322a5f-aab6-470a-bcf9-b1477c2ecc9d_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other payables recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsAxis_97925f7b-713f-49b5-849d-be6c0ee22011_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TradeAndOtherReceivableMember_6a9bbc03-ef75-4300-ab8a-319cb416dbf0_terseLabel_en-US" xlink:label="lab_gsk_TradeAndOtherReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables</link:label>
    <link:label id="lab_gsk_TradeAndOtherReceivableMember_label_en-US" xlink:label="lab_gsk_TradeAndOtherReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Receivable [member]</link:label>
    <link:label id="lab_gsk_TradeAndOtherReceivableMember_documentation_en-US" xlink:label="lab_gsk_TradeAndOtherReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade and other receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivableMember" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TradeAndOtherReceivableMember" xlink:to="lab_gsk_TradeAndOtherReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired_9b42734c-46fb-4c32-ac3d-655caad3d18f_terseLabel_en-US" xlink:label="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination step acquisition remaining equity interest acquired</link:label>
    <link:label id="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired_label_en-US" xlink:label="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition Remaining Equity Interest Acquired</link:label>
    <link:label id="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired_documentation_en-US" xlink:label="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business combination step acquisition remaining equity interest acquired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" xlink:to="lab_gsk_BusinessCombinationStepAcquisitionRemainingEquityInterestAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineAgMember_4e1b1478-cf32-4040-82fe-488f164815d6_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineAgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline AG (Switzerland)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineAgMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineAgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline AG [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineAgMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineAgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline AG.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineAgMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineAgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineAgMember" xlink:to="lab_gsk_GlaxosmithklineAgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LegacyProgrammesMember_3eeab047-e261-4d90-91c8-246c9c564caf_terseLabel_en-US" xlink:label="lab_gsk_LegacyProgrammesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legacy programmes</link:label>
    <link:label id="lab_gsk_LegacyProgrammesMember_label_en-US" xlink:label="lab_gsk_LegacyProgrammesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legacy programmes [Member]</link:label>
    <link:label id="lab_gsk_LegacyProgrammesMember_documentation_en-US" xlink:label="lab_gsk_LegacyProgrammesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legacy programmes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegacyProgrammesMember" xlink:href="gsk-20241231.xsd#gsk_LegacyProgrammesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LegacyProgrammesMember" xlink:to="lab_gsk_LegacyProgrammesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PostEmploymentBenefitExpense_e59db6b8-fd6f-44d0-a4d4-d8925cebb192_verboseLabel_en-US" xlink:label="lab_gsk_PostEmploymentBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Pension and other post-employment costs, including augmentations (Note 31)</link:label>
    <link:label id="lab_gsk_PostEmploymentBenefitExpense_label_en-US" xlink:label="lab_gsk_PostEmploymentBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post Employment Benefit Expense</link:label>
    <link:label id="lab_gsk_PostEmploymentBenefitExpense_documentation_en-US" xlink:label="lab_gsk_PostEmploymentBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of post-employment benefit expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostEmploymentBenefitExpense" xlink:href="gsk-20241231.xsd#gsk_PostEmploymentBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PostEmploymentBenefitExpense" xlink:to="lab_gsk_PostEmploymentBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_73f64fe6-8aec-487b-ad4c-4151d83c130c_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other additions</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_e6e413a5-dfa5-40b1-97fa-a303b1f5eb40_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_a4520cb2-ca85-4001-adc3-9ce0eb7707cd_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_94529b85-85e4-48c4-b15e-b7027617cc13_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Overdrafts</link:label>
    <link:label id="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesAbstract_342ec306-11ec-4827-8596-77cd371acc48_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_6701c3c4-17ab-4bd8-b1d1-d69e35ba2b61_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember_e9c6a12b-5152-4498-932b-6e4c5d2596e6_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15% increase in sales forecasts</link:label>
    <link:label id="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember_label_en-US" xlink:label="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk Fifteen Percentage Increase In Sales Forecasts [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk fifteen percentage increase in sales forecasts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" xlink:href="gsk-20241231.xsd#gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" xlink:to="lab_gsk_OtherRiskFifteenPercentageIncreaseInSalesForecastsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember_6923f058-092f-4330-ab92-d3d6157fef00_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) increase in Sterling interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Point Five Percent Increase In Sterling Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest rate risk one point five percent increase in sterling interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInSterlingInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UpfrontCashConsiderationPaidReceived_bd394dd8-d012-4347-b9ee-3fb0932a5a4b_terseLabel_en-US" xlink:label="lab_gsk_UpfrontCashConsiderationPaidReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront cash consideration paid (received)</link:label>
    <link:label id="lab_gsk_UpfrontCashConsiderationPaidReceived_label_en-US" xlink:label="lab_gsk_UpfrontCashConsiderationPaidReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront Cash Consideration Paid (Received)</link:label>
    <link:label id="lab_gsk_UpfrontCashConsiderationPaidReceived_documentation_en-US" xlink:label="lab_gsk_UpfrontCashConsiderationPaidReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upfront Cash Consideration Paid (Received)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UpfrontCashConsiderationPaidReceived" xlink:href="gsk-20241231.xsd#gsk_UpfrontCashConsiderationPaidReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UpfrontCashConsiderationPaidReceived" xlink:to="lab_gsk_UpfrontCashConsiderationPaidReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PreHedgingOfLongTermInterestRatesMember_3718b584-6be4-427d-8079-37bc5f273b8b_terseLabel_en-US" xlink:label="lab_gsk_PreHedgingOfLongTermInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-hedging of long-term interest rates</link:label>
    <link:label id="lab_gsk_PreHedgingOfLongTermInterestRatesMember_label_en-US" xlink:label="lab_gsk_PreHedgingOfLongTermInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Hedging Of Long-Term Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_PreHedgingOfLongTermInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_PreHedgingOfLongTermInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-hedging of long-term interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PreHedgingOfLongTermInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_PreHedgingOfLongTermInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PreHedgingOfLongTermInterestRatesMember" xlink:to="lab_gsk_PreHedgingOfLongTermInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_a5015c41-e43f-4e4a-a6c5-3f9d4abf0aa7_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [domain]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_f704de35-460c-4130-8e8f-2fa3b5a786eb_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental payments due between three and four years</link:label>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ca862020-fdae-4a4a-9634-bcade715d8ca_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Between three and four years</link:label>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than three years and not later than four years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDepreciationExpense_58580bb6-7682-4b57-b26d-017f6463574c_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDepreciationExpense_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember_5a03b497-3b3a-443f-9bbf-92d6e9572b27_terseLabel_en-US" xlink:label="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.000% &#8364; Euro Medium Term Note 2026</link:label>
    <link:label id="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember_label_en-US" xlink:label="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Zero Zero Percent Euro Medium Term Note Two Thousand Twenty Six [Member]</link:label>
    <link:label id="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember_documentation_en-US" xlink:label="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One percent European medium term note two thousand twenty six.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" xlink:href="gsk-20241231.xsd#gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" xlink:to="lab_gsk_OnePointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentySixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonInterestBearingDebt_7f8f3fc0-6f00-4cde-9c87-c0802c75b460_negatedTerseLabel_en-US" xlink:label="lab_gsk_NonInterestBearingDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non interest bearing</link:label>
    <link:label id="lab_gsk_NonInterestBearingDebt_label_en-US" xlink:label="lab_gsk_NonInterestBearingDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Interest Bearing Debt</link:label>
    <link:label id="lab_gsk_NonInterestBearingDebt_documentation_en-US" xlink:label="lab_gsk_NonInterestBearingDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Interest Bearing Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonInterestBearingDebt" xlink:href="gsk-20241231.xsd#gsk_NonInterestBearingDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonInterestBearingDebt" xlink:to="lab_gsk_NonInterestBearingDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_f501649a-51b2-4176-b3fc-cf54b2f3a94e_terseLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of impairments</link:label>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CommercialOperationsMember_4dd2b660-d1a3-41d3-a465-b8155b39be6e_terseLabel_en-US" xlink:label="lab_gsk_CommercialOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial Operations</link:label>
    <link:label id="lab_gsk_CommercialOperationsMember_6aa3afce-cfdc-4846-9398-08adca2241aa_verboseLabel_en-US" xlink:label="lab_gsk_CommercialOperationsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commercial operations</link:label>
    <link:label id="lab_gsk_CommercialOperationsMember_label_en-US" xlink:label="lab_gsk_CommercialOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Operations [Member]</link:label>
    <link:label id="lab_gsk_CommercialOperationsMember_documentation_en-US" xlink:label="lab_gsk_CommercialOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commercial operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialOperationsMember" xlink:href="gsk-20241231.xsd#gsk_CommercialOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CommercialOperationsMember" xlink:to="lab_gsk_CommercialOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_c84f9142-052e-4eb7-8442-21a64babfef7_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_affe9a8c-156d-4200-8655-a768bc530b43_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summarised Financial Information of Joint Venture</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Information About The Amounts Attributable To Non Controlling Interests Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Information About The Amounts Attributable To Non Controlling Interests Explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfFinancialInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossOnHedgeIneffectiveness_6bcd099d-1a5b-4888-bea8-9834c66736ed_terseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnHedgeIneffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ineffectiveness of hedges</link:label>
    <link:label id="lab_ifrs-full_GainLossOnHedgeIneffectiveness_label_en-US" xlink:label="lab_ifrs-full_GainLossOnHedgeIneffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) on hedge ineffectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnHedgeIneffectiveness" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnHedgeIneffectiveness" xlink:to="lab_ifrs-full_GainLossOnHedgeIneffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_8f8a1439-eb76-4e9f-b904-a95a9d57477e_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for provisions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MeningitisPortfolioMember_a9962966-1179-4c17-8447-54f4ac78c94f_terseLabel_en-US" xlink:label="lab_gsk_MeningitisPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Meningitis Portfolio</link:label>
    <link:label id="lab_gsk_MeningitisPortfolioMember_label_en-US" xlink:label="lab_gsk_MeningitisPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Meningitis Portfolio [member]</link:label>
    <link:label id="lab_gsk_MeningitisPortfolioMember_documentation_en-US" xlink:label="lab_gsk_MeningitisPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Meningitis portfolio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MeningitisPortfolioMember" xlink:href="gsk-20241231.xsd#gsk_MeningitisPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MeningitisPortfolioMember" xlink:to="lab_gsk_MeningitisPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AverageNumberOfEmployees_9c214a3a-2012-4da8-b42e-70cdb071bd74_totalLabel_en-US" xlink:label="lab_ifrs-full_AverageNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Average number of employees</link:label>
    <link:label id="lab_ifrs-full_AverageNumberOfEmployees_label_en-US" xlink:label="lab_ifrs-full_AverageNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average number of employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageNumberOfEmployees" xlink:to="lab_ifrs-full_AverageNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets_6156fd76-5b97-4efc-823a-6e134e911c5b_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiquidInvestmentsMember_bccbce7d-9668-43f1-bb12-2173950b4d0c_terseLabel_en-US" xlink:label="lab_gsk_LiquidInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquid investments</link:label>
    <link:label id="lab_gsk_LiquidInvestmentsMember_label_en-US" xlink:label="lab_gsk_LiquidInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquid Investments [member]</link:label>
    <link:label id="lab_gsk_LiquidInvestmentsMember_documentation_en-US" xlink:label="lab_gsk_LiquidInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liquid investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsMember" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiquidInvestmentsMember" xlink:to="lab_gsk_LiquidInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_26fd11b0-5104-4403-ab7e-2534e78116cb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about unconsolidated structured entities controlled by investment entity [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BancoDeCreditoDelPeruMember_1d74a89f-a3ad-4678-bc80-94123cfb3d89_terseLabel_en-US" xlink:label="lab_gsk_BancoDeCreditoDelPeruMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Banco De Credito Del Peru</link:label>
    <link:label id="lab_gsk_BancoDeCreditoDelPeruMember_label_en-US" xlink:label="lab_gsk_BancoDeCreditoDelPeruMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Banco De Credito Del Peru [Member]</link:label>
    <link:label id="lab_gsk_BancoDeCreditoDelPeruMember_documentation_en-US" xlink:label="lab_gsk_BancoDeCreditoDelPeruMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Banco De Credito Del Peru</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancoDeCreditoDelPeruMember" xlink:href="gsk-20241231.xsd#gsk_BancoDeCreditoDelPeruMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BancoDeCreditoDelPeruMember" xlink:to="lab_gsk_BancoDeCreditoDelPeruMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_281d681e-88dd-442a-98c1-30850d54eacc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial information of associates and joint ventures [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities_d21a208a-1d2d-43eb-8bd2-5a3e0c9fa752_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends from joint ventures and associates</link:label>
    <link:label id="lab_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends received from investments accounted for using equity method, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_66a95117-5bf8-458e-80f2-ab6db596dc21_terseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption_9f8fac6c-de56-4e93-9bc0-fa687ca55c0a_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in annual pension cost</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Pension Cost Due To Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Pension Cost Due To Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_4dffe100-1578-46e1-a906-c7d121a28445_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_Wholesalers3Member_ccbfaee2-a3e6-4291-8c2a-0f8f1c44e901_terseLabel_en-US" xlink:label="lab_gsk_Wholesalers3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wholesalers 3</link:label>
    <link:label id="lab_gsk_Wholesalers3Member_label_en-US" xlink:label="lab_gsk_Wholesalers3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholesalers 3 [member]</link:label>
    <link:label id="lab_gsk_Wholesalers3Member_documentation_en-US" xlink:label="lab_gsk_Wholesalers3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wholesalers 3.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Wholesalers3Member" xlink:href="gsk-20241231.xsd#gsk_Wholesalers3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_Wholesalers3Member" xlink:to="lab_gsk_Wholesalers3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount_2de884cb-a6a5-4105-879f-de02d6847260_terseLabel_en-US" xlink:label="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Savings-related options grant price discount</link:label>
    <link:label id="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount_label_en-US" xlink:label="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Savings Related Options Grant Price Discount</link:label>
    <link:label id="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount_documentation_en-US" xlink:label="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Savings related options grant price discount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedOptionsGrantPriceDiscount" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedOptionsGrantPriceDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SavingsRelatedOptionsGrantPriceDiscount" xlink:to="lab_gsk_SavingsRelatedOptionsGrantPriceDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherAssetsNet_b12b2cb1-06f5-41d0-8baf-b38b56786f28_terseLabel_en-US" xlink:label="lab_gsk_OtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_gsk_OtherAssetsNet_label_en-US" xlink:label="lab_gsk_OtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets Net</link:label>
    <link:label id="lab_gsk_OtherAssetsNet_documentation_en-US" xlink:label="lab_gsk_OtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other assets net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAssetsNet" xlink:href="gsk-20241231.xsd#gsk_OtherAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherAssetsNet" xlink:to="lab_gsk_OtherAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CostChargedToOperatingProfit_672a09e3-e255-4e9f-b891-5e053f0301e6_totalLabel_en-US" xlink:label="lab_gsk_CostChargedToOperatingProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cost charged to operating profit</link:label>
    <link:label id="lab_gsk_CostChargedToOperatingProfit_label_en-US" xlink:label="lab_gsk_CostChargedToOperatingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Charged to Operating Profit</link:label>
    <link:label id="lab_gsk_CostChargedToOperatingProfit_documentation_en-US" xlink:label="lab_gsk_CostChargedToOperatingProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost charged to operating profit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostChargedToOperatingProfit" xlink:href="gsk-20241231.xsd#gsk_CostChargedToOperatingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CostChargedToOperatingProfit" xlink:to="lab_gsk_CostChargedToOperatingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RespiratoryMember_937b156b-5e58-4a92-9513-dc6cad703594_terseLabel_en-US" xlink:label="lab_gsk_RespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Respiratory</link:label>
    <link:label id="lab_gsk_RespiratoryMember_label_en-US" xlink:label="lab_gsk_RespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Respiratory [member]</link:label>
    <link:label id="lab_gsk_RespiratoryMember_documentation_en-US" xlink:label="lab_gsk_RespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Respiratory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RespiratoryMember" xlink:href="gsk-20241231.xsd#gsk_RespiratoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RespiratoryMember" xlink:to="lab_gsk_RespiratoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_0dd47331-8b01-430b-aa01-3edc8bd7a2e6_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TreasurySharesMember_a478d23c-20b5-43df-8ee0-666939592b39_terseLabel_en-US" xlink:label="lab_ifrs-full_TreasurySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
    <link:label id="lab_ifrs-full_TreasurySharesMember_label_en-US" xlink:label="lab_ifrs-full_TreasurySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasurySharesMember" xlink:to="lab_ifrs-full_TreasurySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointVenturesMember_10e78fdd-7e3a-4682-a3c3-45917128c589_verboseLabel_en-US" xlink:label="lab_ifrs-full_JointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share of after-tax losses of joint ventures</link:label>
    <link:label id="lab_ifrs-full_JointVenturesMember_d7d1e1c0-dd94-4934-afaf-885882f52b07_terseLabel_en-US" xlink:label="lab_ifrs-full_JointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint ventures</link:label>
    <link:label id="lab_ifrs-full_JointVenturesMember_label_en-US" xlink:label="lab_ifrs-full_JointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total for all joint ventures [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointVenturesMember" xlink:to="lab_ifrs-full_JointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_05b6334d-679e-4164-a7cd-997fbcbaf3a7_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Fair Values of the Assets Acquired in Business Combinations, Including Goodwill</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain_4b810bfd-ff71-4a53-b6c1-888cf79d629b_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associates</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associates [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentAndDeferredTaxation_e98460f6-56f2-4e0b-9acc-71524908c2d5_terseLabel_en-US" xlink:label="lab_gsk_CurrentAndDeferredTaxation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current and deferred taxation</link:label>
    <link:label id="lab_gsk_CurrentAndDeferredTaxation_label_en-US" xlink:label="lab_gsk_CurrentAndDeferredTaxation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current And Deferred Taxation</link:label>
    <link:label id="lab_gsk_CurrentAndDeferredTaxation_documentation_en-US" xlink:label="lab_gsk_CurrentAndDeferredTaxation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current And Deferred Taxation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentAndDeferredTaxation" xlink:href="gsk-20241231.xsd#gsk_CurrentAndDeferredTaxation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentAndDeferredTaxation" xlink:to="lab_gsk_CurrentAndDeferredTaxation" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_ea064f0f-6449-4285-b59b-7c43838fd841_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Pension And Post Retirement [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Pension And Post Retirement [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit pension and post retirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations_dacac5a5-c67e-4c16-bd0d-edc8ea1e0fa0_negatedLabel_en-US" xlink:label="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxation paid from discontinued operations</link:label>
    <link:label id="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid (Refund), Classified As Operating Activities, Discontinued Operations</link:label>
    <link:label id="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations_documentation_en-US" xlink:label="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income taxes paid refund classified as operating activities discontinued operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" xlink:to="lab_gsk_IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock_bf1425d7-06b5-47a9-96f8-246eda2617e5_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Valuation Model Used to Valuing Saving - Related Option to Arrive at the Share Based Payment Charge</link:label>
    <link:label id="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Share Options Assumptions Related To Savings Related Schemes [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of share options outstanding savings related schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" xlink:to="lab_gsk_DisclosureOfShareOptionsAssumptionsRelatedToSavingsRelatedSchemesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxReformsPeriodOfApplicationDomain_6d6336d6-5670-4571-a837-ade3fb65eede_terseLabel_en-US" xlink:label="lab_gsk_TaxReformsPeriodOfApplicationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax reforms period of application [domain]</link:label>
    <link:label id="lab_gsk_TaxReformsPeriodOfApplicationDomain_label_en-US" xlink:label="lab_gsk_TaxReformsPeriodOfApplicationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax reforms period of application [domain]</link:label>
    <link:label id="lab_gsk_TaxReformsPeriodOfApplicationDomain_documentation_en-US" xlink:label="lab_gsk_TaxReformsPeriodOfApplicationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Domain member that defines period of applications for tax reforms.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxReformsPeriodOfApplicationDomain" xlink:href="gsk-20241231.xsd#gsk_TaxReformsPeriodOfApplicationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxReformsPeriodOfApplicationDomain" xlink:to="lab_gsk_TaxReformsPeriodOfApplicationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory_635a3cd2-057a-48f4-b06a-b305efc25677_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover by Product &amp; Service</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of products and services [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member_c7c224c5-8c33-4a48-b8f6-71249484b889_terseLabel_en-US" xlink:label="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables, other provisions and other non-current liabilities</link:label>
    <link:label id="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member_label_en-US" xlink:label="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Payables Other Provisions And Other Noncurrent Liabilities In Scope Of IFRS 9 [Member]</link:label>
    <link:label id="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member_documentation_en-US" xlink:label="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade and other payables, other provisions and other non-current liabilities in scope of IFRS 9.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" xlink:to="lab_gsk_TradeAndOtherPayablesOtherProvisionsAndOtherNoncurrentLiabilitiesInScopeOfIfrs9Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShare_fade45f4-55f9-4dbd-bd66-ad23d51289b1_totalLabel_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total diluted earnings per share (pence) (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShare_label_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherOverseasPensionPlansMember_45bef927-9c25-4a1c-83c9-f9ab6a67bbd4_terseLabel_en-US" xlink:label="lab_gsk_OtherOverseasPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other overseas pension schemes</link:label>
    <link:label id="lab_gsk_OtherOverseasPensionPlansMember_label_en-US" xlink:label="lab_gsk_OtherOverseasPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Overseas Pension Plans [member]</link:label>
    <link:label id="lab_gsk_OtherOverseasPensionPlansMember_documentation_en-US" xlink:label="lab_gsk_OtherOverseasPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other overseas pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherOverseasPensionPlansMember" xlink:href="gsk-20241231.xsd#gsk_OtherOverseasPensionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherOverseasPensionPlansMember" xlink:to="lab_gsk_OtherOverseasPensionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_a49d603a-55ce-4d58-a5ba-ff2f5437f5d2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_35ea600f-53f1-4d9c-89b5-68c9908a5eb6_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_91ed4b11-6cf9-4fa5-bd93-c43abd5c17b9_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense for financial liabilities not at fair value through profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:to="lab_ifrs-full_InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_3eef2814-86e3-4f84-bf6a-f6ad09963580_terseLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax losses</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_label_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused tax losses [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesMember" xlink:to="lab_ifrs-full_UnusedTaxLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_fb3e7510-b0ae-4669-a5ba-f887f5c98941_terseLabel_en-US" xlink:label="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone income</link:label>
    <link:label id="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_label_en-US" xlink:label="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Income Recognised From Performance Obligations Satisfied In Previous Periods</link:label>
    <link:label id="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_documentation_en-US" xlink:label="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone income recognised from performance obligations satisfied in previous periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:href="gsk-20241231.xsd#gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:to="lab_gsk_MilestoneIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CorixaCorporationMember_33dcf968-444a-4ffd-b029-d9e5f5a60d51_terseLabel_en-US" xlink:label="lab_gsk_CorixaCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corixa Corporation</link:label>
    <link:label id="lab_gsk_CorixaCorporationMember_label_en-US" xlink:label="lab_gsk_CorixaCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corixa Corporation [member]</link:label>
    <link:label id="lab_gsk_CorixaCorporationMember_documentation_en-US" xlink:label="lab_gsk_CorixaCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corixa Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CorixaCorporationMember" xlink:href="gsk-20241231.xsd#gsk_CorixaCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CorixaCorporationMember" xlink:to="lab_gsk_CorixaCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_a918ecac-80d9-49ae-b9d0-5b29e9bf3f27_terseLabel_en-US" xlink:label="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market value of shares held by trust under employee share ownership plan</link:label>
    <link:label id="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_label_en-US" xlink:label="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Shares Held By Trust Under Employee Share Ownership Plan</link:label>
    <link:label id="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_documentation_en-US" xlink:label="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of shares held by trust under employee share ownership plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:href="gsk-20241231.xsd#gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:to="lab_gsk_FairValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_d39bc8b1-6362-4da8-aeee-f2c5772de151_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting principles and policies</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of material accounting policy information [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_2d27af51-312e-4c0c-a6bc-9719102d5341_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful lives of property plant and equipment</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_919e69d3-69dc-4489-85d8-0e6b1b7f3e27_terseLabel_en-US" xlink:label="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of ViiV Healthcare put option liabilities and preferential dividends</link:label>
    <link:label id="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_label_en-US" xlink:label="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurement Of Put Option Liabilities And Preferential Dividends</link:label>
    <link:label id="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends_documentation_en-US" xlink:label="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurement Of Put Option Liabilities And Preferential Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" xlink:to="lab_gsk_RemeasurementOfPutOptionLiabilitiesAndPreferentialDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_1a1e6658-bed6-49ff-a807-2ba9924f48f1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_b7f6bb34-931a-4139-abde-3bccc11c6dfa_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Deferred Tax Assets and Liabilities Recognised on the Balance Sheet</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of deferred taxes [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetDebtMember_57de3626-3d28-4920-af81-dd19a8685c86_terseLabel_en-US" xlink:label="lab_gsk_NetDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_gsk_NetDebtMember_label_en-US" xlink:label="lab_gsk_NetDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Debt [Member]</link:label>
    <link:label id="lab_gsk_NetDebtMember_documentation_en-US" xlink:label="lab_gsk_NetDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetDebtMember" xlink:href="gsk-20241231.xsd#gsk_NetDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetDebtMember" xlink:to="lab_gsk_NetDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems_0ce77a4c-72ba-48ef-96e5-b824484a6637_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_90aaac8d-2d41-4c71-ab65-83f37e243a93_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets and liabilities held for sale or distribution and discontinued operations</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_VaccineDomain_9d3d1ee6-469c-45e6-8fbb-f78577734b63_terseLabel_en-US" xlink:label="lab_gsk_VaccineDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vaccine [Domain]</link:label>
    <link:label id="lab_gsk_VaccineDomain_label_en-US" xlink:label="lab_gsk_VaccineDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vaccine [Domain]</link:label>
    <link:label id="lab_gsk_VaccineDomain_documentation_en-US" xlink:label="lab_gsk_VaccineDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vaccine [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccineDomain" xlink:href="gsk-20241231.xsd#gsk_VaccineDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_VaccineDomain" xlink:to="lab_gsk_VaccineDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_381c76ac-6f83-43ba-b270-fe2bb42f51bf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfInventoriesAbstract_f957b2bb-1554-43a6-bae6-87dfa4228c29_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_ifrs-full_ClassesOfInventoriesAbstract_label_en-US" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of current inventories [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember_97dbf64e-e75a-4880-b246-99a8543bad8d_terseLabel_en-US" xlink:label="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK and GSKs Consolidated ESOT Trusts</link:label>
    <link:label id="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember_label_en-US" xlink:label="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK and GSKs Consolidated ESOT Trusts [Member]</link:label>
    <link:label id="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember_documentation_en-US" xlink:label="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK and GSK's consolidated ESOT trusts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskAndGsksConsolidatedEsotTrustsMember" xlink:href="gsk-20241231.xsd#gsk_GskAndGsksConsolidatedEsotTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskAndGsksConsolidatedEsotTrustsMember" xlink:to="lab_gsk_GskAndGsksConsolidatedEsotTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments_988a203f-7cc7-4c31-811e-7de3d41f082a_terseLabel_en-US" xlink:label="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of bonds</link:label>
    <link:label id="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Value Of Bonds That Were Designated As Hedging Instruments</link:label>
    <link:label id="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments_documentation_en-US" xlink:label="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">carrying value of bonds that were designated as hedging instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" xlink:href="gsk-20241231.xsd#gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" xlink:to="lab_gsk_CarryingValueOfBondsThatWereDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_6fb9be93-0c1a-45b2-9f80-c658ada94b90_verboseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of awards (in pounds per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfProductGroups_9e9d4c24-7941-42ee-8f89-a112efc6cb4f_terseLabel_en-US" xlink:label="lab_gsk_NumberOfProductGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of product groups</link:label>
    <link:label id="lab_gsk_NumberOfProductGroups_label_en-US" xlink:label="lab_gsk_NumberOfProductGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Product Groups</link:label>
    <link:label id="lab_gsk_NumberOfProductGroups_documentation_en-US" xlink:label="lab_gsk_NumberOfProductGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Product Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfProductGroups" xlink:href="gsk-20241231.xsd#gsk_NumberOfProductGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfProductGroups" xlink:to="lab_gsk_NumberOfProductGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember_ba604443-9286-41b6-92ae-c09e1da30e5b_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% (100 basis points) increase in Sterling interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Percent Increase In Sterling Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1% (100 basis points) increase in sterling interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePercentIncreaseInSterlingInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_3d92366f-b897-4785-b14e-98a532cc9ceb_terseLabel_en-US" xlink:label="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual commitments for acquisition of property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_0c76109a-d587-47c0-873b-987c5052c049_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inflation rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of inflation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_2be15585-7644-4f7a-8668-848eada2374c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Net Defined Benefit Liability</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfStateCasesRemaining_6a353ab6-a8e3-4850-97f2-12da68de7c40_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfStateCasesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of state cases remaining</link:label>
    <link:label id="lab_gsk_PercentageOfStateCasesRemaining_label_en-US" xlink:label="lab_gsk_PercentageOfStateCasesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of State Cases Remaining</link:label>
    <link:label id="lab_gsk_PercentageOfStateCasesRemaining_documentation_en-US" xlink:label="lab_gsk_PercentageOfStateCasesRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of State Cases Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfStateCasesRemaining" xlink:href="gsk-20241231.xsd#gsk_PercentageOfStateCasesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfStateCasesRemaining" xlink:to="lab_gsk_PercentageOfStateCasesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfProvisionsAxis_7c4b98c8-e9fe-4f46-b1c4-dcf708b63b4c_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of other provisions [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfProvisionsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of other provisions [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis" xlink:to="lab_ifrs-full_ClassesOfProvisionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bce5181c-ad5b-4999-8dc0-a4a3e35c6bdc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CommercialPaperDebtMember_dddc21b4-5082-4ace-aec5-30e026ea92a1_terseLabel_en-US" xlink:label="lab_gsk_CommercialPaperDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_gsk_CommercialPaperDebtMember_label_en-US" xlink:label="lab_gsk_CommercialPaperDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper, Debt [Member]</link:label>
    <link:label id="lab_gsk_CommercialPaperDebtMember_documentation_en-US" xlink:label="lab_gsk_CommercialPaperDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commercial paper.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPaperDebtMember" xlink:href="gsk-20241231.xsd#gsk_CommercialPaperDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CommercialPaperDebtMember" xlink:to="lab_gsk_CommercialPaperDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AccountingPrinciplesAndPoliciesAbstract_label_en-US" xlink:label="lab_gsk_AccountingPrinciplesAndPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Principles And Policies [Abstract]</link:label>
    <link:label id="lab_gsk_AccountingPrinciplesAndPoliciesAbstract_documentation_en-US" xlink:label="lab_gsk_AccountingPrinciplesAndPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounting Principles And Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AccountingPrinciplesAndPoliciesAbstract" xlink:href="gsk-20241231.xsd#gsk_AccountingPrinciplesAndPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AccountingPrinciplesAndPoliciesAbstract" xlink:to="lab_gsk_AccountingPrinciplesAndPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock_80e99ffc-179f-46c3-9763-1d9764309707_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Group companies</link:label>
    <link:label id="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Principal Group Companies [Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of Principal Group Companies Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfPrincipalGroupCompaniesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" xlink:to="lab_gsk_DisclosureOfPrincipalGroupCompaniesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_23097e66-824e-4dbf-83d7-253c7dd8711e_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in pension obligation</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Pensions Obligation Due To Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Pensions Obligation Due To Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ArrangementTypeDomain_2790a258-7a29-41d9-9789-2058685274b0_terseLabel_en-US" xlink:label="lab_gsk_ArrangementTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Type [domain]</link:label>
    <link:label id="lab_gsk_ArrangementTypeDomain_label_en-US" xlink:label="lab_gsk_ArrangementTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Arrangement Type [Domain]</link:label>
    <link:label id="lab_gsk_ArrangementTypeDomain_documentation_en-US" xlink:label="lab_gsk_ArrangementTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Arrangement Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeDomain" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ArrangementTypeDomain" xlink:to="lab_gsk_ArrangementTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock_7892ef3a-fa89-424e-bd64-dcbfc8807b88_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Effectiveness of Hedging Relationships and Amounts Reclassified from Hedging Reserve to Profit or Loss</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Detailed Information about Effectiveness of Hedging Relationships and Amounts reclassified from hedging reserve to profit or loss text block [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of Detailed Information about Effectiveness of Hedging Relationships and Amounts reclassified from hedging reserve to profit or loss [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutEffectivenessOfHedgingRelationshipsAndAmountsReclassifiedFromHedgingReserveToProfitOrLossTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_227adcc3-4e74-4527-bd7d-96ab287d8093_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions, contingent liabilities and contingent assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember_85a9c3e6-37c6-4656-a61a-cea4bdc0456d_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property Development Limited</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property Development Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property Development Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" xlink:to="lab_gsk_GlaxosmithklineIntellectualPropertyDevelopmentLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_bfd56d4e-2d47-4dd2-9f6a-ae433523ec93_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of exchange movements on liquidation or disposal of overseas subsidiaries and associates</link:label>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_label_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on exchange differences on translation of foreign operations, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdditionalProvisionForDividendPayable_d9ba2d2a-c6c7-4621-bfca-2b5088504662_terseLabel_en-US" xlink:label="lab_gsk_AdditionalProvisionForDividendPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional provision for dividend payable</link:label>
    <link:label id="lab_gsk_AdditionalProvisionForDividendPayable_label_en-US" xlink:label="lab_gsk_AdditionalProvisionForDividendPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Provision For Dividend Payable</link:label>
    <link:label id="lab_gsk_AdditionalProvisionForDividendPayable_documentation_en-US" xlink:label="lab_gsk_AdditionalProvisionForDividendPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional provision for dividend payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionalProvisionForDividendPayable" xlink:href="gsk-20241231.xsd#gsk_AdditionalProvisionForDividendPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdditionalProvisionForDividendPayable" xlink:to="lab_gsk_AdditionalProvisionForDividendPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MaturedInThePastPeriodMember_9d9f73f1-d97f-4611-a6bd-a8291df0c0b6_terseLabel_en-US" xlink:label="lab_gsk_MaturedInThePastPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Matured in the past period</link:label>
    <link:label id="lab_gsk_MaturedInThePastPeriodMember_label_en-US" xlink:label="lab_gsk_MaturedInThePastPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Matured In The Past Period [Member]</link:label>
    <link:label id="lab_gsk_MaturedInThePastPeriodMember_documentation_en-US" xlink:label="lab_gsk_MaturedInThePastPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Matured in the past.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MaturedInThePastPeriodMember" xlink:href="gsk-20241231.xsd#gsk_MaturedInThePastPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MaturedInThePastPeriodMember" xlink:to="lab_gsk_MaturedInThePastPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_a73086bd-a614-4a2a-9046-dd526371d9f3_negatedLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Post-retirement benefits/Pension schemes in deficit and surplus</link:label>
    <link:label id="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_label_en-US" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current net defined benefit liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:to="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForOtherServices_bf07ef2e-8970-4278-a251-7e21374cd4a8_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor's remuneration for other services</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForOtherServices_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor's remuneration for other services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForOtherServices" xlink:to="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_be92d1e5-c187-4ad1-a9ae-23750381e4ce_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals_3308c235-ab06-4437-a256-172ebd0bd068_terseLabel_en-US" xlink:label="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover from changes to estimates of RAR accruals</link:label>
    <link:label id="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals_label_en-US" xlink:label="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue From Changes To Estimates Of RAR Accruals</link:label>
    <link:label id="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals_documentation_en-US" xlink:label="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from changes to estimates of RAR accruals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevenueFromChangesToEstimatesOfRARAccruals" xlink:href="gsk-20241231.xsd#gsk_RevenueFromChangesToEstimatesOfRARAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RevenueFromChangesToEstimatesOfRARAccruals" xlink:to="lab_gsk_RevenueFromChangesToEstimatesOfRARAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures_a36fc1e3-1096-44db-ba69-eec49e65c6e6_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Increase)/decrease in adjusted net debt</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Net Debt Through Foreign Currency Exchange Exposures</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net debt through foreign currency exchange exposures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" xlink:to="lab_gsk_IncreaseDecreaseInNetDebtThroughForeignCurrencyExchangeExposures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssets_10e20d7e-6b2d-48ee-94cc-209934fc1299_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssets_983f164b-645c-4a2c-8bad-13a3b717e601_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="lab_ifrs-full_CurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BusinessCombinationsMember_d74007d3-bd15-418f-a2c4-10dcd6948bb3_terseLabel_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total for all business combinations</link:label>
    <link:label id="lab_ifrs-full_BusinessCombinationsMember_de65a402-e9ab-4d80-b2ff-08e247368b02_verboseLabel_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition</link:label>
    <link:label id="lab_ifrs-full_BusinessCombinationsMember_label_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total for all business combinations [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsMember" xlink:to="lab_ifrs-full_BusinessCombinationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member_1e44082a-0f7d-43c2-bdf8-df7d0cb0245d_terseLabel_en-US" xlink:label="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">6.375% Notes due 2038</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member_label_en-US" xlink:label="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Six Point Three Seven Five Notes due 2038 [Member]</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member_documentation_en-US" xlink:label="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">6.375% Notes due 2038.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFiveNotesDue2038Member" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFiveNotesDue2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SixPointThreeSevenFiveNotesDue2038Member" xlink:to="lab_gsk_SixPointThreeSevenFiveNotesDue2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncomeTaxExpenseBenefitsLineItems_37bd67e7-f0ae-428a-a771-881467111567_terseLabel_en-US" xlink:label="lab_gsk_IncomeTaxExpenseBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense benefits [line items]</link:label>
    <link:label id="lab_gsk_IncomeTaxExpenseBenefitsLineItems_label_en-US" xlink:label="lab_gsk_IncomeTaxExpenseBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense Benefits [line items]</link:label>
    <link:label id="lab_gsk_IncomeTaxExpenseBenefitsLineItems_documentation_en-US" xlink:label="lab_gsk_IncomeTaxExpenseBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Expense Benefits [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsLineItems" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsLineItems" xlink:to="lab_gsk_IncomeTaxExpenseBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_7fd8d280-38c9-453a-b5db-424ed004e686_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in associates and joint ventures</link:label>
    <link:label id="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake_cd43ab69-724c-4569-a66b-4b7f7741c163_terseLabel_en-US" xlink:label="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional gain amount</link:label>
    <link:label id="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake_label_en-US" xlink:label="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Gain On Remeasurement Of Retained Stake</link:label>
    <link:label id="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake_documentation_en-US" xlink:label="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional gain on remeasurement of retained stake.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionalGainOnRemeasurementOfRetainedStake" xlink:href="gsk-20241231.xsd#gsk_AdditionalGainOnRemeasurementOfRetainedStake"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdditionalGainOnRemeasurementOfRetainedStake" xlink:to="lab_gsk_AdditionalGainOnRemeasurementOfRetainedStake" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_7b528979-c53e-4e5d-97dc-26635971c562_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current taxation</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax relating to items credited (charged) directly to equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:to="lab_ifrs-full_CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesDomain_9eab8a1d-04a9-4437-8686-2dba5998c619_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets and liabilities</link:label>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember_117279e6-7fc1-4523-83ad-31caff58020f_terseLabel_en-US" xlink:label="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.000% &#8364; Euro Medium Term Note 2027</link:label>
    <link:label id="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember_label_en-US" xlink:label="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Zero Percent Euro Medium Term Note Two Thousand Twenty Seven [Member]</link:label>
    <link:label id="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember_documentation_en-US" xlink:label="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three point zero percent euro medium term note two thousand twenty seven.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:href="gsk-20241231.xsd#gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:to="lab_gsk_ThreePointZeroPercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_06470545-cdb4-4f9c-8b8f-607b3a053132_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post balance sheet events</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of events after reporting period [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemainingBookValueMember_663ecf22-9d7f-4510-b50b-c578d24290ef_terseLabel_en-US" xlink:label="lab_gsk_RemainingBookValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining Book Value</link:label>
    <link:label id="lab_gsk_RemainingBookValueMember_label_en-US" xlink:label="lab_gsk_RemainingBookValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining Book Value [Member]</link:label>
    <link:label id="lab_gsk_RemainingBookValueMember_documentation_en-US" xlink:label="lab_gsk_RemainingBookValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remaining book value [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemainingBookValueMember" xlink:href="gsk-20241231.xsd#gsk_RemainingBookValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemainingBookValueMember" xlink:to="lab_gsk_RemainingBookValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OncologyMember_26904e75-73bb-49e2-afbe-672ce4f31c61_verboseLabel_en-US" xlink:label="lab_gsk_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Oncology</link:label>
    <link:label id="lab_gsk_OncologyMember_label_en-US" xlink:label="lab_gsk_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oncology [Member]</link:label>
    <link:label id="lab_gsk_OncologyMember_documentation_en-US" xlink:label="lab_gsk_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oncology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OncologyMember" xlink:href="gsk-20241231.xsd#gsk_OncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OncologyMember" xlink:to="lab_gsk_OncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsDomain_c2921615-5e17-4d58-9309-69a5f56bece4_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial assets</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossFromContinuingOperations_a54a7ed2-58b8-45d0-8736-88449053965d_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Profit after taxation for the year from continuing operations</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromContinuingOperations_2cb4cde6-9cae-43b3-988b-79e82fb820bf_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total profit after tax from continuing operations</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from continuing operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember_00052730-ccf3-4144-bd50-b890e1a014e0_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15 yen appreciation of the Yen</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Yen Appreciation Of Yen [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Yen Appreciation Of Yen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenYenAppreciationOfYenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" xlink:to="lab_gsk_CurrencyRiskFifteenYenAppreciationOfYenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations_40b885b1-14e2-43ee-a8bd-4a8f1d2baf81_terseLabel_en-US" xlink:label="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement attributable to discontinued operations</link:label>
    <link:label id="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations_label_en-US" xlink:label="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement In Translation Exchange Attributable To Discontinued Operations</link:label>
    <link:label id="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations_documentation_en-US" xlink:label="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movement in translation exchange attributable to discontinued operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" xlink:href="gsk-20241231.xsd#gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" xlink:to="lab_gsk_MovementInTranslationExchangeAttributableToDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_ca314eac-ac7e-45ee-a60a-e1d0106bc6bd_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b5a3bffb-8068-431e-aaea-0e66b29a54d3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_3e2b97ba-4c9d-4f68-8201-633410764dfa_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15 cent appreciation of the US Dollar</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_f611a04f-d1a5-48c1-8820-0db0e3bf58c9_verboseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">15 cent appreciation of US Dollar</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Appreciation Of US Dollar [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Appreciation Of US Dollar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:to="lab_gsk_CurrencyRiskFifteenCentAppreciationOfUsDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c3386857-f914-4517-b58c-62cbb0c25185_terseLabel_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share of after tax profit/(loss) of associates and joint ventures</link:label>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_ba00fed8-6e2d-43d0-865d-7d1f005268a3_verboseLabel_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Profit/(loss) after tax recognised in the consolidated income &#8232; statement</link:label>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonInterestBearingMember_c51f71a6-fc06-482c-824e-8a4174cc4a53_terseLabel_en-US" xlink:label="lab_gsk_NonInterestBearingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non interest bearing</link:label>
    <link:label id="lab_gsk_NonInterestBearingMember_label_en-US" xlink:label="lab_gsk_NonInterestBearingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Interest Bearing [Member]</link:label>
    <link:label id="lab_gsk_NonInterestBearingMember_documentation_en-US" xlink:label="lab_gsk_NonInterestBearingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non Interest Bearing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonInterestBearingMember" xlink:href="gsk-20241231.xsd#gsk_NonInterestBearingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonInterestBearingMember" xlink:to="lab_gsk_NonInterestBearingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentsAxis_21791b03-6476-4cca-a5f8-a4d27f7bba66_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [axis]</link:label>
    <link:label id="lab_ifrs-full_SegmentsAxis_label_en-US" xlink:label="lab_ifrs-full_SegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsAxis" xlink:to="lab_ifrs-full_SegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_c4e461ee-f64b-4729-bd97-8dbe85ba5e89_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for leases [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments_adca982f-883a-43bf-8ce3-72c38b028a4f_terseLabel_en-US" xlink:label="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective interest rate on liquid investment</link:label>
    <link:label id="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments_label_en-US" xlink:label="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Interest Rate On Available For Sale Financial Investments</link:label>
    <link:label id="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments_documentation_en-US" xlink:label="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective interest rate on available for sale financial investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" xlink:href="gsk-20241231.xsd#gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" xlink:to="lab_gsk_EffectiveInterestRateOnAvailableForSaleFinancialInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption_19904798-7632-4949-8d21-e998c766d063_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in annual pension cost</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Pension Cost Due To Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Pension Cost Due To Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_gsk_IncreaseDecreaseInAnnualPensionCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination_50325584-d3ae-4d7b-a3a7-89877644459f_terseLabel_en-US" xlink:label="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange movement through reserves</link:label>
    <link:label id="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange Movement Through Reserves Contingent Liabilities Recognised In Business Combination</link:label>
    <link:label id="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination_documentation_en-US" xlink:label="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchange movement through reserves contingent liabilities recognised in business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_gsk_ExchangeMovementThroughReservesContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_d89f7126-a0bd-403e-a48c-57e7e34157b8_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashOutflowInflowExcludingTransactionCosts_55508f5d-1f31-44a1-bed6-730eddf2ddfc_totalLabel_en-US" xlink:label="lab_gsk_CashOutflowInflowExcludingTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash outflow inflow excluding transaction costs</link:label>
    <link:label id="lab_gsk_CashOutflowInflowExcludingTransactionCosts_label_en-US" xlink:label="lab_gsk_CashOutflowInflowExcludingTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Outflow Inflow Excluding Transaction Costs</link:label>
    <link:label id="lab_gsk_CashOutflowInflowExcludingTransactionCosts_documentation_en-US" xlink:label="lab_gsk_CashOutflowInflowExcludingTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash outflow inflow excluding transaction costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashOutflowInflowExcludingTransactionCosts" xlink:href="gsk-20241231.xsd#gsk_CashOutflowInflowExcludingTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashOutflowInflowExcludingTransactionCosts" xlink:to="lab_gsk_CashOutflowInflowExcludingTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoWellcomeUkLimitedMember_c54ac1b1-0009-4f7d-87a2-061f8f03818e_terseLabel_en-US" xlink:label="lab_gsk_GlaxoWellcomeUkLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome UK Limited</link:label>
    <link:label id="lab_gsk_GlaxoWellcomeUkLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoWellcomeUkLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome UK Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxoWellcomeUkLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoWellcomeUkLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome UK Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeUkLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeUkLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoWellcomeUkLimitedMember" xlink:to="lab_gsk_GlaxoWellcomeUkLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_169b1975-ce4e-4b46-a286-642257bafa83_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_7812e307-d5e0-4ead-886c-9bc94f9db522_periodStartLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment at beginning of period</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_28fc5896-1aba-4e9f-9472-f2c95aea516c_periodEndLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment at end of period</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RevolvingCreditFacilityTerm_bf7c2aab-2a6c-4cd9-be71-718cbbe44886_terseLabel_en-US" xlink:label="lab_gsk_RevolvingCreditFacilityTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit facility, term</link:label>
    <link:label id="lab_gsk_RevolvingCreditFacilityTerm_label_en-US" xlink:label="lab_gsk_RevolvingCreditFacilityTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Term</link:label>
    <link:label id="lab_gsk_RevolvingCreditFacilityTerm_documentation_en-US" xlink:label="lab_gsk_RevolvingCreditFacilityTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilityTerm" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilityTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RevolvingCreditFacilityTerm" xlink:to="lab_gsk_RevolvingCreditFacilityTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto_9cc166d5-c339-4782-92cb-6bef9bec79fa_terseLabel_en-US" xlink:label="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring, Number Of Companies Separated Into</link:label>
    <link:label id="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto_label_en-US" xlink:label="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring, Number Of Companies Separated Into</link:label>
    <link:label id="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto_documentation_en-US" xlink:label="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring, Number Of Companies Separated Into</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringNumberOfCompaniesSeparatedInto" xlink:href="gsk-20241231.xsd#gsk_RestructuringNumberOfCompaniesSeparatedInto"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RestructuringNumberOfCompaniesSeparatedInto" xlink:to="lab_gsk_RestructuringNumberOfCompaniesSeparatedInto" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous non-current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfReportableOperatingSegments_a7ac9a88-73b3-4347-8ecf-75cb0e59ef40_terseLabel_en-US" xlink:label="lab_gsk_NumberOfReportableOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable operating segments</link:label>
    <link:label id="lab_gsk_NumberOfReportableOperatingSegments_label_en-US" xlink:label="lab_gsk_NumberOfReportableOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Reportable Operating Segments</link:label>
    <link:label id="lab_gsk_NumberOfReportableOperatingSegments_documentation_en-US" xlink:label="lab_gsk_NumberOfReportableOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of reportable operating segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfReportableOperatingSegments" xlink:href="gsk-20241231.xsd#gsk_NumberOfReportableOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfReportableOperatingSegments" xlink:to="lab_gsk_NumberOfReportableOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesAxis_1fb0ae12-1be4-4b4e-b2e0-d5bcc5e4a8f2_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets and liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_1c13ad63-1702-4aea-a67a-5edc1460907a_terseLabel_en-US" xlink:label="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_label_en-US" xlink:label="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions in Investments in Associates And Joint Ventures</link:label>
    <link:label id="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additions in investments in associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" xlink:href="gsk-20241231.xsd#gsk_AdditionsInInvestmentsInAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" xlink:to="lab_gsk_AdditionsInInvestmentsInAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets_76139525-2a79-4c56-9659-fdfcdf57925c_terseLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Impairment Reversals</link:label>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:to="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKLifeSciencesFZEMember_dac994e0-08cc-4556-aa68-e1ce83e05af6_terseLabel_en-US" xlink:label="lab_gsk_GSKLifeSciencesFZEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Life Sciences FZE (United&#160;Arab&#160;Emirates)</link:label>
    <link:label id="lab_gsk_GSKLifeSciencesFZEMember_label_en-US" xlink:label="lab_gsk_GSKLifeSciencesFZEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Life Sciences FZE [Member]</link:label>
    <link:label id="lab_gsk_GSKLifeSciencesFZEMember_documentation_en-US" xlink:label="lab_gsk_GSKLifeSciencesFZEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Life Sciences FZE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKLifeSciencesFZEMember" xlink:href="gsk-20241231.xsd#gsk_GSKLifeSciencesFZEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKLifeSciencesFZEMember" xlink:to="lab_gsk_GSKLifeSciencesFZEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_073dba80-283d-496e-9359-41798279e1c3_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_9a44ff71-16ae-4335-ae14-18091f97cc3a_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract" xlink:to="lab_ifrs-full_CurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations_28f3aa06-2bc8-4474-9e5d-23056840604d_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in cash and bank overdrafts</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes For Continuing Operations</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease in cash and cash equivalents before effect of exchange rate changes for continuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" xlink:to="lab_gsk_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChangesForContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ParentMember_3086c236-d0e3-45ea-8061-0a1f6d7b0186_terseLabel_en-US" xlink:label="lab_ifrs-full_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK PLC</link:label>
    <link:label id="lab_ifrs-full_ParentMember_label_en-US" xlink:label="lab_ifrs-full_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParentMember" xlink:to="lab_ifrs-full_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_4f45ba81-c652-4db4-89a5-52b6700caa77_terseLabel_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_label_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_1e6e3c4d-3aec-4635-ab2a-cfc6b9717d55_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments in Associates and Joint Ventures</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information of investments in associates and joint ventures [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of investments in associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_ea0800df-961b-458c-87d0-f590b57461f4_verboseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Items that will not be reclassified to continuing operations income statement:</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_480029e4-acca-46e8-9ce5-7d00d7c0a810_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Items that will not be reclassified to income statement:</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e83e9de2-d764-46b4-9a6d-c3c61b3dd958_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_b9385919-d20a-4829-a1b4-c18c150dcab5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_370f7153-de5f-47bf-87c9-8a94780d3d03_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PerformanceSharePlansMember_206a6096-efa8-48d2-a25c-71d808ca0e53_terseLabel_en-US" xlink:label="lab_gsk_PerformanceSharePlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance share plan</link:label>
    <link:label id="lab_gsk_PerformanceSharePlansMember_label_en-US" xlink:label="lab_gsk_PerformanceSharePlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Share Plans [member]</link:label>
    <link:label id="lab_gsk_PerformanceSharePlansMember_documentation_en-US" xlink:label="lab_gsk_PerformanceSharePlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance share plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PerformanceSharePlansMember" xlink:href="gsk-20241231.xsd#gsk_PerformanceSharePlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PerformanceSharePlansMember" xlink:to="lab_gsk_PerformanceSharePlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SetFirstLimitedMember_3e5ed634-efbe-4580-9337-27ab581b3059_terseLabel_en-US" xlink:label="lab_gsk_SetFirstLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Setfirst Limited</link:label>
    <link:label id="lab_gsk_SetFirstLimitedMember_label_en-US" xlink:label="lab_gsk_SetFirstLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Set First Limited [member]</link:label>
    <link:label id="lab_gsk_SetFirstLimitedMember_documentation_en-US" xlink:label="lab_gsk_SetFirstLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Setfirst Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SetFirstLimitedMember" xlink:href="gsk-20241231.xsd#gsk_SetFirstLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SetFirstLimitedMember" xlink:to="lab_gsk_SetFirstLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RetranslationOfLoan_b78d7984-c9f2-4f1a-a9fc-c5529852e69f_negatedLabel_en-US" xlink:label="lab_gsk_RetranslationOfLoan" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Retranslation of loans</link:label>
    <link:label id="lab_gsk_RetranslationOfLoan_label_en-US" xlink:label="lab_gsk_RetranslationOfLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retranslation Of Loan</link:label>
    <link:label id="lab_gsk_RetranslationOfLoan_documentation_en-US" xlink:label="lab_gsk_RetranslationOfLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Re translation of loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RetranslationOfLoan" xlink:href="gsk-20241231.xsd#gsk_RetranslationOfLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RetranslationOfLoan" xlink:to="lab_gsk_RetranslationOfLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember_852d1fc0-a4b0-49d2-9611-c3e03a630b25_terseLabel_en-US" xlink:label="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">European/US MTN &amp; Bank facilities</link:label>
    <link:label id="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember_label_en-US" xlink:label="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">European/US Medium Term Notes and Bank Facilities [member]</link:label>
    <link:label id="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember_documentation_en-US" xlink:label="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">European US Medium Term Notes and Bank Facilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" xlink:href="gsk-20241231.xsd#gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" xlink:to="lab_gsk_EuropeanUsMediumTermNotesAndBankFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParent_c3577666-4adc-4c88-88bb-e72548ae81b5_totalLabel_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_753937b7-e2f1-433f-8e36-9674629aef7f_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxation</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDividendPayables_c4cb7f13-fcb4-4ec3-b3e4-572de4528a4b_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDividendPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for dividend payable</link:label>
    <link:label id="lab_ifrs-full_CurrentDividendPayables_label_en-US" xlink:label="lab_ifrs-full_CurrentDividendPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current dividend payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDividendPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDividendPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDividendPayables" xlink:to="lab_ifrs-full_CurrentDividendPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition_d49e1c98-58f8-4ce4-b6e6-2bd3d6ae5130_terseLabel_en-US" xlink:label="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurements of contingent consideration payable for acquisition</link:label>
    <link:label id="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition_label_en-US" xlink:label="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurements Of Contingent Consideration Payable For Acquisition</link:label>
    <link:label id="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition_documentation_en-US" xlink:label="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurements of contingent consideration payable for acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" xlink:href="gsk-20241231.xsd#gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" xlink:to="lab_gsk_RemeasurementsOfContingentConsiderationPayableForAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineIncMember_4eb1774a-55f7-4ae6-b1b9-cad125ad10d4_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Inc. (Canada)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineIncMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Inc [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineIncMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineIncMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineIncMember" xlink:to="lab_gsk_GlaxoSmithKlineIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZejulaRoyaltyDisputeMember_5df7fcbc-2ca5-4133-b228-7001ab0a8ade_terseLabel_en-US" xlink:label="lab_gsk_ZejulaRoyaltyDisputeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zejula Royalty Dispute</link:label>
    <link:label id="lab_gsk_ZejulaRoyaltyDisputeMember_label_en-US" xlink:label="lab_gsk_ZejulaRoyaltyDisputeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zejula Royalty Dispute [Member]</link:label>
    <link:label id="lab_gsk_ZejulaRoyaltyDisputeMember_documentation_en-US" xlink:label="lab_gsk_ZejulaRoyaltyDisputeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zejula Royalty Dispute</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZejulaRoyaltyDisputeMember" xlink:href="gsk-20241231.xsd#gsk_ZejulaRoyaltyDisputeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZejulaRoyaltyDisputeMember" xlink:to="lab_gsk_ZejulaRoyaltyDisputeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineCapitalIncMember_db8216f5-ac37-4127-8041-144782591720_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineCapitalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Capital Inc.</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineCapitalIncMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineCapitalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Capital Inc [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineCapitalIncMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineCapitalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Capital Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineCapitalIncMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineCapitalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineCapitalIncMember" xlink:to="lab_gsk_GlaxoSmithKlineCapitalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock_5035cb2a-27f3-4c1c-9ee3-d726f6c76ccd_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Employee Costs</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about employee costs explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of detailed information about employee costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutEmployeeCostsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_bb710ca1-8d69-4f80-b989-c1a987e70807_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment (reversals)/losses recognised</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsLineItems_263c6187-ab81-42f5-843f-93e6698bef69_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of restructuring costs [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of restructuring costs [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of restructuring costs line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfRestructuringCostsLineItems" xlink:to="lab_gsk_DisclosureOfRestructuringCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_840a75af-3e7b-4965-8829-ce6df5122ef9_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of debt instruments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of debt instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember_55d65f6b-804a-4ae9-b362-271588b63baa_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15 yen depreciation of the Yen</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Yen depreciation Of Yen [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Yen depreciation Of Yen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenYenDepreciationOfYenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" xlink:to="lab_gsk_CurrencyRiskFifteenYenDepreciationOfYenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost_80335f5c-5e3d-4f03-8de7-9cfcf00d1ac1_terseLabel_en-US" xlink:label="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest accrued on financial liabilities at amortized cost</link:label>
    <link:label id="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost_label_en-US" xlink:label="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Accrued On Financial Liabilities At Amortized Cost</link:label>
    <link:label id="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost_documentation_en-US" xlink:label="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest accrued on financial liabilities at amortized cost .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" xlink:to="lab_gsk_InterestAccruedOnFinancialLiabilitiesAtAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_520a1e9f-e8d2-4fb4-b633-ea8abbcc8e02_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax on remeasurement losses/(gains) on defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_b5b009be-7f84-4c84-a855-2ad6e94ba0f5_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Tax on remeasurement defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax relating to remeasurements of defined benefit plans included in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" xlink:to="lab_ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LandAndBuildingsMember_c56d9dc7-7906-4f13-a90b-3d434a2027fb_terseLabel_en-US" xlink:label="lab_ifrs-full_LandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land and buildings</link:label>
    <link:label id="lab_ifrs-full_LandAndBuildingsMember_label_en-US" xlink:label="lab_ifrs-full_LandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land and buildings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandAndBuildingsMember" xlink:to="lab_ifrs-full_LandAndBuildingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AcceleratedCapitalAllowancesMember_ff2c20a8-dcda-484a-aeac-0c5f7d33a2fd_terseLabel_en-US" xlink:label="lab_gsk_AcceleratedCapitalAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated capital allowances</link:label>
    <link:label id="lab_gsk_AcceleratedCapitalAllowancesMember_label_en-US" xlink:label="lab_gsk_AcceleratedCapitalAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Capital Allowances [member]</link:label>
    <link:label id="lab_gsk_AcceleratedCapitalAllowancesMember_documentation_en-US" xlink:label="lab_gsk_AcceleratedCapitalAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accelerated capital allowances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AcceleratedCapitalAllowancesMember" xlink:href="gsk-20241231.xsd#gsk_AcceleratedCapitalAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AcceleratedCapitalAllowancesMember" xlink:to="lab_gsk_AcceleratedCapitalAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DiscontinuedOperationsMember_be267d0d-08fe-4073-b218-5e091fb7557b_terseLabel_en-US" xlink:label="lab_ifrs-full_DiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_ifrs-full_DiscontinuedOperationsMember_label_en-US" xlink:label="lab_ifrs-full_DiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued operations [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember" xlink:to="lab_ifrs-full_DiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock_83583351-3d1f-430c-8d03-c4f7d7e8dc82_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Post-Retirement Benefit Obligation Analysed By Membership Category</link:label>
    <link:label id="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Post Retirement Benefit Obligation Analysed By Membership Category Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of post retirement benefit obligation analysed by membership category explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfPostRetirementBenefitObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1509ad56-641c-4fc7-bea2-b915903eef7e_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of non-current assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MethodsOfGenerationAxis_91ed3c18-83d3-4721-965c-3a47f0226a0c_terseLabel_en-US" xlink:label="lab_ifrs-full_MethodsOfGenerationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Methods of generation [axis]</link:label>
    <link:label id="lab_ifrs-full_MethodsOfGenerationAxis_label_en-US" xlink:label="lab_ifrs-full_MethodsOfGenerationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Methods of generation [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MethodsOfGenerationAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodsOfGenerationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis" xlink:to="lab_ifrs-full_MethodsOfGenerationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_f9de2667-da39-44e6-9601-1ce439be4f29_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_label_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other adjustments to reconcile profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:to="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations_3d22ae53-0069-4f77-80e5-898fdf44ef0a_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average duration of the defined benefit obligation</link:label>
    <link:label id="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations_label_en-US" xlink:label="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Duration of Defined Benefit Obligations</link:label>
    <link:label id="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations_documentation_en-US" xlink:label="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average duration of defined benefit obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageDurationOfDefinedBenefitObligations" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageDurationOfDefinedBenefitObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageDurationOfDefinedBenefitObligations" xlink:to="lab_gsk_WeightedAverageDurationOfDefinedBenefitObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TotalRestructuringCosts_9fa8eb9e-d4f8-48ca-9407-1bae166a6663_terseLabel_en-US" xlink:label="lab_gsk_TotalRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total restructuring costs</link:label>
    <link:label id="lab_gsk_TotalRestructuringCosts_c0295183-fdf2-41a2-a56c-972c6f5a5aa7_totalLabel_en-US" xlink:label="lab_gsk_TotalRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total restructuring costs</link:label>
    <link:label id="lab_gsk_TotalRestructuringCosts_label_en-US" xlink:label="lab_gsk_TotalRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Restructuring Costs</link:label>
    <link:label id="lab_gsk_TotalRestructuringCosts_documentation_en-US" xlink:label="lab_gsk_TotalRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalRestructuringCosts" xlink:href="gsk-20241231.xsd#gsk_TotalRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TotalRestructuringCosts" xlink:to="lab_gsk_TotalRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement_6a58ab87-13c6-4c34-9979-1225f51aa5ff_terseLabel_en-US" xlink:label="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number share options were not exercisable (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share Options Not Exercisable In Share Based Payment Arrangement</link:label>
    <link:label id="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share options not exercisable in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" xlink:href="gsk-20241231.xsd#gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" xlink:to="lab_gsk_NumberOfShareOptionsNotExercisableInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InvestmentsInJointVenturesAndAssociates_ee6c2cb5-1e49-4518-92da-fb3db79cbedc_terseLabel_en-US" xlink:label="lab_gsk_InvestmentsInJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in associates and joint ventures</link:label>
    <link:label id="lab_gsk_InvestmentsInJointVenturesAndAssociates_label_en-US" xlink:label="lab_gsk_InvestmentsInJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments In Joint Ventures And Associates</link:label>
    <link:label id="lab_gsk_InvestmentsInJointVenturesAndAssociates_documentation_en-US" xlink:label="lab_gsk_InvestmentsInJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments in joint ventures and associates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsInJointVenturesAndAssociates" xlink:href="gsk-20241231.xsd#gsk_InvestmentsInJointVenturesAndAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InvestmentsInJointVenturesAndAssociates" xlink:to="lab_gsk_InvestmentsInJointVenturesAndAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_9bbea858-1aa2-4de9-9e9e-c3e1ed953c1a_terseLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of assets</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_e067f8d7-c207-4b6c-9377-2f83b82584a6_periodStartLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Plan assets, at fair value at the beginning of the period</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_e5e3dc07-e6da-4121-a486-a82c9f0f25fa_periodEndLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Plan assets, at fair value at the end of the period</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan assets, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_468127ad-e50c-467a-9446-0bd618dd6e66_terseLabel_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_79db36cf-2efe-483d-ac71-47ea0dd06c3d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueAndOperatingIncome_cb9802b7-f345-4787-aa81-b5a048b4a191_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueAndOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized in deferred income</link:label>
    <link:label id="lab_ifrs-full_RevenueAndOperatingIncome_label_en-US" xlink:label="lab_ifrs-full_RevenueAndOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue and other operating income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueAndOperatingIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAndOperatingIncome" xlink:to="lab_ifrs-full_RevenueAndOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed_6bc4bd70-e5a5-4734-9a2d-e27683cfeb3b_terseLabel_en-US" xlink:label="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, for which impairments have been charged or reversed</link:label>
    <link:label id="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed_label_en-US" xlink:label="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets For Which Impairments Have Been Reversed</link:label>
    <link:label id="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed_documentation_en-US" xlink:label="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible assets, for which impairments have been charged or reversed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" xlink:href="gsk-20241231.xsd#gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" xlink:to="lab_gsk_IntangibleAssetsForWhichImpairmentsHaveBeenReversed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OperatingExpense_d76e6d6c-16e4-4f81-a822-dbe01c1aeb23_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expense</link:label>
    <link:label id="lab_ifrs-full_OperatingExpense_label_en-US" xlink:label="lab_ifrs-full_OperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense" xlink:to="lab_ifrs-full_OperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock_98ca4997-41d9-4d76-85f0-e8ec3a747231_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information Of Inventories [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information of inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationOfInventoriesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IDBiomedicalCorporationOfQuebecMember_5826437d-930f-4884-a6b5-0306417ab2d0_terseLabel_en-US" xlink:label="lab_gsk_IDBiomedicalCorporationOfQuebecMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ID Biomedical Corporation of Quebec (Canada)</link:label>
    <link:label id="lab_gsk_IDBiomedicalCorporationOfQuebecMember_label_en-US" xlink:label="lab_gsk_IDBiomedicalCorporationOfQuebecMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">I D Biomedical Corporation Of Quebec [member]</link:label>
    <link:label id="lab_gsk_IDBiomedicalCorporationOfQuebecMember_documentation_en-US" xlink:label="lab_gsk_IDBiomedicalCorporationOfQuebecMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ID Biomedical Corporation of Quebec.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IDBiomedicalCorporationOfQuebecMember" xlink:href="gsk-20241231.xsd#gsk_IDBiomedicalCorporationOfQuebecMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IDBiomedicalCorporationOfQuebecMember" xlink:to="lab_gsk_IDBiomedicalCorporationOfQuebecMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1007d411-61cf-491d-908d-c45cb626faf7_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_24fe853e-b9db-453b-9489-27038e2f3c4a_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxation</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_ccd483ac-3a87-40f8-b30a-de12d499735c_terseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxation</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_64597755-ac1d-4d22-b617-3d03880a871a_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxation</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_b1846e06-50e9-474f-9a74-3b7062364654_totalLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Tax charge/tax rate</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2be6c495-b10e-4034-a83e-6840e7406c40_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FutureFinanceChargeOnFinanceLeases_c3bc7523-cb07-45a9-8d0a-b6db744fab99_negatedLabel_en-US" xlink:label="lab_gsk_FutureFinanceChargeOnFinanceLeases" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Finance charge on lease liabilities</link:label>
    <link:label id="lab_gsk_FutureFinanceChargeOnFinanceLeases_label_en-US" xlink:label="lab_gsk_FutureFinanceChargeOnFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Future Finance Charge On Finance Leases</link:label>
    <link:label id="lab_gsk_FutureFinanceChargeOnFinanceLeases_documentation_en-US" xlink:label="lab_gsk_FutureFinanceChargeOnFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Future Finance Charge On Finance Leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FutureFinanceChargeOnFinanceLeases" xlink:href="gsk-20241231.xsd#gsk_FutureFinanceChargeOnFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FutureFinanceChargeOnFinanceLeases" xlink:to="lab_gsk_FutureFinanceChargeOnFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about unconsolidated subsidiaries [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesAbstract" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LowerCarbonPropellantMember_bc1ef511-c395-4c50-a930-491d2c8d1388_terseLabel_en-US" xlink:label="lab_gsk_LowerCarbonPropellantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lower-carbon propellant</link:label>
    <link:label id="lab_gsk_LowerCarbonPropellantMember_label_en-US" xlink:label="lab_gsk_LowerCarbonPropellantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lower-Carbon Propellant [Member]</link:label>
    <link:label id="lab_gsk_LowerCarbonPropellantMember_documentation_en-US" xlink:label="lab_gsk_LowerCarbonPropellantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lower-Carbon Propellant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LowerCarbonPropellantMember" xlink:href="gsk-20241231.xsd#gsk_LowerCarbonPropellantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LowerCarbonPropellantMember" xlink:to="lab_gsk_LowerCarbonPropellantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax_692f0435-1b1b-4b53-be79-506503301753_negatedTerseLabel_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of hedges from other comprehensive income</link:label>
    <link:label id="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax_label_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments On Hedges, Net Of Tax</link:label>
    <link:label id="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax_documentation_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments On Hedges, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentsOnHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" xlink:to="lab_gsk_ReclassificationAdjustmentsOnHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_ab8d4a0b-3ec1-42b6-aa96-1830620c3d6f_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortised cost</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost, class [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_7d7bd175-8799-4f01-870f-e453f239a7d9_terseLabel_en-US" xlink:label="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_label_en-US" xlink:label="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Number Of Employees From Discontinuing operations</link:label>
    <link:label id="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations_documentation_en-US" xlink:label="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average number of employees from discontinuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" xlink:href="gsk-20241231.xsd#gsk_AverageNumberOfEmployeesFromDiscontinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" xlink:to="lab_gsk_AverageNumberOfEmployeesFromDiscontinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_48de7121-3045-4a7a-a657-0e13fd1f2705_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_d2400860-1953-441c-b082-8e902b7eb380_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_72791297-a8eb-4c72-b02f-7285c8e88b7a_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKServicesSPZOOMember_9532606f-f272-4de5-9f6a-16f97a84f6c6_terseLabel_en-US" xlink:label="lab_gsk_GSKServicesSPZOOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Services Sp z o.o. (Poland)</link:label>
    <link:label id="lab_gsk_GSKServicesSPZOOMember_label_en-US" xlink:label="lab_gsk_GSKServicesSPZOOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">G S K Services S P Z O O [member]</link:label>
    <link:label id="lab_gsk_GSKServicesSPZOOMember_documentation_en-US" xlink:label="lab_gsk_GSKServicesSPZOOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Services Sp z o.o.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKServicesSPZOOMember" xlink:href="gsk-20241231.xsd#gsk_GSKServicesSPZOOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKServicesSPZOOMember" xlink:to="lab_gsk_GSKServicesSPZOOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SecondInterimMember_a5ffa17e-19b8-45cb-9c5f-e98adacd703c_terseLabel_en-US" xlink:label="lab_gsk_SecondInterimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Second interim</link:label>
    <link:label id="lab_gsk_SecondInterimMember_label_en-US" xlink:label="lab_gsk_SecondInterimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Second Interim [member]</link:label>
    <link:label id="lab_gsk_SecondInterimMember_documentation_en-US" xlink:label="lab_gsk_SecondInterimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Second interim.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SecondInterimMember" xlink:href="gsk-20241231.xsd#gsk_SecondInterimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SecondInterimMember" xlink:to="lab_gsk_SecondInterimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_46ed1a87-a378-43b5-98d1-4f6f465bf97e_terseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of share-based incentive plans</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NotionalInterest_7754a501-7efb-4279-902e-a830fb760f31_terseLabel_en-US" xlink:label="lab_gsk_NotionalInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional interest</link:label>
    <link:label id="lab_gsk_NotionalInterest_label_en-US" xlink:label="lab_gsk_NotionalInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notional Interest</link:label>
    <link:label id="lab_gsk_NotionalInterest_documentation_en-US" xlink:label="lab_gsk_NotionalInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notional Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NotionalInterest" xlink:href="gsk-20241231.xsd#gsk_NotionalInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NotionalInterest" xlink:to="lab_gsk_NotionalInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LossContingencyNumberOfPlaintiffsInCase_48381887-d519-4593-826c-9906aea87253_terseLabel_en-US" xlink:label="lab_gsk_LossContingencyNumberOfPlaintiffsInCase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency number of plaintiffs</link:label>
    <link:label id="lab_gsk_LossContingencyNumberOfPlaintiffsInCase_label_en-US" xlink:label="lab_gsk_LossContingencyNumberOfPlaintiffsInCase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Number Of Plaintiffs In Case</link:label>
    <link:label id="lab_gsk_LossContingencyNumberOfPlaintiffsInCase_documentation_en-US" xlink:label="lab_gsk_LossContingencyNumberOfPlaintiffsInCase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss contingency, number of plaintiffs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingencyNumberOfPlaintiffsInCase" xlink:href="gsk-20241231.xsd#gsk_LossContingencyNumberOfPlaintiffsInCase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LossContingencyNumberOfPlaintiffsInCase" xlink:to="lab_gsk_LossContingencyNumberOfPlaintiffsInCase" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DividendsDistributedFromCashBalance_94d50e83-ad47-4dc0-9642-8e7a77336326_terseLabel_en-US" xlink:label="lab_gsk_DividendsDistributedFromCashBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends distributed from cash balance</link:label>
    <link:label id="lab_gsk_DividendsDistributedFromCashBalance_label_en-US" xlink:label="lab_gsk_DividendsDistributedFromCashBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Distributed From Cash Balance</link:label>
    <link:label id="lab_gsk_DividendsDistributedFromCashBalance_documentation_en-US" xlink:label="lab_gsk_DividendsDistributedFromCashBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividends distributed from cash balance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsDistributedFromCashBalance" xlink:href="gsk-20241231.xsd#gsk_DividendsDistributedFromCashBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DividendsDistributedFromCashBalance" xlink:to="lab_gsk_DividendsDistributedFromCashBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PeriodCoveredByFinancialStatements_46c727a7-543a-4d3d-91fd-c599725a6b2c_terseLabel_en-US" xlink:label="lab_ifrs-full_PeriodCoveredByFinancialStatements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period covered by financial statements</link:label>
    <link:label id="lab_ifrs-full_PeriodCoveredByFinancialStatements_label_en-US" xlink:label="lab_ifrs-full_PeriodCoveredByFinancialStatements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Period covered by financial statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PeriodCoveredByFinancialStatements" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PeriodCoveredByFinancialStatements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PeriodCoveredByFinancialStatements" xlink:to="lab_ifrs-full_PeriodCoveredByFinancialStatements" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfCompaniesSplitInto_0a37e2c7-8a56-405e-abe7-5a63f0e244a9_terseLabel_en-US" xlink:label="lab_gsk_NumberOfCompaniesSplitInto" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of companies split into</link:label>
    <link:label id="lab_gsk_NumberOfCompaniesSplitInto_label_en-US" xlink:label="lab_gsk_NumberOfCompaniesSplitInto" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Companies Split Into</link:label>
    <link:label id="lab_gsk_NumberOfCompaniesSplitInto_documentation_en-US" xlink:label="lab_gsk_NumberOfCompaniesSplitInto" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Companies Split Into</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCompaniesSplitInto" xlink:href="gsk-20241231.xsd#gsk_NumberOfCompaniesSplitInto"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfCompaniesSplitInto" xlink:to="lab_gsk_NumberOfCompaniesSplitInto" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness_f229291d-1a0c-4840-bf91-998963abce4c_terseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Periodic change in value for calculating hedge ineffectiveness</link:label>
    <link:label id="lab_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness_label_en-US" xlink:label="lab_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) on change in fair value of hedged item used as basis for recognising hedge ineffectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" xlink:to="lab_ifrs-full_GainLossOnChangeInFairValueOfHedgedItemUsedAsBasisForRecognisingHedgeIneffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates reported in separate financial statements [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract" xlink:to="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_6089ea0f-7759-4730-a028-c14b0e9dbb6f_terseLabel_en-US" xlink:label="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables</link:label>
    <link:label id="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables Recognised As Of Acquisition Date</link:label>
    <link:label id="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade and other receivables recognised as of acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:to="lab_gsk_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_4d89b059-719b-4656-a147-64c38029f0e3_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wages and salaries</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_41a40610-f092-4404-b0bc-11cb66187467_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15% increase in sales forecasts</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Percentage Increase In Sales Forecasts Or Sales Multiple Applied [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Percentage Increase In Sales Forecasts Or Sales Multiple Applied</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:to="lab_gsk_CurrencyRiskFifteenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_c55173ba-b7fa-425f-8d83-d6639f9e1b2b_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SavingsRelatedShareOptionSchemesMember_3c0c1273-e25c-496a-88e9-3d47418b2fd1_terseLabel_en-US" xlink:label="lab_gsk_SavingsRelatedShareOptionSchemesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Savings-related share option schemes</link:label>
    <link:label id="lab_gsk_SavingsRelatedShareOptionSchemesMember_label_en-US" xlink:label="lab_gsk_SavingsRelatedShareOptionSchemesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Savings Related Share Option Schemes [member]</link:label>
    <link:label id="lab_gsk_SavingsRelatedShareOptionSchemesMember_documentation_en-US" xlink:label="lab_gsk_SavingsRelatedShareOptionSchemesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Savings related share option schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SavingsRelatedShareOptionSchemesMember" xlink:href="gsk-20241231.xsd#gsk_SavingsRelatedShareOptionSchemesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SavingsRelatedShareOptionSchemesMember" xlink:to="lab_gsk_SavingsRelatedShareOptionSchemesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SellForeignCurrencyOverSixMonthsMember_a3678e2c-b0fa-4eea-9b11-92158f006fd8_terseLabel_en-US" xlink:label="lab_gsk_SellForeignCurrencyOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sell foreign currency, over 6 months</link:label>
    <link:label id="lab_gsk_SellForeignCurrencyOverSixMonthsMember_label_en-US" xlink:label="lab_gsk_SellForeignCurrencyOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sell Foreign Currency Over Six Months [Member]</link:label>
    <link:label id="lab_gsk_SellForeignCurrencyOverSixMonthsMember_documentation_en-US" xlink:label="lab_gsk_SellForeignCurrencyOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sell Foreign Currency over six months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellForeignCurrencyOverSixMonthsMember" xlink:href="gsk-20241231.xsd#gsk_SellForeignCurrencyOverSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SellForeignCurrencyOverSixMonthsMember" xlink:to="lab_gsk_SellForeignCurrencyOverSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperations_1c81d899-cd31-4e9d-be47-75bfb6dc86ed_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cash generated from operations</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HedgingInstrumentsAndDerivativesAssets_10bafbdc-2a48-4cdc-959a-ae13cb301e77_terseLabel_en-US" xlink:label="lab_gsk_HedgingInstrumentsAndDerivativesAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total derivative instruments, assets</link:label>
    <link:label id="lab_gsk_HedgingInstrumentsAndDerivativesAssets_label_en-US" xlink:label="lab_gsk_HedgingInstrumentsAndDerivativesAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Instruments And Derivatives, Assets</link:label>
    <link:label id="lab_gsk_HedgingInstrumentsAndDerivativesAssets_documentation_en-US" xlink:label="lab_gsk_HedgingInstrumentsAndDerivativesAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hedging Instruments And Derivatives, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingInstrumentsAndDerivativesAssets" xlink:href="gsk-20241231.xsd#gsk_HedgingInstrumentsAndDerivativesAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HedgingInstrumentsAndDerivativesAssets" xlink:to="lab_gsk_HedgingInstrumentsAndDerivativesAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EnglandMember_69879dd3-a435-4941-8afa-ad610a912450_terseLabel_en-US" xlink:label="lab_gsk_EnglandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">England</link:label>
    <link:label id="lab_gsk_EnglandMember_label_en-US" xlink:label="lab_gsk_EnglandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">England [Member]</link:label>
    <link:label id="lab_gsk_EnglandMember_documentation_en-US" xlink:label="lab_gsk_EnglandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">England</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EnglandMember" xlink:href="gsk-20241231.xsd#gsk_EnglandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EnglandMember" xlink:to="lab_gsk_EnglandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_bed2b237-b35c-45f0-a423-233d89cd8e56_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_15b1a452-4f85-415c-b248-6ea07060758d_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZantacMember_3bcecea1-1ba1-4a08-90c9-1786255ff1e4_terseLabel_en-US" xlink:label="lab_gsk_ZantacMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zantac</link:label>
    <link:label id="lab_gsk_ZantacMember_label_en-US" xlink:label="lab_gsk_ZantacMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zantac [Member]</link:label>
    <link:label id="lab_gsk_ZantacMember_documentation_en-US" xlink:label="lab_gsk_ZantacMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zantac</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZantacMember" xlink:href="gsk-20241231.xsd#gsk_ZantacMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZantacMember" xlink:to="lab_gsk_ZantacMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MRNAMember_857d4290-0abc-488c-8133-7ba5431f9830_terseLabel_en-US" xlink:label="lab_gsk_MRNAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">mRNA</link:label>
    <link:label id="lab_gsk_MRNAMember_label_en-US" xlink:label="lab_gsk_MRNAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">mRNA [Member]</link:label>
    <link:label id="lab_gsk_MRNAMember_documentation_en-US" xlink:label="lab_gsk_MRNAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">mRNA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MRNAMember" xlink:href="gsk-20241231.xsd#gsk_MRNAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MRNAMember" xlink:to="lab_gsk_MRNAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory_81c1f789-574d-43b2-b323-8c3ad92da9c5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Amortisation and Impairment Losses, Net of Reversals</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of impairment loss and reversal of impairment loss [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory" xlink:to="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_a10c997c-91b5-4fe5-8857-6633f20d7c22_terseLabel_en-US" xlink:label="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit impairment of financial instruments</link:label>
    <link:label id="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit impairment of financial instruments [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain" xlink:to="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsTable_498667c4-b5c9-494c-b84b-4054952a70c1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BalancesWithBanks_a47d122e-aaf2-432c-a02e-db86028740c7_terseLabel_en-US" xlink:label="lab_ifrs-full_BalancesWithBanks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balances or deposits with banks</link:label>
    <link:label id="lab_ifrs-full_BalancesWithBanks_label_en-US" xlink:label="lab_ifrs-full_BalancesWithBanks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balances with banks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BalancesWithBanks" xlink:to="lab_ifrs-full_BalancesWithBanks" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateDomain_03ea27e1-8efb-4746-afbf-a586c570d56a_terseLabel_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate [Domain]</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateDomain_label_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate [Domain]</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateDomain_documentation_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateDomain" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateDomain" xlink:to="lab_gsk_ActuarialAssumptionPercentageRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_ae967f51-d433-46dc-88dc-de5738abee9e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_28edbe8d-53b4-4df3-adc4-49291c8dabe9_terseLabel_en-US" xlink:label="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current equity investments</link:label>
    <link:label id="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_label_en-US" xlink:label="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Equity Investments Recognised At Of Acquisition Date</link:label>
    <link:label id="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate_documentation_en-US" xlink:label="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Equity Investments Recognised At Of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" xlink:href="gsk-20241231.xsd#gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" xlink:to="lab_gsk_NonCurrentEquityInvestmentsRecognisedAtOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DepreciationOfEuro_9e81af77-24ea-4bea-a867-f15f7eb134f2_negatedLabel_en-US" xlink:label="lab_gsk_DepreciationOfEuro" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Depreciation of Euro</link:label>
    <link:label id="lab_gsk_DepreciationOfEuro_label_en-US" xlink:label="lab_gsk_DepreciationOfEuro" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation Of Euro</link:label>
    <link:label id="lab_gsk_DepreciationOfEuro_documentation_en-US" xlink:label="lab_gsk_DepreciationOfEuro" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depreciation of euro.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DepreciationOfEuro" xlink:href="gsk-20241231.xsd#gsk_DepreciationOfEuro"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DepreciationOfEuro" xlink:to="lab_gsk_DepreciationOfEuro" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_869b2ef5-cac9-4c2c-bfb9-9d5c729bc4e2_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Profit before taxation from continuing operations</link:label>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_f4360a0e-eea1-48e9-8273-f1471f320d7b_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit before tax</link:label>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_label_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="lab_ifrs-full_ProfitLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateAxis_2027a877-b14b-439e-af53-f39c7ad68f55_terseLabel_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate [Axis]</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateAxis_label_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate [Axis]</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateAxis_documentation_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateAxis" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateAxis" xlink:to="lab_gsk_ActuarialAssumptionPercentageRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock_11f04e95-0488-4c50-9ea4-d196f466f665_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of After Tax Profits and Losses of Associates and Joint Ventures</link:label>
    <link:label id="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share of After Tax Profits and Losses of Associates and Joint Ventures Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of share of after tax profits and losses of associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfShareOfAfterTaxProfitsAndLossesOfAssociatesAndJointVenturesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExchangeOnNetDebt_d07386f5-85bd-497c-bb56-7529efa34059_terseLabel_en-US" xlink:label="lab_gsk_ExchangeOnNetDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_gsk_ExchangeOnNetDebt_label_en-US" xlink:label="lab_gsk_ExchangeOnNetDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange On Net Debt</link:label>
    <link:label id="lab_gsk_ExchangeOnNetDebt_documentation_en-US" xlink:label="lab_gsk_ExchangeOnNetDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchange on net debt to reconcile profit (loss) to net cash flow from (used in) operating activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeOnNetDebt" xlink:href="gsk-20241231.xsd#gsk_ExchangeOnNetDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExchangeOnNetDebt" xlink:to="lab_gsk_ExchangeOnNetDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_JscGlaxosmithklineTradingMember_c9f4f1b6-b13c-4454-aa91-ba661663bb60_terseLabel_en-US" xlink:label="lab_gsk_JscGlaxosmithklineTradingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">JSC GlaxoSmithKline Trading (Russia)</link:label>
    <link:label id="lab_gsk_JscGlaxosmithklineTradingMember_label_en-US" xlink:label="lab_gsk_JscGlaxosmithklineTradingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JSC GlaxoSmithKline Trading [Member]</link:label>
    <link:label id="lab_gsk_JscGlaxosmithklineTradingMember_documentation_en-US" xlink:label="lab_gsk_JscGlaxosmithklineTradingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">JSC GlaxoSmithKline Trading.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_JscGlaxosmithklineTradingMember" xlink:href="gsk-20241231.xsd#gsk_JscGlaxosmithklineTradingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_JscGlaxosmithklineTradingMember" xlink:to="lab_gsk_JscGlaxosmithklineTradingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_2ff2da9e-4a27-4b8c-b83a-a216a3954fe6_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Social security</link:label>
    <link:label id="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_label_en-US" xlink:label="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current payables on social security and taxes other than income tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:to="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_929d9902-a8d0-4770-8391-a2dfedcd9df0_terseLabel_en-US" xlink:label="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty income</link:label>
    <link:label id="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_label_en-US" xlink:label="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Income Recognised From Performance Obligations Satisfied In Previous Periods</link:label>
    <link:label id="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods_documentation_en-US" xlink:label="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty income recognised from performance obligations satisfied in previous periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:href="gsk-20241231.xsd#gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:to="lab_gsk_RoyaltyIncomeRecognisedFromPerformanceObligationsSatisfiedInPreviousPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExchangeAdjustments_428c44b0-f9c0-4fb6-8af5-944383b58182_negatedLabel_en-US" xlink:label="lab_gsk_ExchangeAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_gsk_ExchangeAdjustments_label_en-US" xlink:label="lab_gsk_ExchangeAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange Adjustments</link:label>
    <link:label id="lab_gsk_ExchangeAdjustments_documentation_en-US" xlink:label="lab_gsk_ExchangeAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchange adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeAdjustments" xlink:href="gsk-20241231.xsd#gsk_ExchangeAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExchangeAdjustments" xlink:to="lab_gsk_ExchangeAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_d6ad671d-3c7e-4896-b271-a583a9151038_terseLabel_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfer to assets held for sale/distribution</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_label_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (Increase) in Net Defined Benefit Liability (Asset) Resulting from Transfer To Assets Held For Sale / Distribution</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution_documentation_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" xlink:to="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromTransferToAssetsHeldForSaleDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_b899899f-9042-4a31-83e1-f2c41c966e24_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InvestmentAxis_a5933d75-37dd-4a7a-b9cb-8a1e33bdba38_terseLabel_en-US" xlink:label="lab_gsk_InvestmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment [Axis]</link:label>
    <link:label id="lab_gsk_InvestmentAxis_label_en-US" xlink:label="lab_gsk_InvestmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment [Axis]</link:label>
    <link:label id="lab_gsk_InvestmentAxis_documentation_en-US" xlink:label="lab_gsk_InvestmentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentAxis" xlink:href="gsk-20241231.xsd#gsk_InvestmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InvestmentAxis" xlink:to="lab_gsk_InvestmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of voluntary change in accounting policy [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract" xlink:to="lab_ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_fbb3edd3-5a19-40ae-a7d6-f04dbca14e82_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement gains/(losses) on defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_18b7f31e-ee0a-43d8-afa3-5a6b439978fe_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement on defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e82b2957-3eb7-4743-9a66-55675cdb1fe9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_0ea349da-ddaf-4109-9f71-80e2b674b9f7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock_6d92af55-37e5-434b-aba7-184f37e7fd18_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Information About Profit Loss</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Profit Loss Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about profit (loss).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutProfitLossExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock_22439f8f-c4d2-465b-8c4f-76e661d2fe32_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Detailed Information about Derivative Instruments</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Derivative Instruments [Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_e65033f6-33a0-4821-a498-13ecc3fa565d_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in provision for Major restructuring programmes (see Note 32)</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Provision For Major Restructuring Programmes</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease in provision for major restructuring programmes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" xlink:to="lab_gsk_IncreaseDecreaseInProvisionForMajorRestructuringProgrammes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d336bcaa-3826-4e1a-a52c-6cef1d5b82a2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TotalfairValueOfDistributedandRetainBusiness_5afb7844-2466-4ca9-aca1-b7651f2c36e4_totalLabel_en-US" xlink:label="lab_gsk_TotalfairValueOfDistributedandRetainBusiness" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total fair value</link:label>
    <link:label id="lab_gsk_TotalfairValueOfDistributedandRetainBusiness_label_en-US" xlink:label="lab_gsk_TotalfairValueOfDistributedandRetainBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Fair Value Of Distributed And Retain Business</link:label>
    <link:label id="lab_gsk_TotalfairValueOfDistributedandRetainBusiness_documentation_en-US" xlink:label="lab_gsk_TotalfairValueOfDistributedandRetainBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total&#8203; fair&#8203; value of&#8203; distributed&#8203; and&#8203; retain&#8203; business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalfairValueOfDistributedandRetainBusiness" xlink:href="gsk-20241231.xsd#gsk_TotalfairValueOfDistributedandRetainBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TotalfairValueOfDistributedandRetainBusiness" xlink:to="lab_gsk_TotalfairValueOfDistributedandRetainBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShinglesMember_13535df9-c35c-48cf-9d65-fe1fe428ad3e_terseLabel_en-US" xlink:label="lab_gsk_ShinglesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shingles</link:label>
    <link:label id="lab_gsk_ShinglesMember_label_en-US" xlink:label="lab_gsk_ShinglesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shingles [member]</link:label>
    <link:label id="lab_gsk_ShinglesMember_documentation_en-US" xlink:label="lab_gsk_ShinglesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shingles.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShinglesMember" xlink:href="gsk-20241231.xsd#gsk_ShinglesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShinglesMember" xlink:to="lab_gsk_ShinglesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShionogiViivHealthcareMember_2c332fb9-85f5-45de-8dd6-b3540c98fd6a_terseLabel_en-US" xlink:label="lab_gsk_ShionogiViivHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shionogi ViiV healthcare</link:label>
    <link:label id="lab_gsk_ShionogiViivHealthcareMember_18fea16c-8a15-494b-aee5-dc68d15bd2e6_verboseLabel_en-US" xlink:label="lab_gsk_ShionogiViivHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shionogi ViiV healthcare</link:label>
    <link:label id="lab_gsk_ShionogiViivHealthcareMember_label_en-US" xlink:label="lab_gsk_ShionogiViivHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shionogi ViiV Healthcare [member]</link:label>
    <link:label id="lab_gsk_ShionogiViivHealthcareMember_documentation_en-US" xlink:label="lab_gsk_ShionogiViivHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shionogi ViiV healthcare.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViivHealthcareMember" xlink:href="gsk-20241231.xsd#gsk_ShionogiViivHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShionogiViivHealthcareMember" xlink:to="lab_gsk_ShionogiViivHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges_61319ee9-0149-4419-907e-56148cdce3a1_terseLabel_en-US" xlink:label="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative balance in cash flow hedge reserve/foreign currency translation reserve &#8232;for continuing hedges</link:label>
    <link:label id="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges_label_en-US" xlink:label="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve Of Cash Flow Hedges Or Exchange Differences On Translation Continuing Hedges</link:label>
    <link:label id="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges_documentation_en-US" xlink:label="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A component of equity representing the reserve of cash flow hedges or the reserve of exchange differences on translation in relation to continuing hedges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" xlink:href="gsk-20241231.xsd#gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" xlink:to="lab_gsk_ReserveOfCashFlowHedgesOrExchangeDifferencesOnTranslationContinuingHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_29ab7c85-a9b8-42ea-b864-26664a8b3975_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_f5e7b952-5713-435c-84e5-ee51a0b6908f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of cash flow hedges to income statement</link:label>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_label_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on cash flow hedges, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_3dfecb7e-7916-47f0-9a96-c956b591eac6_totalLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amounts charged to operating profit</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:to="lab_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherCurrentDebtMember_0f49de9a-39cc-4a9f-97c5-7376d2f6f7b7_terseLabel_en-US" xlink:label="lab_gsk_OtherCurrentDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_gsk_OtherCurrentDebtMember_label_en-US" xlink:label="lab_gsk_OtherCurrentDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Debt [member]</link:label>
    <link:label id="lab_gsk_OtherCurrentDebtMember_documentation_en-US" xlink:label="lab_gsk_OtherCurrentDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other current debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCurrentDebtMember" xlink:href="gsk-20241231.xsd#gsk_OtherCurrentDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherCurrentDebtMember" xlink:to="lab_gsk_OtherCurrentDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ForeignExchangeRatesAbstract_label_en-US" xlink:label="lab_ifrs-full_ForeignExchangeRatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange rates [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeRatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ForeignExchangeRatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignExchangeRatesAbstract" xlink:to="lab_ifrs-full_ForeignExchangeRatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9b990de4-140a-4737-b87e-60bc619b82e4_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Classes Share Capital And Share Premium [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialAssets_39b24589-4eec-458d-9440-dc157b7432e9_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialAssets_7b54469e-6de4-400b-82f7-0dd446822496_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current derivative financial assets</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current derivative financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialAssets" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SegmentConsolidationItemAxis_3e00d625-b0e4-4bb9-907a-897f0c7513d1_terseLabel_en-US" xlink:label="lab_gsk_SegmentConsolidationItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment consolidation items [axis]</link:label>
    <link:label id="lab_gsk_SegmentConsolidationItemAxis_label_en-US" xlink:label="lab_gsk_SegmentConsolidationItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Consolidation Item [Axis]</link:label>
    <link:label id="lab_gsk_SegmentConsolidationItemAxis_documentation_en-US" xlink:label="lab_gsk_SegmentConsolidationItemAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment consolidation item.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemAxis" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SegmentConsolidationItemAxis" xlink:to="lab_gsk_SegmentConsolidationItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_9b3bb46d-f306-4efa-98df-ad939efe79c5_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_label_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember_f8303245-53de-4a62-8a4d-f5566834b025_terseLabel_en-US" xlink:label="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In line with other pharmaceutical companies</link:label>
    <link:label id="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember_label_en-US" xlink:label="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Line With Other Pharmaceutical Companies [Member]</link:label>
    <link:label id="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember_documentation_en-US" xlink:label="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">In line with other pharmaceutical companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InLineWithOtherPharmaceuticalCompaniesMember" xlink:href="gsk-20241231.xsd#gsk_InLineWithOtherPharmaceuticalCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InLineWithOtherPharmaceuticalCompaniesMember" xlink:to="lab_gsk_InLineWithOtherPharmaceuticalCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares_ac9f841e-7f13-494d-8200-049408f1c413_terseLabel_en-US" xlink:label="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Par value of shares surrendered in lieu of new shares (in pence per share)</link:label>
    <link:label id="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares_label_en-US" xlink:label="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Par Value Of Shares Surrendered In Lieu Of New Shares</link:label>
    <link:label id="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares_documentation_en-US" xlink:label="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Par value of shares surrendered in lieu of new shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" xlink:href="gsk-20241231.xsd#gsk_ParValueOfSharesSurrenderedInLieuOfNewShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" xlink:to="lab_gsk_ParValueOfSharesSurrenderedInLieuOfNewShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_13c6c3b5-7099-465f-bb00-e0d4329b0ea7_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in trade receivables</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_07aa5d0d-fe2a-4970-9b72-c7f0df93fd78_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate of increase of future earnings</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of salary increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member_63ba9f2c-d881-4256-82d3-74c39b24336e_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Single Member A.E.B.E. (Greece)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member_label_en-US" xlink:label="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Single Member A.E.B.E. [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Single Member A.E.B.E.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineSingleMemberA.e.b.e.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" xlink:to="lab_gsk_GlaxosmithklineSingleMemberA.e.b.e.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_1fe49ffb-0e29-4eee-a008-952d7579d41b_terseLabel_en-US" xlink:label="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_label_en-US" xlink:label="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Tax On Share Based Payments Charged Or Credited Directly To Equity And Comprehensive Income</link:label>
    <link:label id="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current tax on share based payments charged or credited directly to equity and comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:to="lab_gsk_CurrentTaxOnShareBasedPaymentsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_ae210db6-2a8d-4837-9e59-0ab00d4c3b6a_terseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D credits (in percent)</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect of Research and Development Credits</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax rate effect of research and development credits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfResearchAndDevelopmentCredits" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfResearchAndDevelopmentCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfResearchAndDevelopmentCredits" xlink:to="lab_gsk_TaxRateEffectOfResearchAndDevelopmentCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax_1259c34f-fe9a-481c-aaa3-c60399058bdc_terseLabel_en-US" xlink:label="lab_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables from taxes other than income tax</link:label>
    <link:label id="lab_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax_label_en-US" xlink:label="lab_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables from taxes other than income tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax" xlink:to="lab_ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PharmaceuticalsMember_1a093419-26f9-452a-9a22-eecfc67bbdd8_terseLabel_en-US" xlink:label="lab_gsk_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceuticals</link:label>
    <link:label id="lab_gsk_PharmaceuticalsMember_label_en-US" xlink:label="lab_gsk_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceuticals [member]</link:label>
    <link:label id="lab_gsk_PharmaceuticalsMember_documentation_en-US" xlink:label="lab_gsk_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceuticals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PharmaceuticalsMember" xlink:href="gsk-20241231.xsd#gsk_PharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PharmaceuticalsMember" xlink:to="lab_gsk_PharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_65ed4c9a-04cf-4c6b-b24e-7acc340126af_negatedTerseLabel_en-US" xlink:label="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Held for sale</link:label>
    <link:label id="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease Through Classed As Held For Sale, Investments Other Than Investments Accounted For Using Equity Method</link:label>
    <link:label id="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_documentation_en-US" xlink:label="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease Through Classed As Held For Sale, Investments Other Than Investments Accounted For Using Equity Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:href="gsk-20241231.xsd#gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_gsk_DecreaseThroughClassedAsHeldForSaleInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember_84e583d7-948e-486a-aa67-97dd6d284d77_terseLabel_en-US" xlink:label="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sell foreign currency, less than 3 months</link:label>
    <link:label id="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember_label_en-US" xlink:label="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sell Foreign Currency Less Than Three Months [Member]</link:label>
    <link:label id="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember_documentation_en-US" xlink:label="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sell Foreign Currency Less than three months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellForeignCurrencyLessThanThreeMonthsMember" xlink:href="gsk-20241231.xsd#gsk_SellForeignCurrencyLessThanThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SellForeignCurrencyLessThanThreeMonthsMember" xlink:to="lab_gsk_SellForeignCurrencyLessThanThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations_cee2e7e1-0404-463d-b617-2c1cde53ed6e_terseLabel_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in net debt from continuing operations</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations_label_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (Increase) In Net Debt From Continuing Operations</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations_documentation_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease Increase In Net Debt From Continuing Operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDebtFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" xlink:to="lab_gsk_DecreaseIncreaseInNetDebtFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DividendYieldShareOptionsGranted_9d385bda-978e-4fbb-9d71-949755707bf2_terseLabel_en-US" xlink:label="lab_gsk_DividendYieldShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_gsk_DividendYieldShareOptionsGranted_label_en-US" xlink:label="lab_gsk_DividendYieldShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend Yield Share Options Granted</link:label>
    <link:label id="lab_gsk_DividendYieldShareOptionsGranted_documentation_en-US" xlink:label="lab_gsk_DividendYieldShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividend yield share options granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendYieldShareOptionsGranted" xlink:href="gsk-20241231.xsd#gsk_DividendYieldShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DividendYieldShareOptionsGranted" xlink:to="lab_gsk_DividendYieldShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_bc1e9e54-23ab-4aee-a606-6021d10f67b2_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of long-term notes</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_039b66b2-77d2-4e80-b915-6d73f2785d54_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Issue of long-term notes</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDividendsLineItems_92b157c1-1d8d-44e0-be75-32e0b0458ba1_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDividendsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of dividends [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfDividendsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Dividends [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDividendsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of dividends.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDividendsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDividendsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDividendsLineItems" xlink:to="lab_gsk_DisclosureOfDividendsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Revenue_b0d66ed9-9bcc-446e-875c-7956e8b28fb7_terseLabel_en-US" xlink:label="lab_ifrs-full_Revenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</link:label>
    <link:label id="lab_ifrs-full_Revenue_d514f7a4-1a3a-44ae-add1-46f376d3e275_verboseLabel_en-US" xlink:label="lab_ifrs-full_Revenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Turnover</link:label>
    <link:label id="lab_ifrs-full_Revenue_label_en-US" xlink:label="lab_ifrs-full_Revenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue" xlink:to="lab_ifrs-full_Revenue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BorrowingThreeToSixMonthsMember_2d8eac51-687c-4cda-b9e2-62ec56943a66_terseLabel_en-US" xlink:label="lab_gsk_BorrowingThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, 3 to 6 months</link:label>
    <link:label id="lab_gsk_BorrowingThreeToSixMonthsMember_label_en-US" xlink:label="lab_gsk_BorrowingThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Three to Six Months [Member]</link:label>
    <link:label id="lab_gsk_BorrowingThreeToSixMonthsMember_documentation_en-US" xlink:label="lab_gsk_BorrowingThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing three to six months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingThreeToSixMonthsMember" xlink:href="gsk-20241231.xsd#gsk_BorrowingThreeToSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BorrowingThreeToSixMonthsMember" xlink:to="lab_gsk_BorrowingThreeToSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems_609359ea-88f7-48af-b826-fa76a8ce57ee_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of noncontrolling interests [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of noncontrolling interests [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of non-controlling interests Line Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNoncontrollingInterestsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfNoncontrollingInterestsLineItems" xlink:to="lab_gsk_DisclosureOfNoncontrollingInterestsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer_31b48e6b-96d1-4573-991c-a346fa5d33c6_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum percentage of trade receivables balance</link:label>
    <link:label id="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer_label_en-US" xlink:label="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Accounts Receivable By Major Customer</link:label>
    <link:label id="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer_documentation_en-US" xlink:label="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of accounts receivable by major customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfAccountsReceivableByMajorCustomer" xlink:href="gsk-20241231.xsd#gsk_PercentageOfAccountsReceivableByMajorCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfAccountsReceivableByMajorCustomer" xlink:to="lab_gsk_PercentageOfAccountsReceivableByMajorCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_b2eaa906-5ddb-4e66-a513-049535588e4e_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ResearchAndDevelopmentMember_96a20724-b4e5-4994-81d9-09db39b33c46_terseLabel_en-US" xlink:label="lab_gsk_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_gsk_ResearchAndDevelopmentMember_label_en-US" xlink:label="lab_gsk_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:label id="lab_gsk_ResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_gsk_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ResearchAndDevelopmentMember" xlink:href="gsk-20241231.xsd#gsk_ResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ResearchAndDevelopmentMember" xlink:to="lab_gsk_ResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CreditRiskMember_ed7f3f64-19ae-4bab-912e-d91e822e3bfb_terseLabel_en-US" xlink:label="lab_ifrs-full_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit risk</link:label>
    <link:label id="lab_ifrs-full_CreditRiskMember_label_en-US" xlink:label="lab_ifrs-full_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit risk [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember" xlink:to="lab_ifrs-full_CreditRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskHoldingMember_0d5aa7ac-226f-4521-8eb4-d0b6ab88277a_terseLabel_en-US" xlink:label="lab_gsk_GskHoldingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Holding</link:label>
    <link:label id="lab_gsk_GskHoldingMember_label_en-US" xlink:label="lab_gsk_GskHoldingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Holding [Member]</link:label>
    <link:label id="lab_gsk_GskHoldingMember_documentation_en-US" xlink:label="lab_gsk_GskHoldingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK holding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskHoldingMember" xlink:href="gsk-20241231.xsd#gsk_GskHoldingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskHoldingMember" xlink:to="lab_gsk_GskHoldingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_a3891737-d386-4a69-ad62-3cda5ef62bd3_verboseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Variable lease payments</link:label>
    <link:label id="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to variable lease payments not included in measurement of lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:to="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_1cd2912a-eb93-4023-b64d-533887cbf77b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted_a077c136-80ec-4ee3-b62f-4cc3910d3d6a_terseLabel_en-US" xlink:label="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future dividend yield percentage share granted</link:label>
    <link:label id="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted_label_en-US" xlink:label="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Future Dividend Yield Percentage Share Granted</link:label>
    <link:label id="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted_documentation_en-US" xlink:label="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected future dividend yield percentage share granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExpectedFutureDividendYieldPercentageShareGranted" xlink:href="gsk-20241231.xsd#gsk_ExpectedFutureDividendYieldPercentageShareGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExpectedFutureDividendYieldPercentageShareGranted" xlink:to="lab_gsk_ExpectedFutureDividendYieldPercentageShareGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_80c23a27-e327-42c4-9b78-4081404aa6a2_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d2254d2f-6abe-4458-b064-0ae12fef4add_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RepaymentOfOtherShortTermLoans_d55e3975-47d1-4578-9362-387c5408aec4_negatedLabel_en-US" xlink:label="lab_gsk_RepaymentOfOtherShortTermLoans" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of other short-term loans</link:label>
    <link:label id="lab_gsk_RepaymentOfOtherShortTermLoans_0d32f8ce-b082-49d6-97f2-fff434963796_terseLabel_en-US" xlink:label="lab_gsk_RepaymentOfOtherShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment of other short-term loans</link:label>
    <link:label id="lab_gsk_RepaymentOfOtherShortTermLoans_label_en-US" xlink:label="lab_gsk_RepaymentOfOtherShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayment Of Other Short-Term Loans</link:label>
    <link:label id="lab_gsk_RepaymentOfOtherShortTermLoans_documentation_en-US" xlink:label="lab_gsk_RepaymentOfOtherShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayment Of Other Short-Term Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RepaymentOfOtherShortTermLoans" xlink:href="gsk-20241231.xsd#gsk_RepaymentOfOtherShortTermLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RepaymentOfOtherShortTermLoans" xlink:to="lab_gsk_RepaymentOfOtherShortTermLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HIVMember_cdeb67be-a6e1-492d-a644-581cfb74dda2_terseLabel_en-US" xlink:label="lab_gsk_HIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">HIV</link:label>
    <link:label id="lab_gsk_HIVMember_label_en-US" xlink:label="lab_gsk_HIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">HIV [member]</link:label>
    <link:label id="lab_gsk_HIVMember_documentation_en-US" xlink:label="lab_gsk_HIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">HIV.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HIVMember" xlink:href="gsk-20241231.xsd#gsk_HIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HIVMember" xlink:to="lab_gsk_HIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OntarioAndQuebecMember_1968a13b-1607-41ea-8c0a-feebbd958f1c_terseLabel_en-US" xlink:label="lab_gsk_OntarioAndQuebecMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ontario and Quebec</link:label>
    <link:label id="lab_gsk_OntarioAndQuebecMember_label_en-US" xlink:label="lab_gsk_OntarioAndQuebecMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ontario And Quebec [Member]</link:label>
    <link:label id="lab_gsk_OntarioAndQuebecMember_documentation_en-US" xlink:label="lab_gsk_OntarioAndQuebecMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ontario And Quebec</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OntarioAndQuebecMember" xlink:href="gsk-20241231.xsd#gsk_OntarioAndQuebecMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OntarioAndQuebecMember" xlink:to="lab_gsk_OntarioAndQuebecMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherGeneralMedicinesMember_f96f60cc-bfad-4056-997b-fa9b6101f35f_terseLabel_en-US" xlink:label="lab_gsk_OtherGeneralMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other General Medicines</link:label>
    <link:label id="lab_gsk_OtherGeneralMedicinesMember_label_en-US" xlink:label="lab_gsk_OtherGeneralMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other General Medicines [Member]</link:label>
    <link:label id="lab_gsk_OtherGeneralMedicinesMember_documentation_en-US" xlink:label="lab_gsk_OtherGeneralMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other General Medicines [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherGeneralMedicinesMember" xlink:href="gsk-20241231.xsd#gsk_OtherGeneralMedicinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherGeneralMedicinesMember" xlink:to="lab_gsk_OtherGeneralMedicinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BbbOrBaaMember_92b8c0a0-b197-48a9-93eb-dec344d36b39_terseLabel_en-US" xlink:label="lab_gsk_BbbOrBaaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BBB/Baa</link:label>
    <link:label id="lab_gsk_BbbOrBaaMember_label_en-US" xlink:label="lab_gsk_BbbOrBaaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BBB Or Baa [member]</link:label>
    <link:label id="lab_gsk_BbbOrBaaMember_documentation_en-US" xlink:label="lab_gsk_BbbOrBaaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BBB/Baa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BbbOrBaaMember" xlink:href="gsk-20241231.xsd#gsk_BbbOrBaaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BbbOrBaaMember" xlink:to="lab_gsk_BbbOrBaaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4a1a242a-04c2-4434-ab6a-7a1ab91722c1_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_156cca19-0fd3-4e87-a162-3565e3c8c23f_terseLabel_en-US" xlink:label="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement through income statement</link:label>
    <link:label id="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurement Through Income Statement Increase (Decrease) In Contingent Liabilities Recognised In Business Combination</link:label>
    <link:label id="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_documentation_en-US" xlink:label="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurement through income statement Increase (decrease) in contingent liabilities recognised in business combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="gsk-20241231.xsd#gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_gsk_RemeasurementThroughIncomeStatementIncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock_1f1c911e-5f4b-4654-bc99-af332ff5ad8d_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Shares Held for Share Award Schemes</link:label>
    <link:label id="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Shares Held For Share Award Schemes And Shares Option Schemes Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of shares held for share award schemes and shares option schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfSharesHeldForShareAwardSchemesAndSharesOptionSchemesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskPharmaVietnamCompanyLimitedMember_ba780d53-01cd-425e-91d3-a8068be3c86a_terseLabel_en-US" xlink:label="lab_gsk_GskPharmaVietnamCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Pharma Vietnam Company Limited (Vietnam)</link:label>
    <link:label id="lab_gsk_GskPharmaVietnamCompanyLimitedMember_label_en-US" xlink:label="lab_gsk_GskPharmaVietnamCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Pharma Vietnam Company Limited [Member]</link:label>
    <link:label id="lab_gsk_GskPharmaVietnamCompanyLimitedMember_documentation_en-US" xlink:label="lab_gsk_GskPharmaVietnamCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Pharma Vietnam Company Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskPharmaVietnamCompanyLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GskPharmaVietnamCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskPharmaVietnamCompanyLimitedMember" xlink:to="lab_gsk_GskPharmaVietnamCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LaboratoriosViiVHealthCareSLMember_0f903e4d-33ec-40a8-a09c-924cfd93d531_terseLabel_en-US" xlink:label="lab_gsk_LaboratoriosViiVHealthCareSLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratorios ViiV Healthcare, S.L. (Spain)</link:label>
    <link:label id="lab_gsk_LaboratoriosViiVHealthCareSLMember_label_en-US" xlink:label="lab_gsk_LaboratoriosViiVHealthCareSLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratorios Vii V Health Care S L [member]</link:label>
    <link:label id="lab_gsk_LaboratoriosViiVHealthCareSLMember_documentation_en-US" xlink:label="lab_gsk_LaboratoriosViiVHealthCareSLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Laboratorios ViiV Healthcare, S.L.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LaboratoriosViiVHealthCareSLMember" xlink:href="gsk-20241231.xsd#gsk_LaboratoriosViiVHealthCareSLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LaboratoriosViiVHealthCareSLMember" xlink:to="lab_gsk_LaboratoriosViiVHealthCareSLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember_92f361a1-8aca-486c-bed4-25a414bc5171_terseLabel_en-US" xlink:label="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sell foreign currency, 3 to 6 months</link:label>
    <link:label id="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember_label_en-US" xlink:label="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sell Foreign Currency Three To Six Months [Member]</link:label>
    <link:label id="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember_documentation_en-US" xlink:label="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sell Foreign Currency Three To Six Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellForeignCurrencyThreeToSixMonthsMember" xlink:href="gsk-20241231.xsd#gsk_SellForeignCurrencyThreeToSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SellForeignCurrencyThreeToSixMonthsMember" xlink:to="lab_gsk_SellForeignCurrencyThreeToSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseInDiscountRateAmount_fd2c1df4-6886-4925-a1f2-90484cdc0b06_terseLabel_en-US" xlink:label="lab_gsk_DecreaseInDiscountRateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in discount rate</link:label>
    <link:label id="lab_gsk_DecreaseInDiscountRateAmount_label_en-US" xlink:label="lab_gsk_DecreaseInDiscountRateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Discount Rate Amount</link:label>
    <link:label id="lab_gsk_DecreaseInDiscountRateAmount_documentation_en-US" xlink:label="lab_gsk_DecreaseInDiscountRateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease in discount rate amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInDiscountRateAmount" xlink:href="gsk-20241231.xsd#gsk_DecreaseInDiscountRateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseInDiscountRateAmount" xlink:to="lab_gsk_DecreaseInDiscountRateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_df6386a3-d85f-4baf-ad1f-85e3e1e4c74c_negatedLabel_en-US" xlink:label="lab_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross financial (liabilities)/assets set off, assets</link:label>
    <link:label id="lab_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_label_en-US" xlink:label="lab_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross financial liabilities set off against financial assets subject to offsetting, enforceable master netting arrangements or similar agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:to="lab_ifrs-full_GrossFinancialLiabilitiesSetOffAgainstFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member_1d7cd9cb-7150-43fc-9f0b-a6ebd875b52a_terseLabel_en-US" xlink:label="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.625% Notes due 2025</link:label>
    <link:label id="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member_label_en-US" xlink:label="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Six Two Five Notes due 2025 [Member]</link:label>
    <link:label id="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member_documentation_en-US" xlink:label="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.625% Notes due 2025.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointSixTwoFiveNotesDue2025Member" xlink:href="gsk-20241231.xsd#gsk_ThreePointSixTwoFiveNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointSixTwoFiveNotesDue2025Member" xlink:to="lab_gsk_ThreePointSixTwoFiveNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfNonControllingInterestsAbstract_label_en-US" xlink:label="lab_gsk_DisclosureOfNonControllingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Non-Controlling Interests [Abstract]</link:label>
    <link:label id="lab_gsk_DisclosureOfNonControllingInterestsAbstract_documentation_en-US" xlink:label="lab_gsk_DisclosureOfNonControllingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of non controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNonControllingInterestsAbstract" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNonControllingInterestsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfNonControllingInterestsAbstract" xlink:to="lab_gsk_DisclosureOfNonControllingInterestsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e4af1616-492f-467b-95da-e00cfd1396d9_negatedLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_0bd5a593-6ff0-4ddc-ae0e-4da42927e3cf_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net impairment losses</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_02391575-b463-4155-8247-7bfda90882a1_terseLabel_en-US" xlink:label="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of exchange movements and net investment hedge movements on disposal of overseas subsidiaries</link:label>
    <link:label id="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_label_en-US" xlink:label="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Of Exchange Movements And Net Investment Hedge Movements On Disposal Of Overseas Subsidiaries</link:label>
    <link:label id="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries_documentation_en-US" xlink:label="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification Of Exchange Movements And Net Investment Hedge Movements On Disposal Of Overseas Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" xlink:to="lab_gsk_ReclassificationOfExchangeMovementsAndNetInvestmentHedgeMovementsOnDisposalOfOverseasSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment_c614ac23-67a9-4cda-8a82-9d5656e6e164_terseLabel_en-US" xlink:label="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer return and rebate accruals</link:label>
    <link:label id="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment_label_en-US" xlink:label="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Return And Rebate Accruals Inclusive Of Cash Discount And Channel Management Payment</link:label>
    <link:label id="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment_documentation_en-US" xlink:label="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer return and rebate accruals, includes Cash discount and Channel Management Payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" xlink:to="lab_gsk_CustomerReturnAndRebateAccrualsInclusiveOfCashDiscountAndChannelManagementPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgingInstrumentsAxis_3f68027d-3da8-47c3-9754-2c340de9e1ac_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging instruments [axis]</link:label>
    <link:label id="lab_ifrs-full_HedgingInstrumentsAxis_label_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging instruments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis" xlink:to="lab_ifrs-full_HedgingInstrumentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_c613f981-634a-48e4-8b98-08edbb22fb0a_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">JPY</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments_93b3a65d-b8a8-4c4b-a2fa-9bcb618fd48b_terseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments gains (losses)</link:label>
    <link:label id="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments_label_en-US" xlink:label="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Foreign Exchange Gains (Losses) on Other Investments</link:label>
    <link:label id="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for foreign exchange other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" xlink:to="lab_gsk_AdjustmentsForForeignExchangeGainsLossesOnOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CustomerReturnAndRebateAccruals_4b132117-412d-4812-8cf2-69d216dc9e52_terseLabel_en-US" xlink:label="lab_gsk_CustomerReturnAndRebateAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer return and rebate accruals</link:label>
    <link:label id="lab_gsk_CustomerReturnAndRebateAccruals_label_en-US" xlink:label="lab_gsk_CustomerReturnAndRebateAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Return And Rebate Accruals</link:label>
    <link:label id="lab_gsk_CustomerReturnAndRebateAccruals_documentation_en-US" xlink:label="lab_gsk_CustomerReturnAndRebateAccruals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer return and rebate accruals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerReturnAndRebateAccruals" xlink:href="gsk-20241231.xsd#gsk_CustomerReturnAndRebateAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CustomerReturnAndRebateAccruals" xlink:to="lab_gsk_CustomerReturnAndRebateAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisposalsInAssociatesAndJointVentures_42d0140d-a08b-4e64-b560-ecd5943ba64c_negatedLabel_en-US" xlink:label="lab_gsk_DisposalsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_gsk_DisposalsInAssociatesAndJointVentures_label_en-US" xlink:label="lab_gsk_DisposalsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals in Associates and Joint Ventures</link:label>
    <link:label id="lab_gsk_DisposalsInAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_gsk_DisposalsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposals in associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalsInAssociatesAndJointVentures" xlink:href="gsk-20241231.xsd#gsk_DisposalsInAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisposalsInAssociatesAndJointVentures" xlink:to="lab_gsk_DisposalsInAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromRoyalties_48cf172b-46f6-419e-b149-e6a186c71138_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty income</link:label>
    <link:label id="lab_ifrs-full_RevenueFromRoyalties_label_en-US" xlink:label="lab_ifrs-full_RevenueFromRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromRoyalties" xlink:to="lab_ifrs-full_RevenueFromRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems_db8bd78b-e796-4a2b-9afd-4ea15e2c0a30_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with disclosure of trade and other payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherPayablesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesLineItems" xlink:to="lab_gsk_DisclosureOfTradeAndOtherPayablesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonFinancialInstrumentsMember_f45f4b7f-9326-49db-9d18-c67d4fc07dd9_terseLabel_en-US" xlink:label="lab_gsk_NonFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non financial instruments</link:label>
    <link:label id="lab_gsk_NonFinancialInstrumentsMember_label_en-US" xlink:label="lab_gsk_NonFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Financial Instruments [member]</link:label>
    <link:label id="lab_gsk_NonFinancialInstrumentsMember_documentation_en-US" xlink:label="lab_gsk_NonFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non financial instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonFinancialInstrumentsMember" xlink:href="gsk-20241231.xsd#gsk_NonFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonFinancialInstrumentsMember" xlink:to="lab_gsk_NonFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SpecialtyMedicineMember_b82928dd-18ae-4415-81a0-329a2b05dcf7_terseLabel_en-US" xlink:label="lab_gsk_SpecialtyMedicineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Specialty Medicines</link:label>
    <link:label id="lab_gsk_SpecialtyMedicineMember_label_en-US" xlink:label="lab_gsk_SpecialtyMedicineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Specialty Medicine [Member]</link:label>
    <link:label id="lab_gsk_SpecialtyMedicineMember_documentation_en-US" xlink:label="lab_gsk_SpecialtyMedicineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Specialty Medicines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SpecialtyMedicineMember" xlink:href="gsk-20241231.xsd#gsk_SpecialtyMedicineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SpecialtyMedicineMember" xlink:to="lab_gsk_SpecialtyMedicineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashAndCashEquivalentMember_96aaa379-0962-48c3-9c39-8d027afcaf12_terseLabel_en-US" xlink:label="lab_gsk_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentMember_label_en-US" xlink:label="lab_gsk_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent [member]</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentMember_documentation_en-US" xlink:label="lab_gsk_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash and cash equivalent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentMember" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashAndCashEquivalentMember" xlink:to="lab_gsk_CashAndCashEquivalentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_391da809-ed19-4150-ab6e-f03bf4bf551f_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications and other movements</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers and other changes, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_90554fe0-f11f-497b-8fc2-d8a7be7c4528_terseLabel_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_a8199deb-2e3f-440d-ab66-77d173b5da3f_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on cash flow hedges</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on cash flow hedges, before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:to="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxReformsPeriodOfApplicationAxis_1e0df229-b284-487a-b0b6-16793365bc45_terseLabel_en-US" xlink:label="lab_gsk_TaxReformsPeriodOfApplicationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax reforms period of application [axis]</link:label>
    <link:label id="lab_gsk_TaxReformsPeriodOfApplicationAxis_label_en-US" xlink:label="lab_gsk_TaxReformsPeriodOfApplicationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax reforms period of application [axis]</link:label>
    <link:label id="lab_gsk_TaxReformsPeriodOfApplicationAxis_documentation_en-US" xlink:label="lab_gsk_TaxReformsPeriodOfApplicationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Axis that defines period of applications for tax reforms.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxReformsPeriodOfApplicationAxis" xlink:href="gsk-20241231.xsd#gsk_TaxReformsPeriodOfApplicationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxReformsPeriodOfApplicationAxis" xlink:to="lab_gsk_TaxReformsPeriodOfApplicationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskCapitalB.v.Member_9ae63085-4f1d-4fd6-93c5-b72a6f96248a_terseLabel_en-US" xlink:label="lab_gsk_GskCapitalB.v.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Capital B.V. (Netherlands)</link:label>
    <link:label id="lab_gsk_GskCapitalB.v.Member_label_en-US" xlink:label="lab_gsk_GskCapitalB.v.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Capital B.V. [Member]</link:label>
    <link:label id="lab_gsk_GskCapitalB.v.Member_documentation_en-US" xlink:label="lab_gsk_GskCapitalB.v.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Capital B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskCapitalB.v.Member" xlink:href="gsk-20241231.xsd#gsk_GskCapitalB.v.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskCapitalB.v.Member" xlink:to="lab_gsk_GskCapitalB.v.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_0e608cab-fd1a-4687-9c4d-f0fe170dc8c2_terseLabel_en-US" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent liabilities, comprising guarantees, discounted bills and other items</link:label>
    <link:label id="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_label_en-US" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated financial effect of contingent liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:to="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans_e3d199ce-5169-4a0c-905a-45996a667423_terseLabel_en-US" xlink:label="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net increase/(decrease) in short-term loans</link:label>
    <link:label id="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans_label_en-US" xlink:label="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds / (Repayments) From/Of Short Term Loans</link:label>
    <link:label id="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans_documentation_en-US" xlink:label="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds / (Repayments) From/Of Short Term Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProceedsRepaymentsFromOfShortTermLoans" xlink:href="gsk-20241231.xsd#gsk_ProceedsRepaymentsFromOfShortTermLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProceedsRepaymentsFromOfShortTermLoans" xlink:to="lab_gsk_ProceedsRepaymentsFromOfShortTermLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_025cc885-216c-42e8-8fb9-164f1e469a5f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityDomain_b41ac0dd-037a-444f-b2ba-aff102574130_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of equity</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityDomain_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain" xlink:to="lab_ifrs-full_ComponentsOfEquityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme_1c33b62c-f9ab-4721-875f-904b27ff0440_terseLabel_en-US" xlink:label="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount held at European medium term note programme</link:label>
    <link:label id="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme_label_en-US" xlink:label="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Held At European Medium Term Note Programme</link:label>
    <link:label id="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme_documentation_en-US" xlink:label="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount held at European medium term note programme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" xlink:href="gsk-20241231.xsd#gsk_AmountHeldAtEuropeanMediumTermNoteProgramme"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" xlink:to="lab_gsk_AmountHeldAtEuropeanMediumTermNoteProgramme" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CommercialPapersIssued_01ff0964-beda-41d5-98ee-383283f94f84_negatedLabel_en-US" xlink:label="lab_ifrs-full_CommercialPapersIssued" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_ifrs-full_CommercialPapersIssued_524b493c-44a3-408e-8fca-6e632ab673aa_verboseLabel_en-US" xlink:label="lab_ifrs-full_CommercialPapersIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commercial papers issued</link:label>
    <link:label id="lab_ifrs-full_CommercialPapersIssued_5657e324-ff0c-414d-9aea-29f2584b2af0_terseLabel_en-US" xlink:label="lab_ifrs-full_CommercialPapersIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term finance access</link:label>
    <link:label id="lab_ifrs-full_CommercialPapersIssued_label_en-US" xlink:label="lab_ifrs-full_CommercialPapersIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial papers issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued" xlink:to="lab_ifrs-full_CommercialPapersIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MiscellaneousComponentsOfEquityDomain_0d84bad5-c263-4fd5-9153-2e63187025d9_terseLabel_en-US" xlink:label="lab_gsk_MiscellaneousComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Miscellaneous Components Of Equity [domain]</link:label>
    <link:label id="lab_gsk_MiscellaneousComponentsOfEquityDomain_label_en-US" xlink:label="lab_gsk_MiscellaneousComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous Components Of Equity [domain]</link:label>
    <link:label id="lab_gsk_MiscellaneousComponentsOfEquityDomain_documentation_en-US" xlink:label="lab_gsk_MiscellaneousComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Miscellaneous Components Of Equity [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousComponentsOfEquityDomain" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousComponentsOfEquityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MiscellaneousComponentsOfEquityDomain" xlink:to="lab_gsk_MiscellaneousComponentsOfEquityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaid_17f006f8-0fba-43ff-987c-600f4e0a02a0_negatedLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_ifrs-full_DividendsPaid_label_en-US" xlink:label="lab_ifrs-full_DividendsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends recognised as distributions to owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaid" xlink:to="lab_ifrs-full_DividendsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_abd216c4-2391-48a8-a349-c7964bdad5f4_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_Wholesalers2Member_448c6d1a-e788-4305-9327-643b805b4fb0_terseLabel_en-US" xlink:label="lab_gsk_Wholesalers2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wholesalers 2</link:label>
    <link:label id="lab_gsk_Wholesalers2Member_label_en-US" xlink:label="lab_gsk_Wholesalers2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholesalers 2 [member]</link:label>
    <link:label id="lab_gsk_Wholesalers2Member_documentation_en-US" xlink:label="lab_gsk_Wholesalers2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wholesalers 2.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Wholesalers2Member" xlink:href="gsk-20241231.xsd#gsk_Wholesalers2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_Wholesalers2Member" xlink:to="lab_gsk_Wholesalers2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_eb55c8d6-36b3-4795-abfa-b3967f1c3c11_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member_6c871137-28e6-4d03-8566-fd6f0adce073_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Ilaclari Sanayi ve Ticaret A.S. (Turkey)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member_label_en-US" xlink:label="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Ilaclari Sanayi ve Ticaret A.S. [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Ilaclari Sanayi ve Ticaret A.S.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" xlink:to="lab_gsk_GlaxosmithklineIlaclariSanayiVeTicaretA.s.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation_4e14774c-c94a-41bc-8bfe-66045f945c2b_terseLabel_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assumption for future medical inflation</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation_label_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Expected Rates Of Medical Inflation</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation_documentation_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The expected rate of medical inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation" xlink:to="lab_gsk_ActuarialAssumptionOfExpectedRatesOfMedicalInflation" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock_95fbe41a-e3d1-461f-876c-47dbb62f647f_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Profit After Taxation on Demerger of Discontinued Operations</link:label>
    <link:label id="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Profit After Taxation On Demerger Of Discontinued Operations [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of&#160;profit after taxation on demerger of discontinued operations .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" xlink:to="lab_gsk_DisclosureOfProfitAfterTaxationOnDemergerOfDiscontinuedOperationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_b8e8e6ca-3e6a-45f1-8d9a-368d911dde9e_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(expense)</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_01cf93f4-8507-4596-8d53-2551b7ffd286_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share of other comprehensive income/(expense)</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_bc0d901d-5bc8-4ad2-a492-6541b3139196_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Share of other comprehensive income/(expense)</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome" xlink:to="lab_ifrs-full_OtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock_ee30e5f1-032a-4076-bd13-dff70065f46d_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Major Restructuring Charges from Continuing Operations by Income Statement</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Major Restructuring Charges Explanatory TextBlock [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of analysis of Major restructuring charges from continuing operations by income statement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutMajorRestructuringChargesExplanatoryTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_40eb16bf-cd5e-4a38-8bc6-361c073c7940_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value remeasurements on contingent consideration recognised in business combinations</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_25f29b44-384a-4f17-a06c-4be552dcab69_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value remeasurements on contingent consideration</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in contingent liabilities recognised in business combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZofranMember_fefd4ee5-2b90-499d-a1cb-ab2a026b3d28_terseLabel_en-US" xlink:label="lab_gsk_ZofranMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zofran</link:label>
    <link:label id="lab_gsk_ZofranMember_label_en-US" xlink:label="lab_gsk_ZofranMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zofran [Member]</link:label>
    <link:label id="lab_gsk_ZofranMember_documentation_en-US" xlink:label="lab_gsk_ZofranMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zofran</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZofranMember" xlink:href="gsk-20241231.xsd#gsk_ZofranMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZofranMember" xlink:to="lab_gsk_ZofranMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_13f9b052-819f-4a6e-a519-dcc156489d51_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from disposal of associates and joint ventures</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_80f9ab88-505b-44c5-94c5-c5ea5674f257_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net balance, liabilities</link:label>
    <link:label id="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_label_en-US" xlink:label="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:to="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember_b5d66104-3c4e-4d81-a694-eccfe717bd31_terseLabel_en-US" xlink:label="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.250% &#163; Euro Medium Term Note 2045</link:label>
    <link:label id="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember_label_en-US" xlink:label="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Four Point Two Five Percent Euro Medium Term Note Two Thousand Forty Five [Member]</link:label>
    <link:label id="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember_documentation_en-US" xlink:label="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Four point two five percent European medium term note two thousand forty five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" xlink:href="gsk-20241231.xsd#gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" xlink:to="lab_gsk_FourPointTwoFivePercentEuroMediumTermNoteTwoThousandFortyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_81795d9a-c259-4f1e-8150-2d5d0e624a78_totalLabel_en-US" xlink:label="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net financial assets/(liabilities), assets</link:label>
    <link:label id="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_label_en-US" xlink:label="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net financial assets subject to offsetting, enforceable master netting arrangements or similar agreements in statement of financial position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:to="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_1552ea6c-0609-48bd-8d76-109abd7e37d6_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of equity investments</link:label>
    <link:label id="lab_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContractLiabilities_e1b5256f-ca06-428b-a3c0-c1883acb510e_terseLabel_en-US" xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_ifrs-full_ContractLiabilities_label_en-US" xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractLiabilities" xlink:to="lab_ifrs-full_ContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets_9220d1e2-aca4-436b-bb8f-ac32ff82806b_verboseLabel_en-US" xlink:label="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Hedging gain after taxation transferred to&#8232; non-financial assets</link:label>
    <link:label id="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets_e40b3f29-7155-49c0-b8c6-e51819afd322_terseLabel_en-US" xlink:label="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging gain/loss transferred to non-financial assets</link:label>
    <link:label id="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets_label_en-US" xlink:label="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Gain (Loss) Transferred To Non Financial Assets</link:label>
    <link:label id="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets_documentation_en-US" xlink:label="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hedging gain loss transferred to non financial assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:href="gsk-20241231.xsd#gsk_HedgingGainLossTransferredToNonFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:to="lab_gsk_HedgingGainLossTransferredToNonFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoOperationsUkLimitedMember_297d1b06-f0a2-42bf-9435-6a2a615336fb_terseLabel_en-US" xlink:label="lab_gsk_GlaxoOperationsUkLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Operations UK Limited</link:label>
    <link:label id="lab_gsk_GlaxoOperationsUkLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoOperationsUkLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Operations UK Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoOperationsUkLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoOperationsUkLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Glaxo Operations UK Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoOperationsUkLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoOperationsUkLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoOperationsUkLimitedMember" xlink:to="lab_gsk_GlaxoOperationsUkLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_db6fddef-002d-41e9-81df-f51292f988a9_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax on fair value movements on cash flow hedges</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_52756cab-0c61-4bff-b4fe-476381995f62_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax on fair value movements on cash flow hedges</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax relating to cash flow hedges included in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:to="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherFinanceIncome_fa916278-990c-49f2-ace9-3a607be9ccc0_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other finance income</link:label>
    <link:label id="lab_ifrs-full_OtherFinanceIncome_label_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other finance income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceIncome" xlink:to="lab_ifrs-full_OtherFinanceIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncontrollingInterests_fdef016e-6070-49d6-87b2-c9756a56cdc8_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_NoncontrollingInterests_4c0056b2-12c1-485e-8c04-f41559e14c05_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest in the consolidated balance sheet</link:label>
    <link:label id="lab_ifrs-full_NoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests" xlink:to="lab_ifrs-full_NoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions_71a3eca6-a80c-4d88-9190-56fa08df2cc2_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unwinding of discount</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase through adjustments arising from passage of time, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_14178873-b913-4680-a218-906d5993f703_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets and liabilities classified as held for sale [axis]</link:label>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_label_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities classified as held for sale [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_63e771c7-44fa-4313-bfcc-a32a3d58b7e0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsTable_3cad32e6-93fa-4cf8-8d73-9ece52a2bfbf_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of restructuring costs</link:label>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsTable_label_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of restructuring costs [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of restructuring costs table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfRestructuringCostsTable" xlink:to="lab_gsk_DisclosureOfRestructuringCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentConsiderationMember_cb833350-88e4-46a1-a6ef-c1eb389703c4_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_ifrs-full_ContingentConsiderationMember_label_en-US" xlink:label="lab_ifrs-full_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentConsiderationMember" xlink:to="lab_ifrs-full_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TotalValueOfTheInsuranceContract_c5f0d2cc-c807-4c3c-973e-094872d57a2f_terseLabel_en-US" xlink:label="lab_gsk_TotalValueOfTheInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total value of the insurance contract</link:label>
    <link:label id="lab_gsk_TotalValueOfTheInsuranceContract_label_en-US" xlink:label="lab_gsk_TotalValueOfTheInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Value of the Insurance Contract</link:label>
    <link:label id="lab_gsk_TotalValueOfTheInsuranceContract_documentation_en-US" xlink:label="lab_gsk_TotalValueOfTheInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total value of the insurance contract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalValueOfTheInsuranceContract" xlink:href="gsk-20241231.xsd#gsk_TotalValueOfTheInsuranceContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TotalValueOfTheInsuranceContract" xlink:to="lab_gsk_TotalValueOfTheInsuranceContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_eb1f8978-38a5-4a95-9060-33711cbe0da8_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis" xlink:to="lab_ifrs-full_BorrowingsByNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests_dd824e7a-d2b6-4264-b729-2cb7d832306a_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes to non-controlling interests</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Other Changes to Noncontrolling Interests</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Other Changes to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" xlink:to="lab_gsk_IncreaseDecreaseThroughOtherChangesToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfHedgesDomain_af0d9274-1b2a-402a-a864-1cbe9ad2e8fd_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of hedges</link:label>
    <link:label id="lab_ifrs-full_TypesOfHedgesDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of hedges [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfHedgesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfHedgesDomain" xlink:to="lab_ifrs-full_TypesOfHedgesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_cce92728-f1d2-4452-b1f0-0ec049140996_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
    <link:label id="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_label_en-US" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiquidInvestmentsCurrent_9b004537-cf1e-41d9-8322-e1136fa4132c_terseLabel_en-US" xlink:label="lab_gsk_LiquidInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquid investments</link:label>
    <link:label id="lab_gsk_LiquidInvestmentsCurrent_label_en-US" xlink:label="lab_gsk_LiquidInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquid Investments Current</link:label>
    <link:label id="lab_gsk_LiquidInvestmentsCurrent_documentation_en-US" xlink:label="lab_gsk_LiquidInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liquid investments current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsCurrent" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiquidInvestmentsCurrent" xlink:to="lab_gsk_LiquidInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfTherapeuticAreas_91c65a1b-5e1d-479b-b453-aa4a776f937b_terseLabel_en-US" xlink:label="lab_gsk_NumberOfTherapeuticAreas" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of therapeutic areas</link:label>
    <link:label id="lab_gsk_NumberOfTherapeuticAreas_label_en-US" xlink:label="lab_gsk_NumberOfTherapeuticAreas" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Therapeutic Areas</link:label>
    <link:label id="lab_gsk_NumberOfTherapeuticAreas_documentation_en-US" xlink:label="lab_gsk_NumberOfTherapeuticAreas" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Therapeutic Areas</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfTherapeuticAreas" xlink:href="gsk-20241231.xsd#gsk_NumberOfTherapeuticAreas"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfTherapeuticAreas" xlink:to="lab_gsk_NumberOfTherapeuticAreas" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_97e4baa0-8da0-4599-8863-ced1f7887c3c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement_7a5609ff-8b96-492c-8b07-22c4a12faf45_terseLabel_en-US" xlink:label="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, awards granted (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share Awards Granted In Sharebased Payment Arrangement</link:label>
    <link:label id="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement_documentation_en-US" xlink:label="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share awards granted in sharebased payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" xlink:href="gsk-20241231.xsd#gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" xlink:to="lab_gsk_NumberOfShareAwardsGrantedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementDomain_cf3a8d6d-b7c9-4bd2-bccf-5f17b8811704_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement</link:label>
    <link:label id="lab_ifrs-full_MeasurementDomain_label_en-US" xlink:label="lab_ifrs-full_MeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementDomain" xlink:to="lab_ifrs-full_MeasurementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_28eec7f4-fc54-494d-ad72-7842d963b4e5_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation, amortization, and impairment</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation, amortisation and impairment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_36241822-0c3e-424e-b86e-af245e82a02a_terseLabel_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administration</link:label>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expense [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_87f80c3a-048d-48e3-bcaa-87feee86ac79_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Net Defined Benefit Liability (Asset) Resulting From Other Expense (Income)</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Net Defined Benefit Liability (Asset) Resulting From Other Expense (Income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" xlink:to="lab_gsk_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromOtherExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InfluenzaMember_bb0a7178-bb3c-4e29-a177-f097e63d7414_terseLabel_en-US" xlink:label="lab_gsk_InfluenzaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Influenza</link:label>
    <link:label id="lab_gsk_InfluenzaMember_label_en-US" xlink:label="lab_gsk_InfluenzaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Influenza [member]</link:label>
    <link:label id="lab_gsk_InfluenzaMember_documentation_en-US" xlink:label="lab_gsk_InfluenzaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Influenza.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InfluenzaMember" xlink:href="gsk-20241231.xsd#gsk_InfluenzaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InfluenzaMember" xlink:to="lab_gsk_InfluenzaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherBondsMember_54e837e8-a95f-48a3-b7a1-2a07b3723e92_terseLabel_en-US" xlink:label="lab_gsk_OtherBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8211; other bonds</link:label>
    <link:label id="lab_gsk_OtherBondsMember_label_en-US" xlink:label="lab_gsk_OtherBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Bonds [member]</link:label>
    <link:label id="lab_gsk_OtherBondsMember_documentation_en-US" xlink:label="lab_gsk_OtherBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other bonds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherBondsMember" xlink:href="gsk-20241231.xsd#gsk_OtherBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherBondsMember" xlink:to="lab_gsk_OtherBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember_2b3c75d7-3444-409c-8820-029b510b4fa0_terseLabel_en-US" xlink:label="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buy foreign currency, less than 3 months</link:label>
    <link:label id="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember_label_en-US" xlink:label="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buy Foreign Currency Less Than Three Months [Member]</link:label>
    <link:label id="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember_documentation_en-US" xlink:label="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Buy Foreign Currency Less than three months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BuyForeignCurrencyLessThanThreeMonthsMember" xlink:href="gsk-20241231.xsd#gsk_BuyForeignCurrencyLessThanThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BuyForeignCurrencyLessThanThreeMonthsMember" xlink:to="lab_gsk_BuyForeignCurrencyLessThanThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_7365c576-9d7c-4b79-8d9f-7b6d55e0a426_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets and non financial assets [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets and non financial assets [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets and non-financial assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" xlink:to="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineUsTradingLimitedMember_88cb0db5-c4d7-4ae0-8b44-da6f853ca9ce_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineUsTradingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline US Trading Limited</link:label>
    <link:label id="lab_gsk_GlaxosmithklineUsTradingLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineUsTradingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline US Trading Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineUsTradingLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineUsTradingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline US Trading Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineUsTradingLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineUsTradingLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineUsTradingLimitedMember" xlink:to="lab_gsk_GlaxosmithklineUsTradingLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetFinancialAssetsLiabilities_a2058e0a-564f-47f8-99bb-0c27f3ed962a_totalLabel_en-US" xlink:label="lab_gsk_NetFinancialAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net financial assets and financial liabilities excluding lease liabilities</link:label>
    <link:label id="lab_gsk_NetFinancialAssetsLiabilities_label_en-US" xlink:label="lab_gsk_NetFinancialAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Financial Assets (Liabilities)</link:label>
    <link:label id="lab_gsk_NetFinancialAssetsLiabilities_documentation_en-US" xlink:label="lab_gsk_NetFinancialAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net financial assets liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFinancialAssetsLiabilities" xlink:href="gsk-20241231.xsd#gsk_NetFinancialAssetsLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetFinancialAssetsLiabilities" xlink:to="lab_gsk_NetFinancialAssetsLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock_29f75d8d-dee0-4a6e-b5a7-6cef6ed24730_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Amounts Recorded in Income Statement and Statement of Comprehensive Income Related to Defined Benefit Pension and Post-retirement Healthcare Schemes</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Pension And Post Retirement Charges Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of defined benefit pension and post retirement charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementChargesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DefinedBenefitObligationActiveMember_3b766f39-82d0-4b50-babb-3d23af1846a7_terseLabel_en-US" xlink:label="lab_gsk_DefinedBenefitObligationActiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Active</link:label>
    <link:label id="lab_gsk_DefinedBenefitObligationActiveMember_label_en-US" xlink:label="lab_gsk_DefinedBenefitObligationActiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Obligation Active [member]</link:label>
    <link:label id="lab_gsk_DefinedBenefitObligationActiveMember_documentation_en-US" xlink:label="lab_gsk_DefinedBenefitObligationActiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined benefit obligation active.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationActiveMember" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationActiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DefinedBenefitObligationActiveMember" xlink:to="lab_gsk_DefinedBenefitObligationActiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_84b3be49-0c7f-4617-a5e6-dd49869e6321_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_23773df4-4300-4c6f-89d8-4ded27ded10b_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_268d8e52-0495-4250-afd1-806545a4d6b5_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DepreciationOfUSDollar_a64ccd4b-4ed6-4414-9c7d-26c165a6a0d3_negatedLabel_en-US" xlink:label="lab_gsk_DepreciationOfUSDollar" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Depreciation Of US Dollar</link:label>
    <link:label id="lab_gsk_DepreciationOfUSDollar_label_en-US" xlink:label="lab_gsk_DepreciationOfUSDollar" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation Of US Dollar</link:label>
    <link:label id="lab_gsk_DepreciationOfUSDollar_documentation_en-US" xlink:label="lab_gsk_DepreciationOfUSDollar" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depreciation of US dollar.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DepreciationOfUSDollar" xlink:href="gsk-20241231.xsd#gsk_DepreciationOfUSDollar"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DepreciationOfUSDollar" xlink:to="lab_gsk_DepreciationOfUSDollar" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInterestIncomeExplanatory_1e3db75d-293d-45af-8d11-ebd0500ddcbf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Finance Income</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInterestIncomeExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of interest income [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInterestIncomeExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest_15f5878c-6ca0-4b0c-a7ef-f9bc8a020c63_terseLabel_en-US" xlink:label="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of investment net of non controlling interest</link:label>
    <link:label id="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest_label_en-US" xlink:label="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Value Of Investment Net Of Non Controlling Interest</link:label>
    <link:label id="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest_documentation_en-US" xlink:label="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value of investment net of non controlling interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest" xlink:to="lab_gsk_CarryingValueOfInvestmentNetOfNonControllingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EuroCommercialPaperProgramMember_d3d6c6ea-0e68-49d8-9f8a-48a96d9115b4_terseLabel_en-US" xlink:label="lab_gsk_EuroCommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro commercial paper program</link:label>
    <link:label id="lab_gsk_EuroCommercialPaperProgramMember_label_en-US" xlink:label="lab_gsk_EuroCommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EURO Commercial Paper Program [Member]</link:label>
    <link:label id="lab_gsk_EuroCommercialPaperProgramMember_documentation_en-US" xlink:label="lab_gsk_EuroCommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Euro commercial paper program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EuroCommercialPaperProgramMember" xlink:href="gsk-20241231.xsd#gsk_EuroCommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EuroCommercialPaperProgramMember" xlink:to="lab_gsk_EuroCommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncome_00111566-ba97-4fc6-abd8-36ff6729c903_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax expense (income)</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_3aff8858-549f-4e42-89f4-33e29357f943_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15 cent depreciation of the US Dollar</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Depreciation Of US Dollar [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Depreciation Of US Dollar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" xlink:to="lab_gsk_CurrencyRiskFifteenCentDepreciationOfUsDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_540b6a38-bd5f-42dd-8f51-66020fecd759_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_label_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress" xlink:to="lab_dei_ContactPersonnelEmailAddress" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfRightOfUseAssetsLineItems_96989aac-cb3c-48b1-a7ed-ffc715506707_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfRightOfUseAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Right Of Use Assets [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfRightOfUseAssetsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfRightOfUseAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Right Of Use Assets [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfRightOfUseAssetsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfRightOfUseAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRightOfUseAssetsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRightOfUseAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsLineItems" xlink:to="lab_gsk_DisclosureOfRightOfUseAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PutOptionPayable_b53aa345-1b33-4768-aa18-86b842a20308_terseLabel_en-US" xlink:label="lab_gsk_PutOptionPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare put option</link:label>
    <link:label id="lab_gsk_PutOptionPayable_label_en-US" xlink:label="lab_gsk_PutOptionPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Put Option payable</link:label>
    <link:label id="lab_gsk_PutOptionPayable_documentation_en-US" xlink:label="lab_gsk_PutOptionPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Put option payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PutOptionPayable" xlink:href="gsk-20241231.xsd#gsk_PutOptionPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PutOptionPayable" xlink:to="lab_gsk_PutOptionPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_9be7c8b5-a609-4c1b-ab0a-39273dbd51fd_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net operating cash flows attributable to discontinued operations</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities, discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentsDomain_90c4b3c1-ebaf-4d3e-bef6-bd5008d4a647_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_ifrs-full_SegmentsDomain_label_en-US" xlink:label="lab_ifrs-full_SegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsDomain" xlink:to="lab_ifrs-full_SegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_2d34b040-6b3e-42e2-be6f-06e879d98468_negatedLabel_en-US" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank borrowings, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseInAnnualPensionCost_d65366a4-4bcc-474d-9671-c661b7b95ff8_terseLabel_en-US" xlink:label="lab_gsk_DecreaseInAnnualPensionCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in annual pension cost</link:label>
    <link:label id="lab_gsk_DecreaseInAnnualPensionCost_label_en-US" xlink:label="lab_gsk_DecreaseInAnnualPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Annual Pension Cost</link:label>
    <link:label id="lab_gsk_DecreaseInAnnualPensionCost_documentation_en-US" xlink:label="lab_gsk_DecreaseInAnnualPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease in annual pension cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInAnnualPensionCost" xlink:href="gsk-20241231.xsd#gsk_DecreaseInAnnualPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseInAnnualPensionCost" xlink:to="lab_gsk_DecreaseInAnnualPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_c039a4b3-770b-4bef-b058-9c2477dcd8b7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_41bae4fa-3a61-43d0-9ff2-091cf18e5690_terseLabel_en-US" xlink:label="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Treasury and Treasury repo only money market funds</link:label>
    <link:label id="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_label_en-US" xlink:label="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury And Treasury Repo Only Money Market Funds</link:label>
    <link:label id="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds_documentation_en-US" xlink:label="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Us treasury and treasury repo only money market funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" xlink:href="gsk-20241231.xsd#gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" xlink:to="lab_gsk_UsTreasuryAndTreasuryRepoOnlyMoneyMarketFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesOtherMember_c84cd6c0-56fd-4362-89f3-02c09bfe6245_terseLabel_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business disposals - other</link:label>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesOtherMember_label_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total For All Business Divestures, Other [Member]</link:label>
    <link:label id="lab_gsk_TotalForAllBusinessDivesturesOtherMember_documentation_en-US" xlink:label="lab_gsk_TotalForAllBusinessDivesturesOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total For All Business Divestures, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TotalForAllBusinessDivesturesOtherMember" xlink:href="gsk-20241231.xsd#gsk_TotalForAllBusinessDivesturesOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TotalForAllBusinessDivesturesOtherMember" xlink:to="lab_gsk_TotalForAllBusinessDivesturesOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_7ebcc91e-89b1-4b3a-bb22-5a9b45747ff6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Loss Allowance</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of allowance for credit losses [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_4f62b683-a050-490f-8f6a-29203e570fef_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherAccruals_1b85e691-3f51-4a0e-a80e-225bb12b247e_terseLabel_en-US" xlink:label="lab_gsk_OtherAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accruals</link:label>
    <link:label id="lab_gsk_OtherAccruals_label_en-US" xlink:label="lab_gsk_OtherAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accruals</link:label>
    <link:label id="lab_gsk_OtherAccruals_documentation_en-US" xlink:label="lab_gsk_OtherAccruals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other accruals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAccruals" xlink:href="gsk-20241231.xsd#gsk_OtherAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherAccruals" xlink:to="lab_gsk_OtherAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about unconsolidated structured entities controlled by investment entity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityAbstract" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_8a564347-935d-4d05-b3cc-96388c0cec19_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_c3690337-dd0e-4a08-9de6-6201e1944b5c_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_25d27615-1369-4a03-ab49-eb111e986b89_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities" xlink:to="lab_ifrs-full_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_56c7f1af-db7d-47e7-a760-941154b67442_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions and disposals</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of business combinations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentReceivables_8afb01a7-7c42-4355-be6b-983a56885173_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentReceivables_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock_945e7843-dbb4-4b71-b4e6-ebebb5d04aef_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Cost of Share-based Incentive Plans</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Detailed Information about Share Based Payment Arrangements Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based payment arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutShareBasedPaymentArrangementsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes_582b7915-238f-4f4d-8c48-964f544f2f72_terseLabel_en-US" xlink:label="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes_label_en-US" xlink:label="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Value Of Shares Held For Share Award Schemes</link:label>
    <link:label id="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes_documentation_en-US" xlink:label="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value of shares held for share award schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfSharesHeldForShareAwardSchemes" xlink:href="gsk-20241231.xsd#gsk_CarryingValueOfSharesHeldForShareAwardSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarryingValueOfSharesHeldForShareAwardSchemes" xlink:to="lab_gsk_CarryingValueOfSharesHeldForShareAwardSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LossContingencyDamageAwardedValue_be87d850-637a-42d5-900b-fdb857b3e06d_terseLabel_en-US" xlink:label="lab_gsk_LossContingencyDamageAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency, damages awarded, value</link:label>
    <link:label id="lab_gsk_LossContingencyDamageAwardedValue_label_en-US" xlink:label="lab_gsk_LossContingencyDamageAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Damage Awarded, Value</link:label>
    <link:label id="lab_gsk_LossContingencyDamageAwardedValue_documentation_en-US" xlink:label="lab_gsk_LossContingencyDamageAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Damage Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingencyDamageAwardedValue" xlink:href="gsk-20241231.xsd#gsk_LossContingencyDamageAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LossContingencyDamageAwardedValue" xlink:to="lab_gsk_LossContingencyDamageAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember_c5bb129e-2617-4c04-a9a9-27fb11d89773_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, designated upon initial recognition or subsequently, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_13d7c1dc-a6be-4246-8993-41231a6df443_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Changes In Assumptions Used on Benefit Obligations, Defined Benefit Pension and Post Retirement Costs</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_7af6eeec-e081-4366-97bc-6587d1301ac2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Changes in Goodwill</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_a7a2d147-fbb2-4ed4-8837-0aa8a4b721de_negatedLabel_en-US" xlink:label="lab_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Tax on share-based incentive plans</link:label>
    <link:label id="lab_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_label_en-US" xlink:label="lab_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) through tax on share-based payment transactions, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" xlink:to="lab_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CoregMember_034bbd1b-954c-4d2f-b63a-ec4be17c4f21_terseLabel_en-US" xlink:label="lab_gsk_CoregMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Coreq</link:label>
    <link:label id="lab_gsk_CoregMember_label_en-US" xlink:label="lab_gsk_CoregMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Coreg [Member]</link:label>
    <link:label id="lab_gsk_CoregMember_documentation_en-US" xlink:label="lab_gsk_CoregMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Coreg</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CoregMember" xlink:href="gsk-20241231.xsd#gsk_CoregMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CoregMember" xlink:to="lab_gsk_CoregMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestRateSwapContractMember_b6ee644b-a6cf-4792-a584-bc9e836f6f44_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestRateSwapContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward starting interest rate swaps</link:label>
    <link:label id="lab_ifrs-full_InterestRateSwapContractMember_label_en-US" xlink:label="lab_ifrs-full_InterestRateSwapContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest rate swap contract [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateSwapContractMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateSwapContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestRateSwapContractMember" xlink:to="lab_ifrs-full_InterestRateSwapContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations_03d5f08c-d032-4f15-9c41-19c54ac08e30_terseLabel_en-US" xlink:label="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Continuing Operations</link:label>
    <link:label id="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations_label_en-US" xlink:label="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Number Of Employees From Continuing Operations</link:label>
    <link:label id="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations_documentation_en-US" xlink:label="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average number of employees from continuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageNumberOfEmployeesFromContinuingOperations" xlink:href="gsk-20241231.xsd#gsk_AverageNumberOfEmployeesFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AverageNumberOfEmployeesFromContinuingOperations" xlink:to="lab_gsk_AverageNumberOfEmployeesFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember_8e9a018a-5569-4264-86e7-f687f4d107c6_terseLabel_en-US" xlink:label="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare UK (No.3) Limited</link:label>
    <link:label id="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember_label_en-US" xlink:label="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ViiV Healthcare United Kingdom No.3 Limited [Member]</link:label>
    <link:label id="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember_documentation_en-US" xlink:label="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ViiV healthcare united kingdom no.3 limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" xlink:to="lab_gsk_ViivHealthcareUnitedKingdomNo.3LimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PaymentsMadeForTransactionCostsAndOther_4031e938-cdee-45ce-8d7e-c9caf9487257_terseLabel_en-US" xlink:label="lab_gsk_PaymentsMadeForTransactionCostsAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments made for transaction costs and other</link:label>
    <link:label id="lab_gsk_PaymentsMadeForTransactionCostsAndOther_label_en-US" xlink:label="lab_gsk_PaymentsMadeForTransactionCostsAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Made For Transaction Costs And Other</link:label>
    <link:label id="lab_gsk_PaymentsMadeForTransactionCostsAndOther_documentation_en-US" xlink:label="lab_gsk_PaymentsMadeForTransactionCostsAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transaction costs and other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PaymentsMadeForTransactionCostsAndOther" xlink:href="gsk-20241231.xsd#gsk_PaymentsMadeForTransactionCostsAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PaymentsMadeForTransactionCostsAndOther" xlink:to="lab_gsk_PaymentsMadeForTransactionCostsAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReservesWithinEquityTable_c6b153ee-c293-4e9e-b721-c904f2224866_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReservesWithinEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reserves within equity [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReservesWithinEquityTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReservesWithinEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reserves within equity [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityTable" xlink:to="lab_ifrs-full_DisclosureOfReservesWithinEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GeneralMedicinesMember_5bbf5cdf-9085-46bb-92e0-f6e4722d9bd7_terseLabel_en-US" xlink:label="lab_gsk_GeneralMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General Medicines</link:label>
    <link:label id="lab_gsk_GeneralMedicinesMember_label_en-US" xlink:label="lab_gsk_GeneralMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General Medicines [Member]</link:label>
    <link:label id="lab_gsk_GeneralMedicinesMember_documentation_en-US" xlink:label="lab_gsk_GeneralMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">General Medicines Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GeneralMedicinesMember" xlink:href="gsk-20241231.xsd#gsk_GeneralMedicinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GeneralMedicinesMember" xlink:to="lab_gsk_GeneralMedicinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativesMember_bb6d9887-6b6f-4280-a308-e889788a0202_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_ifrs-full_DerivativesMember_label_en-US" xlink:label="lab_ifrs-full_DerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativesMember" xlink:to="lab_ifrs-full_DerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_1ed793d7-5e80-48c4-940e-8607d8ae8a9b_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Expected Useful Lives of Property Plant and Equipment</link:label>
    <link:label id="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Estimated Useful Lives Of Property Plant And Equipment Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of estimated useful lives of property plant and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_c507d86b-78d1-41ae-86e1-73b89aafc5da_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New accounting requirements</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_5a3c4443-7a16-4ab9-b448-37dbc4fe044b_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net financial assets/(liabilities), liabilities</link:label>
    <link:label id="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition_label_en-US" xlink:label="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements in statement of financial position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:to="lab_ifrs-full_NetFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreementsInStatementOfFinancialPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_7b630c23-a825-4ff7-91bf-9a236c4bf1cc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movements in equity</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reserves within equity [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LegalProceedingsProvisionAbstract_label_en-US" xlink:label="lab_ifrs-full_LegalProceedingsProvisionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal proceedings provision [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalProceedingsProvisionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvisionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsProvisionAbstract" xlink:to="lab_ifrs-full_LegalProceedingsProvisionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_77de6693-36d5-4dc0-afd8-16c42d87d3ba_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental payments due after five years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_00aca6d7-1516-4dba-813a-43777dc3763e_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets and liabilities not classified as held for sale</link:label>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_label_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities not classified as held for sale [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AuditorsRemunerationForOtherAssuranceServices_e88859e3-1064-4d95-8123-549e119e2898_terseLabel_en-US" xlink:label="lab_gsk_AuditorsRemunerationForOtherAssuranceServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Audit-related and other assurance services</link:label>
    <link:label id="lab_gsk_AuditorsRemunerationForOtherAssuranceServices_label_en-US" xlink:label="lab_gsk_AuditorsRemunerationForOtherAssuranceServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditors Remuneration For Other Assurance Services</link:label>
    <link:label id="lab_gsk_AuditorsRemunerationForOtherAssuranceServices_documentation_en-US" xlink:label="lab_gsk_AuditorsRemunerationForOtherAssuranceServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditor's remuneration for other assurance services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditorsRemunerationForOtherAssuranceServices" xlink:href="gsk-20241231.xsd#gsk_AuditorsRemunerationForOtherAssuranceServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AuditorsRemunerationForOtherAssuranceServices" xlink:to="lab_gsk_AuditorsRemunerationForOtherAssuranceServices" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_46d0ae1d-29a5-4305-a65e-8ee25a9cf3c7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfExternalCreditExposuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of external credit grades [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfExternalCreditExposuresLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfExternalCreditExposuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of external credit grades [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExternalCreditExposuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfExternalCreditExposuresLineItems" xlink:to="lab_ifrs-full_DisclosureOfExternalCreditExposuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TitleOfEachClassAxis_a31e39df-3b40-4abf-8a8d-bd45905332e4_terseLabel_en-US" xlink:label="lab_gsk_TitleOfEachClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title Of Each Class [Axis]</link:label>
    <link:label id="lab_gsk_TitleOfEachClassAxis_label_en-US" xlink:label="lab_gsk_TitleOfEachClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title Of Each Class [Axis]</link:label>
    <link:label id="lab_gsk_TitleOfEachClassAxis_documentation_en-US" xlink:label="lab_gsk_TitleOfEachClassAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Title of Each Class.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfEachClassAxis" xlink:href="gsk-20241231.xsd#gsk_TitleOfEachClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TitleOfEachClassAxis" xlink:to="lab_gsk_TitleOfEachClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherCostsCashSettlement_7cc83145-e041-4465-a7a1-3a5360acd58e_terseLabel_en-US" xlink:label="lab_gsk_OtherCostsCashSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other cash costs</link:label>
    <link:label id="lab_gsk_OtherCostsCashSettlement_label_en-US" xlink:label="lab_gsk_OtherCostsCashSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Costs Cash Settlement</link:label>
    <link:label id="lab_gsk_OtherCostsCashSettlement_documentation_en-US" xlink:label="lab_gsk_OtherCostsCashSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other costs cash settlement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCostsCashSettlement" xlink:href="gsk-20241231.xsd#gsk_OtherCostsCashSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherCostsCashSettlement" xlink:to="lab_gsk_OtherCostsCashSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisposalsAndSettlementsOtherInvestments_30facadf-8a98-4f90-81be-0f2a6bbab8de_negatedLabel_en-US" xlink:label="lab_gsk_DisposalsAndSettlementsOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_gsk_DisposalsAndSettlementsOtherInvestments_label_en-US" xlink:label="lab_gsk_DisposalsAndSettlementsOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals And Settlements Other Investments</link:label>
    <link:label id="lab_gsk_DisposalsAndSettlementsOtherInvestments_documentation_en-US" xlink:label="lab_gsk_DisposalsAndSettlementsOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposals and settlements other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalsAndSettlementsOtherInvestments" xlink:href="gsk-20241231.xsd#gsk_DisposalsAndSettlementsOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisposalsAndSettlementsOtherInvestments" xlink:to="lab_gsk_DisposalsAndSettlementsOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RestOfWorldMember_6d71b047-24f5-44fa-9b23-c15e5dea506b_terseLabel_en-US" xlink:label="lab_gsk_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_gsk_RestOfWorldMember_label_en-US" xlink:label="lab_gsk_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_gsk_RestOfWorldMember_documentation_en-US" xlink:label="lab_gsk_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rest of world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestOfWorldMember" xlink:href="gsk-20241231.xsd#gsk_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RestOfWorldMember" xlink:to="lab_gsk_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskShareholdersMember_fc95073d-7c85-41d3-b449-84ffc0f6aa75_terseLabel_en-US" xlink:label="lab_gsk_GskShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Shareholders</link:label>
    <link:label id="lab_gsk_GskShareholdersMember_label_en-US" xlink:label="lab_gsk_GskShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Shareholders [Member]</link:label>
    <link:label id="lab_gsk_GskShareholdersMember_documentation_en-US" xlink:label="lab_gsk_GskShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK shareholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskShareholdersMember" xlink:href="gsk-20241231.xsd#gsk_GskShareholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskShareholdersMember" xlink:to="lab_gsk_GskShareholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_32aa0b61-db36-45eb-9cbb-c1a16c01ba5a_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfChangeInTaxRate_6048487b-9df9-41c0-bb0c-c55e12865c90_verboseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfChangeInTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in tax rates (in percent)</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfChangeInTaxRate_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfChangeInTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect Of Change In Tax Rate</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfChangeInTaxRate_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfChangeInTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax rate effect of change in tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfChangeInTaxRate" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfChangeInTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfChangeInTaxRate" xlink:to="lab_gsk_TaxRateEffectOfChangeInTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_61b9b6ce-d060-41c5-ab6a-e972b2d9f2aa_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProvisionsForUncertainTaxPosition_36e7c3a2-53f9-4ac6-b476-53192ba460e4_terseLabel_en-US" xlink:label="lab_gsk_ProvisionsForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for uncertain tax position</link:label>
    <link:label id="lab_gsk_ProvisionsForUncertainTaxPosition_label_en-US" xlink:label="lab_gsk_ProvisionsForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions For Uncertain Tax Position</link:label>
    <link:label id="lab_gsk_ProvisionsForUncertainTaxPosition_documentation_en-US" xlink:label="lab_gsk_ProvisionsForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provisions for uncertain tax position.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProvisionsForUncertainTaxPosition" xlink:href="gsk-20241231.xsd#gsk_ProvisionsForUncertainTaxPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProvisionsForUncertainTaxPosition" xlink:to="lab_gsk_ProvisionsForUncertainTaxPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_1a3420d2-819e-469c-8cef-572598ca23bd_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FinancialInstrumentsMember_ee7eb672-7192-47f0-ae95-0e350bf4db47_terseLabel_en-US" xlink:label="lab_gsk_FinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments</link:label>
    <link:label id="lab_gsk_FinancialInstrumentsMember_label_en-US" xlink:label="lab_gsk_FinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [member]</link:label>
    <link:label id="lab_gsk_FinancialInstrumentsMember_documentation_en-US" xlink:label="lab_gsk_FinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Instruments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialInstrumentsMember" xlink:href="gsk-20241231.xsd#gsk_FinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FinancialInstrumentsMember" xlink:to="lab_gsk_FinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentReceivables_301d74e5-bfe4-4115-93ec-f3ef0bcc5774_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentReceivables_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables" xlink:to="lab_ifrs-full_OtherNoncurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill_38822199-dcf3-4a9e-ab4c-024b21d33661_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfer to assets held for sale/distribution</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Classified As Held For Sale or Distribution Intangible Assets Other Than Goodwill</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease through classified as held for sale or distribution intangible assets other than goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" xlink:to="lab_gsk_IncreaseDecreaseThroughClassifiedAsHeldForSaleOrDistributionIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember_f911c0f1-87b8-40e7-896f-e116748623b4_terseLabel_en-US" xlink:label="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investments measured at fair value through profit or loss</link:label>
    <link:label id="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember_label_en-US" xlink:label="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Investments Measured At Fair Value Through Profit Or Loss [Member]</link:label>
    <link:label id="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember_documentation_en-US" xlink:label="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Investments Measured At Fair Value Through Profit Or Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:href="gsk-20241231.xsd#gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:to="lab_gsk_EquityInvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock_6959108f-f982-4102-b938-8a3a54e1e57d_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Average Monthly Number of Persons Employed by the Group (Including Directors)</link:label>
    <link:label id="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Number Of Employees [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of number of employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNumberOfEmployeesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNumberOfEmployeesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfNumberOfEmployeesTableTextBlock" xlink:to="lab_gsk_DisclosureOfNumberOfEmployeesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointOperationsDomain_287dabfd-08a6-4c5b-885f-7ef3e0ae7007_terseLabel_en-US" xlink:label="lab_ifrs-full_JointOperationsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint operations</link:label>
    <link:label id="lab_ifrs-full_JointOperationsDomain_label_en-US" xlink:label="lab_ifrs-full_JointOperationsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint operations [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointOperationsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointOperationsDomain" xlink:to="lab_ifrs-full_JointOperationsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InventoryWritedown2011_4b151217-fdbd-477c-9a88-79130eb006d2_terseLabel_en-US" xlink:label="lab_ifrs-full_InventoryWritedown2011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-down of inventories</link:label>
    <link:label id="lab_ifrs-full_InventoryWritedown2011_label_en-US" xlink:label="lab_ifrs-full_InventoryWritedown2011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoryWritedown2011" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryWritedown2011"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011" xlink:to="lab_ifrs-full_InventoryWritedown2011" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PlanAssetsMember_e652002d-56ca-4c73-9d66-a60da06b5747_terseLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan assets</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsMember_label_en-US" xlink:label="lab_ifrs-full_PlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PlanAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsMember" xlink:to="lab_ifrs-full_PlanAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Cash_b2792d91-6420-433f-83ba-93cbc21c8f58_terseLabel_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash at bank and in hand</link:label>
    <link:label id="lab_ifrs-full_Cash_label_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash" xlink:to="lab_ifrs-full_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_187fc52f-04cc-478e-a060-d30737bfaa9a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FixedInterestRateMember_01472b97-803c-48d9-9fa9-406eceda5dba_terseLabel_en-US" xlink:label="lab_ifrs-full_FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed rate interest</link:label>
    <link:label id="lab_ifrs-full_FixedInterestRateMember_label_en-US" xlink:label="lab_ifrs-full_FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixed interest rate [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixedInterestRateMember" xlink:to="lab_ifrs-full_FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DerivativeFinancialAssetsMember_fc93c448-4c1e-4ede-8a4d-e25862e8ed50_terseLabel_en-US" xlink:label="lab_gsk_DerivativeFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_gsk_DerivativeFinancialAssetsMember_label_en-US" xlink:label="lab_gsk_DerivativeFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Financial Assets [member]</link:label>
    <link:label id="lab_gsk_DerivativeFinancialAssetsMember_documentation_en-US" xlink:label="lab_gsk_DerivativeFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative financial assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativeFinancialAssetsMember" xlink:href="gsk-20241231.xsd#gsk_DerivativeFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DerivativeFinancialAssetsMember" xlink:to="lab_gsk_DerivativeFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExternalCreditGradesAxis_5bf104eb-65f7-44b1-a440-874d4d43aeed_terseLabel_en-US" xlink:label="lab_ifrs-full_ExternalCreditGradesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">External credit grades [axis]</link:label>
    <link:label id="lab_ifrs-full_ExternalCreditGradesAxis_label_en-US" xlink:label="lab_ifrs-full_ExternalCreditGradesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">External credit grades [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExternalCreditGradesAxis" xlink:to="lab_ifrs-full_ExternalCreditGradesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3ad29efe-6124-4140-a5ff-5cf137b23493_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RevenueFromCoPromotionalActivities_f475a487-3f94-4013-8b01-2a2cf07ee3ca_terseLabel_en-US" xlink:label="lab_gsk_RevenueFromCoPromotionalActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from co-promotional activities</link:label>
    <link:label id="lab_gsk_RevenueFromCoPromotionalActivities_label_en-US" xlink:label="lab_gsk_RevenueFromCoPromotionalActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue From Co Promotional Activities</link:label>
    <link:label id="lab_gsk_RevenueFromCoPromotionalActivities_documentation_en-US" xlink:label="lab_gsk_RevenueFromCoPromotionalActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from co-promotional activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevenueFromCoPromotionalActivities" xlink:href="gsk-20241231.xsd#gsk_RevenueFromCoPromotionalActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RevenueFromCoPromotionalActivities" xlink:to="lab_gsk_RevenueFromCoPromotionalActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPanelMembersAtRehearing_d3235179-aeac-4bc9-84fa-b12bbb0e4e96_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPanelMembersAtRehearing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of panel members at rehearing</link:label>
    <link:label id="lab_gsk_NumberOfPanelMembersAtRehearing_label_en-US" xlink:label="lab_gsk_NumberOfPanelMembersAtRehearing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Panel Members At Rehearing</link:label>
    <link:label id="lab_gsk_NumberOfPanelMembersAtRehearing_documentation_en-US" xlink:label="lab_gsk_NumberOfPanelMembersAtRehearing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Panel Members At Rehearing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPanelMembersAtRehearing" xlink:href="gsk-20241231.xsd#gsk_NumberOfPanelMembersAtRehearing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPanelMembersAtRehearing" xlink:to="lab_gsk_NumberOfPanelMembersAtRehearing" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherReceivables_dc08e680-9ae9-4960-9255-b150e3aa475c_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_ifrs-full_OtherReceivables_label_en-US" xlink:label="lab_ifrs-full_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables" xlink:to="lab_ifrs-full_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments_7861010b-7cad-45c4-9fb2-5339b54bd3c5_terseLabel_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments_label_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligations And Commitments Of Investments</link:label>
    <link:label id="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments_documentation_en-US" xlink:label="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual obligations and commitments of investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContractualObligationsAndCommitmentsOfInvestments" xlink:href="gsk-20241231.xsd#gsk_ContractualObligationsAndCommitmentsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContractualObligationsAndCommitmentsOfInvestments" xlink:to="lab_gsk_ContractualObligationsAndCommitmentsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_a7b56e99-b02f-47f0-8eda-d6e03d02ccb9_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions from non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from contributions of non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:to="lab_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SierraOncologyMember_4be40275-14e6-4135-8435-e64501a8df0c_terseLabel_en-US" xlink:label="lab_gsk_SierraOncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sierra Oncology</link:label>
    <link:label id="lab_gsk_SierraOncologyMember_label_en-US" xlink:label="lab_gsk_SierraOncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sierra Oncology [Member]</link:label>
    <link:label id="lab_gsk_SierraOncologyMember_documentation_en-US" xlink:label="lab_gsk_SierraOncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sierra Oncology [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SierraOncologyMember" xlink:href="gsk-20241231.xsd#gsk_SierraOncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SierraOncologyMember" xlink:to="lab_gsk_SierraOncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateSensitivityMember_8863cb54-6281-4634-b844-de7633d30f8c_terseLabel_en-US" xlink:label="lab_gsk_InterestRateSensitivityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate sensitivity</link:label>
    <link:label id="lab_gsk_InterestRateSensitivityMember_label_en-US" xlink:label="lab_gsk_InterestRateSensitivityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Sensitivity [Member]</link:label>
    <link:label id="lab_gsk_InterestRateSensitivityMember_documentation_en-US" xlink:label="lab_gsk_InterestRateSensitivityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest rate sensitivity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateSensitivityMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateSensitivityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateSensitivityMember" xlink:to="lab_gsk_InterestRateSensitivityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GoodwillMember_a18f9d5d-48d0-468f-877a-bf6a5cf53566_terseLabel_en-US" xlink:label="lab_ifrs-full_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_GoodwillMember_label_en-US" xlink:label="lab_ifrs-full_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillMember" xlink:to="lab_ifrs-full_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_55b02142-e401-45a9-b577-c9f9f13f7389_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_60fced97-55f1-46f4-818c-32db9d3faecd_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="lab_ifrs-full_OtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaximumExposureToCreditRisk_ebb05474-d2f8-48ab-811f-f2baf23dfcda_terseLabel_en-US" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:label id="lab_ifrs-full_MaximumExposureToCreditRisk_label_en-US" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable_7a62455c-f1e3-491a-ae26-a3b1f38729f0_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Trade and Other Receivables [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable_label_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Trade and Other Receivables [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherReceivablesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesTable" xlink:to="lab_gsk_DisclosureOfTradeAndOtherReceivablesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SaudiBritishBankMember_a15311e0-fe79-4872-9577-0dfae2ee5051_terseLabel_en-US" xlink:label="lab_gsk_SaudiBritishBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Saudi British Bank</link:label>
    <link:label id="lab_gsk_SaudiBritishBankMember_label_en-US" xlink:label="lab_gsk_SaudiBritishBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Saudi British Bank [Member]</link:label>
    <link:label id="lab_gsk_SaudiBritishBankMember_documentation_en-US" xlink:label="lab_gsk_SaudiBritishBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Saudi British Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SaudiBritishBankMember" xlink:href="gsk-20241231.xsd#gsk_SaudiBritishBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SaudiBritishBankMember" xlink:to="lab_gsk_SaudiBritishBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContinuingOperationsMember_e0c33ef4-7576-41fa-bf25-8e383b7949c3_terseLabel_en-US" xlink:label="lab_ifrs-full_ContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations, unless line item indicates otherwise</link:label>
    <link:label id="lab_ifrs-full_ContinuingOperationsMember_label_en-US" xlink:label="lab_ifrs-full_ContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing operations, unless line item indicates otherwise [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingOperationsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContinuingOperationsMember" xlink:to="lab_ifrs-full_ContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_1e2822e6-717f-4e20-a42c-1e961bff31a4_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SGD</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementExplanatory_bfdb59ca-b153-4cac-9822-a663db95ffbd_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement [text block]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_afdb59e8-0bcb-4198-8343-31ec65d4df74_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension and other post-employment costs</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, post-employment benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaterialReconcilingItemsMember_95ca1b60-d8e5-4cca-b7cf-b3e210d8c5ad_terseLabel_en-US" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other reconciling items between segment profit and operating profit</link:label>
    <link:label id="lab_ifrs-full_MaterialReconcilingItemsMember_2276b2fc-e904-43a0-9392-42dc8a91f7f4_verboseLabel_en-US" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other reconciling items between segment depreciation and amortisation and total depreciation and&#8232; amortisation</link:label>
    <link:label id="lab_ifrs-full_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material reconciling items [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaterialReconcilingItemsMember" xlink:to="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisabledEmployeesMember_a140d0fe-c70b-4f6a-bee1-a278108abe45_terseLabel_en-US" xlink:label="lab_gsk_DisabledEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disabled employees</link:label>
    <link:label id="lab_gsk_DisabledEmployeesMember_label_en-US" xlink:label="lab_gsk_DisabledEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disabled Employees [member]</link:label>
    <link:label id="lab_gsk_DisabledEmployeesMember_documentation_en-US" xlink:label="lab_gsk_DisabledEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disabled employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisabledEmployeesMember" xlink:href="gsk-20241231.xsd#gsk_DisabledEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisabledEmployeesMember" xlink:to="lab_gsk_DisabledEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarnings_33bed218-3033-4119-8965-7aed99da3949_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_ifrs-full_RetainedEarnings_label_en-US" xlink:label="lab_ifrs-full_RetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings" xlink:to="lab_ifrs-full_RetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_a9280ef6-e38c-490d-8078-3d3e97b391f3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Intangible Assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock_3dab4c4a-eeaa-4868-b84d-3d3751659f78_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current equity investments</link:label>
    <link:label id="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Current Equity Investments [Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of current equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfCurrentEquityInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" xlink:to="lab_gsk_DisclosureOfCurrentEquityInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember_06aa9b0b-2170-49a0-a7ac-b17733361fe4_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss that meet definition of held for trading, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable_1135760e-4190-4357-b78a-cf074f919135_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Information About Maturity Profile of Defined Benefit Obligation [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable_label_en-US" xlink:label="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Information About Maturity Profile of Defined Benefit Obligation [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of information about maturity profile of defined benefit obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" xlink:to="lab_gsk_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_31b6dc2f-4bdd-4071-ab92-c1540cc1ac1f_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FlagshipPioneeringMember_05c7799f-b559-4f51-bbe1-99d0019c9714_terseLabel_en-US" xlink:label="lab_gsk_FlagshipPioneeringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Flagship Pioneering</link:label>
    <link:label id="lab_gsk_FlagshipPioneeringMember_label_en-US" xlink:label="lab_gsk_FlagshipPioneeringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Flagship Pioneering [Member]</link:label>
    <link:label id="lab_gsk_FlagshipPioneeringMember_documentation_en-US" xlink:label="lab_gsk_FlagshipPioneeringMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Flagship Pioneering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FlagshipPioneeringMember" xlink:href="gsk-20241231.xsd#gsk_FlagshipPioneeringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FlagshipPioneeringMember" xlink:to="lab_gsk_FlagshipPioneeringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_3d013e29-a0c9-40c3-88fc-43c9c9b13fe8_terseLabel_en-US" xlink:label="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated and effective as hedging instruments (fair value movements through other comprehensive income)</link:label>
    <link:label id="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_16d43fc9-87fe-43bc-903f-0c624de76c27_verboseLabel_en-US" xlink:label="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated and effective as hedging instruments (fair value movements through OCI)</link:label>
    <link:label id="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_label_en-US" xlink:label="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives Designated And Effective As Hedging Instruments [Member]</link:label>
    <link:label id="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember_documentation_en-US" xlink:label="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivatives designated and effective as hedging instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:href="gsk-20241231.xsd#gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:to="lab_gsk_DerivativesDesignatedAndEffectiveAsHedgingInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset_fe69b72d-9d89-459f-b3c8-a16381d8701a_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions to plan, net defined benefit liability (asset)</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssets_6fbf2569-38bc-4ba0-bfcf-19b41095350c_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_3a359173-4528-44fb-8052-f7eb7388ed97_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">At 1 January</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_5cab0f3d-e491-49e7-92a4-466af47728c3_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">At 31 December</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_b4fed670-6d35-404c-b772-802390812615_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_feeeab75-d826-4ac3-8a8c-7c625a3a6a0e_totalLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_label_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets" xlink:to="lab_ifrs-full_FinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_8b88151a-a175-4fbe-bf25-e692fdd4f3a2_verboseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_8752c772-d952-4d8a-966b-7b8228162aa1_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapital_ca191ffd-1e73-40bc-8d27-cc3bec98610f_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_IssuedCapital_label_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations_c4bc82f4-e009-41d8-b4a3-d3216c2c0641_verboseLabel_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of exchange movements on liquidation or disposal of overseas subsidiaries and associates</link:label>
    <link:label id="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations_label_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment of Net Exchange Differences on Disposal of Foreign Operations</link:label>
    <link:label id="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations_documentation_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment of Net Exchange Differences on Disposal of Foreign Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" xlink:to="lab_gsk_ReclassificationAdjustmentOfNetExchangeDifferencesOnDisposalOfForeignOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_Wholesalers1Member_32424219-98d0-446b-8976-ac8430a31be6_terseLabel_en-US" xlink:label="lab_gsk_Wholesalers1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wholesalers 1</link:label>
    <link:label id="lab_gsk_Wholesalers1Member_label_en-US" xlink:label="lab_gsk_Wholesalers1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholesalers 1 [member]</link:label>
    <link:label id="lab_gsk_Wholesalers1Member_documentation_en-US" xlink:label="lab_gsk_Wholesalers1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wholesalers 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Wholesalers1Member" xlink:href="gsk-20241231.xsd#gsk_Wholesalers1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_Wholesalers1Member" xlink:to="lab_gsk_Wholesalers1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract_1cdb9cb1-5fd2-4042-80e4-f186a4b8a802_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income for the year attributable to:</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income attributable to [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_76b8f16a-3c0e-4373-ab77-6130dbde0d0a_totalLabel_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted, (in shares)</link:label>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherCommercialPaperMember_044603c6-d75f-4fa7-bb57-8ed16f828925_terseLabel_en-US" xlink:label="lab_gsk_OtherCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8211; other commercial paper</link:label>
    <link:label id="lab_gsk_OtherCommercialPaperMember_label_en-US" xlink:label="lab_gsk_OtherCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commercial Paper [Member]</link:label>
    <link:label id="lab_gsk_OtherCommercialPaperMember_documentation_en-US" xlink:label="lab_gsk_OtherCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other commercial paper.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherCommercialPaperMember" xlink:href="gsk-20241231.xsd#gsk_OtherCommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherCommercialPaperMember" xlink:to="lab_gsk_OtherCommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfNonControllingInterestsLineItems_e757942c-8a8e-4489-a30e-5e00fdc5cfff_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Non-controlling Interests [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfNonControllingInterestsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Non-controlling Interests [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfNonControllingInterestsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of Non-controlling Interests [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNonControllingInterestsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNonControllingInterestsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfNonControllingInterestsLineItems" xlink:to="lab_gsk_DisclosureOfNonControllingInterestsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock_a5f58462-0933-4134-8018-c664966848ee_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Major Restructuring Charges From Continuing Operations</link:label>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Restructuring Costs Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of Major Restructuring Charges from continuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfRestructuringCostsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseInAnnualPensionCost_f641ae06-bd7a-4e95-90c9-f46019fc6033_terseLabel_en-US" xlink:label="lab_gsk_IncreaseInAnnualPensionCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in annual pension cost</link:label>
    <link:label id="lab_gsk_IncreaseInAnnualPensionCost_label_en-US" xlink:label="lab_gsk_IncreaseInAnnualPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase In Annual Pension Cost</link:label>
    <link:label id="lab_gsk_IncreaseInAnnualPensionCost_documentation_en-US" xlink:label="lab_gsk_IncreaseInAnnualPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase in annual pension cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInAnnualPensionCost" xlink:href="gsk-20241231.xsd#gsk_IncreaseInAnnualPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseInAnnualPensionCost" xlink:to="lab_gsk_IncreaseInAnnualPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NominalAmountOfHedgingInstrument_63128457-75e4-4ada-8ba4-4bb6baddf018_terseLabel_en-US" xlink:label="lab_ifrs-full_NominalAmountOfHedgingInstrument" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional value</link:label>
    <link:label id="lab_ifrs-full_NominalAmountOfHedgingInstrument_7c4240b2-9686-4883-a22c-61c0c9fe2bcb_verboseLabel_en-US" xlink:label="lab_ifrs-full_NominalAmountOfHedgingInstrument" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notional value</link:label>
    <link:label id="lab_ifrs-full_NominalAmountOfHedgingInstrument_label_en-US" xlink:label="lab_ifrs-full_NominalAmountOfHedgingInstrument" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nominal amount of hedging instrument</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NominalAmountOfHedgingInstrument" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NominalAmountOfHedgingInstrument"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NominalAmountOfHedgingInstrument" xlink:to="lab_ifrs-full_NominalAmountOfHedgingInstrument" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EmployeeRelatedProvisionsMember_9f235d44-0d54-4176-8cbd-2f11859bd518_terseLabel_en-US" xlink:label="lab_gsk_EmployeeRelatedProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related provisions</link:label>
    <link:label id="lab_gsk_EmployeeRelatedProvisionsMember_label_en-US" xlink:label="lab_gsk_EmployeeRelatedProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Related Provisions [member]</link:label>
    <link:label id="lab_gsk_EmployeeRelatedProvisionsMember_documentation_en-US" xlink:label="lab_gsk_EmployeeRelatedProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee related provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeRelatedProvisionsMember" xlink:href="gsk-20241231.xsd#gsk_EmployeeRelatedProvisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EmployeeRelatedProvisionsMember" xlink:to="lab_gsk_EmployeeRelatedProvisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember_7a01bec1-5b3b-460b-b355-daf93f7f09f7_terseLabel_en-US" xlink:label="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments measured at FVTPL</link:label>
    <link:label id="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember_label_en-US" xlink:label="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Equity Investments Measured As FVTPL [Member]</link:label>
    <link:label id="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember_documentation_en-US" xlink:label="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current equity investments measured as FVTPL.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" xlink:href="gsk-20241231.xsd#gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" xlink:to="lab_gsk_CurrentEquityInvestmentsMeasuredAsFVTPLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_b3cf70e1-fd38-4ca7-9828-31bad69b9212_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charge for the year</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_8a8290a1-8a54-4fdc-8afa-338ffbc3c644_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock_09ec670f-11b1-40f3-8b7f-7c0627433bb1_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movement in Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of movement in deferred tax assets and liabilities explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of movement in deferred tax assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme_ed363699-a23f-4c91-9bfe-555c0927cbaf_terseLabel_en-US" xlink:label="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes issued at European medium term note programme</link:label>
    <link:label id="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme_label_en-US" xlink:label="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Issued At European Medium Term Note Programme</link:label>
    <link:label id="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme_documentation_en-US" xlink:label="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes issued at European medium term note programme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" xlink:href="gsk-20241231.xsd#gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" xlink:to="lab_gsk_NotesIssuedAtEuropeanMediumTermNoteProgramme" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKBiopharmaArgentinaS.A.Member_ddc4c4ef-0e07-4129-a231-37dc048e521f_terseLabel_en-US" xlink:label="lab_gsk_GSKBiopharmaArgentinaS.A.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Biopharma Argentina S.A.</link:label>
    <link:label id="lab_gsk_GSKBiopharmaArgentinaS.A.Member_label_en-US" xlink:label="lab_gsk_GSKBiopharmaArgentinaS.A.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Biopharma Argentina S.A. [Member]</link:label>
    <link:label id="lab_gsk_GSKBiopharmaArgentinaS.A.Member_documentation_en-US" xlink:label="lab_gsk_GSKBiopharmaArgentinaS.A.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Biopharma Argentina S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKBiopharmaArgentinaS.A.Member" xlink:href="gsk-20241231.xsd#gsk_GSKBiopharmaArgentinaS.A.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKBiopharmaArgentinaS.A.Member" xlink:to="lab_gsk_GSKBiopharmaArgentinaS.A.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_08863286-142d-49eb-9f07-84b95168f470_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets" xlink:to="lab_ifrs-full_DeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems_05ced8df-e262-49c3-96a9-59a521c9d157_terseLabel_en-US" xlink:label="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement In Deferred Tax Assets And Liabilities [line items]</link:label>
    <link:label id="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems_label_en-US" xlink:label="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement In Deferred Tax Assets And Liabilities [line items]</link:label>
    <link:label id="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems_documentation_en-US" xlink:label="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movement in deferred tax assets and liabilities line items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" xlink:href="gsk-20241231.xsd#gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="lab_gsk_MovementInDeferredTaxAssetsAndLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock_d9f9f440-aa6f-4aae-9a9b-6a1ab4e8f4dd_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of financial instruments with Trade and other receivables and Other non-current assets</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Assets And Non Financial Assets Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Assets And Non Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfFinancialAssetsAndNonFinancialAssetsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_9907395d-4a4e-4699-b489-0cb2cf846abb_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10 cent appreciation of the US Dollar</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Cent Appreciation Of US Dollar [member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency risk 10 cent appreciation of US dollar.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" xlink:to="lab_gsk_CurrencyRiskTenCentAppreciationOfUSDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDebtLineItems_60f6ddb2-b3c2-49fe-861f-789923bbd3d4_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of debt [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDebtLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Debt [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDebtLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDebtLineItems" xlink:to="lab_gsk_DisclosureOfDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsDomain_acc90cbf-e22c-4287-9126-2284cced3ecf_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial assets</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts_f23ae30f-9ccc-4f60-b398-dbe4c9ebabfc_terseLabel_en-US" xlink:label="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Social security costs</link:label>
    <link:label id="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts_label_en-US" xlink:label="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation, Social Security Costs</link:label>
    <link:label id="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts_documentation_en-US" xlink:label="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, social security costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" xlink:href="gsk-20241231.xsd#gsk_KeyManagementPersonnelCompensationSocialSecurityCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" xlink:to="lab_gsk_KeyManagementPersonnelCompensationSocialSecurityCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember_8d124d78-3905-49f6-bf87-30b1d1dd615b_terseLabel_en-US" xlink:label="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pensions &amp; other post employment benefits</link:label>
    <link:label id="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember_label_en-US" xlink:label="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pensions And Other Post-Employment Benefits [Member]</link:label>
    <link:label id="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember_documentation_en-US" xlink:label="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pensions and other post-employment benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember" xlink:href="gsk-20241231.xsd#gsk_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PensionsAndOtherPostEmploymentBenefitsMember" xlink:to="lab_gsk_PensionsAndOtherPostEmploymentBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MomelotinibMember_dbc00529-1658-40dd-8d08-3a4c086ffe58_terseLabel_en-US" xlink:label="lab_gsk_MomelotinibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Momelotinib</link:label>
    <link:label id="lab_gsk_MomelotinibMember_label_en-US" xlink:label="lab_gsk_MomelotinibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Momelotinib [Member]</link:label>
    <link:label id="lab_gsk_MomelotinibMember_documentation_en-US" xlink:label="lab_gsk_MomelotinibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Momelotinib.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MomelotinibMember" xlink:href="gsk-20241231.xsd#gsk_MomelotinibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MomelotinibMember" xlink:to="lab_gsk_MomelotinibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromSaleOfGoods_e9067a26-8170-43ee-9bef-bbce97b55277_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover</link:label>
    <link:label id="lab_ifrs-full_RevenueFromSaleOfGoods_label_en-US" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoods" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateChangeMember_21a35e95-262f-4d35-820a-976abc0a2581_terseLabel_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateChangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial assumption percentage rate change</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateChangeMember_label_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateChangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Percentage Rate Change [Member]</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionPercentageRateChangeMember_documentation_en-US" xlink:label="lab_gsk_ActuarialAssumptionPercentageRateChangeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial assumption percentage rate change.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionPercentageRateChangeMember" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionPercentageRateChangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ActuarialAssumptionPercentageRateChangeMember" xlink:to="lab_gsk_ActuarialAssumptionPercentageRateChangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AmortisableProportionOverExclusivityPeriod_b238822d-0946-47a2-99c1-4373cbd80b06_terseLabel_en-US" xlink:label="lab_gsk_AmortisableProportionOverExclusivityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortisation rate, Intangible assets other than goodwill</link:label>
    <link:label id="lab_gsk_AmortisableProportionOverExclusivityPeriod_label_en-US" xlink:label="lab_gsk_AmortisableProportionOverExclusivityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisable Proportion Over Exclusivity Period</link:label>
    <link:label id="lab_gsk_AmortisableProportionOverExclusivityPeriod_documentation_en-US" xlink:label="lab_gsk_AmortisableProportionOverExclusivityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortisable proportion over exclusivity period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmortisableProportionOverExclusivityPeriod" xlink:href="gsk-20241231.xsd#gsk_AmortisableProportionOverExclusivityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AmortisableProportionOverExclusivityPeriod" xlink:to="lab_gsk_AmortisableProportionOverExclusivityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_c8eec83e-78af-4dc2-b419-abc9125d5cbb_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets at FVTPL</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DerivativeFinancialLiabilitiesMember_42093402-68bb-4798-a8e9-68cc791bf7ba_terseLabel_en-US" xlink:label="lab_gsk_DerivativeFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_gsk_DerivativeFinancialLiabilitiesMember_label_en-US" xlink:label="lab_gsk_DerivativeFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Financial Liabilities [Member]</link:label>
    <link:label id="lab_gsk_DerivativeFinancialLiabilitiesMember_documentation_en-US" xlink:label="lab_gsk_DerivativeFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativeFinancialLiabilitiesMember" xlink:href="gsk-20241231.xsd#gsk_DerivativeFinancialLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DerivativeFinancialLiabilitiesMember" xlink:to="lab_gsk_DerivativeFinancialLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_ede744de-a4c2-49fe-9a77-45b49710fbe7_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Investments in joint ventures and associates</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of interests in investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_913d7b72-de92-4979-8b99-fd2b493644a8_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for trade and other receivables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeDomain_04736396-7a21-4c67-9c92-c2b68ceca943_verboseLabel_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Range [domain]</link:label>
    <link:label id="lab_ifrs-full_RangeDomain_dca990e0-5433-4b45-bcb1-70bc246b1c49_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range</link:label>
    <link:label id="lab_ifrs-full_RangeDomain_label_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeDomain" xlink:to="lab_ifrs-full_RangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock_01110905-2f51-4435-b54a-e0969e2417a3_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Assets Held for Sale</link:label>
    <link:label id="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Assets Held for Sale Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of assets held for sale explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfAssetsHeldForSaleExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_f31e27e3-8868-4c1d-af1c-8dab14b3f0e5_terseLabel_en-US" xlink:label="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of the Consumer Healthcare business distributed (54.5%)</link:label>
    <link:label id="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_label_en-US" xlink:label="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of The Consumer Healthcare Business Distributed</link:label>
    <link:label id="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed_documentation_en-US" xlink:label="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of The Consumer Healthcare Business Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheConsumerHealthcareBusinessDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" xlink:to="lab_gsk_FairValueOfTheConsumerHealthcareBusinessDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember_6353c735-0a30-473d-a797-d04abb92aa09_terseLabel_en-US" xlink:label="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United Bank for Africa, Zenith Bank, Access Bank and Stanbic IBTC Bank</link:label>
    <link:label id="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember_label_en-US" xlink:label="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United Bank for Africa, Zenith Bank, Access Bank and Stanbic IBTC Bank [Member]</link:label>
    <link:label id="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember_documentation_en-US" xlink:label="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">United Bank for Africa, Zenith Bank, Access Bank and Stanbic IBTC Bank.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" xlink:href="gsk-20241231.xsd#gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" xlink:to="lab_gsk_UnitedBankForAfricaZenithBankAccessBankAndStanbicIbtcBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_f14329c9-768e-45b6-b664-f9afb8c1713a_totalLabel_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total basic earnings per share (pence) (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_52b26ccd-a2f5-4fd7-9211-cade0132b715_terseLabel_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total basic earnings per share (pence) (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_label_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember_597a91f4-6201-4681-9f4d-527152f5aead_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10 yen depreciation of the Yen</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Yen depreciation Of Yen [member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency risk ten yen depreciation of yen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenYenDepreciationOfYenMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenYenDepreciationOfYenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskTenYenDepreciationOfYenMember" xlink:to="lab_gsk_CurrencyRiskTenYenDepreciationOfYenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ChangeInFairValueOfNetDebt_3fddbe8d-828c-4475-a4eb-a0873959a8ae_terseLabel_en-US" xlink:label="lab_gsk_ChangeInFairValueOfNetDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_gsk_ChangeInFairValueOfNetDebt_label_en-US" xlink:label="lab_gsk_ChangeInFairValueOfNetDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change In Fair Value Of Net Debt</link:label>
    <link:label id="lab_gsk_ChangeInFairValueOfNetDebt_documentation_en-US" xlink:label="lab_gsk_ChangeInFairValueOfNetDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change in fair value of net debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInFairValueOfNetDebt" xlink:href="gsk-20241231.xsd#gsk_ChangeInFairValueOfNetDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ChangeInFairValueOfNetDebt" xlink:to="lab_gsk_ChangeInFairValueOfNetDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ScottishLimitedPartnershipsMember_6d816809-ae39-431f-a4b6-84153db05bc9_terseLabel_en-US" xlink:label="lab_gsk_ScottishLimitedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scottish Limited Partnerships</link:label>
    <link:label id="lab_gsk_ScottishLimitedPartnershipsMember_label_en-US" xlink:label="lab_gsk_ScottishLimitedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scottish Limited Partnerships [Member]</link:label>
    <link:label id="lab_gsk_ScottishLimitedPartnershipsMember_documentation_en-US" xlink:label="lab_gsk_ScottishLimitedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Scottish limited partnerships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ScottishLimitedPartnershipsMember" xlink:href="gsk-20241231.xsd#gsk_ScottishLimitedPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ScottishLimitedPartnershipsMember" xlink:to="lab_gsk_ScottishLimitedPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3d804c07-8698-48c7-9c0b-bc26bc515ab4_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities_19de010e-221c-48ff-a560-5eb9dd0a6e20_negatedLabel_en-US" xlink:label="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Distributions to non-controlling interests</link:label>
    <link:label id="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distributions To Non-Controlling Interests, Classified As Financing Activities</link:label>
    <link:label id="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities_documentation_en-US" xlink:label="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distributions To Non-Controlling Interests, Classified As Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" xlink:href="gsk-20241231.xsd#gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" xlink:to="lab_gsk_DistributionsToNonControllingInterestsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineLimitedMember_6e67a3c1-e634-467c-b45a-97b03fdfdf76_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Limited (Hong Kong)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember_b2ee4075-653e-4962-8aad-d891f01189a8_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10% decrease in sales forecasts</link:label>
    <link:label id="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember_label_en-US" xlink:label="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk Ten Percentage Decrease In Sales Forecasts [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk ten percentage decrease in sales forecasts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember" xlink:to="lab_gsk_OtherRiskTenPercentageDecreaseInSalesForecastsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AvailableIndefinitelyMember_59a8b4a8-5550-478e-be71-b30c0b803c73_terseLabel_en-US" xlink:label="lab_gsk_AvailableIndefinitelyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available indefinitely</link:label>
    <link:label id="lab_gsk_AvailableIndefinitelyMember_label_en-US" xlink:label="lab_gsk_AvailableIndefinitelyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available Indefinitely [member]</link:label>
    <link:label id="lab_gsk_AvailableIndefinitelyMember_documentation_en-US" xlink:label="lab_gsk_AvailableIndefinitelyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Available indefinitely.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AvailableIndefinitelyMember" xlink:href="gsk-20241231.xsd#gsk_AvailableIndefinitelyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AvailableIndefinitelyMember" xlink:to="lab_gsk_AvailableIndefinitelyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_c99facb5-6354-40fb-a3be-369c24e5a7c8_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash inflow/(outflow) from continuing operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities, continuing operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_3bc908e2-b3ea-40f1-94ce-23ad8e3e2afd_terseLabel_en-US" xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis for Each Type of Market Risk</link:label>
    <link:label id="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_label_en-US" xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity analysis for types of market risk [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:to="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TwoThousandThirtyOneAndThereafterMember_dc6ac8fe-4634-41f9-8021-22e64233cb55_terseLabel_en-US" xlink:label="lab_gsk_TwoThousandThirtyOneAndThereafterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2031 and thereafter</link:label>
    <link:label id="lab_gsk_TwoThousandThirtyOneAndThereafterMember_label_en-US" xlink:label="lab_gsk_TwoThousandThirtyOneAndThereafterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Thirty One And Thereafter [Member]</link:label>
    <link:label id="lab_gsk_TwoThousandThirtyOneAndThereafterMember_documentation_en-US" xlink:label="lab_gsk_TwoThousandThirtyOneAndThereafterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand thirty one and thereafter.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TwoThousandThirtyOneAndThereafterMember" xlink:href="gsk-20241231.xsd#gsk_TwoThousandThirtyOneAndThereafterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TwoThousandThirtyOneAndThereafterMember" xlink:to="lab_gsk_TwoThousandThirtyOneAndThereafterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory_2f45eaa5-1fa6-4e5f-8f5d-fa60b6bbc175_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory_label_en-US" xlink:label="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contingent Consideration Liabilities [text block]</link:label>
    <link:label id="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory_documentation_en-US" xlink:label="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of contingent consideration liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" xlink:to="lab_gsk_DisclosureOfContingentConsiderationLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember_0b745350-1932-42fa-9c5c-a210b6011ec4_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% increase in discount rate</link:label>
    <link:label id="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember_label_en-US" xlink:label="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk One Point Five Percentage Increase In Discount Rate [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk one point two five percentage increase in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" xlink:to="lab_gsk_OtherRiskOnePointFivePercentageIncreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SurplusDeficitInPlan_58b903c9-3ab5-497d-8cbc-c8aa3ce36fdd_negatedLabel_en-US" xlink:label="lab_ifrs-full_SurplusDeficitInPlan" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deficit in plan</link:label>
    <link:label id="lab_ifrs-full_SurplusDeficitInPlan_4f47b3b1-9d4c-415d-bb6c-e8fb01d6aee9_totalLabel_en-US" xlink:label="lab_ifrs-full_SurplusDeficitInPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net surplus/(obligation)</link:label>
    <link:label id="lab_ifrs-full_SurplusDeficitInPlan_label_en-US" xlink:label="lab_ifrs-full_SurplusDeficitInPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Surplus (deficit) in plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SurplusDeficitInPlan" xlink:to="lab_ifrs-full_SurplusDeficitInPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemainingBalanceMember_10f56953-6112-488e-9acd-f3d28fa46137_terseLabel_en-US" xlink:label="lab_gsk_RemainingBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining balance</link:label>
    <link:label id="lab_gsk_RemainingBalanceMember_label_en-US" xlink:label="lab_gsk_RemainingBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining Balance [member]</link:label>
    <link:label id="lab_gsk_RemainingBalanceMember_documentation_en-US" xlink:label="lab_gsk_RemainingBalanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remaining balance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemainingBalanceMember" xlink:href="gsk-20241231.xsd#gsk_RemainingBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemainingBalanceMember" xlink:to="lab_gsk_RemainingBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits_dd0cb0ba-1596-4c79-b359-c8663c3e613b_negatedTerseLabel_en-US" xlink:label="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D credits</link:label>
    <link:label id="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits_label_en-US" xlink:label="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect of Research and Development Credits</link:label>
    <link:label id="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits_documentation_en-US" xlink:label="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of research and development credits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfResearchAndDevelopmentCredits" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfResearchAndDevelopmentCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxEffectOfResearchAndDevelopmentCredits" xlink:to="lab_gsk_TaxEffectOfResearchAndDevelopmentCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesDomain_6cbf7797-ab85-4935-ac3c-8d81e53b2072_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of liabilities</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation_0421b99a-afed-4757-8d9c-f67932c20259_verboseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D credits utilisation</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Research And Development Credits Utilisation</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease through research and development credits utilisation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" xlink:to="lab_gsk_IncreaseDecreaseThroughResearchAndDevelopmentCreditsUtilisation" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonDerivativesFinancialLiabilitiesMember_70f48cef-a59c-40df-ba88-d05258092333_terseLabel_en-US" xlink:label="lab_gsk_NonDerivativesFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non derivatives financial liabilities</link:label>
    <link:label id="lab_gsk_NonDerivativesFinancialLiabilitiesMember_label_en-US" xlink:label="lab_gsk_NonDerivativesFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Derivatives Financial Liabilities [member]</link:label>
    <link:label id="lab_gsk_NonDerivativesFinancialLiabilitiesMember_documentation_en-US" xlink:label="lab_gsk_NonDerivativesFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non derivatives financial liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonDerivativesFinancialLiabilitiesMember" xlink:href="gsk-20241231.xsd#gsk_NonDerivativesFinancialLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonDerivativesFinancialLiabilitiesMember" xlink:to="lab_gsk_NonDerivativesFinancialLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_09620bb7-88a1-4816-be5b-b1fe3ec4daaf_terseLabel_en-US" xlink:label="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit attributable to shareholders from discontinued operations</link:label>
    <link:label id="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_dc2dce65-8fff-44da-bad3-2a57330c8ef4_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings attributable to shareholders from discontinued operations</link:label>
    <link:label id="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income from discontinued operations attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RAndDNewProductPerformanceMember_de1cb8ca-d6bf-4c9e-bf64-6d6ef8c3e166_terseLabel_en-US" xlink:label="lab_gsk_RAndDNewProductPerformanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D new product performance</link:label>
    <link:label id="lab_gsk_RAndDNewProductPerformanceMember_label_en-US" xlink:label="lab_gsk_RAndDNewProductPerformanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">R And D New Product Performance [Member]</link:label>
    <link:label id="lab_gsk_RAndDNewProductPerformanceMember_documentation_en-US" xlink:label="lab_gsk_RAndDNewProductPerformanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">R&amp;D new product performance Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RAndDNewProductPerformanceMember" xlink:href="gsk-20241231.xsd#gsk_RAndDNewProductPerformanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RAndDNewProductPerformanceMember" xlink:to="lab_gsk_RAndDNewProductPerformanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RestructuringProvisionMember_1d3de515-2bf6-4dad-8abf-bd5f38fb6f45_terseLabel_en-US" xlink:label="lab_ifrs-full_RestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major restructuring programmes</link:label>
    <link:label id="lab_ifrs-full_RestructuringProvisionMember_label_en-US" xlink:label="lab_ifrs-full_RestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring provision [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvisionMember" xlink:to="lab_ifrs-full_RestructuringProvisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember_69ef0ee4-851f-49af-9fd2-c57e8efbd09e_terseLabel_en-US" xlink:label="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.375% US$ US Medium Term Note 2034</link:label>
    <link:label id="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember_label_en-US" xlink:label="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Five Point Three Seven Five Percent US Medium Term Note Two Thousand Thirty Four [member]</link:label>
    <link:label id="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember_documentation_en-US" xlink:label="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Five point three seven five percent US medium term note two thousand thirty four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" xlink:href="gsk-20241231.xsd#gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" xlink:to="lab_gsk_FivePointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable_80026fce-94a7-459b-900b-c36e2f13bd32_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Non-current Assets [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable_label_en-US" xlink:label="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Non-current Assets [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOtherNoncurrentAssetsTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfOtherNoncurrentAssetsTable" xlink:to="lab_gsk_DisclosureOfOtherNoncurrentAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock_ab59233d-df86-4e06-93fa-8c8a7dd1d4e6_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Number of Shares and ADS Issuable</link:label>
    <link:label id="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Employee Share Value Plan [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of employee share value plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" xlink:to="lab_gsk_DisclosureOfEmployeeShareValuePlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_2c3f28b4-a6f4-4946-8f6f-29c2b1940f90_negatedLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Awards cancelled (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments forfeited in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_888f8869-6dfe-40e8-9f3a-7886fa42ef7d_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Consumer Healthcare Holdings Limited</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Consumer Healthcare Holdings Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Consumer Healthcare Holdings Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineConsumerHealthcareHoldingsLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_512f714e-ce73-4a4e-9f6e-c0ee16ec05d1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Operating Income Expense [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock_ed173134-8d62-4f42-beae-8ff070e3b486_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Current Equity Investments</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Current Equity Investments Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about&#160;current equity investments explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutCurrentEquityInvestmentsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FinancialAssetsAndLiabilities_48d4627b-d054-425c-b180-e73ec988f086_periodStartLabel_en-US" xlink:label="lab_gsk_FinancialAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">At 1 January</link:label>
    <link:label id="lab_gsk_FinancialAssetsAndLiabilities_bceea291-01ee-4565-bc87-bf149bf81f78_periodEndLabel_en-US" xlink:label="lab_gsk_FinancialAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">At 31 December</link:label>
    <link:label id="lab_gsk_FinancialAssetsAndLiabilities_label_en-US" xlink:label="lab_gsk_FinancialAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Assets And Liabilities</link:label>
    <link:label id="lab_gsk_FinancialAssetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_FinancialAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialAssetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_FinancialAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FinancialAssetsAndLiabilities" xlink:to="lab_gsk_FinancialAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DefinedBenefitObligationRetiredMember_a2130318-3e6a-44d1-9141-2de73e4112cb_terseLabel_en-US" xlink:label="lab_gsk_DefinedBenefitObligationRetiredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retired</link:label>
    <link:label id="lab_gsk_DefinedBenefitObligationRetiredMember_label_en-US" xlink:label="lab_gsk_DefinedBenefitObligationRetiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Obligation Retired [member]</link:label>
    <link:label id="lab_gsk_DefinedBenefitObligationRetiredMember_documentation_en-US" xlink:label="lab_gsk_DefinedBenefitObligationRetiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined benefit obligation retired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitObligationRetiredMember" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitObligationRetiredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DefinedBenefitObligationRetiredMember" xlink:to="lab_gsk_DefinedBenefitObligationRetiredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_e3526f44-4ce8-40d0-ba53-b385f4922b38_negatedTerseLabel_en-US" xlink:label="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Re-assessments of prior year current tax estimates</link:label>
    <link:label id="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_label_en-US" xlink:label="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Reassessments Of Prior Year Estimates</link:label>
    <link:label id="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates_documentation_en-US" xlink:label="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of reassessments of prior year estimates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfReassessmentsOfPriorYearEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" xlink:to="lab_gsk_TaxEffectOfReassessmentsOfPriorYearEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AugmentationCostsIncludedInPastServiceCosts_11636e26-b961-47c6-a68c-9dd7adf1e6f3_terseLabel_en-US" xlink:label="lab_gsk_AugmentationCostsIncludedInPastServiceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Augmentation costs included in past service costs</link:label>
    <link:label id="lab_gsk_AugmentationCostsIncludedInPastServiceCosts_label_en-US" xlink:label="lab_gsk_AugmentationCostsIncludedInPastServiceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Augmentation Costs Included In Past Service Costs</link:label>
    <link:label id="lab_gsk_AugmentationCostsIncludedInPastServiceCosts_documentation_en-US" xlink:label="lab_gsk_AugmentationCostsIncludedInPastServiceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Augmentation costs included in past service costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AugmentationCostsIncludedInPastServiceCosts" xlink:href="gsk-20241231.xsd#gsk_AugmentationCostsIncludedInPastServiceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AugmentationCostsIncludedInPastServiceCosts" xlink:to="lab_gsk_AugmentationCostsIncludedInPastServiceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AtFairValueMember_b385adb5-80bd-4042-808d-1f0835b0c5c7_terseLabel_en-US" xlink:label="lab_ifrs-full_AtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At fair value</link:label>
    <link:label id="lab_ifrs-full_AtFairValueMember_label_en-US" xlink:label="lab_ifrs-full_AtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At fair value [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember" xlink:to="lab_ifrs-full_AtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetInvestmentHedgesMember_41beb7ca-463f-456c-bd74-508208f65730_terseLabel_en-US" xlink:label="lab_gsk_NetInvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_gsk_NetInvestmentHedgesMember_label_en-US" xlink:label="lab_gsk_NetInvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment Hedges [member]</link:label>
    <link:label id="lab_gsk_NetInvestmentHedgesMember_documentation_en-US" xlink:label="lab_gsk_NetInvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net investment hedges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetInvestmentHedgesMember" xlink:href="gsk-20241231.xsd#gsk_NetInvestmentHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetInvestmentHedgesMember" xlink:to="lab_gsk_NetInvestmentHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ac6e6f8d-5f14-4b17-b9a9-90e8a0b1c854_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_4e8b907a-2ae6-498e-ad5f-c510d38b6d4e_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net financing cash flows attributable to discontinued operations</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities, discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AverageEffectiveTaxRate_f7c86442-d66b-487b-bcd6-c48b9b8cbaf8_terseLabel_en-US" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax rate (in percent)</link:label>
    <link:label id="lab_ifrs-full_AverageEffectiveTaxRate_label_en-US" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average effective tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="lab_ifrs-full_AverageEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member_65415c50-ee81-41da-85ff-7b2bba022c99_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Mexico S.A. de C.V. (Mexico)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member_label_en-US" xlink:label="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Mexico S.A. de C.V. [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Mexico S.A. de C.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineMexicoS.a.DeC.v.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" xlink:to="lab_gsk_GlaxosmithklineMexicoS.a.DeC.v.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Accruals_0adddb0b-0c53-4731-b229-530b52195147_terseLabel_en-US" xlink:label="lab_ifrs-full_Accruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accruals</link:label>
    <link:label id="lab_ifrs-full_Accruals_label_en-US" xlink:label="lab_ifrs-full_Accruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Accruals" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Accruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Accruals" xlink:to="lab_ifrs-full_Accruals" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_733efa3a-df20-45e4-9888-8c3c8bb68b93_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in deferred tax liability (asset) [abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in deferred tax liability (asset) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:to="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets_73c08b41-03de-45e1-85b1-f467ebc0c8df_terseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit on sale of intangible assets</link:label>
    <link:label id="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets_label_en-US" xlink:label="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Profit On Sale Of Intangible Assets</link:label>
    <link:label id="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for profit on sale of intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" xlink:to="lab_gsk_AdjustmentsForProfitOnSaleOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_974bba97-0e27-48b0-aabc-da42ffcf3df5_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_123adc8c-37ef-4ae2-aa9f-6dedd36400b2_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_USPharmaceuticalsAndVaccinesMember_b3638995-efe2-4c4e-8344-42e154d3c726_terseLabel_en-US" xlink:label="lab_gsk_USPharmaceuticalsAndVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Pharmaceuticals and vaccines</link:label>
    <link:label id="lab_gsk_USPharmaceuticalsAndVaccinesMember_label_en-US" xlink:label="lab_gsk_USPharmaceuticalsAndVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Pharmaceuticals And Vaccines [Member]</link:label>
    <link:label id="lab_gsk_USPharmaceuticalsAndVaccinesMember_documentation_en-US" xlink:label="lab_gsk_USPharmaceuticalsAndVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">US Pharmaceuticals and vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_USPharmaceuticalsAndVaccinesMember" xlink:href="gsk-20241231.xsd#gsk_USPharmaceuticalsAndVaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_USPharmaceuticalsAndVaccinesMember" xlink:to="lab_gsk_USPharmaceuticalsAndVaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContinuingAndDiscontinuedOperationAxis_97df6f66-5638-4537-b9d1-8b4b924032f9_terseLabel_en-US" xlink:label="lab_gsk_ContinuingAndDiscontinuedOperationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing and discontinued operations [axis]</link:label>
    <link:label id="lab_gsk_ContinuingAndDiscontinuedOperationAxis_label_en-US" xlink:label="lab_gsk_ContinuingAndDiscontinuedOperationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing And Discontinued Operation [Axis]</link:label>
    <link:label id="lab_gsk_ContinuingAndDiscontinuedOperationAxis_documentation_en-US" xlink:label="lab_gsk_ContinuingAndDiscontinuedOperationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Continuing and discontinued operation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingAndDiscontinuedOperationAxis" xlink:href="gsk-20241231.xsd#gsk_ContinuingAndDiscontinuedOperationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContinuingAndDiscontinuedOperationAxis" xlink:to="lab_gsk_ContinuingAndDiscontinuedOperationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RestructuringCostsAxis_974c7225-78c2-4d0d-9bd6-1a826d02a983_terseLabel_en-US" xlink:label="lab_gsk_RestructuringCostsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs [axis]</link:label>
    <link:label id="lab_gsk_RestructuringCostsAxis_label_en-US" xlink:label="lab_gsk_RestructuringCostsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs [Axis]</link:label>
    <link:label id="lab_gsk_RestructuringCostsAxis_documentation_en-US" xlink:label="lab_gsk_RestructuringCostsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCostsAxis" xlink:href="gsk-20241231.xsd#gsk_RestructuringCostsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RestructuringCostsAxis" xlink:to="lab_gsk_RestructuringCostsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities_c3b45dc3-0355-459f-98c5-ea45cef2cf54_terseLabel_en-US" xlink:label="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration and put option liabilities</link:label>
    <link:label id="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities_label_en-US" xlink:label="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Contingent Consideration And Put Option Liabilities</link:label>
    <link:label id="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities_documentation_en-US" xlink:label="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (loss) on contingent consideration and put option liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" xlink:href="gsk-20241231.xsd#gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" xlink:to="lab_gsk_GainLossOnContingentConsiderationAndPutOptionLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption_6114d8a2-9303-4df5-9d41-695bcbd03e3a_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in annual post-retirement benefits cost</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Post-Retirement Benefit Cost Due To Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Post-Retirement Benefit Cost Due To Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AffinivaxIncMember_fd25e9e7-0fe9-4d6a-a329-9b592e351e58_terseLabel_en-US" xlink:label="lab_gsk_AffinivaxIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affinivax, Inc</link:label>
    <link:label id="lab_gsk_AffinivaxIncMember_label_en-US" xlink:label="lab_gsk_AffinivaxIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affinivax, Inc [Member]</link:label>
    <link:label id="lab_gsk_AffinivaxIncMember_documentation_en-US" xlink:label="lab_gsk_AffinivaxIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Affinivax, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxIncMember" xlink:href="gsk-20241231.xsd#gsk_AffinivaxIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AffinivaxIncMember" xlink:to="lab_gsk_AffinivaxIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfUSWholesalers_978ad6d9-ceae-4cc9-bef4-80131fb09ec4_terseLabel_en-US" xlink:label="lab_gsk_NumberOfUSWholesalers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of US wholesalers</link:label>
    <link:label id="lab_gsk_NumberOfUSWholesalers_label_en-US" xlink:label="lab_gsk_NumberOfUSWholesalers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of US Wholesalers</link:label>
    <link:label id="lab_gsk_NumberOfUSWholesalers_documentation_en-US" xlink:label="lab_gsk_NumberOfUSWholesalers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of US Wholesalers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUSWholesalers" xlink:href="gsk-20241231.xsd#gsk_NumberOfUSWholesalers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfUSWholesalers" xlink:to="lab_gsk_NumberOfUSWholesalers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_a3359747-58a6-4ce8-82e1-bdb92765acac_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxation paid</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_cdf822cd-a941-46fc-acfb-a90404576a26_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scheme participants&#8217; contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklinePharmaGmbhMember_e70f7614-bfca-4126-bbcd-e5e660169d47_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklinePharmaGmbhMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharma GmbH (Austria)</link:label>
    <link:label id="lab_gsk_GlaxosmithklinePharmaGmbhMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklinePharmaGmbhMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharma GmbH [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklinePharmaGmbhMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklinePharmaGmbhMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharma GmbH.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklinePharmaGmbhMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklinePharmaGmbhMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklinePharmaGmbhMember" xlink:to="lab_gsk_GlaxosmithklinePharmaGmbhMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_544c5750-f735-4a1c-ae31-31e94e518098_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax_9d128e90-47ae-4297-b012-c281d072401f_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging &#8232;gains/(losses) recognised in reserves</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on cash flow hedges, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax" xlink:to="lab_ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpense_4b1a78a2-e711-46b7-af77-13f716f5e743_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_ifrs-full_InterestExpense_label_en-US" xlink:label="lab_ifrs-full_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpense" xlink:to="lab_ifrs-full_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PledgedInvestments_d1ecb5b7-3af0-430d-bc05-297ea78c145c_terseLabel_en-US" xlink:label="lab_gsk_PledgedInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pledged investments value</link:label>
    <link:label id="lab_gsk_PledgedInvestments_label_en-US" xlink:label="lab_gsk_PledgedInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pledged Investments</link:label>
    <link:label id="lab_gsk_PledgedInvestments_documentation_en-US" xlink:label="lab_gsk_PledgedInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pledged Investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PledgedInvestments" xlink:href="gsk-20241231.xsd#gsk_PledgedInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PledgedInvestments" xlink:to="lab_gsk_PledgedInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_679ff5c5-ab87-44b8-9db0-3b16a14f90fa_negatedLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfProvisionsForCostOfRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amount of provision reversed unused (see Note 32)</link:label>
    <link:label id="lab_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_label_en-US" xlink:label="lab_ifrs-full_ReversalOfProvisionsForCostOfRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of provisions for cost of restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfProvisionsForCostOfRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring" xlink:to="lab_ifrs-full_ReversalOfProvisionsForCostOfRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_e8597874-9816-4c7b-ab7d-1b696b97598c_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total profit attributable to shareholders</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKKoreaMember_13419521-2076-462f-a8fa-5a3e1e711f40_terseLabel_en-US" xlink:label="lab_gsk_GSKKoreaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Korea</link:label>
    <link:label id="lab_gsk_GSKKoreaMember_label_en-US" xlink:label="lab_gsk_GSKKoreaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Korea [Member]</link:label>
    <link:label id="lab_gsk_GSKKoreaMember_documentation_en-US" xlink:label="lab_gsk_GSKKoreaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Korea.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKKoreaMember" xlink:href="gsk-20241231.xsd#gsk_GSKKoreaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKKoreaMember" xlink:to="lab_gsk_GSKKoreaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineKoreaLimitedMember_f1e0af0d-a7fa-44be-971f-df86370be404_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineKoreaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Korea Limited (Republic of Korea)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineKoreaLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineKoreaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Korea Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineKoreaLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineKoreaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Korea Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineKoreaLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineKoreaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineKoreaLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineKoreaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member_a6e90a3e-7f7c-46f0-9d7c-3280eb462eb9_terseLabel_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.375% Notes due 2029</link:label>
    <link:label id="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member_label_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Three Seven Five Notes due 2029 [Member]</link:label>
    <link:label id="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member_documentation_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.375% Notes due 2029.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointThreeSevenFiveNotesDue2029Member" xlink:href="gsk-20241231.xsd#gsk_ThreePointThreeSevenFiveNotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointThreeSevenFiveNotesDue2029Member" xlink:to="lab_gsk_ThreePointThreeSevenFiveNotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale or as held for distribution to owners [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermBorrowings_d83574f6-9e6d-4151-b771-50deb2ca1304_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowings_718de21a-a54e-40ec-83cf-ee1e772fc556_negatedLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowings_16a0d9b8-3249-4910-9221-9f3b80cf9c04_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowings_label_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings" xlink:to="lab_ifrs-full_LongtermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsAbstract_2431f480-7da5-476b-af6c-21ffecbcd025_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SegmentConsolidationItemDomain_e4d09cef-8e67-418e-9be6-9fb4837657e8_terseLabel_en-US" xlink:label="lab_gsk_SegmentConsolidationItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Consolidation Item [Domain]</link:label>
    <link:label id="lab_gsk_SegmentConsolidationItemDomain_label_en-US" xlink:label="lab_gsk_SegmentConsolidationItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Consolidation Item [Domain]</link:label>
    <link:label id="lab_gsk_SegmentConsolidationItemDomain_documentation_en-US" xlink:label="lab_gsk_SegmentConsolidationItemDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Consolidation Item [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemDomain" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SegmentConsolidationItemDomain" xlink:to="lab_gsk_SegmentConsolidationItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_7e515bf8-4510-44d7-bdcc-1ed86d0731f7_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Anticipated Contractual Cash Flows for Derivative Instruments, Excluding Embedded Derivatives and Equity Options, Using Undiscounted Cash Flows</link:label>
    <link:label id="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentPeriodMember_cc97a3b6-de0e-4035-814e-20dfcdea99a0_terseLabel_en-US" xlink:label="lab_gsk_CurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_gsk_CurrentPeriodMember_label_en-US" xlink:label="lab_gsk_CurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Period [member]</link:label>
    <link:label id="lab_gsk_CurrentPeriodMember_documentation_en-US" xlink:label="lab_gsk_CurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentPeriodMember" xlink:href="gsk-20241231.xsd#gsk_CurrentPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentPeriodMember" xlink:to="lab_gsk_CurrentPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsAbstract_8ca29f84-34f6-44b6-995d-081bc5ec5efa_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term borrowings:</link:label>
    <link:label id="lab_ifrs-full_BorrowingsAbstract_label_en-US" xlink:label="lab_ifrs-full_BorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAbstract" xlink:to="lab_ifrs-full_BorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_056f8159-bf33-4382-9a10-586237984f41_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of property, plant and equipment, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoWellcomeProductionS.A.SMember_e87e8458-93bc-4afd-9bb5-e307f3a105f7_terseLabel_en-US" xlink:label="lab_gsk_GlaxoWellcomeProductionS.A.SMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome Production S.A.S (France)</link:label>
    <link:label id="lab_gsk_GlaxoWellcomeProductionS.A.SMember_label_en-US" xlink:label="lab_gsk_GlaxoWellcomeProductionS.A.SMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome Production S.A.S [Member]</link:label>
    <link:label id="lab_gsk_GlaxoWellcomeProductionS.A.SMember_documentation_en-US" xlink:label="lab_gsk_GlaxoWellcomeProductionS.A.SMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome Production S.A.S</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeProductionS.A.SMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeProductionS.A.SMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoWellcomeProductionS.A.SMember" xlink:to="lab_gsk_GlaxoWellcomeProductionS.A.SMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetInvestmentHedgedMember_f184f2f6-e2a2-40b0-8c40-8f72a1543fc5_terseLabel_en-US" xlink:label="lab_gsk_NetInvestmentHedgedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Investment Hedged</link:label>
    <link:label id="lab_gsk_NetInvestmentHedgedMember_label_en-US" xlink:label="lab_gsk_NetInvestmentHedgedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment Hedged [Member]</link:label>
    <link:label id="lab_gsk_NetInvestmentHedgedMember_documentation_en-US" xlink:label="lab_gsk_NetInvestmentHedgedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net investment hedged.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetInvestmentHedgedMember" xlink:href="gsk-20241231.xsd#gsk_NetInvestmentHedgedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetInvestmentHedgedMember" xlink:to="lab_gsk_NetInvestmentHedgedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestCostsAbstract_label_en-US" xlink:label="lab_ifrs-full_InterestCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest costs [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestCostsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestCostsAbstract" xlink:to="lab_ifrs-full_InterestCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ConsolidatedStructuredEntitiesAxis_dec5a35a-6625-4406-bce1-e82cd85f103b_terseLabel_en-US" xlink:label="lab_ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated structured entities [axis]</link:label>
    <link:label id="lab_ifrs-full_ConsolidatedStructuredEntitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated structured entities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="lab_ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProfitMeasureMember_d122dd42-08a5-4c02-be60-97a4e853e511_terseLabel_en-US" xlink:label="lab_gsk_ProfitMeasureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit measure</link:label>
    <link:label id="lab_gsk_ProfitMeasureMember_label_en-US" xlink:label="lab_gsk_ProfitMeasureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit Measure [Member]</link:label>
    <link:label id="lab_gsk_ProfitMeasureMember_documentation_en-US" xlink:label="lab_gsk_ProfitMeasureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Profit Measure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitMeasureMember" xlink:href="gsk-20241231.xsd#gsk_ProfitMeasureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProfitMeasureMember" xlink:to="lab_gsk_ProfitMeasureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember_870fc164-2432-45e5-ac78-d21b2f6069d4_terseLabel_en-US" xlink:label="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis for actuarial assumptions</link:label>
    <link:label id="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember_label_en-US" xlink:label="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Actuarial Assumptions [Member]</link:label>
    <link:label id="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember_documentation_en-US" xlink:label="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity analysis for actuarial assumptions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SensitivityAnalysisForActuarialAssumptionsMember" xlink:href="gsk-20241231.xsd#gsk_SensitivityAnalysisForActuarialAssumptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SensitivityAnalysisForActuarialAssumptionsMember" xlink:to="lab_gsk_SensitivityAnalysisForActuarialAssumptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxAssets_b02b5373-9c15-4346-b825-e3799a2de18c_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax recoverable</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxAssets" xlink:to="lab_ifrs-full_CurrentTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProductsAndServicesDomain_db58b2ec-2d5e-4d29-96f0-2632a5c7d9cb_terseLabel_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Products and services</link:label>
    <link:label id="lab_ifrs-full_ProductsAndServicesDomain_label_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Products and services [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesDomain" xlink:to="lab_ifrs-full_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceCostExplanatory_7e350528-5253-4118-a1cd-b346c446ba13_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Finance Cost</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceCostExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of finance cost [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceCostExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OptionContractMember_435661d3-808e-45f5-acf2-d03c9fd2d4d4_terseLabel_en-US" xlink:label="lab_ifrs-full_OptionContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option contract</link:label>
    <link:label id="lab_ifrs-full_OptionContractMember_label_en-US" xlink:label="lab_ifrs-full_OptionContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option contract [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OptionContractMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OptionContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OptionContractMember" xlink:to="lab_ifrs-full_OptionContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TrancheAxis_bb022aeb-e947-4216-8014-4dea75018070_terseLabel_en-US" xlink:label="lab_gsk_TrancheAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche [Axis]</link:label>
    <link:label id="lab_gsk_TrancheAxis_label_en-US" xlink:label="lab_gsk_TrancheAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche [Axis]</link:label>
    <link:label id="lab_gsk_TrancheAxis_documentation_en-US" xlink:label="lab_gsk_TrancheAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TrancheAxis" xlink:href="gsk-20241231.xsd#gsk_TrancheAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TrancheAxis" xlink:to="lab_gsk_TrancheAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AppreciationOfUSDollar_cb6a321e-a202-4145-a63a-cb2ec7295851_terseLabel_en-US" xlink:label="lab_gsk_AppreciationOfUSDollar" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Appreciation of US Dollar</link:label>
    <link:label id="lab_gsk_AppreciationOfUSDollar_label_en-US" xlink:label="lab_gsk_AppreciationOfUSDollar" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Appreciation Of US Dollar</link:label>
    <link:label id="lab_gsk_AppreciationOfUSDollar_documentation_en-US" xlink:label="lab_gsk_AppreciationOfUSDollar" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Appreciation of US dollar.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AppreciationOfUSDollar" xlink:href="gsk-20241231.xsd#gsk_AppreciationOfUSDollar"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AppreciationOfUSDollar" xlink:to="lab_gsk_AppreciationOfUSDollar" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDividendsPaidTableTextBlock_90b2c511-7760-41ff-8da9-8820dc528c18_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDividendsPaidTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Dividends to Shareholders</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsPaidTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDividendsPaidTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of dividends paid [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsPaidTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDividendsPaidTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of dividends paid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDividendsPaidTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDividendsPaidTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDividendsPaidTableTextBlock" xlink:to="lab_gsk_DisclosureOfDividendsPaidTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_9d698760-48a7-4bf4-a454-1044f8670d66_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_bfc54b14-3dfa-4469-ba1a-20e785187357_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale (excluding cash and cash equivalents)</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_7b55b80d-116e-43dc-a8d8-86f635c4d3b0_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total asets held sale</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_ea947ae6-eaaf-41ac-a708-fe02174a12f5_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_29cd3008-a02e-4393-818e-a2d49ae7b737_periodStartLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_dbc467bd-84cf-40a9-9cef-9baa4112b675_periodEndLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent liabilities recognised in business combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CapitalLosses_3d6d4488-d3cd-4e22-8871-0d21e830eeb2_terseLabel_en-US" xlink:label="lab_gsk_CapitalLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax losses</link:label>
    <link:label id="lab_gsk_CapitalLosses_label_en-US" xlink:label="lab_gsk_CapitalLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Losses</link:label>
    <link:label id="lab_gsk_CapitalLosses_documentation_en-US" xlink:label="lab_gsk_CapitalLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CapitalLosses" xlink:href="gsk-20241231.xsd#gsk_CapitalLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CapitalLosses" xlink:to="lab_gsk_CapitalLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemeasurementsAbstract_066ea904-1e68-41a2-8ffe-020c161fe18b_terseLabel_en-US" xlink:label="lab_gsk_RemeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurements:</link:label>
    <link:label id="lab_gsk_RemeasurementsAbstract_label_en-US" xlink:label="lab_gsk_RemeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurements [Abstract]</link:label>
    <link:label id="lab_gsk_RemeasurementsAbstract_documentation_en-US" xlink:label="lab_gsk_RemeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementsAbstract" xlink:href="gsk-20241231.xsd#gsk_RemeasurementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemeasurementsAbstract" xlink:to="lab_gsk_RemeasurementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale_0e303c3c-40bf-49f0-a755-e7adf3ebb1aa_terseLabel_en-US" xlink:label="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of tangible and intangible assets held for sale, net of reversals</link:label>
    <link:label id="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale_label_en-US" xlink:label="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment Loss Recognised In Profit Or Loss Property Plant And Intangible Assets Equipment Held For Sale</link:label>
    <link:label id="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale_documentation_en-US" xlink:label="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss property plant and equipment held for sale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" xlink:href="gsk-20241231.xsd#gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" xlink:to="lab_gsk_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndIntangibleAssetsEquipmentHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember_92dad34b-e89b-4b3c-9a5c-99c0152b72f0_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% (100 basis points) increase in US Dollar interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Percent Increase In US dollar Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1% (100 basis points) increase in US Dollar interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePercentIncreaseInUSDollarInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_Debt1Member_e435bfcb-3c99-45cf-8121-be463bba8e8d_terseLabel_en-US" xlink:label="lab_gsk_Debt1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_gsk_Debt1Member_label_en-US" xlink:label="lab_gsk_Debt1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt 1 [member]</link:label>
    <link:label id="lab_gsk_Debt1Member_documentation_en-US" xlink:label="lab_gsk_Debt1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_Debt1Member" xlink:href="gsk-20241231.xsd#gsk_Debt1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_Debt1Member" xlink:to="lab_gsk_Debt1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_ecb38f05-3047-43a8-819d-5ab81108ffdf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Principal Subsidiaries and Their Countries of Incorporation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_473b25bc-8a12-4df4-abb6-af18028f04ea_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate</link:label>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_label_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate" xlink:to="lab_ifrs-full_BorrowingsInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Prepayments_75093874-1478-445d-a287-fd9a42d08984_verboseLabel_en-US" xlink:label="lab_ifrs-full_Prepayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepayments</link:label>
    <link:label id="lab_ifrs-full_Prepayments_label_en-US" xlink:label="lab_ifrs-full_Prepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Prepayments" xlink:to="lab_ifrs-full_Prepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_b6e25f75-65cf-465d-8d90-c489e45e38e4_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through other changes, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_e5288339-7e48-490d-bbfe-eb0054a99a66_terseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Re-assessments of prior year deferred tax estimates (in percent)</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect Of ReassessmentsOf Prior Year Deferred Tax Estimates</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax rate effect of reassessments&#160;of prior year deferred tax estimates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:to="lab_gsk_TaxRateEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember_83c1288c-a7a8-4943-8b88-d311d5a92c4c_terseLabel_en-US" xlink:label="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plant, equipment and vehicles</link:label>
    <link:label id="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember_label_en-US" xlink:label="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Plant and Equipment and Vehicles [member]</link:label>
    <link:label id="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember_documentation_en-US" xlink:label="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property plant and equipment and vehicles.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PropertyPlantAndEquipmentAndVehiclesMember" xlink:href="gsk-20241231.xsd#gsk_PropertyPlantAndEquipmentAndVehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PropertyPlantAndEquipmentAndVehiclesMember" xlink:to="lab_gsk_PropertyPlantAndEquipmentAndVehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_81894fe4-4ea4-4adf-b646-e8cdff70f7a8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredConsiderationReceivedPaid_5e4abb26-d0bd-40bf-99ed-44912c1b0cfc_terseLabel_en-US" xlink:label="lab_gsk_DeferredConsiderationReceivedPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net deferred consideration paid</link:label>
    <link:label id="lab_gsk_DeferredConsiderationReceivedPaid_label_en-US" xlink:label="lab_gsk_DeferredConsiderationReceivedPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Consideration Received (Paid)</link:label>
    <link:label id="lab_gsk_DeferredConsiderationReceivedPaid_documentation_en-US" xlink:label="lab_gsk_DeferredConsiderationReceivedPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred consideration received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredConsiderationReceivedPaid" xlink:href="gsk-20241231.xsd#gsk_DeferredConsiderationReceivedPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredConsiderationReceivedPaid" xlink:to="lab_gsk_DeferredConsiderationReceivedPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_9359e883-9e3d-474d-a0d2-0d6c7e96c276_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_9792f991-91d9-4ac0-a4ee-b4f504a2c873_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Items that will not be reclassified to continuing operations income statement</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherReserves_29ebeed2-ee01-4031-b882-dff03fb82d9e_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
    <link:label id="lab_ifrs-full_OtherReserves_317be8ac-c49c-4a8b-9bd5-ab96ae5fd109_periodStartLabel_en-US" xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Other reserves, beginning balance</link:label>
    <link:label id="lab_ifrs-full_OtherReserves_0ae4e04f-83c4-4439-b900-cbb319d15fb5_periodEndLabel_en-US" xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Other reserves, ending balance</link:label>
    <link:label id="lab_ifrs-full_OtherReserves_label_en-US" xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReserves" xlink:to="lab_ifrs-full_OtherReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CounterpartiesDomain_22e2a6ce-b769-4a11-b3ff-5598f044a839_terseLabel_en-US" xlink:label="lab_ifrs-full_CounterpartiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparties</link:label>
    <link:label id="lab_ifrs-full_CounterpartiesDomain_label_en-US" xlink:label="lab_ifrs-full_CounterpartiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparties [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesDomain" xlink:to="lab_ifrs-full_CounterpartiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_76ee9365-b9b6-475a-b18e-3390b4d3c307_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of related parties [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of related parties [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ManufacturingMember_2141fe9e-710e-48e8-9b09-2b7507a6a0d6_terseLabel_en-US" xlink:label="lab_gsk_ManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacturing</link:label>
    <link:label id="lab_gsk_ManufacturingMember_label_en-US" xlink:label="lab_gsk_ManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing [member]</link:label>
    <link:label id="lab_gsk_ManufacturingMember_documentation_en-US" xlink:label="lab_gsk_ManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Manufacturing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ManufacturingMember" xlink:href="gsk-20241231.xsd#gsk_ManufacturingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ManufacturingMember" xlink:to="lab_gsk_ManufacturingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LongTermBorrowingsAbstract_58956e71-3948-40f8-9140-e47456cadd5d_terseLabel_en-US" xlink:label="lab_gsk_LongTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings:</link:label>
    <link:label id="lab_gsk_LongTermBorrowingsAbstract_label_en-US" xlink:label="lab_gsk_LongTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Borrowings [Abstract]</link:label>
    <link:label id="lab_gsk_LongTermBorrowingsAbstract_documentation_en-US" xlink:label="lab_gsk_LongTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Longterm borrowings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LongTermBorrowingsAbstract" xlink:href="gsk-20241231.xsd#gsk_LongTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LongTermBorrowingsAbstract" xlink:to="lab_gsk_LongTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShionogiViiVHealthcareJointVentureMember_cc8fb7a0-5c05-415a-b370-01b193ecd3f7_terseLabel_en-US" xlink:label="lab_gsk_ShionogiViiVHealthcareJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shionogi-ViiV healthcare joint venture</link:label>
    <link:label id="lab_gsk_ShionogiViiVHealthcareJointVentureMember_label_en-US" xlink:label="lab_gsk_ShionogiViiVHealthcareJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shionogi-ViiV Healthcare Joint Venture [member]</link:label>
    <link:label id="lab_gsk_ShionogiViiVHealthcareJointVentureMember_documentation_en-US" xlink:label="lab_gsk_ShionogiViiVHealthcareJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shionogi-ViiV healthcare joint venture.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShionogiViiVHealthcareJointVentureMember" xlink:href="gsk-20241231.xsd#gsk_ShionogiViiVHealthcareJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShionogiViiVHealthcareJointVentureMember" xlink:to="lab_gsk_ShionogiViiVHealthcareJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DueFromThreeWholesalersMember_b13789a9-f073-4940-8254-d02c186bab8e_terseLabel_en-US" xlink:label="lab_gsk_DueFromThreeWholesalersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due from three wholesalers</link:label>
    <link:label id="lab_gsk_DueFromThreeWholesalersMember_label_en-US" xlink:label="lab_gsk_DueFromThreeWholesalersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Due From Three Wholesalers [Member]</link:label>
    <link:label id="lab_gsk_DueFromThreeWholesalersMember_documentation_en-US" xlink:label="lab_gsk_DueFromThreeWholesalersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Due from three wholesalers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DueFromThreeWholesalersMember" xlink:href="gsk-20241231.xsd#gsk_DueFromThreeWholesalersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DueFromThreeWholesalersMember" xlink:to="lab_gsk_DueFromThreeWholesalersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AccruedInterestMember_93182ada-b580-4a05-b8d6-018e98d034a9_terseLabel_en-US" xlink:label="lab_gsk_AccruedInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_gsk_AccruedInterestMember_label_en-US" xlink:label="lab_gsk_AccruedInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest [Member]</link:label>
    <link:label id="lab_gsk_AccruedInterestMember_documentation_en-US" xlink:label="lab_gsk_AccruedInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued interest [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AccruedInterestMember" xlink:href="gsk-20241231.xsd#gsk_AccruedInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AccruedInterestMember" xlink:to="lab_gsk_AccruedInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarryingAmountOfTheNciDerecognized_a183b38c-af78-4b95-83e6-1bfc2885e654_terseLabel_en-US" xlink:label="lab_gsk_CarryingAmountOfTheNciDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount of the non-controlling interest de-recognised</link:label>
    <link:label id="lab_gsk_CarryingAmountOfTheNciDerecognized_label_en-US" xlink:label="lab_gsk_CarryingAmountOfTheNciDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount of the NCI derecognized</link:label>
    <link:label id="lab_gsk_CarryingAmountOfTheNciDerecognized_documentation_en-US" xlink:label="lab_gsk_CarryingAmountOfTheNciDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying amount of the NCI derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingAmountOfTheNciDerecognized" xlink:href="gsk-20241231.xsd#gsk_CarryingAmountOfTheNciDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarryingAmountOfTheNciDerecognized" xlink:to="lab_gsk_CarryingAmountOfTheNciDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueOfHolding_c516b48a-75e2-4b8d-a9c1-9136de451bc6_terseLabel_en-US" xlink:label="lab_gsk_FairValueOfHolding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of holding</link:label>
    <link:label id="lab_gsk_FairValueOfHolding_label_en-US" xlink:label="lab_gsk_FairValueOfHolding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Holding</link:label>
    <link:label id="lab_gsk_FairValueOfHolding_documentation_en-US" xlink:label="lab_gsk_FairValueOfHolding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of holding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfHolding" xlink:href="gsk-20241231.xsd#gsk_FairValueOfHolding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueOfHolding" xlink:to="lab_gsk_FairValueOfHolding" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BankOverdrafts1Member_503f8523-b7c2-4c98-8981-b655f0e0ddc2_terseLabel_en-US" xlink:label="lab_gsk_BankOverdrafts1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Overdrafts</link:label>
    <link:label id="lab_gsk_BankOverdrafts1Member_label_en-US" xlink:label="lab_gsk_BankOverdrafts1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank Overdrafts 1 [member]</link:label>
    <link:label id="lab_gsk_BankOverdrafts1Member_documentation_en-US" xlink:label="lab_gsk_BankOverdrafts1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bank overdrafts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankOverdrafts1Member" xlink:href="gsk-20241231.xsd#gsk_BankOverdrafts1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BankOverdrafts1Member" xlink:to="lab_gsk_BankOverdrafts1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherProvisionsMember_b18bcfea-75e2-476b-96e5-3c67703e69b0_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherProvisionsMember_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous other provisions [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherProvisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:to="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts_013047da-3dc2-491a-bec4-f7bce09dbd72_terseLabel_en-US" xlink:label="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares acquired by ESOP Trusts (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts_label_en-US" xlink:label="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Treasury Shares Transferred To Employee Share Trusts</link:label>
    <link:label id="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts_documentation_en-US" xlink:label="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of treasury shares transferred to employee share trusts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" xlink:href="gsk-20241231.xsd#gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" xlink:to="lab_gsk_NumberOfTreasurySharesTransferredToEmployeeShareTrusts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_47dcc9a2-beac-456b-8af8-e00b881a39a5_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_38af8f3c-4690-4f7c-94b1-f73a9913d228_totalLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SpikevaxMember_92c59e62-1192-4134-a35d-e4b002ea98df_terseLabel_en-US" xlink:label="lab_gsk_SpikevaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spikevax</link:label>
    <link:label id="lab_gsk_SpikevaxMember_label_en-US" xlink:label="lab_gsk_SpikevaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spikevax [Member]</link:label>
    <link:label id="lab_gsk_SpikevaxMember_documentation_en-US" xlink:label="lab_gsk_SpikevaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spikevax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SpikevaxMember" xlink:href="gsk-20241231.xsd#gsk_SpikevaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SpikevaxMember" xlink:to="lab_gsk_SpikevaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_2459f669-87d5-4439-af15-c465b212396e_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15 cent depreciation of the Euro</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Depreciation Of Euro [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Cent Depreciation Of Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" xlink:to="lab_gsk_CurrencyRiskFifteenCentDepreciationOfEuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestBearingDebt_7c8cf050-629a-4f83-ad56-2bf2f07cafc1_negatedLabel_en-US" xlink:label="lab_gsk_InterestBearingDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest bearing debt</link:label>
    <link:label id="lab_gsk_InterestBearingDebt_label_en-US" xlink:label="lab_gsk_InterestBearingDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Bearing Debt</link:label>
    <link:label id="lab_gsk_InterestBearingDebt_documentation_en-US" xlink:label="lab_gsk_InterestBearingDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest bearing debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestBearingDebt" xlink:href="gsk-20241231.xsd#gsk_InterestBearingDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestBearingDebt" xlink:to="lab_gsk_InterestBearingDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear_81e67079-2f7a-4060-8e82-e2ffcf4d3711_terseLabel_en-US" xlink:label="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends to shareholders</link:label>
    <link:label id="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear_label_en-US" xlink:label="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Dividends Paid to Shareholders Recognized in Year</link:label>
    <link:label id="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear_documentation_en-US" xlink:label="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash dividends paid to shareholders recognized in year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashDividendsPaidToShareholdersRecognizedInYear" xlink:href="gsk-20241231.xsd#gsk_CashDividendsPaidToShareholdersRecognizedInYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashDividendsPaidToShareholdersRecognizedInYear" xlink:to="lab_gsk_CashDividendsPaidToShareholdersRecognizedInYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_7615a6ab-e063-4fc0-9155-0d7bc3ce88ad_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-cash dividend to shareholders</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through other distributions to owners, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest_ceb43fc6-998e-4219-a851-0a9429f059cb_verboseLabel_en-US" xlink:label="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other movements (Note 41)</link:label>
    <link:label id="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest_label_en-US" xlink:label="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase In Goodwill Due To Pension Liabilities Payment To Non Controlling Interest</link:label>
    <link:label id="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest_documentation_en-US" xlink:label="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase &#8203;in goodwill&#8203; due &#8203;to pension &#8203;liabilities &#8203;payment to &#8203;non&#8203; controlling &#8203;interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" xlink:href="gsk-20241231.xsd#gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" xlink:to="lab_gsk_IncreaseinGoodwillDuetoPensionliabilitiespaymentTononControllinginterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DefinedBenefitHybridPensionSchemeMember_e415cdd7-987f-4d5e-8609-0b9626fc221b_terseLabel_en-US" xlink:label="lab_gsk_DefinedBenefitHybridPensionSchemeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funded defined benefit/hybrid pension schemes</link:label>
    <link:label id="lab_gsk_DefinedBenefitHybridPensionSchemeMember_label_en-US" xlink:label="lab_gsk_DefinedBenefitHybridPensionSchemeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit/Hybrid Pension Scheme [Member]</link:label>
    <link:label id="lab_gsk_DefinedBenefitHybridPensionSchemeMember_documentation_en-US" xlink:label="lab_gsk_DefinedBenefitHybridPensionSchemeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Funded defined benefit pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DefinedBenefitHybridPensionSchemeMember" xlink:href="gsk-20241231.xsd#gsk_DefinedBenefitHybridPensionSchemeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DefinedBenefitHybridPensionSchemeMember" xlink:to="lab_gsk_DefinedBenefitHybridPensionSchemeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherNonCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_gsk_OtherNonCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Non-Current Liabilities [Abstract]</link:label>
    <link:label id="lab_gsk_OtherNonCurrentLiabilitiesAbstract_documentation_en-US" xlink:label="lab_gsk_OtherNonCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other non-current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNonCurrentLiabilitiesAbstract" xlink:href="gsk-20241231.xsd#gsk_OtherNonCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherNonCurrentLiabilitiesAbstract" xlink:to="lab_gsk_OtherNonCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_61383df3-4336-44a3-ac42-2f6fc4aac337_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_6cfdf4c4-25bf-4991-af25-0b30e6f75773_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EUR</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineKKMember_868b0232-9dc1-47e8-bf5f-29dd1505cb1f_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineKKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline K.K. (Japan)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineKKMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineKKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline K K [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineKKMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineKKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline K.K.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineKKMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineKKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineKKMember" xlink:to="lab_gsk_GlaxoSmithKlineKKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OkairosMember_987978be-363a-45d3-8f24-96cc03632daa_terseLabel_en-US" xlink:label="lab_gsk_OkairosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Okairos</link:label>
    <link:label id="lab_gsk_OkairosMember_label_en-US" xlink:label="lab_gsk_OkairosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Okairos [Member]</link:label>
    <link:label id="lab_gsk_OkairosMember_documentation_en-US" xlink:label="lab_gsk_OkairosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Okairos.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OkairosMember" xlink:href="gsk-20241231.xsd#gsk_OkairosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OkairosMember" xlink:to="lab_gsk_OkairosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DividendsRecognisedInYear_35192286-fc6d-4e57-b61f-a0816c01a2cc_totalLabel_en-US" xlink:label="lab_gsk_DividendsRecognisedInYear" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_gsk_DividendsRecognisedInYear_label_en-US" xlink:label="lab_gsk_DividendsRecognisedInYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Recognised In Year</link:label>
    <link:label id="lab_gsk_DividendsRecognisedInYear_documentation_en-US" xlink:label="lab_gsk_DividendsRecognisedInYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividends Recognised In Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendsRecognisedInYear" xlink:href="gsk-20241231.xsd#gsk_DividendsRecognisedInYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DividendsRecognisedInYear" xlink:to="lab_gsk_DividendsRecognisedInYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_05011184-8daa-4d12-aae2-85d70d500de2_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_ac8c5736-8ef9-47a5-ae71-2ec4bbeeec3a_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Net losses)/net gains arising from net investment hedge relationships</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on change in value of forward elements of forward contracts, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:to="lab_ifrs-full_GainsLossesOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseOfRestructuringActivities_4cabb3d5-cf5f-4b82-bfa7-7bb1fdd53475_terseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major restructuring costs</link:label>
    <link:label id="lab_ifrs-full_ExpenseOfRestructuringActivities_label_en-US" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense of restructuring activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeReceivablesMember_67de25a7-f255-413b-8220-e33001d14d0d_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables</link:label>
    <link:label id="lab_ifrs-full_TradeReceivablesMember_23133388-18e9-4c88-8ec9-0ec136005633_verboseLabel_en-US" xlink:label="lab_ifrs-full_TradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_ifrs-full_TradeReceivablesMember_label_en-US" xlink:label="lab_ifrs-full_TradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivablesMember" xlink:to="lab_ifrs-full_TradeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ForeignExchangeContractsMember_a2581000-78a1-4b6c-aac4-b6cf9e3a1ce8_terseLabel_en-US" xlink:label="lab_gsk_ForeignExchangeContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_gsk_ForeignExchangeContractsMember_label_en-US" xlink:label="lab_gsk_ForeignExchangeContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contracts [member]</link:label>
    <link:label id="lab_gsk_ForeignExchangeContractsMember_documentation_en-US" xlink:label="lab_gsk_ForeignExchangeContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign exchange contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeContractsMember" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ForeignExchangeContractsMember" xlink:to="lab_gsk_ForeignExchangeContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKVaccinesSRLMember_d04baf6d-f3d6-45cc-8a0c-991d276a9a24_terseLabel_en-US" xlink:label="lab_gsk_GSKVaccinesSRLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Vaccines S.r.l. (Italy)</link:label>
    <link:label id="lab_gsk_GSKVaccinesSRLMember_label_en-US" xlink:label="lab_gsk_GSKVaccinesSRLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">G S K Vaccines S R L [member]</link:label>
    <link:label id="lab_gsk_GSKVaccinesSRLMember_documentation_en-US" xlink:label="lab_gsk_GSKVaccinesSRLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Vaccines S.r.l.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKVaccinesSRLMember" xlink:href="gsk-20241231.xsd#gsk_GSKVaccinesSRLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKVaccinesSRLMember" xlink:to="lab_gsk_GSKVaccinesSRLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ESGEnvironmentMember_94b49db0-fa0b-46c6-babc-4b1e4aa5d865_terseLabel_en-US" xlink:label="lab_gsk_ESGEnvironmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESG environment</link:label>
    <link:label id="lab_gsk_ESGEnvironmentMember_label_en-US" xlink:label="lab_gsk_ESGEnvironmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ESG Environment [Member]</link:label>
    <link:label id="lab_gsk_ESGEnvironmentMember_documentation_en-US" xlink:label="lab_gsk_ESGEnvironmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ESG Environment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ESGEnvironmentMember" xlink:href="gsk-20241231.xsd#gsk_ESGEnvironmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ESGEnvironmentMember" xlink:to="lab_gsk_ESGEnvironmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_321e20ff-2e95-4718-ae4d-29386caf46a3_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Valuation Techniques And Key Model Inputs Used To Measure Contingent Consideration [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_label_en-US" xlink:label="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Valuation Techniques And Key Model Inputs Used To Measure Contingent Consideration [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Valuation Techniques And Key Model Inputs Used To Measure Contingent Consideration [table].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" xlink:to="lab_gsk_DisclosureOfValuationTechniquesAndKeyModelInputsUsedToMeasureContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember_a4cdf38a-3127-4c28-acc2-6d7b6e288cc1_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property Limited</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineIntellectualPropertyLimitedMember" xlink:to="lab_gsk_GlaxosmithklineIntellectualPropertyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BorrowingsLessThanThreeMonthsMember_50faf6ba-51f1-44b2-860e-2f759cbe19e3_terseLabel_en-US" xlink:label="lab_gsk_BorrowingsLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, less than 3 months</link:label>
    <link:label id="lab_gsk_BorrowingsLessThanThreeMonthsMember_label_en-US" xlink:label="lab_gsk_BorrowingsLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings Less Than Three Months [Member]</link:label>
    <link:label id="lab_gsk_BorrowingsLessThanThreeMonthsMember_documentation_en-US" xlink:label="lab_gsk_BorrowingsLessThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings less than three months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsLessThanThreeMonthsMember" xlink:href="gsk-20241231.xsd#gsk_BorrowingsLessThanThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BorrowingsLessThanThreeMonthsMember" xlink:to="lab_gsk_BorrowingsLessThanThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember_7b52bcfa-c151-4c72-aa82-dd7b5fca7f9f_terseLabel_en-US" xlink:label="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value of defined benefit obligation</link:label>
    <link:label id="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember_label_en-US" xlink:label="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Present value of defined benefit obligation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:to="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember_a9debeba-a072-4162-b464-7f346c8451da_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) increase in US Dollar interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Point Five Percent Increase In Us Dollar Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest rate risk one point five percent increase in us dollar interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInUsDollarInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures_01e3243e-f9b1-4abe-a840-70d638084393_terseLabel_en-US" xlink:label="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net fair value movements through other comprehensive income</link:label>
    <link:label id="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures_label_en-US" xlink:label="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment Investments In Associates And Joint Ventures</link:label>
    <link:label id="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value Adjustment investments in associates and joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" xlink:href="gsk-20241231.xsd#gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" xlink:to="lab_gsk_FairValueAdjustmentInvestmentsInAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsAxis_b2974c3d-cc61-47e0-92da-64bb0fc7d3f2_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsAxis_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:to="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfFinancialAssetsDomain_61eeb917-50cb-4ae9-be04-b00d88e3905f_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of financial assets</link:label>
    <link:label id="lab_ifrs-full_TypesOfFinancialAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of financial assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_TypesOfFinancialAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6bc92732-88a3-4a24-aed6-c046e175cfb2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfMajorRestructuringProgrammes_646ec6a6-3a98-4ae9-946c-59ea858ae438_terseLabel_en-US" xlink:label="lab_gsk_NumberOfMajorRestructuringProgrammes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of major restructuring programmes</link:label>
    <link:label id="lab_gsk_NumberOfMajorRestructuringProgrammes_label_en-US" xlink:label="lab_gsk_NumberOfMajorRestructuringProgrammes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Major Restructuring Programmes</link:label>
    <link:label id="lab_gsk_NumberOfMajorRestructuringProgrammes_documentation_en-US" xlink:label="lab_gsk_NumberOfMajorRestructuringProgrammes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Major Restructuring Programmes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfMajorRestructuringProgrammes" xlink:href="gsk-20241231.xsd#gsk_NumberOfMajorRestructuringProgrammes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfMajorRestructuringProgrammes" xlink:to="lab_gsk_NumberOfMajorRestructuringProgrammes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameDomain_61494b4d-4f05-4d28-8658-ad68fb24d843_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [domain]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameDomain_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameDomain" xlink:to="lab_ifrs-full_BorrowingsByNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_c4208882-a4e8-43d9-81c7-b92149f3658b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Analysis of Defined Benefit Pension Plans</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock_403c87c3-8fae-4625-93a7-de16d65babad_terseLabel_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock_label_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for cash and cash equivalents explanatory [Policy Text Block]</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock_documentation_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The description of the entity's accounting policy for cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" xlink:href="gsk-20241231.xsd#gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" xlink:to="lab_gsk_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup_4ec80698-7ac9-47ea-bccb-fe6db7e1faa9_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents not available for general use</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents held by entity unavailable for use by group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" xlink:to="lab_ifrs-full_CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_d8fa778a-901a-4b20-9e95-d9c4c71612b2_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount rate applied to cash flow projections</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_371499fe-f4ee-4eb3-a80a-09355088a82b_periodStartLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">At 1 January</link:label>
    <link:label id="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_41c9f8cf-5aa0-4ed9-a01a-861c7ac70527_periodEndLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">31 December</link:label>
    <link:label id="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_91586b58-afe0-4219-924c-2fff3ca72efa_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments other than investments accounted for using equity method</link:label>
    <link:label id="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments other than investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember_1e63b47c-87e6-4000-a12c-da0fff407f69_verboseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Research &amp; Development Limited</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Research And Development Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Research and Development Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineResearchAndDevelopmentLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProvisionReversalRestructuring_da3093e3-57ef-4761-ad10-8d10733ce754_terseLabel_en-US" xlink:label="lab_gsk_ProvisionReversalRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision reversal restructuring</link:label>
    <link:label id="lab_gsk_ProvisionReversalRestructuring_label_en-US" xlink:label="lab_gsk_ProvisionReversalRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision Reversal Restructuring</link:label>
    <link:label id="lab_gsk_ProvisionReversalRestructuring_documentation_en-US" xlink:label="lab_gsk_ProvisionReversalRestructuring" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease provision reversal restructuring.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProvisionReversalRestructuring" xlink:href="gsk-20241231.xsd#gsk_ProvisionReversalRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProvisionReversalRestructuring" xlink:to="lab_gsk_ProvisionReversalRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_982f92a8-d276-4676-992b-669ea55d727f_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest received, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_cd150eb5-88d4-48a4-b84f-9ece8dfe7f95_terseLabel_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee costs (Note 9)</link:label>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_d78c897f-112a-4bf6-a97f-6dd90db008d4_totalLabel_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Employee costs</link:label>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_label_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee benefits expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MedicxiVenturesILimitedPartnerMember_bc0dbe23-3055-40ea-ad7a-4293420f6311_terseLabel_en-US" xlink:label="lab_gsk_MedicxiVenturesILimitedPartnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicxi Ventures I Limited Partner</link:label>
    <link:label id="lab_gsk_MedicxiVenturesILimitedPartnerMember_label_en-US" xlink:label="lab_gsk_MedicxiVenturesILimitedPartnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicxi VenturesI Limited Partner [member]</link:label>
    <link:label id="lab_gsk_MedicxiVenturesILimitedPartnerMember_documentation_en-US" xlink:label="lab_gsk_MedicxiVenturesILimitedPartnerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medicxi Ventures I Limited Partner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MedicxiVenturesILimitedPartnerMember" xlink:href="gsk-20241231.xsd#gsk_MedicxiVenturesILimitedPartnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MedicxiVenturesILimitedPartnerMember" xlink:to="lab_gsk_MedicxiVenturesILimitedPartnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPersonalInjuryCasesDefendant_75876bce-0e84-4ca0-bf57-bc23167c3a75_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPersonalInjuryCasesDefendant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of personal injury cases, defendant</link:label>
    <link:label id="lab_gsk_NumberOfPersonalInjuryCasesDefendant_label_en-US" xlink:label="lab_gsk_NumberOfPersonalInjuryCasesDefendant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Personal Injury Cases, Defendant</link:label>
    <link:label id="lab_gsk_NumberOfPersonalInjuryCasesDefendant_documentation_en-US" xlink:label="lab_gsk_NumberOfPersonalInjuryCasesDefendant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Personal Injury Cases, Defendant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPersonalInjuryCasesDefendant" xlink:href="gsk-20241231.xsd#gsk_NumberOfPersonalInjuryCasesDefendant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPersonalInjuryCasesDefendant" xlink:to="lab_gsk_NumberOfPersonalInjuryCasesDefendant" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiabilityEliminatedOnDemerger_9287c582-980d-43ff-b033-e33c144ad5a4_terseLabel_en-US" xlink:label="lab_gsk_LiabilityEliminatedOnDemerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability eliminated on demerger</link:label>
    <link:label id="lab_gsk_LiabilityEliminatedOnDemerger_label_en-US" xlink:label="lab_gsk_LiabilityEliminatedOnDemerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Eliminated On Demerger</link:label>
    <link:label id="lab_gsk_LiabilityEliminatedOnDemerger_documentation_en-US" xlink:label="lab_gsk_LiabilityEliminatedOnDemerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liability eliminated on demerger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiabilityEliminatedOnDemerger" xlink:href="gsk-20241231.xsd#gsk_LiabilityEliminatedOnDemerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiabilityEliminatedOnDemerger" xlink:to="lab_gsk_LiabilityEliminatedOnDemerger" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_e4439ec8-f7d0-4689-9e9c-f645a414bae5_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_ca2b07e1-5828-443b-b16e-b2a7836cea06_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets_09768452-50c6-49e0-9c19-498ab7ef83e1_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equities:</link:label>
    <link:label id="lab_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity instruments, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments_06f2a3a3-f351-42a2-856e-04e0dd07d740_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging gains/(losses) recognised in reserves</link:label>
    <link:label id="lab_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments_label_en-US" xlink:label="lab_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of gains and losses on hedging instruments that hedge investments in equity instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" xlink:to="lab_ifrs-full_ReserveOfGainsAndLossesOnHedgingInstrumentsThatHedgeInvestmentsInEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SignificantAcquisitionsMember_84ab3452-3b75-469d-93b8-86f52e3a507b_terseLabel_en-US" xlink:label="lab_gsk_SignificantAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant acquisitions</link:label>
    <link:label id="lab_gsk_SignificantAcquisitionsMember_label_en-US" xlink:label="lab_gsk_SignificantAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Acquisitions [Member]</link:label>
    <link:label id="lab_gsk_SignificantAcquisitionsMember_documentation_en-US" xlink:label="lab_gsk_SignificantAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant acquisitions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SignificantAcquisitionsMember" xlink:href="gsk-20241231.xsd#gsk_SignificantAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SignificantAcquisitionsMember" xlink:to="lab_gsk_SignificantAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_16889c2e-e8c0-49ec-931b-125b5e7e1269_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party transactions</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of related party [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets_f83ad8c9-20ea-40ac-a5fa-ca83035165c3_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Utilised</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Utilisation, Financial Assets</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Utilisation, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughUtilisationFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" xlink:to="lab_gsk_IncreaseDecreaseThroughUtilisationFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PensionSurplus_365ae2b2-8092-440e-876b-282c1c75c3ca_terseLabel_en-US" xlink:label="lab_gsk_PensionSurplus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension surplus</link:label>
    <link:label id="lab_gsk_PensionSurplus_label_en-US" xlink:label="lab_gsk_PensionSurplus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension surplus</link:label>
    <link:label id="lab_gsk_PensionSurplus_documentation_en-US" xlink:label="lab_gsk_PensionSurplus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pension surplus.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionSurplus" xlink:href="gsk-20241231.xsd#gsk_PensionSurplus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PensionSurplus" xlink:to="lab_gsk_PensionSurplus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_ffaf31bd-da7f-4815-9489-4908f3545b0a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExternalCreditGradesDomain_15e583f2-4093-421e-80af-185d31d61701_terseLabel_en-US" xlink:label="lab_ifrs-full_ExternalCreditGradesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">External credit grades</link:label>
    <link:label id="lab_ifrs-full_ExternalCreditGradesDomain_label_en-US" xlink:label="lab_ifrs-full_ExternalCreditGradesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">External credit grades [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExternalCreditGradesDomain" xlink:to="lab_ifrs-full_ExternalCreditGradesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets_e83b69fc-3074-40b1-a156-bde68e77f716_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairments</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement_e2f3919b-cfed-4cb2-82d3-7e97bb0840e0_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of options granted (in shares)</link:label>
    <link:label id="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Fair Value Of Share Option Granted In Share Based Payment Arrangement</link:label>
    <link:label id="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average fair value of share option granted in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" xlink:to="lab_gsk_WeightedAverageFairValueOfShareOptionGrantedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskEnterpriseManagementCoLtdMember_dc21e957-ef9b-4d0a-bad6-877b95980dc9_terseLabel_en-US" xlink:label="lab_gsk_GskEnterpriseManagementCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Enterprise Management Co, Ltd (China)</link:label>
    <link:label id="lab_gsk_GskEnterpriseManagementCoLtdMember_label_en-US" xlink:label="lab_gsk_GskEnterpriseManagementCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Enterprise Management Co, Ltd [Member]</link:label>
    <link:label id="lab_gsk_GskEnterpriseManagementCoLtdMember_documentation_en-US" xlink:label="lab_gsk_GskEnterpriseManagementCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Enterprise Management Co, Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskEnterpriseManagementCoLtdMember" xlink:href="gsk-20241231.xsd#gsk_GskEnterpriseManagementCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskEnterpriseManagementCoLtdMember" xlink:to="lab_gsk_GskEnterpriseManagementCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption_8cc58e85-950a-45db-8deb-e0d99755a315_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in annual post-retirement benefits cost</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Post-Retirement Benefit Cost Due To Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Annual Post-Retirement Benefit Cost Due To Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_gsk_IncreaseDecreaseInAnnualPostRetirementBenefitCostDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDebtTable_2499fd6b-1730-4839-8604-e2323c602db1_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of debt [Table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDebtTable_label_en-US" xlink:label="lab_gsk_DisclosureOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Debt [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDebtTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDebtTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDebtTable" xlink:to="lab_gsk_DisclosureOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_e99dafe4-e165-464a-987a-68d476a96a18_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in other receivables</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in other operating receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_f002ed8a-b965-4c9c-95d5-d97916f0c51c_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock_2e0e64cb-5aaf-4e6e-9bd8-bdc871202032_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Numbers of Shares Earnings Per Share</link:label>
    <link:label id="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Weighted Average Numbers of Shares Earnings Per Share [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of weighted average numbers of shares earnings per share explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" xlink:to="lab_gsk_DisclosureOfWeightedAverageNumbersOfSharesEarningsPerShareTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_61406bca-8b3f-4325-88be-71db97adac72_negatedLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of businesses, net of cash acquired</link:label>
    <link:label id="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TopOfRangeMember_27e31146-71b3-482a-933f-56a0e3c8348a_terseLabel_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Top of range</link:label>
    <link:label id="lab_ifrs-full_TopOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanTenYearsMember_895604a5-f82e-46c8-bd8a-550e784cd642_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">More than 10 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanTenYearsMember_5337429d-5adf-4d10-a3ec-1b0c3565bde0_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_ifrs-full_LaterThanTenYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than ten years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTenYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTenYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTenYearsMember" xlink:to="lab_ifrs-full_LaterThanTenYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract_label_en-US" xlink:label="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation of leases for lessee [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainOnDemergerOfDiscontinuedOperation_0a3163f5-899e-4559-b68f-5e605e8af167_terseLabel_en-US" xlink:label="lab_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total gain on the demerger of Consumer Healthcare</link:label>
    <link:label id="lab_gsk_GainOnDemergerOfDiscontinuedOperation_7b69ac2a-e1f9-4439-960b-2b7022d69a2a_totalLabel_en-US" xlink:label="lab_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total gain on the demerger of Consumer Healthcare</link:label>
    <link:label id="lab_gsk_GainOnDemergerOfDiscontinuedOperation_label_en-US" xlink:label="lab_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain On Demerger Of Discontinued Operation</link:label>
    <link:label id="lab_gsk_GainOnDemergerOfDiscontinuedOperation_documentation_en-US" xlink:label="lab_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain on demerger of discontinued operation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:to="lab_gsk_GainOnDemergerOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_cfd8aea8-4fb5-4a3c-a6af-bb20957b68af_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Experience gain/(loss)</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_279a3464-2637-41cc-a29e-5bf7e96a7c6b_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Experience gain/(loss)</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ArrowheadMember_4a766f6c-d3fe-4741-bd0c-d764e1c0e3e9_terseLabel_en-US" xlink:label="lab_gsk_ArrowheadMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrowhead</link:label>
    <link:label id="lab_gsk_ArrowheadMember_label_en-US" xlink:label="lab_gsk_ArrowheadMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Arrowhead [Member]</link:label>
    <link:label id="lab_gsk_ArrowheadMember_documentation_en-US" xlink:label="lab_gsk_ArrowheadMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Arrowhead</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrowheadMember" xlink:href="gsk-20241231.xsd#gsk_ArrowheadMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ArrowheadMember" xlink:to="lab_gsk_ArrowheadMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_457c643a-f3df-4d22-98cf-a3c106b90fb7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember_4e747360-17b1-4994-8885-92331cc804d8_verboseLabel_en-US" xlink:label="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">&#8211; commercial paper in a designated hedging relationship</link:label>
    <link:label id="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember_label_en-US" xlink:label="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial paper in a designated hedging relationship [Member]</link:label>
    <link:label id="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember_documentation_en-US" xlink:label="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commercial paper in a designated hedging relationship.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialPaperInADesignatedHedgingRelationshipMember" xlink:href="gsk-20241231.xsd#gsk_CommercialPaperInADesignatedHedgingRelationshipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CommercialPaperInADesignatedHedgingRelationshipMember" xlink:to="lab_gsk_CommercialPaperInADesignatedHedgingRelationshipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_57e5c238-7e93-43c1-ac99-ff01db31e875_terseLabel_en-US" xlink:label="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funded</link:label>
    <link:label id="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholly or partly funded defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember_b5a1cd67-57c3-4676-ac9f-e9963b457c48_terseLabel_en-US" xlink:label="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.375% &#8364; Euro Medium Term Note 2024</link:label>
    <link:label id="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Three Seven Five Percent Euro Medium Term Note Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One Point Three Seven Five Percent Euro Medium Term Note Two Thousand Twenty Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" xlink:href="gsk-20241231.xsd#gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" xlink:to="lab_gsk_OnePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax_1936f142-910e-48af-aad4-681d0096c620_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging &#8232;gains/(losses) recognised in reserves</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on hedges of net investments in foreign operations, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" xlink:to="lab_ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_11382b80-cdec-4d44-b8a8-5bcaf069774f_terseLabel_en-US" xlink:label="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax on fair value movements on equity investments</link:label>
    <link:label id="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_label_en-US" xlink:label="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Deferred Tax On Fair Value Movements On Equity Investments</link:label>
    <link:label id="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments_documentation_en-US" xlink:label="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other comprehensive income deferred tax on fair value movements on equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" xlink:to="lab_gsk_OtherComprehensiveIncomeDeferredTaxOnFairValueMovementsOnEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialInstrumentsCreditimpairedMember_999d4824-52cf-477f-9d4a-30f9d20e917d_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsCreditimpairedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments credit-impaired</link:label>
    <link:label id="lab_ifrs-full_FinancialInstrumentsCreditimpairedMember_label_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsCreditimpairedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments credit-impaired [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsCreditimpairedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsCreditimpairedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialInstrumentsCreditimpairedMember" xlink:to="lab_ifrs-full_FinancialInstrumentsCreditimpairedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows_4028f022-5701-4a67-bc46-5f8a7d682b71_terseLabel_en-US" xlink:label="lab_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of specific projected cash flows</link:label>
    <link:label id="lab_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows_label_en-US" xlink:label="lab_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Explanation of period over which management has projected cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows" xlink:to="lab_ifrs-full_ExplanationOfPeriodOverWhichManagementHasProjectedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_25328414-f474-4395-bc3a-df0abbbd28c3_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interest in acquiree recognised at acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:to="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions_83430ba1-bc7b-40eb-9ffc-d66896b99d5b_terseLabel_en-US" xlink:label="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charges on other provisions</link:label>
    <link:label id="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions_label_en-US" xlink:label="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Provisions Net Of Reversals And Recoveries Other Provisions</link:label>
    <link:label id="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions_documentation_en-US" xlink:label="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional provisions net of reversals and recoveries other provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" xlink:href="gsk-20241231.xsd#gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" xlink:to="lab_gsk_AdditionalProvisionsNetOfReversalsAndRecoveriesOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BMSAssetsMember_73bf312b-2844-4ef6-92dd-6e5c561a02cb_terseLabel_en-US" xlink:label="lab_gsk_BMSAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BMS Assets</link:label>
    <link:label id="lab_gsk_BMSAssetsMember_label_en-US" xlink:label="lab_gsk_BMSAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BMS Assets [Member]</link:label>
    <link:label id="lab_gsk_BMSAssetsMember_documentation_en-US" xlink:label="lab_gsk_BMSAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BMS Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BMSAssetsMember" xlink:href="gsk-20241231.xsd#gsk_BMSAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BMSAssetsMember" xlink:to="lab_gsk_BMSAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember_7e709cef-4a48-4020-b8c4-0a290d53c746_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives classified as held for trading</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, classified as held for trading, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_c09ff63c-f4aa-4d2c-8af7-722bae5b1040_totalLabel_en-US" xlink:label="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_label_en-US" xlink:label="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Assets Liabilities Including Goodwill As Of Acquisition Date</link:label>
    <link:label id="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net assets liabilities including goodwill as of acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" xlink:href="gsk-20241231.xsd#gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" xlink:to="lab_gsk_NetAssetsLiabilitiesIncludingGoodwillAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZeroPointTwoFivePercentMember_a4112bf7-22e8-44c4-9cce-ff41c945a380_terseLabel_en-US" xlink:label="lab_gsk_ZeroPointTwoFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">0.25% increase / decrease</link:label>
    <link:label id="lab_gsk_ZeroPointTwoFivePercentMember_label_en-US" xlink:label="lab_gsk_ZeroPointTwoFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zero Point Two Five Percent [Member]</link:label>
    <link:label id="lab_gsk_ZeroPointTwoFivePercentMember_documentation_en-US" xlink:label="lab_gsk_ZeroPointTwoFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zero Point Two Five Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZeroPointTwoFivePercentMember" xlink:href="gsk-20241231.xsd#gsk_ZeroPointTwoFivePercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZeroPointTwoFivePercentMember" xlink:to="lab_gsk_ZeroPointTwoFivePercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemuneration_cc791d08-c6c6-44aa-bfa0-4eeeaf001b60_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fees payable to the company&#8217;s auditor and its associates in relation to the Group (see below)</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemuneration_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor's remuneration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemuneration" xlink:to="lab_ifrs-full_AuditorsRemuneration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1438c955-64c7-44f6-a715-864abd36912d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseInPlanDeficit_11c77e1a-12d7-4052-9cf5-3dbf853d1c23_terseLabel_en-US" xlink:label="lab_gsk_IncreaseInPlanDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net pension deficit</link:label>
    <link:label id="lab_gsk_IncreaseInPlanDeficit_label_en-US" xlink:label="lab_gsk_IncreaseInPlanDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase In Plan Deficit</link:label>
    <link:label id="lab_gsk_IncreaseInPlanDeficit_documentation_en-US" xlink:label="lab_gsk_IncreaseInPlanDeficit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase in plan deficit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInPlanDeficit" xlink:href="gsk-20241231.xsd#gsk_IncreaseInPlanDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseInPlanDeficit" xlink:to="lab_gsk_IncreaseInPlanDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_d1d092a1-dd96-4472-a575-16fb427c6b5f_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through financing cash flows, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_68d8b5c1-5fdb-4d88-9a9f-241689b86740_terseLabel_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortisation of intangible assets</link:label>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_ade72701-ccb6-4a84-8c14-206aaed94203_negatedLabel_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Charge for the year</link:label>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_89aaa7a0-1bf7-4277-81aa-586e7ff1291f_verboseLabel_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortisation</link:label>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_72cc3ca6-1c54-4167-9bfe-8b60f2cc3048_terseLabel_en-US" xlink:label="lab_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative gain (loss) on disposal of investments</link:label>
    <link:label id="lab_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative gain (loss) on disposal of investments in equity instruments designated at fair value through other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:to="lab_ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementAxis_49a49234-0fa6-4e04-84fd-17fd843b5dda_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
    <link:label id="lab_ifrs-full_MeasurementAxis_label_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis" xlink:to="lab_ifrs-full_MeasurementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_a751f2bb-8192-460a-9711-2fd475fbacb3_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionalRecognitionGoodwill_46cbd0ca-bcee-4c1b-9631-55a83f0b6db0_verboseLabel_en-US" xlink:label="lab_ifrs-full_AdditionalRecognitionGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions through business combinations (Note 41)</link:label>
    <link:label id="lab_ifrs-full_AdditionalRecognitionGoodwill_label_en-US" xlink:label="lab_ifrs-full_AdditionalRecognitionGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional recognition, goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalRecognitionGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionalRecognitionGoodwill" xlink:to="lab_ifrs-full_AdditionalRecognitionGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired_5ef90bf7-9838-4992-846d-402571b5fe84_negatedTerseLabel_en-US" xlink:label="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net investments/(debt) of subsidiary undertakings acquired</link:label>
    <link:label id="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired_label_en-US" xlink:label="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment (Debt) Of Subsidiary Undertakings Acquired</link:label>
    <link:label id="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired_documentation_en-US" xlink:label="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt of subsidiary undertakings acquired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" xlink:href="gsk-20241231.xsd#gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" xlink:to="lab_gsk_NetInvestmentDebtOfSubsidiaryUndertakingsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EsopTrustMember_ee5dc6cd-d142-485d-b08f-b44203b2555a_terseLabel_en-US" xlink:label="lab_gsk_EsopTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESOP trust shares</link:label>
    <link:label id="lab_gsk_EsopTrustMember_label_en-US" xlink:label="lab_gsk_EsopTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ESOP Trust [member]</link:label>
    <link:label id="lab_gsk_EsopTrustMember_documentation_en-US" xlink:label="lab_gsk_EsopTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ESOP Trust.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EsopTrustMember" xlink:href="gsk-20241231.xsd#gsk_EsopTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EsopTrustMember" xlink:to="lab_gsk_EsopTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarryInterestAtEffectiveRates_3e74e2f8-d560-4a06-8968-fae33bd5d0ef_terseLabel_en-US" xlink:label="lab_gsk_CarryInterestAtEffectiveRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest at effective rates</link:label>
    <link:label id="lab_gsk_CarryInterestAtEffectiveRates_label_en-US" xlink:label="lab_gsk_CarryInterestAtEffectiveRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carry Interest At Effective Rates</link:label>
    <link:label id="lab_gsk_CarryInterestAtEffectiveRates_documentation_en-US" xlink:label="lab_gsk_CarryInterestAtEffectiveRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carry interest at effective rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryInterestAtEffectiveRates" xlink:href="gsk-20241231.xsd#gsk_CarryInterestAtEffectiveRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarryInterestAtEffectiveRates" xlink:to="lab_gsk_CarryInterestAtEffectiveRates" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes_dff35a00-92e1-4ad2-aff0-1bb6b4d935bc_terseLabel_en-US" xlink:label="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued under employee share schemes (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes_label_en-US" xlink:label="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Shares Issued And Fully Paid Under Employee Share Schemes</link:label>
    <link:label id="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes_documentation_en-US" xlink:label="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid under employee share schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" xlink:href="gsk-20241231.xsd#gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" xlink:to="lab_gsk_NumberOfSharesIssuedAndFullyPaidUnderEmployeeShareSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RevolvingCreditFacilities_0742cf86-f1e7-496e-b6a1-597f33540b1e_terseLabel_en-US" xlink:label="lab_gsk_RevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit facilities</link:label>
    <link:label id="lab_gsk_RevolvingCreditFacilities_label_en-US" xlink:label="lab_gsk_RevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facilities</link:label>
    <link:label id="lab_gsk_RevolvingCreditFacilities_documentation_en-US" xlink:label="lab_gsk_RevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revolving Credit Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilities" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RevolvingCreditFacilities" xlink:to="lab_gsk_RevolvingCreditFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_f86d09d2-fef4-40b7-b5e0-ee08e9b53875_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TradesAndOtherPayablesMember_b9769fbc-4f6b-46ae-90c3-ff394388c5ed_terseLabel_en-US" xlink:label="lab_gsk_TradesAndOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_gsk_TradesAndOtherPayablesMember_label_en-US" xlink:label="lab_gsk_TradesAndOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trades And Other Payables [Member]</link:label>
    <link:label id="lab_gsk_TradesAndOtherPayablesMember_documentation_en-US" xlink:label="lab_gsk_TradesAndOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trades and other payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradesAndOtherPayablesMember" xlink:href="gsk-20241231.xsd#gsk_TradesAndOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TradesAndOtherPayablesMember" xlink:to="lab_gsk_TradesAndOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermEmployeeBenefitsExpenseAbstract_label_en-US" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term employee benefits expense [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsExpenseAbstract" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock_0e613c1a-ad88-4ee2-9beb-3ba1285e9fb1_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Interim Financial Reporting</link:label>
    <link:label id="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Interim Dividend Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of interim dividend explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfInterimDividendExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_ec69c05d-1c4a-4cee-b69a-ed61941ffac8_verboseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Items that may be reclassified subsequently to continuing operations income statement:</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_13508ba9-dd12-408f-b81f-2d60f300d44e_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Items that may be subsequently reclassified to income statement:</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ea77f33b-bb75-44c1-b85f-54db762e3740_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets_55b223e3-6634-47b0-8699-29be340875a6_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Subsequent recoveries of amounts provided for</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Subsequent Recoveries Of Amounts Provided For, Financial Assets</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Subsequent Recoveries Of Amounts Provided For, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" xlink:to="lab_gsk_IncreaseDecreaseThroughSubsequentRecoveriesOfAmountsProvidedForFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_6d220689-4b31-4960-a69d-dd69c7f57be3_terseLabel_en-US" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilution for share options and awards, (in shares)</link:label>
    <link:label id="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_label_en-US" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dilutive effect of share options on weighted average number of ordinary shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfLargestUSWholesalers_f03925b6-513c-4155-a496-ce4f25173c1b_terseLabel_en-US" xlink:label="lab_gsk_NumberOfLargestUSWholesalers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of largest US wholesalers</link:label>
    <link:label id="lab_gsk_NumberOfLargestUSWholesalers_label_en-US" xlink:label="lab_gsk_NumberOfLargestUSWholesalers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Largest US Wholesalers</link:label>
    <link:label id="lab_gsk_NumberOfLargestUSWholesalers_documentation_en-US" xlink:label="lab_gsk_NumberOfLargestUSWholesalers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Largest US Wholesalers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfLargestUSWholesalers" xlink:href="gsk-20241231.xsd#gsk_NumberOfLargestUSWholesalers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfLargestUSWholesalers" xlink:to="lab_gsk_NumberOfLargestUSWholesalers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_98391b7a-9e35-4788-9aee-6257875ff668_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for fair value losses (gains)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset_ad4d2b5b-07b0-4aed-bee4-056e136f9983_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Expenses Net Defined Benefit Liability (Asset)</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments in expenses net defined benefit liability asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" xlink:to="lab_gsk_IncreaseDecreaseInExpensesNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DTMember_d67d16d2-2c2d-4131-b295-2f15c7cc489d_terseLabel_en-US" xlink:label="lab_gsk_DTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DT</link:label>
    <link:label id="lab_gsk_DTMember_label_en-US" xlink:label="lab_gsk_DTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DT [Member]</link:label>
    <link:label id="lab_gsk_DTMember_documentation_en-US" xlink:label="lab_gsk_DTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">DT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DTMember" xlink:href="gsk-20241231.xsd#gsk_DTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DTMember" xlink:to="lab_gsk_DTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineIhcLimitedMember_ea8fa81d-85a7-47f4-9e4f-3439b9a27885_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineIhcLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline IHC Limited</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIhcLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineIhcLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline IHC Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIhcLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineIhcLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline IHC Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIhcLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIhcLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineIhcLimitedMember" xlink:to="lab_gsk_GlaxosmithklineIhcLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_1b9efd3f-3daa-4089-bfad-cac3c7a03972_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based incentive plans</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for share-based payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PandemicVaccinesMember_5061d154-5795-4bac-8135-ed729eb5c39c_terseLabel_en-US" xlink:label="lab_gsk_PandemicVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pandemic Vaccines</link:label>
    <link:label id="lab_gsk_PandemicVaccinesMember_label_en-US" xlink:label="lab_gsk_PandemicVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pandemic Vaccines [Member]</link:label>
    <link:label id="lab_gsk_PandemicVaccinesMember_documentation_en-US" xlink:label="lab_gsk_PandemicVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pandemic vaccines member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PandemicVaccinesMember" xlink:href="gsk-20241231.xsd#gsk_PandemicVaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PandemicVaccinesMember" xlink:to="lab_gsk_PandemicVaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointVenturesAxis_b0492af1-7635-41b3-8b0e-0ebaa2461e1d_terseLabel_en-US" xlink:label="lab_ifrs-full_JointVenturesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint ventures [axis]</link:label>
    <link:label id="lab_ifrs-full_JointVenturesAxis_label_en-US" xlink:label="lab_ifrs-full_JointVenturesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint ventures [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointVenturesAxis" xlink:to="lab_ifrs-full_JointVenturesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssets_32f1d92a-cff2-4c84-a817-e5e537b333e5_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssets_3de1b7f1-a378-400f-85c3-68666e6ea646_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember_da144ff0-a811-423b-b3cf-f1f649c3e440_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15% decrease in sales forecasts</link:label>
    <link:label id="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember_label_en-US" xlink:label="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk Fifteen Percentage Decrease In Sales Forecasts [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk fifteen percentage decrease in sales forecasts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" xlink:href="gsk-20241231.xsd#gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" xlink:to="lab_gsk_OtherRiskFifteenPercentageDecreaseInSalesForecastsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MiscellaneousOtherIncomeExpense_60f337a6-1f97-4dfc-9808-6b760e7dba26_terseLabel_en-US" xlink:label="lab_gsk_MiscellaneousOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense)/income</link:label>
    <link:label id="lab_gsk_MiscellaneousOtherIncomeExpense_label_en-US" xlink:label="lab_gsk_MiscellaneousOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous Other Income (Expense)</link:label>
    <link:label id="lab_gsk_MiscellaneousOtherIncomeExpense_documentation_en-US" xlink:label="lab_gsk_MiscellaneousOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Miscellaneous Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousOtherIncomeExpense" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MiscellaneousOtherIncomeExpense" xlink:to="lab_gsk_MiscellaneousOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_8363ce62-fd12-469f-a53f-9945a983e450_totalLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income/(expense) for the year</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems_9a3e92b3-20b3-4361-b570-f96832b5f6c1_terseLabel_en-US" xlink:label="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense from share based payment transactions with employees [line items]</link:label>
    <link:label id="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems_label_en-US" xlink:label="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense From Share Based Payment Transactions With Employees [line items]</link:label>
    <link:label id="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems_documentation_en-US" xlink:label="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expense From Share Based Payment Transactions With Employees [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" xlink:href="gsk-20241231.xsd#gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" xlink:to="lab_gsk_ExpenseFromShareBasedPaymentTransactionsWithEmployeesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cd0dcf8a-49b1-4148-9f29-6c2000aadae2_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BancaPopolareDiSondrioMember_1cdc9895-5511-4163-89fa-31a066075e53_terseLabel_en-US" xlink:label="lab_gsk_BancaPopolareDiSondrioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Banca Popolare Di Sondrio</link:label>
    <link:label id="lab_gsk_BancaPopolareDiSondrioMember_label_en-US" xlink:label="lab_gsk_BancaPopolareDiSondrioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Banca Popolare Di Sondrio [Member]</link:label>
    <link:label id="lab_gsk_BancaPopolareDiSondrioMember_documentation_en-US" xlink:label="lab_gsk_BancaPopolareDiSondrioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Banca Popolare Di Sondrio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancaPopolareDiSondrioMember" xlink:href="gsk-20241231.xsd#gsk_BancaPopolareDiSondrioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BancaPopolareDiSondrioMember" xlink:to="lab_gsk_BancaPopolareDiSondrioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineSPAMember_c5e45e64-7dd9-44eb-a560-c32bf0819e37_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineSPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline S.p.A. (Italy)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineSPAMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineSPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline S P A [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineSPAMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineSPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline S.p.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineSPAMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineSPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineSPAMember" xlink:to="lab_gsk_GlaxoSmithKlineSPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDebtInstrumentsIssued_bd6c7035-e574-4380-9a47-53f6681fa3ef_negatedLabel_en-US" xlink:label="lab_ifrs-full_CurrentDebtInstrumentsIssued" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_ifrs-full_CurrentDebtInstrumentsIssued_label_en-US" xlink:label="lab_ifrs-full_CurrentDebtInstrumentsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current debt instruments issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDebtInstrumentsIssued" xlink:to="lab_ifrs-full_CurrentDebtInstrumentsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_90051e2a-6490-4eca-92de-61853fa5b2d2_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax_01ff4b08-9f9c-49ad-a8d8-3c8f51504d63_terseLabel_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedged future cash flows no longer expected to occur</link:label>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax_label_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on cash flow hedges for which hedged future cash flows are no longer expected to occur, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedFutureCashFlowsAreNoLongerExpectedToOccurNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_a794b3ce-137c-44a1-b162-f726285bbd84_periodStartLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning of investments</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_5660921c-dd8e-4154-aa47-1e1f14afef33_periodEndLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending of investments</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates reported in separate financial statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_VehiclesMember_f241aaa5-fbef-4bf7-91bd-290f30f667f0_terseLabel_en-US" xlink:label="lab_ifrs-full_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_ifrs-full_VehiclesMember_label_en-US" xlink:label="lab_ifrs-full_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vehicles [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_VehiclesMember" xlink:to="lab_ifrs-full_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_879ecb46-a5d6-45e4-9481-46f8942193b9_terseLabel_en-US" xlink:label="lab_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average interest rate for capitalised borrowing costs</link:label>
    <link:label id="lab_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_label_en-US" xlink:label="lab_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalisation rate of borrowing costs eligible for capitalisation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:to="lab_ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_5357ee3c-4e83-4977-94f3-0b04d0b22f53_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Profit after taxation from discontinued operations</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_4cadd03d-8ae5-4416-aaa6-0eca49b67944_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Loss)/profit after taxation from discontinued operations: Consumer Healthcare</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_label_en-US" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AwardType1Axis_8e93ce27-21b9-4f12-ac32-c8e30f88488a_terseLabel_en-US" xlink:label="lab_gsk_AwardType1Axis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award type</link:label>
    <link:label id="lab_gsk_AwardType1Axis_label_en-US" xlink:label="lab_gsk_AwardType1Axis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type 1 [axis]</link:label>
    <link:label id="lab_gsk_AwardType1Axis_documentation_en-US" xlink:label="lab_gsk_AwardType1Axis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information by award type pertaining to equity-based compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AwardType1Axis" xlink:href="gsk-20241231.xsd#gsk_AwardType1Axis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AwardType1Axis" xlink:to="lab_gsk_AwardType1Axis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDebt_15f89a3e-8ce2-4400-bad1-f1b7d167922d_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NetDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_ifrs-full_NetDebt_label_en-US" xlink:label="lab_ifrs-full_NetDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDebt" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDebt" xlink:to="lab_ifrs-full_NetDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CounterpartiesAxis_137f12ab-fdd7-484d-b0ad-9b1be9287027_terseLabel_en-US" xlink:label="lab_ifrs-full_CounterpartiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparties [axis]</link:label>
    <link:label id="lab_ifrs-full_CounterpartiesAxis_label_en-US" xlink:label="lab_ifrs-full_CounterpartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparties [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis" xlink:to="lab_ifrs-full_CounterpartiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions_95a084c3-f63c-4086-b4ce-c3b6dce69b60_terseLabel_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deficit reduction contributions</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions_label_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Deficit Reduction Contributions</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions_documentation_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Deficit Reduction Contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" xlink:to="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromDeficitReductionContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_0a6df4cb-5ffd-4e18-9fad-2776bb4cb1f3_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deconsolidation of former subsidiaries</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through disposal of subsidiary, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_eac1887c-78dc-4213-8914-adaa0940238f_terseLabel_en-US" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_label_en-US" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MajorRestructuringProgrammesMember_44f74cd9-6539-48db-b68e-faea3223afe1_terseLabel_en-US" xlink:label="lab_gsk_MajorRestructuringProgrammesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major restructuring programmes</link:label>
    <link:label id="lab_gsk_MajorRestructuringProgrammesMember_label_en-US" xlink:label="lab_gsk_MajorRestructuringProgrammesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Restructuring Programmes [member]</link:label>
    <link:label id="lab_gsk_MajorRestructuringProgrammesMember_documentation_en-US" xlink:label="lab_gsk_MajorRestructuringProgrammesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major restructuring programmes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MajorRestructuringProgrammesMember" xlink:href="gsk-20241231.xsd#gsk_MajorRestructuringProgrammesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MajorRestructuringProgrammesMember" xlink:to="lab_gsk_MajorRestructuringProgrammesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OTPBankMember_07bdb609-5113-495d-bdd1-3e0ea1401b60_terseLabel_en-US" xlink:label="lab_gsk_OTPBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OTP Bank</link:label>
    <link:label id="lab_gsk_OTPBankMember_label_en-US" xlink:label="lab_gsk_OTPBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OTP Bank [Member]</link:label>
    <link:label id="lab_gsk_OTPBankMember_documentation_en-US" xlink:label="lab_gsk_OTPBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">OTP Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OTPBankMember" xlink:href="gsk-20241231.xsd#gsk_OTPBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OTPBankMember" xlink:to="lab_gsk_OTPBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ListedInvestments_4dfb1968-68da-499e-ae7b-8a4de6392bd7_terseLabel_en-US" xlink:label="lab_gsk_ListedInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Listed investments</link:label>
    <link:label id="lab_gsk_ListedInvestments_label_en-US" xlink:label="lab_gsk_ListedInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Listed Investments</link:label>
    <link:label id="lab_gsk_ListedInvestments_documentation_en-US" xlink:label="lab_gsk_ListedInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Listed investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ListedInvestments" xlink:href="gsk-20241231.xsd#gsk_ListedInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ListedInvestments" xlink:to="lab_gsk_ListedInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock_95fe535c-f874-44b4-866c-507161a9e462_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Cash and Cash Equivalents</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about cash and cash equivalents [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure for detailed information about cash and cash equivalent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_5d5da6a3-3f65-4866-ad6c-7b0b4f7fdd0e_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associates [axis]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associates [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_5166ae69-cd28-42e1-8813-077c8c96a6a8_terseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences on disposals, acquisitions and transfers (in percent)</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect Of Permanent Differences Percentage On Disposals Acquisitions and Transfers</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Rate Effect Of Permanent Differences Percentage On Disposals Acquisitions and Transfers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" xlink:to="lab_gsk_TaxRateEffectOfPermanentDifferencesPercentageOnDisposalsAcquisitionsAndTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IteosAssetsMember_5b7e8741-7d0b-4923-b71c-dda835a79576_terseLabel_en-US" xlink:label="lab_gsk_IteosAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Iteos Assets</link:label>
    <link:label id="lab_gsk_IteosAssetsMember_label_en-US" xlink:label="lab_gsk_IteosAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Iteos Assets [Member]</link:label>
    <link:label id="lab_gsk_IteosAssetsMember_documentation_en-US" xlink:label="lab_gsk_IteosAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Iteos Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IteosAssetsMember" xlink:href="gsk-20241231.xsd#gsk_IteosAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IteosAssetsMember" xlink:to="lab_gsk_IteosAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePercentMember_72c4813f-1f68-4f08-b264-f836e90da106_terseLabel_en-US" xlink:label="lab_gsk_OnePercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One percent increase</link:label>
    <link:label id="lab_gsk_OnePercentMember_label_en-US" xlink:label="lab_gsk_OnePercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Percent [Member]</link:label>
    <link:label id="lab_gsk_OnePercentMember_documentation_en-US" xlink:label="lab_gsk_OnePercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePercentMember" xlink:href="gsk-20241231.xsd#gsk_OnePercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePercentMember" xlink:to="lab_gsk_OnePercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_f1d3447b-e7f0-4db4-aade-7419a022cd2e_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total charge/(credit) to equity and statement of comprehensive income</link:label>
    <link:label id="lab_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_label_en-US" xlink:label="lab_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current and deferred tax relating to items credited (charged) directly to equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:to="lab_ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember_6c0f72a1-3bd9-4480-b9eb-2f04a93681ed_terseLabel_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate at 0.75%</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember_label_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Discount Rates at Zero Point Seven Five Percent [Member]</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember_documentation_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Discount Rates at Zero Point Seven Five Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" xlink:to="lab_gsk_ActuarialAssumptionOfDiscountRatesAtZeroPointSevenFivePercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember_44e5a428-4b0c-4918-8087-5121b192dd2c_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Brasil Limitada (Brazil)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Brasil Limitada [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Brasil Limitada.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineBrasilLimitadaMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineBrasilLimitadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineBrasilLimitadaMember" xlink:to="lab_gsk_GlaxoSmithKlineBrasilLimitadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock_3aa72673-35bc-4666-940f-93559383b9c4_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Defined Benefit Pension Obligation Analysed by Membership Category</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Pension Obligation Analysed By Membership Category Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit pension obligation analysed by membership category explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPensionObligationAnalysedByMembershipCategoryExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_0bfcdab5-dc88-4317-a904-8f412d5417fd_terseLabel_en-US" xlink:label="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated rebates, discounts or allowances payable to customers</link:label>
    <link:label id="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_label_en-US" xlink:label="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Rebates Discounts or Allowance Payable To Customer [member]</link:label>
    <link:label id="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember_documentation_en-US" xlink:label="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Estimated rebates discounts or allowance payable to customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" xlink:href="gsk-20241231.xsd#gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" xlink:to="lab_gsk_EstimatedRebatesDiscountsOrAllowancePayableToCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_1bf8b980-ecac-4277-8a91-1aa6fea2f290_verboseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease charge</link:label>
    <link:label id="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_label_en-US" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to short-term leases for which recognition exemption has been used</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilities_d9d1db85-1112-48b9-ab5c-eaf13d218847_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilities_5cd8aeec-3775-4db0-9876-a634ba06727d_negatedLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="lab_ifrs-full_CurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ChangeInAssumptionsDomain_7b1cca1c-4e13-4b73-938e-31eb80ce5611_terseLabel_en-US" xlink:label="lab_gsk_ChangeInAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change In Assumptions [Domain]</link:label>
    <link:label id="lab_gsk_ChangeInAssumptionsDomain_label_en-US" xlink:label="lab_gsk_ChangeInAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change In Assumptions [Domain]</link:label>
    <link:label id="lab_gsk_ChangeInAssumptionsDomain_documentation_en-US" xlink:label="lab_gsk_ChangeInAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change In Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInAssumptionsDomain" xlink:href="gsk-20241231.xsd#gsk_ChangeInAssumptionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ChangeInAssumptionsDomain" xlink:to="lab_gsk_ChangeInAssumptionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_0779a7a0-70f9-4c31-9512-57eaee298a6e_negatedLabel_en-US" xlink:label="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange forward contracts and swaps</link:label>
    <link:label id="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_label_en-US" xlink:label="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables On Derivative Financial Instruments Undiscounted Cash Flows</link:label>
    <link:label id="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_documentation_en-US" xlink:label="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payables on derivative financial instruments undiscounted cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:href="gsk-20241231.xsd#gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:to="lab_gsk_PayablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForAmortisationExpense_9d6d7dee-2860-4c49-90e2-56f30fce11f4_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortisation of intangible assets</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForAmortisationExpense_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for amortisation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="lab_ifrs-full_AdjustmentsForAmortisationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_b461b71a-cfaf-4aeb-b025-4c4c8c0e57e2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermLegalProceedingsProvision_16cf771d-8c8d-4e42-ad81-5ee33cd3559f_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermLegalProceedingsProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short term legal proceedings</link:label>
    <link:label id="lab_ifrs-full_ShorttermLegalProceedingsProvision_label_en-US" xlink:label="lab_ifrs-full_ShorttermLegalProceedingsProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current legal proceedings provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermLegalProceedingsProvision" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermLegalProceedingsProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermLegalProceedingsProvision" xlink:to="lab_ifrs-full_ShorttermLegalProceedingsProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_b0d3442d-5412-4635-8c64-44866f86995d_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate of future healthcare inflation</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of medical cost trend rates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGoodwillExplanatory_86596de9-28d8-4b96-b8c0-c28e3b62c114_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AllocationToReturnSeekingAssets_a2a9ec9c-be7f-4332-a8e0-ecd30c06a01f_terseLabel_en-US" xlink:label="lab_gsk_AllocationToReturnSeekingAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage allocated to return seeking assets</link:label>
    <link:label id="lab_gsk_AllocationToReturnSeekingAssets_label_en-US" xlink:label="lab_gsk_AllocationToReturnSeekingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocation To Return Seeking Assets</link:label>
    <link:label id="lab_gsk_AllocationToReturnSeekingAssets_documentation_en-US" xlink:label="lab_gsk_AllocationToReturnSeekingAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Allocation to return seeking assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AllocationToReturnSeekingAssets" xlink:href="gsk-20241231.xsd#gsk_AllocationToReturnSeekingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AllocationToReturnSeekingAssets" xlink:to="lab_gsk_AllocationToReturnSeekingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestReceivable_6bb7a867-526d-4111-b2e0-c0a016f6657f_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_ifrs-full_InterestReceivable_label_en-US" xlink:label="lab_ifrs-full_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivable" xlink:to="lab_ifrs-full_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_1c505dc5-fe0e-414f-b230-eda4b84c4db8_terseLabel_en-US" xlink:label="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments held as current assets</link:label>
    <link:label id="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Held As Current Assets Recognised As Of Acquisition Date</link:label>
    <link:label id="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments Held As Current Assets Recognised As Of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:href="gsk-20241231.xsd#gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:to="lab_gsk_InvestmentsHeldAsCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_7340f36b-5405-4c2b-a610-26ab1c6fb33e_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of accounting principles and policies [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounting Principles And Policies [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting principles and policies [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems" xlink:to="lab_gsk_DisclosureOfAccountingPrinciplesAndPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_3dc36b4f-2ce7-47ed-8585-030ce6112f4d_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_b39b95a2-d40c-4bbf-ad54-61cd0e8354ae_negatedLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DerivativeFinancialInstrumentsMember_ae63bb7d-7765-4736-b3ac-e77507c7a7e5_terseLabel_en-US" xlink:label="lab_gsk_DerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_gsk_DerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_gsk_DerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments [Member]</link:label>
    <link:label id="lab_gsk_DerivativeFinancialInstrumentsMember_documentation_en-US" xlink:label="lab_gsk_DerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative financial instruments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DerivativeFinancialInstrumentsMember" xlink:href="gsk-20241231.xsd#gsk_DerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DerivativeFinancialInstrumentsMember" xlink:to="lab_gsk_DerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_41bd677d-6bfa-45e9-9521-0e598b442033_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10% increase in sales forecasts</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Percentage Increase In Sales Forecasts Or Sales Multiple Applied [member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Percentage Increase In Sales Forecasts Or Sales Multiple Applied [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:to="lab_gsk_CurrencyRiskTenPercentageIncreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill_9f12d6d5-0bf8-4667-9287-dd3b8858872a_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_260473d1-a14b-46aa-98b2-22cd741bbd20_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_VN_eef0087e-7df6-456d-bf48-4032e0ed9e14_terseLabel_en-US" xlink:label="lab_country_VN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vietnam</link:label>
    <link:label id="lab_country_VN_label_en-US" xlink:label="lab_country_VN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">VIET NAM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_VN" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_VN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_VN" xlink:to="lab_country_VN" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_a22466a8-1b0d-4853-8789-7e0af1ead420_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on equity investments</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) from investments in equity instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasDomain_776fe1e8-c901-403c-9d9c-74c375dcc999_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical areas</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasDomain_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasDomain" xlink:to="lab_ifrs-full_GeographicalAreasDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_a2e91568-6db4-4210-ab5f-a02b73dee93d_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15% decrease in sales forecasts</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Percentage Decrease In Sales Forecasts Or Sales Multiple Applied [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk Fifteen Percentage Decrease In Sales Forecasts Or Sales Multiple Applied</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:to="lab_gsk_CurrencyRiskFifteenPercentageDecreaseInSalesForecastsOrSalesMultipleAppliedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProductsAndServicesAxis_7e4bfe8d-6adb-4b16-8659-689beafbe85e_terseLabel_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Products and services [axis]</link:label>
    <link:label id="lab_ifrs-full_ProductsAndServicesAxis_label_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Products and services [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesAxis" xlink:to="lab_ifrs-full_ProductsAndServicesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfIncreaseInDiscountRate_92865d0d-5d0b-445f-9dee-e78a577fd97c_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of increase in discount rate</link:label>
    <link:label id="lab_gsk_PercentageOfIncreaseInDiscountRate_label_en-US" xlink:label="lab_gsk_PercentageOfIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Increase In Discount Rate</link:label>
    <link:label id="lab_gsk_PercentageOfIncreaseInDiscountRate_documentation_en-US" xlink:label="lab_gsk_PercentageOfIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of increase in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfIncreaseInDiscountRate" xlink:href="gsk-20241231.xsd#gsk_PercentageOfIncreaseInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfIncreaseInDiscountRate" xlink:to="lab_gsk_PercentageOfIncreaseInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfCancerTypes_099bdad1-3f96-4074-a620-3f38eac1d717_terseLabel_en-US" xlink:label="lab_gsk_NumberOfCancerTypes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cancer types</link:label>
    <link:label id="lab_gsk_NumberOfCancerTypes_label_en-US" xlink:label="lab_gsk_NumberOfCancerTypes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Cancer Types</link:label>
    <link:label id="lab_gsk_NumberOfCancerTypes_documentation_en-US" xlink:label="lab_gsk_NumberOfCancerTypes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Cancer Types</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfCancerTypes" xlink:href="gsk-20241231.xsd#gsk_NumberOfCancerTypes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfCancerTypes" xlink:to="lab_gsk_NumberOfCancerTypes" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid_d4d65794-5f12-4ea5-9031-b72f189952da_terseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments: operating cash flows</link:label>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid_e97337e3-f63e-4f50-b041-d5e286f60516_verboseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration paid (see Note 33)</link:label>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid_label_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For (Decrease) Increase In Contingent Consideration Paid</link:label>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for decrease increase in contingent consideration paid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:to="lab_gsk_AdjustmentsForDecreaseIncreaseInContingentConsiderationPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_e9004fee-ce57-48fd-b001-8dba9fab8a75_negatedLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Awards exercised (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShareValuePlanMember_6a86df76-4caf-45de-8892-a85c2bd80166_terseLabel_en-US" xlink:label="lab_gsk_ShareValuePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share value plan</link:label>
    <link:label id="lab_gsk_ShareValuePlanMember_label_en-US" xlink:label="lab_gsk_ShareValuePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Value Plan [member]</link:label>
    <link:label id="lab_gsk_ShareValuePlanMember_documentation_en-US" xlink:label="lab_gsk_ShareValuePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share value plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareValuePlanMember" xlink:href="gsk-20241231.xsd#gsk_ShareValuePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShareValuePlanMember" xlink:to="lab_gsk_ShareValuePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_f719da41-d20d-43bf-ae51-7366a9f73cca_terseLabel_en-US" xlink:label="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities mandatorily measured at fair value through profit or loss (FVTPL):</link:label>
    <link:label id="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_label_en-US" xlink:label="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, mandatorily measured at fair value, category [member]</link:label>
    <link:label id="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_documentation_en-US" xlink:label="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, mandatorily measured at fair value, category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:href="gsk-20241231.xsd#gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:to="lab_gsk_FinancialLiabilitiesAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CostOfSalesMember_b02777d9-4524-42ab-a3f2-57a75f36ab2e_terseLabel_en-US" xlink:label="lab_ifrs-full_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_ifrs-full_CostOfSalesMember_label_en-US" xlink:label="lab_ifrs-full_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSalesMember" xlink:to="lab_ifrs-full_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationAbstract_608e9647-4059-45e1-a9b5-30cb7bce913a_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor's remuneration [abstract]</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationAbstract_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor's remuneration [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract" xlink:to="lab_ifrs-full_AuditorsRemunerationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AmortizedCostMember_a455bb28-534b-4679-8b48-7bea73a0002c_terseLabel_en-US" xlink:label="lab_gsk_AmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_gsk_AmortizedCostMember_label_en-US" xlink:label="lab_gsk_AmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortized Cost [Member]</link:label>
    <link:label id="lab_gsk_AmortizedCostMember_documentation_en-US" xlink:label="lab_gsk_AmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortized Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AmortizedCostMember" xlink:href="gsk-20241231.xsd#gsk_AmortizedCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AmortizedCostMember" xlink:to="lab_gsk_AmortizedCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember_ee002eeb-b812-489e-89c4-5b8f1e10e918_terseLabel_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">6.375% US$ US Medium Note 2038</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember_label_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Six Point Three Seven Five Percent US Medium Term Note Two Thousand Thirty Eight [member]</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember_documentation_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Six point three seven five percent US medium term note two thousand thirty eight.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" xlink:to="lab_gsk_SixPointThreeSevenFivePercentUsMediumTermNoteTwoThousandThirtyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems_cca6ab7c-e3e6-4906-bcd2-48917e76cba3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of products and services [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of products and services [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:to="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfRisksDomain_3e534ecb-c2cb-4b24-911e-ebf626d83258_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfRisksDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of risks [domain]</link:label>
    <link:label id="lab_ifrs-full_TypesOfRisksDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfRisksDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of risks [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksDomain" xlink:to="lab_ifrs-full_TypesOfRisksDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncomeTaxExpenseBenefitsTable_2ced8a17-658d-4156-bbbb-3567f38776ed_terseLabel_en-US" xlink:label="lab_gsk_IncomeTaxExpenseBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Expense Benefits [table]</link:label>
    <link:label id="lab_gsk_IncomeTaxExpenseBenefitsTable_label_en-US" xlink:label="lab_gsk_IncomeTaxExpenseBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense Benefits [table]</link:label>
    <link:label id="lab_gsk_IncomeTaxExpenseBenefitsTable_documentation_en-US" xlink:label="lab_gsk_IncomeTaxExpenseBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Expense Benefits [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncomeTaxExpenseBenefitsTable" xlink:href="gsk-20241231.xsd#gsk_IncomeTaxExpenseBenefitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncomeTaxExpenseBenefitsTable" xlink:to="lab_gsk_IncomeTaxExpenseBenefitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdditionsToOtherInvestments_62117b17-bca4-4a66-bc11-1892bdb86cac_terseLabel_en-US" xlink:label="lab_gsk_AdditionsToOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_gsk_AdditionsToOtherInvestments_label_en-US" xlink:label="lab_gsk_AdditionsToOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions To Other Investments</link:label>
    <link:label id="lab_gsk_AdditionsToOtherInvestments_documentation_en-US" xlink:label="lab_gsk_AdditionsToOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additions to other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsToOtherInvestments" xlink:href="gsk-20241231.xsd#gsk_AdditionsToOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdditionsToOtherInvestments" xlink:to="lab_gsk_AdditionsToOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_243fbcb8-0f65-4162-b49c-2484a2af8c1e_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsDomain_52ba40e1-7bfc-4bd8-b47e-7d5fa494cf54_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsDomain_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain" xlink:to="lab_ifrs-full_ActuarialAssumptionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivables_7f6f334c-1b1f-45a1-8f8a-a2c963ce5e3d_totalLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total trade and other receivables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivables_937d7f97-2c46-4a50-b04b-ee5731c3bcc2_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total trade and other receivables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivables_95f06337-910f-4dfa-90a3-f83dde6e4f40_verboseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables (Note 26)</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivables_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables" xlink:to="lab_ifrs-full_TradeAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves_db192d1c-8526-4c97-a779-ca2c4757aacc_negatedLabel_en-US" xlink:label="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares acquired by ESOP Trusts</link:label>
    <link:label id="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves_label_en-US" xlink:label="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary Shares Acquired By Esop Trusts Included In Other Reserves</link:label>
    <link:label id="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves_documentation_en-US" xlink:label="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ordinary shares acquired by Esop trusts included in other reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" xlink:href="gsk-20241231.xsd#gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" xlink:to="lab_gsk_OrdinarySharesAcquiredByEsopTrustsIncludedInOtherReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax_a2fb8ccf-83f5-43d8-be40-13ccc9d165f8_terseLabel_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due to hedged item affecting balance sheet</link:label>
    <link:label id="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax_label_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected, Balance Sheet, Net Of Tax</link:label>
    <link:label id="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax_documentation_en-US" xlink:label="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected, Balance Sheet, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" xlink:href="gsk-20241231.xsd#gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" xlink:to="lab_gsk_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedBalanceSheetNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock_c857f30c-1ea9-40ba-8bab-2f1e99d4c92a_terseLabel_en-US" xlink:label="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Currencies Translations and Relevant Exchange Rates</link:label>
    <link:label id="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock_label_en-US" xlink:label="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Currencies And The Relevant Exchange Rates [Table Text Block]</link:label>
    <link:label id="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of detailed information about significant currencies and the relevant exchange rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" xlink:to="lab_gsk_SignificantCurrenciesAndTheRelevantExchangeRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgedItemsDomain_c4c98ca0-efa5-43cc-b254-46fe50663e23_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgedItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedged items</link:label>
    <link:label id="lab_ifrs-full_HedgedItemsDomain_label_en-US" xlink:label="lab_ifrs-full_HedgedItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedged items [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgedItemsDomain" xlink:to="lab_ifrs-full_HedgedItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TH_0b4945e5-2e62-46d0-8569-98627fb886b2_terseLabel_en-US" xlink:label="lab_country_TH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thailand</link:label>
    <link:label id="lab_country_TH_label_en-US" xlink:label="lab_country_TH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">THAILAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TH" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_TH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TH" xlink:to="lab_country_TH" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued_bfcd928d-a7b4-4f28-8bee-ec8d0680455f_terseLabel_en-US" xlink:label="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average effective pre-swap interest rate notes</link:label>
    <link:label id="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued_label_en-US" xlink:label="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Effective Pre Swap Interest Rate Notes Issued</link:label>
    <link:label id="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued_documentation_en-US" xlink:label="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average effective pre swap interest rate issued.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageEffectivePreSwapInterestRateNotesIssued" xlink:href="gsk-20241231.xsd#gsk_AverageEffectivePreSwapInterestRateNotesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AverageEffectivePreSwapInterestRateNotesIssued" xlink:to="lab_gsk_AverageEffectivePreSwapInterestRateNotesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgedItemsAxis_b06b8857-c4c2-420f-a4a9-e10197ea3278_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgedItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedged items [axis]</link:label>
    <link:label id="lab_ifrs-full_HedgedItemsAxis_label_en-US" xlink:label="lab_ifrs-full_HedgedItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedged items [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgedItemsAxis" xlink:to="lab_ifrs-full_HedgedItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable_b4df1342-811e-49f2-8dd2-3ae3931a693d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of information about activities subject to rate regulation [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about activities subject to rate regulation [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutActivitiesSubjectToRateRegulationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_d3460555-7aee-400e-a500-dd118cc87fb1_terseLabel_en-US" xlink:label="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on cash flow hedges</link:label>
    <link:label id="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_label_en-US" xlink:label="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Tax On Fair Value Movements On Cash Flow Hedges Charged Or Credited Directly To Comprehensive Income</link:label>
    <link:label id="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current tax on fair value movements on cash flow hedges charged or credited directly to comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:to="lab_gsk_CurrentTaxOnFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GileadSciencesIncMember_950d292e-e135-458c-8a36-7fb9dc48fdde_terseLabel_en-US" xlink:label="lab_gsk_GileadSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gilead Sciences, Inc</link:label>
    <link:label id="lab_gsk_GileadSciencesIncMember_label_en-US" xlink:label="lab_gsk_GileadSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gilead Sciences Inc [Member]</link:label>
    <link:label id="lab_gsk_GileadSciencesIncMember_documentation_en-US" xlink:label="lab_gsk_GileadSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gilead sciences Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GileadSciencesIncMember" xlink:href="gsk-20241231.xsd#gsk_GileadSciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GileadSciencesIncMember" xlink:to="lab_gsk_GileadSciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_8353ed43-18cf-4181-8e0d-bec2469fbd21_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TR_591bfb74-9f0e-4c7e-93e6-1d6c3d98afe8_terseLabel_en-US" xlink:label="lab_country_TR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turkey</link:label>
    <link:label id="lab_country_TR_label_en-US" xlink:label="lab_country_TR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">T&#220;RKIYE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_TR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TR" xlink:to="lab_country_TR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory_f9cc525b-520b-4467-a619-af36dc35b046_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Provisions</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TW_e8345bb4-70cf-4d69-9c99-36ff1f0bb6b5_terseLabel_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taiwan</link:label>
    <link:label id="lab_country_TW_label_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TAIWAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_TW"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TW" xlink:to="lab_country_TW" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember_61b061d5-fa24-46a0-b950-f4e27adda68d_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property (No.3) Limited</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property (No.3) Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Intellectual Property (No.3) Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" xlink:to="lab_gsk_GlaxosmithklineIntellectualPropertyNo.3LimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MaximumDrawdownOfCommercialPapers_c8ff9b1e-7c67-4840-a7ff-7046ae3c6c97_terseLabel_en-US" xlink:label="lab_gsk_MaximumDrawdownOfCommercialPapers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum drawdown of commercial papers</link:label>
    <link:label id="lab_gsk_MaximumDrawdownOfCommercialPapers_label_en-US" xlink:label="lab_gsk_MaximumDrawdownOfCommercialPapers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Drawdown of Commercial Papers</link:label>
    <link:label id="lab_gsk_MaximumDrawdownOfCommercialPapers_documentation_en-US" xlink:label="lab_gsk_MaximumDrawdownOfCommercialPapers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Drawdown of Commercial Papers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MaximumDrawdownOfCommercialPapers" xlink:href="gsk-20241231.xsd#gsk_MaximumDrawdownOfCommercialPapers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MaximumDrawdownOfCommercialPapers" xlink:to="lab_gsk_MaximumDrawdownOfCommercialPapers" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_3d9a1f23-daed-4fcd-85ff-c1ecae409071_terseLabel_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets and net investment hedges</link:label>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_label_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange Movements On Overseas Net Assets And Net Investment Hedges</link:label>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges_documentation_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets and net investment hedges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" xlink:to="lab_gsk_ExchangeMovementsOnOverseasNetAssetsAndNetInvestmentHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKVaccinesGmbHMember_4812f466-42d3-4ddb-8243-d56f0ec5e269_terseLabel_en-US" xlink:label="lab_gsk_GSKVaccinesGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Vaccines GmbH (Germany)</link:label>
    <link:label id="lab_gsk_GSKVaccinesGmbHMember_label_en-US" xlink:label="lab_gsk_GSKVaccinesGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">G S K Vaccines Gmb H [member]</link:label>
    <link:label id="lab_gsk_GSKVaccinesGmbHMember_documentation_en-US" xlink:label="lab_gsk_GSKVaccinesGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Vaccines GmbH.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKVaccinesGmbHMember" xlink:href="gsk-20241231.xsd#gsk_GSKVaccinesGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKVaccinesGmbHMember" xlink:to="lab_gsk_GSKVaccinesGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_b7ed0f5d-4efa-43d4-9776-86c90763349e_periodStartLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_b41af4af-6d35-4419-9f22-306882ac3b74_periodEndLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_label_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of exchange differences on translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_38caba26-eaa3-43b5-8bb1-badac03d2dbf_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_897737b9-b2bc-4f7d-888a-7019a8b192ee_totalLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_f56cac41-f121-47cb-aef6-14f6c5635088_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayables_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfInventoryWritedown_cb7fe9e0-d61f-4bb0-a95d-7f9b55c78e49_negatedLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfInventoryWritedown" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reversal of prior year write-down of inventories</link:label>
    <link:label id="lab_ifrs-full_ReversalOfInventoryWritedown_label_en-US" xlink:label="lab_ifrs-full_ReversalOfInventoryWritedown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of inventory write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfInventoryWritedown" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfInventoryWritedown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfInventoryWritedown" xlink:to="lab_ifrs-full_ReversalOfInventoryWritedown" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EventDomain_3f9418af-6986-455f-8129-d2ba8a6dc7b8_terseLabel_en-US" xlink:label="lab_gsk_EventDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Event [Domain]</link:label>
    <link:label id="lab_gsk_EventDomain_label_en-US" xlink:label="lab_gsk_EventDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Event [Domain]</link:label>
    <link:label id="lab_gsk_EventDomain_documentation_en-US" xlink:label="lab_gsk_EventDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Event.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EventDomain" xlink:href="gsk-20241231.xsd#gsk_EventDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EventDomain" xlink:to="lab_gsk_EventDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_54e56e95-2a4a-4b49-8dda-de0c49fe87ec_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax_455cd589-86fa-4b31-ad86-4ea1a0970ce3_terseLabel_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due to hedged item affecting profit or loss</link:label>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on cash flow hedges for which hedged item affected profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FourthInterimMember_028f0deb-469d-4247-b788-0839e047f17f_terseLabel_en-US" xlink:label="lab_gsk_FourthInterimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fourth interim</link:label>
    <link:label id="lab_gsk_FourthInterimMember_label_en-US" xlink:label="lab_gsk_FourthInterimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fourth Interim [member]</link:label>
    <link:label id="lab_gsk_FourthInterimMember_documentation_en-US" xlink:label="lab_gsk_FourthInterimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fourth interim.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourthInterimMember" xlink:href="gsk-20241231.xsd#gsk_FourthInterimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FourthInterimMember" xlink:to="lab_gsk_FourthInterimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_10a1bd0b-93ab-4ddc-bb6e-1eee74d4f291_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Assets And Liabilities [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Assets And Liabilities [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets and liabilities line Items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" xlink:to="lab_gsk_DisclosureOfFinancialAssetsAndLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineCapitalPLCMember_1a81f922-c1d1-4a0e-8368-8b7930ac24ae_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineCapitalPLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Capital plc</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineCapitalPLCMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineCapitalPLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Capital PLC [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineCapitalPLCMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineCapitalPLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Capital PLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineCapitalPLCMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineCapitalPLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineCapitalPLCMember" xlink:to="lab_gsk_GlaxoSmithKlineCapitalPLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssetsHeldForTrading_fb370346-db8c-4592-92ba-13c4cab0a9d4_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssetsHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives classified as held for trading, assets</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssetsHeldForTrading_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssetsHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial assets held for trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssetsHeldForTrading" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssetsHeldForTrading"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssetsHeldForTrading" xlink:to="lab_ifrs-full_DerivativeFinancialAssetsHeldForTrading" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FloatingInterestRateMember_e8291be5-ecb6-4227-bf33-8e01b36820aa_terseLabel_en-US" xlink:label="lab_ifrs-full_FloatingInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating rate interest</link:label>
    <link:label id="lab_ifrs-full_FloatingInterestRateMember_label_en-US" xlink:label="lab_ifrs-full_FloatingInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating interest rate [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FloatingInterestRateMember" xlink:to="lab_ifrs-full_FloatingInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShortTermNotesMember_05826907-4b29-4a6d-9a71-7ff2090b2424_terseLabel_en-US" xlink:label="lab_gsk_ShortTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term notes</link:label>
    <link:label id="lab_gsk_ShortTermNotesMember_label_en-US" xlink:label="lab_gsk_ShortTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Notes [Member]</link:label>
    <link:label id="lab_gsk_ShortTermNotesMember_documentation_en-US" xlink:label="lab_gsk_ShortTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Short-term notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShortTermNotesMember" xlink:href="gsk-20241231.xsd#gsk_ShortTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShortTermNotesMember" xlink:to="lab_gsk_ShortTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherComputerSoftwareMember_2625059a-61a2-4dd0-86bb-d8ea044a2190_terseLabel_en-US" xlink:label="lab_gsk_OtherComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other computer software</link:label>
    <link:label id="lab_gsk_OtherComputerSoftwareMember_label_en-US" xlink:label="lab_gsk_OtherComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Computer Software [Member]</link:label>
    <link:label id="lab_gsk_OtherComputerSoftwareMember_documentation_en-US" xlink:label="lab_gsk_OtherComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other computer software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComputerSoftwareMember" xlink:href="gsk-20241231.xsd#gsk_OtherComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherComputerSoftwareMember" xlink:to="lab_gsk_OtherComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ForeignExchangeRiskMember_b5571965-9b5d-4440-963f-9b401ffb1211_terseLabel_en-US" xlink:label="lab_gsk_ForeignExchangeRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange risk</link:label>
    <link:label id="lab_gsk_ForeignExchangeRiskMember_label_en-US" xlink:label="lab_gsk_ForeignExchangeRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Risk [Member]</link:label>
    <link:label id="lab_gsk_ForeignExchangeRiskMember_documentation_en-US" xlink:label="lab_gsk_ForeignExchangeRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign exchange risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeRiskMember" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ForeignExchangeRiskMember" xlink:to="lab_gsk_ForeignExchangeRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AppreciationOfEuro_1df04b12-cd82-4356-983b-4ee97cf72cfb_terseLabel_en-US" xlink:label="lab_gsk_AppreciationOfEuro" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Appreciation of Euro</link:label>
    <link:label id="lab_gsk_AppreciationOfEuro_label_en-US" xlink:label="lab_gsk_AppreciationOfEuro" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Appreciation Of Euro</link:label>
    <link:label id="lab_gsk_AppreciationOfEuro_documentation_en-US" xlink:label="lab_gsk_AppreciationOfEuro" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Appreciation of euro.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AppreciationOfEuro" xlink:href="gsk-20241231.xsd#gsk_AppreciationOfEuro"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AppreciationOfEuro" xlink:to="lab_gsk_AppreciationOfEuro" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_332ed3f1-9170-4ec5-b1ec-50358f0c5749_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ViiVHealthcareCompanyMember_2b00b000-2a66-495e-a08f-3b95c9a7183d_verboseLabel_en-US" xlink:label="lab_gsk_ViiVHealthcareCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare Company</link:label>
    <link:label id="lab_gsk_ViiVHealthcareCompanyMember_label_en-US" xlink:label="lab_gsk_ViiVHealthcareCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vii V Healthcare Company [Member]</link:label>
    <link:label id="lab_gsk_ViiVHealthcareCompanyMember_documentation_en-US" xlink:label="lab_gsk_ViiVHealthcareCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ViiV Healthcare Company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthcareCompanyMember" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthcareCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ViiVHealthcareCompanyMember" xlink:to="lab_gsk_ViiVHealthcareCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherGainsLossesOnDemerger_cd5f9952-44c8-424a-bc8c-3aacf91e04d1_terseLabel_en-US" xlink:label="lab_gsk_OtherGainsLossesOnDemerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other gains/(losses) on demerger</link:label>
    <link:label id="lab_gsk_OtherGainsLossesOnDemerger_label_en-US" xlink:label="lab_gsk_OtherGainsLossesOnDemerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Gains(Losses) On Demerger</link:label>
    <link:label id="lab_gsk_OtherGainsLossesOnDemerger_documentation_en-US" xlink:label="lab_gsk_OtherGainsLossesOnDemerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other gains/(losses) on demerger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherGainsLossesOnDemerger" xlink:href="gsk-20241231.xsd#gsk_OtherGainsLossesOnDemerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherGainsLossesOnDemerger" xlink:to="lab_gsk_OtherGainsLossesOnDemerger" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_ca21f059-e912-4655-9ee5-be7f2bd5d99f_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of contingent consideration [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of contingent consideration [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueOfContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" xlink:to="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TransferToPensionObligationsOtherProvisions_c33b6ebd-1dd3-47d9-b930-64862e1765d5_negatedLabel_en-US" xlink:label="lab_gsk_TransferToPensionObligationsOtherProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transfer to pension obligations</link:label>
    <link:label id="lab_gsk_TransferToPensionObligationsOtherProvisions_label_en-US" xlink:label="lab_gsk_TransferToPensionObligationsOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfer To Pension Obligations, Other Provisions</link:label>
    <link:label id="lab_gsk_TransferToPensionObligationsOtherProvisions_documentation_en-US" xlink:label="lab_gsk_TransferToPensionObligationsOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transfer to pension obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransferToPensionObligationsOtherProvisions" xlink:href="gsk-20241231.xsd#gsk_TransferToPensionObligationsOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TransferToPensionObligationsOtherProvisions" xlink:to="lab_gsk_TransferToPensionObligationsOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfOtherProvisionsDomain_44c405e9-4537-4989-b1c1-579c0c175c15_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfOtherProvisionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_ClassesOfOtherProvisionsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfOtherProvisionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of other provisions [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="lab_ifrs-full_ClassesOfOtherProvisionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock_1c83a00e-d6a8-4463-8205-be447bf2caf2_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Increase/(Decrease) in Financial Liability and Loss/(Gain) in Income Statement</link:label>
    <link:label id="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Income Statement And Balance Sheet Sensitivity Of Put Option To Reasonably Possible Changes In Key Assumption [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of income statement and balance sheet sensitivity of put option to reasonably possible changes in key assumption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" xlink:to="lab_gsk_DisclosureOfIncomeStatementAndBalanceSheetSensitivityOfPutOptionToReasonablyPossibleChangesInKeyAssumptionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_10ec1784-98d5-4b96-b869-f5352710cab9_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in post-retirement benefits obligation</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets_44446521-b9a7-4521-aad1-a3e15a4defcb_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AuditInformationAbstract_label_en-US" xlink:label="lab_gsk_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_gsk_AuditInformationAbstract_documentation_en-US" xlink:label="lab_gsk_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AuditInformationAbstract" xlink:href="gsk-20241231.xsd#gsk_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AuditInformationAbstract" xlink:to="lab_gsk_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember_57157bad-0fc4-4065-8dbc-b9c4ebba0346_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% decrease in discount rate</link:label>
    <link:label id="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember_label_en-US" xlink:label="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk One Percentage Decrease In Discount Rate [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk one percentage decrease in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" xlink:to="lab_gsk_OtherRiskOnePercentageDecreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfProductLiabilityCasesDismissed_4ec7c940-f02c-4fa2-815a-ddc0af641d28_terseLabel_en-US" xlink:label="lab_gsk_NumberOfProductLiabilityCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of product liability cases, dismissed</link:label>
    <link:label id="lab_gsk_NumberOfProductLiabilityCasesDismissed_label_en-US" xlink:label="lab_gsk_NumberOfProductLiabilityCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Product Liability Cases, Dismissed</link:label>
    <link:label id="lab_gsk_NumberOfProductLiabilityCasesDismissed_documentation_en-US" xlink:label="lab_gsk_NumberOfProductLiabilityCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Product Liability Cases, Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfProductLiabilityCasesDismissed" xlink:href="gsk-20241231.xsd#gsk_NumberOfProductLiabilityCasesDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfProductLiabilityCasesDismissed" xlink:to="lab_gsk_NumberOfProductLiabilityCasesDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_da5c09fa-5d5f-4a85-90e9-26908d027941_verboseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment of property, plant and equipment, net of reversals</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_47485970-5f77-4e57-81f2-defd828b1218_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading_b05a50e9-5768-4f04-93c0-a4fbf2a1b391_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derivatives classified as held for trading, liabilities</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities held for trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SperoMember_3ca56fdd-e353-4434-8ef3-12f19793c048_terseLabel_en-US" xlink:label="lab_gsk_SperoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spero</link:label>
    <link:label id="lab_gsk_SperoMember_label_en-US" xlink:label="lab_gsk_SperoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spero [Member]</link:label>
    <link:label id="lab_gsk_SperoMember_documentation_en-US" xlink:label="lab_gsk_SperoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spero.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SperoMember" xlink:href="gsk-20241231.xsd#gsk_SperoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SperoMember" xlink:to="lab_gsk_SperoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WagesAndSalariesPayable_88ec3f46-fcc7-47a7-b543-fec85e07c83b_terseLabel_en-US" xlink:label="lab_gsk_WagesAndSalariesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wages and salaries</link:label>
    <link:label id="lab_gsk_WagesAndSalariesPayable_label_en-US" xlink:label="lab_gsk_WagesAndSalariesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wages And Salaries Payable</link:label>
    <link:label id="lab_gsk_WagesAndSalariesPayable_documentation_en-US" xlink:label="lab_gsk_WagesAndSalariesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wages and salaries payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WagesAndSalariesPayable" xlink:href="gsk-20241231.xsd#gsk_WagesAndSalariesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WagesAndSalariesPayable" xlink:to="lab_gsk_WagesAndSalariesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_4f722f91-7004-4252-b331-a67d8c2905f3_totalLabel_en-US" xlink:label="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net balance, assets</link:label>
    <link:label id="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_label_en-US" xlink:label="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net financial assets subject to offsetting, enforceable master netting arrangements or similar agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:to="lab_ifrs-full_NetFinancialAssetsSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level1OfFairValueHierarchyMember_2ec914ac-3f10-4d89-acbb-b32d6127cf80_terseLabel_en-US" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_ifrs-full_Level1OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 1 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_d2801e5f-d74e-4c27-93fd-ca368b4f0776_terseLabel_en-US" xlink:label="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on cash flow hedges</link:label>
    <link:label id="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_label_en-US" xlink:label="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Before Tax Gains Losses On Cash Flow Hedges</link:label>
    <link:label id="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges_documentation_en-US" xlink:label="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Before Tax Gains Losses On Cash Flow Hedges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" xlink:to="lab_gsk_OtherComprehensiveIncomeBeforeTaxGainsLossesOnCashFlowHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IndexVenturesMember_6b604d69-c8f4-4b65-8ded-785d30e5fe8e_terseLabel_en-US" xlink:label="lab_gsk_IndexVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Index Ventures</link:label>
    <link:label id="lab_gsk_IndexVenturesMember_label_en-US" xlink:label="lab_gsk_IndexVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Index Ventures [Member]</link:label>
    <link:label id="lab_gsk_IndexVenturesMember_documentation_en-US" xlink:label="lab_gsk_IndexVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Index Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IndexVenturesMember" xlink:href="gsk-20241231.xsd#gsk_IndexVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IndexVenturesMember" xlink:to="lab_gsk_IndexVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAbstract_15c2328b-25d2-400d-a640-ea528c067a0a_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_ifrs-full_AssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_43d943ec-df0c-4f77-b35a-e274447d3145_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory_86072867-e374-4b82-bb9a-b5ad3d634b0a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Comprehensive Income by Equity Category</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations_19932069-8027-44ea-9050-8de3ee07a086_terseLabel_en-US" xlink:label="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement attributable to continuing operations</link:label>
    <link:label id="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations_label_en-US" xlink:label="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement In Translation Exchange Attributable To Continuing Operations</link:label>
    <link:label id="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations_documentation_en-US" xlink:label="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movement in translation exchange attributable to continuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementInTranslationExchangeAttributableToContinuingOperations" xlink:href="gsk-20241231.xsd#gsk_MovementInTranslationExchangeAttributableToContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MovementInTranslationExchangeAttributableToContinuingOperations" xlink:to="lab_gsk_MovementInTranslationExchangeAttributableToContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineExportLimitedMember_1a2103ad-2c4f-41cd-899d-3a6a9e737526_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineExportLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Export Limited</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineExportLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineExportLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Export Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineExportLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineExportLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Export Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineExportLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineExportLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineExportLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineExportLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets_fa06d3b2-0003-4bce-ba00-70c039778e41_terseLabel_en-US" xlink:label="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government bonds:</link:label>
    <link:label id="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Bonds, Contributed To Fair Value Of Plan Assets</link:label>
    <link:label id="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets_documentation_en-US" xlink:label="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Bonds, Contributed To Fair Value Of Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GovernmentBondsContributedToFairValueOfPlanAssets" xlink:href="gsk-20241231.xsd#gsk_GovernmentBondsContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GovernmentBondsContributedToFairValueOfPlanAssets" xlink:to="lab_gsk_GovernmentBondsContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_773c850b-dd13-477e-9ec6-cd9020582b18_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_25644d4f-2596-4e01-b11a-761d01b384e1_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_6b897efa-dd36-4ccd-9eab-fb3c01ca4bd7_negatedLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities (Note 34)</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable_464ffb07-f858-4696-b1d2-5f9ad1089d95_terseLabel_en-US" xlink:label="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement gain (loss) of the contingent consideration payable</link:label>
    <link:label id="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable_label_en-US" xlink:label="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurement Gain (Loss) of the Contingent Consideration Payable</link:label>
    <link:label id="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable_documentation_en-US" xlink:label="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remeasurement of the contingent consideration payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" xlink:href="gsk-20241231.xsd#gsk_RemeasurementGainLossOfTheContingentConsiderationPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" xlink:to="lab_gsk_RemeasurementGainLossOfTheContingentConsiderationPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_264c4d05-e195-4c1e-8575-4aee5a852d9a_terseLabel_en-US" xlink:label="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing and discontinued operations [axis]</link:label>
    <link:label id="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing and discontinued operations [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember_a6d96a90-0ccc-486b-a7da-4633204aa83e_terseLabel_en-US" xlink:label="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK pension schemes</link:label>
    <link:label id="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember_label_en-US" xlink:label="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UK Defined Benefit and Defined Contribution Plans [Member]</link:label>
    <link:label id="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember_documentation_en-US" xlink:label="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">UK defined benefit and defined contribution plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UkDefinedBenefitAndDefinedContributionPlansMember" xlink:href="gsk-20241231.xsd#gsk_UkDefinedBenefitAndDefinedContributionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UkDefinedBenefitAndDefinedContributionPlansMember" xlink:to="lab_gsk_UkDefinedBenefitAndDefinedContributionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxEffectOfForeignTaxRates_1c213d9f-ad39-4128-9779-69f9b08fa4f9_terseLabel_en-US" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Differences in overseas taxation rates</link:label>
    <link:label id="lab_ifrs-full_TaxEffectOfForeignTaxRates_label_en-US" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of foreign tax rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_b7f7c3ba-60eb-45fa-960f-ff366a681b50_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities mandatorily measured at fair value through profit or loss (FVTPL):</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_602c1a31-015f-433f-8fa2-2d408b6045ee_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities at FVTPL</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NovartisMember_0abfb4d1-1df6-4c25-ba29-f03242ebf697_verboseLabel_en-US" xlink:label="lab_gsk_NovartisMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Novartis Vaccines</link:label>
    <link:label id="lab_gsk_NovartisMember_label_en-US" xlink:label="lab_gsk_NovartisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis [member]</link:label>
    <link:label id="lab_gsk_NovartisMember_documentation_en-US" xlink:label="lab_gsk_NovartisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Novartis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisMember" xlink:href="gsk-20241231.xsd#gsk_NovartisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NovartisMember" xlink:to="lab_gsk_NovartisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_cedb901e-7bb7-4d5a-b075-164d938aee45_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid_d831336c-bada-4b27-b2f5-c8bd58a76ba6_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid beginning balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid_6f13cc58-31df-4835-ba7b-16fb58ffcae4_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid ending balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:to="lab_ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TransfereeAxis_d42ef309-219e-486d-9423-67452f79099c_terseLabel_en-US" xlink:label="lab_gsk_TransfereeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transferee [Axis]</link:label>
    <link:label id="lab_gsk_TransfereeAxis_label_en-US" xlink:label="lab_gsk_TransfereeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferee [Axis]</link:label>
    <link:label id="lab_gsk_TransfereeAxis_documentation_en-US" xlink:label="lab_gsk_TransfereeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transferee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeAxis" xlink:href="gsk-20241231.xsd#gsk_TransfereeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TransfereeAxis" xlink:to="lab_gsk_TransfereeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_ff4b1725-6688-445c-9bd5-5bec8b9a111f_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CAD</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_c3f0b85a-6389-484e-b323-64bccfc00438_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10 cent depreciation of the Euro</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Cent Depreciation Of Euro [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Euro exchange rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentDepreciationOfEuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskTenCentDepreciationOfEuroMember" xlink:to="lab_gsk_CurrencyRiskTenCentDepreciationOfEuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IDRxInc.Member_6727fe00-6089-43a5-8dfb-3f57ede01b76_terseLabel_en-US" xlink:label="lab_gsk_IDRxInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IDRx, Inc.</link:label>
    <link:label id="lab_gsk_IDRxInc.Member_label_en-US" xlink:label="lab_gsk_IDRxInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IDRx, Inc. [Member]</link:label>
    <link:label id="lab_gsk_IDRxInc.Member_documentation_en-US" xlink:label="lab_gsk_IDRxInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">IDRx, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IDRxInc.Member" xlink:href="gsk-20241231.xsd#gsk_IDRxInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IDRxInc.Member" xlink:to="lab_gsk_IDRxInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember_8b7c621a-3bf9-4119-95bc-c7fe7eddd822_terseLabel_en-US" xlink:label="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit/(charge) to income statement</link:label>
    <link:label id="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember_label_en-US" xlink:label="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Origination And Reversal Of Temporary Differences [Member]</link:label>
    <link:label id="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Origination and reversal of temporary differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OriginationAndReversalOfTemporaryDifferencesMember" xlink:href="gsk-20241231.xsd#gsk_OriginationAndReversalOfTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OriginationAndReversalOfTemporaryDifferencesMember" xlink:to="lab_gsk_OriginationAndReversalOfTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments_e111fccd-2aca-4f85-bb42-6948431070d3_terseLabel_en-US" xlink:label="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transferred to retained earnings in the year on disposal of equity investments</link:label>
    <link:label id="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments_label_en-US" xlink:label="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferred to Retained Earnings On Disposal Of Equity Investments</link:label>
    <link:label id="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments_documentation_en-US" xlink:label="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transferred to retained earnings on disposal of equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" xlink:href="gsk-20241231.xsd#gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" xlink:to="lab_gsk_TransferredToRetainedEarningsOnDisposalOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PipelineAssetsMember_b2436007-4756-49d4-81ac-a087887a47e1_terseLabel_en-US" xlink:label="lab_gsk_PipelineAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pipeline Assets</link:label>
    <link:label id="lab_gsk_PipelineAssetsMember_label_en-US" xlink:label="lab_gsk_PipelineAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pipeline Assets [Member]</link:label>
    <link:label id="lab_gsk_PipelineAssetsMember_documentation_en-US" xlink:label="lab_gsk_PipelineAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pipeline Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PipelineAssetsMember" xlink:href="gsk-20241231.xsd#gsk_PipelineAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PipelineAssetsMember" xlink:to="lab_gsk_PipelineAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_b3dbaa0e-d90a-4d4f-acfb-a079414c2e49_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of commitments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_7cbf35d1-022a-46bd-9a12-5189ea7ceb28_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net cash inflow/(outflow) from operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_21cdda28-ffc7-41f1-9f7c-e0aae96f3f97_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash inflow from operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock_970689b0-1783-44f2-92d1-247d84e0a10e_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Disclosure of Detailed Information About Right Of Use Assets</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Right Of Use Assets [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" xlink:to="lab_gsk_DisclosureOfDetailedInformationAboutRightOfUseAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AiolosBioInc.Member_f03239fb-5897-4117-812d-4f5f94dd30ea_terseLabel_en-US" xlink:label="lab_gsk_AiolosBioInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aiolos Bio, Inc.</link:label>
    <link:label id="lab_gsk_AiolosBioInc.Member_label_en-US" xlink:label="lab_gsk_AiolosBioInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aiolos Bio, Inc. [Member]</link:label>
    <link:label id="lab_gsk_AiolosBioInc.Member_documentation_en-US" xlink:label="lab_gsk_AiolosBioInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aiolos Bio, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosBioInc.Member" xlink:href="gsk-20241231.xsd#gsk_AiolosBioInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AiolosBioInc.Member" xlink:to="lab_gsk_AiolosBioInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MRESVIAMember_9162b2d9-feb2-4721-9d87-4f8629cd577a_terseLabel_en-US" xlink:label="lab_gsk_MRESVIAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">mRESVIA</link:label>
    <link:label id="lab_gsk_MRESVIAMember_label_en-US" xlink:label="lab_gsk_MRESVIAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">mRESVIA [Member]</link:label>
    <link:label id="lab_gsk_MRESVIAMember_documentation_en-US" xlink:label="lab_gsk_MRESVIAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">mRESVIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MRESVIAMember" xlink:href="gsk-20241231.xsd#gsk_MRESVIAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MRESVIAMember" xlink:to="lab_gsk_MRESVIAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate_fda46a07-4592-475a-ac65-c9ec5d5b630f_terseLabel_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash balance credit/conversion rate</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate_label_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Cash Balance Credit Rate</link:label>
    <link:label id="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate_documentation_en-US" xlink:label="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial assumption of cash balance credit rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ActuarialAssumptionOfCashBalanceCreditRate" xlink:href="gsk-20241231.xsd#gsk_ActuarialAssumptionOfCashBalanceCreditRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ActuarialAssumptionOfCashBalanceCreditRate" xlink:to="lab_gsk_ActuarialAssumptionOfCashBalanceCreditRate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AssetsHeldForSaleLineItems_d1b37321-0170-4e5b-a5c4-b1097adde4fd_terseLabel_en-US" xlink:label="lab_gsk_AssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets Held For Sale [line items]</link:label>
    <link:label id="lab_gsk_AssetsHeldForSaleLineItems_label_en-US" xlink:label="lab_gsk_AssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Held For Sale [line items]</link:label>
    <link:label id="lab_gsk_AssetsHeldForSaleLineItems_documentation_en-US" xlink:label="lab_gsk_AssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Assets Held For Sale [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssetsHeldForSaleLineItems" xlink:href="gsk-20241231.xsd#gsk_AssetsHeldForSaleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AssetsHeldForSaleLineItems" xlink:to="lab_gsk_AssetsHeldForSaleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_e2a59562-dc86-4a90-9515-13e85021cee1_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_b780ca86-38b0-45a2-8963-1281d5d3f7b3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Classes Share Capital And Share Premium [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock_1bd37070-b535-48b2-9bfd-b912dfd4fc5d_terseLabel_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal and other disputes</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock_label_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of Accounting Policy for Legal and other Disputes [Policy Text Block]</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock_documentation_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for legal and other disputes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" xlink:href="gsk-20241231.xsd#gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" xlink:to="lab_gsk_DescriptionOfAccountingPolicyForLegalAndOtherDisputesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfNetDebtAbstract_label_en-US" xlink:label="lab_gsk_DisclosureOfNetDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Net Debt [Abstract]</link:label>
    <link:label id="lab_gsk_DisclosureOfNetDebtAbstract_documentation_en-US" xlink:label="lab_gsk_DisclosureOfNetDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of net debt abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfNetDebtAbstract" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfNetDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfNetDebtAbstract" xlink:to="lab_gsk_DisclosureOfNetDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NewYorkStockExchangeMember_fd383b27-42c9-41d1-a966-a96f928a7cb3_terseLabel_en-US" xlink:label="lab_gsk_NewYorkStockExchangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York Stock Exchange</link:label>
    <link:label id="lab_gsk_NewYorkStockExchangeMember_label_en-US" xlink:label="lab_gsk_NewYorkStockExchangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New York Stock Exchange [member]</link:label>
    <link:label id="lab_gsk_NewYorkStockExchangeMember_documentation_en-US" xlink:label="lab_gsk_NewYorkStockExchangeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New York Stock Exchange.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NewYorkStockExchangeMember" xlink:href="gsk-20241231.xsd#gsk_NewYorkStockExchangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NewYorkStockExchangeMember" xlink:to="lab_gsk_NewYorkStockExchangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_45f53df2-3998-4bed-b3d1-a5e03a24b3f3_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MajorRestructuringCostThreshold_67438f8f-414c-453a-9982-268db90357c7_terseLabel_en-US" xlink:label="lab_gsk_MajorRestructuringCostThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_gsk_MajorRestructuringCostThreshold_label_en-US" xlink:label="lab_gsk_MajorRestructuringCostThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Restructuring Cost Threshold</link:label>
    <link:label id="lab_gsk_MajorRestructuringCostThreshold_documentation_en-US" xlink:label="lab_gsk_MajorRestructuringCostThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major restructuring costs considered to be significant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MajorRestructuringCostThreshold" xlink:href="gsk-20241231.xsd#gsk_MajorRestructuringCostThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MajorRestructuringCostThreshold" xlink:to="lab_gsk_MajorRestructuringCostThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments_8911571b-b47b-4e94-96ad-c0d04aeaada2_terseLabel_en-US" xlink:label="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net fair value movements through profit or loss</link:label>
    <link:label id="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments_label_en-US" xlink:label="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Fair Value Movements Through Profit Or Loss Current Investments</link:label>
    <link:label id="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments_documentation_en-US" xlink:label="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net fair value movements through profit or loss current investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" xlink:to="lab_gsk_NetFairValueMovementsThroughProfitOrLossCurrentInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember_de8e1874-024c-4693-a1ea-df55edea72c8_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharmaceuticals Limited (India)</link:label>
    <link:label id="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharmaceuticals Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharmaceuticals Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" xlink:to="lab_gsk_GlaxosmithklinePharmaceuticalsLimitedIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_6030042f-a505-4209-9d25-b94b76f484f1_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentDebtInstrumentsIssued_dec2c70a-e15e-4395-94ef-e3ad91f1e343_negatedLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt, non-current</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDebtInstrumentsIssued_label_en-US" xlink:label="lab_ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current debt instruments issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDebtInstrumentsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:to="lab_ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_5eb53c5d-c63b-4f70-81b4-ea3d19cddb66_terseLabel_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_label_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer software [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember" xlink:to="lab_ifrs-full_ComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_94180c8b-8cec-4735-b390-40c9da763015_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital issued (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued" xlink:to="lab_ifrs-full_NumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BankLoansOverdraftsAndOther_2b7e7d35-9fa1-4413-aa6f-f5b943d47e9c_negatedLabel_en-US" xlink:label="lab_gsk_BankLoansOverdraftsAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Bank loans, overdrafts and other</link:label>
    <link:label id="lab_gsk_BankLoansOverdraftsAndOther_label_en-US" xlink:label="lab_gsk_BankLoansOverdraftsAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank Loans Overdrafts And Other</link:label>
    <link:label id="lab_gsk_BankLoansOverdraftsAndOther_documentation_en-US" xlink:label="lab_gsk_BankLoansOverdraftsAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bank loans and overdrafts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankLoansOverdraftsAndOther" xlink:href="gsk-20241231.xsd#gsk_BankLoansOverdraftsAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BankLoansOverdraftsAndOther" xlink:to="lab_gsk_BankLoansOverdraftsAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense_fcd07e90-a888-4001-ab0d-5a0a8e237ba7_terseLabel_en-US" xlink:label="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net losses on financial instruments held</link:label>
    <link:label id="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense_label_en-US" xlink:label="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Losses Attributable To Level 3 Financial Instruments Reported In Other Operating Income Expense</link:label>
    <link:label id="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense_documentation_en-US" xlink:label="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Losses attributable to level 3 financial instruments reported in other operating income expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" xlink:href="gsk-20241231.xsd#gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" xlink:to="lab_gsk_LossesAttributableToLevel3FinancialInstrumentsReportedInOtherOperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherAssociatesMember_c91bd1c4-bf01-4505-b2d7-ea938801e209_terseLabel_en-US" xlink:label="lab_gsk_OtherAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other associates</link:label>
    <link:label id="lab_gsk_OtherAssociatesMember_label_en-US" xlink:label="lab_gsk_OtherAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Associates [member]</link:label>
    <link:label id="lab_gsk_OtherAssociatesMember_documentation_en-US" xlink:label="lab_gsk_OtherAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Associates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherAssociatesMember" xlink:href="gsk-20241231.xsd#gsk_OtherAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherAssociatesMember" xlink:to="lab_gsk_OtherAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock_3ffe90fe-b788-449c-aafb-97f22a26f464_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Tax on Items Charged to Equity and Statement of Comprehensive Income</link:label>
    <link:label id="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity And Comprehensive Income Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of current and deferred tax relating to items charged or credited directly to equity and comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfCurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncomeExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_79d963dc-5c6b-41d4-b020-8a55ce0cd3f8_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in associates and joint ventures</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of investments accounted for using equity method [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_7ce1fafb-68f4-4d8d-bd40-f2d3cd6200df_terseLabel_en-US" xlink:label="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_label_en-US" xlink:label="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of contributions expected to be paid to plan for next annual reporting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:to="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock_ca79a3fe-f279-4938-90bc-138a816326f6_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Analysis of Changes in Net Debt</link:label>
    <link:label id="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Analysis Of Changes In Net Debt Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of analysis of changes in net debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfAnalysisOfChangesInNetDebtExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_5a4aa679-76b6-497c-a6fb-285bb9a82c5b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other operating income/(expense)</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other operating income (expense) [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_48e2f7b3-0c1a-4abc-a91c-d7072a3ce6b3_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember_6c152af2-3319-4881-a266-0944033b4c29_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline GmbH &amp; Co. KG (Germany)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Gmb H And Co K G [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline GmbH and Co. KG.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineGmbHAndCoKGMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineGmbHAndCoKGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineGmbHAndCoKGMember" xlink:to="lab_gsk_GlaxoSmithKlineGmbHAndCoKGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_abd4f06c-172a-44fe-a374-c4d34a2beeeb_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_4d2d09cc-9a13-4cf7-9780-2b1980e83384_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureExplanatory_ede9c53a-064e-438f-8629-7f49926df80c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary Disclosure of credit risk exposure</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of credit risk exposure [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_03bbdeaa-8783-42e3-89fd-8f08dd5d02cf_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Between five and ten years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years and not later than ten years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UsCommercialPaperProgramMember_ac413ec2-230c-4120-a4f0-cd5d422b36fe_terseLabel_en-US" xlink:label="lab_gsk_UsCommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US commercial paper program</link:label>
    <link:label id="lab_gsk_UsCommercialPaperProgramMember_label_en-US" xlink:label="lab_gsk_UsCommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Commercial Paper Program [member]</link:label>
    <link:label id="lab_gsk_UsCommercialPaperProgramMember_documentation_en-US" xlink:label="lab_gsk_UsCommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">US commercial paper programme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UsCommercialPaperProgramMember" xlink:href="gsk-20241231.xsd#gsk_UsCommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UsCommercialPaperProgramMember" xlink:to="lab_gsk_UsCommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashEquivalents_84863c32-e557-47e7-b8db-324e832518d9_terseLabel_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashEquivalents" xlink:to="lab_ifrs-full_CashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiquidityFunds_614241a1-9d67-41f1-8111-778cc1cf6217_terseLabel_en-US" xlink:label="lab_gsk_LiquidityFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquidity funds</link:label>
    <link:label id="lab_gsk_LiquidityFunds_label_en-US" xlink:label="lab_gsk_LiquidityFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquidity Funds</link:label>
    <link:label id="lab_gsk_LiquidityFunds_documentation_en-US" xlink:label="lab_gsk_LiquidityFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liquidity funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidityFunds" xlink:href="gsk-20241231.xsd#gsk_LiquidityFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiquidityFunds" xlink:to="lab_gsk_LiquidityFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RSVMember_029296db-2de8-458f-ba51-ed1c09810886_terseLabel_en-US" xlink:label="lab_gsk_RSVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSV</link:label>
    <link:label id="lab_gsk_RSVMember_label_en-US" xlink:label="lab_gsk_RSVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RSV [Member]</link:label>
    <link:label id="lab_gsk_RSVMember_documentation_en-US" xlink:label="lab_gsk_RSVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RSV</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RSVMember" xlink:href="gsk-20241231.xsd#gsk_RSVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RSVMember" xlink:to="lab_gsk_RSVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_1e92ac7a-972b-4d7e-8ec8-79d1124c7aee_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Pensions and other post-employment benefits</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_cb225d5a-8180-4c67-b292-d38d5c8f25ff_negatedLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-current provisions for employee benefits</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current provisions for employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:to="lab_ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LegalAndOtherDisputesMember_af20fd48-82fa-4957-9da1-bf1c4e6d8916_terseLabel_en-US" xlink:label="lab_gsk_LegalAndOtherDisputesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal and other disputes</link:label>
    <link:label id="lab_gsk_LegalAndOtherDisputesMember_label_en-US" xlink:label="lab_gsk_LegalAndOtherDisputesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal And Other Disputes [member]</link:label>
    <link:label id="lab_gsk_LegalAndOtherDisputesMember_documentation_en-US" xlink:label="lab_gsk_LegalAndOtherDisputesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legal and other disputes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegalAndOtherDisputesMember" xlink:href="gsk-20241231.xsd#gsk_LegalAndOtherDisputesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LegalAndOtherDisputesMember" xlink:to="lab_gsk_LegalAndOtherDisputesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock_2de2c25b-6e45-4119-8b0a-5ff2fa2eedf7_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Average Life Expectancy Assumed</link:label>
    <link:label id="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of average life expectancy assumptions [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of average life expectancy assumptions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" xlink:to="lab_gsk_DisclosureOfAverageLifeExpectancyAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfStateCourtCases_d1eac0a7-8d7c-49cf-a577-7ec12d5e5b71_terseLabel_en-US" xlink:label="lab_gsk_NumberOfStateCourtCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of state court cases</link:label>
    <link:label id="lab_gsk_NumberOfStateCourtCases_label_en-US" xlink:label="lab_gsk_NumberOfStateCourtCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of State Court Cases</link:label>
    <link:label id="lab_gsk_NumberOfStateCourtCases_documentation_en-US" xlink:label="lab_gsk_NumberOfStateCourtCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of State Court Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfStateCourtCases" xlink:href="gsk-20241231.xsd#gsk_NumberOfStateCourtCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfStateCourtCases" xlink:to="lab_gsk_NumberOfStateCourtCases" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageofGSKHolding_69b1bb8c-fe56-4f96-a4fd-73ce4895c2e5_terseLabel_en-US" xlink:label="lab_gsk_PercentageofGSKHolding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of GSK holding</link:label>
    <link:label id="lab_gsk_PercentageofGSKHolding_label_en-US" xlink:label="lab_gsk_PercentageofGSKHolding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of GSK Holding</link:label>
    <link:label id="lab_gsk_PercentageofGSKHolding_documentation_en-US" xlink:label="lab_gsk_PercentageofGSKHolding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of GSK holding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageofGSKHolding" xlink:href="gsk-20241231.xsd#gsk_PercentageofGSKHolding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageofGSKHolding" xlink:to="lab_gsk_PercentageofGSKHolding" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_65ea65f0-a54b-4512-8023-ca2e665ebddb_terseLabel_en-US" xlink:label="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquid investments, cash and cash equivalents and overdrafts</link:label>
    <link:label id="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquid Investments, Cash And Cash Equivalents [Member]</link:label>
    <link:label id="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember_documentation_en-US" xlink:label="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liquid investments, cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidInvestmentsCashAndCashEquivalentsMember" xlink:href="gsk-20241231.xsd#gsk_LiquidInvestmentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiquidInvestmentsCashAndCashEquivalentsMember" xlink:to="lab_gsk_LiquidInvestmentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RestructuringCostsDomain_187f9822-3ea1-4257-9ab0-0e54ba75c6f9_terseLabel_en-US" xlink:label="lab_gsk_RestructuringCostsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs [domain]</link:label>
    <link:label id="lab_gsk_RestructuringCostsDomain_label_en-US" xlink:label="lab_gsk_RestructuringCostsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs [Domain]</link:label>
    <link:label id="lab_gsk_RestructuringCostsDomain_documentation_en-US" xlink:label="lab_gsk_RestructuringCostsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Costs [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RestructuringCostsDomain" xlink:href="gsk-20241231.xsd#gsk_RestructuringCostsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RestructuringCostsDomain" xlink:to="lab_gsk_RestructuringCostsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019_a683a0a6-2755-42cb-84bb-67818c472e0b_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial assumption of life expectancy after retirement</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of life expectancy after retirement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" xlink:to="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_ba394aba-dcf2-4415-9b18-5730a18ab071_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CNH</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AffinivaxAssetsMember_c48d7239-ff0d-4768-b46f-1455e1391cd3_terseLabel_en-US" xlink:label="lab_gsk_AffinivaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affinivax Assets</link:label>
    <link:label id="lab_gsk_AffinivaxAssetsMember_label_en-US" xlink:label="lab_gsk_AffinivaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affinivax Assets [Member]</link:label>
    <link:label id="lab_gsk_AffinivaxAssetsMember_documentation_en-US" xlink:label="lab_gsk_AffinivaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Affinivax assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AffinivaxAssetsMember" xlink:href="gsk-20241231.xsd#gsk_AffinivaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AffinivaxAssetsMember" xlink:to="lab_gsk_AffinivaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember_1b75e9ae-083d-4a01-8e59-03e479d990ec_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% (100 basis points) increase in Euro interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Percent Increase In Euro Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1% (100 basis points) increase in Euro interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePercentIncreaseInEuroInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssociatesMember_0ff27ded-013d-4348-9955-ae091ce19e63_verboseLabel_en-US" xlink:label="lab_ifrs-full_AssociatesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share of after-tax (losses)/profits of associates</link:label>
    <link:label id="lab_ifrs-full_AssociatesMember_d5204aaa-8af5-450c-885d-a51c3f6f687c_terseLabel_en-US" xlink:label="lab_ifrs-full_AssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associates</link:label>
    <link:label id="lab_ifrs-full_AssociatesMember_label_en-US" xlink:label="lab_ifrs-full_AssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total for all associates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssociatesMember" xlink:to="lab_ifrs-full_AssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales_4345b39d-60b3-483b-aabc-d22b11c8de6c_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of royalty payable on future sales</link:label>
    <link:label id="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales_label_en-US" xlink:label="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Royalty Payable On Future Sales</link:label>
    <link:label id="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales_documentation_en-US" xlink:label="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Royalty Payable On Future Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfRoyaltyPayableOnFutureSales" xlink:href="gsk-20241231.xsd#gsk_PercentageOfRoyaltyPayableOnFutureSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfRoyaltyPayableOnFutureSales" xlink:to="lab_gsk_PercentageOfRoyaltyPayableOnFutureSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_67f1e13f-777e-4229-9a41-4b3558afd384_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax on profits</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for income tax expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="lab_ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember_58fd727a-7070-40ef-85ec-0f9cf96d6df4_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline UK Limited</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline United Kingdom Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline UK Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineUnitedKingdomLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineUnitedKingdomLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_efa8a12b-c578-482a-8939-584afb21d427_terseLabel_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_label_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RSVArexvyMember_f9928cce-f320-450a-94f0-1d2bb376d241_terseLabel_en-US" xlink:label="lab_gsk_RSVArexvyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSV</link:label>
    <link:label id="lab_gsk_RSVArexvyMember_label_en-US" xlink:label="lab_gsk_RSVArexvyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RSV (Arexvy) [Member]</link:label>
    <link:label id="lab_gsk_RSVArexvyMember_documentation_en-US" xlink:label="lab_gsk_RSVArexvyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RSV (Arexvy)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RSVArexvyMember" xlink:href="gsk-20241231.xsd#gsk_RSVArexvyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RSVArexvyMember" xlink:to="lab_gsk_RSVArexvyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_9022791a-3d2d-45ef-ad02-fcb117e7652f_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_29a8859b-36ad-4737-a931-d8121b4551c2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Fair Values of Assets and Liabilities of UK and US Defined Benefit Pension Schemes Together with Aggregated Data for Other Defined Benefit Pension Schemes in Group</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of plan assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory_20e6207d-1844-41d4-9d4d-191ae93e76ab_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Weighted Average Duration of Defined Benefit Obligation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about maturity profile of defined benefit obligation [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutMaturityProfileOfDefinedBenefitObligationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_37e20a3b-be8c-4717-a8c6-a9dc9da2dcd6_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_573eabb5-b75f-4d60-b254-8fc1fb8eabb5_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current derivative financial assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current derivative financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherShorttermProvisions_62e0ea2e-7ba9-4a06-b56c-3ee64e0528eb_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OtherShorttermProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Short-term provisions</link:label>
    <link:label id="lab_ifrs-full_OtherShorttermProvisions_010a0995-01b7-4ff6-a64f-419b6229a19d_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherShorttermProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">To be settled within one year</link:label>
    <link:label id="lab_ifrs-full_OtherShorttermProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherShorttermProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherShorttermProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherShorttermProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherShorttermProvisions" xlink:to="lab_ifrs-full_OtherShorttermProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock_8c8b242a-4ff4-47bd-9296-2e6dd7df3408_terseLabel_en-US" xlink:label="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Funded and Unfunded Defined Benefit Pension Obligation</link:label>
    <link:label id="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock_label_en-US" xlink:label="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Funded And Unfunded Defined Benefit Pension Obligation [Table Text Block]</link:label>
    <link:label id="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock_documentation_en-US" xlink:label="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary Of Funded And Unfunded Defined Benefit Pension Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" xlink:to="lab_gsk_SummaryOfFundedAndUnfundedDefinedBenefitPensionObligationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TrancheDomain_62a5dd21-cb33-4758-b685-d11a49f5855d_terseLabel_en-US" xlink:label="lab_gsk_TrancheDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche [Domain]</link:label>
    <link:label id="lab_gsk_TrancheDomain_label_en-US" xlink:label="lab_gsk_TrancheDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche [Domain]</link:label>
    <link:label id="lab_gsk_TrancheDomain_documentation_en-US" xlink:label="lab_gsk_TrancheDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TrancheDomain" xlink:href="gsk-20241231.xsd#gsk_TrancheDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TrancheDomain" xlink:to="lab_gsk_TrancheDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain_38820afb-b48c-4974-926c-a629954c2929_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial instruments</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CostOfMajorRestructuringMember_140ba11d-2079-4d9b-b2fd-8a31fa948f8d_terseLabel_en-US" xlink:label="lab_gsk_CostOfMajorRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of major restructuring</link:label>
    <link:label id="lab_gsk_CostOfMajorRestructuringMember_label_en-US" xlink:label="lab_gsk_CostOfMajorRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Major Restructuring [Member]</link:label>
    <link:label id="lab_gsk_CostOfMajorRestructuringMember_documentation_en-US" xlink:label="lab_gsk_CostOfMajorRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost of major restructuring [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostOfMajorRestructuringMember" xlink:href="gsk-20241231.xsd#gsk_CostOfMajorRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CostOfMajorRestructuringMember" xlink:to="lab_gsk_CostOfMajorRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_8e05392c-ac73-4bf7-a9b9-3133a81d0d2b_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on change in fair value of derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:to="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BusinessCombinationsAxis_363ed9b4-c406-452b-9696-72c96f3737c0_terseLabel_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</link:label>
    <link:label id="lab_ifrs-full_BusinessCombinationsAxis_label_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis" xlink:to="lab_ifrs-full_BusinessCombinationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember_9189257b-27db-4fd0-bcb6-9580e7968655_terseLabel_en-US" xlink:label="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Respiratory/Immunology and Other</link:label>
    <link:label id="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember_label_en-US" xlink:label="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Immuno Inflammation Respiratory And Other [Member]</link:label>
    <link:label id="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember_documentation_en-US" xlink:label="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Immuno inflammation respiratory and other [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ImmunoInflammationRespiratoryAndOtherMember" xlink:href="gsk-20241231.xsd#gsk_ImmunoInflammationRespiratoryAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ImmunoInflammationRespiratoryAndOtherMember" xlink:to="lab_gsk_ImmunoInflammationRespiratoryAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock_02f77545-e1cf-460f-843e-08f11bee4ecf_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Aggregated Financial Information</link:label>
    <link:label id="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Aggregated Financial Information of associates and joint ventures [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of aggregated financial information of associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" xlink:to="lab_gsk_DisclosureOfAggregatedFinancialInformationOfAssociatesAndJointVenturesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures_6527e77f-534c-457d-bad3-3057acada1df_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in income</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Income Through Foreign Currency Exchange Exposures</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) in income through foreign currency exchange exposures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" xlink:to="lab_gsk_IncreaseDecreaseInIncomeThroughForeignCurrencyExchangeExposures" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SeparationRestructuringProgrammeMember_d471bc29-9625-4b9b-96aa-a09139a24116_terseLabel_en-US" xlink:label="lab_gsk_SeparationRestructuringProgrammeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Separation restructuring programme</link:label>
    <link:label id="lab_gsk_SeparationRestructuringProgrammeMember_label_en-US" xlink:label="lab_gsk_SeparationRestructuringProgrammeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Separation Restructuring Programme [Member]</link:label>
    <link:label id="lab_gsk_SeparationRestructuringProgrammeMember_documentation_en-US" xlink:label="lab_gsk_SeparationRestructuringProgrammeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Separation preparation programme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SeparationRestructuringProgrammeMember" xlink:href="gsk-20241231.xsd#gsk_SeparationRestructuringProgrammeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SeparationRestructuringProgrammeMember" xlink:to="lab_gsk_SeparationRestructuringProgrammeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember_281006b0-7d1b-492a-9772-30ca8c18b622_terseLabel_en-US" xlink:label="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.200% US$ US Medium Term Note 2043</link:label>
    <link:label id="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember_label_en-US" xlink:label="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Four Point Two Percent US Medium Term Note Two Thousand Forty Three [member]</link:label>
    <link:label id="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember_documentation_en-US" xlink:label="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Four point two percent US medium term note forty three.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" xlink:href="gsk-20241231.xsd#gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" xlink:to="lab_gsk_FourPointTwoPercentUsMediumTermNoteTwoThousandFortyThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilities_67d6073e-a8ed-4009-9f89-c4515ac00ea3_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current tax payable</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilities_5efc10bc-cccf-49e2-a217-9bce34c8995f_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax payable, current</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilities" xlink:to="lab_ifrs-full_CurrentTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisposalOfBusinessesAndAssets_d37e37f9-b888-423d-a292-6bca56df68eb_terseLabel_en-US" xlink:label="lab_gsk_DisposalOfBusinessesAndAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal of businesses and assets</link:label>
    <link:label id="lab_gsk_DisposalOfBusinessesAndAssets_label_en-US" xlink:label="lab_gsk_DisposalOfBusinessesAndAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Of Businesses And Assets</link:label>
    <link:label id="lab_gsk_DisposalOfBusinessesAndAssets_documentation_en-US" xlink:label="lab_gsk_DisposalOfBusinessesAndAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of businesses and assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalOfBusinessesAndAssets" xlink:href="gsk-20241231.xsd#gsk_DisposalOfBusinessesAndAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisposalOfBusinessesAndAssets" xlink:to="lab_gsk_DisposalOfBusinessesAndAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition_c91789dc-4386-4af0-886b-aca44618b00f_terseLabel_en-US" xlink:label="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination consideration payable for step acquisition</link:label>
    <link:label id="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition_label_en-US" xlink:label="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Payable For Step Acquisition</link:label>
    <link:label id="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition_documentation_en-US" xlink:label="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business combination consideration payable for step acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationConsiderationPayableForStepAcquisition" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationConsiderationPayableForStepAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BusinessCombinationConsiderationPayableForStepAcquisition" xlink:to="lab_gsk_BusinessCombinationConsiderationPayableForStepAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_0d120a06-acd4-45cc-b1d4-c8668aff5ee5_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c9d584a5-b66e-4417-a29d-150208737670_negatedLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Profit on sale of investments in associates</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerSoftware_e247372b-4da6-472e-8648-ab7cbb5fb4be_terseLabel_en-US" xlink:label="lab_ifrs-full_ComputerSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net book value of computer software</link:label>
    <link:label id="lab_ifrs-full_ComputerSoftware_label_en-US" xlink:label="lab_ifrs-full_ComputerSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftware" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftware" xlink:to="lab_ifrs-full_ComputerSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_b44f0121-c25b-4ff8-b3e7-7677df4a8c23_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major customers [axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ConclusionOfMajorLitigationMember_b6d18c88-fdb9-4db0-9a35-72464ce21759_terseLabel_en-US" xlink:label="lab_gsk_ConclusionOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conclusion of major litigation</link:label>
    <link:label id="lab_gsk_ConclusionOfMajorLitigationMember_label_en-US" xlink:label="lab_gsk_ConclusionOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conclusion Of Major Litigation [Member]</link:label>
    <link:label id="lab_gsk_ConclusionOfMajorLitigationMember_documentation_en-US" xlink:label="lab_gsk_ConclusionOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conclusion Of Major Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConclusionOfMajorLitigationMember" xlink:href="gsk-20241231.xsd#gsk_ConclusionOfMajorLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ConclusionOfMajorLitigationMember" xlink:to="lab_gsk_ConclusionOfMajorLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves_0bb66c99-0ce4-4336-9cf6-6daadfb7f5fd_terseLabel_en-US" xlink:label="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of cumulative exchange differences arising on translation of foreign currency net assets of divested subsidiaries and offsetting net investment hedges reserves</link:label>
    <link:label id="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves_label_en-US" xlink:label="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Of Cumulative Exchange Differences Arising On Translation Of Foreign Currency Net Assets Of Divested Subsidiaries And Offsetting Net Investment Hedges Reserves</link:label>
    <link:label id="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves_documentation_en-US" xlink:label="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of cumulative exchange differences arising on translation of foreign currency net assets of divested subsidiaries and offsetting net investment hedges reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" xlink:to="lab_gsk_ReclassificationOfCumulativeExchangeDifferencesArisingOnTranslationOfForeignCurrencyNetAssetsOfDivestedSubsidiariesAndOffsettingNetInvestmentHedgesReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedProvisionReversedOtherProvisions_20ba4c04-588a-4a3a-87c6-69ec00ba7344_negatedLabel_en-US" xlink:label="lab_ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reversed unused</link:label>
    <link:label id="lab_ifrs-full_UnusedProvisionReversedOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused provision reversed, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:to="lab_ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossProfit_3ab7589e-8863-4ff0-9533-a7c9d1473f26_totalLabel_en-US" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_ifrs-full_GrossProfit_label_en-US" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="lab_ifrs-full_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_cb472213-1b2d-44b4-8aee-44fa55ff7d89_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inflation rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of inflation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetAssetsLiabilities_9a110715-9ea9-4d2a-b1e2-a3a970848a87_totalLabel_en-US" xlink:label="lab_ifrs-full_NetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_ifrs-full_NetAssetsLiabilities_label_en-US" xlink:label="lab_ifrs-full_NetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets (liabilities)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetAssetsLiabilities" xlink:to="lab_ifrs-full_NetAssetsLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities_17a63405-df32-4376-b3d6-5ba6a5f6d5de_verboseLabel_en-US" xlink:label="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net losses recognised in other comprehensive income</link:label>
    <link:label id="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities_label_en-US" xlink:label="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains Losses Recognised In Other Comprehensive Income Fair Value Measuremen tAssets And Liabilities</link:label>
    <link:label id="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gains losses recognized in other comprehensive income fair value measurement assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" xlink:to="lab_gsk_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasuremenTassetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche_b0426d07-ff85-4590-91e1-3dd612103117_terseLabel_en-US" xlink:label="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination potential milestone payment per tranche</link:label>
    <link:label id="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche_label_en-US" xlink:label="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Potential Milestone Payment Per Tranche</link:label>
    <link:label id="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche_documentation_en-US" xlink:label="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business combination potential milestone payment per tranche.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationPotentialMilestonePaymentPerTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" xlink:to="lab_gsk_BusinessCombinationPotentialMilestonePaymentPerTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfRightOfUseAssetsTable_8cecdfbf-9beb-422e-96b4-6488044a0e60_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfRightOfUseAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Right Of Use Assets [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfRightOfUseAssetsTable_label_en-US" xlink:label="lab_gsk_DisclosureOfRightOfUseAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Right Of Use Assets [Table]</link:label>
    <link:label id="lab_gsk_DisclosureOfRightOfUseAssetsTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfRightOfUseAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfRightOfUseAssetsTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfRightOfUseAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfRightOfUseAssetsTable" xlink:to="lab_gsk_DisclosureOfRightOfUseAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_975c8225-d5df-4152-a1c9-c81084cd9b7d_terseLabel_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_label_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_d10e839a-806d-4595-ab28-108302439834_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover by location of customer</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_f5578ea7-05f6-47a3-b5b1-2cafabb6f782_verboseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on hedge ineffectiveness recognised in profit or loss</link:label>
    <link:label id="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_2690f596-6bc6-47dd-a445-8e97a65627db_terseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of hedge ineffectiveness recognised in profit or loss</link:label>
    <link:label id="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) on hedge ineffectiveness recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShareOptionPlanMember_5abc6fc3-9a72-46af-a62b-c4966b50e6a0_terseLabel_en-US" xlink:label="lab_gsk_ShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share option plans</link:label>
    <link:label id="lab_gsk_ShareOptionPlanMember_label_en-US" xlink:label="lab_gsk_ShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Option Plan [member]</link:label>
    <link:label id="lab_gsk_ShareOptionPlanMember_documentation_en-US" xlink:label="lab_gsk_ShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share option plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOptionPlanMember" xlink:href="gsk-20241231.xsd#gsk_ShareOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShareOptionPlanMember" xlink:to="lab_gsk_ShareOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_b7fb7cbb-5486-45d1-82e3-a2cef5ac32b7_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Credit/(charge) to income statement</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_915b6ff9-756c-4b51-8fb9-2de586dab2ae_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property:</link:label>
    <link:label id="lab_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real estate, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Goodwill_1d6147e0-94be-4f57-b752-1ff9bae1a1ad_terseLabel_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_Goodwill_9ca52032-9ebd-404f-8c22-b413c62ca231_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill beginning balnce</link:label>
    <link:label id="lab_ifrs-full_Goodwill_3b6f929d-3444-4ab7-8ad6-ddedd25d560a_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill ending balance</link:label>
    <link:label id="lab_ifrs-full_Goodwill_label_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill" xlink:to="lab_ifrs-full_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NotesIssuedUnderUsShelfRegistration_411f9885-0b09-4506-9bf2-cd62631356eb_terseLabel_en-US" xlink:label="lab_gsk_NotesIssuedUnderUsShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes issued under us shelf registration</link:label>
    <link:label id="lab_gsk_NotesIssuedUnderUsShelfRegistration_label_en-US" xlink:label="lab_gsk_NotesIssuedUnderUsShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Issued Under US Shelf Registration</link:label>
    <link:label id="lab_gsk_NotesIssuedUnderUsShelfRegistration_documentation_en-US" xlink:label="lab_gsk_NotesIssuedUnderUsShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes issued under US shelf registration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NotesIssuedUnderUsShelfRegistration" xlink:href="gsk-20241231.xsd#gsk_NotesIssuedUnderUsShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NotesIssuedUnderUsShelfRegistration" xlink:to="lab_gsk_NotesIssuedUnderUsShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember_46c76355-1ed8-472c-a333-c5269a07aaae_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Holdings Limited</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Holdings Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Finance PLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineHoldingsLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineHoldingsLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineHoldingsLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlineHoldingsLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff_c934e2ee-6070-4424-83bd-c42b661e5e02_terseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment and assets written off</link:label>
    <link:label id="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff_label_en-US" xlink:label="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Impairment And Assets Written Off</link:label>
    <link:label id="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for impairment and assets written off.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForImpairmentAndAssetsWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" xlink:to="lab_gsk_AdjustmentsForImpairmentAndAssetsWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_cac9aa04-84fa-45f8-a6e3-f3dddc0d9a83_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other permanent differences</link:label>
    <link:label id="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other tax effects for reconciliation between accounting profit and tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember_fe8110b2-bb5f-43e2-b637-8a140c811d84_terseLabel_en-US" xlink:label="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Licenses, patents, amortised brands</link:label>
    <link:label id="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember_label_en-US" xlink:label="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licences And Franchises Amortised Brands [Member]</link:label>
    <link:label id="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember_documentation_en-US" xlink:label="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Licences And Franchises Amortised Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LicencesAndFranchisesAmortisedBrandsMember" xlink:href="gsk-20241231.xsd#gsk_LicencesAndFranchisesAmortisedBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LicencesAndFranchisesAmortisedBrandsMember" xlink:to="lab_gsk_LicencesAndFranchisesAmortisedBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_4ecad264-c461-4a2a-893c-153ccda3b2de_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange rates</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of effect of changes in foreign exchange rates [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_9e7633b6-68e5-4033-bb3a-fff1363808da_negatedLabel_en-US" xlink:label="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of equity investments</link:label>
    <link:label id="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock_cf8af3a9-674e-4356-bed8-7deae379321e_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Net Debt</link:label>
    <link:label id="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Reconciliation of Net Cash Flow to Movement in Net Debt Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of net cash flow to movement in net debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfReconciliationOfNetCashFlowToMovementInNetDebtExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansAxis_86e5400f-0b24-43ab-89b6-73abf5d59c49_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseInSalesForecastAmount_4339ef63-f76e-411e-aa14-29915f76edfe_terseLabel_en-US" xlink:label="lab_gsk_IncreaseInSalesForecastAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in sales forecasts</link:label>
    <link:label id="lab_gsk_IncreaseInSalesForecastAmount_label_en-US" xlink:label="lab_gsk_IncreaseInSalesForecastAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase In Sales Forecast Amount</link:label>
    <link:label id="lab_gsk_IncreaseInSalesForecastAmount_documentation_en-US" xlink:label="lab_gsk_IncreaseInSalesForecastAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase in sales forecast amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseInSalesForecastAmount" xlink:href="gsk-20241231.xsd#gsk_IncreaseInSalesForecastAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseInSalesForecastAmount" xlink:to="lab_gsk_IncreaseInSalesForecastAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WithinTenYearsMember_48a78204-8e66-496b-b55f-f8c20351bcf3_terseLabel_en-US" xlink:label="lab_gsk_WithinTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Within 10 years</link:label>
    <link:label id="lab_gsk_WithinTenYearsMember_label_en-US" xlink:label="lab_gsk_WithinTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Within Ten Years [Member]</link:label>
    <link:label id="lab_gsk_WithinTenYearsMember_documentation_en-US" xlink:label="lab_gsk_WithinTenYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Later than one year and not later than ten year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WithinTenYearsMember" xlink:href="gsk-20241231.xsd#gsk_WithinTenYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WithinTenYearsMember" xlink:to="lab_gsk_WithinTenYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_217dbc9a-ab06-4c91-9d6c-3fb0a414f485_negatedTerseLabel_en-US" xlink:label="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Re-assessments of prior year current tax estimates</link:label>
    <link:label id="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_label_en-US" xlink:label="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of ReassessmentsOf Prior Year Deferred Tax Estimates</link:label>
    <link:label id="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates_documentation_en-US" xlink:label="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of reassessments&#160;of prior year deferred tax estimates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:to="lab_gsk_TaxEffectOfReassessmentsofPriorYearDeferredTaxEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_5dbd004e-cb9d-4cb7-aa21-8d28bc6bc9c4_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_a8b88a62-cbfd-4bec-9666-b1aaf5879620_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Plan Actuarial Assumptions [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Plan Actuarial Assumptions [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Plan Actuarial Assumptions [line items].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPlanActuarialAssumptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_6e57fca5-51d3-4a75-bc4d-8229a565806a_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest on debt</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:to="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_d88f849e-7395-4833-b5ca-67f80694e216_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_41bc8c6d-727a-4e09-b211-d8909bb8e3ca_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee share plans</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_81beda0c-9f25-4306-99d0-c8bab5fca6d8_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedge accounting</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for hedging [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_fa2aa4f2-9489-4174-aaf7-a440b392c3ac_verboseLabel_en-US" xlink:label="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Re-measurement of discontinued operations distributed to shareholders on demerger</link:label>
    <link:label id="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_ad5b0cbd-0ba6-4707-be57-066f8c95b8d9_terseLabel_en-US" xlink:label="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of discontinued operations distributed to shareholders on demerger</link:label>
    <link:label id="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_label_en-US" xlink:label="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurement Of Discontinued Operations Distributed To Shareholders On Demerger</link:label>
    <link:label id="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger_documentation_en-US" xlink:label="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Re-measurement of discontinued operations distributed to shareholders on demerger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:href="gsk-20241231.xsd#gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:to="lab_gsk_RemeasurementOfDiscontinuedOperationsDistributedToShareholdersOnDemerger" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentPayables_7eef0066-7e31-49d6-83df-ffd6e4ec991f_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other payables</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentPayables_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentPayables" xlink:to="lab_ifrs-full_OtherNoncurrentPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_629f7cd3-4e2d-4247-be95-1b3ab2cbad81_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents acquired/(divested)</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents in subsidiary or businesses acquired or disposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="lab_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses_9cf68347-7127-4bb9-b8b5-fd256f59f4ad_terseLabel_en-US" xlink:label="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognised deferred tax asset</link:label>
    <link:label id="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses_label_en-US" xlink:label="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognised Deferred Tax Asset On Trading Losses</link:label>
    <link:label id="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses_documentation_en-US" xlink:label="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognised Deferred Tax Asset On Trading Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" xlink:href="gsk-20241231.xsd#gsk_UnrecognisedDeferredTaxAssetOnTradingLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" xlink:to="lab_gsk_UnrecognisedDeferredTaxAssetOnTradingLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZeroPointSevenFivePercentMember_832d9a78-0800-4a74-a4b3-22a7c4289e62_terseLabel_en-US" xlink:label="lab_gsk_ZeroPointSevenFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">0.75% increase / decrease</link:label>
    <link:label id="lab_gsk_ZeroPointSevenFivePercentMember_label_en-US" xlink:label="lab_gsk_ZeroPointSevenFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zero Point Seven Five Percent [Member]</link:label>
    <link:label id="lab_gsk_ZeroPointSevenFivePercentMember_documentation_en-US" xlink:label="lab_gsk_ZeroPointSevenFivePercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zero Point Seven Five Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZeroPointSevenFivePercentMember" xlink:href="gsk-20241231.xsd#gsk_ZeroPointSevenFivePercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZeroPointSevenFivePercentMember" xlink:to="lab_gsk_ZeroPointSevenFivePercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherReservesMember_b014aa0c-fa6c-49f1-afde-d448dfdd0f80_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
    <link:label id="lab_ifrs-full_OtherReservesMember_label_en-US" xlink:label="lab_ifrs-full_OtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReservesMember" xlink:to="lab_ifrs-full_OtherReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_05d61b0a-5904-4cf8-ac00-086acb3636ee_totalLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Key management personnel compensation</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage_6200516d-9905-4139-942b-52f532cf6003_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average cost of capital post tax discount rate percentage</link:label>
    <link:label id="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage_label_en-US" xlink:label="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Cost Of Capital After Tax Discount Rate Percentage</link:label>
    <link:label id="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage_documentation_en-US" xlink:label="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average cost of capital after tax discount rate percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" xlink:to="lab_gsk_WeightedAverageCostOfCapitalAfterTaxDiscountRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock_b1f00941-1ded-447d-a523-0a18c5ed91fb_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Option Outstanding</link:label>
    <link:label id="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Share Options And Savings Related Options Outstanding Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of share options and savings related options outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfShareOptionsAndSavingsRelatedOptionsOutstandingExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_669a9ce9-dd30-47fb-b7b1-eb49858346e5_terseLabel_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actual return/(loss) on plan assets</link:label>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_7168ea31-19ff-4347-a598-f1bf524345ff_verboseLabel_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Return on plan assets, excluding amounts included in interest</link:label>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReclassificationOfNetDebt_7a53d6ea-2f10-4c85-938e-950dada647ad_terseLabel_en-US" xlink:label="lab_gsk_ReclassificationOfNetDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_gsk_ReclassificationOfNetDebt_label_en-US" xlink:label="lab_gsk_ReclassificationOfNetDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Of Net Debt</link:label>
    <link:label id="lab_gsk_ReclassificationOfNetDebt_documentation_en-US" xlink:label="lab_gsk_ReclassificationOfNetDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of net debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReclassificationOfNetDebt" xlink:href="gsk-20241231.xsd#gsk_ReclassificationOfNetDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReclassificationOfNetDebt" xlink:to="lab_gsk_ReclassificationOfNetDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfOwnershipDivested_e7e7b755-36c3-4538-8998-e8692e1f7642_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfOwnershipDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of ownership divested</link:label>
    <link:label id="lab_gsk_PercentageOfOwnershipDivested_label_en-US" xlink:label="lab_gsk_PercentageOfOwnershipDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Ownership divested</link:label>
    <link:label id="lab_gsk_PercentageOfOwnershipDivested_documentation_en-US" xlink:label="lab_gsk_PercentageOfOwnershipDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ownership of the Consumer Healthcare business divested.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfOwnershipDivested" xlink:href="gsk-20241231.xsd#gsk_PercentageOfOwnershipDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfOwnershipDivested" xlink:to="lab_gsk_PercentageOfOwnershipDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_0e8dc0f9-a101-4097-a254-3071746b41e3_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected pension increases</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of pension increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherInvestmentsNoncurrentMember_4694d2ca-c001-4160-9d49-868654510835_terseLabel_en-US" xlink:label="lab_gsk_OtherInvestmentsNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_gsk_OtherInvestmentsNoncurrentMember_label_en-US" xlink:label="lab_gsk_OtherInvestmentsNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Investments Noncurrent [Member]</link:label>
    <link:label id="lab_gsk_OtherInvestmentsNoncurrentMember_documentation_en-US" xlink:label="lab_gsk_OtherInvestmentsNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other investments non-current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherInvestmentsNoncurrentMember" xlink:href="gsk-20241231.xsd#gsk_OtherInvestmentsNoncurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherInvestmentsNoncurrentMember" xlink:to="lab_gsk_OtherInvestmentsNoncurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AssociatesAndJointVenturesMember_d4e218b7-d566-4817-baab-ab36679fd8e0_terseLabel_en-US" xlink:label="lab_gsk_AssociatesAndJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associates and joint ventures</link:label>
    <link:label id="lab_gsk_AssociatesAndJointVenturesMember_label_en-US" xlink:label="lab_gsk_AssociatesAndJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associates And Joint Ventures [Member]</link:label>
    <link:label id="lab_gsk_AssociatesAndJointVenturesMember_documentation_en-US" xlink:label="lab_gsk_AssociatesAndJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssociatesAndJointVenturesMember" xlink:href="gsk-20241231.xsd#gsk_AssociatesAndJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AssociatesAndJointVenturesMember" xlink:to="lab_gsk_AssociatesAndJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain_778de811-3851-4850-9a59-d73eb31e9ddd_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal_220d3c8c-70d3-4877-a857-3a35109627b2_terseLabel_en-US" xlink:label="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of intangible assets, net of reversals</link:label>
    <link:label id="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal_label_en-US" xlink:label="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment Of Intangible Assets Net Of Reversal</link:label>
    <link:label id="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal_documentation_en-US" xlink:label="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impairment of intangible assets net of reversal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ImpairmentOfIntangibleAssetsNetOfReversal" xlink:href="gsk-20241231.xsd#gsk_ImpairmentOfIntangibleAssetsNetOfReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ImpairmentOfIntangibleAssetsNetOfReversal" xlink:to="lab_gsk_ImpairmentOfIntangibleAssetsNetOfReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_dc68855f-0739-42c2-8508-e8e9cdc29031_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash inflow/(outflow) from continuing investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities, continuing operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory_c41cbd27-6d3d-45fb-ba59-9b46ba53feea_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in associates, joint ventures and joint operations</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for investment in associates and joint ventures [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_a1514fe0-6950-4d23-a453-8b9472c54796_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Property, Plant and Equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefund_77ac3214-3b32-44df-81bf-88c907506c58_terseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefund" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of corporation tax</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefund_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefund" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefund" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefund" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefund" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLoss_c4dba453-00b1-4ff8-a319-a49d289efb41_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total profit after taxation for the year</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_7fc47ac9-0a79-47de-9e39-226f93c79d0c_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total profit for the year</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_8d4ec4d3-3fd3-4ce7-8a29-696345477b9b_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share of after-tax losses</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_label_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock_465ae161-6a94-4a37-9c79-aef36b3558c0_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments reconciling Total profit after tax to operating cash flows</link:label>
    <link:label id="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of adjustments reconciling profit after tax to operating cash flows explanatory [Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of adjustments reconciling profit after tax to operating cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" xlink:to="lab_gsk_DisclosureOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_65b173ce-2ffe-4478-a09c-9c869af07ccb_totalLabel_en-US" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</link:label>
    <link:label id="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_label_en-US" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidToNoncontrollingInterests_8ff9187f-1344-4b69-bf8f-93dd60b24b24_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid to non-controlling interest</link:label>
    <link:label id="lab_ifrs-full_DividendsPaidToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends paid to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:to="lab_ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities_98bc8f7f-c58b-4ead-9ac8-142d497a1c98_terseLabel_en-US" xlink:label="lab_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities transferred out of level three</link:label>
    <link:label id="lab_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities_label_en-US" xlink:label="lab_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfers out of Level 3 of fair value hierarchy, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities" xlink:to="lab_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses_077b7013-6d34-4511-87a7-9cc523054176_terseLabel_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses_label_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (Increase) in Net Defined Benefit Liability (asset) Resulting from Expenses</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses_documentation_en-US" xlink:label="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease (Increase) in Net Defined Benefit Liability (asset) Resulting from Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" xlink:to="lab_gsk_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_94482680-9741-4a94-848f-80b725f219a7_verboseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Charge/(credit) in respect of prior periods</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for current tax of prior periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:to="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfCashFlowHedgesMember_340d87c0-690e-48fd-894d-e1e9f78e10d2_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedge reserve</link:label>
    <link:label id="lab_ifrs-full_ReserveOfCashFlowHedgesMember_label_en-US" xlink:label="lab_ifrs-full_ReserveOfCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of cash flow hedges [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfCashFlowHedgesMember" xlink:to="lab_ifrs-full_ReserveOfCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PutOption_41469aed-05e9-4b0e-9ea4-9a3e6a2b24e4_terseLabel_en-US" xlink:label="lab_gsk_PutOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pfizer put option</link:label>
    <link:label id="lab_gsk_PutOption_label_en-US" xlink:label="lab_gsk_PutOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Put Option</link:label>
    <link:label id="lab_gsk_PutOption_documentation_en-US" xlink:label="lab_gsk_PutOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Put option.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PutOption" xlink:href="gsk-20241231.xsd#gsk_PutOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PutOption" xlink:to="lab_gsk_PutOption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities_7c797df5-05b2-428f-860e-f76224e437e9_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related amounts not offset, liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments subject to enforceable master netting arrangement or similar agreement not set off against financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" xlink:to="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AllocationToLiabilityMatchingAssets_3f935a43-e550-4bbc-830c-89a43a4fc585_terseLabel_en-US" xlink:label="lab_gsk_AllocationToLiabilityMatchingAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage allocated to liability matching assets</link:label>
    <link:label id="lab_gsk_AllocationToLiabilityMatchingAssets_label_en-US" xlink:label="lab_gsk_AllocationToLiabilityMatchingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocation To Liability Matching Assets</link:label>
    <link:label id="lab_gsk_AllocationToLiabilityMatchingAssets_documentation_en-US" xlink:label="lab_gsk_AllocationToLiabilityMatchingAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Allocation to liability matching assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AllocationToLiabilityMatchingAssets" xlink:href="gsk-20241231.xsd#gsk_AllocationToLiabilityMatchingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AllocationToLiabilityMatchingAssets" xlink:to="lab_gsk_AllocationToLiabilityMatchingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major components of tax expense (income) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_60a704fd-76a8-4256-8c4d-9189daf6df76_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets and net investment hedges</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_a9974e92-67bc-4131-8157-e3d2f51008af_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_7940b176-0bd6-4ac6-bfcd-6fe4395a72c1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_2baeaf7e-b5ce-41ff-b657-856592364924_terseLabel_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investment in foreign operations</link:label>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_098577b3-5067-4420-9a1e-e797344243be_verboseLabel_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Variability in cash flows from foreign exchange exposure arising on Euro denominated coupon payments relating to debt issued</link:label>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_label_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variability In Cash Flows From Foreign Exchange Exposure Arising On Euro Denominated Coupon Payments Relating To Debt Issued [Member]</link:label>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember_documentation_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variability in cash flows from foreign exchange exposure arising on Euro denominated coupon payments relating to debt issued [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:href="gsk-20241231.xsd#gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:to="lab_gsk_VariabilityInCashFlowsFromForeignExchangeExposureArisingOnEuroDenominatedCouponPaymentsRelatingToDebtIssuedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssets_b494cf4d-0495-4dd0-82dd-fce2e6a8f730_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third-party financial derivatives</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssets" xlink:to="lab_ifrs-full_DerivativeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesAxis_bb20a0a0-7c9f-4581-be48-8e6fbeded4da_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of interest rates [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of interest rates [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:to="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_68c2eb0a-ca2d-495e-bee7-d932411ef150_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_6ab3102f-2c0b-487c-a172-8f3581ec32d2_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets in construction reclassified to intangible assets</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers from construction in progress, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_48117a82-0973-4d5e-829d-e54ab664e17d_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets_bc2dd91f-1c1f-4815-abe7-88dc4d663e88_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Multi-asset funds</link:label>
    <link:label id="lab_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment funds, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_InvestmentFundsAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DE_123811a4-51cf-428c-8c0d-23a126f1d9b6_terseLabel_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Delaware</link:label>
    <link:label id="lab_stpr_DE_label_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DELAWARE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DE" xlink:to="lab_stpr_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThirdInterimMember_6d492f25-7596-4bb8-b4af-f34f6b705e83_terseLabel_en-US" xlink:label="lab_gsk_ThirdInterimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third interim</link:label>
    <link:label id="lab_gsk_ThirdInterimMember_label_en-US" xlink:label="lab_gsk_ThirdInterimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Third Interim [member]</link:label>
    <link:label id="lab_gsk_ThirdInterimMember_documentation_en-US" xlink:label="lab_gsk_ThirdInterimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Third interim.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThirdInterimMember" xlink:href="gsk-20241231.xsd#gsk_ThirdInterimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThirdInterimMember" xlink:to="lab_gsk_ThirdInterimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SharePremiumMember_f57acc94-9b25-4290-8fa6-d0e341d8464b_terseLabel_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share&#8232;premium</link:label>
    <link:label id="lab_ifrs-full_SharePremiumMember_label_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember" xlink:to="lab_ifrs-full_SharePremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RoyaltiesReceivable_bf0e1823-f76a-49bb-a067-c1d94f4a516c_terseLabel_en-US" xlink:label="lab_gsk_RoyaltiesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties receivable</link:label>
    <link:label id="lab_gsk_RoyaltiesReceivable_label_en-US" xlink:label="lab_gsk_RoyaltiesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties Receivable</link:label>
    <link:label id="lab_gsk_RoyaltiesReceivable_documentation_en-US" xlink:label="lab_gsk_RoyaltiesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RoyaltiesReceivable" xlink:href="gsk-20241231.xsd#gsk_RoyaltiesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RoyaltiesReceivable" xlink:to="lab_gsk_RoyaltiesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DebtSecurities_e53808d9-6de6-4800-9a4e-179b1a807d88_negatedLabel_en-US" xlink:label="lab_ifrs-full_DebtSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt instruments issued</link:label>
    <link:label id="lab_ifrs-full_DebtSecurities_label_en-US" xlink:label="lab_ifrs-full_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt instruments issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtSecurities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DebtSecurities" xlink:to="lab_ifrs-full_DebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_1f91345c-85d1-4fe0-965d-a240500b99f5_verboseLabel_en-US" xlink:label="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Past service cost</link:label>
    <link:label id="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_a87ee6ad-389a-4dd7-8a78-3d0eb608a3cb_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Past service cost</link:label>
    <link:label id="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from past service cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember_a5514bb4-bf72-4985-9e0b-9c164bf0cba3_terseLabel_en-US" xlink:label="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buy foreign currency, 3 to 6 months</link:label>
    <link:label id="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember_label_en-US" xlink:label="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buy Foreign Currency Three To Six Months [Member]</link:label>
    <link:label id="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember_documentation_en-US" xlink:label="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Buy Foreign Currency three to six months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BuyForeignCurrencyThreeToSixMonthsMember" xlink:href="gsk-20241231.xsd#gsk_BuyForeignCurrencyThreeToSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BuyForeignCurrencyThreeToSixMonthsMember" xlink:to="lab_gsk_BuyForeignCurrencyThreeToSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_f22a893a-9904-42ee-a93d-84a2c4f45b79_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember_d823486f-d88f-4543-adf5-9a13e66fb10c_terseLabel_en-US" xlink:label="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Meningitis, influenza, shingles, established vaccines</link:label>
    <link:label id="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember_label_en-US" xlink:label="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Meningitis, Influenza, Shingles, Established Vaccines, RSV (Arexvy) [Member]</link:label>
    <link:label id="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember_documentation_en-US" xlink:label="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Meningitis, Influenza, Shingles, Established Vaccines, RSV (Arexvy)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" xlink:href="gsk-20241231.xsd#gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" xlink:to="lab_gsk_MeningitisInfluenzaShinglesEstablishedVaccinesRSVArexvyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LeaseholdLandAndBuildingsMember_4188da33-95e9-4dc5-8372-8856d26a5fa9_terseLabel_en-US" xlink:label="lab_gsk_LeaseholdLandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold land and buildings</link:label>
    <link:label id="lab_gsk_LeaseholdLandAndBuildingsMember_label_en-US" xlink:label="lab_gsk_LeaseholdLandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Land And Buildings [Member]</link:label>
    <link:label id="lab_gsk_LeaseholdLandAndBuildingsMember_documentation_en-US" xlink:label="lab_gsk_LeaseholdLandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leasehold land and buildings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LeaseholdLandAndBuildingsMember" xlink:href="gsk-20241231.xsd#gsk_LeaseholdLandAndBuildingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LeaseholdLandAndBuildingsMember" xlink:to="lab_gsk_LeaseholdLandAndBuildingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_856ed384-76c7-4ee5-b411-8742bbded97b_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investing cash flows attributable to discontinued operations</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities, discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GovernmentSecurities_3f2bb450-a632-41ba-95d2-34270270d6fc_terseLabel_en-US" xlink:label="lab_gsk_GovernmentSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government securities</link:label>
    <link:label id="lab_gsk_GovernmentSecurities_label_en-US" xlink:label="lab_gsk_GovernmentSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Securities</link:label>
    <link:label id="lab_gsk_GovernmentSecurities_documentation_en-US" xlink:label="lab_gsk_GovernmentSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GovernmentSecurities" xlink:href="gsk-20241231.xsd#gsk_GovernmentSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GovernmentSecurities" xlink:to="lab_gsk_GovernmentSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDividendsExplanatory_49cd4b76-41cc-41c9-9c1b-34ea545b9aad_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDividendsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDividendsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDividendsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of dividends [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDividendsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDividendsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDividendsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDividendsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashSettledAndOtherPlansMember_c4e7b8ef-9ac9-46d9-8ebc-c4bd68c248c3_terseLabel_en-US" xlink:label="lab_gsk_CashSettledAndOtherPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash settled and other plans</link:label>
    <link:label id="lab_gsk_CashSettledAndOtherPlansMember_label_en-US" xlink:label="lab_gsk_CashSettledAndOtherPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash settled and other plans [member]</link:label>
    <link:label id="lab_gsk_CashSettledAndOtherPlansMember_documentation_en-US" xlink:label="lab_gsk_CashSettledAndOtherPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash settled and other plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashSettledAndOtherPlansMember" xlink:href="gsk-20241231.xsd#gsk_CashSettledAndOtherPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashSettledAndOtherPlansMember" xlink:to="lab_gsk_CashSettledAndOtherPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineManufacturingSpAMember_13b2ad0a-069e-4a6f-97c9-b3403c627c26_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineManufacturingSpAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Manufacturing SpA (Italy)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineManufacturingSpAMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineManufacturingSpAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Manufacturing SpA [Member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineManufacturingSpAMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineManufacturingSpAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Manufacturing SpA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineManufacturingSpAMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineManufacturingSpAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineManufacturingSpAMember" xlink:to="lab_gsk_GlaxoSmithKlineManufacturingSpAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CrisprTherapeuticsMember_7ac5446d-f68d-4256-aa9c-1bd4d6f67d75_terseLabel_en-US" xlink:label="lab_gsk_CrisprTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Crispr Therapeutics</link:label>
    <link:label id="lab_gsk_CrisprTherapeuticsMember_label_en-US" xlink:label="lab_gsk_CrisprTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Crispr Therapeutics [Member]</link:label>
    <link:label id="lab_gsk_CrisprTherapeuticsMember_documentation_en-US" xlink:label="lab_gsk_CrisprTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Crispr Therapeutics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CrisprTherapeuticsMember" xlink:href="gsk-20241231.xsd#gsk_CrisprTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CrisprTherapeuticsMember" xlink:to="lab_gsk_CrisprTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_88c7a156-f5c1-4d17-a9e4-e11664930e5b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_37f4a1cb-afbd-413f-878f-8148a59566e5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of intangible assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage_2302895c-96d1-495e-bd63-75167c71ab81_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average cost of capital pre-tax discount rate percentage</link:label>
    <link:label id="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage_label_en-US" xlink:label="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Cost Of Capital Pre Tax Discount Rate Percentage</link:label>
    <link:label id="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage_documentation_en-US" xlink:label="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average cost of capital pre- tax discount rate percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" xlink:to="lab_gsk_WeightedAverageCostOfCapitalPreTaxDiscountRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_25ccc966-eab1-43c8-94d3-870a83fb778a_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial assets measured at fair value through other comprehensive income (FVTOCI):</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_d628a674-3d55-48c9-8991-3f7acafab63a_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets measured at fair value through other comprehensive income (FVTOCI):</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through other comprehensive income, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_cc4dc1a9-7792-49bb-ac8f-6c6c8b1ee4c8_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalised borrowing costs</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through other changes, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_85854c69-5b46-4961-b93d-2a6a870a2076_terseLabel_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variability in cash flows from a highly probable forecast transaction</link:label>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_label_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variability In Cash Flows From A Highly Probable Forecast Transaction [Member]</link:label>
    <link:label id="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember_documentation_en-US" xlink:label="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variability in cash flows from a highly probable forecast transaction [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" xlink:href="gsk-20241231.xsd#gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" xlink:to="lab_gsk_VariabilityInCashFlowsFromAHighlyProbableForecastTransactionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities_33387464-a9a5-4e93-b7f5-9bff356cbe20_terseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash increase in contingent consideration liabilities</link:label>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities_label_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Decrease Increase In Other Non Cash Contingent Consideration Liabilities</link:label>
    <link:label id="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for decrease increase in other non cash increase in contingent consideration liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" xlink:to="lab_gsk_AdjustmentsForDecreaseIncreaseInOtherNonCashContingentConsiderationLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InternallyGeneratedMember_cd649d3e-7e7d-4631-9ec3-d4ba208e3f00_terseLabel_en-US" xlink:label="lab_ifrs-full_InternallyGeneratedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Internally generated</link:label>
    <link:label id="lab_ifrs-full_InternallyGeneratedMember_label_en-US" xlink:label="lab_ifrs-full_InternallyGeneratedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internally generated [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InternallyGeneratedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InternallyGeneratedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InternallyGeneratedMember" xlink:to="lab_ifrs-full_InternallyGeneratedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineColombiaS.A.Member_eea1811f-cab3-4176-a67a-8723df8924ab_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineColombiaS.A.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Colombia S.A.</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineColombiaS.A.Member_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineColombiaS.A.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Colombia S.A. [Member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineColombiaS.A.Member_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineColombiaS.A.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Colombia S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineColombiaS.A.Member" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineColombiaS.A.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineColombiaS.A.Member" xlink:to="lab_gsk_GlaxoSmithKlineColombiaS.A.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfSharesHeldForShareAwardSchemes_6242c3e9-083c-4326-b173-15a714e7ac18_terseLabel_en-US" xlink:label="lab_gsk_NumberOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfSharesHeldForShareAwardSchemes_label_en-US" xlink:label="lab_gsk_NumberOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Shares Held For Share Award Schemes</link:label>
    <link:label id="lab_gsk_NumberOfSharesHeldForShareAwardSchemes_documentation_en-US" xlink:label="lab_gsk_NumberOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares held for share award schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSharesHeldForShareAwardSchemes" xlink:href="gsk-20241231.xsd#gsk_NumberOfSharesHeldForShareAwardSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfSharesHeldForShareAwardSchemes" xlink:to="lab_gsk_NumberOfSharesHeldForShareAwardSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ConsumerHealthcareBusinessMember_955767e6-d702-4617-b672-cff067918b93_terseLabel_en-US" xlink:label="lab_gsk_ConsumerHealthcareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumer Healthcare Business</link:label>
    <link:label id="lab_gsk_ConsumerHealthcareBusinessMember_label_en-US" xlink:label="lab_gsk_ConsumerHealthcareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumer Healthcare Business [Member]</link:label>
    <link:label id="lab_gsk_ConsumerHealthcareBusinessMember_documentation_en-US" xlink:label="lab_gsk_ConsumerHealthcareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumer healthcare business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConsumerHealthcareBusinessMember" xlink:href="gsk-20241231.xsd#gsk_ConsumerHealthcareBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ConsumerHealthcareBusinessMember" xlink:to="lab_gsk_ConsumerHealthcareBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_b34300b7-29c6-424c-9149-7c0f075ecc4a_negatedLabel_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of lease liabilities</link:label>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2a7e496f-7371-4c2c-b02a-861da539a252_terseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment of lease liabilities</link:label>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SocialSecurityContributions_22cc1e1f-f310-4b81-a03a-1d1492f39d56_terseLabel_en-US" xlink:label="lab_ifrs-full_SocialSecurityContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Social security costs</link:label>
    <link:label id="lab_ifrs-full_SocialSecurityContributions_label_en-US" xlink:label="lab_ifrs-full_SocialSecurityContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Social security contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SocialSecurityContributions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SocialSecurityContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SocialSecurityContributions" xlink:to="lab_ifrs-full_SocialSecurityContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnallocatedAmountsMember_94b0f31e-5f9c-4c35-bdd6-5c1b08ef7430_terseLabel_en-US" xlink:label="lab_ifrs-full_UnallocatedAmountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate and other unallocated costs</link:label>
    <link:label id="lab_ifrs-full_UnallocatedAmountsMember_8735d473-0d5a-46b8-b33c-e0df2071b8ac_verboseLabel_en-US" xlink:label="lab_ifrs-full_UnallocatedAmountsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate and other unallocated depreciation and amortisation</link:label>
    <link:label id="lab_ifrs-full_UnallocatedAmountsMember_label_en-US" xlink:label="lab_ifrs-full_UnallocatedAmountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unallocated amounts [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnallocatedAmountsMember" xlink:to="lab_ifrs-full_UnallocatedAmountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_1fda8925-5395-45b8-b536-9f24c1a7b393_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_8cdbb38c-aad0-4065-8cc8-37c9b901da6c_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_ca4a4bd3-07a3-4196-a8c0-d06d72d28c73_terseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Benefit of intellectual property incentives (in percent)</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect of Benefit of Intellectual Property Incentives</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax rate effect of benefit of intellectual property incentives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" xlink:to="lab_gsk_TaxRateEffectOfBenefitOfIntellectualPropertyIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_db01263b-aa10-4d56-8bb2-853e2ece9fa5_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis" xlink:to="lab_ifrs-full_GeographicalAreasAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember_3e7be538-c6ed-4bea-be02-9980bc063f10_terseLabel_en-US" xlink:label="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.625% &#163; Euro Medium Term Note 2035</link:label>
    <link:label id="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Six Two Five Euro Medium Term Note Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One Point Six Two Five European Medium Term Note Two Thousand Twenty Five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:href="gsk-20241231.xsd#gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:to="lab_gsk_OnePointSixTwoFiveEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineSAMember_d9419125-801e-4913-a460-d0c72596423c_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline S.A. (Spain)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineSAMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline S A [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineSAMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineSAMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineSAMember" xlink:to="lab_gsk_GlaxoSmithKlineSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsRightofuseAssets_7cb9f2d3-fc69-4154-9968-0ee6b522a92e_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DisposalsRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_ifrs-full_DisposalsRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_DisposalsRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsRightofuseAssets" xlink:to="lab_ifrs-full_DisposalsRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_96283c43-88fa-47fc-b41a-a1aba82296ee_verboseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember_a25790ee-3fe4-4580-bce3-c404335783cd_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) movement in EUR or Sterling interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Point Five Percent Movement In EUR Or Sterling Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) movement in EUR or Sterling interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePointFivePercentMovementInEUROrSterlingInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax_e7ee644a-6e99-4569-be9b-653135f60207_terseLabel_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cash generated from operations</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax_label_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flows From (Used In) Operations Before Tax</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax_documentation_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Flows From (Used In) Operations Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashFlowsFromUsedInOperationsBeforeTax" xlink:href="gsk-20241231.xsd#gsk_CashFlowsFromUsedInOperationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashFlowsFromUsedInOperationsBeforeTax" xlink:to="lab_gsk_CashFlowsFromUsedInOperationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation_aa3cc7d7-92a2-46a4-949d-348be3136669_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of share consolidation shares (in shares)</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Shares From Share Consolidation</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impact of share consolidation shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" xlink:to="lab_gsk_IncreaseDecreaseInNumberOfSharesFromShareConsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_0756e536-010e-4598-8183-14d635ba1601_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials and consumables</link:label>
    <link:label id="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_label_en-US" xlink:label="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current raw materials and current production supplies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:to="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities_bac040f3-48ef-410c-9c0c-d7209822b2d7_negatedLabel_en-US" xlink:label="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transfers from Level 3</link:label>
    <link:label id="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities_label_en-US" xlink:label="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfers Out Of Level Three Of Fair Value Hierarchy Assets And Liabilities</link:label>
    <link:label id="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transfers out of level three of fair value hierarchy assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" xlink:to="lab_gsk_TransfersOutOfLevelThreeOfFairValueHierarchyAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_8740735a-bc4e-482f-b61f-52049ad68b34_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests_b5c6cc96-39c7-4071-af70-59a55b8b5928_terseLabel_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets of non-controlling interests</link:label>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests_label_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange Movements On Overseas Net Assets Of Non Controlling Interests</link:label>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests_documentation_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets of non controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" xlink:to="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_93d65a1f-a63b-4d3e-8c07-4db4d14c54b7_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_fbf70928-d835-4980-babe-45cd76c3ffc7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory_9c47d5bf-c949-4e66-be57-6e9916babe8a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Discounted Cash Flow Models Used in Impairment Tests</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information for cash-generating units [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_96c10a06-519b-42eb-a99c-d3355eff0baa_terseLabel_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation of right of use assets</link:label>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_41d01a5e-efaa-4f62-b256-542153982993_negatedLabel_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember_d6723688-c52b-46af-b76e-6be140111148_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharmaceuticals SA (Belgium)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Pharmaceuticals S A [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pharmaceuticals S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlinePharmaceuticalsSAMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlinePharmaceuticalsSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlinePharmaceuticalsSAMember" xlink:to="lab_gsk_GlaxoSmithKlinePharmaceuticalsSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AAAOrAaaMember_28f52efd-6232-4797-a4bf-288b1da10880_terseLabel_en-US" xlink:label="lab_gsk_AAAOrAaaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AAA/Aaa</link:label>
    <link:label id="lab_gsk_AAAOrAaaMember_label_en-US" xlink:label="lab_gsk_AAAOrAaaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AAA Or Aaa [member]</link:label>
    <link:label id="lab_gsk_AAAOrAaaMember_documentation_en-US" xlink:label="lab_gsk_AAAOrAaaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AAA/Aaa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AAAOrAaaMember" xlink:href="gsk-20241231.xsd#gsk_AAAOrAaaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AAAOrAaaMember" xlink:to="lab_gsk_AAAOrAaaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_ccbc9570-110d-4a28-8237-d286360de8ca_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in pension obligation</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Pensions Obligation Due To Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Pensions Obligation Due To Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_gsk_IncreaseDecreaseInPensionsObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxLosses_8f831840-430b-4cda-b797-068fce7ab2fa_terseLabel_en-US" xlink:label="lab_gsk_TaxLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax losses</link:label>
    <link:label id="lab_gsk_TaxLosses_label_en-US" xlink:label="lab_gsk_TaxLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Losses</link:label>
    <link:label id="lab_gsk_TaxLosses_documentation_en-US" xlink:label="lab_gsk_TaxLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax losses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxLosses" xlink:href="gsk-20241231.xsd#gsk_TaxLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxLosses" xlink:to="lab_gsk_TaxLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeReceivables_29d8a064-4a7d-4b72-9a4e-e9d06adab373_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables, net of loss allowance</link:label>
    <link:label id="lab_ifrs-full_TradeReceivables_label_en-US" xlink:label="lab_ifrs-full_TradeReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables" xlink:to="lab_ifrs-full_TradeReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherFinanceIncomeCost_b4508f70-3dd0-4623-9bcf-d1bf1c8e7846_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other finance expense</link:label>
    <link:label id="lab_ifrs-full_OtherFinanceIncomeCost_label_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other finance income (cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceIncomeCost" xlink:to="lab_ifrs-full_OtherFinanceIncomeCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesDomain_203753f2-0d11-4dd6-aae5-319a680bea01_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of related parties</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of related parties [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_d80eb2e5-784b-4480-be52-8876db6476a2_terseLabel_en-US" xlink:label="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-downs (reversals of write-downs) of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Write-downs (reversals of write-downs) of property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDividendsAbstract_label_en-US" xlink:label="lab_gsk_DisclosureOfDividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Dividends [Abstract]</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsAbstract_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of dividends.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDividendsAbstract" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDividendsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDividendsAbstract" xlink:to="lab_gsk_DisclosureOfDividendsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_61898ba6-f03c-4e29-8369-a33aaefe759e_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit attributable to non-controlling interests from continuing operations</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_c8891b49-caec-41d2-9e86-cb07d906392f_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share of profit for the year attributable to non-controlling interest</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from continuing operations attributable to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_102e1407-8b1d-45ff-a8d3-fc95e6f5b020_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents contributed to fair value of plan assets</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfScottishLimitedPartnerships_3e78e630-d429-4135-817f-7c952b92166c_terseLabel_en-US" xlink:label="lab_gsk_NumberOfScottishLimitedPartnerships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Scottish limited partnerships</link:label>
    <link:label id="lab_gsk_NumberOfScottishLimitedPartnerships_label_en-US" xlink:label="lab_gsk_NumberOfScottishLimitedPartnerships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Scottish Limited Partnerships</link:label>
    <link:label id="lab_gsk_NumberOfScottishLimitedPartnerships_documentation_en-US" xlink:label="lab_gsk_NumberOfScottishLimitedPartnerships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Scottish Limited Partnerships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfScottishLimitedPartnerships" xlink:href="gsk-20241231.xsd#gsk_NumberOfScottishLimitedPartnerships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfScottishLimitedPartnerships" xlink:to="lab_gsk_NumberOfScottishLimitedPartnerships" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MeningitisMember_6cbf0353-e180-4363-a428-4f4f53610952_terseLabel_en-US" xlink:label="lab_gsk_MeningitisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Meningitis</link:label>
    <link:label id="lab_gsk_MeningitisMember_label_en-US" xlink:label="lab_gsk_MeningitisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Meningitis [member]</link:label>
    <link:label id="lab_gsk_MeningitisMember_documentation_en-US" xlink:label="lab_gsk_MeningitisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Meningitis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MeningitisMember" xlink:href="gsk-20241231.xsd#gsk_MeningitisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MeningitisMember" xlink:to="lab_gsk_MeningitisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_fcad7575-1ea7-4930-b592-5e3c7d3467c9_verboseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Low-value lease charge</link:label>
    <link:label id="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_label_en-US" xlink:label="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to leases of low-value assets for which recognition exemption has been used</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty_cbbb404f-702c-40f9-b945-c664dbec4b58_terseLabel_en-US" xlink:label="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Female&#8232;Years</link:label>
    <link:label id="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty_label_en-US" xlink:label="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Female Pensioners Average Life Expectancy At Sixty</link:label>
    <link:label id="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty_documentation_en-US" xlink:label="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Female pensioners average life expectancy at sixty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FemalePensionersAverageLifeExpectancyAtSixty" xlink:href="gsk-20241231.xsd#gsk_FemalePensionersAverageLifeExpectancyAtSixty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FemalePensionersAverageLifeExpectancyAtSixty" xlink:to="lab_gsk_FemalePensionersAverageLifeExpectancyAtSixty" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_7ae5064b-98eb-4bf0-80f5-f4b98ec211e5_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement (in pounds per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdvertisingExpense_5e396f60-1584-4a5c-974f-05e5fb698330_terseLabel_en-US" xlink:label="lab_ifrs-full_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_ifrs-full_AdvertisingExpense_label_en-US" xlink:label="lab_ifrs-full_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdvertisingExpense" xlink:to="lab_ifrs-full_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities_f74de4c8-efd7-4599-a8da-c93b7d950485_negatedTerseLabel_en-US" xlink:label="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total derivative instruments, liabilities</link:label>
    <link:label id="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities_label_en-US" xlink:label="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Instruments And Derivatives, Liabilities</link:label>
    <link:label id="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities_documentation_en-US" xlink:label="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hedging Instruments And Derivatives, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HedgingInstrumentsAndDerivativesLiabilities" xlink:href="gsk-20241231.xsd#gsk_HedgingInstrumentsAndDerivativesLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HedgingInstrumentsAndDerivativesLiabilities" xlink:to="lab_gsk_HedgingInstrumentsAndDerivativesLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_81047448-1816-4477-bd1b-5f98c7c533cb_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_817c91e4-f442-4b8b-8056-dc34ee31e588_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">To be settled after one year</link:label>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherLongtermProvisions" xlink:to="lab_ifrs-full_OtherLongtermProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_bc414975-d4fb-4500-8261-d1a522a7e2ec_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_7ba9da96-f6c1-4091-8034-380916ee4171_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments designated as measured at FVTOCI</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember_99049882-d940-4112-93ae-ff265562f5d4_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% decrease in discount rate</link:label>
    <link:label id="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember_label_en-US" xlink:label="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk One Point Five Percentage Decrease In Discount Rate [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk one point five percentage decrease in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" xlink:to="lab_gsk_OtherRiskOnePointFivePercentageDecreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember_7f6b0001-c53c-4a83-a1bf-04b7e6621e7a_terseLabel_en-US" xlink:label="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated and effective as hedging instruments (fair value movements through OCI)</link:label>
    <link:label id="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Liabilities At Fair Value Through Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember_documentation_en-US" xlink:label="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through other comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" xlink:href="gsk-20241231.xsd#gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lab_gsk_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WholesalerInTheUsMember_7766c54e-0282-4f51-a022-fd127273caf3_terseLabel_en-US" xlink:label="lab_gsk_WholesalerInTheUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wholesaler in the US</link:label>
    <link:label id="lab_gsk_WholesalerInTheUsMember_label_en-US" xlink:label="lab_gsk_WholesalerInTheUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholesaler In The US [Member]</link:label>
    <link:label id="lab_gsk_WholesalerInTheUsMember_documentation_en-US" xlink:label="lab_gsk_WholesalerInTheUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wholesaler in the US.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WholesalerInTheUsMember" xlink:href="gsk-20241231.xsd#gsk_WholesalerInTheUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WholesalerInTheUsMember" xlink:to="lab_gsk_WholesalerInTheUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1_a2743f13-216b-4ebd-9361-f83229dee3a1_terseLabel_en-US" xlink:label="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance in cash flow hedge reserve arising from hedging relationships for which hedge accounting is no longer applied</link:label>
    <link:label id="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1_label_en-US" xlink:label="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve Of Cash Flow Hedges, Hedging Relationships For Which Hedge Accounting Is No Longer Applied 1</link:label>
    <link:label id="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1_documentation_en-US" xlink:label="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reserve of cash flow hedges, hedging relationships for which hedge accounting is no longer applied 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" xlink:href="gsk-20241231.xsd#gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" xlink:to="lab_gsk_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_fac38682-10dc-4298-85b4-a06e47408ab9_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPensionSchemesInSurplus_a5b3d575-e72c-4fec-9935-4c47af22d620_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPensionSchemesInSurplus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of pension schemes in surplus</link:label>
    <link:label id="lab_gsk_NumberOfPensionSchemesInSurplus_label_en-US" xlink:label="lab_gsk_NumberOfPensionSchemesInSurplus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Pension Schemes In Surplus</link:label>
    <link:label id="lab_gsk_NumberOfPensionSchemesInSurplus_documentation_en-US" xlink:label="lab_gsk_NumberOfPensionSchemesInSurplus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Pension Schemes In Surplus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPensionSchemesInSurplus" xlink:href="gsk-20241231.xsd#gsk_NumberOfPensionSchemesInSurplus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPensionSchemesInSurplus" xlink:to="lab_gsk_NumberOfPensionSchemesInSurplus" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock_65277114-6852-4d4d-828d-d4a42450c1f7_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Financial Instruments Within Trade and Other Payables, Other Provisions, Other Non-current Liabilities and Contingent Consideration Liabilities</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Liabilities And Non Financial Liabilities Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities and non financial liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfFinancialLiabilitiesAndNonFinancialLiabilitiesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level3OfFairValueHierarchyMember_3aabedcb-7519-4505-9dda-f0ee489a2d7f_terseLabel_en-US" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_ifrs-full_Level3OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PostRetirementBenefitMember_ee2073f9-0fb9-4c26-b6c1-d8affd9ae88f_terseLabel_en-US" xlink:label="lab_gsk_PostRetirementBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-retirement benefits</link:label>
    <link:label id="lab_gsk_PostRetirementBenefitMember_label_en-US" xlink:label="lab_gsk_PostRetirementBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post Retirement Benefit [member]</link:label>
    <link:label id="lab_gsk_PostRetirementBenefitMember_documentation_en-US" xlink:label="lab_gsk_PostRetirementBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Post retirement benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitMember" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PostRetirementBenefitMember" xlink:to="lab_gsk_PostRetirementBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfOperatingProfitTable_0013828a-e435-49b0-b3b9-c221012d932a_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfOperatingProfitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of operating profit [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfOperatingProfitTable_label_en-US" xlink:label="lab_gsk_DisclosureOfOperatingProfitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating profit [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfOperatingProfitTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfOperatingProfitTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of operating profit [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOperatingProfitTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOperatingProfitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfOperatingProfitTable" xlink:to="lab_gsk_DisclosureOfOperatingProfitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MajorRestructuringProvisionsMember_4bb6af6a-0eea-42c2-8334-1bc626aedb82_terseLabel_en-US" xlink:label="lab_gsk_MajorRestructuringProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major restructuring provisions</link:label>
    <link:label id="lab_gsk_MajorRestructuringProvisionsMember_label_en-US" xlink:label="lab_gsk_MajorRestructuringProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Restructuring Provisions [Member]</link:label>
    <link:label id="lab_gsk_MajorRestructuringProvisionsMember_documentation_en-US" xlink:label="lab_gsk_MajorRestructuringProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Restructuring Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MajorRestructuringProvisionsMember" xlink:href="gsk-20241231.xsd#gsk_MajorRestructuringProvisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MajorRestructuringProvisionsMember" xlink:to="lab_gsk_MajorRestructuringProvisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock_48d71697-d5a3-4a16-8d41-7b59c23eacbc_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Book Values of Largest Individual Items</link:label>
    <link:label id="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Licences Included In Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of licences included in intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" xlink:to="lab_gsk_DisclosureOfLicencesIncludedInIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_eec7afcd-e65a-4172-8848-502ea8c45eaa_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current investments other than investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BellusMember_9230105a-553d-4952-af98-da20b80b9dbb_terseLabel_en-US" xlink:label="lab_gsk_BellusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bellus</link:label>
    <link:label id="lab_gsk_BellusMember_label_en-US" xlink:label="lab_gsk_BellusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bellus [Member]</link:label>
    <link:label id="lab_gsk_BellusMember_documentation_en-US" xlink:label="lab_gsk_BellusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bellus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BellusMember" xlink:href="gsk-20241231.xsd#gsk_BellusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BellusMember" xlink:to="lab_gsk_BellusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit_e10c4b83-331e-4635-a7da-9e32a5162d9a_terseLabel_en-US" xlink:label="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold applied to disclosed reconciliating items</link:label>
    <link:label id="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit_label_en-US" xlink:label="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Threshold Applied To Disclosed Reconciliating Items Between Segment Profit And Operating Profit</link:label>
    <link:label id="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit_documentation_en-US" xlink:label="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Threshold Applied To Disclosed Reconciliating Items Between Segment Profit And Operating Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" xlink:href="gsk-20241231.xsd#gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" xlink:to="lab_gsk_ThresholdAppliedToDisclosedReconciliatingItemsBetweenSegmentProfitAndOperatingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue_f1a7d6bc-f7b3-4aec-98f1-bb5ce2bd0e42_verboseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments mandatorily measured at fair value through profit or loss</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on financial assets at fair value through profit or loss, mandatorily measured at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" xlink:to="lab_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UnlistedMember_59b41745-4f46-4029-ba57-42e6e0084dd2_terseLabel_en-US" xlink:label="lab_gsk_UnlistedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8211; unlisted</link:label>
    <link:label id="lab_gsk_UnlistedMember_label_en-US" xlink:label="lab_gsk_UnlistedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unlisted [Member]</link:label>
    <link:label id="lab_gsk_UnlistedMember_documentation_en-US" xlink:label="lab_gsk_UnlistedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unlisted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnlistedMember" xlink:href="gsk-20241231.xsd#gsk_UnlistedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UnlistedMember" xlink:to="lab_gsk_UnlistedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsMaterialToEntityAxis_a8c36576-7223-4aa2-bd98-6d19eacfeca6_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsMaterialToEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets material to entity [axis]</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsMaterialToEntityAxis_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsMaterialToEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets material to entity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsMaterialToEntityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsMaterialToEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsMaterialToEntityAxis" xlink:to="lab_ifrs-full_IntangibleAssetsMaterialToEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e13ba09b-4943-4e4f-bdcf-6223c86c2be1_terseLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of impairments</link:label>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_27e97b31-1a48-4ee5-808a-1b78afb63e01_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, deferred tax liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable_56a0a31c-07d2-4980-877b-8868569f392e_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Of Contingent Consideration [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable_label_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Of Contingent Consideration [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueOfContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationTable" xlink:to="lab_gsk_DisclosureOfFairValueOfContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CreditExposure_c594fb70-ce30-4eef-b80c-cf36e342927e_terseLabel_en-US" xlink:label="lab_ifrs-full_CreditExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of credit risk</link:label>
    <link:label id="lab_ifrs-full_CreditExposure_label_en-US" xlink:label="lab_ifrs-full_CreditExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditExposure" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditExposure" xlink:to="lab_ifrs-full_CreditExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_a6a9c54b-0b91-41f3-81e4-51bd7574c855_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_ae7f5012-7849-4f8c-bc0a-bc8993e908aa_verboseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss allowance-trade receivables</link:label>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated impairment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WagesAndSalaries_45a511bc-72fe-4818-8dba-f36da6d6b0d6_terseLabel_en-US" xlink:label="lab_ifrs-full_WagesAndSalaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wages and salaries</link:label>
    <link:label id="lab_ifrs-full_WagesAndSalaries_label_en-US" xlink:label="lab_ifrs-full_WagesAndSalaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wages and salaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries" xlink:to="lab_ifrs-full_WagesAndSalaries" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_e24d2408-e570-4400-8f29-ab04700e8f7b_terseLabel_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share (pence) from discontinued operations (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_c1249e25-f2c5-4af8-9ba5-5e6c839c6c98_verboseLabel_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share from discontinued operations (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_label_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share from discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashRestructuringCharges_313f419b-fcee-40a9-a145-f6eb415a8814_verboseLabel_en-US" xlink:label="lab_gsk_CashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_gsk_CashRestructuringCharges_label_en-US" xlink:label="lab_gsk_CashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Restructuring Charges</link:label>
    <link:label id="lab_gsk_CashRestructuringCharges_documentation_en-US" xlink:label="lab_gsk_CashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash restructuring charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashRestructuringCharges" xlink:href="gsk-20241231.xsd#gsk_CashRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashRestructuringCharges" xlink:to="lab_gsk_CashRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_ac6b715e-dd24-409c-aab3-1c22787bb23c_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EstablishedVaccinesMember_482a5812-7e8a-4864-9609-9dc11309e121_terseLabel_en-US" xlink:label="lab_gsk_EstablishedVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Established Vaccines</link:label>
    <link:label id="lab_gsk_EstablishedVaccinesMember_label_en-US" xlink:label="lab_gsk_EstablishedVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Established Vaccines [member]</link:label>
    <link:label id="lab_gsk_EstablishedVaccinesMember_documentation_en-US" xlink:label="lab_gsk_EstablishedVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Established vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EstablishedVaccinesMember" xlink:href="gsk-20241231.xsd#gsk_EstablishedVaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EstablishedVaccinesMember" xlink:to="lab_gsk_EstablishedVaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember_da6719fb-5dff-494c-add2-0904eadc21ea_terseLabel_en-US" xlink:label="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.250% &#163; Euro Medium Term Note 2042</link:label>
    <link:label id="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember_label_en-US" xlink:label="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Five Point Two Five Percent Euro Term Note Two Thousand Forty Two [Member]</link:label>
    <link:label id="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember_documentation_en-US" xlink:label="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Five point two five percent European term note two thousand forty two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" xlink:href="gsk-20241231.xsd#gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" xlink:to="lab_gsk_FivePointTwoFivePercentEuroTermNoteTwoThousandFortyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember_4b0de9ff-0e6b-4772-8aff-31c844d2daf9_terseLabel_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember_label_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents, Financial Assets [Member]</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember_documentation_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsFinancialAssetsMember" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashAndCashEquivalentsFinancialAssetsMember" xlink:to="lab_gsk_CashAndCashEquivalentsFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember_2adfd2f5-1959-4ddc-b09f-142f80b00e41_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10 yen appreciation of the Yen</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Yen Appreciation Of Yen [member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">10 Yen appreciation of the Yen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenYenAppreciationOfYenMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenYenAppreciationOfYenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskTenYenAppreciationOfYenMember" xlink:to="lab_gsk_CurrencyRiskTenYenAppreciationOfYenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_f9440732-6576-4cfd-a7d2-a5e73c1e8109_terseLabel_en-US" xlink:label="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right Of Use Assets Recognised As Of Acquisition Date</link:label>
    <link:label id="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right Of Use Assets Recognised As Of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" xlink:href="gsk-20241231.xsd#gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" xlink:to="lab_gsk_RightOfUseAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExecutiveSupplementalSavingsPlanMember_aea99a38-a681-44d6-9b3b-deca462d9d03_terseLabel_en-US" xlink:label="lab_gsk_ExecutiveSupplementalSavingsPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive supplemental savings plan</link:label>
    <link:label id="lab_gsk_ExecutiveSupplementalSavingsPlanMember_label_en-US" xlink:label="lab_gsk_ExecutiveSupplementalSavingsPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Supplemental Savings Plan [Member]</link:label>
    <link:label id="lab_gsk_ExecutiveSupplementalSavingsPlanMember_documentation_en-US" xlink:label="lab_gsk_ExecutiveSupplementalSavingsPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Executive Supplemental Savings Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExecutiveSupplementalSavingsPlanMember" xlink:href="gsk-20241231.xsd#gsk_ExecutiveSupplementalSavingsPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExecutiveSupplementalSavingsPlanMember" xlink:to="lab_gsk_ExecutiveSupplementalSavingsPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_5a800abf-9118-4d58-afc1-3fe853596611_terseLabel_en-US" xlink:label="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Amount Attributable to Joint Venture Included in GSK's Consolidated Statement of Comprehensive Income, Consolidated Statement of Changes in Equity and Consolidated Balance Sheet</link:label>
    <link:label id="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Information about the Amounts Attributable to Non Controlling Interests Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of information about the amounts attributable to non controlling interests explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:to="lab_gsk_ScheduleOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity_221194bb-7cef-4151-ac5d-d53ba259d83c_verboseLabel_en-US" xlink:label="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contributions from non-controlling interests</link:label>
    <link:label id="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity_label_en-US" xlink:label="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Through Other Contributions By Noncontrolling Interests, Equity</link:label>
    <link:label id="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity_documentation_en-US" xlink:label="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The increase in equity through other contributions by non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" xlink:href="gsk-20241231.xsd#gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" xlink:to="lab_gsk_IncreaseThroughOtherContributionsByNoncontrollingInterestsEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember_c67870e8-6049-4a9f-aa0f-0d9ce179730a_terseLabel_en-US" xlink:label="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Banco De America Central And Banco De Honduras</link:label>
    <link:label id="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember_label_en-US" xlink:label="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Banco De America Central And Banco De Honduras [Member]</link:label>
    <link:label id="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember_documentation_en-US" xlink:label="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Banco De America Central And Banco De Honduras</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" xlink:href="gsk-20241231.xsd#gsk_BancoDeAmericaCentralAndBancoDeHondurasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" xlink:to="lab_gsk_BancoDeAmericaCentralAndBancoDeHondurasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TesaroMember_1d28771f-08fb-4898-97de-924c1ad57280_verboseLabel_en-US" xlink:label="lab_gsk_TesaroMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Tesaro, Inc.</link:label>
    <link:label id="lab_gsk_TesaroMember_label_en-US" xlink:label="lab_gsk_TesaroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tesaro [member]</link:label>
    <link:label id="lab_gsk_TesaroMember_documentation_en-US" xlink:label="lab_gsk_TesaroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tesaro.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TesaroMember" xlink:href="gsk-20241231.xsd#gsk_TesaroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TesaroMember" xlink:to="lab_gsk_TesaroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ChimagenMember_89a0183a-a45d-4bac-aa39-69551bfc0195_terseLabel_en-US" xlink:label="lab_gsk_ChimagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chimagen</link:label>
    <link:label id="lab_gsk_ChimagenMember_label_en-US" xlink:label="lab_gsk_ChimagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chimagen [Member]</link:label>
    <link:label id="lab_gsk_ChimagenMember_documentation_en-US" xlink:label="lab_gsk_ChimagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Chimagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChimagenMember" xlink:href="gsk-20241231.xsd#gsk_ChimagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ChimagenMember" xlink:to="lab_gsk_ChimagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivablesAbstract_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other receivables [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BuyForeignCurrencyOverSixMonthsMember_df26c49d-48f0-4e5d-9e22-2e1403b62805_terseLabel_en-US" xlink:label="lab_gsk_BuyForeignCurrencyOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buy foreign currency, over 6 months</link:label>
    <link:label id="lab_gsk_BuyForeignCurrencyOverSixMonthsMember_label_en-US" xlink:label="lab_gsk_BuyForeignCurrencyOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buy Foreign Currency Over Six Months [Member]</link:label>
    <link:label id="lab_gsk_BuyForeignCurrencyOverSixMonthsMember_documentation_en-US" xlink:label="lab_gsk_BuyForeignCurrencyOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Buy Foreign Currency over six months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BuyForeignCurrencyOverSixMonthsMember" xlink:href="gsk-20241231.xsd#gsk_BuyForeignCurrencyOverSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BuyForeignCurrencyOverSixMonthsMember" xlink:to="lab_gsk_BuyForeignCurrencyOverSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities_c4d4db52-8e24-46af-8d97-2f34dfe24f08_terseLabel_en-US" xlink:label="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration paid</link:label>
    <link:label id="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outflow Of Cash Through CCL Classified As Investing Activities</link:label>
    <link:label id="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities_documentation_en-US" xlink:label="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Outflow Of Cash Through CCL Classified As Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" xlink:href="gsk-20241231.xsd#gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" xlink:to="lab_gsk_OutflowOfCashThroughCCLClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember_1377ffb3-6a80-49f4-9be1-9efeb27c15ef_terseLabel_en-US" xlink:label="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.125% &#8364; Euro Medium Term Note 2032</link:label>
    <link:label id="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember_label_en-US" xlink:label="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point One Two Five Percent Euro Medium Term Note Two Thousand Thirty Two [Member]</link:label>
    <link:label id="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember_documentation_en-US" xlink:label="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three point one two five percent euro medium term note two thousand thirty two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" xlink:href="gsk-20241231.xsd#gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" xlink:to="lab_gsk_ThreePointOneTwoFivePercentEuroMediumTermNoteTwoThousandThirtyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RevolvingCreditFacilityExtensionTerm_4f36aac6-9896-45bd-8cd3-4f8b0a9e4ed7_terseLabel_en-US" xlink:label="lab_gsk_RevolvingCreditFacilityExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit facility, extension term</link:label>
    <link:label id="lab_gsk_RevolvingCreditFacilityExtensionTerm_label_en-US" xlink:label="lab_gsk_RevolvingCreditFacilityExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Extension Term</link:label>
    <link:label id="lab_gsk_RevolvingCreditFacilityExtensionTerm_documentation_en-US" xlink:label="lab_gsk_RevolvingCreditFacilityExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RevolvingCreditFacilityExtensionTerm" xlink:href="gsk-20241231.xsd#gsk_RevolvingCreditFacilityExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RevolvingCreditFacilityExtensionTerm" xlink:to="lab_gsk_RevolvingCreditFacilityExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentEquityAndOtherInvestmentsMember_085d9bc1-b00d-410c-a5d9-2a8850c9ea0d_verboseLabel_en-US" xlink:label="lab_gsk_CurrentEquityAndOtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current equity investments and other investments</link:label>
    <link:label id="lab_gsk_CurrentEquityAndOtherInvestmentsMember_label_en-US" xlink:label="lab_gsk_CurrentEquityAndOtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Equity And Other Investments [Member]</link:label>
    <link:label id="lab_gsk_CurrentEquityAndOtherInvestmentsMember_documentation_en-US" xlink:label="lab_gsk_CurrentEquityAndOtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current equity and other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentEquityAndOtherInvestmentsMember" xlink:href="gsk-20241231.xsd#gsk_CurrentEquityAndOtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentEquityAndOtherInvestmentsMember" xlink:to="lab_gsk_CurrentEquityAndOtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfClassActionsPending_23f5a735-fc40-4c6d-a9c4-9c8e60d1a7b4_terseLabel_en-US" xlink:label="lab_gsk_NumberOfClassActionsPending" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of class actions pending</link:label>
    <link:label id="lab_gsk_NumberOfClassActionsPending_label_en-US" xlink:label="lab_gsk_NumberOfClassActionsPending" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Class Actions Pending</link:label>
    <link:label id="lab_gsk_NumberOfClassActionsPending_documentation_en-US" xlink:label="lab_gsk_NumberOfClassActionsPending" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Class Actions Pending</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfClassActionsPending" xlink:href="gsk-20241231.xsd#gsk_NumberOfClassActionsPending"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfClassActionsPending" xlink:to="lab_gsk_NumberOfClassActionsPending" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_226b670d-b1a2-4732-b4e9-285041dc8ac8_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember_a400495d-6efe-4b88-80f1-6c6b9206f357_terseLabel_en-US" xlink:label="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unfunded post-retirement healthcare schemes</link:label>
    <link:label id="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember_label_en-US" xlink:label="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unfunded Post-Retirement Healthcare Schemes [Member]</link:label>
    <link:label id="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember_documentation_en-US" xlink:label="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unfunded post retirement pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnfundedPostRetirementHealthcareSchemesMember" xlink:href="gsk-20241231.xsd#gsk_UnfundedPostRetirementHealthcareSchemesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UnfundedPostRetirementHealthcareSchemesMember" xlink:to="lab_gsk_UnfundedPostRetirementHealthcareSchemesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock_e9c7e5b6-9399-4f32-9272-c2fb0bf1a627_verboseLabel_en-US" xlink:label="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Sensitivity Impact Of Non Functional Currency</link:label>
    <link:label id="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock_label_en-US" xlink:label="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Sensitivity Impact Of Non Functional Currency [Table Text Block]</link:label>
    <link:label id="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock_documentation_en-US" xlink:label="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign exchange sensitivity impact of non-functional currency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" xlink:to="lab_gsk_ForeignExchangeSensitivityImpactOfNonFunctionalCurrencyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales_5556ae14-2420-4e7b-95a9-6a32edd8fd8d_terseLabel_en-US" xlink:label="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit sharing costs (recoveries) and royalties due to the counterparty included in cost of sales</link:label>
    <link:label id="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales_label_en-US" xlink:label="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit Sharing Costs And Royalties Due (From) To The Counterparty Included In Cost Of Sales</link:label>
    <link:label id="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales_documentation_en-US" xlink:label="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Profit sharing costs and royalties due to the counterparty included in cost of sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" xlink:href="gsk-20241231.xsd#gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" xlink:to="lab_gsk_ProfitSharingCostsAndRoyaltiesDueFromToTheCounterpartyIncludedInCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_e9798717-c15f-4448-bd1d-730a4a280f4d_terseLabel_en-US" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfAuditorsRemunerationLineItems_4e4f2046-f4e6-47f0-9d43-d6e2a0f300ff_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfAuditorsRemunerationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Auditors Remuneration [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfAuditorsRemunerationLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfAuditorsRemunerationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Auditors Remuneration [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfAuditorsRemunerationLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfAuditorsRemunerationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of auditors remuneration..</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfAuditorsRemunerationLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfAuditorsRemunerationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfAuditorsRemunerationLineItems" xlink:to="lab_gsk_DisclosureOfAuditorsRemunerationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeStatementAbstract_label_en-US" xlink:label="lab_ifrs-full_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit or loss [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract" xlink:to="lab_ifrs-full_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1955aca9-946d-4558-90b6-7b80006876b6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_cf94c62b-d3b9-4a9b-9409-9125c87c496d_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Anticipated Contractual Cash Flows Including Interest Payable for the Non-Derivative Financial Liabilities on Undiscounted Basis</link:label>
    <link:label id="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:to="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1806dea0-32d0-4ac1-a221-970b0c36af9e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Critical accounting judgements and key sources of estimation uncertainty</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_1bf120b7-058c-41a5-949e-fb7f6e98fd82_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of discount rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FirstInterimMember_98483386-e91d-4c56-9d43-2576de636e2b_terseLabel_en-US" xlink:label="lab_gsk_FirstInterimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First interim</link:label>
    <link:label id="lab_gsk_FirstInterimMember_label_en-US" xlink:label="lab_gsk_FirstInterimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Interim [member]</link:label>
    <link:label id="lab_gsk_FirstInterimMember_documentation_en-US" xlink:label="lab_gsk_FirstInterimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First interim.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FirstInterimMember" xlink:href="gsk-20241231.xsd#gsk_FirstInterimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FirstInterimMember" xlink:to="lab_gsk_FirstInterimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TreasuryShares_30bb0b71-ef6f-4ca1-9e60-0e6ae7ac016e_terseLabel_en-US" xlink:label="lab_ifrs-full_TreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares at cost</link:label>
    <link:label id="lab_ifrs-full_TreasuryShares_label_en-US" xlink:label="lab_ifrs-full_TreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares" xlink:to="lab_ifrs-full_TreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherBusinessMember_d2974e90-637f-4864-a5e2-cd8362fba7ef_terseLabel_en-US" xlink:label="lab_gsk_OtherBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_gsk_OtherBusinessMember_label_en-US" xlink:label="lab_gsk_OtherBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Business [Member]</link:label>
    <link:label id="lab_gsk_OtherBusinessMember_documentation_en-US" xlink:label="lab_gsk_OtherBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherBusinessMember" xlink:href="gsk-20241231.xsd#gsk_OtherBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherBusinessMember" xlink:to="lab_gsk_OtherBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDividendsTable_1d2bfd58-e761-4c97-ae61-44e9ba260c5c_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDividendsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Dividends [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsTable_label_en-US" xlink:label="lab_gsk_DisclosureOfDividendsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Dividends [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfDividendsTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDividendsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of Dividends [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDividendsTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDividendsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDividendsTable" xlink:to="lab_gsk_DisclosureOfDividendsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement_b1120927-96db-45c5-ad38-3fb015414b95_terseLabel_en-US" xlink:label="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of outstanding awards (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Awards Outstanding In Share-Based Payment Arrangement</link:label>
    <link:label id="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of awards outstanding in a share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" xlink:href="gsk-20241231.xsd#gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" xlink:to="lab_gsk_NumberOfAwardsOutstandingInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageShares_e8634c09-5fbe-42cd-a339-f786fb3f41ce_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic , (in shares)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Borrowings_d8193558-64ac-465e-9e8f-c9bac33e113e_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_ifrs-full_Borrowings_6c9fdd45-7818-4a17-adfd-15acfbae4b44_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Net debt, at beginning of year, as adjusted</link:label>
    <link:label id="lab_ifrs-full_Borrowings_20e918f6-490b-4a94-8e75-6f410d74b792_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Total net debt at end of year</link:label>
    <link:label id="lab_ifrs-full_Borrowings_3a490f18-9df8-49a1-b971-d7df8133c7c7_terseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_Borrowings_label_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings" xlink:to="lab_ifrs-full_Borrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BalanceAmountDerecognisedOnDemerger_8a3ef623-5b29-4fb0-8961-9d43a747197b_negatedLabel_en-US" xlink:label="lab_gsk_BalanceAmountDerecognisedOnDemerger" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Balances derecognised on demerger</link:label>
    <link:label id="lab_gsk_BalanceAmountDerecognisedOnDemerger_label_en-US" xlink:label="lab_gsk_BalanceAmountDerecognisedOnDemerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Amount Derecognised On Demerger</link:label>
    <link:label id="lab_gsk_BalanceAmountDerecognisedOnDemerger_documentation_en-US" xlink:label="lab_gsk_BalanceAmountDerecognisedOnDemerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Balance amount derecognised on demerger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BalanceAmountDerecognisedOnDemerger" xlink:href="gsk-20241231.xsd#gsk_BalanceAmountDerecognisedOnDemerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BalanceAmountDerecognisedOnDemerger" xlink:to="lab_gsk_BalanceAmountDerecognisedOnDemerger" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PostRetirementBenefitsMember_8c65e4b9-0d78-479b-9b8e-e110da6e0d7b_terseLabel_en-US" xlink:label="lab_gsk_PostRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-retirement&#8232;benefits</link:label>
    <link:label id="lab_gsk_PostRetirementBenefitsMember_label_en-US" xlink:label="lab_gsk_PostRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-Retirement Benefits [Member]</link:label>
    <link:label id="lab_gsk_PostRetirementBenefitsMember_documentation_en-US" xlink:label="lab_gsk_PostRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Post-retirement benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PostRetirementBenefitsMember" xlink:href="gsk-20241231.xsd#gsk_PostRetirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PostRetirementBenefitsMember" xlink:to="lab_gsk_PostRetirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFinancialAssets_60b33b56-c14b-4c34-aa8a-3678d1037b51_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in financial assets</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInFinancialAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseInFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherProvisionMember_b43c1863-e451-4f27-8756-83933c3c3ac9_terseLabel_en-US" xlink:label="lab_gsk_OtherProvisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_gsk_OtherProvisionMember_label_en-US" xlink:label="lab_gsk_OtherProvisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Provision [member]</link:label>
    <link:label id="lab_gsk_OtherProvisionMember_documentation_en-US" xlink:label="lab_gsk_OtherProvisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other provision.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherProvisionMember" xlink:href="gsk-20241231.xsd#gsk_OtherProvisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherProvisionMember" xlink:to="lab_gsk_OtherProvisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock_6f45c0ef-6921-48a6-a83a-330ec47068a0_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Cumulative Translation Exchange in Equity</link:label>
    <link:label id="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Cumulative Translation Exchange In Equity [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of cumulative translation exchange in equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" xlink:to="lab_gsk_DisclosureOfCumulativeTranslationExchangeInEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures_2b079c8d-e303-4255-86b9-eb3d83f86fce_terseLabel_en-US" xlink:label="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share of after-tax (profits)/losses of associates and joint ventures</link:label>
    <link:label id="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures_label_en-US" xlink:label="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Share Of After Tax Profits (Losses) Of Associates And Joint Ventures</link:label>
    <link:label id="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for share of after tax profits of associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" xlink:href="gsk-20241231.xsd#gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" xlink:to="lab_gsk_AdjustmentsForShareOfAfterTaxProfitsLossesOfAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss_e1c07095-6e9c-4242-af78-801da907d265_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets measured at fair value through profit or loss</link:label>
    <link:label id="lab_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest income on financial assets designated at fair value through profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" xlink:to="lab_ifrs-full_InterestIncomeOnFinancialAssetsDesignatedAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember_8c8be3e5-0282-4e5b-a070-67c8e4143d0f_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.5% (150 basis points) increase in Euro interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Point Five Percent Increase In Euro Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest rate risk one point five percent increase in euro interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePointFivePercentIncreaseInEuroInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_6be8c11f-8146-449a-a40a-753b0e005de0_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_dc064559-032f-4ae6-ab0b-a67278d613fe_totalLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract_ca694c03-5a3a-46a3-8212-4aba94d664d1_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and bank overdrafts at end of year comprise:</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents if different from statement of financial position [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_5e92197d-8a6e-4a96-af4e-5f7294508b1d_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of share-based incentive plans</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, share-based payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_8d4fc476-243a-4ac0-abd4-71beffacba5e_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental payments due between one and two years</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_a184d7ca-a872-4ad3-9085-2c544d3aba95_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Between one and two years</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year and not later than two years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationAndAmortisationExpense_12c75a04-76d1-44cf-bc53-9eff97760ae8_terseLabel_en-US" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total depreciation and amortisation</link:label>
    <link:label id="lab_ifrs-full_DepreciationAndAmortisationExpense_label_en-US" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and amortisation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_2e0af87f-90cc-480c-97e3-906d3f1c0de0_negatedLabel_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_7523c620-7ebe-4ead-ba1e-0c0792104250_terseLabel_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PandemicMember_bc43b973-f758-4165-b06a-15cc4e6b8aa6_terseLabel_en-US" xlink:label="lab_gsk_PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pandemic</link:label>
    <link:label id="lab_gsk_PandemicMember_label_en-US" xlink:label="lab_gsk_PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pandemic [Member]</link:label>
    <link:label id="lab_gsk_PandemicMember_documentation_en-US" xlink:label="lab_gsk_PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pandemic [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PandemicMember" xlink:href="gsk-20241231.xsd#gsk_PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PandemicMember" xlink:to="lab_gsk_PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeFromContinuingOperations_8f12df11-9267-4e9e-a38d-1ae636883abc_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (expense)/income for the year from continuing operations</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeFromContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income from continuing operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromContinuingOperations" xlink:to="lab_ifrs-full_ComprehensiveIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetOperatingAssets_3f3c69e2-b728-4087-b0b9-4d6dcf26b253_terseLabel_en-US" xlink:label="lab_gsk_NetOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating assets</link:label>
    <link:label id="lab_gsk_NetOperatingAssets_label_en-US" xlink:label="lab_gsk_NetOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Assets</link:label>
    <link:label id="lab_gsk_NetOperatingAssets_documentation_en-US" xlink:label="lab_gsk_NetOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetOperatingAssets" xlink:href="gsk-20241231.xsd#gsk_NetOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetOperatingAssets" xlink:to="lab_gsk_NetOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CommercialisedProductsMember_bdfd6d11-5591-420f-a8a3-925ede56df67_terseLabel_en-US" xlink:label="lab_gsk_CommercialisedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercialised Products</link:label>
    <link:label id="lab_gsk_CommercialisedProductsMember_label_en-US" xlink:label="lab_gsk_CommercialisedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercialised Products [Member]</link:label>
    <link:label id="lab_gsk_CommercialisedProductsMember_documentation_en-US" xlink:label="lab_gsk_CommercialisedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commercialised Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CommercialisedProductsMember" xlink:href="gsk-20241231.xsd#gsk_CommercialisedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CommercialisedProductsMember" xlink:to="lab_gsk_CommercialisedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_8741db77-e439-4aec-9145-fe78a5ff7d2c_terseLabel_en-US" xlink:label="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Characteristics of defined benefit plans [domain]</link:label>
    <link:label id="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_label_en-US" xlink:label="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Characteristics of defined benefit plans [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain" xlink:to="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WaveLifeSciencesMember_976aa599-a802-417d-a20c-10fe77e46254_terseLabel_en-US" xlink:label="lab_gsk_WaveLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wave Life Sciences</link:label>
    <link:label id="lab_gsk_WaveLifeSciencesMember_label_en-US" xlink:label="lab_gsk_WaveLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wave Life Sciences [Member]</link:label>
    <link:label id="lab_gsk_WaveLifeSciencesMember_documentation_en-US" xlink:label="lab_gsk_WaveLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wave Life Sciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WaveLifeSciencesMember" xlink:href="gsk-20241231.xsd#gsk_WaveLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WaveLifeSciencesMember" xlink:to="lab_gsk_WaveLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis_71f172ab-92ed-41c1-a9ca-54557f661746_terseLabel_en-US" xlink:label="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit impairment of financial instruments [axis]</link:label>
    <link:label id="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis_label_en-US" xlink:label="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit impairment of financial instruments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis" xlink:to="lab_ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_StiefelTradeNameMember_1501591c-c60e-430b-b1bd-9b5de0ad35f7_terseLabel_en-US" xlink:label="lab_gsk_StiefelTradeNameMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stiefel Trade Name</link:label>
    <link:label id="lab_gsk_StiefelTradeNameMember_label_en-US" xlink:label="lab_gsk_StiefelTradeNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stiefel Trade Name [member]</link:label>
    <link:label id="lab_gsk_StiefelTradeNameMember_documentation_en-US" xlink:label="lab_gsk_StiefelTradeNameMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stiefel Trade Name [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_StiefelTradeNameMember" xlink:href="gsk-20241231.xsd#gsk_StiefelTradeNameMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_StiefelTradeNameMember" xlink:to="lab_gsk_StiefelTradeNameMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities_1ebf01a6-99aa-4328-ac9f-c6b9959331fd_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current deferred income other than non-current contract liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" xlink:to="lab_ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShingrixMember_bc04594c-49b8-4a89-95dd-622ac2cda230_terseLabel_en-US" xlink:label="lab_gsk_ShingrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shingrix</link:label>
    <link:label id="lab_gsk_ShingrixMember_label_en-US" xlink:label="lab_gsk_ShingrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shingrix [Member]</link:label>
    <link:label id="lab_gsk_ShingrixMember_documentation_en-US" xlink:label="lab_gsk_ShingrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shingrix.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShingrixMember" xlink:href="gsk-20241231.xsd#gsk_ShingrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShingrixMember" xlink:to="lab_gsk_ShingrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NovartisVaccinesBusinessMember_65dd2039-bcd1-4441-8854-9a352016bc70_terseLabel_en-US" xlink:label="lab_gsk_NovartisVaccinesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novartis Vaccines Business</link:label>
    <link:label id="lab_gsk_NovartisVaccinesBusinessMember_label_en-US" xlink:label="lab_gsk_NovartisVaccinesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Vaccines Business [Member]</link:label>
    <link:label id="lab_gsk_NovartisVaccinesBusinessMember_documentation_en-US" xlink:label="lab_gsk_NovartisVaccinesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Novartis vaccines business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NovartisVaccinesBusinessMember" xlink:href="gsk-20241231.xsd#gsk_NovartisVaccinesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NovartisVaccinesBusinessMember" xlink:to="lab_gsk_NovartisVaccinesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember_098054b8-8294-4a58-89fa-fd8f3708240e_terseLabel_en-US" xlink:label="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome Manufacturing Pte Ltd (Singapore)</link:label>
    <link:label id="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember_label_en-US" xlink:label="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome Manufacturing Pte Ltd [member]</link:label>
    <link:label id="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember_documentation_en-US" xlink:label="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Glaxo Wellcome Manufacturing Pte Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoWellcomeManufacturingPteLtdMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoWellcomeManufacturingPteLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoWellcomeManufacturingPteLtdMember" xlink:to="lab_gsk_GlaxoWellcomeManufacturingPteLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CountryOfDomicileMember_2c444a3c-f729-405a-ad8d-28ee3e6d15dd_verboseLabel_en-US" xlink:label="lab_ifrs-full_CountryOfDomicileMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">UK</link:label>
    <link:label id="lab_ifrs-full_CountryOfDomicileMember_01efd4dd-a0f9-4dc6-b038-5b7506cc5046_terseLabel_en-US" xlink:label="lab_ifrs-full_CountryOfDomicileMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK</link:label>
    <link:label id="lab_ifrs-full_CountryOfDomicileMember_label_en-US" xlink:label="lab_ifrs-full_CountryOfDomicileMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Country of domicile [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfDomicileMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CountryOfDomicileMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CountryOfDomicileMember" xlink:to="lab_ifrs-full_CountryOfDomicileMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UCBMember_70d50c66-7d3f-493a-ba9a-187e20c25d7c_terseLabel_en-US" xlink:label="lab_gsk_UCBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UCB</link:label>
    <link:label id="lab_gsk_UCBMember_label_en-US" xlink:label="lab_gsk_UCBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UCB [Member]</link:label>
    <link:label id="lab_gsk_UCBMember_documentation_en-US" xlink:label="lab_gsk_UCBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">UCB</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UCBMember" xlink:href="gsk-20241231.xsd#gsk_UCBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UCBMember" xlink:to="lab_gsk_UCBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SegmentConsolidationItemMember_405e077d-e932-46fb-b2ec-6db760e0c998_terseLabel_en-US" xlink:label="lab_gsk_SegmentConsolidationItemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity's total for segment consolidation items</link:label>
    <link:label id="lab_gsk_SegmentConsolidationItemMember_label_en-US" xlink:label="lab_gsk_SegmentConsolidationItemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Consolidation Item [Member]</link:label>
    <link:label id="lab_gsk_SegmentConsolidationItemMember_documentation_en-US" xlink:label="lab_gsk_SegmentConsolidationItemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment consolidation item.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SegmentConsolidationItemMember" xlink:href="gsk-20241231.xsd#gsk_SegmentConsolidationItemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SegmentConsolidationItemMember" xlink:to="lab_gsk_SegmentConsolidationItemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_91ac4e2a-d3c7-47ea-8f98-7e405ef662fe_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ApplicableTaxRate_9a6b0762-ffb1-4193-a398-7cefa8027297_verboseLabel_en-US" xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">UK statutory rate of taxation (in percent)</link:label>
    <link:label id="lab_ifrs-full_ApplicableTaxRate_label_en-US" xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Applicable tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate" xlink:to="lab_ifrs-full_ApplicableTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FreeCashFlowMember_96962bd8-fe2d-46e2-b5be-56846447f2a4_terseLabel_en-US" xlink:label="lab_gsk_FreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Free cash flow</link:label>
    <link:label id="lab_gsk_FreeCashFlowMember_label_en-US" xlink:label="lab_gsk_FreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Free Cash Flow [Member]</link:label>
    <link:label id="lab_gsk_FreeCashFlowMember_documentation_en-US" xlink:label="lab_gsk_FreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Free cash flow Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FreeCashFlowMember" xlink:href="gsk-20241231.xsd#gsk_FreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FreeCashFlowMember" xlink:to="lab_gsk_FreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SierraOncologyIncMember_228ac326-7523-46ec-aa26-86d9a720e6d6_terseLabel_en-US" xlink:label="lab_gsk_SierraOncologyIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sierra Oncology Inc</link:label>
    <link:label id="lab_gsk_SierraOncologyIncMember_label_en-US" xlink:label="lab_gsk_SierraOncologyIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sierra Oncology Inc [Member]</link:label>
    <link:label id="lab_gsk_SierraOncologyIncMember_documentation_en-US" xlink:label="lab_gsk_SierraOncologyIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sierra oncology inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SierraOncologyIncMember" xlink:href="gsk-20241231.xsd#gsk_SierraOncologyIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SierraOncologyIncMember" xlink:to="lab_gsk_SierraOncologyIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherReceivableMember_a1a9eec5-ac04-4914-9324-6c80f96ecd6e_terseLabel_en-US" xlink:label="lab_gsk_OtherReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivable</link:label>
    <link:label id="lab_gsk_OtherReceivableMember_label_en-US" xlink:label="lab_gsk_OtherReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivable [Member]</link:label>
    <link:label id="lab_gsk_OtherReceivableMember_documentation_en-US" xlink:label="lab_gsk_OtherReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherReceivableMember" xlink:href="gsk-20241231.xsd#gsk_OtherReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherReceivableMember" xlink:to="lab_gsk_OtherReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_9c97c5cf-667d-4c93-98c8-20be7fc6d463_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxation</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments_a5f98198-7e5d-4bc8-a817-f748d8d30070_verboseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Realised after tax profit/(losses) on disposal or liquidation of equity investments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Disposal Of Equity Investments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Disposal Of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" xlink:to="lab_gsk_IncreaseDecreaseThroughDisposalOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExternalCreditGradesMember_1d8fa2f1-c521-40ee-9564-bfefc881353c_terseLabel_en-US" xlink:label="lab_ifrs-full_ExternalCreditGradesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total for all external credit grades</link:label>
    <link:label id="lab_ifrs-full_ExternalCreditGradesMember_label_en-US" xlink:label="lab_ifrs-full_ExternalCreditGradesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total for all external credit grades [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExternalCreditGradesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExternalCreditGradesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExternalCreditGradesMember" xlink:to="lab_ifrs-full_ExternalCreditGradesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsDomain_22e86895-9ba0-47ec-9084-84e58f691e1b_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of assets</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesAbstract_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other payables [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherPayablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointOperationsAxis_2c9c19cc-4170-4164-9983-87c9a309b938_terseLabel_en-US" xlink:label="lab_ifrs-full_JointOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint operations [axis]</link:label>
    <link:label id="lab_ifrs-full_JointOperationsAxis_label_en-US" xlink:label="lab_ifrs-full_JointOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint operations [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_JointOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointOperationsAxis" xlink:to="lab_ifrs-full_JointOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashTransferred_37828b03-fb2a-47ec-823c-19a99c9a6231_terseLabel_en-US" xlink:label="lab_ifrs-full_CashTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashTransferred_label_en-US" xlink:label="lab_ifrs-full_CashTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred" xlink:to="lab_ifrs-full_CashTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UncertainTaxPositionsRecognised_03f989a3-0c3c-4da7-a575-7349d0a31d35_terseLabel_en-US" xlink:label="lab_gsk_UncertainTaxPositionsRecognised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax position charge</link:label>
    <link:label id="lab_gsk_UncertainTaxPositionsRecognised_label_en-US" xlink:label="lab_gsk_UncertainTaxPositionsRecognised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Uncertain Tax Positions Recognised</link:label>
    <link:label id="lab_gsk_UncertainTaxPositionsRecognised_documentation_en-US" xlink:label="lab_gsk_UncertainTaxPositionsRecognised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Uncertain tax positions recognised.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UncertainTaxPositionsRecognised" xlink:href="gsk-20241231.xsd#gsk_UncertainTaxPositionsRecognised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UncertainTaxPositionsRecognised" xlink:to="lab_gsk_UncertainTaxPositionsRecognised" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_af5be809-ff8a-4fc0-b3d8-2af97f78db6a_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10 cent appreciation of the Euro</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_17197104-89d9-40c3-b370-cebc6f8604b2_verboseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">10 cent appreciation of Euro</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk Ten Cent Appreciation Of Euro [member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency risk 10 cent appreciation of Euro.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskTenCentAppreciationOfEuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:to="lab_gsk_CurrencyRiskTenCentAppreciationOfEuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_bf166a6a-1ba1-41b8-8d10-5398883fac55_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, liabilities</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:to="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsMember_5e15ede4-9253-4bce-b2d0-130792baeaa2_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsMember_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember" xlink:to="lab_ifrs-full_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_205dcd32-dc86-4276-9628-23e3b34fb236_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing items</link:label>
    <link:label id="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other inflows (outflows) of cash, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetBookValueMember_60e85ad9-eb2d-403f-9321-5c34a7b7394e_terseLabel_en-US" xlink:label="lab_gsk_NetBookValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net book value</link:label>
    <link:label id="lab_gsk_NetBookValueMember_label_en-US" xlink:label="lab_gsk_NetBookValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Book Value [Member]</link:label>
    <link:label id="lab_gsk_NetBookValueMember_documentation_en-US" xlink:label="lab_gsk_NetBookValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Book Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetBookValueMember" xlink:href="gsk-20241231.xsd#gsk_NetBookValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetBookValueMember" xlink:to="lab_gsk_NetBookValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContingentConsiderationLiabilities_74aa3a1b-3938-4616-a3fe-5f54c8e3ef6c_negatedTerseLabel_en-US" xlink:label="lab_gsk_ContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_gsk_ContingentConsiderationLiabilities_label_en-US" xlink:label="lab_gsk_ContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liabilities</link:label>
    <link:label id="lab_gsk_ContingentConsiderationLiabilities_documentation_en-US" xlink:label="lab_gsk_ContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationLiabilities" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContingentConsiderationLiabilities" xlink:to="lab_gsk_ContingentConsiderationLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_9893f5d2-616f-452c-80b7-e0aa24c33f67_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-derivative financial liabilities, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssueOfEquity_b0b91ffb-b141-483e-aee6-99fe836b7b11_verboseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued</link:label>
    <link:label id="lab_ifrs-full_IssueOfEquity_14c9cf44-f224-44cf-a577-90a88d3f43a4_terseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued under employee share schemes</link:label>
    <link:label id="lab_ifrs-full_IssueOfEquity_label_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue of equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity" xlink:to="lab_ifrs-full_IssueOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings_08dfc0ca-269b-4517-abb8-26d90799d8de_terseLabel_en-US" xlink:label="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of current portion of noncurrent borrowings</link:label>
    <link:label id="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings_label_en-US" xlink:label="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments Of Current Portion Of Noncurrent Borrowings</link:label>
    <link:label id="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings_documentation_en-US" xlink:label="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repayments Of Current Portion Of Noncurrent Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" xlink:href="gsk-20241231.xsd#gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" xlink:to="lab_gsk_RepaymentsOfCurrentPortionOfNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_0c80e549-13e3-4230-9664-41fbda8977d4_terseLabel_en-US" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of bonds, notes and debentures</link:label>
    <link:label id="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_label_en-US" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of bonds, notes and debentures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock_dd256e0c-fc51-42c4-ada5-c1ce0ac7a7f6_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Fair Value of Contingent Consideration Liabilities</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of contingent consideration liabilities [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of fair value of contingent consideration liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" xlink:to="lab_gsk_DisclosureOfFairValueOfContingentConsiderationLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Equity_d92adc2d-baee-4449-b060-a9bcb1a02bc9_totalLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_ifrs-full_Equity_72f496e6-88fb-4a9d-a7cc-2a1bc318a638_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Equity at beginning of period</link:label>
    <link:label id="lab_ifrs-full_Equity_4b8c427c-7e37-43a4-8bcd-0f241c1a3f55_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Equity at end of period</link:label>
    <link:label id="lab_ifrs-full_Equity_c7abab01-37c5-4c75-b739-f536888033fd_terseLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_ifrs-full_Equity_label_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineB.v.Member_5269e37c-15e7-44ef-85a9-66f8f03bb366_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineB.v.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline B.V. (Netherlands)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineB.v.Member_label_en-US" xlink:label="lab_gsk_GlaxosmithklineB.v.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline B.V. [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineB.v.Member_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineB.v.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineB.v.Member" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineB.v.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineB.v.Member" xlink:to="lab_gsk_GlaxosmithklineB.v.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember_8edda368-8b0e-4976-a4c8-26a27aba937d_terseLabel_en-US" xlink:label="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.000% &#8364; Euro Medium Term Note 2025</link:label>
    <link:label id="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Four Point Zero Zero Percent Euro Medium Term Note Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Four point zero zero percent European medium term note two thousand twenty five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:href="gsk-20241231.xsd#gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:to="lab_gsk_FourPointZeroZeroPercentEuroMediumTermNoteTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock_2a9489eb-b079-44b7-8589-4ed9c59f0646_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movements in Defined Benefit Obligations</link:label>
    <link:label id="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Movement In Defined Benefit Liability [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of movement in defined benefit liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" xlink:to="lab_gsk_DisclosureOfMovementInDefinedBenefitLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueOfTheAssetsDistributed_85b69eb3-925f-4f4c-b84f-5cc404c4c35b_terseLabel_en-US" xlink:label="lab_gsk_FairValueOfTheAssetsDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of the assets distributed</link:label>
    <link:label id="lab_gsk_FairValueOfTheAssetsDistributed_label_en-US" xlink:label="lab_gsk_FairValueOfTheAssetsDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of the Assets Distributed</link:label>
    <link:label id="lab_gsk_FairValueOfTheAssetsDistributed_documentation_en-US" xlink:label="lab_gsk_FairValueOfTheAssetsDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of the assets distributed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheAssetsDistributed" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheAssetsDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueOfTheAssetsDistributed" xlink:to="lab_gsk_FairValueOfTheAssetsDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TitleOfEachClassDomain_c008aa50-d376-4c66-8626-7734168dcdb2_terseLabel_en-US" xlink:label="lab_gsk_TitleOfEachClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title Of Each Class [Domain]</link:label>
    <link:label id="lab_gsk_TitleOfEachClassDomain_label_en-US" xlink:label="lab_gsk_TitleOfEachClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title Of Each Class [Domain]</link:label>
    <link:label id="lab_gsk_TitleOfEachClassDomain_documentation_en-US" xlink:label="lab_gsk_TitleOfEachClassDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Title of Each Class.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TitleOfEachClassDomain" xlink:href="gsk-20241231.xsd#gsk_TitleOfEachClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TitleOfEachClassDomain" xlink:to="lab_gsk_TitleOfEachClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember_42c0e625-6223-4cad-9b5a-67fe278d1aa2_terseLabel_en-US" xlink:label="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.875% US$ US Medium Term Note 2028</link:label>
    <link:label id="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember_label_en-US" xlink:label="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Eight Seven Five Percentage U- S- Medium Term Note Two Thousand Twenty Eight [member]</link:label>
    <link:label id="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember_documentation_en-US" xlink:label="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three point eight seven five percentage US medium term note two thousand twenty eight.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" xlink:href="gsk-20241231.xsd#gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" xlink:to="lab_gsk_ThreePointEightSevenFivePercentageUSMediumTermNoteTwoThousandTwentyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_f528f238-f448-4a4e-9b34-545901a2382a_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current equity investments</link:label>
    <link:label id="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_b316abe2-3f77-401d-9288-5ab9cdaa4ff2_periodStartLabel_en-US" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">At 1 January</link:label>
    <link:label id="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_f99e99d9-1846-4f68-a511-e54a9720a789_periodEndLabel_en-US" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">At 31 December</link:label>
    <link:label id="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_label_en-US" xlink:label="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current financial assets at fair value through profit or loss, classified as held for trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:to="lab_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_462997ef-b885-478d-aa72-58b2634904b9_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_9686bf83-3e1c-421f-b2d0-2e2ecdddd14d_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:to="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions_90824be9-1899-46c7-b778-1746a8a7c2b4_terseLabel_en-US" xlink:label="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loans outstanding</link:label>
    <link:label id="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions_label_en-US" xlink:label="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Receivable Made By Entity Related Party Transactions</link:label>
    <link:label id="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions_documentation_en-US" xlink:label="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loans receivable made by entity related party transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" xlink:href="gsk-20241231.xsd#gsk_LoansReceivableMadeByEntityRelatedPartyTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" xlink:to="lab_gsk_LoansReceivableMadeByEntityRelatedPartyTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FinancialLiabilitiesOneMember_01e697f5-3fcf-44da-815f-aa5db76cf0c4_terseLabel_en-US" xlink:label="lab_gsk_FinancialLiabilitiesOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities one</link:label>
    <link:label id="lab_gsk_FinancialLiabilitiesOneMember_label_en-US" xlink:label="lab_gsk_FinancialLiabilitiesOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Liabilities One [Member]</link:label>
    <link:label id="lab_gsk_FinancialLiabilitiesOneMember_documentation_en-US" xlink:label="lab_gsk_FinancialLiabilitiesOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial liabilites one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialLiabilitiesOneMember" xlink:href="gsk-20241231.xsd#gsk_FinancialLiabilitiesOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FinancialLiabilitiesOneMember" xlink:to="lab_gsk_FinancialLiabilitiesOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MiscellaneousComponentsOfEquityAxis_6f57836b-606f-4d22-ab50-7c90b3dc28c5_terseLabel_en-US" xlink:label="lab_gsk_MiscellaneousComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Miscellaneous Components Of Equity [axis]</link:label>
    <link:label id="lab_gsk_MiscellaneousComponentsOfEquityAxis_label_en-US" xlink:label="lab_gsk_MiscellaneousComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous Components Of Equity [axis]</link:label>
    <link:label id="lab_gsk_MiscellaneousComponentsOfEquityAxis_documentation_en-US" xlink:label="lab_gsk_MiscellaneousComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Miscellaneous Components Of Equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MiscellaneousComponentsOfEquityAxis" xlink:href="gsk-20241231.xsd#gsk_MiscellaneousComponentsOfEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MiscellaneousComponentsOfEquityAxis" xlink:to="lab_gsk_MiscellaneousComponentsOfEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_7305cdc6-4f8e-4d24-ba16-79f8da746092_totalLabel_en-US" xlink:label="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income /(expense) for the year from continuing operations</link:label>
    <link:label id="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_label_en-US" xlink:label="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Expense) Income For The Year From Continuing Operations</link:label>
    <link:label id="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations_documentation_en-US" xlink:label="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other comprehensive expense income for the year from continuing operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" xlink:href="gsk-20241231.xsd#gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" xlink:to="lab_gsk_OtherComprehensiveExpenseIncomeForTheYearFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfFinancialLiabilitiesAxis_8bf3e01e-1884-4777-b90a-c87631513516_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of financial liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfFinancialLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of financial liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfFinancialLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfFinancialLiabilitiesAxis" xlink:to="lab_ifrs-full_TypesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DolutegravirIncludingCabotegravirMember_f5b07d8c-91e4-46c2-82d2-e7b2845e6cbc_terseLabel_en-US" xlink:label="lab_gsk_DolutegravirIncludingCabotegravirMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dolutegravir (including Cabotegravir)</link:label>
    <link:label id="lab_gsk_DolutegravirIncludingCabotegravirMember_label_en-US" xlink:label="lab_gsk_DolutegravirIncludingCabotegravirMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dolutegravir (including Cabotegravir) [Member]</link:label>
    <link:label id="lab_gsk_DolutegravirIncludingCabotegravirMember_documentation_en-US" xlink:label="lab_gsk_DolutegravirIncludingCabotegravirMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dolutegravir (including Cabotegravir)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DolutegravirIncludingCabotegravirMember" xlink:href="gsk-20241231.xsd#gsk_DolutegravirIncludingCabotegravirMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DolutegravirIncludingCabotegravirMember" xlink:to="lab_gsk_DolutegravirIncludingCabotegravirMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_label_en-US" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis of income and expense [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_8a0fcdc9-39db-4bd3-ac29-e6f28fbb8f0e_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental payments due between two and three years</link:label>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9e795742-a6bc-4a1f-9e6e-279cf1cf7c06_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Between two and three years</link:label>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than two years and not later than three years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity_df99b247-3824-4b37-a0d1-f3424c1a6781_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of share consolidation</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Consolidating Shares, Equity</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Consolidating Shares, Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughConsolidatingSharesEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" xlink:to="lab_gsk_IncreaseDecreaseThroughConsolidatingSharesEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPatentsRevocationRequested_01fb0a7e-4b25-4a1a-acb3-c2c588724f53_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPatentsRevocationRequested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents revocation requested</link:label>
    <link:label id="lab_gsk_NumberOfPatentsRevocationRequested_label_en-US" xlink:label="lab_gsk_NumberOfPatentsRevocationRequested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of patents revocation requested</link:label>
    <link:label id="lab_gsk_NumberOfPatentsRevocationRequested_documentation_en-US" xlink:label="lab_gsk_NumberOfPatentsRevocationRequested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of patents revocation requested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsRevocationRequested" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsRevocationRequested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPatentsRevocationRequested" xlink:to="lab_gsk_NumberOfPatentsRevocationRequested" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets_463ebc71-b0fe-40cb-9fa2-b260a34d5aa9_terseLabel_en-US" xlink:label="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loans on structured debt amount contributed to fair value of plan assets</link:label>
    <link:label id="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans On Structured Debt Amount Contributed To Fair Value Of Plan Assets</link:label>
    <link:label id="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets_documentation_en-US" xlink:label="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loans on structured debt amount contributed to fair value of plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" xlink:href="gsk-20241231.xsd#gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" xlink:to="lab_gsk_LoansOnStructuredDebtAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities_87fb801f-6095-4fb7-8891-4287c2c5636f_negatedLabel_en-US" xlink:label="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals and settlements</link:label>
    <link:label id="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities_label_en-US" xlink:label="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals and Settlements Fair Value Measurement Assets And Liabilities</link:label>
    <link:label id="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposals and Settlements Fair Value Measurement Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" xlink:to="lab_gsk_DisposalsAndSettlementsFairValueMeasurementAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_9941ec20-2726-4cd8-9c54-541f5819b075_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Pension And Post Retirement [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Pension And Post Retirement [Line Items]</link:label>
    <link:label id="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit pension and post retirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" xlink:to="lab_gsk_DisclosureOfDefinedBenefitPensionAndPostRetirementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock_d54141a7-24ba-4e40-ae22-dab3f4e702a1_terseLabel_en-US" xlink:label="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Financial Information Relating to Discontinued Operations</link:label>
    <link:label id="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock_label_en-US" xlink:label="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Information Relating To Discontinued Operations [Table Text Block]</link:label>
    <link:label id="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of&#160;financial information relating to discontinued operations .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" xlink:to="lab_gsk_FinancialInformationRelatingToDiscontinuedOperationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfPlaintiffsAgreementReached_12ea9197-f6ab-49cd-b614-b1a0a2428ad6_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfPlaintiffsAgreementReached" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of plaintiffs, agreement reached</link:label>
    <link:label id="lab_gsk_PercentageOfPlaintiffsAgreementReached_label_en-US" xlink:label="lab_gsk_PercentageOfPlaintiffsAgreementReached" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Plaintiffs, Agreement Reached</link:label>
    <link:label id="lab_gsk_PercentageOfPlaintiffsAgreementReached_documentation_en-US" xlink:label="lab_gsk_PercentageOfPlaintiffsAgreementReached" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Plaintiffs, Agreement Reached</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfPlaintiffsAgreementReached" xlink:href="gsk-20241231.xsd#gsk_PercentageOfPlaintiffsAgreementReached"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfPlaintiffsAgreementReached" xlink:to="lab_gsk_PercentageOfPlaintiffsAgreementReached" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount_d16cf3e4-a753-4cf8-8e54-6932a7e8b3b2_terseLabel_en-US" xlink:label="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on distribution of fair value less book value of the attributable net assets of discontinued business amount</link:label>
    <link:label id="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount_label_en-US" xlink:label="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain On Distribution Of Fair Value Less Book Value Of The Attributable Net Assets Of Discontinued Business Amount</link:label>
    <link:label id="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount_documentation_en-US" xlink:label="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain on distribution of fair value less book value of the attributable net assets of discontinued business amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" xlink:href="gsk-20241231.xsd#gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" xlink:to="lab_gsk_GainOnDistributionOfFairValueLessBookValueOfTheAttributableNetAssetsOfDiscontinuedBusinessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_ae4e5c1b-cde1-49da-8447-e19670336d19_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities measured at amortised cost:</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_gsk_DisclosureOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_gsk_DisclosureOfContingentConsiderationAbstract_documentation_en-US" xlink:label="lab_gsk_DisclosureOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfContingentConsiderationAbstract" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfContingentConsiderationAbstract" xlink:to="lab_gsk_DisclosureOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_b19f0523-c1b9-4440-9388-f064453f0e75_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash inflow/(outflow) from continuing financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities, continuing operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PlantAndMachineryMember_a5be21b4-098b-499d-b4d1-3fa946eedee9_terseLabel_en-US" xlink:label="lab_gsk_PlantAndMachineryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plant and machinery</link:label>
    <link:label id="lab_gsk_PlantAndMachineryMember_label_en-US" xlink:label="lab_gsk_PlantAndMachineryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plant And Machinery [Member]</link:label>
    <link:label id="lab_gsk_PlantAndMachineryMember_documentation_en-US" xlink:label="lab_gsk_PlantAndMachineryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plant and machinery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PlantAndMachineryMember" xlink:href="gsk-20241231.xsd#gsk_PlantAndMachineryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PlantAndMachineryMember" xlink:to="lab_gsk_PlantAndMachineryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_ea16a075-6d9b-44bd-ab6a-313b56717708_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareAbstract_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract" xlink:to="lab_ifrs-full_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FreeholdBuildingsMember_5b6a4c70-f48e-4fac-b00b-28312f8e3ca9_terseLabel_en-US" xlink:label="lab_gsk_FreeholdBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Freehold buildings</link:label>
    <link:label id="lab_gsk_FreeholdBuildingsMember_label_en-US" xlink:label="lab_gsk_FreeholdBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Freehold Buildings [Member]</link:label>
    <link:label id="lab_gsk_FreeholdBuildingsMember_documentation_en-US" xlink:label="lab_gsk_FreeholdBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Freehold buildings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FreeholdBuildingsMember" xlink:href="gsk-20241231.xsd#gsk_FreeholdBuildingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FreeholdBuildingsMember" xlink:to="lab_gsk_FreeholdBuildingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_8e3d61af-5653-4cf3-aec5-266d7e170b76_terseLabel_en-US" xlink:label="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of the retained ownership in Haleon plc (13.5%)</link:label>
    <link:label id="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_label_en-US" xlink:label="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of The Retained Ownership In Haleon Plc</link:label>
    <link:label id="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc_documentation_en-US" xlink:label="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of The Retained Ownership In Haleon Plc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" xlink:href="gsk-20241231.xsd#gsk_FairValueOfTheRetainedOwnershipInHaleonPlc"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" xlink:to="lab_gsk_FairValueOfTheRetainedOwnershipInHaleonPlc" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PensionDefinedBenefitPlansMember_bb353aec-ccff-4f5d-aea0-c4c244de27fd_terseLabel_en-US" xlink:label="lab_ifrs-full_PensionDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension benefits</link:label>
    <link:label id="lab_ifrs-full_PensionDefinedBenefitPlansMember_623acfc5-6e42-425e-b7aa-e97e76ba932e_verboseLabel_en-US" xlink:label="lab_ifrs-full_PensionDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unfunded defined benefit pension schemes</link:label>
    <link:label id="lab_ifrs-full_PensionDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_PensionDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PensionDefinedBenefitPlansMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PensionDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PensionDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_PensionDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_9e95074e-2447-4907-9b1d-b2deb21802af_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current service cost</link:label>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_03ff279a-80fb-467c-bb56-4aff0ee37048_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase in net defined benefit liability (asset) resulting from current service cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PastDueStatusAxis_816300c2-8cf4-40e4-8adc-2edc6f4dfae2_terseLabel_en-US" xlink:label="lab_ifrs-full_PastDueStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Past due status [axis]</link:label>
    <link:label id="lab_ifrs-full_PastDueStatusAxis_label_en-US" xlink:label="lab_ifrs-full_PastDueStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past due status [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastDueStatusAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PastDueStatusAxis" xlink:to="lab_ifrs-full_PastDueStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_4faf60e4-dff8-4839-8c30-b665af1abd4f_negatedLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net foreign exchange (gains)/losses</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_27b6a86a-bf6d-429c-8c1a-7ab428091c75_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net foreign exchange gains (losses)</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LegalProceedingsProvision_b2f175d5-4bb2-46a7-869b-f635ef51d144_terseLabel_en-US" xlink:label="lab_ifrs-full_LegalProceedingsProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for legal and other disputes</link:label>
    <link:label id="lab_ifrs-full_LegalProceedingsProvision_label_en-US" xlink:label="lab_ifrs-full_LegalProceedingsProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal proceedings provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalProceedingsProvision" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsProvision" xlink:to="lab_ifrs-full_LegalProceedingsProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_741ea0b1-9b7e-47b4-a3d3-d869d1941041_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent liabilities recognised as of acquisition date</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_a9aa6d25-dbac-42e7-b5ef-df365750e527_negatedLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities (Note 33)</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent liabilities recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed_5b93943c-5fd7-45d0-85c4-ad7ff96784f0_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents allegedly invalidly infringed</link:label>
    <link:label id="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed_label_en-US" xlink:label="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Patents Allegedly Invalidly Infringed</link:label>
    <link:label id="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed_documentation_en-US" xlink:label="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Patents Allegedly Invalidly Infringed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsAllegedlyInvalidlyInfringed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" xlink:to="lab_gsk_NumberOfPatentsAllegedlyInvalidlyInfringed" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonCashDistributionToNonControllingInterests_3da33bda-3896-4ce7-aba7-6506cdee7495_negatedLabel_en-US" xlink:label="lab_gsk_NonCashDistributionToNonControllingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-cash distribution to non-controlling interests</link:label>
    <link:label id="lab_gsk_NonCashDistributionToNonControllingInterests_label_en-US" xlink:label="lab_gsk_NonCashDistributionToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Cash Distribution To Non Controlling Interests</link:label>
    <link:label id="lab_gsk_NonCashDistributionToNonControllingInterests_documentation_en-US" xlink:label="lab_gsk_NonCashDistributionToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash distributions to noncontrolling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCashDistributionToNonControllingInterests" xlink:href="gsk-20241231.xsd#gsk_NonCashDistributionToNonControllingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonCashDistributionToNonControllingInterests" xlink:to="lab_gsk_NonCashDistributionToNonControllingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GskAggregateHoldingMember_9df3b88b-ac92-4e91-a0bc-e82abdd63097_terseLabel_en-US" xlink:label="lab_gsk_GskAggregateHoldingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Aggregate Holding</link:label>
    <link:label id="lab_gsk_GskAggregateHoldingMember_label_en-US" xlink:label="lab_gsk_GskAggregateHoldingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Aggregate Holding [Member]</link:label>
    <link:label id="lab_gsk_GskAggregateHoldingMember_documentation_en-US" xlink:label="lab_gsk_GskAggregateHoldingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK aggregate holding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GskAggregateHoldingMember" xlink:href="gsk-20241231.xsd#gsk_GskAggregateHoldingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GskAggregateHoldingMember" xlink:to="lab_gsk_GskAggregateHoldingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_7c1d2282-3451-48c9-869e-ca24f573c9cb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Information Of Associates And Joint Ventures [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_726cb4c6-4ab1-4007-b2ab-1e1ff52bc7e9_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgingInstrumentsDomain_7e655791-a02e-4e27-bc3d-8bc66cd954f8_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging instruments</link:label>
    <link:label id="lab_ifrs-full_HedgingInstrumentsDomain_label_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging instruments [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HedgingInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain" xlink:to="lab_ifrs-full_HedgingInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_0f76d0b9-035f-421e-adb5-eb20ec67231b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-current assets held for sale and discontinued operations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ConsolidatedStructuredEntitiesDomain_54542def-b2fd-4e9f-8013-fcb22c24f91e_terseLabel_en-US" xlink:label="lab_ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated structured entities</link:label>
    <link:label id="lab_ifrs-full_ConsolidatedStructuredEntitiesDomain_label_en-US" xlink:label="lab_ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated structured entities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="lab_ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_9bac0dcc-55f4-4461-9a2d-5f85527e8159_negatedLabel_en-US" xlink:label="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unwinding of discounts on provisions</link:label>
    <link:label id="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_label_en-US" xlink:label="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense arising from passage of time on other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:to="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_c21d6938-fbcd-4a01-a7dc-18631ad03dbe_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net decrease/(increase) in short-term loans</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) increase (decrease) in current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:to="lab_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ArrangementTypeAxis_07e729c6-1ce8-42af-b1df-55cb0f2c5ca2_terseLabel_en-US" xlink:label="lab_gsk_ArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Type [axis]</link:label>
    <link:label id="lab_gsk_ArrangementTypeAxis_label_en-US" xlink:label="lab_gsk_ArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Arrangement Type [Axis]</link:label>
    <link:label id="lab_gsk_ArrangementTypeAxis_documentation_en-US" xlink:label="lab_gsk_ArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Arrangement Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ArrangementTypeAxis" xlink:href="gsk-20241231.xsd#gsk_ArrangementTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ArrangementTypeAxis" xlink:to="lab_gsk_ArrangementTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_7eae215b-6157-44b5-bdee-2fb64b55a6cc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PipelineProgressMember_56b26117-757b-4698-85f8-9c0f4b866127_terseLabel_en-US" xlink:label="lab_gsk_PipelineProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pipeline progress</link:label>
    <link:label id="lab_gsk_PipelineProgressMember_label_en-US" xlink:label="lab_gsk_PipelineProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pipeline Progress [Member]</link:label>
    <link:label id="lab_gsk_PipelineProgressMember_documentation_en-US" xlink:label="lab_gsk_PipelineProgressMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pipeline progress Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PipelineProgressMember" xlink:href="gsk-20241231.xsd#gsk_PipelineProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PipelineProgressMember" xlink:to="lab_gsk_PipelineProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember_d975b98e-7897-4846-adaa-f52f4e762b91_terseLabel_en-US" xlink:label="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.750% &#8364; Euro Medium Term Note 2030</link:label>
    <link:label id="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember_label_en-US" xlink:label="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Seven Five Zero Percentage Euro Medium Term Note Two Thousand Thirty [Member]</link:label>
    <link:label id="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember_documentation_en-US" xlink:label="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One point seven five zero percentage European medium term note two thousand thirty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" xlink:href="gsk-20241231.xsd#gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" xlink:to="lab_gsk_OnePointSevenFiveZeroPercentageEuroMediumTermNoteTwoThousandThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments_3b8eecc4-731e-4e91-bfac-7a4933e76f0b_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value remeasurements of equity investments</link:label>
    <link:label id="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments_label_en-US" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, entity's own equity instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementEntitysOwnEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_bb9b5f4b-3b3e-4466-aeb6-10c704348e97_negatedLabel_en-US" xlink:label="lab_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transfer to assets held for sale/distribution</link:label>
    <link:label id="lab_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through classified as held for sale, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:to="lab_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome_63da1877-4577-49fc-a42b-04e7dcbe7672_terseLabel_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plans</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome_label_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Relating To Defined Benefit Plans Charged Or Credited Directly To Comprehensive Income</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax relating to defined benefit plans charged or credited directly to comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" xlink:to="lab_gsk_DeferredTaxRelatingToDefinedBenefitPlansChargedOrCreditedDirectlyToComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets_427b8c7d-7940-4754-a188-c3ca3913ffb4_negatedLabel_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Related amounts not offset, assets</link:label>
    <link:label id="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments subject to enforceable master netting arrangement or similar agreement not set off against financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" xlink:to="lab_ifrs-full_FinancialInstrumentsSubjectToEnforceableMasterNettingArrangementOrSimilarAgreementNotSetOffAgainstFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_cb98aa0c-3244-4857-bfd6-e9773288a7cf_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated and effective as hedging instruments</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_27bd7f8c-36ae-4d41-a2e0-147860d45a09_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial assets mandatorily measured at fair value through profit or loss (FVTPL):</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, mandatorily measured at fair value, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ViivHealthcareK.kMember_32b1ad00-4b08-4581-814f-8822807d4f9a_terseLabel_en-US" xlink:label="lab_gsk_ViivHealthcareK.kMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare K.K (Japan)</link:label>
    <link:label id="lab_gsk_ViivHealthcareK.kMember_label_en-US" xlink:label="lab_gsk_ViivHealthcareK.kMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ViiV Healthcare K.K [Member]</link:label>
    <link:label id="lab_gsk_ViivHealthcareK.kMember_documentation_en-US" xlink:label="lab_gsk_ViivHealthcareK.kMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ViiV Healthcare K.K.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareK.kMember" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareK.kMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ViivHealthcareK.kMember" xlink:to="lab_gsk_ViivHealthcareK.kMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_f9569fa3-26f0-4b6c-b858-1ce5ef223f66_terseLabel_en-US" xlink:label="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange forward contracts and swaps</link:label>
    <link:label id="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_label_en-US" xlink:label="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables On Derivative Financial Instruments Undiscounted Cash Flows</link:label>
    <link:label id="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows_documentation_en-US" xlink:label="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivables on derivative financial instruments undiscounted cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:href="gsk-20241231.xsd#gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:to="lab_gsk_ReceivablesOnDerivativeFinancialInstrumentsUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments_a6ca5920-867c-43e0-b792-bcb4ac2359fe_terseLabel_en-US" xlink:label="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net fair value movements through profit or loss</link:label>
    <link:label id="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments_label_en-US" xlink:label="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Fair Value Movements Through Profit Or Loss Other Investments</link:label>
    <link:label id="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments_documentation_en-US" xlink:label="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net fair value movements through profit or loss other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" xlink:href="gsk-20241231.xsd#gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" xlink:to="lab_gsk_NetFairValueMovementsThroughProfitOrLossOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HansohPharmaAssetsMember_c17a9624-e23d-4dfc-9b3f-3333dc8d56b7_terseLabel_en-US" xlink:label="lab_gsk_HansohPharmaAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hansoh Pharma Assets</link:label>
    <link:label id="lab_gsk_HansohPharmaAssetsMember_label_en-US" xlink:label="lab_gsk_HansohPharmaAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hansoh Pharma Assets [Member]</link:label>
    <link:label id="lab_gsk_HansohPharmaAssetsMember_documentation_en-US" xlink:label="lab_gsk_HansohPharmaAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hansoh Pharma Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HansohPharmaAssetsMember" xlink:href="gsk-20241231.xsd#gsk_HansohPharmaAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HansohPharmaAssetsMember" xlink:to="lab_gsk_HansohPharmaAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_58ddfb96-94f6-42a7-b8f3-8a361c14effb_terseLabel_en-US" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK statutory rate of taxation</link:label>
    <link:label id="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_label_en-US" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income) at applicable tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfProductsAndServicesTable_b16cef38-48ae-48c1-b74f-4e4986bc9532_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of products and services [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfProductsAndServicesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of products and services [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable" xlink:to="lab_ifrs-full_DisclosureOfProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_dcbc8610-942e-40a4-bbf2-a0812ea34b67_negatedLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Finance expense net of finance income</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for finance income (cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CustomerMember_b7271c24-cb08-4d9b-ade7-0b2472772287_terseLabel_en-US" xlink:label="lab_gsk_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer</link:label>
    <link:label id="lab_gsk_CustomerMember_label_en-US" xlink:label="lab_gsk_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Member]</link:label>
    <link:label id="lab_gsk_CustomerMember_documentation_en-US" xlink:label="lab_gsk_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CustomerMember" xlink:href="gsk-20241231.xsd#gsk_CustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CustomerMember" xlink:to="lab_gsk_CustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TradeAndOtherPayableMember_716e033c-cb21-41b5-a6f1-befbf538c43f_terseLabel_en-US" xlink:label="lab_gsk_TradeAndOtherPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other payables</link:label>
    <link:label id="lab_gsk_TradeAndOtherPayableMember_label_en-US" xlink:label="lab_gsk_TradeAndOtherPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and Other Payable [member]</link:label>
    <link:label id="lab_gsk_TradeAndOtherPayableMember_documentation_en-US" xlink:label="lab_gsk_TradeAndOtherPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade and other payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherPayableMember" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TradeAndOtherPayableMember" xlink:to="lab_gsk_TradeAndOtherPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1a3b0e34-f4e2-420d-babd-de63d3a3f8c0_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental payments due between four and five years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_32b37918-2194-48e9-81f0-62bcb09ccdfd_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Between four and five years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than four years and not later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InvestmentFairValue_0c7d6604-74c1-433e-a651-b33618952b73_terseLabel_en-US" xlink:label="lab_gsk_InvestmentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment fair value</link:label>
    <link:label id="lab_gsk_InvestmentFairValue_label_en-US" xlink:label="lab_gsk_InvestmentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Fair Value</link:label>
    <link:label id="lab_gsk_InvestmentFairValue_documentation_en-US" xlink:label="lab_gsk_InvestmentFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentFairValue" xlink:href="gsk-20241231.xsd#gsk_InvestmentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InvestmentFairValue" xlink:to="lab_gsk_InvestmentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_aaa3ed54-d4ce-400e-945b-2a8d8e97a260_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total impairment reversals</link:label>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseInSalesForecastAmount_f55d3edf-fe33-4fb4-9dac-3e4456bb3c2c_terseLabel_en-US" xlink:label="lab_gsk_DecreaseInSalesForecastAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in sales forecasts</link:label>
    <link:label id="lab_gsk_DecreaseInSalesForecastAmount_label_en-US" xlink:label="lab_gsk_DecreaseInSalesForecastAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Sales Forecast Amount</link:label>
    <link:label id="lab_gsk_DecreaseInSalesForecastAmount_documentation_en-US" xlink:label="lab_gsk_DecreaseInSalesForecastAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease in sales forecast amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInSalesForecastAmount" xlink:href="gsk-20241231.xsd#gsk_DecreaseInSalesForecastAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseInSalesForecastAmount" xlink:to="lab_gsk_DecreaseInSalesForecastAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_d39f5aeb-3999-4e0d-9a20-69719d69afbb_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_label_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ReceivablesRelatedToInsuranceContracts_81c11166-c905-4a44-8d2c-65510a3f2056_terseLabel_en-US" xlink:label="lab_gsk_ReceivablesRelatedToInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts receivable under insurance contracts</link:label>
    <link:label id="lab_gsk_ReceivablesRelatedToInsuranceContracts_label_en-US" xlink:label="lab_gsk_ReceivablesRelatedToInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables Related To Insurance Contracts</link:label>
    <link:label id="lab_gsk_ReceivablesRelatedToInsuranceContracts_documentation_en-US" xlink:label="lab_gsk_ReceivablesRelatedToInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivables related to insurance contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ReceivablesRelatedToInsuranceContracts" xlink:href="gsk-20241231.xsd#gsk_ReceivablesRelatedToInsuranceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ReceivablesRelatedToInsuranceContracts" xlink:to="lab_gsk_ReceivablesRelatedToInsuranceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FloatingAndFixedRateDebtMember_4e2f6a56-2a14-4491-8082-e268c6de556b_terseLabel_en-US" xlink:label="lab_gsk_FloatingAndFixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating and fixed rate debt</link:label>
    <link:label id="lab_gsk_FloatingAndFixedRateDebtMember_label_en-US" xlink:label="lab_gsk_FloatingAndFixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating And Fixed Rate Debt [Member]</link:label>
    <link:label id="lab_gsk_FloatingAndFixedRateDebtMember_documentation_en-US" xlink:label="lab_gsk_FloatingAndFixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Floating and fixed rate debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FloatingAndFixedRateDebtMember" xlink:href="gsk-20241231.xsd#gsk_FloatingAndFixedRateDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FloatingAndFixedRateDebtMember" xlink:to="lab_gsk_FloatingAndFixedRateDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock_984e7dd2-c41d-4246-a9ed-56997037c085_terseLabel_en-US" xlink:label="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Cash Generated from Operations</link:label>
    <link:label id="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Adjustments Reconciling Profit After Tax to Operating Cash Flows Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of adjustments reconciling profit after tax to operating cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" xlink:to="lab_gsk_ScheduleOfAdjustmentsReconcilingProfitAfterTaxToOperatingCashFlowsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment_42ac57e6-254a-4342-a6a0-e82ee564aa0e_terseLabel_en-US" xlink:label="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum potential milestone payment</link:label>
    <link:label id="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment_label_en-US" xlink:label="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Maximum Potential Milestone Payment</link:label>
    <link:label id="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment_documentation_en-US" xlink:label="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Maximum Potential Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BusinessCombinationMaximumPotentialMilestonePayment" xlink:href="gsk-20241231.xsd#gsk_BusinessCombinationMaximumPotentialMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BusinessCombinationMaximumPotentialMilestonePayment" xlink:to="lab_gsk_BusinessCombinationMaximumPotentialMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived_f39138a0-6be7-46ac-833f-5e35650e813a_terseLabel_en-US" xlink:label="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Surrendered shares for every four new shares received (in shares)</link:label>
    <link:label id="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived_label_en-US" xlink:label="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Surrendered Shares For Every Four New Shares Received</link:label>
    <link:label id="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived_documentation_en-US" xlink:label="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Surrendered shares for every four new shares received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SurrenderedSharesForEveryFourNewSharesReceived" xlink:href="gsk-20241231.xsd#gsk_SurrenderedSharesForEveryFourNewSharesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SurrenderedSharesForEveryFourNewSharesReceived" xlink:to="lab_gsk_SurrenderedSharesForEveryFourNewSharesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HaleonPlcMember_0583e8d2-3b8b-426d-a062-1897c16943fc_terseLabel_en-US" xlink:label="lab_gsk_HaleonPlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Haleon plc</link:label>
    <link:label id="lab_gsk_HaleonPlcMember_label_en-US" xlink:label="lab_gsk_HaleonPlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Haleon plc [Member]</link:label>
    <link:label id="lab_gsk_HaleonPlcMember_documentation_en-US" xlink:label="lab_gsk_HaleonPlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Haleon plc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HaleonPlcMember" xlink:href="gsk-20241231.xsd#gsk_HaleonPlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HaleonPlcMember" xlink:to="lab_gsk_HaleonPlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AorAMember_24d54043-a7f4-47ce-88c4-ca0a97abd692_terseLabel_en-US" xlink:label="lab_gsk_AorAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">A/A</link:label>
    <link:label id="lab_gsk_AorAMember_label_en-US" xlink:label="lab_gsk_AorAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">A or A [member]</link:label>
    <link:label id="lab_gsk_AorAMember_documentation_en-US" xlink:label="lab_gsk_AorAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A/A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AorAMember" xlink:href="gsk-20241231.xsd#gsk_AorAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AorAMember" xlink:to="lab_gsk_AorAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets_3910a776-e8c6-4a88-bf2f-becb41225321_terseLabel_en-US" xlink:label="lab_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate bonds:</link:label>
    <link:label id="lab_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt instruments, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_DebtInstrumentsAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_41c8d707-1d6b-4b5d-b5a1-c18de95ca993_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments reconciling profit after tax to operating cash flows</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SalesToAssociatesAndJointVentures_f2523a65-f1e8-4aef-aaf0-d9a6a040f44a_terseLabel_en-US" xlink:label="lab_gsk_SalesToAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales to associates and joint ventures</link:label>
    <link:label id="lab_gsk_SalesToAssociatesAndJointVentures_label_en-US" xlink:label="lab_gsk_SalesToAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales To Associates And Joint Ventures</link:label>
    <link:label id="lab_gsk_SalesToAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_gsk_SalesToAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales To Associates And Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SalesToAssociatesAndJointVentures" xlink:href="gsk-20241231.xsd#gsk_SalesToAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SalesToAssociatesAndJointVentures" xlink:to="lab_gsk_SalesToAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_9ff616c5-77ff-487a-9afc-043a4de97266_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses_c95fa071-cab6-4e4a-a70f-349d9ef03f87_terseLabel_en-US" xlink:label="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital losses</link:label>
    <link:label id="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses_label_en-US" xlink:label="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognised Deferred Tax Asset On Capital Losses</link:label>
    <link:label id="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses_documentation_en-US" xlink:label="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognised Deferred Tax Asset On Capital Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" xlink:href="gsk-20241231.xsd#gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" xlink:to="lab_gsk_UnrecognisedDeferredTaxAssetOnCapitalLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock_15139506-4859-4a0b-993d-4cccad6ada78_terseLabel_en-US" xlink:label="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Trade and Other Payables</link:label>
    <link:label id="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Trade Payables Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of trade payables explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_SummaryOfTradePayablesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" xlink:to="lab_gsk_SummaryOfTradePayablesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseIncreaseInLiquidInvestment_88e13c47-7780-4b0c-98e2-f76bbf94ca0f_negatedTerseLabel_en-US" xlink:label="lab_gsk_DecreaseIncreaseInLiquidInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease in liquid investments</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInLiquidInvestment_label_en-US" xlink:label="lab_gsk_DecreaseIncreaseInLiquidInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease Increase In Liquid Investment</link:label>
    <link:label id="lab_gsk_DecreaseIncreaseInLiquidInvestment_documentation_en-US" xlink:label="lab_gsk_DecreaseIncreaseInLiquidInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease increase in liquid investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseIncreaseInLiquidInvestment" xlink:href="gsk-20241231.xsd#gsk_DecreaseIncreaseInLiquidInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseIncreaseInLiquidInvestment" xlink:to="lab_gsk_DecreaseIncreaseInLiquidInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentTaxationAbstract_109c471e-b027-42a1-a73b-ee057f577832_terseLabel_en-US" xlink:label="lab_gsk_CurrentTaxationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current taxation</link:label>
    <link:label id="lab_gsk_CurrentTaxationAbstract_label_en-US" xlink:label="lab_gsk_CurrentTaxationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Taxation [Abstract]</link:label>
    <link:label id="lab_gsk_CurrentTaxationAbstract_documentation_en-US" xlink:label="lab_gsk_CurrentTaxationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Taxation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxationAbstract" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentTaxationAbstract" xlink:to="lab_gsk_CurrentTaxationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_2186cbcd-4552-4e57-b20a-36272def9b22_terseLabel_en-US" xlink:label="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences on disposals, acquisitions and transfers</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_label_en-US" xlink:label="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Rate Effect Of Permanent Differences On Disposals Acquisitions and Transfers</link:label>
    <link:label id="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers_documentation_en-US" xlink:label="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Rate Effect Of Permanent Differences On Disposals Acquisitions and Transfers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" xlink:href="gsk-20241231.xsd#gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" xlink:to="lab_gsk_TaxRateEffectOfPermanentDifferencesOnDisposalsAcquisitionsAndTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AiolosAcquisitionMember_6651a7ee-1b83-4cf2-b0d0-920fd6b5bfaa_terseLabel_en-US" xlink:label="lab_gsk_AiolosAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aiolos Assets</link:label>
    <link:label id="lab_gsk_AiolosAcquisitionMember_label_en-US" xlink:label="lab_gsk_AiolosAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aiolos Acquisition [Member]</link:label>
    <link:label id="lab_gsk_AiolosAcquisitionMember_documentation_en-US" xlink:label="lab_gsk_AiolosAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aiolos Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AiolosAcquisitionMember" xlink:href="gsk-20241231.xsd#gsk_AiolosAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AiolosAcquisitionMember" xlink:to="lab_gsk_AiolosAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInLiquidInvestments_59acba45-4ef7-4bd5-a4db-33319a190a7c_negatedLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInLiquidInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">(Increase)/decrease in liquid investments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInLiquidInvestments_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInLiquidInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Liquid Investments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInLiquidInvestments_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInLiquidInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease in liquid investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInLiquidInvestments" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInLiquidInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInLiquidInvestments" xlink:to="lab_gsk_IncreaseDecreaseInLiquidInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_MovementsInOtherReservesTableTextBlock_18d1d685-de25-4563-aa4d-ac8de90249aa_terseLabel_en-US" xlink:label="lab_gsk_MovementsInOtherReservesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movements In Other Reserves</link:label>
    <link:label id="lab_gsk_MovementsInOtherReservesTableTextBlock_label_en-US" xlink:label="lab_gsk_MovementsInOtherReservesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movements In Other Reserves [Table Text Block]</link:label>
    <link:label id="lab_gsk_MovementsInOtherReservesTableTextBlock_documentation_en-US" xlink:label="lab_gsk_MovementsInOtherReservesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movements In Other Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_MovementsInOtherReservesTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_MovementsInOtherReservesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_MovementsInOtherReservesTableTextBlock" xlink:to="lab_gsk_MovementsInOtherReservesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyDomain_23dfc3eb-5707-44f9-9e78-7108ba8533f3_terseLabel_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy</link:label>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyDomain_label_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeAxis_865a73e7-cbe5-4cc7-a853-24ebe23abc30_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
    <link:label id="lab_ifrs-full_RangeAxis_label_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember_822405a3-7d09-4034-ad0a-e04da2d535d9_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember_label_en-US" xlink:label="lab_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets held to hedge liabilities arising from financing activities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="lab_ifrs-full_AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals_b96c7b80-b625-4107-9ba0-a7d6a4509330_verboseLabel_en-US" xlink:label="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment of right of use assets, net of reversals</link:label>
    <link:label id="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals_label_en-US" xlink:label="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment Of Right Of Use Assets, Net Of Reversals</link:label>
    <link:label id="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals_documentation_en-US" xlink:label="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" xlink:href="gsk-20241231.xsd#gsk_ImpairmentOfRightOfUseAssetsNetOfReversals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" xlink:to="lab_gsk_ImpairmentOfRightOfUseAssetsNetOfReversals" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_a9299f16-026b-40d2-9ec2-c1b0dfcd190f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ViivHealthcareFinanceLimitedMember_1ed7647b-4386-4f7e-b804-ff8b94473178_terseLabel_en-US" xlink:label="lab_gsk_ViivHealthcareFinanceLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare Finance Limited</link:label>
    <link:label id="lab_gsk_ViivHealthcareFinanceLimitedMember_label_en-US" xlink:label="lab_gsk_ViivHealthcareFinanceLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ViiV Healthcare Finance Limited [Member]</link:label>
    <link:label id="lab_gsk_ViivHealthcareFinanceLimitedMember_documentation_en-US" xlink:label="lab_gsk_ViivHealthcareFinanceLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ViiV Healthcare Finance Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViivHealthcareFinanceLimitedMember" xlink:href="gsk-20241231.xsd#gsk_ViivHealthcareFinanceLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ViivHealthcareFinanceLimitedMember" xlink:to="lab_gsk_ViivHealthcareFinanceLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherProvisions_9f759669-541f-47b9-a29c-b6b714503156_periodStartLabel_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Other provisions, beginning balance</link:label>
    <link:label id="lab_ifrs-full_OtherProvisions_ff08e61e-6773-4a5e-be3c-4b3df5814184_periodEndLabel_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Other provisions, ending balance</link:label>
    <link:label id="lab_ifrs-full_OtherProvisions_f801936c-41f5-49d2-b9b6-69240c98fea0_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_OtherProvisions_6569db58-9148-4eaf-9d5f-fcc901a19d32_negatedLabel_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other provisions &#8232; (Note 32)</link:label>
    <link:label id="lab_ifrs-full_OtherProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisions" xlink:to="lab_ifrs-full_OtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlineBiologicalsSAMember_2d1cc1b6-de97-4604-8e21-33a3a7ec8c50_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Biologicals SA (Belgium)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineBiologicalsSAMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Biologicals S A [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlineBiologicalsSAMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Biologicals SA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlineBiologicalsSAMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlineBiologicalsSAMember" xlink:to="lab_gsk_GlaxoSmithKlineBiologicalsSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_StiefelLaboratoriesIncMember_dc16c1d3-d924-4185-aea5-fab870c943d9_terseLabel_en-US" xlink:label="lab_gsk_StiefelLaboratoriesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stiefel Laboratories, Inc.</link:label>
    <link:label id="lab_gsk_StiefelLaboratoriesIncMember_label_en-US" xlink:label="lab_gsk_StiefelLaboratoriesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stiefel Laboratories Inc [member]</link:label>
    <link:label id="lab_gsk_StiefelLaboratoriesIncMember_documentation_en-US" xlink:label="lab_gsk_StiefelLaboratoriesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stiefel Laboratories, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_StiefelLaboratoriesIncMember" xlink:href="gsk-20241231.xsd#gsk_StiefelLaboratoriesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_StiefelLaboratoriesIncMember" xlink:to="lab_gsk_StiefelLaboratoriesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable_8985a312-134e-4751-80a5-867edcaa214e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Current Equity Investments [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about unconsolidated subsidiaries [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached_c3a89f61-f004-4f3a-9664-8b60ebe681c0_terseLabel_en-US" xlink:label="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency number of plaintiffs in case, agreement reached</link:label>
    <link:label id="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached_label_en-US" xlink:label="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Number Of Plaintiffs In Case, Agreement Reached</link:label>
    <link:label id="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached_documentation_en-US" xlink:label="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency Number Of Plaintiffs In Case, Agreement Reached</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" xlink:href="gsk-20241231.xsd#gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" xlink:to="lab_gsk_LossContingencyNumberOfPlaintiffsInCaseAgreementReached" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_ddc6f9fe-6955-41f0-994d-9eae3e20a781_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansDomain_73de5c88-b609-490d-ae8c-6a73d954042d_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plans [domain]</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansDomain_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plans [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain" xlink:to="lab_ifrs-full_DefinedBenefitPlansDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_7fffd9e0-5116-4855-aba1-469e8f595a0a_terseLabel_en-US" xlink:label="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of shares held by trust under employee share ownership plan</link:label>
    <link:label id="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_label_en-US" xlink:label="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Value Of Shares Held By Trust Under Employee Share Ownership Plan</link:label>
    <link:label id="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan_documentation_en-US" xlink:label="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value of shares held by trust under employee share ownership plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:href="gsk-20241231.xsd#gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:to="lab_gsk_CarryingValueOfSharesHeldByTrustUnderEmployeeShareOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_da412278-2f21-4591-b4ee-abe4481db4ff_negatedTerseLabel_en-US" xlink:label="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefit of intellectual property incentives</link:label>
    <link:label id="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_label_en-US" xlink:label="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Benefit Of Intellectual Property Incentives</link:label>
    <link:label id="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives_documentation_en-US" xlink:label="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of benefit of intellectual property incentives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" xlink:to="lab_gsk_TaxEffectOfBenefitOfIntellectualPropertyIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_e284f557-11f5-4d35-be33-ebd40272342f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of net cash flow to movement in net debt</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of cash flow statement [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory_05b97a96-09ee-4ca3-b279-38d0b013a1f8_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance income</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of finance income [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_UpfrontSettlementIncome_d2572d31-16cd-4e0f-9ede-12b728b771a7_terseLabel_en-US" xlink:label="lab_gsk_UpfrontSettlementIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront settlement income</link:label>
    <link:label id="lab_gsk_UpfrontSettlementIncome_label_en-US" xlink:label="lab_gsk_UpfrontSettlementIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront Settlement Income</link:label>
    <link:label id="lab_gsk_UpfrontSettlementIncome_documentation_en-US" xlink:label="lab_gsk_UpfrontSettlementIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upfront settlement income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_UpfrontSettlementIncome" xlink:href="gsk-20241231.xsd#gsk_UpfrontSettlementIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_UpfrontSettlementIncome" xlink:to="lab_gsk_UpfrontSettlementIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DecreaseInPlanDeficit_8d77c481-1e04-42dd-9b9e-cee92376fca1_terseLabel_en-US" xlink:label="lab_gsk_DecreaseInPlanDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net pension deficit</link:label>
    <link:label id="lab_gsk_DecreaseInPlanDeficit_label_en-US" xlink:label="lab_gsk_DecreaseInPlanDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Plan Deficit</link:label>
    <link:label id="lab_gsk_DecreaseInPlanDeficit_documentation_en-US" xlink:label="lab_gsk_DecreaseInPlanDeficit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease in plan deficit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DecreaseInPlanDeficit" xlink:href="gsk-20241231.xsd#gsk_DecreaseInPlanDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DecreaseInPlanDeficit" xlink:to="lab_gsk_DecreaseInPlanDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember_3a4c490f-fa64-4ecd-9de9-8fa9d8fe3f67_terseLabel_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.375% &#163; Euro Medium Term Note 2027</link:label>
    <link:label id="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember_label_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Three Seven Five Percent Euro Medium Term Note Two Thousand Twenty Seven [Member]</link:label>
    <link:label id="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember_documentation_en-US" xlink:label="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three point three seven five percent European medium term note two thousand twenty seven.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:href="gsk-20241231.xsd#gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:to="lab_gsk_ThreePointThreeSevenFivePercentEuroMediumTermNoteTwoThousandTwentySevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_8e8a01d1-57ad-43b8-a6a6-3b2daab3edfd_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of hedging</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_f87ed18c-2ebd-452e-9904-6dce9b278047_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of hedging</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_74ddf0f1-63d9-488a-a85d-139e394025ef_verboseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Hedging &#8232;gains/(losses) recognised in reserves</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on change in value of time value of options, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:to="lab_ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9bc2d125-b4c5-4dcb-ba38-e688cbb75ff1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_6d0fdc8d-fdd0-443e-a6f9-4775a9de064d_terseLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined contribution pension schemes</link:label>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_label_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense, defined contribution plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfSharesHeldForShareOptionSchemes_489f15f9-5fed-4a2b-8e7e-4c7765f04048_terseLabel_en-US" xlink:label="lab_gsk_NumberOfSharesHeldForShareOptionSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_gsk_NumberOfSharesHeldForShareOptionSchemes_label_en-US" xlink:label="lab_gsk_NumberOfSharesHeldForShareOptionSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Shares Held For Share Option Schemes</link:label>
    <link:label id="lab_gsk_NumberOfSharesHeldForShareOptionSchemes_documentation_en-US" xlink:label="lab_gsk_NumberOfSharesHeldForShareOptionSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares held for share option schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfSharesHeldForShareOptionSchemes" xlink:href="gsk-20241231.xsd#gsk_NumberOfSharesHeldForShareOptionSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfSharesHeldForShareOptionSchemes" xlink:to="lab_gsk_NumberOfSharesHeldForShareOptionSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProvisionsForEmployeeBenefits_cb37a2c1-4724-4665-be04-553ce8188d9c_terseLabel_en-US" xlink:label="lab_ifrs-full_ProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for employee benefits</link:label>
    <link:label id="lab_ifrs-full_ProvisionsForEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_ProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions for employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsForEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionsForEmployeeBenefits" xlink:to="lab_ifrs-full_ProvisionsForEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareExplanatory_0751000b-b012-4032-9b9c-5cefcd5192aa_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_67d18c80-d868-4728-a73a-c092c3629a43_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share option schemes - shares weighted exercise price (in pounds per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk_daaeb162-014b-4321-a7b3-41c0458df89c_negatedTerseLabel_en-US" xlink:label="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of hedging</link:label>
    <link:label id="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk_label_en-US" xlink:label="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Hedged Item Attributable To Hedged Risk</link:label>
    <link:label id="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk_documentation_en-US" xlink:label="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Of Hedged Item Attributable To Hedged Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CostOfHedgedItemAttributableToHedgedRisk" xlink:href="gsk-20241231.xsd#gsk_CostOfHedgedItemAttributableToHedgedRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CostOfHedgedItemAttributableToHedgedRisk" xlink:to="lab_gsk_CostOfHedgedItemAttributableToHedgedRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_StateBankOfIndiaMember_75b9d310-6c03-4aeb-a7a6-d65b691f84be_terseLabel_en-US" xlink:label="lab_gsk_StateBankOfIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State Bank of India</link:label>
    <link:label id="lab_gsk_StateBankOfIndiaMember_label_en-US" xlink:label="lab_gsk_StateBankOfIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State Bank Of India [member]</link:label>
    <link:label id="lab_gsk_StateBankOfIndiaMember_documentation_en-US" xlink:label="lab_gsk_StateBankOfIndiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">State Bank of India.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_StateBankOfIndiaMember" xlink:href="gsk-20241231.xsd#gsk_StateBankOfIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_StateBankOfIndiaMember" xlink:to="lab_gsk_StateBankOfIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock_5ce229e0-0f9c-419c-a23a-5c0cfa4f6016_terseLabel_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discounting</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock_label_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for discounting [Policy Text Block]</link:label>
    <link:label id="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock_documentation_en-US" xlink:label="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The description of the entity's accounting policy for discounting .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" xlink:href="gsk-20241231.xsd#gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" xlink:to="lab_gsk_DescriptionOfAccountingPolicyForDiscountingPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities_12da6875-a4ea-4058-a3ef-479ffc8b41ce_negatedLabel_en-US" xlink:label="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net losses recognised in the income statement</link:label>
    <link:label id="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities_label_en-US" xlink:label="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (Losses) Recognised In Profit Or Loss, Fair Value Measurement, Assets And Liabilities</link:label>
    <link:label id="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gains (losses) recognised in profit or loss, fair value measurement, assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" xlink:to="lab_gsk_GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfFinancialPositionAbstract_1f7fb3b2-4325-41ed-abf9-7fc54ebb8006_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of financial position [abstract]</link:label>
    <link:label id="lab_ifrs-full_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of financial position [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities_6ff41253-0acf-4ee2-9623-320858b0dcd0_negatedLabel_en-US" xlink:label="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities_label_en-US" xlink:label="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions Fair Value Measurement Assets And Liabilities</link:label>
    <link:label id="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities_documentation_en-US" xlink:label="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additions fair value measurement assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" xlink:href="gsk-20241231.xsd#gsk_AdditionsFairValueMeasurementAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" xlink:to="lab_gsk_AdditionsFairValueMeasurementAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NonCashRestructuringCharges_ae0aa54f-d8dc-45f9-9260-581a58493886_terseLabel_en-US" xlink:label="lab_gsk_NonCashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash</link:label>
    <link:label id="lab_gsk_NonCashRestructuringCharges_label_en-US" xlink:label="lab_gsk_NonCashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non cash restructuring Charges</link:label>
    <link:label id="lab_gsk_NonCashRestructuringCharges_documentation_en-US" xlink:label="lab_gsk_NonCashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non cash restructuring charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NonCashRestructuringCharges" xlink:href="gsk-20241231.xsd#gsk_NonCashRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NonCashRestructuringCharges" xlink:to="lab_gsk_NonCashRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember_9ba03adc-1456-4098-999b-1d3625ecac2f_terseLabel_en-US" xlink:label="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">HIV, oncology, immuno-inflammation, respiratory and other</link:label>
    <link:label id="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember_label_en-US" xlink:label="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">HIV, Oncology, Immuno-Inflammation, Respiratory And Other [Member]</link:label>
    <link:label id="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember_documentation_en-US" xlink:label="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">HIV, Oncology, Immuno-Inflammation, Respiratory And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" xlink:href="gsk-20241231.xsd#gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" xlink:to="lab_gsk_HIVOncologyImmunoInflammationRespiratoryAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_b5b1021a-ea75-4fc0-8722-e84643861fcf_negatedLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Trade payables and other liabilities not in net debt</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other payables, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:to="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_e16afbf0-2766-4ad1-b1c9-54f7c825e0c3_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in inventories</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_7473e666-7885-48da-8fda-db6aa920fa28_terseLabel_en-US" xlink:label="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on demerger before exchange movements and transaction costs</link:label>
    <link:label id="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_label_en-US" xlink:label="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain On Demerger Before Exchange Movements And Transaction Costs</link:label>
    <link:label id="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts_documentation_en-US" xlink:label="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net assets and liabilities distributed / derecognised as part of gain on the demerger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" xlink:href="gsk-20241231.xsd#gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" xlink:to="lab_gsk_GainOnDemergerBeforeExchangeMovementsAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes_2bad120c-a997-4140-8358-f35f7ef96434_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax expense (income), related to Pillar Two income taxes</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income), related to Pillar Two income taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeRelatedToPillarTwoIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_47e8ccaf-212a-433f-9e2c-9d4172340fa1_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorBusinessCombinationMember_64279d7f-7e4a-433d-9d2d-d8c6813cda7d_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorBusinessCombinationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major business combination</link:label>
    <link:label id="lab_ifrs-full_MajorBusinessCombinationMember_label_en-US" xlink:label="lab_ifrs-full_MajorBusinessCombinationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major business combination [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorBusinessCombinationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorBusinessCombinationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorBusinessCombinationMember" xlink:to="lab_ifrs-full_MajorBusinessCombinationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets_8fac8e7c-ed98-4ba9-8b5b-d187742782c0_terseLabel_en-US" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions through business combinations</link:label>
    <link:label id="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through business combinations, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EquityAndDebtNet_18f40bac-bfcf-46eb-95b2-4c0ff9fee69b_terseLabel_en-US" xlink:label="lab_gsk_EquityAndDebtNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total capital including that provided by non-controlling interests</link:label>
    <link:label id="lab_gsk_EquityAndDebtNet_label_en-US" xlink:label="lab_gsk_EquityAndDebtNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity And Debt Net</link:label>
    <link:label id="lab_gsk_EquityAndDebtNet_documentation_en-US" xlink:label="lab_gsk_EquityAndDebtNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of total capital consisting of equity and net debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EquityAndDebtNet" xlink:href="gsk-20241231.xsd#gsk_EquityAndDebtNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EquityAndDebtNet" xlink:to="lab_gsk_EquityAndDebtNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished_c28f4855-a4eb-4215-9883-fd88e330fade_terseLabel_en-US" xlink:label="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of investments in fund assets</link:label>
    <link:label id="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished_label_en-US" xlink:label="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Investments In Assets Where Price Quotations Published</link:label>
    <link:label id="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished_documentation_en-US" xlink:label="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of investments in Fund Assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" xlink:href="gsk-20241231.xsd#gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" xlink:to="lab_gsk_FairValueOfInvestmentsInAssetsWherePriceQuotationsPublished" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAssetsMember_4949d183-4dfd-400a-8349-21b490048183_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_ifrs-full_OtherAssetsMember_label_en-US" xlink:label="lab_ifrs-full_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssetsMember" xlink:to="lab_ifrs-full_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SubsidiariesMember_0aa22ba5-d079-4302-bb34-4a3f94fb8b28_terseLabel_en-US" xlink:label="lab_ifrs-full_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total for all subsidiaries</link:label>
    <link:label id="lab_ifrs-full_SubsidiariesMember_label_en-US" xlink:label="lab_ifrs-full_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total for all subsidiaries [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubsidiariesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubsidiariesMember" xlink:to="lab_ifrs-full_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GroupMember_9424e799-bc61-4325-93d9-56287bf64d09_terseLabel_en-US" xlink:label="lab_gsk_GroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Group</link:label>
    <link:label id="lab_gsk_GroupMember_label_en-US" xlink:label="lab_gsk_GroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Group [member]</link:label>
    <link:label id="lab_gsk_GroupMember_documentation_en-US" xlink:label="lab_gsk_GroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Group.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GroupMember" xlink:href="gsk-20241231.xsd#gsk_GroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GroupMember" xlink:to="lab_gsk_GroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityInterestsOfAcquirer_89a7de84-519b-4ee1-bda0-15fdf750ed09_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interests of acquirer</link:label>
    <link:label id="lab_ifrs-full_EquityInterestsOfAcquirer_label_en-US" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity interests of acquirer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_6f84b5db-697a-4cc7-b842-dbecfa9bd6f5_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of options granted (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied_f8cd2f61-4ae8-4bb2-b64f-2116bd56b50b_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedge reserve arise from hedge relationships for which hedge accounting is no longer applied</link:label>
    <link:label id="lab_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied_label_en-US" xlink:label="lab_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of cash flow hedges, hedging relationships for which hedge accounting is no longer applied</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" xlink:to="lab_ifrs-full_ReserveOfCashFlowHedgesHedgingRelationshipsForWhichHedgeAccountingIsNoLongerApplied" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember_f78010c8-b2a5-4086-b170-e63ececa6f1e_terseLabel_en-US" xlink:label="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations defined benefit pension and post-retirement healthcare scheme</link:label>
    <link:label id="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember_label_en-US" xlink:label="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing Operations Defined Benefit Pension And Postretirement Healthcare Scheme [Member]</link:label>
    <link:label id="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember_documentation_en-US" xlink:label="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Continuing operations defined benefit pension and post-retirement healthcare scheme. [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" xlink:href="gsk-20241231.xsd#gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" xlink:to="lab_gsk_ContinuingOperationsDefinedBenefitPensionAndPostretirementHealthcareSchemeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContingentConsiderationPayableDiscountedPercentage_5e3631e2-a434-47f5-ab6b-f40a6610d5aa_terseLabel_en-US" xlink:label="lab_gsk_ContingentConsiderationPayableDiscountedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liability discount percentage</link:label>
    <link:label id="lab_gsk_ContingentConsiderationPayableDiscountedPercentage_label_en-US" xlink:label="lab_gsk_ContingentConsiderationPayableDiscountedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Payable Discounted Percentage</link:label>
    <link:label id="lab_gsk_ContingentConsiderationPayableDiscountedPercentage_documentation_en-US" xlink:label="lab_gsk_ContingentConsiderationPayableDiscountedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consideration payable discounted percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationPayableDiscountedPercentage" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationPayableDiscountedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContingentConsiderationPayableDiscountedPercentage" xlink:to="lab_gsk_ContingentConsiderationPayableDiscountedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_65fdf6db-6593-4c6d-9d92-ba200efdcc9b_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other net temporary differences</link:label>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_label_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other temporary differences [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:to="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ConsiderationPaidReceived_474e95cb-d6c9-451a-b51c-3e7617f9ee45_terseLabel_en-US" xlink:label="lab_ifrs-full_ConsiderationPaidReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration paid (received)</link:label>
    <link:label id="lab_ifrs-full_ConsiderationPaidReceived_label_en-US" xlink:label="lab_ifrs-full_ConsiderationPaidReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration paid (received)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConsiderationPaidReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsiderationPaidReceived" xlink:to="lab_ifrs-full_ConsiderationPaidReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BorrowingsOverSixMonthsMember_56c52f6d-ea4c-401c-9c9e-f4bb2fbb2740_terseLabel_en-US" xlink:label="lab_gsk_BorrowingsOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, over 6 months</link:label>
    <link:label id="lab_gsk_BorrowingsOverSixMonthsMember_label_en-US" xlink:label="lab_gsk_BorrowingsOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings Over Six Months [Member]</link:label>
    <link:label id="lab_gsk_BorrowingsOverSixMonthsMember_documentation_en-US" xlink:label="lab_gsk_BorrowingsOverSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings over six months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BorrowingsOverSixMonthsMember" xlink:href="gsk-20241231.xsd#gsk_BorrowingsOverSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BorrowingsOverSixMonthsMember" xlink:to="lab_gsk_BorrowingsOverSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory_93e09f3e-cb99-4ef8-9801-41eb98faffc0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of profit (loss) from operating activities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_06fbdaeb-2123-4b56-819e-db00e8b61f1a_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">At 1 January</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_ec31fb69-71cb-4f91-b011-b4e94b87e6e8_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">At 31 December</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ConcentrationsOfRiskRevenuePercentage_22c827aa-68a1-459f-bbdf-d81f4df344d3_terseLabel_en-US" xlink:label="lab_gsk_ConcentrationsOfRiskRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of sales of US Commercial Operation business to three largest wholesalers</link:label>
    <link:label id="lab_gsk_ConcentrationsOfRiskRevenuePercentage_label_en-US" xlink:label="lab_gsk_ConcentrationsOfRiskRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentrations Of Risk Revenue Percentage</link:label>
    <link:label id="lab_gsk_ConcentrationsOfRiskRevenuePercentage_documentation_en-US" xlink:label="lab_gsk_ConcentrationsOfRiskRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Concentrations of risk revenue percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ConcentrationsOfRiskRevenuePercentage" xlink:href="gsk-20241231.xsd#gsk_ConcentrationsOfRiskRevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ConcentrationsOfRiskRevenuePercentage" xlink:to="lab_gsk_ConcentrationsOfRiskRevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember_d56ae8f7-b9bf-4986-8812-4102cff622e4_terseLabel_en-US" xlink:label="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share consolidation as a result of Consumer Healthcare business demerger</link:label>
    <link:label id="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember_label_en-US" xlink:label="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Consolidation As A Result Of Consumer Healthcare Business Demerger [Member]</link:label>
    <link:label id="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember_documentation_en-US" xlink:label="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share consolidation as a result of Consumer Healthcare business demerger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" xlink:href="gsk-20241231.xsd#gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" xlink:to="lab_gsk_ShareConsolidationAsAResultOfConsumerHealthcareBusinessDemergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoSmithKlinePakistanLimitedMember_26e7d9c9-2bc0-4528-99cc-2ccc7cacd4ed_terseLabel_en-US" xlink:label="lab_gsk_GlaxoSmithKlinePakistanLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pakistan Limited (Pakistan)</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlinePakistanLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoSmithKlinePakistanLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Smith Kline Pakistan Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoSmithKlinePakistanLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoSmithKlinePakistanLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Pakistan Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoSmithKlinePakistanLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoSmithKlinePakistanLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoSmithKlinePakistanLimitedMember" xlink:to="lab_gsk_GlaxoSmithKlinePakistanLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember_e0456634-60b7-42dc-9d0d-1ca3d680eb37_terseLabel_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% (100 basis points) movement in USD interest rates</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember_label_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Risk One Percent Movement In USD Interest Rates [Member]</link:label>
    <link:label id="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember_documentation_en-US" xlink:label="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1% (100 basis points) movement in USD interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" xlink:href="gsk-20241231.xsd#gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" xlink:to="lab_gsk_InterestRateRiskOnePercentMovementInUSDInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_24529781-3d77-43ea-9d7c-29c128ed7a1e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-controlling interests [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments_c4534496-10e4-48cb-8391-9d4c4aabb40c_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange adjustments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Exchange Adjustments Of Other Investments</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) through exchange adjustments of other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" xlink:to="lab_gsk_IncreaseDecreaseThroughExchangeAdjustmentsOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cbb84661-d086-4ca9-88da-b3b7f7dd3aa0_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_d4fcc08b-0b4b-4c65-b8bc-35ffc4b89049_negatedLabel_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals and write-offs</link:label>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_4c7da0e0-2aac-4ded-8d9e-224008842743_terseLabel_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposals and retirements, property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals and retirements, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsReceived_3bd5dc77-b440-443c-9893-bfbeb5c02b87_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends received</link:label>
    <link:label id="lab_ifrs-full_DividendsReceived_label_en-US" xlink:label="lab_ifrs-full_DividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsReceived" xlink:to="lab_ifrs-full_DividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExpectedLifeOfShareOptionsGranted_03ee3c09-341e-405d-a1ed-2b6f5cde0ac8_terseLabel_en-US" xlink:label="lab_gsk_ExpectedLifeOfShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_gsk_ExpectedLifeOfShareOptionsGranted_label_en-US" xlink:label="lab_gsk_ExpectedLifeOfShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Life of Share Options Granted</link:label>
    <link:label id="lab_gsk_ExpectedLifeOfShareOptionsGranted_documentation_en-US" xlink:label="lab_gsk_ExpectedLifeOfShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected life of share options granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExpectedLifeOfShareOptionsGranted" xlink:href="gsk-20241231.xsd#gsk_ExpectedLifeOfShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExpectedLifeOfShareOptionsGranted" xlink:to="lab_gsk_ExpectedLifeOfShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CreditExposure1_0dda8d51-72c0-4a36-bb1c-9d359b31767a_terseLabel_en-US" xlink:label="lab_gsk_CreditExposure1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit exposure</link:label>
    <link:label id="lab_gsk_CreditExposure1_label_en-US" xlink:label="lab_gsk_CreditExposure1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Exposure1</link:label>
    <link:label id="lab_gsk_CreditExposure1_documentation_en-US" xlink:label="lab_gsk_CreditExposure1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Exposure1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CreditExposure1" xlink:href="gsk-20241231.xsd#gsk_CreditExposure1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CreditExposure1" xlink:to="lab_gsk_CreditExposure1" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TransfereeDomain_26b619e6-7120-4882-9398-a626f408e8bd_terseLabel_en-US" xlink:label="lab_gsk_TransfereeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transferee [Domain]</link:label>
    <link:label id="lab_gsk_TransfereeDomain_label_en-US" xlink:label="lab_gsk_TransfereeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferee [Domain]</link:label>
    <link:label id="lab_gsk_TransfereeDomain_documentation_en-US" xlink:label="lab_gsk_TransfereeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transferee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TransfereeDomain" xlink:href="gsk-20241231.xsd#gsk_TransfereeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TransfereeDomain" xlink:to="lab_gsk_TransfereeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_764cb77a-3fa3-4855-9bfb-aa91c40d06fc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LowerThanBBBBaa3Member_d27331a7-eb18-4296-a026-9682a4bda1ae_terseLabel_en-US" xlink:label="lab_gsk_LowerThanBBBBaa3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lower than BBB-/Baa3</link:label>
    <link:label id="lab_gsk_LowerThanBBBBaa3Member_label_en-US" xlink:label="lab_gsk_LowerThanBBBBaa3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lower Than BBB Baa3 [Member]</link:label>
    <link:label id="lab_gsk_LowerThanBBBBaa3Member_documentation_en-US" xlink:label="lab_gsk_LowerThanBBBBaa3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lower than BBB-/Baa3.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LowerThanBBBBaa3Member" xlink:href="gsk-20241231.xsd#gsk_LowerThanBBBBaa3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LowerThanBBBBaa3Member" xlink:to="lab_gsk_LowerThanBBBBaa3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_4439f0f6-8d41-4771-9eb6-4c14664d7b05_terseLabel_en-US" xlink:label="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting requirements for share-based payment arrangement, vesting period</link:label>
    <link:label id="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_label_en-US" xlink:label="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</link:label>
    <link:label id="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod_documentation_en-US" xlink:label="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Requirements For Share-Based Payment Arrangement, Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:href="gsk-20241231.xsd#gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:to="lab_gsk_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_d143dab8-4495-4fe2-a271-8bcddc3a4b4b_terseLabel_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">6.375% &#163; Euro Medium Term Note 2039</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_label_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Six Point Three Seven Five Percent Euro Medium Term Note Two Thousand Thirty Nine [Member]</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember_documentation_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Six point three seven five percent European medium term note two thousand thirty nine.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" xlink:to="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_9e9efc58-a374-49dc-92fe-db22fbfa64b0_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of employee costs and numbers [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Employee Costs and Numbers [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of employee costs and numbers line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfEmployeeCostsAndNumbersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" xlink:to="lab_gsk_DisclosureOfEmployeeCostsAndNumbersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1a8869ee-8e72-43fc-b91c-2cc8a7603985_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments and related disclosures</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_d14a5afd-fde8-4303-8524-5936fa1e568d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashOutflowForLeases_d15266cf-129f-415b-a469-2a26ff3286a5_terseLabel_en-US" xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash outflow for leases</link:label>
    <link:label id="lab_ifrs-full_CashOutflowForLeases_label_en-US" xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash outflow for leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases" xlink:to="lab_ifrs-full_CashOutflowForLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineThailandLimitedMember_2a049275-fe38-460c-8504-4d9905a9a2b3_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineThailandLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline (Thailand) Limited (Thailand)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineThailandLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxosmithklineThailandLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline (Thailand) Limited [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineThailandLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineThailandLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline (Thailand) Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineThailandLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineThailandLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineThailandLimitedMember" xlink:to="lab_gsk_GlaxosmithklineThailandLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember_2e5af760-a202-420d-808e-bb839bb203a5_terseLabel_en-US" xlink:label="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquidation or disposal of interest in associates</link:label>
    <link:label id="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember_label_en-US" xlink:label="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquidation Or Disposal Of Interest In Associates [Member]</link:label>
    <link:label id="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember_documentation_en-US" xlink:label="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liquidation Or Disposal Of Interest In Associates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LiquidationOrDisposalOfInterestInAssociatesMember" xlink:href="gsk-20241231.xsd#gsk_LiquidationOrDisposalOfInterestInAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LiquidationOrDisposalOfInterestInAssociatesMember" xlink:to="lab_gsk_LiquidationOrDisposalOfInterestInAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_de9d57d2-55f0-47ec-b583-fc0df89d0f6b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about unconsolidated structured entities controlled by investment entity [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedStructuredEntitiesControlledByInvestmentEntityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_ffe34f9a-3ec2-4ac0-857d-9c90ee5d36e9_terseLabel_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on cash flow hedges</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_label_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Relating to Fair Value Movements on Cash Flow Hedges Charged or Credited Directly to Comprehensive Income</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax relating to fair value movements on cash flow hedges charged or credited directly to comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:to="lab_gsk_DeferredTaxRelatingToFairValueMovementsOnCashFlowHedgesChargedOrCreditedDirectlyToComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_b19c8ca1-200a-4400-8336-fb2467e02f10_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_8186f9e2-f177-42e1-a41a-3497f754ad86_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock_2c255a7f-3526-4ddd-90bf-3192c5125353_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Contractual Obligations and Commitments</link:label>
    <link:label id="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contractual Obligations And Commitments Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Contractual Obligations And Commitments Explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfContractualObligationsAndCommitmentsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AssetImpairmentsCredit_d589d107-0ed8-487f-9c8f-5e2391e0573b_negatedLabel_en-US" xlink:label="lab_gsk_AssetImpairmentsCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Asset impairments credit</link:label>
    <link:label id="lab_gsk_AssetImpairmentsCredit_label_en-US" xlink:label="lab_gsk_AssetImpairmentsCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairments (Credit)</link:label>
    <link:label id="lab_gsk_AssetImpairmentsCredit_documentation_en-US" xlink:label="lab_gsk_AssetImpairmentsCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset impairments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssetImpairmentsCredit" xlink:href="gsk-20241231.xsd#gsk_AssetImpairmentsCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AssetImpairmentsCredit" xlink:to="lab_gsk_AssetImpairmentsCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_7dc97b3b-67ed-4fe0-9ac3-2ae31917ae6d_terseLabel_en-US" xlink:label="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Held for trading derivatives that are not in a designated and effective hedging relationship</link:label>
    <link:label id="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_label_en-US" xlink:label="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Held For Trading Derivatives That Are Not In A Designated And Effective Hedging Relationship [Member]</link:label>
    <link:label id="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember_documentation_en-US" xlink:label="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Held for trading derivatives that are not in a designated and effective hedging relationship.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" xlink:href="gsk-20241231.xsd#gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" xlink:to="lab_gsk_HeldForTradingDerivativesThatAreNotInADesignatedAndEffectiveHedgingRelationshipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LegalCosts_2a457c42-aecb-48e5-99f2-e8cff24cedd3_terseLabel_en-US" xlink:label="lab_gsk_LegalCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal costs</link:label>
    <link:label id="lab_gsk_LegalCosts_label_en-US" xlink:label="lab_gsk_LegalCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Costs</link:label>
    <link:label id="lab_gsk_LegalCosts_documentation_en-US" xlink:label="lab_gsk_LegalCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legal costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LegalCosts" xlink:href="gsk-20241231.xsd#gsk_LegalCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LegalCosts" xlink:to="lab_gsk_LegalCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_VaccinesMember_1cd548d5-ceff-4c6f-8587-b922e473ca37_terseLabel_en-US" xlink:label="lab_gsk_VaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vaccines</link:label>
    <link:label id="lab_gsk_VaccinesMember_label_en-US" xlink:label="lab_gsk_VaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vaccines [member]</link:label>
    <link:label id="lab_gsk_VaccinesMember_documentation_en-US" xlink:label="lab_gsk_VaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_VaccinesMember" xlink:href="gsk-20241231.xsd#gsk_VaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_VaccinesMember" xlink:to="lab_gsk_VaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_508cdc9d-551a-49e1-8b18-e65f4fb7cb29_terseLabel_en-US" xlink:label="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value movements on equity investments</link:label>
    <link:label id="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_label_en-US" xlink:label="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Tax On Fair Value Movements On Equity Investments Charged Or Credited Directly To Comprehensive Income</link:label>
    <link:label id="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current tax on fair value movements on equity investments charged or credited directly to comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" xlink:to="lab_gsk_CurrentTaxOnFairValueMovementsOnEquityInvestmentsChargedOrCreditedDirectlyToComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfDecreaseInDiscountRate_1ca43e54-f2c5-4a46-929b-8b2203a00178_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfDecreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of decrease in discount rate</link:label>
    <link:label id="lab_gsk_PercentageOfDecreaseInDiscountRate_label_en-US" xlink:label="lab_gsk_PercentageOfDecreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Decrease In Discount Rate</link:label>
    <link:label id="lab_gsk_PercentageOfDecreaseInDiscountRate_documentation_en-US" xlink:label="lab_gsk_PercentageOfDecreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of decrease in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfDecreaseInDiscountRate" xlink:href="gsk-20241231.xsd#gsk_PercentageOfDecreaseInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfDecreaseInDiscountRate" xlink:to="lab_gsk_PercentageOfDecreaseInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_ffea4351-9477-45cc-a793-955d97822a99_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AaOrAaMember_56de1ecc-b95c-434a-8c13-f745c29811aa_terseLabel_en-US" xlink:label="lab_gsk_AaOrAaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AA/Aa</link:label>
    <link:label id="lab_gsk_AaOrAaMember_label_en-US" xlink:label="lab_gsk_AaOrAaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AA Or Aa [member]</link:label>
    <link:label id="lab_gsk_AaOrAaMember_documentation_en-US" xlink:label="lab_gsk_AaOrAaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AA /Aa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AaOrAaMember" xlink:href="gsk-20241231.xsd#gsk_AaOrAaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AaOrAaMember" xlink:to="lab_gsk_AaOrAaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_831c65ea-60a6-4a76-9f8c-9c3093b72436_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in pension and other provisions</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherMaterialNoncashItems_afd758e1-6db3-4608-999e-4fdc334ae0d1_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherMaterialNoncashItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash charges/(credit)</link:label>
    <link:label id="lab_ifrs-full_OtherMaterialNoncashItems_label_en-US" xlink:label="lab_ifrs-full_OtherMaterialNoncashItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other material non-cash items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherMaterialNoncashItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherMaterialNoncashItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherMaterialNoncashItems" xlink:to="lab_ifrs-full_OtherMaterialNoncashItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseInOtherShortTermLoans_086b9231-c701-4005-9a13-1e867687758b_terseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in other short-term loans</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInOtherShortTermLoans_08992e2c-01e9-4f54-b500-e7455b998416_negatedTerseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in other short-term loans</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInOtherShortTermLoans_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Other Short-Term Loans</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseInOtherShortTermLoans_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Other Short-Term Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseInOtherShortTermLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:to="lab_gsk_IncreaseDecreaseInOtherShortTermLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear_df936396-a7fe-4443-b91f-80e0b79e5a6e_verboseLabel_en-US" xlink:label="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Dividends in specie to shareholders in Haleon plc shares</link:label>
    <link:label id="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear_26c46896-0c87-403f-ae3a-63bafae22131_terseLabel_en-US" xlink:label="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends in specie to shareholders in Haleon plc shares (Note 41)</link:label>
    <link:label id="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear_label_en-US" xlink:label="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend Paid To Shareholders On Demergerd Entity Recognized In Year</link:label>
    <link:label id="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear_documentation_en-US" xlink:label="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividend paid to shareholders on demergerd entity recognized in year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:href="gsk-20241231.xsd#gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:to="lab_gsk_DividendPaidToShareholdersOnDemergerdEntityRecognizedInYear" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BondsInDesignatedHedgingRelationshipMember_00e13f0f-73bf-4875-8e35-8b2421ba2923_terseLabel_en-US" xlink:label="lab_gsk_BondsInDesignatedHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8211; bonds in a designated hedging relationship</link:label>
    <link:label id="lab_gsk_BondsInDesignatedHedgingRelationshipMember_label_en-US" xlink:label="lab_gsk_BondsInDesignatedHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bonds In A Designated Hedging Relationship [member]</link:label>
    <link:label id="lab_gsk_BondsInDesignatedHedgingRelationshipMember_documentation_en-US" xlink:label="lab_gsk_BondsInDesignatedHedgingRelationshipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bonds in a designated hedging relationship.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BondsInDesignatedHedgingRelationshipMember" xlink:href="gsk-20241231.xsd#gsk_BondsInDesignatedHedgingRelationshipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BondsInDesignatedHedgingRelationshipMember" xlink:to="lab_gsk_BondsInDesignatedHedgingRelationshipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_90d11d84-1374-4b2c-bb3d-18ee9730700c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_1c1cc16c-69c2-44b2-964e-f51f12aac2b7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Current Equity Investments [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of information about unconsolidated subsidiaries [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember_4f4f9b96-55ac-4dbd-8eb5-b24233953255_terseLabel_en-US" xlink:label="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ViiV Healthcare UK Limited</link:label>
    <link:label id="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember_label_en-US" xlink:label="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vii V Health Care United Kingdom Limited [member]</link:label>
    <link:label id="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember_documentation_en-US" xlink:label="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ViiV Healthcare UK Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ViiVHealthCareUnitedKingdomLimitedMember" xlink:href="gsk-20241231.xsd#gsk_ViiVHealthCareUnitedKingdomLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ViiVHealthCareUnitedKingdomLimitedMember" xlink:to="lab_gsk_ViiVHealthCareUnitedKingdomLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PlantAndEquipmentMember_d2b2edb5-7bb7-4cf5-ba7d-07621154060a_terseLabel_en-US" xlink:label="lab_gsk_PlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_gsk_PlantAndEquipmentMember_label_en-US" xlink:label="lab_gsk_PlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plant And Equipment [Member]</link:label>
    <link:label id="lab_gsk_PlantAndEquipmentMember_documentation_en-US" xlink:label="lab_gsk_PlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plant And Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PlantAndEquipmentMember" xlink:href="gsk-20241231.xsd#gsk_PlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PlantAndEquipmentMember" xlink:to="lab_gsk_PlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxoGroupLimitedMember_af3a8b8f-b305-4485-b6d5-3130a139e35b_terseLabel_en-US" xlink:label="lab_gsk_GlaxoGroupLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Glaxo Group Limited</link:label>
    <link:label id="lab_gsk_GlaxoGroupLimitedMember_label_en-US" xlink:label="lab_gsk_GlaxoGroupLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxo Group Limited [member]</link:label>
    <link:label id="lab_gsk_GlaxoGroupLimitedMember_documentation_en-US" xlink:label="lab_gsk_GlaxoGroupLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Glaxo Group Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxoGroupLimitedMember" xlink:href="gsk-20241231.xsd#gsk_GlaxoGroupLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxoGroupLimitedMember" xlink:to="lab_gsk_GlaxoGroupLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_4deb15e7-1d33-4cd0-86ab-194220c4aebe_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current taxation</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income) and adjustments for current tax of prior periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_EmployeeShareOwnershipPlanMember_c669f26d-3a05-4ee0-9adc-68255c1379f7_terseLabel_en-US" xlink:label="lab_gsk_EmployeeShareOwnershipPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee share ownership plan</link:label>
    <link:label id="lab_gsk_EmployeeShareOwnershipPlanMember_label_en-US" xlink:label="lab_gsk_EmployeeShareOwnershipPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Share Ownership Plan [member]</link:label>
    <link:label id="lab_gsk_EmployeeShareOwnershipPlanMember_documentation_en-US" xlink:label="lab_gsk_EmployeeShareOwnershipPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee share ownership plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_EmployeeShareOwnershipPlanMember" xlink:href="gsk-20241231.xsd#gsk_EmployeeShareOwnershipPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_EmployeeShareOwnershipPlanMember" xlink:to="lab_gsk_EmployeeShareOwnershipPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentIncome_45de10a9-0685-475f-8fdd-baa0ab0b5c71_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from investment</link:label>
    <link:label id="lab_ifrs-full_InvestmentIncome_label_en-US" xlink:label="lab_ifrs-full_InvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentIncome" xlink:to="lab_ifrs-full_InvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_3a708df5-432e-40b0-a2fb-f0b39b88c5a3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Turnover and segment information</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of entity's operating segments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_f939d2a6-f333-41f2-b224-9361cc0f4ee1_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments_d1b6218b-0a9d-4005-aeb9-dac2e86829f0_terseLabel_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and liquid investments</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments_label_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents And Liquid Investments</link:label>
    <link:label id="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments_documentation_en-US" xlink:label="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and liquid investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashAndCashEquivalentsAndLiquidInvestments" xlink:href="gsk-20241231.xsd#gsk_CashAndCashEquivalentsAndLiquidInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashAndCashEquivalentsAndLiquidInvestments" xlink:to="lab_gsk_CashAndCashEquivalentsAndLiquidInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ChangeInAssumptionsAxis_3c45a235-8464-47a5-99ce-004f075cf1e4_terseLabel_en-US" xlink:label="lab_gsk_ChangeInAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change In Assumptions [Axis]</link:label>
    <link:label id="lab_gsk_ChangeInAssumptionsAxis_label_en-US" xlink:label="lab_gsk_ChangeInAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change In Assumptions [Axis]</link:label>
    <link:label id="lab_gsk_ChangeInAssumptionsAxis_documentation_en-US" xlink:label="lab_gsk_ChangeInAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change In Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ChangeInAssumptionsAxis" xlink:href="gsk-20241231.xsd#gsk_ChangeInAssumptionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ChangeInAssumptionsAxis" xlink:to="lab_gsk_ChangeInAssumptionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes_5a4ef67b-39ea-4560-ad18-e7b397e5d3cd_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of principal UK defined benefit pension schemes</link:label>
    <link:label id="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes_label_en-US" xlink:label="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Principal UK Defined Benefit Pension Schemes</link:label>
    <link:label id="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes_documentation_en-US" xlink:label="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Principal UK Defined Benefit Pension Schemes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" xlink:href="gsk-20241231.xsd#gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" xlink:to="lab_gsk_NumberOfPrincipalUKDefinedBenefitPensionSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember_7ee50a61-7713-4366-af18-4c1336db4d84_terseLabel_en-US" xlink:label="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.625% US$ US Medium Term Note 2025</link:label>
    <link:label id="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three Point Six Two Five Percent US Medium Term Note Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three point six two five percent US medium term note two thousand twenty five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" xlink:href="gsk-20241231.xsd#gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" xlink:to="lab_gsk_ThreePointSixTwoFivePercentUSMediumTermNoteTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember_eb777f8e-a246-41dd-8d04-4fa394faaee4_terseLabel_en-US" xlink:label="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.250% Euro medium term note 2033 repaid loan</link:label>
    <link:label id="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember_label_en-US" xlink:label="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Five Point Two Five Percent Euro Medium Term Note Two Thousand Thirty Three Repaid Loan [Member]</link:label>
    <link:label id="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember_documentation_en-US" xlink:label="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Five Point Two Five Percent Euro Medium Term Note Two Thousand Thirty Three Repaid Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" xlink:href="gsk-20241231.xsd#gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" xlink:to="lab_gsk_FivePointTwoFivePercentEuroMediumTermNoteTwoThousandThirtyThreeRepaidLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherReservesMember_d330eb6c-b7ce-41f5-9d6f-7e6e0ed67865_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Miscellaneous other reserves</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherReservesMember_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous other reserves [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherReservesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousOtherReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherReservesMember" xlink:to="lab_ifrs-full_MiscellaneousOtherReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock_a8d438f2-a4a1-44df-a0d7-e168b4d8ea08_verboseLabel_en-US" xlink:label="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange sensitivity impact on equity</link:label>
    <link:label id="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock_label_en-US" xlink:label="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Sensitivity Equity Impact [Table Text Block]</link:label>
    <link:label id="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock_documentation_en-US" xlink:label="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign exchange sensitivity equity impact.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock" xlink:to="lab_gsk_ForeignExchangeSensitivityEquityImpactTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember_500a47bf-57e9-488b-bd49-bf26e031fbed_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10% increase in sales forecasts</link:label>
    <link:label id="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember_label_en-US" xlink:label="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk Ten Percentage Increase In Sales Forecasts [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk ten percentage increase in sales forecasts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember" xlink:href="gsk-20241231.xsd#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"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember" xlink:to="lab_gsk_OtherRiskTenPercentageIncreaseInSalesForecastsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SaleMeasureMember_cd1e27d2-3361-4db2-b596-2efcdfbf6ab4_terseLabel_en-US" xlink:label="lab_gsk_SaleMeasureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale measure</link:label>
    <link:label id="lab_gsk_SaleMeasureMember_label_en-US" xlink:label="lab_gsk_SaleMeasureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Measure [Member]</link:label>
    <link:label id="lab_gsk_SaleMeasureMember_documentation_en-US" xlink:label="lab_gsk_SaleMeasureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Measure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SaleMeasureMember" xlink:href="gsk-20241231.xsd#gsk_SaleMeasureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SaleMeasureMember" xlink:to="lab_gsk_SaleMeasureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember_6835ceda-485f-4cc8-9ed0-4dbe5212f7c5_terseLabel_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">6.375% pound medium term note 2029 repaid loan</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember_label_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Six Point Three Seven Five Percent Euro Medium Term Note Two Thousand Thirty Nine Repaid Loan [Member]</link:label>
    <link:label id="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember_documentation_en-US" xlink:label="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Six Point Three Seven Five Percent Euro Medium Term Note Two Thousand Thirty Nine Repaid Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" xlink:href="gsk-20241231.xsd#gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" xlink:to="lab_gsk_SixPointThreeSevenFivePercentEuroMediumTermNoteTwoThousandThirtyNineRepaidLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables_d614a87a-5a50-4273-86e9-2ade4a1f7fac_terseLabel_en-US" xlink:label="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carbon based receivables</link:label>
    <link:label id="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables_label_en-US" xlink:label="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Nature-Based Carbon Receivables</link:label>
    <link:label id="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables_documentation_en-US" xlink:label="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Noncurrent Nature-Based Carbon Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherNoncurrentNatureBasedCarbonReceivables" xlink:href="gsk-20241231.xsd#gsk_OtherNoncurrentNatureBasedCarbonReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherNoncurrentNatureBasedCarbonReceivables" xlink:to="lab_gsk_OtherNoncurrentNatureBasedCarbonReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_71cb6cb8-0b00-4d4a-a465-9f863391ae59_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of cash flow hedges to income statement</link:label>
    <link:label id="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax_label_en-US" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on cash flow hedges, before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearMember_74ccf057-6b01-4ecd-9588-fbbec6dad64a_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non current</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearMember_fb59b2e0-b861-44a3-a68d-5e40d07c9f5c_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Floating and fixed rate debt less than one year</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember" xlink:to="lab_ifrs-full_LaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BR_0d1b3902-01cb-4bcf-8ba7-0da49d7800d5_terseLabel_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Brazil</link:label>
    <link:label id="lab_country_BR_label_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BRAZIL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_BR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BR" xlink:to="lab_country_BR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations_441be591-aff4-4401-b9aa-28633e632742_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (expense)/income for the year from discontinued operations</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income from discontinued operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations" xlink:to="lab_ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AvandiaMember_e9b00680-7706-48f1-a1b0-e066acc4114a_terseLabel_en-US" xlink:label="lab_gsk_AvandiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Avandia</link:label>
    <link:label id="lab_gsk_AvandiaMember_label_en-US" xlink:label="lab_gsk_AvandiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Avandia [Member]</link:label>
    <link:label id="lab_gsk_AvandiaMember_documentation_en-US" xlink:label="lab_gsk_AvandiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Avandia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AvandiaMember" xlink:href="gsk-20241231.xsd#gsk_AvandiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AvandiaMember" xlink:to="lab_gsk_AvandiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TaxEffectOfChangeInTaxRate_90a40804-d044-4774-8cb4-0003cf99d246_negatedTerseLabel_en-US" xlink:label="lab_gsk_TaxEffectOfChangeInTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in tax rates</link:label>
    <link:label id="lab_gsk_TaxEffectOfChangeInTaxRate_label_en-US" xlink:label="lab_gsk_TaxEffectOfChangeInTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Change In Tax Rate</link:label>
    <link:label id="lab_gsk_TaxEffectOfChangeInTaxRate_documentation_en-US" xlink:label="lab_gsk_TaxEffectOfChangeInTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of change in tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TaxEffectOfChangeInTaxRate" xlink:href="gsk-20241231.xsd#gsk_TaxEffectOfChangeInTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TaxEffectOfChangeInTaxRate" xlink:to="lab_gsk_TaxEffectOfChangeInTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_289f4d8b-c1c9-4e1f-9048-c903c1f03f4b_terseLabel_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [domain]</link:label>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_label_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:to="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_95523831-9106-4948-81ab-ba81cf0ab6f3_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_50641e35-83cd-4d4c-81a3-6c9fbf080169_terseLabel_en-US" xlink:label="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Characteristics of defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Characteristics of defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember_074cae0b-8b79-420f-99c5-d38150be7f48_terseLabel_en-US" xlink:label="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.50% (150 basis points) increase in discount rate</link:label>
    <link:label id="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember_label_en-US" xlink:label="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Risk One Fifty Basis Points increase in discount rate [Member]</link:label>
    <link:label id="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Risk One Fifty Basis Points increase in discount rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" xlink:href="gsk-20241231.xsd#gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" xlink:to="lab_gsk_CurrencyRiskOneFiftyBasisPointsIncreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SellingGeneralAndAdministrationMember_a5f0a2b7-0371-4cbe-a9a3-5aecf83646e4_terseLabel_en-US" xlink:label="lab_gsk_SellingGeneralAndAdministrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administration</link:label>
    <link:label id="lab_gsk_SellingGeneralAndAdministrationMember_label_en-US" xlink:label="lab_gsk_SellingGeneralAndAdministrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administration [member]</link:label>
    <link:label id="lab_gsk_SellingGeneralAndAdministrationMember_documentation_en-US" xlink:label="lab_gsk_SellingGeneralAndAdministrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Selling, General and Administration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SellingGeneralAndAdministrationMember" xlink:href="gsk-20241231.xsd#gsk_SellingGeneralAndAdministrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SellingGeneralAndAdministrationMember" xlink:to="lab_gsk_SellingGeneralAndAdministrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GainLossOnDisposalOfInterestInAssociates_c6dc6ad3-1543-4a7e-a3fb-0b2052cb9671_terseLabel_en-US" xlink:label="lab_gsk_GainLossOnDisposalOfInterestInAssociates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on disposal of interest in associates</link:label>
    <link:label id="lab_gsk_GainLossOnDisposalOfInterestInAssociates_label_en-US" xlink:label="lab_gsk_GainLossOnDisposalOfInterestInAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Disposal Of Interest In Associates</link:label>
    <link:label id="lab_gsk_GainLossOnDisposalOfInterestInAssociates_documentation_en-US" xlink:label="lab_gsk_GainLossOnDisposalOfInterestInAssociates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain loss on disposal of interest in associates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GainLossOnDisposalOfInterestInAssociates" xlink:href="gsk-20241231.xsd#gsk_GainLossOnDisposalOfInterestInAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GainLossOnDisposalOfInterestInAssociates" xlink:to="lab_gsk_GainLossOnDisposalOfInterestInAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_1a1cc33c-f0f6-4182-9153-6f65789101cb_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_d0739767-41c2-46d6-b012-c28284e6c53d_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial assets at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_030cd76e-7457-4ba1-be8c-409b573d8fd8_terseLabel_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets of non-controlling interests</link:label>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_label_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange Movements On Overseas Net Assets Of Non-Controlling Interest</link:label>
    <link:label id="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest_documentation_en-US" xlink:label="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchange movements on overseas net assets of non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" xlink:href="gsk-20241231.xsd#gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" xlink:to="lab_gsk_ExchangeMovementsOnOverseasNetAssetsOfNonControllingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_4f25358f-dd56-4022-a4cf-1f37ca2f5929_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_9fe75575-1e99-49aa-a72c-500ab4edce0e_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, liabilities</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:to="lab_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_label_en-US" xlink:label="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate information and statement of IFRS compliance [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_91722e8b-38c1-40d4-89da-e573af9bb227_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_04392507-252f-4a66-9b7e-6a3eb31dc1ba_periodStartLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_fb59d85f-73ab-4eb5-9826-1de03c6fbcd6_periodEndLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9dd9ce36-714c-40f3-bacf-5d60f7af79b0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_1d55c78f-09aa-4def-b89d-a9b24625a488_terseLabel_en-US" xlink:label="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments measured at FVTPL</link:label>
    <link:label id="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_label_en-US" xlink:label="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Measured At Fair Value Through Profit Or Loss [Member]</link:label>
    <link:label id="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember_documentation_en-US" xlink:label="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments measured at fair value through profit or loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:href="gsk-20241231.xsd#gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:to="lab_gsk_InvestmentsMeasuredAtFairValueThroughProfitOrLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfWorldwidePatentLicenseAgreements_dd887a79-7cbc-4f36-86a2-2fc90263b837_terseLabel_en-US" xlink:label="lab_gsk_NumberOfWorldwidePatentLicenseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of worldwide patent license agreements</link:label>
    <link:label id="lab_gsk_NumberOfWorldwidePatentLicenseAgreements_label_en-US" xlink:label="lab_gsk_NumberOfWorldwidePatentLicenseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Worldwide Patent License Agreements</link:label>
    <link:label id="lab_gsk_NumberOfWorldwidePatentLicenseAgreements_documentation_en-US" xlink:label="lab_gsk_NumberOfWorldwidePatentLicenseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Worldwide Patent License Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfWorldwidePatentLicenseAgreements" xlink:href="gsk-20241231.xsd#gsk_NumberOfWorldwidePatentLicenseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfWorldwidePatentLicenseAgreements" xlink:to="lab_gsk_NumberOfWorldwidePatentLicenseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_b122bd78-e889-40e2-9fee-2df150f4601f_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashManagedForSubsidiaryCompany_abcfd933-4339-4af1-a292-43b784647da8_terseLabel_en-US" xlink:label="lab_gsk_CashManagedForSubsidiaryCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash managed by group for subsidiary</link:label>
    <link:label id="lab_gsk_CashManagedForSubsidiaryCompany_label_en-US" xlink:label="lab_gsk_CashManagedForSubsidiaryCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Managed For Subsidiary Company</link:label>
    <link:label id="lab_gsk_CashManagedForSubsidiaryCompany_documentation_en-US" xlink:label="lab_gsk_CashManagedForSubsidiaryCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash managed for subsidiary company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashManagedForSubsidiaryCompany" xlink:href="gsk-20241231.xsd#gsk_CashManagedForSubsidiaryCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashManagedForSubsidiaryCompany" xlink:to="lab_gsk_CashManagedForSubsidiaryCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_5e583829-15c1-4335-a0bb-b729c0c9dcae_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2596e03c-b762-4583-942a-1fd06fb1ef30_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement (in pounds per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CO_68dc5ff9-c971-47dd-9476-bdad8ac23011_terseLabel_en-US" xlink:label="lab_country_CO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Colombia</link:label>
    <link:label id="lab_country_CO_label_en-US" xlink:label="lab_country_CO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">COLOMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CO" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CO" xlink:to="lab_country_CO" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare_fa0d8ae1-2e9a-4064-a6f4-c9818b58d457_terseLabel_en-US" xlink:label="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of interest in subsidiary, consideration per share (in USD per share)</link:label>
    <link:label id="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare_label_en-US" xlink:label="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition Of Interest In Subsidiary, Consideration Per Share</link:label>
    <link:label id="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare_documentation_en-US" xlink:label="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition Of Interest In Subsidiary, Consideration Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" xlink:href="gsk-20241231.xsd#gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" xlink:to="lab_gsk_AcquisitionOfInterestInSubsidiaryConsiderationPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalAxis_afa6fdfd-d7d6-455f-b24c-8719154314cc_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations_50e6213d-2e11-43e9-9b65-d0cbf9fd60c5_terseLabel_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash generated from operations attributable to discontinued operations</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations_144e74c0-3dd5-4f97-a29a-08cdaad23317_verboseLabel_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flow from discontinued operations</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations_label_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flows From (Used In) Operations Before Tax, Discontinued Operations</link:label>
    <link:label id="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations_documentation_en-US" xlink:label="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash from used in operations before tax discontinued operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:href="gsk-20241231.xsd#gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:to="lab_gsk_CashFlowsFromUsedInOperationsBeforeTaxDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_4f24127b-a5aa-44e5-a6af-2451974dcaf2_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AT_1b1ff9f7-3eab-4b87-8c85-b92dad169aa0_terseLabel_en-US" xlink:label="lab_country_AT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Austria</link:label>
    <link:label id="lab_country_AT_label_en-US" xlink:label="lab_country_AT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AUSTRIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AT" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AT" xlink:to="lab_country_AT" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_3e8c8d54-8683-490b-84b0-0e34ec913cd5_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilitiesAbstract_5887537c-8ca2-4a64-839c-0f628892b6fa_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AU_3139f0b0-ad67-469b-8a2b-d810738d5b9d_terseLabel_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Australia</link:label>
    <link:label id="lab_country_AU_label_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AUSTRALIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AU" xlink:to="lab_country_AU" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AR_6ea63fa3-80b9-4c7e-ab02-f742b5ad7a41_terseLabel_en-US" xlink:label="lab_country_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Argentina</link:label>
    <link:label id="lab_country_AR_label_en-US" xlink:label="lab_country_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARGENTINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AR" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AR" xlink:to="lab_country_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_4b97152f-f702-4b2b-b8f1-b1974fdfcc65_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) from change in financial assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_727f9750-0e22-4cfb-ad67-eef81181ce85_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain from change in demographic assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ERPSoftwareSystemsMember_6e9c7017-0f84-490e-9040-b1755c424ce0_terseLabel_en-US" xlink:label="lab_gsk_ERPSoftwareSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ERP software systems</link:label>
    <link:label id="lab_gsk_ERPSoftwareSystemsMember_label_en-US" xlink:label="lab_gsk_ERPSoftwareSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ERP Software Systems [member]</link:label>
    <link:label id="lab_gsk_ERPSoftwareSystemsMember_documentation_en-US" xlink:label="lab_gsk_ERPSoftwareSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ERP software systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ERPSoftwareSystemsMember" xlink:href="gsk-20241231.xsd#gsk_ERPSoftwareSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ERPSoftwareSystemsMember" xlink:to="lab_gsk_ERPSoftwareSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember_c062a673-a712-4939-adc2-7a5e224400ed_terseLabel_en-US" xlink:label="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1% increase in discount rate</link:label>
    <link:label id="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember_label_en-US" xlink:label="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Risk One Percentage Increase In Discount Rate [Member]</link:label>
    <link:label id="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other risk one percentage increase in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" xlink:href="gsk-20241231.xsd#gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" xlink:to="lab_gsk_OtherRiskOnePercentageIncreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member_e13236ee-7074-4b38-b2dd-2c1dda1f7c14_terseLabel_en-US" xlink:label="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.200% Notes due 2043</link:label>
    <link:label id="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member_label_en-US" xlink:label="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Four Point Two Zero Zero Notes due 2043 [Member]</link:label>
    <link:label id="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member_documentation_en-US" xlink:label="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.200% Notes due 2043.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FourPointTwoZeroZeroNotesDue2043Member" xlink:href="gsk-20241231.xsd#gsk_FourPointTwoZeroZeroNotesDue2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FourPointTwoZeroZeroNotesDue2043Member" xlink:to="lab_gsk_FourPointTwoZeroZeroNotesDue2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_7266b36f-db06-46ad-9148-0621ace9018a_negatedLabel_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Credit/(charge) to statement of comprehensive income</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_label_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Relating To Items Charged Or Credited Directly To Equity And Comprehensive Income</link:label>
    <link:label id="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome_documentation_en-US" xlink:label="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax relating to items charged or credited directly to equity and comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:href="gsk-20241231.xsd#gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:to="lab_gsk_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAndComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_8808c1bc-82f6-4508-98eb-aa47ca599a57_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross financial (liabilities)/assets set off, liabilities</link:label>
    <link:label id="lab_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements_label_en-US" xlink:label="lab_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross financial assets set off against financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:to="lab_ifrs-full_GrossFinancialAssetsSetOffAgainstFinancialLiabilitiesSubjectToOffsettingEnforceableMasterNettingArrangementsOrSimilarAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CarbonRemovalProjectsMember_47482a86-d6a3-4733-94c0-f42fe29f5d70_terseLabel_en-US" xlink:label="lab_gsk_CarbonRemovalProjectsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carbon Removal Projects</link:label>
    <link:label id="lab_gsk_CarbonRemovalProjectsMember_label_en-US" xlink:label="lab_gsk_CarbonRemovalProjectsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carbon Removal Projects [Member]</link:label>
    <link:label id="lab_gsk_CarbonRemovalProjectsMember_documentation_en-US" xlink:label="lab_gsk_CarbonRemovalProjectsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carbon Removal Projects</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CarbonRemovalProjectsMember" xlink:href="gsk-20241231.xsd#gsk_CarbonRemovalProjectsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CarbonRemovalProjectsMember" xlink:to="lab_gsk_CarbonRemovalProjectsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BE_ae768f85-8901-4781-b65d-619348e30888_terseLabel_en-US" xlink:label="lab_country_BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Belgium</link:label>
    <link:label id="lab_country_BE_label_en-US" xlink:label="lab_country_BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BELGIUM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_BE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BE" xlink:to="lab_country_BE" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_aeeac038-87da-4718-9995-c01fa16022a3_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_label_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GSKFinanceNo2LimitedMember_50aa4695-a517-451b-a289-fae4d59b7699_terseLabel_en-US" xlink:label="lab_gsk_GSKFinanceNo2LimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Finance (No. 2) Limited</link:label>
    <link:label id="lab_gsk_GSKFinanceNo2LimitedMember_label_en-US" xlink:label="lab_gsk_GSKFinanceNo2LimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Finance (No 2) Limited [Member]</link:label>
    <link:label id="lab_gsk_GSKFinanceNo2LimitedMember_documentation_en-US" xlink:label="lab_gsk_GSKFinanceNo2LimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GSK Finance (No 2) Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GSKFinanceNo2LimitedMember" xlink:href="gsk-20241231.xsd#gsk_GSKFinanceNo2LimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GSKFinanceNo2LimitedMember" xlink:to="lab_gsk_GSKFinanceNo2LimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AverageForeignExchangeRate_28610394-bd45-4df5-95cb-2f656ebfa765_verboseLabel_en-US" xlink:label="lab_ifrs-full_AverageForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Average rates:</link:label>
    <link:label id="lab_ifrs-full_AverageForeignExchangeRate_4ce53a45-86dd-448c-8a63-82497ebbfbaa_terseLabel_en-US" xlink:label="lab_ifrs-full_AverageForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8232;Average exchange rate&#8232;</link:label>
    <link:label id="lab_ifrs-full_AverageForeignExchangeRate_label_en-US" xlink:label="lab_ifrs-full_AverageForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average foreign exchange rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageForeignExchangeRate" xlink:to="lab_ifrs-full_AverageForeignExchangeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_d6a88e62-fbf8-40d2-ba2c-3d14c6556022_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Assets_f7ab91cb-b5b0-4cee-ab36-ee3c6ab13c5e_totalLabel_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_ifrs-full_Assets_label_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_ee8e49e8-380d-4aa2-b7c9-68b0aa000fa7_terseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_720af105-08e1-4caa-8994-08cf2b191268_verboseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due in less than one year</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfPerformanceSharePlan_53229d56-0872-4690-8fd7-2e2ff145f4ad_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfPerformanceSharePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of performance share plan</link:label>
    <link:label id="lab_gsk_PercentageOfPerformanceSharePlan_label_en-US" xlink:label="lab_gsk_PercentageOfPerformanceSharePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Performance Share Plan</link:label>
    <link:label id="lab_gsk_PercentageOfPerformanceSharePlan_documentation_en-US" xlink:label="lab_gsk_PercentageOfPerformanceSharePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of performance share plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfPerformanceSharePlan" xlink:href="gsk-20241231.xsd#gsk_PercentageOfPerformanceSharePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfPerformanceSharePlan" xlink:to="lab_gsk_PercentageOfPerformanceSharePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PensionObligationAugmentationCosts_9d1bb89b-e34c-40fb-9dc6-80282fe23a7b_terseLabel_en-US" xlink:label="lab_gsk_PensionObligationAugmentationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension augmentations arising from staff redundancies</link:label>
    <link:label id="lab_gsk_PensionObligationAugmentationCosts_label_en-US" xlink:label="lab_gsk_PensionObligationAugmentationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Obligation, Augmentation Costs</link:label>
    <link:label id="lab_gsk_PensionObligationAugmentationCosts_documentation_en-US" xlink:label="lab_gsk_PensionObligationAugmentationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pension obligation provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PensionObligationAugmentationCosts" xlink:href="gsk-20241231.xsd#gsk_PensionObligationAugmentationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PensionObligationAugmentationCosts" xlink:to="lab_gsk_PensionObligationAugmentationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits_6b78e710-6768-4013-81ec-9630eff7016e_terseLabel_en-US" xlink:label="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of UK pension plans with technical provisions deficits</link:label>
    <link:label id="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits_label_en-US" xlink:label="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of UK Pension Plans With Technical Provisions Deficits</link:label>
    <link:label id="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits_documentation_en-US" xlink:label="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of UK Pension Plans With Technical Provisions Deficits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" xlink:href="gsk-20241231.xsd#gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" xlink:to="lab_gsk_NumberOfUKPensionPlansWithTechnicalProvisionsDeficits" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SLPPartneshipsMember_2845d557-ee15-4875-8d61-7649f20ad8da_terseLabel_en-US" xlink:label="lab_gsk_SLPPartneshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SLP Partneships</link:label>
    <link:label id="lab_gsk_SLPPartneshipsMember_label_en-US" xlink:label="lab_gsk_SLPPartneshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SLP Partneships [Member]</link:label>
    <link:label id="lab_gsk_SLPPartneshipsMember_documentation_en-US" xlink:label="lab_gsk_SLPPartneshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SLP partneships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SLPPartneshipsMember" xlink:href="gsk-20241231.xsd#gsk_SLPPartneshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SLPPartneshipsMember" xlink:to="lab_gsk_SLPPartneshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_24bd4c4e-2016-4a57-b8d3-f26bf2701031_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of share capital</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issuing shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OverseasMember_8e11aa2c-d1eb-4ea5-8eb6-1385a42c6bdf_terseLabel_en-US" xlink:label="lab_gsk_OverseasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Overseas</link:label>
    <link:label id="lab_gsk_OverseasMember_label_en-US" xlink:label="lab_gsk_OverseasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Overseas [member]</link:label>
    <link:label id="lab_gsk_OverseasMember_documentation_en-US" xlink:label="lab_gsk_OverseasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Overseas.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OverseasMember" xlink:href="gsk-20241231.xsd#gsk_OverseasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OverseasMember" xlink:to="lab_gsk_OverseasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_66a023df-c463-4ec4-9441-4344b61019dc_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration related to business acquisitions in the period</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in contingent consideration asset (liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:to="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AE_3380a369-5fae-4752-b08b-c32f1a02ac85_terseLabel_en-US" xlink:label="lab_country_AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United Arab Emirates</link:label>
    <link:label id="lab_country_AE_label_en-US" xlink:label="lab_country_AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED ARAB EMIRATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AE" xlink:to="lab_country_AE" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_BankLoansAndOverdraftsMember_13ddbbd9-aed2-44d3-a2ac-f21d30061104_terseLabel_en-US" xlink:label="lab_gsk_BankLoansAndOverdraftsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8211; bank loans and overdrafts</link:label>
    <link:label id="lab_gsk_BankLoansAndOverdraftsMember_label_en-US" xlink:label="lab_gsk_BankLoansAndOverdraftsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank loans and overdrafts [member]</link:label>
    <link:label id="lab_gsk_BankLoansAndOverdraftsMember_documentation_en-US" xlink:label="lab_gsk_BankLoansAndOverdraftsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bank loans and overdrafts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_BankLoansAndOverdraftsMember" xlink:href="gsk-20241231.xsd#gsk_BankLoansAndOverdraftsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_BankLoansAndOverdraftsMember" xlink:to="lab_gsk_BankLoansAndOverdraftsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfPatentsInvalidated_cff7ae1e-bf85-4420-9c0d-6295890c1c46_terseLabel_en-US" xlink:label="lab_gsk_NumberOfPatentsInvalidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents invalidated</link:label>
    <link:label id="lab_gsk_NumberOfPatentsInvalidated_label_en-US" xlink:label="lab_gsk_NumberOfPatentsInvalidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Patents Invalidated</link:label>
    <link:label id="lab_gsk_NumberOfPatentsInvalidated_documentation_en-US" xlink:label="lab_gsk_NumberOfPatentsInvalidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Patents Invalidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfPatentsInvalidated" xlink:href="gsk-20241231.xsd#gsk_NumberOfPatentsInvalidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfPatentsInvalidated" xlink:to="lab_gsk_NumberOfPatentsInvalidated" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_cd5057a2-abce-4a8a-89d5-c789c65d99e5_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Non Current Assets [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Non Current Assets [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:to="lab_gsk_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_f5bb67e1-0b03-4fe2-8e6f-85b8803e9420_verboseLabel_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity of key model input to measure contingent consideration [line items]</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_label_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Change In Probability Of Milestones Success Contingent Liabilities Recognised In Business Combination [Line Items]</link:label>
    <link:label id="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems_documentation_en-US" xlink:label="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease through change in probability of milestones success contingent liabilities recognised in business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" xlink:href="gsk-20241231.xsd#gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" xlink:to="lab_gsk_IncreaseDecreaseThroughChangeInProbabilityOfMilestonesSuccessContingentLiabilitiesRecognisedInBusinessCombinationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_USCashBalancePlanMember_e4924499-4603-41d7-ba46-eef2a50ddda0_terseLabel_en-US" xlink:label="lab_gsk_USCashBalancePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Cash Balance Plan</link:label>
    <link:label id="lab_gsk_USCashBalancePlanMember_label_en-US" xlink:label="lab_gsk_USCashBalancePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Cash Balance Plan [Member]</link:label>
    <link:label id="lab_gsk_USCashBalancePlanMember_documentation_en-US" xlink:label="lab_gsk_USCashBalancePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">US Cash Balance Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_USCashBalancePlanMember" xlink:href="gsk-20241231.xsd#gsk_USCashBalancePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_USCashBalancePlanMember" xlink:to="lab_gsk_USCashBalancePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_48975607-ea9e-4dcc-a48b-95398a89fd08_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major ordinary share transactions</link:label>
    <link:label id="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_label_en-US" xlink:label="lab_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major ordinary share transactions [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:to="lab_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock_ba7c2411-e03e-4615-9ef2-c595eeeba959_terseLabel_en-US" xlink:label="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Non-Current Assets</link:label>
    <link:label id="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Receivables In Other Non Current Assets Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of receivables in other non current assets explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" xlink:to="lab_gsk_SummaryOfReceivablesInOtherNonCurrentAssetsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ContingentConsiderationLiabilitiesMember_906a6e0d-a1cf-49fc-9616-18ee7e3e8bde_terseLabel_en-US" xlink:label="lab_gsk_ContingentConsiderationLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_gsk_ContingentConsiderationLiabilitiesMember_label_en-US" xlink:label="lab_gsk_ContingentConsiderationLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liabilities [member]</link:label>
    <link:label id="lab_gsk_ContingentConsiderationLiabilitiesMember_documentation_en-US" xlink:label="lab_gsk_ContingentConsiderationLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ContingentConsiderationLiabilitiesMember" xlink:href="gsk-20241231.xsd#gsk_ContingentConsiderationLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ContingentConsiderationLiabilitiesMember" xlink:to="lab_gsk_ContingentConsiderationLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AssetsHeldForSaleTable_591abd97-089d-4b01-9909-14b2fe60bff1_terseLabel_en-US" xlink:label="lab_gsk_AssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets Held For Sale [table]</link:label>
    <link:label id="lab_gsk_AssetsHeldForSaleTable_label_en-US" xlink:label="lab_gsk_AssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Held For Sale [table]</link:label>
    <link:label id="lab_gsk_AssetsHeldForSaleTable_documentation_en-US" xlink:label="lab_gsk_AssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Held For Sale [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AssetsHeldForSaleTable" xlink:href="gsk-20241231.xsd#gsk_AssetsHeldForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AssetsHeldForSaleTable" xlink:to="lab_gsk_AssetsHeldForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_LetterOfCreditHeldMember_c7d889c2-2213-4a72-9e7d-7cfe60d83ca7_terseLabel_en-US" xlink:label="lab_gsk_LetterOfCreditHeldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_gsk_LetterOfCreditHeldMember_label_en-US" xlink:label="lab_gsk_LetterOfCreditHeldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter Of Credit Held [Member]</link:label>
    <link:label id="lab_gsk_LetterOfCreditHeldMember_documentation_en-US" xlink:label="lab_gsk_LetterOfCreditHeldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Letter of credit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_LetterOfCreditHeldMember" xlink:href="gsk-20241231.xsd#gsk_LetterOfCreditHeldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_LetterOfCreditHeldMember" xlink:to="lab_gsk_LetterOfCreditHeldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_ae368f06-ea18-4085-8242-73d708841106_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_0319758c-484f-40c3-87ad-88932f9d0807_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total profit attributable to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_c00df464-3796-4144-8412-846e04499ed6_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit after taxation</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_a971ca6b-5dcd-47bc-8eff-a75efc3fd762_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/increase in post-retirement benefits obligation</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_b746847d-d310-4b23-ba57-06c195480312_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transfer to assets held for sale/distribution</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from business combinations and disposals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_GlaxosmithklineFarEastB.v.Member_4a28cc3d-1577-4a3d-ae93-e430a6bc2e15_terseLabel_en-US" xlink:label="lab_gsk_GlaxosmithklineFarEastB.v.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Far East B.V. (Taiwan)</link:label>
    <link:label id="lab_gsk_GlaxosmithklineFarEastB.v.Member_label_en-US" xlink:label="lab_gsk_GlaxosmithklineFarEastB.v.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Far East B.V. [Member]</link:label>
    <link:label id="lab_gsk_GlaxosmithklineFarEastB.v.Member_documentation_en-US" xlink:label="lab_gsk_GlaxosmithklineFarEastB.v.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Far East B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_GlaxosmithklineFarEastB.v.Member" xlink:href="gsk-20241231.xsd#gsk_GlaxosmithklineFarEastB.v.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_GlaxosmithklineFarEastB.v.Member" xlink:to="lab_gsk_GlaxosmithklineFarEastB.v.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_83e750c2-111a-4f16-b12a-5999379acb47_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_a81d8a5a-f49e-4c9e-b890-6ae8a97d1b35_negatedLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Current derivative financial liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeAbstract_9fd62741-698f-4714-8c20-3995347bc214_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(expense) for the year</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_1b2009b3-1635-469a-8ee7-587e24a54c61_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) from change in demographic assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_111ec131-9f27-41c0-882f-948e73832c38_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) from change in financial assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes_1b80db8d-ea54-4543-aa5e-e5fb24f49311_terseLabel_en-US" xlink:label="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nominal value</link:label>
    <link:label id="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes_label_en-US" xlink:label="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nominal Value Of Shares Held For Share Award Schemes</link:label>
    <link:label id="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes_documentation_en-US" xlink:label="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nominal Value Of Shares Held For Share Award Schemes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NominalValueOfSharesHeldForShareAwardSchemes" xlink:href="gsk-20241231.xsd#gsk_NominalValueOfSharesHeldForShareAwardSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NominalValueOfSharesHeldForShareAwardSchemes" xlink:to="lab_gsk_NominalValueOfSharesHeldForShareAwardSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClosingForeignExchangeRate_bd28e268-a9a2-4559-ae7d-13ffe67f06a9_terseLabel_en-US" xlink:label="lab_ifrs-full_ClosingForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period end rates:</link:label>
    <link:label id="lab_ifrs-full_ClosingForeignExchangeRate_label_en-US" xlink:label="lab_ifrs-full_ClosingForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Closing foreign exchange rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClosingForeignExchangeRate" xlink:to="lab_ifrs-full_ClosingForeignExchangeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_d9525752-4365-4ad1-8f32-a5fd859e8416_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow from financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_bd2bd6cc-60f8-437c-94ba-9b85cc300651_terseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid, classified as operating activities</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid, classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_e58dd5b3-f1ab-4309-8993-37e40a8c7a90_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK current year charge</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember_84f71175-da02-4359-81dd-0b8dd765ec56_terseLabel_en-US" xlink:label="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">0.883% &#165; Euro Medium Term Note 2028</link:label>
    <link:label id="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember_label_en-US" xlink:label="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zero Point Eight Eight Three Percent Euro Medium Term Note Two Thousand Twenty Eight [Member]</link:label>
    <link:label id="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember_documentation_en-US" xlink:label="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zero Point Eight Eight Three Percent Euro Medium Term Note Two Thousand Twenty Eight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" xlink:href="gsk-20241231.xsd#gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" xlink:to="lab_gsk_ZeroPointEightEightThreePercentEuroMediumTermNoteTwoThousandTwentyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NoncurrentAssetsOtherMember_e67fc3b4-a7e5-4fb0-8464-dd112ef76081_terseLabel_en-US" xlink:label="lab_gsk_NoncurrentAssetsOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension schemes in surplus</link:label>
    <link:label id="lab_gsk_NoncurrentAssetsOtherMember_ee1eb276-440e-4b50-8126-d310f00af9ac_verboseLabel_en-US" xlink:label="lab_gsk_NoncurrentAssetsOtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_gsk_NoncurrentAssetsOtherMember_label_en-US" xlink:label="lab_gsk_NoncurrentAssetsOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncurrent Assets, Other [Member]</link:label>
    <link:label id="lab_gsk_NoncurrentAssetsOtherMember_documentation_en-US" xlink:label="lab_gsk_NoncurrentAssetsOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Noncurrent Assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NoncurrentAssetsOtherMember" xlink:href="gsk-20241231.xsd#gsk_NoncurrentAssetsOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NoncurrentAssetsOtherMember" xlink:to="lab_gsk_NoncurrentAssetsOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesDomain_9c671602-6215-404d-9eac-a00015fb9342_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of interest rates</link:label>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of interest rates [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain" xlink:to="lab_ifrs-full_TypesOfInterestRatesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CureVacAssetsMember_cd2b9967-1875-4302-b0cf-ca164c4fa969_terseLabel_en-US" xlink:label="lab_gsk_CureVacAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CureVac Assets</link:label>
    <link:label id="lab_gsk_CureVacAssetsMember_label_en-US" xlink:label="lab_gsk_CureVacAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CureVac Assets [Member]</link:label>
    <link:label id="lab_gsk_CureVacAssetsMember_documentation_en-US" xlink:label="lab_gsk_CureVacAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CureVac Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CureVacAssetsMember" xlink:href="gsk-20241231.xsd#gsk_CureVacAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CureVacAssetsMember" xlink:to="lab_gsk_CureVacAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_ea3a8c9c-8c5b-4430-a562-019af055c797_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties_0f990782-b00c-4b0a-93e8-d3e454e29420_terseLabel_en-US" xlink:label="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash held at sub-investment rated counterparties</link:label>
    <link:label id="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties_label_en-US" xlink:label="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Held At Unrated or Sub-Investment Rated Counterparties</link:label>
    <link:label id="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties_documentation_en-US" xlink:label="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" xlink:href="gsk-20241231.xsd#gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" xlink:to="lab_gsk_CashHeldAtUnratedOrSubInvestmentRatedCounterparties" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalDomain_5a5592f8-2805-4d96-a069-a08e65f7180f_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital</link:label>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain" xlink:to="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_PercentageOfOwnershipDistributed_30eb3c8e-f7d2-4115-b555-5e23419d94e3_terseLabel_en-US" xlink:label="lab_gsk_PercentageOfOwnershipDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of ownership distributed</link:label>
    <link:label id="lab_gsk_PercentageOfOwnershipDistributed_label_en-US" xlink:label="lab_gsk_PercentageOfOwnershipDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Ownership Distributed</link:label>
    <link:label id="lab_gsk_PercentageOfOwnershipDistributed_documentation_en-US" xlink:label="lab_gsk_PercentageOfOwnershipDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ownership of the Consumer Healthcare business distributed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_PercentageOfOwnershipDistributed" xlink:href="gsk-20241231.xsd#gsk_PercentageOfOwnershipDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_PercentageOfOwnershipDistributed" xlink:to="lab_gsk_PercentageOfOwnershipDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GR_be85734f-e771-485a-b1b3-f1288642cdb0_terseLabel_en-US" xlink:label="lab_country_GR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Greece</link:label>
    <link:label id="lab_country_GR_label_en-US" xlink:label="lab_country_GR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GREECE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GR" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GR" xlink:to="lab_country_GR" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_NumberOfUKPensionPlans_f37b6b10-bb07-4c40-b3a2-a8a745ce62f3_terseLabel_en-US" xlink:label="lab_gsk_NumberOfUKPensionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of UK pension plans</link:label>
    <link:label id="lab_gsk_NumberOfUKPensionPlans_label_en-US" xlink:label="lab_gsk_NumberOfUKPensionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of UK Pension Plans</link:label>
    <link:label id="lab_gsk_NumberOfUKPensionPlans_documentation_en-US" xlink:label="lab_gsk_NumberOfUKPensionPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of UK Pension Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_NumberOfUKPensionPlans" xlink:href="gsk-20241231.xsd#gsk_NumberOfUKPensionPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_NumberOfUKPensionPlans" xlink:to="lab_gsk_NumberOfUKPensionPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock_b6c14635-254a-42c0-b5bf-4c2a9d00daf0_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Noncurrent Liabilities</link:label>
    <link:label id="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Other Non current Liabilities Details Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of other non current liabilities details.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfOtherNonCurrentLiabilitiesDetailsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock_5aa76764-7117-48f5-b320-6419b1e32d57_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Obligations</link:label>
    <link:label id="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Obligations Explanatory [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of lease obligations explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" xlink:to="lab_gsk_DisclosureOfLeaseObligationsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_WeightedAverageInterestRateOnBorrowings_49197e74-e586-4146-b124-00239ff58646_terseLabel_en-US" xlink:label="lab_gsk_WeightedAverageInterestRateOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average interest rate of borrowings</link:label>
    <link:label id="lab_gsk_WeightedAverageInterestRateOnBorrowings_label_en-US" xlink:label="lab_gsk_WeightedAverageInterestRateOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Interest Rate On Borrowings</link:label>
    <link:label id="lab_gsk_WeightedAverageInterestRateOnBorrowings_documentation_en-US" xlink:label="lab_gsk_WeightedAverageInterestRateOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average interest rate on borrowings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_WeightedAverageInterestRateOnBorrowings" xlink:href="gsk-20241231.xsd#gsk_WeightedAverageInterestRateOnBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_WeightedAverageInterestRateOnBorrowings" xlink:to="lab_gsk_WeightedAverageInterestRateOnBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_051bb5f0-c4d7-42de-ab4f-0118224920d0_verboseLabel_en-US" xlink:label="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables and other noncurrent assets</link:label>
    <link:label id="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_label_en-US" xlink:label="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables,Other Noncurrent Assets And Assets Held For Sale In Scope Of IFRS 9 [Member]</link:label>
    <link:label id="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member_documentation_en-US" xlink:label="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade and other receivables and other noncurrent assets in scope of IFRS 9.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" xlink:href="gsk-20241231.xsd#gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" xlink:to="lab_gsk_TradeAndOtherReceivablesOtherNoncurrentAssetsAndAssetsHeldForSaleInScopeOfIFRS9Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_c7f6aa17-915d-45d9-b606-0817f3057d63_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combinations</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for business combinations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_country_ES_a4ab1d0d-36c8-4111-8b07-4b57373f59ea_terseLabel_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spain</link:label>
    <link:label id="lab_country_ES_label_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SPAIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_ES"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_ES" xlink:to="lab_country_ES" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember_2acf01ac-5ff9-4a6c-8297-ad1e5a607243_terseLabel_en-US" xlink:label="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.875% &#8364; Euro Medium Term Note 2031</link:label>
    <link:label id="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember_label_en-US" xlink:label="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Point Eight Seven Five Percentage Euro Medium Term Note Two Thousand Thirty One [Member]</link:label>
    <link:label id="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember_documentation_en-US" xlink:label="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Point Eight Seven Five Percentage Euro Medium Term Note Two Thousand Thirty One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" xlink:href="gsk-20241231.xsd#gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" xlink:to="lab_gsk_TwoPointEightSevenFivePercentageEuroMediumTermNoteTwoThousandThirtyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_183635a0-035e-4c64-97fa-4e3277bc255e_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherReceivablesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfTradeAndOtherReceivablesLineItems" xlink:to="lab_gsk_DisclosureOfTradeAndOtherReceivablesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OthersMember_819980bd-180a-4228-87be-73c55b1060d6_terseLabel_en-US" xlink:label="lab_gsk_OthersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Others</link:label>
    <link:label id="lab_gsk_OthersMember_label_en-US" xlink:label="lab_gsk_OthersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Others [Member]</link:label>
    <link:label id="lab_gsk_OthersMember_documentation_en-US" xlink:label="lab_gsk_OthersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Others</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OthersMember" xlink:href="gsk-20241231.xsd#gsk_OthersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OthersMember" xlink:to="lab_gsk_OthersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember_3abf3a98-c1a7-446b-ac8d-1240af6d694b_terseLabel_en-US" xlink:label="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.250% &#8364; Euro Medium Term Note 2026</link:label>
    <link:label id="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember_label_en-US" xlink:label="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Two Five Percentage Euro Medium Term Note Two Thousand Twenty Six [Member]</link:label>
    <link:label id="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember_documentation_en-US" xlink:label="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One point two five percentage European medium term note two thousand twenty six.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" xlink:href="gsk-20241231.xsd#gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" xlink:to="lab_gsk_OnePointTwoFivePercentageEuroMediumTermNoteTwoThousandTwentySixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm_91944763-a389-4e5a-9221-8a4cfadeb778_terseLabel_en-US" xlink:label="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average effective pre-swap interest rate on short term notes</link:label>
    <link:label id="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm_label_en-US" xlink:label="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Effective Pre-Swap Interest Rate Short Term</link:label>
    <link:label id="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm_documentation_en-US" xlink:label="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average effective pre swap interest rate short term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AverageEffectivePreSwapInterestRateShortTerm" xlink:href="gsk-20241231.xsd#gsk_AverageEffectivePreSwapInterestRateShortTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AverageEffectivePreSwapInterestRateShortTerm" xlink:to="lab_gsk_AverageEffectivePreSwapInterestRateShortTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock_451f178d-8230-49d3-8359-852670512ce3_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Cash Flows from Business Combinations</link:label>
    <link:label id="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock_label_en-US" xlink:label="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Cash Flows From Business Combinations [Table Text Block]</link:label>
    <link:label id="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock_documentation_en-US" xlink:label="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure Of Cash Flows From Business Combinations Explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" xlink:to="lab_gsk_DisclosureOfCashFlowsFromBusinessCombinationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherPayablesTable_936c88e4-28f8-4cc3-818d-22c0c666554d_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherPayablesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherPayablesTable_label_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherPayablesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [table]</link:label>
    <link:label id="lab_gsk_DisclosureOfTradeAndOtherPayablesTable_documentation_en-US" xlink:label="lab_gsk_DisclosureOfTradeAndOtherPayablesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to disclosure of trade and other payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfTradeAndOtherPayablesTable" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfTradeAndOtherPayablesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_DisclosureOfTradeAndOtherPayablesTable" xlink:to="lab_gsk_DisclosureOfTradeAndOtherPayablesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_AlectorAssetsMember_1844fa3a-9456-4911-8203-dd85904895b6_terseLabel_en-US" xlink:label="lab_gsk_AlectorAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alector Assets</link:label>
    <link:label id="lab_gsk_AlectorAssetsMember_label_en-US" xlink:label="lab_gsk_AlectorAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alector Assets [Member]</link:label>
    <link:label id="lab_gsk_AlectorAssetsMember_documentation_en-US" xlink:label="lab_gsk_AlectorAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alector Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_AlectorAssetsMember" xlink:href="gsk-20241231.xsd#gsk_AlectorAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_AlectorAssetsMember" xlink:to="lab_gsk_AlectorAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_SharePlanPerformanceAssessmentPeriod_00a5bcea-9479-4b5a-a0ee-4322bbd4b00c_terseLabel_en-US" xlink:label="lab_gsk_SharePlanPerformanceAssessmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share plan performance assessment period</link:label>
    <link:label id="lab_gsk_SharePlanPerformanceAssessmentPeriod_label_en-US" xlink:label="lab_gsk_SharePlanPerformanceAssessmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Plan Performance Assessment Period</link:label>
    <link:label id="lab_gsk_SharePlanPerformanceAssessmentPeriod_documentation_en-US" xlink:label="lab_gsk_SharePlanPerformanceAssessmentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Plan Performance Assessment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_SharePlanPerformanceAssessmentPeriod" xlink:href="gsk-20241231.xsd#gsk_SharePlanPerformanceAssessmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_SharePlanPerformanceAssessmentPeriod" xlink:to="lab_gsk_SharePlanPerformanceAssessmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost_b2338025-1673-4fce-b2e9-d2547b1c9dde_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets measured at amortised cost</link:label>
    <link:label id="lab_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost_label_en-US" xlink:label="lab_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest revenue for financial assets measured at amortised cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" xlink:to="lab_ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PastDueStatusDomain_6ae1d40f-bd46-4820-bcd3-6713e4817188_terseLabel_en-US" xlink:label="lab_ifrs-full_PastDueStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Past due status</link:label>
    <link:label id="lab_ifrs-full_PastDueStatusDomain_label_en-US" xlink:label="lab_ifrs-full_PastDueStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past due status [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastDueStatusDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PastDueStatusDomain" xlink:to="lab_ifrs-full_PastDueStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments_01d321e3-9a85-46d3-88b4-cbf026530df4_terseLabel_en-US" xlink:label="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share of associates and joint ventures realised profits/(losses) on disposal of equity investments</link:label>
    <link:label id="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments_label_en-US" xlink:label="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Of Associates And Joint Ventures Realised Profits On Disposal Of Equity Investments</link:label>
    <link:label id="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments_documentation_en-US" xlink:label="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share of associates and joint ventures realised profits on disposal of equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" xlink:href="gsk-20241231.xsd#gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" xlink:to="lab_gsk_ShareOfAssociatesAndJointVenturesRealisedProfitsOnDisposalOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_FairValueReserveMember_dff3a1c9-c028-4cff-b5f4-2915c3b7396f_terseLabel_en-US" xlink:label="lab_gsk_FairValueReserveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value reserve</link:label>
    <link:label id="lab_gsk_FairValueReserveMember_label_en-US" xlink:label="lab_gsk_FairValueReserveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Reserve [member]</link:label>
    <link:label id="lab_gsk_FairValueReserveMember_documentation_en-US" xlink:label="lab_gsk_FairValueReserveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value reserve.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_FairValueReserveMember" xlink:href="gsk-20241231.xsd#gsk_FairValueReserveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_FairValueReserveMember" xlink:to="lab_gsk_FairValueReserveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_HumanGenomeSciencesIncMember_2cbfb888-91b1-4893-9233-e6ff1c77407b_terseLabel_en-US" xlink:label="lab_gsk_HumanGenomeSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Human Genome Sciences, Inc.</link:label>
    <link:label id="lab_gsk_HumanGenomeSciencesIncMember_label_en-US" xlink:label="lab_gsk_HumanGenomeSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Human Genome Sciences Inc [member]</link:label>
    <link:label id="lab_gsk_HumanGenomeSciencesIncMember_documentation_en-US" xlink:label="lab_gsk_HumanGenomeSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Human Genome Sciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_HumanGenomeSciencesIncMember" xlink:href="gsk-20241231.xsd#gsk_HumanGenomeSciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gsk_HumanGenomeSciencesIncMember" xlink:to="lab_gsk_HumanGenomeSciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_e53ca806-7bf4-443a-af1e-f2ffc611818d_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ParValuePerShare_61b849c7-c304-4743-b00d-03b3f2246a1e_terseLabel_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Par value per share (in pence per share)</link:label>
    <link:label id="lab_ifrs-full_ParValuePerShare_label_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Par value per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_bbf99110-4805-46c4-b5d0-76c9f194f081_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_label_en-US" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities classified as held for sale [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_301c7db7-c9ca-43cb-97de-a1d7025129d2_terseLabel_en-US" xlink:label="lab_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of offsetting of financial assets and financial liabilities [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_label_en-US" xlink:label="lab_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of offsetting of financial assets and financial liabilities [line items]</link:label>
    <link:label id="lab_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems_documentation_en-US" xlink:label="lab_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of offsetting of financial assets and financial liabilities line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gsk_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesLineItems" xlink:href="gsk-20241231.xsd#gsk_DisclosureOfOffsettingOfF